HIV,NEOPLASMS,PCR
198,222,HEMOSTASIS,RESISTANT
AFTER,DOTAP,SPC,SVV,TUNEL,WESTERN
WHILE
001,114,243,BACKGROUND,BASED,COLORECTAL,CONCLUSION,COX,CXR,GOVERNMENT,HRS,INTERVIEW,LABEL,METHODS,OVARIAN,PRESS,PUBLISHED,RESULTS,SCREENING,TRIAL,UNIVERSITY
HOWEVER,NON,NSCLC,TODAY
EVERY,STILL
177,BACKGROUND,LABEL,MEDICAL,METHODS,SIXTEEN,THERE,THREE
CHEST,JOURNAL,SCI
AFTER,CURRENTLY,DESPITE,HCC,SEVEN,THREE
HOWEVER,PTX,STAGE
DESPITE,GEFITINIB,STAGE,THEREAFTER
160,DEBATES,HOWEVER,INITIALLY,OBESITY
99M,DUE,HYNIC,LATER,SPECT,TOC
DUE,HOWEVER,ZDA
549,956,DYSIDEA,ESI,NMR,THEIR,VIETNAMESE
177,239,BACKGROUND,CRP,HOWEVER,LABEL,METHODS,PENTRAXIN,RESULTS
AFTER,AWS,BENTALL,EXCHANGER
009,106,201,AIM,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SUBCARINAL,THESE
AIM,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVENTY,WHILE
AFTER
ANOVA,BACKGROUND,CRP,ICU,LABEL,METHODS,POD,RESULTS,THERE,WBC
100,177,215,2MM,CONCLUSION,DISTANCES,DTA,ECLIPSE,LABEL,METHODS,NOVALISTX,PTW,RESULTS,SEVEN29,SSD,SURFACE,TPS,TREATMENT
001,013,014,037,049,125,177,187,219,221,808,853,898,AUC,FINALLY,HOWEVER,LABEL,MAS,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,ROC,TNM
946,CONCLUSION,LABEL,METHODS,OBJECTIVE,OCT,PCR,PURPOSE,RESULTS,WESTERN,WNT
CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TNM
007,008,018,024,030,136,177,596,BASED,CEA,COLORECTAL,CONCLUSION,CRC,EMERGENCY,HOWEVER,LABEL,METHODS,MPV,NLR,OBJECTIVE,PURPOSE,RDW,RESULTS,THERE
003,276,284,469,704,853,898,BMI,CONCLUSION,DFS,LABEL,METHODS,OBESE,OBESITY,OBJECTIVE,PURPOSE,RESULTS,THERE
002,057,290,292,AMONG,BACKGROUND,BRISTOL,CHECKMATE,LABEL,METHODS,MYERS,NIVOLUMAB,NSCLC,OVERALL,RESULTS,TREATMENT
100,945,946,956,964,CANDIDA,CLEVENGER,DIOSPYROS,FID,MIC
177,BACKGROUND,FIFTEEN,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VO2
014,036,946,HOXB7,MMP,MTT,SMAD3,TAKEN,TGF,TRANSWELL,VEGFA
113,146,354,AMONG,BASED,BESIDES,DFS,FIRST,III,NANTONG,NUCLEAR
18F,690,BECAUSE,DISCOVERY,DSTEP,ELITE,HOWEVER,PET,PSF,SUV,TOF
CSF,DIAGNOSES,DUE,HODGKIN,PNS
ACCORDING
HOWEVER
137,366,413,965,JANUARY,THREE
100,956,GST,HOWEVER,MNO,PCR,PEG,ROS
177,956,985,AES,ICP,NCI,NMR,PAMAM,TEM,THEREFORE,VIS
BACKGROUND,CONCLUSION,EGD,LABEL,METHODS,UNDERGOING,USING
280,AGREEMENT,BACKGROUND,END,LABEL,METHODS,PATHOLOGIC,RESULTS,TNM
ADHESIONS,BACKGROUND,EIGHT,LABEL,LAD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
PRESENTED
MRI,SPIOS
CMV,DOX,EXPRESSION,PCR,TAP73,TUNEL
CHEST
100,956,AFFYMETRIX,AKT,BMP,CANONICAL,DEGUSSA,INGENUITY,IPA,PATHWAY,RAS
AFTER,ESOPHAGEAL,IVA,LNS,NEC,NSE,STAGE
093,318,411,527,726,811,BETWEEN,GROUP,JAPAN,JLCRG,MARCH,UFT
BETWEEN,GRADE,HOWEVER,MAY,NSCLC,OCTOBER,TKI
169,COPYRIGHT,DRUGS,INC,ONGOING,PROGRAMMED
001,003,006,009,022,169,32X10,35X10,467,591,72X10,BACKGROUND,CH12Q24,GECCO,INSTITUTE,LABEL,METHODS,NETWORK,PRESS,PUBLISHED,RESULTS,SH2B3,UNIVERSITY
140,169,AUTHORS,EXPRESSION,FGF23,LIMITED,PRESS,THESE
INC,PUBLISHED,SCREENING
ASSOCIATES,BAPTIST,FLORIDA,RADIOLOGY,SOUTH
ASSESSMENT,BANQIAO,EPA,ICP,MODEL,XUANWEI
001,006,FURTHER,GRADE,III,NSCLC,SEVERAL
FDG,HOWEVER,JANUARY,MEIER,PATIENT,PET
947,AFTER,ENGLISH,HCC,IMAGING
CARDIAC,CHINA,JANUARY,PULMONARY,PVS,THREE,UNIVERSITY,VEINS
002,178,351,594,BMI,CHINESE,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SCHOLAR,SEPTEMBER,SEVEN,WANFANG
129,132,145,BIOMEDICAL,CBM,CHINA,CHINESE,CONCLUSION,DATABASES,ETS,JANUARY,KNOWLEDGE,LABEL,LITERATURE,METHODS,OBJECTIVE,QUALIFIED,RESULTS,SCIENCE,STRATIFIED,VIP,WANFANG,WEB
C60,CYTOTOXIC,DOX,LEWIS
BASED
239,MAYAK,POTENTIAL,YEARS
001,149,169,185,378,399,807,BACKGROUND,CD3,CONCLUSION,COX,FOXP3,HEIDELBERG,HOWEVER,HRS,IMMUNOCRIT,LABEL,LABORATORY,METHODS,PRESS,PUBLISHED,REGARDING,RESULTS,UNIVERSITY
169,BACKGROUND,COMPARISON,CONCLUSION,CONTINUED,COX,EVALUATION,HOWEVER,LABEL,METHODS,METRICS,NSCLC,PRESS,PUBLISHED,RESULTS,SOLID,UNIVERSITY
001,007,012,013,020,036,161,CONCLUSION,COX,DFS,FDG,III,LABEL,MATERIALS,MEIER,METHODS,MTV,NSCLC,OBJECTIVE,OVERALL,PET,RESULTS
001,016,024,193,405,AFTER,CHRONIC,CONCLUSION,DISEASE,FVC,INITIATIVE,JANUARY,LABEL,LOWER,MARCH,MATERIALS,METHODS,OBJECTIVE,RESULTS,THEREFORE
122,BACKGROUND,CHESTER,ERDHEIM,GENENTECH,LABEL,LANGERHANS,METHODS,RESULTS,ROCHE,THERE
001,003,027,041,123,197,415,437,514,781,916,967,982,984,BIO,COX,DFS,DIFFERENCE,HOWEVER,III,JANUARY,NSCLC,OPIOIDS,PROVINCIAL,UNIVARIATE
PHYLLODES,RENAL,SURGERY,TREATMENT
001,097,153,773,BIM,DCR,ELECTRONIC,HOWEVER,NSCLC,ORR,PFS,TKI
ELDERLY,HOWEVER
MALIGNANT,REGARDING,THERE
ALK,FURTHER,HOWEVER,SEVERAL,TKI
OPTIMIZED
AIM,ALPHA,AMACR,BACKGROUND,COA,CONCLUSION,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,OVERALL,RESULTS
001,169,CHANGES,CONTOUR,COPYRIGHT,DIR,INC,LABEL,MEASURING,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RIGID,THERE
139,154,169,COPYRIGHT,CROWN,DISTANT,EASTERN,FDG,GROUP,IMAGING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PUBLISHED,PURPOSE,RESULTS
169,ADDITIONAL,AES,COPYRIGHT,EASTERN,FIFTY,GROUP,INC,LABEL,MATERIALS,METHODS,MTD,NSCLC,OBJECTIVE,PRECISION,PURPOSE,RESULTS,THERE,TREATMENT
011,028,032,033,102,108,109,118,138,169,170,172,201,260,303,ACT,BETWEEN,CONTINUED,COPYRIGHT,CSI,EBT,FVC,INC,IQR,LABEL,MARCH,METHODS,OBJECTIVE,PFT,PULMONARY,PURPOSE,RESULTS,THERE,THESE,TLC
BACKGROUND,CURRENT,LABEL,METHODS,PULMONARY,RESULTS,SOCIETY,THERE
001,169,338,365,BCS,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THEREFORE
100,115,117,169,183,232,BACKGROUND,COPYRIGHT,EDUCATION,FUNDING,GERMANY,INNOVATION,LABEL,LTD,METHODS,RESULTS,STATE,SWISS,THOSE,THREE
160,916,946,956,968,BILIRUBIN,CONCLUSION,DAILY,LABEL,METHODS,OBJECTIVE,PACO2,RESULTS,SETTING,SPRAGUE
19DEL,ACCORDING,CONCLUSION,L858R,LABEL,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SOCIETY
216,270,282,284,350,566,604,ALK,AMONG,IHC,III,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VENTANA
JANUARY,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,THERE,UNIVARIATE
177,ACADEMY,CHINESE,COLLEGE,CONCLUSION,DEC,FEDERATION,GYNECOLOGY,IB1,IB2,IIA,JAN,JUL,LABEL,MEDICAL,METHODS,NECUC,OBJECTIVE,OBSTETRICS,PATHOLOGIC,PFS,RECURRENT,RESULTS,TEN,UNION
236,911,BSS,EOL,INDIVIDUAL,INSURANCE,MEDICAL,MRI,PET,TAIWANESE,UNDERGOING
016,143,150,293,356,7TH,ACCORDING,APM,COMMITTEE,DFS,EFFECTIVE,GREATER,HOWEVER,JANUARY,JOINT,NSCLC
000,114,398,456,580,649,933,974,APRIL,CIS,COCHRAN,ECM,GALBR,HOWEVER,III,ORS,POTENTIAL,SIX,SMD,STUDIES
001,259,343,399,412,473,949,JANUARY,MEIER,NSCLC,PATIENT
160,169,COPYRIGHT,INC,MTT,NSCLC,PCR,RIP,TDP
036,BASED,COPYRIGHT,EMA,FGF,HOWEVER,III,NINTEDANIB,PDGFR,PHASE,PROUS,SCIENCE,THERE
169,FMS,MAM,USING
AFTER,BILATERAL,LAPAROTOMY
PRIMARY,YST
CSF,MRI,NEOPLASTIC,PET
00001,002,AAS,CIS,ELECTRONIC,HRS,III,NSCLC,OTHER,TCC,TOXICITIES
GIVEN,PRIMARY
SEBACEOUS,THREE,TORRE
542,BACKGROUND,FINNISH,LABEL,METHODS,RESULTS,THERE
MANAGEMENT
THESE



956,ADDITIONAL,HEP3B,STAT3
HISTOLOGIC,SURGERY
266,912,946,EIGHT,III,NSCLC,OPTIMAL,PFS,STUDIES,THESE,TKI
ALK,FLT,G469R,KIT,NSCLC,PDGFR,RAF,RET,SORAFENIB,VEGFR
00084,013,169,215,485,BACKGROUND,CCP,COPYRIGHT,COX,LABEL,LTD,METHODS,MORTALITY,NOVEL,PCR,PRIMARY,RESULTS
169,COPYRIGHT,HISTOLOGIC,INC,PUBLISHED,SOCIETY
160,169,AFTER,COPYRIGHT,INC,PRIMARY,PUBLISHED,PULMONARY,SOCIETY
956,BACKGROUND,CONTEXT,FIBER,LABEL,METHODS,OBJECTIVE,SIMILAR,SIMILARLY,SOURCES,THERE
BACKGROUND,CONTEXT,LABEL,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,SOURCES
THESE
109,120,169,197,235,238,289,339,938,BASED,COPYRIGHT,ENTROPY,INC,KIT,NGS,SEQUENCING,SHANNON,THERE
945,947,ACCORDING,AMONG,CD3,CD4,CTL,ELISA,FCM,IFN,INJECTION,LDH,MTT,PHA,TANREQING,TNF
945,946,947,CHINESE,CONCLUSION,DDP,EFFORTS,ELISA,FUZHENG,IFN,INTERVENED,LABEL,LEWIS,METHODS,OBJECTIVE,RESULTS,TCM,TGF,TNF
945,946,AKT,CELASTROL,CHINESE,GSK,PCR,RAF,THEREFORE,WESTERN
ASIAN,CAP,CD143,CIS,FEM,ORS,SCHOLAR,SNP,THERE
CONSORTIUM,IMAGE,INITIATIVE,MULTI,TOMOGRAPHY
GIVEN,HASHING,HOWEVER,THEREFORE
169,GENOMIC,LABORATORY,PRESS,PUBLISHED
169,33342,AMONG,ANNEXIN,BACKGROUND,CONCLUSION,COPYRIGHT,GASTRIC,HOECHST,LABEL,METHODS,MTT,OBJECTIVE,PHASE,PROTEIN,PURPOSE,RESULTS,ROSAMULTIC,SGC
277,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,RXWBS,SPECT,THESE,TNM,WBS
AKT,BMP,HOWEVER,NSCLC,SMAD1,SQCCS,TARGETING,TKI
APT,FURTHER,NUCLEIC,SELEX,USING
169,COPYRIGHT,ERP,INC,SURGERY
169,231,233,CONCLUSION,COPYRIGHT,GRADE,LABEL,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SAS,SBR
10YEARS,169,231,233,COPYRIGHT,PROGNOSIS,PUBLISHED,SAS
AFTER,ANEURYSMAL,BACKGROUND,CONCLUSION,LABEL,METHODS
122,125,250,CONCLUSION,LABEL,METHODS,OBJECTIVE,ONCOLOGIC,PURPOSE,RAPID,RESULTS,SINCE,TRANSIENT
00001,009,889,CONTROLLED,FURTHER,HOWEVER,LABEL,LRF,LVI,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,VPI
100,EXPRESSION,LABEL,METHODS,MUC,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS
001,APRIL,DFS,GIVEN,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS
CURRENT,WHETHER
100,150,CESSATION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,002,003,004,007,013,021,029,031,038,044,049,AAD,HENCE,LABEL,MEIER,METHODS,MPM,OBJECTIVE,OBJECTIVES,PCI,RESULTS,SPECIMENS,USING
100,122,138,525,945,BEP,LABEL,LONGEST,METHODS,OBJECTIVE,OBJECTIVES,PACLITAXEL,RESULTS,TEN,THESE
122,169,178,194,300,380,381,652,660,ADC,AUC,CA125,CEA,COPYRIGHT,CYFRA21,IRELAND,LTD,NSCLC,SCC,THREE
169,COPYRIGHT,CYP3A,FURTHER,GEF,GEFITINIB,GSH,HOWEVER,INC,USING
12P,169,BAD,BAX,BCL,COPYRIGHT,FURTHER,INC,MMP,ROS,TAKEN
169,COPYRIGHT,LTD,PCI,SMALL
215,645,BACKGROUND,COLLEGE,COMMISSION,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE
177,947,CALCULATED,CONCLUSION,CRT,DVH,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS
100,133,AFTER,AIM,BETWEEN,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,SEMSS,THERE,ULTIMATELY
113,AIM,INSTITUTE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,ROMANIA
CEA,CONCLUSION,LABEL,OBJECTIVE,SCREENING,TRIAL
ANOMALOUS,COLORECTAL,CONCLUSION,LABEL,OBJECTIVE,OVARIAN,SCREENING,TRIAL
167,AIM,AMONG,CONCLUSION,EASTERN,GROUP,HOWEVER,HRV,KOREA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVERAL,SOUTH
AIM,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVEN
101,177,1ST,FEWER,FIFTY,HENCE,OCTOBER,REASONS,SEPTEMBER,THESE
FDG,FINALLY,MRI,PPDLBCL,PRIMARY
18F,224,229,740,780,788,808,843,853,875,897,925,JANUARY,SCN,SUV,THERE
MRI
AFTER,FOLLOWING
GUIDELINES,HOWEVER,HT3,NK1,SOCIETY,THEREFORE,THESE
CCR,GRADE,MAY,NON,THERE,THEREFORE,UNIVERSITY
1ST,AFTER,CHEST,MHE,THREE

CUSHING,PULMONARY

THERE
120,2ND,AFTER,LEUCOVORIN
CLINICIANS,PCI,TKI
549,841,956,CCD,CON,MRC,WHILE
000,099,100,181,193,236,449,453,464,507,AMONG,CALIFORNIA,COHORTS,CRUDE,EXPOSURES,HODGKIN,IMPORTANCE,LABEL,METHODS,OBJECTIVE,PERMANENTE,RELEVANCE,RESULTS,SETTING,STUDIES
160,169,18F,COPYRIGHT,FIFTY,FLT,HOWEVER,INC,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,USING
100,160,169,CONCLUSION,COPYRIGHT,GRADE,HDR,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,THERE
000,CD161,CIBERSORT,FOXM1,HOWEVER,KLRB1,MOLECULAR
ACCESSORY,AFTER,BACKGROUND,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,METHODS,PRIMARY,THERE
224,945,DESPITE,ERK,HOWEVER,INCREASED,LOCAL,NSCLC,SMAD4,TNF,TNFAIP1
160,169,680,956,AIR,COPYRIGHT,FVB,HISTOLOGY,INC,KUPFFER,MBS,NIR,OCCASIONAL,PVA,VIVOTAG
CONCLUSION,DOPPLER,LABEL,PAS,PRIMARY,PTE,UNLABELLED
135,169,COPYRIGHT,LABEL,METHODS,NUCLEAR,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY
013,038,046,140,169,AFFILIATED,FIBULIN,HOWEVER,LABEL,METHODS,NANTONG,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY,WESTERN
111,177,ACTUARIAL,CONCLUSION,DSS,GRADE,KNOWLEDGE,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,SECONDARY,TREATMENT
ADVANCE,CONCLUSION,ITV,LABEL,METHODS,OBJECTIVE,RESULTS,STUDIES
15Q15,169,17Q24,OVERALL,SNP
00018,037,125,127,268,607,BACKGROUND,CEA,CYFRA,LABEL,LAMC2,METHODS,NON,NSCLC,PROGNOSTIC,RESULTS,SCC
003,004,005,120,169,AMONG,BACKGROUND,CONCLUSION,COX,DFI,INC,LABEL,MEIER,METHODS,PULMONARY,RESULTS,WHILE,WILEY
169,AUTHORS,BCL,BH3,COPYRIGHT,FOLLOWING,INC,MYC,PUBLISHED,TAXOL,THESE,USING
160,169,COPYRIGHT,EPIGENETIC,GSK2879552,INC
160,169,COPYRIGHT,INC,INHIBITION
150,169,BACKGROUND,CONCLUSION,COPYRIGHT,EVALUATION,HOWEVER,LABEL,LOW,LTD,METHODS,NSCLC,RESULTS,SOLID,TREATMENT,TUMOURS
BACKGROUND,CONCLUSION,LABEL,MALIGNANT,METASTATIC,METHODS
001,048,150,169,360,CONCLUSION,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY,SOCIETY,TIVANTINIB
160,169,AKT,ALK,COPYRIGHT,ERK,H3122,INC,THROUGH
AGING,BACKGROUND,BASED,DISCUSSION,EXCEPTFOR,HOWEVER,LABEL,METHODS,OVERALL,RESULTS
169,945,946,947,948,ANTICANCER,CD8,COPYRIGHT,HOWEVER,INSTITUTE,TH1,THESE,TREGS
169,916,AIM,ANTICANCER,BACKGROUND,COPYRIGHT,DDS,DISCUSSION,INSTITUTE,LABEL,LPETG,MATERIALS,METHODS,N59SRTA,OBJECTIVE,RESULTS,SEVERAL,THESE
018,047,178,550,715,940,967,APRIL,BAL,GMG,HOWEVER,JANUARY,OTHER,PCP,PCR,WEGENER
231,361,753,RADON
169,COPYRIGHT,INC,NSCLC,STAT3,THESE,TTP
134,169,COPYRIGHT,H69,INC,LACTATE,LDH,MICRORNAS,MIR,MTT,NSCLC,PCR,THESE
169,COPYRIGHT,IRELAND,LTD,MSC,POTENTIAL
AVASTIN,CETUXIMAB,EWING,PNETS,PRIMITIVE
BASED,BECAUSE
DCR,EIGHT,NSCLC,ORR,TTP
106,109,164,169,177,AAS,COPYRIGHT,EPIDERMAL,HOWEVER,IGF,INC

5AS,ARRANGE,ASK,TOBACCO
169,COPYRIGHT,COUNTRIES,IRELAND,LTD,OPTIMAL,RTU
169,COPYRIGHT,HOWEVER,IRELAND,KSN,LTD,MES,MICROARRAY,PRIMARY,TNNT1,UTERINE
ADENOVIRUS
CEA,CURRENT,HOWEVER,TABLE
10878,169,1MONTHS,8MONTHS,BACKGROUND,CHT,COPYRIGHT,COX,IRELAND,KPS,LABEL,LTD,MATERIALS,METHODS,NSCLC,PRIMARY,RESULTS,THERE,THEREFORE,TREATMENT
169,500,COPYRIGHT,EXPRESSION,KNOCKDOWN,PRR11,REMARKABLY,SIRNA
100,160,946,947,956,AP105,GYY4137,H2S,HOWEVER
215,809,951,A2780,ATM,DOWNSTREAM,I257V,L517P,N447S,ND5,PF6,ROS,SUPEROXIDE,WHOLE
169,AML,COPYRIGHT,INC,LPS,MSC,NKG2D,THESE
107,132,133,169,183,250,265,500,AFTER,BACKGROUND,BETWEEN,COPYRIGHT,DEC,EVALUATION,FUNDING,IMPRESS,LABEL,LTD,MARCH,MAY,METHODS,NSCLC,OPTIMUM,PACIFIC,RESULTS,SOLID
137,160,BACKGROUND,III,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STAGE,THEIR
103,150,157,169,183,201,224,227,392,395,397,398,795,ADVERSE,ASIAN,BACKGROUND,BOEHRINGER,CLINICIANS,COPYRIGHT,FUNDING,INGELHEIM,IQR,LABEL,LTD,LUX,METHODS,RESULTS,THERE
005,012,105,139,CONCLUSION,HT3,LABEL,METHODS,OBJECTIVE,PERHAPS,RESULTS,SOCIETY,TREATMENT
042,CONCLUSION,EPIDERMAL,LABEL,METHODS,OBJECTIVE,RESULTS
160,320,954,CNR,CONCLUSION,EMPHYSEMA,FBP,GGO,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SIMULATED,THERE,THESE
169,AMONG,BACKGROUND,CONCLUSION,INC,LABEL,LIMITED,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WILEY
156,191,APC,BACKGROUND,ESTIMATED,INCIDENCE,JOINPOINT,LABEL,MALIGNANT,METHODS,PERCENT,PLEURAL,POPULATION,RATES,RESULTS,UMBRIAN
DUE
PROVING
ABOUT,AKT,BIM,DESPITE,DUSP6,ETS,GTP,MEK,NSCLC,RAF,RAS,REDUCTION,RTK,SRC,THEREFORE,THESE
143,169,209,211,420,437,APRIL,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PATIENT,PFS,PURPOSE,RESULTS,SEVENTEEN,SOCIETY
169,ALK,ATLAS,COPYRIGHT,LTD,SEQUENCING,THESE,TREATMENT
169,AKT,COPYRIGHT,FEDERATION,ILT,NSCLC,PUBLISHED,SOCIETIES
169,410,AKT,COPYRIGHT,FEDERATION,HOWEVER,INHIBITION,MIR,NSCLC,PUBLISHED,SOCIETIES
054,939,993,SCREENING,TRIAL
001,049,6TH,APRIL,CONCLUSION,DOPPLER,HOWEVER,IVA,LABEL,METHODS,NEITHER,OBJECTIVE,RESULTS,RIGHT,RVFAC,TAPSE,TDI
COMPOUNDS,GYY4137,H2S,POTENCY,THEIR
169,ALK,COPYRIGHT,FINALLY,INC,THESE
160,169,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PC9,PUBLISHED,RESULTS,SOCIETY
126,156,190,ENB,PRIMARY,THESE,UPPER
169,COPYRIGHT,INC,PUBLISHED,SOCIETY,VARIOUS
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,DESPITE,INC,MK2,THESE

169,946,ACUTE,AKT,AUTHORS,CAS9N,CCP,CME,DYNAMIN,EGF,H1299,RPE,THESE
169,193,543,703,AMSTERDAM,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RPA,UNIVARIATE,WORLD
001,110,160,169,193,303,945,946,BACKGROUND,BIOMARKER,BMP,COPYRIGHT,EGF,HGF,IGF,IGFBP,INC,LABEL,LOW,METHODS,NSCLC,PUBLISHED,RESULTS,SDF,SOCIETY,THESE,TNF,WHITNEY
BACKGROUND,LABEL,METHODS,RESULTS,SMALL,THEREFORE
945,BACKGROUND,FMS,LABEL,METHODS,RESULTS
BMJ,BRITISH,GROUP,LIMITED,PUBLISHED,PUBLISHING,SOCIETY
PALLIATIVE
100NM,169,24H,5GY,945,AKT,CL1,COPYRIGHT,HIF,INC,KEY,LABEL,METHODS,MTT,OBJECTIVE,PTX,RESULTS,TUNEL,WESTERN
169,209,APRIL,AUSTRALIA,CONCLUSION,DIAGNOSIS,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PULMONARY,RESULTS,SIXTY,SOCIETY,SPECT,THERE,THREE,UNLABELLED
177,215,6XFFF,CONCLUSION,FFF,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PLANS,RESULTS,STAGE,TREATMENT
439,668,AID,ASXL1,BACKGROUND,DARWINIAN,GRANT,HOWEVER,LABEL,METHODS,MUTATIONS,RESULTS,SCIENTIFIC,SOMATIC
ACADEMY,COPYRIGHT,CSD,ETHICAL,HOSPICE,JOURNAL,MEDICAL,PALLIATIVE
102,160,215,224,300,354,GENOMIC,GIVEN,HOWEVER,MENDELIAN,SIMILAR,SINCE
876,AGE,BASED,CRC,INSURANCE,SIR,SPM
001,157,297,444,628,740,AFTER,CAP,IDS,INCIDENCE,INSURANCE,IRR,MEIER,NHIRD,POISSON,PYS
176,177,185,FDG,IMAGE,PET,PHYSICIANS,ROBOT,STATE
000,160,169,945,BACKGROUND,COPYRIGHT,FIFTY,INC,LABEL,METHODS,MOLECULAR,PUBLISHED,RESULTS,SURGERY
946,CD4,CD8
ANAPLASTIC,BACKGROUND,CONCLUSION,IMAGING,LABEL,METHODS,VIDEO
AZD6244,BACKGROUND,CONCLUSION,DIFFERENT,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS
101,AUC,BACKGROUND,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,THERE
215,246,454,529,APPLIED,BACKGROUND,CONTEXT,ERBB2,INDIANA,LABEL,METHODS,OBJECTIVE,RESULTS,ROCHE,SCIENCE
150,169,956,ATLAS,CONCLUSION,LABEL,METHODS,NOD,NSCLC,OBJECTIVE,PATIENT,PDX,PURPOSE,RESULTS,SOCIETY,SURGICALLY,TKI
169,315,321,ADDITIONAL,AFTER,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
139,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SMALL,TNM
111,161,169,198,AIM,ANTICANCER,COMPARING,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,SPECT,SRS,TOMOGRAPHY
169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,CPB,ILD,INSTITUTE,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,RESULTS
169,569,AFRICAN,AGE,AMERICANS,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,INSTITUTE,INSURANCE,LABEL,MEIER,METHODS,RESULTS
169,215,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,MEV,MPM,OBJECTIVE,RESULTS,THREE,UNTIL
000,001,169,661,675,747,AIM,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,END,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SIR
001,169,177,AIM,ANTICANCER,BACKGROUND,BCE,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MBDLC,METHODS,NTX,OBJECTIVE,RESULTS,THERE
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EPIDERMAL,INSTITUTE,LABEL,MATERIALS,METHODS,MUTATIONS,NSCLC,RESULTS,SWEDISH,TKI,WESTERN
169,358,716,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,IIFESTYLE,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TAIWANESE,XRCC3
025,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,G719S,G719X,G874S,INSTITUTE,L858R,L861Q,LABEL,MARCH,METHODS,NON,NSCLC,OBJECTIVE,PFS,RESULTS,THREE,TKI,TREATMENT
169,963,ANTICANCER,BRCA1,COPYRIGHT,H2A,HISTONE,INSTITUTE,NCI,TAKEN
215,SEVERAL,THEREBY,THESE
HOWEVER,MICRORNAS,MMP15,NSCLC,RHO,ROCK1,THESE,TNF,TRAIL
169,ALK,HOWEVER,NSCLC
950,ARG,BACKGROUND,CD11B,CHRONIC,ELISA,HLA,LABEL,LIN,MDSCS,METHODS,MYELOID,RESULTS,TCR,THESE
033,036,054,382,III,THROUGH
001,CONCLUSION,COX,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM,USP9X
169,231,233,COPYRIGHT,PUBLI,PUBLISHED,SAS
169,231,233,COPYRIGHT,PUBLI,PUBLISHED,SAS
169,231,233,ALK,COPYRIGHT,HOWEVER,HSP,INHIBITORS,INTERGROUP,NON,NSCLC,PFS,PROTEIN,PUBLI,PUBLISHED,SAS,SHOCK,SMALL,STRATEGIES,THESE
300,BACKGROUND,HOWEVER,IHC,LABEL,METHODS,MYC,NSCLC,PREDICTIVE,RESULTS,THESE,TMA,USING
124,196,3A9,BACKGROUND,CEA,CONTROL,CURRENTLY,III,LABEL,METHODS,NSCLC,RESULTS,SERUM,UNION

174,BAYER,LOW
129,160,169,COPYRIGHT,HCC,INC,TAKEN
169,3DPET,4DPET,665,716,733,750,CONCLUSION,COPYRIGHT,EVALUATION,FDG,INTER,IRELAND,ITV,LABEL,LTD,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
B16,KHT,THESE
169,946,954,BIOLOGY,FINALLY,FURTHER,INC,K11,K48,LPS,MOLECULAR,NFKB2,PAGET,PARTIAL,SCF,SOCIETY
035,169,312,353,355,ACCORDING,ALLELIC,AMONG,ASIAN,BPH,COPYRIGHT,DUE,GENOTYPING,HRM,INC,MINOR,PCA,PCR,PSA,SERBIAN
CONCLUSION,GLC,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PCR,RESULTS
169,ACADEMY,CRMP5,EATON,GABAB,GAD65,HUD,LABEL,LAMBERT,MA2,METHODS,NEUROLOGY,OBJECTIVE,OTHER,RESULTS,SERUM
169,ABCC1,AUTHORS,EXPRESSION,H69,JOURNAL,LOW,MICRORNAS,PATHOLOGY,THERE,UTR
BASED,CHINA,KOREA,OBC
001,022,036,169,277,304,503,547,590,593,599,624,640,682,988,BACKGROUND,COPYRIGHT,COX,INC,LABEL,METHODS,NLR,NSCLC,PLR,RESULTS,SIX
100,169,CONCLUSION,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIATION,RESULTS,STRIKINGLY,THERAPY,V45,V55
131,138,156,169,229,256,372,ACCORDING,AMONG,BACKGROUND,CONCLUSION,CONTEXT,DTC,FACTORS,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS,SOCIETY,WBS,YOUNGER
ERLOTINIB,MARCH,SMOKING
169,ABL,COPYRIGHT,FAK,INC,INULA,NSCLC,SRC,TAKEN,VEGFR
HOWEVER
001,005,106,947,EIGHT,FIFTEEN,GAD,GAD65,IMPORTANCE,LABEL,METHODS,OBJECTIVE,PNS,PREDICTORS,RELEVANCE,RESULTS,SETTING
19A,19B,945,EMT,HOWEVER,TAKEN,TNF
169,6MM,7MM,BACKGROUND,CBCTS,COPYRIGHT,FORTY,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
125,169,183,956,APRIL,BACKGROUND,COPYRIGHT,DEPARTMENT,DUE,FUNDING,FURTHER,INSTITUTE,LABEL,LTD,METHODS,RADIATION,RESULTS,SECONDARY,SIMON,UNIVERSITY
169,474,4T1,AUTHORS,COPYRIGHT,IRELAND,LTD,PRLRS,PUBLISHED,USING
001,004,005,006,016,019,040,046,160,169,BACKGROUND,CHICAGO,COPYRIGHT,IBM,INC,LABEL,METHODS,MVD,NSCLC,PUBLISHED,RESULTS,SOCIETY,STATISTICS,THEIR,THESE
160,169,ASP,BAX,CADM1,COPYRIGHT,FOXA2,GLU,HDAC1,HDAC3,HOWEVER,HSP,INC,NR0B2,THESE
CAD,CTR,EWING,MC3T3,THESE
169,CCC,CCG,CGC,CHRONIC,COPYRIGHT,HOWEVER,III,INC,MECHANISMS,SELECTION,SER15,TCG,THESE
100,153,186,783,ATLAS,FINALLY,RCC,THESE
ASIAN,AVAIL,COMBINING,DISEASE,III,JO19907,NSCLC,RANDOMIZED,RESULTS
INSTITUTE,JOINPOINT,OVERALL,PANAMANIAN,REGRESSION,STATISTICS
AMONG,OVERALL
021,HOWEVER,NSCLC,PET,RFS,SIX
18F,FDG,NSCLC,PET,RFA
016,100,149,215,407,508,CONCLUSION,FIRSTLY,IPA,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,USING
100,169,99M,CONCLUSION,CURRENT,IMAGING,INC,KNOWLEDGE,LABEL,MAA,METHODS,MOLECULAR,NMI,NUCLEAR,RESULTS,SOCIETY,SPECT,THREE,UNLABELLED
001,169,239,BACKGROUND,DEPLETION,E2F,HOWEVER,LABEL,MEIER,METHODS,MICROARRAY,PHD,PRESS,PUBLISHED,RESULTS,STUDENT,THESE,UHRF1,UNIVERSITY
000,120,175,200,240,AIM,CONCLUSION,CTS,FATPH,LABEL,LIVPH,LUNPH,MATERIALS,METHODS,OBJECTIVE,RESULTS,THREE,TVS
169,764,AKT,APC,BON,BRCA1,COPYRIGHT,EP300,EXCAVATOR,INC,KDR,NCI,NET,RB1,STK11,THESE,UMC11,YY1
65310,945,AFTER,HOWEVER,PULMONARY
001,DISCOVERY,OBJECTIVE
HOWEVER,OTHER,PLANT,REDUCTIONS
160,169,COPYRIGHT,ERBB1,ERBB2,FGF,FGFR1,GROUCHO,HOWEVER,INC,PREVIOUSLY,TSA
169,BIOLOGY,DNMT1,FURTHER,INC,KIT,MOLECULAR,SOCIETY,THESE
003,004,731,909,ADIPOSITY,ALPHA,BLOOMBERG,COLORECTAL,GOVERNMENT,HOPKINS,INCIDENCE,JOHNS,NUTRITION,OVARIAN,OVERALL,PRESS,PREVENTION,PUBLISHED,SCREENING,SEX,THERE,TOCOPHEROL,TRIAL,UNIVERSITY
ACCORDING,COX,FLAVONOIDS,THEIR
MAJOR,MRI,PET
BASED,CHINA,DALYS,DISABILITY,DISEASE,GBD,THERE,YLD
000,038,055,060,118,120,130,140,152,154,214,230,235,236,260,280,284,330,360,404,410,429,458,460,600,605,770,926,970,CHINA,CONCLUSION,GBD,LABEL,METHODS,OBJECTIVE,PAF,RESULTS
000,100,150,169,196,206,269,303,521,529,749,787,830,892,968,CHINA,CONCLUSION,DISEASE,GBD,LABEL,METHODS,OBJECTIVE,PREVENTION,RESULTS,THEIR,YLD,YLL
946,BACKGROUND,BAECKEA,CIOCALTEAU,CONCLUSION,FOLIN,H1299,LABEL,METHODS,MTT,NCI,PENINSULAR,RESULTS
177,197,332,592,997,BETWEEN,CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,OCTOBER,RESULTS,UNIVARIATE
169,BACKGROUND,CONCLUSION,GRADE,INC,LABEL,MACCALLUM,METHODS,PATIENT,PETER,RESECTION,RESULTS,THERE,WILEY
7TM,FTP
100,30C,954,FINALLY,HOWEVER,TNF,TRAIL
ALGORITHM,ASIAN,BACKGROUND,ENGLAND,GROUP,LABEL,METHODS,NAMES,RESULTS,SOUTH
169,AUTHORS,BUTADIENE,CLARA,COPYRIGHT,INHALATION,IRELAND,LTD,METABOLIC,PUBLISHED,PULMONARY,RESULTS,SINCE,VOC,WHERE
169,459,461,816,AFTER,CONCLUSION,COX,DESPITE,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
AFTER,ATTENUATED,CHEST,CONCLUSION,DEPENDING,FLAIR,FLUID,INVERSION,LABEL,METHODS,MRI,OBJECTIVE,PATHOLOGY,PLE,PURPOSE,RECOVER,SIX
068,08092,102,169,257,600,64YEARS,800MG,AES,BACKGROUND,COPYRIGHT,EORTC,GRADE,LABEL,LTD,METHODS,NON,NSCLC,PAZOPANIB,PFS,RESULTS,SMALL,TKI
160,169,189,614,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PET,PUBLISHED,RESULTS,SIX,SOCIETY,THERE
BECAUSE
943,VARIOUS
CGA,LARGE,SYN,THESE
169,COPYRIGHT,FRA,LPS,PCR,PREVIOUSLY,SOCIETY,WESTERN
169,BIG,OTHER,PRESS,PUBLISHED,RIGID,SUBXIPHOID,SURGERY,THROUGH,UNIVERSITY
169,COPYRIGHT,CSC,IRELAND,LTD
100,169,177,400,AFTER,CONCLUSION,HENCE,IFP,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,PTF,RESULTS,SIX,SOCIETY,TBF,UNLABELLED,VOLUMES
137,169,557,791,ASSESSMENT,CBCTS,COPYRIGHT,COX,CRT,D43,HISTOLOGIC,INC,LABEL,MATERIALS,METHODS,NEITHER,NSCLC,OBJECTIVE,OVERALL,PERCENTAGE,PURPOSE,RESULTS
001,013,019,165,169,COPYRIGHT,COX,FACTORS,GLASGOW,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,RPA,SCORE,SEPTEMBER
169,APT,COPYRIGHT,DISCOIDIN,INC,PEPTIDE
AFTER,CHEST,UNDER
AFTER,BECAUSE,CHEST,FORTY
169,COPYRIGHT,INC,MOFFITT,NSCLC,SEVERAL,V600E
169,945,COPYRIGHT,HTO,NSCLC,SOCIETY
947,ATLAS,IFN,THESE,WHEREAS
669,AKT,ELISA,GFP,HEPATOCYTE,HGF,LABEL,MET,METHODS,MTT,NSCLC,OBJECTIVE,PI3KP85,PURPOSE,RESULTS,THESE,THR,TKI,WESTERN,XENOGRAFT
177,CD4,CD8,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SIMILARLY,TIM
001,100,160,169,183,18G,664,COMPARING,COMPARISON,CONCLUSION,GEORG,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMOKERS,STUTTGART,THERE,USING
018,026,037,046,060,135,177,185,200,286,99M,AFTER,MAA,PET,PFS,SPECT
METASTASES,NSCLC,PANCREATIC,RCC
CENTRAL,CIS,MEDLINE,NSCLC,OPTIMAL,ORS,PFS,SEVEN,THERE
084,160,169,177,CONCLUSION,COPYRIGHT,DEPARTMENT,FIFTY,GERMANY,HALLE,INC,LABEL,METHODS,NK1,OBJECTIVE,PURPOSE,RADIATION,RANDOMIZED,RESULTS,SAALE,UNIVERSITY
001,006,122,169,ACT,BACKGROUND,CONCLUSION,COPYRIGHT,DOCTORS,FACTORS,IQR,LABEL,LTD,METHODS,NSCLC,RESULTS
169,ANALYZING,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FIRST,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SRT,TCP
005,CONCLUSION,DEPARTMENT,EXPLORE,HENCE,JANUARY,LABEL,METHODS,OBJECTIVE,RADIOLOGY,RESULTS,SIXTY,TNB
169,AZD9291,COPYRIGHT,INC,T790M
100,168,200,350,584,ASSESSMENT,BACKGROUND,CD4,CHEST,CROSS,HIV,LABEL,METHODS,PREVALENCE,RESULTS,SMOKING,THREE
BACKGROUND,BRCA1,FINALLY,FURTHER,LABEL,METHODS,RESULTS,THESE
001,400,AFFYMETRIX,INSULIN,PPB,SAMPLES
TREATMENT
122,169,224,AMONG,LABEL,METHODS,OBJECTIVE,PRE,PRESS,PUBLISHED,RESULTS,T1BN0,UNIVERSITY
HOWEVER,NPS,NSCLC,PEG,USING
001,135,169,312,AMONG,CANDIDATE,CONCLUSION,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,R331W,RESULTS,SOCIETY,THESE,VALIDATION,WHOLE
000,100,161,169,315,925,BIOMEDICAL,BOARD,CDC,CHINA,CONCLUSION,COPYRIGHT,EDITORIAL,GANSU,LABEL,METHODS,MORTALITY,OBJECTIVE,PUBLISHED,RESULTS,TREND
001,002,177,281,735,CONCLUSION,GTV,KNOWLEDGE,LABEL,LNS,METHODS,NSCLC,OBJECTIVE,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FINALLY,KRG,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,RU486,SIRT1,TAKEN,THIRD,WESTERN
169,BPD,NCSLC,NSCLC,PDT,RESULTS,SIMILAR,THESE
100,169,183,600,ASIAN,BACKGROUND,BOEHRINGER,COPYRIGHT,FUNDING,GLY719XAA,HOWEVER,INGELHEIM,LABEL,LEU858ARG,LEU861GLN,LTD,LUX,METHODS,RESULTS,SER768ILE,THERE,THESE,THR790MET
169,ANN,ARTIFICIAL,BACKGROUND,CEA,CYFRA,FINALLY,HOWEVER,ITALY,KNN,LABEL,LLM,LOGIC,MACHINE,METHODS,MPM,MTX,NEAREST,NEIGHBOUR,NETWORK,RESULTS,SWITCHING
160,293,757,CNS,COMPETING,CONCLUSION,COX,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE
169,FGFR2,GOLGI
001,016,169,254,BACKGROUND,COPYRIGHT,FIFTY,III,INC,LABEL,METHODS,NSCLC,OPTIONS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY,THERE
169,946,956,COPYRIGHT,IRELAND,LTD,MMP,THESE
033,BMJ,GROUP,HOWEVER,LIMITED,NSCLC,PUBLISHED,PUBLISHING
001,239,947,ACTIVATED,CD4,FOXP3,III,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PERIPHERAL,REGULATORY,RESULTS,ROR,SAMPLES,TREGS,USA
169,946,COPYRIGHT,EMT,IRELAND,LRRFIP1,LTD,SILENCING,WNT
169,COPYRIGHT,EBV,EPSTEIN,INC,PUBLISHED,SOCIETY
169,CD3,CD4,CD8,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,HOWEVER,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,ENGLISH,INC,PUBLISHED,PULMONARY,SOCIETY
ADC,ALDH1,CD133,CSC,LOW,NSCLC,SCC
120,169,183,184,203,257,333,388,538,541,545,548,800,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,EASTERN,ELI,FEB,FUNDING,GROUP,INCLUDING,JAN,LABEL,LILLY,LTD,METHODS,NEITHER,OVERALL,RESULTS
000,065,100,160,188,514,530,845,AMONG,BACKGROUND,BMJ,BRONI,COR,DIAGNOSTIC,GROUP,ITALIAN,ITALY,LABEL,LIMITED,METHODS,MONFALCONE,MONFERRATO,NAZIONALE,OPERATING,PUBLISHED,PUBLISHING,RENAM,RESULTS,TRIESTE
100,ACCORDING,AFFYMETRIX,ANNOTATION,BACKGROUND,COL10A1,DAVID,DISCOVERY,EXPRESSION,FINALLY,GENOMES,GEO,INITIALLY,KYOTO,LABEL,METHODS,OMNIBUS,RESULTS,TMEM100
CAR,CRLF2,FINALLY,SHORT,TSLPR
TAKEN,UROKINASE
ALK,CRIZOTINIB,DOCKING,EVIDENCES,FDA,HENCE,HOWEVER,NSCLC,THESE
000003177,001,044,150,155,305,310,BACKGROUND,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,UTB
6TH,AFTER,BARRE,BASED,SEVERAL,UNDER
AFTER,BECAUSE,LATER,PECOMAS,THEREFORE
DFS,HOWEVER,NSCLC,SIX,SIXTEEN
002,016,033,102,117,177,ACEIS,HOWEVER,NSCLC,RASBS
3RD,BASED,HOWEVER,INTRONR,SERUM,SINCE
169,846,BACKGROUND,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,PUBLISHED,RESULTS,SOCIETY,UNION,UNIVARIATE,UNIVERSITY
158,169,211,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
021,115,BACKGROUND,BSA,CONCLUSION,GEFITINIB,LABEL,METHODS,NSCLC,PFS,RESULTS
AKT,EPIDERMAL,FOXO1,HOWEVER,NSCLC,TKI
126,169,BACKGROUND,CASES,CHRONIC,CLINICIAN,CLINICIANS,COPYRIGHT,DISEASE,INITIATIVE,IRELAND,LABEL,LIMITED,LTD,METHODS,NSCLC,OBJECTIVE,PULMONARY,PURPOSE,RESPONSES,RESULTS,SURGERY,WORLD
AFTER,CARIBBEAN,CONCLUSION,LABEL,METHODS,REGARDING,RESULTS,SAN,SECONDARY,UNLABELLED,VTE
246,312,ACCORDING,BETWEEN,NOVALIS,OCTOBER,OCTREOTID,PET,TOTAL
BASED,CTV,INSTITUTE,ITV,PTV,USING
001,177,185,18FDG,3DCRT,4N1,AFTER,CUP,DSS,GTV,GTVCT,ICT,PET,PRIOR,VOLUMETRIC
10878,265,281,546,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NAB,NSCLC,ORR,PFS,PHASE,QOL,RESULTS,TWIST,USING
000,AOR,BACKGROUND,IMPLANTING,LABEL,METHODS,RESULTS,WHILE
116,945,946,947,956,COMPOUNDS,HCT,IC50S,MALAYSIAN,NMR,THEIR,VITEX,VITEXOLIDE
169,COPYRIGHT,EXPEC,FOLLOWING,SOCIETY,THERE
000,024,160,169,200,AUTHORS,CONVERSELY,HOWEVER,JAPAN,LTD,PTY,PUBLISHING,SCIENCE,SUMMARY,THEREFORE,WILEY
163,169,200,ADL,ADVERSE,AMONG,BACKGROUND,CTCAE,EASTERN,GROUP,INSTITUTE,LABEL,METHODS,RESULTS,SIXTY,SOCIETY,WITHOUT
215,ARIZONA
169,183,200,956,CELLS,MMP,MRC,QDS,QUANTUM
160,169,COPYRIGHT,INC,NON
160,169,COPYRIGHT,FAK,GEO,HOS,INC,KNOCKDOWN,MEANWHILE,SPON1,SPONDIN,SRC,TAKEN,TREATMENT
169,COLLEGE,FINALLY,PHYSICIANS,ROYAL,THERE,THEREFORE,VARIOUS
100,ACCORDING,GERTSEN,INSTITUTE,OVERALL,THERE
169,177,326,665,956,AVERAGE,CLARK,INC,INTRA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROSWELL,THERE,THREE,WILEY
946,BECAUSE,CERTAIN,CLR01,LYS,THEREFORE
BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN
017,111,143,151,169,183,206,207,ADT,AVENTIS,BACKGROUND,COPYRIGHT,DOCETAXEL,EARLY,FUNDING,GLEASON,IQR,LABEL,LIGUE,LOCAL,LTD,METHODS,NEITHER,RESULTS
001,008,017,272,AMONG,BACKGROUND,BRISTOL,CHECKMATE,LABEL,METHODS,MYERS,NSCLC,RESULTS,TREATMENT
113,134,169,753,AGE,CONCLUSION,COPYRIGHT,DFS,ENDPOINTS,GTV,III,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS
100,ABI,APPLIED,BIOSYSTEMS,BLAST,CONCLUSION,DAB,DENMARK,FFPBS,KIT,LABEL,METHODS,OBJECTIVE,PCR,POLYMERASE,PRISM,QIAMP,RESULTS,STATISTICA,USA
001,218,4B5,CONCLUSION,INTRATUMOR,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VENTANA
BASED,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
169,954,COPYRIGHT,ICP,IRELAND,L858R,LTD,MEIER,RFS,SPRY2
169,ANTICANCER,COPYRIGHT,HOWEVER,INSTITUTE,THESE
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CTA,ESO,ESOPHAGEAL,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS
003,169,ANTICANCER,COPYRIGHT,CRC,GROUP,INSTITUTE,LMS,OVERALL,SEVENTY,THERE
169,AIM,ANTICANCER,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY,THERE
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,RESULTS,THREE
169,946,ANTICANCER,BACKGROUND,BASED,CATENIN,CONCLUSION,COPYRIGHT,HMB,HMB45,INSTITUTE,LABEL,LAM,LHS,MATERIALS,METHODS,RESULTS,THERE
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EZR,INSTITUTE,LABEL,LAM,MATERIALS,METHODS,MYH10,PCR,RAPAMYCIN,RESULTS
169,947,ADC,CARLO,CONCLUSION,COPYRIGHT,D02,D50,D95,INC,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TCP
100,122,160,169,945,946,BED10,COLORECTAL,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
CAUCASIAN,CD4,CD8,EPITOPE,THESE
CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
169,AKT,BIOLOGY,ERK,FINALLY,GLUT1,HOWEVER,INC,LAD,MEK,MOLECULAR,ONCOGENIC,PPP,RAS,SOCIETY,TAKEN
169,34A,COPYRIGHT,HEPG2,MSA,SOCIETY,THESE
169,BELGICA,CHIRURGICA,COPYRIGHT,EARLY,INITIAL,VIDEO
169,BELGICA,CHIRURGICA,COPYRIGHT,DIAGNOSIS,SBO,SMALL,THEREFORE
177,219,242,250,252,494,995,BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS
BECAUSE,BLOOD,THEREFORE
100,YEARS
673,AMONG,ASIAN,LIBRARY,NSCLC,OVERALL,SCHOLAR,SCIENCE,THERE,WEB
185,FDG,PATHOLOGIC,PET
BLOOD,LIBRARY,MEDLINE,NSCLC,PFS,SERUM
COPYRIGHT,III,PROUS,SCIENCE,VEGFR
169,177,285,BACKGROUND,LABEL,METHODS,MVMMS,NUTRITION,OBJECTIVE,PREVALENCE,RESULTS,SOCIETY
IMT,RENAL,WILMS
ALK,CONCLUSION,CRIZOTINIB,LABEL,METHODS,NSCLC,OBJEVTIVE,OOR,PFS,RESULTS,UNASSIGNED
169,ALK,INSTEAD,NOTABLY,NPM,NSCLC
169,BIOLOGY,CONSISTENT,FOS,INC,INDUCIBLE,JUN,MOLECULAR,PREVIOUSLY,SOCIETY,TAP73,THESE

47Q,COUNTER
016,107,160,177,527,563,AFTER,THERE
ABORIGINAL,ABOUT,AMONG,APRIL,CONCLUSION,FRAMING,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OUTCOME,RESULTS,SETTING,SHS,SIMILARLY,TALKING
246,ANA,IGG,IGM,RAYNAUD,SECONDARY
ROD,SINCE,THERE
110,2M0,2N0,513,DESPITE,TIS,V20
124,125,259,DISEASE,IDENTIFIED,III,THERE
427,616,CRR,GENERAL,THEREFORE
KARNOFSKY,SOD
207,FOLLOWING,PALLIATIVE,THERE
CONGO,INITIALLY,PATIENT,PULMONARY
055,138,BACKGROUND,CENTRAL,LABEL,METHODS,PROGRAMME,RESULTS,TOTAL
001,138,169,175,276,CHINESE,CONCLUSION,III,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SOCIETY
001,10877,10878,149,169,1YEAR,583,5DAYS,732,CONCLUSION,COPYRIGHT,COX,DIAGNOSIS,FACTORS,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RECEIPT,RESULTS
ACCORDING,EMT,EPITHELIAL,H1299,HES,HEY,HYPOXIA,JAGGED1,NOBILETIN,NOTCH,TREATMENT
HO1,INCREASED,ISR,THESE
CRT,DMEAN,FFF,FLATTENING,MUS,NSCLC,OCTOBER,THERE
169,AFTER,AUTHORS,BRCA1,FIRST,LTD,MALIGNANT,PTY,PUBLISHING,SCIENCE,WILEY
001,003,011,014,021,029,126,147,164,166,197,200,285,321,374,376,429,486,499,548,577,583,588,648,733,741,791,792,82G,831,874,924,931,934,965,AUG,CAUCASIANS,CHINA,CONCLUSION,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
001,015,046,168,223,ABSENCE,CONCLUSION,COX,CRT,EASTERN,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RELATIVELY,RESULTS,THERE
ETHIC,HOWEVER,MALIGNANT,MPM
163,173,178,289,660,BACKGROUND,CLEAR,ENGLAND,HOWEVER,ICERS,LABEL,METHODS,NSCLC,QALYS,RESULTS,SUBJECT
169,529,955,ACS,BACKGROUND,BMI,CONCLUSION,COPYRIGHT,III,INC,LABEL,METHODS,NSQIP,OBESE,OVERWEIGHT,PROPENSITY,RESULTS,WORLD,WORSE
169,BACKGROUND,COPYRIGHT,CRF,CRP,LABEL,LTD,METHODS,RESULTS
003,022,128,169,387,473,512,823,951,BACKGROUND,COPYRIGHT,DFS,INC,LABEL,METHODS,MORBIDITY,OPERATIVE,PROPENSITY,PUBLISHED,QOL,RESULTS,SOCIETY,UNMATCHED,USING
001,062,169,284,370,BACKGROUND,CARDIAC,COPYRIGHT,COX,INC,INDEX,LABEL,MEIER,METHODS,MORTALITY,PUBLISHED,RESULTS,REVISED,SOCIETY
169,72H,AUTHORS,BACKGROUND,COPYRIGHT,GB3,GCS,H1299,HOWEVER,INC,LABEL,METHODS,MPM,NSCLC,P31,PUBLISHED,RESULTS,THERAPY
169,COPYRIGHT,KINGDOM,PUBLISHED,SAS
169,366,BDA,BH4,COPYRIGHT,INC
150,160,BETWEEN,ELDERLY,EPIDERMAL,ERLOTINIB,L858R,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,011,012,101,150,157,160,161,224,326,913,931,946,967,BRCA1,CHI,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIMILARLY
169,ACS,AMONG,CNA,COPYRIGHT,HOWEVER,III,INC,NSCLC,SCC
001,169,887,888,BACKGROUND,COPYRIGHT,FALSE,FNA,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,SPECIMENS,TCP,THERE
169,408,COPYRIGHT,IRELAND,LTD,NTRK1,PCR,THESE,TPR,USING
169,JNK,LARYNGEAL,SRY,THEREFORE,TU212
169,304,946,947,948,949,950,951,952,963,964,ABD,COPYRIGHT,HOWEVER,INHIBITION,MOL,NCI,PHYSIOL,SOCIETY,UTR
630,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PULMONARY,RESULTS,THESE
193,248,525,760,954,CONCLUSION,DELAY,IIP,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,RESULTS,T1A,T1B
SCIENTIFIC,THESE
169,MOAP1,NSCLC,PRESS,PUBLISHED,UNIVERSITY
169,BELGIUM,CONCLUSION,COPYRIGHT,DTT,IRELAND,JAPAN,LABEL,LTD,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SEVERAL,THESE,UZB
001,200,215,2F8,511,956,HOWEVER,MONOCLONAL,NANOSTRING,SPLENOCYTE,THESE,TREATMENT
160,169,954,COPYRIGHT,HOWEVER,INC,NON,NSCLC,THESE,TKI
AFTER,MCG,MRI,MULTIFOCAL,PET,THROUGH
AMONG,HENCE,HOWEVER,P63,PCR,TOTALLY
001,100,177,CONCERNING,CONCLUSION,KNOWLEDGE,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PTV,RESULTS,STAGE,THERE,THESE,TOKYO,UNIVERSITY
169,916,ALTOGETHER,BIOLOGY,FINALLY,HIPPO,INC,MOLECULAR,PDZ,SOCIETY,TAZ
001,150,160,BACKGROUND,CONCLUSION,GMR,HOWEVER,LABEL,METHODS,RESULTS
169,21153,21162,289,945,946,BARKANA,BECAUSE,CARDIAC,COPYRIGHT,H1299,HAVIV,KARLISH,MARCOVICH,RABAH,SJD,SOCIETY,TAL,THESE,XENOPUS
HISTOLOGY,MAJOR,NON,NSCLC,NSQ,OVERALL,PARAMOUNT,PEMETREXED,QOL,QUALITY
ALK,CRIZOTINIB,JOHNSON,NSCLC,STEVENS
ACCORDING,CAD
169,945,946,947,ATL,COPYRIGHT,INC,PREVIOUSLY,THESE
CONCLUSION,FRANKEL,JANUARY,KARNOFSKY,LABEL,LOG,METHODS,RESULTS,SCORE,SIXTY,SPINE,UNLABELLED,VERTEBRAL
ANOTHER,THROUGH,VARIOUS,WHILE
BESIDES,DESPITE,MORTALITY
169,ADVANTAGES,ALK,COPYRIGHT,LTD,NSCLC,TKI
ALK
ACT,CONCLUSION,HEPATIC,HST,INSURANCE,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SOT,THERE
107,CCL,CONCLUSION,ERCC1,LABEL,LOW,METHODS,NPC,OBJECTIVE,RESULTS,THERE,TNM
169,COPYRIGHT,INC,METASTASIS,PUBLISHED
001,104,153,169,189,293,HEMATOLOGY,LOG,OVERALL,SOCIETY,THERE
169,COPYRIGHT,CPT,INC,NSCLC,REGARDLESS
130,157,169,177,956,ATP,BIP,COPYRIGHT,DOCKING,H1299,INC,INS,INSP3
160,215,CKD,COCKCROFT,EPI,EQUATIONS,FORTY,GAULT,LABEL,METHODS,MSA,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCR,STUDIES
169,177,2N0M0,972,986,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,PUBLISHED,PULMONARY,RESULTS,SOCIETY
ACP,ASSESSMENT,CLINICIANS,EVALUATION,GRADE,GRADING,IMPORTANCE,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,PSYCHINFO,RELEVANCE,RESULTS,SERIOUS,SEVENTEEN
443,938,956,BACKGROUND,HOWEVER,IMT,IPT,LABEL,LABORATORY,LESIONS,METHODS,MORPHOLOGY,OBJECTIVE,REPORTS,RESULTS,THERE
053,100,177,324,877,945,APRIL,BACKGROUND,COX,HIF,HYPOXIA,LABEL,MAY,METHODS,OBJECTIVE,RESULTS
001,003,037,169,244,BACKGROUND,CGEMS,COLORECTAL,DRE,INC,LABEL,MARKERS,METHODS,OVARIAN,PCA,PGS,PSA,RESULTS,SCREENING,TRIAL,WILEY
231,GPIIB,MDA,THESE
169,AKT,BRIEFLY,COPYRIGHT,DSB,ECS,FINALLY,H1975,IRELAND,LTD,NSCLC,USING,VEGR2
017,037,100,169,183,190,ACCURAY,AWARD,BACKGROUND,BECAUSE,COPYRIGHT,ESTIMATED,FUNDING,GRADE,INC,IQR,LABEL,LTD,METHODS,NCI,NSCLC,RECURRENCE,RESULTS,ROSEL,SCIENCE,SIX,STARS,SUPPORT,THREE
DESPITE,FOLLOWING,GEM,HOWEVER,SMV,STAGE,THEREFORE,THREE
215
046,134,669,784,AMONG,BASED,COMMITTEE,THESE
GRADE,HANGE,HOWEVER,III,LUX,MAY,PFS,SEVEN,TKI
100,600,AICHI,ALDH2,JAPAN,MEDICAL,MULTI
101,298,341,639,AEGIS,ALLEGRO,AUC,BACKGROUND,CURRENT,LABEL,METHODS,RESULTS
169,945,ACCORDING,BNIP3,COPYRIGHT,DESPITE,HIF,INC,KNOCK,NSCLC,TAKEN,TREATMENT
15P,169,5MM,ANOVA,BASED,BEV,CONCLUSION,COPYRIGHT,CYBERKNIFE,FIFTEEN,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
007,169,ASA,BACKGROUND,CARDIAC,CONCLUSION,COPYRIGHT,INCIDENCE,LABEL,LTD,METHODS,MORBIDITY,OVERALL,RESULTS,THERE
170,177,213,956,BCL,MCF,PREVIOUSLY,THESE
1ST,HODGKIN,MOUTH,MRI,MYELOMA,NON,PET,RAY,SINCE,THERE,VISIBLE
169,CAR,CASCS,CLINICALLY,FAP,FIBROBLAST,HOWEVER,MALIGNANT,PRIOR,THESE
000,100,169,APRIL,BRCA1,COPYRIGHT,ERC,ERCC1,HOWEVER,III,LITERATURE,LTD,MALIGNANT,MESOTHELIN,MPM,MUTATIONS
002,150,169,399,ADDITIONAL,AMONG,BACKGROUND,BSC,CONCLUSION,COPYRIGHT,COX,LABEL,LTD,MCC,METHODS,PFS,RESULTS,RIGHT
169,945,AUTHORS,MET,METHIONINE,RXR,SAM

169,BIOLOGY,CONVERSELY,EVANS,INC,MOLECULAR,NADPH,NCX,PAR,REVERSE,ROS,SEA0400,SOCIETY,TARGETING
169,676,713,HOSPITALS,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
001,104,177,747,AUC,BACKGROUND,BPE,CEA,CONCLUSION,FIFTY,HOWEVER,LABEL,METHODS,MPE,PLEURAL,RESULTS,USING
CAD,EIGHT,HOWEVER,ROI,SMOTE,SVM
AFTER,BMJ,CIS,EMP,GROUP,LABEL,LIMITED,METHODS,MINNESOTA,OBJECTIVE,ORS,PUBLISHED,PUBLISHING,RESULTS
169,ERK,MEK,MET,ONCOGENIC,RAS,REMARKABLY
169,239,945,AMONG,COPYRIGHT,DIGITAL,EVALUATION,HEALTHY,IRELAND,LABEL,LTD,METHODS,MIP,NSCLC,OBJECTIVE,RESULTS,SCORE
169,945,ATP,BECAUSE,CONSISTENT,COPYRIGHT,H1299,HIF,HSP90,L80,SOCIETY,THEREFORE,THESE
160,DOCETAXEL,JANUARY,LABEL,METHODS,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
004,017,278,329,65285,CONCLUSION,COX,LABEL,LOG,MARCH,METHODS,OBJECTIVE,RESULTS,THEIR
AGE,DISTANT,III,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
266,ADC,LABEL,METHODS,OBJECTIVE,RESULTS,TNM,UNIVARIATE
001,004,007,010,035,160,165,169,954,CHINESE,COPYRIGHT,HAN,INC,KARNOFSKY,MST,OVERALL,STAT3
145,1522B,AG0,MCT,RIBES,SCT,THESE,UNDER
946,AMONG,BEL,IC50S,PC3,SAR,SGC
HRQOL,JANEIRO,LABEL,METHODS,NON,NSCLC,OBJECTIVE,QUALITY,RESULTS,RIO,TREATMENT
169,945,AGS,ANTITUMOR,BATF3,CD103,CD8,COPYRIGHT,IFN,INC,SIMILARLY,THESE
169,BCC,BRCA1,COPYRIGHT,EARLY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SIX,SOCIETY,THESE
169,ALI,CONCLUSION,COPYRIGHT,DISEASE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY
BACKGROUND,ISOPURE,LABEL,REPLACING,RESULTS
EGF,EPIDERMAL,L858R,PREVIOUSLY,T790M,THESE,TKI,Y1068,Y1086,Y1173
005,177,AIM,DYSPNEA,LABEL,MATERIALS,METHODS,NEOPLASTIC,OBJECTIVE,PEARSON,RESULTS
NON,PROCEDURES,THERE
PERINEURAL
001,110,AIS,BETWEEN,HOWEVER,TAKEN,TTF
169,CAM,CHROMATIN,GEO,LABEL,LUCIFERASE,METASTASIS,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,TRANSWELL,UNIVERSITY,WOUND
150,169,178,610,AUC,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,MONDAYS,OBJECTIVE,PURPOSE,RESULTS,TUESDAY
169,954,COPYRIGHT,NAC,PUBLISHED,ROS,SINCE,SO2
169,ALK,ANAPLASTIC,BACKGROUND,BASEL,CONCLUSION,FNA,HOWEVER,ICC,LABEL,METHODS,RESULTS
068,157,281,519,805,868,954,ABSTRACTS,BMJ,GROUP,LABEL,LIMITED,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,REFERENCE,RESULTS,SURGERY,SYSTEMATIC
169,DAMPS,FOUNDATION,IMMUNOLOGY,JOURNAL,THESE
169,COPYRIGHT,INC,KEY,MEK
169,COPYRIGHT,INC,NIVOLUMAB,PUBLISHED
169,COPYRIGHT,HOWEVER,INC,MONOCLONAL
169,COPYRIGHT,CURRENT,INC,MALIGNANT
169,COPYRIGHT,DESPITE,INC,NSCLC
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,OBJECTIVE,PLC,RESULTS,THEREFORE
001,133,169,675,933,ANTICANCER,BACKGROUND,CHI,CONCLUSION,COPYRIGHT,COX,EXCEL,INSTITUTE,LABEL,METHODS,MICROSOFT,PRIMARY,PRISM,RADIATION,RESULTS,USING
169,ALK,ANTICANCER,ATM,COPYRIGHT,INSTITUTE,KIRSTEN,NSCLC,STK11,TESTING
169,176,500,956,AMONG,ANTICANCER,COPYRIGHT,FDG,FORTY,INSTITUTE,PET,THESE
012,027,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,AAA,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FORTY,GUIDELINES,INSTITUTE,LABEL,METHODS,OBJECTIVE,PBC,RESULTS,THEIR,THESE
169,AIM,AKT,ANOIKIS,ANTICANCER,BACKGROUND,BCL,CONCLUSION,COPYRIGHT,ERK,INSTITUTE,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS
169,AIM,ANTICANCER,BACKGROUND,BLOOD,CONCLUSION,COPYRIGHT,CTC,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,RFA,SCREENCELL
169,AMONG,ANRIL,ANTICANCER,COPYRIGHT,INSTITUTE,PLD
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FPR,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS
169,963,ANTICANCER,BRCA1,CHINESE,COMET,COPYRIGHT,DMC,H2A,INSTITUTE,NCI,TAKEN,WESTERN
169,177,956,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FORTY,III,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,PTX,RESULTS,TUBB3
169,177,916,AIM,ANTICANCER,AUC,BACKGROUND,BL6,C57,CONCLUSION,COPYRIGHT,EGF,FINALLY,INSTITUTE,LABEL,LEWIS,LLC,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIMAX,USING
169,AIM,ANTICANCER,BACKGROUND,CFP,CONCLUSION,COPYRIGHT,GFP,INSTITUTE,LABEL,MATERIALS,METASTASES,METHODS,OBJECTIVE,OLYMPUS,PANCREATIC,RESULTS,RFP,THREE,XPA
169,ANTICANCER,COPYRIGHT,FIRST,HOWEVER,III,INSTITUTE,NSCLC,PFS,SEVERAL,THEREFORE,TKI
169,ANTICANCER,COPYRIGHT,INSTITUTE,MALIGNANT,MPM
AFTER,CNS,CRANIOTOMY,III,RESTAGING
121,169,BACKGROUND,HOWEVER,KIT,LABEL,METHODS,MULTITECH,PNA,RESULTS,SOCIETY
ACH,ACTIVATION,AFTER,AKT,HOWEVER,M3R,NSCLC,TAKEN
177,BACKGROUND,CONCLUSION,INC,LABEL,METHODS,NTG,PUBLISHED,RESULTS,SEM
001,008,169,HODGKIN,INC,NHL,USING,WILEY
CHEST,HOWEVER
6TH,AFTER,MARCH,THESE
2ND,RIGHT
IRINOTECAN,LIVER,PCG,UPPER
100MG,AUC
B12,CONCLUSION,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THEREFORE
ALK,MOLECULAR,NSCLC,T790M,TKI
169,231,233,4TH,COPYRIGHT,LEA,PUBLISHED,SAS,SOCIETY,THERAPY,UNDER
ADVANTAGES,CORRECT,THERE
PET,RUSSIAN,THERE
PCH,PULMONARY
CAESARIAN,FIBREOPTIC
ALK,NSCLC
215,365,809,ABCA1,ACOT4,AFRICAN,AMERICANS,BLOOD,DISCOVERY,ESP,EXOME,HEART,IMPORTANCE,INSTITUTE,JANUARY,LABEL,METHODS,NHLBI,OBJECTIVE,PDE4DIP,PROJECT,RELEVANCE,RESULTS,SEQUENCING,SETTING,THESE,ZFHX3
169,COPYRIGHT,FGFRS,LTD,NSCLC
169,183,BASED,BRITISH,CHINESE,DETECTION,IMMUNOLOGY,PCR,RIBOSOMAL,ROC,SOCIETY,THESE
169,321,BIOLOGY,INC,MDA,MOLECULAR,SOCIETY,UTR
169,COPYRIGHT,MACROPHAGE,MIF,SOCIETY

HISTONE
ILD
ALK
250,ACTIVATING,AFTER,ALK,CAUCASIAN,GEFITINIB,HOWEVER,NSCLC
169,177,BECAUSE,CONCLUSION,EVALUATION,HOUNSFIELD,IMAGING,INC,INTER,LABEL,METHODS,MOLECULAR,NUCLEAR,PEDIATRIC,PET,RESULTS,SDS,SEGBASE,SEGWBONEAD,SEGWBONEPE,SOCIETY,UNLABELLED,VOI
BRAIN,HOWEVER,THERAPIES
169,COPYRIGHT,CURRENTLY,HOWEVER,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,GGO,INC,PUBLISHED,SOCIETY,THEREFORE
169,ABDOMINAL,COPYRIGHT,INC,PUBLISHED,SOCIETY,STERNAL
169,COPYRIGHT,HEART,INC,PUBLISHED,SOCIETY
ERLOTINIB,HOWEVER,NSCLC,PFS
160,169,APN,AUTHORS,B16,GIVEN,H1299,LTD,NOD,PTY,PUBLISHING,SCIENCE,THESE,WILEY
001,10878,AWARENESS,BACKGROUND,BELIEFS,HOWEVER,LABEL,METHODS,RESULTS,SMOKERS,SMOKING,THESE
CHEST,DPB,HOB
004,005,006,026,194,CONCLUSION,LABEL,METHODS,NVBNA,OBJECTIVE,RCT,RESULTS,VBN
177,215,ACUTE,AMONG,CONCLUSION,IPF,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,TTV
ATM,BCL,CSC,JUN,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PRO,PROTEIN,PURPOSE,RESULTS,RIP,SER,THR,TRADD
ANAMORELIN,AREAS,BACKGROUND,COVERED,LABEL,METHODS,NSCLC,OPINION,TARGETING
CAD,FCM,GGO
169,ASTRO,BECAUSE,COMMITTEE,CURRENT,GUIDELINE,III,IMPORTANT,LABEL,METHODS,NSCLC,OBJECTIVE,PANEL,PRACTICAL,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE
123,361,AMDIS,AUC,AUTOMATIC,FURTHER,SQL
GENERALLY,PARTICULAR
169,CONSISTENT,DESPITE,FP3,RDB,TAKEN,VARIOUS
169,504,789,AML,BENZENE,CHINA,CHINESE,HLD,HODGKIN,POISSON,RRS
169,COPYRIGHT,FINALLY,LTD,SILIBININ,SILYBUM,STAT3
169,BAHRAIN,COPYRIGHT,COUNCIL,DESPITE,HODGKIN,LTD,QATAR,SAUDI
101,AFTER,APRIL,BACKGROUND,BETWEEN,CLINICIANS,CONCLUSION,FDG,HODGKIN,LABEL,METHODS,ONTARIO,PET,RESULTS,SOMETIMES
IAP
160,169,218,945,ECTOPIC,HOWEVER,SLIT2,SRC,THESE,UTR
001,160,169,172,412,535,AUTHORS,CURRENTLY,HOWEVER,LTD,MALIGNANT,PTY,PUBLISHING,SCIENCE,THREE,WELFARE,WILEY
100,160,169,946,956,ACC,AMP,ASPIRIN,AUTHORS,COA,LIMITED,MRC,PNT1A,PRE,PRESS,SALICYLATE
100,956,ABCG2,ALDH1A3,ALDH1B1,ATP,CD105,CONCLUSION,DDP,EPCAM,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THERE,THEREFORE,WESTERN
ASSOCIATED
BASED,PET,SEVERAL
101,169,AMONG,BACKGROUND,BAL,CONCLUSION,INC,LABEL,METHODS,PROCEDURE,RESULTS,THERE,WILEY
137,169,PREDICTIVE,USING
104,208,BDE,BLOOMBERG,CASES,COLORECTAL,GOVERNMENT,HOPKINS,INCREASING,JOHNS,OVARIAN,PBDES,PRESS,PUBLISHED,SCREENING,TRIAL,UNIVERSITY
AZD9291,C797S,PCR,T790M,TKI
178,568,BACKGROUND,BMI,CONCLUSION,COX,ENGLAND,FUNDING,HOWEVER,INSTITUTE,LABEL,LIMITATION,METHODS,OBJECTIVE,OVERWEIGHT,PRIMARY,RESULTS,SERVICE,SETTING,UNIVERSITY,WHETHER
001,006,1544C,169,20Q11,215,348,699,915,998,COPYRIGHT,FKBPL,HOWEVER,INC,PRO137LEU,PRO515LEU,PUBLISHED,SOCIETY,VAL284MET
169,AKT,COPYRIGHT,ERK,HENCE,IRELAND,LTD,MEK,NSCLC,RAS
169,175,916,945,946,AFTER,COPYRIGHT,FACTORS,INC,INT,JAC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V20,VENTINT,VENTJAC
169,ADC,AST,COPYRIGHT,FURTHER,INC,NSCLC,ROS,SCC,SIMILAR
048,130,169,174,548,AUTHORS,COPYRIGHT,COX,DSS,III,INC,LABEL,MATERIALS,METHODS,NOMOGRAMS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TNM,VARIABLES,WORLD
100,169,177,947,BASED,COPYRIGHT,CYBERKNIFE,HOUNSFIELD,INC,KOREA,LABEL,LOKIT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THOSE,THREE
169,COPYRIGHT,DUE,HOWEVER,LTD,NSCLC
0GY,169,4GY,5GY,7GY,8GY,BACKGROUND,CONCLUSION,COPYRIGHT,D95,FUNCTIONAL,IRELAND,LABEL,LTD,MATERIALS,METHODS,MLD,NSCLC,OBJECTIVE,PET,PLANS,PTV,PURPOSE,RESULTS,SUV,THERE,V10,V20,V30,V40,V50,V60,VLUNG
AUSTRALIA,BETWEEN,TRANSPLANT,ZEALAND
COPYRIGHT,OCT,SLACK
001,019,265,329,342,409,413,452,803,917,999,ANOVA,BECAUSE,CHI,METHODS,MIS,RESULTS,THERE
112,160,166,169,250,374,946,99M,CONCLUSION,HOWEVER,IMAGING,INC,JANUARY,LABEL,MAA,MARCH,MBQ,METHODS,MOLECULAR,NUCLEAR,RESULTS,SOCIETY,SPECT,THESE,UNLABELLED,VOLUMES
169,BACKGROUND,LABEL,MEDICAL,METHODS,MINNESOTA,NORTH,OSA,RESULTS,SHORE,SOCIETY,THERE,THREE,UNIVERSITY

169,BACKGROUND,END,ESOPHAGEAL,GISTS,HODGKIN,HOWEVER,LABEL,METHODS,OVARIAN,RESULTS,SIR,SOCIETY,SPR,THERE,THESE
EVALUATION,HOWEVER
DOSIMETRIC,ECS,PTV,V20,VERSION
CIS,FURTHER,INSURANCE,MDS,NHI,ORS,OVERALL,TAIWANESE
ADDITIONAL,BASED,CTS,DOSIMETRIC,FDG,FLT,MAXIMUM,METABOLIC,MVS,NSCLC,ORS,OVERLAP,PET,PVS,SUVMEAN,TCP,TOTALLY
MBC,RECURRENCE
AMERICA,AUSTRALIA,BACKGROUND,GROUP,LABEL,METHODS,MONOGRAPHS,NORTH,RESULTS,SMR,SOURCES,WORKING
ADJUSTING,BACKGROUND,BLACK,EXAMINE,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RATIONALE,RESULTS,SCREENING,SMOKING,TRIAL
025,149,272,313,362,589,643,878,946,BACKGROUND,C509T,CHINESE,G875A,GENOTYPING,HOWEVER,LABEL,METHODS,RESULTS,SNP,TGF,TGFB1
403,414,420,436,442,461,510,744,BACKGROUND,COX,JANUARY,LABEL,METHODS,PROWESS,REGISTERED,RESULTS,SHOCK,SIMILARLY,TRIAL
BACKGROUND,DDP,DNMT1,DNMTS,LABEL,METHODS,MICRORNAS,MTT,NSCLC,PCR,RESULTS,SPC,UTR,WHILE
169,AMONG,BACKGROUND,BASEL,LABEL,METHODS,NSCLC,RESULTS
169,947,BIOLOGY,CATENIN,EXPRESSION,HAI,HGF,HOWEVER,INC,MET,MOLECULAR,NSCLC,SOCIETY,SPINT,TAKEN,THEREFORE
169,183,375,AFTER,BACKGROUND,BETWEEN,CD79B,CLL,COPYRIGHT,FUNDING,GENENTECH,GRADE,HODGKIN,LABEL,LTD,MARCH,METHODS,NHL,NOV,RESULTS,SERIOUS,SEVEN
WHETHER
160,239,500,APRIL,BETWEEN,CONCLUSION,EASTERN,FEBRILE,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,PEMETREXED,PFS,PURPOSE,RESULTS,SEPTEMBER,SIXTEEN,THERE
093,169,496,638,735,CLPTM1L,HOWEVER,ISRAELI,SMOKING
150,185,ADP,GPC,LY293,METHOXY,MITOTIC,NMR,POLYMERIC,TREATMENT,TUBULIN
BACKGROUND,BCA,CO2,CONCLUSION,FIG,HCA,HCG,HYDRATASE,I50,INHIBITION,LABEL,OBJECTIVE,PAP,REF,RESULTS,TAB
000,160,169,176,183,513,BACKGROUND,BASED,BETWEEN,DUE,EUR,FEDERAL,GEORG,INSURANCE,LABEL,METHODS,NUMBERS,OUTPATIENT,PHYSICIANS,POPULATION,PREVALENT,REGISTRIES,RESULTS,STATISTICS,STATUTORY,STUTTGART,THESE,WINHO
160,169,183,FDG,GEORG,PET,STUTTGART
130,150,500,625,750,900,BACKGROUND,HBR,KEY,LABEL,METHODS,NON,NSCLC,RESULTS,T790M,TREATMENT
127,222,240,253,AMONG,AZD9291,BACKGROUND,LABEL,METHODS,RESULTS,T790M
169,BACKGROUND,COX,FINLAND,FINNISH,HEART,HISTORICAL,INC,LABEL,MEIER,METHODS,OBJECTIVE,POSTSTROKE,PURPOSE,RESULTS,STATISTICS,YOUNG
169,231,233,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,THERE
160,AFTER,APRIL,BACKGROUND,BETWEEN,CNS,CONCLUSION,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SURVIVALS
001,009,025,169,492,AKT,BACKGROUND,INC,LABEL,MALDI,METHODS,MUTATIONS,OBJECTIVE,OBJECTIVES,RAF,RAS,RESULTS,SOMATIC,TOF,WILEY
956,DU145,NTUB1,SOLANUM
169,199,229,BACKGROUND,CCAT2,INC,LABEL,LNM,METHODS,MYC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TNM,WILEY
177,231,OVERALL
231,956,CHCL3,EIGHT,KAEMPFERIA,MDA,MYANMAR,PSN,TIG
13C,ESI,MEL,NMR,NOESY,RHIZOPHORA
100,169,AMONG,BAL,CMV,HCT,HEMATOLOGY,HHV,HRV,IPS,MORTALITY,NEWER,SOCIETY
169,AIM,ANY,BACKGROUND,BRITISH,CONCLUSION,CONTINUITY,ENGLAND,GENERAL,JOURNAL,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SECONDARY,SETTING,TRS
169,227,AFRICAN,AMERICANS,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMARCA4,SOCIETY
169,BCL,COPYRIGHT,FBXW7,HENCE,MCL,SCF,SOCIETY,TORKINIBS
169,947,ATM,ATR,BIOLOGY,ERK,HOWEVER,INC,MOLECULAR,NCI,SOCIETY,TAKEN
169,COPYRIGHT,INC,RCC,RENAL
058,079,101,169,286,781,ADJUSTING,COLORECTAL,CONCLUSION,COPYRIGHT,GLEASON,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OVARIAN,PSA,RESULTS,RISKS,SCREENING,TRIAL
036,169,384,387,CHINESE,COPYRIGHT,NFKB1,THERE
169,BID,COPYRIGHT,DR5,HOWEVER,IRELAND,LTD,SRB,TAKEN
001,169,688,794,AMONG,BACKGROUND,END,INSURANCE,LABEL,METHODS,PATIENT,RATES,RESULTS,SOCIETY,VARIATION
549,956,ETOAC,THREE
003,160,169,967,BACKGROUND,BECAUSE,BRIEFER,COPYRIGHT,INC,KRUSKAL,LABEL,MEIER,METHODS,PUBLISHED,RESECTIONS,RESULTS,SOCIETY,STAGE
PROSPECTS,SPECIAL
197,300,956,BECAUSE,GMP,MIC50,MTHGPRT,THESE
945,946,AMONG,ANXA2,MET5A,THEREAFTER,THESE
946,954,AB1,EVALUATION,KIT,MCS,MPE,TREATMENT
079,100,105,304,467,691,920,AMONG,BACKGROUND,COPENHAGEN,GENERAL,LABEL,METHODS,NEVER,OBJECTIVE,OBJECTIVES,POPULATION,RATIONALE,RESULTS
169,AIM,COPYRIGHT,LTD,RESULTS
001,160,169,459,631,714,AMONG,BACKGROUND,CCI,COPYRIGHT,COX,CRS,FACTORS,INC,INDEX,LABEL,METHODS,NSCLC,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,THERE
169,AFTER,COPYRIGHT,INC,PUBLISHED,SOCIETY
004,160,169,BACKGROUND,COPYRIGHT,INC,LABEL,LIPOB,METHODS,POSTERIOR,PUBLISHED,RESULTS,SOCIETY,TEA,THERE
169,AMONG,COPYRIGHT,EGFRS,EPIDERMAL,IMMUNOBLOT,NSCLC,PUBLISHED
AREAS,ASPECTS,BACKGROUND,BESIDES,COVERED,HOWEVER,LABEL,METHODS,OPINION
BACKGROUND,JANUARY,LABEL,LYMPH,METASTASIS,METHODS,OBJECTIVE,RESULTS
000,150,205,956,AGILENT,C18,CONCLUSION,DAD,ESI,LABEL,METHODS,OBJECTIVE,RESULTS,USING
169,946,BECAUSE,C5A,COPYRIGHT,DEPLETION,INC,TGF,TH1,TH2,USING
169,177,398,5DN,945,946,FASEB
045,440,AGE,BACKGROUND,COMBINING,LABEL,METHODS,OBJECTIVE,OLDER,PRESENTING,RESULTS,WEB
GASTRIC
ACCORDING,MAMMARY,THREE
BACKGROUND,BDUMP,BMJ,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,THESE,TREATMENT
008,169,177,ACRIN,BLAND,CONCLUSION,FDG,III,IMAGING,INC,LABEL,MERCK,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RCS,RESULTS,SOCIETY,SOLID,SUV,SUVPEAK,UNLABELLED
116,500,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,TES,THERE
001,019,105,140,669,BACKGROUND,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
ASIAN,BACKGROUND,FIRST,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RESULTS,TTP
GTN,PLACENTAL,PRIMARY,PSTTS
FIRST,HOWEVER,TKI
AVP,ECTOPIC,OTHER,SIADH
ALK,CRIZOTINIB,INCREASED,NON
BACKGROUND,LABEL,METHODS,MRI,STAGING,ULTRASOUND
AFTER,BACKGROUND,BRONCHIAL,DOCETAXEL,FIBEROPTIC,LABEL,MATERIALS,METHODS,NSCLC,PULMONARY,RESULTS,SPIROMETRY
512,64257,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SUBSEQUENT
BACKGROUND,CUMULATIVE,FDG,LABEL,MEIER,METHODS,NSCLC,PET,RADDX,RECORDS,RESULTS,SIXTY

130,BACKGROUND,CIGARETTE,CONCLUSION,HNC,LABEL,METHODS,PRIMARY,RESULTS,SECONDARY,SIXTY
169,APMIS,GIANT,LTD,PUBLISHED,WILEY
ANOTHER,AREAS,ASIAN,BACKGROUND,BASED,COVERED,DEL19,L858R,LABEL,METHODS,NSCLC,OPINION,ROUTINE
169,954,E2F,FINALLY,MARK2,MARKS,MAX,MYC
283,656,AHS,AMONG,BMJ,GROUP,LABEL,LIMITED,METHODS,NEWLY,NORTH,OBJECTIVE,POISSON,PUBLISHED,PUBLISHING,RESULTS,RRS
PAH,PULMONARY,REDUCED,SHORTNESS,SMOKING
394,438,439,CONCLUSION,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPGGN
DCLDS,LANGERHANS
001,022,182,954,BACKGROUND,CHROMATIN,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RATIONALE,RESULTS
113,144,181,286,312,BOSNIAK,CAPTURE,CONCLUSION,ELECTRONIC,IIF,III,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PATHOLOGIC,RESULTS,THERE,WEB
CENTERS,POPULATION,THESE
100,169,295,590,BACKGROUND,BETWEEN,CIS,COLORECTAL,CONCLUSION,DBP,FURTHER,LABEL,METHODS,NUTRITION,OBJECTIVE,ORS,OVARIAN,RESULTS,SOCIETY,VITAMIN
169,BRITAIN,COPYRIGHT,EMT,FINALLY,GREAT,IRELAND,LTD,NSCLC,PUBLISHED,SOCIETY,WILEY
108,126,167,169,299,762,AMONG,HEAVY,HOWEVER,POISSON,SPC
004,160,250,CONCLUSION,DCR,FORTY,GEFITINIB,HOWEVER,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,OCTOBER,OPTIMIZED,PCR,PFS,PNA,PURPOSE,REGARDING,RESULTS,SEVENTY,SMALL,TKI
101,169,CONCLUSION,ENROLLMENT,LABEL,METHODS,NOGUCHI,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
169,BASED,CL1,COPYRIGHT,FIRSTLY,HOWEVER,IRELAND,JNK,JUN,LTD,MAP,MMP,PIPOXOLAN,PUBLISHED,THEREFORE,THESE
001,160,278,421,CHI,CRC,ESPECIALLY,HOWEVER,MEIER,STAGE
AKT,CTL,EMT,METASTATIC,NANOG,PREVIOUSLY,TCL1A,THEREFORE,THESE
169,233,CLEVELAND,COPYRIGHT,DUB
001,002,ACCORDING,CHANGES,CONCLUSION,COX,EVALUATION,FDG,FIRST,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PERCENTAGE,PET,PURPOSE,RESULTS,SOLID
129,169,AMONG,CONCLUSION,GRADE,LABEL,METHODS,NIVOLUMAB,NSCLC,OBJECTIVE,PROGRAMMED,PURPOSE,RANDOMIZED,RESULTS,SOCIETY,THREE
001,169,649,CIS,CONCLUSION,HRS,L858R,LABEL,METHODS,NEVER,OBJECTIVE,PFS,PURPOSE,RESULTS,SOCIETY,THESE,WOMEN
169,182,538,772,CANCERS,CONCLUSION,LABEL,METHODS,NUTRITION,OBJECTIVE,PREVENTION,PURPOSE,RESULTS,SOCIETY
169,AIM,ANNEXIN,COPYRIGHT,FURTHER,INC,JNK,KEY,LABEL,METHODS,MNQ,OBJECTIVE,OXIDATIVE,RESULTS,ROS,WESTERN
169,945,947,COPYRIGHT,FURTHER,IRELAND,LTD,NCI,RESULTS,THESE,TNF
0MM,169,177,181,945,954,CHRONIC,COX,FURTHER,I3C,LPS,NNK,PRESS,PUBLISHED,SIL,THEREFORE,THESE,UNIVERSITY
160,INC,PUBLISHED,TYPICAL
FURTHER,THESE
946,RIG,TGF
160,CISPLATIN,CONCLUSION,HOWEVER,JNK,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,ROS,SIMILAR,TREATMENT
CLINICIANS,FORCE,PREVENTIVE,SCREENING,TRIAL
001,BACKGROUND,BCS,COMPARISON,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS,V10,V15,V20
001,136,169,AIM,CONCLUSION,COPYRIGHT,CURRENT,ENF,FORTY,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,REPORTS,RESULTS,THERE,THESE
MLC
169,AUTHORS,FANCONI,ICL,LTD,PTY,PUBLISHING,SCIENCE,THESE,WILEY
169,ACCORDING,BACKGROUND,BECAUSE,COPYRIGHT,EIGHT,INC,JANUARY,LABEL,METHODS,RESULTS
169,946,ADDITIONAL,BACKGROUND,CONSORTIUM,CRC,HRQOL,LABEL,MCS,MEDICAL,METHODS,PCS,RESULTS,SOCIETY,TREATMENT
001,182,313,495,AMONG,BACKGROUND,KEYNOTE,LABEL,MERCK,METHODS,RESULTS
169,BACKGROUND,HOWEVER,LABEL,METASTATIC,METHODS,NSCLC,OLDER,ONTARIO,PATIENT,RESULTS,SOCIETY,THOSE
000,001,022,160,169,177,658,995,BACKGROUND,COPYRIGHT,DELAY,DELAYED,HOWEVER,INC,LABEL,METHODS,NSCLC,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,STRATEGIES,THOSE,TREATMENT
AKT,APOPTOSIS,BACKGROUND,BAX,BID,CASPASE,HOWEVER,LABEL,METHODS,MTT,NSCLC,RESULTS,RYONG,THESE,WESTERN
169,956,COPYRIGHT,INC,PCR
169,956,CARROLL,COLIGAN,COMMITTEE,COPYRIGHT,ENSEMBL,FAIM3,FAS,FCR,HOWEVER,IGM,INC,MCANDREWS,MICHAEL,MOUSE
BACKGROUND,BASED,DESPITE,HODGKIN,HOWEVER,LABEL,METHODS,REDUCTION,RESULTS,STUDIES
001,105,181,BACKGROUND,CHINA,HAN,L858R,LABEL,RESULTS
160,169,BACKGROUND,COPYRIGHT,DEFINITIVE,INC,LABEL,LOBECTOMY,METHODS,NSCLC,PUBLISHED,RESULTS,SALVAGE,SOCIETY,THERE
112,388,419,858,942,AMBER,AMONG,BACKGROUND,EPIDERMAL,HOWEVER,L858R,LABEL,NSCLC,RESULTS,ROSETTA,STRUCTURAL,THESE
947,948
000,213,249,375,415,501,541,672,833,BACKGROUND,CENTRAL,DESPITE,LABEL,METHODS,REGARDING,RESULTS,SEYLL,YEARS
150,205,ALA205LEU,AMP,CATHEPSINS,LEU205ALA,MOLECULAR
AFTER,ASKIN
BACKGROUND,HGF,LABEL,MET,RESULTS,SCC,SEVERAL,THESE
DIETARY
185,554,604,677,681,710,715,739,744,748,760,766,781,784,837,839,897,923,AUC,CONCLUSION,FUDAN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,231,233,AFTER,COPYRIGHT,PEDIATRIC,PUBLISHED,SAS
G719X,KEY,S768I
100,DIAGNOSTIC,FDG,HOUNSFIELD,NPV,PET,PPV,SPN,SUV
169,BACKGROUND,HISTORY,HNC,LABEL,METHODS,RESULTS,SPLCS
016,024,109,169,1A1,416,ALDH1A1,BESIDES,COPYRIGHT,FURTHER,III,INC,LEUCINE,NSCLC,PCR,TNM
CONCLUSION,DCR,FACTORS,III,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TOTALLY,YCR
223,BACKGROUND,EPB41L3,INCUBATION,LABEL,MVS,NSCLC,RESULTS
120,160,BACKGROUND,CCL16,EMT,FEW,LABEL,RESULTS,SEVENTY
001,179,AFTER,FILIPINOS,HAWAIIANS,LABEL,METHODS,NMR,OBJECTIVE,OBJECTIVES,RESULTS,WHITE
A2780,BACKGROUND,BFU,FIRSTLY,HEPG2,LABEL,LEWIS,LLC,METHODS,MTT,MVD,NOTABLY,RESULTS,THESE
ABCC1,BACKGROUND,H69,H69AR,HOWEVER,KCNJ2,KIR21,KNOCKDOWN,LABEL,MDR,MEK,METHODS,PKC,RAS,RESULTS
000,100,152,312,330,CDC,CENTRAL,CESSATION,LABEL,METHODS,POPULATION,RICAN,STATISTICS,UNLABELLED
ACCORDING,AIM,ASSESSMENT,BACKGROUND,BIA,BMI,CONCLUSION,FAT,FMI,LABEL,METHODS,MNA,OBJECTIVE,OVERWEIGHT,RESULTS
169,183,197,BIOLOGY,INC,LYS,MOLECULAR,PPE,SOCIETY,STRUCTURAL
169,452,ACADEMY,CLASS,CONCLUSION,FATAL,IMPAIRMENT,LABEL,METHODS,NEUROLOGY,NEUROPATHY,OBJECTIVE,POEMS,PREDICTED,RESULTS,ROCHESTER,SCALE,SCORE,SIX,SIXTY
169,EPIDERMAL,EVALUATION,HOWEVER,L858R,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEVENTY,SOLID,THERE,UNIVERSITY
005,161,169,926,BACKGROUND,COX,LABEL,MEIER,METHODS,RESULTS,SHS,SOCIETY,SPOUSAL,THERE
967
001,123,177,201,382,533,607,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THROMBOSIS
AMONG,FURTHER,LABEL,METHODS,OBJECTIVE,POLYMERASE,RESULTS,TA5,TA7,UGT,UTG
180,212,AFB,CONCLUSION,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,RESULTS,WLB
160,169,214,945,ABNORMALLY,AUTHORS,EPO,FDA,FINALLY,HIF,JOURNAL,PHT,PLACENTAL,SCD,SOCIETY,THESE,UTR
AE1,AE3,CHINESE,CK5,CONCLUSION,HOWEVER,LABEL,METHODS,MOC31,OBJECTIVE,RESULTS,TEN,THERE,WILMS,WT1
001,100,176,738,967,ACADEMY,CHINESE,EXTRACTED,INSTITUTE,KAPPA,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SAMPLES,SCORPIONS
001,105,171,177,183,264,342,423,471,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,STRATIFIED,THERE
204,205,821,AFTER,CHINESE,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
CHEST,PTE
ALECTINIB,ALK,COPYRIGHT,DUE,FDA,HOWEVER,III,JAPAN,NSCLC,PROUS,SCIENCE
001,003,169,AMONG,ANECDOTAL,BACKGROUND,ERLOTINIB,EVALUATION,FACTORS,LABEL,METHODS,RESULTS,SOCIETY,SOLID,TTC
155,216,252,307,341,460,471,946,956,994,ACADEMY,CHINESE,CONCLUSION,HAN,JANUARY,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SCIENCE,SMOKING,THERE,TNF,TOTAL
315,ACCORDING,AFTER,CONCLUSION,LABEL,LINGTAI,METHODS,OBJECTIVE,RESULTS,SPF,THERE
169,BRITAIN,COPYRIGHT,GREAT,GREMLIN,IRELAND,JOURNAL,LAVOZ,LTD,PATHOLOGY,PUBLISHED,SOCIETY,WILEY
15A,CHICAGO,GLO,MICRORNAS,NSCLC,PCR,USA,UTR,WESTERN
072,15Q25,169,AMONG,BACKGROUND,COCHRAN,CONCLUSION,COX,GIVEN,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
169,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PULMONARY,RESULTS,SOCIETY,UNTIL,WHILE
169,COPYRIGHT,EWING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THREE
08113,22113,EORTC,HOWEVER,NSCLC,OUTLINE,TREATMENT
AMONG,BACKGROUND,COMMITTEE,COX,GOVERNMENT,III,JOINT,LABEL,MEIER,METHODS,NSCLC,OLDER,PUBLISHED,RESULTS,USA
BMJ,BRITAIN,COX,CVD,FURTHER,GREAT,GROUP,IHD,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR
001,038,181,222,AFTER,COX,LABEL,LOBECTOMY,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PROPENSITY,RESULTS,THESE,UNIVERSITY
18F,FDG,INSTEAD,LABEL,NSCLC,OBJECTIVE,PET,THESE
001,006,018,025,041,049,441,ABSENCE,BACKGROUND,CONCLUSION,EASTERN,FIRST,FOLLOWING,GROUP,LABEL,METHODS,PEARSON,PFS,RESULTS,TKI
449,480,8G7G3,CURRENTLY,HOWEVER,SPT24,TTF
BMJ,BRITISH,BTS,GROUP,GUIDELINE,LIMITED,PUBLISHED,PUBLISHING,SOCIETY
169,AZD6244,AZD9291,EARLY,EGFRM,H1975,MEK,NCI,PC9,RESISTANCE,T790M
150,169,CONCLUSION,HSP,HSP90,LABEL,METHODS,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,SOCIETY,T790M
169,AUTHORS,COPYRIGHT,CRP,FDG,IRELAND,LTD,NSCLC,PET,PROJECT,PUBLISHED,RTP,THESE,TVD
001,007,130,169,224,446,840,BACKGROUND,COLLEGE,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MST,OPERATIVE,PROPENSITY,PUBLISHED,RESULTS,SHORT,THERE,VIDEO
CHEST,THERE
206,DIAGNOSTIC,HISTOLOGIC,KARNOFSKY,MONTENEGRO,SPECIAL,SURGERY,THERE
013,032,036,042,045,124,197,AGILENT,BACKGROUND,LABEL,METHODS,MIR,NSCLC,RESULTS,TOTAL
AIM,BACKGROUND,CONCLUSION,IIB,LABEL,METHODS,NSCLC,OBJECTIVE,PRIMARY,RESULTS,THEIR,WORLD
946,FOXQ1,INCREASED,LAMA4,THESE,THROUGH
169,4AI,593,ATP,COPYRIGHT,DENV1,DENV2,DENV3,INC,PKR
MALIGNANT
100,169,183,315,AFTER,BACKGROUND,BESIDES,COMPLIANCE,COPYRIGHT,FTE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SELECTION
160,AIM,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,RESULTS
946,CEA,PCR,PLC,TGF
PTN,TNM
169,173,AUTHORS,CCL20,CLINICALLY,COPYRIGHT,IRELAND,LTD,NNK,PUBLISHED,THESE,TOBACCO
019,110,150,169,967,AUTHORS,COPYRIGHT,FEW,GROUP,HODGKIN,INC,LABEL,MATERIALS,METHODS,NHL,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RADIATION,RESULTS,SEVERAL,THERAPY,THESE,V10,V15,V20
004,038,169,AER,CARDIAC,COPYRIGHT,CRT,DISEASE,HODGKIN,INC,LABEL,LAR,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,AUTHORS,COMMISSION,COPYRIGHT,ENL,EXTRANODAL,GROUP,HODGKIN,ILROG,INC,NHL,ORGAN,PUBLISHED,RADIATION,UNITS
169,ADDITIONAL,ASTN1,CSMD2,EXOME,EXPRESSION,MUTATED,PRESS,PUBLISHED,RB1,SCLCS,SMALL,SPTA1,THEREFORE,UNIVERSITY
007,027,035,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SKAP2,SRC,THEREFORE
135,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EPIRUBICIN,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SIXTY
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LA1,LABEL,MATERIALS,METHODS,OBJECTIVE,PDCD4,PEI,RESULTS,SDA,THEREFORE
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,L858R,LABEL,LUNG3,LUNG6,LUX,MATERIALS,METHODS,MTT,NSCLC,RESULTS,TKI,WESTERN
100,143,155,169,210,372,AIM,ANTICANCER,BAL,CLUSTER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
169,CELLS,COPYRIGHT,FALLS,IGUASSU,OVERALL,PAN,SOCIETY,THESE
001,140,169,CONSORTIUM,GRADE,LABEL,MEDICAL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SAPPORO,THERE,UNIVERSITY
379,ADDITIONAL,CENTRAL,CONCLUSION,CSO,LABEL,METHODS,OBJECTIVE,RESULTS,SAM,UNIVERSITY
169,915,972,APRIL,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FACTORS,IQR,IRELAND,JANUARY,LABEL,LTD,METHODS,NHS,OVERALL,PUBLISHED,RESULTS
836,864,AMONG,ATLAS,AUC,BACKGROUND,CPG,EPIGENETIC,HOWEVER,LABEL,METHODS,RELIEFF,RESULTS,SEQ,SEQUENTIAL,TSS1500,VARIOUS
AMONG,ANGPTL5,ATLAS,C7ORF16,DAVID,FUNCTIONAL,III,IL1F5,LAC,LOC150622,PPI,USH1G,WNT
143,AIM,BACKGROUND,DISTANT,LABEL,METHODS,NODAL,OBJECTIVE,PET,RESULTS,SIXTY,TOMOGRAPHY,VALUE
ATS,BASED,DIAGNOSTIC,MAC,NTM,SPN,WINDERMERE
163,BACKGROUND,DENDRIX,FURTHER,LABEL,LARGE,MAXIMUM,METHODS,MULTI,NBM,P53,PROBLEM,RAS,RESULTS,RME,RTK,SUB
169,946,BASED,COPYRIGHT,ECM,ENDOGENOUS,FN1,INC,LAMC1,TGF,TGFB1,THESE
169,AUTHORS,CAM,COPYRIGHT,GADD153,GEF,GEFITINIB,GRP78,INC,KNOCKDOWN,MEF,NSCLC,PUBLISHED,THESE
169,946,947,CD8,ELICITING,GENERATED,IFN,RADIATION,TGF
AMERICANS,GREATER,HIV,INSTITUTES,NIH
169,CONCLUSION,DIXON,FDG,FINALLY,GMM,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
116,148,169,226,384,712,AMONG,BACKGROUND,BAL,CONCLUSION,COPYRIGHT,INDIA,LABEL,METHODS,PUBLISHED,RESULTS
COLORECTAL,ERSPC,GROUP,OVARIAN,PIVOT,PSA,RANDOMIZED,SCREENING,TRIAL
HODGKIN,THERE
176,177,945,954,BACKGROUND,BCL,CONCLUSION,HIF,IRI,LABEL,LEWIS,METHODS,PHOSPHO,RECIPIENTS,RESULTS,SOLTRAN,TLR,XENON
150,169,254,519,595,746,CHINA,CHINESE,COX,EASTERN,GROUP,LABEL,METHODS,NON,OBJECTIVE,PHASE,PRESS,PUBLISHED,RESULTS,STAGE,TARCEVA,TREATMENT,TRUST,UNIVERSITY
169,200,230,ALK,LADCS,RET,SNF,SWI,THESE,WHOLE
108,169,AKT,AUTHORS,BECAUSE,EXPRESSION,LTD,PTY,PUBLISHING,SCIENCE,WILEY
371,ACA,ANGIOGENIC,CAM,CD105,EXPRESSION,EXTENSIVE,LOW,MEL,MVD,NSCLC,SCC
169,ANALOGOUS,ANGPTL7,ATLAS,CD11B,CONCLUSION,EXPRESSION,HEPATIC,LABEL,LEWIS,LIVER,MYELOID,UNLABELLED
231,954,H1339,HSP90,INHIBITION,MDA,NKG2D,NVP,SP1,THEREFORE,THESE
ACCORDING,AFTER,CONCLUSION,ERM,GV248,LABEL,LENTI,LENTIVIRAL,LENTIVIRUS,METHODS,MOI,OBJECTIVE,PCR,RAT,RESULTS,WESTERN
104,145,169,279,DEPENDING,FOXM1,FUNCTIONAL,HOWEVER,LABORATORY,MITRA,PRESS,PUBLISHED,SOCIETY,USING

169,COPYRIGHT,INC,KEAP1,WHOLE
ANNEXIN,CCK,GINSENG,HCS,RADIX,RHIZOMA,SALVIAE
CLONTRACER,HOWEVER,RESISTANCE,THESE
DIFFUSE,PULMONARY,THESE
PARP1,USING
REDUCED
169,AMONG,CHILDHOOD,CONCLUSION,DIFFUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SURVIVORS,THESE
DIAGNOSIS
001,005,169,367,711,ACUTE,BACKGROUND,END,HOWEVER,IRR,LABEL,MATCHED,METHODS,MORTALITY,NSCLC,OVERALL,POISSON,RESULTS,SOCIETY
157,158,169,245,248,249,273,AUTHORS,BAP,COPYRIGHT,CPG,FOLLOWING,FURTHER,HUF,HUPKI,NER,PUBLISHED,SOMATIC,THEREFORE,WHILE,XPA
169,ARG,BIOLOGY,EMT,HOWEVER,INC,MOLECULAR,PRMT1,PROTEIN,SOCIETY,TAKEN,THEREFORE
AIR,FEW,ILD,THERE
169,COPYRIGHT,LTD,NSCLC
ALTERED,FIBULIN,PVA
180,210,240,AIM,BACKGROUND,BLOOD,CERVICO,CONTROL,LABEL,METHODS,NEITHER,OBJECTIVE,RESULTS,SIX
140,THERE
002,ART,BACKGROUND,CONVERSELY,HIV,HODGKIN,IRR,JOINT,KAMPALA,LABEL,METHODS,NATIONS,POISSON,PROGRAM,RESULTS,SAHARAN,THESE
169,COPYRIGHT,EMT,INC,NSCLC,TRIPARTITE
169,30D,CCNE2,COPYRIGHT,IRELAND,LTD,MICRORNAS,NSCLC
160,169,CONSISTENT,COPYRIGHT,EFFECTORS,INC,NSCLC,RAC,TRAIL
ADC,CPG,FUNCTIONAL,SCC,USING
204,347,856,POPULATION,POTENTIAL
NATURAL
169,ALK,AMONG,COPYRIGHT,FGFR1,LTD,MET,NSCLC,RET
160,169,COPYRIGHT,HOWEVER,III,LOCALLY,METASTATIC,PUBLISHED,SAS
169,AFTER,COPYRIGHT,INC,LOBECTOMY,PUBLISHED,SOCIETY
169,AFTER,COPYRIGHT,GENERALLY,HOWEVER,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PRIMARY,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,GIVEN,INC,PUBLISHED,SOCIETY
001,021,100,169,268,826,COPYRIGHT,INC,LABEL,MALIGNANT,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SPN,SURGERY
169,ADVERSE,COPYRIGHT,DFS,DISTANT,INC,KARNOFSKY,LABEL,LRC,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THREE,TOXICITIES,TREATMENT
169,COPYRIGHT,III,MEDLINE,PUBLISHED,SAS
107,169,COPYRIGHT,INC,LABEL,LOW,METHODS,NUCLEAR,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY
169,AKT,COPYRIGHT,ERK,HUVEC,INC,NSCLC,PD0325901,SINCE
500,916,945,956,968,BACKGROUND,BAX,BCL,CLEAVED,CONCLUSION,DEX,LABEL,METHODS,OXIDATIVE,RESULTS,ROS,THEIR
COLON,EXPERIMENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
026,169,BRCA2,LATIN,PRESS,PUBLISHED,SNP,UNIVERSITY
HOWEVER,JANUARY,OCTOBER
125,169,228,283,327,373,624,658,677,725,729,799,874,COX,FURTHER,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
001,500,945,946,BACKGROUND,BED,DMEAN,HEART,LABEL,LADCA,METHODS,RESULTS,V10,V14,V90,V95
187,BACKGROUND,CLINICIANS,DETECTION,ITALIAN,LABEL,METHODS,OBJECTIVE,RESULTS,TRIAL
026,100,116,139,169,374,704,ASSESSMENT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSI,SIXTY,THESE
169,230,233,584,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
001,004,064,108,130,238,569,AFTER,CONVERSION,FEW,INTUBATED,OVERALL,SEPTEMBER,TEA
001,002,006,034,113,771,954,IIP,NTM
109,129,361,554,745,AMONG,DESPITE,HCV,INCREASING,WHETHER
99M,CURRENT,FDG,HOWEVER,MDP,NAF,PET
000,071,099,100,102,112,124,130,152,168,169,174,617,945,AFTER,BLOOMBERG,HOPKINS,HOWEVER,JOHNS,PLATEAU,PRESS,PUBLISHED,UNIVERSITY
169,946,AUTOPHAGY,COPYRIGHT,FOXO1,GAL,HDAC1,IMR,NRF,SIRT1,SIRT6,THEREFORE
1930S,1950S,PAP,SINCE
100,AMONG,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PNA,PTC,PURPOSE,RESULTS,SEVENTY,THESE,V600E
485,7TH,CONCLUSION,EIGHT,GENERAL,LABEL,METHODS,MRI,OBJECTIVE,OPERATIVE,RECORDS,RESULTS,RULES,THREE
BECAUSE,RCC,UNDER
101,934,BMS,DES,HOWEVER,INCREASING,MARCH
CHEST,COLLEGE,PHYSICIANS,SINCE
047,AMONG,APRIL,ASPIRIN,EIGHT,MARCH,THREE
005,ACCORDING,AMONG,BACKGROUND,IHD,JANUARY,JAPAN,LABEL,LOBECTOMY,MATERIALS,MEN,METHODS,RESULTS,UNIVARIATE,UNIVERSITY,VIDEO
135,DRUGELUTED,IHD,SHORT,THERE,THESE,VSA
FIFTEEN,HOWEVER,THESE
458,BETWEEN,FORTY,SHORT,THERE
001,005,023,024,177,467,APRIL,CONCLUSION,FIFTY,LABEL,MARCH,RESULTS,THERE,UNLABELLED
399,411,418,ASIAN,BIOLOGY,CHINESE,THEIR,XRCC1
169,442,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
100,169,196,225,497,552,8GY,BED,BIOLOGICAL,COPYRIGHT,COX,EFFECTIVE,GROUP,III,INC,IQR,LABEL,MATCHED,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THERE
169,946,947,ATM,CELLS,COPYRIGHT,H1299,INC,INHIBITION,LABEL,LEWIS,LLC,MATERIALS,METHODS,NCI,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,TGF,THESE,TRP53
231,946,956,HOWEVER,HSA,MANNICH,MAP,MDA,THREE
BAL,CHEST
FOLLOWING,MINIMAL,THEREFORE,TKI


ABDOMINAL,PHYSICIANS,SEVEN,THEREFORE
137,160,169,250,53BP1,947,956,BRAGG,COPYRIGHT,FANCONI,GROWING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RAD51,RBE,RESULTS
000,160,169,836,COPYRIGHT,EAR,INC,LABEL,LRT,MATERIALS,METHODS,MVA,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SIR
HOWEVER,PCR,SGMS1
104,172,177,181,198,204,226,300,393,74YEARS,ASA,ECG,ILL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,P4E,RESULTS,THESE,UNLABELLED
CONCLUSION,DEPARTMENT,HOWEVER,LABEL,METHODS,OBJECTIVE,PULMONARY,RESULTS,SEPTEMBER,SURGERY,THERE
489,EMT,HOWEVER,INHIBITION,NON,NSCLC,SMALL,SUZ12,WESTERN
125,169,ADC,AIM,ALK,ATS,BASEL,ERS,IASLC,L858R,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,THESE
GPCRS,S1P,WHILE
124,317,513,CONGESTIVE,HOWEVER,INPATIENT,THERE
308,473,AKT,ALDH1,CD133,NSCLC,SER,SGPP1,TARGETING,THR
169,629,ACIDS,NUCLEIC,PRESS,PUBLISHED,UNIVERSITY,USING
101,103,105,109,12H,158,AUC,BACKGROUND,COMPARISON,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS
169,BACKGROUND,FNA,LABEL,MEDICAL,METHODS,PANCREATIC,RESULTS,SOCIETY,THERE
169,CD207,DESPITE,HEMATOLOGY,LANGERHANS,LCH,REGARDLESS,SOCIETY
DIAGNOSIS,HOWEVER,PEH,PET,THERE
ABOUT,CHEST,COP,DESPITE,HOWEVER,NIP,VIDEO
143,169,BACKGROUND,COPYRIGHT,CPG,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
001,002,003,169,AFTER,BACKGROUND,C30,COPYRIGHT,EPD,HRQOL,INC,LABEL,MAXIMAL,METHODS,PUBLISHED,PULMONARY,QUALITY,RESULTS,SOCIETY,TREATMENT,WORLD
121,147,169,177,198,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE
169,BACKGROUND,COPYRIGHT,FEW,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
169,COPYRIGHT,DARWINIAN,OWING,PUBLISHED
169,231,946,COPYRIGHT,EMT,FAK,IRELAND,LTD,MDA,PACLITAXEL,STRIKINGLY,TAKEN,U87VIII
116,956,ANOTHER,H1299,HCT,ROS,SAN4601,SAN5201,SAN7401
169,COPYRIGHT,HLA,HOWEVER,INC,LFA,NKG2A
169,COPYRIGHT,CURRENT,LTD
100,169,291,ACCORDING,BACKGROUND,COPYRIGHT,GGO,INC,LABEL,METHODS,PUBLISHED,RECURRENCE,RESULTS,SOCIETY
109,169,BACKGROUND,COPYRIGHT,COX,INC,LABEL,METHODS,METHYLATED,NSCLC,PUBLISHED,RESULTS,SOCIETY,SURGERY
169,177,BACKGROUND,CONCLUSION,COPYRIGHT,DEFORMABLE,DIR,ELASTICITY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MPN,OBJECTIVE,PURPOSE,RESULTS,VOLUMES
169,ACADEMY,ADDITIONAL,BACKGROUND,BASEL,GROUP,IAC,LABEL,METHODS,OBJECTIVE,PARIS,RATIONALE,REFERENCE,SOURCES
169,COPYRIGHT,INC,MALIGNANT,MPM,SEVERAL,THESE
169,33324,946,ANNEXIN,BAD,BAX,BCL,COPYRIGHT,H1299,HOECHST,IRELAND,LTD,MTT,NCI,WESTERN
169,AMONG,COPYRIGHT,EGF,IRELAND,LTD,RG3,THESE,THROUGH
169,CELLULITIS,COLLEGE,PHYSICIANS,ROYAL
100,945,946,AMRUBICIN,FEBRILE,GRADE,NSCLC,ORR
001,100,120,169,480,600,ADDITIONAL,ASPIRATES,BASEL,CHINA,JAPAN,LABEL,LBC,METHODS,OBJECTIVE,OL8,OLYMPUS,RESULTS,SEPTEMBER,TOKYO
215,ABDOMINAL,CLOSE,FIFTEEN,THERE,TREATMENT
ACCORDING,AIM,BAL,BASED,CONCLUSION,LABEL,LATER,METHODS,OBJECTIVE,RESULTS,THREE,TREATMENT,USG
ADULT,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SHAUKAT
CHEST,FIBREOPTIC
100,178,AMONG,BACKGROUND,GEFITINIB,INDIA,KARNOFSKY,LABEL,LIMITED,METHODS,NORTH,NSCLC,OCCURRENCE,RESULTS,TKI
160,947,DOTATOC,HOWEVER,PHE,TAKEN,THEIR,TYR
BACKGROUND,LABEL,METHODS,PCB,RESULTS,THESE
954,EPIGENETIC,MEDIP,THESE,USING
945,INHIBITION
169,987,COX,F2RL3,HARRELL,HRS,MASSARRAY,SMOKING,THESE
169,207,ATP,COX,GLN,NSCLC,TARGETING,THESE
AKT,ERK,IGF,IRS,SRC,TREATMENT,WESTERN
001,016,024,043,065,072,078,115,127,177,453,547,813,814,816,946,ELISA,FIRST,NSCLC,OCTOBER,PLT,TGF,THEREFORE
103,946,CLAUDIN,DECREASED,SIMILARLY,TNM,UNIVARIATE
008,033,034,038,041,115,946,954,COX,DFS,EXPRESSION,IHC,NUCLEAR
169,16HBE,HOWEVER,INC,LOC728228,PCR,WILEY
169,COPYRIGHT,INC,NSCLC
160,169,1ST,231,233,ALK,AP26113,COPYRIGHT,HOWEVER,III,NSCLC,PROFILE,PUBLISHED,SAS
169,490,BCL,CCND1,COPYRIGHT,FEDERATION,GYNECOLOGY,IRELAND,LTD,MIR,OBSTETRICS,P53,SMARCD1,THESE
293,711,861,CONCLUSION,FIFTY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
001,005,008,017,026,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM,WESTERN
008,084,100,157,178,185,298,356,453,474,501,692,927,967,CONCLUSION,EUR,FDG,LABEL,METHODS,NPV,OBJECTIVE,PET,PPV,RESULTS,ROC,SPECT
177,CONCLUSION,LABEL,METHODS,MWA,OBJECTIVE,RESULTS,SEVEN,ULTRASOUND
BACKGROUND,INCREASING,LABEL,METHODS,NONCODING,NSCLC,RESULTS,SNHG1
AFTER,BACKGROUND,COMPARING,GEFITINIB,LABEL,LIBRARY,MATERIALS,METHODS,NSCLC,ORR,PFS,RESULTS,THERE
300,500,CONCLUSION,DDP,ELISA,LABEL,METHODS,MPM,OBJECTIVE,ORR,PFS,RESULTS,THERE,TOXICITIES
FURTHER,L9981,LABEL,MATERIALS,METHODS,MICRORNAS,NEAT1,OBJECTIVE,PCR,RESULTS
BACKGROUND,CHINESE,COLLEGE,CONCLUSION,ENGLISH,III,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,STATA,STATION
945,947,BARRETT,DUOX1,DUOX2,KNOWLEDGE,NADPH,NOX,ROS
169,176,257,BACKGROUND,CBCTS,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NCC,OBJECTIVE,PURPOSE,RESULTS,USING,VPE
169,COPYRIGHT,COX,DESPITE,INC,NSCLC,SILENCING,USP22
169,4DCTS,BECAUSE,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFT,PULMONARY,PURPOSE,REGRESSION,RESULTS,V20,VALIDATION
131,162,169,214,323,500PG,504,COPYRIGHT,DIAGNOSTIC,DTC,INC,KEY,LABEL,MEIER,METASTASIS,METHODS,MIDKINE,OBJECTIVE,PRE,PROGNOSTIC,RESULTS,ROC
100,375,CNB,JANUARY,MOLECULAR,ROUGHLY
169,178,AIM,BMI,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,RESULTS
169,946,ABL,ARG,HEART,INC,THESE
169,ALLOGENEIC,CONSISTENT,DLI,GVL,HEMATOLOGY,MEMBERS,SOCIETY,TREGS
019,169,CONCLUSION,DTC,FDG,FORTY,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PDTCS,PET,RESULTS,SOCIETY,THERE,THESE,THYROID,UNLABELLED,V600E
169,COPYRIGHT,INC,STUDIES,THESE
100,169,200,518A2,956,COPYRIGHT,DECREASED,FURTHER,HACAT,HOWEVER,IRELAND,LTD,MRC,NCI,ROS,TEMPONE,TXR
100,169,250,53BP1,956,CAPSAICIN,COPYRIGHT,DU145
169,360,386,400,ALK,ALKEX20,AMONG,COPYRIGHT,DCTN1,DETECTION,EML4EX6,IRELAND,LTD,NSCLC,OVERALL,PCR,PUBLISHED,SYSTEMATIC
ALK,DETECTION,III,NSCLC,PRIMARY,SEVENTY
001,005,169,353,BACKGROUND,COPYRIGHT,EXCLUDING,HEALTHCARE,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,PROJECT,QUALITY,RESULTS,USING
65291,AFTER,HODGKIN,UNDER
100,945,AFTER,OVERALL,RCC
CBDCA,PFS,PTX
DTX,PTX,THEREFORE
CK7,HOWEVER,SUBSEQUENT,THEREFORE
STAGE
HOWEVER,PACLITAXEL,PFS
CARVEDILOL,FURTHER,JOINT,NADPH,PHYCB
114,945,950,HACAT,HDF,MANGOSTIN,MCF,MTT,NMR
DESCRIBED,NOTABLY,RUNX3
THERE
RESPONSES,RESULTS
176,177,CONCLUSION,CT0,D95,DIR,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,THREE
169,945,946,AAN,AKT,BRITAIN,COPYRIGHT,GREAT,HOWEVER,IRELAND,LTD,PAI,PUBLISHED,SER15,SIMILARLY,SMA,SMAD3,SOCIETY,STZ,TGF,TUBULAR,UUO,WILEY
COMPETING,GRAPHICAL,MRE,THEREFORE,UTR,VIA,WHILE
169,AKT,CLEAVED,EXPRESSION,HOWEVER,LEC,LM2,VEGFR
169,ANEUPLOIDY,CELLS,CP110,MECHANISMS
169,CDC20,INC,SIXTY,WEBGESTALT,WILEY
169,CONCLUSION,CXCR4,DEN,HCC,LABEL,LIVER,MMP,MMP10,PREVIOUSLY,UNLABELLED
100,BAX,CASPASE,CONCLUSION,FURTHER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,UNDER,WESTERN
ANNEXIN,BACKGROUND,LABEL,METHODS,PCR,RESULTS,TAXOL,THERE,WESTERN
AKT,ALK,RAF
HOWEVER,NSCLC
001,008,032,113,GCN,INCREASED,LABEL,MATERIALS,METHODS,MYC,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SCC,UNIVERSITY
AMONG,EIF3L
169,231,BAPTA,BIOLOGY,ENO,GOLGI,INC,LPS,MDA,MOLECULAR,ORAI1,SOCIETY,STIM1,THESE
152,170,200,247,274,280,291,300,320,690,956,AFTER,CATLE,EMT,ERK,HIF1A,HMOX1,HPL,INC,INCREASED,INORGANIC,PUBLISHED,SLC38A3,VIM
169,COPYRIGHT,INC,PECOMAS,TFE,THERAPY
CURRENTLY,ELISA,HOWEVER,SMOKING,TOF
BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,THEREFORE,URINE
ACR,COLLEGE,INDUCTION,LITERATURE,PANEL,RADIOLOGY,THERE
169,CONCLUSION,HIPAA,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS
945,BECAUSE,CMPTS,TEN,TTF
12A,169,945,946,AMONG,INC,MRC,TNF,WILEY
BACKGROUND,IIA,IIB,ITALY,LABEL,METHODS,POPULATION,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
032,AMONG,PFS,PRIMARY
169,APMIS,DESPITE,EMA,INTRA,LTD,MRI,PUBLISHED,WILEY
169,183,300,329,332,661,AFTER,BACKGROUND,COPYRIGHT,FEB,FUNDING,KARNOFSKY,LABEL,LTD,MERCK,METHODS,RESULTS,VORINOSTAT
169,348,ACIDS,CBP,FURTHER,H3K27,HOWEVER,NUCLEIC,PRESS,PUBLISHED,SIRT1,UNIVERSITY
229,248,477,CELSIUS,INSTITUTE,JANUARY,LOCAL,MRI,RADIOLOGY
169,FINALLY,G3BP1,SGS,UNDER,UTR
212,225,252,257
COLORECTAL,DUE,EBOLA,PREVENTION,PRITELIVIR
AREAS,BACKGROUND,COVERED,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,OPINION,PROTEOMIC
191,BENEFICIAL,CHINESE,FURTHER,PARKINSON,PHYSICIANS,TAI
115,169,COPYRIGHT,IONTORRENT,MALIGNANT,PUBLISHED,THERE
100,188,ACTIVIN,TNM
169,BIBX1382BS,CONCLUSION,COPYRIGHT,EGF,FUNCTIONAL,H1299,H3122,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SINCE,STRIKINGLY
005,007,023,027,033,046,10878,110,169,331,808,ACCORDING,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,GROUP,IRELAND,LABEL,LTD,MALIGNANCY,MASAOKA,METHODS,RECURRENCE,RELAPSE,RESULTS,WORLD
169,CONTINUOUS,HOWEVER,LOW,PRESS,PUBLISHED,SMOKING,THESE,UNIVERSITY
001,130,140,165,166,169,313,529,852,977,AMERICANS,ASIAN,BACKGROUND,BECAUSE,CHINESE,CSM,DESPITE,END,HAWAIIANS,KOREANS,LABEL,METHODS,PACIFIC,PAKISTANI,PRESS,PROGRAM,PUBLISHED,RESULTS,SOUTH,THESE,UNIVERSITY,VIETNAMESE
005,029,047,102,169,222,508,578,896,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,HCC,INC,JANUARY,KOREA,LABEL,MEDICAL,MEIER,METHODS,PIVKA,RECURRENCE,RESECTION,RESULTS,SAMSUNG
169,231,233,BACKGROUND,CAUCASIANS,CHINA,COPYRIGHT,HOWEVER,KNOWLEDGE,LABEL,MEDLINE,METHODS,OVERALL,PUBLISHED,RESULTS,SAS,STRATIFIED,THERE,THR241MET,TOTAL,XRCC3
BIOLOGICAL,COMMITTEE,CONCLUSION,EFFECTS,END,INCREASES,LABEL,MATERIALS,METHODS,OBJECTIVE,RADIATION,RESULTS,SCREENING,VII
100,120,177,CONCLUSION,FBP,FIFTY,IMAGE,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS
041,141,177,242,CHEST,CONCLUSION,HEALTHCARE,INDIVIDUAL,ITERATIVE,LABEL,MATERIALS,MAXIMUM,METHODS,MICRODOSE,MIP,OBJECTIVE,RESULTS,SIEMENS,STELLAR,THESE
339,APM,COX,DATABASES,JANUARY,NETWORK,PROGRAM,USING
239,947,CD4,IFN,MHC,STUDIES,THESE
174,CDK,IBRANCE,III,INSTITUTE,PHASE,USA
148,169,224,299,811,AMONG,BACKGROUND,COPYRIGHT,COX,END,III,INC,LABEL,METHODS,MPM,OVERALL,RESULTS
169,COPYRIGHT,FURTHER,INC
100,168,169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,RESULTS,RFS
169,COPYRIGHT,IIA,LPS,PLA2G2A,PRE
HARMS
001,149,169,183,285,BACKGROUND,BJS,CONCLUSION,GROUP,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SOCIETY,TEN,WILEY
004,872,BACKGROUND,FREQUENTLY,LABEL,LAM,METHODS,MORTALITY,NINTH,POPULATION,RESULTS,REVISIONS,THERE,THESE,TSC
009,169,ADC,BACKGROUND,GUIDELINES,HOWEVER,LABEL,METHODS,NUCLEAR,RESECTIONS,RESULTS,SOCIETY
122,AEG,AUF,HCC,PCR,TAKEN,TREATMENT,WESTERN
169,956,BIOLOGY,INC,MOLECULAR,NMR,SOCIETY
RESTORING
III,MRI,PPB
100,APC,CRC,FBXW7,SMAD4,SOMATIC,SYNE1
158,221,COHEN,INTERNS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
162,169,179,885,999,AUC,AUTHORS,INC,NON,NSCLC,PIS,PSS,PUBLISHED,ROC,SMS,THESE,WILEY
ANTAGOMIR,CD133,CSLCS,SRC,THESE
116,11C,18F,FDG,LABEL,METHODS,OBJECTIVE,PET,REGARDLESS,RESULTS,SUV,THREE,VALUE
001,003,169,496,635,AMONG,BACKGROUND,III,JANUARY,KARNOFSKY,LABEL,MEIER,METHODS,PROGNOSTIC,RESULTS,SOCIETY,STAGE,TNM
EIGHT,SCP1833,SCP4175,THESE
001,005,011,AIM,CONCLUSION,CRC,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SERUM,SIX
169,454,BLEISWIJK,COPYRIGHT,ION,LABEL,MACHINE,METHODS,NGS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,ROCHE,ROTOR,SEQUENCER,SOCIETY,TORRENT,VENLO
169,531,AFRICAN,AMERICANS,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THESE
169,COPYRIGHT,HACAT,HEPG2,LTD,ROOTS,WHILE,WILEY
110,150,160,172,222,ADULT,CHINA,CLINICALLY,COLLEGE,CONCLUSION,JANUARY,LABEL,LANGERHANS,LCH,MEDICAL,METHODS,OBJECTIVE,RESULTS,SCIENCE,SICHUAN,TECHNOLOGY,THERE,UNION,UNIVERSITY
233,HYACINTHE,LAENNEC,PARIS,REN
114,BECAUSE,DFS,DIAGNOSTIC,INSTITUTE,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIOLOGY,RESULTS
105,112,120,149,151,BED,CRC,CSS,DFS,EXCELLENT,LABEL,LOCAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THREE
004,007,100,217,3RD,CHT,EARLY,FORTY,LABEL,METHODS,MST,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THESE,THREE
668,677,CBS,CONCLUSION,EPIDERMAL,FORTY,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS
CONCLUSION,JANUARY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SEVENTY
719,CONCLUSION,CRC,EVALUATING,LABEL,MCNEMAR,METHODS,OBJECTIVE,PCR,PFS,PURPOSE,RESULTS,WHILE
112,BACKGROUND,BMJ,CARCINOID,DISEASE,GROUP,IBT,ICEBERG,LABEL,LIMITED,METHODS,MINIMUM,PUBLISHED,PUBLISHING,RESULTS
169,CK5,COPYRIGHT,IHC,INC,NSCLC,SCC,SEVERAL,TTF
100,128,169,ALK,BECAUSE,CK7,COLLOID,COPYRIGHT,INC,SEVEN,THREE,TTF
CALCIUM,CD318,CDCP1,CUB,FUNCTIONAL,ORAI1,STIM1,STOCS,THESE,TRASK
22G,ASSESSMENT,COMPARISON,CONCLUSION,GLOBE,GROUP,HITACHI,LABEL,METHODS,OBJECTIVE,RESULTS,SEQUENTIAL
041,075,172,239,239PU,439,849,945,947,CONTROL,EXB,GSTM1,GSTP1,GSTT1,HARDY,ILE105VAL,MAYAK,MAYAL,NAT,THREE
ANP,B16,THESE
945,947,ALTOGETHER,HOWEVER,MYC,SCF,USP,USP36
100,ALK,BACKGROUND,CONCLUSION,HRS,LABEL,METHODS,NSCLC,PFS,RESULTS
945,AMD3100,BACKGROUND,CXCR4,ENDOGENOUS,FINALLY,FUNCTIONAL,FURTHER,H1299,HIF,LABEL,METHODS,PCR,PRINCIPAL,RESULTS,SDF
012,033,119,BACKGROUND,CASES,E1L3N,LABEL,METHODS,MPM,PD1,RESULTS,THERE
IMMEDIATE

500,946,EIGHT,H1299,ITGB3BP,SHC,SRPK1,USING
ACADEMY,AWARD,BRINKER,DIMITRIOS,DOCTORATES,FOUNDATION,HARVARD,HONOR,INSTITUTE,KAROLINSKA,MEDAL,PRESIDENT,PREVENTION,PROFESSOR,UNIVERSITY
160,169,COPYRIGHT,H3K4ME1,HISTONE,HOWEVER,INC,OGT
CONCLUSION,LABEL,METHODS,OBJECTIVE,OCT,OHP,PCR,PURPOSE,RESULTS,WESTERN
HOWEVER,LOW,NSCLC,VIDEO
100,693,ADC,ALU,CPG,STAGE
125,160,169,COPYRIGHT,EXPRESSION,INC,MIR,MMP,NSCLC,PCR
001,012,017,169,218,COPYRIGHT,INC,MEIER,NSCLC,OLFM4,OVERALL
109,149,169,452,946,956,AHR,COPYRIGHT,CZECH,EOM,PM2,TGF,WNT
015,036,169,215,CHINESE,COPYRIGHT,GLU185GLN,HOWEVER,PUBLISHED,THESE
000,100,169,90S,AMONG
106,169,ABOUT,AIM,BRAIN,CNS,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNLABELLED
169,1MM,1SD,2MM,4MM,8MM,931,945,9MM,CONCLUSION,COPYRIGHT,GTV,III,INSTITUTE,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,SIXTEEN
169,183,264,276,298,304,364,374,BIOLOGY,DDIT3,HOWEVER,INC,JUN,K14,KAT2A,MOLECULAR,SOCIETY,THESE,TNFRSF10A,TNFRSF10B,TRAIL
169,179,215,AMONG,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SPHINCTER,UPFRONT
169,AHR,COPYRIGHT,ILC2S,INC,STAT5,TH2
020,024,030,067,072,100,113,121,128,141,169,177,215,698,890,CONCLUSION,COPYRIGHT,ESTIMATED,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERCENTAGE,PURPOSE,RESULTS,THESE,USING
000,001,002,006,102,169,1ST,2ND,3RD,440,4TH,5TH,956,ACUTE,BACKGROUND,CHINA,CONCLUSION,COPYRIGHT,III,INSTITUTE,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,RESULTS,SEPTEMBER
169,BAX,BENZO,CL3,COPYRIGHT,EMSAS,ERK,EXPRESSION,H1299,H1355,H23,MYC,NSCLC,PD98059,PHOSPHO,SER15,SER20,TAKEN,WESTERN
100,BACKGROUND,LABEL,METHODS,QOL,RESULTS,THERE
169,AUTHORS,FK506,FKBPL,HOWEVER,IL8,LABEL,MOUSE,OBJECTIVE,RESULTS
169,392,946,BIOLOGY,ERK,INC,MH2,MOLECULAR,R175H,SER,SILENCING,SMAD2,SMAD3,SMAD4,SOCIETY,TGF
154,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,ENGLAND,FIFTY,LABEL,LTD,MATERIALS,MAY,METHODS,MRI,NETWORK,OBJECTIVE,PUBLISHED,RESPONSES,RESULTS,ROYAL,THERE
169,716751G,AFTER,ALK,AML,COPYRIGHT,INC,PCR,REVERSE
039,042,112,177,500,712,BACKGROUND,ELISA,LABEL,METHODS,NSCLC,RESULTS,THERE
169,16S,177,231,458,488,BCL,COPYRIGHT,FOURIER,IRELAND,LTD,MDA,MPCAB,NMR,THESE
169,CD8,COPYRIGHT,SCIENCE
163,169,964,FOS,GIANT,INC,MEIER,MICROARRAY,MMP,PROTEIN,PUBLISHED,RANKL,SOCIETY,WILEY
INTEGRATED,MOLECULAR
100,241,556,718,762,ADC,BACKGROUND,CUMULATIVE,FURTHER,HODGKIN,JANUARY,LABEL,METHODS,NNRTI,PIS,POISSON,RESULTS
006,015,027,169,215,247,251,657,AFTER,BACKGROUND,BONFERRONI,COLORECTAL,LABEL,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OVARIAN,PEARSON,RESULTS,SCREENING,SERUM,SOCIETY,TRIAL,USUAL
169,440,AMONG,ANXIETY,DEPRESSION,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SCALE,UNIVERSITY
26B,KNOCKDOWN,LUCIFERASE,SMAD1
045,AMONG,BACKGROUND,CONCLUSION,COX,EFFORTS,LABEL,METHODS,ORS,RESULTS,SEP
BACKGROUND,CHILE,CHILEAN,DISABILITY,HINDERING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PERSISTENT,RESULTS,SOUTH,YEARS
HOWEVER,IMAGING
NSCLC
000,100,186,264,410,413,433,543,544,688,700,709,993,BACKGROUND,BECAUSE,CXR,DANTE,DETECTION,HOWEVER,LABEL,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SCREENING,SECONDARY,TECHNOLOGY,THEIR,TRIAL
AFTER,ERBB1,MNS
100,101,210,315,CAC,CHD,CONCLUSION,COX,HIPAA,IMAGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCREENING,TRIAL
500,RESECTION,SURGERY,VINCI
AUTOPSY,CD117,GASTRIC,HISTOLOGY,HOWEVER,III,RADIATION
ACTN4,BINDING,CONSISTENT,DESPITE,HCC,HOWEVER,PLC,PRF,PROTEIN,THESE
BMJ,CALIFORNIA,CIS,COX,GROUP,HRS,INDEX,LABEL,LIMITED,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR,WORKERS
169,ALK,AMONG,COPYRIGHT,INC,P2Y,PKC
342,BACKGROUND,BMJ,DISEASE,GROUP,LABEL,LIMITED,METHODS,ORS,PUBLISHED,PUBLISHING,RESULTS,THERE
CUSHING
FURTHER,NSCLC,OCTOBER,ORS
169,BASED,COPYRIGHT,CXR,DTS,INTER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
ANCHORAGE,H2009,SIMILAR
001,002,10878,147,257,272,453,490,576,BACKGROUND,IQR,LABEL,METHODS,MPM,NEUTROPHIL,NLR,PET,RESULTS,SERUM,SEVENTY,TGV,TTP
006,012,BACKGROUND,BSC,C30,COMPLIANCE,EORTC,HRQOL,LABEL,METHODS,MPM,PATIENT,QLQ,RESULTS,SEVENTY
174
320,484,BACKGROUND,EXPRESSION,FRESH,HSA,INTEGRATED,LABEL,MET,METHODS,NOTCH,RESULTS,THESE
169,COPYRIGHT,EXOGENOUS,H1299,IRELAND,LTD,THESE,USING,UTR
001,160,169,3DCRT,COMBINING,COPYRIGHT,HODGKIN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TREATMENT,V20GY
169,ADVERSE,AMONG,APRIL,COPYRIGHT,FURTHER,GRADE,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RBE,RESULTS,V20,V95
027,074,169,AFTER,CHEST,COPYRIGHT,HOWEVER,INC,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,THERE,WILMS
169,AGA,BACKGROUND,COLORECTAL,COPYRIGHT,CRC,EXPRESSION,INC,INSTITUTE,LABEL,LYMPH,METASTASES,METHODS,OBJECTIVE,PUBLISHED,RESULTS,STRATEGIES,VEGFC
169,664,751,773,803,804,830,860,973,ASIAN,MORTALITY,PCDFS,SMR,YUCHENG,YUSHO
230,584,CYTOSCAPE,DATASET,ENRICHMENT,EXPRESSION,INADL,LABEL,LIMMA,MAP,MATERIALS,METHODS,NSCLC,OBJECTIVE,OMNIBUS,PLCB3,PLCE1,PPI,PROTEIN,RESULTS
169,ADP,BAX,BCL,COPYRIGHT,GBA,HOWEVER,LEWIS,LTD,MCL,MYELOID,NSCLC,OVERALL,TUNEL,WESTERN,WILEY
003,016,047,946,BBS,BESNIER,BOECK,ELISA,NSCLC,SCHAUMANN,SERUM,TGF
EARLY,FAM107A,MSP,NSCLC,TOTAL,TSG
169,726,956,B16,COLON,COMPLEX,COPYRIGHT,DFT,IRELAND,LTD,MDA
169,945,946,CONCLUSION,COPYRIGHT,CSC,DCC,DLQ,FITTING,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLQ,SMALLER
000,169,200,569,ART,CONCLUSION,COPYRIGHT,CRT,INC,LABEL,LYS,MAASTRO,MATERIALS,METHODS,MODEL,NSCLC,OBJECTIVE,PET,PRIMARY,PURPOSE,QALYS,RESULTS
169,COPYRIGHT,HSP27,HSP70,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WESTERN
169,359,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SASKATOON,SEVENTY
001,169,BECAUSE,COPYRIGHT,CRI,EASTERN,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PRE,PRIMARY,PURPOSE,RESULTS,SCALE,SECONDARY,SPR,TREATMENT,VAS
001,125,161,169,202,COMPETING,COPYRIGHT,CUMULATIVE,CURRENT,INC,LABEL,MATERIALS,MEIER,METHODS,NETWORK,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,215,COPYRIGHT,EIGHT,OVERALL,THEREFORE
BASED,FURTHER,H2SO4,MCF,SRB,VIS
AIM,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,PVN,RESULTS
001,015,049,120,130,177,225,ANOVA,BACKGROUND,CONCLUSION,COX,FRONTAL,GROUP,HOWEVER,LABEL,MATERIALS,MBT,MEIER,METHODS,OVERALL,RESULTS
123,F354L,FVPTC,JEGHERS,KDR,MET,N375S,PAPILLARY,PEUTZ,PPARG,PTC,Q472H,RET,STK11
BACKGROUND,CONTEXT,HOWEVER,LABEL,METHODS,PTS,SIX
001,225,323,ACTIVIN,BACKGROUND,CNC,CONTEXT,GIVEN,JANUARY,LABEL,MARCH,METHODS,MYOSTATIN,OBJECTIVE,OUTCOME,RESULTS,SETTING,THESE
100,149,177,407,BETWEEN,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
169,AIM,ALK,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SDI
169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DFS,DISTANT,INSTITUTE,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,OUTCOME,RADIATION,RESULTS
169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,177,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,LOBAR,METHODS,OBJECTIVE,RESULTS
104,169,254,293,422,678,ACTN4VA,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS
169,ANTICANCER,BACKGROUND,COPYRIGHT,DISCUSSION,EWING,INSTITUTE,LABEL,METHODS,NMC,NUT
036,037,074,147,169,745,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVERSITY
001,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
169,945,AIM,AKT,ANTICANCER,CK2,CONCLUSION,COPYRIGHT,FACSCAN,H1299,HOWEVER,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PACLITAXEL,PARP1,RESULTS,TREATMENT
169,17A,947,ANTICANCER,BACKGROUND,CD3,CD4,CONCLUSION,COPYRIGHT,HOWEVER,IFN,IL17A,IL6,INSTITUTE,LABEL,METHODS,REGULATORY,RESULTS,ROR,TREGS
169,ANTICANCER,CHINESE,COPYRIGHT,INSTITUTE,NSCLC,SHH,SMO,SONIC,YANGZHENG
169,214,452,574,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HNACC,HNSCC,INSTITUTE,LABEL,MATERIALS,METHODS,MIR,OBJECTIVE,RESULTS
169,4T1,APRIL,PRESS,PUBLISHED,SILENCING,STUDIES,TLR,UNIVERSITY
AMONG,BASED,SIMULATING,SYNTHETIC,UNTIL
BULKY,CROSS,CUMULATIVE,DETECTION,INERTNESS,INNOVATIVE,POC
000,150,800,900,CORRECTED,COSTS,GAMMA,HODGKIN,LABEL,METHODS,OBJECTIVE,PER,RESULTS,ZEALAND
021,103,151,209,236,339,564,599,938,AMONG,BIOMEDICAL,CONCLUSION,INNOVATION,INSTITUTE,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SMOKING,THYROID,UPPER
169,405,624,COPYRIGHT,INC,INDIVIDUAL
BACKGROUND,DFI,LABEL,METHODS,POTENTIAL,RESECTION,RESULTS,THREE
169,183,421,ASCOT,BACKGROUND,COPYRIGHT,FUNDING,INSTITUTES,JUPITER,LABEL,LTD,MALMO,METHODS,PROVE,RESULTS,SIMILARLY
169,COPYRIGHT,H1299,HOWEVER,IRELAND,LTD,MYC,RAS
002,003,127,168,169,179,215,315,341,849,925,AFRICAN,COPYRIGHT,INC,MERGING,PUBLISHED,SOCIETY,STUDIES,TGSII
169,945,AUTHORS,COPYRIGHT,HIF,INC,MYC,NSCLC,PUBLISHED,THESE
169,916,968,BAX,BCL,COPYRIGHT,H1299,HOWEVER,INC,NAC,ROS,THESE
064,100,875,901,ANALYZING,COLON,CONCLUSION,JAPAN,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SURGERIES,USING
CHANGES,ERK,INHIBITORS,JUN,MEK,MIGRATION,MTT,TAKEN,U0126,WESTERN
185,228,AFTER,AGNOR,BMF,LPG,NO2,PM2,ROS,SOD
169,945,ACCORDING,COPYRIGHT,IGFBP,INC,RESULTS,SERUM,VARIATIONS
BACKGROUND,BMJ,GROUP,INSPECTION,LABEL,LIMITED,METHODS,POE,PUBLISHED,PUBLISHING,RESULTS,SPN,THERE,TRIAL,USING
001,002,015,018,022,026,035,101,125,141,210,222,242,490,707,ADC,NSCLC,PCR,ROC,SCC,TNM
169,COPYRIGHT,FFF,FLATTENING,IRELAND,LTD
169,215,635,BACKGROUND,COPYRIGHT,FDR,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RADIOMICS,RESULTS,UNIVARIATE
169,COPYRIGHT,DELETED,DIFFERENT,DLEC1,HNSCC,HOWEVER,PCR
BOB,HODGKIN,OCT,PRIMARY
100,956,AUTOPHAGIC,AUTOPHAGY,BPA,CASPASE,DETECTION,DHA,EPA,GLO,KIT,PROMEGA,PUFAS,VIABILITY,XTT

ALK,BACKGROUND,EXPRESSION,IMT,LABEL,METHODS,THERE
AFTER,ARA,CCK,CONCLUSION,DDP,EFFECTS,LABEL,LRP,METHODS,NPC,OBJECTIVE,PCR,RESULTS,WESTERN
169,946,EMT,EPITHELIAL,OTHER,TGF
169,946,CSC,FUNCTIONAL,IKBKB,IKK,NOTABLY,THESE,WNT
169,EGF,FINALLY,MOUSE,RES,STAT3,STUDIES,TAKEN
169,233,HOWEVER,PCR,THESE
AFTER,HB1,LUNGS
169,945,946,BIOLOGY,IPF,LEUKOCYTE,ONO,SMA,SOCIETY,TGF,TREATMENT
CHEST,LABORATORY,PTHRP
THREE
1ST,2ND,HEMORRHAGE,STENT
CLEAR
CUSHING,HORMONE,SINCE
177,ADHERENCE,AFTER,ASSOCIATED,AUC,AUCSS,CONCLUSION,ERLOTINIB,ESPECIALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY

AFTER,HOWEVER,PARTIAL
HOWEVER
50S,AFTER,HOWEVER,III,JANUARY,MAY,PET,RFA
EIGHT,JOHNSON,SJS,STEVENS
GRADE
500,BACKGROUND,CISPLATIN,CONCLUSION,GRADE,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,THERE,THEREFORE
000,CHIBA,CURRENTLY,DAV,HEAVY,HIMAC,HOWEVER,HSP90,INSTITUTE,PROJECT
BRAGG,CHARGED,HENCE,PBT,TSUKUBA,UNIVERSITY
CONCURRENT,DISEASE,GRADE,GYE,NSCLC,PBT,V20
177,18F,197,251,FDG,FINALLY,MTV,NSCLC,PET,SUV,SUVMEAN,THERE,TLG,TNM
BMJ,COP,GOP,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SIXTY,WHILE


CHEST,DIAGNOSING
ACTIVATION,BACKGROUND,EXPRESSION,HOWEVER,KNOCKDOWN,LABEL,METHODS,NOTCH,RESULTS,THEREFORE
100,854,ACTIONABLE,AGENA,AUSTRALIA,BACKGROUND,BIOSCIENCE,LABEL,MASSARRAY,METHODS,MPS,OVERALL,PANEL,RESULTS,WHEREAS
328,543,ARG458X,BACKGROUND,BAX,FUNCTIONAL,LABEL,LYS469GLU,METHODS,NEITHER,NSCLC,PPM1D,RESULTS,THEIR,THESE
001,008,252,291,CLEVELAND,DETAILS,DISTANT,HOWEVER,HPV,III,IMPORTANCE,IMPORTANT,IVB,JANUARY,LABEL,METHODS,OBJECTIVE,OPSCC,RELEVANCE,RESULTS,SECONDARY,SETTING
001,002,115,947,ASA,BACKGROUND,CHEST,COLLEGE,EDUCATION,EVALUATION,FIFTEEN,LABEL,METHODS,PHYSICIANS,QUALITY,RELATIVELY,RESULTS,SECONDARY,SOCIETY,THERE,THESE
GRADUAL
104,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
450,BIVARIATE,LABEL,METHODS,MODEL,OBJECTIVE,OBJECTIVES,RECURSIVE,RESULTS,TAIWANESE
PJP
001,143,170,210,221,246,414,AFTER,AMONG,AUC,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
118,120,162,169,200,300,956,CAD,COPYRIGHT,FALSE,FBP,IRELAND,LABEL,LTD,METHODS,NOISE,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,SIMILARLY
945,946,PDGFR,POSTMORTEM,PULMONARY,TREATMENT
ABELSON,ALK,ASP,EML,H2228,MTS,NSCLC,RECURRENT,THESE,TRP
167,169,291,BACKGROUND,COPYRIGHT,GCT,GIANT,JOINT,JOURNAL,LABEL,METHODS,RESULTS,SURGERY,THERE
169,APC,APPROACHES,APRIL,AVERAGE,BACKGROUND,CAUTION,END,FIRST,INSTITUTE,LABEL,METHODS,RESULTS,SOCIETY
169,BACKGROUND,BECAUSE,BLADDER,HIV,LABEL,METHODS,ORS,RESULTS,SOCIETY
263,311,500,ABT,AZD8055,BCL,BH3,BIM,HOWEVER,MCL,RB1,SCLCS,THEREFORE,TORC1,WHEREAS
001,169,APHASIA,BACKGROUND,COX,HEART,INC,INSTITUTES,LABEL,METHODS,OBJECTIVE,PNEUMONIA,PURPOSE,RECURRENCE,RECURRENT,RESULTS,SCALE,TIA
DESPITE,NSCLC,THEREFORE
001,305,CD133,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM
169,ALK,CD133,COPYRIGHT,EMT,ERK,H1299,HOWEVER,INC,NSCLC,TAKEN
100,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS
169,COPYRIGHT,EOC,INC,LABEL,METHODS,OBJECTIVE,PCR,PFS,PRSS3,RESULTS,THERE,THESE
160,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STAT3
000,JAPAN,SCREENING
ERP29,HOWEVER,INHIBITION,THESE
160,169,183,GEORG,HENCE,STUTTGART
160,169,183,ALK,GEORG,GERMANY,STUTTGART
160,169,183,DIAGNOSIS,GEORG,STUTTGART,WORLDWIDE
003,037,106,124,168,475,963,AMONG,BACKGROUND,CHEST,DIAGNOSTIC,ENGLISH,LABEL,METHODS,PROGRAMMES,RESULTS
645,749,AMONG,BACKGROUND,CRUDE,DIAGNOSIS,HODGKIN,LABEL,METHODS,RESULTS,SIMILARLY
222,BACKGROUND,LABEL,METHODS,RESULTS,SEA,THERE
BACKGROUND,ENGLAND,FURTHER,LABEL,METHODS,RESULTS,SERVICE,STAGE
001,AWARENESS,BACKGROUND,CAM,CLEAR,ENGLAND,ENGLISH,GPS,LABEL,LIFESTYLE,MEASURE,METHODS,OCTOBER,RESULTS,STATISTICS
355,486,BACKGROUND,ENGLAND,LABEL,MEN,METHODS,OVERALL,RESULTS,THERE,UNPROMPTED
ALK,ATP,CNS,FIG,HOWEVER,MET,ONCOGENIC,TAKEN,XALKORI
BECAUSE,FRAGILE,NSCLC,RELATED,SCC
160,169,COPYRIGHT,INC
160,169,ATL,AUTHORS,BRITISH,GRADE,JOURNAL,LTD,ORR,SEVERAL,WILEY
169,AKT,CAF,LEWIS
128,143,160,BASED,CHINESE,COX,DFS,ERCC1,HOWEVER,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS

DESPITE,HOWEVER,INITIALLY
HOWEVER,SMALL
100,138,169,30504,945,CONCLUSION,CROSS,GRADE,GROUP,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SOCIETY,TEN,THREE
002,160,169,231,233,AMONG,COPYRIGHT,PUBLISHED,SAS
045,127,169,219,411,ACCORDING,BACKGROUND,BASED,CEA,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NOTABLY,PDC,RESULTS
BACKGROUND,CISPLATIN,CONCURRENT,DISTANT,III,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SIMILAR,SIX
FDA,NON,NSCLC,OCTOBER,VEGFR
003,024,032,125,130,293,HOWEVER,NSCLC,PCR
AFTER,TAE
ALK,IMT,RECURRENCE
ANAPLASTIC,SIX
BEV,CRC,DTX,THREE
18F,60S,FDG,MALIGNANT,PARTIAL,PET
AFTER,APRIL,FOLFIRI,JANUARY,LEUCOVORIN,MARCH,STAGE
178,185,CDX,CHEST,CK7,EARLY,FDG18,PET,STAGE,TTF
003,004,132,231,562
300,SINCE
5MM,AFTER,CPT,KRUKENBERG,MST,QOL,STAGE
70S,LIVER
III,SRT,STAGE
100,DIAGNOSIS,MARCH,OCTOBER,PRE,SEPTEMBER,STAGEIB,TTF
CBDCA,EOB,FIRST,HCC,MRI,PEM,STAGE,THERE
102,AFTER,BASED,FIRSTLY,HCC,HOWEVER,PRS,REMNANT,RFA,THERE
ICC,IVB,STAGE
AFTER,EVANS,GRADEIB,RADIATION,SEVEN
AFTER,ERBITUX,FINALLY,FOLFIRI,HAI,HDHAI,HOWEVER,RFA,TAE
AFTER,EVALUATION,FOLFIRI,FURTHER,IVC,JANUARY,LEUCOVORIN,RESECTION,SOLID,UFT,XELOX
APRIL,GRADE,LEUCOVORIN,MARCH,MAY,SEPTEMBER
CURRENTLY,HOWEVER,THESE
192,NSCLC,PRS,TREATMENTS
APC,EIGHT,SCC

PDT,TODAY
HOWEVER
ADRIAMYCIN,AFTER,EMR,ENDOSCOPIC,ESD,FAP,UPPER
ACCORDING,AFTER,AMR,CBDCA,CHEST,CPT,HOWEVER,IVB,NGT,SMALL,STAGE,UPPER
AFTER,IVB,STAGE
AFTER,APRIL,BECAUSE,CRANIOTOMY,CRT,ESOPHAGEAL,IVA,JANUARY,MARCH,MAY,TXT
STM
HMB45,MALIGNANT,MELAN,PARTIAL
215,MASTECTOMY,OCTOBER
OCTOBER,STAGE,THEREFORE,TREATMENT
STAGEIV,T4BN1M1
215,CHEST,IIB,SUBSEQUENT,ULTRASOUND
AFTER,CARCINOMA,DESPITE,RECURRENT,SIMILAR,T1CN2M0
AFTER,APRIL,CLINICIANS,HOWEVER,LEUCOVORIN,SIX,STAGE,UNDER
ASECOND,CPT,DELAYED,FOLFIRI,HOWEVER,QOL,XELOX
DIGESTIVE,JAPAN,LEUCOVORIN,LIVER,MANEC,NEC,SEVERAL
BILATERAL,FOLFOX6
CUR,FOLFIRI,JANUARY,MULTI,OCTOBER,SINCE
DEPARTMENT,HOWEVER,LOX,REMOVAL,SURGERY,THEREFORE,TREATMENT,XELOX
III,THEREFORE
187,283,600,AFTER,CEA,JANUARY,LEUCOVORIN,OCTOBER,SEPTEMBER,UFT,XELOX
EXTRA,LABEL,LIVER,LYMPH,MALIGNANT,METHODS,OBJECTIVE,OPERATIVE,PERITONEAL,PRIMARY,PROCEDURE,PURPOSE,RESULTS
DESPITE,FOLFIRI,HOWEVER,LEUCOVORIN,SEVEN,VIRCHOW
CARCINOMA,COLORECTAL,EVALUATION,FOLFOX6,GRADE,METASTASIS,SIGMOID,SOLID

000,304,420,BASED
SEVEN,SRT
007,013,026,ACA,BMJ,CASP3,CD44S,DESPITE,EXPRESSION,FURTHER,GROUP,LABEL,LCC,LIMITED,METHODS,NSCLC,OBJECTIVE,OPN,PUBLISHED,PUBLISHING,RESULTS,RHAMM,THREE,UNION,WHILE
200,956,ANESTHESIA,CAD,DESPITE
BACKGROUND,DIAGNOSIS,DISCUSSION,HOWEVER,LABEL,METHODS,PCR
009,107,AUTHORS,BACKGROUND,CANCERLIT,COLLECTION,IPD,LABEL,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,SELECTION,SURGERY,THERE
107,108,169,249,ADULT,ADVERSE,ALISERTIB,AMONG,BACKGROUND,COMPANY,COPYRIGHT,CZECH,ENROLMENT,EVALUATION,FEB,FUNDING,INC,LABEL,LIMITED,LTD,MAY,METHODS,MILLENNIUM,RESULTS,SERIOUS,SOLID,THESE,USA
121,169,BCI,CRC,H3K4ME2,INC,SMYD3,THESE,WILEY
169,575,COPYRIGHT,FEDERATION,NSCLC,PUBLISHED,SOCIETIES,UTR
169,COPYRIGHT,COX,FDG,INC,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SEVENTY,SIXTY,SURGERY,UNIVARIATE
169,A24,ANOTHER,AUTHORS,BASED,CD4,CTL,FURTHER,HLA,HNSCC,LPS,LTD,PTY,PUBLISHING,SCIENCE,SPS,TAA,WILEY
001,002,003,028,120,169,239,CONCLUSION,COPYRIGHT,ILA,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE,TKI
169,500,956,AFTER,COPYRIGHT,DF0,DF7,DOC,DPF,RME,TA102,TAKEN
169,1ST,743,BACKGROUND,COPYRIGHT,LABEL,LINKAGE,LTD,METHODS,OCTOBER,PRESCRIBED,RESULTS,SWEDISH,THESE
169,COPYRIGHT,INC,NSCLC,PUBLISHED,SOCIETY,THESE
001,017,159,160,169,177,967,BACKGROUND,BONFERRONI,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY,STUDENT
1930S,215,5CM,LARGE,METASTASIS,PAROTID,PRIMARY,SMALL,THERE
DEPLETION,HOWEVER,MIR,NAIF1,NSCLC,NUCLEAR
169,ABCG2,BIOMARKERS,CD271,COPYRIGHT,IRELAND,JARID1B,LTD,MMP,RESISTANT,V600E
169,CD103,CD8,COPYRIGHT,CTL,HOWEVER,INC,NSCLC,TCR,THESE,TIL,TIM
169,945,946,948,COPYRIGHT,EMT,FINALLY,H1650,NOTABLY,NSCLC,PKC,SNAIL,SOCIETY,TWIST,WHEREAS
NEURALGIA,SEVEN
169,GROUP,HOWEVER,III,JAPAN,PHASE,PRESS,PUBLISHED,STAGE,TNM,UFT,UNIVERSITY
001,005,009,034,114,115,296,525,ACCORDING,DFS,OVERALL,SEX,THEREFORE,TNM
005,027,046,121,356,ALCOHOLISM,BACKGROUND,DESPITE,EMERGENCY,GERMANY,LABEL,METHODS,RESULTS
IATROGENIC
CNS,HOWEVER,USA
945,BECAUSE,GLU81,LPMAB,OTS,PODOPLANIN,THR76,WESTERN
CD147,FINALLY,THESE
169,BH3,COPYRIGHT,DYNAMIC,INC,PROFILING,THERE,WHILE
001,004,009,010,016,020,569,ADC,HOWEVER,LIMITED
ALK,FUSIONSEQ,HOWEVER,IMT,NTRK1,RET,TFG,THERE
001,169,BLOOD,CONCLUSION,FDG,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PASTEUR,PET,RESULTS,SMALL,SOCIETY,SUV,UNLABELLED,WARBURG
169,ACT,CONCLUSION,FDG,IMAGING,INC,INSURANCE,LABEL,METHODS,MOLECULAR,NUCLEAR,PEARSON,PERFORMING,PET,RESULTS,SOCIETY,UNLABELLED
100,169,ALK,BACKGROUND,CONCLUSION,IHC,LABEL,MATERIALS,METHODS,NGS,PRESS,RESULTS,SCREENING,THREE
169,COPYRIGHT,FINALLY,HDACS,HISTONE,HOWEVER,IGF,IRELAND,LTD,MTT,NSCLC,OTHER,THESE,TREATMENT,USING
169,AUTHORS,COPYRIGHT,HSP70,HSP90,IRELAND,LTD,NVP,PUBLISHED,TREATMENT
001,021,145,169,BACKGROUND,BASEL,CRT,LABEL,METHODS,NSCLC,PFS,RESULTS,STAGE
169,2OCL3,4RU,956,ADP,AG311,ATP,COPYRIGHT,HMGB1,NH3,RU360,SOCIETY,THERAPY,THEREFORE
169,BASEL,HEPATIC,SINCE
169,181,BACKGROUND,BASEL,CHINESE,DESPITE,LABEL,METHODS,MYRICANONE,RESULTS,THESE,TRITIATED
226,BACKGROUND,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,WESTERN
046,114,132,138,362,652,906,AUSTRALIA,BACKGROUND,CONCLUSION,CONTEXT,LABEL,LITERATURE,METHODS,OBJECTIVE,PTHRP,QUEENSLAND,RESULTS,SETTING,SOLID,THERE
154,159,3OST2,APC,BACKGROUND,FAM19A4,LABEL,METHODS,PCR,PHACTR3,RASSF1A,RESULTS,THREE
107,120,169,227,238,746,AMONG,ANXIETY,BACKGROUND,GUIDELINES,HODGKIN,HOWEVER,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SPM,SURVIVORS,UNIVERSITY,VITAL
169,945,COPYRIGHT,INC,OSCAR,SFTPD,SURFACTANT,TNF
AGE,ANZDATA,AUSTRALIA,CIS,COX,HOWEVER,INDIGENOUS,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,RRT,SETTING,TRANSPLANT,UNADJUSTED,ZEALAND
001,191,954,ABORIGINAL,AFTER,CONCLUSION,CROSS,LABEL,MEASURE,METHODS,NSW,OBJECTIVE,OUTCOME,OVERALL,RESULTS,RRR,SETTING,SOUTH,WALES
169,95D,BIOMEDICAL,BOARD,CCK,CDC,CHINA,CONCLUSION,COPYRIGHT,EDITORIAL,GFP,LABEL,LC3,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SAECS,SMO,WESTERN
129,AKT,EGF,HOWEVER,NSCLC,TAKEN
004,005,17558,19385,BACKGROUND,CAUCASIANS,CIS,HOWEVER,LABEL,METHODS,OCTOBER,ORS,RESULTS,TELOMERASE
AMERICANS,THEREFORE

120,129,CCA,END,HOWEVER,INCREASED,INSTITUTE,LOWER,RESULTS,SIR
001,263,542,953,AFFILIATED,AMONG,FIRST,GUANGZHOU,HOWEVER,MEDICAL,NSCLC,PCR,UNIVERSITY
181,470,562,ADR,ANNONACEAE,BASED,CAFFEIC,NCI,OVERALL,UA251
003,004,005,009,012,028,286,324,335,363,374,378,500,956,B12,BETWEEN,PEMETREXED
ACUTE,CASES,CONCLUSION,CRT,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PFS,RESULTS
084,177,714,918,AFTER,CONTINUED,CUMULATIVE,EARLIER,HOWEVER
15Q12,169,215,BACKGROUND,DETECTION,GABAERGIC,LABEL,METHODS,PATHWAY,PRESS,PUBLISHED,RESULTS,RS73371737,UNIVERSITY
169,259,945,ACTIVATION,BIOLOGY,ERK,H1299,H89,INC,INHIBITING,MEK,MG132,MOLECULAR,PKA,RAF,REDUCED,SER,SIRT6,SIRTUIN,SOCIETY,THEREFORE,TREATMENT,WESTERN
100,125,130,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNDER
120,180
000,001,100,154,163,222,260,353,CHEST,CVATL,EARLY,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
001,BACKGROUND,FEV,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
113,119,135,138,146,147,177,1ST,3RD,CONCLUSION,FIRST,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OPERATIONS,RESULTS,VAS,VIDEO
140,150,CONCLUSION,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OPERATION,RESULTS
1990S,300,CHINA
170,183,BACKGROUND,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,VIDEO
169,ACADEMY,CIGARETTE,DICER
001,015,169,432,AAG,ALLYLAMINO,AUTHORS,FOUNDATION,HOWEVER,JOURNAL,LAC,LAST1,LATS1,LTD,MOLECULAR,TAKEN,WILEY,YAP
169,COPYRIGHT,CXCR2,CXCR4,INC,MIF,MSC
123,169,170,COPYRIGHT,MDR,PARKINSON,PGP
100,115,134,169,210,BACKGROUND,CARCINOMAS,CBX,FNA,LABEL,METHODS,RESULTS,SOCIETY,THERE
BMJ,GROUP,IDC,LIMITED,METASTATIC,OESTROGEN,PUBLISHED,PUBLISHING
100,109,135,946,BACKGROUND,BAL,BASED,FUNGITELL,GROUP,IFI,LABEL,METHODS,MYCOSIS,RESULTS,TREATMENT
169,BACKGROUND,COPYRIGHT,CT0,CTS,DVH,EQUIVALENT,EUD,HOWEVER,IRELAND,ITV,LABEL,LTD,METHODS,MFO,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,ROBUSTNESS
001,169,AFFAIRS,AMONG,ASIAN,BACKGROUND,CANCORS,CHINESE,CONSORTIUM,ENGLISH,FURTHER,HISPANICS,LABEL,METHODS,NON,RESULTS,SOCIETY,SPANISH
CPG,IGE,THERAPIES
169,AUTHORS,HOWEVER,LTD,PTY,PUBLISHING,SCIENCE,WILEY
169,BACKGROUND,COPYRIGHT,IHC,INC,LABEL,MALIGNANT,METHODS,MEXICAN,MPM,OBJECTIVE,PUBLISHED,RESULTS
AKT,BIM,ERK,FINALLY,HOMOLOG,MEK,NSCLC,RAF,SARCOMA,TRAMETINIB,V600E,VIRAL
HOWEVER,WHILE
231,DESPITE,FINALLY,MDA,PROBING,USING
DESPITE
006,BACKGROUND,BASED,CMV,KINGDOM,LABEL,METHODS,RESULTS,STATISTICS,THERE,TRANSPLANT
000,160,169,427,600,BACKGROUND,CHINA,COPYRIGHT,INC,KNOWLEDGE,LABEL,LIBRARY,METHODS,PUBLISHED,RESULTS,SOCIETY
169,COPYRIGHT,EPITHELIUM,ILC2S,LTD,TH2
117,169,183,BACKGROUND,BETWEEN,BRISTOL,COPYRIGHT,FUNDING,GERMANY,IQR,ITALY,LABEL,LTD,METHODS,MYERS,NIVOLUMAB,NOV,RESULTS,THERE,THESE,USA
169,EPIGENOMIC,INCREASED,KCA,KCNN4,NSCLC
002,008,135,169,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RANDOMIZED,RESULTS,STERNAL,SURGERY
108,13433,AFTER,BACKGROUND,EXPRESSION,JAK,LABEL,METHODS,OBJECTIVE,OMNIBUS,RESULTS,TGF,WNT
BACKGROUND,DISCUSSION,LABEL,METHODS,OBJECTIVE
101,143,ACADEMY,BACKGROUND,DEPARTMENT,FIFTEEN,GULHANE,LABEL,MEDICAL,METHODS,OBJECTIVE,OCTOBER,RADIATION,RESULTS,THERE,TREATMENT
AFTER,IMPORTANT,NSCLC
SIADH,SMALL
ACUTE,CEF,CHT,CRT,GRADE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY
BACKGROUND,BRONCHIAL,DIAGNOSES,LABEL,METHODS,OBJECTIVE,RESULTS
000,100,180,195,217,239,AMONG,CONTINENTS,INCIDENCE,OVERALL,RESULTS,THERE,THYROID,USING
705,988,BACKGROUND,EARLY,LABEL,LOW,METHODS,OBJECTIVE,RESULTS
34B,448,654,BAC,BACKGROUND,EXPRESSION,GEO,LABEL,METHODS,MICRORNAS,NON,NSCLC,OMNIBUS,RESULTS
IRINOTECAN
BASED,EARLY
025,130,COMPARISON,EPIDERMAL,GEHAN,KIRSTEN,NSCLC,PFS,SEVERAL,TKI
1N9,2N6,4N6,5N3,ADC,BASED,FATTY,ROC,SCC
168,549,945,FINALLY,MPT,PCL,PTX,TAXOL
160,169,231,233,244,ALPES,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,GPS,INSTITUTE,LABEL,MAY,MCS,METHODS,OBJECTIVE,PCS,PRESENT,PUBLISHED,RESULTS,SAS
AFTER,CISPLATIN,CONCLUSION,LABEL,METHODS,NON,NSCLC,OBJECTIVE,ORR,PARTIAL,PURPOSE,RESULTS,THREE
107,145,190,215,275,348,535,AMR,BASED,EPNEC,LABEL,METHODS,OBJECTIVE,ORR,PATIENT,PFS,PRIMARY,PRIOR,PURPOSE,RESULTS
169,COPYRIGHT,EPIDERMAL,ERK,INC,MAPKS
103,127,155,169,183,304,312,315,318,500,633,800,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,EASTERN,ELI,ENROLMENT,FEB,FUNDING,GROUP,LABEL,LILLY,LTD,METHODS,NOV,NSCLC,RESULTS,SERIOUS,THERE
160,169,BACKGROUND,COPYRIGHT,CTC,H1299,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
169,COPYRIGHT,INC,TOOLS
946,ABCB1,BAX,BCL,DOCETAXEL,EMT,NSCLC,TGF
946,EMT,ERK,FOXM1,KNOCKDOWN,LENTIVIRUS,NSCLC,TGF,TRANSWELL,U0126
AFTER,AKT,HOS,HOWEVER,TRAF4
198,945,946,ESTROGENS,HOWEVER,IHC,NSCLC,PCR,THESE,TMA,WESTERN
169,947,CD3,CD4,CD8,COPYRIGHT,HFE,IFN,LTD,MHC,PUBLISHED,THESE,TNF
CHEST,HOWEVER,IDIOPATHIC,IPF,SMALL
HOWEVER,IIB,METASTASES,PATIENT,PROGNOSIS,SPLENIC,STAGE,SURGERY,T3BN0M0
138,AFTER,CONSISTENT,FINALLY,H2081,NCI,RESULTS
AMONG,BACKGROUND,DFI,LABEL,METHODS,OBJECTIVE,RESULTS
EGF,ERK,LAM,SNAIL,THESE,TSC
000,125,169,CONCLUSION,GIP,GLP,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,RESULTS,SOCIETY,TYR,UNLABELLED,USING
001,169,177,179,267,311,ANATOMY,CONCLUSION,FDG,FNA,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,SUV,THERE,UNLABELLED
HOWEVER,RAY,SMALL
009,014,015,084,099,177,916,BACKGROUND,LABEL,METHODS,NON,NSCLC,PCR,RESULTS
162,AKT,ERK,MEK
004,009,014,169,177,946,A549EPOB40,BACKGROUND,CD1,DIFFERENT,FOXN1,ICRNU,INHIBITION,LABEL,MEIER,METHODS,MSA,PRESS,PUBLISHED,RESISTANCE,RESULTS,SIDAK,SW480,TREATMENT,UNIVERSITY
169,215,GEWIS,INC,THROUGH,WILEY
011,076,ACUTE,ALI,CONCLUSION,GREATER,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OPERATIVE,RESULTS
CHINA,CONCLUSION,JANUARY,LABEL,MATERIALS,MEDICAL,METHODS,MRI,OBJECTIVE,PROVINCIAL,RESULTS,THESE,WHILE
AUNPS,BAP,BAX,BCL,BENZO,COF,FOURIER,FURTHER,IAP,INCUBATION,THESE
169,946,COPYRIGHT,MCS,SOCIETY,TGF,THESE,THROUGH,TRANSPLANT
CUTANEOUS,EPS
018,023,103,185,18F,945,946,ANOTHER,CURRENTLY,FDG,FES,KETTERING,LOUIS,MBQ,PET,SEATTLE,SLOAN,SUV,UNIVERSITY,USING,WASHINGTON
AFTER,ANESTHESIA,CONCEALED,PARKINSON,RECURRENT,WHITE,WOLFF,WPW
238PU,BYSTANDER,CHIBA,HEAVY,HIMAC,HOWEVER,INSTITUTE,ION,MEDICAL,NOW,P53,PHASE,SINCE,THERE
ADT,EVENTUALLY,FURTHER,GPCRS,KETTERING,MEIER,PCA,SLOAN
101,DFS,EMT,HCC,HOWEVER,RAC,RHO,ROCK2,STMN1,THESE
BACKGROUND,HOWEVER,LABEL,METHODS,PET
AIM,BRIGHTVIEW,CONCLUSION,HEALTHCARE,LABEL,METHODS,NSCLC,OBJECTIVE,PHILIPS,RESULTS,SPECT,WHOLE,XCT
000,006,100,140,153,272,368,604,652,695,759,775,777,BACKGROUND,CZECH,LABEL,METHODS,REGARDING,RESULTS
945,946,BACKGROUND,CONCLUSION,EPIDERMAL,GEFITINIB,LABEL,LAC,METHODS,PC9,RESULTS,TAMOXIFEN
001,007,027,239,CANCEROUS,CD133,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM
169,ATP,BCL,COPYRIGHT,E1B,MIEAP,SINCE,SOCIETY,THESE,WHILE
169,COPYRIGHT,NETWORK,PROPONENTS,SURGERY
169,COPYRIGHT,NETWORK
AFTER,BACKGROUND,CONCLUSION,DEPARTMENT,DUE,LABEL,MEDICAL,METHODS,NEITHER,RADIATION,RESULTS,UNIVERSITY
001,005,008,100,101,180,BACKGROUND,CRC,FURTHER,JANUARY,LABEL,METHODS,MOLECULAR,RESULTS
PAZOPANIB

003,021,032,171,191,BACKGROUND,DTI,III,LABEL,METHODS,OBJECTIVE,REGARDLESS,RESULTS,SEVERAL
GIOVANI,GROUP,HIGHLIGHTS,MEMBERS,WORKING,YOUNG
001,169,189,214,ACRIN,BACKGROUND,CONCLUSION,COX,FDG,III,LABEL,LRC,METHODS,MTV,NSCLC,PET,PRESS,PUBLISHED,RESULTS,TGA,UNIVERSITY
169,512,COPYRIGHT,DOCK3,GEF,H1299,KNOCKDOWN,LTD,MICRORNAS,NSCLC
169,177,956,CHINA,COPYRIGHT,GUANGZHOU,LTD
169,628,CCK,COPYRIGHT,HOWEVER,HOXA5,INC,MICRORNAS,NSCLC,WESTERN
10877,139MONTHS,169,1FR,311MONTHS,3FR,3MONTHS,4FR,8FR,ADVERSE,ARC,COPYRIGHT,CTCAE,III,LABEL,LTD,METHODS,MODULATED,OBJECTIVE,OVERALL,PURPOSE,RESULTS,STS,THERAPY,TREATMENTS,VOLUMETRIC
780,BACKGROUND,LABEL,LNCAP,METHODS,OATP1B3,RESULTS,THERE
001,002,007,008,320,593,ASX,CONCLUSION,INCIDENTAL,LABEL,METHODS,MORTALITY,NSCLC,OBJECTIVE,OVERALL,RESULTS
ENDOSCOPIC,PANCREATIC,VARIOUS
CONCLUSION,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PRIMARY,PURPOSE,RESULTS,SOCIETY,SURGERY
31042,ADULT,AMERICA,CHEST,MPM,NORTH
100,417,483,ABCG5,ABCG8,CALIFORNIA,CNV,DAVID,EXPRESSION,FINALLY,KO05223,LABEL,MATERIALS,MEANWHILE,METHODS,NUCLEOTIDE,OBJECTIVE,OMNIBUS,PENNCNV,RESULTS,SANTA,SNP,UNIVERSITY
LN2,SEPARATOR,SMALLER,THESE,VAPOR
121,169,ARMADILLO,ARVCF,INC,NSCLC,WILEY
BACKGROUND,CCNB3,CIC,FOXO4,GENERALLY,LABEL,METHODS,NEWER,RESISTANCE,THEIR
000,169,AGA,BACKGROUND,COLORECTAL,COPYRIGHT,CRC,GERMANY,INC,INSTITUTE,LABEL,METHODS,OBJECTIVE,OVARIAN,PUBLISHED,RESULTS,SCREENING,SIMILAR,TRIAL
105,157,169,199,434,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,CRC,LABEL,LTD,METHODS,RESULTS,RFA,THERE
001,140,169,643,683,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,NSCLC,RESULTS,SIX,THERE
169,790,COPYRIGHT,CPG,INC,NSCLC,PC9,T790M,TKI
169,177,945,946,947,956,ATP,COPYRIGHT,INCREASING,LTD,WHEREAS
169,ATP,COPYRIGHT,III,IRELAND,LTD,PGP,THESE
169,BIOLOGY,GEFITINIB,H1650,HOWEVER,INC,LAD,MOLECULAR,ROS,SEVERAL,SOCIETY,TARCEVA,THESE,WESTERN
169,ACCORDING,AIS,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MIA,RESULTS
169,177,COPYRIGHT,DEFORMABLE,INC,LABEL,LCS,LUMPECTOMY,MATERIALS,METHODS,OBJECTIVE,POPULATION,PTV,PURPOSE,RESULTS,SIMILARLY,SIXTEEN
120,169,COPYRIGHT,COX,FDG,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
245,AKT,EGF,ERK,ETS,H1299,INHIBITORS,MAD,MYC,SNP,THESE,USING
169,AMERICANS,DUE,LESIONS,NORTH,SINCE,THESE
169,COPYRIGHT,INC
131,DTC,FDG,PET,WBS
372,643,E542K,FGFR1,FGFR4,HOWEVER,KDR,MUTATIONAL,MUTATIONS,P126S,PRIMARY,RAS,V550M,VEGFR
169,500,AUTHORS,FOLLOWING,NAVIGATOR,PUBLISHED
100,160,169,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,MALIGNANT,METHODS,PUBLISHED,RESULTS,SOCIETY
118,169,185,249,294,330,479,724,BACKGROUND,BETWEEN,BOARD,COMPLEX,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MTB,OVERALL,PATIENT,PUBLISHED,RESULTS,SOCIETY
169,CONCURRENT,COPYRIGHT,CSR,DESPITE,DISCUSSION,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE,USING
004,021,037,045,046,177,ADVERSE,CONCLUSION,DISEASE,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
004,100,31G,9904341,PCR,PRESENTLY
036,AFP,ASIAN,AUC,CA153,CCAT2,CPG,ESOPHAGEAL,KYSE410,NSE
001,210,CCRCC,MALDI,NSCLC,TOF
008,009,021,024,030,128,COX,KLK13,MEIER,NSCLC,PCR,TOTAL
169,722,AFTER,AMONG,BACKGROUND,LABEL,METHODS,RESULTS,SOCIETY,STILL
169,ADVANCING,BECAUSE,BLOOD,CARDIOLOGY,COLLEGE,COPYRIGHT,FOUNDATION,GROUP,HEART,HIV,HLB,INC,INSTITUTE,NHLBI,PUBLISHED,WORKING
DECADES,THESE
169,188,BACKGROUND,CAREGIVERS,LABEL,METHODS,NEEDS,NETWORK,PATIENT,PREDICTION,RESULTS,SOCIETY,SUPPORTIVE,THEREFORE
169,ALCHEMIST,ALK,ENRICHMENT,HOWEVER,INSTITUTE,SEQUENCING,SOCIETY,TRIAL
CER
169,BIOMARKER,EFFORTS,III,MAP,PHASE,S1400,SOCIETY,THERAPY
169,AEF,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTWCS,OBJECTIVE,PURPOSE,RESULTS,THERE,THREE,UIP,WHILE
169,AMERICA,INFECTIOUS,PRESS,PUBLISHED,SOCIETY,TAKEN,UNIVERSITY
160,169,290,BACKGROUND,BASED,COPYRIGHT,FLV,INC,JANUARY,LABEL,METHODS,RESULTS
CAF,HOWEVER
NSCLC,TKI
006,011,013,021,025,026,125,199,ASA,BACKGROUND,BMI,CA125,CA199,CEA,CYFRA21,FORTY,LABEL,METHODS,NSE,PATIENT,PVB,RESULTS,SCC,SERUM,SOCIETY,VAS
013,956,BACKGROUND,LABEL,METHODS,PC9,RESULTS,THEREFORE,TUNEL,WST
AFTER,BACKGROUND,EPIGENETIC,EXPRESSION,H1299,LABEL,LUCIFERASE,METHODS,MMP,MSP,PCR,RESULTS,WESTERN
ALK,ECHINODERM,MEANWHILE,MPC,NSCLC
250,ADVERSE,ALK,BACKGROUND,CONCLUSION,CRIZOTINIB,CTC,DISTANT,EVALUATION,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SOLID,TUMOURS
115,ALK,ANAPLASTIC,BACKGROUND,IHC,LABEL,METHODS,NON,NSCLC,PCR,RESULTS,SCORPIONS,WHILE
172,ALK,AMONG,BACKGROUND,BESIDES,IHC,LABEL,METHODS,NSCLC,RESULTS
ALK,EPIDERMAL,NON,NSCLC,THEIR,TKI
ALK,CURRENTLY,NSCLC,THERE

FURTHER,SMALL,THERE
AIM,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
CHINA,EGF,III,NSCLC,PHASE,TREATMENTS
BROWN,FDG,PET,SEVEN,THERE
100,FDG,HOWEVER,PET,SUV,WHOLE
500,COX,DDD,HOWEVER,INSURANCE,LOE
DESPITE
CALRETININ,CEA,HEPATOCYTE,TTF,WT1
CD271,FURTHER,HOWEVER,METASTASES,PRIMARY
112,296,369,444,CARCINOMA,CUP,FDG,MBQ,PET,THERE
BACKGROUND,EXPRESSION,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS
100,AMONG,HRM,NSCLC
001,012,021,022,026,032,143,960,GST,MNSOD,PRIMARY,ROS,TXNIP,UNIVARIATE
946,AKT,DHA,GSK,MTS,NON,NSCLC,SCC,THESE
ASTRAGALUS,H23,MEANWHILE,MTT,NCI,NSCLC,SER15,SER20
018,106,119,357,363,BACKGROUND,COX,DFS,ERCC1,LABEL,MEANWHILE,MEIER,METHODS,NSCLC,PCR,RESULTS,THEREFORE
DESPITE,DIAGNOSIS
160,215,224,339,BMI,METABOCHIP,OBESITY,PATHWAY
160,215,224,459,BMI,PATHWAY
00019,00044,012,017,107,181,BACKGROUND,BMJ,CD4,CD8,DEE,GROUP,HOWEVER,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS
500,DHA,EPA,HIV,OTHER,RAISING
100,2279744,309,309GG,309TT,EXPRESSION,NON,PRESENTLY,T309G
108,ABBOTTABAD,BACKGROUND,BRONCHIAL,CONCLUSION,DIAGNOSTIC,FOB,LABEL,METHODS,RESULTS,TBA,TBB
INDIA

169,AKT,ASIAN,CAUCASIAN,FGFR1,PRESS,PUBLISHED,RET,TARGETING,THESE,UNIVERSITY,WHILE
169,COPYRIGHT,CTV,EARLY,GROUP,HODGKIN,HOWEVER,ILROG,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SEVEN,TEN
106,120,168,169,215,916,AUC,COPYRIGHT,INC,INDIVIDUAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGRESSION,RESULTS,ROI,USING
005,160,BACKGROUND,CONCLUSION,HDL,INC,INCREASED,LABEL,LDL,LOW,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,BECAUSE,RESULTS,SAPOSIN,THESE,USING,VIABILITY
169,184,185,412,617,BACKGROUND,COPYRIGHT,FUNDING,HOWEVER,HRS,LABEL,LTD,METHODS,RESULTS,SWEDISH,UNIVERSITY,VASALOPPET
000,146,160,169,172,400,BACKGROUND,COPYRIGHT,CRP,EASTERN,GROUP,INC,LABEL,METHODS,MPM,PERSISTENT,PLT,PUBLISHED,RESULTS,SOCIETY,VAT
100,150,169,400,600,BACKGROUND,CONCLUSION,LABEL,METHODS,MTD,PRESS,RESULTS,SAR245408,THERE
160,AUSTRALIA,BECAUSE,CONCLUSION,EMERGENCY,LABEL,METASTATIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS
ALK,COMPANION,EGFRS,FINALLY,GISTS,HODGKIN,IHC,KIT,NON,RITUXIMAB
500,FAX,LABORATORY,SOCIETY,THEREFORE
061,638,AMONG,BACKGROUND,COMBINING,DETECTION,EARLY,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PITTSBURGH,PLUSS,PROGRAM,RATIONALE,RESULTS,SCREENING,TRIAL
169,183,CHURG,FIRST,GEORG,IMPORTANT,STRAUSS,STUTTGART,SUBSEQUENT,WEGENER
BAX,BCL
ATTRACTIVE,EARLY

140,BACKGROUND,KINESIN,KLC,LABEL,METHODS,MIR,NSCLC,RESULTS
002,007,10877,ARF,BACKGROUND,LABEL,MALIGNANT,MEIER,METHODS,MPM,P14,P53,PFS,RESULTS,SCORE,UNTIL
BACKGROUND,EMT,EPITHELIAL,FAS,HEPG2,LABEL,METHODS,RESULTS
169,196,213,374,929,ANTICANCER,CENTERS,CONCLUSION,CONTROL,COPYRIGHT,DISEASE,INSTITUTE,LABEL,MATERIALS,METHODS,NUTRITION,OBJECTIVE,PREVENTION,RESULTS
001,169,375,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,FORTY,INSTITUTE,LABEL,METHODS,MPE,NSCLC,OBJECTIVE,PFS,RESULTS,SERUM
002,007,169,361,970,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HOWEVER,INSTITUTE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SEN,SEVENTEEN,SUN,YAT
008,145,169,835,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS
169,AIM,ANTICANCER,CNS,CONCLUSION,COPYRIGHT,CSF,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,PPS,RESULTS,T790M,TKI
100,123,169,956,ANTICANCER,CONCLUSION,COPYRIGHT,COUMARINS,INSTITUTE,LABEL,MMP,MRC,PCFDA,RESULTS,ROS,THESE,UNLABELLED
169,954,ANTICANCER,B19,COPYRIGHT,CURCUMA,EPHB2,HDAC4,INSTITUTE,SEPP1,STAT3
102,169,929,AMONG,BACKGROUND,BROADER,CONCLUSION,COX,END,HOWEVER,LABEL,METHODS,OVERALL,PRESS,PRIOR,PUBLISHED,RESULTS,UNIVERSITY
AFTERWARDS,GAS,NEITHER,SNIFFER,SOLID
169,FURTHER
150,169,567,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PATIENT,PFS,PURPOSE,RESULTS,SOCIETY,THERE
014,169,483,633,798,850,886,988,CONCLUSION,COX,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
169,ALK,CONCLUSION,CRIZOTINIB,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SOCIETY
169,AKT,ALK,COMPLETION,CONCLUSION,ERBB2,KIT,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX,SOCIETY
169,CONVERSELY,COPYRIGHT,H1299,HN6,SOCIETY,TAKEN,THESE,WHEREAS
029,169,566,669,749,ABCB1,ATP,B17,CYP2A13,FASEB,FOXA2,III,INHALED,MDR,R257C,TAP,THEIR,UDP,UGT2B17
231,264,954,EXTENSIVE,FINALLY,MDA,MOUSE,QUE,RANKL,RAW,THEREFORE
169,ACCORDING,CHROMATIN,CONSISTENT,COPYRIGHT,H1299,HOWEVER,INC,PCC,PRR11,TAKEN
001,166,169,177,258,268,424,579,CONCLUSION,COPYRIGHT,LABEL,METHODS,NEUTROPHIL,PARTNER,PUBLISHED,RESULTS,ROC,SOCIETY,UNLABELLED,URBAN
169,BIOLOGY,CONSISTENT,FOS,INC,MOLECULAR,NCI,REDUCED,SIMILAR,SOCIETY
100,169,ACCOUNTING,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,COX,END,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,STATINS
BMJ,ENGLISH,EXTRACTION,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SELECTION,SOURCES,SYNTHESIS,WATERPIPE,WTS
169,567,BACKGROUND,BMI,CONCLUSION,COPYRIGHT,INC,LABEL,LOS,METHODS,NSQIP,OBESITY,OVERALL,POISSON,PROGRAM,QUALITY,RESULTS,WORLD
169,231,233,COPYRIGHT,PUBLISHED,SAS
130,197,945,CONCLUSION,FOS,FRA,LABEL,MB231,MDA,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE,THESE,USING
DOCTORS,LIMITED,PULMONARY
954,BACKGROUND,CONCLUSION,CONTOURING,CTV,DESPITE,DR1,DR2,DRS,FDG,GTV,KAPPA,LABEL,MATERIALS,METHODS,NSCLC,OVERALL,PET,RESULTS,THEREFORE,TVS
EPITHELIAL,HLCCS,HOWEVER,LCC,LH2,UTILIZING
945,GLUTAMINE,METABOLIC,NCOA2,SRC,SREBP,TCA
374,388,SHP
455,671,722,BACKGROUND,COLLEGE,CONCLUSION,FUNDING,INSTITUTES,LABEL,LIMITATION,METHODS,OBJECTIVE,PRIMARY,RADIOLOGY,RESULTS,SCREENING,SECONDARY,SETTING,TRIAL
956
998,LOD,LOQ,MSM,NSM,PSM,SEM,TYR
HOWEVER,SMALL,THESE
169,HOWEVER,PRESS,PUBLISHED,UNIVERSITY
000,001,100,440,740,900,910,AMONG,BACKGROUND,END,HIV,HODGKIN,LABEL,METHODS,NHL,POISSON,PRESS,PUBLISHED,RESULTS,UNIVERSITY
342,FINALLY,MICRORNAS,NSCLC,RAP2B,UTR
AET,MMC,SLCCS,TAKEN,USING,VX2
BOS,COP,IPS,TNF,WHILE
000,100,128,160,169,194,482,510,767,860,923,AMONG,BACKGROUND,COPYRIGHT,FACTORS,FOUNDATION,HISPANICS,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RATES,RESULTS,SETTING,SIR,THESE
169,AUHNS,COPYRIGHT,DOX,LTD,NIR,PEGYLATED,TAKEN
176,AFTER,M1A,MORBIDITY,MPD,MPM,SIX,WEDGE
AIM,CATANIA,CONCLUSION,INCLUSION,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,RESULTS
021,113,177,CUMULATIVE,THERE
110,190,GUIDELINES,MARCH,PULMONARY,THERE
DESPITE,DIFFERENT

PULMONARY,TYPICALLY,WHILE
300,PET,PULMICC
PULMICC,PULMONARY,UNTIL
169,AKT,COMBINING,COPYRIGHT,GEFITINIB,H1975,HOWEVER,HSP90,INC,NSCLC,THESE,TKI,XRCC1
163,169,COPYRIGHT,CXCR4,HSC,INC,R334X
169,COPYRIGHT,EMT,INC
110,130,140,169,AUC,BIS,CONCLUSION,COPYRIGHT,DBONE,DWA,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,VMS
104,120,160,169,413,AFTER,BACKGROUND,COPYRIGHT,CSS,FORTY,INC,LABEL,METHODS,NSCLC,PROPENSITY,PUBLISHED,RESULTS,RFS,SOCIETY
ABSTRACTED,BMJ,CHRONIC,EXTRACTION,GROUP,HOWEVER,LABEL,LIMITED,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SELECTION,SOURCES,SYNTHESIS,THREE,WPS
116,169,16S,COPYRIGHT,EIGHT,FIFTY,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PPI,PRINCIPAL,RESULTS,THERE
169,303,532,682,915,COPYRIGHT,INDICATING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMR,STATISTICS
169,CHANGES,COPYRIGHT,CROWN,MMP,MYPT1,PREVIOUSLY,PUBLISHED,RHO,SAS,SPCA1,TAKEN,THROUGH
169,954,APOPTOSIS,COPYRIGHT,HOWEVER,HSP90,NSCLC,ROMIDEPSIN,ROS,SAS,THESE
145,169,BIOMARKERS,COPYRIGHT,DFS,ISH,NON,NSCLC,PCR,SAS,THESE
169,COPYRIGHT,DDP,HOECHST,ICAM1,MTT,NSCLC,PCR,SAS,TIMP4,WISP2
169,COPYRIGHT,MEANWHILE,MICRORNAS,MIR,SAS,TAKEN
160,169,177,460,683,760,780,961,976,CCL20,CD4,COPYRIGHT,FOXP3,HOWEVER,IHC,III,MFI,NSCLC,PCR,SAS,TIL
169,BANCR,COPYRIGHT,ERK,JNK,LNCRNAS,SAS,THESE
169,ATP,CD3,CIK,COPYRIGHT,CRT,DOCETAXEL,HMGB1,HOWEVER,SAS,SPC
140,160,169,177,210,6NM,945,956,9NM,ANOVA,CIS,CISPLATIN,CONCLUSION,COPYRIGHT,DSC,GNS,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAS,THEREFORE
169,ARRAY,COPYRIGHT,GENOTYPING,HPV,INC,INK4A,PATHOLOGIC,ROCHE,SMALL
BMJ,DUE,EXCELLENCE,GROUP,INSTITUTE,LIBRARY,LIMITED,MEDLINE,NSCLC,PFS,PUBLISHED,PUBLISHING,THERE
147,169,264,8MRNA,954,CD147,COPYRIGHT,INC,RAW,TAKEN
169,NSCLC,PRESS,UNTIL
CURRENT,DESPITE,IDIOPATHIC,IPF
047,115,169,992,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,LOCAL,METHODS,NSCLC,RESULTS,SRS
148,169,CONCLUSION,COPYRIGHT,DDLPS,DISTANT,IQR,LABEL,LOG,LTD,MATERIALS,METASTATIC,METHODS,OBJECTIVE,RECORDS,RESULTS
ALK,AREAS,BACKGROUND,COVERED,CRIZOTINIB,FDA,HOWEVER,LABEL,MET,METHODS,NSCLC,OPINION
AAH,ACTIVATION,AID,AT2,BASED,HOWEVER,INCREASED,MALLS,SIMILAR
001,003,023,111,386,AGGREGATE,GAMMA,KNIFE,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS,THEREFORE
FDA,IPILIMUMAB,MEDICINES
169,AHR,COPYRIGHT,PER,SIM,SOCIETY,THEREFORE
001,007,169,261,649,AMONG,BACKGROUND,COMPARISON,CONCLUSION,EGFRM,HRS,III,LABEL,LUX,METHODS,NSCLC,OPTIMAL,PFS,PRESS,RESULTS,TKI,UNIVARIATE,WJTOG3405
169,AKT,BP1,COPYRIGHT,FAK,GBC,IHC,IRELAND,LTD,MMP,NOZ,THESE
169,DISCOVERY,FLYNN
169,231,233,ALK,COPYRIGHT,PUBLISHED,SAS,SEVERAL
100,107,113,138,169,500,AIM,COLLEGE,CONCLUSION,COPYRIGHT,INCIDENTAL,LABEL,LTD,MALIGNANT,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SEPTEMBER,THEREFORE
ABI,H12,H14,H17,RESULTS,THEIR,WESTERN
036,042,043,228,301,501,CHINESE,HAN,HOWEVER,RS8042059,SEVENTEEN
ACUTE,PATIENT,PRIMARY
112,238,AVERAGE,BACKGROUND,CLOSE,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,THERE
CHRONIC,CLL
BACKGROUND,LABEL,MDPCR,METHODS,RESULTS,THERE
020,348,BACKGROUND,BASED,CHINESE,GRADE,III,LABEL,METHODS,OBJECTIVE,ORR,PFS,RESULTS,THERE
BACKGROUND,CONCLUSION,FINALLY,LABEL,METHODS,NOTABLY,RESULTS
GROWING
CFM,GSH,ID8,L1210,L1210FR,NOVEL,OET,PET,RME
AFTER,AIR,AUTOIMMUNE,BACKGROUND,CONCLUSION,LABEL,LABORATORY,METHODS,THESE
000,400,SHS
AFTER,CHINA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SYNERGY,THERE,ZEALAND
BAC,NSCLC
100,875,879,886,CHINA,EPIDERMAL,FURTHER,JANUARY,LDA,NSCLC,PRIMARY,SOUTHWEST,SVM,USING
513,ASPIRATION,HIV,LAD,METHODS,OBJECTIVE,POTENTIAL,RESULTS,ULTRASOUND,VIRUS
001,036,037,121,HOWEVER,NSCLC,PCR,THEREFORE,WNT,WNT7A
169,CSC,NPS,PRESS,PUBLISHED,RES,THESE,UNIVERSITY
160,AFTER,BACKGROUND,CD11C,CD123,CHI,CHINESE,CHUAN,CONCLUSION,DC11C,LABEL,METHODS,NKT,NSCLC,PBMCS,PERIPHERAL,REGULAR,RESULTS,TAI,TCC,TRC,TRIAL
956,ANNEXIN,CCK,CONCLUSION,DDP,LABEL,LRP,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
002,005,012,014,015,017,026,177,BMJ,BRITISH,GD1,GROUP,HOWEVER,LABEL,LIMITED,MACROPHAGE,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PRIMARY,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,SETTING,THERE,TOTAL,VANCOUVER
HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SURGERY,THESE,UNDERGOING
169,ENGINEERS,MALIGNANT,OCT,OPTICAL,PHOTO,RAMAN,SOCIETY
284,469,ADDITIONAL,LABEL,METHODS,MHD,MLD,OBJECTIVE,OVH,PRINCIPAL,PTV,PURPOSE,RESULTS
CARLO,DOSIMETRY,FURTHER,LABEL,LINAC,LORENTZ,METHODS,MONTE,MRI,OBJECTIVE,ORIENTING,PTV,PURPOSE,RESULTS
DRX,LABEL,METHODS,NU2,OBJECTIVE,PARTIAL,PET,PSF,PURPOSE,PVE,RESULTS,RICHARDSON,SNR
HEALTHCARE,INITIAL,LABEL,MEDICAL,METHODS,NUCLEAR,OBJECTIVE,OPTIMIZED,PHILIPS,PURPOSE,RESULTS,SUN,SYSTEMS,UIMAT
174,CARLO,CHANGES,DVH,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TREATMENT
177,CARLO,DOSIMETRIC,LABEL,METHODS,MONTE,OBJECTIVE,PHASE,PURPOSE,RESULTS
AGENT,BAX,BCL,BESIDES,METADHERIN,MTT,NSCLC,TAKEN,WESTERN
AST,BACKGROUND,ELISA,GRECO,HILIT,KAN,LABEL,METHODS,RESULTS,SAFRA,SAVDA,SPP24
169,BACKGROUND,CURRENT,FRAMINGHAM,HIGHEST,LABEL,METHODS,OFFSPRING,RESULTS,SOCIETY,THESE
169,BASED,OTHER,SOCIETY
000,600,ABOUT,AMI,AMONG,ITALIAN,OBVIOUSLY,THEREFORE
954,JNK,KEY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,TNF,TNFIS,USING,WHEREAS
COEXISTENT,OPHN1,OTHER,PECOMAS,PSF,RRAGB,ST3GAL1,TSC
ALK,GENOMIC,UNIFIED
169,BPE,CHRONIC,COLLEGE,CRT,NSCLC,PHYSICIANS,ROYAL,THESE
001,169,202,350,552,BACKGROUND,CD3,CD8,DIAMIDINO,HOWEVER,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PRESS,PUBLISHED,QIF,RESULTS,STUDIES,TIL,UNIVERSITY,USING,YTMA140
169,COPYRIGHT,CURRENT,III,IRELAND,LTD,MEDLINE,NSCLC,PEMETREXED,WHILE
169,198,351,522,708,906,COPYRIGHT,CPG,DESPITE,EPIGENETIC,INC,THERE,THESE,USING
000,169,900,BACKGROUND,BETWEEN,END,LABEL,METHODS,OVERALL,PREDICTING,RESULTS,SINCE,SOCIETY
169,BRAIN,COPYRIGHT,PUBLISHED,SAS
169,956,BACKGROUND,ECS,HEART,HOWEVER,INC,JAK,JANUS,LABEL,METHODS,OBJECTIVE,RATIONALE,RESULTS,SMALL,SOCS3,STAT3
169,AFTER,AMONG,HOWEVER,THESE
024,107,176,ASN118ASN,C8092,ERCC1,THESE,XPD,XRCC1
141,183,AMONG,BACKGROUND,HINTS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SMOKING
JANUARY,NSCLC,TOXICITIES
C25,DR5,HOWEVER,MTS,SHORT,SOLUBLE,TRAIL
001,011,012,021,169,BACKGROUND,BSP,COPYRIGHT,CPG,EPIGENETIC,INC,LABEL,METHODS,MSP,NPTX1,PCR,RESULTS,THESE,TNM
500,AMONG,CD8,ELISPOT,HLA,HOWEVER,IAV,M13,PB1,PB2,POISSON,PR8,X31
003,169,215,232,259,328,378,591,945,COMPARING,HOWEVER,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,S100B,THEREFORE,UNIVERSITY
ECM
100,169,COPYRIGHT,PUBLISHED,ULTRASOUND
160,169,215,COPYRIGHT,DISTANT,GIVEN,INC,TRANSPLANT
ACUTE,AFTER,AMONG,CONCLUSION,KNOWLEDGE,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,946,AKT,COPYRIGHT,EMT,INC,TGF
169,945,BIO,BRITISH,CCL,IMMUNOLOGY,MDSCS,MYELOID,NSCLC,PERIPHERAL,RFA,SOCIETY,THERE,THESE,TNF,TREGS
169,946,ADC,DOCK4,LABORATORY,PRESS,PUBLISHED,TGF,THESE
169,351,428,557,747,AMONG,CONSISTENT,COX,JANUARY,USING
111,169,215,476,510,730,953,DISCOVERY,FDR,FFAR4,INC,WILEY
IRELAND,LTD,PUBLISHED,SEVERAL,THEREFORE
BACKGROUND,BETWEEN,CALLS,CONCLUSION,DESPITE,FUNDING,HRS,INDIVIDUAL,INSTITUTE,LABEL,LIMITATION,METHODS,NURSING,OBJECTIVE,PRIMARY,PROXY,RESULTS,RETIREMENT,SETTING
169,750,BACKGROUND,CETUXIMAB,DECREASED,DLT,ERBB2,FIFTY,FURTHER,JAK,LABEL,METHODS,RESULTS,SOCIETY
169,FORCE,PREVENTIVE,SCREENING,SINCE,SOCIETY,TRIAL
169,231,233,COPYRIGHT,PEMETREXED,PUBLISHED,SAS
ADDITIONAL,AFTER,BACKGROUND,CELLS,FINAL,LABEL,PATIENT,PAZOPANIB,PEC,PSA,RESULTS,T1B,THERE,THEREFORE,THREE
160,169,510,900,CHINA,COPYRIGHT,ELISA,GENOMIC,HOWEVER,IGG,IRELAND,LTD,PCR,PREVALENCE,THREE,TOXOPLASMA
169,CONCLUSION,COPYRIGHT,DESPITE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,169,4N0,7TH,AFTER,BACKGROUND,GYE,IIA,LABEL,LCR,METHODS,NSCLC,RESULTS,SHORT,SOCIETY
169,COLORECTAL,COPYRIGHT,CPG,CUR,CURCUMA,DELETED,DLEC1,HDAC4,INC,KNOCKDOWN,MSP,TAKEN
169,AUTHORS,FURTHER,G3H,GFP,HGF,HOWEVER,LTD,MET,PTY,PUBLISHING,SCIENCE,SMALL,THEREFORE,THESE,WILEY
169,ARG275TRP,COPYRIGHT,INC,PARK2,PARKINSON,PUBLISHED,SOCIETY,THESE
001,016,042,045,100,127,130,135,212,334,AFTER,ALONG,BACKGROUND,HOWEVER,IIA,IIB,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
10G,BACKGROUND,GLN,LABEL,MATERIALS,METHODS,RESULTS,SIXTEEN
BACKGROUND,DISEASE,FDG,LABEL,MATERIALS,METABOLIC,METHODS,NSCLC,PERCIST,PET,PFS,RESULTS
BACKGROUND,DARUSSALAM,HOWEVER,LABEL,MATERIALS,METHODS,PROTEIN,RESULTS
103,183,188,205,285,388,BACKGROUND,BAL,LABEL,MATERIALS,METHODS,NPV,PPV,RESULTS
HOWEVER,NSCLC,RAD51
000,100,109,112,138,150,684,999,BACKGROUND,FAO,HOUSEHOLD,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,SHATT,THESE
695,AMONG,BACKGROUND,KERMANSHAH,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,UNIVERSITY
169,VCH,WILEY
963,BIS,FINALLY,HAMMETT,INHIBITOR,PEG,WHILE
001,054,10540,169,178,HCC,HIV,INC,INSURANCE,PWH,THERE,WILEY
169,COPYRIGHT,HCC,INC,PUBLISHED,SOCIETY,TAE
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
DISCUSSION,DUE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCT,PET,SIX,SUB,TENON
169,AKT,CDR,CONCLUSION,COPYRIGHT,CPG,EGR,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PC9,PCR,RESULTS,TREATMENT
32P,AAI,AAN,BEN,CONCLUSION,DICOUMAROL,EXPRESSION,HOWEVER,LABEL,METHODS,NAD,OBJECTIVE,OBJECTIVES,RESULTS,UNASSIGNED,WESTERN
001,169,BACKGROUND,BASED,END,HODGKIN,HOWEVER,LABEL,LARGE,METHODS,PRESS,PUBLISHED,RESULTS,SEPARATELY,SMALLER,UNIVERSITY,YOUNGER
460,CAT,FINALLY,GPX,HAG,HOP,LCC,OXIDATIVE,SOD,TXNIP,USING
004,146,169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS,ROBOTIC,UNIVARIATE
EARLY,PALLIATIVE,WHOLE
169,946,947,BAX,CELLS,COPYRIGHT,INC,SER
169,177,COPYRIGHT,GENERAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PBS,PHANTOM,PURPOSE,RESULTS,SURFACE
001,169,ARM,BCS,COPYRIGHT,DUE,GROUP,HOWEVER,IMN,INC,LABEL,MATERIALS,METHODS,MRM,OBJECTIVE,PURPOSE,RADIATION,RESULTS
169,CBCTS,CONCLUSION,COPYRIGHT,DAVIS,INC,KRESS,LABEL,MATERIALS,METHODS,OBJECTIVE,PICCS,PURPOSE,RESULTS,SMEIR,USING
003,100,169,945,COPYRIGHT,EVALUATION,FDG,FIFTEEN,GTV,INC,LABEL,MAASTRICHT,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,RESULTS
001,106,150,166,169,215,498,945,946,AMONG,BED,COPYRIGHT,COX,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
100,169,BECAUSE,COPYRIGHT,GRADE,INC,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
169,231,233,ASSESSMENT,COPYRIGHT,PROGNOSTIC,PUBLISHED,SAS,THESE
169,231,233,COPYRIGHT,PUBLISHED,SAS,SEVERAL,THESE
CHEMICALLY,CRE,FINALLY,FLP,INTRANASAL,NSCLC,TET,THESE
POTENTIAL,RAS
MALIGNANT,MPE,PLEURAL
HOWEVER
CETUXIMAB,GROUP,III,INSPIRE,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOUTHWEST,SUMMARY
100,BACKGROUND,BESIDES,CANCERS,LABEL,PREVENTIVE,WOMEN
176,AFTER,CASPASE,DU145,H1299,HSP90,LABEL,MATERIALS,METHODS,OBJECTIVE,PC3,PURPOSE,RESULTS,U87MG,VIABILITY
946,MMP,TGF,THEREFORE
END,FIFTY,FORTY,FRANKEL,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SELECTING,SRS,TRILOGY
AMONG,BOARD,CHECK,FORCE,HOWEVER,MEDICAL,PHE,PREVENTIVE,SERVICE,SINCE,SWISS,THEREFORE
549,BACKGROUND,BF1,EXPRESSION,LABEL,METHODS,MIGRATION,MMP,NSCLC,PCR,RESULTS,RIZ,TIMP1,TIMP2,TIMPS
18F,BACKGROUND,BESIDES,FDG,LABEL,METHODS,PET,RESULTS,SPM,UNIVERSITY,ZHENGZHOU
026,056,870,ACCORDING,BACKGROUND,COX,LABEL,METHODS,NEWLY,RESULTS,SIR,SPM
169,BIOLOGY,HOWEVER,IAP,INC,MKN45,MOLECULAR,SOCIETY,TREATMENT,YM155
100,EMA,GLUT1,HOWEVER,IHC,VARIOUS
138,AUC,EBC,EXHALED,NSCLC,THERE
160,969,AMONG,BACKGROUND,CONCLUSION,DENMARK,GENERAL,HOWEVER,III,INITIATING,LABEL,METHODS,NON,OBJECTIVE,PATIENT,PHD,RESULTS,SERVICE,SPIROMETRY,STUDIES,UNIVERSITY,UNLABELLED,WOMEN
ACUTE,GRADE,HOWEVER,III
CONFIRMED,FDG,OUTCOME,PET,PSP
120,BECAUSE,COMPARING,COX,HOWEVER,INSURANCE,PFS,PREDICTORS,THERE,TKI
399,BESIDES,CASES,COEXISTING,COX,HOWEVER,HRS,INSURANCE,TAIWANESE
103,332,BASED,LOW,NSCLC,PET,PULMONARY,STAGE,THERE,THREE
100,177,354,956,95C,CSPECIFIC,NUMERICAL,YOUNG
001,012,016,018,029,033,036,045,083,160,169,172,187,371,433,546,558,568,681,976,991,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PROGNOSTIC,PUBLISHED,RESULTS,SOCIETY,SOLID
141,ECTOPIC,FINALLY,GASTRIC,HOWEVER,INCREASING,MIR,PDZ,TAZ,THESE
001,048,187,AFTER,BACKGROUND,CONCLUSION,CRP,ESTIMATING,LABEL,METHODS,MPM,NLR,RESULTS
001,005,124,150,AMONG,BACKGROUND,CONTEXT,ETE,LABEL,LARGE,METHODS,OBJECTIVE,PREDICTORS,PTC,RECURRENCE,RESULTS,RFS,SECULAR
ACETATE,AFTER,DECOCTION,INCREASED,LABEL,LCC,METHODS,NPY,OBJECTIVE,PCR,RESULTS,SERUM,THERE,THOSE,TOTALLY,XIAOYAN
956,ADM,ADRIAMYCIN,BUTYL,CELLS,CURCUMA,CWN,CWNAE,FCM,GCS,IHC,LABEL,LRP,MDR,METHODS,OBJECTIVE,RESULTS,SGC7901,VCR,VERAPAMIL,W20,W40,W80,WESTERN
HEP,STEMONA,THESE
549,AMONG,COMPOUNDS,ESPECIALLY,THP,URSOLIC
125,956,DAD,INDIA
945,GROSS,HMB45,SINCE,THEREFORE
169,231,ATTACHMENT,COPYRIGHT,FAK,FINALLY,FOCAL,LVC,MDA,PAX,SOCIETY,THESE
946,ERK,FBS,FPP,HOWEVER,MTT,RII,STATINS,TGF,THEREFORE,WESTERN
169,COPYRIGHT,ECG,INC
946,ERK,FAK,MMP,ROS,SRC,SUPPRESSED
544,891,AIM,CENTRAL,CNS,LIVER,PFS,PPS,PROGNOSIS,RESULTS,THERE
100,116,205,549,956,HCT,MCF,METHANOLIC,NCI,SPP,SRB,THP
145,956,A1CL3,ALP,AMONG,ANTICANCER,CHLOROFORM,DRIED,FLAVONOID,IGR,MCF,OVI,PIPER,SRB,THP
CONVERSELY,NON,THESE
001,400,945,BAX,BCL,FORTY,HIF,IHC,MYRICANOL,PCR,THESE,TIR,TUNEL
177,ACCORDING,BSE,CONCLUSION,EUCLIDEAN,GTV,LABEL,METHODS,OBJECTIVE,REFERENCE,RESULTS,SOBEL
001,106,169,AFTER,AMONG,FORCEPS,INDIVIDUAL,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,18F,216,609,AMONG,LABEL,LY0V0PL0N0,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SMALL,SOLID,STAGE,UNIVERSITY
130,169,ENDOSCOPIC,GRADE,III,MAY,PHASE,PRESS,PUBLISHED,SECONDARY,UNIVERSITY
BMJ,DESPITE,GROUP,LIMITED,PUBLISHED,PUBLISHING

BRAIN,HISTOLOGY,NSCLC
169,535,956,COPYRIGHT,ESI,HOWEVER,IMS,THEREFORE,UNDER
KIF5B,LADCS,NSCLC,REARRANGED,RET,SEVERAL
001,006,007,019,041,264,BACKGROUND,CONCLUSION,LABEL,METHODS,MTSS1,NSCLC,RESULTS,SCC
169,ACTIVATION,CISPLATIN,COPYRIGHT,CROSS,CYCLINB,HOWEVER,INC,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,TYR15
CARDIAC,THREE

090,169,482,ADVERSE,AGREEMENT,CONCLUSION,EXAMINING,GIVEN,INSTITUTE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SOCIETY,SUBJECTIVE,TREATMENT
111,148,169,261,CHINA,COMMITTEE,CONCLUSION,IASLC,JOINT,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX,SOCIETY,TNM
001,109,166,169,253,275,888,ALK,AMONG,CONCLUSION,CRIZOTINIB,DCR,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PROFILE,PURPOSE,RESULTS,SOCIETY,TTP
001,160,169,APRIL,BACKGROUND,COPYRIGHT,FURTHER,III,INC,LABEL,MARCH,METHODS,PUBLISHED,RESULTS,SOCIETY
002,011,014,034,052,054,169,945,AKT,COPYRIGHT,EDUCATION,FAK,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WESTERN
169,COLLEGE,COMBINING,COPYRIGHT,EARLY,LTD,PUBLISHED,PULMONARY,ROYAL
326,408,AMONG,CONCLUSION,CURRENT,INDICATORS,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SHS
003,009,208,DFS,LCR,LNR,NCR,NSCLC,THEREFORE
169,ATM,BIOLOGY,EPHA5,FINALLY,INC,MOLECULAR,SOCIETY
100,160,169,AGE,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,PURPOSE,RESULTS,TEN,THESE
089,169,481,577,AFTER,AMSTERDAM,COPYRIGHT,ERASMUS,GUIDELINE,IRELAND,LABEL,LTD,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,ROTTERDAM,UNIVERSITY
169,CONCLUSION,COPYRIGHT,CROWN,IMAGE,LABEL,LAT,LTD,MATHWORKS,MEDICAL,METHODS,OBJECTIVE,ORGAN,PUBLISHED,PURPOSE,RESULTS,SYSTEMS,USA
038,048,152,196,ACCORDING,LABEL,METHODS,NBI,OBJECTIVE,OLYMPUS,RESULTS,THERE,WLB
001,150,300,AIM,BACKGROUND,COLORECTAL,CONCLUSION,CRC,LABEL,METHODS,MINIA,OBJECTIVE,RESULTS,SEDENTARY
100,169,177,956,AUC,BROMO,COPYRIGHT,HENCE,HOWEVER,INC,NOS,THEREFORE
122,THESE
CARD9,CXCL1,CXCL2,CXCL5,EXOGENOUS,MYD88,USING
ITALY
EXOGENOUS,FAK,FOCAL,PHOSPHATE,S1P
003,014,021,145,877,FDG,NSCLC,ROC
177,FURTHER,JANUARY,MALIGNANT,MFH,MRI,PATHOLOGY,PATIENT,THERE

169,ADC,COPYRIGHT,IHC,IRELAND,LARGE,LCC,LCNEC,LTD,NET,NGS,NOS,NSCLC,SQC
001,028,143,160,169,316,AMONG,BACKGROUND,BASED,BETWEEN,COPYRIGHT,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY
001,045,118,160,167,169,347,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RECURRENCE,RESULTS,SOCIETY
001,132,155,172,177,190,421,CCL18,CD4,CSF,FCM,FINALLY,FOXP3,HLA,LABEL,METHODS,MFI,MPE,NSCLC,OBJECTIVE,RESULTS,SIMILARLY
945,HOWEVER,L755P
CD133,CELLS,EPCAM,EPITHELIAL,FIRSTLY,HOWEVER,NSCLC,THESE
967,BLOOD,EVALUATION,PBV,SOLID,SURFACE,THROUGH
004,006,945,AKT,LAC,MMP,MTT,PENTRAXIN,TAKEN,TRANSWELL
169,COPYRIGHT,INC
95D,AKT,CXCR4,LOW,MILLICELL,MTT,THEREFORE,TRANSWELL,WESTERN
946,BAD,BAX,EMT,JUN,KNOCKDOWN,NSCLC,SHORT,THESE,USING,WESTERN
947,AFTER,ASSESSMENT,CONCLUSION,CONVERSELY,DCS,FUNCTIONAL,GPS,INF,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,TH1,TH2,TREATMENT
169,786,945,AUC,BACKGROUND,BECAUSE,HOWEVER,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THEREFORE,UNIVERSITY
GIANT,OPG,RANKL
169,244,468,ACCORDING,ALPES,BACKGROUND,COPYRIGHT,LABEL,METHODS,PATIENT,PUBLISHED,RESULTS,SAS,THEREFORE
107,169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,MONITORING,PUBLISHED,SAS,SIADH
157,160,169,37YEARS,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTY,HBS,LABEL,METHODS,PREVIOUSLY,PROTECTIVE,PUBLISHED,RESULTS,SAS,VITAMIN
001,005,169,CONCLUSION,COPYRIGHT,EXPRESSION,FURTHER,IGF,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PROTEIN,RESULTS,TKI,UNIVARIATE
001,007,169,BACKGROUND,BESIDES,CONCLUSION,COPYRIGHT,EBSCO,HOWEVER,HRS,IRELAND,LABEL,LTD,METHODS,RESULTS,THERE
169,COPYRIGHT,IRELAND,LTD,PUBLISHED,THERE
169,COPYRIGHT,IRELAND,LTD,NSCLC,PTP1B,THESE
169,BCL,CDK,COPYRIGHT,RESULTS,TNF
002,006,HDACI,LABEL,LARGAZOLE,METHODS,OBJECTIVE,PURPOSE,RESULTS,TGI,THESE,USING
ADP,AUSTRALIA,CHINA,EWING,III,JAPAN,KOREA,SOUTH,USA
150,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TEN,THESE
BACKGROUND,BRIGHAM,DEPARTMENT,HOWEVER,LABEL,MALIGNANT,MATERIALS,MEDICAL,METHODS,MPM,RADIATION,RESULTS,STAGE,UNIVERSITY,WASHINGTON
BACKGROUND,CONCLUSION,GROUP,III,LABEL,MALIGNANCY,METHODS,RESULTS,STAGE,THERE,WORLD
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
143,169,BASED,COPYRIGHT,FEDERATION,LUCIFERASE,MYB,NCP,NPC,PUBLISHED,SOCIETIES
001,045,169,172,242,CMV,CSA,INC,MMF,MTX,PSM,THERE,WILEY
ALK,HODGKIN
177,197,ASSESSMENT,BRM,CNS,GPA,INTRABEAM,KARNOFSKY,LABEL,LOCAL,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SCALE,SIX,SURGERY
177,4T1,AKT,IGF,IGFBP,INSULIN,WHILE
AMONG,CHANG,CLOSE,MCT,MEDICAL,OTHER
169,181,954,BACKGROUND,BASEL,CNS,CONCLUSION,EFFORTS,INSTITUTE,LABEL,METHODS,NCI,RESULTS,SCREENING,SRC,SRS06,STAT3,TRANSAM,WESTERN
BAC,CONCLUSION,FDG,GGO,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SUV
946,BAD,BAX,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,STS,WESTERN
136,149,155,169,171,285,AMONG,CENTERS,CONCLUSION,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
169,215,CONCLUSION,FDG,HENCE,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SNR,SOCIETY,SUPPORTED,SUVMEAN,UNLABELLED
169,BACKGROUND,BASEL,CONCLUSION,H1299,H1568,LABEL,METHODS,MTT,MYC,NSCLC,PCR,RESULTS,TUNEL,WT1
250,BACKGROUND,C30,DEVIATION,EORTC,FURTHER,HRQOL,LABEL,METHODS,PEMETREXED,QLQ,RESULTS,SEVERAL,SOUTH,SWAMP
003,BSP,HOWEVER,NSCLC,PCR,TMA
001,002,007,008,170,196,343,665,HOWEVER,III
001,004,104,529,ANNEXIN,ARNT2,MTT,NSCLC,OVERALL,TAKEN
203,ADP,BACKGROUND,CFZ,H1299,H1993,LABEL,METHODS,NSCLC,PHASE,RESULTS,SHP77,WESTERN
100,120,169,GRADE,IRINOTECAN,LABEL,METHODS,NON,OBJECTIVE,PHASE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
BACKGROUND,CONCLUSION,ILD,LABEL,METHODS,PTV,RADIATION,SIX
992,CARLO,LABEL,METHODS,MONTE,OBJECTIVE,OBJECTIVES,RESULTS
474,EARLIER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
OPTIMAL
SINCE
AFTER,AMPUTATION,COPYRIGHT,HOWEVER,III,SLACK
34C,DAC,ECTOPIC,HOWEVER,KNOCKDOWN,MET,NPC,PCR
DAC,DESPITE,NALP1,PCR,THEREFORE
163,AMONG,BACKGROUND,CONCLUSION,EGFRS,ERLOTINIB,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE
ADDITIONAL,AKT,BACKGROUND,CONCLUSION,EVEROLIMUS,LABEL,METHODS,MPM,OVERALL,PFS,RESULTS,THERE
001,939,ASSESSMENT,BACKGROUND,CHEMONAIVE,EASTERN,FUNCTIONAL,GENERAL,GROUP,III,LABEL,METHODS,NSCLC,NTX,POINTBREAK,QOL,RANDOMIZED,RESULTS,THERAPY,TREATMENT
005,100,127,138,BACKGROUND,BECAUSE,CORRECT,KOREA,LABEL,METHODS,NPV,NSCLC,RESULTS
DRESDEN,EVALUATION,HOWEVER,IASLC,SOLID,WORLD
PROGNOSIS,PULMONARY,RADIOLOGY
001,005,006,553,BACKGROUND,CONTEXT,LABEL,LBP,METHODS,OBJECTIVE,PULMONARY,RESULTS
BACKGROUND,CONTEXT,DISEASE,IDR,LABEL,METHODS,OBJECTIVE,RESULTS
ADVERSE,DFS,EPIDERMAL,III,LABEL,NSCLC,OBJECTIVE,PHASE,PURPOSE,RESULTS,SUMMARY,THERE,TKI
AZD9291,HM61713,L858R,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THIRD,TKI
169,ACIDS,AKT,CLINICALLY,HDAC1,HOWEVER,NOTABLY,NUCLEIC,OC4,PRESS,PUBLISHED,SP1,THROUGH,TNC,UNIVERSITY
169,231,233,BIOLOGICAL,COPYRIGHT,CPMHS,CPMRC,HSMPC,MCRPC,PUBLISHED,SAS
169,231,233,254,APRIL,BACKGROUND,CEA,COPYRIGHT,FASAY,JANUARY,LABEL,LOUIS,METHODS,PFS,PUBLISHED,RESULTS,ROUTINE,SAINT,SAS,THERE
001,002,100,164,18F,202,442,555,662,963,BACKGROUND,CONCLUSION,FDG,HOWEVER,LABEL,METHODS,MTV,PET,RESULTS,THERE,TLG,VOLUMETRIC
045,083,092,102,178,441,639,644,653,665,682,967,ELISA,EPIDERMAL,HOWEVER,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PROTEIN,RESULTS,SERUM,THESE,TNM,TTF
088,093,102,109,131,136,139,148,150,155,178,179,199,203,205,220,223,237,241,243,253,255,260,310,410,435,446,498,528,567,656,697,741,831,893,919,967,999,CIGARETTE,CONCLUSION,ERAP2,HAN,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SNP
101,119,139,163,172,177,181,431,556,589,633,655,725,AMONG,EXPRESSION,LABEL,METHODS,OBJECTIVE,RESULTS,VAN
003,008,009,019,025,030,148,160,163,227,558,925,BACKGROUND,LABEL,METHODS,PET,RESULTS,SOLID,USING
946,BACKGROUND,DAL,EMT,EPITHELIAL,HSPA5,LABEL,METASTASIS,METHODS,PCR,RESULTS,STRIKINGLY,THESE
MTT
169,MMP,RIBAVIRIN
100,BACKGROUND,CONCLUSION,DEFINITELY,FDG,FREQUENCY,HOWEVER,LABEL,MALIGNANT,METHODS,PET,RESULTS,THERE,WHILE
00001,005,160,205,520,967,AAH,AIS,BACKGROUND,BETWEEN,JANUARY,LABEL,METHODS,MIA,PEARSON,RESULTS,ROC
114,AFTER,BACKGROUND,BLINDED,CARCINOMA,CONCLUSION,EUS,F18,FDG,HOWEVER,LABEL,METHODS,NEITHER,NON,NSCLC,PET,REFERENCE,RESULTS,SMALL,STAGING,THEREFORE
945,BACKGROUND,CELLS,CISPLATIN,EXPRESSION,H23,HDAC4,HDACS,HIF,LABEL,METHODS,NSCLC,RESULTS,THESE,TOXIC
461,682,BACKGROUND,CONCLUSION,DIFFERENT,LABEL,METHODS,OTHER,RESULTS
18F,FDG,HISTOLOGIC,PET,SUBSEQUENT
001,246,311,618,EPIDERMAL,LABEL,LOW,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEVENTY,SUV,WHITNEY
001,100,18F,APRIL,DEFINITIVE,FDG,HISTOLOGY,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,SUV,TCS
13C,DUE,FRESHLY,GLS,KREBS,NSCLC,THESE
JCI,SELLERS,TCA,THERE
100,FURTHER,HOWEVER,IMPORTANCE,KERATOSIS,LABEL,METHODS,OBJECTIVE,RAF,RELEVANCE
SUBSEQUENT,THEREFORE
HOWEVER,NSCLC
169,4T1,600,802,946,AMONG,BIOLOGY,EMT,EPITHELIAL,HIT,HOWEVER,INC,KNOCKDOWN,MOLECULAR,NMUMG,SOCIETY,TGF
BACKGROUND,CEA,CONCLUSION,HENCE,LABEL,METHODS,PCR,RESULTS,THREE
174,ACCURAY,CONCLUSION,FIF,HELICAL,INC,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SIB,SIMILARLY,SIX,SUNNYVALE,TOMODIRECT
ASSESSING,BLAND,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS
000,009,018,028,ADVERSE,COX,GEFITINIB,III,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PFS,RESULTS
038,105,166,167,946,III,NSCLC,RAR,SIMILAR,SINCE,THESE
BACKGROUND,CHINESE,EFFECTS,EXPRESSION,LABEL,MATERIALS,METHODS,MMP,MTT,PARIS,RESULTS,WESTERN
005,021,037,041,151,ACE,BACKGROUND,BLOOD,INDIA,LABEL,MATERIALS,METHODS,NORTHEAST,RESULTS,SMOKING
001,002,034,177,272,544,BACKGROUND,INDIA,LABEL,MANIPUR,METHODS,MIZORAM,NORTH,PRO,RESULTS
001,177,552,619,680,813,ASIAN,BACKGROUND,EPIDERMAL,ESPECIALLY,HOWEVER,LABEL,MATERIALS,METHODS,OVERALL,RESULTS
123,DDP,HOWEVER,MDR,MTT,PCR,TAKEN
339,365,570,663,756,BACKGROUND,CONSISTENT,HOWEVER,IHC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,ROC,THREE,TNF,TNM,TRAF6
1ST,AGE,BACKGROUND,CONCLUSION,LABEL,METHODS,OLOMOUC,PET,RESECTION,RESULTS,SURGERY,UNIVERSITY
169,215,21H,23H,945,CDS,CEA,COPYRIGHT,LTD,NSE,WILEY
19A,CONVERSELY,HOWEVER,NSCLC,PCR,SOCS1,STAT3,TAKEN,UTR
AREAS,BACKGROUND,CAR,COVERED,EWING,GD2,IGG,LABEL,METHODS,OPINION
169,4T1,BV8,CSF,CXCR2,IFN,LLC,METASTASES,OVERALL
035,045,CONCLUSION,COX,LABEL,METHODS,MLN,NSCLC,OBJECTIVE,RECURRENCE,RESULTS
COMPETING,THERE
001,029,037,049,067,160,263,479,547,768,779,CIORR,CIPFS,ERLOTINIB,HRPFS,LIBRARY,MEDLINE,NSCLC,ORR,PFS,RRORR,SCIENCE,STATA,TKI,WEB
001,002,014,025,028,107,120,157,158,160,164,187,279,321,338,374,399,416,470,499,541,686,732,746,757,818,821,823,82G,840,882,908,936,976,981,ASIAN,CAUCASIAN,LIBRARY,MEDLINE,OVERALL,SCHOLAR
169,801,803,BACKGROUND,BTMED,CAUSE,CONTINUED,DEPARTMENT,DOE,INC,LABEL,MEDICAL,METHODS,MORTALITY,PROGRAM,RESULTS,RISKS,SCREENING,WILEY,WORKERS
MICRORNAS,NANOG,OCTAMER,POU,SEVERAL
ALK,FGFR1,NGS,NSCLC,SEVERAL
CHINA,HOWEVER,LYMPH,NON,NSCLC
001,115,961,AUC,BACKGROUND,DETECTION,ELISA,FORTY,III,LABEL,METHODS,RESULTS,SERUM,TNM
001,014,025,031,038,041,120,BACKGROUND,CHI,COX,LABEL,MEIER,METHODS,P53,RESULTS
107,130,70C,BACKGROUND,BAOSHAN,CHINA,CIS,ESTIMATES,EX1,EX6,GST,GSTM1,HOWEVER,LABEL,LONGTAN,METHODS,ORS,PCR,RESULTS,THERE,XUANWEI
945,954,956,BACKGROUND,EXOGENOUS,IKB,JNK,LABEL,METHODS,NSCLC,PCR,RESULTS,SPC,TREATED,WESTERN,WHILE
000,163,177,689,99MTC,BACKGROUND,DYNAMIC,LABEL,METHODS,PET,RESULTS,ROI
155,AFTER,CBM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,STATA,VIP,WANFANG
169,242,ABCG2,CISPLATIN,COPYRIGHT,DCR,HOWEVER,INC,INOPERABLE,MTT,PFS,QCR,USING
169,ABCB1,ABCC1,ATP,CONVERSELY,COPYRIGHT,HDL,HOWEVER,INC,LDL,LRP,MDR,MULTIDRUG
246,327,345,513,AMONG,AUDIT,BACKGROUND,DIAGNOSIS,ENGLISH,EXCELLENCE,GENERAL,INSTITUTE,IQR,KINGDOM,LABEL,METHODS,PRESENTING,PRIMARY,RESULTS
FINALLY,III,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TARGETING
LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
138,169,ALK,COPYRIGHT,HOWEVER,IHC,IRELAND,LTD,NSCLC,PCR,TKI
001,169,1ST,232,2ND,330,BACKGROUND,COPYRIGHT,CROWN,DESPITE,FURTHER,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,REASONS,RESULTS,STAGE
169,945,946,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SCC
169,COPYRIGHT,DESPITE,IHC,IRELAND,LABORATORY,LTD,NGS,NSCLC,ONCOGENIC,SEVERAL
169,239,ALK,COPYRIGHT,CRIZOTINIB,IRELAND,LTD,NSCLC,TKI
004,110,121,147,160,166,169,185,200,205,207,217,228,237,250,400,AUC,BACKGROUND,BETWEEN,BRISTOL,COPYRIGHT,FUNDING,III,INSTITUTE,IQR,LABEL,LTD,METHODS,MYERS,NOV,PET,RADIATION,RESULTS,THERE,USA
169,BASED,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,SMALL
169,COPYRIGHT,INC,KISS1,NON,NSCLC,SINCE,SMALL,SRC
169,CONVERSELY,FUNCTIONAL,NSCLC,THERE
169,946,CIGARETTE,EMT,NSCLC,SRC,TAKEN
144,169,179,956,ANTICANCER,CONSOLE,COPYRIGHT,DMC,EXPRESSION,HOWEVER,INSTITUTE,MULTICHIP,NCI,RMA
146,BACKGROUND,CONCLUSION,FACTORS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PULMONARY,RESULTS,THERE
100,169,183,AMONG,DIP,DUE,EXTENSIVE,GEORG,HISTOLOGIC,HISTOLOGY,STUTTGART,THERE,VO2
263,360,485,824,993,AFRICAN,ASIAN,DANES,EASTERNERS,EUROPEANS,HRS,IRANIAN,LOW,NORTH,ORDINAL,PANCREATIC,SOUTHEAST,SWEDISH,TURKISH,TURKS
169,AFTER,BACKGROUND,CATHETERS,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,TEXAS,THESE,UNIVERSITY
169,945,946,AKT,AUTHORS,CONVERSELY,DNMT1,ERK,FOUNDATION,HOWEVER,JOURNAL,LTD,METFORMIN,MOLECULAR,NSCLC,PD98059,RHIZOMA,SP1,TAKEN,WILEY
312,CONCLUSION,FACTORS,LABEL,METHODS,OBJECTIVE,PREVALENCE,PREVENTION,RESULTS,TIANJIN
169,COPYRIGHT,ECD,ESI,INITIAL,NARCISSUS,NMR
169,BECAUSE,COPYRIGHT,HOWEVER,III,NSCLC,PUBLISHED,SUSTAINED,VEGFS
169,248,ACCORDING,ADF,COFILIN,COPYRIGHT,KNOCKDOWN,LIN28,LNA,NSCLC,PREVIOUSLY,TAKEN,TWIST
169,COPYRIGHT,FGF,HOWEVER,IRELAND,LTD,THESE
001,CONCLUSION,ELEVATION,FIRST,III,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PHASE,QOL,RESULTS
142,169,251,651,BIOMARKERS,FDR,IL12A,IL8,INC,NSCLC,SNP,THESE,WILEY
GPS,NSCLC,PET,PROJECT,SMOKING,SURGERY,THOSE
025,169,BACKGROUND,COPYRIGHT,FIFTY,INC,LABEL,LARGE,LCNEC,MARCH,METHODS,OVERALL,PUBLISHED,RECURRENCE,RESULTS,SOCIETY
CAV,FAS,FMK,HOWEVER,INHIBITION,P62,RSV
001,005,018,127,130,ARG399GLN,ASN118ASN,COX,ERCC1,ERCC2,LYS751GLN,MEIER,NSCLC,RFS,XPD,XRCC1
002,183,ERK,HOWEVER,MEANWHILE,NSCLC,THERE,THEREFORE,TNM
ACTIS,BETWEEN,CRO,HAPPY,JANUARY,MEDICAL,SYSTEMS,THEREFORE,TOSHIBA
106,AES,AFTER,NSAIS
ADVERSE,BETWEEN,CTCAE,GRADE,JANUARY,LABORATORY,THERE
CGA,HOWEVER,JAPAN,NSCLC,TREATMENT
169,48H,500,769,BENZO,COPYRIGHT,FINALLY,INC,TEN,THESE,THREE,WESTERN
169,AKT,ERBB2,ERBB3,ERK,FINALLY,GAB,L858R,MET,SIMILAR
007,015,120,169,ALK,CNB,COPYRIGHT,FNA,LABEL,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,OBTAINING,PATHOLOGY,RESULTS,SOCIETY,UNIVARIATE
008,010,1377G,196,379,844,844CC,AGE,APOPTOSIS,CHINA,FAS,HOWEVER,OCTOBER,PCR,SNP,SOUTH
215,APR,M1A,PBT,RBE,STAGE,THREE
012,033,CCR,GRADE,THEREFORE
131,223,HODGKIN,III,STRONTIUM,THEREFORE,YTTRIUM,ZEVALIN
GUNMA,HEAVY,INSTITUTE,ION,JAPAN,MEDICAL,PRIMARY,SCIENCE,UNIVERSITY
CRT,HCC,HOWEVER,JAPAN,SEVERAL
160,ANNEXIN,TREATMENT,WESTERN
169,COPYRIGHT,DIAGNOSES,INC,MALIGNANT,PNSTS,SIX
169,891,946,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LABEL,LTD,LUCIFERASE,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SMAD3,SMAD4,SMADS,SPC,TGF,WESTERN
153,364,6TH,ANY,GDP,HEALTHCARE,HOWEVER,LMI,LOW,MEDICAL,MEDLINE,NCD,SCHOLAR,STUDIES
001,018,027,ACCORDING,AMONG,BMJ,CBC,CNS,DMS,EXPRESSION,GEMININ,GROUP,LABEL,LIMITED,MBC,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,THERE

CURRENTLY,EPP,MALIGNANT,MPM,MST,THERE
100,169,215,420,500,597,956,BEH,C18,COPYRIGHT,DEUTERATED,ERLOTINIB,EXTRACTION,OSI,PRECISION,XBRIDGE
AMONG,DESPITE,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PREVENTION,RESULTS,SCC,SIX
001,004,005,018,042,046,051,100,111,FEDERATION,GYNECOLOGY,III,LABEL,LRP,METHODS,MRP,OBJECTIVE,OBSTETRICS,PGP,RELAPSE,RESULTS
122,136,155,169,210,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SPN,USING
169,26210,428,CLINICALLY,DECREASED,DUSP1,GEFITINIB,HDAC1,HISTONE,HOWEVER,LABEL,METHODS,MTT,NON,NSCLC,OBJECTIVE,PCR,PROTEIN,PURPOSE,RES,RESULTS
169,217,839,CONCLUSION,FIFTY,IMAGING,INC,LABEL,METHODS,MOLECULAR,NAF,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,UNLABELLED
100,169,945,946,CONSISTENT,COPYRIGHT,EMT,ESTRADIOL,INC,MALAT,PTBP2
002,169,185,607,610,AMONG,COPYRIGHT,EIGHT,INC,REGULOMEDB,XRCC1
169,AMONG,ASPIRATION,BACKGROUND,CHEST,COPYRIGHT,INC,LABEL,METHODS,RESULTS,ROCHESTER,THESE
CXCR4,FINALLY,FURTHER,HOWEVER,LPS,ML171,NADPH,NSCLC,ROS
169,177,183,COPYRIGHT,LEVENBERG,LTD,MARQUARDT,PDI,USING
169,ALK,BACKGROUND,CLONOGENIC,COPYRIGHT,CRIZOTINIB,H3122,IRELAND,LABEL,LLC,LTD,METHODS,MVD,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,LTD,MICRORNAS,THEREFORE,WHILE
100,138,143,INVADER,L858R,MUTATIONS,NSCLC,PCR
169,CD4,HOWEVER,ILC,INC,TH2
150,AES,CHINA,CHINESE,ERLOTINIB,FORTY,PCR,SIXTY
1210477,263,ABT,BCL,BH3,BIM,HOWEVER,MCL
DUMON,PALLIATIVE,UNDER
CRYOPROBE,CRYOPROBES
RIGID
100,182,561,902,BACKGROUND,CAO,DESPITE,LABEL,METHODS,RESULTS
BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,THERE
032,120,BACKGROUND,LABEL,METHODS,RESULTS
181,183,GEORG,NMR,STUTTGART
137,177,230,312,326,854,900,935,AUC,BACKGROUND,CONCLUSION,DISCUSSION,KYNURENIC,LABEL,METHODS,NODAL,NPV,NSCLC,OBJECTIVE,PPV,RESULTS,ROC
954,BCL,FURTHER,NOTCH
CNS,CORONAL,DIFFUSION,FLAIR,IIC,ISSUE,ITSSS,LABEL,MELANOTIC,METASTASIS,METHODICAL,METHODS,MRI,OBJECTIVE,PRACTICAL,STAGE
023,111,113,169,209,213,229,237,239,246,345,364,BACKGROUND,BOEHRINGER,COPYRIGHT,FUNDING,HOWEVER,INGELHEIM,IQR,LABEL,LEU858ARG,LTD,LUX,METHODS,PREVIOUSLY,RESULTS,THESE
019,041,045,071,076,088,105,107,109,111,115,125,149,159,160,190,195,202,248,254,273,308,313,410,730,974,CYS,OVERALL,SER,SER326CYS,WEIPU
001,160,182,290,384,470,652,920,946,961,COX,MYC,NPC,RBMS3,THEREFORE,TSG,WESTERN,WNT
001,006,008,121,BACKGROUND,CAREFULLY,CBM,CHINA,FINALLY,HOWEVER,III,KNOWLEDGE,LABEL,LIBRARY,METHODS,MMP,ORS,RESULTS,SCIENCE,STATA,TNM,VERSION,WEB
114,159,BMJ,BRAIN,COMMONEST,EPSCC,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PRIMARY,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,SETTING
231,LNCAP,MCF,MDA,PCA,RAMAN
011,396,ALK,AP26113,ASP3026,BASED,CHALLENGES,CRIZOTINIB,FDA,III,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TSR
HOWEVER,TAKEN,THERE
144,701,BACKGROUND,BMI,CONCLUSION,COX,CUTOFFS,INITIATIVE,LABEL,METHODS,OBESITY,RESULTS,ROC,USING,WHR,WOMEN
177,RTP
169,COPYRIGHT,PLA,SCIENCE,STRATEGIES
169,AMERICANS,HODGKIN,MARIJUANA,ORS,STUDIES,THERE,THREE
036,169,AMONG,BACKGROUND,COPYRIGHT,COX,IRELAND,LABEL,LTD,MEIER,METHODS,OVERALL,RESULTS
100,177,1EP,206,215,300,AFP,CONCLUSION,HCG,INCLUSION,LABEL,LDH,METHODS,OBJECTIVE,PURPOSE,RESULTS,ULN
001,006,037,141,169,174,259,279,456,950,ABCC4,ATP,BACKGROUND,COPYRIGHT,GST,LABEL,METHODS,OTHER,RESULTS,THESE
011,ACS,ASSESSMENT,COMPARING,CONCLUSION,FAACT,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,THERAPY
947,APOPTOTIC,BCL,FIFTY,H1299,INHIBITION,MTT,NCI,NSCLC,ROS,TREATMENT,TUNEL
181,ANNEXIN,BAX,BCL,BID,CONSISTENT,H28,HOWEVER,LCA,MALIGNANT,MCL,MPM,SP1
BACKGROUND,EUS,FNA,JANUARY,LABEL,MCC,METHODS,OBJECTIVE,PET,RESULTS,THREE,TTF
042,102,107,113,215,DFS,FUKUSHIMA,HOWEVER,IHC,IMMUNOBLOT,JAPAN,MEDICAL,NSCLC,SCC,SPECIMENS,UNIVERSITY
107,169,ACCORDING,AGE,BACKGROUND,CR2,EWING,EWS,FIFTY,HDT,IFO,III,INC,ISG,LABEL,METHODS,PROCEDURE,PRS,RESULTS,RFI,SSG,WILEY,WITHOUT
916,936,BET,BETULINIC,CYT,DCA,PDK,ROS,SELECTIVE,TAKEN,WARBURG
169,215,COPYRIGHT,FINALLY,INC,LABEL,MARGINS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL
100,169,177,AAA,AXB,CALCULATED,COPYRIGHT,D95,GTV,HOWEVER,INC,ITV,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
FORTY
100,675,BACKGROUND,BNP,LABEL,METHODS,RESULTS,SINCE
737,ABT,APOPTOSIS,BCL,MCL,MR29072,PYRIDOCLAX,SURFACE,WHEREAS,WITHOUT
169,248,277,490,501,946,COPYRIGHT,GSH,INC,NADPH,SRC,TAKEN,TGF
160,169,COPYRIGHT,INC,INCREASING,OVERALL,VERAPAMIL
169,CILENGTIDE,COPYRIGHT,INC,VERAPAMIL
169,946,AUTHORS,BLOOD,COPYRIGHT,ERG,ETS,FINALLY,INC,INDUCIBLE,PUBLISHED,THESE,WNT
032,956,H2122,SNC
001,004,010,023,805,CONCLUSION,COX,FDG,LABEL,MATERIALS,MEIER,METHODS,MTBWB,MTVWB,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,TLGWB,TNM
001,119,136,140,954,ACCURACIES,AGREEMENTS,CONCLUSION,FDG,LABEL,MATERIALS,MCNEMAR,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,TNM
135,228,676,ADVERSE,CONCLUSION,ELEVATION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,SUV,SUV95
COMPOUNDS,IAP
169,239,276,996,CONCLUSION,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
169,INJECTIONS
169,COPYRIGHT,GUIDELINES,NETWORK
169,COPYRIGHT,GUIDELINES,LOW,NETWORK,REPORTING,SCREENING,STORAGE,THESE,TOMOGRAPHY
169,COPYRIGHT,HCL,MALIGNANT,NETWORK,V600E
001,049,10877,10878,13YEARS,169,201,321,587,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PROGNOSTIC,PURPOSE,RESULTS,RFA
169,363,AES,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS,THERE,TKI,UPFRONT
038,169,234,264,424,494,984,ADDITIONAL,CONCLUSION,FORTY,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,PREFECTURE,PRESS,PUBLISHED,RESULTS,SEVENTEEN,THREE,UNIVERSITY
160,A427V,DEPENDING,ECH,G333C,G350S,G364C,G379D,G430C,G476R,ITC,KEAP1,KELCH,NMR,R413L,R415G
169,365,AUSTRALIA,CONCLUSION,COPYRIGHT,EXCLUDING,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,SOUTH,WALES
127,169,622,947,956,BASED,COPYRIGHT,FIFTEEN,HOWEVER,LTD,MDR,TAXOL,THF,THOSE,VERAPAMIL
001,003,006,142,169,ACADEMY,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCL,SSC,UNDER
169,5H1,AUTHORS,BESIDES,COPYRIGHT,E1L3N,LTD,PUBLISHED,SMALL,USING
158,169,788,ALK,ATS,CHINESE,CONCLUSION,COPYRIGHT,ERS,GGO,HISTOLOGIC,IASLC,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,PULMONARY,RESULTS,SOCIETY,STUDENT,SURGICALLY,THESE,TNM
100,AE1,AE3,AMONG,CD117,EMA,EPITHELIAL,III,LABEL,METHODS,OBJECTIVE,PPB,RESULTS,SMA
100,ALK,AMONG,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
BASED,CGA,CK7,CKPAN,GROSS,LABEL,METHODS,NEC,OBJECTIVE,RESULTS,SYN,TTF
001,005,115,AIM,JANUARY,LABEL,METHODS,OBJECTIVE,PEARSON,RESULTS,SURGERIES
169,A20,A925L,ALK,AUTHORS,LTD,PTY,PUBLISHING,SCIENCE,WILEY
EARLY,VTE
1ST,4TH,6TH,BACKGROUND,LABEL,LPS,MATERIALS,METHODS,NSCLC,RESULTS,VRI,VRIXP
BACKGROUND,CONCLUSION,DESPITE,GROUP,IIA,IIB,III,LABEL,MATERIALS,METHODS,MRI,NSCLC,PET,RESULTS,SERUM,THERE,TNM,YKL
169,3T3,946,956,NIH,VCH,WILEY
169,945,AAD,ALDH7A1,ATP,COPYRIGHT,GBM,GSC,HNPCS,INHIBITION,LTD,METABOLITE,NMR,WILEY
FFAR2,FFAR3
169,ACS,ACT,AFFORDABLE,INTERVIEW,SOCIETY
169,200,916,936,956,APOPTOSIS,CELLS,CONCLUSION,DIOC6,LABEL,LTD,MATERIALS,MELATONIN,METHODS,MTT,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,WILEY
169,ABL,AES,BCR,FAERS,FDA,GAMMA,INC,MULTI,POISSON,REPORTING,SIGNALS,THESE,WILEY
169,7WT,960,COPYRIGHT,DOX,PEO,SEM
713,BACKGROUND,CONTROLLED,CURRENT,KNOWLEDGE,LABEL,LIBRARY,METHODS,MST,NSCLC,RESULTS,SBM,SRS,STATA,THERE,WEB
160,170,363,CBM,CHINA,JANUARY,NSCLC,PFS,SCIENCE,WAN,WEB
AKT,CISPLATIN,DDP,ERK,EXPRESSION,MTT,SGC7901,SORAFENIB,WESTERN
ALK,COLLEGE,GIVEN,MOLECULAR,PATHOLOGY,THEREFORE
160,169,BECAUSE,COPYRIGHT,INC,METASTATIC,PUBLISHED,RENAL
169,AKT,COPYRIGHT,ERK,FINALLY,HOWEVER,IRELAND,LTD,SEVERAL,THESE,UBIQUITIN,UCH,UCHL1
264,486,956,95D,DAVID,EGR,NSCLC,PATHWAY,TOTAL,VALIDATION,WNT
100,DETECTION,MONITORING,NON,USING

016,026,039,500,CHINESE,COX,HAN,MCT,MEIER,NON,NSCLC,RFS,SNP
001,002,003,132,166,177,346,ALK,CHEST,KEY,LABEL,LOWER,METHODS,OBJECTIVE,RESULTS,SOLID,TDR,TKI
CONCLUSION,EIGHT,LABEL,METHODS,MOTIVATION,OBJECTIVE,PURPOSE,RESULTS,RICOEUR
153,859,AFTER,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,REGARDING,RESULTS
169,ALK,BIOVIEW,COPYRIGHT,CRIZOTINIB,III,IKONISCOPE,INC,PHASE
169,25A,BASED,BTG,COPYRIGHT,INC,NSCLC,THEREFORE
JANUARY,PULMONARY,RESULTS,VARIOUS
203,BACKGROUND,BMJ,COMMITTEE,GROUP,LABEL,LIMITED,METHODS,MPM,PTM,PUBLISHED,PUBLISHING,SECONDARY,SMART,THERE,TRIAL
178,215,CASITAS,CBL,H1299,SH2
001,002,005,049,130,170,198,238,445,485,789,815,855,950,954,961,ALK,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
APRIL,BASED,HOWEVER,LABEL,METHODS,OBJECTIVE,OCTOBER,OVERALL,RESULTS,UNIVERSITY
025,227,CHINESE,DELC1,DLEC1,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
169,ATLAS,BACKGROUND,FURTHER,LABEL,MODEL,MOTIVATION,PRESS,PUBLISHED,RESULTS,SIMULATION,UNIVERSITY
BIP,CHINESE,E2F,ERP72,NCI,NSCLC,UPR,WESTERN
110,113,117,130,163,ALDH1,FGFR1,HOWEVER,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,AKT,CBL,COPYRIGHT,IRELAND,LTD,NSCLC,SH2,SPC,TARGETING,UPS
DIF,FBS,NSCLC,PC9,SIMILARLY,VNR
112,121,177,233,767,870,BETWEEN,FEV,FVC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
181,946,A549CIS,CALU1,H460CIS,WNT
001,169,177,BACKGROUND,BASEL,HCC,LABEL,MAM,METHODS,RESULTS,SIX,TEN
AKT,BAX,BCL,ERK,FINALLY,MAPKS,PD98059,REGULATION,TAKEN,WHILE
001,140,160,320,916,AES,FORTY,MWA,NSCLC,OBJECTIVE,PFS
EGF,EGFRS,THREE
EMT,HOWEVER,MEANWHILE,METASTASIS,NOTCH,NSCLC,OVERALL,STUDIES,WNT,WNT3A
008,047,129,945,BASEL,GMD,LABEL,METHODS,OBJECITIVE,RESULTS,UNLABELLED,USING
104,130,160,191,205,224,230,269,271,CED,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS
GPS,ITALIAN,THEREFORE
181,AIF,ALONG,ARSENIC,ATO,BCL,BHA,DMS79,GSH,H69,NAC,ROS,WESTERN
169,954,ERK,OVERALL,TNBCS
169,AREAS,CONCLUSION,FDG,III,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SEVENTEEN,SOCIETY,UNLABELLED,VARIOUS
060,100,160,169,198,200,206,300,324,662,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,LABEL,METHODS,NSCLC,OVERALL,RENAL,RESULTS,UNTREATED
005,169,1ST,BACKGROUND,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MARCH,METHODS,RESULTS,SIGNS
956,ADR,CONCLUSION,LABEL,LDH,MCF,METHODS,OBJECTIVE,RESULTS,WESTERN
177,321,336,341,361,378,399,423,457,500,771,916,942,ACCORDING,AMONG,CONCLUSION,III,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,OPERATIVE,RESULTS,THERE,THREE,TOKUHASHI,VAS
ELCAP
ELECTRICAL,FREQUENCY,HOWEVER,RADIO,RFA,THEREFORE
AIDED,CAD,DIAGNOSIS
RESULTS
460,CYBERKNIFE,EKF,LCM,RESULTS,SVM
CL1,THEREFORE
BNCTS
480,PATIENT,SIX,SURGERY
ZNO
215,INTENSE,SKULL
169,ENGLISH,LABEL,METHODS,OBJECTIVE,RESULTS,SELECTING,SOURCES,STUDIES,SYSTEMATIC
149,187,202,657,737,763,777,958,980,994,996,998,AOR,BACKGROUND,ESTIMATED,LABEL,MALIGNANT,METHODS,NPV,OVERALL,PET,RESULTS,SPECIMENS,TTNBS
169,BOARD,COPYRIGHT,THEREFORE
006,012,FACTORS,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SIXTY
652,AMONG,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SLC34A2
001,007,023,025,037,049,097,127,169,177,673,890,915,963,965,970,ADM,DDP,H69,H69AR,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,SELECTIVE,WESTERN,WIG
001,002,004,011,160,168,GSE3268,III,MEANWHILE,NSCLC,PCR,UNIVARIATE,USING
112,169,ABC,AFTER,BREATHING,COPYRIGHT,III,INC,INCIDENTAL,LABEL,LBC,MATERIALS,METHODS,MHD,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SECONDARY,SOCIETY,ULTIMATELY
10Q25,349,457,609,731,AMONG,CLASS,CONSORTIUM,FLCCA,HAP,HLA,HOUSEHOLD,SOUTHEAST
129,948,AZA,CPG,HOWEVER,LUCIFERASE,PCR,THESE,VCP,WESTERN
032,174,424,CYTOKINES,NSCLC,PCR,REGARDING,SNP
ERK,FGFR1,INHIBITION,JNK,MMP26,NSCLC
AIM,BACKGROUND,CONCLUSION,COUNSELING,ECG,LABEL,LIMITATION,METHODS,OBJECTIVE,RESULTS,SCALE,TSC,USG
186,SIXTY
SIXTY,SPECT,SPIROMETRY,THREE
169,459,AMONG,APRIL,BACKGROUND,ILD,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,TKI
001,169,BACKGROUND,CONSORTIUM,CORRELATES,COX,EUROQOL,EXAMINING,HRQOL,LABEL,MEIER,METHODS,RESULTS,SOCIETY,YOUNGER
169,AAS,AFRICAN,AMERICANS,BACKGROUND,CANCORS,CONSORTIUM,CRC,CURRENT,HISPANICS,LABEL,METHODS,RESULTS,SOCIETY
169,2OH,946,AKT,BNPP1,COPYRIGHT,EMT,KNOCKDOWN,SCIENCE,SMAD2,SMAD3,SMAD4,TGF,TGFBR,TGFBRII,THESE,USING
284,369,COX,JANUARY,LABEL,METHODS,OBJECTIVE,OPIOIDS,OSAKA,PURPOSE,RESULTS,THERE,UNIVARIATE
134,169,388,838,DENMARK,FINLAND,HOPEFULLY,ICELAND,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SOCIETIES
106,ACADEMY,CHINESE,DFI,IIB,JANUARY,LABEL,MEDICAL,METASTASES,METHODS,OBJECTIVE,PULMONARY,REGULAR,RESULTS
177,181,611,614,H1975,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,T790M,THERE,WESTERN
177,181,ACCORDING,AKT,AZD6244,BAX,BCL,ERK,GDC,LABEL,MEK,METHODS,MTT,NSCLC,OBJECTIVE,RAS,RESULTS,WESTERN
169,2YL,COPYRIGHT,FURTHER,HENCE,LTD,MCF
ALK,NSCLC
BIOCOAT,CHAMBER,DECREASED,DPI,FINALLY,FURTHER,INCREASED,INHIBITION,ISOLATION,KIT,NADPH,NOX,PRIMARY
160,AUC,CONCLUSION,FORTY,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS,SIXTY
104,160,314,517,842,ILD,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
AMONG,CHEST,INADEQUATE,JOB,LABEL,METHODS,OBJECTIVE,RESULTS,TELEPHONE
000,006,023,024,031,129,722,781,927,ALTERED,BACKGROUND,CD3,CD8,CHI,COX,LABEL,MEIER,METHODS,NSCLC,RESULTS
CARLO,LABEL,METHODS,MONTE,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,SCATTERED
10000,11000,215,800,EPSON,FILMQAPRO,LABEL,LRA,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCANNED,THESE,TRILOGY
916,AVERAGE,EUCLIDEAN,FRAUNHOFER,LABEL,METHODS,MEVIS,OBJECTIVE,PRETHERAPY,PURPOSE,RESULTS,USING
135,BASED,HOWEVER,LABEL,METHODS,MSE,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,THESE,WHERE
016,120,177,FRAME,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEQUENTIAL,TEN
130,400,752,ACCURATELY,DCT,DUE,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PURPOSE,RESULTS,SINCE,SOA,USING
1564A,3073A,320,346,ARG194TRP,ARG399GLN,CHINESE,XRCC1
169,945,947,948,954,AKT,CLAUDIN,CLDN1,CONVERSELY,COPYRIGHT,FURTHER,INC,MAPKS,PKC,SRC,TNF
100,AFTER,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCT,OPTICAL,RATIONALE,READERS,RESULTS,SCC
945,BACKGROUND,CONCLUSION,EMT,LABEL,METHODS,RESULTS,RHOGDI2,SMA,SNAIL,THESE
155,AFFYMETRIX,EMT,FOXM1,INHIBITION,KNOCKDOWN,SNAIL
169,BORCK,III,LABORATORY,POL,PRESS,PUBLISHED,TAKEN,TBP,WHOLE
174,214,DIEGO,EPIDERMAL,FINALLY,HOWEVER,MASSARRAY,NSCLC,RESPONSIVE,SAN,TKI,USA
032,101,184,2N0M0,AFTER,BACKGROUND,GENERALLY,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
ASIAN,CHINA
FINALLY,FIRST,SEVERAL,SINCE
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DELINASIOS,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PROTEOMIC,RESULTS
016,169,177,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DELINASIOS,INSTITUTE,LABEL,METHODS,OBJECTIVE,PCR,PFS,RESULTS,T790M,TKI
MIB
128,ASSOCIATED,BACKGROUND,CELSIUS,CONCLUSION,IMMEDIATE,LABEL,LOCAL,MARCH,MATERIALS,METHODS,RESULTS,THERE
1298A,ABCB1,AIM,CONCLUSION,ERCC1,LABEL,MATERIALS,METHODS,MTHFR,MTT,OBJECTIVE,PCR,RESULTS,THERE,THESE
014,021,035,115,139,140,177,181,339,351,465,AIM,CONCLUSION,CRP,LABEL,METHODS,OBJECTIVE,OLV,PRE,RESULTS,THERE
001,002,006,148,169,BAL,CENTRAL,CONCLUSION,CONTROLLED,ENGLISH,GUIDELINES,HOWEVER,LABEL,MEDLINE,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STUDIES
022,118,169,200,650,779,CONCLUSION,HRS,LABEL,LINIFANIB,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SOCIETY
1970S,ANOTHER,DROSOPHILA,FDA,HOWEVER,PTCH1,SINCE,VISMODEGIB
000,100,169,201,BACKGROUND,EARLIER,END,HNSCC,HOWEVER,LABEL,MEDICAL,METHODS,PITTSBURGH,PLUSS,RANDOMIZED,RESULTS,SCREENING,SOCIETY
100,111,AIM,BACKGROUND,CONCLUSION,GP5,GP6,HOWEVER,HPV,INFECTION,LABEL,MASHHAD,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SIXTY
169,946,ACTIVIN,AUTHORS,COPYRIGHT,ERK,INC,MALIGNANT,MIGRATION,MIGRATORY,PUBLISHED,SMAD2,SMAD3,TGF,THESE
169,181,350,900,AFTER,AUC,BACKGROUND,INC,LABEL,METHODS,MOL,PROCEDURE,RESULTS,SCA,WILEY
AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,METHODS,NSCLC,OPINION,SQCLC
169,233,403,CAD,COPYRIGHT,LTD,SVM
169,ADDITIONAL,ALK,BACKGROUND,HOWEVER,KRISTEN,LABEL,METHODS,RESULTS,SALIENT,SOCIETY
131,169,201,APMIS,L858R,LMD,LTD,PCR,PUBLISHED,SAMPLES,SEVERAL,WILEY
169,PHASE,VARIOUS
169,215,5FU,7DAYS,HOWEVER,LEWIS,LLC,SINCE,VEGFA
BASED,RELIEFF
045,1014O16,215,482,501G6,629,672F9,AMONG,ARRAY,ARRAYSTAR,BACKGROUND,C14ORF132,CALCA,CALCB,CNC,HCC,LABEL,MATERIALS,METASTASIS,METHODS,NCRNA00173,PCR,RESULTS,RP5,USING
BACKGROUND,BUFALIN,CCK,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,WESTERN
BACKGROUND,ENDOMETRAL,HIF,HYPOXIA,LABEL,MATERIALS,METHODS,PCR,RESULTS
010,098,101,168,170,195,370,452,578,798,806,A4T14,BACKGROUND,CHINA,CHINESE,G4C14,HOWEVER,HRM,LABEL,MATERIALS,METHODS,NSCLC,PCR,RESULTS
001,019,036,111,139,298,409,BACKGROUND,BEV,FIRST,FOLFIRI,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,RESULTS,XELOX
001,314,529,ACCORDING,HOWEVER,MEDLINE,NSCLC,OVERALL,PROQEST,RASSF1A,SCIENCE,STATA,WEB
176,186,1ST,221,319,424,5X109,BACKGROUND,BETWEEN,FEC,JANUARY,LABEL,MATERIALS,MBC,MEDICAL,MEIER,METHODS,NAUROIS,RESULTS,TRD,UNIVERSITY
001,003,177,264,290,606,ACCORDING,BACKGROUND,HODGKIN,LABEL,MASHHAD,MATERIALS,METHODS,NON,OVERALL,RESULTS,SCREENING,THERE
BACKGROUND,FDG,HOWEVER,LABEL,MATERIALS,METHODS,PET,RESULTS,ROC,SEVENTY
947,950,ECTOPIC,HNSCC,HOWEVER,IFN,LPS,STAT3,TAKEN
SIC,THESE
ALECTINIB,ALK,CRIZOTINIB,CSF,FURTHER,MET
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,AFTER,COPYRIGHT,INC,PUBLISHED,SOCIETY
100,120,160,183,956,ABP,ANESTHESIA,ASA,BIS,BLOOD,CCO,CVP,ECG,GENERAL,LABEL,MAP,METHODS,OBJECTIVE,OLV,RESULTS,ROCURONIUM,SGB,THERE,TLV
AMONG,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
163,DFS,LABEL,METHODS,NSCLC,OBJECTIVE,OPN,RESULTS,THESE
100,169,17P13,420,BACKGROUND,BETWEEN,BLOOD,CLL,COPYRIGHT,DEC,FOUNDATION,FUNDING,GRADE,HEART,INC,INSTITUTE,INSTITUTES,INTRAMURAL,IQR,JAN,LABEL,LTD,MEDICAL,METHODS,NORDISK,PROGRAM,RESULTS,SOCIETY,USA
169,215,2YL,BAX,BCL,COPYRIGHT,H2O,HOWEVER,INC,MTT,SGC7901,WESTERN
000,547,592,689,7TH,DEC,IIA,IIB,JAN,TNM,TYPICAL
169,199,363,COPYRIGHT,ELISA,HOWEVER,INC,NON,NSCLC
169,453,464,722,AUTHORS,CIR,CONCLUSION,COPYRIGHT,LABEL,LIVER,LTD,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QALYS,RESULTS,WHILE
160,945,946,AAH,EGF
INCREASED,MOLECULAR
APRIL,BACKGROUND,LABEL,MAY,METHODS,S3C,SMPLC,SPMLC,THEREFORE
10A,123,169,231,AMONG,COPYRIGHT,COUMARINS,CYTOTOXIC,DOCETAXEL,ESTER,INC,MCF,MDA,MMP,MRC,PC3,RHODAMINE,THESE
00001,25800,31964,36883,41089,652,ASIAN,ASPARTATE,CASP8,CASPASE,D302H,FURTHER,HISTIDINE,HOMOZYGOUS,HOWEVER,OVERALL,THEREFORE
100,AUNPS,OVERALL
160,200,250,300,400,FIFTY,HOWEVER,LABEL,METHODS,MTD,NSCLC,OBJECTIVE,PFS,PLANNED,PURPOSE,RESULTS,THERE,THREE,TREATMENT,VORINOSTAT
BECAUSE,LOCAL,STILL,THERE
014,108,488,608,CARDIAC,CUMULATIVE,STRATEGIES,TIC
117,129,156,177,411,489,567,AIM,AMONG,BACKGROUND,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,RESULTS
382,AGE,CONCLUSION,ESS,III,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SIXTEEN
226
MPM,THESE
99MTC,ACCORDING,DIAGNOSTIC,NPV,NSCLC,PNEUMONIA,PPV,SEN,SPECT
DISBALANCE,HODGKIN,OPG,RANKL
CD66C,CEA,CYFRA,FORTY,MPE,VARIOUS
215,954,EXPLANTED,KNOCKDOWN,LABEL,METHODS,MTT,NCI,NUCLEAR,OBJECTIVE,RESULTS
PCR
FDG,HOWEVER,PET,THESE
HOWEVER,LARYNGEAL,METASTASES,PRIMARY
BASED,HOWEVER
001,002,003,009,043,110,222,241,277,279,292,299,365,550,643,735,AUC,FURTHER,HOWEVER,IRAK1,NSCLC,ROC,TLR,TNM
967,COX,ELISA,FINALLY,JAN,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OCT,RESULTS,ROC
018,123,206,ATS,ERS,IASLC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,045,115,119,121,130,NSCLC,PER,PERIOD1,PERIOD2,PERIOD3,SIMILARLY,THESE,TNM
001,008,027,100,111,116,136,140,369,947,COX,FURTHER,REG
001,016,019,031,047,162,EXPRESSION,PIPOX,SARCOSINE,SARDH
FINALLY,H510A,LABEL,LUCIFERASE,METHODS,MTT,OBJECTIVE,PCR,PURPOSE,RESULTS
001,002,008,011,012,013,116,CHA,DFS,NLCMA
BCL,CD117,COLLEGE,COUGH,FIFTEEN,LABEL,MEDICAL,METHODS,OBJECTIVE,P16,P53,P63,PUMCH,RESULTS,RFS,SMA,TEN,TTF,UNION
001,013,015,124,MEIER,NON,NSCLC,SEX,SOX,SRY
169,AMONGST,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EHE,INSTITUTE,JANUARY,LABEL,MARSDEN,METHODS,RESULTS,ROYAL,SURGERY,THERE
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EIGHT,FHP,INSTITUTE,LABEL,METASTATIC,METHODS,RESULTS
169,945,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HIF,INSTITUTE,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,RESULTS
001,169,267,AES,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,RESULTS
169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FOXD1,INSTITUTE,LABEL,MATERIALS,METHODS,MICROARRAY,NSCLC,OBJECTIVE,RESULTS
169,ADP,AIM,ANTICANCER,ANTITUMOR,BASED,CONCLUSION,COPYRIGHT,HISTONE,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PAT,RESULTS
169,945,946,956,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DENDROBIUM,EMT,INSTITUTE,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,SNAIL
169,AUTHORS,BACKGROUND,CELLS,CHRONIC,HEART,INC,LABEL,METHODS,PUBLISHED,RESULTS,SMC,TELOMERASE,WOLTERS
BECAUSE,BIOMARKERS,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,THESE
EMC


HOWEVER,HOX,HOXA5,NSCLC,TNM
ACCORDING,KAZAKHSTAN,PROBLEM
BASAL,EIGHT,ENB,HOWEVER,KINOMIC,LABEL,METHODS,OBJECTIVE,PAMSTATION,PURPOSE,RESULTS
001,100,BACKGROUND,CONCLUSION,COX,DBF,FORTY,LABEL,MEIER,METHODS,OBJECTIVE,PRIMARY,RESULTS
NANOG,THROUGH
008,123,130,174,175,190,595,722,BACKGROUND,III,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SOUTHWEST,THERE,TOTAL
21V,946,BHP18,CONVERSELY,DECREASED,FTI,GTP,HDAC1,HDAC3,THYROID,TRS
945,AFTER,BASED,EGF,RESAMPLING,TNF
BENEFICIAL,THERE
DIFFERENT
177,GTV,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SMALL,WHILE
104,161,235,396,980,ADC,AMONG,ATLAS,CLCA2,HAMAMATSU,SCC,THESE,UNIVERSITY
169,ANOTHER,COPYRIGHT,HEPOXILIN,INC,USING
ADI,ASS,CELLS,LABEL,LCNEC,METHODS,OBJECTIVE,PEG,PURPOSE,RESULTS,SIXTY,THESE,TREATMENT
113,127,169,198,242,555,561,871,AMONG,CONCLUSION,COPYRIGHT,COX,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SWEDISH
397,BCR,THERE
105,140,160,200,BACKGROUND,BETWEEN,LABEL,METHODS,OCTOBER,RESULTS,SINCE,THERE,VIDEO
001,169,362,573,844,CONCLUSION,LABEL,MEIER,METHODS,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS,SOCIETY
FIRST,INCREASING,NSCLC,TAKEN,USP22
160,CONCLUSION,LABEL,LOW,METHODS,OBJECTIVE,PS1,PS2,PS3,PURPOSE,RESULTS,TNM,URINE
AFFECTIVE,BACKGROUND,BOOLEAN,CUSHING,DEPRESSION,ISI,LABEL,MANIA,MEDLINE,METHODS,PHYSICIANS,RESULTS,SCIENCE,WEB
100,BACKGROUND,BASED,CDC42,CHROMATIN,HBL,LABEL,METHODS,MTLN3,RESULTS,SINCE,TRANSDUCER
APRIL,SURGERY,TEN,WEDGE
CRYSTAL,DISCOVERY,SCIENCE,TKI
516,AFTER,FURTHER,HOWEVER,INSURANCE,NHI,SIR
156,238,ABL,AKT,CDK,CHINESE,ERBB2,FGFR1,FGFR3,KIT,MET,MOLECULAR,OTHERWISE,PCR,POLYGENIC,RET,SEVERAL,SIX,T790M,THERE,USING
169,CD11C,DCS,EMT,INC,MALAT,SNAIL,TADCS,WILEY
007,010,020,023,035,043,168,18F,324,439,506,537,695,897,916,953,973,BACKGROUND,EARLY,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,TLG,UNIVARIATE
FDG,HYNIC,PET,SPECT,SPN,TOC,WHOLE
BACKGROUND,CONCLUSION,ECTOPIC,LABEL,METHODS,MTC,MYH13,OBJECTIVE,ONCOGENIC,RESULTS,RET,THREE
100,169,946,99M,CCA,LTD,PET,PTY,PUBLISHING,RESULTS,SOUTH,WILEY
AKT,CPT,DII,HB1,NDEPT,OVERALL
044,128,134,ADC,CHEST,FEMALES,HPV,NSCLC,PCR,SAMPLES,SQC,THERE,TNM
001,010,013,016,025,105,272,766,CONCLUSION,DFS,HOWEVER,LABEL,MACC1,METASTASIS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
FDA,INSURANCE
100,169,241,572,859,967,996,ALT,COPYRIGHT,INC,LABEL,MARCH,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY
MALIGNANT,OCCASIONAL,RIGHT,THESE
BACKGROUND,BIOLOGY,C677T,CBM,CHINA,CHINESE,CIS,KNOWLEDGE,LABEL,METHODS,MTHFR,NORTH,ORS,OVERALL,RELATED,RESULTS,SERVICE,STUDIES,WANFANG
BUN,NOTABLY,NSCLC,THESE
NNK,THOUSANDS
234,716,AFRICAN,BACKGROUND,HOWEVER,LABEL,RESULTS
169,COPYRIGHT,HRT,INC,INHALATION,PAH,PM1,PM2,RESULTS,TEQ,THESE,THREE

140,BELARUS,CHERNOBYL,COMPARISON,CONCLUSION,FREEMAN,KRUSKAL,LABEL,MARCH,METHODS,OBJECTIVE,PEARSON,PTC,RESULTS
100,169,ACTIVATING,AE1,AE3,BREAKPOINT,COPYRIGHT,EWING,EWSR1,INC,SARCOMA
160,169,AUTHORS,COPYRIGHT,DEPLETING,FINALLY,HGF,HUWE1,INC,PUBLISHED,RAC,TIAM1
169,231,946,HOWEVER,HOXB7,INCREASED,MDA,PCR,PROVIDING,SMAD3,TAKEN,TAM,TGF
169,3T3,COPYRIGHT,GCMSN,LTD,NMSNS,SERVING
169,5GY,CARLO,CLINICALLY,COPYRIGHT,DVH,GTV,INC,MEDICAL,MONTE,PTV,PUBLISHED,STAGE,TCP
169,761,946,947,AFTER,ATP,COPYRIGHT,HOWEVER,LABEL,LAP,NAD,NSCLC,PARP1,PEG,PLA,PRE,UNASSIGNED,UNLABELLED
169,BACKGROUND,COPYRIGHT,EWS,LABEL,METHODS,PUBLISHED,RESULTS,SIX,SOCIETY
169,BACKGROUND,CONCLUSION,COPYRIGHT,DECISIONS,DISCUSSION,FERRAND,GLIOMAS,LABEL,METHODS,OPTIC,RESULTS,SAS,THROUGH,TREATMENT,UNIVERSITY
001,160,169,201,AMONG,AUR,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RAREA,RATIONALE,RESULTS,ROC,SIXTY

INSTITUTE,INTENTION,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,VARIABLES
169,992,AMONG,COPYRIGHT,FURTHER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,DISCUSSION,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SECONDARY
002,004,III,MMP,NEUTROPHIL,PROGNOSIS,SUR,TUMORAL,UNIVARIATE
CISPLATIN,DDP,FANCONI,HOWEVER
100,200,300,400,500,956,AGS,AKT,ANNEXIN,BAX,ECM,FLUOS,P53,PCR
001,006,169,BCL,COPYRIGHT,H1299,HBE,INC,NSCLC,TAKEN,TIPE2,TNM
504,APC,HCL,HSP90,IPI,MTA,NSCLC,SEVERAL,SILAC,SUPPORTING,THEREFORE,TREATMENT,XENOGRAFT
200,223,CHROMATIN,EMT,H3K27,HISTONE,TGF,ZEB
024,059,201,215,406,546,570,577,AFRICAN,AMERICANS,AMONG,BACKGROUND,CHD,CONSORTIUM,COX,HEALTHABC,HOWEVER,INITIATIVE,LABEL,METABOCHIP,METHODS,MYC,RESULTS,SNP,SORT1,WHI,WOMEN
945,946,CK2,HOWEVER,MEIER,PLOTTER,THERE,THESE
ATLAS,MYC,NOTABLY,THESE,TTP,ZFP36
176,177,180,270,650,670,BASED,CONCLUSION,DTS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
122,HCC
169,571,661,676,800,801,970,BACKGROUND,COPYRIGHT,III,JAPAN,LABEL,LTD,METHODS,RESULTS
169,BCL,BIRC5,COPYRIGHT,DR4,DR5,FAS,HOWEVER,LTD,MICROARRAY,TNF,TRAIL
169,AMONG,AZD6244,BCL,BIM,CISPLATIN,COPYRIGHT,IRELAND,LTD,NSCLC,THESE,USING
130,169,COPYRIGHT,CPG,GISTS,KIT,SCIENCE,SDH,SIX,SUCCINATE
169,AMONG,BACKGROUND,CONCLUSION,DIFFUSION,DOCETAXEL,EFFORTS,END,FDA,III,LABEL,MAY,METHODS,PRESS,PROGRAM,PUBLISHED,RESULTS,UNIVERSITY
169,600,CNNM2,COPYRIGHT,MAGNESIUM,MAGT1,SOCIETY,TRPM6
BACKGROUND,COLORECTAL,CONCLUSION,INITIATIVE,KEY,LABEL,LARGE,OVARIAN,PREVENTION,RESULTS,SCREENING,TRIAL,USING,VITAMIN,WHILE,WOMEN
160,HOWEVER,LWR,RCC,THEREFORE
HOWEVER,NSCLC,TFS
160,BACKGROUND,CONCLUSION,GOSERELIN,LABEL,METHODS
PPC
METASTATIC,SURGERY
LENTIVIRAL
PRIMARY
MICRORNAS,NSCLC,TKI
ARG,ASP,GLY,INTEGRINS,RGD,SUSTAINED
ALK,AP26113,CH5424802,HOWEVER,III,NSCLC,RO5424802,SEVERAL
100,AGGRESSIVE,BACKGROUND,GGO,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
013,140,AMONG,BACKGROUND,LABEL,METHODS,NETWORK,NSCLC,OBJECTIVE,PFS,RESULTS,THESE,TREATMENT,UNIVARIATE
023,519,BACKGROUND,H1975,LABEL,LOWER,METHODS,NCI,OBJECTIVE,RESULTS,TKI
AD5,AFTER,ANNEXIN,BACKGROUND,CASPASE,F35,LABEL,LOW,METHODS,MOI,MTT,OBJECTIVE,PCR,RESULTS,WESTERN
CALCIFIED
412,CONCLUSION,DIAGNOSTIC,EWING,FDG,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,RESULTS
100,225,CONCLUSION,EXCLUSION,GIVEN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
001,004,009,011,012,750,CONCLUSION,DIAGNOSTIC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
100,111,306,876,929,AMONG,BACKGROUND,DSS,END,HOWEVER,LABEL,MEIER,METHODS,OVERALL,PROGRAM,RESULTS
169,A3B,BECAUSE,COPYRIGHT,HPV,IMPORTANCE,KNOCKDOWN,LABEL,OBJECTIVE,SEVERAL,TAKEN,UNLABELLED
169,16Q23,BIOLOGY,DESPITE,SOCIETY
ACADEMY,COPYRIGHT
169,COPYRIGHT,FEW,FURTHER,INC
380,CASP8,CONCLUSION,DFS,LABEL,MEIRE,METHODS,OBJECTIVE,RESULTS,SRC,WESTERN
AKT,ATP,COA,INCREASING,INHIBITION,OAA,STUDIES
231,231SHCXCR3,CONVERSELY,CXCR3,MDA,TARGETING,THERE
AGE,BRONCHIAL,CHINESE,CONCLUSION,COUGH,ENGLISH,FIBEROPTIC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,SMA,THESE,VIP,WANFANG
916,936,GSH,HOWEVER,MMP,NAC,ROS,TRX,WHILE
934,945,BACKGROUND,DOWNSTREAM,FAS,LABEL,LEWIS,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THESE
CUL4A,DEPLETION,HOWEVER,TAKEN
160,AKT,BECAUSE,ERK,FGFR3,K508M,NPC,TACC3,TAKEN
AML,LSC,NSG,PRIMARY,PUBLISHED
BACKGROUND,ENZYMATIC,FUNCTIONAL,FURTHER,LABEL,METHODS,PCR,PREDICTED,RESULTS
002,007,202,494,BACKGROUND,LABEL,METHODS,OVERALL,RESULTS
FINALLY,NSCLC,THERE
945,HIF,TAP73
HOWEVER
BMJ,DIGITAL,GROUP,INITIALLY,LTD,PALLIATIVE,PUBLISHING
003,029,045,123,124,136,169,177,250,788,BACKGROUND,COPYRIGHT,FIFTY,IHM,INC,LABEL,METHODS,RESULTS,WOMEN
169,200,ACT,AFFORDABLE,CONCLUSION,IIB,III,INSTITUTE,LABEL,METHODS,NETWORK,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STUDIES,USING
169,181,842,CONCLUSION,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,PURPOSE,RESULTS,SES,SOCIETY
169,AUTHORS,BACKGROUND,C30,CONCLUSION,COPYRIGHT,EUROQOL,LABEL,LTD,METHODS,NSCLC,PATIENT,PRO,PUBLISHED,QOL,QUALITY,RATES,RESULTS,THERE,TREATMENT,VAS
160,GBM
001,0CM,169,3CM,8GY,9CM,COPYRIGHT,INC,MEDICAL,OAR,OVERALL,PUBLISHED,REGRESSION,V20
000,023,024,042,471,629,759,885,928,ACCORDING,CHEST,COX,III,JANUARY,LABEL,LOGRANK,MEIER,METHODS,OBJECTIVE,QINGDAO,RESULTS,THEIR,TNM
115,125,177,215,BACKGROUND,BTV,D95,D99,DSC,FDG,LABEL,METHODS,PET,PLANS,PTV,PTVCT,R50,RESULTS,SIB
HOWEVER,PFS
PET
000,169,254,BACKGROUND,CIS,COLORECTAL,COX,HOWEVER,INCIDENCE,INSTITUTE,LABEL,METHODS,NBP,OVARIAN,RESULTS,SCREENING,SOCIETY,SQX,TRIAL,WOMEN
169,AUTHORS,COPYRIGHT,DESPITE,LTD,PUBLISHED,WHILE
176,HSA,INC,PET,PUBLISHED,RSA,TFP,THESE
169,945,COPYRIGHT,CROHN,EMPLOYING,HOWEVER,IEC,INC,PARKINSON,TAKEN,TNF,VPS4B
160,169,AUTHORS,COPYRIGHT,DIETARY,HCD,INC,PROVIDING,PUBLISHED,UNRESOLVED,UPR,WHOLE
169,COPYRIGHT,HCC,THESE,TNM
AIR,COHORTS,EFFECTS,POLLUTION
100,101,169,186,400,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METHODS,NRI,OBJECTIVE,PUBLISHED,RESULTS,SMOKING,SOCIETY,TOMOGRAPHY
CW2,H2052,MKN45,NCI
001,169,967,BECAUSE,CARCINOIDS,CASES,COPYRIGHT,DIFFUSE,DIPNECH,INC,NEP,THREE
HOWEVER,PERTUZUMAB
ANAPLASTIC,BACKGROUND,CONCLUSION,LABEL,METHODS
CHINESE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TCM,UNDERSTAND,URINARY
1950S,ANTICANCER,MCF,MYC,SF5,THEREFORE
789,790,797,947,BIMAS,CTL,ELISPOT,EPIDERMAL,H1975,HLA,HOWEVER,IFN,IMQLMPFGC,ITQLMPFGC,NCSLC,NSCLC,PBMCS,T790M,TKI,USING
124,DFS,FURTHER,NCL,NSCLC,STAT3,TNM,UTR
125,164,169,875,940,BACKGROUND,CA125,CA153,CONCLUSION,CYFRA21,LABEL,METHODS,RESULTS,SCC,SCREENING,SPN,THROUGH,USING
169,451,AIM,CONCLUSION,LABEL,LITERATURE,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS
DESPITE,NSCLC
153,753,ATLAS,HIPPO,MET,NF1,THESE
100,119,ACA,ADJUNCTIVE,DAH,DIFFUSE,ICU,OVERALL,PRIMARY,TREATMENT
169,AKT,BDE,CAD,COPYRIGHT,EMT,ERK,FURTHER,GENERALLY,HOWEVER,PBDES,PD98059,SILENCING,SNAIL,VIM
CRK
HOWEVER,HYPOXIA,SINCE
AIM,BACKGROUND,CHINESE,CONCLUSION,LABEL,MATERIALS,MEDICAL,METHODS,NETWORK,NPC,OBJECTIVE,PREVIOUSLY,RESULTS,TCD6120,TRIAL,UNIVERSITY
945,946,AKT,FOCAL,H1299,H4K16,IMMUNOBLOT,INTERGRIN,KINDLIN,LUNASIN,NSCLC,PROXIMITY,SILENCING
06H,169,5MG,AES,AZD1480,BID,COPYRIGHT,IWG,JANUS,LTD,MRT
120,ARG753GLN,ASP299GLY,ELISA,IGE,IRANIAN,PCR
BAL,CSF,IEP
160,169,AUDIT,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,LYMPH,METHODS,PUBLISHED,RESULTS,SOCIETY
169,AMD3100,CD8,CONCLUSION,CXCR4,HCC,HOWEVER,INHIBITION,LABEL,LIVER,SORAFENIB,UNLABELLED,USING
AKT,HOWEVER,INHIBITION,NSCLC,SNAIL,SPHK1,TAKEN
100,169,AUTHORS,EPR,LTD,PREVIOUSLY,PTY,PUBLISHING,SCIENCE,SMA,THESE,THP,WILEY
169,COPYRIGHT,EBC,FIRST,FURTHER,LTD,MET,SAR
140,169,AUTHORS,BACKGROUND,BECAUSE,CNB,FNA,HOWEVER,INC,KIRSTEN,LABEL,METHODS,MOLECULAR,NON,NSCLC,RESULTS,SOCIETY,WILEY
100,169,ALK,BACKGROUND,CURRENTLY,FIFTY,IHC,LABEL,METHODS,MPE,NSCLC,PCR,RESULTS,SOCIETY,VENTANA

169,183,967,BACKGROUND,BJS,CONCLUSION,CRC,FAILURE,FIFTY,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SOCIETY,THOSE,WILEY
AUTOPHAGY,HOWEVER,SIMILARLY,TAKEN,WHILE
102,C30,DEPRESSION,EORTC,INVENTORY,LABEL,MATERIALS,METHODS,OBJECTIVE,QLQ,RESULTS,THOSE
954,AKT,FIRSTLY,MAP,NSCLC,SOMATIC,TAKEN
004,024,177,MOUSE,PROGNOSIS,RFP,SALMONELLA,THEREFORE
102,169,512,688,BACKGROUND,COPYRIGHT,FURTHER,III,INC,INCOMPLETE,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
169,183,231,CLL,COPYRIGHT,INC,MDA,MTT,NMR,PDCL2
169,562,616,930,BIM,COPYRIGHT,NCI,NON,OVARIAN,OVCAR,SAS,TEN,USA
146,245,464,ACCORDING,AFTER,AIC,BACKGROUND,CONCLUSION,COX,CRITERION,EVALUATION,IQR,LABEL,METHODS,NSCLC,RESULTS,SOLID,TRIAL
BMJ,CD4,EPOCH,GROUP,HIV,HODGKIN,LTD,NHL,NON,PPL,PRIMARY,PUBLISHING
158,241,6TH,AFRICAN,CKD,EASTERN,FINANCIAL,GIVEN,LATIN,MEDLINE,OOP,PACIFIC,RANDOMIZED,SCHOLAR,STUDIES,WESTERN
110,231,AFTERWARD,BACKGROUND,FINALLY,LABEL,MCF,MDA,METHODS,MMP,PCR,PIT,POU,RESULTS,WESTERN
HOWEVER,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,WHEREAS
001,005,215,260,464,724,HOWEVER,LDH,PNI,UNIVARIATE
169,COPYRIGHT,INC,MINIMALLY,VIDEO
169,CONTINUED,COPYRIGHT,INC
169,COPYRIGHT,INC,PROGNOSTIC,SOCIETY
169,COPYRIGHT,DESPITE,INC,PUBLISHED,SLN
169,AFTER,COPYRIGHT,INC,MALIGNANT,RADIATION,SURGERY,THERAPY
025,030,042,058,098,100,114,134,150,234,956,ADDITIVES,AFTER,BACKGROUND,BENCHMARK,COMMITTEE,CONFIDENCE,FAO,GREEN,HCL,HGAAS,HOWEVER,INORGANIC,JECFA,JOINT,KEY,LABEL,LIMIT,LOWER,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THEIR,WORDS
2D3,APART,BACKGROUND,CALCITRIOL,HOWEVER,KEY,LABEL,LANGERHANS,THESE,UNLABELLED,VITAMIN,WORDS
160,169,946,ACTIVATED,CD4,CONVERSELY,COPYRIGHT,INC,RLR,SMAD3,TGF
COX,THERE
001,002,008,012,022,1ST,290,2ND,3RD,AMONG,FDG,METABOLIC,NSCLC,PERCIST,PET,PFS,SOLID,UNIVARIATE
033,041,228,301,CHINA,CHINESE,CIS,CLPTM1L,FURTHER,GTTATCTGT,HAN,HAPLOTYPE,ORS
394,AMONG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,VETERAN,VHA
143,169,AGE,AHMEDABAD,BACKGROUND,C03,C33,C34,CONTEXT,GUJARAT,GUTKA,ICD,INDIA,LABEL,METHODS,MOUTH,RESULTS,USING
600,ADDITIONAL,ALECTINIB,ALK,BACKGROUND,CURRENTLY,FDA,LABEL,METHODS,NSCLC,OVERALL,RESULTS,THREE
100,105,131,160,205,BRCA1,BRCA2,CHINESE,DICER,HOWEVER,IVS11,IVS16,IVS19,LOW,SIXTY,THREE
BACKGROUND,CONCLUSION,LABEL,METHODS,PATIENT,RESULTS,SARCOID
545,601,622,627,670,742,ACCORDING,AUC,HOWEVER,MALAT,PCA,PSA,ROC
100,118,AIM,CONCLUSION,CYBERKNIFE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,STUDIED,THREE
100,174,400,MAY,MEETING,SCIENTIFIC,SOCIETY,SRS,USA
ADVOCATES,COMMITTEE,FORCE,PREVENTIVE,SCREENING,TRIAL
HIF
BREATHING,FIFTEEN,PTV
ACO,VARIANT
100,826,882,954,A750DEL,ADX,BACKGROUND,CONCLUSION,EPIDERMAL,EXCELLENT,IHC,L858R,LABEL,MATERIALS,METHODS,NSCLC,QDS,RESULTS,SINCE
040,064,114,119,129,134,159,169,177,248,541,676,812,CONCLUSION,DESPITE,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RECURRENCE,RESULTS,SOCIETY,SUV,T1A,T1B,TLG,UNLABELLED
169,170,237,406,CONCLUSION,CTN,DIFFERENT,IMAGING,INC,INDIVIDUAL,LABEL,METHODS,MOLECULAR,NETWORK,NUCLEAR,PET,PHANTOM,RESULTS,SCANNER,SINCE,SNMMI,SOCIETY,THESE,UNLABELLED
129,255,ADS,ADTAV,E1A,ONCOLYTIC,TAV
FURTHER,MALIGNANT,MSC,THESE,TRAIL,USING
BACKGROUND,BASED,BIOMEDICAL,CHINESE,CONCLUSION,ELECTRONIC,HRS,LABEL,LITERATURE,LOW,METHODS,NSCLC,OBJECTIVE,PFS,PROGNOSTIC,RESULTS,SCIENCE,THERE,WEB
008,011,030,039,077,118,120,133,149,196A2,217,300,357,987,BACKGROUND,CIS,FINALLY,HOWEVER,LABEL,MAY,METHODS,MIR,ORS,RESULTS,SCIENCE,SNP,THESE,WEB
946,AGE,BACKGROUND,CONCLUSION,DACT1,DACT2,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TGF,THERE,THESE,WNT
AKT,CELECOXIB,CXB,MTT,NSCLC,THEREFORE,THESE,TUNEL
AKT,CURRENTLY,SINCE
105,137,155,160,169,AMONG,COPYRIGHT,DISCUSSION,INC,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SNS
169,FOUNDATION,INITIALLY,JOURNAL,SOCIETY,STICHTING
181,BCL,MICRORNAS,NSCLC,TAKEN
946,CHINA,DECORIN,DEPARTMENT,HOWEVER,JINLING,MARCH,NANJING,NSCLC,P21,P53,PCR,SEPTEMBER,SURGERY,TGF,THROUGH,UNIVERSITY,VIA,WESTERN
169,COPYRIGHT,FINALLY,IRELAND,LTD,NSCLC,OVERALL,SAC
100,BACKGROUND,HUD,LABEL,METHODS,RESULTS
169,BACKGROUND,BASED,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PURPOSE,PVP,RADIOLOGIC,RESULTS,THERE,UNDER,VAS
ENTROPY,LIEBLER
AGE,BACKGROUND,CONCLUSION,END,INCIDENCE,INCREASES,JOINPOINT,LABEL,METHODS,MORTALITY,PROGRAM,REGRESSION,RESULTS,STATISTICS,TREND
001,006,007,105,BACKGROUND,CONCLUSION,LABEL,LATER,METHODS,NULMS,OUTCOME,RESULTS,THEREFORE,UNIVARIATE
BACKGROUND,EPCAM,LABEL,RESULTS,SINCE,TROP1,TROP2
169,BECAUSE,ERLOTINIB,HGF,HOWEVER,MET,NSCLC,TKI
206,AKT,EBC,EXPRESSION,MET,SCC,THEREFORE
945,C57BL,CHA,CONCLUSION,GAN,LABEL,METHODS,MONGOLIAN,OBJECTIVE,PGC,RESULTS
BCL,FLICE,FURTHER,NSCLC,ROS,TRAIL
001,750,BACKGROUND,END,FURTHER,LABEL,METFORMIN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PRIOR,PROPENSITY,RATIONALE,RESULTS,USING
CISPLATIN,EHRLICH,METAL,THERE,THESE
BACKGROUND,DETECTION,EARLY,LABEL,LUCSS,METHODS,OBJECTIVE,OBJECTIVES,PITTSBURGH,PLUSS,PROGRAM,RATIONALE,RESULTS,SCREENING,VALIDATION
003,956,AVERAGE,BACKGROUND,CNB,CONTEXT,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,TOUCH,TPS
BACKGROUND,G583R,GFP,LABEL,NON,NSCLC,POLA2,RESULTS,SNP,USING
ABOUT,AMONG,AUTOMATIC,BACKGROUND,INTEGRATED,LABEL,NON,NSCLC,RESULTS,THESE,TINAGL1
122,AFFAIRS,AMONG,BACKGROUND,DEPARTMENT,EVENT,INCIDENTAL,LABEL,MEASURE,MEDICAL,METHODS,OBJECTIVES,RATIONALE,RESULTS,SCALE
CONVERSELY,MCC,MCC13,MCC26,MKL,USING,YET
DEFINITIVE,THESE
001,031,100,233,BACKGROUND,BIOVICA,DIVITUM,LABEL,METHODS,NSCLC,RESULTS,THYMIDINE,TK1
224,ADC,BACKGROUND,CONCLUSION,IHC,LABEL,METHODS,NOS,NSCLC,RESULTS,SIXTY,THESE,TTF
BACKGROUND,LABEL,METHODS,NSCLC,PFS,PFS4M,RESULTS,WESTERN
COMMITTEE,INSTITUTE,NCI,PROTOCOLS
BACKGROUND,CL1,DDA,EXTRACTION,FINALLY,LABEL,RESULTS,WHILE
100,126,182,205,356,601,ALTERED,BACKGROUND,CONCLUSION,LABEL,MENDELIAN,METHODS,RESULTS,RPS6KA3,SCC,THESE
169,FIRST,NSCLC,SOCIETY,T790M,TKI
177,CONCLUSION,DESPITE,ECC,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,REF,RESULTS,TAB,TEN
ASR,BACKGROUND,LABEL,MATERIALS,METHODS,MUSLIMS,NHL,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS
BACKGROUND,CD3,CD56BRIGHT,CD56DIM,III,LABEL,MATERIALS,METHODS,NKT,RESULTS,TIM
100,190,245,BACKGROUND,DEPARTMENT,FACTORS,FNA,LABEL,MALIGNANT,MATERIALS,MEDICAL,METHODS,OTHER,PATHOLOGY,RESULTS
006,180,ABO,BACKGROUND,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,SPC,TAIWANESE,THERE
150,193,664,665,805,CEA,CYFRA21,LABEL,MATERIALS,METHODS,NSE,OBJECTIVE,PURPOSE,RESULTS,SERUM
946,HOWEVER,VARIOUS
AMONG,SIMILARLY,SINCE,UTR
16953,RESULTS,SINGAPORE,USING
JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHWAY,PUBLISHED,UNASSIGNED
EPIGENETIC,NMD,PTC
CLOSE,CRE,OWING
20S,BMJ,GROUP,HOWEVER,LTD,PUBLISHING
BMJ,GROUP,LTD,PUBLISHING
AEA,FDA,OEA,PEA,USING
169,956,FLT,PAZOPANIB,TKI
110,AFTER,BAD,CLINICALLY,FINALLY,HBE,NSCLC
160,174,956,AFFYMETRIX,AMP,BACKGROUND,CIC,EPISTEM,INITIAL,LABEL,MICROARRAY,NSCLC,NUGEN,OVATION,PATHWAY,RESULTS,SEQ
169,HISEQ,HOWEVER,LABORATORY,PRESS,PUBLISHED,RPM,SMALL,SOCIETY,THESE
001,002,005,006,023,043,051,206,966,AVERAGE,BACKGROUND,COX,GENERALLY,LABEL,METHODS,PATHOLOGIC,PULMONARY,RESULTS
233,AGE,BACKGROUND,DUB,FINALLY,LABEL,METHODS,RESULTS
169,92A,945,CYP24A1,NOTABLY,NSCLC
231,4T1,MDA,METASTASES,MVS,PCR,THESE
BACKGROUND,FIFTEEN,III,JANUARY,LABEL,METHODS,RESULTS,STAGE,THERE,THREE,TREATMENT
026,038,047,051,054,061,069,073,074,115,121,124,125,172,475,566,575,669,769,787,817,850,875,878,975,A05,BCL,CONCLUSION,FAS,LABEL,METHODS,NCI,OBJECTIVE,PCR,RESULTS,WESTERN
KNOWN
ACCORDING,GLC,GROUP,LABEL,LRT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
177,956,BACKGROUND,BIOLOGICAL,CIOCALTEU,CONCLUSION,COR,FOLIN,L23,LABEL,LPS,MCF,METHODS,MRC,OBJECTIVE,RESULTS,SRB,SXH,TOTAL,YET,YOD
177,688,956,BACKGROUND,CONCLUSION,CYTOTOXIC,H1688,LABEL,METHODS,MRC,NCI,OBJECTIVE,PIPER,PLUMBAGIN,RESULTS,SIX,SRB,VLC
215,CONCLUSION,DIFFUSION,EIGHT,FUNCTIONAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
10878,AGE,CXR,ELDERLY,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,VITAL
GREATER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
COPYRIGHT,GRANEHEIM,JOURNAL,LUNDMAN,PHYSICIANS
ASIAN,III,LUX,NSCLC,OVERALL,PFS,PRIMARY,SIMILARITY,THERAPY,THERE,TKI
SEVERAL,THESE
10Q,215,640,AMONG,AWT,BACKGROUND,LABEL,MAGI2,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SNP,THREE
INCREASING,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SONIC,SUMMARY
530,650,PARKINSON,SPR,UBIQUITIN,UCH
215,457,493,536,AMERICA,ASIAN,GOVERNMENT,GRS,PUBLISHED,SNP,STRATIFIED,USING,WBC,WOMEN
169,LABEL,TELOMERASE,THESE,TREATMENT,UNLABELLED
169,BAL,COLLEGE,COPYRIGHT,HOWEVER,IDIOPATHIC,IPH,ROYAL
945,CDK,FURTHER,HOWEVER,MTT
177,ANNEXIN,BLM,MSC,MTT,PARACRINE
001,CPG,EXPRESSION,KNOWLEDGE,SCC
320,954,ANNOTATION,CCAAT,CEBPD,COL11A1,DAVID,DISCOVERY,ECM,EXPRESSION,GENOMES,GEO,INTEGRATED,KYOTO,LABEL,MATERIALS,METHODS,OBJECTIVE,OMNIBUS,PATHWAY,PPI,PURPOSE,REL,RESULTS,RETRIEVAL,TFS
340,CALCIUM,CONCLUSION,INDEX,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,SIXTY,VHI,VOICE
AKT,ERK,FGFR1,FGFR2,ITK,MEK,MOS,MST1R,NSCLC,NTRK1,NTRK2,ORF,PC9,SRC
945,946,CXC,CXCL6,SMA,THESE,TSPAN12
BESIDES,CURVE,FORESTS,HOWEVER,IFS,LOOCV,MAXIMUM,MINIMUM,NSCLC,OPERATING,RECEIVING,REDUNDANCY,RELEVANCY,RFS,ROC,SQCLC,TAKEN,THERE
169,BACKGROUND,COPYRIGHT,HPV,ICAHN,INC,LABEL,LMICS,METHODS,MOUNT,OBJECTIVE,ORGANIZED,PUBLISHED,RESULTS,SCREENING,SINAI,VIA
169,BACKGROUND,COPYRIGHT,ICAHN,INC,LABEL,LMICS,MOUNT,OBJECTIVE,PUBLISHED,RESULTS,SINAI,WOMEN,WORLD
169,ALCOHOL,BACKGROUND,CANCERS,CONCLUSION,COPYRIGHT,ICAHN,INC,LABEL,LMICS,MOUNT,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SINAI,TOBACCO
160,169,BACKGROUND,CONTINENTS,CONTROL,COPYRIGHT,HBV,HPV,ICAHN,INC,INCIDENCE,LABEL,LMICS,METHODS,MOUNT,NCD,OBJECTIVE,OBJECTIVES,PACIFIC,PREVENTION,PUBLISHED,RAPID,RESULTS,SINAI,VOL,WESTERN,WORLD,WPR
000,100,169,ASIAN,ASR,BACKGROUND,BAHRAIN,CANCERS,COPYRIGHT,COUNTRIES,ICAHN,INC,IRANIAN,LABEL,LEBANON,METHODS,MOUNT,OBJECTIVE,OBJECTIVES,PUBLISHED,QATAR,RESULTS,SAUDI,SINAI,THEREFORE,THESE,TURKISH,WESTERN
101,160,184,186,213,291,292,296,625,733,908,BACKGROUND,CONCLUSION,ERLOTINIB,ICERS,III,LABEL,METHODS,NSCLC,RESULTS,UTILITY
169,295,945,ACC,AMP,ATP,COPYRIGHT,INC,INDONESIA,SER79,U87
169,945,COLLAGENS,COPYRIGHT,IRELAND,LTD
HGF,HOWEVER,NSCLC,SEVERAL,THESE,TKI
EPIDERMAL,MET,NSCLC,SEVERAL,T790M
133,177,321,402,499,556,838,ACCORDING,DETECTION,ELISA,LABEL,MALIGNANT,MARCH,METHODS,OBJECTIVE,PROVINCIAL,RESULTS,ROC
030,044,048,297,BACKGROUND,FXIII,LABEL,MARCH,METHODS,PAL,RESULTS
BACKGROUND,BECAUSE,CONCLUSION,LABEL,METHODS,OVERALL,PRIMARY
169,COPYRIGHT,IRELAND,LTD,MWCNT,THERE,USING
001,010,162,169,177,193,248,386,395,398,492,600,642,961,CFD,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PRESURGERY,RESULTS,SOCIETY,TNM
CTC,EPCAM,HOWEVER,KEY,PATIENT
ACE,CAPTOPRIL,HOWEVER,HYPOXIA,LEWIS,LLC,RAS,THESE
FACTORS,HOWEVER
367,BACKGROUND,LABEL,MALIGNANT,MEN,METHODS,PILONIDAL,SPAIN
550,666,APRIL,CONCLUSION,COUNCIL,LABEL,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
EPIDERMAL,HOWEVER,KIT,TAKEN,THESE
APOPTOSIS,BAX,CHANGES,HEPG2,MCF,MTT,PT2
168,169,180,200,COPYRIGHT,PBS,PF127,PVA
001,039,095,147,187,199,253,298,303,408,ANXIETY,BACKGROUND,CBM,CHINESE,CUMULATIVE,HOWEVER,INVENTORY,JANUARY,LABEL,METHODS,MODERATING,MODERATOR,RANDOMIZED,RESULTS,SCIENCE,SMD,STATE,TRAIT,VIP,WANFANG,WEB
AFTER,BACKGROUND,CASPASE,IFN,KSY,LABEL,METHODS,MTT,RESULTS,SIN,TNF,TUNEL,UNDER,YIN
ASSESSMENT,BACKGROUND,CONCLUSION,DEPARTMENT,FUNCTIONAL,JANUARY,LABEL,METHODS,NON,NSCLC,OBJECTIVE,QOL,RAJAVITHI,RESULTS,SURGERY,THERAPY
111,251,263,369,415,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RAJAVITHI,RESULTS,TTF
128,956,BAX,BCL,CLONE,DHA,DIFFERENT,GLC,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,SER,WESTERN
AML,COX,DCBCL,LASSO,SIMULATION
CONSORTIUM,EARLY,HOWEVER,IMAGE,INITIATIVE,PHYSICIANS
169,ASP,BIOLOGY,FINALLY,HOWEVER,INC,MOLECULAR,SOCIETY
169,COPYRIGHT,GUIDELINES,NETWORK,NON,NSCLC,SMALL,TREATMENT
169,IMT,INC,VDA,WILEY,WILMS,XRT
169,ANRIL,ATM,HOWEVER,INK4B,NSCLC,P21,PC9
079,169,231,AKT,CXCR4,ERK,GTP,HODGKIN,LY2510924,MDA,SDF
150,169,800,AFTER,DL1,DL2,DLT,MTR,PAZOPANIB
039,042,083,1B1,4326C,4390A,967,COX,CYTOCHROME,FORTY,HISTOLOGY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PEARSON,PFS,PURPOSE,RESULTS,SEVERAL
001,023,024,139,AIM,APRIL,ARSENIC,BETWEEN,CHINA,DCR,GUANGZHOU,LABEL,METHODS,OBJECTIVE,ORR,RESULTS,TTP
169,UTILIZING,VCH,WILEY
001,002,009,012,017,020,045,113,224,234,648,945,HGF,MET,NSCLC
BACKGROUND,BECAUSE,EVERY,LABEL,METHODS,RESULTS,THEREFORE,THESE
CXCR4,METASTASIS,SBC,SDF,STROMAL
BACKGROUND,III,LABEL,METHODS,NSCLC,NSCLS,PFS,REGARDING,RESULTS,THEREFORE
100,BACKGROUND,FORCE,HOWEVER,LABEL,MAJOR,METHODS,RESULTS,SCREENING,THESE,TRIAL
169,4T1,936,BACKGROUND,BASEL,BCL,CONCLUSION,FINALLY,LABEL,MDSCS,MEANWHILE,METHODS,RESULTS,ROS,YLT26
169,ANTICANCER,BETWEEN,CONCLUSION,COPYRIGHT,COX,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,PFS,RESULTS
169,544,ANTICANCER,BACKGROUND,CONSLUSION,COPYRIGHT,COX,INSTITUTE,LABEL,NSCLC,PFS,RESULTS,UNASSIGNED
169,AIM,ANTICANCER,BACKGROUND,BIO,CIS,CONCLUSION,COPYRIGHT,DETECTION,ELISA,GIF,HOWEVER,INSTITUTE,LABEL,MATERIALS,MESOTHELIN,METHODS,MPM,OBJECTIVE,RESULTS
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,RESULTS,THREE
110,111,124,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DEVIATIONS,HOWEVER,IMAGE,INSTITUTE,LABEL,LOWER,METHODS,OBJECTIVE,PTV,RESULTS,UPPER
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,RESULTS
049,169,656,ANTICANCER,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,HRQOL,INSTITUTE,LABEL,MELATONIN,METHODS,NON,NSCLC,RESULTS
169,AFTER,ANTICANCER,AUTOPSY,BACKGROUND,BILATERAL,CONCLUSION,COPYRIGHT,DESPITE,INSTITUTE,LABEL,LITERATURE,METHODS,SINCE
030,043,100,169,AIM,ANTICANCER,BASED,CONCLUSION,COPYRIGHT,INSTITUTE,KARNOFSKY,KPS,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS
025,056,062,131,169,177,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FOXP3,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,PCR,REGULATORY,RESULTS,TREGS
169,945,946,AKT,ANTICANCER,ATP,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,FAK,GTP,INSTITUTE,LABEL,MATERIALS,METHODS,MIGRATION,MTT,RAC,RESISTANCE,RESULTS,RHO
1082G,169,358,716,ANTICANCER,COPYRIGHT,FURTHER,INSTITUTE
169,215,358,716,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TAIWANESE,XRCC7
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,MMR,OBJECTIVE,RESULTS,TMA
100,169,205,ANTICANCER,CASKI,COPYRIGHT,CTG,H69,HOWEVER,INSTITUTE,TGI,THESE,TUMORGRAFT
169,6D1,946,ANTICANCER,COPYRIGHT,FYN,INSTITUTE,MCS,RAF,SCC
169,946,ANTICANCER,COPYRIGHT,INSTITUTE,USING
169,ANTICANCER,ARG,B1R,COPYRIGHT,INSTITUTE,KLK10,KLK11,LYS
100,181,APOPTOSIS,BACKGROUND,BAX,CODON,HOWEVER,LABEL,PRINCIPAL,RESULTS,THESE
ALK,CRIZOTINIB,H2228,H3122,HGF,HOWEVER,MET,NON,NSCLC,THESE
500,BACKGROUND,CASP8,CONCLUSION,D302H,LABEL,METHODS,RESULTS,SNP
AFTER,APOPTOSIS,DEPLETING,FIRST,HOWEVER
169,239,500,AUC,BASEL,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
AUNPS,CETUXIMAB,FINALLY,H1299,HOWEVER,IGG,NSCLC,OVERALL
169,811,AKT,AMYLOID,APP,CELLS,INC,NSCLC,PI3,PRECURSOR,PROTEIN,SINCE,THESE,WILEY
BACKGROUND,III,LABEL,METHODS,NON,NSCLC,RESULTS,THERE
946,ATP,BIM,DASATINIB,DESPITE,KNOCKDOWN,NSCLC,SMAD2,SMAD3,TGF,THEREFORE
660,DESPITE,H1299,MICRORNAS,NCI,TRANSIENT
046,778,ADDITIONAL,AML,CPG,FURTHER,HTB56,NSCLC,TALALAY,THESE,WHILE
DESPITE,PTH,PULMONARY
HOWEVER,KRUPPEL,NSCLC,TNM
148,152,300,452,AFTER,AUC,BLOOD,CURRENT,FURTHER,HENCE,HOWEVER,LOW,MICRORNAS,NSCLC,PCR,SERUM,STRATIFIED
001,003,101,565,CARDIAC,INSURANCE,LABEL,MALIGNANCY,MALIGNANT,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,THERE
34A,946,H1299,LUCIFERASE,MICRORNAS,NSCLC,PCR,TGF,UTR,WESTERN
015,100,AES,AFTER,ALK,ALT,AST,AUG,BACKGROUND,CHINESE,CRIZOTINIB,FORTY,GRADE,HOWEVER,LABEL,MAY,METHODS,NSCLC,PFS,QOL,RESULTS,SIX
169,945,946,AKT,CSC,HOWEVER,MALIGNANT,MET,MYC,NK4,THESE,WNT
77T,ASIAN,CIS,HOWEVER,ORS,XRCC1
132,165,297,CHINESE,ERCC1,NSCLC,SEPTEMBER
500,CHINA,HOWEVER,KNOWLEDGE,SCHOLAR,T241M,XRCC3
242,AMONG,COX,LYMPH,METASTASIS
001,003,005,036,045,2E1,332,ASIAN,CHINA,DATABASES,KNOWLEDGE,LIBRARY,PROTECTION,PST,RSA,WANFANG
024,219,759,AMONG,COEXISTING,COX,EFFECTS,HOWEVER,HRS,INSURANCE
002,019,107,209,DFS,NEITHER,NSCLC,POSITIONS,USING
CEACAMS,FURTHER,HNO,HOWEVER,THESE
169,BRITAIN,COPYRIGHT,GREAT,INHERITED,IRELAND,LTD,PPB,PUBLISHED,SOCIETY,THESE,WILEY
001,014,018,024,028,044,100,177,691,753,ACCORDING,ACS,CTP,LABEL,LCC,MATERIALS,METHODS,MTT,NSCLC,OBJECTIVE,OBJECTIVES,PIMAX,PULMONARY,RESULTS,THERE,UNION,USING
002,169,415,555,CONCLUSION,COX,FDG,IMAGING,INC,LABEL,MATVS,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SOCIETY,THESE,UNLABELLED
169,177,293,360,947,99M,AFTER,BECAUSE,CCK2R,CONCLUSION,CRL,HEK,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,RESULTS,SOCIETY,SPECT,UNLABELLED
200,632,DUE,HOWEVER,INFECTIOUS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEOUL,TREATMENT,UNIVERSITY
AUTOPSIES,PULMONARY,TMA,TROUSSEAU
233,DUB,DUE
CHEST,HOWEVER
169,BROADLY,COLLEGE,COPYRIGHT,ENGLAND,LTD,MALTHUS,PUBLISHED,ROYAL
020,100,169,AES,BACKGROUND,CALIFORNIA,COLLEGE,COPYRIGHT,DIEGO,FURTHER,GROUP,HOWEVER,INC,LABEL,MCS,METHODS,PCS,PRIOR,PUBLISHED,QOL,RESULTS,SAN,SHORT,SHORTNESS,SURGERY,T1A,T1B,THERE,UNIVERSITY,Z4032
11A,11C,169,177,956,COPYRIGHT,FINALLY,HEPG2,MCF,NOTABLY,SAR,SAS
003,169,177,BACKGROUND,COPYRIGHT,DESPITE,EUROQOL,FIFTY,INC,IQR,LABEL,METHODS,RESULTS,RHO,THERE,VAS
169,468,47D,495,562,568,956,CNS,COPYRIGHT,HOP,INSTITUTE,MDA,MOTIVATED,RESULTS,SAS,SNB,USA
169,COPYRIGHT,SAS,SRB
BMSCS,MICROARRAY,TBD,THESE
169,COPYRIGHT,INC,MPM,NSCLC,PDT,SIMILARLY
169,CHORDOMAS,COPYRIGHT,HODGKIN,INC,THERE
169,COPYRIGHT,INC,NSCLC,SEVERAL
169,175,31001,BACKGROUND,CALGB,COMPARISON,COPYRIGHT,INC,LABEL,MCNEMAR,METHODS,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,THERE
042,096,169,612,629,AFTER,BACKGROUND,COPYRIGHT,FINALLY,INC,LABEL,MEIER,METHODS,OVERALL,PUBLISHED,RESULTS,SOCIETY,THERE,THESE,TREATMENT
030,038,169,APRIL,BACKGROUND,CEA,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OWING,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,THERE
052,105,10878,128,134,169,290,BACKGROUND,COPYRIGHT,EVALUATION,KAPPA,LABEL,LTD,METHODS,RESULTS,SOLID,TUMOURS,UNIVARIATE
100,169,183,409,432,841,BACKGROUND,BETWEEN,BLOOD,COPYRIGHT,FEB,FOCUS,FUNDING,HEART,INSTITUTE,IQR,LABEL,LIBERAL,LTD,METHODS,RESULTS,THESE,TREATMENT,USA
169,COPYRIGHT,INC,ISP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PHYSICIANS,PUBLISHED,RATIONALE,RESULTS,VOLUNTEERS
169,CONVERSELY,COPYRIGHT,FINALLY,HOWEVER,IRELAND,LTD,LYS,OTU,OTUD5,PDCD5,PROGRAMMED
169,945,954,COPYRIGHT,H1299,IRELAND,LTD,SILENCING,V12
169,176,210,2CM,359,8CM,COPYRIGHT,D99,ECLIPSE,INC,MEDICAL,MUS,PTV,PUBLISHED,V10
454,AMONG,BACKGROUND,CONCLUSION,COUNTRIES,ENGLISH,FACTORS,INITIATIVE,LABEL,LMC,MEDLINE,METHODS,PROPORTION,RESULTS,WORLD
169,BLOOD,BOS,COPYRIGHT,FIFTY,INC,INSTITUTES,PUBLISHED,SOCIETY
160,169,549,BACKGROUND,COPYRIGHT,H322M,HENCE,INC,LABEL,METHODS,MTT,NEWER,NSCLC,PAC,PROCASPASE,RESULTS,SIMILARLY,WESTERN
003,006,169,AMBULATORY,ASPIRATION,CHANGES,COPYRIGHT,DYSPHAGIA,FIFTEEN,HNC,IMPAIRMENT,INC,INVENTORY,LABEL,METHODS,OBJECTIVE,OUTCOME,PAS,PROFILE,PUBLISHED,RESULTS,SCALE,SETTING,SWALLOW,USING
169,COPYRIGHT,HOWEVER,INC,LOW,PATHOLOGY,PUBLISHED,SOCIETY,TEC,THESE,VERAPAMIL
BMJ,EARLY,GROUP,LTD,MALIGNANCY,PUBLISHING
131,169,177,215,330,669,BBS,BECAUSE,COPYRIGHT,INC,LABEL,LYS,METHODS,RESULTS,TREATMENT,UNLABELLED
169,AWARENESS,COPYRIGHT,IRELAND,LTD,NORTH,PRIORITIES,RADIATION
169,BLY,COMPARING,COPYRIGHT,GVP,HMOX1,HOWEVER,HSP70,NCI,REFERENCE,TPM
0MONTHS,169,5MG,7DAYS,9MONTHS,COPYRIGHT,FIFTY,III,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OVERALL,PFS,PRIMARY,PURPOSE,RESULTS
001,169,BACKGROUND,CARDIAC,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WBI
169,COPYRIGHT,HOWEVER,MMP1A,MMP1B,THESE,USING
106,243,946,BACKGROUND,BASED,CELLS,CG200,DLS,IFIT2,IFIT3,INF,LABEL,METHODS,RESULTS,SLS,SMALL,ST3GAL4,ST6GAL1,SWCNT,THESE
169,23A,CISPLATIN,COPYRIGHT,IMIDAZO,KINASES,SAS
169,COPYRIGHT,FURTHER,HOWEVER,INC,LOBECTOMY,NSCLC,PUBLISHED,SOCIETY
104,169,18F,BACKGROUND,COPYRIGHT,FDG,IIA,IIB,INC,LABEL,METHODS,NSCLC,PET,PUBLISHED,RESULTS,SOCIETY,T1A,T1B,T2A,T2B,THERE
001,169,177,493,ASSOCIATES,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OPTIMIZING,PUBLISHED,RESULTS,THERE,THEREFORE,THESE,USING
169,2DAYS,945,97L,BERBERINE,CONSISTENT,COPYRIGHT,HCC,HIF,STRIKINGLY,USING
100,169,ALPPS,ASSOCIATES,BACKGROUND,BILIARY,COPYRIGHT,DISCRETION,DISCUSSION,FLR,HEPATIC,HOWEVER,ISS,LABEL,LTD,MATERIALS,METHODS,PUBLISHED,PVL,PVO,RESULTS
169,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,LABEL,PUBLISHED,RENAL,RESULTS,SAS
169,COPYRIGHT,HOWEVER,ICU,NSCLC,PUBLISHED,SAS,WESTERN
169,CD4,COPYRIGHT,HIV,PUBLISHED,SAS
169,CONCLUSION,COPYRIGHT,DIPNECH,ELECTRONIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS

3HE,BACKGROUND,CRT,CURRENT,DISCUSSION,EVERY,III,LABEL,METHODS,MRI,NSCLC,QOL,SECONDARY,STAGE,TRIAL
BACKGROUND,JANUARY,LABEL,METHODS,NSCLC,RESULTS,THERE
CIMAVAX,NON,NSCLC,TECETOMIDE
001,008,BACKGROUND,CONCLUSION,EASTERN,GROUP,LABEL,METHODS,RESULTS,SINCE,TEN,TREATMENT
001,008,BECAUSE,CA125II,COLORECTAL,OVARIAN,SCREENING,THESE,TRIAL
956,BACKGROUND,LABEL,RESULTS,TAKEN
BACKGROUND,LABEL,RESULTS,TOOLBOX
10442,10869,14289,945,ASIAN,BACKGROUND,CIS,HIF,HOWEVER,LABEL,METHODS,ORS,RESULTS,SCIENCE,SIMILARLY,THEREFORE,WEB
BASED,CURRENTLY,DESPITE,NGS,NON,NSCLC
ANOVA,BACKGROUND,CELLTITER,GLO,INHIBITION,LABEL,METHODS,MYC,PCR,PRKDC,PROMEGA,RESULTS,SYNTHETIC,WESTERN,WHITNEY
208,215,231,AFTER,AUNCS,CURRENT,H1650,MPE,PCA,PRINCIPAL,RAMAN,SOMATIC,SVM
001,003,014,032,046,118,181,199,239,257,326,329,345,357,360,381,383,389,460,508,846,BACKGROUND,CHINESE,FURTHER,LABEL,METHODS,NSCLC,PEMETREXED,PROPENSITY,RESULTS
240,CONTEXT,HOWEVER,IHC,LABEL,METHODS,NEN,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SIMILAR,SSTR1,SSTR5,SSTRS
000,100,258,475,681,802,BACKGROUND,CONCLUSION,CZECH,LABEL,METHODS,POPULATION,RECORDS,RESULTS
169,945,946,947,CONFIRMING,IFN,IL4,IL6,TAKEN,TAM,TGF,TNF,USING
CURRENTLY,DWI,MRI
017,025,177,181,350,371,ACCORDING,ANY,BACKGROUND,BIOLOGICAL,BLOOD,CHRONIC,CONCLUSION,FIFTY,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,TNM
120,160,800,956,HCC,HIF,KEEPING,MMP,MVD,PRESENTLY,SP1,STAT3,TAKEN,TUNEL
160,CHEMOKINE,OVERALL
AFTER,CHEST,GENERALLY,GMA,PULMONARY,SEVEN,SINCE,WEGENER
947,BASIC,CD4,CTLA4,DOWNSTREAM,FOLR4,FOXP3,INTRANASAL,RAR,ROR,STAT3
100,160,169,955,AUR,COPYRIGHT,DESCT,INC,LABEL,MATERIALS,METHODS,NIC,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,ROC,SIXTY
169,394,441,477,786,918,AMONG,BACKGROUND,CASES,CRC,LABEL,METHODS,RAS,RESULTS,SOCIETY
HOX
1GIMNSS,ATLAS,BACKGROUND,CARLO,CHAIN,HOWEVER,LABEL,LACKING,MONTE,OBC,POISSON,RESULTS,SEQ,SEQUENCING,THROUGH
001,047,169,322,437,BACKGROUND,CHINESE,CONCLUSION,COX,CRP,HOWEVER,KAILUAN,LABEL,METHODS,RESULTS
00006,004,006,009,116,ANXIETY,BACKGROUND,DEPRESSION,INVENTORY,LABEL,METHODS,RESULTS,SCALE,SYMPTOM,TAIWANESE
169,COPYRIGHT,INC,MYC,SMALL,USING
169,COPYRIGHT,INC,SMALL,USING
169,AKT,COPYRIGHT,HOWEVER,HSP90,INC,NSCLC,THEREFORE,THESE
313,CHANGES,CONCLUSION,GODDARD,JAPAN,KNOWLEDGE,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,STAGE,THERE,TOKYO,UNIVERSITY
ACRAL,CARCINOMA,HOWEVER,METASTASES,ORTHOPEDIC,THERE
001,049,151,178,329,BACKGROUND,COX,EXTENSIVE,GROUP,HRS,LABEL,METHODS,PFS,PROGNOSTIC,RECURSIVE,RESULTS,SOUTHWEST,SUBSEQUENT,THESE,VALIDATION
009,045,049,133,143,177,189,AUC,BACKGROUND,EFFECTIVE,ELISA,GM2,GM2AP,LABEL,METHODS,RESULTS,SERUM,THERE,USING,WESTERN
CIGARETTE,CONSISTENT,FOS,FRA,HEIGHTENED
169,183,GEORG,HOWEVER,NSCLC,STUTTGART
169,215,956,COPYRIGHT,INC,LABEL,MET,METHODS,OBJECTIVE,OBJECTIVES,PCR,PUBLISHED,RESULTS,SERUM,SOCIETY,TNM
169,382,953,AUSTRALIAN,HODGKIN,LABEL,METHODS,OBJECTIVE,READERS,RESULTS
088,091,092,160,169,954,AUR,BECAUSE,CLOUD,COPYRIGHT,EVALUATION,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,REFERENCE,RESULTS,RIDER,SOLID,THESE,VBR
169,929,BACKGROUND,COLLEGE,COMMISSION,COPYRIGHT,COX,DIMINISHED,INC,LABEL,METHODS,PUBLISHED,RESULTS,SEVERAL,SOCIETY
169,177,946,VCH,WILEY
169,ADDITIONAL,AKT,COPYRIGHT,CYTOSCAPE,DOCK1,GEFITINIB,H1975,LOW,MOLECULAR,PROTEIN,PROTEOMICS,SDS,SOCIETY,TRANSWELL,WESTERN
169,777,BRITAIN,CONTINUED,COPYRIGHT,GREAT,INC,LABEL,METHODS,OBJECTIVE,PAF,PURPOSE,RESULTS
ELECTRONIC,FINALLY,ISI,LABEL,MATERIALS,METHODS,NON,OBJECTIVE,RESULTS,STUDIES
LABEL,MATERIALS,METHODS,OBJECTIVE,RADIATION,RESULTS
001,005,015,021,053,177,916,CTL,FVC,GROUP,KEOWN,LABEL,METHODS,OBJECTIVE,POPCS,RESULTS,SIMILARLY,THESE
169,945,AMONG,CDP,CHOLINE,RSM
134,947,OVERALL,SUV39H2
24H,AKT,ERK,GLC,H1184,K252A,MEK,MYC,PROCESS,THESE,UCN
14MONTH,169,COPYRIGHT,HISTOLOGY,INC,PRIMARY,WILMS
038,045,132,169,177,1980S,2000S,948,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
160,190,217,793,AMONG,APOA5,III,LDL,MYOCARDIAL,PREVIOUSLY
578,AXL,BACKGROUND,ESRP1,GREATER,HOXB4,LABEL,RESULTS
CAM,CD326,CTC,PDT
946,CCND1,EGF,FINALLY,IFN,LAC,PML
FEV,LABEL,MEANS,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
ARF,PERIOSTIN,STRIKINGLY,THESE
3MA,CK2,GFP,HOWEVER,LC3,PROTEIN,RESISTANT,T790M,TKI
173,317,BRCA2,DEFECTS,PRO
169,199,263,ABT,BAK,BCL,BH3,COPYRIGHT,GDC,INC,MCL,SMALL
CONCRETELY
CURRENT,HOWEVER,PCA,THEREFORE,TOMOGRAPHY
002,100,169,ACCORDING,COPYRIGHT,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,NCA,NEOPLASTIC,OBJECTIVE,RESULTS,SCHOLAR,SCIENCE,WEB
169,30A,AEG,COPYRIGHT,SNAIL,THEREFORE,THESE
111,125,CONSISTENT,DELTA,MAXIMAL,MV522,THESE
LA1

009,EMT,H1975,HOWEVER,KIRSTEN,L858R,NCI,NON,NSCLC,RAF,T790M,THESE,TKI
145,946,EMT,WNT,WNT3A
BLP25,CD4,CD8,III,TECEMOTIDE,TH1,TREATMENT
ADDITIONAL,III,NSCLC,PHASE,TAA
5T4,CURRENTLY,DESPITE,MVA,THERE

HSC,THEREFORE
181,BECAUSE,H2052,IC50S,MALIGNANT,MET,MPM
115,218,333,ABO,BACKGROUND,CEA,LABEL,METHODS,NSCLC,RESULTS,STUDIES
CDK,HDAC1,HOWEVER,MICROARRAY,NSCLC,SP1,STRAP,THESE,USING
945,CONSISTENT,EVEROLIMUS,HIF
444,461,ADVERSE,NSCLC,PCR,THIRD
013,PHASE,VEGFR
004,011,040,045,114,131,142,466,ANGPTL2,ANGPTL5,ANGPTLS,NSCLC,THEREFORE
950,HAIYPRH,PEG,PTX,TAT
587,731,936,LNCRNAS,NSCLC,SEVERAL,SIX
SOLID
169,946,COPYRIGHT,EGF,ELK,INC,MEK,RAS,SMAD3,TGF,U0126
AKT,IGFBP,NSCLC
AKT,BRAIN,HOWEVER,OTHER,RAF,RASSF,RASSF1A,V600E
712,954,CDK,CKD,G2M,MMP,TAKEN,THI
169,231,397,944,COLLEGE,COPYRIGHT,LTD,ONTARIO,OVERALL,PALLIATIVE,PRT,PUBLISHED,ROYAL
169,ACUTE,CONCLUSION,COPYRIGHT,EASTERN,FIFTY,GROUP,HYPOTRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,AUR,CONSENSUS,COPYRIGHT,CTP,DCE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PERFUSION,PUBLISHED,RATIONALE,RESULTS,ROI,TCC
001,004,018,126,160,FINALLY,HOWEVER,PCR,USING
169,AKT,BASED,BESIDES,COPYRIGHT,HUVEC,INC,INVERSELY,VEGFR
125,130,151,169,255,AIS,APA,ATS,CONCLUSION,COPYRIGHT,COX,ERS,FDG,IASLC,IIA,IIB,IMA,IRELAND,LABEL,LPA,LTD,MATERIALS,MEIER,METHODS,MIA,MPA,MPP,OBJECTIVE,OBJECTIVES,OVERALL,PET,PPA,RESULTS,SPA,THEREFORE
BACKGROUND,FOLLOWING,HOWEVER,LABEL,METHODS,RESULTS
169,COPYRIGHT,CTLA4,INC
CONCLUSION,H1299,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,UBB,UBC,WESTERN
181,CHROMATIN,COX,INHIBITION,NSCLC,RFPL3,THESE,UNIVARIATE
169,BACKGROUND,CONCLUSION,CONSORTIUM,CONTACT,FEDERATION,FINDING,HOWEVER,IMMUNOLOGY,LABEL,METHODS,MOTIVATION,PRESS,PROJECT,PUBLISHED,RESULTS,SOCIETIES,UNIVERSITY
136,169,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,PRESS,PROVISION,PUBLISHED,RECEIPT,RESULTS,SOCIETY,STAGE,UNIVERSITY
018,029,033,046,067,069,079,169,375,436,461,973,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
008,049,169,CXCR2,HOWEVER,IL8,SNP,USING,UTR
790,945,CAD,CCK,EMT,ERR,MCF,PCR,SILENCING,SNAIL,TARGETING,TRANSWELL,TWIST,VIM,WESTERN,XCT
10877,169,239,CONCLUSION,COPYRIGHT,CTC,CTCAE,EFFECTS,FATIGUE,GRADE,III,LABEL,LTD,METHODS,MGN1703,OBJECTIVE,PURPOSE,RESULTS,SAE,SIX,THERE,TWICE
ACTIVATION,BACKGROUND,BAX,BID,INDIVIDUAL,LABEL,METHODS,MMP,RESULTS,THESE,U87MG
EXPRESSION,HOWEVER,PCR,SMALL
001,106,160,177,ELISA,MEIER,NSCLC,TNM,UNIVARIATE,USING
007,016,022,169,CONCLUSION,COPYRIGHT,DIFFUSE,FIFTEEN,IIA,IIB,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM,USING
ABCG2,AKT,DELE747,FINALLY,H1650,KO143,MDR,RAS,REMARKABLY,THESE,WHILE
189,896,LABEL,METHODS,OBJECTIVE,RESULTS,SWEDISH,THERE,WORKERS
279,ANIMALS,BACKGROUND,CONCLUSION,E26,ERG,ETS,EXPRESSION,GLYATL2,INHIBITION,LABEL,LNCAP,METHODS,RESULTS,THEREFORE
169,CONCLUSION,COPYRIGHT,DISCS,HOWEVER,INC,KNOCKDOWN,LABEL,MEIER,THESE,UNLABELLED
954,BELGIAN,CAD,COHEN,DUTCH,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,CONCLUSION,LABEL,METHODS,NINTEDANIB,RESULTS
183,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,MINIMALLY,MIS,RESULTS,STUTTGART,WILMS
169,946,ANXA2,CONVERSELY,KMT1E,RESTORING,SMAD2,TGF
169,AZD9291,METASTATIC,T790M,USING
008,010,042,169,AGGRESSIVE,BACKGROUND,COPYRIGHT,DFS,HOWEVER,LABEL,LTD,METHODS,OCTOBER,PREVENTING,RECURRENCE,RESULTS,SACRECTOMY,STUDIED,THREE
169,ADULT,COPYRIGHT,LOY,MEN,SCIENCE,SENIORS,TOBACCO,UPPSALA
109,160,169,AUNPS,COPYRIGHT,DESPITE,LTD,NPS,SAECS,SILAC,THERE
169,UPDATED
169,WHILE
DEPLETION,HOWEVER,INHIBITION,MODULATION,NSCLC,PDCD4,REDUCED,WESTERN
EMT,NOTCH,NSCLC,THROUGH
018,120,150,169,177,BETWEEN,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SEVENTY,SURGERY,UNIVERSITY
145,169,182,LABEL,LOBECTOMY,MALIGNANT,MARCH,MAY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
115,169,COPYRIGHT,FINALLY,SATISFIED,UNDER
169,231,945,946,954,CHINESE,COPYRIGHT,ECM,FINALLY,IRELAND,LTD,MCF,MDA,MMP,MORUS,MORUSIN,STAT3,THESE
231,BACKGROUND,CK5,LABEL,LUMINAL,MCF,MDA,METASTATIC,METHODS,RESULTS,SIMILAR,THEIR,WHILE
BACKGROUND,CURRENT,DESIRABLE,LABEL,OVERALL,RESULTS
C30,EASTERN,ELD14,EORTC,GROUP,HRQOL,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,QLQ,RESULTS,SIX,UNION
153,169,COPYRIGHT,FURTHER,HOWEVER,INC,KNOCKDOWN,LUCIFERASE,MIR,NSCLC,PCR,TAKEN,USING,UTR
169,COPYRIGHT,INC,UNREPORTED
1970S,1980S,1990S,AUSTRALIA,CHINA,GDP,INDUSTRIAL,ITALIAN,ITALY,JOURNAL,SIX
500,523,888,AAA,BACKGROUND,CENTRAL,EMR,ESTIMATES,GEISINGER,JANUARY,KNOWN,LABEL,METHODS,PERIPHERAL,RESULTS,SIMILARLY,USING,VARIABLES
169,COPYRIGHT,INC,INCREASING,IRS
169,600,COPYRIGHT,EXPOSED,NO2,PUBLISHED,STUDIES,THESE,TODAY
ALA119SER,ASN453SER,CAUCASIANS,LEU432VAL
169,COPYRIGHT,INC
DIAGNOSIS,EWSR1,PNETS,PRIMARY
169,178,AIM,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,DESPITE,IMPROVING,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PATIENT,RESULTS,THERE,THESE
001,002,006,169,947,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS

AFTER,CK7,DIAGNOSIS,FDG,PET,TTF
FLT,III,IPF,NINTEDANIB,NSCLC,PDGFR,SRC,VEGFR
AKT,ERK,HRM,IGF,INDEX,LABEL,MECHANISM,METHODS,MTT,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
CONVERSELY,FURTHER,NSCLC,PDX,PRIMING,TAKEN,THERE,USING

OHP
AFTER,CHB,HCC,HOWEVER,THESE
001,085,169,327,389,AMONG,CUMULATIVE,END,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,USING,VALIDATED
122,CCNG1,HOWEVER,MEF2D,OLEANOLIC,RESTORING
945,946,947,BACKGROUND,LABEL,METHODS,NUCLEAR,RESULTS
177,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TPS
750,AUC,CAD,FALSE,MACHINE,ROC,SUPPORT,SVM,SVMFEATURE,THREE
121,177,BACKGROUND,DEPARTMENT,EARLY,INCOMPLETE,LABEL,MARCH,METHODS,RADIATION,RESULTS
001,055,068,118,254,BACKGROUND,LABEL,MAY,METHODS,OSAKA,REGISTERED,RENAL,RESULTS,SERUM,THERE,TRIAL,UNIVERSITY
CAUCASIANS,HENCE,OVERALL
UNIVERSITY,WARTHIN
CARLO,CTV,DAO,ECLIPSE,FINALLY,FURTHER,HOWEVER,LABEL,MEDICAL,METHODS,MONTE,OAR,OBJECTIVE,PTV,PURPOSE,REGARDING,RESULTS,SWISS,SYSTEMS,THESE,TPS
177,250,300,COLLECTION,HOWEVER,LABEL,METHODS,OBJECTIVE,PRECISE,PURPOSE,RESULTS,SIMILAR
BEV,DRR,EOE,GTV,HOUNSFIELD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THROUGH,USING
169,919,ABSTRACTS,AES,CENTRAL,CONTROLLED,HOWEVER,INCREASED,MEDLINE,NSCLC,TREATMENT
169,945,946,BASED,CSF,HUVEC,PRE,TNF
EXTENSIVE,HPF,IGE,IGG,LABEL,MAXVISION,METHODS,MULTI,OBJECTIVE,OTHER,RESULTS
CONCLUSION,H69,H69AR,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SALL4,WESTERN
005,105,178,877,967,AG85B,BEIJING,CAPITAL,CHEST,CONCLUSION,IHC,JANUARY,LABEL,MEDICAL,METHODS,NEELSEN,OBJECTIVE,RESULTS,UNIVERSITY,ZIEHL
AFRICAN,ASIAN,BACKGROUND,CAUCASIAN,III,LABEL,METHODS,RESULTS,WHILE
169,AMONG,BACKGROUND,BASEL,LABEL,METHODS,RESULTS,TEN,THERE,URACHAL
THEREFORE
010,015,018,032,059,380,461,502,519,589,649,684,688,697,912,914,969,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,RFS
HOWEVER,III,MBC,PHASE
001,250,343,500,ALK,BACKGROUND,CRIZOTINIB,CROSSOVER,LABEL,METHODS,NSCLC,OBJECTIVE,PROFILE,RESULTS
CONCLUSION,GREATER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS
177,947,956,HOWEVER
231,BAD,BAK,BAX,BCL,GAS,HEP,LNCAP,MDA,OVERALL,SOE,TREATMENT
039,160,169,AUTHORS,DFS,FGFR1,HOWEVER,LTD,MET,NSCLC,PATIENT,PDX,WILEY
169,945,946,BRITAIN,COPYRIGHT,GREAT,IRELAND,LTD,OVERALL,PCR,PLACING,PUBLISHED,SOCIETY,TGF,WILEY
001,005,016,024,160,169,17A,330,382,73G,APMIS,FURTHER,HOWEVER,LTD,NSCLC,PUBLISHED,WILEY
001,002,2578C,460TT,BACKGROUND,BASED,CAUCASIANS,HOWEVER,LABEL,METHODS,RESULTS,SIMILAR,THESE
169,CONCLUSION,COPYRIGHT,EATON,EQUAL,INC,JANUARY,LABEL,LAMBERT,MAJOR,METHODS,OBJECTIVE,RESULTS,SETTING
169,BECAUSE,COPYRIGHT,NSLCC,PUBLISHED,THROUGH
ADVANCE,HELPING,THERE,WHILE
146,169,ADC,AMONGST,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,RESULTS
120,132,140,145,169,177,200,364,COPYRIGHT,FINALLY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SUCCESSFUL
169,ACTIVATION,CAR,COPYRIGHT,CTL,IRELAND,LTD,RECOVERIN,SUBSEQUENT
011,050,169,236,250,946,AMONG,CONCLUSION,COPYRIGHT,COX,DFS,DPD,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS
001,039,169,CIR,COMPETING,CONCLUSION,COPYRIGHT,CRT,FDG,III,IRELAND,LABEL,LOW,LTD,METHODS,MTV,MTV_LES,MTV_PAT,NSCLC,OBJECTIVE,PATIENT,PET,PFS,PRE,PURPOSE,RESULTS,SELECTIVE,SUV,SUVMAX_PAT,USING
169,BRCA1,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MPM,OBJECTIVE,RESULTS
110,169,COPYRIGHT,HOWEVER,INCREASED,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,ROMO1
169,ALK,COPYRIGHT,CTC,INC,PREDICTIVE,PROGNOSTIC,THESE
169,COPYRIGHT,INC,MEANWHILE,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY,SVC,WHILE
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,FETAL,INC,PUBLISHED,SOCIETY
001,169,CAIRO,COMBINING,CONCLUSION,COPYRIGHT,DOPPLER,EGYPT,FEDERATION,FLV,GYNECOLOGY,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OBSTETRICS,PUBLISHED,RDS,RESULTS,RIS
160,169,ALK,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ERBB2,IHC,INC,LABEL,MATERIALS,METHODS,PCR,PUBLISHED,RESULTS,RET
160,169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,III,INC,INTENSITY,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SIB
131,169,177,231,233,BACKGROUND,CAV,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,PFS,RESULTS
000,169,183,279,AGAINST,AMERICA,ATLANTA,AUSTRALIA,BACKGROUND,BELFAST,CENTERS,CONTINUOUS,CONTROL,COPYRIGHT,DEC,DISEASE,ECUADOR,ESTIMATES,FOCUS,FUNDING,INDIVIDUAL,INSTITUTE,IRELAND,JAPAN,KOREA,LABEL,LEXINGTON,LIVER,LTD,METHODS,NORTH,PREVENTION,PUBLISHED,RESULTS,SOUTH,SWISS,TORONTO,UNIVERSITY,USA,WALES,WORLDWIDE
109,169,956,COPYRIGHT,FINALLY,PTERIDINES,QUANTIFIED,RSD,WHILE
100,169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,UPRIGHT
10C,169,231,946,AKT,AMONG,BCL,COPYRIGHT,COX,ERK,H1299,LTD,MCF,MDA,MMP,MRC
169,COPYRIGHT,LTD,MALIGNANT,MPM,PROGNOSIS
169,COLLEGE,COPYRIGHT,FURTHER,HENCE,HOWEVER,LTD,MODELLING,PATIENT,POPULATION,PUBLISHED,ROYAL,WHITE
112,129,142,160,184,284,INITIAL,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROBOTIC,SEPTEMBER,THERE
128,169,177,210,BACKGROUND,COPYRIGHT,IRELAND,ITACS,LABEL,LIGHT,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TRAFFIC,TYPES
127,169,AFTER,COPYRIGHT,COX,EXPRESSION,GLC,HOWEVER,INC,LAK,MEIER,PBK,PDZ,THEREFORE,TNM,WESTERN
169,AUTHORS,BELGIAN,BELGIUM,COPYRIGHT,HOWEVER,INCIDENCE,LTD,POISSON,PUBLISHED,THESE,WORLD
169,COPYRIGHT,IRELAND,LTD,NSCLC
012,026,101,155,169,221,BACKGROUND,COPYRIGHT,CRT,HOWEVER,IRELAND,LABEL,LTD,METHODS,MICRORNAS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,V50
169,183,198,APRIL,BACKGROUND,CENTRAL,CONTROLLED,COPYRIGHT,FUNDING,INDIVIDUAL,LABEL,LTD,MEDLINE,METHODS,OVERALL,RESULTS,SCIENCE,SOCIETY,WEB
100,239,4EBP1,AKT,BACKGROUND,LABEL,METHODS,NON,NSCLC,P7170,RESULTS,SMALL,THEREFORE
169,969,COPYRIGHT,LTD,THESE
169,COPYRIGHT,DIVERSE,FCP,LTD,MCF
002,006,169,188,398,BACKGROUND,BROAD,CHALLENGE,CONCLUSION,COX,CRTC1,INSTITUTE,LABEL,MAP,METHODS,PGE,PRESS,PUBLISHED,RESULTS,SOMATIC,THESE,UNIVERSITY
169,ARB,BASED,COPYRIGHT,DESPITE,FDA,HOWEVER,IRELAND,LTD,PUBLISHED
169,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS
048,105,169,183,BACKGROUND,BETWEEN,CHRONIC,COPYRIGHT,DISEASE,FUNDING,HIGGINSON,INSTITUTE,LABEL,MASTERY,METHODS,OCT,PUBLISHED,RESULTS,SOUTH
METASTATIC,PITUITARY,PROGNOSIS
BECAUSE,COLLEGE,ROYAL,TREATMENT
169,954,BECAUSE,COPYRIGHT,EXTRACTED,INC,SGP40,SGP65,THESE,TREATMENT
231,4T1,BESIDES,CE6,CHLORIN,FURTHER,MCF,MDA,MMP,MTT,NAC,PDT,PROPIDIUM,ROS,SDT,THESE,TUNEL
169,177,ADDITIONAL,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOT
7TH,BASED,MODEL,RESILIENCY
BECAUSE,DTC,THEREFORE
169,24H,AKR,AKR1B10,COPYRIGHT,ERK,HOWEVER,IRELAND,JUN,LTD,MAP,THESE,TPA,U0126
10001,333,APART,DESPITE,MEDICAL,PERFORMING,PUBLISHERS,SEVENTH,THESE,USA
10001,333,DESPITE,MEDICAL,PERIPHERAL,PUBLISHERS,SEVENTH,USA,VIRTUAL,WHILE
10001,333,BECAUSE,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,USA
169,COPYRIGHT,FURTHER,HOWEVER,ISSUE,KNOCKDOWN,MEDICAL,PCR,PROTEOMIC,PROTEOMICS,PUBLISHED,ROS,SPECIAL,THESE,WESTERN
116,169,460,549,COMPOUNDS,COPYRIGHT,HCT,INC,MOLECULAR,SAR
160,169,33258,803,BAX,BCL,COPYRIGHT,DHA,HOECHST,MGC,MTT,NCI,ROS,SAS,TUNEL
160,169,177,CALIXARENE,COPYRIGHT,FOLLOWING,HUVEC,MA148,SAS,STILL,WHILE
145,160,169,956,AKT,AMONG,COPYRIGHT,FURTHER,HEPG2,HOECHST,MCF,PKB,SAS
169,ATP,AUTHORS,COPYRIGHT,CYS,DIMINISHED,FOXM1,PUBLISHED,USING
001,404,425,BACKGROUND,DEPARTMENT,ENGLAND,LABEL,METHODS,RESULTS
BACKGROUND,DEPENDING,HOWEVER,INCREASED,LABEL,METHODS,RESULTS,SLT,SYMPTOM,THESE,TIMES
160,169,239,446,ACADEMY,ASSESSMENT,BACKGROUND,CHRONIC,CONCLUSION,CONTEXT,COPYRIGHT,EASTERN,FATIGUE,FUNCTIONAL,GENERAL,GROUP,HOSPICE,ILLNESS,INC,KARNOFSKY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,QOL,RESULTS,THERAPY,VISIT
130,169,AGA,BACKGROUND,COPYRIGHT,EMAST,EXPRESSION,IL6,INC,INCUBATION,INSTITUTE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,STAT3
169,170,ALK,BASED,COMPOUNDS,COPYRIGHT,KIST301072,SAS
169,COPYRIGHT,INC,LABEL,THESE,UNASSIGNED,UNLABELLED
001,100TH,143,184,255,291,327,452,711,754,963,BACKGROUND,COLORECTAL,CURRENTLY,CXR,EDITORS,FORCE,LABEL,METHODS,OVARIAN,PPV,PREVENTIVE,RESULTS,RISKS,SCREENING,SMOKERS,SUMMARY,TRIAL
169,1PM,AUNPS,COPYRIGHT,NEANA
169,ASSESSMENT,COPYRIGHT,INC,INORGANIC,LEBANON,PM2,URBAN,USING
945,956,AFTER,BCL,HIF,THESE
175,18F,459,960,CENTERS,CHINA,CHINESE,CNY,CONCLUSION,GDP,GUIDELINES,LABEL,METHODS,MODEL,NON,NSCLC,OBJECTIVE,PET,RESULTS,ROBUSTNESS,SMALL
169,552,COPYRIGHT,GAB,INC,MAP,PI3,PLC,PREVIOUSLY,RHO
169,COPYRIGHT,FEW,HOWEVER,IRELAND,LTD,PUBLISHED,RDI,STUDIES
169,COPYRIGHT,CROWN,CTC,FURTHER,IRELAND,LTD,ONGOING,PUBLISHED,THERE
140,169,CARLO,COPYRIGHT,CPU,IRELAND,LTD,MONTE,PET
169,COPYRIGHT,SAS
169,ASIAN,BMI,CAUCASIAN,COPYRIGHT,HCC,LIBRARY,SAS,STUDIES
169,COPYRIGHT,FOLLOWING,HOWEVER,LTD,THEREFORE,WHILE
001,015,029,160,169,ACT,AMENDMENTS,ARIZONA,ASSESSMENT,BACKGROUND,BECAUSE,CENTERS,CONCLUSION,CONTROL,COPYRIGHT,DISEASE,EDUCATION,INC,LABEL,LOW,MATERIALS,METHODS,PREVENTION,PROGRAM,RADIATION,RESEP,RESULTS,SCREENING,SOCIETY,THESE,TOBACCO,TOTAL,VARIATIONS,YET
169,ALK,COPYRIGHT,III,INC
160,169,500,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTEEN,INC,LABEL,METHODS,NSCLC,PFS,RESULTS
169,945,946,99M,COPYRIGHT,CURRENTLY,EC145,FOLIC,LTD,PHASE,THEREFORE,VINCA
169,AUTHORS,AUTOPHAGY,BECLIN1,BEV,C26,HSA,LTD,PTY,PUBLISHING,SCIENCE,SIMILAR,SNO,THEREFORE,WILEY
112,146,169,COPYRIGHT,CTNBS,INC
169,BESIDES,COPYRIGHT,MEANS,RIGHT,SAS,TDM,TNM
001,024,113,169,967,ANTIFUNGAL,BACKGROUND,CONCLUSION,COPYRIGHT,JANUARY,LABEL,METHODS,RESULTS,SAS
100,169,COPYRIGHT,PTX,TENPS,VITAMIN
169,177,334,604,946,956,BESIDES,COPYRIGHT,HENCE,SAS,THESE,U87MG
APPROACHES,MA148,PUBLISHED,THESE
039,169,467,ASIAN,BACKGROUND,C216T,C228A,C228T,C229G,C250T,C295T,COPYRIGHT,G233C,G267C,IHC,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,RFS,TNM
169,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,EMT,H1688,H69,H69AR,IRELAND,LABEL,LTD,MATERIALS,METHODS,NOTCH,OBJECTIVE,RESULTS
500,ALPHA,COMPARING,CONCLUSION,COX,DBP,HRS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PREVENTION,PUBLISHED,RESULTS,SERUM,THERE,TOCOPHEROL,VITAMIN
169,AKT,AUTHORS,ERK,HOWEVER,LTD,METASTASIS,PTY,PUBLISHING,RAF,RAS,SCIENCE,TREATMENT,WILEY
169,ABC,ANNEXIN,BACKGROUND,COPYRIGHT,DCM,DNR,FURTHER,INDIA,IRELAND,LABEL,LTD,MATERIALS,MCF,MDR,METHODS,PET,RELEVANCE,RESULTS,SIMILARLY,SRB
169,COPYRIGHT,HOWEVER,LTD
100,169,183,APRIL,BACKGROUND,BETWEEN,COPYRIGHT,EVALUATION,FUNDING,HOWEVER,LABEL,LTD,MARCH,METHODS,RESULTS,SOLID
169,COPYRIGHT,FOURIER,LTD
169,ALK,AUTHORS,COPYRIGHT,GEMMS,GENERATION,GENOMIC,INC,PUBLISHED
001,100,143,169,177,217,BACKGROUND,COPYRIGHT,FDG,LABEL,LTD,MATERIALS,METHODS,PET,PUBLISHED,REGARDING,RESULTS,SUV,THROMBOSIS,VTE
100,169,BACKGROUND,CANDIDA,COPYRIGHT,COX,DELAYED,GROUP,HEART,IFD,INC,LABEL,METHODS,MYCOSES,PUBLISHED,RESULTS,SOCIETY,THERE,THREE,TREATMENT
BECAUSE,HOWEVER,OTHER,PRESENTLY,PRIMA,THESE
169,ACR,COLLEGE,COPYRIGHT,FORCE,INC,NETWORK,PREVENTIVE,PUBLISHED,RADIOLOGY,SCREENING
001,005,110,134,160,169,177,340,450,COPYRIGHT,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,946,COPYRIGHT,FEDERATION,FINALLY,IKB,IKK,LARGE,MCF,MLL,PC3,PKC,PUBLISHED,RAPID,SOCIETIES,SW620,TARGETING
169,215,956,AIR,BOARD,CALIFORNIA,COMMISSION,COMMITTEE,COMPANY,COPYRIGHT,DESPITE,DUTCH,EPA,GIVEN,INTEGRATED,IUR,LTD,MONTANA,PROTECTION,QUALITY,RESOURCES,SINCE,TEXAS,USING,WASHINGTON
130,138,147,169,AMONG,BASED,BRONI,COPYRIGHT,FEW,ITALIAN,LTD,STRADELLA
003,149,169,177,284,433,915,ADVERSE,AGE,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MHD,MLD,OBJECTIVE,OBJECTIVES,PTV,RESULTS,V20
019,048,169,CONCERNING,COPYRIGHT,DIFFERENT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,1ST,468,762,BACKGROUND,COPYRIGHT,DESPITE,HOWEVER,IRELAND,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,RRS,THERE
169,COPYRIGHT,NLLGLIEAK,PEPTIDE,ULTIMATELY
169,COPYRIGHT,IMPORTANT,INC
001,160,169,433,740,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ELECTRONIC,HOWEVER,INC,LABEL,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,SMOKING,TKI
169,CONTINUED,COPYRIGHT,INC
100,169,231,COPYRIGHT,DPB,LTD,MDA,PEG,PEGYLATION,RESULTS,THESE
002,169,183,292,AMONG,CLINICO,COPYRIGHT,GPA,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,WHILE
169,617,727,ADVANCE,COPYRIGHT,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STAGE,VTE
001,005,014,126,169,193,339,ACCORDING,BETWEEN,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PCI,RESULTS
113,169,BACKGROUND,COPYRIGHT,D102Y,D990N,IRELAND,ITALIAN,KIT,L858R,LABEL,LTD,MATERIALS,MET,METHODS,OVERALL,R988C,RESULTS,SAMPLES,TARGETABLE,THEIR,TTF
169,801,ADC,BACKGROUND,COPYRIGHT,CTS,EXPRESSION,IRELAND,LABEL,LCC,LCNEC,LTD,METHODS,NSCLC,PCS,RESULTS,SCC,SQC,THESE
169,945,COPYRIGHT,LTD,MCF,NATURAL,PALLADIUM,SCREENING
177,946,956,BASED,EG5,HR22C16,MCF,ME180,MOLECULAR,MTT,THESE
169,AMONG,BACKGROUND,COPYRIGHT,ENDPOINTS,IRELAND,LABEL,LTD,MEANWHILE,METHODS,NSCLC,RESULTS,THERE,THEREFORE
013,048,049,100,159,169,250MG,250ML,AMONG,AUTHORS,BACKGROUND,CHINESE,CHM,COPYRIGHT,FUZHENG,LABEL,LTD,METHODS,MST,NSCLC,PFS,PUBLISHED,RESULTS
169,239,BAGGING,BAYES,CISLS,COPYRIGHT,LTD,SVM,THESE
169,ASIAN,BCL,BCL2L11,BH3,BIM,COPYRIGHT,EMT,GEFITINIB,HOWEVER,PUBLISHED,SOCIETY,TKI
169,1990S,COPYRIGHT,III,JAPAN,PUBLISHED,SOCIETY
169,ALK,ANAPLASTIC,COPYRIGHT,CRIZOTINIB,HOWEVER,III,NSCLC,PUBLISHED,SOCIETY,TKI,TREATMENT
169,ALONG,COPYRIGHT,CURRENTLY,JAPAN,MEANWHILE,PUBLISHED,SOCIETY,THESE
169,COMMITTEE,COPYRIGHT,JAPAN,JOINT,PREVIOUSLY,PUBLISHED,SOCIETY,TNM
CONSISTENT,PROTEIN,USING
916,MB231,NSCLC,SW620,T790M,TKI
169,AIM,BACKGROUND,BRITISH,CONCLUSION,ENGLAND,EXCELLENCE,GENERAL,GPS,INSTITUTE,JOURNAL,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING
101,142,169,193,400,500,APRICOXIB,CONCLUSION,COX,DOCETAXEL,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PGE,PURPOSE,RESULTS,SOCIETY
GAP,HOWEVER,RHO
169,CARLO,DOSIMETRIC,MONTE,PRESS,PUBLISHED,RESULTS,TPS,UNIVERSITY
169,34S,COPYRIGHT,CRC,FURTHER,HCC,NPC,NSCLC,PCA,SCIENCE,THEREFORE,ULTIMATELY,WEB
169,COPYRIGHT,CROWN,GSTM1,HMOX1,IMPORTANT,INC,NRF,PUBLISHED,THESE,USING
001,002,018,169,225,292,877,APRIL,BACKGROUND,CERTAIN,COPYRIGHT,COULTER,COX,III,LABEL,METHODS,NSCLC,RESULTS,WBC
181,H1299,IND,INDANONES,INHIBITORY,MTT,NMR
3540C,CHINESE,HOWEVER,PPB,REMARKABLY,SAS,SERTOLI,TYR1180
169,6MONTHS,BACKGROUND,CHOROIDAL,COPYRIGHT,DEPENDING,DISCUSSION,FOCALIZED,HOWEVER,LABEL,LTD,METHODS,RADIATION,RESULTS
169,COPYRIGHT,DIFFUSING,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,THERE,TREATMENT
169,197,BASED,BH3,COPYRIGHT,EBP,FOXJ2,HMGCR,LNA,NAC,NCI,PREVIOUSLY,ROS,STAT6,UTR
000,956,PET,THERE
CURRENTLY,NGS,SELECTIVE,THESE
169,COPYRIGHT,IRELAND,LTD,THESE
169,945,COPYRIGHT,H23,NSCLC,THESE
100,169,171,206,AGENZIA,BACKGROUND,COMMITTEE,CONCLUSION,COPYRIGHT,EASTERN,FARM6PMFJM,FARMACO,GOIRC,GROUP,III,INC,LABEL,MAJOR,METHODS,MONITORING,SECONDARY,SEPTEMBER,TREATMENT
15D,169,276,586,BACKGROUND,C30,CENTRAL,COPYRIGHT,EORTC,HRQOL,INC,JANUARY,LABEL,METHODS,NSCLC,QLQ,RESULTS,UNIVERSITY
169,CHT,COPYRIGHT,III,INC,NSCLC,SIMILARLY
169,685,COPYRIGHT,FIFTEEN,III,IMPROVING,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PEARSON,PURPOSE,RESULTS,THERE
001,017,036,100,124,169,310,809,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,RESULTS,T790M,THERE,TKI
169,COPYRIGHT,FORTY,GRADE,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,TKI,TREATMENT
169,673,946,ACEIS,ASPIRIN,BACKGROUND,CONCLUSION,COPYRIGHT,COX,DFS,III,INC,INCIDENTAL,LABEL,LRPFS,METHODS,NSCLC,RESULTS
169,215,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,COX,CSS,EASTERN,FFR,GENOTYPING,GROUP,INC,LABEL,MEIER,METHODS,NSCLC,RESULTS,SEVEN,T1A
018,160,169,710,816,983,BACKGROUND,COPYRIGHT,INC,INSURANCE,LABEL,MEDICATION,METHODS,OLDER,OVERALL,RESULTS,SCC
169,177,956,AKT,COPYRIGHT,CXCR4,DOX,HOWEVER,LIP,METASTASIS,MIGRATION,PEGYLATED,PEPTIDE
169,ALPHA,COPYRIGHT,FINALLY,H1299,INC,MOTIF,NSCLC,SAMD9,STERILE
132,169,ADDITIONAL,COPYRIGHT,HN1,INC,MIR,TAKEN,UTR
GIVEN,SERUM
956,CONCLUSION,CYFRA21,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,SIXTY
1A1,CONCLUSION,FNX01,IRINOTECAN,LABEL,MATERIALS,METHODS,OBJECTIVE,ORR,PFS,RESULTS,THERE
65U,945,BACKGROUND,BASED,CA125,CA199,CA242,CA724,CONCLUSION,COX,LABEL,MATERIALS,MEIER,METHODS,RESULTS,SERUM,TMS,UNIVARIATE
013,045,058,145,176,363,403,529,575,AIM,CENTRAL,CONCLUSION,DOR,HOWEVER,LABEL,METHODS,NLR,OBJECTIVE,PLR,RESULTS,SEVEN,STUDIES,SUMMARY
ASIAN,BACKGROUND,CRP,EIGHT,ENGLAND,HRS,LABEL,MANAGER,MATERIALS,METHODS,NSCLC,RELATED,RESULTS
131,265,396,AMONG,CONCLUSION,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
000,185,257,318,710,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
500,590,AIM,CHINA,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,THESE
049,AFTER,CONCLUSION,CYFRA21,LABEL,MEDLINE,METHODS,NSCLC,OBJECTIVE,RESULTS
169,COPYRIGHT,EPCAM,HOWEVER,NOTABLY,PSS
169,616,COPYRIGHT,COX,IRELAND,LTD,NSCLC,PROTEIN,STROMAL,THEREFORE
169,946,COCL2,COPYRIGHT,GLYCOLYSIS,HYPOXIC,IRELAND,LTD,NADPH,ROS,SINCE,SRC,THESE
169,COPYRIGHT,IRELAND,KNOCKDOWN,LTD,PCR,THESE
105,169,COPYRIGHT,CTC,CVB,IRELAND,LTD,MBC,PVB,TCE
169,3LL,ALDH1A1,COPYRIGHT,CSC,ID1,INCREASED,IRELAND,LTD,NOTCH,OCT,PKH26,SCA,SOX,THROUGH,USING
169,945,946,AKT,COPYRIGHT,FURTHER,HGF,HOWEVER,IRELAND,LTD,MET,PC3,SILENCING,THESE,XL184
169,505,551,COPYRIGHT,EOC,INC,INHIBITION,NER,NSCLC,PROTEIN,RPA,THESE
169,AUTHORS,CISPLATIN,COPYRIGHT,CURRENT,HOWEVER,LTD,NSCLC,PRODUCTION
169,ACCOUNTING,ADC,AKT,COPYRIGHT,ERK,INC,LOH,MEK,NAC,NSCLC,RAF,RAS,SCC,THESE
169,COPYRIGHT,FINALLY,INC,TAKEN
169,COPYRIGHT,HOWEVER,INC,THESE
169,946,COPYRIGHT,INC
169,946,COPYRIGHT,FEDERATION,FRMD5,HOWEVER,PUBLISHED,ROCK1,SOCIETIES,TAKEN
169,182,ASSOCIATES,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,CTS,DISCUSSION,III,LABEL,LTD,METHODS,PRE,PUBLISHED,RESULTS,ROUTINE,THERE
169,945,946,954,956,AKT,BCL,CAT,COPYRIGHT,COX,FAK,HEXAVALENT,HIF,INC,INHIBITION,MMP,NADPH,NOX,OVERALL,ROS,TNF,TREATMENT,WESTERN
169,231,4T1,945,946,COPYRIGHT,EMT,INHIBITION,LTD,MDA,METASTATIC,PD0325901,TGF,THEREFORE,TNF
10000,169,BACKGROUND,CONCLUSION,ENGLAND,GPS,LABEL,METHODS,OBJECTIVE,ONGOING,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
169,COPYRIGHT,DE3,LATCRIPIN,LENTINULA,MTT,ROSETTA,SIMILARLY,TEM
125,150,169,BACKGROUND,COPYRIGHT,DISEASE,LABEL,METHODS,NSCLC,PRIOR,RESULTS,THREE
169,AAA,ATPASES,COPYRIGHT,G780AGPSQ,PAGET,VALOSIN,VCP
ALK
169,CISPLATIN,COPYRIGHT,FEDERATION,MAJOR,MVP,NON,NSCLC,PROTEIN,PUBLISHED,SMALL,SOCIETIES,THEREFORE,VAULT,WILMS,WT1
169,327,AHR,COPYRIGHT,GGGGC,INC,STATE,THESE
169,24H,COPYRIGHT,CSE,EMT,HBE,HOX,INC,STAT3,THESE
169,243,AMONG,CONVERSELY,COPYRIGHT,CRC,THESE
160,169,BATF3,CD103,COPYRIGHT,CSF,CTL,DCS,FLT3L,INC,REGRESSING,THESE
169,945,AKT,BAX,BCL,CHINA,COPYRIGHT,DHTMF,DIHYDROXY,HIF,IRELAND,KOREA,LTD,TAKEN,THESE,VITEX
028,087,ALDH1,AMONG,CD204,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,THESE
169,COPYRIGHT,INCREASING,PUBLISHED
169,COPYRIGHT,EMT,HOWEVER,INC,LOW
169,945,946,COPYRIGHT,EMT,EPITHELIAL,FINALLY,HCC2935,HYPOXIA,IGF,IGF1R,INC,INHIBITION,INSULIN,NSCLC,PCR,TGF,THESE
CONVERSELY,EMT,EXOGENOUS,GROUCHO,HDACS,INC,PUBLISHED,THESE,THROUGH,TSA
169,APOPTOSIS,BIM,CETUXIMAB,COMBINING,COPYRIGHT,EGFRS,HOWEVER,INC,L858R,T790M,TKI,WHILE
AFRICAN,ASIAN,LEGUMES,SOCIETY,STATISTICS,WHILE
169,231,ABC,CAS,COPYRIGHT,CSGALNACT1,EXOGENOUS,GD3G7,HCC38,HEF,INC,MDA,MICROARRAY,NEDD9,SERGLYCIN,THERE,THESE
169,177,337,340NM,3DAYS,598,678,8MG,COPYRIGHT,DOX,HSA,TRAIL
III,ROSSI
169,176,177,267,CONTINUOUS,COPYRIGHT,DOF,INC,KIM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,VARIOUS
027,043,063,087,093,169,208,224,227,340,355,447,586,604,686,808,844,856,948,AMONG,COLLEGE,COPYRIGHT,ENGLISH,JANUARY,LIBRARY,LTD,NSCLC,PUBLISHED,ROYAL,STUDIES,THEREFORE,THESE
169,327,ACCORDING,BASED,BESTKEEPER,BRCA1,COPYRIGHT,ERCC1,GAPDH,INC,NORMFINDER,PCR,RPLPO,STMN1,TOP2A,TUBB3,USING
169,563,BLOOD,COPYRIGHT,SOCIETY,TRANSPLANT
164,169,174,582,ASA,COPYRIGHT,COX,DEFINITIVE,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,302,ANIMALS,COPYRIGHT,CROWN,HOWEVER,IPM,IRELAND,LTD,PUBLISHED
169,945,AMD3100,COPYRIGHT,CXCR4,HIF,IRELAND,KC7F2,LTD,THESE
169,946,AEROBIC,AKT,COPYRIGHT,ERK,HOWEVER,IRELAND,LTD,NSCLC,SILENCING,THESE
169,192,215,CONVERSELY,COPYRIGHT,FINALLY,FUNCTIONAL,H1299,IRELAND,LTD,R273H,TAKEN
169,202,293,315,ALK,ATM,COPYRIGHT,EP300,HGF,IRELAND,KDR,LTD,MOLECULAR,OTHER,PDX,RUNX1,SETD2,STK11
169,945,954,CD163,COPYRIGHT,IRELAND,LTD,MIP,STAT3
169,180,210,916,BECAUSE,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,PDCD5
169,COPYRIGHT
FINALLY
001,ASP,BACKGROUND,COX,FDG,LABEL,MEIER,METHODS,MTV,NCSLC,NSCLC,OAS,PET,PFS,RESULTS,ROVER,SUV,TLG,UNIVARIATE
BACKGROUND,CONCLUSION,DUE,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,PUBLISHED,SEPAR
169,177,5TH,BACKGROUND,CONCLUSION,COPYRIGHT,CTV,FURTHER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
169,177,18F,COPYRIGHT,DEVIATIONS,FDG,GTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,QFS,RESULTS,RMS,SIX,SIXTEEN,SUV,SUVPEAK
169,183,956,AIM,B16,CHINA,CONCLUSION,COPYRIGHT,CSF,CTX,ICR,LABEL,METHODS,MULTI,OBJECTIVE,PUBLISHED,QGY,RESULTS,THESE,UNIVERSITY,WBC
169,AMONG,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
001,019,169,BORDERLINE,COPYRIGHT,COX,DISABILITY,END,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
160,169,BACKGROUND,CONVERSION,COPYRIGHT,HOWEVER,INC,JANUARY,LABEL,MARCH,METHODS,OPERATIVE,PUBLISHED,RESULTS,SOCIETY,UNIPORTAL
004,031,041,042,160,169,BACKGROUND,BILATERAL,COPYRIGHT,HOWEVER,INC,LABEL,LOBECTOMY,METHODS,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE
100,108,114,160,169,BACKGROUND,BRONCHIAL,COPYRIGHT,ENDOSCOPIC,INC,LABEL,METHODS,PUBLISHED,REGULAR,RESULTS,SIXTY,SOCIETY,THERE
119,146,160,169,ADVERSE,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,OVERALL,PRIMARY,PUBLISHED,RESULTS,SOCIETY
017,039,102,160,169,247,300,514,AFTER,BACKGROUND,CAREFUL,COPYRIGHT,INC,LABEL,MEIER,METHODS,MORTALITY,NETWORK,OCTOBER,ORGAN,PROPENSITY,PUBLISHED,RESULTS,SHARING,SOCIETY,THERE,USING
013,160,169,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,FIRST,INC,LABEL,MATERIALS,METHODS,RESULTS
022,023,111,160,169,AFTER,AMONG,BACKGROUND,BMS,CLINICIANS,CONCLUSION,COPYRIGHT,COX,CRC,INC,INCREASED,JANUARY,JAPAN,KINKI,LABEL,LOG,MATERIALS,METHODS,MST,RESULTS,THERE,UNIVERSITY
HOWEVER,IMAGING
169,AUR,BOOSTED,CONSORTIUM,CONTENT,COPYRIGHT,FILTERING,IMAGE,INC,INITIATIVE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
15A,169,954,COPYRIGHT,FINALLY,FIRST,HOWEVER,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,UTR
100,102,169,177,215,CARLO,COPYRIGHT,INC,IONIZATION,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TPS,VIEWRAY
169,ADULT,ASSESSMENT,BETWEEN,BRAIN,COPYRIGHT,FIFTY,FUNCTIONAL,GTV,HOWEVER,INC,INDIVIDUAL,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PARTS,PTV,PURPOSE,RESULTS,SECONDARY,SRS,STATE,THERAPY,THREE,TRAIL
100,110,119,132,169,196,229,3N0M0,945,946,967,ADVERSE,AES,CENTRAL,CONCLUSION,COPYRIGHT,GRADE,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PFT,PTV,PULMONARY,PURPOSE,RESULTS
043,045,169,198,274,528,AFTER,BETWEEN,COPYRIGHT,CRT,III,INC,JANUARY,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUFFICIENT
169,ADVERSE,COPYRIGHT,EPP,GRADE,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PFS,PULMONARY,PURPOSE,RESULTS
169,945,956,AMONG,COPYRIGHT,LTD,MICROWAVE
169,259,722,771,916,981,AMONG,BASED,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,SIX,THERE
008,169,CONCLUSION,COPYRIGHT,CTS,DAILY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,V50,V95,WBI
169,ACUTELY,COPYRIGHT,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RADIATION,RBE,RESULTS
001,003,006,013,023,025,081,169,177,5FC,5MC,BACKGROUND,CONCLUSION,COPYRIGHT,EIA,GROWING,HRP,LABEL,METHODS,PUBLISHED,RESULTS
150,169,COPYRIGHT,INC,PUBLISHED,SEVERAL,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
160,169,COPYRIGHT,HISTOLOGIC,INC,PUBLISHED,PULMONARY,SOCIETY
169,BASED,BRAIN,COPYRIGHT,INC,PITUITARY,PUBLISHED,SOCIETY,SUBSEQUENT
169,450,945,947,954,ACADEMY,ALLERGY,BACKGROUND,CD3,CD4,CONCLUSION,COPYRIGHT,GATA3,IFN,IGE,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,OVA,PUBLISHED,REMARKABLY,RESULTS,TH1,TH2,THESE,TNF
001,002,011,10878,110,115,169,68L,73L,94L,AUTHORS,COPYRIGHT,IRELAND,JANUARY,LABEL,LRRFS,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RATIO,RESULTS
105,169,COPYRIGHT,CRC,CTS,IRELAND,LABEL,LRS,LTD,METASTASES,METHODS,OBJECTIVE,PET,PTV,PURPOSE,RESULTS
169,COPYRIGHT,HOWEVER,LTD,MULTI,SWEDISH,USING
169,376,425,BACKGROUND,COPYRIGHT,DECREASES,DEPARTMENT,INC,JOURNAL,LABEL,METHODS,MULTILEVEL,OBJECTIVE,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS
BACKGROUND,LABEL,LENTIVIRAL,METHODS,NSCLC,PCR,RESULTS,SALMONELLA,TY21A,WESTERN
169,ACA,AIS,ALK,ASIDE,COPYRIGHT,INC,ISHLT,LAS,MIA,THOSE
169,CARINAL,COPYRIGHT,HOWEVER,INC,NSCLC,THESE
169,ADDITIONAL,COPYRIGHT,EPP,INC,NSCLC
169,COPYRIGHT,INC
ACQUIRING,CURRENT,HOWEVER,INC,LOCALIZED,NETWORK,PROGNOSIS,PUBLISHED,THEREFORE
169,COPYRIGHT,INC,NSCLC,THERE
DISCOVERY,INC,PUBLISHED,SVC
169,CAREFUL,CENTRAL,COPYRIGHT,INC,LIMITED,NSCLC,OPERATIONS,WEDGE
169,COPYRIGHT,GENERALLY,INC,NSCLC,SEPARATION,SRS
169,COPYRIGHT,INC,LOBECTOMY
169,COPYRIGHT,INC,SMALL
169,COPYRIGHT,INC
169,COPYRIGHT,INC,MORBIDITY,OBTAINING,WHILE
169,ASSESSMENT,CAREFUL,COPYRIGHT,INC,OPERATIVE
169,CAREFUL,COPYRIGHT,INC,MIS
169,COPYRIGHT,CURRENT,DEVELOPING,FINALLY,LTD,PUBLISHED,THERAPIES,THESE
169,AWARENESS,CONTINUED,COPYRIGHT,INC,PERSISTENT,SOCIETY
169,AMONG,BACKGROUND,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
CA755,INSTITUTE,NSC,USA
169,BECAUSE,COPYRIGHT,EWING,GD2,INC
160,166,169,ACADEMY,BACKGROUND,COPYRIGHT,INC,INCREASING,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIROLIMUS
169,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,METHYLENE,OCTOBER,PUBLISHED,PULMONARY,RESULTS,SOCIETY,THERE
169,663,AMONG,BACKGROUND,COPYRIGHT,GGO,INC,LABEL,METHODS,OVERALL,PUBLISHED,RADIOLOGIC,RESULTS,SOCIETY,WEDGE
001,169,227,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PUBLISHED,PULMONARY,RESULTS,SOCIETY,THREE,VIDEO
106,125,169,175,333,344,356,438,4N2M0,649,949,BACKGROUND,COPYRIGHT,COX,III,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
112,120,158,169,209,256,313,BACKGROUND,COPYRIGHT,DISSECTION,INC,LABEL,METHODS,OPERATIONS,PUBLISHED,PULMONARY,RESULTS,ROUTINE,SOCIETY,SUBGROUPS,UNEXPECTED
169,COPYRIGHT,FURTHER,LTD,MONOCLONAL,NSCLC,RCC
006,014,160,169,COPYRIGHT,EPIDERMAL,INC,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROTEIN,PUBLISHED,RESULTS,THESE,WESTERN
022,160,169,COPYRIGHT,IIA,IIB,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY,WEDGE
160,177,FURTHER,INC,JANUARY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SELECTIVE
001,160,169,194,336,517,623,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PLANNED,PUBLISHED,RESULTS,SURGERY,VALIDATING
169,COPYRIGHT,LOCAL,LTD
001,041,049,169,183,185,239,240,477,480,506,BACKGROUND,BETWEEN,COPYRIGHT,DEC,FUNDING,HOWEVER,INSTITUTE,IQR,JANUARY,LABEL,LTD,METHODS,RESULTS,SOCIETY,TREATMENT
022,104,134,150,169,183,229,253,256,263,439,587,802,834,878,941,ASIAN,BACKGROUND,BETWEEN,COPYRIGHT,EASTERN,FUNDING,FURTHER,GROUP,LABEL,LTD,MARCH,METHODS,RESULTS,SERIOUS,TREATMENT
169,COPYRIGHT,LTD
001,005,009,011,018,027,033,160,169,304,310,615,AFTER,COPYRIGHT,EPITHOR,INC,INDUCTION,LABEL,METHODS,OBJECTIVE,OPERATIVE,OVERWEIGHT,PUBLISHED,RESULTS,SEVERAL,SOCIETY,SURGERY
008,018,019,169,592,692,AGE,BCP,COPYRIGHT,COX,IRELAND,IRR,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS
169,417,748,BACKGROUND,BRITISH,COPYRIGHT,COX,HAZARDS,HISTOLOGY,IRELAND,JANUARY,LABEL,LTD,MEIER,METHODS,NOS,NSCLC,PATIENT,PREDICTORS,RESULTS,STRATEGIES,THERE
169,COPYRIGHT,CROWN,DLBCL,INC,PUBLISHED
169,849,ACADEMY,ALLERGY,ATOPY,BACKGROUND,CIS,CONCLUSION,COPYRIGHT,COX,HOWEVER,IGE,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
169,AUTHORS,BACKGROUND,BFC,COHORTS,COPYRIGHT,FSC,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEPTEMBER
169,COPYRIGHT,FINALLY,GRIDMOS,HOWEVER,IRELAND,LTD
148,CONCLUSION,INC,LABEL,MALIGNANCY,METHODS,OBJECTIVE,PUBLISHED,RESULTS
AAS,ACCORDING,HCT,NEITHER,RBC,WBC

001,117,197,379,475,AFFAIRS,BACKGROUND,CHARITABLE,CONCLUSION,DEPARTMENT,DORIS,FOUNDATION,FUNDING,GEOGRAPHIC,LABEL,LIMITATION,METHODS,MULTILEVEL,OBJECTIVE,OLDER,PER,PRIMARY,RESULTS,SETTING
BESIDES,EMPLOYING,HOWEVER,PHGDH,PSAT1,SHMT2,THEREFORE
111,177,355,403,543,705,BACKGROUND,DVL,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,WNT,XENOPUS
COLORECTAL,CORRECT,CRC,MPR,MRI,PET
005,006,008,110,CD11B,CD4,HLA,INCREASED,LIN,MDSCS,MYELOID,NSCLC
BACKGROUND,CHINESE,CONCLUSION,ETHANOL,LABEL,MATERIALS,METHODS,NMR,ODS,OPTICAL,RADIX,RESULTS,SGC
169,1ML,CAP,COPYRIGHT,EPCAM,FINALLY,H1650,MCF,NCI,THEIR
169,BCL,COPYRIGHT,DESPITE,HOWEVER,INC,NON,PACLITAXEL,PREVIOUSLY
100,115,120,121,CACTTTG,ECTOPIC,OVERALL,SOX,SOX30,SRY
100,116,169,539,549,956,CEM,CNS,COLON,COPYRIGHT,HCT,LTD,MALME,NCI,NON,NSC,OVARIAN,OVCAR,RENAL,SMALL
132,212,CELLS,CONVERSELY,H1299
CURRENTLY,ERBB1,ERBB2,ERBB3,ERBB4,FINAL,III,LAPATINIB,NSCLC,PHASE,THESE,THREE,TKI
946,956,AIM,BAK,BAX,CONCLUSION,FMK,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,TREATMENT,VAD,WESTERN
100,BECAUSE,GAMMA,GKS,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PER,RESULTS,SUBSEQUENT
009,110,289,AVERAGE,CRITICS,DESPITE,KARNOFSKY,KPS,LABEL,MAY,MEIER,METHODS,MVA,OBJECTIVE,OVERALL,RESULTS,SALVAGE,SCALE,SRS,TREATMENT
008,012,024,CLASS,COX,DISTANT,FOLLOWING,GAMMA,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SALVAGE,SRS,WHILE
003,006,110,625,817,ACCORDING,ACTUARIAL,COX,FACTORS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OPTIMAL,PENDING,RESULTS,SCALE,SHERBROOKE,SRS,UNIVARIATE
215,CNS,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,WHOLE
134,176,178,204,219,268,302,305,318,355,382,749,792,825,ACCORDING,BASIC,BRAIN,HOWEVER,LABEL,LORENZONI,METASTASES,METHODS,MRI,NPS,OBJECTIVE,RESULTS,SCORE,SRS,SUBGROUPS
110,116,130,150,169,176,180,210,230,250,3DCRT,4GY,COPYRIGHT,INC,MEDICAL,OAR,PHYSICS,PROGRAMME,PUBLISHED,RADIATION
COLORECTAL,CRC,HCT16,HOWEVER,THESE,USING
10878,169,BACKGROUND,CONCLUSION,COPYRIGHT,FHV,HNSCC,IRELAND,LABEL,LTD,METHODS,NSCLC,PET,RESULTS,TEN,THEREFORE
ERCC1,EXPRESSION,FCM,FIRSTLY,H1299,MRP,MTT,NSCLC,THEREFORE
BPS,LEWIS,LLC
001,AGE,ALK,NSCLC,ROC,THESE
BMP,CHEST,EXCISIONAL,HISTOLOGIC
AFTER,HEPARIN,HIT,HOWEVER,JAPAN,LOW,PF4,PLATE,WESTERN
215,5MM,AFTER,CHEST,III,PET,SUBSEQUENT,THERE
HOWEVER,ROBOTIC,WHILE
169,COPYRIGHT,MEIER,NSCLC,NTC31,TAKEN,WESTERN
169,COPYRIGHT,FINALLY,IRELAND,LFS,LTD,TKI
000,001,028,037,169,259,416,615,877,959,961,BACKGROUND,CONCLUSION,COPYRIGHT,CURRENT,FGFR1,IRELAND,LABEL,LIBRARY,LTD,METHODS,PEARSON,PFS,RESULTS,SCHOLAR,SCI,USING,WEB,WHETHER
033,169,916,ANXIETY,BACKGROUND,BEHAVIOUR,COPYRIGHT,COS,DEJECTION,DLCST,FOCUS,HEALTHY,HEAVY,INTROVERT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMOKING,THERE,TRIAL
169,177,500,B12,BACKGROUND,CONCLUSION,COPYRIGHT,EPO,LABEL,NSCLC,PUBLISHED,RATIONALE,RESULTS,SAS
10YEARS,119,169,1ST,BACKGROUND,COLLEGE,COMPARISON,COPYRIGHT,GENERAL,JANUARY,KBP,LABEL,METHODS,NSCLC,PHYSICIANS,PUBLISHED,RESULTS,SAS,THEIR,VARIOUS
177,200,500,507,577,617,730,838,864,956,BACKGROUND,GAE,LABEL,MIC,RESULTS
946,APOPTOSIS,EXPRESSION,GAL,INJURED,LCC,PLEURAL,PMC,TGF,WESTERN
960,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,USAGE
169,945,946,BIOLOGY,COPYRIGHT,EDA,EDB,PUBLISHED,SOCIETY,THESE
001,002,004,012,1686C,169,391,398,COPYRIGHT,CRS,GROWING,PCR,THESE,XRCC1
001,160,AMONG,CONCLUSION,DSS,FDG,III,INITIAL,LABEL,METHODS,MORTALITY,NAC,OBJECTIVE,PET,PURPOSE,RESULTS
14097,169,937,BACKGROUND,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,THESE,TRIAL,UNIVERSITY,USING
169,945,946,CONSISTENT,CSC,TAKEN
169,946,954,ACTIVIN,CIC,EMT,INHBA,NSCLC,SOLUBLE,TGF,USING
CDC42,NSCLC,PCR
160,954,956,ELISA,ERK,GLC,MMP,MTT,MYD88,OXIDATIVE,THEREFORE,TRADD,TRAF2,TRAF6,TUNEL,WESTERN
FOLLOWING,GTP,MHC,NATURAL,NKP46,RAL,RAS,THESE,YET
161,ACT,CERTAIN,CONCLUSION,IMAGING,INSURANCE,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,PLEURAL,PRIMARY,RECURRENT,RESULTS,SMALLER,SSS
946,RED,THESE
ARSENIC,AS2O3,FAS,HOWEVER
945,AKT,HOWEVER,KNOCKDOWN,LENTIVIRUS,METASTASIS,MMP,PI3KP85,TAKEN,THESE
002,107,408,998,AMERICA,CIS,COLORECTAL,COX,GOVERNMENT,HRS,OVARIAN,PUBLISHED,RCC,SCREENING,TRIAL
169,309GG,331,501,532,717,749,830,AUTHORS,CONSISTENT,INC,PUBLISHED,SNP285C,SNP285G,SNP309T,WILEY
169,945,946,BRITAIN,COPYRIGHT,GREAT,IIB,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
807,945,BACKGROUND,CHINA,HLA,KNOWLEDGE,LABEL,METHODS,OVERALL,RESULTS,TEN,WANFANG
124,131,200,APOPTOSIS,CURRENTLY,FDG,FLT,HOWEVER,PET,SURGERY,THREE
104,235,380,BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PCR,PUBLISHED,PUBLISHING,QUBIT,RESULTS
BMJ,GENOMIC,GROUP,LABEL,LIMITED,METHODS,MILLISECT,OBJECTIVE,PROTEOMIC,PUBLISHED,PUBLISHING,RESULTS,SLIDE
134,CONCLUSION,COX,HOWEVER,LABEL,LSMIS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,002,005,015,046,100,AMONG,BACKGROUND,COX,DESPITE,III,INHIBITION,LABEL,METHODS,NON,NSCLC,PCR,RESULTS,SENP1,SIXTY,TNM
174,BOEHRINGER,COMMITTEE,INGELHEIM,IPF,MEDICINAL,MEDICINES,NINTEDANIB,OCTOBER,PHASE
001,003,177,489,665,CD11B,HLA,LABEL,MDSCS,METHODS,OBJECTIVE,RESULTS
LABEL,METHODS,OBJECTIVE,RESULTS,SURGICALLY
ATLAS,CLUSTERING,HOWEVER
100,500,BACKGROUND,CONCLUSION,GRADE,LABEL,METHODS,ORR,PEMETREXED,PFS,RESULTS,SECONDARY,SEVEN
001,118,EMT,EPITHELIAL,EXPRESSION,HOWEVER,THERE,TWIST
132,339,365,386,672,753,788,EASTERN,GROUP,INDWELLING,JANUARY,LABEL,MALIGNANT,METHODS,MPE,OBJECTIVE,RESULTS,SIXTY,THERE
956,AMONG,FOURIER,MWCNT
001,138,947,966,ADIPOSE,ADSCS,ANOVA,BACKGROUND,C31,CD4,CD8,FOXP3,IFN,JAK,LABEL,METHODS,RESULTS,STAT1,STUDENT,TRAIL,TREATMENT,TREGS
160,174,300,ALECTINIB,ALK,CNS,JAPAN,NSCLC,PATIENT,TREATMENT,WHILE
BMJ,GROUP,IMPORTANCE,LABEL,LIMITED,METHODS,MORTALITY,OBJECTIVE,ONTARIO,POPULATION,PUBLISHED,PUBLISHING,RELEVANCE,RESULTS,SETTING
104,ACCORDING,CHINESE,DRAFT,EVALUATION,III,KAPPA,KARNOFSKY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,REC,RESULTS,SOLID,TCM,WESTERN
158,181,204,362,JANUARY,L858R,LABEL,LBC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BMJ,GROUP,LTD,PUBLISHING
ALCOHOL,ALDH2,CURRENTLY,GROUP,HOWEVER
100,157,282,439,CEACAM6,CEACMA6,SMALL
LABEL,METHODS,OBJECTIVE,RESULTS,SMOKING
BACKGROUND,CONTEXT,DIAGNOSTIC,KNOWING,LABEL,LITERATURE,METHODS,OBJECTIVE,SOURCES
HEPATOCYTE,HGF,MET
946,AMONG,COX,FOXHEAD,FOXM1,GNM,HOWEVER,HPV,INDUCTION,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,WNT
160,4T1,BACKGROUND,CD4,CD8,CNB,CONCLUSION,CTC,EMT,INCISIONAL,LABEL,MDSCS,METHODS,RESULTS
177,244,471,ATLAS,CONSORTIUM,CUP,METASTATIC,SEQ
100,160,CRE,INHIBITION,METASTASIS,NEUROG3,RELAPSE,TSC
169,AUTOPSY,DESPITE,PRESS,PUBLISHED,UNIVERSITY
136,169,CYFRA21,LABEL,METHODS,OBJECTIVE,PLEURAL,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,COPYRIGHT,DAI,LOW,SNP,THESE
145,945,ADP,ATF,BIP,BORON,DIETARY,GRP78,LOW
017,027,035,106,123,128,312,316,919,BETWEEN,BRAIN,CONCLUSION,DFS,IIB,LABEL,LOCAL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE
AKT,ERK,HOWEVER,NSCLC,THESE,USING
946,BACKGROUND,EMT,LABEL,METHODS,MMP,OSCCS,RESULTS,SIRT1,SMAD4,TGF,THESE
BACKGROUND,BELIEFS,CONCLUSION,LABEL,METHODS,RESULTS,SEVERAL,SMOKERS,USING,WHEREAS
109,119,121,133,141,145,AVERAGE,BACKGROUND,CONCLUSION,DESPITE,HOWEVER,LABEL,METHODS,OBJECTIVE,QUESTIONS,RESULTS
215,947,954,AKT,CD147,HAB18,HUH,THESE
ANAPLASTIC,ATC,BACKGROUND,CONTEXT,DESPITE,JNK,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,USING
FDG,PET,THROUGH
FDA,FDG,FDOPA,MRI
HPV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TREATMENT
AEROSOL,AREAS,BACKGROUND,COVERED,EFFICIENT,FINALLY,LABEL,MEANWHILE,METHODS,OPINION,PEGYLATION,VIRAL
430,500,520,955,FURTHER,THESE,THIOL
916,C57BL,HOWEVER,LPS,SALMONELLA,SIMILARLY
EXPRESSION,GFP,INHIBITOR,MIIYRDLISH,NH2,PTD
070,177,BACKGROUND,CONCLUSION,LABEL,METHODS,PREFS,PRS,RELAPSE,RESULTS,SIXTEEN,THERE
486,538,572,ALCOHOL,BACKGROUND,HEAVY,HODGKIN,LABEL,METHODS,NON,RESULTS,RRS,THERE
001,169,499,842,AFTER,CONCLUSION,COX,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TREATMENT
169,ALTOGETHER,CDC42,DISCOIDIN,FINALLY,GEF,RHOGTPASE,SRC
169,AIM,ANOTHER,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DELINASIOS,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROC,SCC
BMJ,CAR,CRMP5,CV2,GROUP,LTD,PUBLISHING,SMALL
BMJ,GROUP,HIV,LTD,PUBLISHING,SYPHILITIC
120,ASA,CCO,CVP,ELISA,FORTY,HEART,LABEL,MAP,MATERIALS,MEANWHILE,METHODS,OBJECTIVE,OLV,RESULTS,SGB,SOCIETY,TOTAL
CONCLUSION,KHUZESTAN,LABEL,METHODS,PREVALENCE,PROVIDENCE,RESULTS,SHAFA,THEREFORE,UNLABELLED
120,128,135,CEA,CRP,CYFRA21,GEP,LDH,NSCLC,NSE,SERUM
AIM,ASIAN,BACKGROUND,C677T,CIS,LABEL,MATERIALS,METHODS,MTHFR,OBJECTIVE,ORS,RESULTS
062,199,364,611,673,835,BACKGROUND,CHINESE,CLPTM1L,HOWEVER,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,RS31489,SENSITIVE
001,003,031,042,053,056,178,241,359,365,382,419,587,768,841,916,930,974,BESIDES,HAN,INNER,LABEL,MATERIALS,METHODS,MONGOLIAN,OBJECTIVE,PCR,PURPOSE,RESULTS,SMOKERS
COX,CRC,CYCLO,MICRORNAS,MIR,THEREFORE,THESE,UTR
JAPAN,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,PALLIATIVE,PROGRAM,PURPOSE,RESULTS,SCALE
636,AUC,BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS,ROC,SERUM
AUTOPHAGY,CONCLUSION,DESPITE,III,LABEL,METHODS,OBJECTIVE,PURPOSE,REGULATION,RESULTS,THESE
109,142,222,250,437,670,802,AMONG,LABEL,MARCH,MAY,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,TKI
956,ANOTHER,HOWEVER,NPS
ADSORPTION,HACAT,HENCE,MTT,PVP,ROS
945,TUNEL
001,160,169,598,658,APMIS,CAUCASIAN,KIT,LTD,MUTATIONS,NSCLC,PCR,PUBLISHED,RGQ,WILEY
CHALLENGES,CPG,EPIGENETIC,GBM,HTB,K27,KIF23,LOX,PBK,THERE
EPIGENETIC,GROUP,HAART,HIV,HODGKIN,HOWEVER,INSTITUTES,NHL,NIH,NOW,SCIENTIFIC,SOCIETY,WORKING
CPG,DESPITE
169,AUTHORS,BIW,FIFTY,GM2,HOWEVER,LTD,MALIGNANT,MPM,PTY,PUBLISHING,SCIENCE,THEREFORE,THESE,WILEY
160,194,268,BACKGROUND,DISEASE,ENGLAND,LABEL,METHODS,NORFOLK,RESULTS,THOSE
169,CD11B,IL6,LABEL,METASTASIS,ST6GALNAC4,THOMSEN,UNLABELLED
DIFFERENT,III,PHASE
BACKGROUND,CONCLUSION,COURT,JAPAN,LABEL,METHODS,OBJECTIVE,PLAINTIFFS,RESULTS,SUPREME
169,175,ANY,EASTERN,GROUP,KETTERING,LABEL,LIVER,METHODS,OBJECTIVE,PHASE,PRESS,PUBLISHED,RESULTS,SLOAN,UNIVARIATE,UNIVERSITY
946,EMT,EPITHELIAL,MORTALITY
549,945,946,NAUCLEA,NMR,THEIR
BAL,CSF,INHALATIVE,PAP,SECONDARY,SEVERAL,WHOLE,WLL
107,160,169,AUTHORS,EPIGENETIC,HPV,LTD,PCDHA13,TESTING,WILEY
450,BECAUSE,HIV,HODGKIN,INSTITUTE
001,002,003,010,018,020,158,186,291,876,III,PRS,RFS,SOLID
8TH,GEFITINIB,NSCLC,TEN,TKI,TOXIC,TREATMENT
1AT,945,EMPHYSEMA,GLU342LYS
1960S,449,708,AMONG,BACKGROUND,CVD,INDEX,INEQUALITY,LABEL,METHODS,NORWEGIAN,RESULTS,RII,SII,SLOPE,STILL
EPHA2,HOWEVER,HRS,SCIENCE,WEB
169,AUTHORS,BACKGROUND,BIRTH,FINALLY,LABEL,LTD,MEDICAL,METHODS,MOTHERS,PAEDIATRIC,PERINATAL,PUBLISHED,RESULTS,SIMILARLY,WILEY
500,B12,BETWEEN,BEV,CHINESE,DISEASE,NSCLC,OCTOBER,OVERALL,PFS,TOXICITIES
239,ATP,BASED,EPIDERMAL,FIRST,LUX,NSCLC,TKI
181,316,690,CONCLUSION,CONTINUED,END,INDIANS,LABEL,METHODS,OBJECTIVE,RESULTS,WHILE,WHITE
BACKGROUND,CONCLUSION,END,LABEL,METHODS,OBJECTIVE,PRESS,PROGRAM,PUBLISHED,RESULTS,UNIVERSITY,USING
169,BACKGROUND,CONCLUSION,END,INSTITUTE,JANUARY,LABEL,METHODS,PRESS,PROGRAM,PUBLISHED,RESULTS,SES,SLT,UNIVERSITY
001,003,025,171,188,LMR
EMT,FRIZZLED2,FYN,STAT3,WNT,WNT5A
001,CONCLUSION,DLP,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,PRECISION,PROCEDURE,RESULTS,ROBOT
001,007,010,050,102,116,372,BACKGROUND,COX,EASTERN,GROUP,HOWEVER,ICU,INTENSIVE,JANUARY,LABEL,METHODS,RESULTS,SEVERANCE,SIXTY,UNIVERSITY
001,005,011,015,028,ANXIETY,AUC,CHANGES,CHRONIC,CONCLUSION,DEPRESSION,DISEASE,FORTY,FVC,IMT,LABEL,MATERIALS,METHODS,NRS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,SCALE,SEVENTY,THESE
116,169,945,946,GRP94,H1975,HSP90,NCI,NVP,TAS,TRAP1
001,002,003,004,006,008,177,BACKGROUND,ELISA,HOWEVER,LABEL,METHODS,NSCLC,OPN,PRE,RESULTS,SIXTY
169,172,AKT,EMT,EPITHELIAL,FINALLY,HOWEVER,JAM,JUNCTIONAL,NPC,PRESS,PUBLISHED,TAKEN,THESE,UNIVERSITY
002,169,407,494,AFRICAN,AMERICANS,COMMUNITY,PRESS,PREVIOUSLY,PUBLISHED,THESE,UNIVERSITY
100,169,1RA,242,IGFBP,NSCLC,THESE,URINE
NON,THERE
100,JANUARY,TRANSIENT
000,500,ADVERSE,GRADE,MEIER,PFS
088,099,170,187,226,229,455,515,904,CHINESE,MET,N375S,PCR,PFS,SNP
001,002,004,005,006,008,015,242,484,BACKGROUND,CONCLUSION,DESPITE,GENERALLY,LABEL,METHODS,OCTOBER,RESULTS,TRAINED
22G,BACKGROUND,FURTHER,LABEL,MALIGNANCY,METHODS,NON,RESULTS,SEVEN,THERE
281,STUDIES,SWEDISH
CONCLUSION,CUMULATIVE,IMAGING,LABEL,OBJECTIVE
PROTONS
CURRENT,NSCLC,RADIATION
215
128,292,ACTIVATION,AUC,GEO,ONCOFINDER,PAS,PATHWAY,SIGNALING,THESE
177,185,212,BACKGROUND,CHEST,FORTY,LABEL,LATISSIMUS,METHODS,OPERATIVE,RESULTS
120,132,AFTER,GRADE,III,METHODS,RESULTS,SINCE,THEREFORE
169,BACKGROUND,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,SAMNETWEB,SUMMARY,THESE,THROUGH,UNIVERSITY
169,ACIDS,CHROMATIN,DISRUPTION,EHF,ETS,NUCLEIC,PRESS,PUBLISHED,THESE,UNIVERSITY
169,946,AKT,FUNCTIONAL,III,NSCLC,OVERALL,TUBB3,TUBULIN
169,AUTHORS,KNOCKDOWN,LTD,NSCLC,PTY,PUBLISHING,SCIENCE,TMPRSS4,WILEY
177,957,968,978,AGREEMENT,BACKGROUND,BLAND,CONCLUSION,ICC,INTERSCAN,IQR,KEY,LABEL,METHODS,RATIONALE,RESULTS,SSN,VOLUMETRIC,WHITNEY
001,084,112,152,169,177,184,194,359,403,665,BECAUSE,BETWEEN,LABEL,LNR,METHODS,MULTIMODAL,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RATIO,RESULTS,SURGERY,UNIVERSITY
AKT,BACKGROUND,CUL4A,EXPRESSION,LABEL,METHODS,MTT,NSCLC,PCR,RESULTS,WESTERN
001,003,037,057,110,132,169,ANY,CENTRAL,CNS,COPYRIGHT,COX,FACTORS,FIFTEEN,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,SRS
ALK,CRIZOTINIB,MET,OPTIMIZING,PROFILE,WHILE,XALKORI
134,946,BACKGROUND,CARCINOID,CONCLUSION,EMT,EPITHELIAL,FOXC2,LABEL,LCNEC,METHODS,PULMONARY,RESULTS,SNAIL,TRANSITION,TWIST,TYPICAL
001,002,006,017,157,COX,HOWEVER,MEIER,NSCLC,PCR,PPM1D
370,624,BETWEEN,CENTRAL,THERE,TPN,TREATMENTS
AFTER,ANFIS,CYBERKNIFE,FINAL,SYNCHRONY
945,CHRONIC,FLICE,GOVERNMENT,KNOCKDOWN,PASSAGE,PRESS,PUBLISHED,SOCIETY,SWCNT,TNF,TOXICOLOGY,UNIVERSITY,WHOLE
169,344,6TH,797,7TH,ABOUT,BACKGROUND,COLLECTION,COMMITTEE,END,IIA,JOINT,LABEL,METHODS,OVERALL,PROGRAM,RESULTS,SOCIETY,STAGE,TNM,VERSION
SHMT1,SHMT2,WHILE
177,CD4,NCI,PBMCS,PNS
204,AKT,BACKGROUND,BP1,CHEMOTAXIS,FINALLY,INCREASED,KNOCKDOWN,LABEL,LUCIFERASE,METHODS,NSCLC,NUAK1,PCR,RESULTS,SCRATCH,THERE,UTR,WESTERN
956,III,TAKEN
300,600,MONTEVIDEO,THESE,URUGUAY
945,BACKGROUND,BASED,HMB,LABEL,LAM,METHODS,RESULTS,TSC,WESTERN,WHEREAS
169,490,705,METASTATIC,PRESS,PUBLISHED,SILENCING,STAT3,TAKEN,TYR,UNIVERSITY
10A,169,231,HOWEVER,MCF,MDA,NAD,SEVERAL,SIRT1,SRT1720
000,169,COPYRIGHT,CTM,GEOMETRIC,HOWEVER,SEVERAL,SINGLET,SOCIETY,THESE,THROMBOTIC,VTE
169,ALDH1A1,CAV,CD133,COPYRIGHT,CSC,RAPID,SOCIETY,THESE
169,BACKGROUND,CONTACT,DEG,LABEL,METHODS,MOTIVATION,NMF,PRESS,PUBLISHED,RESULTS,TREMENDOUS,UNIVERSITY
169,ATLAS,BINDING,BIOLOGY,INC,MOLECULAR,MUTATIONS,SCCRO,SOCIETY,UBA
119,149,169,189,192,196,370,945,946,ACH,ACTIVATION,ARG,BIOLOGY,CONUS,CYS,INC,MOLECULAR,PHE,SER,SOCIETY,TRP,TYR
169,181,344,ADVERSE,BACKGROUND,EXPOSURES,INSTITUTE,LABEL,METHODS,MTD,RESULTS,SOCIETY,THERE
001,004,005,008,009,B4W,BACKGROUND,BLOOD,GEFITINIB,LABEL,METHODS,NSCLC,PCR,PFS,RESULTS
001,119,127,281,AMONG,BACKGROUND,CONCLUSION,FURTHER,KOREA,LABEL,METHODS,NSCLC,RESULTS
100,ALONG,HOWEVER,MRI
LABEL,METHODS,OBJECTIVE,PET,RESULTS,STATIONARY,TBR
177,CONCLUSION,DISCUSSION,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS,VOLUMETRIC
160,CHINA,HEAVY,HOWEVER,POISSON,RESULTS
200
169,BACKGROUND,COMMITTEE,CONCLUSION,END,FT4,JOINT,LABEL,METHODS,PRESS,RESULTS,SERUM,TSH
225,ANTIBIOTIC,APRIL,CDI,CONVERSELY,CURIOUSLY,HOWEVER,INPATIENT,JANUARY,LABEL,LATER,METHODS,OBJECTIVE,OCTUBRE,PURPOSE,RESULTS,UNIVERSITY
231,IGF1R,MDA,MET,METASTASIS,TCM
946,BACKGROUND,CAUCASIANS,CIS,HOWEVER,LABEL,METHODS,NSCLC,ORS,OVERALL,RESULTS,SUMMARY
EARLY,METASTATIC
001,012,072,086,BACKGROUND,CRT,JANUARY,LABEL,METHODS,NEITHER,OTHERWISE,PRECISE,RECURRENCE,RESULTS
001,004,024,927,AFTER,BACKGROUND,BLACK,FINALLY,LABEL,METHODS,RESULTS,THESE,WHITE
946,EMT,PCC,SMAD3,TAKEN,TGF
001,013,016,121,AGE,BACKGROUND,CD4,CHEST,CROSS,HIV,LABEL,METHODS,OVERALL,PITTSBURGH,RESULTS,UNIVERSITY
AFRICAN,ALA,CAP,FURTHER,LNCAP,R1881,T877A
ACRYLAMIDE,GATEKEEPER,H1975,L858R,MICHAEL,NSCLC,SW620,T790M,THESE
946,AMS,ATP,CONVERSELY,FURTHER,LIPID
945,946,BROAD,THERE
AIM,BACKGROUND,CEACAM6,CONCLUSION,HOWEVER,IHC,LABEL,MEIER,METHODS,RESULTS
100,109,148,AMONG,BACKGROUND,CONCLUSION,DFI,DISCUSSION,LABEL,PROGNOSTIC,RESECTIONS,RESULTS
179,INDUSTRIAL,INSURANCE,LAW
ADP,BCL,MCL,MG132,PCR
NOR,TNM
HOWEVER,NUCLEASES
015,150,189,1A1,AUC,BACKGROUND,BLOOD,CYP,ERLOTINIB,KOREA,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
356,ALK,BACKGROUND,CHINESE,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,STUDIES,TKI
005,1FX,CTV,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN
110,177,AVERAGE,DOSIMETRIC,GREATER,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,ROTATIONAL,V95
API,CONTOUR,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SYSTEMS,THESE,TPS,XML

PLA,PLG
001,005,169,343,446,897,D140E,E139D,INC,SNV,THERE,WILEY
160,284,AMONG,BACKGROUND,BETWEEN,CONCLUSION,FOLFIRINOX,III,JANUARY,LABEL,METHODS,RADICAL,RESECTION,RESULTS
161,945,946,BACKGROUND,DOX,DRZ,DSB,LABEL,METHODS,RESULTS,TAKEN,TOP2A,TOP2B
169,AUTOPSY,FORTY,LABEL,LTD,MAY,METHODS,OBJECTIVE,RESULTS,UNUSUAL,WILEY
001,047,086,178,314,324,330,356,AMONG,BACKGROUND,HOWEVER,JANUARY,LABEL,METHODS,OCTOBER,RESULTS
005,100,169,225,AMONG,BACKGROUND,CONCLUSION,FDG,FOUNDATION,FOV,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SMM,TORSO
001,007,015,044,135,239,AMONG,BACKGROUND,CONCLUSION,DETECTION,DHPLC,LABEL,MATERIALS,MET,METHODS,NSCLC,PCR,PFS,RESULTS,T790M,TKI
016,021,024,028,029,031,035,042,046,048,412,GENOTYPES,RS16904853,RS2929946,WISP1
ABCC1,ABCC4,ERCC2,FOLH1,LC6,LU130,PRSS3,SHMT1,TGI,TK1,TST,TXN
ATLAS,FINALLY,INTEGRATED,MUTATIONS,RADIA
001,375,CIS,HRS,LABEL,LIBRARY,MAY,METHODS,NSCLC,OBJECTIVE,RESULTS,STUDIES
169,DISRUPTION,ECM,MMP,MT1,ORAI1,SRC,STIM1,SUN
AMP,MMP,TAKEN,THEREFORE
106,169,387,946,BRITAIN,COPYRIGHT,GREAT,IRELAND,LTD,NSCLC,P53,PUBLISHED,SOCIETY,WILEY,WNT
MOLECULAR,NSCLC
BCL,BH3,BIM,NON,NSCLC,THEREFORE
CONSISTENT,STUDIES
113,177,BACKGROUND,COLLECTED,HOWEVER,III,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,STUDIES,THERE
001,040,050,AFB,BACKGROUND,DISEASE,HGD,LABEL,LGD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILARLY,YUV
001,004,005,014,017,032,048,604,BACKGROUND,FIB,FIFTY,HEBEI,III,INR,JANUARY,LABEL,MEDICAL,METHODS,NON,NSCLC,OBJECTIVE,PLT,PROLONGED,PTA,RESULTS,TNM,UNIVERSITY
100,946,ADD,AFTER,ALTERATION,BACKGROUND,CASPASE,CCK,FCM,LABEL,METHODS,NSCLC,OBJECTIVE,P53,PCR,RESULTS,WESTERN
AFTER,BACKGROUND,H1975,HSP90,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,TKI,WESTERN
ADM,BACKGROUND,DDP,FIRSTLY,H69,H69AR,LABEL,MDR,MEANWHILE,METHODS,OBJECTIVE,PCR,QRT,RESULTS,SPHK1,WESTERN
248,984,AMONG,BACKGROUND,CDE,CHILDHOOD,CROSS,GENERALLY,LABEL,LOG,LOW,METHODS,MTE,NDE,NIE,PARAMED,RESULTS,RRS,STATA,THESE,TROMS
169,462,501,539,963,AFTER,AUTHORS,COX,DIETARY,FURTHER,HORDALAND,INC,PAR,PLP,PUBLISHED,PYRIDOXAL,WILEY
169,AGC,CALCIUM,EGF,EGFRS,FINALLY,JANUS,L858R,MUTATIONS,PXD001101,SILAC,STE,T790M,TKI,TOP,VCH,WILEY
AFTER,BETWEEN,CHRONIC,CONSENSUS,ELDERLY,FURTHER,GROUP,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,CHOMP,VCH,WILEY

100,200,MRC,OVERALL,TAXOL,THEIR
160,MPM
169,181,AMONG,RRS
III,MEN,REGARDLESS
109,231,AHR,HSP70,MDA,NOTABLY,TAKEN
169,947,948,956,ALT,AST,BOLUS,CD8,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
APC,BLACK,HOWEVER,THESE
HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
ACTIVATION,BAK,BAX,BID,CASPASE,CYT
FURTHER
001,169,222,344,AMONG,ATTENDING,BACKGROUND,BASEL,CONCLUSION,DIAGNOSING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,TBNAS,THESE
169,BASEL,TAKEN,THESE,USING,VBN,VIRTUAL
169,204,260,464,BACKGROUND,BASEL,CONCLUSION,H23,IGF,IGF2R,INSULIN,LABEL,MEANWHILE,METHODS,NCI,NON,NOTABLY,NSCLC,RESULTS
169,945,BACKGROUND,BASEL,CXC,CXCR4,INFLIXIMAB,LABEL,METHODS,RESULTS,RHO,THESE,TNF
100,104,175,239,386,526,ADVENTIST,AFRICAN,AMERICANS,AMONG,BLACK,BMI,COLORECTAL,COMMUNITY,COX,HRS,NIH,OBESITY,OVARIAN,PREVENTION,SCREENING,TRIAL,WOMEN
169,BASEL,PROBE
946,AMONG,ARRB1,CHALLENGE,GPCRS,KIT,NSCLC,SCF,SET,THESE
CURRENTLY,ERK,FURTHER,H1299,HOWEVER,MIG,NON,NSCLC,THERE,THESE
032,107,177,HOWEVER,MTT,NSCLC,PCR,WESTERN
CHEST,IHC,PULMONARY
CSF,DESCENDING,FURTHER,HOWEVER,WHILE
044,HOWEVER,IHC,MEANWHILE,NKP30,NSCLC,SIMILARLY,THREE
BACKGROUND,INCREASED,INCREASING,LABEL,METHODS,MTT,NON,NSCLC,PCR,RESULTS
001,004,029,033,080,090,AGE,APRIL,CEA,LYMPH,MAY,PFS,PULMONARY,TNM
025,267,494,913,BACKGROUND,COX,JANUARY,LABEL,LDH,METHODS,PARP1,RESULTS,SMALL
002,045,157,294,427,DFS,HRS,IGF1R,MEDLINE,NSCLC,ORS,OVERALL
AXL,EMT,MTT,NSCLC,THOSE,TKI,WESTERN
001,013,015,124,MEIER,NON,NSCLC,SEX,SOX,SRY
ABDOMINAL,AMENORRHEA,ENDOSCOPIC,PNETS
CHINA,DESPITE,EARLY,HOWEVER,PANCREATIC,PET,SURGERY
130,160,ABOUT,ACCORDING,AUTHORS,BACKGROUND,BASICALLY,CENTRAL,CETUXIMAB,CIS,COLLECTION,CONTROLLED,EASTERN,GROUP,HRS,ISSUE,LABEL,LIBRARY,MANAGER,MEDICAL,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,RRS,SELECTION,SOCIETY,THERE,WORLD
200,HOWEVER,THORACO

PULMONARY,THESE
046,557,587,AFFILIATED,APRIL,FUDAN,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,RESULTS,TKI,UNIVERSITY,ZHONGSHAN
001,004,005,012,178,185,200,215,250,290,422,645,ACCORDING,CHINESE,COX,GENERAL,GUANGDONG,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,ORR,PFS,RESULTS,SEPTEMBER,TKI
038,114,181,313,677,AMONG,CEA,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
001,014,022,030,036,167,170,181,344,357,444,578,622,840,903,BETWEEN,CEA,CHEST,CLOSE,CYFRA21,DCR,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RESULTS,SEPTEMBER,THOSE,TKI,UNIVARIATE
169,INC,LYMPHATIC,WHILE,WILEY
951,C1B,NSCLC,PKC,PROTEIN
150,BACKGROUND,BEV,LABEL,METHODS,PHLNM,RECURRENCE
TEN,TOXIC
350,397,500,CHINESE,CONCLUSION,MAF,METHODS,NSCLC,PHACTR2,RESULTS
102,141,169,DUE,PRESS,PUBLISHED,STUDIES,SURGERY,UNIVERSITY
BALTOMA,BMJ,GROUP,LTD,MALTOMA,PUBLISHING
169,ANTICANCER,COPYRIGHT,HOWEVER,INSTITUTE,NSCLC,OVERALL,VARIOUS
000,100,169,4T1,8430506,956,COMBINING,FASEB,HEPG2,KI16425,KNOCKDOWN,LPA,ONO
HOWEVER,PARTNER,PCR,WESTERN
169,947,GROUP,HEP3B,NPS,OVERALL,PRESS,PUBLISHED,ROS,SOCIETY,TOXICOLOGY,UNIVERSITY
102ND,169,ALECTINIB,ALK,LABORATORY,PHASE,PRESS,PUBLISHED,STAGE,THERE,UNIVERSITY
BMJ,FORMULA,FURTHER,GROUP,LIMITED,MEDLINE,OUTCOME,PAH,POLYCYCLIC,POPULATION,PUBLISHED,PUBLISHING,WHILE
ASK,THERE
ALTOGETHER,EFIRM,ELM,GAPDH,GFP,THESE
000,226,578,859,885,NEUCH,REGISTRIES,SHN,SWISS,THESE
EGF,NON,NSCLC
143,946,AZA,CATENIN,NSCLC,PCR,SPC,SUBSEQUENT,TNM,WNT,WNT3A
00027,215,650,BACKGROUND,CCP,COX,LABEL,METHODS,RESULTS,USING
176,BACKGROUND,INCREASING,LABEL,METHODS
ACADEMY,COMMITTEE,FACTORS,GROUP,IASLC,ITMIG,LYMPH,MALIGNANCY,PROGNOSTIC,SOCIETY,STAGING,SURGERY
105,808,8TH,COMMITTEE,CONTROL,DESPITE,GROUP,JOINT,STAGING,UNION
8TH,GROUP,TNM
ANNEXIN,BACKGROUND,CONCLUSION,LABEL,MATERIALS,MES,METHODS,MTT,OPUNTIA,P53,RESULTS,WESTERN
BMJ,CARCINOMA,GROUP,LTD,METASTASES,PLEURAL,PUBLISHING
141,222,CSF,FIFTY,FOXL1,POU,SP1,THESE
001,078,161,594,CTX,FURTHER,GCT,IPFSG,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SALVAGE
DESPITE,HDAC4,NOTABLY,STAT1,THESE,TSA
180,BLOOMBERG,EPIDEMIOL,GOVERNMENT,HOPKINS,JOHNS,METRICS,PRESS,PUBLISHED,ROTHMAN,UNIVERSITY,USING
169,181,BLOOMBERG,ESTIMATES,HOPKINS,HOWEVER,JOHNS,PRESS,PREVENTION,PUBLISHED,UNIVERSITY
ASPIRATION,ESOPHAGEAL,ULTRASOUND
AFTER,EBV,EPSTEIN,MMP,PAH,PTSMT,THESE,USING
470,AFTER,ASSAY,CFI,CHINESE,COMPLEMENT,GENOTYPING,HAPLOVIEW,MASSARRAY,NSCLC,ORS,THERE,TOTALLY
33342,945,946,954,AKT,BCL,CHANGES,DDP,FAK,FAS,FINALLY,HOECHST,HUVEC,MRP,MTS,VBMDM
169,ALK,COPYRIGHT,FGFR3,MEK,SCIENCE,SRC
102,109,242,385J1,586,AMONG,HOWEVER,NSCLC,SEVERAL,USING
AUSTRALIA,CHEST,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROYAL,SOUTH,SUPPORT
169,16HBE,AUTHORS,BCI,ERK,MEK,NS1,RAS
003,032,033,044,046,DFS,III,INCREASING,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OVERALL,OVERSIZED,PURPOSE,RESULTS,RFA,SEX,TREATMENT
EXPRESSION,FOLLOWING,GFP,HOS,NIS,SJSA1,VIRAL
169,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
123,954,960,ABCA2,ABCA5,AKT,ATP,CHINA,DDP,ERK,HOWEVER,MDR,MULTIDRUG,STAT5
A20,ALK,H21,H28,H30,HOWEVER,HUNTINGTIN,NSCLC
001,165,927,ALK,BACKGROUND,BETWEEN,LABEL,METHODS,NSCLC,RESULTS,SPAIN,SPANISH
AMR,BACKGROUND,CBDCA,FURTHER,LABEL,METHODS,OCTOBER,ORR,RESULTS,THERE
COMMITTEE,IASLC,PATHOLOGY,SOCIETY,WORLD
000,100,185,400,465,679,APRIL,AUTHORS,BACKGROUND,COLLECTION,EXCELLENCE,FDG,HSROC,INSTITUTE,LABEL,LIBRARY,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OTHER,PET,PREMEDLINE,RESULTS,ROC,SELECTION,THERE,UNDER
163,193,266,283,549,CHINA,MIXED,PAH,THESE,XUANWEI
035,103,AMONG,BACKGROUND,LABEL,METHODS,RESULTS
001,002,004,013,BPM,CCR,DPM,MCM,PCI,PERITONEAL,SOLID,THERE,TPM
215,ADENOSINE,FE3O4,RAMAN,THROUGH
001,019,705,805,AMONG,AUC,BACKGROUND,COX,FURTHER,GLASGOW,GPS,HOWEVER,LABEL,METHODS,NLR,NPC,PLR,PROGNOSTIC,RESULTS,SCORE,SEVERAL
ADC,AMONG,BACKGROUND,BASED,COX,DFS,FDG,HOWEVER,LABEL,METHODS,PET,RESULTS,SQC
001,002,004,017,029,100,169,380,437,ALK,MSI,SIMILARLY,TIL
181,HOECHST,HOWEVER,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,TYPICAL,VAD
160,ADR,AFTER,BACKGROUND,DDP,DIA,IFO,LABEL,MEIER,METHODS,MTX,RESULTS
BMJ,FDG,FINALLY,GROUP,LTD,OWING,PET,PUBLISHING,THREE
65292,65310,946,AFTER,INF,SIX,UNDER
GASTRIC,RCC
169,BECAUSE,BIOLOGY,ERBB4,INC,MOLECULAR,SOCIETY,TAKEN,UTR
000,002,177,CONCLUSION,GTV,LABEL,MATERIALS,METHODS,MIP,OBJECTIVE,OBJECTIVES,RESULTS,SPL,THERE
100,ACUTE,BASED,CLINICALLY,PROGNOSIS
AFTER,CHEST,EPSTEIN,FDG,PET,S10

CHEST
AKT,BAX,BCL,CAV,DENDROBIUM,ERK,GTP,MCL,RAC,RESISTANCE,RHO,TAKEN,WESTERN
183,956,GSH,HOWEVER,NAC,ROS,TRX
954,HOWEVER,LARGE,LATS2,NSCLC,TAKEN
640,915,ASIAN,CIS,CRUDE,GROWING,ORS,SEPTEMBER,STATA
231,4T1,MDA,SUBSEQUENT
231,4T1,AKT,BACKGROUND,EGF,ERK,FINALLY,LABEL,LUC,MDA,METHODS,MLC,PIV,RESULTS,WESTERN
95D,CCNG2,DEPLETION,ECM,MICROARRAY,NUPR1,PCR,THESE,TIMMDC1,TIMP3
EMT,ENA,HOWEVER,REVERSE
BACKGROUND,CLINICIANS,EARLY,LABEL,METHODS,RESULTS,THESE
100,169,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PAX,RESULTS,SOCIETY,SP1,SPT24,TTF,USING
169,199A2,945,BINDING,BIOLOGY,ENDOTHELIN,HIF,HOWEVER,INC,MOLECULAR,SCD,SOCIETY,UTR
132,169,ALR,AUTHORS,BREFELDIN,CONNEXINS,FOUNDATION,H1299,HOWEVER,JOURNAL,KNOCKDOWN,LC3,LTD,MOLECULAR,TAKEN,UNDER,UPS,WILEY
169,737,ABT,AUTHORS,FOUNDATION,H1299,JOURNAL,LTD,MOLECULAR,REGULAR,WILEY
200,247,CONCLUSION,GSTM1,GSTP1,GSTT1,ILE462VAL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,PORTUGUESE,RESULTS,TOBACCO
051,053,162,164,608,612,749,750,BACKGROUND,C30,CARLO,CONCLUSION,EORTC,LABEL,METHODS,MONTE,QLQ,QUADRATIC,QUALITY,RESULTS,TOBIT,TOPICAL,YEARS
106,169,CAF,EPIDERMAL,ERK,LABEL,METHODS,NSCLC,OBJECTIVE,PODOPLANIN,PURPOSE,RESULTS,TKI
001,028,169,ACTIVATION,HIPPO,III,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,STRATIFIED
BACKGROUND,BASED,CONCLUSION,HOWEVER,LABEL,METHODS,THESE,THREE,THYROID
CURRENTLY,NON,NSCLC,USING
ABL,BCR,CML,HLA,LINEAGE,PRS,SCT,TKI
III,PHASE,STUDIES
001,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OLDER,RATIONALE,RESULTS
154,892,957,HOWEVER,LNA
AKT,APS,ASTRAGALUS,BACKGROUND,C57BL,HOWEVER,LABEL,METHODS,RESULTS,ROS,THESE,TREATMENT,TUNEL,WESTERN
PROBIOTICS,SPECIES,WORLD
001,170,232,442,469,984,999,AFTER,AMERICA,BACKGROUND,CASES,EST,FOLLOWING,LABEL,LATIN,METHODS,OBJECTIVE,RESIDENTS,RESULTS,SES,SITES,THERE
169,BENEFIT,GEP,IDEAL,INTRA,NET,SOCIETY,TAE,THESE
169,179,386,552,967,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THESE
169,276,ADS,CONCLUSION,DISCREPANT,GENOMIC,LABEL,LASER,METHODS,MULTIFOCAL,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SQCCS,USING
001,003,004,018,043,047,169,170,223,637,759,802,880,AMRUBICIN,CONCLUSION,GRADE,III,LABEL,METHODS,OBJECTIVE,ORR,PFS,PRIMARY,PURPOSE,RESULTS,SOCIETY
16S,181,946,ATCC204508,ENDOPHYTIC,FDC83,INDOLES,KOCURIA,LGMB259,PC3,R5A,VINYL
954,C57BL,CHINESE,EUPATORIUM,FURTHER,HOWEVER,HUVEC,JNK,MMP,TAKEN,WEF
H2052,H2452,H28,MPM,PDT,PEMETREXED,WST
100,160,267,ACTUARIAL,AMONG,D95,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OVERALL,PTV,PURPOSE,RESULTS,SIX,T1A,T1B,THERE,TREATMENT
100,H23,MMP,NCI,NKG2DLS,PREVIOUSLY
ADDITIONAL,FDA,HODGKIN,MPDL3280A
007,ASIAN,CHINA,CHINESE,COX,FGFR1,III,JAPAN
26S,947,FURTHER,MG132,R175H,THESE
126,128,15A,210,34A,EXPRESSION,HOWEVER,NSCLC,PCR,SAMPLES,SCC,TNM
169,HOWEVER
945,947,CD62L,CROSS,CXCR3,CXCR4,IFN,MCP,MIP,OX40L
120,212,765,942,ASIAN,BACKGROUND,BIM,CONCLUSION,HOMOZYGOTE,HOWEVER,LABEL,METHODS,RESULTS
100,AUC,BACKGROUND,BASED,HOWEVER,III,LABEL,MARCH,METHODS,MOLECULAR,OCTOBER,PFS,RESULTS,SEVENTY,TREATMENT
BACKGROUND,CCDC6,CONCLUSION,HCC78,LABEL,METHODS,NSCLC,RESULTS,RET,SLC34A2
790,946,BACKGROUND,CATENIN,CONCLUSION,LABEL,METHODS,NSCLC,RESULTS,T790M,TKI,WNT
001,003,022,033,113,247,320,825,FINALLY,HOWEVER,MEIER,NSCLC,PCR,STMN1,TNM
100,319,986,AMP,ARHGEF2,CHTOP,CREB5,FGFR2,MSN,NTRK1,PCR,PPL,RET,RUFY2,TRIM4,VALIDATION,VAMP2
402,BACKGROUND,CHEST,COX,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PLEURAL,RATIONALE,RESULTS
CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
119,266,648,BACKGROUND,CHEST,CME,CONCLUSION,CONTINUING,EARLY,EDUCATION,GPS,LABEL,MEDICAL,METHODS,RESULTS,THERE,TRIAL,WHETHER
BACKGROUND,LABEL,MCC,METHODS,RESULTS,USING
945,949,MCF,NAD,SAR,SIRT2,SIRTS
790,ACTIVATING,DUE,HTS,L858R,T790M
111,BACKGROUND,FURTHER,GRADE,HOWEVER,IPN,LABEL,METHODS,RESULTS,T1A,T1B,T2A
007,106,406,534,IQR,MEIER,MEM,THERE
169,INC,MEK,RAS,SMYD3,THESE,WILEY
002,125,BACKGROUND,BCS,LABEL,METHODS,OWING,RESULTS,THEREFORE
169,CASPASE,FINALLY,H1975,HISTONE,HOWEVER,T790M,TKI,WHILE
169,COPENHAGEN,DENMARK,DEPARTMENT,DESPITE,FOLLOWING,LABEL,METHODS,OBJECTIVE,OUTCOME,PURPOSE,RELEVANCE,RESULTS,SURGERY,UNIVERSITY
2ND,3RD,EPIDERMAL,MET,NSCLC,TKI
ALK,HGF,HOWEVER,MET,THERE,THESE
A2780,AKT,CONCLUSION,EPHA1,ERBB4,ERK,ERLOTINIB,FGF,JM118,JM216,LABEL,RAS,STAT3,UNLABELLED,VEGFR
ALK,AREAS,BACKGROUND,CERITINIB,CONTINUED,COVERED,CRIZOTINIB,III,LABEL,METHODS,NSCLC,OPINION,PHASE,SEVERAL,TKI,TREATMENT
INTRAVITAL,KIF22,KIF2C,NOTCH,SRF,SUBSEQUENT
ANGIOMOTIN,CL1,CYR61,FURTHER,HOWEVER,KNOCKDOWN,LEWIS,PDZ,RESULTS,TAZ,THESE,YAP,YES
637,BACKGROUND,DESPITE,IPF,LABEL,METHODS,RESULTS
FAILURE,FINALLY,LCS,RCT,SCREENING,TRIAL
947,948,CYTOTOXIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
946,BACKGROUND,CONCLUSION,EMT,EPITHELIAL,GC7,H1299,LABEL,METHODS,NCI,NSCLC,RESULTS,TGF
160,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,231,549,945,956,BHA,FURTHER,MTT
956,AGS,DUE,GASTRIC,HOWEVER,LC3,THESE,WESTERN
169,556,ACTUARIAL,BRCA1,END,PRESS,PUBLISHED,RESULTS,TEN,UNIVERSITY
BACKGROUND,CRIZOTINIB,CYFRA21,INCREASES,LABEL,METHODS
120,177,472,AFTER,AIM,AMONG,BACKGROUND,COMPARISON,CRM,DFS,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS
CELLS,CONCLUSION,H1299,HEP3B,INHIBITION,LABEL,MATERIALS,MCF,METHODS,MGC,NCI,OBJECTIVE,PURPOSE,RESULTS,TAXOL
014,120,258,531,AFTER,BACKGROUND,CRD,EMG,FURTHER,IIM,ILD,LABEL,METHODS,OBJECTIVE,RESULTS
077,112,169,C000000146,COMMITTEE,CTR,ELDERLY,FURTHER,LABEL,METHODS,MONITORING,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIXTY,UNIVERSITY
169,200,AFTER,CAR,CD4,CD8,COPYRIGHT,SCIENCE
BMJ,GROUP,INCREASING,LIMITED,PUBLISHED,PUBLISHING
114,187,196,BMJ,COLON,GROUP,ION,LABEL,LIMITED,METHODS,NGS,OBJECTIVE,PANEL,PUBLISHED,PUBLISHING,RAS,RESULTS,TAT,TORRENT
169,217,385,536,552,573,ACIDS,H3K27AC,H3K4ME1,H3K4ME3,NUCLEIC,PRESS,PUBLISHED,SEQ,UNIVERSITY
169,322,ACIDS,DBTSS,NUCLEIC,PRESS,PUBLISHED,RELEASE,SINCE,SNV,TSS,UNIVERSITY
169,947,ACIDS,ADP,BER,NUCLEIC,PARP1,PARYLATED,POL,PRESS,PUBLISHED,UNIVERSITY
375,PULMONARY,RITUXIMAB,THERE,TREATMENT
2PATIENTS,AIM,LABEL,METHODS,OBJECTIVE,QUALITY,RESULTS,UNIVERSITY,WASHINGTON
169,ALK,BACKGROUND,BASEL,LABEL,LIBRARY,METHODS,MOLECULAR,NEITHER,OBJECTIVE,OBJECTIVES,OBTAINING,RATIONALE,RESULTS,REVIEWS,SYSTEMATIC,THERE
036,169,245,271,298,307,407,453,507,672,699,870,897,BACKGROUND,COLORECTAL,DESPITE,INCIDENCE,INPATIENT,LABEL,METHODS,NATIONWIDE,RESULTS,SOCIETY
032,132,140,169,180,BACKGROUND,LABEL,METHODS,NSCLC,OCTOBER,PFS,RESULTS,SOCIETY,TREATMENT
169,A2A,A2ARS,ADORA2A,CD8,DCS,DEPLETION,LEWIS,LYSMCRE,MDSCS,MHCII,MYELOID,OVERALL,REDUCED
169,183,DUE,GEORG,GRAFT,LOCAL,MAJOR,NSCLC,RADICAL,STUTTGART,SVC
024,036,094,691,709,726,775,892,910,945,988,COX,FURTHER,MEIER,NSCLC,ROC
CD105,CD106,HBMMSCS,LIPID,MYOD1,P10,P25,P57
096,149,157,169,217,254,IQR,LABEL,LEPIDIC,LOCAL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THESE,UNIVERSITY
169,CD147,CHINA,METUZUMAB,NCI,NSCLC,SPRAGUE,THESE
169,5ENVE,BRAIN,FINALLY,TREATMENT
222,338,577,597,615,696,944,FURTHER,HISEQ,MICRORNAS,NSCLC,SEQ,SINCE,TARGETS,THERE
014,048,099,137,214,299,335,914,BACKGROUND,EPIDERMAL,GENOMIC,LABEL,METHODS,NSCLC,RESULTS
BACKGROUND,LABEL,METHODS,MULTILEVEL,RESULTS,SWEDISH,THERE
001,020,157,1YEAR,BACKGROUND,GR2,GR3,ILD,LABEL,METHODS,PRE,RESULTS
NUR77,TR3
ALZHEIMER,LIPIDOMICS
160,BACKGROUND,IMPLANT,LABEL,METHODS,OVERALL,RESULTS
169,188,368,854,AUSTRIA,BASEL,BURKITT,DLBCL,DUE,HODGKIN,PRIMARY,RICHTER
000,072,100,242,286,363,480,554,612,654,725,787,BACKGROUND,DEPARTMENT,DESPITE,EMERGENCY,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,NUMBERS,RESULTS
ERCC1,HOWEVER,ORR,PFS,SCIENCE,THEREFORE,WEB
223,AFTER,AKT,ALK,CHK,FAK,INHIBITION,LYN,METFORMIN,NSCLC,PHOSPHO,REMARKABLY,SAL,SRC,THEREFORE,YES
140,BACKGROUND,CELSIUS,CONCLUSION,ESOPHAGEAL,FIRST,LABEL,METHODS,OVERALL,RESULTS,TECHNIQUE
110,678,LABEL,MAY,MEDICAL,METHODS,MRI,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,TMC,TUFTS
000,500,POLES
AFTER,ASKIN
001,011,023,035,041,043,046,048,104,DFS,DISEASE,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,SUV,WHILE
160,FIFTY,GRADE,III,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE
001,003,006,008,357,375,ALK,CNG,DFS,NSCLC,THERE
156,BACKGROUND,CARCINOID,CTS,LABEL,METHODS,NATIONWIDE,OBJECTIVE,PURPOSE,RESULTS,SPM,THREE
177,300OCCW,3DCRT,5000CGY,6MV,90O,BACKGROUND,HOWEVER,LABEL,MATERIALS,METHODS,OAR,PTV,RESULTS,RPM,TEN,V20GY,V30GY
100,956,CONCLUSION,LABEL,LYS,METHODS,MRI,OBJECTIVE,RESULTS,TEM,UNDER,VSM
BACKGROUND,LABEL,MAA,MATERIALS,METHODS,MTT,PCR,PINX1,RESULTS
003,004,007,008,022,029,036,039,045,177,BACKGROUND,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SPARC,STAGE
634,765,BACKGROUND,BCL,CIS,DFS,FURTHER,HRS,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
BACKGROUND,LABEL,MALIGNANT,MATERIALS,METHODS,RESULTS,UNDER
113,116,17A,17F,469,7488A,BACKGROUND,LABEL,MATERIALS,METHODS,PCR,RESULTS
AFTER,ASSESSMENT,BACKGROUND,CELLS,FBS,FOURIER,HSP90,LABEL,MATERIALS,METHODS,MTT,OTHER,PCR,PEG,RESULTS,THEREFORE
EXPRESSION,GSTA1,MRC,MTT,PCR,RESULTS,SIRNA,THREE,WESTERN
ADVERSE,AFTER,CONTROL,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
160,200,ACCEPTABLE,BACKGROUND,BEZMIALEM,CISPLATIN,DEPARTMENT,FACULTY,GRADE,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,RADIATION,RESULTS,STAGE,TEN,UNIVERSITY,VAKIF
945,946,947,948,AMONG,BASED,DUSP1,ERK,HOWEVER,JNK,JUN,MAP,MEK,MITOGEN,RAF,RAS,SEVERAL,THERE
ACCORDING,CHINA,HOWEVER,PROTEOMICS
CCK,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THEIR
338,ECTOPIC,HOWEVER,NSCLC,RAB14,RAS,THEREFORE,THESE
045,049,176,562,946,967,BACKGROUND,CHI,INCREASING,LABEL,MEIER,METHODS,RESULTS,SMAD2,TGF,THERE,THEREFORE
ALK,HOWEVER,IHC,MET,OTHER,V600E
MEDICAL,RADIOLOGY,SOCIETY,SPANISH,TNM
133,248,916,NSCLC
AFFAIRS,BACKGROUND,COMPARE,COMPOSITE,LABEL,METHODS,OBJECTIVE,RESULTS
ADP,BCL,CHINESE,FORSYTHIA,FSEER,FSFEE,FSLEE,FSREE,JANUS,THESE
129,155,BACKGROUND,EMT,FURTHER,HOWEVER,LABEL,MCRS1,METHODS,MICROARRAY,MIR,NSCLC,PCR,RESULTS,RETROVIRUS,SYSTEMATIC,UTR
001,004,396,AES,CONCLUSION,DCR,ELECTRONIC,FURTHER,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS
100,210,789,BACKGROUND,CONCLUSION,CTC,DESPITE,HENCE,HOWEVER,LABEL,METHODS,PRIMARY,RESULTS
AMONGST,PROSTATIC
200
CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESULTS
416,ADDITIONAL,BACKGROUND,BETWEEN,DESPITE,EXPOSURES,LABEL,METHODS,REGRESSION,RESULTS,UNITS
003,004,014,226,261,268,BACKGROUND,BIOMARKERS,CBQ,DENMARK,LABEL,MEASURE,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RATIONALE,RBM,RESULTS,THERE,TOMOGRAPHY,WESTERN
000,106,186,557,631,709,BACKGROUND,COSTS,HOWEVER,ICERS,INSTITUTE,LABEL,METHODS,QALYS,QUALITY,RESULTS,SCREENING,TRIAL
NOTCH,NSCLC,RHO
AKT,ALK,HOWEVER,MER,NSCLC,STAT6,THESE,TOTAL,TREATMENT
100,AMONG,CANDIDA,PCR
001,120,466,MEIER,NSCLC,ROC,THESE
ARSENIC,AS4S4,CELLS,CHINESE,HEPG2,L02,LEWIS,MKN45,THESE
169,946,HOWEVER,INC,TGF,THEREFORE,WILEY
100,BACKGROUND,CHINA,CHINESE,HABIT,LABEL,METHODS,RESULTS,SMOKING,TOBACCO
100,169,181,288,AFTER,ARSENIC,BLOOMBERG,CHILE,HOPKINS,JOHNS,PRESS,PREVIOUSLY,PUBLISHED,THESE,UNIVERSITY
119,166,177,274,293,341,720,747,946,947,CCL17,CCL20,ELISA,FOXP3,HOWEVER,MPE,PCR,PPE,ROR,TGF,THEIR,TREGS
109,BASED,ECA,HEL,MTT,THESE
822,BACKGROUND,CONCLUSION,HISPANICS,LABEL,METHODS,NSCLC,RESULTS,THERE,THESE,TREATMENT
552,APART,BACKGROUND,CENTRAL,CONCLUSION,COX,DENMARK,DUE,INITIAL,LABEL,METHODS,PATIENT,POPULATION,RESULTS,TREATMENT,WOMEN
176,179,182,200,500,BACKGROUND,BEV,COMMITTEE,DCR,EASTERN,G4PFS,GROUP,JOINT,LABEL,METHODS,NSCLC,ORR,PAC,PEM,PFS,PRONOUNCE,RESULTS,SECONDARY
133,142,196,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LYMPH,MARCH,METHODS,RESULTS,THREE,USING
DENMARK,FINALLY,FURTHER,HOWEVER,PAPER,THESE
CLINICIANS,LABEL,METHODS,PEMETREXED,TTP
945,ERK,FOLLOWING,HOWEVER,NSCLC
231,ELISA,ERK,MDA,MMP,THESE,TRANSWELL,WESTERN
ISOTROPIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOMETIMES,THEIR
177,BAA,HOWEVER,IMAGE,LABEL,METHODS,OBJECTIVE,OPAST,PURPOSE,RESULTS,SAA,THEIR
001,150,DSI,FDG,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PROGRESSOR,PURPOSE,RESULTS,SIXTEEN,SUV
176,CARLO,D95,DVH,HOWEVER,LABEL,METHODS,MONTE,MRI,OBJECTIVE,PURPOSE,RESULTS,SITES,V20
117,CTV,DESPITE,ITV,LABEL,MAO,METHODS,OAR,OBJECTIVE,PHANTOM,PURPOSE,RESULTS,THROUGH,V20,V25,V30,WHILE
142,160,177,179,DSC,INDIVIDUAL,ITV,LABEL,LUCAS,METHODS,MRI,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,THEIR
001,282,803,ARID2,BAF,CATALOGUE,MUTATIONS,PEARSON,SMARCA4,SNF,SOMATIC,SWI,THEREFORE
T2TMETS
AKT,CISPLATIN,H1299,H1975,HOWEVER,NSCLC
001,177,CASES,CONCLUSION,CURRENT,CVD,LABEL,METHODS,OBJECTIVE,RESULTS,SCREENING,TRIAL
100,169,195,720,COLLEGE,ICU,METABOLISM
001,011,177,BACKGROUND,CONTROL,LABEL,METHODS,RESULTS
001,177,380,455,677,718,768,813,927,985,998,AIF,BLAND,CONCLUSION,ICC,ICCMANUAL,KCC,KENDALL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROI,THREE
156,169,BACKGROUND,FNABS,KNOWLEDGE,LABEL,METHODS,RESULTS,SECONDARY,SNTGS,SOCIETY
SOLID,THESE
EFFECTIVE,FORCE,PREVENTIVE,SCREENING,TRIAL
10001,333,HCC,JAPAN,MEDICAL,PUBLISHERS,SCREENING,SEVENTH,SPECIAL,THERE,USA
095,169,224,549,BACKGROUND,COMPONENT,EMOTIONAL,END,HODGKIN,HRQOL,LABEL,MCS,METHODS,PCS,RESULTS,SCALE,SHORT,SOCIETY,SUMMARY,SURVIVORS
EPIGENETIC,HDAC4,HDACS,MEF,MEF2C,THESE,WHETHER
116,CA224,HCT,MTD,NCI,WESTERN
169,AANHPIS,AGE,AMERICANS,APC,ASIAN,BACKGROUND,CHINESE,HAWAIIANS,ISLANDERS,JOINPOINT,LABEL,METHODS,PACIFIC,RESULTS,SCC,THESE
169,584,AMERICANS,BACKGROUND,DHBMA,GSTT1,HAWAIIANS,HOWEVER,LABEL,METHODS,MHBMA,RESULTS,THESE
169,954,BRMS1,COPYRIGHT,EMT,KNOCKDOWN,NSCLC,SOCIETY,THESE,USING
169,CTV,DVH,GYE,IIB,JAPAN,NSCLC,PBT,PLANS,PRESS,PUBLISHED,RADIATION,SOCIETY,TNM,UNIVERSITY,V20,V50
169,745,762,793,855,ADP,AKT,ASP,ATP,BCL,BIM,BIOLOGY,EGF,GLU,H1975,ILQ,INC,L858R,LYS,MET,MOLECULAR,NON,NSCLC,SOCIETY,T790M,TAKEN,TKI,TREATMENT
051,169,445,AIM,ANTICANCER,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EASTERN,GROUP,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,OLDER,PRT,RESULTS,SHORT,UNI
138,169,2ND,376,ANTICANCER,BREAK,CONCLUSION,COPYRIGHT,INDIVIDUAL,INSTITUTE,LABEL,METHODS,RECORDS,RESULTS,UNLABELLED
169,250,956,AIM,ANTICANCER,BACKGROUND,BIS,COMPOUNDS,CONCLUSION,COPYRIGHT,DENDROBIUM,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TEN,THESE
169,956,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE,VPA
169,ACF,ADP,AIM,ANTICANCER,BAX,BCL,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,MTT,NSCLC,RESULTS,THESE,TREATMENT,UNLABELLED
169,ADC,ANGLE,MAGIC,NMR,NOTABLY,NUCLEAR,OTHER,OVERALL,PRESS,PUBLISHED,RESOLUTION,RESONANCE,UNIVERSITY
169,945,946,ARS,CARVEDILOL,EGF,GRK,HOWEVER,JB6
000,169,CROSSROADS,IMMUNOLOGY,METASTATIC
169,NSCLC,PFS
169,EMT,LABEL,LUCAS,MET,SUMMARY,TMPRSS2
169
001,003,008,011,018,019,LINKS,NUTRITION,SURVEYS,THERE,THEREFORE,URINARY
002,ABCB4,ATP,CPG,EPIGENETIC,SILENCING
EBV,EPSTEIN,HLA,NPC
191,ELISA,HOWEVER,LABEL,METHODS,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,USING
HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFA,VIRTUAL
001,ALA,CERTAIN,ESI,HOWEVER,ILE,LEU,VAL
945,ATP,HOWEVER,LIMAPROST
163,COX,ERCC1,NSCLC
00001,024,177,BRAC1,IHC,III,LCT,NSCLC,OCTOBER,SEPTEMBER,STMN1,TNM,TOP2A,TTF,TUBB3
GEFITINIB,NSCLC
119,195,318,796,ADJUSTMENT,CONCLUSION,HISTOLOGY,LABEL,METHODS,OBJECTIVE,RESULTS
215,CY5,DISCOVERY,M13,NOVEL
AFRICAN,BACKGROUND,IIB,LABEL,METASTASES,METHODS,NORTH,SPLENIC
160,ACCORDING,DIPNECH,LCNEC,NET,NSE,WORLD
BASED
174,APRIL,HCC
BACKGROUND,FIFTEEN,HOWEVER,INTENSITY,LABEL,LARGE,LIMITED,METHODS,MLC,MUS,NSCLC,OAR,PTV,RESULTS,SIMULATED,THERE,TOMOGRAPHY,V90,V95,WHILE
007,011,188,7TH,COMMITTEE,DFS,IIA,JANUARY,JOINT,LNR,NSCLC,UNDER
176,ACCORDING,AREAS,BACKGROUND,LABEL,METHODS,RECURRENCE,RESULTS,TUMOURS
956,BAX,BCL,FLAVONOIDS,FURTHER,GYNOSTEMMA,THESE
1990S,DESPITE,RESULTS
G12,H28,IST,MET,NCI,OTHER,REN,SIMILARLY,THESE
192,CPG,LA2,MNU,THESE
446,ESI,LIGULARIA,NCI,NMR

169,AFTER,ANTICANCER,APRIL,BACKGROUND,JAPAN,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,REGARDING,RESULTS,SOCIETY,UNIVERSITY
104,169,AAH,AIS,ALK,AMONG,BACKGROUND,GGN,HOWEVER,INCIDENCE,LABEL,MEDICAL,METHODS,MIA,PRESS,PUBLISHED,PULMONARY,QUADRUPLE,RESULTS,SOCIETY,THREE,UNIVERSITY
169,AKT,CABLES1,CLINICALLY,ECTOPIC,MUTAGENIC,T44
000,177,348,855,917,979,CHANGES,CORRECTED,DETECTION,III,PFS,ROC,THEREFORE
BMJ,C30,COMPLIANCE,EORTC,EUROQOL,GROUP,HOWEVER,HRQOL,LABEL,LIMITED,LUX,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PUBLISHED,PUBLISHING,QLQ,RESULTS,THESE,TREATMENT
215,BACKGROUND,CONCLUSION,HOWEVER,IMAGING,LABEL,LARGE,METHODS,SRI
00001,BACKGROUND,CENTRAL,ENGLISH,JADAD,LABEL,MARCH,MEDLINE,METHODS,PCI,RANDOMIZED,RESULTS,SCIENCE,SMALL,THREE,WEB
169,COPYRIGHT,NETWORK,NSCLC
129,169,BACKGROUND,CHEST,CONCLUSION,ITEMS,LABEL,MATERIALS,METHODS,PREFERRED,PRESS,RADIATION,REPORTING,RESULTS,REVIEWS,SYSTEMATIC
000,110,1980S,1990S,2000S,374,ADDITIONAL,EVERY,EXTENSIVE,MAJOR,REFINED
946,ATP,GSK,H1395,HOWEVER,LDH,NSCLC,ROS,TAKEN
CURRENT,RAS,REDUNDANT
00001,ALK,BACKGROUND,CONCLUSION,EGGER,LABEL,METHODS,NSCLC,RESULTS,SEVENTEEN
177,AFTER,DEPARTMENT,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,UNIVERSITY
HOWEVER,INFANTILE

169,AGING,AMERICA,CCI,DISCUSSION,DUE,INDEX,LABEL,METHODS,NCI,NSHAP,OBJECTIVE,PRESS,PROJECT,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
169,BIOLOGY,CAREFUL,DESPITE,LEUKOCYTE,SOCIETY
CD4,CD8,GATA2,USING
001,055,114,169,181,196,389,408,450,475,505,680,AFTER,AMONG,GIVEN,LAR
145,15A,169,19B,203,294,295,483,615,ADENO,ADV,AFTER,AMONG,CRE,INC,LEWIS,LOX,LSL,MIR,MIRNA,PCR,SCA,UTR,WILEY
231,946,CULTURE,HOWEVER,MDA,PCR,PTHRP,RWGT2,STROMAL,TCF,TGF,THEREFORE,THESE,WHILE,WNT,WNT3A
169,ALTOGETHER,CELASTROL,JNK,NSCLC,THESE
100,160,169,ECM,LTD,NSCLC,THERE,THOSE,WILEY
001,169,177,946,AKT,CRC,CXCR4,FASEB,FOLLOWING,KIRSTEN,SERPINE,VEGFA
100,BAX,BCL,FURTHER,THEREFORE
946,ANNEXIN,HOWEVER,MAPKS,TGF
000,215,AMONG,CONCLUSION,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN
100,122,BMJ,CIS,ENGLAND,GROUP,HODGKIN,LABEL,LIMITED,METHODS,MORTALITY,NOR,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR,WALES
701,ASSESSMENT,C30,CCD,CHINA,EORTC,FUNCTIONAL,GENERAL,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,QOL,RESULTS,THERAPY,TREATMENT
ARRAY,BACKGROUND,EXPRESSION,LABEL,METHODS,RESULTS,ROS,TIC
HOWEVER,MALIGNANT,MPM
004,005,051,082,106,162,169,180,256,296,337,395,565,687,841,CEA,CRC,LABEL,LNI,LNR,METHODS,OBJECTIVE,OBJECTIVES,OTHERWISE,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
169,BACKGROUND,BASEL,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
001,102,148,362,BACKGROUND,CONCLUSION,GRADING,HOWEVER,LABEL,METHODS,NEN,RESULTS,SEVENTEEN
170,250,265,387,425,549,558,907,946,955,EQULLIBRIA
115,183,187,947,ASA,BACKGROUND,CLINICALLY,FIFTEEN,GREATER,HRQOL,LABEL,METHODS,RESULTS,SECONDARY,SOCIETY,TECHNICAL,THERE
AVERAGE,BACKGROUND,LABEL,METHODS,PULMONARY,RESULTS
ATS,CHEST,COLLEGE,NETWORK,PHYSICIANS,PREVENTIVE,SOCIETY,STATEMENTS,SURGERY
EMT,FOXQ1,NSCLC
954,956,BAX,BCL,CYTOTOXIC,FAK,H3255,JNK,MMP,NSCLC,PCA,RESULTS,THESE
NSCLC,SENSITIVE,THESE
IVA,MWA,REGULAR,SEG
1950S,1980S,1990S,RANDOMISED
169,ACCORDING,ADP,BAX,BCL,CL1,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
054,169,294,372,391,456,471,566,645,709,888,914,BACKGROUND,EPIDERMAL,FIFTY,G719A,HOTSPOT,KOREA,L858R,LABEL,MEDICAL,MET,METHODS,NEVER,OTHER,PANEL,PRESS,PUBLISHED,RB1,RESULTS,SMAD4,SOCIETY,UNIVERSITY
008,075,086,169,177,AMONG,ANOTHER,BASED,CEA,HOWEVER,PRESS,PUBLISHED,SURGERY,UNIVERSITY
LOCALLY,MEANWHILE,NSCLC,SEVERAL,STAGE
CPT,EFFORTS,FDA,FIRST,OTHER,TPT
169,AUTHORS,BASED,LTD,METASTASIS,OTHER,WILEY
101,155,169,199,HOWEVER,MAX,PRESS,PUBLISHED,SMARCA2,SMARCA4,SNF,SWI,UNIVERSITY
011,013,169,949,956,MPG,PRESS,PUBLISHED,UNIVERSITY
18F,CONCLUSION,FDG,LABEL,MAY,METHODS,NEGLECTING,OBJECTIVE,OTHER,PET,RESULTS,THERE
DONABEDIAN,LCSDP,PROJECT,SCREENING,THROUGH,WHILE
16HBE,CSE,HFL,HSP,HSP10,HSP60,NOTEWORTHY,VARIATIONS
163,169,509,LNT,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,THESE,WILEY
169,ENDOSCOPIC,FORCE,JAPAN,LTD,PTY,PUBLISHING,SOCIETY,SURGERY,THEREFORE,WILEY
USING
000,111,113,224,BACKGROUND,BETWEEN,BLOOD,HEART,HLA,HOWEVER,III,INSTITUTE,LABEL,METHODS,RESULTS,SIMILAR,THEREFORE,TREATMENT,UMBILICAL
954,CONCERNING,GROUP,LABEL,METHODS,MPM,OBJECTIVE,PET,PURPOSE,RESULTS,SIXTY,TNM
160,640,8X60K,AGILENT,AMONG,ARRAY,C10ORF116,EXPRESSION,PC9,S100P,SUREPRINT
015,020,022,028,169,CDR,DTC,HERC5,NSCLC,PCR,QRT,SEVEN,STAGE
001,010,026,042,EAS,EHE,MALIGNANT,WWTR1
160,FGF,FGF10,H69,H82,NSCLC,PC9
169,COPYRIGHT,FURTHER,HUVEC,NSCLC,PAT,REMARKABLE,SOCIETY,SRC,TAKEN
022,215,439,559,709,907,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,UIP
CD40L,HOWEVER,THESE
181,ADM,CDDPR,ETHYL,H1299,MERM1,MMC,PTX,WBSCR22
99A,DU145,FOLLOWING
NON,NSCLC,THESE
020,022,023,026,035,037,313GG,351,NSCLC,PFS,SIPA1
169,947,IFN,IL2,INHIBITION,NKP30,OVERALL,PLX4720,V600E
2MAPK,AKT,CD151,FAK,FINALLY,LAC,MEK,MTT,REDUCED,TAKEN
169,ALK,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RET,TKI,VEGFR,XL184
160,203,477,ADDITIONAL,ASSESSMENT,CHRONIC,EVALUATION,FAACT,FACIT,FATIGUE,FUNCTIONAL,HCL,III,ILLNESS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,QOL,RESULTS,SEA,SEF,SIMPLIFIED,THERAPY,THESE
169,BRITAIN,COPYRIGHT,FOLKMAN,GREAT,HOWEVER,IRELAND,LTD,PUBLISHED,SOCIETY,THESE,WILEY
CD4,HOWEVER,KEY
CAV,HOWEVER,H_AR1,H_AR2,KNOCK,RESULTS,SHRNA,THESE
000,012,026,048,111,177,178,208,224,227,967,CONCLUSION,ENB,LABEL,MAY,METHODS,OBJECTIVE,PATHOLOGIC,RESULTS,SEPTEMBER,SEVENTEEN
169,ALK,COPYRIGHT,MYC,SCIENCE,SIGNALING
MEDICAL,PATHOLOGY,SOCIETY,SPANISH
INSTITUTE,JANEIRO,RIO,THROMBOSIS
EMT,HIPPO,LATS1,WW1,YAP
177,183,376,490,967,BACKGROUND,DOPPLER,FUNCTIONAL,HOWEVER,LABEL,METHODS,PFT,PULMONARY,RESULTS,SEVENTEEN
177,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,TCP,TREATMENT
105,248,ALTOGETHER,AMONG,AUTHORITY,BACKGROUND,INSPECTION,LABEL,METHODS,NAV,NORWEGIAN,RESULTS,WELFARE
103,105,160,169,177,ACADEMY,APRIL,BACKGROUND,CHINA,CKS,HHV,JANUARY,LABEL,METHODS,NORTHWEST,OBJECTIVE,OBJECTIVES,RESULTS,THERE
BACKGROUND,CONCLUSION,LABEL,RESULTS,SALMONELLA,TOPIC
100,895,AFTER,CONCLUSION,EARLY,MATERIALS,METHODS,OBJECTIVE,PROGRAM,RESULTS
001,005,006,125,ALK,BACKGROUND,LABEL,METHODS,NSCLC,PD1,RESULTS,TTP
HOWEVER,THERE,USING
169,ALECTINIB,ALK,CH5424802,KIF5B,NSCLC,RET,V804L,V804M
001,169,CHEMOTAXIS,CXCL1,CXCR2,HOWEVER,INCREASED,MPE,NSCLC,TREGS
169,AFTER,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SOCIETY
169,AMONG,BOEHRINGER,CONCLUSION,COPYRIGHT,EGFRT790M,III,INC,INGELHEIM,LABEL,NSCLC,OBJECTIVE,OTHER,PHASE,PURPOSE,SOCIETY,SUMMARY,T790M,TKI
169,188,947,BMEDA,CONCLUSION,EXM,IMAGING,INC,LABEL,METHODS,MOLECULAR,NCI,NON,NSCLC,NUCLEAR,PEG,PEGYLATED,RESULTS,SOCIETY,SPECT,UNLABELLED,WINNONLIN
169,BIOLOGY,CAND1,DCUN1D1,EXPRESSION,INC,MOLECULAR,NEDD8,SCCRO,SOCIETY,TAKEN,UBC12
169,DISEASE,EMD,FORTY,FURTHER,IGM,INC,WILEY
169,AKT,CONVERSELY,ERK,IGF1R,MET,OVERLAYING,RTK,SCC,SRC
BACKGROUND,CONCLUSION,LABEL,METHODS,RFA,TAE,THERE
129,160,ALK,ASIAN,BACKGROUND,BASED,DESPITE,FGFR1,FGFR2,KIF5B,LABEL,MET,METHODS,PCR,RESULTS,RET,THESE
169,KEY
001,218,CEP17,TNM
169,CD8,GAL,INHIBITION,THESE
001,003,231,420,442,468,691,906,GINS2,MDA,MEIER
169,185,369,560,894,BACKGROUND,CIS,COX,CURRENT,LABEL,METHODS,RESULTS,SIR,SOCIETY,STUDIES,WILMS
CD8,FINALLY,LEWIS,ROBO4,THESE,VACCINATED
200,CD8,EMT,THESE,TIL
169,707,834,844,905,919,945,ADC,AUC,ELISA,FURTHER,GLYCANS,NSCLC,PRESS,PUBLISHED,UNIVERSITY
157,169,EMT,LTD,OVERALL,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
129,FINALLY,SINCE,SRC
23A,946,BLIMP,CD8,CTL,FUNCTIONAL,TGF
956,CHRONIC,MTM,PMCON,PMMTM,THESE,XENOGRAFT
ALP,CONCLUSION,DETECTION,ESR,GENERAL,LABEL,LDH,METHODS,OBJECTIVE,PLA,RESULTS
001,011,036,120,169,ADC,AGAIN,BRITAIN,COPYRIGHT,GREAT,HOWEVER,IRELAND,LTD,PUBLISHED,RAS,SCC,SOCIETY,TAKEN,WILEY
115,215,BAP,LOD,PAH,SOUTHWEST,SPAIN
B23,BACKGROUND,BCL,CAM,CHIJONGDAN,FMK,H1299,KOREA,LABEL,METHODS,MTT,NPM,NSCLC,PANAX,PERSICARIA,REALGAR,RESULTS,THESE,UBF,USA,VAD,WESTERN
200,460,956,AKT,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,MMP,MTT,NCI,OPN,OVERALL,PCR,RESULTS
AREAS,BACKGROUND,CLASS,COVERED,GIVEN,III,LABEL,METHODS,NSCLC,OPINION,PHASE,SIX
169,209,215,381,AGILENT,AMENDMENTS,BACKGROUND,COLLEGE,EXCISIONAL,HISEQ,LABEL,LABORATORY,METHODS,MISEQ,NGS,NSCLC,RESULTS,SEQUENCING,SOCIETY,SURESELECT,TAT
169,365,COX,DFS,INSTITUTE,JANUARY,KOFUKAI,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THEREFORE,UNIVERSITY
160,169,945,946,ALTERATION,FOURIER,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SECONDARY,WILEY
CONCLUSION,CSF,HODGKIN,LABEL,METHODS,NHL,OBJECTIVE,OVERALL,RESULTS,ROUTINE,SIRIRAJ,THREE
002,007,009,109,125,169,CYBERKNIFE,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,SRS,SRT,UNIVERSITY
HOWEVER,ID1,MEIER,NSCLC
AKT,HOWEVER,IGF1R,OTHER
HOWEVER,LEUKOCYTES,THERE,WHILE
ADT,CTL,CURRENTLY,DESPITE,FAILURE,FUNCTIONAL
946,ENPP1,IFN,STING,STUDIES,TMEM173
ELISA,ERLOTINIB,H1975,LABEL,METHODS,MOUSE,MTS,NSCLC,OBJECTIVE,PC9,PURPOSE,RESULTS,THESE,TKI
007,009,205,246,461,473,AGE,FRAMINGHAM,GRS,HDL,HEART,IMPORTANCE,LABEL,LDL,MENDELIAN,METHODS,MULTI,OBJECTIVE,RELEVANCE,RESULTS,REYKJAVIK,SETTING,USING,WHETHER
004,022,169,232,693,762,771,792,817,824,BACKGROUND,CONCLUSION,DFS,FOUNDATION,GGO,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,USING
000,300,450,BACKGROUND,CONCLUSION,DUE,INITIAL,LABEL,METHODS,NON,NSCLC,RESULTS,SMALL
169,176,ALK,BACKGROUND,IHC,LABEL,MEDICAL,MET,METHODS,PRESS,PUBLISHED,RESULTS,SEVEN,SOCIETY,THREE,UNIVERSITY
169,HOWEVER,MEDICAL,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
108,221,AFTER,ASIAN,CAUCASIANS,HOWEVER,OVERALL
169,17P,947,956,CHRONIC,CLL,IGM,NOD,NOTABLY,NSG,THREE
149,152,160,796,ANXA1,IGG,PEARSON,ROC,STUDENT
001,002,003,010,EXPRESSION,GEO,HMGA1,III,MEANWHILE,NSCLC,OMNIBUS,PCR,USING
049,177,DUSP6,MKP,NSCLC,OCTUBRE,PCR,UNIVERSITY,USING
AKT,BACKGROUND,CETUXIMAB,CTX,FIRST,HOWEVER,INCUBATION,LABEL,NSCLC,RESULTS,SINCE,THESE,TREATMENT
AUSTRALIA,BACKGROUND,CHRISTMAS,EASTERN,ENGLAND,HOWEVER,LABEL,METHODS,NORTH,RESULTS,SYMPTOM,WESTERN
169,AS2O3,COPYRIGHT,GSH,HOWEVER,TRIVALENT
ADDITIONAL
104,107,160,239,COEXISTENT,DESPITE,FOLLOWING,LABEL,MANAGEMENT,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESULTS
172,BACKGROUND,CALRETININ,FOCAL,HOWEVER,LABEL,OBJECTIVE,RESULTS,THESE
1A1,526,65285,BACKGROUND,CHINESE,CYP,CYTOCHROME,ILE,ILE462VAL,LABEL,METHODS,OBJECTIVE,RESULTS,VAL
029,048,BACKGROUND,BMI,LABEL,LDH,METHODS,OBJECTIVE,OVERALL,RESULTS,TTP
002,150,645,ADHERENCE,BACKGROUND,CORRECT,ITALIAN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE
BECAUSE,GSC,HCC
005,013,021,074,124,165,169,172,179,282,309,316,432,852,AMONG,CLAVIEN,DINDO,GRADE,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,PULMONARY,RESULTS,SURGERY,THERE,UNIVERSITY,VARIOUS
001,019,026,101,486,504,BACKGROUND,LABEL,NSCLC,PCR,PIM,REDUCED,RESULTS,UTR,WESTERN
ANNEXIN,APOPTOTIC,BACKGROUND,BAX,BCL,DIOSCOREA,LABEL,METHODS,NSCLC,RESULTS,SRB,VAD
009,010,023,031,169,230,361,ASPIRIN,BACKGROUND,COLORECTAL,LABEL,MEN,METHODS,OVARIAN,RESULTS,THESE,TRIAL
018,169,AKT,CONCLUSION,FDG,GLUT1,HK2,HOWEVER,IMAGING,INC,KNOCKDOWN,LABEL,LACTATE,MAXIMUM,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,THESE,UNLABELLED
102,160,AMONG,BACKGROUND,DISTANT,EMA,III,LABEL,METHODS,RESULTS,VINFLUNINE
BACKGROUND,BASED,CIGARETTE,LABEL,METHODS,MICRORNAS,RESULTS
169,99M,DIFFUSE,IMAGING,INC,MOLECULAR,NUCLEAR,SOCIETY
945,AKT,BAD,BECAUSE,CONCLUSION,ERK,HOWEVER,LABEL,MEK,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TAKEN,THEREFORE
PPL,PRIMARY

HGF,HOWEVER,MET,NSCLC,TKI
NSCLC,SOCIETY
MDR,THEREFORE
ACTIVATION,CURRENTLY,DESPITING,NSCLC
945,BACKGROUND,CRP,LABEL,METHODS,OBJECTIVE,RESULTS,TNF
BACKGROUND,CONTINUOUS,CTC,ENRICHMENT,INHIBITORY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE,USING,VEGFR
614,ALTERED,BACKGROUND,LABEL,METHODS,MICRORNAS,MIR,OBJECTIVE,PCR,PGCL3,PGLH7,PSA,RESULTS,TRANSWELL,UTR,WESTERN
NSCLC
169,930,BASEL,CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,JANUARY,LABEL,LEADING,METASTATIC,METHODS,RESULTS,THEREFORE,TMJ
100,AUC,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,WHOLE
CXCL4,CXCR4,CXCR7,HCC,TARGETING,U0126
BCL,H1299,MCL,MIGRATION,NSCLC,ROS,THESE,VDAC1,VDAC2
188,HOWEVER,IGG,THESE
THEREFORE
30C,EMT,FINALLY,FN1,FRAGILE,HISTIDINE,HMGA2,METADHERIN,METASTASIS,TRIAD,VIM
ABCB1,ABCC1,ABCG2,AFTER,AIM,CONCLUSION,ERCC4,GENOMIC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,XPC
111,857,BACKGROUND,CD3,CONCLUSION,HODGKIN,INDUCTION,LABEL,MATCH,METHODS,MUROMONAB,NHL,POISSON,POLYCLONAL,RECIPIENTS,REGISTRIES,RESULTS,SCIENTIFIC,STUDIES,TRANSPLANT
000,RADIOLOGY
RADIOLOGIC
000,BACKGROUND,EGGER,JANUARY,LABEL,MEDLINE,METHODS,RESULTS,SIXTEEN,THERE
158,176,HISTORY,LABEL,METHODS,PARTIAL,PERTINENT,THERE
NET
100,123,160,200,956,FURTHER,MTT,NPS,PCR,TAKEN,TYPICAL
160,33258,CNE,DDP,HOECHST,INDUCIBLE,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,SMT
174,181,BIOCHIP,MICROARRAY,PARAFLO,PROTEIN,THERE
090,110,169,270,444,513,620,716,929,959,977,ASIAN,BACKGROUND,CONCLUSION,DOR,LABEL,LIBRARY,METHODS,NSCLC,RESULTS,ROC,SCIENCE,WEB
ABCA1,DDP,FEWER,MICRORNAS,NSCLC,REVERSE
155,ANX,MICRO,MTT
138,169,CLINICALLY,EPIGENETIC,GATA3,NOTABLY,PATIENT,PDX
169,NSCLC,ONCOGENIC,TPA,TRE
180,180MG,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
001,010,066,087,179,186,287,297,481,580,838,861,ASIAN,CHINESE,CIS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORS,RASSF1A,RESULTS
001,019,022,287,310,696,CONCLUSION,COX,LABEL,METHODS,MPE,OBJECTIVE,RESULTS,THERE,USING
440,CIS,FURTHER,HOWEVER
BACKGROUND,FACULTY,LABEL,MATERIALS,METHODS,NORTHEAST,RESULTS,THYROID,UNIVERSITY
105,153,156,893,ASR,ASR12,ASR13,BACKGROUND,INCIDENCES,IRANIAN,KHUZESTAN,LABEL,MATERIALS,METHODS,RESULTS
263,BACKGROUND,INDIA,KARNATAKA,KSRTC,LABEL,MANGALORE,MATERIALS,METHODS,RESULTS,SMOKING,STATE,THESE,TOBACCO,TRANSPORT
001,004,064,841,BACKGROUND,LABEL,MARCH,MATERIALS,METHODS,ORR,PFS,PSA,RESULTS,SCIENCE,SIMILARLY,SOCIETY,STUDENT,WEB
000,002,030,194,565,874,946,LEICA,NSCLC,TGF,TNM,UNIVARIATE
EARLY,GASTRIC,HOWEVER,MICROARRAY,NGS
1195G,COX,HOWEVER,NSCLC,SNP,TREGS
140,225,315,ACCORDING,ELISA,HGF,MBP,MONITORING,PCR,T790M
169,COPYRIGHT,SCIENCE,SIMILAR
AIM,CBA,FDA,HENCE,LABEL,MCA,MCF,OBJECTIVE,RESULTS
169,945,946,AUTHORS,ERK,JANUARY,LTD,MEK,PE089,PTY,PUBLISHING,SCIENCE,WILEY
169,AGAINST,FINALLY,JOURNAL
CIGARETTE,DCS,EIGHT,EVIDENT,EXCESSIVE,MYELOID,USING
JANUARY,MARCH,SCIENTISTS
160,177,231,956,BLUME,DUNAL,HEPG2,LNCAP,MCF,MDA,NMR,SW480,THEIR,VIETNAM
BACKGROUND,CONCLUSION,CSC,HEP,LABEL,METASTASIS,METHODS,MSC,PRINCIPAL,RESULTS
178,946,CD8,MHC
149,196A2,499,ASIAN,BACKGROUND,CAUCASIAN,CONFIDENCE,DISEASE,INTERVALS,LABEL,METHODS,NON,OVERALL,RECURRENCE,RESULTS,SMALL
CRE,HOWEVER,USING
ERSPC,NOW,PSA,RANDOMIZED,SCREENING
05009,100,946,954,ATP,CONTINUING,EMT,ERK,FAK,JNK,MAP,NCK,SINCE,SRC,TGF,TRAF2,WNT
AXL,EMT,TARGETING
100,215,AFTER,CONCLUSION,FOCAL,HEMORRHAGE,HMB45,LABEL,MELAN,METASTATIC,METHODS,OBJECTIVE,RESULTS,SMA
ABDOMINAL,HOWEVER,MRI,THEREFORE
176,HODGKIN,HOWEVER,LDH,PPD,PRIMARY
100,CARCINOMA,CHINESE,DESPITE,MGA,MGACA,MPC,NST,P63,PAS
110,ECM,IHC,LOX,LYSYL,MEIER,NSCLC,PCR,UNIVARIATE
956,AKT,GRANDININ,HOWEVER,LABEL,MALIGNANT,MELALEUCA,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THESE,WESTERN
002,006,016,021,037,ACCORDING,EMT,LU1,SCC
108,394,487,CK5,CONSISTENT,ICC,LAC,MAC,PCR,RMS
786,BACKGROUND,COX,HOWEVER,IT1,LABEL,MEIER,METHODS,PCR,RESULTS,SMALL,SPRY4
002,006,324,471,COX,HRADJ,MEIER,NETWORK,WHILE
956,CUP,DEPENDING,DIFFERENT,ERLOTINIB,PULMONARY,THERE,TREATMENTS
001,169,193,386,425,660,CONCLUSION,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THROUGH
000,169,1970S,DESPITE,NSCLC,SMALL,SOCIETY
169,946,954,CCL11,CD8,DEPLETING,IKK,MHC,MYELOID,TH2,V600E
169,APC,ATROGIN,HOWEVER,LEWIS,LLC,MAFBX,MIN,MURF1,MYOSTATIN,NOTABLY,TAKEN
110,127,160,237,448,663,AUC,CONCLUSION,HOWEVER,III,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,POPULATION,PURPOSE,RESULTS
074,093,508,828,HENCE,HOWEVER,OVERALL,THERE
BACKGROUND,DISCUSSION,ELECTRONIC,GOVERNMENT,INSTITUTES,LABEL,OBJECTIVE,PRESS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THEIR,THESE,TOBACCO,UNIVERSITY
140,169,AUSTRALIAN,BACKGROUND,COLLEGE,FDG,LABEL,METHODS,MICROWAVE,MWA,NSCLC,PET,RESULTS,ROYAL,SEVEN,THERE,THREE,ZEALAND
006,016,017,042,248,257,312,532,BACKGROUND,HOWEVER,HRS,INTENSIVE,LABEL,METHODS,OBJECTIVE,ORS,RESULTS
945,BACKGROUND,CIS,CONCLUSION,CRP,HOWEVER,HRS,INCREASED,LABEL,METHODS,NSCLC,RESULTS,TNF
001,012,046,ACCORDING,ADC,AMONG,BACKGROUND,INCREASED,LABEL,LCC,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,UNIVARIATE
AFTER,BECAUSE,FIRST,HOWEVER,STAGE
107,215,292,313,DCR,DCS,EVALUATION,MAY,MST,MUC,OCTOBER,OVERALL,PARTIAL,SOLID,THESE,WILMS,WT1
309,939,OVARIAN,THERE
500MG,AFTER,AUC,BEV,CBDCA,PEM,RIGHT
001,004,009,023,027,176,AIM,CONCLUSION,IDC,ILC,LABEL,METHODS,OBJECTIVE,RESULTS
CONCLUSION,FCM,LABEL,LAP,METHODS,MTT,OBJECTIVE,PCR,RESULTS
160,181,ANNEXIN,ARSENIC,ATO,BAK,BCL,H2052,H28,JUN,MALIGNANT,MTT,THERE
AMONG,BACKGROUND,CONCLUSION,COORDINATE,LABEL,NSCLC,RESULTS,SCC
AIR,DESPITE,DIRECTIVE,HENCE,HOWEVER,NO2,NOX,QUALITY,SEVERAL
160,4T1,64258,BMDCS,FACTORS,PRIMARY,SUBSEQUENT,THESE,TREATMENT
453,950,AMAXA,MDA,MHC,PCR,SEVERAL,SKBR3,THESE
HOWEVER,NSCLC
001,005,041,123,150,740,CIGARETTE,COX,IHC,MEIER,NON,NSCLC,UNIVARIATE
HAYASHI,HOWEVER
III,NET
500,946,CDKL2,EMT,NOTABLY,SUBSEQUENT,TAKEN
945,946,947,ADP,AMP,AMPELOPSIN,ANNEXIN,BCL,CERTAIN,FBW,FOLLOWING,HDAC1,MTT,MYC,THR58
ANY,FINALLY,METASTASES
MAX,MYC
124,131,168,169,300,ADS,CONCLUSION,IMAGING,INC,LABEL,LMS,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SMALL,SOCIETY,THEIR,TRS,UNLABELLED
169,370,III,JAPAN,PHASE,PRESS,PUBLISHED,UNIVERSITY
169,287,471,581,ELISA,VCH,WILEY
255,CENTRAL,JANUARY,LABEL,LHD,METHODS,NSCLC,NSW,OBJECTIVE,OUTCOME,POTENTIAL,RESECTION,RESULTS,SETTING,SOUTH,THOSE,WALES
169,946,BIOLOGY,C459S,EMT,HOOK1,HOWEVER,INC,MOLECULAR,PHPS1,SH2,SOCIETY,SRC,TGF,THESE,USING
169,174,AIM,ANTICANCER,APC,ASSAY,BACKGROUND,CONCLUSION,COPYRIGHT,DELINASIOS,EPI,GERMANY,INK4A,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RAS,RASSF1A,RESULTS,SHOX2
169,569,598,945,SMALL,THEREFORE,VCH,WILEY
032,043,131,BACKGROUND,CONCLUSION,COX,DTC,JANUARY,LABEL,MEIER,METHODS,PTC,RESULTS,SERUM
160,169,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IRELAND,LABEL,METHODS,NIH,OBJECTIVE,RESULTS,SOCIETY,TRIAL
000,001,042,051,178,181,203,300,437,450,454,465,485,491,494,499,946,ACCORDING,CYSTEINYL,GDP,IMAGE,LABEL,METHODS,MTT,OBJECTIVE,QUANT,RESULTS,RHO,WESTERN
009,024,110,116,187,579,787,AGE,AMONG,CHINA,CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,REGRESSION,RESULTS,SEPTEMBER
169,372,BRAIN,BRESLOW,CLARK,COX,HOWEVER,LEVEL,RECURRENCE,SEVENTY,STAGE,THESE
041,042,045,047,125,175,177,494,633,664,711,CEA,CONCLUSION,CYFRA21,FIRST,JAN,LABEL,METHODS,NSE,OBJECTIVE,RESULTS,ROC,SCC,SPN,THERE,UNIVERSITY
BACKGROUND,CRS,DEFINITIVE,HIPEC,LABEL,MALIGNANT,METHODS,MPM,MRI,PET,PROGNOSTIC,PROMISING,RESULTS
002,012,CTV,GTV,OAR
946,CONVERSELY,GSK,HOWEVER,NSCLC,S1P,SPNS2,STAT3,THESE
001,253,467,BACKGROUND,CONCLUSION,COX,HARRELL,HOWEVER,LABEL,METHODS,OTHER,RESULTS,SEVERAL,THOSE
003,568,ASIAN,COMPARING,CONCLUSION,CURRENTLY,DESPITE,FURTHER,III,LABEL,METHODS,NSCLC,OBJECTIVE,ORS,PURPOSE,RESULTS,SCIENCE,WEB
011,15Q25,177,400,491,BACKGROUND,CHINESE,HAN,HOWEVER,LABEL,METHODS,NPC,RESULTS,THERE,UNIVARIATE
ADJUSTMENT,BACKGROUND,CATALONIA,IRR,LABEL,MEDEA,METHODS,OBJECTIVE,POISSON,PRIMARY,RESULTS,SPAIN,SPANISH,THERE,THESE
001,025,104,177,BACKGROUND,DESPITE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SIROLIMUS
009,COMPLIANCE,EPA,SERUM,SIXTY
EARLY,HMB45
005,006,054,106,10834,BACKGROUND,DCR,ELECTRONIC,HOWEVER,III,LABEL,MATKI,METHODS,MULTI,NSCLC,ORR,OVERALL,PFS,RESULTS
TLH
029,199,319,342,377,690,ACADEMY,ACCORDING,AFTER,BESIDES,CHINA,CHINESE,EARLY,ELCAP,LABEL,MEDICAL,METHODS,NETWORK,NSCLC,OBJECTIVE,PROGRAM,RESULTS,TNM
001,138,189,236,245,270,APART,CHI,GGO,HOWEVER,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,RESULTS,USUALLY
711,COX,IIA,IIB,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM
LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN
001,003,100,177,180,194,205,227,236,287,334,354,510,AMONG,BEIJING,FORTY,FPS,GEFITINIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SEQ
009,250,AMONG,CIV,LABEL,METHODS,OBJECTIVE,PRODROMES,RESULTS
005,044,047,100,AMONG,DISEASE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE
ALK,AMONG,IHC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTY,THERE,VENTANA
HOWEVER,PROTEIN
100,215,987,ANN,AUC,ROC,VOI
121,122,142,ANN,CONCLUSION,INDEX,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS
AMONG,HOWEVER,SEVERAL,SINCE,TDD,TED
000,100,160,AFTER,FIRST,GBP,HOWEVER,THEREFORE
160,198,EGFR2,ERBB2,MBC,MUTATIONS,NEU
160,BACKGROUND,CONCLUSION,FDG,LABEL,METHODS,PET,PRIMARY,RESECTION
11598,169,18141,4MM,BACKGROUND,CONCLUSION,LABEL,METHODS,PRESS,PUBLISHED,RAISING,RESULTS,SCREENING,THERE,TRIAL,UNIVERSITY
3RD,BMJ,GROUP,HOWEVER,LTD,PUBLISHING
169,CD4,CD8,COPYRIGHT,INC,ORIGINALLY,TH2,THESE
BACKGROUND,COMBINING,CPG,DA3,LABEL,METHODS,RESULTS
APOPTOSIS,BACKGROUND,BID,CELLS,CK2,LABEL,LNCAP,LOW,METHODS,MTT,PC3,RESULTS,TAT,THEREFORE,TRAIL,WESTERN
157,ATTRITION,FUNCTIONAL,LABEL,METHODS,MISSING,OBJECTIVE,PURPOSE,RESULTS,SEM,T12,T13,T24
000,148,153,186,217,231,280,300,301,326,422,52ADS,ADS,AIR,BMJ,DIRECTIVE,GROUP,GUIDELINES,LABEL,LIMITED,METHODS,OBJECTIVE,OUTCOME,PM2,PUBLISHED,PUBLISHING,QUALITY,RESULTS,SETTING,SOURCES,SPAIN,VALLADOLID
1950S,AFTER,AGE,AMONG,BMJ,CURRENT,GROUP,LABEL,LIMITED,MEASURE,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PREVIOUSLY,PRIMARY,PROVIDING,PUBLISHED,PUBLISHING,RESULTS,SETTING
368,AP1M2_1,BASED,FAD,FLAD1,GENMAPP,GOLGI,PEARSON
169,947,949,BECAUSE,COPYRIGHT,FCR,IGS,INC,RIV,THEREFORE
001,482,552,784,BACKGROUND,HISTOLOGY,LABEL,METHODS,NSCLC,OVERALL,RESULTS,THERE
1970S,1980S,CONFERENCE,THESE,WORLD
899,911,BACKGROUND,CCL22,CD127,CD3,CD4,CD8,FOXP3,LABEL,MDC,METHODS,PBMCS,RESULTS,TH2,TREGS
BACKGROUND,CONCLUSION,DIFFUSION,FOLLOWING,LABEL,METHODS,RESULTS,VOXEL
100,103,114,124,143,157,990,992,CONCLUSION,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,DISCUSSION,EPA,GST,HODGKIN,INTEGRATED,LABEL,METHODS,OBJECTIVE,OBJECTIVES
169,CONCLUSION,DYNAMIC,ICC,IMAGING,INC,LABEL,LOGAN,METHODS,MOLECULAR,NLR,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
100,169,700,800,956,99M,AFTER,CONCLUSION,FMS,IMAGING,INC,LABEL,METHODS,MOLECULAR,NIR,NUCLEAR,OPTIMIZED,RESULTS,SOCIETY,SPECT,UNLABELLED,USING
169,ACIDS,BCL,FGF,FIBROBLAST,NUCLEIC,PRESS,PUBLISHED,UNIVERSITY
945,946,ACH,AKT,DEPENDING,EFFECTIVE,EPITHELIAL,ERK,INHIBITION,RAF,RAS,TIOTROPIUM
AKT,H1975,HGF,LABEL,MAP,MEK,MET,METHODS,OBJECTIVE,PD0325901,PURPOSE,RESULTS,T790M,THESE
AUTOPHAGY,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WESTERN
169,CTL,CURRENT,DESPITE,EFFORTS,IMMUNOLOGY,IPILIMUMAB,SOCIETY
104,108,110,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
CID,COMBINING,E1A,HOWEVER,KNOCKDOWN,MSC,NSCLC,THESE,TREATMENT
ECTOPIC,ISH
001,002,006,007,012,015,177,1RM,BACKGROUND,BMJ,GROUP,LABEL,LIMITED,METHODS,OTHER,PUBLISHED,PUBLISHING,QOL,RESULTS,TRIAL
196,383,673,AFTER,COX,FOLLOWING,FURTHER,HOUNSFIELD,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNITS,VERTEBRAL
LCSCR
123,960,AKT,DDP,E2F,FURTHER,MDR,MPR,RHODAMINE,SEVERAL,TWIST
BMJ,CLINICALLY,GROUP,LTD,PEARSON,PUBLISHING
165,169,192,550,ERS,PCV,PCV13
169,946,AD5,BACKGROUND,BASEL,GFP,INF,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PILOT,RESULTS,SIMILAR,STENT,THESE
946,CYT,EMT,EPITHELIAL,NSCLC,RESULTS,TGF
143,ATG2B,H1299,HOWEVER,KNOCKDOWN,NSCLC,PREVIOUSLY,THESE
001,003,004,047,070,149,169,174,227,231,263,402,417,502,530,542,556,671,780,808,856,926,BACKGROUND,CSS,INC,LABEL,METHODS,NSCLC,RESULTS,RFS,WILEY
042,100,588,HOWEVER,JANUARY,MAY,SUN,THERE,THESE,TREATMENT,UNIVERSITY,YAT
64257,64258,AVULAVIRUS,EARLY,FMK,HOWEVER,MTT,NDV,NEWCASTLE,PCR,RVG,THEREFORE,VAD
AUTOSOMAL,CHINA,COMMITTEE,MEDICAL,THERE,VANISHING,ZHANGYE
730,ANNEXIN,BAX,BCL,HOECHST,HOWEVER,MTT,NSCLC,PARIS,PSI,RHIZOMA
011,101,37440,396,ALK,AP26113,ASP3026,CANCERS,CEP,CH5424802,MET,NSCLC,RESISTANCE,RO5424802,TSR
AKT,IAP,MAPKS,NSCLC
CRT,ESCCS,FACTORS,HOWEVER,PC4,THESE,XLF
HOWEVER
CD4
HISTOLOGIC,THESE
DIFFUSE,DIPNECH,THERE,THESE
004,BACKGROUND,III,LABEL,METHODS,MMP,NON,NSCLC,RESULTS,TOTAL
00001,001,147,BACKGROUND,BECAUSE,DESPITE,DIAGNOSTIC,INADEQUATE,LABEL,METHODS,OVERALL,RESULTS
BACKGROUND,FNA,FORTY,LABEL,METHODS,RESULTS
100,122,CLINICALLY,EBV,EPSTEIN,GRADING,INSTITUTE,LYG
001,004,008,AHR,END,HOWEVER,IMPORTANCE,JANUARY,LABEL,LOBECTOMY,METHODS,NSCLC,OBJECTIVE,OVERALL,PROPENSITY,RELEVANCE,RESULTS,SETTING,UNADJUSTED
008,124,131,216,268,333,344,357,AFTER,AIM,CONCLUSION,DEPARTMENT,HOWEVER,LABEL,LYMPH,MATERIALS,MEDICAL,METASTASIS,METHODS,NUCLEAR,OBJECTIVE,PET,RAI,RESULTS,UNIVERSITY
100,111,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MAY,METHODS,NEWLY,NOTABLY,OCTREOSCAN,RESULTS,SMALL,SSTRS
945,BACKGROUND,CEA,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEX,THEREFORE,TNF
945,ENZYMES,GLUT1,HIF,INCREASED,MIA,MKN45,NUGC3,PANC1,PFKFB,PSN
001,100,169,FINALLY,IHC,L858R,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,B16,BRITAIN,C26,C38,COPYRIGHT,FINALLY,GREAT,III,INSTEAD,IRELAND,LTD,MAT,PUBLISHED,SOCIETY,THESE,WILEY
BOLTZMANN,OES,ROS
169,AKT,BAK,BAX,ERK,FURTHER,JNK,NSCLC,SCREENING,THESE
AFTER,THERAPY
621,BACKGROUND,COX,CURRENT,III,LABEL,LOBECTOMY,MEIER,METHODS,RESULTS,THESE
SEVERAL
169,BACKGROUND,CASES,FIFTY,LABEL,METHODS,RESULTS,SARCOID,SOCIETY,THESE,TYPICALLY
BACKGROUND,CONCLUSION,FALSE,LABEL,MARCH,METHODS,RADICAL,REF,RESULTS,SEPTEMBER,TAB,TNM,ULTRASOUND
945,BECLIN1,CLONOGENIC,H1299,HIF,HYPOXIA,JUN,LC3,NH2,PCR,REDUCED,UNDER,WESTERN
PULMONARY,THESE
NSCLC,TAKEN
CHEST
BECAUSE,MALIGNANT,MPM,PMT
EMT,NSCLC,STAT3,TWIST
169,AUC,COPYRIGHT,DIAGNOSTIC,LTD,PARAMETRIC,ROC,WILEY
169,211,257,276,ABS,ADRAGNA,ALTER,BAK,BCL,BCLXL,BH1,BH3,BIOCHEM,BROWN,COPYRIGHT,FHLCS,HEINY,NKA,NOTABLY,PHYSIOL,SOCIETY,THESE
AKT,BACKGROUND,FINALLY,FURTHER,LABEL,METHODS,MPS,OBJECTIVE,OBJECTIVES,PSD,RATIONALE,RESULTS,THESE,THROUGH,USING
ACT,AFFORDABLE,CENTERS,CMS,FORCE,LEGITIMATE,PREVENTIVE,SCREENING,SINCE,THESE,TRIAL
BACKGROUND,DETECTION,EFIRM,FINALLY,L858R,LABEL,METHODS,MUTATIONS,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SABER
BACKGROUND,FOLLOWING,FORTY,HOWEVER,NSCLC,THREE
180,GROUP,IIA,LABEL,METHODS,OBJECTIVE,RESULTS
HOWEVER,LABEL,MATERIALS,METHODS,MMP,MTT,OBJECTIVE,PCR,RESULTS,WESTERN
FURTHER,IMPORTANCE,KIT,RAF,RAS,RELEVANCE,S628N,THEREFORE,USING
CTC,DUE,EPCAM,HOWEVER,MCF,OVERALL,UNDER
ACT,AFFORDABLE,CENTERS,CMS,FORCE,PREVENTIVE,SCREENING,TRIAL,UNDER,UNTIL
169,CONCLUSION,FDG,GTV,HX4,HYPOXIC,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,REMARKABLY,RESULTS,SUV
001,007,169,247,695,749,761,813,945,ALTERED,ELISA,HSP90,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,USING
169,304,676,901,AMONG,BACKGROUND,COX,CURRENT,GOV,HOWEVER,INITIATIVE,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY,WHI,WHILE,WOMEN
METASTASIS,MTA
024,177,258,267,5TH,908,AVAPS,PACO2,THERE
177,AHI,CD40L,OSA,SAO,THERE
002,128167809,128393157,128498051,145,169,215,961,CAUCASIAN,CHROMOSOME,COLORECTAL,CPG,FDR,MYC,OVARIAN,POU5F1B,SCREENING,SNP,THESE,TRIAL
174,AVASTIN,III,RESULTS
AFTER,BASED,HOWEVER,RADIATION
009,125,127,229,340,868,BACKGROUND,COX,LABEL,METHODS,OBJECTIVE,PLACENTAL,PURPOSE,RESULTS,THERE,TRIAL
116,181,215,250,2YL,AGILENT,C18,COLON,DAD,EPIDERMOID,FINALLY,HCT,MTT,NCI,PRANGOS
788,BACKGROUND,LABEL,METHODS,REGISTERS,RESULTS,SIR,SWEDISH
026,168,174,BOARD,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGY,PROXIMITY,PURPOSE,RESULTS,THESE
145,169,956,AMONG,ANNEXIN,HOECHST,MCF,THESE,VCH,WILEY
215,FONTANA,HMB,MALIGNANT,PATHOLOGIC,STOMACH

231,ANOVA,BACKGROUND,CONCLUSION,DEVELOPING,H1299,LABEL,MATERIALS,MDA,METHODS,MTT,RESULTS,TAMOXIFEN,TREATMENT
001,046,178,279,967,998,AIM,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
011,021,324,634,828,LABEL,MATERIALS,METHODS,OBJECTIVE,RECURSIVE,RESULTS,SALVAGE,THERE
BACKGROUND,DISEASE,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,THERE
ADDITIONAL,ERK,FINALLY,NOD
CD209,ERK,HOWEVER,HYPOXIA,LEWIS,LLC,NON,NSCLC,SMALL
169,BACKGROUND,COLON,CXR,END,LABEL,METHODS,MPSTS,OVARIAN,RESULTS,SCREENING,TRIAL
169,ALK,COPYRIGHT,IRELAND,L858R,LTD,NSCLC,ONCOGENIC
005,127,169,5CM,953,969,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,RESULTS,WHILE
169,945,946,BPA,COPYRIGHT,FURTHER,MMP,SAS
169,BECAUSE,BFD,COPYRIGHT,DR4,INDEX,NCI,ROS,SAS,TRAIL
125,177,215,435,945,946,99M,GALACTO,MDA,RGD,SINCE,SIX,THERE,THESE,THREE,U87MG
162,BACKGROUND,CEA,CONCLUSION,CYFRA,LABEL,METHODS,NSE,RECURSIVE,RESULTS
177,AFTER,AMONG,APRIL,DVT,DYSPNEA,JANUARY,LABEL,METHODS,OBJECTIVE,PTE,RESULTS,THERE,VTE
169,AKT,ALREADY,COPYRIGHT,DESPITE,LTD,PI3
169,215,CD105,CD117,CD133,CONTROL,LABEL,MCS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PRIMARY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
522,725,ARG,ASIAN,CHINESE,HIS139ARG,STRATIFIED,THESE,TYR,TYR113HIS
108,155,160,169,ANGELES,CALIFORNIA,COPYRIGHT,INC,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SARCOMA,SURGERY,UNIVARIATE,UNIVERSITY
001,002,011,100,123,169,224,945,946,COPYRIGHT,IGF,IGFBP,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,REFINEMENT,RESULTS,SURGERY,THESE,UNIVERSITY,WHITNEY
160,BACKGROUND,CONCLUSION,EGF,IHC,LABEL,METHODS,NSCLC,RESULTS
169,252,COPYRIGHT,FEDERATION,FOXO1,NSCLC,P21,P27,POK,POZ,PUBLISHED,SOCIETIES,THEREFORE
169,549,929,CD2,COMPLEX,COPYRIGHT,DIC,DICLOFENAC,FRIDOVICH,H2O,MCF,T24
142,BACKGROUND,BMJ,CXR,GROUP,INDIVIDUAL,LABEL,LIMITED,METHODS,NETWORK,PUBLISHED,PUBLISHING,RESULTS
BACKGROUND,HMC,KIT,LABEL,METHODS,PCR,PKH67,RESULTS,SCF,WESTERN
251,265,607,HOWEVER,OVERALL
116,HCT,HOWEVER,PAS,POLYAMINES,SW480,THEREFORE
169,ALK,AMP,CAP,COLLEGE,CONCLUSION,DISCUSSION,IASLC,LABEL,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PURPOSE,RESULTS,SOCIETY
169,945,COPYRIGHT,HOWEVER,LIPOSOMAL,NSAID,NSCLC,PHOSPHO,PIA,ROS
200,4T1,946,EBP,EO771,PRIMARY,REDUCED,STAT6,TAKEN,TCM,YM1
568,BACKGROUND,COMPLEX,CONCLUSION,EMT,H3K27,LABEL,METHODS,NFAT5,NUCLEAR,REPRESSIVE,RESULTS
169,451,946,COPYRIGHT,DTX,EMT,EPITHELIAL,ERK,GSK,H1299,HOWEVER,LAD,LTD,MET,MIR,MYC,SPC
DOCETAXEL
HOWEVER,PULMONARY,THESE,VARIOUS
HOWEVER,METASTASES,METASTATIC,THEREFORE
COMMITTEE,GROUP,HOWEVER,JOINT,SMALL,VALSG
GROUP,HOWEVER,MALIGNANT,MPM,PET
CONSISTENT,DRESLER,IASLC,SOCIETY
BECAUSE,FLEISCHNER,FURTHER,PET,SEMISOLID,SPN
AUTOPSY,ITALY
KOREA,MET,NOTABLY,NSCLC,PULSATILLA,SB365,THEREFORE
160,226,468,692,A24,A26,AMONG,CTL,HLA,IGG,NSCLC,PPV,THEREFORE,THESE
AROMATASE,CYP19A1,ELISA,NSCLC,PCR
005,198,BASED,H1703,HOWEVER,IHC,IMR,LCC,NCI,NSCLC,SOX18,SQC
107,175,322,643,BIAGINI,BORIANI,JANUARY,KARNOFSKY,LABEL,LOG,MEIER,METHODS,OBJECTIVE,RESULTS,SCORE,WALKING,WEINSTEIN
JUN,NOTABLY,SOUTH,THEREFORE
MICRORNAS,SEVERAL
158,169,3NM,945,COPYRIGHT,CRIZOTINIB,HOWEVER,PLA,SILDENAFIL,THESE
100,160,EDX,MANGANESE
169,231,233,ART,COPYRIGHT,CYT,INHIBITION,MDA,MOL,NAC,POTENCY,PRE,ROS,SCAVENGING,SCC25,SFBBM,SIMILAR
956,DOX,H1299
EXACTLY,GENERAL,SURGEON
MEN,MTC,PAPILLARY,PTC
169,COPYRIGHT,FURTHER,HOWEVER,INC,MTT,THESE,TUNEL
169,COPYRIGHT,EPSTEIN,HLA,PTLDS,SOCIETY,SOT,TRANSPLANT
150,306,945,DESPITE,MEIER

ALZHEIMER
226
175,BACKGROUND,CAUCASIAN,CEA,CONCLUSION,LABEL,METASTASES,METHODS,SERUM
516,ALONG,CME,EVIDENCED,MET
001,114,388,588,910,950,AGONIST,AUC,BACKGROUND,CCL20,CDH,CHRONIC,EMPHYSEMA,ICAM1,LAA,LABEL,LP15A,METHODS,OTHER,RATIONALE,REGRESSION,RESULTS,SELECTIVE,TESRA,TREATMENT,ULTIMATELY,USING,VALIDATION
18F,AXILLAR,BACKGROUND,CONCLUSION,FDG,LABEL,METHODS,PET,SCHWANNOMA
ADP,CBP,H2B,K12,THROUGH,USING
169,ASP,CNP,COPYRIGHT,MTX,THERE
001,008,118,169,226,294,654,APRIL,BNP,FOLLOWING,HOWEVER,IQR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY

169,211,252,331,AMONG,COPYRIGHT,COX,GPA,GROUP,INC,LABEL,MATERIALS,METHODS,MST,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SRS,THERAPY,TREATMENT
140,160,169,COPYRIGHT,FORCE,INC,JANUARY,LABEL,METHODS,OBJECTIVE,OLDER,OUTPATIENT,PUBLISHED,RESULTS,SETTING,THESE,UNIVERSITY
001,169,327,AUTHORS,CLINICALLY,CONTROLLED,COPYRIGHT,CRT,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RANDOMISED,RESULTS,SIB,TCP,THESE
169,237,AMONG,BACKGROUND,BPD,COPYRIGHT,CYFRA,ECL,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,ROC,SERUM,THEREFORE,WHITNEY
119,EZRIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
WORLD
495,IASLC,THESE,TNM
043,130,169,682,BACKGROUND,CONCURRENT,COPYRIGHT,III,LABEL,LTD,METHODS,NON,NSCLC,PUBLISHED,RESULTS,SECONDARY,SEQUENTIAL,SMALL,STAGE,TREATMENT
ABC,ADDITIONAL,DCN,DPT,EXPRESSION,GIANT,LUM,PCR,VALIDATION
169,946,OBESITY,SRC,STAT3,T2D,THESE
110,160,ATI,FIBONACCI,LABEL,METHODS,MTD,OBJECTIVE,PHASE,PKS,PURPOSE,RESULTS
022,024,105,169,19S,AMONG,BACKGROUND,BETWEEN,COPYRIGHT,DEL,DELETIONAL,EFFICACIES,INSERTIONS,IRELAND,L858R,LABEL,LTD,METHODS,PFS,RESULTS,TKI
HOWEVER,INCREASING,MVD,NSCLC,PCR
169,FDA,HOWEVER,MET,SEVERAL,T790M,THERE,TKI
004,177,AIR,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
116,169,COPYRIGHT,INC,RET
103,108,169,AMONG,BED,COPYRIGHT,COX,DOSIMETRIC,ESOPHAGEAL,GTV,INC,INCIDENCE,LABEL,LOCAL,MATERIALS,METHODS,MVA,NFZ,OBJECTIVE,PBT,PTV,PURPOSE,RESULTS,SIXTEEN,THERE,USING
169,COPYRIGHT,H1299,HOMOLOGUE,HOWEVER,SILENCING,THESE
PDGFS
169,H1435,NCI,NMR,USING,VCH,WILEY
CASES,JANUARY,LABEL,METASTATIC,METHODS,MRI,OBJECTIVE,RESULTS,THESE
AKT,FINALLY,ONCOGENIC,RAF,RAL,RAS
169,AMONG,CAD,COMPARISON,CONSORTIUM,COPYRIGHT,FPS,IMAGE,LAPLACIAN,LTD,THESE
169,CCDC6,FINALLY,NON,NSC,NSCLC,PARP1,RAD51,REMARKABLY,TMA
169,AMINOBENZ,ICP,NCI,NSCLC,VCH,WILEY
110,169,270,290,BACKGROUND,BECAUSE,BETWEEN,LABEL,METASTATIC,METHODS,RESULTS,SOCIETY,STUDIES
102,468,AMONG,FINALLY,H322M,INSTITUTE,MDA,NCI,STRUCTURE,THESE
HOWEVER,NON,NSCLC,T790M
955,BACKGROUND,CONCLUSION,III,LABEL,METHODS,PHASE,RESULTS,THESE
BACKGROUND,BMJ,CROSS,DEG,FURTHER,GROUP,HOWEVER,LABEL,LIMITED,MEANWHILE,METHODS,PUBLISHED,PUBLISHING,RESULTS,SEQ,UNASSIGNED
169,BOC,COPYRIGHT,DDP,LTD,MCF
ADENOVIRUS,E1A,HAT,HSPA5
ATR,AZD7762,H39,SER10,SMALL,THESE,TYR15
AMONG,BACKGROUND,CONVERSELY,HDACI,ITF2357,LABEL,NON,NSCLC,OVERALL,PEMETREXED,RESULTS,SIMILARLY,SINCE
169,CANCERS,COPYRIGHT,ITH,SCIENCE,THESE,WES
169,COPYRIGHT,DESPITE,NSCLC,SCIENCE,SPATIAL,THERE
169,945,BASEL,FAS,H2052,NAFTOPIDIL,NCI,TNF
169,5A1,6A1,COPYRIGHT,GLC,IRELAND,LTD,OATP4A1,OATP5A1,OATP6A1,OATPS,SCLCS,TREATMENT,WESTERN
160,663,956,BCL,H3255,HOWEVER
004,039,655,715,HOWEVER,ORR,PFS,SIXTY
160,169,2M0,3N0M0,4N1,ADDITIONAL,BACKGROUND,COPYRIGHT,INC,LABEL,LUMINEX,METHODS,PUBLISHED,RESULTS,SIMILARLY,SOCIETY,T1A
945,946,AKT,BACKGROUND,CONCLUSION,CXCL1,ELISA,HOWEVER,JNK,LABEL,MAP,METHODS,OBJECTIVE,PCR,RESULTS,TGF,TNF,TRANSWELL
BACKGROUND,CAUCASIAN,HOWEVER,LABEL,METHODS,THESE,TREATMENT
AFTER,AGAIN,ALDHBRIGHT,BACKGROUND,CD133,CSC,FEW,INCREASING,LABEL,METHODS,PARAMETRIC,RESULTS,TKI,TMA
171,174,BACKGROUND,C2P,CONCLUSION,COX,LABEL,METHODS,RESULTS
956,BACKGROUND,CD9,CDCP1,COLO320,CUB,DETERGENT,ENGINEERED,LABEL,METHODS,RESULTS,SW480,TREATMENT,WESTERN
ALK,ANAPLASTIC,AREAS,AVAILABLE,BACKGROUND,COVERED,III,LABEL,METHODS,NOVEL,NSCLC,OPINION,PHASE
946,ECTOPIC,EMT,EPITHELIAL,FOS,FRA,INHIBITING,MOLECULAR,TGF
001,100,107,169,177,215,ACADEMY,AFRICAN,ALLERGY,AMONG,BACKGROUND,CHILDHOOD,CONCLUSION,COPYRIGHT,IMMUNOLOGY,LABEL,LATINOS,METHODS,OBJECTIVE,RESULTS,THESE
001,004,010,015,044,048,075,158,216,284,287,296,491,510,597,936,975,BACKGROUND,CAUCASIAN,HOWEVER,ITALIAN,LABEL,METHODS,PCR,PFS,RAS,RESPONSES,RESULTS,SIXTY,TKI
946,AIM,CONCLUSION,ELISA,HOWEVER,HSP90,LABEL,METHODS,OBJECTIVE,RESULTS
001,007,129,164,169,281,COLLEGE,CONCLUSION,COPYRIGHT,GROUP,LABEL,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SARCOMA,SURGERY
004,073,100,169,BLOOD,CARDIAC,COPYRIGHT,INC,PUBLISHED,SEVENTEEN,SOCIETY,THESE,TMA
169,AUR,COPYRIGHT,CTP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,MSM,PANCREATIC,RADIATION,RESULTS,SMAD4,THERE,WHIPPLE
169,COPYRIGHT,CSF,DESPITE,IDIOPATHIC,PAP,PAS,PUBLISHED,PULMONARY,ROSEN,SINGH,SPECIALIST,WHOLE
169,BRCA1,CNS,COLLEGE,COPYRIGHT,FINALLY,LTD,PUBLISHED,ROYAL,THERE,TNBCS
AFTER,HOWEVER,JANUS
945,947,AMPAR,BACKGROUND,BARCELONA,BMJ,DISCUSSION,EEG,GROUP,LABEL,LIMITED,METHODS,MRI,PUBLISHED,PUBLISHING,RESULTS,SERUM,THREE
169,440,500,610,679,BACKGROUND,BASEL,BIOMARKER,L858R,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,THEIR
169,BACKGROUND,BASEL,EXPRESSION,FIFTY,IHC,LABEL,METHODS,MMP,OBJECTIVE,OBJECTIVES,PCR,PSP,RESULTS,THESE
169,1MM,COPYRIGHT,DFT,NMR,PET,THERE
800,ACCORDING,RDA,VITAMIN
AKT,BET,ENDOGENOUS,MYC,PANNETS,THESE
ALK,CRIZOTINIB,DIETARY,DIGESTIVE,MET,MONITORING,PROFILE,XALKORI
100,BASED,H1299,HOWEVER,NSCLC
018,025,036,042,044,046,151,473,BACKGROUND,CIS,COX,HRS,LABEL,METHODS,NSCLC,RESULTS,RTL,WOMEN
001,146,149,250,BACKGROUND,BASED,CONCLUSION,LABEL,MEIER,METHODS,NLR,PLR,RESULTS,ROC,THERE
100,150,200,AMONG,BACKGROUND,BSA,CONCLUSION,CONTINUOUS,FORTY,LABEL,METHODS,RESULTS
001,736,828,909,ACCORDING,ACTN4,BACKGROUND,CL1,LABEL,METHODS,NSCLC,RESULTS,THESE
169,200,AUTHORS,BECAUSE,FOUNDATION,JOURNAL,LTD,MOLECULAR,NON,NSCLC,WILEY
215,MODEL,PAH,STILL
169,215,ATLAS,BACKGROUND,LABEL,MOTIVATION,PRESS,PUBLISHED,RESULTS,THESE,THETA,UNIVERSITY,WGS,WXS
BCG
ACS,CCL25,DESPITE,EXPRESSION,NSCLC,SCC,SIMILAR
169,369,545,577,766,912,961,987,AUTHORS,FURTHER,IGE,LTD,SIR,THERE,WILEY
BPF,PRIMARY
001,003,042,ASSESSMENT,BACKGROUND,ELISA,LABEL,METHODS,RCAS1,RESULTS,SERUM,UNIVARIATE
000,100,231,241,262,311,AGE,ASRWS,AVERAGE,COLORECTAL,DCO,JOINPOINT,METHODS,OVERALL,RESULTS,SOFIA
ATP,AZD9291,CLASSIC,L858R,NON,NSCLC,ONGOING,T790M
791,LABEL,MANAGER,MEDLINE,METHODS,NSCLC,OBJECTIVE,RESULTS,SYSTEMATIC,THERE,VERSION,WHETHER
SIGNATURES,THESE
0MG,666,CONCLUSION,DISEASE,FOUNDATION,GROUP,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,RENAL,RESULTS,WORKING
THEREFORE
BIOMARKERS,CURRENT,EVS,MICRORNAS,REMARKABLY,THEIR
169,ATM,ATMIN,BIOLOGISTS,COMPANY,DEPLETION,DYNC2H1,EXPRESSION,H210Q,IFT,INITIALLY,LC8,LTD,PUBLISHED,WDR34
109,169,AKI,ATP,BACKGROUND,CHEMISTRY,COX,LABEL,MEIER,METHODS,PCR,PREDICTING,RESULTS,TAPSAKI,TRANSCRIPT
169,576,ASIAN,CAUCASIAN,EXPRESSION,FGFR3,HOWEVER,IL3,LABEL,METHODS,NGS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TACC3,TARGETABLE,THESE
CBP,CHROMATIN,CONVERSELY,HOWEVER,INHIBITION,SP1
108,162,169,COMPONENTS,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PARTIAL,PIC,RESULTS
038,047,160,215,500,CBDCA,EPIDERMAL,FORTY,FURTHER,LABEL,METHODS,MTHFR,NSCLC,OBJECTIVE,PEM,PURPOSE,RESULTS
FOLLOWING,PULMONARY
132,169,BACKGROUND,CONCLUSION,FINAL,FLEISCHNER,FORTY,FOUNDATION,INTER,LABEL,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,SOCIETY,THERE,THREE
155,169,215,239,241,311,364,437,453,490,674,802,892,AFRICAN,AMERICANS,AMONG,BACKGROUND,EVALUATING,FIFTEEN,HAWAIIANS,LABEL,LATINOS,METHODS,RESULTS,SNP,UGT2B10,URINARY
049,142,169,1ST,292,301,3RD,ALPHA,BACKGROUND,CLL,COLORECTAL,GREATER,HODGKIN,LABEL,METHODS,NHL,OVARIAN,PREVIOUSLY,RESULTS,SLL,THESE,TOCOPHEROL
169,ALPHA,BACKGROUND,BIOMARKERS,COLORECTAL,EPIDEMIOL,LABEL,MATERIALS,METHODS,ORS,OVARIAN,OVERALL,RESULTS,TOCOPHEROL,WOMEN
AFTER,ANOTHER,HOWEVER,RADICAL
945,947,BASED,LABEL,METHODS,OBJECTIVE,PLS,PURPOSE,RESULTS,SAMPLES,SERUM
AWARENESS,BACKGROUND,KEY,LABEL,METHODS,RESULTS
001,003,100,160,169,177,COILS,COPYRIGHT,CROWN,GROWING,INC,LABEL,MARCH,METHODS,NODULES,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PUBLISHED,RESULTS,SIXTY,THERE
160,AMPLITUDE,BACKGROUND,FDG,GATED,ITV,LABEL,MATERIALS,METHODS,MIP,NON,OBJECTIVE,PET,PURPOSE,RESULTS,UNIFORM
160,325,AFFYMETRIX,AGGRESSIVE,COCULTURE,EMT,EPITHELIAL,EXPRESSION,FORTY,GENERATED,MCF,PCR,PROTEIN,TWIST,VIM
MRI,SURGERY
382,CSC,EMT,TAKEN
AMONG,CHRONIC,LABEL,MATERIALS,METHODS,MMP12,OBJECTIVE,RESULTS,THERE,TIMP1
947,DR5,H322M,HOWEVER,IDO,IFN,INTERFERON,NCSLC,NOTABLY,NSCLC,THESE
001,117,238,355,BLOOD,HEART,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RCC,RENAL,RESULTS
101,434,ACTIVATING,ADX,AMONG,BACKGROUND,HOWEVER,LABEL,LBC,MARCH,MATERIALS,METHODS,NSCLC,REFRACTORY,RESULTS,TKI
AD5,ADENOVIRUS,AFTER,CONCLUSION,F35,LABEL,METHODS,MOI,MTT,OBJECTIVE,PCR,RESULTS,THEREFORE,WESTERN
000,011,017,018,168,267,379,513,552,577,897,967,BACKGROUND,CHINESE,LABEL,LOI,MATERIALS,METHODS,PCR,RESULTS
5TH,623,865,APRIL,BIOLOGY,CBM,CHINA,CHINESE,GSTM1,KNOWLEDGE,OVERALL,RELATED,SERVICE,WANFANG
011,401,544,586,688,AKDENIZ,AUC,BACKGROUND,BECAUSE,JANUARY,LABEL,MATERIALS,METHODS,NLR,NPV,PCR,RESULTS,SIXTEEN,UNIVERSITY
AIM,ERK,EXPRESSION,LABEL,MAPKS,MATERIALS,METHODS,MLC,MTT,OBJECTIVE,PD98059,PMA,RESULTS,WESTERN,WOUND
003,048,061,063,068,275,381,486,508,523,670,697,719,806,851,888,909,931,952,970,985,992,993,998,BACKGROUND,CHINESE,CIS,ERCC4,HOWEVER,KNOWLEDGE,LABEL,LITERATURE,MATERIALS,METHODS,ORS,RESULTS,SCIENCE,THERE,WANFANG,WEB
001,CURRENTLY,DFS,NSCLC,THEREFORE,TNM
AMONG,BACKGROUND,LABEL,METHODS,MST,NSCLC,PCR,RESULTS,THESE
BACKGROUND,CA199,CEA,LABEL,METHODS,NSCLC,RESULTS,SERUM,TKI
137,478,ALTOGETHER,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
BACKGROUND,BASED,BETWEEN,CONCLUSION,JANUARY,LABEL,MAY,METHODS,NSCLC,PBT,PFS,RBE,RESULTS,SEX,THERE
169,COPYRIGHT,LDL,LUC,MCF,PGA
123,164,169,956,ACTIVATION,APOPTOSIS,BCL,COLO320DM,COPYRIGHT,CYTOTOXIC,IRELAND,LTD,MOLECULAR,MTT,THESE,TREATMENT
169,3MA,AKR,AKR1B10,BHQ,COPYRIGHT,IRELAND,LC3,LTD,NEITHER,TBE,TBQ
002,011,100,600,800,ADC,ANOVA,CHANGES,COMMITTEE,CONCLUSION,IMAGING,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TREATMENT
001,003,013,17A,322,366,NSCLC,THESE
000,169,CONCLUSION,DISCUSSION,FURTHER,LABEL,METHODS,OBJECTIVE,OLHDE,OPTIONS,SUMMARY,VTE
169,BIOLOGY,ENDOGENOUS,HNE,I217R,INC,MOLECULAR,PR3,SOCIETY,THESE,WEGENER
001,002,169,1MONTHS,957,BACKGROUND,CIS,COPYRIGHT,JANUARY,LABEL,LTD,METHODS,NSCLC,RESULTS,TREATMENT
AAVS1,CGD,THERE,USING,ZFN
AKT,BACKGROUND,CONCLUSION,FUNCTIONAL,LABEL,METHODS,MTT,PCR,RESULTS,SHORT,TARGETSCAN,UTR
169,COPYRIGHT,INC,STRATAKIS,VON
169,ALK,ASIAN,BECAUSE,COPYRIGHT,INC,KRISTEN,NSCLC,RAF
BACKGROUND,DESPITE,DISCUSSION,ESO,EUDRACT,GRADE,LABEL,METHODS,NSCLC,THREE,TRIAL
00001,005,CHINESE

ALK,CNS,CTLA4,FGFR1,MEDICAL,METASTASES,NETWORK,RAS,SOCIETY
169,INC
160,169,277,360,429,AUTHORS,CONCURRENT,COX,EASTERN,ERLOTINIB,GROUP,ILD,JAPAN,LTD,ML21590,OCTOBER,OVERALL,POLARSTAR,PRIMARY,PTY,PUBLISHING,SCIENCE,THESE,WILEY
946,CHROMATIN,EMT,EPITHELIAL,EPRAS,FOXQ1,NOTABLY,PCR,TGF,WOUND
115,130,300,CONCLUSION,DIAGNOSIS,FLEISCHNER,HOUNSFIELD,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
000,100,169,ANOTHER,CONCLUSION,COPYRIGHT,EARLY,EMA,FETAL,HCG,LABEL,METHODS,OBJECTIVE,PUBLISHED,THERE
FINALLY,FOXO3,MICRORNAS,MIR,NSCLC,PCR,SPC,THEREFORE,TRANS,UTR,WESTERN
495,MICRORNAS,NSCLC,THESE
100,215,EPIDERMAL,IHC,L858R,PCR
027,AFTER,CCT,CTF,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREAFTER
APRIL,COMMITTEE,FORCE,HOWEVER,PREVENTIVE,SCREENING,SINCE,TRIAL
001,177,945,946,947,99M,CONCLUSION,LABEL,MATERIALS,METHODS,MICRO,NCI,OBJECTIVE,PURPOSE,RESULTS,SPECT
160,169,231,233,COPYRIGHT,FINALLY,FIRST,IIA,III,MOL,SEVERAL,SFBBM,THERE
956,COUNSELING,EXCESSIVE,PM2,SHORT,WESTERN,WORLD
148,234,BACKGROUND,DISTANT,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PULMONARY,RESULTS,THERE,THREE
169,3MA,AKT,BESIDES,COPYRIGHT,INC,P53,ROS,SPC,SUBSEQUENT,THESE
181,CD133,CD177,ISOLATING,NANOG,OVCA429,PROM1,SKOV3,SURVIVING,THEREFORE
000,134,491,501,ADVANCING,AMBULATORY,AUTHORS,BACKGROUND,BETWEEN,BLOOD,CARDIAC,CONCLUSION,CROSS,FUNDING,HEART,INSTITUTE,LABEL,LIMITATION,MEDICAL,METHODS,OBJECTIVE,PHYSICIAN,PRIMARY,RESULTS,SETTING
001,106,386,BACKGROUND,CHART,FIFTY,FUNCTIONAL,HOWEVER,LABEL,METHODS,MORTALITY,REGRESSION,RESULTS,SHORT
200,2ND,945,946,956,AKT,EMT,FAK,GTPASES,MOLECULAR,PC3,PCA,PREVENTING,SILIBININ,SRC,TRANSWELL
ANHUI,ANOTHER,CHEST,CONCLUSION,FIRST,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
143,177,946,AFTER,AICAR,APOPTOSIS,BAX,CONCLUSION,FURTHER,LABEL,METHODS,MRC,MTT,OBJECTIVE,PEE,RESULTS,THESE,TUNEL
169,203,AUTHORS,COPYRIGHT,EXPRESSION,HNSCC,INC,INDUCIBLE,LASP1,METASTATIC,NUAK1,PUBLISHED,SPARC,USING
169,AUTHORS,COPYRIGHT,GILFORD,HUTCHINSON,INC,PUBLISHED,RESISTANCE
231,AKT,EMT,ERK,HOWEVER,MDA,PCR,PIGMENT,SKBR3,THESE,WESTERN
946,EMT,HOWEVER,METASTATIC,TGF,THESE
CLINICALLY,DUB,FURTHER,HOWEVER,MYC,UBIQUITIN,USP37,WARBURG
ARSENIC,HOWEVER,INORGANIC,KOREA,SOUTH,THERE,WHILE
177,ABL,ERK,G12,NSCLC,RAS,REDUCED
031,069,169,BACKGROUND,CURRENT,INCREASING,LABEL,METHODS,NSCLC,OVERALL,RATES,RESULTS,SOCIETY,SPLCS,THERE,TOBACCO
B54,CHRONIC,DESPITE,DPB,HLA,KV1,TEN
001,160,169,AMIODARONE,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,MEDICAL,METHODS,PUBLISHED,RESULTS,SOCIETY
169,181,231,H1299,MDA,MEL,MRC,NCI,THREE,VCH,WILEY
169,ABUNDANCE,AUTHORS,INSTEAD,PROTEOMICS,PUBLISHED,VCH,WHILE,WILEY
169,947,ADDITIONAL,AFTER,AMYLOID,APP,BP1,COMPLEX,GSI,HYPOXIC,INC,KEY,NOTCH,NSCLC,PRECURSOR,PROTEIN,RAPAMYCIN,TARGETING,TORIN,WILEY
946,BACKGROUND,BAX,BCL,HOUTT,LABEL,METHODS,MTT,RESULTS,RUMEX
169,954,COPYRIGHT,DIAGNOSTIC,INC,KEY,LABEL,METHODS,MIDKINE,MNG,NUCLEAR,OBJECTIVE,PROTEIN,PTC,RESULTS,ROC,WESTERN
530,CONCLUSION,LABEL,MAC,METHODS,OBJECTIVE,OBJECTIVES,PHYSICIANS,RESULTS,SIX
AFTER,AKT,ALONG,AMONG,BUZHONG,CISPLATIN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TOTALLY
100,169,ACCORDING,BEL,BRAIN,COMPONENT,COPYRIGHT,EMOTIONAL,HGG,LTD,PCA,PRINCIPAL,THEREFORE
169,ABCG2,BCRC5,CD133,COPYRIGHT,EMT,HOWEVER,LTD,NANOG,NSCLC,THESE
001,008,014,168,169,BACKGROUND,COPYRIGHT,EXHALED,INC,LABEL,METHODS,PNEUMONIA,RESULTS
100,169,183,300,400,600,BACKGROUND,CHEST,COLLEGE,COPYRIGHT,FONDS,FUNDING,IMMEDIATE,LABEL,LTD,MANAGEMENT,METHODS,NEDERLAND,PHYSICIANS,RESULTS,SMALL,WILHELMINA
003,005,102,169,183,187,196,822,BACKGROUND,COPYRIGHT,CTS,FONDS,FUNDING,HOWEVER,III,INITIALLY,IQR,LABEL,LOW,LTD,METHODS,NEDERLAND,RESULTS,SCREENING,WILHELMINA
160,169,COPYRIGHT,INC,MYCOLOGIC,PUBLISHED,RADIOLOGIC,RESOLUTION,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY,VHL
169,ADHERENCE,BACKGROUND,CHEST,COPYRIGHT,COVARIATES,CURRENT,CXR,EFFORTS,END,IMAGING,INC,LABEL,METHODS,NETWORK,NSCLC,PET,PUBLISHED,REDUCED,RESULTS,SOCIETY
128,136,160,169,505,BACKGROUND,CHF,CIS,COPYRIGHT,COX,HRS,IHM,INC,LABEL,METHODS,ONTARIO,ORS,PATIENT,PDM,PUBLISHED,RESULTS,SOCIETY
000,253,288,423,500,697,700,946,USING,WNT
144,177,500,CT1,DSC,HAUSDORFF,INCREASING,LABEL,MBQ,METHODS,OBJECTIVE,ORGAN,PET,PURPOSE,RESULTS,SIMPLIFIED,VOI,VOLUMES,ZIRCONIUM
AGREEMENT,IMAGE,IRB,LABEL,LINAC,METHODS,NCC,OBJECTIVE,PROJECTION,PURPOSE,RESULTS,RMC,USING
075,215,BECAUSE,FFT,KODAK,LABEL,LANEX,LAPLACIAN,LARGEST,METHODS,OBJECTIVE,PI200,PURPOSE,RESULTS,VISICOILS,XRD
176,AUSTRALIA,AUSTRALIAN,DOSIMETRY,LABEL,LEVEL,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,RESULTS,SCORING,SERVICE,TOLERANCE
000,175,256,947,COMBINING,CPU,GPU,LABEL,METHODS,NVB,OBJECTIVE,PURPOSE,RESULTS,THERE
EVALUATION,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS
169,240BP,CCAAT,COPYRIGHT,FOS,FURTHER,GIVEN,HOWEVER,LNCAP,PKC,PMA,PRMT5,PROTEIN
001,077,108,157,161,169,250,500,6VERSUS,877,BACKGROUND,COMMITTEE,CTONG0806,IDENTIFIER,IRC,LABEL,MEDICAL,METHODS,NSCLC,PFS,PRESS,PUBLISHED,QUALITY,RESULTS,SOCIETY,UNASSIGNED,UNIVERSITY
169,PRESS,PUBLISHED,SURGERY,UNIVERSITY
169,AZD3965,INHIBITION,THESE
169,DESPITE,USING,VARIOUS
169,COPYRIGHT,FINALLY,INC
008,124,169,427,BACKGROUND,CCI,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,NSCLC,PROPENSITY,PSM,RESULTS,SLR
019,031,169,177,AGGRESSIVE,AGING,BLOOD,CONCLUSION,COPYRIGHT,DEFICIENCY,HEART,INC,INSTITUTE,LABEL,LOH,MATERIALS,METHODS,OBJECTIVE,PCA,RESULTS,THERE,THESE
001,169,AFRICAN,CHRNA,CHRNB,FURTHER,GIVEN,SNP,UTR
BACKGROUND,BNA,CIS,DISCUSSION,ITEMS,LABEL,MEDLINE,METHODS,MOOSE,ORS,OVERALL,PREFERRED,REPORTING,REVIEWS,STUDIES,SYSTEMATIC
169,946,ADC,FAK,HOWEVER,LABEL,NSCLC,SCC,TAF,THESE,UNLABELLED
169,COPYRIGHT
150,169,300,ANTISENSE,ASSOCIATED,EXPRESSION,FUNCTIONAL,HOX,INTERGENIC,METASTASIS,MKN45,PCR,PRESS,PUBLISHED,SIRNA,TRANSCRIPT,UNIVERSITY
946,ATLAS,ATTENUATED,BACKGROUND,CD11B,CONCLUSION,CXCL1,DNIIR,GR1,HOWEVER,LABEL,MAMMARY,METHODS,MMTVNEU,NEU,PREVIOUSLY,RESULTS,RII,TGF,VEGFA,WHOLE
135,148,169,AUTHORS,COPYRIGHT,ERLOTINIB,ILD,IRELAND,JAPAN,LABEL,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,OTHER,PFS,POLARSTAR,PUBLISHED,RESULTS
EVALUATION,MICHAEL,NAD,NADPH,PAH,ROS,THESE,USING
234,522,681,780,BACKGROUND,DESPITE,INSURANCE,LABEL,NHI,PRINCIPAL,RESULTS,THEREFORE
18F,FDG,III,LABEL,METHODS,OBJECTIVE,RESULTS
18F,BACKGROUND,CONCLUSION,FDG,FVC,LABEL,METABOLIC,METHODS,PET,RATIONALE,RESULTS,SUV,THERE
001,177,588,800,942,AMONG,BACKGROUND,CAH,CONTEXT,CYP21A2,INCLUDING,LABEL,METHODS,MORTALITY,OBJECTIVE,OUTCOME,REPORTS,RESULTS,SETTING,THERE
122,124,169,695,BEADARRAYS,HOWEVER,KEAP1,LABEL,LCNEC,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMARCA4,SQCCS,STK11,SUBGROUPS,WHOLE
160,169,BACKGROUND,CONCLUSION,COPYRIGHT,DCR,EPC,IAP,LABEL,METHODS,NUCLEOTIDE,PUBLISHED,RESULTS
169,409,AKT,BACKGROUND,BASEL,COX,FUNCTIONAL,LABEL,LAD,LOW,MET,METHODS,MIR,OBJECTIVE,PCR,RESULTS
ACCORDING,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SAMPLES
169,CONCLUSION,END,INFLUENCE,LABEL,MEASURE,METHODS,OBJECTIVE,OUTCOME,PROPENSITY,RESULTS,SETTING
004,317,394,711,BACKGROUND,HOWEVER,JANUARY,LABEL,METHODS,MLS,NSCLC,RCT,RESULTS,SML,THERE,THESE
ANXIETY,FEW,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,USING
169,COPYRIGHT,LTD,PEGYLATION,PEI,TAKEN
946,BACKGROUND,CD1,LABEL,MET5A,METHODS,RESULTS,SELECTIVE
169,AKT,COPYRIGHT,FOXA2,FURTHER,INC,KNOCKDOWN,MEP50,MICROARRAY,MYC,PRMT5,RAS,WESTERN
169,ASO,BACKGROUND,BASEL,LABEL,LOW,LUCIFERASE,MEIER,METHODS,MIR,MTT,NON,NSCLC,PCR,RESULTS,WHETHER
006,169,AUNPS,BIO,COPYRIGHT,DELFTIA,KCM,RSV
AKT,HOWEVER,MEK,ONCOGENIC,RAT,SARCOMA,SIGNALING
150,AKT,DCR,ERK,MEK,NSCLC,OVERALL,PFS,SEPTEMBER,SEVERAL
946,BOX,FURTHER,GROUP,HMGB1,PKA
BACKGROUND,DISCUSSION,GALLIUM,INCREASING,LABEL,MAA,MACCALLUM,METHODS,NON,NSCLC,PET,PETER,RADIATION,THESE,TRIAL,U1111,UNIVERSAL,UTN
117,169,171,215,BASED,BECAUSE,COPYRIGHT,LTD,WILEY
169,280,C60,COPYRIGHT,III,LTD,MULTIMODE,WILEY
ACCORDING,BASED,CHINESE,CONCLUSION,LABEL,MEDICINAL,MEDICINES,METHODS,OBJECTIVE,RESULTS,TCM
NANOG,OCT,STUDIES,THOSE
ADDITIONAL,AMONG,BACKGROUND,CURRENT,DIPNECH,FORTY,LABEL,METHODS,RESULTS
122,152,190,275,338,520,522,556,718,816,824,946,DFS,INCREASING,LMR,NSCLC,UNIVARIATE
001,004,014,033,034,049,054,131,133,151,171,177,230,311,336,435,456,628,813,974,984,995,AGING,BACKGROUND,CURRENT,DISEASE,FVC,GROUP,HOWEVER,IPF,LABEL,METHODS,RESULTS,THESE
17P,233,AKT,DUB,ERK,RENAL
127,176,946,DSC,FOURIER,FRANZ,HYDROGELS,MTT,PBS,PEO,PF127,SEM,XRD
18F,ERLOTINIB,FDG,PET
004,086,170,295,391,531,877,950,ATS,BACKGROUND,DFS,DRESLER,IASLC,LABEL,LNS,MEIER,METHODS,NSCLC,RESULTS,SOCIETY
169,226,AIM,ANTICANCER,ARM,CONCLUSION,COPYRIGHT,FIFTY,INSTITUTE,LABEL,METHODS,NON,NSCLC,OBJECTIVE,ORR,PFS,RESULTS,SMALL,THERE
169,946,ADC,AIM,ANTICANCER,CAS,CONCLUSION,COPYRIGHT,FIFTY,INCREASED,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC
169,945,946,ACCORDING,ANCHORAGE,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INSTITUTE,LABEL,MATERIALS,METHODS,MTT,OUABAIN,RESULTS
123,169,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INSTITUTE,LABEL,MATERIALS,METHODS,MPP,NSCLC,RESULTS
169,ANTICANCER,ANY,COPYRIGHT,INSTITUTE,MRI,REGULAR,STS
169,ANTICANCER,COPYRIGHT,DESPITE,INSTITUTE
169,ANTICANCER,CLASSICAL,COPYRIGHT,INSTITUTE
004,009,016,060,160,197,304,501,CONCLUSION,DFS,DISEASE,GGN,KEY,LABEL,MAXIMAL,METHODS,OBJECTIVE,RESULTS
1RA,414,548,946,BACKGROUND,CCL,CCL11,CCL17,COLORECTAL,CRP,CURRENT,EOTAXIN,LABEL,METHODS,ORS,OVARIAN,PRESS,PUBLISHED,RESULTS,SCREENING,SMOKING,THESE,TRIAL,UNIVERSITY
546,INITIAL
169,AFTER,DUE,EPHB4,MFH,NVP,SEVERAL,SILENCING,STS,THEREFORE
BACKGROUND,BASED,LABEL,METHODS
000,BASED,GWASS,LOG,MINUS,OTHER,SELECTING,SNP,SUCCESSFUL

100,160,945,BACKGROUND,BRONCHIAL,CD1,CD3,HOWEVER,IGH,LABEL,METHODS,PCR,PPL,PRIMARY,RESULTS,UNASSIGNED,VIA,VIRTUAL
001,003,045,169,733,945,951,ALK,AMONG,BACKGROUND,CONSORTIUM,KIRSTEN,LABEL,MET,METHODS,RAS,RESULTS,SOCIETY,THESE,V600E
037,045,047,051,FURTHER,MENDELIAN,OVERALL,THERE,TOTAL,USING,WMD
HOWEVER,MED23,NSCLC,RAS,TCF
126,160,179,956,AIR,BACKGROUND,BEIJING,BTDAS,CHINA,CONCLUSION,ELEMENTAL,FVC,HOWEVER,IQR,LABEL,METHODS,POLLUTION,RESULTS,TRUCK

NON,NSCLC,STAT3,THESE,WHILE
DESPITE,HOWEVER,LIVER,THESE
BRIEFLY,CADMIUM
AZD9291,DESPITE,EGFRM,EPIDERMAL,FOLLOWING,NSCLC,T790M,TKI
001,006,100,194,393,409,442,464,BACKGROUND,CALORIC,CONTROLLED,CURRENT,ENGLISH,INSTITUTE,KINGDOM,LABEL,METHODS,RESULTS,THERE
001,110,130,142,170,185,ACS,AFTER,CXCR5,H1915,NCI,NUCLEAR,SCC,SERUM,THESE
100,120,169,215,945,AMGEN,BAL,BLOOD,COPYRIGHT,IDIOPATHIC,INC,IPS,OVERALL,PUBLISHED,SOCIETY,TNF
169,ALTERED,BECAUSE,BIOLOGY,DEFECTIVE,MOLECULAR,SLC26,UNION,ZIP
954,AKT,COX,HOWEVER,MAPKS,MMP,THESE
169,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,ZEALAND
III
ECM,THREE,VARIOUS
FURTHER,HOWEVER,MALAT,PANCREATIC,THEREFORE
169,344,GUA,HPB,METASTASIS,NNK,PHB,POB,PRESS,PUBLISHED,PULMONARY,SIMILAR,TOTAL,UNIVERSITY
ACCORDING,DOTATOC,USA
169,946,AUTHORS,HAT,HOWEVER,IFN,INSTEAD,KAT2A,KAT2B,VIRAL
BASED,CRF,CURRENT,CVD,INC,NON,PUBLISHED
160,169,72H,956,ADP,CDK,CELLS,COPYRIGHT,INC,MTT,PHELLINUS
CENTROSOME,EG5,IGF,NSCLC,PPP,THESE
005,006,AES,BACKGROUND,CIK,CIS,DCR,DISEASE,EFFICIENCY,HOWEVER,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS,RRS,SIX,TEMPORARY,THEREFORE
916,CNR,COMMITTEE,CONCLUSION,DRR,EPL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DUE,FURTHER,HENCE,NPS,THESE,TOXIC
023,041,CHINESE,LOW,PXR,THESE,UTR
945,BASED,CCDC131,CSRC2,DROSOPHILA,ERCC1,TNF
108,10878,177,BACKGROUND,EARLY,FURTHER,LABEL,METHODS,OCTOBER,RESULTS,TREATMENT
160,169,183,AFTER,CONCLUSION,CONSISTENT,GEORG,HISTORY,LABEL,METHODS,SERUM,SIADH,STUTTGART,TREATMENT
GIVEN,RCC,THEREFORE
169,519,AFP,BACKGROUND,CONCLUSION,EIGHT,FOUNDATION,HCC,ITPAS,LABEL,METHODS,MULTI,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,THEIR,THESE
169,613,831,ACT,AFFAIRS,AFTER,CENTERS,CHANGES,CONCLUSION,CONSORTIUM,CRC,FFS,IHN,IMPORTANT,LABEL,MEDICAL,METHODS,MMA,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
AFTER,ALK,NSCLC,ONCHEST
1000NMOLL,169,998,COPYRIGHT,IMPRINTED
000,AGGRESSIVE,AMONG,ASCL1,CLL,NSCLC,SEQ
169,221,453,672,679,845,860,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RATES,RESULTS
169,356,AFTER,CHINESE,COPYRIGHT,INDEX,INSURANCE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOTALLY
945,AUTOCAD,EOV
946,AP4,HEPG2,NSCLC,SINCE,SMAD2,TAKEN,TGF,USING
AFTER,AKT,GDP,HOWEVER,MMP,RHO,RHOGDI2,VERIFYING
169,ACADEMY,AFFILIATED,AIM,CAREFUL,COPYRIGHT,LABEL,LTD,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,RIS
BACKGROUND,HOWEVER,LABEL,METHODS,RECURRENCE,RESULTS,SRC,STAT3,TREFOIL
HOWEVER,LABEL,MALIGNANT,MPM,OPINION,SEVERAL,STATEMENT,UNASSIGNED
ALK,CURRENTLY,HGF,LABEL,MET,OPINION,PROLONGED,STATEMENT,UNASSIGNED
AFTER
CLEARANCE,CMV,CTL,E2A,EBV,EPSTEIN,PHA
100,BACKGROUND,DOX,EGF,GNP,INHALATION,LABEL,MMP,OVERALL,RESULTS
100,119,158,177,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,SINCE,SURGERY,USING
GIVEN,PROVIDING
143,183,336,341,APRIL,ASSESSMENT,BACKGROUND,BETWEEN,CONCLUSION,EARLY,INTERVIEWS,LABEL,MARCH,METHODS,MNA,OBJECTIVE,RESULTS,TRIAL
500,504,956,AGE,AMONG,CD4,CONCLUSION,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
PSA,SCREENING,SEVERAL
BASED,CHRONIC,RCF,SCOEL,THEREFORE
913,924,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
001,003,018,028,046,069,608,613,710,CEA,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,ROC,SERUM
183,BACKGROUND,GEORG,HOWEVER,LABEL,METHODS,MINIMALLY,NAS,NSC,PDK,PIRITRAMID,REGARDLESS,RESULTS,ROPIVACAIN,STUTTGART,SUFENTANIL
250,ALK,AMONG,BACKGROUND,CRIZOTINIB,LABEL,MET,METHODS,NSCLC,RESULTS
169,228,ASPCR,CONCLUSION,COPYRIGHT,EPIDERMAL,FNA,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RGQ,THEREAFTER
001,030,114,169,324,3CM,CONCLUSION,COPYRIGHT,COX,DISEASE,FDG,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS
001,002,135,169,203,239,259,CONCLUSION,COPYRIGHT,COX,EPIDERMAL,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,THESE,TKI
AMPLIFIED,ATOH1,BESIDES,CRC,HES,HOWEVER,MASTERMIND,NCOA3,NOTCH
DROSOPHILA,EPIDERMAL,EPS15,PDZ,PTPN3,RAS,TAKEN,USING
210,945,A549L,ACTIVATION,AKT,DOWNSTREAM,HIF,P85,RAD52,THESE,VMP
169,946,DVL,HBE,HEK293T,HOWEVER,INC,INCREASED,P120CTN,THESE,TNM,WESTERN,WILEY,WNT,ZBED3
100,177,179,181,185,CHLORAMINE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,ROI,SPECT,THESE,ZEALAND
185,945,946,CD8,CONCLUSION,HLA,LABEL,METHODS,OBJECTIVE,RESULTS,TCR,THESE,WT1
120,169,215,AAT,AMINO,BACKGROUND,COPYRIGHT,DU145,INC,LABEL,MB468,MDA,METHODS,PET,RESULTS,SIMILAR,SKOV3,THESE,U87
100PG,169,174,ARCHITECT,BACKGROUND,CHINA,CHINESE,COPYRIGHT,ELECSYS,INCREASED,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,THERE
100,185,CHEST,CHINESE,FDG,GENERAL,HODGKIN,LABEL,METHODS,NHL,OBJECTIVE,PET,PLA,PPL,RESULTS,SINCE,SPL,SUV,THERE
169,CEM,COMPOUNDS,COPYRIGHT,EFFICIENT,L1210,LTD,NCI
156,169,204,360,COPYRIGHT,COX,DFS,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
169,COPYRIGHT,LTD,MALIGNANT,MPM
ABCG2,ATP,CD133,CSC,PRIMARY
103,176,229,423,762,APRIL,BETWEEN,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RCT,RESULTS,THOSE
001,002,003,018,035,133,154,169,514,BIOLOGY,CHINA,CNB,COLOR,COPYRIGHT,DOPPLER,FEDERATION,HOWEVER,INC,MEDICAL,PUBLISHED,ULTRASOUND,UNIVERSITY,WORLD
169,CHEST,COPYRIGHT,LTD,MANAGEMENT,PATIENT
169,COPYRIGHT,CXCL8,HEL,IE1,INC
ASIAN,CAUCASIAN,CONCLUSION,K109R,LABEL,METHODS,OBJECTIVE,ORS,OVERALL,PURPOSE,RESULTS,SNP,THESE
CHEST,CONCLUSION,DUE,HISTOLOGY,LABEL,METHODS,OBJECTIVE,PET,PULMONARY,PURPOSE,RELATIVELY,RESULTS,SUV
131,185,99M,99MTC,CONCLUSION,CTV,DIAGNOSTIC,GTV,LABEL,MBQ,MDP,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SPECT
CONCLUSION,LABEL,LIVIN,METHODS,MTT,OBJECTIVE,PCR,PURPOSE,RESULTS,TUNEL,WESTERN
017,020,177,AFTER,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,STUDENT,TREATMENT
001,338,368,403,486,552,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OPN,PEARSON,PFS,PURPOSE,RESULTS
169,AGS,CD8,COPYRIGHT,HLA,INC,THEIR,THESE
001,025,169,BRITISH,COMMITTEE,CONFERENCE,DIAMOND,HILTI,HYGIENE,HYGIENISTS,INDUSTRIAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RCS,RESPIRABLE,RESULTS,SCIENTIFIC,SOCIETY,TOTAL,UNIVERSITY
002,051,080,169,220,327,362,419,537,663,796,CONCLUSION,COPYRIGHT,HOWEVER,HSP70,IIA,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
125,169,327,614,665,BACKGROUND,BETWEEN,CHINA,COPYRIGHT,DCR,ILD,IRELAND,LABEL,LTD,METHODS,NSCLC,ORR,PFS,RESULTS
160,DESPITE
100,169,947,COPYRIGHT,INC,INTENSITY,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,PATIENT,PURPOSE,RBE,RESULTS,V20,V40,V60
142,169,934,AFTER,CONCLUSION,COPYRIGHT,COX,DUTCH,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METASTASIS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VAS,VRS
000,169,350,500,956,AFTER,B12,BACKGROUND,CONCLUSION,LABEL,METHODS,PRESS,PRIOR,RESULTS
ACUTE,BACKGROUND,HOWEVER,ILM,LABEL,LOCAL,METHODS,NSCLC,OTHER,PEARSON,PFS,PTV,RESULTS
100,169,955,956,BARRETT,CACO3,CAR,COPYRIGHT,DOX,FOURIER,HALENDA,RAMAN
BASIS,DISCOVERY,MEANWHILE
000,480,DESPITE,SINCE,TODAY,WOMEN
014,020,042,916,9FL,COX,DFS,MEIER,NSCLC,THESE
001,003,169,916,936,956,COPYRIGHT,ROS,SAS,SRB
114,169,239,400,750,ALK,CERITINIB,EXTRACTION,LABEL,LITERATURE,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,SCHOLAR,SELECTION,SOURCES,SYNTHESIS
169,177,BACKGROUND,CONCLUSION,COPYRIGHT,IIA,INC,LABEL,METHODS,MOLECULAR,NSCLC,RECURRENCE,RESULTS
025,077,135,169,753,ACCORDING,CHI,COPYRIGHT,DESPITE,GSTP1,KRUSKAL,NSCLC,TNM,WHITNEY
BACKGROUND,CAREFUL,FEV,LABEL,MEDICAL,METHODS,PREDICTED,RESULTS,THESE
091,138,234,326,462,967,DFS,GLASGOW,GPS,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SIMILAR
105,BMJ,GROUP,LTD,PUBLISHING,THERE
169,COPYRIGHT,ERK,HOWEVER,IRELAND,LTD,MEK,NSCLC,OTHER,RAF,TRAMETINIB
160,187,AGE,PGR,SIMILARLY,TNM
118,NOR
145,169,495,COPYRIGHT,EGF,HOWEVER,INC,LOOCV,MICROARRAY,NSCLC
CARLO,GSA,MONTE,THERE
DELAYED,DESPITE,IPA,MWA,THREE
TECHNIQUES
001,160,359,460,CRP,GLASGOW,HOWEVER,LDH,PROGNOSTIC,SCORE,UNIVARIATE
200,272,318,CD133,CRTC2,NSCLC,NSCLS,PCR,PREVIOUSLY,PROM1
169,FGF,LTD,PUBLISHED,RGP,SNAI2,THESE,TSP,VEGFR,WILEY
956,AF4,FURTHER,HEPG2,OVERALL,SORAFENIB,SPY,TREATMENT,WESTERN
169,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE
CONTROL
169,ACT,AFFORDABLE,CALIFORNIA,CCR,COLLECTION,CONTINUOUS,DISCHARGE,EXPANSION,EXTRACTION,LABEL,METHODS,OBJECTIVE,PATIENT,PDD,PRINCIPAL,RESULTS,SOURCES,TRUST
160,AFFILIATED,BACKGROUND,CHINA,CONCLUSION,FIRST,LABEL,MEDICAL,METHODS,OCTOBER,PANCREATIC,PMS,RADICAL,RESULTS,SEVEN,THREE,UNIVERSITY
050,169,BAY,BOARD,CONCLUSION,FDG,FIFTY,FMT,FURTHER,HNSCC,IMAGING,INC,LABEL,LAT,METHODS,MOLECULAR,NSCLC,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,UNLABELLED
169,III,IMAGING,INC,MOLECULAR,NUCLEAR,PEPTIDE,SOCIETY
AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,LIMITED,METHODS,OPINION,SIMILARLY,SMALL
945,946,954,TARGETING
169,240,384,946,ACR,AKT,BRITAIN,CCL19,CCL21,CCRL1,CLINICALLY,COPYRIGHT,GREAT,HCC,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
28A,946,AD5,ADF35,BACKGROUND,CAR,EXPRESSION,LABEL,METHODS,RESULTS
001,160,169,216,979,BACKGROUND,COPYRIGHT,INC,JANUARY,JRS,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,SOCIETY,THERE,UNIVERSITY
00049,169,177,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METASTASES,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,SIR
BACKGROUND,FIBULIN,LABEL,METHODS,RESULTS

AFTER,GRADE,IHC,LABEL,LND,LNS,LNU,MEIER,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,RFS,THEREFORE
946,AUNPS,AZO,AZOBENZENE,FERROCENE,GFP,HOWEVER,USING
ACA,ALK,BACKGROUND,CONTEXT,ERBB2,LABEL,METHODS,OBJECTIVE,RET,SOURCES
231,2BS,630,CIS,DDIT4,EP300,H1299,HOWEVER,MDA,PARP3,THESE,UTR
017,029,031,045,967,CHINESE,HAN
DURAL,ESOPHAGEAL,THERE
384,ADJUSTING,BACKGROUND,CELLS,ERCC1,GENERAL,LABEL,METHODS,PLEURAL,PRIMARY,RESULTS
13072,169,207,BACKGROUND,EASTERN,END,FIFTY,FORTY,GROUP,LABEL,METHODS,PRESS,PRIOR,PUBLISHED,RESULTS,UNIVERSITY
160,177,207,614,BACKGROUND,CHRONIC,DIAGNOSIS,JAPAN,LABEL,MARCH,METHODS,PHYSICIANS,PROCEDURE,RESULTS
AREAS,BACKGROUND,COVERED,LABEL,METHODS,NSCLC,OPINION
160,BETWEEN,BSA,HOWEVER,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,THERE,THREE
BACKGROUND,BTBD7,DISORDERS,HOWEVER,INCREASED,LABEL,METHODS,RESULTS,WESTERN
CHEST,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
001,002,015,017,022,023,031,033,039,045,COX,HUR,NSCLC
MORPHOLOGY,S6K
000,100,BECAUSE,INHIBITION,METHODS,REGARDING,THERE
BASED,CURRENTLY,SIMILAR
169,191,946,BASP1,CSC,EMT,HBE,INC,THERE,WILEY,WNT,WT1
169,332,ALK,ANAPLASTIC,BAR,CLB,ERK,HOWEVER,INC,SAMPLES,STAT3,TAKEN,THESE,WHEREAS,WILEY
126,169,BACKGROUND,III,INC,LABEL,METHODS,PRETEXT,PROCEDURES,RESULTS,WILEY
177,300,600,CONCLUSION,DELIVERED,FORMULA,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,REDUCED,RESULTS
023,107,169,BACKGROUND,CONCLUSION,EWING,EWS,INC,LABEL,METHODS,PROCEDURE,RESULTS,WILEY
BACKGROUND,LABEL,METHODS,MMP,MMP19,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,TAKEN
003,749,779,887,953,954,BACKGROUND,LABEL,LNCRNAS,METHODS,NUCLEOTIDE,PATHWAY,PCR,RESULTS,THERE
030,239,870,ABO,ADC,BACKGROUND,CHROMOSOME,CLUSTER,COX,DIAGNOSTIC,IHC,IL1R2,LABEL,METHODS,NCK,NK2,NSCLC,PFS,PHASE,PREVIOUSLY,RESULTS,THESE,TRAF2,TREATMENT
257,270,366,449,CONCLUSION,IMD,LABEL,METHODS,NLP,OBJECTIVE,PURPOSE,RESULTS,ROC
946,ANIMALS,DYING,MERTK,TGF,THESE,USING
630,643,72ARG,896,909,BACKGROUND,CISPLATIN,ERCC1,FRAMINGHAM,LABEL,METHODS,OTHER,RESULTS,RIFLE,SCR,TAIWANESE
100,CONCLUSION,DISCOVERY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIX,STE,SUV
169,ACIDS,ATM,FBXL5,HOWEVER,NUCLEIC,PRESS,PUBLISHED,SCF,THEREFORE,UNIVERSITY
100,169,382,530,ACIDS,MSG,NUCLEIC,PRESS,PUBLISHED,REDUCED,UNIVERSITY
389,EGF,III,NEUREGULIN,NTS,NTSR1
169,COPYRIGHT,DCR,EPIDERMAL,ERLOTINIB,EXPRESSION,FORTY,G719X,HGF,HOWEVER,IRELAND,L858R,LABEL,LNA,LTD,MARCH,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PCR,PFS,PNA,RESULTS,SIX
169,COPYRIGHT,IRELAND,LARGE,LTD,UNTIL
169,409,CONCLUSION,COPYRIGHT,IGF1R,INGENUITY,ION,IRELAND,KIT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PANEL,PGM,PROVEAN,RESULTS,SEQUENCER,THERE,VARIANT
167,ANXIETY,FCS,HOWEVER,IL1,IL1R2,LABEL,METHODS,NFKB2,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,USING,VARIATIONS
30B,30C,BACKGROUND,CDS,H23,INCREASING,KNOCKDOWN,LABEL,LUCIFERASE,METHODS,MICRORNAS,MTT,NSCLC,PCR,RAB18,RESULTS,THESE,WESTERN
125,169,703,BACKGROUND,BMI,CCL13,CCL19,COLORECTAL,CRP,CXCL5,CXCL6,ENA,FDR,HOWEVER,LABEL,MARKERS,MCP,METHODS,MIP,ORS,OVARIAN,RESULTS,SCREENING,SDF,TRIAL
169,BRITISH,CONTACT,COPYRIGHT,LTD,PUBLISHED
IRASA
003,011,013,040,044,114,COX,LABEL,LYMPHATIC,METHODS,OBJECTIVE,RESULTS,THERE
ADVERSE,STAGE
5MM,HCC,HOWEVER,III,IVC,LOW,THEREFORE
177,18F,197,251,FDG,FINALLY,MTV,NSCLC,PET,SUV,SUVMEAN,THERE,TLG,TNM
050,062,100,177,956,ALKYL,EPC,MRI,PEI2K,SEVEN
160,EPOXIDE,HOWEVER
239,CONCLUSION,EMA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,RESULTS,SEQUENCES,WEIBULL,WHILE
177,AHI,ECG,HEART,HRV,OSA,PACO2
100,5A4,ALK,BACKGROUND,BASED,BIOVIEW,FDA,FORTY,HOWEVER,IHC,LABEL,METHODS,NOVOCASTRA,NSCLC,RESULTS,THERE,VENTANA,VYSIS
001,177,AFTER,BELGIAN,CONCLUSION,DUTCH,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,SCREENING,TRIAL
CONCLUSION,IMAGING,LABEL,OBJECTIVE
104,CONCLUSION,EARLY,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGRAM,RESULTS,THREE
184,AGE,BECAUSE,ELECTRONIC,GIVEN,HOWEVER,SURVEYS,TOBACCO,UNTIL,YOUTH
ABOUT,HOWEVER,OVERALL
257,ABSTRACTS,APRIL,DATABASES,EXTRACTION,FDG,IMPORTANCE,LABEL,LOWER,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OUTCOME,PET,RELEVANCE,RESULTS,SCIENCE,SELECTION,SEVENTY,SOURCES,STUDIES,SYNTHESIS,THERE,THESE,WEB
169,BACKGROUND,BASEL,GAMMA,KNIFE,LABEL,LEKSELL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,TEN,USING
004,108,131,173,177,BACKGROUND,COX,EVALUATION,FIFTY,LABEL,MEIER,METHODS,NSCLC,RESULTS,SOLID
150,175,AES,AFTER,BACKGROUND,BORTEZOMIB,DESPITE,GRADE,HOWEVER,III,LABEL,METHODS,RESULTS,SECONDARY
ALK,CRIZOTINIB,NSCLC,SINCE
100,120,395,541,573,BACKGROUND,CNS,CONCLUSION,FIRST,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,SIXTY,TKI
AGE,AIM,APRIL,BCA,FIFTY,FURTHER,JANUARY,LABEL,METHODS,OBJECTIVE,PET,RESULTS,TNM
18F,FDG,PET,PULMONARY,STOMACH
NEITHER,PRIMARY,TTF

BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,SEVERAL,SINCE,WHILE
028,169,BACKGROUND,CONCLUSION,COPYRIGHT,ERCC1,EXPRESSION,FIFTY,GENOMIC,GREATER,HOWEVER,INC,INSERTION,LABEL,METHODS,MTHFR,PEMETREXED,PFS,RESULTS,SNP,USING,UTR
001,003,106,124,169,272,318,507,544,BACKGROUND,BECAUSE,CONCLUSION,CONCURRENT,COPYRIGHT,COX,ERLOTINIB,FACTORING,FURTHER,INC,LABEL,METHODS,NSCLC,PERTINENT,PFS,RECORDS,RESULTS,STAGE,TKI
169,COPYRIGHT,DESPITE,III,INC,NSCLC,STUDIES
169,COPYRIGHT,INC,NEWLY
001,004,169,225,706,AIM,COPYRIGHT,III,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SNP
ADM,HOWEVER,OSM,THESE
954,956,COX,ERK,FURTHER,MG132,RESULTS,U0126
169,COPYRIGHT,IMAGING,INC
169,CANDIDATES,COPYRIGHT,INC,MELANOMAS,METASTATIC
169,ACIDS,MIZ,NUCLEIC,POK,PRESS,PUBLISHED,SHORT,UNIVERSITY,ZNF509L
060,160,476,659,772,APRIL,ILD,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,OPTIMAL,PURPOSE,RESULTS,THEIR,THEREFORE
004,169,947,HOWEVER,P63,SCC
CHEST
BACKGROUND,CONCLUSION,GENITAL,HPV,LABEL,METHODS,THESE
169,945,961,COPYRIGHT,HMGA2,INC,KIT,UNIVARIATE,USING
H23
001,610,ANDALUSIA,BACKGROUND,III,LABEL,METHODS,RESULTS,SPAIN,THERE,THESE
100,108,ACUTE,APRIL,BACKGROUND,BETWEEN,CHART,CONCLUSION,KARNOFSKY,LABEL,METHODS,NSCLC,RESULTS,THERE,TOTAL,WHILE
169,180,808,AFFAIRS,CENTRAL,COLLEGE,CONCLUSION,DEPARTMENT,IIB,LABEL,METHODS,NETWORK,OBJECTIVE,OPTIMIZING,OVERUSE,PET,PURPOSE,RADIOLOGY,RECEIPT,RESULTS,SOCIETY
203,AKT,AQA,CQC,EMT,MEK,NON,NSCLC,THESE
HISTONE,HOWEVER,KDM2A,PDCD4,TAKEN
BFL,RGD,SV129
001,169,182,237,576,70YEARS,AGE,CCI,CIGARETTE,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECEIPT,RESULTS,SCS,THEIR,THERE,TKI
CONCLUSION,FUNCTIONAL,FURTHER,LABEL,LUCIFERASE,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE,WESTERN
169,AMONG,BLOOMBERG,HOPKINS,JOHNS,PLATEAU,PRESS,PUBLISHED,UNIVERSITY,WORKERS
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NEN,PNS,SPECIAL
000,AFRICAN,COLLEGE,COLORECTAL,EVERY,HOWEVER
945,ATP,NEO
279,316,948,AAL,ALEURIA,FIRST,HHL,NSCLC,PNA
ABOVE,HOWEVER,LEWIS,MMP
001,005,016,028,208,221,788,ALK,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PET,RESULTS,THEREFORE,TTF
169,BECAUSE,CLASS,HOWEVER,III,LTD,NEUROD1,NSCLC,PATHOLOGY,POU,PTY,PUBLISHING,SOCIETY,THESE,WILEY
COMPARISON,FORTY,FVC,PERIPHERAL,PIU,PTERYGIUM
100,169,BECAUSE,BONFERRONI,CONCLUSION,LABEL,MATERIALS,MCNEMAR,METHODS,MPD,MPM,OBJECTIVE,PLEURAL,PURPOSE,RESULTS
945,AFTER,BILATERAL,HEPATIC
169,AUCL3,COPYRIGHT,HOWEVER,III,INC,THESE
CDC45,CMG,MCM,MUTATIONS
169,BACKGROUND,CONCLUSION,COPYRIGHT,DUTCH,EPIDERMAL,EVALUATION,INC,IRENE,LABEL,METHODS,NSCLC,NVALT,PFS,RESULTS,SECONDARY,SEVERAL,SOLID,TKI,VERISTRAT
001,169,ACCORDING,AES,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,INC,JACKMAN,LABEL,MATERIALS,METHODS,NSCLC,OUTCOME,PFS,RESULTS,T790M
169,BASED,COPYRIGHT,EUDRACT,INC,METAL,METFORMIN,SECONDARY
001,104,169,312,315,375,997,CENTRAL,CRC,JANUARY,RECORDS,SEPTEMBER,SIR,SMR,SOUTH,USA,VITAL
FINALLY,FURTHER,MIA,NOVEL,NSCLC,NUAK1,TARGETSCAN,UTR
138,169,852,AGE,CASES,CHINA,ESTIMATES,FOLLOWING,LIMITED,WHILE
160,169,AUTHORS,BCL2L15,COPYRIGHT,HOWEVER,INC,PROX1,PUBLISHED,THESE,WNT
110,130,160,169,CHINESE,COPYRIGHT,HOWEVER,IL6ST,INC,PCR,PROTEIN,STAT3
160,APOPTOSIS,CUB,NATURAL
069,169,BACKGROUND,BRCA1,COHORTS,HIF1A,LABEL,METHODS,RESULTS,THESE
001,159,169,AUTHORS,BACKGROUND,COPYRIGHT,DSS,ESPECIALLY,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STAGE
001,169,571,BACKGROUND,CTC,HOWEVER,LABEL,METHODS,NSCLC,PERIPHERAL,RESULTS,SEQUENTIAL,SOCIETY
ACADEMY,CHINESE,JANUARY,LABEL,MEDICAL,METASTASIS,METHODS,OBJECTIVE,RESULTS
177,CD4,FCM,FURTHER,III,LABEL,LAG,METHODS,NSCLC,OBJECTIVE,RESULTS
112,161,177,178,610,95C,95D,CCK,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,THESE,TRANSWELL,WESTERN
100,181,786,LDL,MTT,RCC,REDUCTION,SI3
169,176,177,1PA,231,400,945,956,ASP,COPYRIGHT,D9K,G17,G21,GXXXG,INC,INCREASING,LYS,M28,MDA,NH2,PIPIDAE
PULMONARY
LABEL,OBJECTIVE,RESULTS,WHILE
101,176,GROUP,INC,PHYSICISTS,PUBLISHED,RADIATION,THERAPY,TREATMENT,USING
101,127,169,177,228,245,857,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,RESULTS
100,100UG,169,200,200UG,400,400UG,500UG,ABOVE,BACKGROUND,BFD,BLACKFOOT,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,POISSON,RESULTS,THERE,USING
031,102,169,382,748,COPYRIGHT,COX,EDUCATION,HARRELL,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RENAL,RESULTS,UROLOGICAL
169,251,BACKGROUND,COPYRIGHT,DIF,HOWEVER,LABEL,METHODS,PATIENT,RESULTS,SOMATIC
169,COPYRIGHT,DESPITE,ISSUE,OXYGENATED,SPECIAL,THERE,THESE
001,002,120,160,177,BACKGROUND,CONCLUSION,EASTERN,GROUP,III,LABEL,METHODS,RESULTS,SCORING,SIX,THREE,WBI
169,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COMPLEX,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,ZEALAND
169,720,BASED,CONCLUSION,COPYRIGHT,COX,DENMARK,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,MRR,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SRE
001,019,035,169,673,BACKGROUND,COPYRIGHT,FIFTY,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,RFA,WHETHER
169,AMP,CONCLUSION,COPYRIGHT,ERLOTINIB,H1299,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,WESTERN
169,ALK,COPYRIGHT,PARTNER,PUBLISHED,ROUTINE,URBAN
122,BACKGROUND,BASED,COX,FINALLY,LABEL,NON,NSCLC,RESULTS
536,954,ASS,BACKGROUND,CURRENTLY,LABEL,METHODS,PANCREATIC,PCR,RESULTS,TREATMENT
169,BAX,COPYRIGHT,FIRST,INC,LM3,THERE
169,215,ARGENTINA,COPYRIGHT,CORDOBA,HOWEVER,LTD,PAH,SAMPLES,THEIR
001,215,AS1,ASSET,BRC,IFNW1,PRC,PRESS,PUBLISHED,RCC,RS10511729,SNP,TUSC1,UNIVERSITY
169,AFTER,BACKGROUND,COPYRIGHT,DISCUSSION,ERLOTINIB,HFS,HOWEVER,LABEL,METHODS,PUBLISHED,SAS,SEVERAL,TKI
169,COPYRIGHT,NF1,PUBLISHED,SAS,THERE
169,239,ALPES,BACKGROUND,CONCLUSION,COPYRIGHT,DEPARTMENT,LABEL,METHODS,NSCLC,PACLITAXEL,PUBLISHED,RESULTS,RHONE,SAS,SINCE,TEN,THEIR,THERE
169,ANN,CD147,CD9,CONCLUSION,COPYRIGHT,HLA,LABEL,METHODS,OBJECTIVE,RESULTS,ULTRA
120,135,250,AUC,BACKGROUND,CTONG1002,DISCUSSION,HOWEVER,III,LABEL,METHODS,TRIAL,UNASSIGNED
169,5MM,646,BASED,CONCLUSION,COPYRIGHT,IRELAND,KINGDOM,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THOSE
003,013,017,039,126,924,BACKGROUND,CONCLUSION,COX,HOWEVER,III,LABEL,LVI,MEIER,METHODS,PCI,RESULTS,TNM
160,ALK,BACKGROUND,CRIZOTINIB,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS,SIX
140,CURRENTLY,LOCAL,PRESENTLY
001,004,006,169,255,332,APRIL,CHEST,CONCLUSION,COPYRIGHT,FIRST,FURTHER,HNC,HOWEVER,INITIAL,IRELAND,LABEL,LTD,MARCH,METHODS,OBJECTIVE,RESULTS,THIRD,USING
3DMCO,4DMCO,4DMCRECAL,4DMCRENORM,ACCURAY,CARLO,COMPARISON,CONCLUSION,CYBERKNIFE,GTV,INC,LABEL,MATERIALS,METHODS,MONTE,OAR,OBJECTIVE,PURPOSE,RESULTS,SUNNYVALE,THREE
169,ALK,BAL,COPYRIGHT,IHC,PCR,USING
169,AFTER,COPYRIGHT,DANESHVARI,MARCH,MASIH,MCC,MCPYV,NSCLC,PCR,SIMILARLY,SMALL
160,956,HOWEVER,MAPKS,MTT,NIGELLA,P16,PCR,PD98059,WESTERN
174,BACKGROUND,CURRENT,DISCUSSION,JANUARY,KINGDOM,LABEL,MALIGNANT,METHODS,SECONDARY,TRIAL,WHILE
665,673,897,BACKGROUND,CONCLUSION,HOURS,INSURANCE,KOS2011,LABEL,LVKOS2011,METHODS,OOH,PRIMARY,RESULTS,RFE,SERVICE,THESE,YET
000,CETUXIMAB,EXCELLENT
231,945,ATP,BMDCS,CD11B,FINALLY,HIF,LOX,MDA,P2Y2R,THEREFORE,THESE,THP,UTP
9F1,ADDITIONAL,CD146
001,013,212,292,946,ECTOPIC,HOWEVER,MEIER,NSCLC,WNT
AKT,ERBB2,T798I
ALK,H2228,H3122,SINCE,TREATMENT
INFLUENCE,LNCAP
HOWEVER,METASTATIC,PRODRUG
162,178,946,AMONG,CD105,ECS,THESE,TOTALLY,USING
THESE
FOXF1,MSC,SEVERAL
011,016,019,020,025,030,043,051,054,067,078,087,140,141,148,150,167,169,200MG,207,347,373,533,597,989,AAD,AUTOIMMUNE,BACKGROUND,BILIARY,BOWEL,BRONCHIAL,CARDIAC,CHRONIC,CONCLUSION,CONDITIONS,COPYRIGHT,DERMATITIS,DIAGNOSTIC,DISORDERS,DSM,GENERAL,GMC,INTERVIEW,IRRITABLE,LABEL,LITHIASIS,MEDICAL,METABOLIC,METHODS,OBESITY,PSORIASIS,RESULTS,REVISED,RHINO,SEBORRHEIC,STRUCTURED,URTICARIA,VERSION
DETECTION,TELOMERASE,TELOMERES
169,571,899,AMONG,BACKGROUND,COPYRIGHT,HODGKIN,INC,ISPOR,LABEL,METHODS,NETWORK,NHL,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SOCIETY,VHA
169,175,AES,AUC,CONCLUSION,COPYRIGHT,IDENTIFIER,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RANDOMIZED,RESULTS,SIMON,TREATMENT,UNASSIGNED
001,002,161,169,248,ATS,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,ERS,IASLC,IRELAND,LABEL,LAC,LTD,MAY,METHODS,MPP,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS,SOCIETY,THERE,THESE,TNM
120,169,BACKGROUND,BRITISH,CO2,JOURNAL,LABEL,MEF50,METHODS,MIF50,PRESS,PUBLISHED,RESULTS,ROBOTIC,THEREFORE,UNIVERSITY
160,169,231,233,945,946,COPYRIGHT,CRGDK,HOWEVER,MCF,MOL,SFBBM,SUBSEQUENT,THESE,TP5
169,864,COPYRIGHT,CSS,DFS,HOWEVER,IRELAND,LABEL,LIBRARY,LTD,MEDLINE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX
169,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS
101,145,169,212,494,ARRAY,COPYRIGHT,COX,INC,MAPK1,MPM,PCR,PLEURAL,USING
163,169,18B,428,BACKGROUND,CDCA3,FINALLY,GBA,HCC,LABEL,MOTIVATION,PCR,PEARSON,PRESS,PUBLISHED,THEREFORE,UNIVERSITY
TKI
136,160,169,ANESTHESIA,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,RESULTS,RML,SOCIETY,WHEREAS
169,BACKGROUND,BETWEEN,COPYRIGHT,END,HOWEVER,INC,LABEL,MATERIALS,METHODS,PRIOR,PROCEDURES,RESULTS,THESE,USING
169,344SQ,BACKGROUND,COPYRIGHT,CURRENTLY,H1299,INC,ITGB4,LABEL,MATERIALS,METHODS,RESULTS
169,945,BASED,COPYRIGHT,GIVEN,HIF,HOWEVER,INC,MYC,PREVIOUSLY,PRMT5
001,100,217,FINALLY,HOWEVER,MIR,PCR,SPC,TARGETSCAN,WESTERN
169,2A6,311,364,437,453,674,AFRICAN,PRESS,PUBLISHED,THERE,TOTAL,UDP,UGT,UGT2B10,UNIVERSITY,WHITE
CTLA4,FINALLY
100,12R,DEPSIDE,ESI,MCF,NCI,NMR,THEIR,THREE,USNEA,USNIC
003,007,215,347,661,CLPTM1L,GWA,HOWEVER,RESULTS,SEVERAL
003,006,021,049,148,157,BACKGROUND,DCR,LABEL,METHODS,NSCLC,PCR,PFS,RESULTS,THERE
169,COPYRIGHT,CROHN,PULMONARY
169,COPYRIGHT,DESPITE
169,956,COMPOUNDS,COPYRIGHT,HDAC1,HEPG2,IIB,IIC,IIF,INC,MOLECULAR,NCI,NON,SMALL,VIA,VIIIA
AMONG,JANUARY,LABEL,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS
954,BCL,THESE
169,DIAPHRAGM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PRESS,PRIMARY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
076,152,169,173,183,411,416,419,568,571,ANAEMIA,BACKGROUND,COPYRIGHT,FUNDING,HOWEVER,LABEL,LTD,METHODS,OVERALL,RESULTS,SECONDARY,SIX,THEREFORE
001,011,032,036,049,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WALKING,WIN
BMJ,FOLLOWING,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,PUBLISHING,RESULTS
BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OTHER,PUBLISHED,PUBLISHING,RESULTS,THESE,VILLAGE
14Q32,379,411,BASED,JAPAN,LUCIFERASE,MALIGNANT,MESO1,MPM,PATHWAY,PCR,PEM,THESE
APPROACHES,AUSTRALIA,AUSTRALIAN,BACKGROUND,BMJ,DIAGNOSTIC,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,TOTAL,TRIAL,UNIVERSITY,WESTERN,WHILE,ZEALAND
169,500,AMATUXIMAB,LABEL,METHODS,MPM,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESPONSES,RESULTS,SECONDARY,SIX
103,169,INC,INHERITED,KNUDSON,USING,WILEY
VGIIB
001,019,033,042,045,115,967,CHI,COX,FURTHER,HOWEVER,IHC,LABEL,MEIER,NAD,PCR,UNASSIGNED
001,177,BATHO,CONCLUSION,EQUIVALENT,KENDALL,LABEL,METHODS,NOVEL,OBJECTIVE,PBC,PURPOSE,RESULTS,SHAPIRO,THESE,WILKS
169,AMERICA,HPYV7,HPYVS,INFECTIOUS,PRESS,PUBLISHED,ROLLING,SOCIETY,UNIVERSITY
REGUCALCIN
001,004,066,169,247,248,498,BACKGROUND,BELGIUM,COPYRIGHT,DEC,DUTCH,FEB,FUNDING,GROUP,HOWEVER,LABEL,LTD,MANCHESTER,METHODS,NEDERLANDS,NETWORK,NTR1527,OVERALL,RESULTS,SCIENCE,SECONDARY,SOCIETY,THREE,TRIAL
EMBRYONAL
155,LAN,MOLECULAR,THEREFORE
112,AFTER,CONCLUSION,HORIZONTE,JANUARY,LABEL,METHODS,MINAS,OBJECTIVE,RESULTS,THESE
DU145,MCF
ML323,ULTIMATELY
160,AMONG,LOIRE,PAPILLOMA
BECAUSE,FIFTEEN,HCC,REMARKABLY
000,169,AYA,BASEL,THEREFORE,USA
169,ALK,CAFEE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TKI,TREATMENT
169,ALK,DIFFERENT,MUTATIONS
160,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUSTAINED,TGD
169,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,EPIDERMAL,JOURNAL,LABEL,METHODS,NSCLC,OBJECTIVE,PHYSICIANS,RESULTS,ROYAL,SAMPLES,THERE,TKI
ALK,DESPITE,LABEL,NSCLC,OPINION,STATEMENT,UNASSIGNED
BACKGROUND,BASED,BAX,BCL,CCNG1,CONCLUSION,LABEL,METHODS,RESULTS,WESTERN
BACKGROUND,BASED,CDK,CONCLUSION,DESPITE,EXPRESSION,GEFITINIB,LABEL,METHODS,NSCLC,RESULTS
FUNCTIONAL,HOWEVER,TAKEN
100,125,AUC,CBP,CONCLUSION,DCR,DDP,FORTY,III,LABEL,METHODS,NAB,NSCLC,OBJECTIVE,ORR,PFS,RESULTS
3DCRT,BACKGROUND,CONCURRENT,DVH,GRADE,GTV,LABEL,MATERIALS,METHODS,PTV,RESULTS,V13,V20,V30,V45
135,144,DCR,ERCC1,LABEL,LRP,MATERIALS,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,SHORT,TTP
100,177,200,400,ADENOVIRUS,BAL,BAX,CLEAVED,CONCLUSION,CONTROL,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,SER,SIRT6,WESTERN
125,19DEL,234,274,4TH,627,672,680,ADR,BACKGROUND,BLOOD,CYP,CYP2C19,III,LABEL,LIVER,M20,M23,M24,M26,MATERIALS,METHODS,NSCLC,PFS,RESULTS,SAS
BACKGROUND,BBSKE,DRI,GSH,LABEL,MATERIALS,METHODS,OBVIOUS,RESULTS,ROS,SRB,TALALAY
480,BACKGROUND,BRIEFLY,COBAS,DEL,G718X,L858R,LABEL,MATERIALS,METHODS,PAKISTANI,PCR,RESULTS,S768I
500,ACACA,COX,DNL,EIGHT,FURTHER,HOWEVER,MEIER,NSCLC,SNP,UNDER
CERTAIN,HPV,HPV16,IRANIAN
004,095,104,126,138,163,208,316,335,418,429,485,508,667,707,924,ACCORDING,BACKGROUND,BANGLADESH,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,SEPTEMBER,SMOKING,SOCIO
013,058,073,088,APRIL,BACKGROUND,COX,KRUSKAL,LABEL,MALIGNANT,METHODS,PFS,RESULTS,STUDIES
001,002,005,008,014,017,018,023,024,025,034,038,039,041,083,214,946,BRCA1,ERCC1,NSCLC,THERE
239,BACKGROUND,COMPANY,DISCUSSION,ELI,FOLLOWING,GIVEN,HRQOL,III,ITEMS,LABEL,LILLY,METHODS,NSCLC,PREFERRED,REPORTING,RESULTS,REVIEWS,SYSTEMATIC,THERE
001,1E1,206,BACKGROUND,CONCLUSION,EPIDERMAL,HIGHEST,IHC,LABEL,METHODS,OVERALL,PHARMDX,PROTEIN,RESULTS,UNASSIGNED,VIRTUAL
NON,NSCLC,PCR,USING
BASED,HESSIAN,RBC
EXTRACTION,INITIALLY
PET,SUV,THEREFORE
001,004,005,030,DFS,FDG,MTV,NSCLC,PET,SUV,THEREFORE,UNIVARIATE
ARTIFICIAL,CAD,FINALLY,FPS,MASSIVE,MTANN,NETWORK
109,BIOLOGICAL,EIT,ELECTRICAL,IMPEDANCE,TOMOGRAPHY
209,DEC,EPIDERMAL,FNA,IRISH,IVD,L858R,MAR,PCR,RESECTION,SAMPLES
494,H69,H69AR,HOWEVER,THESE
003,100,ALK,ATS,BACKGROUND,ERS,HOWEVER,IASLC,III,LABEL,METHODS,MPC,MPP,OBJECTIVE,RESULTS,RET,RFS
AMONG,BACKGROUND,COX,HOWEVER,III,LABEL,METHODS,NSCLC,OVERALL,PROPENSITY,RESULTS,USING
280,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,RFS,SCC,SQCCS,T2A
150,BACKGROUND,CONCLUSION,FDG,FLT,LABEL,METHODS,NSCLC,PET,RESULTS
BACKGROUND,CONCLUSION,EXOME,LABEL,METHODS,PULMONARY,RESULTS,THERE,THREE,WESTERN
001,002,003,047,111,137,BACKGROUND,CONTEXT,COX,CVD,FAT,FRAMINGHAM,HEART,HOUNSFIELD,LABEL,METHODS,NON,OBJECTIVE,RESULTS,SIMILAR,THERE,THESE,VAT
169,COPYRIGHT,H23,NCI,SAS
181,22RV1,361,945,946,A2780,AURANOFIN,COMPLEXES,HLN,HOS,NMR,THP,TNF
027,068,100,109,119,139,141,142,162,235,246,365,420,484,520,564,676,691,BACKGROUND,CHINA,ICU,LABEL,METHODS,RESULTS
ADDRESSING,BACKGROUND,LABEL,METHODS,OVERALL,PCG,RESULTS
001,003,006,016,020,021,027,031,335,BACKGROUND,DSS,LABEL,METHODS,NSCLC,RESULTS
013,015,018,027,042,045,188,217,240,489,528,543,566,595,625,637,643,645,AFTER,CHINESE,LABEL,METHODS,OBJECTIVE,RESULTS
070,138,169,571,ADJUSTMENT,CIS,COLORECTAL,CONCLUSION,COX,GLEASON,HOWEVER,HRS,III,LABEL,METHODS,OBJECTIVE,OTHER,OVARIAN,PURPOSE,RESULTS,SCREENING,SOCIETY,THEREFORE,TRIAL
CERTAIN,HOWEVER,SIGLECS,SUPPORTING
169,947,BIOLOGY,FAP,FAS,HOWEVER,INC,MOLECULAR,PIGMENT,SIMILARLY,SOCIETY
002,003,007,023,040,071,073,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,SARCOPENIA,SIXTEEN,STAGE,THERE
BRA,SEVERAL
RAG,THESE
126,169,HCC,IL8,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RCC,RESULTS
000,001,002,007,039,169,174,295,832,ABI,AFFYMETRIX,AGILENT,ARRAY,AUTHORS,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,INTEGRATED,IRELAND,LABEL,LOWER,LTD,MAPPING,MATERIALS,METHODS,NORTH,NSCLC,PUBLISHED,RESULTS,ROC,SNP,STY,UNIVERSITY
130,3T3,COFE2O4,HACAT,MRI,THESE
CHINA,HOUSEHOLD,OVERALL,XUANWEI
169,178,844,AMONG,BACKGROUND,CENTRAL,KOREA,LABEL,METHODS,RESULTS,SOCIETY,THYROID
286,AFTER,CONCLUSION,LABEL,LOD,METHODS,OBJECTIVE,PCR,RESULTS
114,160,169,1990S,BACKGROUND,CCS,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,RESULTS,T1AN0,THERE
001,019,BACKGROUND,BASED,COMPARISON,HOWEVER,HRTKI,L858R,LABEL,METHODS,NSCLC,PFS,RESULTS
108,600,CIGARETTE,DNMT1,EPIDERMAL,KIRSTEN,MET,NAD,NSCLC
21E,536,ATLANTA,COX,CPG,FDR,GOLDENGATE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SILENCING
B72,CAM,CD117,CEA,DIFFUSE,EMA,PAS
001,177,197,AKT,ARQ,GDC,MALIGNANT,MET,MPM,NVP,STUDIES,WHILE
005,025,101,149,169,ACCORDING,COX,GASC1,MYC,NANOG,PPARG,ROC,THEREFORE
169,231,233,916,966,APOPTOSIS,BAX,COPYRIGHT,DEPLETION,MOL,NSCLC,ROS,SFBBM,THERE,THESE,WESTERN,ZERUMBONE
000,169,723,745,ESTIMATES,OVERALL
169,BASED,COPYRIGHT,THESE
169,COPYRIGHT,CTC,EFFICIENT,INTRA,MCA,UNDER
102,169,CONCURRENT,COPYRIGHT,EASTERN,GROUP,HOWEVER,INC,INTENSITY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
005,046,169,177,CCC,COPYRIGHT,COX,HISTOGRAM,III,INC,LABEL,LRC,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PENALIZED,PREDICTIVE,PURPOSE,RESULTS,T50
183,956,AIM,AUTOGRAFT,B16,COLON26,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,TREATMENT,WESTERN
169,AKT,AUTHORS,COPYRIGHT,DIFFERENT,ERBB2,INC,PUBLISHED,RELAPSE
169,COPYRIGHT,III,INC,NSCLC,STAGE,T1A
128,169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,KINGDOM,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
169,220,34A,COPYRIGHT,PCS,PTX
169,AFRICAN,AMERICANS,AUTHORS,CULTURALLY,FIRST,LTD,WILEY
169,17Q,AUTHORS,INC,NPY,PDX,PUBLISHED,SYP,WHOLE,WILEY
007,169,2003_VS,2005_VS,2006_VS,2012_VS,428,64_VS,BESIDES,COX,EINDHOVEN,HRMALE_VS,HROTHER_VS,NSCLC,_2001,_2010,_FEMALE
675,AMONG,BACKGROUND,EXPRESSION,GEO,INGENUITY,LABEL,MATERIALS,METHODS,MICRORNAS,OMNIBUS,RB1,RESULTS,TEN
AREAS,BACKGROUND,COVERED,EIGHT,III,LABEL,METHODS,NSCLC,OPINION,PHASE
169,231,233,COPYRIGHT,DOSIMETRIC,HOWEVER,INTENSITY,METHODS,PUBLISHED,SAS,SEVERAL
AREAS,BACKGROUND,COVERED,CURRENT,LABEL,MDA,METHODS,OPINION,ORIGINALLY,PDZ,THROUGH
DEX,IHC,MKP,MTT,PCR,SGK,SPC
000,4294A,AGLIENT,COMPANY,EIT,HOWEVER,MHZ
001,147,15N,169,695,809,908,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,NSE,OBJECTIVE,OBJECTIVES,PCT,PUBLISHED,RESULTS,SERUM,SOCIETY
945,946,THESE,USING
ATR,BRCA2,GENOMIC,HIPPO,LATS1,RAD51,RASSF1A
046,160,169,232,322,554,603,639,958,AFTER,APRIL,COPYRIGHT,COX,INC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SUCCESSIVE,SURGERY,THERE
169,AUTHORS,BCL6B,CLL,COPYRIGHT,ECTOPIC,HCC,HEPG2,HIV,IRELAND,LTD,MHCC97L,PUBLISHED,TAT,VEGFA
0A549,961,CONCLUSION,CY5,DAVID,GENOMES,KYOTO,LABEL,MAX,METHODS,MYC,OBJECTIVE,PURPOSE,RESULTS
169,300,COPYRIGHT,DCR,IIB,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PFS,RESULTS,THESE,TREATMENT
169,945,946,954,956,ASTRAGALI,COPYRIGHT,ELISA,ERK,HOWEVER,METASTASIS,MMP,MTT,PKC,PUBLISHED,RADIX,TGF,TNF,U0126,WESTERN,WOUND
177,198,215,480,565,CNS,IRANIAN,JCV,PCR,WBC
001,BRAIN,EMT,FURTHER,H1915,HOWEVER,METASTASIS,NSCLC,PCR,THEREFORE
169,287,AFRICAN,AMONG,ASIAN,BACKGROUND,ENROLLMENT,III,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,STRATEGIES,UNIVERSITY
001,29321,BACKGROUND,CIS,COLORECTAL,CONCLUSION,COX,HRS,LABEL,METHODS,OVARIAN,PRESS,PUBLISHED,RESULTS,TVU,UNIVERSITY
169,946,954,BIOLOGY,EXPRESSION,HOWEVER,INC,MOLECULAR,RAS,SCF,SOCIETY,WNT
169,ALK,BACKGROUND,GEC,HOWEVER,IHC,INSTITUTE,ISH,LABEL,MCNEMAR,METHODS,MOLECULAR,NCI,NSCLC,PRESS,PUBLISHED,RESULTS,TESTING,UNIVERSITY
169,NSCLC
001,169,946,BERBERINE,COPYRIGHT,EMT,METASTASIS,SELECTIVE,SOCIETY,TAKEN
112,COX,DFS,ERCC1,HOWEVER,MEIER,MTT,NSCLC,OVERALL
124,137,169,203,323,544,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MALIGNANT,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PARTIAL,RATIONALE,RESULTS,STUDIES
169,AUNPS,COPYRIGHT,DENSITY,GEFITINIB,H1975,NCI,RAMAN
001,004,005,390,945,BIO,NSCLC,PROVINCIAL
001,112,198,273,AMONG,CFE,COOKING,EPIDERMAL,KNOWLEDGE,NSCLC,OBJECTIVE,ORR,PFS,TKI
177,384,AMONG,FIRST,GROUP,HOWEVER,NON,NSCLC
000,001,004,008,016,018,105,133,AMONG,PRS,RML
169,CLT,COPYRIGHT,COX,FACTORS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PROPENSITY,PURPOSE,RESULTS,ULTIMATELY
169,BACKGROUND,CONCURRENT,COPYRIGHT,CRT,EASTERN,EIGHT,GROUP,HOWEVER,IIA,INC,LABEL,MATERIALS,MAY,METHODS,NSCLC,ORR,PFS,RECURSIVE,RESULTS,SECONDARY,THREE,XRT
HOWEVER,MEDICINAL,SYSTEMATIC
024,368,BETWEEN,CONCLUSION,HODGKIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,USING
AUC,FORTY,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,ROC,TEXTURE,USING,WHITNEY
149,177,BACKGROUND,JANUARY,LABEL,METHODS,PRIMARY,RESULTS,SGA,SUBJECTIVE,THERE
169,177,18F,COPYRIGHT,FDG,IDC,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,VARIOUS,VCT,VPATH
005,012,013,022,037,050,071,091,177,181,214,239,397,662,668,815,938,ATS,BACKGROUND,COX,ERS,IASLC,LABEL,LVI,METHODS,RESULTS,RFS,SOCIETY,T1AN0M0
160,ALDOA,MMP
C21,MARSDENIA,NMR,THEIR,TKI
12074,181,AHR,ASSAY,BAP,BENZO,FURTHER,MTT,NPS,PAH,POLYCYCLIC,ROS
002,018,177,946,BACKGROUND,CONTEXT,ESTRADIOL,ESTRONE,FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SERUM,SETTING
160,CADM1,HOWEVER,INCREASING,MMP,PCR,TSLC1
261,598,996,BACKGROUND,COBAS,CROSS,GROUP,LABEL,MALDI,METHODS,MTS,RESULTS,SCORPIONS,TOF
ADMET,FINALLY,FOLLOWING,ROS,SIX,THESE
169,CONCLUSION,COX,FDG,HOWEVER,IMAGING,INC,LABEL,MEIER,METHODS,MOLECULAR,MTV,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,SUV,UNLABELLED
008,169,H1975,IBRUTINIB,MEIER,NSCLC,PRESS,PUBLISHED,T790M,UNIVERSITY,Y1068,Y1173
169,AUTHORS,EMT,EPITHELIAL,PUBLISHED,YET
100,169,CONCLUSION,COPYRIGHT,GUIDELINES,IRELAND,LABEL,LTD,MAY,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SECONDARY
150,169,COMBINING,COPYRIGHT,DESPITE,FREQUENCY,INC,LEWIS,NON,NSCLC,PUBLISHED
BMJ,GROUP,LTD,PES,PUBLISHING
181,DDP,DIFFERENT,FINALLY,H1299,H2347,JAK,NSCLC,STAT3
005,GBM,GSC,THESE,U87
23A,ABL,BCR,CML,ECTOPIC,MIR,PCR
001,002,177,183,BETWEEN,CO2,PET,TEN
169,BAMHI,BART3,BART7,EBV,EPSTEIN,III,NPC,SYSTEMATIC,THESE
169,COPYRIGHT,CTLA4,CYTOTOXIC,FOXP3,INHERITED,SCIENCE,WHEREAS
000,169,811,904,972,983,993,AUC,BASED,CH2,CH3,CHRONIC,CIGARETTE,COPYRIGHT,DECREASED,III,NMR,NOVEL,TNM
169,ALIKE,BIOLOGY,COMMONS,HOWEVER,LICENSE,PACLITAXEL,SHARE,SOCIETY,TAXOL
4T1,BACKGROUND,EPC40,EPRAS,HOWEVER,LABEL,METHODS,NONCLEAVED,PROTEASES,RESULTS,WESTERN
160,BACKGROUND,E1A,HSPA5,LABEL,METHODS,RESULTS,THERE
326,BACKGROUND,HOWEVER,KNOCKDOWN,LABEL,METHODS,RESULTS,SRC,THESE,WESTERN
823,BACKGROUND,BETWEEN,FEW,JANUARY,LABEL,METHODS,RESULTS
169,231,233,COPYRIGHT,DEDICATED,HADRONS,PUBLISHED,SAS,THESE
016,169,750,956,GIVEN,III,INC,INITIAL,NIH,SN29751,SN30000,WILEY
100,101,129,158,177,294,593,637,772,908,AGE,BETWEEN,CONCLUSION,FURTHER,IRE,JANUARY,LABEL,MATERIALS,METHODS,MRI,NANOKNIFE,OBJECTIVE,OVERALL,PURPOSE,RESULTS,TEN,WHIPPLE,WHITNEY
BACKGROUND,CRT,FDG,GRADE,LABEL,LIVER,METHODS,MRI,PET,RESULTS
100,BACKGROUND,LABEL,METHODS,NPV,RESULTS,TEN,TRIAL,URL
157,181,268,BACKGROUND,FURTHER,FVC,GAP,HOWEVER,IPF,LABEL,METHODS,RESULTS,SEOUL,UNIVERSITY,WESTERN
BRAZILIAN,MALIGNANT
001,022,113,CERTAIN,IPN,LABEL,METHODS,OBJECTIVE,PNS,RESULTS,STUDENT,VARIABLES
101,CONSISTENT,ECTOPIC,THESE,UTR
MTT,NON,NSCLC
ATTENDEES,BLOOD,HEART,HOWEVER,INSTITUTE,MARCH,NCI,NHLBI,PRESS,PUBLISHED,UNIVERSITY
169,BECAUSE,CETUXIMAB,GRADE,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIXTY,TEN,THERE,UNIVERSITY
169,BACKGROUND,CONCLUSION,EIGHT,LABEL,LARGE,METHODS,RESULTS,SDT,SOCIETY,SOLID,THESE
103,108,177,300,396,956,ALT,BACKGROUND,DESPITE,GOVERNMENT,HEPATIC,HOWEVER,INITIAL,LABEL,LABORATORY,METHODS,OVERALL,PHLEBOTOMY,PRIOR,PROVIDING,PUBLISHED,RBC,RESULTS,TIO,USA
169,350,435,BACKGROUND,DFS,DISEASE,III,LABEL,METASTATIC,METHODS,PPB,RESULTS,SIXTY,SOCIETY,THERE
169,ASIAN,COLORECTAL,COPYRIGHT,CRC,HENCE,INC,UFT
127,169,325,ACR,COLLEGE,OVERALL,SLE,SMR
CONCLUSION,COT,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SNR,THERE
AE1,AE3,CLINICALLY,DIAGNOSIS,HOWEVER,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,RESULTS,SEPTEMBER,SINCE,SMM,THERE,TTF,WT1
000,253,300,382,504,600,800,877,ASBESTOSIS,CHEST,LDH,MALIGNANT,WBC
009,019,020,022,037,108,197,779,AMONG,NSCLC
426,891,CIS,HYPOTHESIS,LABEL,LIBRARY,METHODS,OBJECTIVE,OVERALL,RESULTS,RRS,THERE
BACKGROUND,CHEST,HOWEVER,LABEL,LOBECTOMY,METHODS
169,IMAGE,STAYING,SUGGESTED,TREATMENT,ULTIMATELY
CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,NON,NSCLC,OBJECTIVE,RESULTS
008,CISPLATIN,CONCLUSION,DDP,LABEL,MATERIALS,METHODS,OBJECTIVE,ORR,RESULTS
000,CHINESE,CONCLUSION,ELECTRONIC,FINALLY,KANGLAITE,KARNOFSKY,KLT,KNOWLEDGE,KPS,KSP,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,STATA11,WANFANG
3MM,947,DVH,M3D,TPS
001,ACCOUNTING,BODYFIX,LESIONS
CRT,GROUP,MONITOR,NSCLC,PTV,RADIATION,THERAPY,V20
CHANGES,DVH,GTV,HOWEVER,III,THEREFORE
2MM,3MM,AGILITY,DYK,MLC,RAYSTATION,TPS,TREATMENT,VAN
AFTER,COMPARISON,SYNERGY
003,004,006,011,019,026,029,031,034,039,042,043,402,445,553,575,ASIAN,BCT,CTA,CTV,D95,DMEAN,HOWEVER,IMAGE,JANUARY,LAD,PLANS,PRV,PTV,SIMILARLY,USING,V10,V20,V25,V30,V40
169,945,DESPITE,EMA,FDA,HLA,IDO,IFN,MEDICAL,NSCLC,PHD,SOCIETY,TMZ
001,025,093,177,DISTANCES,DRS,FDG,GROUP,HENCE,NSCLC,PET,SUCCESSFUL
60012,ECLIPSE,FINALLY,IBA,MLC,NUCLEAR,PTW,SUN,THESE,USING,VERSION
947,GAMMA,PIERMATTEI,SOLID,USING,WATER
120,176,210,513,562,660,ADVERSE,CTCAE,GRADE,MUS,PATIENT,PET,PLANS,PULMONARY
176,177,ACPDP,DELIVERED,DVH,MACHINE,OAR,PINNACLE3,PLANNED,PTV,SRS,TPS,TREATMENT,VIE
AUSTRALIA,CHINA,ECOLOGICAL,FRANK,GARLAND,JAPAN,SPAIN,UVB
169,AFTER,DESPITE,EMT,INC,MALIGNANT,THEREFORE,WILEY
169,AUSTRALIA,HPV,KINGDOM,OPC
ALECTINIB,ALK,CH5424802,H2228,LABEL,METHODS,NCI,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
112,169,231,233,COPYRIGHT,EARLY,FCV,HOWEVER,INCLUSION,PUBLISHED,PULMONARY,SAS
160,250,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS
ACCORDING,AFTER,BACKGROUND,CONCLUSION,DYSPNOE,III,LABEL,MEDICAL,METHODS,PFO,PLATYPNEA
169,946,CDK,SMAD3,TGF
169,946,BACKGROUND,BCL,CHINESE,CONCLUSION,COPYRIGHT,ELEMENE,FURTHER,IRELAND,LABEL,LTD,METHODS,MTT,P53,PCR,RESULTS,WESTERN,XENOGRAFT,ZEDOARY
121,169,500,817,827,AMIGO,IMAGE,OPERATING,SOCIETY
FIRST,MTT,NSCLC,PCR,SUCCESSFUL,WESTERN
ALCOHOL,CEA,CONCLUSION,LABEL,LEWIS,METHODS,MTT,OBJECTIVE,RESULTS,SEMEN,WESTERN
101,118,131,181,224,529,AMONG,BACKGROUND,EPP,LABEL,MEIER,METHODS,MPM,OBJECTIVE,OUTCOME,RADICAL,RESULTS,SURGERY
BPS,CURRENTLY,ZOLEDRONIC
169,183,BACKGROUND,CONCLUSION,GEORG,LABEL,METHODS,NSCLC,RESULTS,STUTTGART,THESE,TKI
733,BACKGROUND,ENGLAND,EPISODE,INTERIM,LABEL,METHODS,NHS,OLDER,RESULTS,STATISTICS,YORKSHIRE
162,224,256,994,BACKGROUND,JANUARY,LABEL,MEIER,METHODS,NSCLC,OCTOBER,RESULTS,RFS,T1A,T2BN0M0
169,BCL,COPYRIGHT,HOWEVER,INC,SRSF1,STRIKINGLY
169,COPYRIGHT,EMT,INC,METASTATIC,SCF,SER,SNAIL,THESE
133,169,198,218,CONCLUSION,DYNAMIC,FDG,FINALLY,LABEL,MATERIALS,MCNEMAR,METHODS,NODULES,OBJECTIVE,PET,PURPOSE,RESULTS,TOTAL,TUKEY
111,126,198,293,BACKGROUND,CONCLUSION,DOR,FIFTEEN,KNOWLEDGE,L858R,LABEL,METHODS,MOLECULAR,NLR,NSCLC,PLR,RESULTS,SCHOLAR,VARIOUS,WEB
000,CENTRAL,CONCLUSION,FVC,ICU,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SIXTY,SOUTH,UNIVERSITY,XIANGYA
CAMBRIDGE,CENTRAL,CONTROLLED,ECONLIT,INPATIENT,JANUARY,JSTOR,MEDLINE,SCIENCE,VTE
150,169,250,372,AFTER,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,ERLOTINIB,HOWEVER,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THEREFORE
002,003,020,026,163,169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,INSTITUTE,LABEL,METHODS,NSCLC,NSE,OBJECTIVE,PFS,RESULTS
169,3DCRT,AIM,ANTICANCER,CCHIA,CONCLUSION,COPYRIGHT,FURTHER,III,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE,USING
169,AIM,ANTICANCER,BETWEEN,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MAY,METHODS,NSCLC,NSQ,OBJECTIVE,RESULTS
014,031,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,EBC,FORTY,FURTHER,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,4FR,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,RBE,RESULTS
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GRADE,INSTITUTE,IRINOTECAN,LABEL,METHODS,NEC,PFS,RESULTS,WORLD
169,655,ANTICANCER,BACKGROUND,CLONOGENIC,CONCLUSION,COPYRIGHT,H1650,INSTITUTE,LABEL,MATERIALS,METHODS,NCI,RESULTS,SEVENTY,THOSE,WNT
169,ANTICANCER,COPYRIGHT,DESPITE,ECBALLIUM,INSTITUTE,NSCLC,PCR
169,174,293,ANTICANCER,COPYRIGHT,CRIZOTINIB,HEK,IC50S,IKR,INSTITUTE,LIPOSOMES,QTC,RABBITS,TASIGNA,XALKORI
169,ANTICANCER,COPYRIGHT,INSTITUTE
ABROGATION,DESPITE,HOWEVER,MTB
169,503,646,786,BOARD,CONCLUSION,COPYRIGHT,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,WOMEN
012,167,226,227,307,348,517,537,582,674,800,888,935,963,AUC,DOR,EPIDERMAL,HOWEVER,NLR,NSCLC,PLR,TKI
169,COPYRIGHT,CSA,CYP,DUE,HTB,INC,MMP,SFA,USING
169,733,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,MAJOR,MCNEMAR,METHODS,MORTALITY,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE,THESE,WEDGE
169,ALT,AST,BETWEEN,CONCLUSION,COPYRIGHT,DCR,IRELAND,LABEL,LTD,MATERIALS,MECHANISMS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PAZOPANIB,RESULTS,SIMON,STAGE
169,945,COPYRIGHT,DESPITE,HIF,IRELAND,LTD,SMALL,THERAPY
100,945
MPNST
AFTER,LAPAROTOMY,MEANWHILE
112,169,MRI,PREVIOUSLY,THESE,USRPS,UTE,VCH,WILEY
CSC,DESPITE,EXTENSIVE,FURTHER,STUDIES,THEREFORE,THESE
DDR,FVC,LABEL,LAM,METHODS,MMP,OBJECTIVE,PURPOSE,RESULTS,SERUM,THERE
169,549,COPYRIGHT,PERFORMED,SAS
160,169,ALK,COPYRIGHT,NPM,SAS,SUP
111,119,169,206,258,269,646,AMONG,BACKGROUND,BECAUSE,CIS,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MORTALITY,OPERATIVE,PUBLISHED,RESULTS,SOCIETY
EXTRA,GENERALLY,PULMONARY
ABCG2,PKH,TAKEN
001,419,508,945,947,AFTER,CCK,CONCLUSION,ELISA,FCM,IFN,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,TH1,TH2,TNF,TREATED
160,946,HCC,MMP,PATERNALLY,PEG10,TNM
169,946,COPYRIGHT,FURTHER,GINSENG,PANAX,PPD,TAKEN
169,231,233,COPYRIGHT,FINALLY,FIRSTLY,PET,PUBLISHED,SAS
169,AUTHORS,COMPOUNDS,COPYRIGHT,ERK,INC,MEK,PROLONGED,PUBLISHED,RAF,RAS,SMALL
169,AKT,BACKGROUND,BAD,BASEL,BCL,H1975,HOWEVER,LABEL,MELATONIN,METHODS,NSCLC,NSCLS,OBJECTIVE,RESULTS,T790M,TKI,TREATMENT
169,40S,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,NSCLC,RFS,RIBOSOMAL,SUBSEQUENT
001,018,039,612,BACKGROUND,CONCLUSION,FUNDING,INSTITUTES,LABEL,LIMITATION,METHODS,OBJECTIVE,PPV,PREVALENCE,PRIMARY,RESECTION,RESULTS,SCREENING,SECONDARY,SETTING,TRIAL
SINCE
CURRENTLY,LAM,RAPAMYCIN,WOMEN
ALTOGETHER,INITIATING
ERK,FOLLOWING,GEFITINIB,IGF,III,SRC
116,1C8,205,B16MELF10,CEA,HCT,IGG2A,WESTERN
001,002,057,260,ATM,BREAK,CHINESE,DDR,SNP
CNV,FINALLY,PLK,PROJECT,REMARKABLY,TAKEN,THERE,USING
282,555,990,BETWEEN,DISCHARGE,HOWEVER,JANUARY,PATIENT,SCORE


251,BACKGROUND,CHINA,CONCLUSION,FIFTEEN,FINALLY,HLS,HODGKIN,HOWEVER,IPS,LABEL,MCCHL,METHODS,NSCHL,PRISM,RESULTS
001,004,005,006,017,025,087,130,336,594,CHI,COX,DEK,IHC,MEIER
ALK,EMA,FURTHER,HOWEVER,MFH,SMA,SUBSEQUENT,TIA
CURRENT,HOWEVER,III,MTT,NAD,NSCLC,SIRT6,TAKEN
AHR,ASICS,TRPV1
169,956,G2M,INITIALLY,PBD,VCH,WILEY
177,AFTER,CONCLUSION,CY5,EPO,HOWEVER,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PROBE,RESULTS,THEREFORE
169,215,289,748,COX,FIRST,ITALY,NCI,PTPRG,SNP,THESE
004,028,045,058,113,169,BASEL,CONCLUSION,FURTHER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
169,946,DAPK1,EARLY,EBV,EPSTEIN,HOWEVER,HRM,NPC,RAR,RASSF1A,SINCE,VIRUS
169,221,AGE,COPYRIGHT,END,FORTY,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PALLIATIVE,POISSON,PURPOSE,RATES,RECEIPT,RESULTS
DESPITE,TLS
ABOUT,BACKGROUND,BCS,BRONCHIAL,CENTRAL,JANUARY,LABEL,METHODS,RESULTS
AFTER,HOWEVER,ISONIAZID,OWING
THERE
160,918,HRS,MANAGER,MMP,MT1
169,231,233,COPYRIGHT,PUBLISHED,SAS
169,233,BHD,COPYRIGHT,DUB,HPV,HPYVS,INC,KAROLINSKA,PCR,SEVEN,UNIVERSITY
AFTER,HOWEVER,OTHER,SCIENTIFIC,STAGE,THERAPY
100,169,177,COPYRIGHT,CSI,EXCLUSIVE,FIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,V95
169,200,CONCLUSION,COPYRIGHT,EPIGENETIC,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SCLCS,SMALL
041,169,396,664,BIOMEDICAL,CHINA,CHINESE,CIS,CONCLUSION,COPYRIGHT,EGGER,INC,JANUARY,JAPAN,LABEL,LIBRARY,METHODS,NEWCASTLE,OBJECTIVE,OVERALL,QUALITY,RESULTS,SCALE,SCHOLAR,SCIENCE,SUMMARY,TEA,WANFANG,WEB,WESTERN

169,ACTUARIAL,CILRR,COPYRIGHT,CRT,ENR,IMAGING,INC,INR,LABEL,LOCAL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THESE
100,169,750,AUTHORS,COPYRIGHT,DESPITE,GIVEN,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SEVEN,THERE
169,COPYRIGHT,D10,ESTIMATES,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRACTICAL,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERAPISTS,TREATMENT,V10,V20,V30
169,189,945,946,BACKGROUND,CONCLUSION,DOSES,EVALUATION,FGF,FGFR1,IIA,LABEL,LUCITANIB,MEDICAL,METHODS,MTD,PFS,PRESS,PUBLISHED,RESULTS,SEVENTY,SEVERAL,SIXTY,SOCIETY,SOLID,THERE,UNIVERSITY,VEGFR
001,003,008,132,169,BACKGROUND,BECAUSE,CONCLUSION,LABEL,MEDICAL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,SOCIETY,TRIAL,UNIVERSITY
RENAL
160,169,AFTER,BACKGROUND,CHANGES,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,LDH,METHODS,MMP,NCI,NSCLC,OBJECTIVE,PUBLISHED,QUERCITRIN,RESULTS,THERE,THESE,WST
CCA,CSA,MUTATIONS,TRNT1,USING
200,ABL,EMT,EPITHELIAL,FAK,NSCLC,SRC,THESE
DSB,GENOMIC,HOWEVER,NGS,PUBLISHED,WHILE
00001,581,CONCLUSION,EVENT,FDG,III,INCLUSION,LABEL,MANAGER,MEDLINE,METHODS,MTV,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,TLG,TNM,VOLUMETRIC
100,105,235,362,AFTER,AUSTRIA,BACKGROUND,HOWEVER,LABEL,METHODS,PREDICTION,RESULTS,STATISTICS,THEREFORE,TYROL
169,945,946,COPYRIGHT,D1A,D1B,FURTHER,HOWEVER,HOXD3,IRELAND,LTD,MCF,NOTABLY,THESE
169,945,946,ALK,EBP,FINALLY,HIF,NSCLC,RAS,STAT3,VEGFA
169,946,954,ACTIVATION,AEG,AKT,BECAUSE,DEN,ERK,HCC,HOWEVER,IL6,LYRIC,OVERALL,STAT3
169,183,AIR,CHRONIC,COMMISSION,COPYRIGHT,LTD,THESE,WOMEN
169,COPYRIGHT,INC,PUBLISHED,RESULTS,SOCIETY
169,COPYRIGHT,INC,PATHOLOGIC,PUBLISHED,SOCIETY,THREE
169,AKT,ANG,ANGIOGENIN,COPYRIGHT,FINALLY,GST,HOWEVER,INC,RNASE,TAKEN,THEREFORE
160,177,3GY,9GY,AAA,BACKGROUND,CONCERNING,CTV,D99,DVH,LABEL,METHODS,PTV,RESULTS,SABRT
107,119,145,226,COX,IIB,INCREASED,PCR
169,956,COLCHICINE,COPYRIGHT,FURTHER,HOECHST,LTD,ROS,SAR
160,172,181,197,238,252,255,492,516,BACKGROUND,DISEASE,LABEL,METHODS,RESULTS,STUDIES,THERE,THESE
008,160,2N1M0,781,784,BACKGROUND,COX,END,FACTORS,LABEL,MEIER,METHODS,NSCLC,OVERALL,RESULTS,THESE
134,135,275,617,BACKGROUND,ESTIMATING,LABEL,METHODS,PLATEAU,RESULTS,THERE,URANIUM,WORKERS
FBI,IST
115,241,CAP67,DESPITE,GALXM,GXM,MPS,PC3,THESE
152,FIBROBLAST,MICRORNAS,NSCLC,OVERALL,THESE
200,CLT,CODONOPSIS,HEMSL,KOIDZ,METASTASIS,MMP,RUNX2
012,160,437,841,967,BACKGROUND,COLORECTAL,CONCLUSION,CRC,GROUP,INTER,IPN,KAPPA,LABEL,METHODS,PATHOLOGY,PATIENT,PRIMARY,RESULTS,WHITNEY
160,SMALL
181,200,800,BACKGROUND,INCUBATION,LABEL,LOW,MEFLOQUINE,MRC,NTS,RESULTS
BIOLOGICAL,FURTHER,KINDS,LABEL,METHODS,OBJECTIVE,RESULTS,SCIENCE,SOURCES,VARIOUS,WEB
IPF,LABEL,MEDLINE,METHODS,OBJECTIVE,RADIOLOGIC,RESULTS,SELECTION,SOURCES,THESE
001,004,006,018,025,035,116,503,612,BACKGROUND,CONCLUSION,GCS,LABEL,LRP,MDR,METHODS,NSCLC,RESULTS,THERE
001,029,045,100,112,160,AFB,BACILLI,CK5,EIGHT,SUBSEQUENT,TTF
169,ANTICANCER,COPYRIGHT,FURTHER,INSTITUTE,SINCE,STUDIES,SUBSEQUENT,WILMS,WT1
946,BCA,K63,METASTATIC,TGF,UBC13
ADDITIONAL,BREAK,HOWEVER
AREAS,BACKGROUND,COVERED,IGF,LABEL,METHODS,OPINION,SMALL
128,252,375,CHO,GUO,HOWEVER,LARYNGEAL,LIANG,NON,PROJECT,THEIR,THEREFORE,THESE
100,169,ILK,SEVERAL,THESE,USING,WHILE
169,AMONG,ASIAN,TAKEN,THERE
118,169,438,COPYRIGHT,DLS,DYNAMIC,EDX,ERYTHRINA,FOURIER,NPS,SURFACE,TEM,TRANSFORM,ULTRA,VARIOUS,VIS,XRD
169,CD8,GAL,INHIBITION,IRRADIATED,LABEL,LEWIS,LLC,LYMPHOCYTE,MATCHED,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,TDG
169,203,AKT,AQA,CQC,EGF,ERK,H1975,L858R,LABEL,MEK,METHODS,NON,NSCLC,OBJECTIVE,PC9GR,PURPOSE,RESULTS,SIMILAR,T790M,TARGETING,THESE
169,533,CONCLUSION,IVL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC,SUPERVISED,USING
169,IMAGING,INC,MOLECULAR,NUCLEAR,RECEPTORS,SELECTIVE,SOCIETY
CTS,KEY,RADIOLOGY,SCREENING,TRIAL
BACKGROUND,FAP,FIBROBLAST,LABEL,METHODS,RESULTS,SIMILAR,SMA,TGF,TWIST
BACKGROUND,EXPRESSION,FGF,FGF18,FGFR1,FIBROBLAST,INHIBITION,LABEL,MALIGNANT,METHODS,MOUSE,OBJECTIVE,OBJECTIVES,RATIONALE,REDUCED,RESULTS,SEVERAL
106,131,181,ANOTHER,BACKGROUND,CONCLUSION,CONTEXT,DISCUSSION,INITIAL,LABEL,MALIGNANCY,MATERIALS,METHODS,PGL,RESULTS
FDG,INTENSE,PET
AGE,AIM,CONCLUSION,LABEL,LNS,METHODS,OBJECTIVE,PET,RESULTS,SIX,T1A,T2B,TNM
CONVERSELY,H1299,LAMP1,METHODS,THESE,USING
951,PDT,TRANSITION
026,232,407,838,ASSESSMENT,BACKGROUND,DIAGNOSTIC,FDG,LABEL,LIBRARY,METHODS,PET,QUALITY,RESULTANT,RESULTS,STUDIES
001,015,048,400,910,AGE,BACKGROUND,BOARD,COX,EORTC,EPP,III,INDEX,LABEL,MEIER,METHODS,MPM,NLR,NSW,PROGNOSTIC,RESULTS,TREATMENT
198,BACKGROUND,CONCLUSION,DIFFERENT,DOX,LABEL,METHODS,NLC,RESULTS,SLN,THEIR
169,177,MALIGNANT,PRESS,PUBLISHED,UNIVERSITY
169,215,414,945,949,AAS,AFRICAN,AMERICANS,CRP,DESPITE,EAS,ESP,HNF1A,NHLBI,PRESS,PUBLISHED,UNIVERSITY
15Q25,169,215,339,363,420,CANADIANS,PRESS,PUBLISHED,UNIVERSITY
169,APOPTOSIS,BCL,COUMARINS,HOWEVER,INHIBITION,JNK,JUN,MOLECULAR,NUR77,PRESS,PUBLISHED,UNIVERSITY
206,CHI,CONCLUSION,COX,ETS,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE,VCP
215,65294,969,A42,A64,A83,AUC,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
169,ADP,AKT,CIP2A,COPYRIGHT,NSCLC,OKADAIC,SOCIETY
BELGIUM,DETECTION,DUTCH,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,THESE
169,99A,FURTHER,INC,MICRORNAS,NSCLC,WILEY
104,124,169,228,394,445,479,AMONG,BACKGROUND,FNA,LABEL,LNS,METHODS,NPV,RESULTS,SOCIETY,STUDIES
398,COX,LPS,NSCLC,THESE
AE1,AE3,CEA,GCDFP,MITOTIC,OTHER,TTF
BACKGROUND,CONCLUSION,FUNDING,JUTLAND,LABEL,METHODS,RESULTS,TRIAL,WOMEN
100,514,CONTINUED,EARLY,LABEL,METHODS,OBJECTIVE,PCF,PURPOSE,RAMAN,RESULTS,SNR
111,543,553,563,586,588,601,CAD,CONSORTIUM,DMEAN,FCM,FINALLY,GMM,IMAGE,JACCARD,LABEL,LBF,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,THEREFORE
169,180,639,AGENT,BACKGROUND,COX,FURTHER,JANUARY,LABEL,METHODS,OVERALL,PRESS,PUBLISHED,RESULTS,UNIVERSITY,VARIOUS,VIETNAM,WAR
DAD,MAMMALIAN
169,COPYRIGHT,LTD
169,231,946,COPYRIGHT,CSE,HMVEC,IMMUNOBLOT,INCUBATION,MDA,PAF,POTENTIAL,SIMILARLY,SOCIETY,TAKEN
120,AFTER,FIRST,SAA
169,GSH,HMOX1,INDUCTION,INHIBITORS,LABEL,ROS,TSC,UNLABELLED,USING
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
ERBB2,HSP90,NSCLC,THROUGH
169,BACKGROUND,CENTRAL,CONTINUED,COPYRIGHT,DESPITE,ENGLISH,LABEL,LIBRARY,MEDLINE,METHODS,RESULTS,SMOKING,THERE
169,COPYRIGHT,INTUBATION

109,BACKGROUND,CONCLUSION,CUTANEOUS,JANUARY,LABEL,LACTATE,METHODS,OBJECTIVE,RESULTS,SIXTY
346,EGF,ERLOTINIB,GEFITINIB,HOWEVER,NOMINALLY,THESE,UNREPORTED
946,AKT,H1299,NAD,NSCLC,OVERALL,SIRT1,THESE
AUTOPSY
GTPASES,HOWEVER,RAB,RAB37,TIMP1
BRAF1,CURRENTLY,DESPITE,EGF,MEK,PDGFR,PIK3A,SEVERAL,VEGFR
10YEARS,169,BOHAN,CONCLUSION,COPYRIGHT,COX,DIAGNOSIS,LABEL,MEIER,METHODS,MORTALITY,OBJECTIVE,PETER,PROGNOSTIC,RESULTS
BACKGROUND,CHEST,JAPAN,LABEL,LEVEL,MEDICAL,MEDLINE,METHODS,MINDS,NETWORK,NSCLC,RESULTS,SERVICE,SURGERY
150,169,266,300,COPYRIGHT,HOWEVER,LTD,NSC,THROUGH
343,400,795,893,AUC,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SPN,USING,VDT
000,005,014,015,023,024,034,046,058,076,080,100,184,269,573,985,986,992,999,AGE,COX,FATAL,FVC,KEY,LABEL,METHODS,NRI,OBJECTIVE,PULMONARY,RESULTS,SPIROMETRY,THESE
169,231,233,COPYRIGHT,PUBLISHED,SAS,THEIR
APO2L,DERIVED,HUVEC,IAP,IEC,ION,O53,SEC,TRAIL,WHILE
31MARCH,759,818,AUDIT,BMJ,CROSS,ENGLAND,ENGLISH,EPISODE,GROUP,LABEL,LIMITED,MEASURE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,PUBLISHED,PUBLISHING,RESULTS,SETTING,STATISTICS
169,BACKGROUND,BMJ,DIFFERENT,FEV,FVC,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEVERAL,SIGNALLING,SNP
DESIGNING,FDA,HCC,HEPATOCYTE,MEDULLARY,MET,MTC,RCC,THYROID,XL184
RAMAN,SINCE,THEREFORE
169,176,178,239,AIM,AUTHORS,CLAVIEN,CONCLUSION,CRS,DINDO,GYNECOLOGY,HIPEC,III,JAPAN,JOURNAL,LABEL,METHODS,OBJECTIVE,OBSTETRICS,RESULTS,SOCIETY
ALTERATION,MICRORNAS,TAKEN
BACKGROUND,HOWEVER,LABEL,LRIG1,LRIG2,LRIG3,METHODS,OPTIMAL,RESULTS,SEVERAL
009,017,021,025,032,038,046,048,120,BACKGROUND,CHI,COX,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,THOP1,TNM,UNIVARIATE

946,EMT,HCC,MMP,THERE,WNT
176,HOWEVER,KRAS2,PNA
COLLEGE,EARLY,NSCLC,PANEL,RADIOLOGY
182,METASTASIS,MICRORNAS,NOTABLY,THESE
AFTER,EFFICIENT,GDP,GTP,NRP,TMR
AIM,BACKGROUND,DISCUSSION,III,LABEL,METHODS,MOMENTS,OBJECTIVE
BASED,BAYES,HOWEVER,NIM
240,300,CALM1,FIFTEEN,FINALLY,FIRST,GRIA2,III,IL3RA,IL6ST,NSCLC,PCR,PLCB4,ROCK2,THBS1,THESE,WESTERN
015,027,042,048,073,160,360,373,AFTER,CHINESE,GENOMIC,HOWEVER,VAL762ALA
169,AIM,COPYRIGHT,EBC,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS
169,AKT,BIOLOGISTS,COMPANY,EMT,HOWEVER,LTD,MEIER,PITPNM1,PUBLISHED,THESE
000,014,020,121,169,900,956,COLLEGE,CONCLUSION,COPYRIGHT,CSF,ENGLISH,HOWEVER,ICHUSHI,JAPAN,LABEL,LTD,MATERIALS,MEDICAL,MEDLINE,METASTASIS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SOCIETY,WEB
169,ALTOGETHER,COPYRIGHT,DELIVERING,FIRST,METABOLIC,PET,PUBLISHED,SAS
100,175,177,950,ANC,BSA,FURTHER,HNC,HOWEVER,ONC,PCA,PCR,REN,TAGUCHI,THESE,TPP
204,CHRONIC,SNP,STUDIES
000,160,AFTER,ALONG,BACKGROUND,CONCLUSION,EMT,FINALLY,LABEL,METHODS,P2J,RESULTS,SNAIL
001,003,169,195,1ST,945,BACKGROUND,CASES,COLORECTAL,GLEASON,III,INDIVIDUAL,LABEL,METHODS,OR4TH,ORS,OVARIAN,RESULTS,SCREENING,TRIAL
102,125,177,PTX,SCLCS
BACKGROUND,BASED,GLU496ALA,LABEL,NSCLC,RESULTS,SNP,UNTIL
169,177,518,AUTHORS,BETWEEN,CONCLUSION,COPYRIGHT,EUROQOL,INTERVIEW,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,QOL,RESULTS,STATISTICS,VITAL
945,HIF,IL6,JUN,LVS,STAT3
ALK,BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,NON,NSCLC,SMALL
169,BAX,BCL,CHINESE,INC,JNK,KEAP1,PRO,PYDDT,ROS,SW620,TAKEN,THERE,WILEY
215,AFTER,GSH,MSA,NA2SEO3,REDUCED,THEREFORE,THESE
169,DESPITE,ERS,NSCLC,T790M
169,AUTHORS,COPYRIGHT,INC,MMP,MT1,PUBLISHED
160,169,296,432,464,760,COLLEGE,CONCLUSION,COPYRIGHT,GUIDELINES,INC,JANUARY,LABEL,METHODS,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SCREENING,SIMILAR,TRIAL
6FL,945,TARGETING,TEM,THESE,TIE2CRE
169,APRIL,BACKGROUND,CCNB3,DIAGNOSIS,EWING,INC,INDUCTION,LABEL,LOCAL,METHODS,PROCEDURE,RESULTS,SIXTEEN,WILEY
160,TAKEN
116,2YL,435,BEL,DU145,ETHYL,HCT,HOWEVER,MDA,MTT,SURGERY,ZCD
169,COPYRIGHT,DU145,LTD,MCF,PUBLISHED,UGI
160,181,ANNEXIN,BAX,BCL,LA795,MTT
181,401,BASED,CTC,GFP,HOWEVER,OBP,SEVEN,THEREFORE
AUTOCRINE,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THESE
160,169,235,238,500,BORON,CAPTURE,CELLS,CONTROL,COPYRIGHT,INT,LTD,NEUTRON,NON,NSCLC,PUBLISHED,SINCE,SMALL,TCP,THERAPY,TREATMENT
106,160,945,946,OBJECTIVE,OBRGT,RECURRENCE,SEVEN,SRS
100,169,COL11A1,COPYRIGHT,FORTY,P63,VARIOUS
160,BAX,BCL,FOLLOWING,MYD88,THESE,WST
169,945,CD3,CD4,CD8,COPYRIGHT,TNF,WATER,WSC
HOWEVER
001,142,BECLIN1,LIVER,NSCLC,PCR,REDUCED,TNM,UNIVARIATE
4T1,954,AMONGST,GIVEN,HIRSUTINE,MMP,NUCLEAR
001,160,169,AMONG,BACKGROUND,BUNDANG,COPYRIGHT,HOWEVER,IDIOPATHIC,IPF,LABEL,LTD,MATCHED,METHODS,RESULTS,SEOUL,SEVENTY,UNIVERSITY
143,946,ALTERED,NSCLC,PCR,RAS,SMAD3,TGF
000,100,106,110,AGE,ALGERIA,APC,ASR,BACKGROUND,BETWEEN,INCIDENCE,INSTITUTE,LABEL,METHODS,RESULTS,SETIF,STATISTICS
087,169,250,ASPIRIN,AUSTRALIA,BECAUSE,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,MATERIALS,METHODS,NON,NSAID,OBJECTIVE,OBJECTIVES,RESULTS,WESTERN,WITTENOOM
169,AIM,COPYRIGHT,FDG,FINALLY,IRELAND,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PET,RESULTS,WMD
MALIGNANT,MPM,THERE
150,154,169,183,BACKGROUND,BETWEEN,COPYRIGHT,EASTERN,ERLOTINIB,FEB,FUNDING,FURTHER,GROUP,JAPAN,LABEL,LTD,MARCH,METHODS,NSCLC,RESULTS,SERIOUS
131,142,169,183,AVERAGE,BACKGROUND,CHECKLIST,CHIEF,CONTROLLED,COPYRIGHT,CURRENT,DEPRESSION,FUNDING,GOVERNMENT,JAN,LABEL,LTD,MANAGEMENT,METHODS,RESULTS,SCALE,SCIENTIST,SCL,SMART,SYMPTOM,TRIAL,USUAL
160,BACKGROUND,C30,CONCLUSION,CONCURRENT,CTC,EORTC,LABEL,METHODS,N35,QLQ,RESULTS,SEVEN
169,ABDOMINAL,APRIL,BACKGROUND,CLEAR,CONCLUSION,EGYPT,III,INC,LABEL,MARCH,METHODS,OVERALL,PROCEDURE,RESULTS,SURGERY,USA,WILEY
100,106,169,2GY,945,946,ACUTE,BED,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RECURRENCE,RESULTS,ROYAL,SRS
CK7,CLCA2,CTC,CURRENTLY,DETECTION,HOWEVER,PCR,THESE
160,946,954,BLM,HOWEVER,LPA,SIMILARLY,TGF
169,COPYRIGHT,NSCLC,PROTEOMICS
160,300,318,ADVERSE,BACKGROUND,BETWEEN,CONCLUSION,CONCURRENT,CRT,CTCAE,III,LABEL,METHODS,NSCLC,OVERALL,PFS,RESULTS,STAGE,THERE,TREATMENT
169,AFTER,BACKGROUND,BOARD,CONCLUSION,COPYRIGHT,ELBOW,INC,JOURNAL,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,SURGERY
700,SMOKING
169,CONCLUSION,EMT,HOWEVER,LABEL,LTD,MATERIALS,METADHERIN,METHODS,MIGRATION,OBJECTIVE,OBJECTIVES,RESULTS,TAKEN,WILEY
004,169,769,939,INC,MTS,THESE,WILEY
169,CTF,GPS,NTF
100,169,956,BASED,COPYRIGHT,FURTHER,INHALATION,IRELAND,LTD,MOA,SUBSEQUENT,THERE,THESE

CDC42,EGF,ERK,H1299,MMP,NSCLC
181,ARSENIC,ATO,BAK,BAX,BCL,BID,H23,JUN,TREATMENT,USING
SPLENIC
169,APC,BACKGROUND,COPYRIGHT,FGFR1,FGFR2,FURTHER,IRELAND,LABEL,LTD,MET,METHODS,MPM,RESULTS,VHL
181,HOWEVER,MDIVI,RED,THEREFORE,TRAIL
169,AFTER,CONSORTIUM,COPYRIGHT,FIRST,IMAGE,INITIATIVE,LTD
006,100,169,216,ACSS1,AFFILIATED,AGA,AGS,BACKGROUND,CCNA1,CHINA,CHINESE,COPYRIGHT,EBV,EPSTEIN,FAM3B,FIRST,GUANGZHOU,IHH,INC,INSTITUTE,INTEGRATED,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SUN,TEN,THESE,TRABD,UNIVERSITY,WALES,WHOLE,YAT
BJE,COLORECTAL,CRC,INSTEAD,LOW,MAPKS
143,ABL,ACCORDING,ADSCC,ASP,CNS,DDR,DISCOIDIN,FLA,NSCLC,PCR,S768R,SRC
169,945,946,947,COPYRIGHT,INHIBITING,JNK,JUN,NAG,STE20,THESE
103,BACKGROUND,BSA,L858R,LABEL,METHODS,MST,NSCLC,PFS,RESULTS,THERE
169,CD3,CD4,COPYRIGHT,INC,PNS,THESE
ALK,CONSISTENT,CRIZOTINIB,IGF,IRS,SIMILAR,TKI
001,073,169,217,COMMITTEE,CONTROL,COPYRIGHT,INC,IPLCC,JOINT,LABEL,METHODS,OBJECTIVE,PLC,PLEURAL,PROGNOSES,PUBLISHED,RESULTS,SURGERY,T2A,THESE,TNM,UNION
100,443,BACKGROUND,CHINESE,ENGLISH,HCC,LABEL,METHODS,RESULTS,THERE
169,239,272,468,506,511,527,995,AUC,BACKGROUND,EXCELLENT,EXTENSION,GENERAL,HOUSTON,LABEL,METHODS,NPB,RESULTS,SPITZ,THERE
169,945,CONVERSELY,COPYRIGHT,ECH,INC,KEAP1,KELCH,KNOCK,P45,RXR
169,177,231,956,ALDER,CH3CN,COPYRIGHT,DIELS,FURTHER,LTD,MCF,MDA
169,185,CCL,COPYRIGHT,DU145,HTB,LTD
115,165,169,197,238,509,COPYRIGHT,EPCAM,FORTY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
124,169,418,COPYRIGHT,HOSPITALS,INC,LABEL,MAJOR,METHODS,MORTALITY,OBJECTIVE,OTHER,PUBLISHED,RESULTS,SIMILAR,SURGERY,THERE
169,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,NSCLC,PARTIAL,RESULTS,TOXICITIES,TRT
003,169,266,946,CHANGES,CONCLUSION,COPYRIGHT,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,UNIVARIATE
CDC,CONCLUSION,END,HISPANICS,HISTOLOGIC,INSTITUTE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PROGRAM,PUBLISHED,REGISTRIES,RESULTS,TREND,USA
169,247,BACKGROUND,CRI,DEVON,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SLT,SYMPTOM,UNIVERSITY
SH2,SIMILAR,SOCS6,THEREFORE
CHINA,RESULTS
135,169,454,610,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FLX,IGE,IGG,IGH,IGHV1,IGHV5,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
169,29A,CEACAM6,COPYRIGHT,FEDERATION,PUBLISHED,SOCIETIES,THEREFORE
169,1735T,594,AIM,BASEL,CONCLUSION,HOWEVER,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS

122,169,COPYRIGHT,MEANWHILE,UNDER
171,AFTER,BACKGROUND,LABEL,MARKERS,METHODS,OBJECTIVE,PRINCIPAL,RESULTS,ROC,THEIR,THROUGH
100,BACKGROUND,CTA,GAGE1,LABEL,METHODS,OBJECTIVE,RESULTS
001,002,011,035,054,076,100,134,161,177,180,186,215,257,356,483,694,880,AFTER,COMMITTEE,PET,PNS,RIS,RIX,SUV,THERE
169,COPYRIGHT,CTC,INC,USING
169,COPYRIGHT,EMT,INC,MMS
169,INC,THESE,WILEY
003,055,063,064,177,215,427,727,CISPLATIN,GROUP,HENCE,HOWEVER,SEM,THESE
AMONG,FOXM1,SRC
130,135,177,263,BACKGROUND,CONCLUSION,DUE,LABEL,METHODS,RAI,RESULTS,THREE
956,BACKGROUND,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
ASSESSMENT,BACKGROUND,CHARTIS,HOWEVER,ILF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
001,226,492,AFFAIRS,AUC,BACKGROUND,BRIER,CONCLUSION,EVALUATION,LABEL,METHODS,RESULTS,TREAT,TREATMENT,VANDERBILT,VETERAN
016,108,BACKGROUND,BIOLOGICAL,CONCLUSION,DFS,FDG,GLUT1,LABEL,METABOLIC,METHODS,NSCLC,PET,RELEVANCE,RESULTS,THESE,TLG
SURGERY
BACKGROUND,BDI,CONCLUSION,DEPRESSION,INVENTORY,LABEL,METHODS,NON,NSCLC,RESULTS,SES,TREATMENT
200,2GENE,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,PFS,RESULTS,SNP,THERAPY,THESE
001,003,009,179,BACKGROUND,COX,DFS,LABEL,METHODS,RESULTS,USING
ALK,BACKGROUND,DIAGNOSTIC,EQA,ITALIAN,LABEL,MEDICAL,METHODS,NSCLC,OVERALL,PATHOLOGY,RESULTS,SEVERAL,SOCIETY
002,005,007,548,945,946,BACKGROUND,BIOMARKERS,COLORECTAL,LABEL,METHODS,OVARIAN,PRESENTLY,RESULTS,THESE
ALK,BACKGROUND,CONCLUSION,FIFTY,IHC,ISH,LABEL,METHODS,NSCLC,REMARKABLY,RESULTS
169,176,COPYRIGHT,INC,NIPAM,TAT,WHILE
001,006,LABEL,LIMITED,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
169,ABC,ALK,AP26113,BECAUSE,CELLS,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,THEREFORE,UNIVERSITY
169,BIOMARKERS,EPIDEMIOL,HE4,YET
MTT,NSCLC,WESTERN
CHINA,CIS,CONFERENCE,EGGER,FIXED,HIGGINS,INDEX,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,ORS,RESULTS,SCIENCE,SEVERAL,SUS,THERE,WEB
100,BACKGROUND,DETECTION,DIFFUSION,DWI,LABEL,METHODS,MRI,PET,RESULTS,WHILE
001,002,017,021,541,578,626,745,751,772,781,815,BACKGROUND,CHINA,LABEL,MATERIALS,METHODS,NSCLC,ORR,PD2,PFS,PULMONARY,RESULTS,SEPTEMBER
00001,004,921,BACKGROUND,CIS,HRS,JANUARY,LABEL,MATERIALS,MEDLINE,METHODS,NSCLC,OVERALL,RESULTS,STATA,THEREFORE
APOPTOSIS,ASSAY,BACKGROUND,HDACI,KLF,KRUPPEL,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PCR,RESULTS,SKOV3,TAKEN,TSA,VYBRANT
169,221,ALTOGETHER,AMONG,FASEB,LAMP3,NAPSA,NSCLC,SFTPB,SFTPC,SFTPD,SLC34A2,TRANSCRIPT
946,947,EMT,MET,NSCLC,SIGNALING,TGF,THESE
169,175,8GY,AMONG,COPYRIGHT,CRT,INC,MEDICAL,OVERALL,PUBLISHED,REGARDING,SIMILARLY,THESE
169,COPYRIGHT,COX,FLS,IRELAND,LTD
HMGB1,MMP,MTT,PCR,RESULTS,TAKEN,WESTERN
CONCLUSION,CTV,FTV,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,TPS,TREATMENT
956,WHILE
027,043,100,169,AUC,BACKGROUND,CONCLUSION,FOUNDATION,GENERAL,LABEL,LCD,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,T1A,T1AN0M0,THERE
030,100,150,177,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,POD,RESULTS,THERE,THREE,VAS
212,369,CD9,ELISA,EXOSOME,HOWEVER
001,169,502,710,BACKGROUND,BETWEEN,COPYRIGHT,INC,INCREASING,INDEX,INPATIENT,LABEL,MCS,METHODS,NATIONWIDE,RESULTS
105,106,123,147,160,169,205,209,257,525,865,982,AGE,BACKGROUND,COPYRIGHT,HOWEVER,INC,JANUARY,LABEL,MAJOR,METHODS,RESULTS,UNIVARIATE,VIDEO
100,BACKGROUND,CASES,DIAGNOSIS,DIFFERENT,LABEL,METHODS
001,177,412,635,AFTER,BACKGROUND,LABEL,LAM,METHODS,RESULTS,SIROLIMUS,THERAPY
DESPITE,HOWEVER,LEWIS,THESE
001,052,158,181,186,260,AMONG,BACKGROUND,DESPITE,DIAGNOSIS,IPF,LABEL,METHODS,PREVALENCE,RESULTS
946,COMPOUNDS,HOWEVER,HUANG,MURRAYA,NMR,THESE
171,217,247,CHIHUAHUA,IDW,INVERSE,KRIGING,MORAN,THROUGH,WEIGHTING
136,169,AKT,LABEL,MBM,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,BACKGROUND,LABEL,MATERIALS,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
002,003,004,169,215,930,AUTHORS,BACKGROUND,BLACKWELL,COHORTE,ELY,FENLAND,FRAMINGHAM,HEART,INC,LABEL,LOSMAPIMOD,METABOLIC,METHODS,OBESITY,OVERALL,POPULATION,PUBLISHED,RESULTS,RS2859144,WILEY
124,169,ACCRUAL,ASIAN,BACKGROUND,BRCA1,CAUCASIAN,CHINA,CHINESE,CONCLUSION,GROUP,HOWEVER,III,LABEL,MEDICAL,METHODS,NSCLC,PFS,PRESS,PUBLISHED,RAP80,RESULTS,SOCIETY,SPANISH,TRC,TRIAL,UNIVERSITY
169,BECAUSE,COPYRIGHT,HOWEVER,III,LTD,ROC,SELECTION,USING,WILEY
001,169,579,775,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,OVERALL,RESULTS
929,AFRICAN,BMJ,CROSS,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PERSONNEL,PUBLISHED,PUBLISHING,RESULTS,SETTING,SURVEYS,USING
PFAAS,TFAAS,VARIATION
169,AMONG,BACKGROUND,BRAZILIAN,DISCUSSION,HODGKIN,INC,LABEL,METHODS,MOR,RESULTS,WILEY
169,946,CATENIN,HOWEVER,L858R,T790M,THESE,TKI
169,BCSCS,NKG2D,PRIMARY
112,ACTUARIAL,BACKGROUND,GTV,LABEL,METHODS,PFS,PRIMARY,RESULTS,SECONDARY,UNIVARIATE
169,AKT,BENZO,HOWEVER,IGF,INC,INSULIN,PPP,TREATMENT,WILEY
00073,169,BACKGROUND,COX,EFS,EWING,FACTORS,HOWEVER,INC,LABEL,MEIER,METHODS,OVERALL,PROCEDURES,RESULTS,SUCCESSFUL,THERE,TREATMENT,VALIDATION,WILEY
144,154,174,364,394,538,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,SEPTEMBER,SIMILARLY,TTFNA
169,HEMATOLOGY,MDS,MPN,RAS,SOCIETY,TREMENDOUS,WORLD
169,946,COPYRIGHT,FINALLY,SERUM,SOCIETY,SRC,TGF,THESE,WHILE
064,110,131,160,177,187,282,283,287,327,387,405,408,462,529,586,663,673,697,722,824,917,977,998,BACKGROUND,DIFFERENT,HODGKIN,LABEL,METHODS,RDS,RESULTS,RHEUMATIC,SIR,SLE,SSC
AFTER,HISTOLOGIC,PULMONARY
116,181,183,295,435,H358M,HCT,MDAMB,NCI,OVCAR,PC3
BACKGROUND,DVT,LABEL,METHODS,OCTOBER,PRIMARY,RESULTS,SECONDARY,THERE,VTE
BACKGROUND,CONCLUSION,DFS,LABEL,LIBRARY,METHODS,NSCLC,RESULTS,STUDIES,THERE
001,ASB,BACKGROUND,CONCLUSION,DETECTION,EOTAXIN,IFN,LABEL,LUMINEX,MALIGNANT,MCP,METHODS,MULTIPLEX,NGF,NOTABLY,PANEL,PCR,RESULTS,TAG,TECHNOLOGY,TNF,WHITNEY
001,028,030,033,034,037,040,044,048,102,945,AKT,BACKGROUND,H1975,HIF,LABEL,MES,METHODS,MVD,NSCLC,PCR,RESULTS,THESE
956,AMONG,H1299,MCF,THEIR,THESE
SEVERAL
947,MAP,THESE
169,ATLAS,AUC,BACKGROUND,CALLING,CONSORTIUM,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,ROC,UNIVERSITY,USING,VARIANT,VCF
169,982,AUC,BACKGROUND,COLLECTED,CURVE,HOWEVER,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THEREFORE,UNDER,UNIVERSITY,WEB
160,177,FALSE,FINAL,FORTY,LABEL,METHODS,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,STUDENT,SUV
169,APC,AUSTRALIAN,COPYRIGHT,INC,JOINPOINT,LABEL,MATERIALS,METHODS,NCP,NORWEGIAN,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RUR,RUR1Y,RUR5Y,TCI
169,176,177,270,BEV,CARLO,COPYRIGHT,GTV,INC,LABEL,MATERIALS,METHODS,MICHELSON,MONTE,OBJECTIVE,PURPOSE,RESULTS,SIX
103,116,208,213,222,876,DON,FURTHER,GIRLS,HEARD,JAPAN,LABEL,METHODS,NEVER,OBJECTIVE,RESULTS,UNDERSTAND
100
126,169,458,NSCLC,PCR,SIX,STAGE
169,AFTER,ASSOCIATES,BPF,BRONCHO,COPYRIGHT,LTD,NSCLC,PUBLISHED
AGE,BACKGROUND,BASED,BIVARIATE,KOREA,KOREANS,LABEL,METHODS,RATIO,RESULTS,THOSE
000,169,252,946,AMH,BECKMAN,COLORECTAL,COULTER,CURRENT,DESPITE,DIFFERENT,ELISA,GEN,MEANWHILE,ORS,OVARIAN,PSA,SCREENING,TGF,TRIAL
13R,169,945,CD8,COPYRIGHT,HIV,LTD,PUBLISHED,TH1,TH2
001,004,613,AVERAGE,BED10,CONCLUSION,DOSES,III,LABEL,LOCAL,MATERIALS,MEIER,METHODS,MORTALITY,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,STAGING
169,ATX,AUTOTAXIN,ENPP2,HOWEVER,LABEL,LPA,THESE,UNLABELLED
CONTINUOUS,FINALLY,HOWEVER,INITIAL
168,AFTER,CALIFORNIA,FCS,GMM,IL1R2,KNOWLEDGE,LABEL,METHODS,NFKB2,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SETTING,VARIABLES
ENGLISH,GENERAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PETER,PURPOSE,RESULTS,SETTING
ACTIVATION,LABEL,MYONUCLEAR,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
BENEFIT,CEA,EBC,NSE,RESULTS,SCC,THESE
COA,HMG,HOWEVER,MDA,MTT,ROS,SOD,THESE,TREATMENT
107,ACC,III,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
108,116,CRC,EXCLUDING,HOWEVER,NSCLC,THESE
008,149,945,CIS,COLORECTAL,CONCLUSION,CRP,INC,INCREASED,LABEL,LIMITED,METHODS,OBJECTIVE,ORS,OVARIAN,PRE,PRO,PUBLISHED,RESULTS,SCREENING,THESE,TNF,TRIAL
AFTER,AH2,IDEPT,PCA,THEREFORE
107
105,170,BACKGROUND,EVALUATION,HOWEVER,LABEL,METHODS,RESULTS,SITES,SOLID,SYSTEMATIC
023,101,720,BACKGROUND,LABEL,METHODS,NOS,RESULTS,STAGE
001,492,ALK,ASIAN,BACKGROUND,DUE,LABEL,METHODS,MULTIPLEX,RESULTS,THEIR,THERE,THESE
BACKGROUND,CONCLUSION,LABEL,METHODS,ORPHELINES,OVERALL,RECHERCHE,RESULTS,VIRTUALLY
125,178,182,200,AMONG,ARM,BACKGROUND,ENROLLMENT,LABEL,METHODS,MOTESANIB,NSCLC,ONCOL,RESULTS,SCAGLIOTTI,THREE,TREATMENT
239,500,BACKGROUND,CONCLUSION,EASTERN,FIFTY,GROUP,HOWEVER,KDR,LABEL,METHODS,PFS,PRIMARY,QOL,QUALITY,RESULTS,THERE,THREE,TREATMENT,VEGFA
132,213,243,663,BACKGROUND,BECAUSE,COMMITTEE,IIA,IIB,JOINT,LABEL,METHODS,RESULTS
269,702,BACKGROUND,BAL,CONCLUSION,DIAGNOSTIC,FAILURE,FURTHER,GENERAL,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER
001,002,104,18F,AUC,BACKGROUND,CONCLUSION,CTC,CTM,CURVE,FDG,FIRST,HOWEVER,LABEL,METHODS,NSCLC,PET,RESULTS
ADP,ANTITUMOR,BACKGROUND,CELLS,EDMONSTON,LABEL,METHODS,NSCLC,ONCOLYTIC,RESULTS,THEREFORE,THESE
954,BACKGROUND,CONTINUAL,CSE,GRP78,HEAVY,HOWEVER,LABEL,METHODS,RESULTS
004,016,151,628,BACKGROUND,COX,LABEL,METHODS,NSCLC,RESULTS,WOMEN
CATALDO,CLCSS,RESULTS,SCALE
141,169,204,COPYRIGHT,MIR,NSCLC,PUBLISHED
169,AMERICA,AMONG,NORTH,PRESS,PUBLISHED,SCATTERED,SIMILAR,THEREFORE,UNIVERSITY
946,ALONG,EMT,EPITHELIAL,FINALLY,FOS,FRA,NSCLC,PBX,PRE,PREP1,PREVIOUSLY,SMAD3,TGF,THESE
946,ATP,EMT,MECHANISMS,SURPRISAL,TGF,USING
169,BCL,BIOLOGY,CADMIUM,GFP,INC,LC3,MOLECULAR,ROS,SOCIETY,SOD,TAKEN,THESE
001,169,ADVERSE,COPYRIGHT,ESTIMATED,GRADE,INC,INSTITUTE,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SECONDARY,SIR,THERE,VERSION
100,956,EPIDERMAL,EXONS,FIFTY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
169,945,954,BAY,DVL,INC,NSCLC,SP1,THESE,TREATMENT,WILEY
123,169,AMONG,BASED,BETWEEN,COX,III,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
008,169,922,APEX1,ASP148GLU,CHINESE,INC,PAH,POLYCYCLIC,SNP,WILEY
160,177,AMONG,HOWEVER,JIKEI,METASTATIC,PFS,PULMONARY,UNIVERSITY
160,231,ATP,BACKGROUND,CONCLUSION,ECS,HOWEVER,LABEL,MCF,MDA,METHODS,MMP,P2Y2R,RESULTS,UTP
1A1,1B1,1C1,1C2,1C3,26S,AKR1B10,CCAAT,MONITORING,NONOATE,PC3,ROS,TREATMENT
127,145,150,169,AMONG,BASED,CBM,CHINA,CHINESE,COMMISSION,HELICAL,LABEL,LIBRARY,LTD,METHODS,OBJECTIVE,OBJECTIVES,PTY,PUBLISHING,RESULTS,SICHUAN,UNIVERSITY,VIP,WANFANG,WILEY
100,169,183,549,956,CHINA,COLON,COPYRIGHT,HCT,PROSTRATE,PUBLISHED,SRB,THP,UNIVERSITY,WMI
169,476,ADJUSTING,CIS,COLORECTAL,DBP,NEITHER,ORS,OVARIAN,SCREENING,TRIAL
DESPITE,III,LOCAL,NETWORK,NSCLC
000,100,169,AGE,APC,AUTHORS,BACKGROUND,BRAIN,CENTRAL,HODGKIN,INC,LABEL,METHODS,RESULTS,SOCIETY,STATISTICS,WILEY
BACKGROUND,CONCLUSION,FIRST,LABEL,LITERATURE,MANAGEMENT,METHODS
169,945,CASTRATION,COPYRIGHT,CURRENT,FGF,FGF23,FGFR1,FGFRI,LTD,TIO,WHILE
169,METASTASIS,NIR,THEREFORE,WHILE
004,008,131,160,BACKGROUND,COMPARISON,CONCLUSION,HOWEVER,LABEL,LOW,MEIER,METHODS,MVD,NOVEL,RESULTS
100,120,159,160,177,99M,EIGHT,GALLIUM,LABEL,METHODS,MSA,OBJECTIVE,PET,PURPOSE,RESULTS
001,005,010,016,022,043,089,112,114,130,136,184,185,215,228,270,273,335,366,514,571,574,688,726,738,820,833,879,890,936,957,968,999,ALT,AMONG,CERTAIN,CHINESE,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE,VTE
107,169,770,989,DESPITE,MEETING,NSCLC,PFS,PHASE,SOCIETY,THESE
08052,169,523,BACKGROUND,CONCLUSION,COPYRIGHT,EORTC,EVALUATION,GROUP,INDIVIDUAL,LABEL,LCG,LTD,METHODS,MPM,RESULTS,SOLID,TREATMENT,TUMOURS,WORLD
107,115,AIP,LABEL,MALIGNANCY,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,ORGAN,RESULTS
0CM,169,177,215,5CM,8CM,COPYRIGHT,FIELD,GROUP,INC,ITV,MEDICAL,PTV,PUBLISHED,RADIATION,THERAPY
005,118,169,BACKGROUND,LABEL,MEIER,METHODS,MUT,RESULTS,RFS,SOCIETY
007,016,160,309,310,967,CHINESE,CLEFT,CLPTM1L,HAN,SNP
169,303,405,460,5MG,634,936,ABIGAIL,BOR,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THREE,UNASSIGNED,VEGFR
169,CHRONIC,COPYRIGHT,HOWEVER,LESIONS,PUBLISHED,SAS
160,3DCRT,BACKGROUND,CONCURRENT,D95,III,INTENSITY,LABEL,LRF,METHODS,MODULATED,NSCLC,PET,RESULTS,SEVENTY,SIXTY,THERE
346,CONCLUSION,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PRIMARY,RESULTS
CHINESE,NSCLC,PCR,SNP

EXPAR,RAMAN
160,315,391,542,891,CAUCASIANS,HENCE,OVERALL,STK15
169,COPYRIGHT,DTT,GTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPHERICAL,T2A
AMONG,RECURRENT,SIADH,THEREFORE,TYPICALLY
001,002,014,180,237,240,251,425,720,ACADEMY,CHINESE,INSTITUTE,MEDICAL
HOWEVER,HSP90,NSCLC
193,CONCURRENT,COX,HCP,KARNOFSKY,KPS,LEE,LFS,NIH,PATIENT,PCS,THESE
COPYRIGHT,DECISIONDX,HOWEVER,SLACK
126,169,217,300,600,900,947,ALECTINIB,ALK,BACKGROUND,CNS,COPYRIGHT,EVALUATION,FUNDING,HOWEVER,IQR,LABEL,LTD,METHODS,MRI,NSCLC,RESULTS,ROCHE,SOLID,THREE
ABOUT,ATTENUATED,DECREASED,LABEL,LUC,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,121,174,259,271,ALK,ANAPLASTIC,BAT,IHC,NSCLC,OVERALL
368,553,581,857,BACKGROUND,CIS,CONCLUSION,HODGKIN,HOWEVER,LABEL,MARCH,METHODS,RESULTS,RRS,SEDENTARY
BACKGROUND,BLACK,CDC,CENTERS,CONTROL,DISCUSSION,DISEASE,INSTITUTE,LABEL,METHODS,PREVENTION,PROGRAM,REGISTRIES,RESULTS
8HQ,956,AROMATASE,CONCLUSION,CYP19,ESTROGENS,GENTEST,LABEL,METHODS,MRC,MTT,OBJECTIVE,PURPOSE,RESULTS
169,AMONG,BASED,COPYRIGHT,ITC,PEITC,PHENETHYL,PRE
169,COPYRIGHT,DNRG1,EMT,INC,NDRG1,SET
CHEST,COLLEGE,FLEISCHNER,PHYSICIAN,SOCIETY,THERE
008,014,100,178,185,359,388,BACKGROUND,HOWEVER,JAPAN,LABEL,METHODS,MUTATIONAL,NSCLC,RESULTS
009,019,025,029,165,189,262,393,447,464,514,579,586,645,651,704,743,801,873,898,948,953,965,ADDITIONAL,AFTER,BACKGROUND,CCCCC,CONCLUSION,HAPLOTYPES,HAPLOVIEW,HOWEVER,LABEL,METHODS,OCCURRENCE,RESULTS,SEVEN,UNIVARIATE,UTR
169,COPYRIGHT,COS,DUE,PDLLA,PEG,PTX,TAXOL
945,954,BACKGROUND,CL1,HOWEVER,LABEL,METABOLIC,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SQS,TARGETING
945,946,EMT,FINALLY,MYC,SILENCING,SRC,STRIKINGLY
221,222,340,CDK,FINALLY,HOWEVER,MET,MICRORNAS,NSCLC,PUMILIO,ROCK1,SCF,THEREFORE,THESE,UTR
CSC,MYC,NOTABLY,STAT3,VEGFR
001,046,049,056,169,174,ADVERSE,CONCLUSION,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SIMILAR,THERE
001,AGE,AMONG,FURTHER,GYN,SEVERAL,UNIVERSITY
001,134,169,ADC,BACKGROUND,COPYRIGHT,FRACTAL,HOWEVER,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,ROC,SCC
AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,SVC
CAF,NOTCH,TIMPS
11Q,169,17P,183,375,420,BACKGROUND,BETWEEN,BTK,CLL,COPYRIGHT,DIARRHOEA,FEB,FUNDING,HOUSTON,IBRUTINIB,INC,INSTITUTE,LABEL,LTD,METHODS,PFS,PREVENTION,RESULTS,SOCIETY,TEXAS,USA
169,BACKGROUND,CONCLUSION,COPYRIGHT,CRT,END,III,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RATES,RESULTS,THERE,THESE
001,007,020,046,103,151,167,172,191,645,945,946,CHI,EXPRESSION,FURTHER,HIF,INTEGRINS,NSCLC,WHITNEY
451,CXCR4,HOWEVER,MICRORNAS,MIR,MMP,MTT,PCR,PSMB8,RESULTS,THEREFORE,TRANSWELL,WESTERN
562,905,ALCOHOL,BLOOMBERG,COLORECTAL,COX,GOVERNMENT,HOPKINS,JOHNS,OVARIAN,PRESS,PUBLISHED,SCREENING,TRIAL,UNIVERSITY,WHETHER
038,169,354,441,BACKGROUND,BOARD,CAIRO,CONCLUSION,COPYRIGHT,DEPARTMENT,DOCTORATE,III,INSTITUTE,IRB,LABEL,MEDICAL,METHODS,NCI,OBJECTIVE,PRODUCTION,RESULTS,UNIVERSITY,WHILE
AAA,BACKGROUND,CAS,DISCUSSION,ENGLISH,FORCE,LABEL,METHODS,OVERALL,PREVENTIVE,RESULTS,SIXTY,SYSTEMATIC
125,144,169,267,469,BETWEEN,COPYRIGHT,CROSS,EIGHT,INC,IQR,LABEL,METHODS,OBJECTIVE,PLANNED,PUBLISHED,RESULTS,SOCIETY,SURGERY
177,AGE,BRONCHIAL,CELSIUS,LABEL,METHODS,RESULTS,THERE,THESE,TNM,UNLABELLED
102,136,167,303,BETWEEN,CELSIUS,JANUARY,NLH
150,CISPLATIN,COX,DFS,FINALLY,MMP,P53,RESULTS
946,AKT,C57BL,CL1,FAK,SMAD2,SMAD7,TGF,TGFRI,TGFRS,UPP
H69,HSP70,SCLCS,TREATMENT
AKT,FURTHER,MMP,SP1,THESE
100,106,113,169,AFTER,BACKGROUND,CHIBA,COPYRIGHT,FINAL,FURTHER,HOWEVER,INC,INTEGRATED,LABEL,MAY,METHODS,PET,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY,THERE
169,181,BACKGROUND,CONCLUSION,COPYRIGHT,COR,DIOSCOREA,HEPG2,IRELAND,L23,LABEL,LTD,MATERIALS,MCF,METHODS,MRC,PC3,RELEVANCE,RESULTS,SRB,TTM
00714,169,170,319,BONFERRONI,CONCLUSION,DESPITE,EQUATIONS,ESTIMATING,FOLLOWING,FURTHER,FVC,GEN,HEART,LABEL,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS,THEREFORE,VO2
013,082,106,119,120,142,153,189,234,481,549,596,643,735,857,GISTS,INCLUSION,KNOWLEDGE,LABEL,MEDLINE,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERE,USING,WEB
CTLA4,HOWEVER,III,PD1,PHASE
946,EXTENSIVE,PEGPH20,TREATMENT
AIM,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SOLUBLE,USING
160,169,956,AMONG,COPYRIGHT,FURTHER,H1299,M10,MCF,MECHANISM,MTT,SAS
AZA,COPYRIGHT,EPIGENETIC,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TREATMENT,UVEAL
011,169,956,INSTITUTE,MCF,MICHAEL,MOLECULAR,VCH,WILEY
AMONG,BACKGROUND,KOREA,LABEL,METHODS,NSCLC,RESULTS,THREE,TKI
100,169,252,264,299,381,956,AMONG,AZ521,CHIMICA,CHINABERRY,COPYRIGHT,COX,EBV,EPSTEIN,HELVETICA,LPS,MELIA,MELIACEAE,RAW,TPA,WESTERN
192,ABOUT,ALTERED,MICRORNAS,NON,NSCLC,THREE
001,002,046,1161G,1779C,420,425,967,CHINESE,HAN,PCR,TAKEN,XRCC1
141,INSTITUTE,JANUARY,SURGERY
025,026,028,048,102,163,169,AFTER,BACKGROUND,CIS,FOLLOWING,INC,JANUARY,LABEL,LIVER,METHODS,OTHER,RESULTS,WILEY
DESPITE,FK866,N39,NAMPT
169,ACUPOINTS,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FATIGUE,FURTHER,LABEL,LI4,LTD,METHODS,OUTCOME,RESULTS,SP6,ZUSANLI
BMJ,GROUP,LTD,PUBLISHING,RECURRENCE,THESE
169,CONVERSELY,GMX,GMX1777,GMX1778,H1299,NAD,NAMPT,NSCLC,PARPS,PEMETREXED,THESE,USING
160,215,327,365,703,906,BACKGROUND,CHINA,CHINESE,COX,LABEL,METHODS,NANJING,NSCLC,RESULTS,STUDIES,THESE
004,025,117,276,AIM,CONCLUSION,DCR,DISEASE,LABEL,METHODS,OBJECTIVE,RESULTS
HOWEVER,III,NON,NSCLC,PHASE,SEVERAL,THESE,TKI
000,100,AIM,AUSTRALIA,AUSTRALIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SIMILAR,SUMMARISED,UNTIL,WORLD,ZEALAND,ZEALANDERS
100,734,829,937,EGGER,KNOWLEDGE,MED,PERTINENT,WAN,WEB
000,100,110,119,BARANJA,C30,C34,C39,FEMALES,HOWEVER,ICD,INSTITUTE,OBC,OTHER,RELATED
127,237,238,250,CUMULATIVE,LCNEC,SMALL,UNIVERSITY
HOWEVER,OVARIAN,SELEX,THEREFORE,USING
BASCS,GLUT1,INDUCIBLE,NOTABLY,NSCLC,ONCOGENIC,RAS,STZ
956,CO3AP,THEREFORE
225,947,BACKGROUND,BRCA1,CONCLUSION,LABEL,METHODS,PROTEIN,RESULTS,SUB,WESTERN
BMJ,CIS,GROUP,LIMITED,OVERALL,PUBLISHED,PUBLISHING,SIR,SMR,WORKERS
169,CH3,FURTHER,GR6,IMMUNOPET,MET,NSCLC
169,99M,ABC,ATP,H1299,MDR,MULTIDRUG,THESE
169,III,LABEL,NSCLC,P27,SIRT1,UNLABELLED
169,200,946,AUTHORS,CATENIN,GIVEN,IVERMECTIN,PUBLISHED,SELAMECTIN,TCF,WNT
169,ALGORITHM,ALIGNMENT,FACTERA,LABEL,MAP,METHODS,PRESS,PUBLISHED,UNIVERSITY,UNLABELLED
169,ASCL1,DNTFS,FURTHER,HGNET,LTD,P53,PATHOLOGY,PTY,PUBLISHING,RB1,SOCIETY,WILEY
001,002,003,006,009,010,015,018,019,120,177,181,185,272,294,353,422,432,688,911,AFTER,AKT,BCL,CONCLUSION,EMT,ERK,LABEL,METHODS,MTS,OBJECTIVE,RESULTS,WESTERN
169,FINALLY,FOCUS,FOXA2,HCC,HEPG2,MMP,PRESS,PUBLISHED,UNIVERSITY
CD3,ENG,EPHA2,HOWEVER,WHILE
169,286,946,E2F,GSK,NSCLC,PSAT1,THESE
400,450,520,AMONG,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,PDD,RESULTS
029,044,047,130,135,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,SEVERAL
001,113,AGE,CONCLUSION,COX,DISTANT,FEDERATION,GYNECOLOGY,LABEL,LOCAL,LOG,METHODS,OBJECTIVE,OBSTETRICS,PREDICTORS,RESULTS,STAGE
169,904,COMBINING,CONCLUSION,LABEL,METHODS,MICROARRAY,OBJECTIVE,PCR,PURPOSE,RESULTS
174,CTC,RFP,THESE
169,947,AUTHORS,FUNCTIONAL,R273H,THESE
011,020,BACKGROUND,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,SHH
12P,ANAPLASTIC,BACKGROUND,CONCLUSION,LABEL,METHODS,OCT,SALL4
006,007,017,018,045,117,125,282,ADC,ADC_CICAMS,ADC_NCI,ASIAN,CHINESE,PTN27
001,005,101,214,BRAZILIAN,DESPITE,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM,TREATMENT,USING
ANTIGENIC,BLAST,DESPITE,FORTY,WESTERN
148,389,730,810,BACKGROUND,CONCLUSION,EXCLUSION,FOLLOWING,GRADE,ITEMS,LABEL,LOCAL,MARCH,MEDLINE,METHODS,OVERALL,PREFERRED,RCC,REPORTING,RESULTS,REVIEWS,SYSTEMATIC,THERE,TREATMENT
203,BECAUSE,ERK,FINALLY,RAS,SRC,UTR
160,169,231,246,COPYRIGHT,HAACK,MDAMB,SAS,VILSMEIER
COLLEGE,CONCURRENT,GROUP,HOWEVER,III,NSCLC,RADIATION,RADIOLOGY,THERAPY,THREE
AFTER,BLOOD,FDG,PET
18F,BASED,FDG,PET
FDG,LIVER,MRI,PET
001,BACKGROUND,CONCERNING,CONCLUSION,DEPARTMENT,LABEL,METHODS,PATHOLOGY,RESULTS,SIXTY,WORLD
946,HOWEVER,OXIDATION,SEVERAL
004,005,006,046,169,188,385,626,BACKGROUND,EMBP1,FIXED,INITIATIVE,INSTITUTE,LABEL,MEC,METHODS,MPC,NHGRI,POPULATION,RESULTS,THESE,WHI,WOMEN
169,460,47D,549,DCFDA,MCF,VCH,WILEY
00001,169,409,AFTER,BACKGROUND,CENTRAL,CETUXIMAB,COPYRIGHT,III,IRELAND,LABEL,LTD,MEDLINE,METHODS,ORR,PFS,RESULTS
169,AIM,COPYRIGHT,COX,EP1,INC,INCREASES,KEY,LABEL,METHODS,OBJECTIVE,RESULTS
956,AEROSOL,ATR,FOURIER,GENERATION,INHALABLE,MMADS,NGI,PTX,THESE,VIS
160,223,BASED,CURRENT,CURRENTLY,SEVERAL
ASIAN,BACKGROUND,LABEL,METHODS,PULMONARY,THERE
169,545,ADP,BACKGROUND,GCI,GRADE,IDENTIFIER,IMBALANCES,LABEL,MEDICAL,METHODS,NSCLC,ORR,PFS,PRESS,PUBLISHED,RESULTS,SECONDARY,SOCIETY,TRIAL,UNIVERSITY
737,ABT,BAK,BAX,BCL,HNSCC,HPV16,MEAYAMYCIN,PCR,SF3B1,WESTERN
186,337,760,945,946,CK2,IMR,ROS,TAKEN,UTR
001,004,005,010,035,037,039,DFS,NSCLC,RESULTS,THESE,TNM
GIANT,HOWEVER,PULMONARY
ICG,THERE

CTCAE,DELAYED,THOSE,THREE
HOWEVER,NOW
CENTRAL,HOWEVER,LASER,STENT,YAG
AFI,ENDOSCOPIC,HOWEVER,KNOWLEDGE,LUNGPOINT,NBI
DWI,MEDICAL,MRI,PET,THEREFORE
177,219,414,741,764,956,ERCC1,LDH,PM2,SALMONELLA,THESE,XPA,XPF,XRCC1,XTT
169,2LL,947,AFTER,CD4,CD8,COPYRIGHT,FOXP3,HOWEVER,IDO,IFN,INCREASED,JAK,LDH,STAT1,THESE,TREGS,WESTERN
169,189,BACKGROUND,CONCLUSION,CSI,DISCLOSURE,GAD,LABEL,METHODS,PHQ,QSC,R10,RESULTS
169,AMONG,COPYRIGHT,DOTAP,OPTIMIZED,THESE
100,169,BCL,COPYRIGHT,DTX,MDR,OVERALL,PEGYLATED,PUBLISHED
160,BACKGROUND,CONCLUSION,FGFR1,FIBROBLAST,LABEL,MPM,REGARDING,RESULTS,TKI
954,AKT,HENCE,LEWIS,LLC,NSCLC,TEC,TFC,TMC,TNC,VEGFR
169,COPYRIGHT,DNC,ROS,SAS,THESE
DESPITE,KEY,MRI
DIAGNOSIS
PALLIATIVE,PATHOLOGY,PET,PULMONARY,UNDER
NTM,SINCE
100,HOWEVER,JAPAN,T1AN0M0
METASTATIC
005,454,ASSESSMENT,BACKGROUND,BLOOD,CELLSEARCH,CTC,LABEL,METHODS,NGS,NSCLC,RESULTS,ROCHE,THESE,TRIGGER,VERIDEX
002,017,034,041,045,048,049,755,COX,NSCLC,PCR,PIAS3,SCC,STAT5,STATS,T1A,T1B,T2A,T2B,THERE,TOTAL
183,BACKGROUND,BETWEEN,BRAIN,DESPITE,GEORG,HISTOLOGY,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,STUTTGART
BASED,FDA,FINALLY,ONCOGENIC,RAS
AFTER,ASSESSMENT,CONCLUSION,EOS,FDG,FTP,HOWEVER,LABEL,MBQ,METHODS,OBJECTIVE,PET,RADIO,RESULTS,TLC
NSCLC
169,AXL,CETUXIMAB,CTX,HNSCC,JUN,NOTABLY,NSCLC,RES,USING
045,100,100TH,169,ABOUT,AMERICA,AMONG,BACKGROUND,DISEASE,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,RETIREMENT,SOCIETY,UNIVERSITY,WHILE
001,007,012,112,169,218,64257,BLOOD,III,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
TOBACCO
CORDYCEPS,CULTURE,HEPG2,MAXIMUM,MCF
FAS,THESE
33258,ANNEXIN,BCL,EPIMEDIUM,ERK,GENUS,HOECHST,HOWEVER,MTT,PCR,ROS,THESE,WESTERN
AKT,ENDOGENOUS,FIRSTLY,INHIBITION,MTT,NSCLC,PROTEIN,RESULTS,SEMAD,THESE,TRANSWELL,WESTERN
202,211,282,954,BACKGROUND,CCI,COMPOSITE,CONCLUSION,FURTHER,INDEX,KAPPA,LABEL,METHODS,NAGELKERKE,OBTAINING,RESULTS,SCORE
160,MICRORNAS,NSCLC,THERE
ACTIVATING,ALK,AP26113,CH5424802,HOWEVER,NSCLC,THERE
EMERGENCY,SEVERAL
169,CCND1,CHROMATIN,COPYRIGHT,EGF,HDAC1,IRELAND,LTD,THESE,TIP30
004,169,788,AIM,CONCLUSION,EIGHT,HOWEVER,HRS,LABEL,LTD,METHODS,OBJECTIVE,PFS,PTY,PUBLISHING,RESULTS,SCC,THERE,WILEY
101,226,237,BAL,COUGH,ILD,JANUARY,MEDICAL,TOR
001,102,160,169,436,532,BACKGROUND,COPYRIGHT,COX,EXCLUSION,INC,LABEL,METHODS,NSCLC,PATIENT,PROCEDURES,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,T2B
025,033,037,039,143,160,169,203,AGE,BACKGROUND,COPYRIGHT,COX,INC,JANUARY,LABEL,MEIER,METHODS,MSPLC,OPERATIVE,OWING,PREDICTORS,PUBLISHED,RESULTS,SOCIETY,TNM
169,231,BACKGROUND,BRITISH,FINALLY,KEY,LABEL,MCF,METHODS,NCI,NVP,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,WESTERN
215,ACCIDENTS,BACKGROUND,DESPITE,INSTITUTE,INSURANCE,ITALIAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROSECUTOR,RESULTS
945,946,954,ADRB2,FDA,IKK,MMP,TNF
CREB1,EWSR1,HOWEVER,OTHER,PCR,PRIMARY,THESE
001,003,005,008,ADDITIONAL,FORTY,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RELEVANCE,RESULTS,SETTING,THERE
169,945,AUTHORS,LTD,OTS,THEREFORE,THESE,WILEY
946,ANNOTATION,DAVID,DISCOVERY,ID1,INTEGRATED,PPARG,SEVERAL,TGF,THEREFORE,THESE
001,111,169,652,749,846,AUC,COLLEGE,LABEL,METHODS,OBJECTIVE,OUTCOME,POPULATION,RESULTS,ROYAL,SETTING,THERE,THESE,WOMEN
100,33258,956,AIM,ANNEXIN,CONCLUSION,HOECHST,LABEL,LC3,MES,METHODS,MTT,OBJECTIVE,RESULTS,SOUTH,WESTERN
100,252,GROSS,INSTITUTE,MULTIFOCAL,PAPILLARY,RADIOLOGY,TOTAL
137,169,COPYRIGHT,HOWEVER,LTD,MRE,TRAIL,WILEY
AFTER,LABEL,METHODS,RFA,WIDESPREAD
DIAGNOSTIC,PERITONEAL
CASES,CONCLUSION,FIFTEEN,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
HOWEVER,III,NSCLC,SEVERAL,THEREFORE
144,169,267,416,ACADEMY,ANXIETY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,DEPRESSION,ENGLAND,FLOOR,GDS,GERIATRIC,GERMANY,HOSPICE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PALLIATIVE,POS,PREVALENCE,PUBLISHED,RESULTS,ROC,SCALE
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PEMETREXED,RESULTS
169,AUTHORS,FURTHER,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY
169,AUSTRALIA,AUSTRALIAN,METASTASES
169,5476423,7919469,AXL,COMPOUNDS,COPYRIGHT,LTD
ALK,CHINESE,CONCLUSION,EIGHT,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,COPYRIGHT,FEW,HOWEVER,SAS,VIDEO
169,AMONG,BACKGROUND,COPYRIGHT,LABEL,METHODS,RESULTS,SAS,SURGERY,TNM
013,169,196,561,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,NSCLC,PLI,RESULTS,SAS
000,016,021,030,124,967,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,RESULTS,THERE
169,945,947,AUTHORS,COPYRIGHT,DESPITE,HIF,INC,NOTCH,PEN,PUBLISHED,SECRETASE

169,177,373,769,946,956,AFTER,APMIS,CATENIN,CISPLATIN,DDP,ENDOGENOUS,LTD,MTT,MYC,PUBLISHED,WILEY
AKT,CISPLATIN
HGF,MET
FGFR1,IGF,MET,SQCLC
002,363,370,634,643,946,967,ABI7500,BACKGROUND,CIS,GENOMIC,LABEL,METHODS,ORS,PCR,RESULTS,THERE
001,083,127,186,204,240,451,APRIL,BACKGROUND,DESPITE,EPIDERMAL,LABEL,METHODS,NSCLC,RESULTS,THEREFORE,USING
BACKGROUND,EMBSE,LABEL,MEDLINE,METHODS,NSCLC,RESULTS,WANFANG
108,119,176,244,352,528,BACKGROUND,CASES,LABEL,METHODS,NSCLC,RESULTS
BACKGROUND,COX,EASTERN,FPS,GROUP,LABEL,LIMITED,MEIER,METHODS,PFS,RESULTS,SMALL,TNM,UNIVARIATE
177,946,BACKGROUND,III,INCREASED,LABEL,METHODS,MTT,NSCLC,PACLITAXEL,PCR,RESULTS,TAXOL,TAXOLCELL,THREE,WESTERN
169,BECAUSE,COPYRIGHT,LTD,WHILE,WILEY
IGFBP,STUDIES,WILLEBRAND
154,160,169,184,186,ACM,ADC,ADDITIONAL,CK5,CK7,IHC,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,SCM,TTF,WILEY
169,ANATOMY,BRITAIN,CDC42,COPYRIGHT,EXOGENOUS,EXPRESSION,GREAT,IRELAND,LTD,NSCLC,PROJECT,PUBLISHED,SOCIETY,USING,WILEY
169,CAUCASIAN,COPYRIGHT,CTA,DESPITE,DIAGNOSIS,INC,LABEL,METHODS,NSG,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PATHOLOGY,RESULTS
169,COPYRIGHT,DESPITE,LTD,MSS,SMOKING,WATER,WORLD,WPS
169,177,AMONG,BACKGROUND,CONCLUSION,DOPPLER,INC,IVA,LABEL,METHODS,MRI,PROCEDURES,RESULTS,THERE,WILEY
443,799,L858R,NSCLC,TKI
169,LTD,THESE,WILEY
169,COPYRIGHT,DIFFUSE,INC,TGCTS
001,113,169,347,548,ANZSCTS,AUSTRALIA,AUSTRALIAN,BACKGROUND,CARDIAC,COPYRIGHT,CSANZ,FURTHER,LABEL,MEIER,METHODS,NON,NSCLC,PUBLISHED,RESULTS,SOCIETY,THESE,YOUNG,YOUNGER,ZEALAND
CGA,CKPAN,EMA,SHL,SMA,SPB,SYN,TTF
001,011,105,128,169,AMONG,COPYRIGHT,END,LABEL,LOWER,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIR
EPSTEIN,GRADE,LYG
ADULT,STILL
DIC,TROUSSEAU
AFTER,BRAIN
001,090,169,2ND,6TH,CONCLUSION,COPYRIGHT,FORTY,HLA,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PEPTIDE,PFS,RESULTS,TERT572,THREE
169,431,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LIVER,LTD,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SWEDISH,WOMEN
085,101,125MEQUIV,126,130,130MEQUIV,134MEQUIV,135MEQUIV,169,463,564,631,CONCLUSION,COPYRIGHT,COX,FINAL,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
107,169,COPYRIGHT,FOURIER,III,INC,JUDICIOUS,LABEL,MARKERS,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SURGERY
007,169,956,CISPLATIN,COPYRIGHT,CTC,H1299,INC,LABEL,METHODS,MMP,MOSBY,OBJECTIVE,PETRI,PUBLISHED,RESULTS,SURGERY
10878,169,190,195,212,343,385,ADVERSE,BACKGROUND,COPYRIGHT,COX,EPO,INDUCTION,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RBC,RESULTS
100,ANNA1,INTRAVITAL
CARLO,DESPITE,HOWEVER,INHIBITION,MEANWHILE,NSCLC
169,ACCORDING,CONCLUSION,COPYRIGHT,ENGLISH,EUS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEMLA,VAMLA
119,169,171,613,665,784,AMONG,AMSTERDAM,ATE,CONCLUSION,COPYRIGHT,FORTY,HISTORY,IRELAND,LABEL,LTD,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,SIX,UNIVERSITY,VTE
123,150MG,169,174,327,CONCLUSION,COPYRIGHT,DISEASE,EASTERN,ERLOTINIB,GROUP,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,SECONDARY,TARCEVA,THERE,THREE,TKI
00035,166,169,183,955,BACKGROUND,BHASKARAN,BMI,COPYRIGHT,COUNCIL,COX,FUNDING,INSTITUTE,LABEL,LTD,MEDICAL,METHODS,PUBLISHED,RESULTS,TRUST
001,002,021,169,390,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,DIFFERENT,LABEL,METHODS,MYASTHENIA,OBJECTIVE,RESULTS
160,NASAL,PPB
FOLFIRI,INTRA,PRIMARY,STAGEIV,THERE,XELOX
100MG,500MG,BACTERIAL,EARLY,HOWEVER,STAGE,T4BN2M1
ACD,ANTICANCER,DRUGS,HOWEVER,INCREASING,PEMETREXED,QOL,TREATED
DISEASE,HOWEVER,ZOLEDRONIC
100,160,300,382,789,961,964,ATLAS,COMPARISON,LCM,MACRO,PATHWAY
169,COPYRIGHT,DISULFIRAM,DSF
169,BFT,BIOLOGICAL,BTV,COPYRIGHT,DUE,ECM,EVIDENTIAL,FDG,FINALLY,FLT,FMISO,MEANS,PET,VOLUMES
169,COPYRIGHT,DUE,ESS,IRELAND,LTD,UES
169,COPYRIGHT,CPB,DIATHERMY,GASEOUS,OPCAB,PULMONARY,SOCIETY,THEREFORE
169,COPYRIGHT,MRC,NCI
169,COPYRIGHT,IRELAND,LTD,TME
000,125,169,818,COLORECTAL,CONCLUSION,CONTROLLED,COPYRIGHT,INC,INSTITUTE,LABEL,MENOPAUSAL,METHODS,NCI,OBJECTIVE,OVARIAN,RANDOMIZED,RESULTS,SCREENING,THERE,TRIAL,WOMEN
169,CTT,H22,HOWEVER,LEWIS,LLC,MMP,RK5,TAKEN
BACKGROUND,LABEL,METHODS,NSCLC,PULMONARY,RESULTS,V10,V20,V30
169,231,233,CANDIDA,COPYRIGHT,DIAGNOSIS,PUBLISHED,SAS
110,150,210,320,BACKGROUND,BED10,FURTHER,GYE,GYE10,LABEL,LOCAL,METHODS,MEV,PATIENT,RESULTS,THERE,UNIVARIATE
177,954,956,AMEAE,BACKGROUND,BAX,BCL,HCS,HOWEVER,LABEL,LDH,METHODS,MMP,MTT,PCR,RESULTS,ROS,TREATMENT
ADP,BACKGROUND,CSC,DR4,DR5,ELISA,HOECHST,LABEL,METHODS,NOD,PEITC,RESULTS,TRAIL
004,013,018,100,215,992,CCGCC,CHINESE,FURTHER,HAN,HARDY,HOWEVER,LABEL,METHODS,OBJECTIVE,RBBP6,RESULTS,TEN,THEREFORE,THESE
BRAIN,FIFTY,HOWEVER,LABEL,MEIER,METASTASIS,METHODS,OBJECTIVE,RESULTS,TEXAS,THOSE,UNIVERSITY,UNTREATED
169,EMT,NOTABLY,SER,SNAIL,TAKEN,THR
169,643,AXL,EMT,EPITHELIAL,HOWEVER,THESE,TKI
169,947,HOWEVER,MUTATIONS,NOTCH
169,177,ACS,CK5,CONCLUSION,COPYRIGHT,IHC,LABEL,LCNEC,METHODS,OBJECTIVE,PATHOLOGY,PULMONARY,RESULTS,SCLCS,SIXTY,SOCIETY,TCS,TTF
160,169,946,ASP,BASED,BIOLOGY,FLK,GLU,KDR,KDRSCFV,LEU,LYS,NSCLC,SOCIETY,THESE,VEGFR
177,CONCLUSION,GIVEN,H69,LABEL,METHODS,NCI,OBJECTIVE,PET,PRCRT,PURPOSE,RESULTS,SMALL,SSTR2
169,231,AUTHORS,FGF,FOUNDATION,JOURNAL,LTD,MCF,MDA,MOLECULAR,WILEY
169,CONCLUSION,GRADUAL,INDEX,LABEL,METHODS,OBJECTIVE,RESULTS,VOICE
946,AKT,EGF,EMT,GSK,HOWEVER,PKC,SNAIL,TAKEN
169,BACKGROUND,INC,LABEL,UNLABELLED,WILEY,WIRES
001,169,GAGED2A,LABEL,METHODS,OBJECTIVE,PHENOTYPIC,PURPOSE,RESULTS,TKI,XAGE1
058,169,CONCLUSION,LABEL,METHODS,OBJECTIVE,PIAS3,PURPOSE,RES,RESULTS,STAT3,THESE
169,COPYRIGHT,EPIGENETIC,HOWEVER,INC
CCNE1,THESE,TRITHORAX,ZESTE
048,169,672,ADP,AUTHORS,DMS53,GLS,H69,HACL1,LTD,MECHANISMS,MTS,UBEC2,VELIPARIB,WILEY
001,012,026,033,037,126,MICRORNAS,NSCLC,PCR,THERE
207,217,247,BMJ,GROUP,JANUARY,LIMITED,PET,PUBLISHED,PUBLISHING,RESULTS
BACKGROUND,CD8,CONCLUSION,LABEL,METHODS,THERE
BACKGROUND,EXPRESSION,H1299,KNOCKDOWN,LABEL,LENTIVIRUS,METHODS,MG2,MN2,MTT,PCR,PPM1D,RESULTS,THEREFORE,THESE,WESTERN
100,160,BACKGROUND,CONCLUSION,FDG,GROSS,GTVPET2,LABEL,METHODS,NSCLC,PET,RESULTS
001,118,169,177,ASIAN,BACKGROUND,CD4,CD8,LABEL,MCP,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,TREATMENT
001,127,151,169,299,445,633,BACKGROUND,COLORECTAL,CONCLUSION,COPYRIGHT,CXR,IRELAND,LABEL,LTD,METHODS,OVARIAN,POTENTIAL,RESULTS,SCREENING,TRIAL
284,CONCLUSION,CRT,HNC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RID,WHEREAS,WHILE
169,946,ABCG2,ADULT,COPYRIGHT,FINALLY,GENESIS,HOWEVER,MSC,NG2,SOCIETY,TGF
169,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,MEDLINE,METHODS,OBJECTIVE,PHYSICIANS,RESULTS,SELECTION,SOURCES,SYNTHESIS,UPDATED
169,COLLEGE,COMMITTEE,CONCLUSION,COPYRIGHT,DISEASE,EARLIER,FPS,GROUP,LABEL,METHODS,NETWORK,OBJECTIVE,ONTARIO,PHYSICIANS,PRIMARY,PROVINCIAL,THESE,UNASSIGNED
000,150,169,36245,BIOLOGY,INC,MOLECULAR,NON,NSCLC,OVERALL,PHF,SOCIETY
10001,333,MEDICAL,PAI,PUBLISHERS,SEVENTH,USA
APPLIED,ATLAS,DIFFERENT,MATCHER,MODMATCHER,MULTI,OMICS
177,190,485,743,914,ATLAS,BACKGROUND,HOWEVER,IHC,L858R,LABEL,METHODS,NSCLC,PFS,RESULTS
001,002,019,177,360,AFTER,AMONG,CAUCASIAN,EASTERN,GENOMIC,GROUP,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,SMOKING
123,195,354,BACKGROUND,DISCUSSION,JANUARY,KINGDOM,LABEL,MANCHESTER,METHODS,NETWORK,RESULTS,SOUTH,UNIVERSITY
133,381,398,BACKGROUND,BETWEEN,CONCLUSION,LABEL,METHODS,RESULTS,TOLERABLE
001,127,185,312,BACKGROUND,CONCLUSION,DESPITE,DFS,DISEASE,LABEL,METHODS,MUT,NSCLC,RESULTS
954,ADC,BACKGROUND,CONCLUSION,FIRST,KAPPA,LABEL,METHODS,RESECTION,RESULTS,WORLD
100,118,224,250,652,784,803,859,AVAILABLE,BACKGROUND,CAUCASIAN,CONCLUSION,LABEL,MANDATORY,METHODS,OBJECTIVE,PREPLANNED,RESULTS
252,ARIES,AVASTIN,BACKGROUND,CONCLUSION,INCIDENCES,LABEL,METHODS,NSCLC,RESULTS,THERE
130,209,639,AKT,BACKGROUND,III,LABEL,METHODS,MYC,RB1,RESULTS,THEREFORE
BACKGROUND,COUPLED,ERK,FURTHER,H1048,LABEL,M918T,METHODS,MYC,PRIMARY,RESULTS,RET,THERE
166,173,242,249,BACKGROUND,CLINICALLY,HOWEVER,KNOCKDOWN,LABEL,MEIER,METHODS,RESULTS
103,157,BACKGROUND,CONTINUOUS,FAK,FOCAL,LABEL,METHODS,NORTH,NSCLC,RESULTS,THERE,TMA
107,ADAMTS8,APC,BACKGROUND,CDH13,CONCLUSION,DAPK1,GSTP1,LABEL,METHODS,METHYLIGHT,PRIMARY,RESULTS,RFS,SOCS3,WHILE
013,025,038,160,698,ABCB1,ATP,BACKGROUND,GSTP1,III,INHERITED,LABEL,METHODS,RESULTS,SNP,USING
100,373,411,5A4,ALK,AMONG,BACKGROUND,FACTORS,IHC,INITIAL,LABEL,METHODS,RESULTS,THREE,VYSIS
003,191,352,AFTER,BACKGROUND,CLINICIANS,CONCLUSION,LABEL,METHODS,OTHER,PATIENT,RESULTS,THESE,THREE,UNADJUSTED
297,363,660,BACKGROUND,LABEL,METHODS,PRO,RESULTS,THESE
169,228,455,AMONG,PDE4D,STK11
100,169,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEVENTY,UNIVERSITY
GFP,JNK,JUN,MEF,REDUCED,T24
000,001,003,007,008,029,107,137,177,BACKGROUND,CONCLUSION,COX,FISHERS,LABEL,LOW,MEIER,METHODS,MICRORNAS,NSCLC,PCR,PFS,RESULTS,TNM
ACUTE,LOBECTOMY
100,115,2573T,ASSESSMENT,IHC,L858R,LEU858ARG,NSCLC,REFRACTORY,THERE,VALIDATION
BACKGROUND,EXPRESSION,HCC,HOWEVER,LABEL,MEIER,METHODS,PCR,RESULTS
100,916,ACS,CK5,FORTY,NOS,NSCLC,SCC,SUBTYPING,TTF,WORLD
945,EMT,PULMONARY,RELATED,SMA,SNAIL,THESE
CXCR4,HOWEVER,UROKINASE
DELTA,RHO
BACKGROUND,CHINA,CONCLUSION,HOWEVER,III,KNOWLEDGE,LABEL,LARGE,METHODS,NSCLC,PROGNOSTIC,RESULTS,SCC,SINCE,STUDIES,SUMMARY,TMN,VALUE
001,008,JANUARY,MAY,MEDICAL,NSCLC,PERCENTAGE
233,943,AMONG,FIFTH,INFLUENZA,KOREA,NUTRITION,SURVEYS
106,160,174,HRM,KIRSTEN,L858R,MOLECULAR,PCR,RGQ,ROTOR,STRIPASSAY,THEREFORE
AMINO,H22,HEPG2,ICD,SGC7901
627,646,823,AUC,COHEN,CONCLUSION,FDG,FIFTY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,TNM
001,125,151,153,239,318,330,648,ACUTE,AFTER,ANTIEMESIS,AUSTRALIA,CHINA,HEC,INDIA,KOREA,LABEL,MASCC,MEC,METHODS,OBJECTIVE,OVERALL,PACIFIC,PURPOSE,RESULTS,SEQUENTIAL,SINGAPORE,SOUTH,SUPPORTIVE,THERE
269,742,BACKGROUND,CONCLUSION,HODGKIN,LABEL,METHODS,RESULTS,SIR,WHETHER
169,BINDING,COPYRIGHT,CXCR4,DOX,NPS
227,CA125,CA153,CA199,COX,CYFRA21,FIRST,GENERALLY,MEIER
196,209,COMPARING,CONCLUSION,CONTROLLED,LABEL,MAY,METHODS,MINOR,NASAL,OBJECTIVE,OCTOBER,PROCEDURE,PURPOSE,RESULTS,THERE
30C,EMT,HOWEVER,NSCLC
021,024,026,483,946,BIOMARKER,ERCC1,GROUP,III,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
III,NINTEDANIB,PHASE
CA125,MPF,THESE
110,177,BACKGROUND,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SEPTEMBER,THREE
100,GIT,PULSE,SITES
005,028,973,AMONG,BACKGROUND,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,RESULTS
BACKGROUND,BRAIN,CONCLUSION,CONTEXT,HENCE,IHC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
LASER,LOCAL,NASAL,PATHOGENIC,PPB,PRESENTING,THREE
950,BACKGROUND,HIF,HOWEVER,HYPOXIA,INCREASED,LABEL,LUBAC,LYS,METHODS,OBJECTIVE,OBJECTIVES,PKC,PROTEIN,RATIONALE,RESULTS,SHANK,SHARPIN,THESE,WESTERN

CHINESE,JUN,MAMMOGRAMS,MAY,MODERATELY,MRI
27632,HOWEVER,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,RHO,SKOV3,TREATMENT
222,BRAIN,EMA,GTN,OVERALL
309,BMJ,GROUP,IGF1R,INSULIN,LABEL,LIMITED,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SCC,THERE
100,169,AIM,BACKGROUND,CONCLUSION,DEPARTMENT,DIFFERENT,EMERGENCY,ENGLISH,FURTHER,GIVEN,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,SCHOLAR,THERE,THREE
023,169,943,AREAS,BACKGROUND,FORCE,HSA,LABEL,METHODS,NEWLY,OBJECTIVE,OBJECTIVES,PREVENTIVE,RESULTS,SCALING,SERVICE
945,946,954,THESE,TNF
005,046,10878,BACKGROUND,DOSIMETRIC,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS
032,169,AUTHORS,CD4,CD8,ENRICHMENT,HOWEVER,IGG,LTD,PBMCS,PD1,PTY,PUBLISHING,SCIENCE,SEVENTY,THESE,WILEY
169,AKT,AUTHORS,DESPITE,ERBB2,ERBB3,HSP90,LTD,MET,NSCLC,PTY,PUBLISHING,SCIENCE,SINCE,T790M,TREATMENT,WILEY
CONCLUSION,FDG,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PET,RESULTS
AUC,CONSORTIUM,GABOR,IMAGE,INITIATIVE,SVM,TEXTURE,THESE,WHILE
100,120,177,RFA,THERE
893,CK7,LYMPH,TTF
078,088,ASODN,PCR,SCODN,TFR,WESTERN
100,215,CURVE,ESI,FFA,LIPIDVIEW,METABOLOME,OPERATING,ROC,SCIEX,TRIPLETOF,UNTARGETED,USING
001,002,169,597,AFTER,BACKGROUND,CHINA,CONCLUSION,COX,DIFFERENT,INSURANCE,LABEL,METHODS,PRESS,RESULTS
000,001,118,120,139,140,173,175,201,373,756,BACKGROUND,EFFORTS,END,ICU,LABEL,METHODS,NINTH,RESULTS
000,111,324,567,BACKGROUND,DUE,FUNCTIONAL,HOWEVER,LABEL,LCAL1,LCALS,RESULTS,THROUGH
169,945,ANNEXIN,APOPTOTIC,CPG,DMS79,INC,RU486,SMALL,THESE,WILEY
COLLAGENS,LTD,M13,PUBLISHED
504,945,946,AKT,CD133,HOWEVER,HSP90,IPI,THESE
DCS,NSCLC,THESE
18F,408,AMONG,BACKGROUND,CONCLUSION,DISCOVERY,FDG,HEALTHCARE,HNSCC,LABEL,METHODS,PET,RESULTS
188,ACCEPTABLE,BACKGROUND,BMI,CONCLUSION,CRP,INITIAL,LABEL,METHODS,NRS,RESULTS,SCREENING
100,174,AIM,BACKGROUND,CERVARIXTM,CONCLUSION,CURRENTLY,CZECH,GENERALLY,HPV,LABEL,LARGE,OBJECTIVE,OVERALL,PERSISTENT,SILGARD,THERE,WHILE
000,150,956,ARSENIC,SEVERAL,SINCE,WORLD
100,181,946,HECOGENIN,MMP,THESE,TREATMENT
001,169,22YEARS,2MONTHS,3MONTHS,410,622,69YEARS,70YEARS,CIS,CONCLUSION,COPYRIGHT,COX,HRS,INSTITUTE,IRELAND,LABEL,LEE,LTD,MATERIALS,MEIER,METHODS,MOFFITT,OBJECTIVE,OBJECTIVES,RESULTS
BAK,BAX,BCL,G13289A,ND5,ROS,STUDIES
6BP,ATP,PFK,TAKEN
ALK,CRIZOTINIB,DESPITE,NSCLC
169,NSCLC,SNF,SWI
169,316,658,CASES,COLORECTAL,GBV,HODGKIN,NHL,OVARIAN,SCREENING,TRIAL
215,AFTER,BACKGROUND,CARDIAC,CONCLUSION,LABEL,METHODS
000,100,120,733,DUTCH,EUR,FIRST,KWF,SOCIETY,THESE
THESE,THREE
001,059,127,CCI,FCI,HOWEVER
150,250,ERLOTINIB,GEFITINIB,JAPAN,NSCLC,PHASE,SIMILAR,TKI
169,GHANA,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TOBACCO,UNIVERSITY,WARNING
34A,KIRSTEN,MICRORNAS,THESE
ECTOPIC,GLUT1,TAKEN,UNDER
169,ADVERSE,ANY,BACKGROUND,CONCLUSION,CTCAE,INSTITUTE,LABEL,MEDICAL,MEIER,METHODS,NCI,NSCLC,OVERALL,PERCIST,PET,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,SOLID,UNIVERSITY
169,COPYRIGHT,JAPAN,LTD
160,169,803,956,BEL,CNE,COPYRIGHT,MGC,SAS
169,1YL,946,956,CHN,COMPLEXES,COPYRIGHT,ESI,FURTHER,ICP,INC,MCF,NMR
169,LEKSELL,LITERATURE,SOCIETY,SRS
169,GIVEN,HOWEVER,SOCIETY
169,1990S,ALK,ASIAN,BACKGROUND,END,HISPANICS,ISLANDERS,LABEL,METHODS,PACIFIC,RESULTS,SOCIETY
044,177,200,916,COX,HOWEVER,III,NSCLC
103,178,224,398,HENCE,LYS751GLN,OVERALL,XPD
946,CHRONIC,EMT,HOWEVER,SMADS,TFS,TGF,TWIST,WNT
169,947,948,950,CONSISTENT,COPYRIGHT,DESPITE,FEDERATION,HOWEVER,PUBLISHED,RNR,RPA,SOCIETIES,SSL,TREATMENT
AFTER,BACKGROUND,LABEL,METHODS
105,954,CHINESE,JAK,NOTABLY,NSCLC
008,009,015,159,169,191,609,800,COPYRIGHT,COX,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,RFS,SURGERY
AES,HOWEVER,INCREASED
169,200,BLANK,INC,PEG,RG3,WILEY
002,010,011,013,033,945,946,NSCLC,TNF
169,386,414,BESIDES,GSH,NCS,VCH,WILEY
169,946,ABC,ABCC1,ADR,AUTHORS,COPYRIGHT,GSH,GST,MDR,PUBLISHED,REGARDING
FFF,ITV,LINAC
001,144,177,216,AIM,AKT,ASPIRIN,CONCLUSION,FURTHER,LABEL,METHODS,NCI,NET,OBJECTIVE,PROPIDIUM,RESULTS,STUDENT,THESE,TREATMENT,WESTERN
945,COLORECTAL,CRC,HOWEVER,RESISTANCE,STUDIES
001,002,169,251,BACKGROUND,BPF,COPYRIGHT,EMPYEMA,EPP,FVCEX,INC,LABEL,MAJOR,METHODS,MPM,PUBLISHED,RESULTS,SEVERAL,SOCIETY
045,153,157,169,181,190,257,294,346,640,BACKGROUND,COPYRIGHT,DISTANT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,STAGE,YET
160,169,BACKGROUND,COPYRIGHT,FORTY,HOWEVER,IIB,INC,INDUCTION,JANUARY,LABEL,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY
160,169,242,276,290,BACKGROUND,COPYRIGHT,INC,LABEL,LEAVING,LUL,METHODS,OVERALL,PUBLISHED,RESULTS,SOCIETY,THERE
946,CPG,RAR
160,169,527,COPYRIGHT,HOWEVER,INC
001,280,555,BACKGROUND,BASED,CONCLUSION,LABEL,RESULTS
123,954,AKT,BCL,DDP,ERCC1,ERK,SNAIL,SUNITINIB,THEREFORE,TWIST
BAX,BCL,FIRST,PDCD5,THEREFORE
161,215,BACKGROUND,CYFLA21,DIAGNOSIS,FINAL,HOWEVER,LABEL,MEDICATION,METHODS,OBJECTIVE,PATIENT,PROCEDURE,PULMONARY,SPECIALTY,THEREFORE
AKT,CANCEROUS,CIP2A,HOWEVER,INITIALLY,NOTABLY,TAA,THEREFORE
AREAS,BACKGROUND,COVERED,CURRENTLY,FURTHER,III,JAPAN,LABEL,METHODS,NSCLC,OPINION,PHASE
169,1980S,1990S,2000S,BACKGROUND,CONCLUSION,COPYRIGHT,INC,INCIDENCE,LABEL,METHODS,RESULTS
169,BACKGROUND,COPYRIGHT,ENDPOINTS,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,V50,VOLUMETRIC
169,7CM,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,GAMMA,JANUARY,KNIFE,KPS,LABEL,LILLE,METHODS,MRI,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SRS,TEN,UNIVERSITY
HOWEVER,INDEX,PALLIATIVE,PPI,PROGNOSTIC
012,133,864,BRAIN,HOWEVER,OVERALL
INC,PFO,PLATYPNEA,PUBLISHED
177,945,956,BASED,CONCLUSION,ELISA,FVC,HIF,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM
EARLY,HOWEVER
169,996,COPYRIGHT,MMSTS,SEVERAL,TYR
000,AWARENESS,BACKGROUND,BELIEFS,DENMARK,HOWEVER,LABEL,METHODS,PREVALENCE,RESULTS,STATISTICS
169,208,946,BECAUSE,CONCLUSION,FINALLY,FIRST,LABEL,METHODS,OBJECTIVE,PURPOSE,RANKL,RESULTS,SD208,SMAD3,SMAD7,TAKEN,TGF
001,006,169,215,AIM,CONCLUSION,COX,LABEL,METASTATIC,METHODS,OBJECTIVE,OCTOBER,RESULTS,SEPTEMBER,THERE,UNIVARIATE
123,169,393,COPYRIGHT,FERRATA,FOUNDATION,THERE
169,3DAYS,CONVERSELY,COPYRIGHT,SAS
169,174,177,APRIL,BASIC,COMPARISON,COPYRIGHT,DEPARTMENT,INC,LABEL,METHODS,OBJECTIVE,PAINBUSTER,POD,RESULTS,SEPTEMBER,SETTING,SUFFICIENT,SURGERY,TEA,THERE,UNTIL
169,COPYRIGHT,DESPITE,INC,SMALL,THESE
169,ADP,BCL,BH3,COPYRIGHT,HENCE,INC,KNOCKDOWN,MCL,PAR,PARP1,SIX
004,008,016,030,040,BRCA1,CONCLUSION,ERCC1,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIMILARLY,TUBB3
116,169,ADVERSE,AGREEMENT,ANXIETY,BACKGROUND,CLINICIANS,COPYRIGHT,CTCAE,DEPRESSION,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OUTCOME,PATIENT,PRO,PURPOSE,QOL,QUALITY,RESULTS,SCALE,THERE,TREATMENT
001,003,102,169,177,383,BACKGROUND,BED,BETWEEN,COPYRIGHT,DOSES,GRONINGEN,GTV,IRELAND,LABEL,LOCAL,LTD,METHODS,NSCLC,OBJECTIVE,OSAKA,PTV,PURPOSE,RESULTS,SUFFICIENT,UNADJUSTED,USING,WESTERN
ANATOMICAL,BACKGROUND,CONCLUSION,ICD,LABEL,METHODS,RESULTS,THEREFORE,TUMOURS
003,008,014,321,AWARENESS,BACKGROUND,CHRONIC,CONCLUSION,DESPITE,DISEASE,F4L,GERMANY,INITIATIVE,LABEL,LLN,LUNGS,MCS,METHODS,PCS,PULMONARY,REGARDING,REGRESSION,RESULTS,USING
946,AMONG,BACKGROUND,LABEL,LENTIVIRAL,METHODS,RESULTS,TGF,THEREFORE
119,169,633,BMI,CAREFUL,COPYRIGHT,COX,ICD,IRELAND,IRREGULAR,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVERAL,SUBSEQUENT
102,160,169,COPYRIGHT,LIVER,LTD,PEG,THESE
001,120,125,130,160,169,178,199,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NODAL,PUBLISHED,RAS,RESULTS,SOCIETY
000,160,169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NIR,PUBLISHED,RESULTS,SMALL,SOCIETY
100,106,255,CONCLUSION,FDG,IMMEDIATE,INTRA,LABEL,LESIONS,MBQ,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
BACKGROUND,LABEL,METHODS,OVARIAN
BESIDES,GERMANY,WHILE
BACKGROUND,COMDP,HOWEVER,LABEL,RESULTS,THEREFORE
169,COPYRIGHT,FEDERATION,HOWEVER,PUBLISHED,SOCIETIES
ALDEFLUOR,ALDHLOW,BACKGROUND,CD8,CSC,CURRENTLY,FURTHER,LABEL,METHODS,RESULTS
061,200,254,344,400,453,505,553,792,935,AMERICANS,BACKGROUND,CONCLUSION,DETECTION,EARLY,LABEL,METHODS,NORTH,PAN,RESULTS
139,204,APOA1,BACKGROUND,CRP,FIRST,GSTP1,LABEL,METHODS,RESULTS,STMN1
176,177,AFTER,BACKGROUND,CONCLUSION,CRC,LABEL,LOCAL,MEIER,METHODS,OPERATIVE,RESULTS,THESE
493,HOWEVER,NSCLC
CALOCEDRUS,DESPITE,FURTHER,H1975,PC9,TKI
169,ADI,BIOLOGY,LEUKOCYTE,PEG20,PMN,ROS,SOCIETY,THESE
005,169,177,500,539,ADVERSE,AUTHORS,BACKGROUND,BLIND,BSC,CISPLATIN,CONCLUSION,CONTROLLED,COPYRIGHT,CTCAE,EUROQOL,FOLLOWING,HOWEVER,INC,INDUCTION,LABEL,MATERIALS,METHODS,NON,NSCLC,OVERALL,PARAMOUNT,PEMETREXED,PHASE,PLACEBO,PUBLISHED,QOL,RESULTS,SMALL,SUPPORTIVE,TREATMENT
002,129,BACKGROUND,CGS,CIS,CONCLUSION,HOWEVER,KINGDOM,LABEL,METHODS,OVERALL,RESULTS,RRS
BACKGROUND,COX,DFS,DISEASE,EVALUATION,EXACT,FISHERS,FURTHER,HEIDELBERG,III,LABEL,MARCH,MEIER,METHODS,NSCLC,OVERALL,RESULTS,TREATMENT,UNIVERSITY
COX,FEW,NSCLC,PFS,SEVENTY,SINCE,TKI,UNIVARIATE
AFTER,BACKGROUND,BRISTOL,CANCERS,CHI,CONCLUSION,EFFORTS,INDIA,KASHMIR,LABEL,MATERIALS,METHODS,PACKAGE,PEARSON,PRESENT,RESULTS,UNIVERSITY
001,002,003,004,009,012,016,022,027,030,031,1801133,215,HOWEVER,MTHFR,NSCLC,PFS
292,946,AMP,BESIDES,BETULIN,MTT,NCI,TAKEN
049,076,169,177,COPYRIGHT,DSC,FVC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFT,PURPOSE,RESULTS,SPECT,V4DCT
000,169,841,AMONG,COPYRIGHT,HODGKIN,INC,LABEL,LDCTS,MATERIALS,METHODS,OBJECTIVE,POPULATION,PURPOSE,QALYS,RESULTS,SCREENING,TRIAL,WTP
RESECTION,RIGHT
007,035,142,169,452,526,BACKGROUND,CAUCASIAN,CHINA,CHINESE,GENERAL,HAN,HOUSTON,LABEL,METHODS,MICRORNAS,NANJING,NSCLC,RESULTS,SNP,TEXAS,THESE,UNIVERSITY
001,057,102,BACKGROUND,EXPRESSION,GLI,III,LABEL,METHODS,RESULTS
DMR
001,004,009,049,113,177,AFTER,BACKGROUND,COX,ENGLAND,LABEL,MEIER,METHODS,RESULTS,SCORE,SFTPS,VALIDATION
169,344,ADDITIONAL,BACKGROUND,BLOOD,LABEL,METHODS,NSCLC,RESULTS,SOCIETY,T790M,THESE
CEA,EARLY,PATTERN,RAS,RECURRENCE
169,ALK,ERS,NSCLC,THEREFORE
ACCORDING,BACKGROUND,CLINICALLY,COX,DFI,LABEL,MEIER,METHODS,NSCLC,OVERALL,POTENTIAL,RCC,RESULTS
100,AFTER,CHINESE,CONCLUSION,GROUP,HFS,LABEL,METHODS,OBJECTIVE,RESULTS
ELCWP,PCI
ELCWP,THESE
ELCWP,THESE,WHICH
ELCWP,III,NSCLC,PCI
ELCWP,NSCLC
001,002,014,016,039,169,436,546,954,CONCLUSION,DIXON,FURTHER,HEALTHCARE,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PRIMARY,PROPELLER,PURPOSE,READERS,RESULTS,WIS
092,169,177,319,981,CONCLUSION,GGN,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PATHOLOGIC,PURPOSE,RESULTS,THREE
191,5TH,780,AIS,CONCLUSION,LABEL,METHODS,MIA,OBJECTIVE,OBJECTIVES,RESULTS
120,288,480,576,DESPITE,OME,PCA
CALIFORNIA,EPSTEIN,FRANCISCO,HIV,HODGKIN,IAS,MARCH,MITSUYASU,MORTALITY,SAN,USA
ALK,CONSORTIUM,COPYRIGHT,EGF,MEK,MET,NETWORK,NSCLC,PROUS,SCIENCE,THERE,THESE,VEGFR
378,ALK,CERITINIB,COPYRIGHT,CRIZOTINIB,LDK,NON,NSCLC,OVERCOMING,PROUS,SCIENCE,SEVERAL
169,HOWEVER,LABEL,THESE,UNLABELLED
169,938,BACKGROUND,CROSS,CURRENT,FORTY,LABEL,METHODS,RESULTS,ROUGHLY,SMOKING
129,130,228,319,467,549,BACKGROUND,BASED,BMJ,COX,EASTERN,GROUP,IQR,LABEL,LIMITED,MALIGNANT,METHODS,MPE,PUBLISHED,PUBLISHING,RESULTS,THREE
202,608,897,ADJUSTMENT,AFFAIRS,AOR,BLACK,CRT,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHITE
000,169,731,984,AUTHORS,FOUNDATION,GIVEN,III,JOURNAL,LTD,MOLECULAR,NSCLC,PFS,POOLING,TKI,WILEY
181,240,676,BACKGROUND,BILIRUBIN,CIS,CONCLUSION,COX,CURRENT,HRS,LABEL,METHODS,PROMOTION,RESULTS,SERUM,SEVERANCE,SMOKING
140,200,225,500,FINALIZING,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIOLOGY,RESULTS,SOCIETY
001,005,007,019,024,026,027,029,126,300,404,445,470,659,FVC,JANUARY,NSCLC
CBL,HOWEVER,KNOCKDOWN,NH4CL,PROLINE,THESE,TRYPSIN
160,ACCORDING,BACKGROUND,BETWEEN,EPIPHYSEAL,IIA,IIB,ISOLS,LABEL,MAY,METHODS,RESULTS,SALVAGE,SOCIETY,THERE
118,169,231,E362A,ECM,HOWEVER,INT,KNOCKDOWN,MCF,MDA,SEVERAL,THESE,VIA
100,956,DEVELOPING,HOWEVER,IGF,USING
129,169,ALK,BACKGROUND,CURRENT,IHC,LABEL,METHODS,MINIMALLY,RESULTS,SOCIETY
4A1,BIS,DIM,NR4A1,NUR77,USING
FINALLY,PARTICULAR,QUESTIONS,THREE
032,109,282,L858R,NSCLC,SRS,TKI
161,177,60S,AGE,CONCLUSION,CRT,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
THESE
130,945,ESI,HOWEVER,METABOLIC,NABH4,NNK
169,ACADEMY,BIOLOGICAL,BIOLOGY,CHINESE,EDITORIAL,INSTITUTE,INSTITUTES,NON,NSCLC,PRESS,PUBLISHED,UNIVERSITY
ADC,LNM
EFFORTS,III,NSCLC,SINCE,THERAPIES
541,ASIAN,CIS,CLINICIANS,COX,DISCUSSION,ETHNICITY,FINALLY,FLORIDA,FLORIDIAN,HOWEVER,HRS,ISLANDERS,LABEL,MEIER,METHODS,NON,NSCLC,OBJECTIVE,PACIFIC,PAKISTANI,PURPOSE,RESULTS,SES
000,006,113,139,153,175,384,574,639,693,713,739,903,976,BACKGROUND,DFS,GROWING,LABEL,MAJOR,MATERIALS,METHODS,NON,NSCLC,RESULTS
110,AWS,POD,POD20,UNDER
RIGHT,TOTAL

000,100,110,128,169,248,360,BINSWANGER,CENTERS,CONTROL,DISEASE,JUSTICE,LABEL,METHODS,OBJECTIVE,OUTCOME,POISSON,PREVALENCE,PREVENTION,PRISONS,RESULTS,SETTING,SMOKING,STATISTICS,THESE
169,CONCLUSION,HOWEVER,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEVERAL,THERE,UNIVERSITY
ARTIFICIAL,CONCLUSION,CXR,GGO,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
AMPLITUDE,FDG,KEY,LABEL,LESIONS,METHODS,OBJECTIVE,OBJECTIVES,ORG,PET,RESULTS,SUVMEAN,WHOLE
169,BACKGROUND,CONCLUSION,COPYRIGHT,EMPIRICAL,ICU,IRELAND,LABEL,LTD,METHODS
169,ASIAN,CAUCASIAN,CHRONIC,COPYRIGHT,IRELAND,LTD,TREATMENT
100,149,169,AUR,BOARD,COPYRIGHT,CTS,ETHICAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,THEREAFTER
169,ACCORDING,AUR,COPYRIGHT,EVALUATION,INC,LABEL,MEIER,METHODS,NCECT,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,ROC,SOLID
160,211,BCL,BIM,COA,HMG,HOWEVER,IAP,NAC,NSCLC,PEMETREXED,ROS,STATINS,THESE
CYTOTOXIC,LABEL,MPDL3280A,NSCLC,ONGOING,OPINION,PROMISING,STATEMENT,THESE,UNASSIGNED
011,169,301,342,BACKGROUND,III,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,STUDIES,TAKEN,THERE,UNIVERSITY
169,621,BIOLOGY,BXB,HOWEVER,INC,MOLECULAR,RAF,RAS,SER,SOCIETY,TAKEN
CTL,PD1,PLATELETS,SAMPLES,STUDIES,THESE
ALK,EMT,H3122,HOWEVER,HYPOXIA,MTT,NSCLC,REGARDING
160,BACKGROUND,III,LABEL,METHODS,RANDOMIZED,RESULTS,SLN,SLNBA,SNLBA,TGF,THERE
169,946,BESIDES,CHALLENGES,COPYRIGHT,EMT,GIVEN,NEDD9,SOCIETY,TGF,TGFB1,WHILE
169,850,AFTER,BACKGROUND,BIRTH,CONCLUSION,COPYRIGHT,COX,INITIATIVE,LABEL,LTD,METHODS,RESULTS,WOMEN
107,160,194,IGF1R,LUCIFERASE,PCR,POTENTIAL,STUDIES,USING
000,AFRICAN,FINALLY,GOVERNMENT,PRESS,PRIOR,PUBLISHED,TEN,UNIVERSITY,USING,WBC,WHITE
ERK,HOWEVER,JNK,NSCLC,SEMAPHORIN
DIAGNOSING,DIAGNOSIS,LITERATURE
1970S,HOWEVER,TODAY,YET
169,231,241,308,458,549,AKT,ANOIKIS,CONVERSELY,COPYRIGHT,COX,CYP,EP4,FLAVONOIDS,INC,ISL,MDA,NOTABLY,PDK,SER,THR,TYR
100,200,400,738,AUSTRALIA,CONTINUOUS,COX,LATENCY,STATINS,WESTERN,WITTENOOM
169,815,CONCLUSION,COPYRIGHT,EXPRESSION,HSPGS,LABEL,LTD,METHODS,MTT,OBJECTIVE,PCR,RESULTS,WESTERN
010,015,24RGD,916,AD5,E1A,EVALUATION,IMPROVING,RGD
BACKGROUND,FINALLY,LABEL,METHODS,NVP,RCC,RESULTS,SMO,SMOOTHENED,SUR,THEREFORE
DESPITE,EFM,METABOLISM,RESULTS,THEREFORE
100,152,169,BACKGROUND,EARLY,ELISA,HCC,HEPATITIS,IGG,INADEQUATE,LABEL,METHODS,RESULTS,SERUM,VARYING
167,BACKGROUND,COLORECTAL,EAGLE,FINALLY,FUNCTIONAL,LABEL,OVARIAN,PRINCIPAL,RESULTS,SCREENING,SNP,TRIAL
143,177,DESPITE,DOCETAXEL,THESE,USING
136,169,231,339,689,945,AMONG,H3K9ME3,HOWEVER,HP1,LABEL,MDA,RRP1B,UNLABELLED
169,AKT,ALI,DESPITE,HOWEVER,INCREASED,KUMAR,RAP1B,SHP
169,BRISTOL,CHECKPOINT,FDA,MARCH,MYERS,SOCIETY
169,UZUNBAS
HOWEVER,LABEL,LARGELY,NET,OPINION,PFS,RESULTS,STATEMENT,TARGETING,UNASSIGNED,UNTIL
15B,169,ATM,ATR,BIOLOGY,CHEK1,HOWEVER,INC,MICRORNAS,MOLECULAR,PCR,PPM1D,RAD,SOCIETY
390,860,ACC,ADRENAL,BACKGROUND,CONCLUSION,JANUARY,LABEL,MEIER,METASTASES,METASTATIC,METHODS,NETWORK,OPERATIVE,RESULTS,SEX
169,COPYRIGHT,INC
PREVIOUSLY,T12
CERTAIN,HOWEVER,SECRETORY
01382,03256,148,520,555,733,849,946,967,AXIN2,CHINESE,CIS,GENOTYPING,HAN,ORS,SNP,T148C,WNT
G719S,NSCLC,T790M
134,945,COA,FOURIER,SIX
169,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,GEELONG,LABEL,LOWER,METHODS,RESULTS,ROYAL,SOUTH,WESTERN,WHETHER,ZEALAND
029,034,160,BACKGROUND,CONCLUSION,FIFTEEN,JANUARY,LABEL,METHODS,OCTOBER,OVERALL,RESULTS
CISPLATIN,CYTOTOXIC,FE3O4,FOURIER,MTT,NPS,PEG,PEG6000
411,BIM,CML,GCS,GIVEN,TKI,UNDERLYING
947,EFFICIENT,GFP,NOD,SIMILAR,UTILIZING
105,767,DECREASED,TET
100,109,420,586,AMONG,BACKGROUND,HOWEVER,LABEL,PCR,PRINCIPAL,RESULTS,RPLP0P2,SEVERAL,USING
946,C1GALT1,ECM,HCC,HOWEVER,THESE
169,969,AFM,COPYRIGHT,FOURIER,MTT,MTX,PBS,REVERSE,TEM,XRD
169,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,FURTHER,LABEL,LTD,METHODS,NET,PRIMARY,RESULTS,SIXTEEN,SUNNYBROOK,WORLD
00001,003,117,169,346,500MG,979,COPYRIGHT,COX,III,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PARAMOUNT,PFS,PUBLISHED,RESULTS
169,203,CARDIAC,CENTERS,CENTRAL,COPYRIGHT,EARLY,ELCAP,EXCELLENCE,IRELAND,LABEL,LOCATIONS,LTD,MATERIALS,METHODS,NORTH,NORTHEAST,OBJECTIVE,OBJECTIVES,PROGRAM,RADIOLOGY,RESULTS,SCREENING,SOCIETY,TRIAL
169,236,COPYRIGHT,CSC,DEPENDING,LTD
HOWEVER
169,220,348,AUSTRALIA,AUSTRALIAN,BACKGROUND,BURNOUT,COLLEGE,CORRECTION,CPD,FURTHER,HSS,INVENTORY,LABEL,MASLACH,MBI,METHODS,RESULTS,ROYAL,SPECIALIST,THERE,THOSE,ZEALAND
AFTER,NEN,SURGERY
158,169,288,767,AUC,BACKGROUND,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,WILEY
116,169,205,549,956,COPYRIGHT,HCT,LTD,MTT
169,ACADEMY,BASED
139,154,157,158,161,169,AUSTRALIAN,COLLEGE,CONCLUSION,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROYAL,TECHNICAL,THERE,ZEALAND
169,946,BECAUSE,COPYRIGHT,EMT,H2DCF,ICW,INC,MEASURING,MET,NADPH,PCA,PHENOTYPE,PRINCIPAL,SMAD2,SMAD3,SMAD4,TGF,WESTERN
945,ARSENIC,AS2O3,HIF,HOWEVER,NOTCH,NSCLC,THESE,VEGFR
947,HOWEVER,THOSE
169,ALZHEIMER,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SCHOLAR,SCIENCE,SOCIETY,WEB
AIF,GNA,THESE
160,169,BACKGROUND,COPYRIGHT,FDG,FNA,INC,LABEL,METHODS,PET,PUBLISHED,QUALITY,RESULTS,SOCIETY
169,655,BACKGROUND,CLINICALLY,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THROUGH,TSP
169,COPYRIGHT,GADD45A,INC,SEVERAL,TARID,TCF21
169,COPYRIGHT,HOWEVER,INC,PUBLISHED,SOCIETY,TYPICALLY
169,COPYRIGHT,HOWEVER,INC,MOLECULAR,PUBLISHED,SOCIETY,THESE
169,283,792,952,COLORECTAL,COPYRIGHT,COX,INC,INSTITUTES,NIH,OVARIAN,SCREENING,SIMILAR,TRIAL,WOMEN
169,204,313,399,517,789,AFRICAN,AMERICANS,BLOOD,COPYRIGHT,EVERY,EXOME,HEART,INC,INSTITUTE,MENDELIAN,NBS,PGX,PROJECT,PUBLISHED,SEQUENCING,SOCIETY,THESE
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
008,037,046,239,250,AMONG,ASSESSMENT,BACKGROUND,CONCLUSION,FIRST,FUNCTIONAL,GRADE,LABEL,LCS,METHODS,NSCLC,OVERALL,RESULTS,THERAPY
003,177,215,221,269,2D3,319,379,580,BETWEEN,CCK,DDP,FURTHER,H1650,PC9,SPC,TABLE,VITAMIN
138,312,450,BACKGROUND,CAUCASIAN,CONCLUSION,DELETIONS,L858R,LABEL,METHODS,NSCLC,PCR,RESULTS,TESTING
946,BACKGROUND,EPIGENETIC,HCC,LABEL,METHODS,RESULTS,WNT
169,ASSESSMENT,COPYRIGHT,INC,INCREASED,LABEL,LSF,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR
169,ACR,COLLEGE,COPYRIGHT,INC,PUBLISHED,RADIOLOGY
164,967,BACKGROUND,LABEL,MEIER,METHODS,RESULTS,THERE
132,160,169,APRIL,BACKGROUND,BRIEF,COPYRIGHT,INC,INDEX,LABEL,MAY,MEDICAL,METHODS,MINIMALLY,PATIENT,PUBLISHED,RESULTS,SHORT,SOCIETY
004,015,027,160,169,287,545,626,698,BACKGROUND,BETWEEN,COPYRIGHT,COX,DISEASE,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE,THESE
005,009,045,AFTER,ARHGDIB,BRMS1,CASP8,CDH11,GSN,KISS1,MDA,METASTASIS,MSG,PDE5A,PEBP1,UGT1A
129,169,ANZSCTS,AUSTRALIA,AUSTRALIAN,BACKGROUND,BPF,CARDIAC,CONCLUSION,COPYRIGHT,CSANZ,EARLY,FOLLOWING,FORTY,LABEL,METHODS,NSCLC,OCTOBER,PUBLISHED,RESULTS,SOCIETY,ZEALAND
169,981,985,COPYRIGHT,EXCELLENT,FINALLY,PREDICTION,USING
CATHEPSIN,JAM,METASTASIS,WHILE
001,033,042,081,123,139,369,DFS,FGFR1,GCN,HOWEVER,NSCLC,THESE
169,BESIDES,COPYRIGHT,HTRA2,NSCLC,WESTERN
MIXED,MUCORALES
215,279,919,ADC,ATC,BACKGROUND,DIFFUSION,DWI,LABEL,METASTASES,METHODS,MRI,PATIENT,RESULTS,THERE
LABEL,METHODS,MRI,OBJECTIVE,PDACS,PURPOSE,RESULTS,THESE
933,ALGORITHM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
100,124,176,177,215,221,358,AAA,AXB,CARLO,ECLIPSE,GERMANY,ITV,LABEL,MEANS,MEDICAL,METHODS,MONTE,NOVALIS,OBJECTIVE,PTV,PURPOSE,RESULTS,SYSTEMS,WATER
177,CARDIAC,DIR,EIGHT,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SPATIAL,TORSO
177,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
AAA,AVG,CURRENT,FBP,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS,THESE,VOLUMETRIC
169,APA,CCAGSCTGG,COPYRIGHT,LTD,RGYRYRGTGG,SVM
001,003,009,035,042,083,ATTEMPTING,BACKGROUND,COMPLETION,FORTY,ICU,III,ITT,JANUARY,LABEL,METHODS,RESULTS,SUCCESSFUL,THERE
169,PRESS,PUBLISHED,RFA,SURGERY,UNIVERSITY
169,BIOLOGY,CDC42,CONVERSELY,GDP,GTP,GTPASES,INC,LIM,MOLECULAR,RHO,SOCIETY
169,AKT,COX,DECREASED,FINALLY,FURTHER,KNOCKDOWN,MUCIN,PRESS,PUBLISHED,ROS,SCAVENGING,UNIVERSITY,USING,WHILE
109,406,533,586,AMONG,HOWEVER,LOC440905,PCR,STUDIES,USING
100,160,169,240,254,311,AMONG,COLLEGE,COPYRIGHT,CRC,LABEL,LOCAL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,POTENTIAL,PREDICTORS,PTV,PUBLISHED,RESULTS,ROYAL
169,ATRTS,COPYRIGHT,HOX,HOXD8,INC,PEDIATRIC,RESULTS,SMARCB1,THESE
CCAR2,MELATONIN,NSCLC,ORDINARILY,SIRT1,THESE,TREATMENT
001,016,066,160,164,169,BACKGROUND,COPYRIGHT,COX,HOWEVER,INC,LABEL,METHODS,OVERALL,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVARIATE
002,009,169,601,BACKGROUND,COPYRIGHT,INC,LABEL,LCC,LCNEC,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE
170,246,254,670,716,BASED,BETWEEN,LABEL,MARCH,MAY,METHODS,OBJECTIVE,RESULTS,SMOKERS,THERE,UNIVARIATE
169,BRITISH,COPYRIGHT,EIGHT,III,LTD,PUBLISHED,RESECTION,SCC,TNM
371,496,CASES,SPANISH
169,HOWEVER,NADPH,NOTABLY,OVERALL,RES,ROS,THESE,TIGAR
00001,015,250,BACKGROUND,CONCLUSION,LABEL,LNS,MANAGER,METHODS,OUTCOME,RESULTS,STATA,WHILE
100,101,117,166,177,400,401,576,719,CAC,CONCURRENT,ECG
001,004,010,241,AKT,BACKGROUND,CD147,LABEL,METHODS,NSCLC,RESULTS,WESTERN
001,0KG,169,1ST,358,5TH,BMI,CONCLUSION,COPYRIGHT,COX,FOLLOWING,INVERSE,IRELAND,LABEL,LITHUANIAN,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,TSC
001,009,044,169,228,335,401,700,BETWEEN,CEREBELLAR,COPYRIGHT,COX,GAMMA,INC,KNIFE,LABEL,LOCAL,MATERIALS,MAY,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SRS,THERE,THESE
BACKGROUND,BCL,CHINA,FINALLY,GEJIU,HOWEVER,LABEL,NCI,NSCLC,PRINCIPAL,RESULTS,SOUTH,YTMLC
169,183,201,384,AMONG,CONCLUSION,COPYRIGHT,HOWEVER,ICC,IHC,INC,LABEL,METHODS,OBJECTIVE,RESULTS,S1PR1,S1PR2,S1PR3,S1PR4,S1PR5,S1PRS,STUDENT,TMA
CONVERSELY,KIT,THEIR
ADULT,CARDIAC,EVALUATION,GENERAL,INDEX,LABEL,LMA,METHODS,MORBIDITY,OBJECTIVE,RESULTS,REVISED,SOCIETY,THERE
215,T2B,TEMLA,THERE,ULTIMATELY
169,COPYRIGHT,DESPITE
160,169,946,CAF,COPYRIGHT,INC,STROMAL,TGF
183,217,237,967,APRIL,BACKGROUND,DEB,DISEASE,EBSCO,LABEL,LIBRARY,METHODS,RESULTS,SCHOLAR,SCIENCE,THERE,WEB,WILEY
169,956,BAX,BCL,COPYRIGHT,DR3,EXPRESSION,FAS,HOWEVER,IRELAND,LTD,NCI,NSCLC,STAT3,WESTERN
BACKGROUND,BRIEF,INVENTORY,LABEL,METHODS,OLDER,OUTCOME,RESULTS,SECONDARY,SYMPTOM
EUS,GUIDELINES,IPMNS,THERE
116,169,946,ARG,ASP,BAX,BCL,FOCAL,GLY,HCT,III,RAPID,RGD
140,169,28000,AML,AMONG,BACKGROUND,CIS,FURTHER,LABEL,METHODS,NORWEGIAN,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIR,SOCIETY,UNIVERSITY
BASED,BIOLOGICAL,CARLO,COMMISSION,EFFECTS,FINALLY,FIRST,MONTE,PROTECTION,RADIATION,SOMETIMES,VII
169,177,956,COPYRIGHT,OVERALL
169,INCUBATION,NSCLC,SURGERY,THESE,TLR,USING
272,274,CTPAS,LOW,REFERRING,WHILE
147,150,169,177,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PFS15,RESULTS,SECONDARY,SEQUENTIAL,SIMON
023,045,126,130,169,256,500MG,822,980,996,ASIAN,CHINESE,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PATIENT,RESULTS
171,187,239,BECAUSE
169,193,COPYRIGHT,GGO,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPE,THEREFORE
ASSESSMENT,BACKGROUND,BMJ,CHINESE,DIAGNOSTIC,ENGLISH,GROUP,ISI,LABEL,LIMITED,MAY,MEDLINE,METHODS,MINIMALLY,PUBLISHED,PUBLISHING,QADAS,QUALITY,RESULTS,REVIEWS,SCIENCE,SINOMED,SYSTEMATIC,TRIAL,WEB
169,ATO,INHIBITION,KNOCKDOWN

005,018,038,102,BACKGROUND,COX,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS
169,320,DYNAMIC,EIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,SVC,UNIVERSITY
169,APOPTOTIC,BACKGROUND,BAX,BCL,CCK,CDK,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MMP,OBJECTIVE,PURPOSE,RESULTS
METASTATIC,THESE
100,169,956,CONCLUSION,HEP3B,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PC3,RESULTS,STIRT,SUCCESSFUL,USNEA,WILEY
115,HOWEVER,IGF,INSULIN,LABEL,METHODS,NSCLC,NVP,OBJECTIVE,PCR,PURPOSE,RESULTS,SIGNALLING,THERE,THESE
5TH,APRIL,CHINESE,DCR,EASTERN,GENERAL,GROUP,LABEL,MAY,METHODS,NSNSCLC,OBJECTIVE,OBJECTIVES,ORR,PFS,PLA,RESULTS
087,104,105,122,147,163,188,209,236,271,305,320,445,641,888,904,982,984,AGE,APC,ASIRC,ASIRW,CHINA,CHINESE,CONTROL,LABEL,METHODS,OBJECTIVE,OVERALL,PREVENTION,PROVINCIAL,RESULTS
300,806,967,IHC,LABEL,MATERIALS,METHODS,MVD,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,021,043,532,899,BACKGROUND,EXPRESSION,GOLGI,HOWEVER,LABEL,MATERIALS,METHODS,MVD,NSCLC,RESULTS
064,141,437,447,842,BACKGROUND,FORTY,IGF1R,LABEL,MATERIALS,METHODS,RESULTS,THERE
LABEL,METHODS,OBJECTIVE,PFS,RESULTS,THERE
748,ABSTRACTS,BACKGROUND,DCR,FURTHER,GRADE,HOWEVER,LABEL,METHODS,NSCLC,PFS,RESULTS,SBT,SORAFENIB,TKI
CHENNAI,CONCLUSION,INDIA,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS
383,456,657,665,691,792,968,984,BACKGROUND,CAUCASIANS,LABEL,MATERIALS,METHODS,RESULTS,THERE
AFTER,CCK,DEPLETION,LABEL,MB231,MDA,METHODS,MMP,OBJECTIVE,PCR,RESULTS,TRANSWELL,WESTERN
000,158,288,AGE,BACKGROUND,CANDIDA,ICU,JANUARY,LABEL,MAJOR,MATERIALS,METHODS,RESULTS,VAP
169,BRITAIN,BUDDING,COPYRIGHT,EMT,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
001,169,279,326,571,COPYRIGHT,GRP78,HOWEVER,INC,NSCLC,SIMILARLY,TNM,USING
001,215,256,ALC,AMC,BETWEEN,COX,HOWEVER,JANUARY,LMR,NPC,PRE
001,014,018,145,COX,GOLGI,HOWEVER,MEIER,NSCLC,TNM
001,002,141,HOWEVER,MARCH,STUDIES
001,031,042,131,517,CASES,COX,CURRENT,FACTORS,HOWEVER,LABEL,MARTINI,MELAMED,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS
169,ACIDS,NUCLEIC,PRESS,PUBLISHED,RESULTS,TFS,THEREFORE,THESE,UNIVERSITY
946,EMT,NOTCH,NSCLC,TGF,WESTERN,ZEB
169,945,AMP,CONSISTENT,NSCLC,THESE
100,14Q21,169,17Q11,336,ASIAN,OPG,PRESS,PUBLISHED,TNFRSF11B,UNIVERSITY
001,106,AFTER,BASED,FDG,HOWEVER,LABEL,METHODS,OBJECTIVE,PARTIAL,PET,PROCEDURES,PURPOSE,PVE,REGRESSION,RESULTS,SUVMEAN,TLG,VOLUMETRIC
169,650,BACKGROUND,COPYRIGHT,DISEASE,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,WILEY
230,ERBB2,MET,MGA,MYC,NF1,RBM10,THESE
655,BACKGROUND,CLINICIANS,CNS,INCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SCIENCE,SEVEN,SURGERY,WEB
441,727,AMONG,CALIFORNIA,CONFIDENCE,COX,EXCLUSIVE,INTERVALS,JANUARY,MHT,SMOKING
001,183,275,ABCB1,ABCC2,ABCG2,BMS,HOWEVER,LLCPK,MDR1A,PGP,PPI,PROTEIN,RESISTANCE,RESULTS
AKT,BACKGROUND,DDP,FMW,GFP,HOWEVER,LABEL,LC3,METHODS,NDV,NEWCASTLE,ONCOLYTIC,PTX,RESULTS,THESE
ACTIVATING,BACKGROUND,HOWEVER,LABEL,MMP,PRINCIPAL,RESULTS
021,673,AFTER,CRT,GTV,NSCLC,RADIATION,THERE
108,269,377,946,BRCA1,HRS,JANUARY,PFS,THESE
6D4,AAD,ANNEXIN,BACKGROUND,CD3,CD326,CD4,CD8,FIRST,GREATER,LABEL,NKG2D,NKP44,THESE,TRIAL,UNLABELLED,WHETHER
009,099,149,196A2,499,705,ASIAN,INSTITUTE,ISI,MAY,REFERENCES,SCIENCE,SCIENTIFIC,SEVEN,WEB
CD8,KIRSTEN,L858R,N17,OVA,OVERALL,RAS
124,144,159,211,370,BMJ,GROUP,JANUARY,LIMITED,PRESTON,PUBLISHED,PUBLISHING
125,137,141,156,DISCUSSION,III,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
160,ADRENAL,BACKGROUND,CONCLUSION,CUSHING,HHV,HIV,IMAGING,LABEL,METHODS,PULMONARY,SUBSEQUENT
500,900,916,AMONG,BACKGROUND,BESIDES,CSF,LA1,LABEL,NON,NSCLC,R172H,RESULTS,SINCE
231,ATM,ATR,ERK,FURTHER,HOWEVER,JNK,MAPKS,MCF,MDA,NAC,ROS,SINOMENINE,SINOMENIUM
169,177,27853,BACKGROUND,CHINESE,COPYRIGHT,ETHYL,IRELAND,LABEL,LTD,MATERIALS,MBC,METHODS,MIC,MTT,RELEVANCE,RESULTS

351,ACCORDING,AFTER,AIM,ASSESSMENT,BMI,LABEL,METHODS,NRS,OBJECTIVE,RESULTS,SCREENING,SEPTEMBER,SGA,SUBJECTIVE,SURGERY,TTR
001,005,AIM,CHICAGO,INC,INSTITUTE,LABEL,MATERIALS,MAY,METHODS,NSCLC,OBJECTIVE,PEARSON,RESULTS,SEX,SURGERY,USA
AMONG,ASSESSMENT,C30,CHEST,EORTC,FUNCTIONAL,GENERAL,QLQ,QOL,SCALE,SYMPTOM,THERAPY,TREATMENT
GIVEN,IGF,MEETING,OLDER,SCHMIDT,SOCIETY
BACKGROUND,CONTEXT,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POSITIVITY,RESULTS,SIXTEEN
ERLOTINIB,NSCLC,THEREFORE
556,873,AFTER,ANNOTATION,BACKGROUND,CCNB2,CDC20,CDC45,CONCLUSION,DAVID,DISCOVERY,EXPRESSION,HOWEVER,INTEGRATED,LABEL,METHODS,OBJECTIVE,OMNIBUS,PTTG1,RESULTS,RETRIEVAL,SET,TOOLKIT,WEB,WEBGESTALT
007,124,BACKGROUND,CRANIAL,FIFTY,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL
047,142,145,177,212,276,807,AFTER,CRAIG,LABEL,METHODS,OBJECTIVE,PROLONGED,RESULTS,SEVENTY,TRIAL
FEATURING
169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,HOWEVER,INSTITUTE,LABEL,METHODS,SIMPLEX,TEN,VIRUS
169,AGE,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,ELDERLY,GRADE,GROUP,INDUCTION,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS
133,140,169,ANTICANCER,CONCLUSION,COPYRIGHT,DFI,INSTITUTE,LABEL,METHODS,RESULTS,THOSE,TPS,UNLABELLED
001,026,029,039,169,191,945,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EXPRESSION,INSTITUTE,LABEL,LOW,MATERIALS,METHODS,NSCLC,RESULTS,SQC,STAGE
169,AIM,ANTICANCER,ANTITUMOR,BACKGROUND,CD4,CD8,CLUSTER,CONCLUSION,COPYRIGHT,DCS,HOWEVER,INSTITUTE,LABEL,MATERIALS,METHODS,MHC,OBJECTIVE,RESULTS
936,HENCE,HOWEVER
000,002,BACKGROUND,BIOMEDICAL,CBM,CHINA,CHINESE,CONCLUSION,CONFERENCE,DCR,EGGER,ENGLISH,EPIDERMAL,EXTRACTION,INCLUSION,JADAD,KARNOFSKY,KNOWLEDGE,KPS,LABEL,LIBRARY,LITERATURE,MEDICAL,METHODS,NSCLC,OBJECTIVE,OCTOBER,ORR,OTHERWISE,RESULTS,SOCIETY,TCMHS,TKI,WORLD
128,153,226,RASMUSSEN
169,899,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS
871,BACKGROUND,BMJ,COX,GREATER,GROUP,HOWEVER,LABEL,LIMITED,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,THESE
001,004,005,013,021,034,038,041,107,262,369,ADVERSE,AMONG,BACKGROUND,III,LABEL,MATERIALS,METHODS,RESULTS,STAGE,THERE,WHETHER
169,C57BL,NOD,RES,TLR
169,17Q,COPYRIGHT,INC,NEC,PRIMARY,RECURRENT
290,522,ASIAN,CIS,ORS,RESULTS,STATA,THERE,USING
BASED,CAUCASIAN,CIS,MEDLINE,ORS,STUDIES
169,BROAD,CELLS,COMPARABLE,CTC,H1650,VCH,WILEY
007,169,3CM,5CM,ADVERSE,BACKGROUND,CONFORMAL,GTV,LABEL,METHODS,NSCLC,OVERALL,PRESS,PTV,PUBLISHED,RESULTS,TOXICITIES,UNIVERSITY
BACKGROUND,HOWEVER,LABEL,MALIGNANT,METHODS,SUGGESTED
169,AFTER,COPYRIGHT,DISTANT,FORTY,INC,INCREASING,LABEL,MATERIALS,MAY,METHODS,MPM,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERE
10R,169,ALK,COPYRIGHT,H3122,PF06463922,ROS,SOCIETY,USING
DUE,EARLY,HOWEVER,METASTATIC,VARIOUS
003,005,169,CIK,CONCLUSION,COPYRIGHT,DCS,FURTHER,HRQOL,LABEL,MEDLINE,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESULTS,SECONDARY,SIX,THERE,WEIPU
ANALOGOUS,BACKGROUND,CD4,EFFECTIVE,INCREASED,LABEL,METHODS,MICROARRAY,NORMALIZED,OBJECTIVE,OBJECTIVES,PDCD1,RATIONALE,RESULTS
159,160,946,956,MAX
001,120,134,135,BACKGROUND,INDUCTION,LABEL,MEDLINE,METHODS,NSCLC,OBJECTIVE,OVERALL,RESULTS,SIX,SPINE,UNIVARIATE
BACKGROUND,FDA,HOWEVER,ICG,LABEL,METHODS,NIR,OPTICAL,RESULTS
00001,004,718,CIS,CONCLUSION,HOWEVER,HRS,LABEL,METHODS,NSCLC,OBJECTIVE,ORS,PCI,PURPOSE,REMAN,RESULTS
003,215,247,521,946,AFRICAN,AMERICANS,BACKGROUND,BECAUSE,BEHAVIORAL,EXHALED,FAGERSTROM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OMNI2,RATIONALE,RESULTS
FTICR,IMS,MALDI,USING
169,CONCLUSION,EFFECTIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SURGERY,TREATMENT
022,100,169,281,ALK,CONCLUSION,IHC,LABEL,LUNGSCAPE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TESTING
BECAUSE,DESPITE
169,AIM,BACKGROUND,BRITISH,CONCLUSION,GENERAL,INDICATORS,JOURNAL,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,THEIR
163,956,DHA,PEG,SUBSEQUENT
DESPITE,HOWEVER,III,NAD,NSCLC,SIRT5,TAKEN
160,945,946,960,CLARIFYING,DKK,GST,MDR,NSCLC,WNT
160,181,ATP7A,CUCL2,GIVEN,MRC,NAC,NCI,ROS,THESE
ABC,ABCE1,ATP,HOWEVER,MCF,MTT,RNASE,STUDIES,THESE,TRANSWELL
947,BACKGROUND,CLASS,FFF,GAMMA,LABEL,MAPCHECK2,METHODS,MLC,PATIENT,QAS,RESULTS,SHIFT,THREE
CONCLUSION,FIFTY,LABEL,LN6216C,METHODS,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,ASSESSMENT,CONCORDANT,HRM,MCNEMAR,MSP,PCR,RASSF1A,RESULTS,SEVERAL
HOWEVER,MMS,THESE
160,AKT,LAM,PROTEIN
18A,231,945,BACKGROUND,ECTOPIC,HIF1A,HOWEVER,LABEL,LUCIFERASE,MDA,METHODS,MIR17HG,MODULATING,PCR,RESULTS
127,160,169,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,HOWEVER,INC,LABEL,MAY,MEIER,METHODS,PFS,RESULTS
100,169,ADVERSE,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,RESULTS,SECONDARY,THESE,TMZ
004,028,050,169,193,AFTER,BACKGROUND,COPYRIGHT,FIFTY,INC,LABEL,LOBECTOMY,METHODS,NSCLC,PATHOLOGIC,PUBLISHED,RESULTS,SIXTY,SOCIETY,UNIVARIATE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PATIENT,PUBLISHED,RESTAGING,RESULTS,SOCIETY,THERE
000,100,240,457,MALIGNANT,MEDIANS,NOW,THESE,UKRAINE
MARGINS,RANGE
169,916,ALTOGETHER,CB1,CB2,CBD,COPYRIGHT,FINALLY,INC,INCREASED,LAK,LFA,THC,THESE,USING
161,169,BIOMARK,COPYRIGHT,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,III,IRELAND,LTD,NSCLC,SNP,XPA,XRCC1,XRCC2
169,AMONG,COPYRIGHT,HOWEVER,LTD,PROMISING,RTK,TKI
954,956,BAX,BCL,CONSISTENT,DR3,DR6,DRS,EXPRESSION,HOWEVER,NCI,THESE,TNF,TUNEL,WESTERN
1ST,246,AMONG,CHINA,CHINESE,ESR,EXTENSIVE,ILD,LABEL,METHODS,NPC,OBJECTIVE,OBJECTIVES,RESULTS
195,956,A2780,ESI,HOS,LNCAP,NMR
EVALUATION,HEPG2
105,169,176,233,945,946,ASTERACEAE,BACKGROUND,BEH,CHINA,COMPOUNDS,COPYRIGHT,ETHANOLIC,HSS,INDIA,IRELAND,JAPAN,LABEL,LTD,MATERIALS,METHODS,RELEVANCE,RESULTS,SAUSSUREA,THEIR
SHH,THERE
HACEK,PULMONARY
160,SIMILARLY,UNDER
169,946,AMONG,COPYRIGHT,HOWEVER,LTD,NMR,SOUTH,THEIR
001,160,169,945,BACKGROUND,CELLS,COPYRIGHT,EMT,IPF,LABEL,LTD,METHODS,RESULTS,SMA,THESE,THREE,UIP
COMPARING,ERR,LABEL,MATERIALS,MAYAK,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RBE,RESULTS
169,219,241,288,306,312,628,798,850,CENTRAL,CNS,COSTS,EASTERN,EVERY,HODGKIN,PREMATURE,STOMACH,THESE,WESTERN,YEARS
169,AUTHORS,BRITISH,CELLS,CTL,EBV,EPSTEIN,HLA,JOURNAL,LTD,NEITHER,SINCE,WILEY
153,169,AKT,AMO,KNOCKDOWN,LUCIFERASE,UTR
001,052,160,DIAGNOSIS,END,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,USING
106,169,215,321,ACCORDING,COLLEGE,COPYRIGHT,CSSCI,LABEL,LIBRARY,MEDICAL,MET,METHODS,OBJECTIVE,PUBLISHED,RELATED,RESULTS,THR,THR241MET,XRCC3
169,946,BCL,COLLEGE,COPYRIGHT,EXPRESSION,GFP,ITGB1,ITGB3,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,AUTHORS,COPYRIGHT,ETC,INC,METASTATIC,PUBLISHED,SRC
169,ALK,CK7,CONGENITAL,LABEL,LTD,METHODS,OBJECTIVE,RAS,RESULTS,STOCKER,TTF,VE1,WILEY
169,COPYRIGHT,INC,PET,THROUGH
169,BECAUSE,COPYRIGHT,FURTHER,INC,LARGE,LCNEC,NSCLC
169,CARCINOID,COPYRIGHT,INC
169,COPYRIGHT,INC
169,COPYRIGHT,FDG,INC,PULMONARY,TYPICAL
169,COPYRIGHT,INC,LARGE,SMALL
169,COPYRIGHT,INC,LCNEC
169,239,COPYRIGHT,INC,SIMILARLY

169,ALK,COPYRIGHT,FGF,INC,JAK,MEK,MET,PATHWAY,STAT3,THESE
169,COPYRIGHT,H3K4ME3,H3K9ME1,INC,NSCLC
169,344,865,ACRIN,ANXIETY,AUTHORS,BACKGROUND,COLLEGE,CXR,HRQOL,INC,INVENTORY,LABEL,LOW,METHODS,RADIOLOGY,RESULTS,SCREENING,SHORT,SIF,SOCIETY,STATE,TRAIT,TRIAL,WILEY
CYR61,PECAM,SPARC,TAKEN,THESE,USING
001,002,004,ANOVA,BACKGROUND,CHANGES,CHEST,CONCLUSION,CONTROLLED,CPT,CURRENT,LABEL,METHODS,NSCLC,PULMONARY,RBR,RESULTS,THERAPY,TRIAL
169,BINDING,CLINICALLY,COPYRIGHT,EATON,FEDERATION,IRELAND,LAMBERT,LTD,NMJ,PUBLISHED,THESE,VGCCS
169,194,219,BACKGROUND,COPYRIGHT,DECREASED,ENGLAND,FURTHER,INCREASED,LABEL,LTD,METHODS,PARKINSON,RESULTS,RRS,THERE
CLEAR
169,945,CK2,COPYRIGHT,FEDERATION,IMR,KNOCKDOWN,NADPH,PUBLISHED,ROS,SOCIETIES,TAKEN
001,002,100,138,NOTABLY,NSCLC,PCR,TNM
001,006,012,018,169,702,ACADEMY,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SMOKING,SPANISH
201,227,587,ARG194TRP,CAUCASIANS,HENCE,OVERALL,XRCC1
001,10877,10878,125,169,5CC,945,946,BACKGROUND,BED,CONVERTING,COPYRIGHT,INCIDENCE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
169,404,874,BASED,COPYRIGHT,HENCE,IRELAND,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RRR,THEREFORE,THESE
169,KIF5B,ONCOGENIC,PRESS,PUBLISHED,RET,SPC,TREATMENT,UNIVERSITY
946,LEWIS,SPF,TGF,XENOGRAFT
ARNTL,BMAL1,CLARA,CXCL5,THESE
145,160,173,177,BACKGROUND,BAT,CHEST,CONCLUSION,LABEL,METHODS,PLT,RESULTS,TOTAL
BACKGROUND,CORRESPOND,DUE,LABEL,METHODS,THERE
083,177,BACKGROUND,LABEL,MALIGNANT,METHODS,MODEL,OBJECTIVE,RESULTS
001,100,169,208,FASEB,LYMPHOCYTE,OLIVE,OTM,RESPONSES,ROC,UVA
169,945,CD133,COPYRIGHT,FINALLY,INHIBITION,SOCIETY,THEREFORE,THESE
AMONG,H3K9ME3,SUV39H1
373,ADDITIONAL,EPIGENETIC,IRAK2,IRELAND,KNOCKDOWN,LAMP1,LTD,NSCLC,PCR,PUBLISHED,TREATMENT
001,003,004,007,033,169,214,239,340,BMI,COPYRIGHT,GIT,HOWEVER,IRELAND,LABEL,LTD,MEIER,METHODS,NEWLY,NON,OBJECTIVE,OBJECTIVES,QFT,RESULTS
015,100,105,111,143,169,340,811,946,CK5,CK7,COPYRIGHT,CROWN,E12,PUBLISHED,SCC,THERE,TTF,UNIVARIATE
110,169,418,BACKGROUND,CENTERS,COPYRIGHT,DESPITE,EHR,FIFTY,FORCE,INC,JANUARY,LABEL,LCS,MEANINGFUL,METHODS,NETWORK,PREVENTIVE,PUBLISHED,RESULTS,SOCIETY,THREE,USPTF
100,177,ASSESSMENT,CONCLUSION,HEC,JAPAN,LABEL,MAY,MEC,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
100,169,CIGARETTE,EIGHT,ERS,FINALLY,FURTHER,IIP,PHASE,SMOKING
169,4EBP1,AKT,COLLEGE,COPYRIGHT,LABEL,MEDICAL,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PUBLISHED,RESULTS,TKI
10B,169,COLLEGE,COPYRIGHT,LABEL,MEDICAL,METHODS,OBJECTIVE,PCR,PUBLISHED,RESULTS,TRANSWELL,WESTERN
149,160,187,206,BAL,FOB,NPV,PPV,PULMONARY,THERE,TREATMENT
169,183,AFTER,AREAS,GEORG,PRIMARY,SINCE,STUTTGART,THEREFORE,WILMS
AFTER,THERE
116,169,205,431,923,936,956,COPYRIGHT,HCT,MTT,NCI,SAS
006,035,APRIL,BACKGROUND,CONCLUSION,LABEL,METHODS,MPS,NSCLC,RESULTS
169,DESPITE,EPP,GIVEN,HOWEVER,MALIGNANT,MPM,PEMETREXED,PRESS,THESE
AGE,ELISA,EPCAM,NSCLC,SERUM,SIMILARLY,THERE
AMONG,BACKGROUND,BASED,CONCLUSION,ECONLIT,EXCELLENCE,HTA,INSTITUTE,LABEL,LYS,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OTHER,QALYS,REFERENCE,RESULTS,SIMILARLY,STUDIES,USA
233,BACKGROUND,BESAG,CONCLUSION,LABEL,METHODS,MOLLI,RESULTS,SPAIN
169,ABL,ADAM9,CDCP1,SRC
086,160,508,727,AMONG,BACKGROUND,CONCLUSION,END,GINET,INCREASING,LABEL,METHODS,NET,RESULTS,STUDIES,USING
AKT,ERK,FIRSTLY,KDR,MTT
169,RAPID
ACUTE,SEVENTY,SRS,SRT
008,028,046,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PACLITAXEL,PFS,PURPOSE,RESULTS,SIXTY
STATE
169,CISPLATIN,COPYRIGHT,HOWEVER
CUTANEOUS,DIAGNOSTIC,HOWEVER,PHYSICIANS
LOBAR,NSCLC,THERE
169,AMONG,AUTOMATED,COPYRIGHT,DUE,GAMMA,GOODMAN,INC,KRUSKAL,OVERALL
945,AKT,BACKGROUND,ELISA,HIF,HPV,JNK,JUN,LABEL,METHODS,NCI,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,WESTERN
003,100,111,211,219,ALK,IHC
759,BACKGROUND,FEMALES,HPV,LABEL,METHODS,NUTRITION,ORADJ,RESULTS
100,140,215,220,225,300,639,AMONG,BACKGROUND,FIFTEEN,FURTHER,IDENTIFIER,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OCTOBER,RELEVANCE,RESULTS,SETTING,THERE,TRIAL
ASKIN,FDG,FIFTEEN,PET,SEVENTEEN
AKT,BESIDES,DFS,ERK,NSCLC,RESISTANCE,TKI
001,AFTER,BACKGROUND,COX,EFFECTS,EXPRESSION,HGF,LABEL,MET,METHODS,NSCLC,RESULTS,TARGETING,TRANSGENIC
BACKGROUND,L858R,LABEL,METHODS,RESULTS,T790M,THESE,TKI,V843I
002,004,005,016,039,050,120,153,204,AMONG,ASIAN,BACKGROUND,BCL,BIM,LABEL,METHODS,NSCLC,PFS,RESULTS
100,23ANDME,AMONG,BACKGROUND,BIO,DNALINK,HELLOGENE,HOWEVER,INSTITUTE,KOREA,LABEL,MATERIALS,METHODS,OPTIMUS,RESULTS,SNP,THESE
100,169,570,958,AFTER,BACKGROUND,III,LABEL,MEDICAL,METHODS,NSCLC,PFS,PRESS,PUBLISHED,RESULTS,SIMILARLY,SOCIETY,THERE,UNASSIGNED,UNIVERSITY
169,239,HOWEVER,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,PULMONARY,RESULTS,UNIVERSITY,WHILE
100,125,169,350,APRIL,EASTERN,FIFTY,GRADE,GROUP,HOWEVER,IRINOTECAN,LABEL,LOW,METHODS,OBJECTIVE,PRESS,PUBLISHED,RANDOMIZED,RESULTS,UNIVERSITY
049,144,159,169,214,235,FURTHER,HISTOLOGIC,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STUDIES,THERE,UNIVERSITY,USA
99M,CONCLUSION,LABEL,METHODS,METHYLENE,NSCLC,OBJECTIVE,RESULTS,SIXTY,SLN
177,181,946,AFTER,ARF,BMI,CISPLATIN,CONCLUSION,DDP,H2AK119,INK4A,LABEL,METHODS,MTT,OBJECTIVE,P14,P16,P21,P53,RESULTS,SILENCING,WESTERN
160,169,945,ALIKE,BIOLOGY,CHATURVEDI,COMMONS,EWING,EWS,FLI,HOFFMAN,LICENSE,SHARE,SILENCING,SOCIETY,USING
169,COPYRIGHT,DEPENDING,EXOGENOUS,IMPORTANCE,LABEL,OBJECTIVE,ONCOLYTIC,SOCIETY,THEREFORE,UNLABELLED
FURTHER,NON
231,AKT,MDA,STC,TAKEN
BMSCS,EPCAM,OPN,TAKEN
120,169,495,617,BRCA1,CCND1,CHUNG,CURRENTLY,DDX3X,EPHA2,FGFR1,FGFR2,FGFR3,HNSCC,HPV,KRIGSFELD,LABEL,METHODS,MUTATIONS,NOTCH,OBJECTIVE,PURPOSE,RESULTS,S249C
BMJ,GROUP,HOWEVER,LTD,PUBLISHING,THESE
HOWEVER,RRA,THEREFORE
120,127,145,280,300,440,FOCUS,THERE
500,INTRABEAM,NBS,PRS,THERE,ZEISS
BRAIN,PCI
ASIAN,EGF,NSCLC
DISCUSSED,NON,NSCLC
739,945,BACKGROUND,CHRONIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SYNERGY
201,220,277,930,AFTER,DDX58,DEFINITIVE,HOWEVER,III,PRKCE,THREE,VALIDATION
001,177,5CM,ASA,ASSESSMENT,BACKGROUND,CONCLUSION,DBP,END,FURTHER,GII,H2O,LABEL,LEWIS,MAP,METHODS,OBJECTIVE,OBJECTIVES,OLV,PCA,RESULTS,SBP,SETTING,SOCIETY,TABDO,TBASELINE,TEA,THERE,TPOSTOP20,VAS
MRI
001,008,169,172,ALK,BACKGROUND,LABEL,METHODS,NEURO,NSCLC,OVERALL,PRESS,PUBLISHED,RECEIPT,RESULTS,SOCIETY,SUBSEQUENT,UNIVERSITY
169,MICROARRAY,MPM,NSCLC,THESE,WESTERN
000,169
169,1970S,5TH,AIRSTREAM,ARCHIVE,BECAUSE,BRITISH,EXECUTIVE,FREEDOM,HYGIENE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PAH,PRESS,PUBLISHED,RESULTS,SOCIETY,STEEL,UNIVERSITY
130,169,506,AIM,BECAUSE,BRONCHIAL,IDIOPATHIC,LABEL,METHODS,OBJECTIVE,RESULTS,WHEREAS
AMERICA,NORTH,THESE
AUC,DOR,HOWEVER,NLR,PLR,SEN,SPE,STATA,WHILE
169,258,415,AMONG,CIS,COX,EHR,HRS,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY,USING,VANDERBILT
AVAILABLE,COLLEGE,CURRENTLY,MEDICAL,MOLECULAR,NETWORK,PATHOLOGY,SOCIETY,THERE,THEREFORE,TKI
169,956,APOPTOTIC,CONCLUSION,GSH,LABEL,LTD,MATERIALS,MELATONIN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNDER,WILEY
169,DEFORMABLE,DIR,HOWEVER,INSIGHT,ITK,JAPAN,PARAMETER,PRESS,PUBLISHED,RADIATION,SOCIETY,TOOLKIT,UNIVERSITY
CASPASE,CONVERSELY,ERBBS,MUCIN,NEU,SINCE,THESE
169,916,946,ALTERED,BMP,FURTHER,HTY,NOTABLY,PC3,RUNX2,SMADS,TGF
IMAGING,THEREFORE
CURRENTLY,DUE,SINCE
160,3RD,5TH,ACUTE,BACKGROUND,CARDIAC,CONCLUSION,CTCAE,III,IMN,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TRIAL
169,AFTER,COPYRIGHT,DFS,ENGLISH,FORTY,INC,LABEL,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,169,CONVERSELY,FLT,H1993,IMAGING,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,TKI
100,108,160,177,AUTOMATED,CAD,CONSORTIUM,EUCLIDEAN,IMAGING,IQR,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,009,169,DELTA,FINALLY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
131,341,436,ADVERSE,CONCLUSION,GGO,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,TNB
AUC,HE4,SERUM,THESE,USING
031,504,778,851,956,998,COX,MEIER,MPM
AFTER
169,177,62Y,COPYRIGHT,DESPITE,FIM,FURTHER,INC,LABEL,MEASURE,MEDICAL,METHODS,OBJECTIVE,OUTCOME,PRIMARY,PUBLISHED,RESULTS,SETTING
120,PTHRP
100,BACKGROUND,DFA,LABEL,METHODS,RESULTS,V12,VOC
004,007,184,233,ADC,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS
160,LENTIVIRUS,MIGRATION,NEDD9,PCR,THESE
169,346,BECAUSE,COLLEGE,COPYRIGHT,FURTHER,INC,MOLECULAR,PATHOLOGY,PCR,PNA,PUBLISHED,SIX,SOCIETY,THESE
004,019,028,070,114,115,185,218,229,237,389,846,BACKGROUND,CONCLUSION,CRC,LABEL,METHODS,PFS,RESULTS
BRAIN,SAPOSIN,TAKEN,THESE,THIRD

CIS,DATABASES,ERCC1,EUROPEANS,FURTHER,LABEL,METHODS,OBJECTIVE,ORS,OVERALL,RESULTS,SCHOLAR,SUMMARY
160,252,945,GIVEN,HIF,HOWEVER,HYPOXIA,USING
11Q13,11Q15,13Q11,15Q11,18P11,19P13,19Q11,20P13,20Q11,ARRAY,CONGENITAL,PATIENT
946,EMT,EPITHELIAL,ERM,HOWEVER,TGF,THEREFORE
169,16HBE,COPYRIGHT,HOWEVER,IRELAND,LTD,PCR,USING
100,BACKGROUND,BETWEEN,EIGHT,FIFTY,JANUARY,LABEL,METHODS,PROCEDURE,PROGNOSTIC,PULMONARY,RELATIVELY,RENAL,RESULTS,WILMS
DECREASED,REGUCALCIN
945,946,947,948,949,ACTIVATING,CSC,CUMULATIVE,H1299,NCI,USING,WESTERN
956,PM2,THESE,USA,WORLD
SMALL,THESE
ASIAN,BACKGROUND,JANUARY,LABEL,METHODS,NSCLC,RESULTS,TKI
ACTIVATING,FOS,JUN
0MM,169,2MM,BASED,CONCLUSION,COPYRIGHT,CTV,GTV,IRELAND,ITV,LABEL,LTD,MATERIALS,METHODS,NSCLC,OAR,OBJECTIVE,PTV,PURPOSE,REDUCTION,RESULTS,TOTAL
125,340,AFTER,KPS,MALIGNANT,TAKEN
99M,AMEDIAN,METHYLENE
029,032,043,048,101,ALPHA,COX,CRYAB,HOWEVER,IHC,MEIER,NSCLC,TNM,WESTERN
100,169,COPYRIGHT,ENDOSCOPIC,EUS,FNA,HISTOLOGIC,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
AXIAL,B13,BRUNNER,FLAIR,GERMANY,MRI,SIEMENS,TESLA,VOLUMES,WMH
FISHERS,FORMULA,HOWEVER,POMEROY,THEREFORE,WHILE
169,COPYRIGHT,IRELAND,LTD,NSCLC
100,200,956,AKT,ERK,MET,PSB
BACKGROUND,EPC,FLK,GIVEN,HOWEVER,KIT,LABEL,METHODS,RESULTS
001,169,243,CASES,CONCLUSION,COPYRIGHT,IHC,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHILE
169,1MO,239,3MO,4MO,ADVERSE,ARM,BACKGROUND,BASED,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MPM,PATIENT,PFS,RESULTS,WHILE
169,CAUCASIAN,COPYRIGHT,CROWN,IRELAND,LTD,PUBLISHED
BACKGROUND,CHINESE,KIF5B,LABEL,METHODS,NSCLC,PCR,RESULTS,RET,STAT3
BASED,DCG,FIRST,FUSHING
169,CK5,LTD,P63,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
954,ARSENIC,ATO,BACKGROUND,CXCR4,IKK,LABEL,METHODS,RESULTS
439,991,FINLAND,FINNISH,HODGKIN,LABEL,LIFESTYLE,METHODS,NHL,OBJECTIVE,OBJECTIVES,RESULTS,SIR,THERE
559,718,BACKGROUND,CONCLUSION,INCREASED,LABEL,METHODS,PCA,RESULTS,SIR,THERE
169,CONVERSELY,CORNETT,COX,LABORATORY,MICRORNAS,PRESS,PUBLISHED,SINCE,SOCIETY,THEREFORE,UTR
CONCLUSION,LABEL,METHODS,OBJECTIVE,P16,PCR,RB1,RESULTS,THERE,UNDER
ALTERATION,CYTOLOGIC,P450S,SMOKING,THESE,USING
100,106,162,169,229,268,300,429,539,805,AUTHORS,BNP,CAD,CARDIOLOGY,CONCLUSION,COX,FAILURE,FRAMINGHAM,HEART,HFPEF,IMPORTANT,INCLUSION,JOURNAL,KAREN,KAROLINSKA,KNOWN,LABEL,METHODS,OBJECTIVE,PREDICTORS,PROGNOSIS,RENIN,RESULTS,SOCIETY
AIM,CONCLUSION,EGF,LABEL,MATERIALS,METHODS,OBJECTIVE,RAMAN,RESULTS
3LP,99A,MICRORNAS,NCI,NSCLC,REGULATING,THESE
00038,00040,114,123,954,ACS,ADDITIONAL,HOWEVER,PULMONARY,TCS
169,BRAIN,CLDN1,TAKEN
BASAL,BASED,HCQ,HOWEVER,PDX,TRP53

947,CD3,CD8,IFN,PBMCS,PMA,THESE
169,AUC,AUTHORS,ELISA,ERC,HOWEVER,LTD,PLEURAL,WILEY
169,181,300,AFTER,BACKGROUND,LABEL,METHODS,MOLECULAR,MULTIGENE,NGS,RESULTS,SOCIETY,SPECIMENS
00001,00033,028,145,167,169,309,381,880,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,SOCIETY
169,COPYRIGHT,HOWEVER,LTD,THEREFORE,WILEY
169,252,AE1,AE3,BACKGROUND,BECAUSE,LABEL,METHODS,RESULTS,SOCIETY,WILMS,WT1
169,252,956,AZ521,CHIMICA,COPYRIGHT,HELVETICA,MELIA,MELIACEAE,THESE,THREE
169,COPYRIGHT,HODGKIN,LTD,WHEREAS,WILEY
100,169,177,956,BIOLOGY,COMBINING,FEDERATION
160,169,186,AUROC,AUTHORS,BIOMARKERS,C1M,ECM,ELM,IMF,IPF,LTD,MMP,WILEY
001,011,028,169,853,967,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,COX,ENHANCING,INC,LABEL,MEIER,METHODS,PMGCT,PMNSGCT,PRIMARY,RESULTS
001,033,089,116,169,176,484,590,607,627,793,7TH,810,824,881,967,ACCORDING,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,GUANGDONG,III,INC,INSTITUTE,JANUARY,LABEL,M1A,M1B,METHODS,NSCLC,OVERALL,RESULTS,TNM,USING
169,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,LABEL,MATERIALS,METHODS,RESULTS,TEN
001,160,169,340,COPYRIGHT,HNSCC,INC,LABEL,OVERALL,PUBLISHED,SOCIETY,THEREFORE,UNLABELLED
001,146,169,197,434,438,566,711,838,875,947,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,HRS,IRELAND,LABEL,LTD,METHODS,NSCLC,ORR,PFS,RESULTS,THERE
001,021,029,080,132,169,210,259,644,902,923,AMONG,BACKGROUND,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WILEY
AFTER,APART,AUTHORS,BACKGROUND,CUTANEOUS,FINAL,KEY,LABEL,METASTASES,METASTATIC,PATIENT,UNLABELLED,WORDS
169,AFTER,CONCLUSION,COPYRIGHT,DEFINITIVE,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PARTIAL,PFS,RCT,RESULTS
032,071,169,263,302,339,430MM,627,765,910,CONCLUSION,COPYRIGHT,COX,HOWEVER,INCREASING,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RFS,ROC
100,108,169,303,611,BACKGROUND,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,METHODS,PEROXISOME,PPARD,PPARG,PPARS,RESULTS
169,AMONG,BACKGROUND,CURRENT,LABEL,LIMITED,METHODS,NEVER,RESULTS,SMOKING,SOCIETY,THERE
169,COPYRIGHT,HOWEVER,INC,NSCLC,SEPTEMBER
120,169,627,645,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ILD,INC,LABEL,METHODS,PRE,PUBLISHED,RESULTS
169,ACC,ADENOID,AFTER,CONCLUSION,COPYRIGHT,DISTANT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
ABOUT,LEWIS,PTHRP
008,169,COPYRIGHT,HOWEVER,IHC,III,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SPECIMENS,TTP
169,COPYRIGHT,IRELAND,LTD,WNT
169,954,ATP,CHROMATIN,CONCLUSION,EMT,HCC,HEPATOLOGY,HOWEVER,IF1,LABEL,LIVER,NIK,SNAI1,THERE,TNF,TRAF1,TRAF2,UNLABELLED
169,COPYRIGHT,FAK,INC,MARK1,MARK4,SIMILAR,SNAIL
169,ACAT2,COPYRIGHT,EGF,EXPRESSING,HDAC4,INC,K76,NADPH,ROS
145,C228T,DESPITE,GENOMIC,NEITHER,PCR,SCC,SMALL
169,290,375,BF4,COPYRIGHT,INC,NO3,NOTABLY,PF6
169,BACKGROUND,CONCLUSION,CRS,FOLFOXIRI,HIPEC,INC,INDEX,LABEL,MAXIMAL,METHODS,PCI,PERITONEAL,RESULTS,SEVENTEEN,WILEY
169,BAYES,BFS,COPYRIGHT,FBF,FINALLY,IBF,LTD,MTS,UNDER,WILEY
001,140,169,601,BACKGROUND,EEC,JEGHERS,LABEL,LIVER,METHODS,MUTATIONAL,MUTATIONS,PEUTZ,RESULTS,SOCIETY,STK11,WESTERN
169,257,COPYRIGHT,INC,NOTABLY,SALIA
169,498,947,ATF,ATM,COPYRIGHT,DOWNSTREAM,INC,JNK,MRN,PRE,SOLUBLE,THR69
026,117,151,364,402,BACKGROUND,CD146,CEC,HOWEVER,INCREASED,LABEL,METHODS,NSCLC,RESULTS
001,169,ACUTE,COX,FVC,LTD,PUBLISHED,SCHEDULED,WILEY
AMONG,ENDOGENOUS
000,002,023,165,609,ANN,AUC,CHI,ROC,STUDENT,VARIABLES,WHITNEY
000,100,291,293,998,AQI,BACKGROUND,CHINA,GEOGRAPHIC,LABEL,MATERIALS,METHODS,NANHU,RESULTS,THEREFORE,YUEQING,YUYAO
103,122,131,155,258,273,380,494,673,744,855,BACKGROUND,INSURANCE,KOREA,LABEL,MATERIALS,METHODS,RESULTS,USING
004,007,008,014,411,471,AGE,CAA,CHINESE,NSCLC,UTR
112,946,EPIGENETIC,HOWEVER,III,MSP,PCR,RAR,RASSF1A,SIMILAR,THERE,THESE
000,001,055,107,144,194,284,290,322,390,456,467,573,578,631,762,884,893,BACKGROUND,CHINA,GSTM1,GSTM3,GSTP1,GSTT1,HAN,ILE,INNER,LABEL,MATERIALS,METHODS,MONGOLIAN,MONGOLIANS,PCR,RESULTS,SIMILARLY,THERE,VAL
014,AFTER,BACKGROUND,CPS,EGGER,LABEL,MATERIALS,METHODS,PAS,RESULTS,SCHOLAR,SMR,WEB
BACKGROUND,BIOMEDICAL,CHINESE,CIS,DATABASES,FURTHER,HARDY,HOWEVER,HWE,LABEL,LITERATURE,MATERIALS,METHODS,ORS,OVERALL,RESULTS,SCIENCE,SYSTEMATIC
169,1RA,945,AUTHORS,BIOMARKERS,CSF,FGF,IFN,LTD,LUMINEX,PTY,PUBLISHING,SCIENCE,TNF,WILEY
STUDIES,USING
169,AUTHORS,LABEL,LTD,METHODS,NUCLEAR,OBJECTIVE,PUBLISHED,RESULTS,THESE,WILEY
132,160,169,175,218,ALZHEIMER,ANGELES,AUTHORS,CALIFORNIA,CLINICALLY,CNS,CONCLUSION,COPYRIGHT,GERIATRICS,JOURNAL,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCHWANNOMA,SETTING,SOCIETY
169,CAUCASIAN,LTD,LTX,NEITHER,PUBLISHED,SCC,WILEY
1990S,BLACK,EPA,HELPFUL,INITIALLY,LABEL,NATURAL,PM2,POLLUTANT,THROUGHOUT,TOXICOLOGY,UNLABELLED,WESTERN
CIRS008,ITV,MODEL
AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,SINCE
34A,AFTER,APOPTOSIS,DDP,FOLLOWING,MTT,PEBP4,WESTERN
ARG,CAUCASIAN,CAUCASIANS,COMBINING,ORS,STRIKINGLY,STUDIES,TRP
011,027,541,662,778,866,BETWEEN,BLAND,COHEN,CTS,FBP,INTER,KEY,LABEL,LOW,MCNEMAR,METHODS,OBJECTIVE,OBJECTIVES,REDUCED,RESULTS,SSN
001,AGREEMENT,CONTINUOUS,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ONSET,RESULTS
215,218,ABDOMINAL,BACKGROUND,BASED,CONCLUSION,FDG,IGG,LABEL,METHODS,PET
169,AFTER,AUTHORS,CELLS,COPYRIGHT,DCS,DENDRITIC,INC,NKS,PUBLISHED
036,154,897,COLORECTAL,CONSENT,COVARIATES,INC,LABEL,METHODS,NON,OBJECTIVE,ORS,OVARIAN,PUBLISHED,RESULTS,SCREENING,TRIAL,USING
169,CISPLATIN,COPYRIGHT,INC,NPS,PSQ,SINCE,THERE,THESE

169,177,COPYRIGHT,SEVERAL,SOCIETY,THESE
169,17A,COPYRIGHT,KNOCKDOWN,LA1,MMP,RAS,SOCIETY,SRSF1,TAKEN,VIRUS
150,157,169,214,232,APRIL,BASED,BETWEEN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,SUSPECTED,UNIVERSITY,WEDGE
145,151,161,169,308,843,BACKGROUND,COPYRIGHT,INC,LABEL,MARTINI,METHODS,NSCLC,ONGOING,PUBLISHED,RESULTS,SMOKERS,SOCIETY,SPLCS,THERE
169,177,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE,THREE
169,177,BACKGROUND,CHEST,COPYRIGHT,DIAGNOSING,INC,JANUARY,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY,SURGEON
011,016,018,046,047,119,169,BACKGROUND,COPYRIGHT,COX,INC,JANUARY,LABEL,MEIER,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SOCIETY
127,169,280,BACKGROUND,CONCLUSION,CONCURRENT,COPYRIGHT,CRT,INC,LABEL,METHODS,NSCLC,RESULTS,SEVEN
012,017,153,588,671,815,822,AUC,BACKGROUND,BIOMARKER,BMJ,ELISA,FDA,FIBULIN,GROUP,LABEL,LIMITED,MESOTHELIN,METHODS,PLEURAL,PUBLISHED,PUBLISHING,RESULTS,SOLUBLE
079,121,169,16P,19P,22Q,277,370,398,423,449,CIGARETTE,GENOMIC,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
524,CHINA,CHINESE,CIS,CLPTM1L,HOWEVER,ORS
AKT,LMO,NON,NSCLC,PCR
169,BIOLOGISTS,COMPANY,LTD,NTRK2,PUBLISHED,TES,USING
13316,169,946,COPYRIGHT,DSC,LTD,NMR,XRD
169,330,COPYRIGHT,GAMMA,KARNOFSKY,KNIFE,KPS,LTD,MEIER,SELECTION,STOCKHOLM
169,AKT,COPYRIGHT,DESPITE,LTD,NSCLC,THESE,VARIOUS
002,048,287,681,AFTER,LABEL,METHODS,MONITORING,NSCLC,OBJECTIVE,PERIPHERAL,PFS,PURPOSE,REGARDING,RESULTS
GENERAL,SURGEON,WHILE
016,AKT,INHIBITION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PANC1,RESULTS,SILENCING,TREATMENT
001,012,036,383,AMONG,APOPTOSIS,APOPTOTIC,BACKGROUND,BCL,BESIDES,COX,HOWEVER,LABEL,LOG,MALAT,MCL,METHODS,NSCLC,PHAPI,RESULTS
001,004,AFTER,BACKGROUND,CHINESE,EGGER,GALBRAITH,GSTM1,GSTT1,LABEL,METHODS,ORGSTM1,ORGSTT1,POTENTIAL,RESULTS
233,237,243,BEN,JUR,THEREFORE
BRCA1,BRCA2,DIGESTIVE,FINALLY,JEGHERS,PEUTZ,PJS,SERTOLI,STK11,THERE
2155G,2573T,2582T,EIGHT,G719C,HOWEVER,L858R,L861Q,SEVERAL,SNP
946,BACKGROUND,CL1,DESPITE,FINALLY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,WNT
169,DIFFERENT,IL6,MDSCS,MYELOID,NOTABLY,OPN,OVERALL,SPP,STAT3
169,FINALLY,GTPASES,PROFILING,RAC,RAP1A,RAP1B,RES,SRC
169,FGFR2,NSCLC,SOMATIC
160,544,COX,HOWEVER,LABEL,MCNEMAR,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,REVISED,TOKUHASHI
001,130,150,158,375,425,ACCORDING,COX,EPR,GRADE,LABEL,LOG,METHODS,MGC,OBJECTIVE,PURPOSE,RESULTS,TTP
169,300,COPYRIGHT,GTV,INC,ITV,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TTV,TTV80
169,947,COPYRIGHT,DSB,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RAD51,RESULTS,THESE,TMA,WILDE
001,004,136,169,339,APRIL,CHART,COPYRIGHT,GOC,HOSPICE,INC,INPATIENT,LABEL,MATERIALS,METHODS,OBJECTIVE,ONCOLOLOGY,PURPOSE,RADIATION,RATES,RECORDS,RESULTS,SOCIETY,THESE
160,169,711,956,COPYRIGHT,COX,DVH,EFS,GTV,III,INC,LABEL,LOWER,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THESE,V10,V60,V70
169,450,AC1,CONCLUSION,COPYRIGHT,INC,INTERRATER,LABEL,MATERIALS,METHODS,MULTIRATER,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,SIX
003,009,169,CONCLUSION,COPYRIGHT,EFS,EWING,GIVEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMOKING,WLI
239,AMRUBICIN,AUC,BACKGROUND,BASED,EVALUATION,FURTHER,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THREE
945,954,GROWING,MYD88,TNF
100,AD5,ANTITUMOR,CMT,CSF,CTLA4,E1A,E2F,FURTHER,UNDER,VIRUS
199,737,ABT,ALTOGETHER,BCL,LCSCS,NSCLC,WHEREAS
169,ACIDS,BCL,ERBB2,HOWEVER,NUCLEIC,PRESS,PUBLISHED,SEQ,SEQUENCING,SPLICENET,UNIVERSITY
0000024531,150,169,500,BACKGROUND,BASEL,CTR,FURTHER,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SEVENTEEN,THERE
NSCLC,TKI
EMT,EPITHELIAL,NSCLC
897,BACKGROUND,LABEL,METHODS,RESULTS,TEN,THREE
PULMONARY,SINCE
126,BACKGROUND,BESIDES,LABEL,LOCAL,MEIER,METHODS,RESULTS,TECHNIQUES,THEREFORE
177,5TH,7TH,8TH,BACKGROUND,CALIFORNIA,GENERAL,INTUITIVE,LABEL,MARCH,METHODS,MILITRARY,RESULTS,SINCE,SPN,THEIR,THERE,VINCI,WEDGE
001,007,032,165,176,186,308,664,701,BACKGROUND,BMI,JANUARY,LABEL,METHODS,RESULTS,THESE
HOWEVER,MICRO,UNIPORTAL
100,169,183,192,200,329,521,CASES,ERS,GALICIA,SPAIN
CRABP,NSCLC,PROTEIN,TAKEN
142,BESIDES,HOWEVER,MENIN,THEREFORE
106,116,967,ARG,BANGLADESH,HOWEVER,PCR,PRO,SNP
001,107,160,169,195,203,673,AMONG,BACKGROUND,CNS,COPYRIGHT,IBC,III,INC,LABEL,METHODS,NETWORK,OVERALL,RESULTS
FIFTEEN,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY,THERE
001,COX,NSCLC,OVERALL,PFS,TKI
001,ACCORDING,ARRIAGADA,BACKGROUND,CONCLUSION,DIFFUSION,LABEL,MAY,METHODS,PULMONARY,RESULTS,SEVENTY,THERE,TLC,V20
124,169,BACKGROUND,BASEL,CONCLUSION,L858R,LABEL,METHODS,NSCLC,RESULTS
169,COPYRIGHT,INC,SLE,THERE
100,174,181,250,ALK,BASED,CRIZOTINIB,MET,UNCHANGED,XALKORI
BECAUSE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,WHOLE
BACKGROUND,CIS,GSTM1,LABEL,METHODS,ORS,RESULTS,SEVERAL
014,022,169,COPYRIGHT,INC,NSCLC,SERUM,THERE
002,008,160,169,177,386,433,BACKGROUND,BECAUSE,COPYRIGHT,H2O,INC,LABEL,MATERIALS,METHODS,RESULTS,THERE
300,DSB,END,GFP,HOMOLOGOUS,JOINING,NON,R26NHEJ,SINCE,USING
169,COPYRIGHT,MMT,MTT,SEM,TEM,THESE
169,183,ALA,AMONG,BIOLOGICAL,COPYRIGHT,EPR,INC,MCF,PHE,TAKEN,VAL
CD4,HIV,HOWEVER,INCREASED,LOWER,PATTERN,SUCCESSFUL,TLR
183,COMPLEX,H2O,HOWEVER,NO3,OAC
400,IMPORTANCE,INITIAL,LABEL,METASTASIS,METASTATIC,METHODS,OBJECTIVE,RELEVANCE,RESULTS,RETINAL,SETTING,TREATMENT
706,AMG,AREAS,ASIAN,BACKGROUND,COVERED,FURTHER,LABEL,METHODS,MOTESANIB,NSCLC,OPINION,SEVERAL,TKI
CSC,DOX,EMT,METASTASIS,NSCLC,THESE
ETS,SHS,SMS,TOBACCO
CILIARY,COPYRIGHT,SLACK
315,389,BACKGROUND,BASED,COMMITTEE,COX,END,HOWEVER,JOINT,LABEL,MEIER,METHODS,NSCLC,OVERALL,RESULTS,USING,VPI
945,946,AGAINST,IDIOPATHIC,IPF,MOTHERS,SMAD4,TGF
MMP,MT2,MVD,NSCLC,PCR
BRAIN,MRI
630,BACKGROUND,EXPRESSION,HOWEVER,LABEL,MEIER,METHODS,MICRORNAS,MIR,PCR,RESULTS
100MG,150,169,BACKGROUND,COX,FIFTEEN,FOLLOWING,GRADE,HRS,KPS,LABEL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,UNIVERSITY
12A,169,500,945,946,C57BL,COPYRIGHT,FLASH,HEP,LUC,SCIENCE,TGF,TNF
160,169,BACKGROUND,CONSORTIUM,COPYRIGHT,IDS,LABEL,LTD,METHODS,MICRORNAS,PUBLISHED,RESULTS,TARGETSCAN,THESE
011,026,036,135,169,AFTER,SOCIETY,THERE
100,CLUSTER,E2F,EXPRESSION,FDG,LABEL,METHODS,MOLECULAR,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL,THESE
946,BLP25,CIMAVAX,EGF,FINALLY,III,IPILIMUMAB,NON,NOVEL,NSCLC,THESE
001,124,181,281,AUC,BAL,CONCLUSION,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,WESTERN
001,002,003,005,006,013,014,015,016,030,266,267,AIR,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
871,929,954,976,FDG,IHC,LABEL,METHODS,MICRO,OBJECTIVE,PET,RESULTS,THEREFORE
233,CHEST,GM1,IGG
169,COPYRIGHT,INC,LIVER,PET,URINARY
160,169,COPYRIGHT,FURTHER,INC,PET
169,COPYRIGHT,EFFORTS,INC,PET,REVIEWING,SEVERAL
18F,FDG,INC,PUBLISHED,SUV
BACKGROUND,CPA,CURRENTLY,FACTORS,GLV,LABEL,METHODS,MTT,PC14PE6,PRO,RESULTS,RFP,THESE,VIRAL
169,COPYRIGHT,DIFFERENT,INC,METABOLIC
600
ANATOMO,DOPPLER,FDG,PALLIATIVE,PET,THERE
BOARD,HOSPICE,MEDICAL,PALLIATIVE,THESE
GIVEN
BIOMEDICAL
946,AFTER,BACKGROUND,CONCLUSION,CONTEXT,HCG,LABEL,METHODS,OBJECTIVE,PERSISTENT,RESULTS
946,ARTHRITIS,BACKGROUND,HEK293T,IFNB1,IL1,IL6,INSTITUTE,INTRAMURAL,JAK,JANUS,LABEL,METHODS,PROGRAM,RESULTS,STAT1,STING,TMEM173,TNF
126,164,197,262,BACKGROUND,CONCLUSION,COX,HOWEVER,LABEL,LEVEL,MEIER,METASTATIC,METHODS,OBJECTIVE,PRIMARY,RESULTS,SUMMARY,UNPLANNED
001,002,009,011,089,517,864,ALK,AMONG,ATS,ERS,HISTOLOGIC,IASLC
DESPITE,INITIALLY,THESE
177,945,BACKGROUND,CD4,CD8,DESPITE,LABEL,METHODS,RESULTS,SMOKERS,WHILE
834,AMONG,BECAUSE,GAPDH,LDH,MALDI,NCI,NSCLC,PPP,PROTEIN,RAS,REGARDING,TKT,TOF,WESTERN
151,187,205,215,512,774,NSCLC,RELAPSE
AMONG,DESPITE,ENDOSCOPIC,SEVERAL,WHILE
035,100,139,204,BACKGROUND,CONCLUSION,DCR,ERLOTINIB,IQR,LABEL,METHODS,NSCLC,PFS,RESULTS
169,954,ERLOTINIB,H1975,H1993,KNOCKDOWN,L858R,MET,NSCLC,QUINACRINE,SSRP1,T790M,TALALAY
169,812,BACKGROUND,CALIFORNIA,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OTHER,RESULTS
001,002,007,011,013,020,022,027,058,160,169,179,261,374,581,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,GENERAL,JANUARY,LABEL,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SERVICE,STAGE,THERE,TRI
169,400,ACTIVATED,ALCAM,BASED,CD166,COPYRIGHT,HNSCC,MEMBRANOUS
115,CAUCASIAN,CONCLUSION,ERCC1,LABEL,METHODS,MOLECULAR,MTHFR,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SNP,UTR
ADDITIONAL,BACKGROUND,CELLS,EGF,GSPT1,H1650,ID1,INHIBITOR,LABEL,METHODS,NSCLC,PCR,RESULTS,STMN3,THESE,ZBP89
169,PRESS,PUBLISHED,SURGERY,UNIVERSITY,VIDEO
169,ATP,AUTHORS,AZD9291,COPYRIGHT,DESPITE,FIRST,HM61713,LTD,NEWER,NSCLC,PUBLISHED,T790M,THESE
110,169,945,946,954,956,ARG,COPYRIGHT,GLN,IKK,LTD,MOLECULAR,TNF,WESTERN
001,349,416,905,COX,HOWEVER,MEIER,NSCLC,PCR,TNM,WESTERN
169,201,231,ATS,COPYRIGHT,ERS,IASLC,PUBLISHED,SAS,TNM,TREATMENT
946,947,948,AFTER,CD103,CD138,CD3,CD4,CD5,CD7,CD79A,CD8,EBV,EPSTEIN,PCR,PET,TCR,TRD,TRG
000,141,145,177,274,293,845,CEA,PLC,THERE
003,007,020,047,130,2548G,762,782,FURTHER,LEP,PCR,Q223R,TURKISH
060,563,AUC,CHINESE,HOWEVER,KNOWLEDGE,MEDLINE,NSCLC,OVERALL,SINOMED
13Q14,169,17Q23,196,471,708,719,779,946,ADULT,AFRICAN,AMERICANS,ASIAN,BLOOD,C5ORF22,ESP,EUROPEANS,EXOME,GH2,HEART,INSTITUTE,MAF,NHLBI,NOTABLY,PRESS,PROJECT,PUBLISHED,SEQUENCING,THESE,UNIVERSITY,USING
000,036,041,215,248,BASED,BETWEEN,CLPTM1L,GOVERNMENT,PRESS,PUBLISHED,UNIVERSITY
000,BACKGROUND,BANGLADESH,CONTROL,DHAKA,EVALUATION,ITC,LABEL,METHODS,RESULTS,SEVERAL,SHS,TOBACCO
001,005,006,154,BACKGROUND,FURTHER,GSTM1,GSTT1,HOWEVER,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TOBACCO
100,BACKGROUND,FEDERATION,FIFTY,GYNECOLOGY,HOWEVER,LABEL,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OBSTETRICS,PRIMARY,RESULTS,STAGING,THERE,THESE
001,002,006,011,028,133,BACKGROUND,DISEASE,HOWEVER,LABEL,LOBECTOMY,MARCH,METHODS,NSCLC,RESULTS,SEPTEMBER,THERE
001,100,177,630,APE,CONCLUSION,EIGHT,FBP,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SCANS,VOLUMETRY
CUC,HEPG2,ICR,NMR,THEIR,VIETNAM,VIS,XYLARIA
003,006,016,042,ELISA,EMT,HGF,MET,SERUM,THESE
946,ELISA,GSK,PDE,PPASE,PRUNE,WNT,WNT3A
ALK,ASP3026,HOWEVER,NPM
169,COPYRIGHT,HACE1,HOWEVER,INC,LYS48,OPTINEURIN
BACKGROUND,CRC,HOWEVER,LABEL,METASTASIS,METHODS,PSF,PTB,PTBP2,RESULTS
BACKGROUND,EMT,FOXC2,HOXB9,LABEL,MEIER,METHODS,RESULTS,SNAIL,TWIST
945,954,CISPLATIN,DHMEQ,EFFECTS,EXPRESSION,GDC,NSCLC,PCR,PHASE,TREATMENT
125,152,183,375,451,516,655,688,BACKGROUND,CONCLUSION,GEORG,IIA,IIB,JANUARY,LABEL,METHODS,NSCLC,PATHOLOGY,PET,RESULTS,STUTTGART
007,177,DUE,FIFTY,ICC,RADIOMICS,THEREFORE,THESE,WHERE
ANN,CARLO,EWING,EWS,FAS,FCGRT,FLI,FNDC5,LABEL,METHODS,MONTE,OBJECTIVE,OLFM1,RESULTS,RHO,RMS,TNNT1,WNT
CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,946,LABORATORY,MITRA,NETWORK,NSCLC,PRESS,PUBLISHED,SOCIETY,TFS,TGF,WHILE
160,A11,CHI,CNT,DPV,FABRICATED,FOURIER,SEM
160,169,AUTHORS,BACKGROUND,BECAUSE,COPYRIGHT,DOR,FIFTY,GRADE,INC,LABEL,METHODS,ORR,PFS,PUBLISHED,RESULTS,TTR
006,946,DACT2,III,MEIER,RESTORING,THESE,WHEREAS,WNT
HOMOLOG,NSCLC,ONCOGENIC,RAS,ROS
001,002,004,006,169,COPYRIGHT,COX,EMX,FIFTY,IRELAND,LABEL,LTD,MALIGNANT,MATERIALS,MEIER,METHODS,MPM,OBJECTIVE,OBJECTIVES,PCR,RESULTS
073,465,APRIL,CAUCASIANS,CBM,ETHNICITY,LIBRARY,MMP,SCHOLAR,SCIENCE,STATA,VERSION,WEB
296,CEA,ELECTRONIC,HOWEVER,MEANWHILE,NSCLC
945,946,EXTENSIVE,IGF
001,006,033,034,046,176,258,310,BETWEEN,HBEAG,HBSAG,HBV,HOWEVER,JANUARY,NSCLC
169,BLADDER,BOWEL,BRAIN,BRAINSTEM,CARLO,CLINICIANS,COPYRIGHT,D50,ESOPHAGUS,EYE,FEMORAL,HEADS,HEART,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,MONTE,OBI,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SCANS,THYROID,TRACHEA
001,002,008,106,114,ABOUT,CLINICIANS,CRC,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SURVIVORS
MEDICAL
169,COPYRIGHT,NSCLC,PET,PUBLISHED,SAS
ENGLISH,FIRST,PNC,PSH,THIRD
BACKGROUND,CAUCASIAN,CROHN,DIAGNOSTIC,EPSTEIN,LABEL,LYG,METHODS,PULMONARY,THIOPURINE
11C,18F,AGENT,DISEASE,FDG,HOWEVER,IMAGING,MICAD,MOLECULAR,PET,PROBE,PROFILING,THEIR,VALIDATED,WEB

HOWEVER
MALIGNANT
PRIMARY
AFTER,MEC
031,079,143,177,196,689,BACKGROUND,CEA,CONCLUSION,HOWEVER,JANUARY,JINLING,LABEL,MATERIALS,MEIER,METHODS,NANJING,NSCLC,RESULTS,ROC,SERUM
525,BETWEEN,CCI,CONCLUSION,FURTHER,LABEL,METHODS,OBJECTIVE,PRT,PURPOSE,RESULTS,UNI,YOUNGER
ALK,APART,BREAK,CDX,COMPANION,CRIZOTINIB,KIT,NSCLC,PATHVYSION,PROBE,VYSIS
ALK,IHC
BECAUSE,CO2,NET,USING
116,CAP,FDA,HCT,HLM,MLM,NCI,ROMIDEPSIN,ZBG
048,067,171,301,358,372,500,686,766,BACKGROUND,CANDIDATES,CHIBA,CONCLUSION,JAPAN,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PFT,RESULTS
945,947,BACKGROUND,BMJ,ERR,GROUP,LABEL,LIMITED,MEDICAL,METHODS,POISSON,PUBLISHED,PUBLISHING,RADON,RESULTS
100,169,436,BED,BODYFIX,COPYRIGHT,FAILURE,INC,JANUARY,LABEL,LOCAL,MATERIALS,METHODS,NOVALIS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SINCE,THERE,USING
169,200,291,COPYRIGHT,G873R,HOTSPOT,INC,ION,MOLECULAR,PANEL,PATHOLOGY,PCR,PUBLISHED,SEQUENCES,SOCIETY,THESE
160,ANNEXIN,BAX,BCL,HOECHST,HOWEVER,MTT,NON,NSCLC,NVB,PCR,TNF,TRAIL,USING
002,006,169,432,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SOMATIC
BACKGROUND,CARLO,CONCLUSION,CSI,IMPORTANT,LABEL,LAR,METHODS,MONTE,OED,REGARDLESS,RESULTS,SECONDARY,TREATMENT,VARIATIONS,VII
169,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,RAPID
C4B,ELISA,FURTHER,H1299,HOWEVER,PDZK1,SLC34A2,THEREFORE
ASIATIC,MOLECULAR,THESE
184,408,523,528,636,642,674,722,734,747,780,823,834,856,899,908,938,ABCAM,BACKGROUND,HSP27,INCREASED,INVITROGEN,LABEL,METHODS,NSCLC,RESULTS
179,484,ATLAS,BACKGROUND,FOXA1,HOWEVER,LABEL,METHODS,ONCOPRINT,PCR,RESULTS,SEQ,WESTERN
169,AMONG,COPYRIGHT,ETOPOSIDE,RESULTS,SAS,THP
169,COPYRIGHT,PUBLISHED
169,ADDITIONAL,COPYRIGHT,LTD,PPI,PSMA3,RIG,TCR,UBC
ADJUSTMENT,AFTER,BMJ,DCM,FURTHER,GROUP,ICARE,LABEL,LIMITED,METHODS,OBJECTIVE,ORS,PCE,PUBLISHED,PUBLISHING,RESULTS,SES,THESE
169,AFTER,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RADIOLOGIC,RESULTS,SOCIETY,ULTRASOUND,USUALLY,WDPMP
001,143,251,ALZHEIMER,CIS,CONCLUSION,EGGER,HOWEVER,LABEL,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,RRS,SCIENCE,STUDIES,THESE,WEB
CAV,HPR,HSA,PCR,SUFFICIENT,THEIR,TUNEL
169,AUSTRIA,CONCLUSION,COPYRIGHT,DEC,ENTRY,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,SMR,STAGE,SUICIDE,THEREFORE,TYROL
046,142,169,177,181,GRADE,III,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,PATIENT,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,THERE,THREE,UNIVERSITY,VIDEO
129,154,169,177,591,700,800,BACKGROUND,COSTS,CTS,FLEISCHNER,HEART,HOWEVER,INC,LABEL,METHODS,PNS,PULMONARY,RESULTS
023,060,169,1930S,1940S,453,542,AFTER,BACKGROUND,BIRTH,CONCLUSION,COX,HODGKIN,HOWEVER,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,USING
169,945,946,BED,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,TLV
169,607,COPYRIGHT,ESOPHAGEAL,GROUP,INC,LABEL,MATERIALS,METHODS,NOTABLY,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THERAPY,THESE
169,COMPARING,COPYRIGHT,EXACTTRAC,FIFTY,INC,LABEL,MATERIALS,METHODS,NOVALIS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,INMATES,LABEL,MATERIALS,METHODS,OBJECTIVE,PALLIATIVE,RATIONALE,RESULTS,TEN,THESE,THREE,TPC,UNIVERSITY
CANCEROUS,CIP2A,INHIBITOR,MYC
BALKANS,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,PERSIAN,PURPOSE,RESULTS,STUDIES,THERE
081,189,352,CRC,CROSS,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING
AFTER,MAP,THESE,USA
120,177,280,ANOTHER,BACKGROUND,CONTEXT,CUSHING,EAS,ELEVATIONS,EXPANDING,LABEL,METHODS,OBJECTIVE,RESULTS,SEM
169,384,COPYRIGHT,EGFL7,ELISA,INC,PCR,UNBOUND,USING
FINALLY,HOWEVER,IPS,PLUNC
013,129,70Y,AGE,LABEL,MAJOR,METHODS,MORBIDITY,MORTALITY,OBJECTIVE,PULMONARY,RESULTS,SUCCESSFUL,SURGERY,UNIVARIATE,VIDEO
100,169,ACCORDING,APRIL,MARCH,PRESS,PUBLISHED,SURGERY,UNIVERSITY
107,169,BIOCAST,CFDNA,CONCLUSION,ERBB2,HOWEVER,IONTORRENT,LABEL,MACHINE,MATCHED,METHODS,MULTIPLEX,NGS,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE
125,169,385,763,BACKGROUND,BMI,CONCLUSION,COX,FINALLY,FRAMINGHAM,HEART,LABEL,METABOLIC,METHODS,OVERWEIGHT,RESULTS,THESE
169,AFTER,FOLLOWING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECLN,RESULTS,SFED3,VCP
169,EVALUATION,IMAGING,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIXTY,SOLID
182,BACKGROUND,LABEL,METHODS,MTT,NSCLC,PCR,PDCD4,RESULTS,UNASSIGNED,VIRTUAL,WESTERN
057,139,161,162,169,250,289,592,604,6MONTHS,BACKGROUND,COPYRIGHT,IQR,IRELAND,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,TRIAL
215,ADC,BACKGROUND,BASED,CHEST,EIGHT,FUNCTIONAL,LABEL,METHODS,MRI,PET,RESULTS
195,402,686,716,BACKGROUND,DESPITE,EPAS1,III,IL8RA,LABEL,METHODS,PFS,RESULTS,VHL
946,BACKGROUND,CD151,CONCLUSION,LABEL,LOG,METHODS,RESULTS,WHILE
160,174,261,355,AFTER,CHI,CONCLUSION,FURTHER,LABEL,METHODS,MYC,OBJECTIVE,PURPOSE,RESULTS,SMALL,WHITNEY,ZYTODOT
27B,INCREASING,NON,NSCLC,SP1
255,COX,ENDOCAN,HOWEVER
BACKGROUND,CONCLUSION,HOWEVER,ILD,LABEL,METHODS,NON,NSCLC,OVERALL,PARTICULAR,PEM,PEMETREXED,RESULTS,THREE,UIP,UNIVERSITY
169,COPYRIGHT,HOWEVER,MARIJUANA,PUBLISHED,SAS
CONCLUSION,DIFFERENT,GASTRIC,LABEL,METHODS,OBJECTIVE,RESULTS,SAVDA,UNSAVDA
169,COPYRIGHT,FEDERATION,MECHANISMS,MET,NOTABLY,PUBLISHED,SOCIETIES,THESE
169,AFTER,BACKGROUND,COPYRIGHT,EPSTEIN,GALLIUM,INC,LABEL,METHODS,SIXTEEN
004,011,025,029,169,3A4,BACKGROUND,BASEL,DOCETAXEL,GRADE,LABEL,METHODS,POTENTIAL,RESULTS
231,AHR,BACKGROUND,CHROMATIN,CXCR4,LABEL,MDA,METHODS,MMP,MTT,OMEPRAZOLE,RESULTS
000,039,093,100,109,112,113,145,148,158,181,184,186,200,235,248,268,403,433,509,622,739,956,969,ASR,CENTRAL,CHINA,CHINESE,GIVEN
CHINA,CHINESE
CUMULATIVE,OUTDOOR,WORLD
164,169,259,261,991,ADH1B,LABEL,MENDELIAN,METHODS,OBJECTIVE,OUTCOME,RESULTS,RS1229984
174,AUSTRALIA,BACKGROUND,COLORECTAL,CRC,DISCUSSION,FOXFIRE,LABEL,LIMITED,MEDICAL,METHODS,NORTH,OXMDG,PFS,RADIATION,SECONDARY,SELECTIVE,SIR,SIRFLOX,SPHERES,THERAPY,TRIAL
169,2DG,BASED,COPYRIGHT,ERSAS,IRELAND,LTD,NSCLC,STUDIES
BECAUSE,HOWEVER,THESE
100,160,169,956,COPYRIGHT,HOP,INC,INSTITUTE,MAESTRO,MOLECULAR,NCI,NSC,SAS,USA
016,BACKGROUND,CARCINOMA,CONCLUSION,DESPITE,FIRST,IL6,LABEL,LEWIS,LLC,MEANWHILE,METHODS,RESULTS,SERUM,THEREFORE
VARIOUS
AFTER,GEFITINIB,MARCH,TKI
100,105,106,115,ACCORDING,AFTER,DIFFERENT,HOWEVER,IBT,REGARDING,TREATMENT,WBI
AMONG,BOARD,CHINA,CHINESE,FINALLY,GENERAL,HOWEVER,LABEL,MATERIALS,METHODS,NEAT1,OBJECTIVE,PLA,RESULTS
001,227,316,BACKGROUND,LABEL,METHODS,PRIMARY,RESULTS,SIXTY

183,404,BACKGROUND,BPH,COLORECTAL,LABEL,MEN,METHODS,OVARIAN,POISSON,RESULTS,SCREENING
MALIGNANT
169,344,946,CHRONIC,COPYRIGHT,FISCHER,HOWEVER,INC,PBK
ALZHEIMER,FINALLY,FULLY,HOWEVER,MRI,PET,POTENTIAL,PROMISING,SINCE,WHILE
130,220,5MM,BACKGROUND,CARCINOMA,CONCLUSION,HEM,LABEL,LOCAL,METHODS,RCC,RENAL,RESULTS,SINCE,THERE
970,ATR,DDR,HOWEVER,THESE
ABDOMINAL
EVALUATION,HOWEVER
169,BRACHYURY,LABEL,METHODS,MICROARRAY,OBJECTIVE,PIN,PURPOSE,RESULTS,SUCCESSFUL
101,124,169,232,355,BACKGROUND,BRITISH,DOSES,IIA,JOURNAL,LABEL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,STAGE,TOTAL,UNIVERSITY
164,169,BACKGROUND,EXPRESSION,LABEL,MEDICAL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
146,169,484,ACTIVATING,AMONG,ATLAS,BACKGROUND,CRC,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,RAS,RECORDS,RESULTS,SOCIETY,THESE,UNIVERSITY
100,102,169,284,705,967,AELAD,BACKGROUND,BASED,CONCLUSION,L858R,LABEL,MAF,MAFLR,MARCH,MEDICAL,METHODS,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,THREE,TKI,UNIVERSITY,WHETHER
125,215,548,761,ACCORDING,ANOTHER,COMMISSION,HEALTHY,ITALY,NETWORK,NON,PROMOTION,USA,WHP,WORKPLACE,YEARS
169,231,AKT,BACKGROUND,BRAIN,GAP,LABEL,MDA,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
177,99M,AFTER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN
EMT,H1975,L858R,MTT,NCI,NSCLC,T790M,THESE
945,ALPHA,BRAIN,FURTHER,GALSA,NSCLC
ADDITIONAL,AFFYMETRIX,EDC,EPIDERMAL,HNC,HNSCC,LCE3D,PCR,S100A11,SPRRS,THESE
006,168,187,222,266,275,763,ALK,ERBB2,KIT,MET,OVERALL,SRC,SURGICALLY
10001,333,FDG,MEDICAL,PET,PUBLISHERS,SEVENTH,USA
ATM,CELLS,IGFBP,RASSF1A,RASSF1C,THESE
169,183,2MM,CLINICALLY,CUSHING,ENDOSCOPIC,GEORG,HPF,LCNEC,PEPTIDE,STUTTGART,THEREFORE,TYPICAL
CA2,ROS,THESE
468,BETWEEN,JANUARY,KOREA,OCTOBER
ACT,DESPITE,HOWEVER,IACIA,INDUSTRIAL,INSURANCE,KOREA,LABOR,LSA,ODS,SINCE,STANDARDS,THERE
116,121,169,388,417,504,519,760,810,979,BETWEEN,CONCLUSION,COPYRIGHT,LABEL,MEDICAL,METHODS,MODIFYING,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SOCIETY,THERE
169,FURTHER,GENERAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,SUV,UNIVERSITY
001,123,169,209,290,AGE,BACKGROUND,LABEL,LARGE,METHODS,MORTALITY,OBJECTIVE,OVERALL,PRESS,PUBLISHED,RESULTS,SERVICE,SOCIETY,TESTICULAR,THESE,UNIVERSITY
001,007,027,169,874,883,AUSTRALIAN,BACKGROUND,BETWEEN,CONCLUSION,DAILY,FIFTY,GPS,LABEL,METHODS,NSCLC,PRIMARY,RESULTS,SECONDARY
001,032,049,259,375,400,CHINESE,G590A
020,042,073,085,160,237,250,263,287,357,362,619,625,GEFITINIB,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
000,500,ARSENIC,BREEDER,CD1,HOWEVER,THESE
223,945,946,AROMATASE,ELISA,ESTROGENS,GBM,III,PCR
009,016,022,034,121,308,324,BACKGROUND,DIAGNOSIS,GPA,KARNOFSKY,KPS,LABEL,METHODS,OVERALL,RADES,RADIATION,RESULTS,SIX,SRS
174,CELGENE,EMA,OCTOBER,USA

DEPARTMENT,ECG,EMERGENCY,QRS
SCREENING,TRIAL
292,324,542,781,843,855,CONCLUSION,FINLAND,FINNISH,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,USING
946,954,ADC,BMP,EMT,NOTCH,TARGETING,TGF,WNT
875,AMONG,EARLY,SHOTGUN
946,954,AKT,COX,IKK,ILK,MIG,THESE,VP1
ATP,EDM,EDMONSTON,PERSISTENT,TAKEN
886,954,CPG,FOS,KNOCKDOWN,MYC,PKR,PROTEIN
169,183,GEORG,MOLECULAR,OBTAINING,STUTTGART
954,BCSCS,CU2,DSF,FDA,HOWEVER,TREATMENT
946,AKT,EMT,LDN193189,NANOG,NSCLC,SMAD1,SNAIL,THESE
115,136,146,148,162,163,166,225,289,956,BURNING,CHINA,CHINESE,DEVIATION,GEOMETRIC,GSD,HAP,LOWER,MIXED,PM2,XUANWEI
HEP,LC3,OVOTHIOLS,THESE
117,132,BACKGROUND,CONCLUSION,FOLFOX7,GRADE,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
369,377,CD8,CYTOTOXIC,ERBB2,HLA,PRIMARY,TCR,USING
143,INTEGRATED,LIM,LIMK1,MICRORNAS,NSCLC
VEGFR
CELLS,ECFCS,EPC,MMP12,PROGENITOR
EVOLUTION,NSCLC,TRACERX
446,877,91533,AUC,BACKGROUND,DOR,HOWEVER,LABEL,MAY,MEDLINE,METHODS,NSCLC,RESULTS,SCIENCE,TEN,TTF,WEB
001,002,009,024,033,141,155,200,549,649,787,BACKGROUND,CONCLUSION,EMT,FUNCTIONAL,H23,HCC,HOWEVER,LABEL,MET,METHODS,MICRORNAS,NSCLC,RESULTS,SCC,SEVERAL,VEGFA
AMONG,CONNECTIVE,ERK,MEK,MMP,TAKEN
11A,200,946,AKT,SRC,STRUCTURAL,USING
AES,AMINO,BCL,CONSISTENT,CONVERSELY,NSCLC,SPLIT,TAKEN
169,189,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SOCIETY,ZIV
001,005,023,051,233,AGE,ARCAD,CONCLUSION,COX,DIGESTIVE,LABEL,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RECHERCHE,RESULTS,YOUNGER
169,ALK,FDA
169
169,177,BECAUSE,COPYRIGHT,IHC,III,PUBLISHED,RCC,STAGE,SURGERY,THREE,TREATMENT
169,PRESS,PUBLISHED,S2B,SURGERY,UNIVERSITY
100,169,264,ALTOGETHER,PRESS,PUBLISHED,STAGE,SURGERY,TEN,THERE,UNIVERSITY
169,225,CD133,COPYRIGHT,CXCR4,DESPITE,LTD,PES,PREVIOUSLY,THESE,UCB

000,200,EMT,FUNCTIONAL,IFN,INTEGRATED,MEIER,MEMBERS,THESE,WNT
001,FIFTY,FORTY,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RAPID,RESULTS,VANCOUVER,VARIABLES
001,013,038,093,169,BACKGROUND,CHANGES,CHI,COPYRIGHT,ENGLAND,IRELAND,LABEL,LTD,METHODS,NSCLC,PACIFIC,RESULTS,UNIVARIATE
001,005,043,169,375,CANDIDATE,CLAUDIN,CLDN1,CONCLUSION,COPYRIGHT,FINALLY,FURTHER,IRELAND,LABEL,LTD,MATERIALS,MES,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCC,THEREFORE
ANTITUMOUR
DISRUPTION
128,169,AKT,COPYRIGHT,ECTOPIC,ERK,LTD,NSCLC,THEREFORE,THESE,VEGFR
000,002,008,035,051,057,120,159,175,201,ACCORDING,BACKGROUND,KARNOFSKY,LABEL,LRPFS,METHODS,NSCLC,RADIATION,RESULTS,TREATMENT
169,PRESS,PRIMARY,PUBLISHED,SEVERAL,SURGERY,UNIVERSITY
001,169,177,ABLATIONS,ADJUNCT,COPYRIGHT,INC,LABEL,LESIONS,MARCH,MATERIALS,METHODS,MICROWAVE,OBJECTIVE,PATIENT,PRIMARY,PROCEDURE,PUBLISHED,PURPOSE,RESULTS,SIR,VAS
500,AFTER,AKT,CDK,ERLOTINIB,FDA,LEWIS,LUX,PCR,PROTEIN,THEREFORE,WESTERN
177,946,956,AMONG,ELAEAGNUS,MAXIM,MTT,THESE
213,318,373,482,589,891,AFSIN,DIFFERENT,KUTAHYA,POWER,PPP,PURCHASING,UNION,USD,VSL,WTP
CERTAIN,PRIOR,THESE
100,ALK,BACKGROUND,BLOOD,CTC,CURRENT,EPCAM,LABEL,NGS,PAN,PBMCS,PRINCIPAL,RESULTS,RETRIEVED
1980S,AUSTRALIA,BACKGROUND,BELGIAN,BELGIUM,ITALY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,COMPANY,INSURANCE,KNOWLEDGE,LABEL,METHODS,METLIFE,OBJECTIVE,OBJECTIVES,RESULTS,SOA,THERE
BESIDES,SPECT
FDG,HISTOLOGIC,PET
100,131IODINE,177,237,300,457,600,639,AIRES,ARGENTINA,COX,DTC,FDG,FTC,GRT,LABEL,METHODS,OBJECTIVE,OVERALL,PTC,RAI,RESULTS,SEVENTEEN,THOSE
FDG,PET,THERE
FDG,PET
FDG,LABEL,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SEVEN
DELHI,FDG,INDIA,INDICATION,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL,THROMBOSIS
38584,AMONG,BACKGROUND,CAUSE,CCI,COX,DESPITE,INDEX,INSURANCE,LABEL,METHODS,NHI,RESULTS,THEREFORE
205,946,ABOUT,MVD,NSCLC,OVERALL,PAS,WNT,WNT5A
STUDIES,WHILE
169,BRAIN,COPYRIGHT,IRELAND,LMC,LTD,MRI,NSCLC,TKI
000,001,005,009,046,169,494,551,ACCORDING,APART,BACKGROUND,BMI,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,RESULTS,WHILE
003,945,946,CHANGES,DETECTION,ELISA,HOWEVER,TGF,TNF

002,017,018,032,169,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,IQR,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,THERE,WHILE
954,AKT,AMONG,FRAGILE,HOWEVER,NSCLC,THEREFORE
BMP,PYVMT,THESE,TREATMENT
916,AMP,FINALLY,NCI,SILENCING
60S,AUTOPSY,PULMONARY
000,550,AMERICA,HCC,LAASL,THESE
ALK,CERITINIB,CRIZOTINIB,III,NSCLC,PHASE
ACCORDING,C91,DE3,LATCRIPIN,LENTINULA,MTT,ROSETTA,WESTERN
ADULT,BACKGROUND,BANGLADESH,CHINA,INDIA,KNOWLEDGE,LABEL,MATERIALS,METHODS,POPULAR,RESULTS,THERE,TOBACCO
60S,BACKGROUND,L39,LABEL,MATERIALS,MDR,METHODS,PCR,RESULTS,RPL39,TDR,TOTAL,VIABILITY
AFTER,BACKGROUND,CDH13,LABEL,MATERIALS,METHODS,MSP,NSCLC,PATIENT,RASSF1A,RESULTS
AFTER,BACKGROUND,JUN,LABEL,MATERIALS,METHODS,RESULTS,THP
100,BESIDES,CONCLUSION,III,LABEL,METHODS,MMP,MPP,NSCLC,OBJECTIVE,PCR,RESULTS,WESTERN
169,COPYRIGHT,PUBLISHED,PULMONARY,SOCIETY,THESE
129,169,246,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,IPF,LABEL,METHODS,PUBLISHED,RESPONSES,RESULTS,SOCIETY,UIP
016,027,034,043,057,154,169,183,2N0M0,982,BACKGROUND,COPYRIGHT,ELDERLY,JANUARY,LABEL,METHODS,NSCLC,PUBLISHED,REGARDING,RESULTS,SOCIETY
BACKGROUND,FARMERS,FURTHER,ITALY,LABEL,LITERATURE,MATERIALS,METHODS,RESULTS
000,080,100,175,420,577,CONCLUSION,LABEL,LPC,METHODS,NSCLC,OBJECTIVE,RESULTS,TOTALLY
BACKGROUND,EMT,FURTHER,GROWING,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,SILENCING,THESE,USP25
208,429,725,BMI,FINNS
127,169,1NG,2575G,48H,7NG,9NG,COPYRIGHT,GEFITINIB,III,IRELAND,LTD,NSCLC,TKI
014,169,CASES,COPYRIGHT,INC,INCIDENTAL,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,REFERENCE,RESULTS,UNIVARIATE
127,140,169,322,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,DFI,HOWEVER,JANUARY,LABEL,LTD,MEDICAL,METHODS,PULMONARY,RESULTS,STS,UNIVERSITY
169,BACKGROUND,BARTHEL,CONCLUSION,COPYRIGHT,DESPITE,FEDERATION,LABEL,METHODS,PUBLISHED,RESULTS,SPAIN
169,574,COPYRIGHT,FERRATA,FOUNDATION,FURTHER,INSTITUTES
054,121,143,155,169,239,823,AES,BCL,CBE,CBEOB,CONCLUSION,COPYRIGHT,EASTERN,GRADE,GROUP,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBATOCLAX,OBJECTIVE,ORR,PFS,RESPONDERS,RESULTS
001,169,296,576,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FURTHER,HDAC2,IRELAND,LABEL,LTD,LUCIFERASE,METHODS,NSCLC,RESULTS
002,005,011,169,ALK,BIOMARKERS,BLOOD,BVI,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MET,METHODS,MORPHOLOGY,NSCLC,OBJECTIVE,OBJECTIVES,P63,PAS,PCR,PULMONARY,RESULTS,SCS,SEVENTY,THEIR
LABEL,METHODS,NOTABLY,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
1ST,2ND,3RD,FDG,FIFTEEN,FLT,HOWEVER,NSCLC,PERCIST,PET,PFS,RESULTS,ROC,SULPEAK,THREE,TKI,TLG
ATL,AUTOPSY,FDG,PET
100,160,CONCLUSION,HODGKIN,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIXTY
011,032,036,037,169,219,BACKGROUND,COPYRIGHT,DFS,FORTY,INC,LABEL,LRC,MATERIALS,METHODS,NSCLC,PROPENSITY,RESULTS
169,4T1,COPYRIGHT,DESPITE,DOX,EOSIN,GNR,IHC,LTD,NIR
160,169,COPYRIGHT,DUE,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,CYSTS,INC,PUBLISHED,PULMONARY,SOCIETY
BASED,HOX,HOXA9
169,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,ZEALAND
002,008,013,240,280,HAPLOTYPE,SNP,TUNISIA,VDR,VITAMIN
ANNEXIN,BACKGROUND,DOCETAXEL,DTX,ERK,HMGB1,III,LABEL,LAD,MEK,METHODS,MTT,NOD,NSCLC,RESULTS,SPC
160,169,956,COPYRIGHT,HOWEVER,SAS,THEREFORE
169,AGE,APC,COPYRIGHT,LTD,POISSON,RESULTS,SWISS,WILEY
169,COPYRIGHT,INC,RAS
169,946,ASIAN,BACKGROUND,HOWEVER,LABEL,LOX,METHODS,OBJECTIVE,PACIFIC,PET,RESULTS,SCC,SMALL,SOCIETY,TGF,THERE
001,GRADE,HELICAL,HOWEVER,OTHER,PTV
100,AFTER,NSCLC,OTHER,RFA,THEREFORE,VARIOUS
169,COPYRIGHT,FURTHER,NETWORK
BMJ,EMP,GROUP,LTD,PUBLISHING
100,153,169,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,PRESS,PUBLISHED,RESULTS,SURGERY,SUV,THREE,UNIVERSITY
120,169,176,NOTES,PRESS,PUBLISHED,REFINEMENT,SURGERY,UNIVERSITY
169,COPYRIGHT,CSF,EPIDERMAL,INC,L858R,MOLECULAR,PATHOLOGY,PCR,PUBLISHED,SOCIETY,THESE
FND
ACCORDING,KNN,SVM
233,BACKGROUND,BHD,CONCLUSION,DUB,LABEL,METHODS
802,H1299,NCI,THEREFORE
315,BACKGROUND,FUNCTIONAL,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOGENS,PDR,RESULTS,VARIABLES
BACKGROUND,ENGLISH,LABEL,METASTASIS,METHODS,THERE,THEREFORE
143,946,EPIDERMAL,ERCC1,III,LABEL,LCT,METHODS,MUTATIONS,NSCLC,OBJECTIVE,RESULTS,TUBB3
169,177,785,BACKGROUND,BASEL,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS
SPARC
160,ECM,NCK,SH3,SRC
001,169,277,481,758,COPYRIGHT,HOWEVER,INC,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,THESE,TNM,UNIVERSITY
169,COPYRIGHT
160,169,945,BACKGROUND,COMBINING,CONCLUSION,COPYRIGHT,FORTY,FRA,INC,KIRSTEN,LABEL,METHODS,NSCLC,PFS,RESULTS,SPECIMENS,THERAPIES
BACKGROUND,GGO,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGARDING,RESULTS,TBB
BACKGROUND,CONCLUSION,DIAGNOSTIC,DUE,EBF,ENDOSCOPY,LABEL,METHODS,RESULTS,STEPS
027,029,038,BACKGROUND,DFS,HOWEVER,JANUARY,LABEL,MARCH,METHODS,NOTABLY,PRIMARY,RELATIVELY,RESULTS,THERE,THESE,UNIVERSITY
686,910,EFS,MICRORNAS,THEIR
169,BASEL,CLEARLY,FINALLY,NON,NSCLC,THESE,TKI
001,008,BERBERINE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
CHINENSIS,CONCLUSION,EIGHT,FORTY,HOWEVER,JNK,JUN,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,TAXUS,THEREFORE,WESTERN,ZEALAND
100,200,430,ALK,COX,IHC,PCR,VENTANA
103,128,761,834,850,ATP,FINALLY,FIRST,L858R
BACKGROUND,INR,LABEL,METHODS,NARANJO,PATIENT
946,BACKGROUND,EXOGENOUS,H1299,LABEL,METHODS,RCM,RESULTS,RIBES,ROS,TGF
HIV,PULMONARY
111,BASED,CCK,F11,MTC,PET,SPECT
954,AKT,CHINESE,DRUCE,DUE,GNA,MTT,POL,ROS
205,ASSOCIATED,DIATOMS,FAS,MTT,PROTEIN,PUA,RIP,THESE,TNFR1,USING
AFTER,JNK,LABEL,MELATONIN,METHODS,MLC,MTT,OBJECTIVE,OPN,RESULTS
ALK,CRC,CRIZOTINIB,FIG
BACKGROUND,CARCINOID,CRYOBIOPSY,HOWEVER,LABEL,METHODS,RESULTS,THERE
100,BACKGROUND,DENMARK,LABEL,MARCH,METHODS,RESULTS,SEPTEMBER,SIXTY
100,102,177,216,BACKGROUND,INDIA,LABEL,LITERATURE,METHODS,NORTH,OVERALL,RAPID,RESULTS,SEPTEMBER,THERE
001,244,787,CONVERSELY,HODGKIN,MCC,QUEENSLAND,SIR,THESE
000,002,014,063,109,132,189,200,329,420,494,498,502,545,660,948,988,AGE,BACKGROUND,INSULIN,INSURANCE,LABEL,METHODS,RESULTS,TAIWANESE
INHIBITION,MCL,MPM,NSCLC,PEMETREXED,USP9X
169,COPYRIGHT,ESI,INC,MCF,MTT,NMR,SIMILAR
HOWEVER,LOCAL,MIDTERM,MINOR,NSCLC,SINCE,WORLDWIDE
100,CDC27,EARLY,KRT18,MICROARRAY,NSCLC,PRKDC,VARIOUS
001,019,160,744,946,CEA,CONCLUSION,CYFRA,FDG,HOWEVER,LABEL,METHODS,MTV,NSCLC,OBJECTIVE,PET,RESULTS,SERUM,SEVENTY,SUV,SUVMEAN,THERE
HOWEVER,NGS,PANEL,SNP
001,102,340,740,773,AUC,BETWEEN,CONCLUSION,FDG,HOWEVER,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PET,PURPOSE,RESULTS,ROC,SUVMEAN,SUVPEAK
160,177,CONCLUSION,FDG,LABEL,METABOLIC,METHODS,MTV,NSCLC,OBJECTIVE,OLM,PET,PURPOSE,RESULTS,ROC,SUV,SUVMEAN,TLG,TOTAL,UNIVARIATE
219,AUC,BET,FOLLOWING,HOWEVER,NSCLC,PRIMARY,THERE,THESE
ASSISTANT,AUDIT,CDS,ENGLISH,HOWEVER,LCA,MDT,WHILE
169,174,ALK,ATP,COLLEGE,CRIZOTINIB,IRT,PIC,XALKORI
169,945,946,947,B16,BL6,CD4,CD8,COPYRIGHT,DCS,DESPITE,HPV,IFN,INC,MYD88,TH1,THEREFORE,TNF
00001,001,CAUCASIANS,CIS,DATABASES,HLA,HOWEVER,ORS,SEVERAL,SUMMARY,WANFANG
001,009,043,104,235,654,707,859,COX,III,LABEL,METHODS,NLR,NSCLC,OBJECTIVE,RESULTS,ROC,THERE,TNM,UNIVARIATE
100,AMONG,CEA,CK7,GGO,III,IMAGING,LABEL,METHODS,MPP,OBJECTIVE,RESULTS,SIXTY,SPA,THERE,TTF
001,002,014,019,021,029,AMONG,ASPP1,ASPP2,EXPRESSION,FIFTEEN,GUIYANG,III,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,P53,RESULTS,SEPTEMBER,UNIVERSITY
173,177,200,285,339,406,435,465,804,946,947,AAD,C57BL,CD4,CD8,ELISA,IFN,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,SERUM,TGF
169,AFTER,BACKGROUND,BAX,DAILY,LABEL,LUCIFERASE,METHODS,PROTEIN,RESULTS,SOCIETY,THERE,WESTERN
149,ANISOTROPY,EUCLIDEAN,FROBENIUS,GTV,IMAGE,LABEL,LOG,METHODS,OBJECTIVE,PURPOSE,RESULTS,TENSORIAL,THEIR,THESE
100,177,AUTOMATIC,CERTAIN,CORRECTION,LABEL,METHODS,OBJECTIVE,PHANTOM,POSITIONAL,PURPOSE,RESULTS,SOBEL,TEMPLATES
204,484,FBS,FDK,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,REGARDING,RESULTS
174,2MM,500,800,BATCH,CARLO,CPU,DOSXYZNRC,DUE,GAMMA,GPU,INTEL,K20,K40,LABEL,M2090,METHODS,MONTE,OBJECTIVE,PATIENT,PSF,PTV,PURPOSE,RESULTS,USING
125,500,BACKGROUND,GOVERNMENT,GRADE,III,LABEL,METHODS,MPM,MTD,OBJECTIVE,OTHER,PEMETREXED,PUBLISHED,RESULTS,SECONDARY,SERUM,SS1,USA
AFTER,EBV,FDG,HOWEVER,LYG,PCR,PET,SUV,THEREFORE
001,008,010,016,035,075,097,137,257,304,312,371,472,543,554,602,652,976,AFRICAN,ASIAN,BACKGROUND,CAUCASIAN,CAUCASIANS,CYTOCHROME,IMPACTS,LABEL,LEU,LEU432VAL,METHODS,P4501B1,RESULTS,VAL
400,776,BACKGROUND,HOWEVER,JANUARY,LABEL,METHODS,NSCLC,RESULTS
169,ABCG2,ATM,AUTHORS,BCL,LTD,MCL,MDR,PTY,PUBLISHING,SCIENCE,TAKEN,WILEY
BRAIN,DESPITE
KNOWING,MARRARO,OLV,UNIVENT
FEHTP,FET,H69,LAT,NCI,PET,REFERENCE,SMALL,THESE
945,CO2,HIF,HOWEVER,MMP,PGC,SCC
089,183,956,ALZHEIMER,BLADDER,DIGESTIVE,INCIDENCE,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,THERE
THERE,VIRTUAL
100,BACKGROUND,CASES,DFS,LABEL,LOWER,LUNGCARTA,MEIER,METHODS,NON,NSCLC,PANEL,QTA,RESULTS,WHITNEY
013,177,DSC,MRF,NSCLC,PET
001,014,104,III,MMP,NSCLC
CURRENT,HOWEVER,LABEL,OPINION,PULMONARY,STATEMENT,UNANSWERED,UNASSIGNED,WHILE
160,18F,AIM,CONCLUSION,CTS,FDG,LABEL,MAXIMUM,METHODS,NSCLC,OBJECTIVE,PALLIATIVE,PERCIST,PET,RESULTS,THREE
169,B16,C26,COLON,INC,LEWIS,LLC,MTT,PEGYLATED,WILEY
169,CHEST,COPYRIGHT,HEMOPTYSIS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PUBLISHED,PURPOSE,RESULTS,SIR
001,169,API,ASIAN,BACKGROUND,LABEL,METHODS,PACIFIC,RESULTS,SOCIETY,USB
169,540,BMI,HOWEVER,INDEX,ISI,JANUARY,MAY,OVERALL,SCIENCE,SRR,WEB
90Y,EARLY,FLIPI,HRQOL,RELAPSE,SPAIN,SPANISH,TTR
169,AFTER,BACKGROUND,COPYRIGHT,DESPITE,GERMANY,HOWEVER,INC,INTRABEAM,LABEL,METHODS,NAC,NSM,OBERKOCHEN,RESULTS,ZEISS
BACKGROUND,CIS,CONCLUSION,JANUARY,LABEL,LITERATURE,METHODS,ORS,RESULTS,UNASSIGNED,VIRTUAL
015,169,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,ELISA,INC,LABEL,MATERIALS,METHODS,PROTEOMICS,RESULTS,USING,WESTERN
001,024,169,848,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HRS,III,INC,LABEL,MATERIALS,MEIER,METHODS,OVERALL,RADIATION,RESULTS,THERE
169,ALK,COPYRIGHT,DESPITE,III,INC,NSCLC,THEREFORE
NOS,PECOMAS
215,249,BACKGROUND,LABEL,ME3,METHODS,NEITHER,RESULTS
LA1,MICHAEL,SPE,THESE
BACKGROUND,CONCLUSION,CRT,HOWEVER,INTENSITY,LABEL,METHODS,RESULTS,THREE
143,341,360,946,A279T,BACKGROUND,BRG,ESC,LABEL,METHODS,MTS,PCR,RESULTS,SEQUENCING,THESE,WNT
169,34A,AKT,COPYRIGHT,HGF,IRELAND,LTD,MET,NSCLC
AVERAGE,BACKGROUND,FEMALES,HOWEVER,LABEL,METHODS,RESULTS,STATISTICS,YLL
ANONYMOUS,BACKGROUND,EQA,FALSE,HOWEVER,LABEL,LEADING,MEDICAL,METHODS,NSCLC,PATHOLOGY,RESULTS
195,AUTOPHAGY,BACKGROUND,INCREASED,LABEL,METHODS,OSCCS,RESULTS,SEVERAL
003,100,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,ROC,SPN,SUV
FINALLY,HENCE
001,114,169,304,ASSESSMENT,BASED,BLOOD,CHRONIC,HCT,HEART,HEMATOLOGY,INSTITUTE,MRD,MTX,MUCOSITIS,NEUTROPHIL,SCALE,SIR,SOCIETY,TAC,THERE
169,AHR,CAREFUL,CONCLUSION,COX,CVC,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
100,169,222,315,CONCLUSION,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SRB,THERE,THREE
045,087,169,648,AMONG,CD4,CONCLUSION,DLBCL,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TEXAS
169,258,312,392,467,800,CONCLUSION,COX,FACTORS,GROUP,LABEL,MEIER,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SOCIETY,THESE
001,169,18F,18FDG,273,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DUE,INSTITUTE,LABEL,MATERIALS,METHODS,OVERALL,PET,RESULTS,SEGMENT
001,169,ALK,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS
169,218,ANTICANCER,BACKGROUND,COPYRIGHT,EXPRESSION,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
169,298,8F1,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,ERCC1,EXPRESSION,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
169,215,ALK,ANAPLASTIC,ANTICANCER,CAUCASIAN,CNS,COPYRIGHT,INSTITUTE,KIRSTEN,NSCLC,THESE
169,ANTICANCER,CONCLUSION,COPYRIGHT,CRT,CTV,HOWEVER,INSTITUTE,ISC,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TEN
169,ABCB1,AMRUBICIN,ANTICANCER,BACKGROUND,C609T,CONCLUSION,COPYRIGHT,FIFTY,INSTITUTE,LABEL,MATERIALS,METHODS,NAD,RESULTS
169,954,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GRP78,INDUCTION,INSTITUTE,JNK,LABEL,MATERIALS,METHODS,RESULTS,VIABILITY
169,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMA,PROTEIN,RESULTS,TNF
100,169,AIM,ANTICANCER,BACKGROUND,BALBC,CONCLUSION,COPYRIGHT,IGR,IMR,INSTITUTE,LABEL,LUC,METASTATIC,METHODS,N91,OBJECTIVE,ORTHOTOPIC,RESULTS,THESE,TREATMENT
169,215,ANTICANCER,COPYRIGHT,EXPANSION,FRESH,INSTITUTE,MORPHOLOGY,PDX,RATES
AKT,FINALLY,HYPOXIA,KNOCKDOWN,NTRK2,THESE
007,046,169,631,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,PS2,RESULTS,TFI,VALIDATION
5TH,6TH,945,BACKGROUND,CNS,CONCLUSION,DISEASE,DYSPNEA,EPSTEIN,INTERFERON,LABEL,LUNGS,LYG,NOVEL,PROGNOSIS,TREATMENT,WORLD
HOWEVER,IMAGE
169,954,ACTIVATION,CD11B,CD204,CD206,COPYRIGHT,EXPRESSION,FETAL,INC,LPS,SIMILAR,USING,YM1
ALK,HOWEVER,MECHANISMS,NSCLC
003,009,013,017,042,108,945,947,ALTOGETHER,BAX,H1975,HOWEVER,HP1,NCI,NSCLC,TNM
100,155,169,228,303,374,529,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PREDICTORS,RESULTS,TARGETING
169,AMONG,GGO,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,THEREFORE,UNIVERSITY
ROBO1,TAKEN,UBIQUITIN,USP33
169,BRITISH,IMMUNOLOGY,SOCIETY,TH2
169,916,CLP,COPYRIGHT,D39,HOWEVER,INHIBITION,SOCIETY,THEREFORE,THESE
ALK,CERITINIB,III,NSCLC,PHASE,REGULATORY,THERAPY
AEA25,AMONG,ATP,FGFR1,NSCLC
ABCG2,AKT,HOWEVER,MDR,NCI,NON,NSCLC,SMALL
FIRST,HDACI,HISTONE,HOWEVER,MPM,THEREFORE,THESE
016,029,ASIAN,ESOPHAGEAL,HOWEVER,NOTCH,TAKEN
127,215,240,340,441,598,946,AXIN2,CXXC4,III,LEMD3,MDACC,NSCLC,SNP,USING,WIF,WNT
AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,HEMATOLOGY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RANDOMIZED,RCT,RESULTS,SELECTION,SEVERAL,SOCIETY,USING
160,169,BACKGROUND,COPYRIGHT,GROUP,INC,INTERGROUP,LABEL,METHODS,PUBLISHED,RESULTS,S0220,SOCIETY,SOUTHWEST,TRIAL
001,015,047,074,114,161,884,BACKGROUND,DFS,LABEL,METHODS,RECURRENCE,RESULTS,THERE
169,DSC,FINALLY,FIRST,GTV,JAPAN,OCS,PET,PRESS,PUBLISHED,RADIATION,SOCIETY,UNIVERSITY
280,679,ANNONACEAE,DIFFERENT,ESI,FURTHER,G10,HC1,MTT,POLYALTHIA,RUBIACEAE,VIOLACEAE
8TH,AFTER,DENTASCAN,EXTENSION,METASTATIC
ANESTHESIA,CORMACK,GLIDESCOPE,III,WHILE
287,ACCORDING,BACKGROUND,HPV,LABEL,LOWER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SYNCHRONIC,THESE
BECAUSE,CLINICIANS,DRY
171,589,BACKGROUND,CONCLUSION,FORTY,FUNDING,HODGKIN,INSTITUTE,LABEL,LIMITATION,MAY,METHODS,MULTI,NETWORK,OBJECTIVE,PHYSICIAN,PRIMARY,RESULTS,SETTING
170,BACKGROUND,BRAFV600E,INDEX,ISI,LABEL,METHODS,NSCLC,OCTOBER,ORS,RESULTS,SCIENCE,TEN,THERE,THESE
000,100,120,153,576,846,AMONG,BACKGROUND,CONSENSUS,EFFICIENT,GUIDELINES,LABEL,METHODS,RESULTS,SCREENING,TRIAL
004,100,109,119,BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
MEANWHILE,SMALL
BACKGROUND,CONCLUSION,DFS,IHC,LABEL,METHODS,NSCLC,PFS,RESULTS,SCIENCE,TNM,WEB
BRONCHIAL,PREVIOUSLY
FDG,HOWEVER,PET,PRIMARY
386,BRCA2,CCND1,EPHA3,FGFR1,FIFTY,GIVEN,GREATER,HISEQ,KIT,LABEL,MARCH,METHODS,NF1,OBJECTIVE,RB1,RESULTS,SMALL
DYSPNEA,ICU,LABEL,NIV,OBJECTIVE,PROCESSES,PURPOSE,RESULTS,SUMMARY
PTPN6,STAT3
AXL,NCI,PET,WESTERN
160,169,183,231,4T1,64258,956,AKT,ASTRAGALUS,GEORG,HOWEVER,MDA,MMP,STUTTGART,THESE,TRIFOLIUM
001,ERBB1,ERBB2,ERBB3,ERBB4,LUX,NSCLC,TKI
435,47D,562,CNS,HCT,INSTITUTE,MAXIMUM,MDA,NCI
231,ASTRAGALUS,MAXIMOWICZ,MDA,SH003,STAT3,THEREFORE
011,018,024,028,048,06895,169,456,807,946,AFTER,ANOTHER,FDR,HAPLOTYPE,HSD11B1,INC,NNK,SCC,SNP,THESE,WILEY
169,184,AKT,AUTHORS,FOUNDATION,HOWEVER,INSTEAD,JOURNAL,JUN,LENTIVIRAL,LTD,MOLECULAR,MYC,NSCLC,WILEY
133,169,916,CB2,COMPARABLE,COPYRIGHT,FINALLY,HOWEVER,HUVEC,INC,INHIBITION,JWH,SIRNA,USING,VIABILITY,WST
169,CHINESE,CLINICALLY,EMT,HUANG,INC,INCREASING,QIN,SNAIL,STAT3,TAKEN,THP,TWIST,WILEY,WOGONIN
003,036,169,217,238,AKT,BACKGROUND,COPYRIGHT,ERK,FIFTY,IRELAND,LABEL,LARGE,LATS2,LTD,METHODS,OVERALL,RESULTS
169,292,309,349,364,441,750,AMONG,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,THERE
001,010,015,158,169,500,525,655,COPYRIGHT,CRT,INDEX,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,MTB,NSCLC,OBJECTIVE,OBJECTIVES,PTV,RESULTS,THESE
001,100,135,169,188,321,7TH,AIS,ATS,CONCLUSION,COPYRIGHT,ERS,HIROSHIMA,IASLC,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,MIA,OBJECTIVE,OBJECTIVES,RESULTS,RFI,T1A,T1B,TNM,UNIVERSITY
138,169,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PULMONARY,RESULTS
169,AFTER,FORCE,PREVENTIVE,PRUDENT,SOCIETY
BECAUSE,HOWEVER,INSTEAD,UNTIL
CLINICIANS,ESR,GIVEN,IIM,OVARIAN,THEREFORE
169,CAC,CLINSEQ,COPYRIGHT,FINALLY,FRAMINGHAM,FURTHER,HEART,INC,KOSSA,OVERALL,PUBLISHED,SOCIETY
169,945,BACKGROUND,CONCLUSION,HOWEVER,INC,LABEL,METHODS,NUCLEAR,PRO,PROEX,RESULTS,TMA,WILEY
169,518,ASSESSMENT,BOWEL,COLORECTAL,COMPOSITE,CONCLUSION,COPYRIGHT,FUNCTIONAL,INC,INDEX,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OVARIAN,PEARSON,PUBLISHED,QOL,RESULTS,SCREENING,SHORT,THERAPY,THESE,TREATMENT,TRIAL,WHITE
AUC,BASED,DISEASE,LEAST,MICRORNAS,MIRNA,PREDICTING,SQUARES
160,ABL,CABLES1,CDK,MACROPAIN,PROSOME,PSMA3
100,160,169,198,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PER,PUBLISHED,RESULTS,SIMILARLY,THERE,THESE
001,147,169,APA,AUTHORS,CPEB1,LTD,MKI67,PCR,PTY,PUBLISHING,SCIENCE,TOP2A,UTR,WILEY
176,BACKGROUND,BRAGG,CONCLUSION,HOWEVER,ITV,LABEL,METHODS,MIP,RESULTS,USING
001,002,169,234,CETUXIMAB,CIS,KNOWLEDGE,NSCLC,RRS,SOCIETY,WEB
169,805,925,AUTHORS,ENGLISH,INCLUSION,LTD,ORS,PTY,PUBLISHING,SCHOLAR,SCIENCE,TESTS,THERE,WILEY
169,FINALLY,INC,MET,NSCLC,RESULTS,THESE,WILEY
BACKGROUND,D50,LABEL,METHODS,NSCLC,RESULTS,TCP
AFTER
169,BECAUSE,CAREFUL,CONGENITAL,COPYRIGHT,INC,MOSBY
001,002,003,052,108,142,146,169,173,183,255,363,581,946,ACADEMY,AGING,BACKGROUND,BLOOD,BPGEN,BRITISH,COHORTS,CONSORTIUM,COPYRIGHT,COUNCIL,DHCR7,FINLAND,FOUNDATION,FUNDING,GENOMIC,HEART,INCREASED,LABEL,LOW,MEDICAL,METHODS,PUBLISHED,RESULTS
169,BECAUSE,CHALLENGES,COPYRIGHT,LTD
001,009,027,032,046,169,AGGRESSIVE,ATT,CAREFUL,CONCLUSION,COPYRIGHT,COX,III,IRELAND,KARNOFSKY,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OPTIMAL,RECEIPT,RESULTS,SBO,SIXTY
169,ASO,BRCA2,COPYRIGHT,CROWN,DECREASED,PUBLISHED,TARGETING,THESE
169,ECM,HOWEVER,INC,TFM
BACKGROUND,BASED,DISCUSSION,DISEASE,HNSCC,HOWEVER,III,LABEL,LUX,METHODS,PHASE,SECONDARY
ACC,ACS,CGG,CTG,EASTERN,L858R,NSCLC,SCC,SIX,THEIR,THREE,TURKISH,WESTERN
024,027,032,114,CD133,CIS,CSC,DFS,HOWEVER,HRS,NSCLC,ORS,OVERALL
001,009,853,AFTER,BACKGROUND,CONCLUSION,CONSORTIUM,CONTEXT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RELATIVELY,RESULTS
169,ATP,COPYRIGHT,HOWEVER,IRELAND,LTD,THESE,WARBURG
AKT,ALK,ERK,H2228,HOWEVER,NSCLC,STAT3
945,APOPTOSIS,CHINESE,CURCUMA,ELEMENE,HIF,MAMMALIAN,OVERALL
001,005,033,169,177,AFTER,BACKGROUND,BLS,COPYRIGHT,DFS,FGS,GREEN,INC,LABEL,MATERIALS,METHODS,RESULTS,SIX,ZOL
100,135,169,AMONG,BETWEEN,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SOLID,SURGERY,THERE,UNIVERSITY
CCND1,CHINESE,HOWEVER
AREAS,AVAILABLE,BACKGROUND,COVERED,LABEL,METHODS,NSCLC,OPINION,ORIGINALLY
169,4T1,945,947,AFTER,CD133,GIVEN,HOWEVER,PRESS,THEREFORE
004,015,034,109,451,BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,NSCLC,RESULTS,THEREFORE,UNASSIGNED,USING,VIRTUAL
100,ADENO,BAF,DCS,EGR,FLT3L,GCV,HCC,HSV,RADIATION,RADIO,THERE,THESE,WESTERN
160,169,BLOOD,COPYRIGHT,HOWEVER,MDS,PLANNED,PRIMARY,RIC,SECONDARY,SOCIETY
100,99MTC,AVP,CH2,ET2,H69,NS3,TYR
BALTIMORE,INCREASED,THESE
140,169,COPYRIGHT,ERK,INC,INTEGRATED,LEWIS,LLC,MMD,NSCLC,THEREFORE
169,946,COPYRIGHT,DEPDC1B,ECTOPIC,FURTHER,INC,NON,NSCLC,TAKEN,WNT
001,009,560,836,CRC,HOWEVER,SATB1,SATB2,SPECIAL,STRIKINGLY,THEREFORE,TNM
945,947,AFTER,BASED,EF1,IFN,TRAIL,TREATMENT
001,169,ACCORDING,CHANGES,CONCLUSION,DYNAMIC,FLT,H2O,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SIMPLIFIED,SOCIETY,SUV,TBR,TEN,TKI,UNLABELLED
169,871,ACIDS,ERBB2,FGFR2,LOW,NUCLEIC,PRESS,PUBLISHED,UNIVERSITY,VALIDATION,WES
34A,34B,34C,AZ521,GASTRIC,NANOG,RESULTS,SOX,TAKEN,UTR,YIN,YY1
BINDING,CONVERSELY,ECTOPIC,GRAP2,H1299,ID1,NSCLC,NSCLS,TAKEN
947,ADP,CLONOGENIC,NIRAPARIB,RAD51,TAKEN,THESE
207,BACKGROUND,CANCERS,COLLEGE,INPATIENT,JANUARY,LABEL,MEDICAL,METHODS,RECORDS,RESULTS,ROYAL,SIR,TAIWANESE
160,169,ARRIAGA,COPYRIGHT,DESPITE,EXCEL,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAS,STATA
169,AMONG,HOWEVER,IL13RA2,SYCE1,VCX,VCX3A,XAGE1
AIM,BACKGROUND,CD4,CK7,CMV,EPSTEIN,FURTHER,HHV,HIV,IMT,L26,LABEL,METHODS,MYCOPLASMA,OBJECTIVE,PATIENT,PULMONARY,RESULTS,ROMANIA
001,002,010,138,169,199,402,961,CONCLUSION,CONCORDANT,COPYRIGHT,COX,INK4A,LABEL,LOW,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE
356,495,BACKGROUND,CRT,LABEL,MATERIALS,METHODS,PLANS,PTV,RESULTS,TANGENTIAL,V20,V95
177,ADC,BAC,BACKGROUND,DIFFUSION,DWI,FDG,HOWEVER,LABEL,MATERIALS,METHODS,PET,RESULTS,ROC,SUV
BACKGROUND,LABEL,MATERIALS,METHODS,MUTATIONS,OSCCS,PCR,RESULTS,SINCE
177,JAN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
003,141,187,707,BACKGROUND,EPIDERMAL,HOWEVER,LABEL,MATERIALS,METHODS,MLN,NSCLC,RESULTS,THERE,TKI
AUC,BACKGROUND,BIOLOGICAL,CBM,CHINESE,DATABASES,DISCOVERY,DOR,KNOWLEDGE,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,ROC,SCHOLAR,SCIENCE,THERE,VIP,WANFANG,WEB
ACCORDING,EARLY,HOWEVER,WORLD
AAN,TAT
436,573,945,CAUCASIANS,CIS,NSCLC,OVERALL,TNF
126,CRK,HOWEVER,MIR,SGC
164,169,177,FACTORS,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESECTION,RESULTS,SURGERY,UNIVARIATE,UNIVERSITY
ENGLISH,PRIMARY,THERE
169,BACKGROUND,CONCLUSION,HAART,HIV,HODGKIN,HOWEVER,LABEL,LIBRARY,METHODS,NADCS,PRESS,RESULTS
160,95D,AKT,CHINESE,CURRENT,IAP,MATRINE,SOPHORA
169,BACKGROUND,BASEL,GRADE,LABEL,METHODS,OPTIMOX,RESULTS,THEIR
160,COX,DUTCH,FORCE,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,RESULTS,SURVEYS,THESE,USING,WESTERN
BACKGROUND,CONFIDENCE,DISCUSSION,HODGKIN,ICD,INCIDENCE,INTERVALS,ITALIAN,ITALY,LABEL,METHODS,NON,NORTH,NPCSS,ONGOING,PROJECT,REGISTRIES,RESULTS,SIR,SITES,SOUTH
BACKGROUND,LABEL,OBJECTIVE,RESULTS
AGE,BACKGROUND,BASES,CURRENT,ISS,ITALY,LABEL,METHODS,MORTALITY,RATES,STATISTICS
100,HESSIAN
160,169,AFTER,APRIL,BACKGROUND,COPYRIGHT,ENB,INC,LABEL,LOCALIZING,METHODS,PUBLISHED,RESECTION,RESULTS,SOCIETY,THREE,VINCI
169,BACKGROUND,BASEL,CAUCASIAN,CONCLUSION,DESPITE,HOWEVER,JAPAN,LABEL,METHODS,MUTATIONS,RESULTS,SAMPLES
169,APC,BACKGROUND,CDH13,DELETIONS,LABEL,MBM,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,UNRAVELING
33258,ANNEXIN,BCL,FINALLY,HOECHST,MTT,SBT
ERK,ETS,MYC,RAS
001,011,133,388,451,641,964,995,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LYMPHOCYTE,METHODS,NSCLC,PLR,RATIO,RESULTS
IT1,NSCLC,SPRY4,THESE
169,885,AGE,COMMUNITY,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PAF,PUBLISHED,RESULTS,STATISTICS,THOUSANDS,WHERE
231,AZA,BECAUSE,GPAT2,MDA,OVERALL,USING
000,203,967,BACKGROUND,BRIER,CHRONIC,COMBINING,CONCLUSION,COX,DISEASE,HARRELL,LABEL,NAGELKERKE,PRINCIPAL,PULMONARY,RESULTS,ROC,SCORE
947,CHANGES,HOWEVER,IFN,RADIATION,THESE
CAV,EMT,H23,HOWEVER,THESE
AFFILIATED,FIRST,HOSPITALS,MEDICAL,NANJING,UNIVERSITY
THREE
215,LOCALIZED,PARTIAL
815,LCT
WILMS
182,2DC,HBE,HTB,LABEL,METHODS,MSP,MTT,OBJECTIVE,PCR,PRDM2,PRDM5,RESULTS,WESTERN
002,008,026,177,241,292,570,862,AGE,AIM,CONCLUSION,DEPARTMENT,LABEL,MEDICAL,METHODS,OBJECTIVE,POMERANIAN,RESULTS,UNIVERSITY
169,FGF,FGFR1,HNSCC,LABEL,MALIGNANT,MPM,PREVIOUSLY,THESE,TKI,UNLABELLED
169,231,23B,27B,4T1,BIOLOGY,ECTOPIC,INC,MDA,MICRORNAS,MOLECULAR,SCP28,SOCIETY,THESE
169,BECAUSE,BLOOMBERG,HOPKINS,JOHNS,PRESS,PUBLISHED,UNIVERSITY
169,400,HEPATITIS,PHYSICIANS,PRESS,PUBLISHED,UNIVERSITY
169,945,A2M,ALK,BREAK,DISCOVERY,FETAL,INC,USING,WILEY
169,INC,LABEL,METHODS,MWA,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,WILEY
177,CK7,CONCLUSION,LABEL,MCC,MELAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
3MA,ACC,AMP,AMPK2,BESIDES,CALU6,CELLS,CONCLUSION,CONSISTENT,GFP,INHIBITION,KNOCKDOWN,LABEL,LC3,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,002,007,131,250,414,519,AES,AMONG,EPIDERMAL,LABEL,METHODS,OBJECTIVE,OCTOBER,PFS,PURPOSE,RESULTS,TKI
001,004,143,243,290,410,CIGARETTE,CONCLUSION,COX,EASTERN,GROUP,LABEL,MEIER,METHODS,NEVER,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCC,STUDENT,THERE,WHITNEY
100,MTD,WBR
JAVASCRIPT,QUERY,SCREENING,SEVERAL,SQL,STRUCTURED,TRIAL,USING
ISRAELI,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TESTING
169,SOCIETY
CLINICIANS,ROUND
1A1,275,406,462,CONCLUSION,GENOTYPES,ILE,ILE462VAL,LABEL,METHODS,OBJECTIVE,ORS,PCR,RESULTS,VAL
177,NANOSCALE
146,181,192,815,AMONG,BMI,CADMIUM,COX,IRR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DESPITE,SILENCING,TAKEN,ZOLEDRONIC
169,BRITAIN,CALPAIN,CAPN4,COPYRIGHT,FAK,GREAT,HCC,HOWEVER,IRELAND,KNOCK,LTD,PROTEIN,PUBLISHED,SOCIETY,SRC,WILEY
001,002,102,211,287,ACCORDING,AFTER,BACKGROUND,CLM,CONCLUSION,GIVEN,JANUARY,LABEL,METHODS,OCTOBER,RESULTS
001,209,216,425,BACKGROUND,CCI,COX,IIB,INDEX,JANUARY,LABEL,METHODS,NSCLC,OVERALL,RESULTS,TNM
102,497,529,EIGHT,KEY,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SPN,THERE
001,006,009,012,028,037,045,048,385,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,THEREFORE,UNIVARIATE
169,BACKGROUND,CONCLUSION,COPYRIGHT,D3S1300,EBC,FRA3B,HPV,INC,LABEL,MAS,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SITES,TNM
169,AMONG,BACKGROUND,CONCLUSION,HPV,INC,LABEL,METHODS,RESULTS,SCC,WILEY
945,954,APOPTOTIC,BIRC3,CYNANCHUM,FINALLY,PCR,REMARKABLY,TNF,TNFAIP3,TNFR1
169,209,466,BACKGROUND,BETWEEN,COPYRIGHT,COX,HOWEVER,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY,TNM,VPI
169,486,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
001,004,007,169,174,18F,421,452,BACKGROUND,COPYRIGHT,COX,FDG,HOWEVER,INC,LABEL,METHODS,PET,PUBLISHED,RESULTS,RFI,SOCIETY,T1B
112,147,169,200,513,700,800,BACKGROUND,COMMUNITY,COMPARING,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,USING
028,160,169,ADM,AUTHORS,CELLS,CISPLATIN,CONVERSELY,CSC,LTD,NOTABLY,WILEY
BACKGROUND,BESIDES,ELASTIC,INHIBITORS,LABEL,NET,PHKG1,RAC,RESULTS,THESE
APRIL,BETWEEN,GIVEN,HOWEVER,NSCLC,PFS,PPS
001,008,NSCLC
215,BACKGROUND,LABEL,METHODS,RESULTS,SIMILAR,THESE
10877,169,358,BASED,COPYRIGHT,CTA_246H3,GENMAPP,INC,MAST1,PEARSON,POU2AF1,SOAT2
001,003,006,007,117,177,183,ACCORDING,BACKGROUND,BMI,GEORG,GROUP,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,STUTTGART
DESPITE,EMT,EPITHELIAL,NSCLC,OCCLUDENS,SMALL,SNAI1,SNAI2,SNAIL,TRANSITION
ANDROSTANE,ATLAS,BACKGROUND,CAR,LABEL,NON,NSCLC,PACLITAXEL,PRINCIPAL,RESULTS,SMALL,TAKEN,TCPOBOP,THEREFORE,WT1
HDX,NCI,PARKINSON,ROS,THESE,UBIQUITIN,UCH
169,CONCLUSION,FINALLY,LABEL,MEIER,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS
169,APRIL,COPYRIGHT,LABEL,METASTASES,METHODS,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SAS,SEPTEMBER,SMOKING,THESE
000,001,007,008,BLOOD,CHINESE,ERCC1,GSTP1,MEIER,TTP
HOWEVER,NON,NSCLC
005,041,056,6TH,ACCORDING,AKDENIZ,ERCIYES,KAYSERI,MPM,UNIVERSITY
039,500,CD4,CD8,DCS,LOG,PFS,TEN,THREE
101,169,945,946,NSCLC,OVERALL
BACKGROUND,BAICALEIN,DIFFERENT,LABEL,RESULTS,ROS,THESE
ACCORDING,BACKGROUND,III,ITALIAN,KURDISH,LABEL,METHODS
169,181,326,COPYRIGHT,INC,INCIDENCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RATES,RESULTS,SIR,THERE
100,1970S,1990S,724,AMONG,BESIDES,COD,GERMANY,INSTITUTE,MAINZ,PATHOLOGY,THESE,UNIVERSITY
100,169,175,AZD,BACKGROUND,COPYRIGHT,EIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,PFS,PLANNED,RESULTS,SRC
036,169,827,AKT,ATP,AZD5363,CONCLUSION,COPYRIGHT,ERK,H1651,HCC,IRELAND,LABEL,LTD,MATERIALS,METHODS,NCI,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,WESTERN
BACKGROUND,CONCLUSION,DUE,HEART,IMN,LABEL,METHODS,MHD,NNH,NNT,NUMBERS,OAR,REFRAINING,RESULTING,RESULTS,TEN,V90
650,BACKGROUND,CONCLUSION,GTV,HOWEVER,LABEL,METHODS,RESULTS
001,005,011,012,029,105,164,172,201,229,BACKGROUND,BED10,COX,JANUARY,LABEL,METHODS,PROGNOSTIC,RADIATION,RESULTS
AKT,ATP,CO2,DEPLETION,DMM,ME2,NAD,NADPH,NSCLC,ROS
113,299,568,758,892,ASIAN,CAUCASIAN,CIS,CRR9P,JANUARY,NSCLC,ORS,SCIENCE,WEB
15F,160,169,549,956,COPYRIGHT,SAS,WHEREAS
007,013,022,024,047,048,139,AIM,CONCLUSION,COX,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,RESULTS,REV3L,TGT
001,010,038,041,049,263,491,670,878,917,AMONG,NSCLC
238,BACKGROUND,DESORPTION,DXS,IONISATION,KIT,LABEL,LASER,MALDI,MATERIALS,METHODS,NSCLC,RAS,REFRACTORY,RESULTS,TOF
232,813,CONCLUSION,EARLY,ELCAP,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGRAM,PURPOSE,RESULTS,SCREENING,TRIAL,USING
AD5,CMV,ECS,HOWEVER,MBP,ROBO4,USING,WHILE
500,956,AZBOCET,QUANTUM,T10
002,009,DONOR,GVH,HCT,HLA,NON,PROGRAM,SCT,SPLITTING,TCE,TRM
APRIL,BACKGROUND,EARLY,LABEL,MEDLINE,METHODS,RESULTS,SOCIETY
BACKGROUND,HOWEVER,LABEL,METHODS,MUTATIONS,OVERCOMING,RESULTS,SINCE,V600E
132,154,286,AIM,LABEL,METHODS,OBJECTIVE,PAI,PCR,RESULTS
100,222,COX,NSCLC,RESULTS,THROUGH
110,CONCLUSION,CONTROL,DEFAULT,FIFTY,JANUARY,KEY,KUWAITI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
169,215,241,682,AGE,CASZ1,COPYRIGHT,DBP,EHBP1L1,GOSR2,GWASS,INC,INDEX,MAP,PUBLISHED,SBP,SINGAPORE,SNP,SOCIETY
000,139,169,600,BACKGROUND,CALIFORNIA,FARMERS,INC,LABEL,METHODS,NHW,RESULTS,STAGE,THESE,UFW,WILEY,WORKERS
169,COPYRIGHT,FINALLY,HEART,IMPORTANT,INC,PUBLISHED,SOCIETY,THESE
169,AFTER,COPYRIGHT,IRELAND,LTD,THREE
15Q25,169,AMONG,COPYRIGHT,EBLN2,FIRST,GON4L,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NELFE,NOP58,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES,TAF1B,TRUNCATING,WISP3
169,AKT,BACKGROUND,CIP2A,COPYRIGHT,EPIDERMAL,ERLOTINIB,EXPRESSION,IRELAND,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,RESULTS
160,169,177,BLOOD,BOS,COPYRIGHT,INC,PRM,PUBLISHED,PULMONARY,SOCIETY
147,169,294,COPYRIGHT,EMT,FOS,INC,RAS
002,004,005,169,COPYRIGHT,IRELAND,IVA,IVB,JANUARY,LABEL,LTD,MARCH,MASAOKA,METASTASIS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SIXTY,TET
158,169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,THESE
103,112,169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBTAINING,RESULTS
130,140,150,160,169,180,BACKGROUND,CONCLUSION,COPYRIGHT,DLT,III,INC,LABEL,METHODS,MTD,RESULTS,THREE
102,153,169,500,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,DISEASE,INC,LABEL,METHODS,NAVOTRIAL,NSCLC,OVERALL,RESULTS,STAGE
169,COPYRIGHT,INC,SURGERY,THESE
200,230,500,956,BSI,CYFRA,CYRFA,ELISA,LOQ,REALIZING,USING,YET
169,COPYRIGHT,DEVIC,IGG,MRI,NMO,PUBLISHED,SPECIALIST
169,ADP,AREAS,BACKGROUND,BLOCKER,CONCLUSION,COPYRIGHT,COVERED,CURRENT,HOWEVER,HSP,LABEL,LTD,MET,METHODS,NOVEL,NSCLC,OTHER,SEVERAL,T790M,TKI,TREATMENT
129,169,BIOMARKERS,COPYRIGHT,GREATER,LTD,MRI,PARAMETERS,THERE,WILEY
169,AUTHORS,COPYRIGHT,EXPRESSION,INC,MOUSE,PUBLISHED,SCC,USING
002,008,10878,114,118,169,217,236,239,250,253,500,APRIL,ASIAN,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,EASTERN,ELI,FUNDING,GROUP,IPASS,ITT,LABEL,LILLY,LTD,METHODS,PAN,PATIENT,PFS,RESULTS
AFTER,COMMITTEE,NOVALIS,PTV,UNIVERSITY
001,102,104,105,169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OPERATIVE,RESULTS,SHORT,SIXTEEN
169,ABSCS,AIRWAYS,COPYRIGHT,HOWEVER,INC,NOTCH,ROS
FIBEROPTIC,HIV,INFECTIOUS,NON
160,169,COPYRIGHT,CSC,HOWEVER,LTD,THEREFORE
BCL,HCC,LC3,LC3II,MCL,OBATOCLAX,PREVIOUSLY,RFX,SHP,STAT3
169,AGE,AIM,BACKGROUND,COPYRIGHT,GROSS,INC,LABEL,MATERIALS,METHODS,MGCTS,OBJECTIVE,RESULTS,THESE
169,COPYRIGHT,FOLLOWING,HOWEVER,INC
169,COPYRIGHT,INC,NSCLC,STAGE
169,COPYRIGHT,INC
000,100,298,SCD,SEVERAL,USING
AKT,ALECTINIB,ALK,HGF,HOWEVER,HSP90,MET,NSCLC,THESE
NSCLC,PCR,THESE
160,446,946,HOWEVER,MEIER,NSCLC,WESTERN
ALICE,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,PURPOSE,RESULTS,USING
FDG,LABEL,LOCAL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RFA,SEVEN,SEVERAL,THERE
549,BLK,CNS,CURRENTLY,DISCOVERY,DU145,HDF,HSP70,IHC,LNCAP,NG108,PC3,SHOCK,TDF,THESE,USING,WESTERN
100,169,200NM,COPYRIGHT,DOX,FNP,HOWEVER,INC,LTD,MATERIALIA,PUBLISHED
ALK,CRIZOTINIB,DOCKING,M1199,REPORTS
169,192,196,345,382,CONCLUSION,LABEL,METHODS,MICROARRAY,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TAZ,WWTR1
005,169,177,492,BACKGROUND,CONCLUSION,DESPITE,FOUNDATION,LABEL,METHODS,MYLAB,OBJECTIVE,PURPOSE,RESULTS,SCC,SINCE,SUBPLEURAL,TUS,TWICE,UNDER
000,002,085,100,161,169,266,318,582,599,608,646,815,909,940,BACKGROUND,BSC,CANADIANS,CARLO,CONCLUSION,ICERS,LABEL,LOBECTOMY,MANAGEMENT,METHODS,MODEL,MONTE,NSCLC,ONTARIO,PRESS,RESULTS,STATISTICS
001,009,169,329,789,847,892,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,ROC,ROMO1,ROS,SERUM,WESTERN
001,033,169,222,945,946,CHINESE,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM,SINGAPORE,USING
169,394,449,AFTER,AMERICA,BACKGROUND,CONVERSELY,COX,ICU,LABEL,MEDICAL,METHODS,MORTALITY,OVERALL,PRESS,PUBLISHED,RESULTS,SOCIETY,SOUTH,UNIVERSITY
BACKGROUND,CAUCASIAN,EPSTEIN,F18,HODGKIN,HOWEVER,INTERIM,LABEL,METHODS,RELATED
169,947,ANNEXIN,CET,CETUXIMAB,COPYRIGHT,EDC,LDH,MTT,NHS,NPS,NSCLC,PGA
ABOUT,BACKGROUND,CRC,DFS,DISEASE,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RELAPSE,RESULTS,VII
005,201,329,463,BACKGROUND,LABEL,METHODS,NEITHER,OBJECTIVE,PRE,RESULTS,SCPNS,SIX,THERE,THESE
027,101,117,177,315,AUSTRALIA,CONCLUSION,CONTEXT,EVERY,FOLLOWING,FURTHER,LABEL,LOWER,METHODS,OBJECTIVE,OUTCOME,PERTH,RESULTS,SETTING,SHR,WESTERN
NSCLC
TTF
DEFINITION,NSCLC
DIAGNOSIS,IPILIMUMAB,SMALL,THEREFORE
100,BACKGROUND,HOWEVER,IIS,LABEL,METHODS,PCR,RESULTS
AMONG,BACKGROUND,DOCTORS,III,LABEL,METHODS,PRIMARY,RESULTS
BACKGROUND,IPSLROM,LABEL,METHODS,NSCLC,PFS,PRIMARY,RELAPSE,RESULTS,RFA,THESE,TREATMENT
009,014,019,041,132,225,267,538,679,888,910,939,948,981,A750DEL,AUC,BACKGROUND,DOR,IHC,L858R,LABEL,MARCH,METHODS,NSCLC,RESULTS,SEAUC,SEQ,TEN
150,300,956,ASSAY,BACKGROUND,BRUCINE,CELLTITER,FORMATION,GLO,LABEL,METHODS,PCR,PROTEIN,RESULTS,VIABILITY,WESTERN
945,946,948,956,BACKGROUND,CD133,CYP2C19,DDP,LABEL,METHODS,RESULTS
CASPASE,DCF,HCT,HEP,HEPG2,MCF,NATURAL,ROS,THESE
500,956,HOWEVER,INCUBATION
001,008,231,4T1,BACKGROUND,BARD1,EXPRESSION,LABEL,MDA,METHODS,PRESS,PUBLISHED,RAD51,RESULTS,THEIR,UNIVERSITY
001,108,125,130,260,ASSESSING,BACKGROUND,ITALY,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,TARGETING,UNIVERSITY
039,041,044,663,BESIDES,COX,INCIDENCE,NSCLC,PFS,TLS,TREATMENT
169,DESPITE,ID1,INHIBITOR,LABEL,METASTASIS,NOVEL,UNLABELLED
169,945,ACADEMY,COPYRIGHT,IFN,INSTITUTE,JV1,NET,PARTNER,PUBLISHED,THEREFORE,URBAN
169,200,300,CETUXIMAB,CONCLUSION,EVALUATION,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESPONSES,RESULTS,SOLID
169,ERK,LABEL,MEK,METHODS,NSCLC,OBJECTIVE,PURPOSE,RAF,RAS,RES,RESULTS,RO4987655,SEQUENTIAL,SIXTY
AFTER,BACKGROUND,LABEL,METHODS,RESULTS,SURGERY,THERE
159,169,985,CONSORTIUM,HOWEVER,ORS,RESULTS,ZEALAND
273,BACKGROUND,CENTRAL,CONCLUSION,COPENHAGEN,COX,DANIELSENS,DENMARK,DIFFERENT,FUNDING,JANUARY,LABEL,METHODS,POPULATION,REGARDING,RESULTS,SIMILARLY,TRIAL,UNIVERSITY,USING,WESTERN
FOXO3,HOWEVER,RRM2B
169,945,CONSISTENT,ECS,HEART,HYPOXIC,INC,LABEL,NTRK2,OBJECTIVE,RESULTS
BACKGROUND,CONCLUSION,FACTORS,LABEL,METHODS,OVERALL,PRIMARY,RESECTION,RESULTS,SURGERY
III
663,AIM,CDC25,CHINESE,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE
FDA,HOWEVER,III,NSCLC,PDGFR,PHASE,THEREFORE,VEGFR
169,CSC,DNMT1,KNOCKDOWN,PCR,STAT3,THESE,WESTERN
169,COPYRIGHT,HOWEVER,LTD,OVERALL,SUB
158,159,400,429,585,591,ATLAS,MUC,MUC12,THESE
000,14284,200,20202,486,BACKGROUND,BLADDER,BRAIN,CANCERS,CONTEXT,EASTERN,ESOPHAGUS,LABEL,METHODS,OBJECTIVE,ORGAN,OROPHARYNX,OVARY,RAJASTHAN,RESULTS,THERE,WESTERN
ACTIVATING,INDIA,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,RESULTS
684,AIM,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,3PRG2,99M,CONCLUSION,CY7,FDG,FMI,HYNIC,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,RGDFK,SOCIETY,SPECT,TPPTS,UNLABELLED
BACKGROUND,CHEST,HOWEVER,LABEL,MALIGNANCY,METHODS,PATHOLOGY,TAIWANESE
169,945,AKT,DECREASED,ERK,IL4,REDUCED,SIMILAR
001,003,018,100,160,COLORECTAL,CRC,IHC,III,MEIER,METADHERIN
954,AKT,HOWEVER,INHIBITION,NADPH,NSCLC,THEREFORE
AKT,HOWEVER,NSCLC,TKI
169,BACKGROUND,CNB,LABEL,METHODS,RESULTS,SOCIETY,TOUCH,TPS
001,002,003,006,011,038,105,112,180,232,349,576,673,946,COMMITTEE,COX,EPS15,EXPRESSION,JOINT,MEIER,NSCLC,OVERALL,TGF
946,BACKGROUND,BMP,CONCLUSION,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,TGF,THERE,UNASSIGNED,USING,VIRTUAL
HOWEVER,ROBOT,SEVERAL,VINCI
1980S,CAHAN,THERE
3CM,FIRST,JAPAN,NSCLC,T1A,T1B,THEREFORE,THIRD
ALK,FGFR1,FGFR3,HOWEVER,JAPAN,OVERCOMING,RET,THESE
2N0,300,ERCC1,GROUP,JAPAN,NSCLC,THESE,THREE,UFT
NSCLC
057,160,169,20S,945,956,CHT,COPYRIGHT,DOCKING,SAS
169,BSA,CAT,COPYRIGHT,FURTHER,GPX,GSH,GST,LDH,ROS,SAS,SOD
169,664,AKT,EPIDERMAL,H1975,PKB,T790M,TREATMENT,VCH,WILEY
330,BACKGROUND,KPT,LABEL,METHODS,NSCLC,RAS,RESULTS
169,CONFUSION,ENGLAND,FINALLY,RECURRING
145,BACKGROUND,DESPITE,FIFTY,LABEL,LEVEL,METHODS,RESULTS
30A,30E,NSCLC,PCR,THESE
141,169,AKT,COPYRIGHT,FEDERATION,NSCLC,PUBLISHED,SOCIETIES
169,722,APRIL,CONCLUSION,COPYRIGHT,DESPITE,FAGERSTROM,INC,ITALIAN,ITALY,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
C5B,THROMBOTIC
210,300,700,945,947,NSE,SIX,SRM
100,215,CONCLUSION,DAILY,FLANK,LABEL,METHODS,OBJECTIVE,PAZOPANIB,RESULTS,SCC
019,022,028,035,040,042,044,052,056,059,064,169,181,250,277,295,296,884,AGS,BACKGROUND,BRAZILIAN,CHACO,COPYRIGHT,IRELAND,J82,LABEL,LTD,MATERIALS,MES,METHODS,MRC,PARAGUAYAN,RELEVANCE,RESULTS,SOUTH,THESE,THREE,TOADS,UNDER
BACKGROUND,ELISA,LABEL,PRINCIPLE,RESULTS,SIMILARLY,TRANSGENIC
169,ANIMALS,AURICULAR,CD3,CONCLUSION,LABEL,METHODS,OBJECTIVE,PBL,PCR,PURPOSE,RABBITS,RESULTS,SOLID,TIL,VX2,WHITE,ZEALAND
137,169,AGE,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,TRA,USING
169,ADDITIONAL,AKI,CONVERSELY,COPYRIGHT,DESPITE,FINALLY,INCREASED,LLC,MAGNESIUM,PK1,SIMILAR,SOCIETY,STAT3,THESE
169,946,COPYRIGHT,FINALLY,HOWEVER,INC,RII,SMAD2,TGF,THESE,WDR77
A549DDP,ALTERATION,DDP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
AFRICAN,CONCLUSION,CPE,LABEL,LLC,MATERIALS,METHODS,MK2,OBJECTIVE,PURPOSE,RESULTS
467,A4T14,CAUCASIAN,CAUCASIANS,CIS,G4C14,ORS
169,AMONG,AUSTRALIAN,PRESS,PUBLISHED,THREE,UNIVERSITY,USA,WHILE
169,229,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,GTV,HNSCC,HOWEVER,INITIAL,LABEL,METHODS,MINIMISING,RESULTS,ROYAL,SIMILARLY,THESE,WHILE,ZEALAND
BACKGROUND,CONCLUSION,DNAEMIA,HPV,HPV11,JORRP,LABEL,MALIGNANT,METHODS,RECURRENT,REMARKABLY,RRP
169,AKT,CONVERSELY,HOWEVER,IGF,IGFBP,INSULIN,NSCLC,PRESS,PUBLISHED,UNIVERSITY
019,169,175,183,196,BACKGROUND,BETWEEN,COPYRIGHT,FOUNDATION,FUNDING,IQR,JAN,LABEL,LTD,MALIGNANT,METHODS,OCT,OVERALL,RESULTS,TREATMENT,VAT
215,916
BCL,DU145,FAK,FOCAL,FOCUSSING,FOS,POD,THESE
000,200,BACKGROUND,BECAUSE,CAUCASIAN,CONCLUSION,FLI,FURTHER,LABEL,METHODS,PERCUSSION,SINCE
001,004,160,169,171,469,ALK,FINNISH,FURTHER,IHC,INC,MET,NSCLC,SCREENING,SEVEN,WILEY
AGE,APRIL,CYTOLOGIC,III,PATIENT,RANDOMIZED,SIX
130,240,275,500,H2122,LY2603618,NCI,NSCLC,THESE
169,BIOLOGY,FEDERATION,TCM,THESE
001,002,007,011,136,281,485,BACKGROUND,COX,HOWEVER,III,LABEL,MEIER,METHODS,OVERALL,RESULTS
169,512,AG490,COPYRIGHT,LTD,MEANWHILE,U0126,WILEY

MICROWAVE,MWA
AFTER,CONCLUSION,EXPRESSION,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,RESULTS
000,007,011,013,023,024,047,133,150,152,154,155,165,172,200,239,ANXIETY,BPI,BRIEF,CHENGDU,CHINA,CONCLUSION,DEPRESSION,INVENTORY,LABEL,METHODS,MUTIPLE,OBJECTIVE,RESULTS,SCALE,SICHUAN,TOTALLY,UNIVERSITY
180,200,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
HOWEVER,LOCALLY,NSCLC
315,322,673,STRIKINGLY,THESE,THOSE,WGD
EXOGENOUS,HOWEVER,NSCLC,THESE,THYROID
FINALLY,SERUM
037,BACKGROUND,LABEL,METHODS,RESULTS,SMOKING,TOBACCO
114,22737,BACKGROUND,CENTRAL,CONCLUSION,CURRENT,DECREASED,LABEL,MEDLINE,METHODS,NEWCASTLE,OBJECTIVE,OBJECTIVES,RESULTS,SCIENCE,WEB
AFTER,AMP,DOX,H2373,HMESO,HOWEVER,MALIGNANT,RESULTS,USING,VAN,VANDETANIB,ZACTIMA
344SQ,916,DMXAA,MACROPHAGE,NSCLC,SINCE,STING,TAM,USING
008,BACKGROUND,CD133,CHINESE,CONCLUSION,JANUARY,LABEL,MANAGER,MEDLINE,METHODS,NSCLC,RESULTS,SCIENCE,WEB
CAV,CSC,SINCE,SWCNT,THESE,USING
003,005,169,433,CCS,FVC,IQR,SMOKING,TLC,TREATMENTS
166,169,CNS,COPYRIGHT,DDI,HOWEVER,I1T,I1U,LEWIS,PUBLISHED,SOCIETY
169,ACTIVATION,CDCP1,CUB,ERK,LABEL,RAS,SRC,UNLABELLED
001,020,044,055,169,177,264,267,291,297,375,397,408,495,607,713,783,852,860,894,975,CROSS,DESPITE,DETERMINE,HEALTHCARE,HYPOTHESIS,INC,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PANEL,RESULTS,SOCIETY
169,233,947,948,CD8,CRTAM,ENGAGEMENT,IFN,TVG9VD2
000,112,945,AFP,AFTER,BMJ,CHEST,ENDODERMAL,GROUP,LTD,PRIMARY,PUBLISHING
169,AFTER,EWING,HOWEVER,INC,WHOLE,WILEY,WILMS,WLI
125,169,956,ABC,ABCB1,ABCG2,AKT,ERBB1,ERBB2,HOWEVER,INC,MDR,NCI,WILEY
169,COPYRIGHT,SMOKING,SOCIETY,THERE
AFTERWARDS,BESIDES,THESE
177,519,588,945,HIF,MVD,NGF,NSCLC,THERE
169,COPYRIGHT,EHE,FLI,PATHOLOGIC,PRIMARY,WHILE
169,956,ASIAN,BASED,BAX,BCL,CASPASE,CHINA,CHINESE,COPYRIGHT,HOWEVER,MYRICANOL,PCR,THEREFORE,THESE,WESTERN
160,AKT,AZD6244,COMBINING,EGF,H1975,H1993,LABEL,MEK,MET,METHODS,MMP,NCI,NSCLC,OBJECTIVE,PURPOSE,RESULTS,T790M,TKI,WESTERN
169,790,CONCLUSION,COPYRIGHT,EPIDERMAL,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MET,METHODS,MUTATIONAL,OBJECTIVE,OBJECTIVES,PCR,RESULTS,T790M,THESE,TKI
001,1A1,926,ASIAN,GSTM1,HOWEVER
239,HIF,INCUBATION,MVS
HYPOXIA,IHC,TAGLN,TNM,TRANSGELIN
25S,945,946,956,COMPOUNDS,ETOAC,GBM,NMR,NSCLC,THEIR
169,DISRUPTION,GLUCOSE,HBP,INSULIN,PKB
ARG194TRP,ARG399GLN,BASED,BIOLOGICAL,CHINA,CHINESE,HOWEVER,KNOWLEDGE,MEDLINE,NSCLC,SIMILARLY,STATA,XRCC1
33258,AKT,BAD,BCL,DECOCTION,HOECHST,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,WESTERN,XJD
286,ECM,NH2,PROGNOSCAN,SPARC
946,FURTHER,HOWEVER,METASTASIS,NSCLC,WNT
AUSTRALIAN,BACKGROUND,ENGLAND,ENGLISH,FOLLOWING,LABEL,METHODS,NORWEGIAN,PCP,RESULTS,SWEDISH
945,AGT,AKT,ANG,CXCR4,EGF,EPC,HIF,SDF,TIE
174,ABDOMINAL,BEP,COLLEGE,CONCLUSION,EMA,LABEL,MEDICAL,METHODS,NGOCS,OBJECTIVE,RESULTS,SURGERY,UNION
015,035,CONCLUSION,EMA,EMACO,FIFTEEN,GTN,LABEL,MAC,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTEEN
AIM,BACKGROUND,CONCLUSION,DISCUSSION,FIRST,GLASGOW,GPS,LABEL,METHODS,MONITORING,NON,NSCLC,OBJECTIVE,PROGNOSTIC,RESULTS,SCORE,TESTING
ABC,BACKGROUND,FINALLY,LABEL,METHODS,MULTIDRUG,PCR,PYVMT,RESISTANCE,RESULTS,THESE
100,CALCA,CHINA,CPG,DLEC1,EARLY,HOXA9,MULTIPLEX,NSCLC,PCR,PITX2,RASSF1A,SILENCING,USING
001,120,BACKGROUND,CONCLUSION,FFF,FLATTENING,LABEL,METHODS,RESULTS,STD
169,COPYRIGHT,EPH,INC,MEMBERS,PICK1,THESE
4T1,ACTIVATION,ADP,BAX,BCL,BESIDES,CLONOGENIC,JNK,LABEL,MATERIALS,METHODS,PURPOSE,RESULTS,UNLABELLED,WESTERN
11H,169,COPYRIGHT,ROS,SAS
169,68936,BACKGROUND,BECAUSE,COMPARING,HODGKIN,HOWEVER,LABEL,MEDLINE,METHODS,PRESS,PROLONGED,PUBLISHED,RESULTS,RRS,SCISEARCH,SEDENTARY,UNIVERSITY
111,120,139,275,321,ARG112DUP,BACKGROUND,BMJ,CIS,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,RRS,SWEDISH,THESE
8TH,AFRICAN,AIR,BACKGROUND,BMJ,CURRENTLY,GIVEN,GROUP,LABEL,LIMITED,METHODS,POS,PRICE,PUBLISHED,PUBLISHING,RESULTS,SINCE,SMOKE,TOBACCO
169,ACC,ASIAN,BACKGROUND,FORTY,INSERTION,JANUARY,LABEL,LOW,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY
AUC,LABEL,METHODS,OBJECTIVE,PATIENT,PHQ,PURPOSE,PURPOSIVE,RESULTS,SAS,SCALE,SUICIDE,THEREFORE,TOBIT,VERSION
ERCC1,III,NSCLC,PROGNOSTIC,SEVERAL,WHILE
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LABORATORY,METHODS,MOROCCO,RABAT,SAS,UNIVERSITY,YOUSSEF
103159646,240,6CONHOH,840,956,CH2,FIRST,H1299,HDAC4,HDAC8,HDACI,HISTONE,N25,PCR,PDB,RNHCO,THESE,U87
CHINA,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,GREEN,GSTP1,LABEL,MATERIALS,METHODS,MSP,NSCLC,PCR,RESULTS,THEREFORE
ASIAN,CHINA,GANODERMA,LINGZHI,THERE
100,BACKGROUND,HODGKIN,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,SIXTY
041,334,545,BACKGROUND,FURTHER,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS
946,BACKGROUND,III,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,THESE,TUBB3,XRCC1
100,HLA,PCR,SEVENTY,SSP
005,041,043,049,050,083,100,BACKGROUND,DEPARTMENT,DFS,ERCC1,ERCIYES,KAYSERI,LABEL,MATERIALS,MEDICAL,METHODS,MPM,RADIATION,RESULTS,THERE,UNIVERSITY
PAH,THESE
160,169,954,COPYRIGHT,HIF,INC,PHD,THESE,XENOGRAFT
921,AMONG,BACKGROUND,CSS,HOWEVER,JANUARY,LABEL,LOCAL,METHODS,NSCLC,PFS,RESULTS
186,189,500,956,AIM,CLEARANCE,CONCLUSION,CURRENT,CYTOTOXIC,EIGHT,FURTHER,HOWEVER,LABEL,METHODS,MTX,OBJECTIVE,PEM,PEMETREXED,RESULTS,THEREAFTER,USING
177,ACTUARIAL,ACUTE,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
PEMETREXED,SERUM
169,ADAMTS1,COPYRIGHT,CYR61,E2F,NUPR1,P4HA1,SOCIETY,TAKEN,THESE,USING,VEGFA,WHILE
000,001,358,49A,737,ASIAN,BACKGROUND,CIS,CONCLUSION,FURTHER,HCC,LABEL,METHODS,ORS,OVERALL,RESULTS,STRATIFIED
012,304,442,ADVERSE,BACKGROUND,COX,HOWEVER,LABEL,MEIER,METHODS,NSCLC,RESULTS
ANTIGEN,BACKGROUND,CEA,CONCLUSION,FEW,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PERIPHERAL,REGISTERED,RESULTS,SEVENTY
001,153,BACKGROUND,CYFRA,ELISA,HE4,KETTERING,LABEL,METHODS,NSCLC,NSE,OBJECTIVE,PFS,RESULTS,SCC,SERUM,SLOAN,TIMP1,UNIVARIATE
METASTASES,METASTASIS,PRIMARY,THREE
169,635,AMONG,ASIAN,BACKGROUND,FIFTY,HOWEVER,LABEL,LDCTS,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY
169,946,COPYRIGHT,DEPLETION,INC,NEDD4,PUBLISHED,TGF,THESE
001,ALTERED,LOH,NUCLEAR,PCR,PROTEIN,WNT
ANOVA,FDR,H1650,HEPES,HOWEVER,ORGANIC,PROTECTION,THEREFORE
023,100,169,183,246,306,594,613,618,625,627,628,BACKGROUND,BETWEEN,COPYRIGHT,DEC,ELI,FUNDING,IQR,JAN,LABEL,LILLY,LTD,METHODS,NSCLC,RESULTS,REVEL,TOXICITIES,VEGFR
169,COPYRIGHT,PUBLISHED,SAS
008,020,028,030,037,156,161,204,244,352,402,478,617,794,934,948,ABCB1,BRCA1,CHINESE,COX,ERCC1,ERCC2,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,XPD,XRCC1,XRCC3
160,169,AMONG,COPYRIGHT,DOSIMETRIC,GATED,GWS,LTD,PUBLISHED,USING,V20
ENGLISH,HCC,IMAGING,METASTASES
HOWEVER,OSSIFYING
169,COPYRIGHT,LTD,MUTATIONS,OTHER,SNF,SWI
AMP,FINALLY,MACROPHAGE,MIF,ROS,SEVERAL
169,192,235,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LML,LOWER,METHODS,NSCLC,RESULTS,SAS,THERE,UML,UPPER
169,COPYRIGHT,HIV,SAS
CASES,DOPPLER,FDG,OTHER,PET,THYROID
169,BACKGROUND,CURRENTLY,HOWEVER,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
000,001,003,100,AFTER,BACKGROUND,CONCLUSION,FINALLY,GOVERNMENT,GRASP,HOWEVER,LABEL,MHC,MOTIVATION,POOLING,POTENTIAL,PRESS,PUBLISHED,RESULTS,RNAEDITING,SEX,SNP,SUMMARY,UNIVERSITY
169,250,577,651,700,740,967,AGE,AUTHORS,CENTRAL,CNS,COX,HODGKIN,IVL,LDH,LTD,RITUXIMAB,WHITNEY,WILEY
BACKGROUND,C459S,EMT,FOLLOWING,LABEL,METHODS,RESULTS,SNAIL,SRC,THESE
FLC,FUNCTIONAL,INCREASED
169,AUTHORS,COPYRIGHT,INC,PUBLISHED,T790M,THESE,TKI
BASED,CONCLUSION,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,THEREFORE,THREE,VAS,WILEY
AGE,ASPECTS,FURTHER,INC,LABEL,METHODS,MINUTES,NUTRITION,OBJECTIVE,PUBLISHED,RESULTS
169,956,COPYRIGHT,LTD,THREE
DU145,H1299,HOWEVER,MUTATIONS,NUCLEAR,SPP,THESE,TMS
008,036,160,169,COPYRIGHT,DATES,EASTERN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
155,166,946,AKT,EB1,MTA,ROS,THREONINE
016,146,150,169,176,257,COPYRIGHT,EUS,FNA,INC,LABEL,MCNEMAR,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
100,169,200,4T1,AFTER,DNP,METASTASIS,VCH,WILEY
HOWEVER,OTHER,PROMISING
150,FOLLOWING,VARIOUS
160,169,239,913,BACKGROUND,COPYRIGHT,FURTHER,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE
169,246,COPYRIGHT,CRI,EPIDERMAL,ESTIMATED,IRELAND,LABEL,LTD,MATERIALS,METHODS,NMA,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS
169,ANTIBODIES,BORONAT,CNS,COPYRIGHT,EATON,GABAB,LAMBERT,LANCASTER,MASON,VGCCS
ANY,ENGLISH,JANUARY,MARSDEN,OCTOBER,ROYAL,THERE
003,160,169,193,COLLEGE,COPYRIGHT,DECREASES,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,REDUCED,RESULTS,ROYAL
570,ACCORDING,BACKGROUND,CUP,FINDING,LABEL,METHODS,RESULTS,SWEDISH
100,169,916,936,956,APOPTOSIS,BAX,BCL,COPYRIGHT,OVERALL,PHYTOLACCA,PUBLISHED
314,370,CHINESE,DEC,HAN,PCR,PRODUCT,SERVICE,SNP
111,118,169,CONCLUSION,COPYRIGHT,DRC,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNITS
003,100,106,115,169,COPYRIGHT,DFS,GRADE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
002,047,160,169,CONCLUSION,COPYRIGHT,COX,CUMULATIVE,EASTERN,FFS,GROUP,INC,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SGR
001,020,100,106,143,169,946,967,AMONG,BACKGROUND,COX,LABEL,MEDICAL,METHODS,PC9,PEARSON,PFS,PRESS,PUBLISHED,RESULTS,SMAD3,SOCIETY,TGF,THERE,UNIVARIATE,UNIVERSITY
121,124,169,250,AES,BACKGROUND,COMPARABLE,CONCLUSION,DRAES,HNSCC,ICR,LABEL,MEDICAL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEQUENTIAL,SOCIETY,UNIVERSITY
169,251,ANGIOGRAM,COPYRIGHT,INC,PULMONARY,VTE
148,158,169,CELLS,GPR81,RES,THESE
169,CANCERS,COPYRIGHT,ERBB1,ERBB2,FOLLOWING,GEFITINIB,LTD,SEVERAL,THESE
000,014,018,020,024,126,128,141,142,169,215,486,720,945,BACKGROUND,CONCLUSION,COPYRIGHT,COX,DFS,INC,LABEL,MEIER,METHODS,NSCLC,RESULTS,SCC
169,196,228,AGE,BACKGROUND,COPYRIGHT,COX,DESPITE,END,INC,LABEL,METHODS,MPM,PUBLISHED,RESULTS,SOCIETY,THERE
122,140,169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PRIMARY,PUBLISHED,RESULTS,SOCIETY,TECHNOLOGY,VIDEO
001,002,003,005,026,076,169,177,BACKGROUND,COPYRIGHT,CSC,IIA,INC,KNOCKDOWN,LABEL,METHODS,PROTEIN,PUBLISHED,RESULTS,SECRETORY,SOCIETY,THESE,WESTERN
107,169,BACKGROUND,CONCLUSION,LABEL,METHODS,OCTOBER,RESULTS,SPECIAL,SUSPECTED,VIRTUAL
169,AMONG,FURTHER,MTA,PRESS,SIXTY
CAD,EGFRTKI,GLUT3,HOWEVER,LAD,MUTATIONS,PPP,TKI
169,29A,424,502,542,60K,8X60K,AGILENT,CONCLUSION,COPYRIGHT,FIFTY,GROUP,IRELAND,LABEL,LTD,MATERIALS,METHODS,MOLECULAR,NSCLC,OBJECTIVE,OBJECTIVES,PATIENT,PCA,PROGNOSTIC,RESULTS,RMA,SIX,SWISS,TEN
169,COPYRIGHT,FEDERATION,FINALLY,FURTHER,H3K27,LYS27,PUBLISHED,SOCIETIES
169,393,435,460,468,570,620,650,680,900,956,ANALOGS,CEM,COPYRIGHT,HOP,LTD,MDA,MMB,PTL,PUBLISHED,RXF
169,945,946,BASED,BLM,COL,COPYRIGHT,ERK,GAL,IMR,INC,PI3,SMA,SMAD2,TGF
ATM,DDR,JNK,JUN,LC3,LY2603618,THESE,TREATMENT
169,COPYRIGHT,INC,PAS,PULMONARY
177,197,CONCLUSION,LABEL,METHODS,NON,OBJECTIVE,RESULTS,THERE,TNM
215,370,ALC,AMC,COX,EASTERN,GROUP,LMR,NSCLC,PFS
169,ALTOGETHER,COPYRIGHT,FURTHER,HOWEVER,LTD,MES,REDUCED
AFTER,MRI,NSCLC,ULTRASHORT,USRPS
169,340,376,627,633,642,759,838,921,934,941,BONFERRONI,CONCLUSION,KRUSKAL,LABEL,MATERIALS,MDT,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,VDT
169,CONCLUSION,CONSENT,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,RFA,SEQUENTIAL,STUDENT,THREE
BASED,RADIATION
ALZHEIMER,KALLIKREIN,KLK,KLK15,PARTICULAR,PSA
AKT,NNK,RESISTANCE
945,CAPSAICIN,COX,DESPITE,HIF,NSCLC,SMAR1
CNS,LABEL,LIMITED,METHODS,OBJECTIVE,OVERALL,PATHOLOGY,RESULTS,SITES
169,556,585,6MONTHS,AFRICAN,AMERICANS,AOR,BACKGROUND,COPYRIGHT,GREATER,LABEL,LATINOS,LTD,METHODS,RESULTS,SMOKING
AXL,MER,NSCLC,RTK,TAKEN,TAM,THESE
001,706,ELECTRONIC,HOWEVER,LABEL,MAY,MEDLINE,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SCIENCE,SEVERAL,STATA,THERE,THEREFORE,VERISTRAT,WEB
HEPG2,SNAIL,TWIST
169,231,233,GEFITINIB,NSCLC
000,032,039,100,132,FURTHER,HOWEVER,LOH,SINCE,THESE
ALK,AMONG,APRIL,BACKGROUND,BETWEEN,FGFR1,FGFR2,LABEL,MET,METHODS,PLEURAL,RESULTS,RET
109,138,215,259,386,485,532,675,725,BACKGROUND,CHINA,CONCLUSION,LABEL,METHODS,NORTH,RESULTS,SOUTH
866,AKT,BACKGROUND,CONCLUSION,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SECONDARY,THERE
001,005,013,016,029,133,BACKGROUND,III,IMAGING,LABEL,MASAOKA,METHODS,RESULTS,SEPTEMBER
447,BACKGROUND,ELDERLY,FINAL,HOWEVER,III,LABEL,METHODS,PARAMOUNT,PFS,PHASE,RESULTS,SUBGROUPS
015,022,ACUTE,BACKGROUND,CTCAE,EXHALED,LABEL,METHODS,NEITHER,RESULTS
BACKGROUND,CIGARETTE,HOWEVER,INDUCTION,LABEL,LIBRARY,MEDLINE,METHODS,RESULTS,SMOKERS,SMOKING,STUDIES,THERE,THESE
169,2N6,4N6,ADC,COPYRIGHT,FATTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,ROC,SCC,SOCIETY,THEIR,THESE
169,AMERICANS,COLUMBIAN,COPYRIGHT,EUROPEANS,MEXICAN,PRE,SCIENCE
169,ERS,FURTHER,LOBECTOMY,THERE,THEREFORE
AIRWAYS,HEALTHY,INNOVATION,INTEGRATED,UNION
AAA,CARLO,ECLIPSE,MONTE,TPS,V10
113,158,169,315,323,391,464,ALK,ANAPLASTIC,BACKGROUND,CONCLUSION,COPYRIGHT,INC,ITALIAN,JANUARY,KIRSTEN,LABEL,METHODS,NSCLC,RESULTS
169,174,CONCLUSION,COPYRIGHT,DIAGNOSTIC,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCREENCELL
169,AMONG,COPYRIGHT,GATA3,INC,INTENSITY,NUCLEAR
169,AVAPERL,COPYRIGHT,FDA,GUIDELINES,NETWORK,NSCLC,PARAMOUNT,POINTBREAK
109,119,169,273,356,629,BACKGROUND,BASEL,BMT,DISTANT,DMS,EAC,FOLLOWING,LABEL,METHODS,RESULTS,TMT
945,HIF,LXY6006,THESE
945,947,ACTIVATION,BACKGROUND,CONCLUSION,EGR,HOWEVER,JNK,JUN,KIT,LABEL,LUCIFERASE,METHODS,MTT,NSCLC,PEROXISOME,RESULTS,WESTERN
000,177,BEIJING,CTA,FDG,JANUARY,LABEL,METHODS,OBJECTIVE,PAS,PET,RADICAL,RESULTS,THEIR
ASSESSMENT,BACKGROUND,EVALUATION,FIXED,GRADE,HOWEVER,LABEL,MEDLINE,METHODS,OCTOBER,RESULTS,SCIENCE,WEB
164,169,326,424,676,774,BASEL,LABEL,METHODS,OBJECTIVE,RESULTS
945,946,THESE,VEGFR
103,ABCC5,ATP,BACKGROUND,BASED,FDA,LABEL,NAD,RESULTS,SNP,TESTING
NATURAL
GENERATING
BACILLE,BCG,EARLY,III,KLEINERMAN,MDP,MTD,MTP,PHASE,THESE,WHILE
153,223,99M,BECAUSE,EDTMP,MDP,ROUTINE
11R,945,CGRRAGGSC,NOVEL
1900S,ONCOLYTIC,SINCE,THEREFORE
000,BECAUSE,SINCE,USA
20A,AEROSOL,FAS,GCB,SUCCESS
ATP,BRIEFLY,CELLS,ERM,EZRIN,RADIXIN,SINCE
GIVEN,OTHER
AUTOPHAGY,EVALUATION,GCB,HOWEVER,INHIBITION,LM7
PARTICULAR
946,FURTHER,NOTCH,WNT
AXL,DESPITE,EPHB2,FGFR2,FUNCTIONAL,RET,RTK,STUDIES,THEREFORE
946,DESPITE,DKK,GIVEN,ULTIMATELY,WIF,WNT
1970S,ADDITIONAL,SINCE,THERE
001,967,BACKGROUND,BMJ,ENGLAND,EPISODE,FURTHER,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,STATISTICS
120,160,169,417,99M,BSA,COPYRIGHT,DIFFERENT,LTD,MAA,MIA,PUBLISHED,RADIATION,SELECTIVE,SURFACE,THERAPY,WITHOUT
000,140,169,CANCERS,FIRST,INDIANS,NATIONS,ONTARIANS,ONTARIO
001,006,119,169,380,435,506,919,967,975,ADC,BLN,CONCLUSION,DWIBS,ELN,INC,LABEL,MATERIALS,METHODS,MLN,NLN,NPV,NSCLC,OBJECTIVE,PPV,PURPOSE,RESULTS,ROC,STUDENT,WILEY
160,169,267,378,777,BACKGROUND,COLORECTAL,COPYRIGHT,LABEL,LTD,METHODS,RCC,RESULTS,RISKS,SIR,SWEDISH

001,046,116,144,169,ANTICANCER,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS
001,135,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,THREE
169,ANTICANCER,COPYRIGHT,INSTITUTE,MOLECULAR,NSCLC,RENAL
035,100,169,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,RESULTS,SIXTY,THESE
169,264,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GLASGOW,GPS,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS,THREE
169,AIM,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GLASGOW,GPS,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
014,047,169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EVALUATION,HOWEVER,INSTITUTE,LABEL,METHODS,RESULTS,SIX,TBB
169,946,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,251,ANTICANCER,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,HOWEVER,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS,THEREAFTER,UNIVARIATE,URINE
038,039,169,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,IGF1R,IHC,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,PCR,RESULTS
169,AKT,ANTICANCER,CACO2,COPYRIGHT,FINALLY,FOCUSSING,INSTITUTE,MTT,POD,PROTEIN,THESE,TREATMENT
169,ANTICANCER,BACKGROUND,CELLS,CONCLUSION,COPYRIGHT,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS,STUDIES,TKI
169,AIM,ANTICANCER,BACKGROUND,COPYRIGHT,HOWEVER,HSP70,HSPA2,INSTITUTE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM
169,9ER,AIM,ANTICANCER,BACKGROUND,CAPILLARY,CONCLUSION,COPYRIGHT,GSTT2,INSTITUTE,LABEL,MATERIALS,METHODS,MYC,NSCLC,OBJECTIVE,RESULTS
003,006,020,027,169,404,411,475,512,ANTICANCER,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,ERCC1,III,INSTITUTE,JANUARY,JAPAN,LABEL,MATERIALS,METHODS,OCTOBER,RESULTS,SHIMANE,UNIVERSITY
169,ANTICANCER,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,CYFRA,EVALUATION,HOWEVER,INSTITUTE,LABEL,METHODS,RESULTS,TPA,UNIVARIATE,VARIOUS
001,005,017,025,516,ASIAN,BACKGROUND,CIS,GCN,INCREASED,LABEL,MET,METHODS,NSCLC,RESULTS,SCHOLAR,SCIENCE,WEB
LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
205,CONTRARILY,EMT,LNCRNAS,ROR
CD4,CLOSE,FINALLY,OVERALL,RE1,THESE,WHETHER
AMONG,BACKGROUND,CENTRAL,CLINICIANS,CONTROLLED,ENGLISH,FALSE,LABEL,MAY,MEDLINE,METHODS,QUARTER,RESULTS,REVIEWS,SYSTEMATIC
001,122,678,779,888,BACKGROUND,COMBINING,CTC,LABEL,METHODS,NCI,PFS,PRS,RESULTS,SEVERAL,V20,VS5
513,BACKGROUND,EPIDERMAL,HOWEVER,L858R,LABEL,METHODS,NORTH,RESULTS,SAMPLES,TTF
136,158,175,187,204,BACKGROUND,BETWEEN,COMPLIANCE,CONTINUOUS,FALSE,HOWEVER,LABEL,LOW,METHODS,NODULES,RESULTS,SMOKING
146,201,AFTER,AKT,BACKGROUND,BSI,COLLECTION,DEVELOPER,HOWEVER,LABEL,METHODS,RESULTS
BACKGROUND,LABEL,METHODS,RESULTS,SILTUXIMAB,STAT3
AKT,CK6,KIT,MALME,NCI,SCF
10877,1970S,267,400,BACKGROUND,CHINA,COX,ENDOTOXIN,LABEL,METHODS,RESULTS,SINCE
005,019,10878,187,205,467,BACKGROUND,GYEONGSANG,LABEL,METHODS,NLR,OCTOBER,PFS,PLR,RESULTS,SAMSUNG,UNIVERSITY
120,BACKGROUND,HOWEVER,LABEL,METHODS,MYO10,RESULTS,SILENCING
224,BACKGROUND,DDP,HOWEVER,INCREASING,LABEL,LAS,METHODS,RESULTS
BRAIN,EFFECTIVE,METASTATIC,STUDIES
106,124,169,170,259,327,945,AE1,AMBIGUOUS,CK7,EMA,GCT,GYSTS,MOC31,MUC,PRIMITIVE,SALL4,SMS,SOMATIC,SYSTS,THESE,TTF,YST
AMONG,CDV,CURRENTLY,HOWEVER,NEOPLASTIC,SEVERAL
139,447,928,CLUSTER,FIFTY,HOXD8,III,LADCS,SPARCL1
500,956,ASSESSMENT,BACKGROUND,CONCLUSION,EMT,EPITHELIAL,ICS,LABEL,METHODS,MMP,RBM,RESULTS
168,ALK,CIGARETTE,HOWEVER,MET,SIXTY,SMOKING,THERE
169,BLOOMBERG,HOPKINS,HOWEVER,JOHNS,METFORMIN,PRESS,PUBLISHED,THERE,UNIVERSITY
169,AUTHORS,FINDING,PUBLISHED,SOX12,TCF,TMED3,TREATMENTS,USING,WNT
BACKGROUND,CONCLUSION,CURRENT,FITTING,LABEL,METHODS,RESULTS,SNP
000,169,500,FRUIT,NUTRITION,SOCIETY,THERE
169,956,BACKGROUND,BRITISH,JOURNAL,LABEL,METHODS,MOR,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
ENTRAPMENT,LABEL,MANGANESE,METHODS,MN3O4,MRI,NPS,OBJECTIVE,PEGYLATED,PURPOSE,RESULTS,UNIFORM,V600E
001,003,101,150,160,169,177,374,AFTER,COLLEGE,CONCLUSION,COPYRIGHT,EFS,EWING,LABEL,LCR,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,UNIVARIATE
169,COPYRIGHT,ECM,METASTASIS,SIMILAR,VCH,WILEY
169,ACTIVATION,AKT,AXL,DASATINIB,ERK,IGF,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PC9,PC9GR,PURPOSE,RESULTS,SFK,SRC,T790M,TKI
AUROC,MICRORNAS,SEVERAL,THESE
166,613
DEFINED,IIALPHA,NOR
387,674,936,CHERNOBYL,N1B,OVERALL,THERE
ADP,ASC,ASN,CYTOSOLIC,DESPITE,FIC,GTPASES,MUTATIONS,OTHER,PRR,PYRIN,RHO,THESE
001,002,177,215,ADC,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NCR,OBJECTIVE,RESULTS,SIXTY,THERE
ADP,AHF,ARGENTINE,CASP3,CASPASE,CONSISTENT,IFN,JUNIN,RIG,RLH,SIMILARLY
001,011,013,BACKGROUND,EMT,KNOCKDOWN,LABEL,METADERIN,METHODS,NSCLC,PCR,RESULTS,THESE,TNM
001,011,014,034,10878,180,241,AGE,BACKGROUND,CCI,CENTRES,EASTERN,GROUP,III,INDEX,ITALIAN,JANUARY,LABEL,METHODS,MPM,NON,RESULTS,THERE,TREATMENT
733,BACKGROUND,EPISODE,HOWEVER,LABEL,LIKELIHOOD,METHODS,RESULTS,STATISTICS,YORKSHIRE
133,207,214,221,224,238,HPV,JANUARY,RRP,USING
GENERALLY,METASTATIC,THERE
174,ARGENTINA,COPYRIGHT,GM3,III,NEU,NSCLC,PROUS,SCIENCE
200,313,474,BACKGROUND,BIOBANK,BRISQ,LABEL,METHODS,RESULTS
AMONG,CSC,QKI,QUAKING,TAKEN,THEREFORE,UTR
FAK,TREATMENT,WESTERN
BACKGROUND,CNS,CURRENTLY,GENERALLY,LABEL,OBJECTIVE,PURPOSE,STILL,THEIR
169,654,BACKGROUND,CONCLUSION,DOR,DTP,EBSCO,FDG,FOUNDATION,HOWEVER,KNOWLEDGE,LABEL,LYMPH,METHODS,NLR,NSCLC,OBJECTIVE,PET,PLR,PURPOSE,RESULTS,STP,SUMMARY,WEB
169,COPYRIGHT,NADPH,ROS,SCIENCE
MASAOKA,MAY,THEREAFTER,WHILE,WORLD
THESE
THERE,THEREFORE
169,320,429,CHINA,COOKING,COX,HOWEVER,IAP,THESE
HOWEVER,HRS,RETIREMENT,THESE
CHEST
CHEST
CEA,SINCE,SVC
CHEST,ESS,FDG,PET
FDG,PET,RUL,TTF
498,ACCORDING,CCI,HOWEVER,III,JAPAN,OWING,SEX,THERE
CAP,CPA,DTX,EPI,FEC,GEM,HOWEVER,PGR,PTX,THEREFORE
AFP,AFTER,METASTATIC,OCT,SERUM,THEREFORE
178,500MG,AMONG,CBDCA,NSCLC,PEM
209,AFTER
GEFITINIB,L858R,NSCLC,SOMATIC,T790M
AFTER,BACKGROUND,III,IMPORTANT,LABEL,MEIER,METHODS,RESULTS,ROC
169,481,829,AFTER,CHINESE,CIS,COX,DIETARY,HRS,TOTAL,VITAMIN,WOMEN
160,234,282,BACKGROUND,BMI,CRS,HIPEC,LABEL,METHODS,OBESITY,RESULTS
169,946,CHINESE,COPYRIGHT,COX,DSS,ERK,INTEGRATED
169,APART,MUTATIONS
169,318,ARID2,PBRM1,SETD2,SMARCA4,SMARCC1,SNF,SWI,THESE
169,DIAGNOSIS,DIAGNOSTIC,JAPAN,LABEL,METHODS,OBJECTIVE,OLYMPUS,PRESS,PUBLISHED,RESULTS,SEPTEMBER,SIXTY,THERE,UNIVERSITY,Y0053

NET,NPS,NPSR1
160,169,963,BACKGROUND,CALIFORNIA,CHRONIC,COX,HISTORY,HIV,HODGKIN,LABEL,MEDICAL,METHODS,PERMANENTE,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY
011,100,3OST2,APC,BMJ,FAM19A4,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PHACTR3,PUBLISHED,PUBLISHING,RASSF1A,RESULTS,SET
032,177,711,716,7TH,908,985,BACKGROUND,COLLEGE,COX,GROUP,HOWEVER,IASLC,III,LABEL,MEDICAL,METHODS,NETWORK,NSCLC,OSI,RADIANT,RESULTS,STAGING,TNM,UNIVARIATE
002,004,006,009,018,019,021,024,025,027,030,032,037,044,048,154,185,CONCLUSION,COX,LABEL,LAC,METHODS,OBJECTIVE,RESULTS,THERE,TTF,UNIVARIATE
000,019,023,ALK,CHINESE,DFS,LABEL,LOG,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SCORPIONS
100,228,CGA,FIFTEEN,GASTRIC,GCDFP15,HMB45,LABEL,LYMPH,METASTASES,METASTATIC,METHODS,MOLECULAR,MPNST,OBJECTIVE,OVARIAN,P504S,PANCREATIC,PSA,RESULTS,SEVEN,SYN,TTF,WT1
169,AICAR,BECAUSE,COPYRIGHT,HOWEVER,IRELAND,KNOCKDOWN,LTD,PML,RAPAMYCIN,SER46
001,100,188,323,BACKGROUND,CENTERS,CONCLUSION,CONTEXT,DUTCH,LABEL,MEDICAL,METHODS,NET,OBJECTIVE,OUTCOME,RESULTS,UNIVERSITY
BACKGROUND,DYSPNEA,GRADE,LABEL,MEDLINE,METHODS,RESULTS,SCHOLAR,UNTIL
DESPITE
PET,STAGING,ULTIMATELY
945,946
215,ABDOMINAL,THREE
CURRENTLY,FINALLY,PANCREATIC,PDA
169,HYGIENE,SOCIETY,TREATMENT
169,BLI,COPYRIGHT,FLASH,LTD,MRI,NSCLC,ULTRA,UTE,WILEY
094,160,251,EXPRESSION,HOWEVER,OMNIBUS,TFS,THESE
169,600,956,CHINA,EXCRETION,GST,GSTT1,RAPID,RIVER,URINARY,YANGTZE
169,AIG,AMONG,CXCL1,FINALLY,P53
024,35U,6MV,CA125,COX,CSS,MEIER,SIXTY
109,ALK,KIRSTEN,SEVERAL,USING
177,485,754,CIS,COX,HISTORY,HOWEVER,HRS,INITIATIVE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERE,WHILE,WOMEN
074,CD44S,ENGLISH,HOWEVER,MARCH,NSCLC
956,BACKGROUND,LABEL,METHODS,RESULTS,THESE,THR15,V158411
946,954,AKT,EGF,IIA,SECRETORY,THERE
169,946,AUTHORS,EMT,FOUNDATION,FURTHER,GNT,HOWEVER,JOURNAL,LTD,MEANWHILE,MOLECULAR,TAKEN,TGF,WILEY
8G7G3,CLONE,CONCLUSION,FOCAL,HOWEVER,III,LABEL,METHODS,OBJECTIVE,RESULTS,SPT24,TTF
002,004,ACCURATELY,BACKGROUND,CONCLUSION,COX,ESTIMATED,HISTOLOGY,INAUGURAL,IQR,LABEL,METHODS,MEYER,NSCLC,PFS,PROGNOSIS,RESULTS,SRE,TTF,UNIVARIATE
BACKGROUND,EPIDERMAL,FURTHER,L858R,LABEL,MEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEVERAL,TKI
169,300,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,GROUP,INC,LABEL,METHODS,NON,RESULTS,VANDETANIB
BAF47,BRM,GATA3,HDAC3,HDAC9,MEF2D,SIMILAR,USING
198,414,504,526,630,706,ADDITIONAL,AFFAIRS,BECAUSE,DEPARTMENT,ESA,FDA,LABEL,MARCH,METHODS,OBJECTIVE,OTHER,PRE,PURPOSE,RESULTS,THOSE
126,143,145,169,239,652,742,COPYRIGHT,INC,MALIGNANT,MOLECULAR,MPM,NNP,OVERALL,PATHOLOGY,PCR,PUBLISHED,SOCIETY
HIP,HOWEVER,S269A,SER,SH3P7,T291A,THR,USING
229,912,930,BACKGROUND,CENTRAL,CONTINUOUS,CPR,DENMARK,GPS,HOWEVER,LABEL,METHODS,OOH,RESULTS,RFE
000,121,123,AMONG,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS
HOWEVER,HUVEC,PDI,THESE,TREATMENT
205,CFC,CRIPTO1,EGF,EMT,NSCLC,PRIMARY,RESISTANCE,SRC,TKI,WHILE
100,15953,AUC,BACKGROUND,DOR,HOWEVER,LABEL,MAY,METHODS,NLR,PLR,RESULTS,STUDIES
000,233,344,625,BACKGROUND,BHD,CHANGES,CURRENT,DUB,LABEL,METHODS,RESULTS,TOPICAL,TRIAL
169,COPYRIGHT,INITIATIVE,LTD,MENOPAUSAL,SINCE,THESE,UNTIL,WOMEN
100,160,169,180,711,BLOOD,COMPONENT,COPYRIGHT,HCT,MEDICAL,NETWORK,SHORT,SOCIETY,STUDIES,SUMMARY,THERE,TRANSPLANT
169,916,BACKGROUND,BRITISH,CBD,CHANGES,DEVELOPING,HOWEVER,ID1,KEY,LABEL,METHODS,MODULATION,MTT,OBJECTIVE,ORTHOTOPIC,PURPOSE,RESULTS,ROS,SOCIETY,THC,WESTERN
400,PARACELSUS,PERHAPS,WHILE
AFTER,BECAUSE,PULMONARY
169,COPYRIGHT,COX,FINALLY,HOWEVER,MRP,PMA,TRANSIENT
169,COLLEGE,COPYRIGHT,LTD,NSCLC,PARTICULAR,PUBLISHED,ROYAL
169,956,ASIAN,BACKGROUND,CERTAIN,CLE,LABEL,METHODS,OBJECTIVE,PACIFIC,PROBE,RESULTS,SOCIETY,THREE
BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,LTD,STUDIES,WHILE
BACKGROUND,DISCUSSION,FIFTEEN,LABEL,METHODS
BARD1,BRCA1,PHOSPHO,RAF,RAS,THESE
160,DERIVED,RNASE
29B,AMONG,COX,MEIER,MYC,NSCLC,RFS,THEREFORE
174,GENEXOL,PACLITAXEL,PTX,TAXOL,THESE,VARIOUS
001,005,151,169,443,627,BACKGROUND,COPYRIGHT,INDIVIDUAL,IRELAND,LABEL,LTD,METHODS,RESULTS,SEVERAL
100,122,254,EXPRESSION,LABEL,MEASURING,NSCLC,PROGNOSTIC,RESULTS,UNLABELLED,ZAPOROZHYE
00055,ERALPHA,EXPRESSION,NSCLC
146,AMONG,DIAGNOSTIC,EBV,EPSTEIN,HHV,HODGKIN,PCR,PRIMARILY
116,160,CEM,CPG,CURRENTLY,DNMT1,EFFECTS,H23,HCT,HOWEVER,IGROV,LABEL,METHODS,NCI,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN
169,360,AKT,COPYRIGHT,ERK,FEDERATION,MEK,NSCLC,PUBLISHED,RAF,RAS,RESULTS,SOCIETIES,THESE
169,CHEST,COPYRIGHT,DIAGNOSIS,HISTOLOGY,INC,PULMONARY
169,600,AUTHORS,COPYRIGHT,GUIDELINES,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
001,002,013,041,169,200,946,ACCORDING,COPYRIGHT,FDA,IRELAND,LABEL,LTD,MATERIALS,METHODS,MICRO,OBJECTIVE,OBJECTIVES,PDGFR,RESULTS,TET,TMA,VEGFA,VEGFC,VEGFD
009,082,19DEL,21L858R,858,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,PFS,RESULTS
001,016,022,169,177,200,618,925,AMONG,ANOVA,CONCLUSION,COPYRIGHT,LABEL,METASTATIC,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,THEREFORE,THREE,TOKUHASHI
769,CHINESE,GCG,GTG,L858R,MUTATIONS,NSCLC,THEREFORE,TKI,V769A
170,179,283,462,671,BEIJING,BETWEEN,CHINA,CHINESE,FRIENDSHIP,RENAL
AGE,BACKGROUND,COLORECTAL,CRC,KATHMANDU,LABEL,MAXIMUM,METHODS,NEPAL,RESULTS
169,CLAUDIN,COPYRIGHT,HOWEVER,NUCLEAR,S208A,ZONAB
000,100,169,1970S,AMERICA,BACKGROUND,BETWEEN,COSTA,HOWEVER,LABEL,LATIN,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,TOBACCO,UNIVERSITY,USA,VENEZUELA,WORLD
169,AFTER,COPYRIGHT,THEREFORE
169,429,431,BACKGROUND,DENMARK,HOWEVER,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,TOBACCO,UNIVERSITY
169,COPYRIGHT,DIAGNOSIS,PATHOLOGY,PUBLISHED,SEPAR
BMJ,GROUP,LTD,MPA,PAS,PUBLISHING
169,ALDEFLUOR,ALDH1A3,CSC,INHIBITION,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,STAT3,WESTERN
109,135,828,AFTER,CAUCASIANS,CLPTM1L,SINCE
149,169,ATLAS,EXPRESSION,LARGE,PRESS,PUBLISHED,UNIVERSITY
AUSTRALIA,BACKGROUND,ICD,LABEL,MATERIALS,METHODS,QUALITY,RESULTS,VICTORIAN
169,231,233,COPYRIGHT,PROTOCOLS,PUBLISHED,SAS
001,169,184,196,417,COPYRIGHT,COX,CSF,INC,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PERHAPS,PUBLISHED,RESULTS,SURGERY,THEIR
169,METHODS,VITAMIN
169,COPYRIGHT,DDP,FINALLY,INC,LNA,MES,NSCLC,PCR,PRE
001,669,983,ASIAN,HOWEVER,SEPTEMBER,SEVENTEEN,SUMMARY
001,003,121,169,189,313,341,968,978,990,BACKGROUND,COPYRIGHT,INC,INSTEAD,LABEL,METHODS,NSCLC,ORDINAL,PUBLISHED,RESULTS,SOCIETY
169,AFFYMETRIX,AMONG,COPYRIGHT,GEO,IRELAND,LTD,NSCLC,SCC
254,350,823,ADDITIONAL,COX,FEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,SUA,VLAGTWEDDE
000,230,CREMORPHOR,FORTY,GENEXOL,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX
EXTENSIVE
AUTOPHAGY,HOWEVER
001,183,BACKGROUND,CONCLUSION,FACTORS,GEORG,LABEL,LVI,MATERIALS,METHODS,NSCLC,RESULTS,STUTTGART,THESE
102,169,954,961,CONCLUSION,COX,FDG,HOWEVER,HVISU,IMAGING,INC,INTRATUMOR,LABEL,MEIER,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
000,001,002,100,126,181,250,438,496,700,AFTER,BACKGROUND,BMJ,GROUP,JANUARY,LABEL,LIMITED,LOW,METHODS,NETWORK,PUBLISHED,PUBLISHING,PYS,RESULTS
311,314,464,541,603,FIRST,ITALIAN,JANUARY,KIRSTEN,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
100,108,BRONCHIAL,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SAHARAN,SETTING,SUB
BMJ,GROUP,LTD,OWING,PUBLISHING
054,160,671,AFRICAN,BACKGROUND,CAUCASIAN,CONSORTIUM,ETHNICITY,HCC,INPATIENT,LABEL,LUNGS,METASTASIS,METHODS,NATIONWIDE,NIS,OBJECTIVE,PREVALENCE,RESULTS,THERE,TREND,UHC,UNIVERSITY
000,040,073,078,169,185,283,BACKGROUND,BASEL,CONCLUSION,COX,LABEL,METHODS,PNEUMONIA,PRIMARY,RESULTS,THESE
145,EMT,FINALLY,HOWEVER,LCICS,MIR,TAKEN
126,169,195,30D,CONVERSELY,PRESS,PUBLISHED,UNIVERSITY
001,177,961,AIRWAYS,ALD,AUTOMATED,AWT,KEY,L10,LABEL,METHODS,MIXED,OBJECTIVE,OBJECTIVES,R10,RESULTS,SCREENING,SEGMENTAL,THEREFORE,TLV,TRIAL
169,179,956,ABC,ABCB1,ABCC1,ABCC2,ABCG2,ATP,AUTHORS,FURTHER,JANUS,LTD,PTY,PUBLISHING,SCIENCE,WHI,WILEY
169,628,632,AFTER,ASIAN,BACKGROUND,CA125,CEA,FIFTY,ILD,LABEL,METHODS,NSE,OBJECTIVE,PACIFIC,RESULTS,ROC,SERUM,SOCIETY,STM
239,351,377,930,ASIAN,BACKGROUND,CENTRAL,EFFECTIVE,KOREA,LABEL,METHODS,PAF,RESULTS,SEX,SMOKING,STATISTICS,TOBACCO
115,120,BACKGROUND,FIFTY,III,LABEL,METHODS,NSCLC,PCR,PHYSICIANS,RESULTS
169,182,BASEL,HOWEVER
169,AGS,AMONG,EGG,HEP,HEPG2,INC,MCF,MES,MTT,POULTRY,SCIENCE,THESE,USING
054,169,177,178,183,365,680,689,705,AGE,BESIDES,BMI,GEORG,NRS,SCREENING,STUTTGART
BACKGROUND,CHRONIC,CONCLUSION,HOWEVER,LABEL,MARCH,MEDLINE,METHODS,RESULTS,TEN,THREE
001,132,242,AIM,AMONG,CANDIDA,CANDIDEMIA,CVC,ICU,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTEEN
000,BAX,BCL,CONSISTENT,H1963,MCL,MEF,USING
95D,THEREFORE,THESE
049,169,AMONG,BACKGROUND,BRITISH,COMMITTEE,CONCLUSION,COX,EASTERN,FURTHER,GROUP,JOINT,LABEL,M1A,M1B,METASTASIS,METHODS,PRESS,RESECTION,RESULTS,UNIVARIATE
169,FINAL,PRESS,PUBLISHED,SIX,SURGERY,UNIVERSITY
160,169,177,4T1,ASM,COPYRIGHT,LTD,METASTASIS,MMP,PEG,PSV,TWIST,VES
179,EGFRS
004,213,225,252,276,326,385,387,426,444,662,ACCORDING,ADMISSION,LABEL,METHODS,MORTALITY,NIV,OBJECTIVE,PURPOSE,RESULTS,SOLID
002,105,238,23A,413,718,COX,IRS,LABEL,LUCIFERASE,MEIER,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THERE,TRANSWELL,UTR,WESTERN
1RM,380,BACKGROUND,DISCUSSION,ENDPOINTS,HRQOL,LABEL,MAXIMAL,METHODS,NSCLC,PROLUCA,SIX,TRIAL,USING,VO2PEAK
169,264,484,805,820,COX,LABEL,METHODS,OBJECTIVE,READERS,RESULTS
AFTER,BASAL,BCC,HOWEVER,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE,SMO,SMOOTHENED,THESE
BACKGROUND,CYTOTOX,DM1,H1781,HER2CL1,LABEL,METHODS,MTT,NSCLC,PC9,RESULTS,TKI,WESTERN
077,106,129,137,188,215,523,940,ARRIAGA,BACKGROUND,KOREA,LABEL,METHODS,RESULTS,SOUTH,SUICIDE,YOUNG
CHANGES,PRESENT,USING
AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,HEMATOLOGY,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RANDOMIZED,RCT,RESULTS,SELECTION,SEVERAL,SOCIETY,USING
95D,AFTER,CXCR4,CXCR6,DESPITE,HOWEVER
BACKGROUND,CONCLUSION,GROUP,INITIAL,INSTITUTE,JANEIRO,LABEL,METHODS,OBJECTIVE,RESULTS,RIO,SMOKING,THERE,TOBACCO
BASED,FDG,PET
CTC,DETECTION,MOLECULAR,NON,NSCLC
124,160,177,231,549,956,ACCORDING,HOWEVER,MCF,MDA,MRC,MTT
CONCLUSION,FLC,IMAGING,KNOWLEDGE,LABEL,LOCATIONS,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS
100,497,956,DRIED,PRESENT,PROTEUS,SALMONELLA
BMJ,GROUP,HOWEVER,LTD,MRI,PUBLISHING,PULMONARY
169,AXL,BIOLOGY,FINALLY,HOWEVER,INC,MOLECULAR,OVERALL,SILAC,SOCIETY
038,047,085,169,16S,352,454,488,BACILLI,BACTERIAL,CHINA,FLX,FURTHER,INC,PAH,PCR,THESE,WILEY,XUANWEI
945,ADP,AML,CHROMATIN,CONVERSELY,DR5,FAS,FURTHER,KNOCKDOWN,PARP1,PARP2,PARP3,PARP4,SP1,TNFRSF10B,TRAIL
169,946,AUTHORS,CONVERSELY,FOUNDATION,HMG,HOWEVER,JOURNAL,LTD,MOLECULAR,NSCLC,WILEY
106,AMONG,CONCLUSION,INFECTION,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS
022,031,044,110,122,237,238,AEF,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
103,215,471,994,AVERAGING,FDG,FURTHER,KEY,LABEL,MER,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SDR,SUV,SUVPEAK
001,002,036,169,339,635,682,757,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FACTORS,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,RPA,SURGERY
102,ANP,B16,C57BL,ECTOPIC,NH2,NPR,THESE
169,218,AMONG,COX,HOWEVER,HPV,HPV16,MEIER,OCSCC,PRESS,PUBLISHED,PXN,RFS,THEREFORE,THESE,UNIVERSITY
BEP,CHEST,GROUP,PET
THESE
003,169,254,278,447,676,BACKGROUND,BONFERRONI,COLORECTAL,LABEL,METHODS,OVARIAN,OVERALL,RESULTS,SCREENING,SERUM,SOCIETY,TRIAL,USING
150,200,BACKGROUND,BMS,BRAIN,CONCLUSION,GRADE,IMBRT,LABEL,METHODS,NSCLC,RESULTS,THREE,TMZ
169,ADP,ATM,BRCA1,DDR,DUB
186,INCREASING,MICRORNAS,NSCLC,RHO,ROCK1
001,022,112,945,946,ARMADILLO,ARMC8,CONSISTENT,COX,H1299,MMP,NSCLC,THEREFORE,THESE,TNM,WESTERN,WNT
020,022,406,812,CHINESE,HIF,HYPOXIA,NSCLC
ATXN2,BACKGROUND,LABEL,METHODS,NOVEL,RESULTS,RPS6KB2,SOMATIC,SP1,TEN,THESE
BACKGROUND,CONCLUSION,ENZYMATIC,G719S,G724S,HOWEVER,INHIBITION,LABEL,RESULTS,THESE,THROUGH
169,177,183,945,947,BRITISH,CD4,CD8,COX,IFN,IMMUNOLOGY,PGE,PREVIOUSLY,SOCIETY,THERE,TNF
169,627,679,ACUTE,BACKGROUND,CONCLUSION,COPYRIGHT,IIP,IRELAND,LABEL,LTD,MARCH,MEDICAL,METHODS,OCTOBER,RESULTS,THEREFORE
169,COPYRIGHT,GGN,HOWEVER,IRELAND,JANUARY,LABEL,LTD,MARCH,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
CIGARETTE,CSE,DESPITE,LYN,STAT1,TAKEN
169,280,AMONG,EASTERN,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,TKI,UNIVERSITY
001,004,005,020,022,035,043,191,731,BACKGROUND,COX,HOWEVER,LABEL,LOG,MEIER,METHODS,NOK,NSCLC,PTK,RESULTS
001,169,231,233,2GY,3GY,4GY,5GY,COPYRIGHT,DYNAMIC,LABEL,METHODS,OBJECTIVE,POPULATION,PUBLISHED,PURPOSE,RESULTS,SAS
001,003,023,101,111,186,187,331,372,375,626,686,766,ATLAS,AUC,BACKGROUND,LABEL,METHODS,RESULTS,ROC,SIXTEEN,UNDER,USING
169,APRIL,COMPARISON,CONCLUSION,HOWEVER,JAPAN,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,OPERATIVE,PRESS,PRIMARY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY,VSD
046,169,CCP,CHEST,FIFTY,III,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RCP,RESULTS,SURGERY,THERE,TNM,UNIVERSITY
BACKGROUND,CONCLUSION,LABEL,METHODS,TREATMENT
169,1960S,1980S,1990S,948,HOWEVER,PDE,RAS,SINCE,THESE
160,AFTER,METASTASIS
200,414,455,CHINESE,INCREASED,KNOCKDOWN,MALAT,MELANOMAS,PCR
491,514,BACKGROUND,CONCLUSION,EARLY,EIGHT,INCREASING,LABEL,METHODS,RESULTS
AMONG,CHINA,CHINESE,IIA,PPD
GIVEN,MEASLES,PVRL4
AAT,ACUTE,ALPHA,APP,CHANGES,FINALLY,SEVERAL
160,169,183,898,ADMISSION,BECAUSE,DIAGNOSIS,ENDOSCOPIC,GEORG,HISTORY,IASLC,LABEL,METHODS,ONCOCYTOMA,PAD,RESECTION,STUTTGART,TREATMENT
019,440,RADIOMICS,THESE
MLD,PRV,PTV,TEN,V10,V20,V30
001,002,233,476,703,CONSENSUS,INDEX,OVERALL,PEARSON
100,300,EBT,GAFCHROMIC,OAR,RSS,TESTING
177,5CM,REGULAR,TEN,THEREFORE
101,282,919,CRT,PTV,THERE,TPS
177,CRT,HOWEVER,PTV,V10,V13,V20,V30
CARLO,FIRST,MONTE
CHANGES,GTV,MRI,TEN
HOWEVER,MIP,PHASE,TEN,THOSE
001,008,160,169,215,BLOOD,COPYRIGHT,HCT,HLA,INC,PUBLISHED,REDUCED,REPORTS,RESULTS,SOCIETY,THESE
169,BEATY,ERM,NHE,SILENCING
120,169,H2B,H3K79,PTM,RNF20,RNF40,SOCIETY,USP22,USP44
169,ACR,ALBERTA,BACKGROUND,BESIDES,BMS,CONCLUSION,KCR,LABEL,LOW,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,946,ALK,DISRUPTION,HSP90
169,ALK,CERITINIB,NSCLC,THESE
169,CHINESE,EMT,FUNCTIONAL,HOWEVER,MUTAGEN,PRESS,PUBLISHED,SNP,SOCIETY,THREE,UNIVERSITY,VEGFR
195,MICRORNAS,NON,NSCLC
169,COPYRIGHT,HESSIAN,HURWITZ,IRELAND,LTD,ROUTH,USING
HOWEVER,NSCLC,TKI
GOVERNMENT,LAM,LAMELLARIN,USING
169,COPYRIGHT,FEW,SOCIETY
169,ACUTE,ADVERSE,BETWEEN,COPYRIGHT,HOWEVER,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE
001,169,COPYRIGHT,III,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE
001,004,008,169,209,CTS,LABEL,LAD,MATERIALS,METHODS,OAR,OBJECTIVE,PURPOSE,RESULTS,THREE,V30
005,013,028,169,527,740,COLLEGE,COPYRIGHT,GROUP,III,INC,LABEL,LEVEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERAPY,Z0011
10Q23,14Q24,16Q11,AFFYMETRIX,CHB,CHINA,CHINESE,CYP2C,HENAN,HOWEVER,IBD,PAIRING,PLCE1,PLINK,SIAH1,SNP,WORLDWIDE
BACKGROUND,CONCLUSION,CXCR4,EMT,FINALLY,GEFITINIB,HFL,LABEL,METHODS,NON,NSCLC,PCR,RESULTS,WESTERN
131,177,945,946,AFTER,BACKGROUND,CONCLUSION,DD3,HOWEVER,KUNMING,LABEL,METHODS,MONOCLONAL,NCI,RESULTS,SIMILARLY,SUCCESSFUL,THEREBY
169,BRITAIN,COPYRIGHT,GREAT,IRELAND,LTD,PUBLISHED,RAS,RASG12D,SOCIETY,WILEY
001,040,100,104,147,ACCORDING,AIS,ATS,BAC,BACKGROUND,ERS,IASLC,JANUARY,LABEL,MEDICAL,METHODS,MIA,OSAKA,RESULTS,UNIVERSITY,VIA
169,649,COPYRIGHT,GIS,LTD,USING
945,AKT,HOWEVER,NSCLC,THESE,TNF
106,ACS,CYTOLOGIC,DIAGNOSTIC,HOWEVER,IHC,NOS,NSCLC
169,AUTHORS,BISULPHITE,CHROMATIN,FOUNDATION,JOURNAL,LTD,MOLECULAR,RUNX3,THESE,WILEY
ATS,BOARD,CHEST,COLLEGE,FOUNDATION,III,OCTOBER,PHYSICIANS,SOCIETY
169,672,BACKGROUND,COX,GROUP,INC,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SARCOMA,SSG,WILEY
160,ALK,AP26113,EPIDERMAL,HISTOLOGY,III,MET,NSCLC,TKI,TREATMENT
160,D95
169,COPYRIGHT,INC,OVERALL
100,131,99M,BECAUSE,DTC,FIFTY,LABEL,METHODS,OBJECTIVE,OVERALL,PRE,RESULTS,SPECT,WBS
169,183,200,671,681,751,871,COMMITTEE,CONCLUSION,FURTHER,IGF,III,LABEL,METHODS,MONITORING,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TREATMENT
105,169,BACKGROUND,CEA,CONCLUSION,COX,INC,LABEL,METHODS,NSCLC,RESULTS,STUDENT,SYSTEMATIC,WILEY
177,181,BAX,CASPASE,CCK,CHINESE,DAN,HOWEVER,IIA,JNK,KIT,MMP,NSCLC,TAKEN,TANSHINONE,TSIIA
169,510,ALK,AMONG,BACKGROUND,INC,LABEL,METHODS,NSCLC,PNA,RESULTS,SEVEN,WILEY
169,BACKGROUND,BETWEEN,DFS,INC,LABEL,MALIGNANT,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,THERE,WILEY
106,124,169,176,813,948,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,DISRUPT,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,PFS,RESULTS
169,COPYRIGHT,DUE,IRELAND,LTD,NSCLC,SOMATIC,V600E
169,ADC,CONCLUSION,COPYRIGHT,H1688,H2170,H69,H69AR,IRELAND,LABEL,LTD,METHODS,NOTCH,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SBC,SCC
169
169
169,STATE
169
169,PULMONARY
169,CARDIAC
169,PRIMARY,THESE
001,005,650,750,CONJUGATED,DYLIGHT,HOWEVER,NIR,PEGYLATED,PEGYLATION,SERUM,THESE
014,967,CRS,DIFFUSE,HIPEC,MARCH,MEIER,STUDENT,THERE
169,4T1,946,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LTD,MMP,NEU,SMAD2,TGF
169,ALECTINIB,ALK,CH5424802,COPYRIGHT,IRELAND,LTD,NSCLC,THESE
177,BACKGROUND,CD4,LABEL,MALIGNANT,METHODS,MPE,PLEURAL,RESULTS
026,044,048,373,410,CMV,NRM,SCT
BACKGROUND,ELISA,LABEL,METHODS,RESULTS,SRC,THESE,WESTERN
INC,PUBLISHED
BRAGG,FURTHER,HOWEVER
GAMMA,KARNOFSKY,KNIFE,KPS,LOCAL
001,002,004,015,027,MACROPHAGE,MEIER,PRIMARY,QUALIFIED,TAKEN,YES
BACKGROUND,BECAUSE,CONCLUSION,FETAL,LABEL,METHODS
ALZHEIMER,DRUGS,JAPAN,UNDER
BACKGROUND,CONCLUSION,FOXO4,LABEL,METHODS,PCR,RESULTS,WESTERN
114,160,BACKGROUND,DFS,LABEL,LOCAL,METHODS,NSCLC,RESULTS,VIDEO
BACKGROUND,CONCLUSION,DOCETAXEL,LABEL,METHODS
4T1,BACKGROUND,CONCLUSION,CSF,CXCR7,FURTHER,IDC,LABEL,METHODS,MMP,RESULTS,STAT3,THESE
BACKGROUND,HOWEVER,LABEL,METHODS,PULMONARY,RIGHT
BACKGROUND,DUSP3,ERK,FGF,HOWEVER,JNK,LABEL,LLC,PKC,RELATED,RESULTS,SINCE,USING,VHR
HOWEVER,PRIMARY
00001,720,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,T1A,THERE
100,BACKGROUND,CELLSEARCH,EPCAM,LABEL,METHODS,RESULTS,SAMPLES,SPIKE,USING
120,160,177,ANATOMICAL,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
BACKGROUND,CAUCASIAN,EPSTEIN,III,LABEL,METHODS,RITUXIMAB
BASED,BIOLOGICAL,EAR,EFFECTS,ERR,HCC,LABEL,LAR,METHODS,OBJECTIVE,OED,PURPOSE,RADIATION,RESULTS,TREATMENTS,VII
125,160,177,CONCLUSION,HAUNS,HOWEVER,LABEL,METHODS,OBJECTIVE,PEG,RESULTS
BACKGROUND,III,LABEL,LOCAL,METHODS,NSCLC,PET,RBE,RESULTS,WORST
001,002,ALDH1,BACKGROUND,CD133,FUNCTIONAL,HOWEVER,LABEL,NON,NSCLC,PCR,RESULTS,TIC
041,100,113,172,ALK,CONCLUSION,HIPAA,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
BACKGROUND,CAUCASIAN,CONCLUSION,GIVEN,HOWEVER,LABEL,METHODS,PULMONARY,WORLD
018,037,119,215,217,ALK,BACKGROUND,CONCLUSION,LABEL,METHODS,NODULAR,PATHOLOGY,RESULTS
177,BACKGROUND,BSC,LABEL,METHODS,MPE,OBJECTIVE,RESULTS,SUCCESSFUL,TPS
945,946,954,BACKGROUND,CHINESE,CTX,FEI,FLP,LABEL,LEWIS,LIU,METHODS,RESULTS,THERE,TNF
002,005,026,048,ADX,BACKGROUND,COX,LABEL,METASTASES,METHODS,RESULTS,RFS
124,523,ALK,ARIZONA,BACKGROUND,CALIFORNIA,CONTEXT,DIEGO,ECHINODERM,IHC,LABEL,MASSARRAY,MEDICAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SAN,SYSTEMS,VENTANA
177,BACKGROUND,DUE,GTV,HOWEVER,ITVSLOW,LABEL,METHODS,RESULTS,THERE,THREE,VOLUMETRIC
001,006,177,190,531,BACKGROUND,FDG,LABEL,METHODS,PET,RCC,RESULTS,THERE,TKI
CONCLUSION,HOWEVER,INTER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SGR
160,956,BACKGROUND,CD133HIGH,CD24LOW,CHRONIC,CNT,CSC,LABEL,METHODS,NANOG,NON,RESULTS,SOX,SWCNT,THESE
231,300,BACKGROUND,CLINICALLY,ECTOPIC,EMT,EPITHELIAL,HNSCC,LABEL,MCF,MDA,METHODS,MIR,PCR,RESULTS,TGF,TWIST,UTR
ALK,BACKGROUND,CHEST,CHINA,CHINESE,CONCLUSION,LABEL,METHODS,RAS,REMARKABLY
BACKGROUND,LABEL,LAM,LAMPOSIUM,METHODS,OBJECTIVE,RESULTS,SHORTNESS,WOMEN
145,229,260,AMONG,ARRHYTHMIC,BACKGROUND,CONFIDENCE,CVD,DISEASE,END,FURTHER,INTERVALS,LABEL,METHODS,NON,PREDICTORS,PRIOR,RATIO,RENAL,RESULTS,STAGE,UNIVARIATE
BACKGROUND,DISCOIDIN,EXPRESSION,G531V,LABEL,METHODS,MMP,MTT,NSCLC,PCR,PROTEIN,RESULTS,S131C,SCC,STUDENT,T681I,THESE
BACKGROUND,D90,GFP,LABEL,METHODS,NDV,NEWCASTLE,PREVIOUSLY,RESULTS
001,002,008,017,023,029,034,035,037,175,185,BACKGROUND,ICU,LABEL,LEA,METHODS,RESULTS,TEA,TOTAL,VAS
1CM,215,ACCORDING,BACKGROUND,CAUCASIAN,CLINICIANS,GLEASON,LABEL,METHODS,SIX,SMALL,THERE
160,200,BACKGROUND,EARLIER,EDU,LABEL,MALIGNANT,METHODS,MPM,PCR,PRIMARY,RESULTS,SILENCING,ZL55SPT
160,HOWEVER,LOCAL,PARTIAL
BACKGROUND,EQUATIONS,ERK,FGF,FGFRS,FIBROBLAST,H1703,HSGAG,LABEL,PSO,RAF,RAS,RESULTS,SWARM,USING
048,136,175,214,ATS,BACKGROUND,COX,ERS,IASLC,LABEL,MEIER,METHODS,RESULTS,SOCIETY,UNIVARIATE
169,225,ADC,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,NON,NSCLC,RESULTS,SQC,THEREFORE,UNASSIGNED,VIRTUAL
LOW
153,357,ACTIVATING,AFTER,BACKGROUND,CAUCASIANS,FIFTY,HOWEVER,LABEL,MEDICINES,METHODS,NSCLC,RESULTS,TEN,TKI
BACKGROUND,BECAUSE,CARCINOID,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,METASTASIS,METHODS,UNRESOLVED
BACKGROUND,CNTNAP2,COX,DSS,LABEL,METHODS,MOLECULAR,PREDICTIVE,RESULTS,TAKEN
048,BACKGROUND,CLINICS,DISCUSSION,LABEL,METHODS,NHS,REGISTERED,SECONDARY,SMOKING,TRIAL
ALDEFLUOR,ALDH1A2,ALDH1A3,BACKGROUND,CIS,CSC,H2052,H28,INDUCTION,LABEL,MESO4,METHODS,MPM,PCR,RESULTS
001,BACKGROUND,LABEL,MANAGER,METHODS,RESULTS,THESE
004,177,230,400,437,455,501,580,625,652,689,840,895,935,946,BACKGROUND,CONCLUSION,COX,HRQOL,LABEL,METHODS,NSCLC,QLQ,QOL,QUALITY,RESULTS,TREATMENT
956,ARSENIC,BACKGROUND,CURRENT,DISCUSSION,LABEL,LITERATURE,SUMMARY,TIGHTER
ARSENIC,BACKGROUND,EMT,HCC,HOWEVER,LABEL,METHODS,MTT,NEITHER,RESULTS
BACKGROUND,CARDIAC,CONCLUSION,FVC,INCLUSION,LABEL,METHODS,RESULTS,THERE
AKT,AMONG,BACKGROUND,CONCLUSION,GEFITINIB,HOWEVER,INDEX,LABEL,MARSDENIA,MET,METHODS,MTE,NON,NSCLC,RESULTS,THEREFORE,THREE,WESTERN
BACKGROUND,BRAIN,HOWEVER,INDEX,LABEL,METASTASES,METHODS,NSCLC,PRIOR,RESULTS,SCORE,SIB,SIR,SIX,THREE,TKI,WHOLE
000,100,AGE,AMONG,BACKGROUND,CONCLUSION,EPI,EXCEL,GHANA,HISTOLOGY,HOUSING,KOMFO,LABEL,LABORATORY,LIVER,METHODS,MICROSOFT,OVARY,PATHOLOGY,POPULATION,REGISTRIES,RESULTS,SOUTH,STOMACH,VERSION
024,025,126,168,174,APEX1,CHINA,CHINESE,COX,GENESKY,GROUP,HAN,INC,KARNOFSKY,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,THERAPY,THREE
946,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,TGF,THEREFORE,THESE
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,THESE
867,BACKGROUND,COD,COMPARING,LABEL,METHODS,NCD,RESULTS
047,180,210,390,ACTIVATING,AFTER,AMONG,BACKGROUND,CRC,DETECTION,III,LABEL,METHODS,NSCLC,RELAPSE,RESULTS,WENCA
108,BACKGROUND,CCK,DGE,ERBB2,HOWEVER,INCREASING,LABEL,MEF2C,METHODS,MMP10,PCR,PDACS,RESULTS,YIN,YY1
100,150,ADX,HRM,NSCLC,PCR,RESULTS,SPACE
945,946,ACD10,BINDING,D10,FURTHER,HOWEVER,M10,MULTIMERIC,NSCLC,PET,RGDLATLRQL
111IN,155,177LU,BASED,DOSIMETRY,DYNAMIC,GELOFUSIN,HER2POS,MBQ,MYC,NANOBODIES,RIT,SIMILAR,SMALLER,THREE
001,011,017,947,CD4,FOXP3,IFN,IL17A,TH1
945,946,B16,CYTOKINES,KNOCKDOWN,LAL,LEWIS,LYSOSOMAL,MDSCS,MYELOID,THEREFORE
169,590,ALBERTA,APRIL,BACKGROUND,COPYRIGHT,DISCHARGE,INC,LABEL,MARCH,METHODS,PUBLISHED,RESULTS,SEVEN,SEVERAL,SOCIETY,USING
100,176,600,DOE,ESI,GBD,MINITAB,MTT,OPTIMIZED,SEL,SEP
169,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GRADE,INCLUDING,IRELAND,JANUARY,LABEL,LTD,MALIGNANT,MARCH,MATERIALS,MEIER,METHODS,MPM,PFS,RESULTS,SEVERAL
009,169,281,CELLSEARCH,CONCLUSION,CONVERSELY,COPYRIGHT,CTC,HARRELL,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,PREVIOUSLY,PRIMARY,RESULTS
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
100,324,AFTER
169,215,995,99M,COPYRIGHT,HOTELLING,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PEARSON,PPS,PUBLISHED,RESULTS,SPECT,SURGERY,THESE
008,169,367,562,860,CD3,CD8,COPYRIGHT,NSCLC,PBMCS,PRIMARY,TKI
HODGKIN,HOWEVER,SPE

GPA
BILIARY
112,159,166,296,BACKGROUND,COLORECTAL,CONCLUSION,DFI,LABEL,METHODS,PRECISE,RESULTS
PREVALENCE
169,ERS,IPF,STRUCTURED,THREE,WHILE
169,COPYRIGHT,IRELAND,LTD,NSCLC
169,183,244,BACKGROUND,BECAUSE,BMI,COMPARABLE,COPYRIGHT,DALYS,FEDERATED,FOUNDATION,FUNDING,GATES,LABEL,LIBYA,LTD,MELINDA,METHODS,MICRONESIA,PREVALENCE,QATAR,RESULTS,SAMOA,SINCE,TONGA,UIS,WORLDWIDE
169,700,956,ALLERGY,BACKGROUND,CD4,CD8,COLLEGE,CONCLUSION,COPYRIGHT,IGM,ILD,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS,THESE
PTHLH,WHEREAS
000,200,CDX,CTC,GENOMIC,SMALL,THESE
001,015,028,034,145,COX,FURTHER,HOWEVER,MEIER,PCR,THESE
529,676,AUC,CHINESE,DOR,LIBRARY,MEDLINE,MOLECULAR,NLR,PLR,SIMILAR,STATA
A2780,BAX,BCL,CHINESE,FURTHER,HOWEVER,OVCAR,TRIPTOLIDE,WESTERN
BASED,DUE,FINALLY,MRI,RESULTS,ULTRASOUND
215,246,295,348,861,BRCA2,CHEK2,GENOMES,ILE157THR,PROJECT,THESE
160,169,ACADEMY,ADHERENCE,ALGORITHM,ASSESSMENT,BACKGROUND,CDS,COMPLETION,CONCLUSION,CONTEXT,COPYRIGHT,DEPRESSION,HOSPICE,INC,LABEL,MANAGEMENT,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RESULTS,SYMPTOM
169,946,COPYRIGHT,ESI,NIH,NMR,NUR77,ROESY,SAR,THEIR
001,135,177,204,382,496,610,701,784,867,BAF,ROC,SERUM,SIXTY
169,AIS,BECAUSE,LINEAGE,MIA,NOTABLY
ACUTE,APRIL,CAT,FIRST,LABEL,MEASURE,METHODS,OBJECTIVE,RESULTS,THEIR,THIRD,THREE
388,446,834,956,ARSENIC,BESIDES,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFT,PULMONARY,RESULTS
183,339,380,ACUTE,CONCLUSION,FVC,GEORG,INCREASED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUTTGART,UNIVERSITY
169,CIGARETTE,COPYRIGHT,ENGLISH,HOWEVER,MEDLINE,SOCIETY,STUDIES,THEREFORE
173,471,NON
CAPSAICIN,DEPLETION,ELISA,SCLCS,STUDIES,TAKEN,TRPV1,TRPV6
ACTIVATION,EARLY,III,NSCLC,PHASE,SEVERAL
AMONG,GAMMA,HOWEVER,KNIFE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE
160,169,COPYRIGHT,III,NSCLC,SAS,SEPTEMBER,SEVERAL,TKI
169,BACKGROUND,BIOLOGICAL,COPYRIGHT,LABEL,M1A,M1B,MANAGEMENT,METHODS,PUBLISHED,SAS,STUDIES
160,169,BACKGROUND,CONCLUSION,COPYRIGHT,GETTING,HOWEVER,LABEL,METHODS,NANCY,PUBLISHED,RESULTS,SAS,UNIVERSITY
BACKGROUND,CARCINOIDS,CONTEXT,LABEL,OBJECTIVE,RESULTS,VHL
001,114,132,169,451,671,827,987,ASIAN,BACKGROUND,CALIFORNIA,CCR,COPYRIGHT,COX,CSS,FEWER,III,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,OCTOBER,RESULTS,VARIABLES
100,5A4,ALK,APART,BACKGROUND,BREAK,CLONE,CONTEXT,ECHINODERM,HOWEVER,IHC,LABEL,LSI,METHODS,NSCLC,OBJECTIVE,PCR,PROBE,RESULTS
DESPITE,LABEL,METHODS,OBJECTIVE,PDF,PURPOSE,RESULTS
176,270,HOUNSFIELD,HUS,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,UPRIGHT
BLD,DRP,DSC,FUZZY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,S3P,S4R,SPATIAL,THOSE
177,CARLO,LABEL,METHODS,MONTE,MRF,OBJECTIVE,PTV,PURPOSE,RESULTS,RIDGE,THERE,TOPAS,USING,V20
177,300,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RLSPS,VARIOUS,XCTNS
119,176,FITCHBURG,IEC,LABEL,MAPCHECK2,MC2,MELBOURNE,METHODS,NUCLEAR,OBJECTIVE,PHILIPS,PURPOSE,RADIATION,RESULTS,SUN,SYSTEMS,USING
BECAUSE,INTENSITY,LABEL,LINAC,METHODS,MLC,MRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIMILAR,STUDIES
948,ABOVE,IMAGE,LABEL,LAS,LOW,MEDICAL,METHODS,OBJECTIVE,PEARSON,PHANTOM,PURPOSE,RESULTS,SYSTEMS,VEGAS
169,ANOTHER,COPYRIGHT,LABEL,LBP,LQP,METHODS,OBJECTIVE,RESULTS,TOWARDS
001,016,026,062,066,169,219,248,298,694,AIM,AUC,COLLEGE,CONCLUSION,COPYRIGHT,FDG,LABEL,LTD,METHODS,NPV,NSCLC,OBJECTIVE,PET,PPV,PUBLISHED,RESULTS,ROC,ROYAL
213,AIM,ASR,BEIDA,CONCLUSION,EASTERN,LABEL,LIBYA,METHODS,NORTH,OBJECTIVE,POTENTIAL,RESULTS
COLORECTAL,CRC,DESPITE,HOWEVER
BCSCS,KNOCKDOWN,L39,RPL39,SELECTIVE,THESE
100,120,169,256,CARLO,CONCLUSION,HOWEVER,IMAGING,INC,LABEL,LPS,MATHEMATIC,METHODS,MOLECULAR,MONTE,NORMALIZED,NUCLEAR,RESULTS,SOCIETY,UNLABELLED
169,BRM,BRMNULL,DIOSMIN,FLAVONOIDS,PRESS,PUBLISHED,RUTIN,THESE,UNIVERSITY
000,169,190,420,538,809,875,AFTER,CKD,COPYRIGHT,NEPHROLOGY,SOCIETY
169,286,359,404,613,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SELECTIVE,SURGERY,UNIVERSITY
169,ACUTE,LABEL,NSCLC,PRIOR,RAS,TRP53,UNLABELLED
947,CPT,DOX,GLU,LTD,NCA,PEG,PUBLISHED,ROP
15B,18A,29A,29B,29C,335,340,367,384,504,576,763,EIGHT,MEMBERS,MICRORNAS
TOBACCO
RAS,THESE
CAUCASIANS,HOWEVER,LIBRARY,SIX,VDR
939,ADJUSTING,DHS,HEART,INC,LABEL,METHODS,MODEL,MULTI,NDI,NON,OBJECTIVE,PUBLISHED,RESULTS,TEXAS,THERE
169,COPYRIGHT,INC,PUBLISHED
169,COPYRIGHT,DESPITE,ENGLISH,HPV,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL,SMCCS
AKT,CANCEROUS,CIP2A,HOWEVER,NSCLC
MAJOR
DESPITE,HOWEVER,STILL,THROUGHOUT
169,CAT,DCA,FINALLY,LABEL,RY4,SZETO,TAKEN,UNLABELLED
ADP,LAM,PARP1,PCR,TARGETING,TORIN
001,005,157,169,183,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,SIXTY,SOCIETY
149,169,196,332,403,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,RESULTS,SAS,SURGERY,THERE
169,COPYRIGHT,CUTANEOUS,SAS
CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ONCONEURAL,RESULTS
124,169,BACKGROUND,CEA,COPYRIGHT,DESPITE,HOWEVER,LABEL,LTD,METHODS,PBC,RESULTS,SIXTEEN,THERE,TMS
DETECTION,LUNGS
FURTHER,INC,PUBLISHED,PULMONARY
195,ECTOPIC,IGF1R,INSULIN,MICRORNAS,NSCLC
FDG,PET,RIGHT
CNT
488,568,ALEXA,DESPITE,FLUOR,QDS

103,200,MALDI,NSCLC,SERUM,SEVERAL
CD4,FOLLOWING,HOWEVER,NOTABLY,PATHOGENIC,TH1,TH2,TREGS
001,15489,169,607,663,706,722,724,785,811,872,912,BACKGROUND,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SCREENING,SMOKING,TRIAL,UNIVERSITY
BMJ,GROUP,LTD,PRIOR,PUBLISHING,RHF
BMJ,BOSNIAK,GROUP,III,LTD,PET,PUBLISHING
BMJ,GROUP,LTD,PUBLISHING,RCC,TKI
001,100,169,FDG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,POSITIVITY,PRESS,PUBLISHED,RESULTS,SURGERY,SUV,UNIVERSITY
169,176,181,AFTERWARDS,CISPLATIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SUBSEQUENT,SURGERY,UNDER,UNIVERSITY
169,BIOLOGY,MICRORNAS,SOCIETY
169,CRIZOTINIB,PRESS,PUBLISHED,SINCE,UNIVERSITY
FURTHER
160,GLRPKYS,HEPG2,HOWEVER,MRC,RWL,SEM,SEVERAL,THESE
105,177,726,798,CHINA,CONFIDENCE,MALIGNANT,MORTALITY,OVERALL,STOMACH,THERE,WASTEWATER
1M0,TNM
963,ATM,ATR,BRCA1,BUFALIN,CHINESE,DDR,NCI,WESTERN
ARGENTINA,MULTILEVEL,SPATIAL,TOBACCO
160,ABC,HOWEVER,MCF,NSCLC,OTHER,SSM,VINCA,VLB
DISTANT,NON,NSCLC
148,353,404,534,614,757,786,979,ASIAN,BACKGROUND,CHILE,CHINA,CLUSTER,COMPONENT,HCA,INDIA,INDIANS,LABEL,MATERIALS,METHODS,NORTH,PCA,PEARSON,PRINCIPAL,RESULTS,SOUTH,USA
001,320,572,ALA,ALA133SER,BACKGROUND,BESIDES,BOTHFIXED,CAUCASIANS,CIS,LABEL,MATERIALS,METHODS,ORS,OVERALL,PUBLISHED,RAS,RASSF1A,RESULTS,SCIENCE,SER,WEB
149,269,335
206,AGE,BACKGROUND,BRAIN,FORTY,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,THESE,WHOLE
010,017,055,153,947,COX,FIFTY,HOWEVER,III,MEIER,NSCLC,THEREFORE
315,BACKGROUND,CEA,HENCE,LABEL,MATERIALS,METHODS,NSCLC,PCR,RESULTS,THERE,TKI
004,ADVERSE,DCR,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RESULTS
001,002,050,414,BACKGROUND,BIOLOGY,CHINA,CHINESE,ENGLISH,HOWEVER,LABEL,LIBRARY,MATERIALS,METHODS,NSCLC,PEMETREXED,RESULTS,SIX,STATA12,THERE
001,449,512,CHINESE,H1299,HAN,NSCLC,PDCD6,PDCD6IP,TNM
001,002,004,128,COX,MEIER,NSCLC,PCR,TNM,WESTERN
017,027,042,160,459,CONCLUSION,DISTANT,HIPAA,III,IMAGING,IRB,KNOWLEDGE,LABEL,LUNGS,MATERIALS,METHODS,OBJECTIVE,RESULTS,THREE
MMP,WHILE
DESPITE,MECHANISMS,PATIENT,PTH,PTHRP
405,FORTY,FVC,LABEL,METHODS,NSCLC,PULMONARY,RAPIDPOINT,RESULTS,SIEMENS,UNLABELLED
AMONG,ASSESSMENT,III,ILL,LABEL,MATERIALS,METHODS,NSCLC,PULMONARY,RESULTS,SYMPTOM,THESE,UNLABELLED
DESPITE,HOWEVER,NSCLC,REGULATORY,TAKEN
001,169,CONCLUSION,FDG,FLT,IMAGING,INC,LABEL,LIVER,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTY,SOCIETY,SUV,THESE,UNLABELLED
169,AES,BACKGROUND,CONCLUSION,CRS,CURRENTLY,DCR,FORTY,FREQUENTLY,HEAVILY,LABEL,METHODS,NSCLC,PFS,PRESS,PRS,RESULTS,SECONDARY
001,150,169,174,BASEL,INC,L858R,MAY,MOLECULAR,NORTHBROOK,NSCLC,ORR,PFS,PRESS,ROCHE,SECONDARY,SYSTEMS,TARCEVA,THERE
169,C000000143,CTR,GRADE,LABEL,LEVEL,METHODS,OBJECTIVE,PHASE,PRESS,PUBLISHED,RESULTS,UNASSIGNED,UNIVERSITY
169,445,701,FASTING,HOWEVER,LABEL,METHODS,MUSLIMS,OBJECTIVE,PRESS,PUBLISHED,RAMADAN,RESULTS,TURKISH,UNIVERSITY
169,AUTHORS,PUBLISHED,RARRES3
000,169,240,248,BACKGROUND,CONCLUSION,GENERAL,IRISH,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SHS,SOCIETY,THERE,TOBACCO,UNIVERSITY
BACKGROUND,FIFTY,III,LABEL,LEVEL,METHODS,PULMONARY,RESULTS,THERE
947,ADP,BACKGROUND,CELLS,FANCG,HRR,LABEL,MASSIVELY,METHODS,MPE,NSCLC,PARP1,PARPI,PRIMARY,RAD51,RESULTS
169,AUTOMATED,AUTOMATIC,COPYRIGHT,COX,EVALUATION,INC,LABEL,LARGE,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PEARSON,PURPOSE,RESULTS
169,181,228,404,BETWEEN,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRONE,PURPOSE,RADIATION,RESULTS,SEVENTY,THERAPY,THERE
043,169,186,COOPERATE,COPYRIGHT,COX,DEFINITIVE,EASTERN,GROUP,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE,USING
EUS,FNA,GAUGE,NSCLC
177,BAC,EFS,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEM,WEIGERT
ANAPLASTIC,ATC,CISPLATIN,EPIRUBICIN,THEREFORE
134,158,313,BACKGROUND,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,TWITTER,WORDS
001,160,177,197,DEBEE,DIM,DOC,DOCETAXEL,ENDDS,EPHA2,EVALUATION,H1650,LABEL,METHODS,OBJECTIVE,PCR,PEG2K,PRO,PURPOSE,RESULTS
169,COPYRIGHT,DIAGNOSTIC,EDUCATION,ENGLISH,FOUNDATION,IDIOPATHIC,INC,IPF,JANUARY,MEDICAL,PUBLISHED
151,CTC,EMT,EPCAM,HGF,IHC,NSCLC,PCR,RECURRENCE,TOTAL

945,954,ADP,BESIDES,COX,CREBANINE,TAKEN,TNF
160,169,183,215,CONCLUSION,DIPNECH,GEORG,GIVEN,HISTORY,LABEL,METHODS,SINCE,STUTTGART,TREATMENT
161,169,388,773,FURTHER,NSCLC,OVERALL,THESE
043,169,CASES,CNB,CONSENSUS,DIAGNOSIS,INC,MEDICAL,WILEY
100,107,18F,BETWEEN,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS
169,429,COPYRIGHT,INC,MICRORNAS,NSCLC,TAKEN,TIMP2
100TH,121,169,COPYRIGHT,FURTHER,INC
000,169,CD8,IHC,PCR,PD1,PROGRAMMED,STUDENT,THEREFORE,TIL,TOTAL
169,IHC,NON,NSCLC,WHEREAS
169,ASSOCIATES,COPYRIGHT,FINALLY,LTD,PUBLISHED,THEREFORE
169,COPYRIGHT,FGF10,MSC,SOCIETY
100,JANUARY,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,PPV,PURPOSE,RESULTS,TECHNICAL,XPERGUIDE
169,ALGORITHMS,ANOTHER,BMJ,FURTHER,GROUP,LTD,PUBLISHING,SCREENING,SUFFICIENT
FDA,NANOFIBRE,PCL,RELEASE
BACKGROUND,CONCLUSION,FINALLY,FOS,LABEL,METHODS,PCR,RESULTS
PULMONARY,THESE,WHILE
1990S,BACKGROUND,CHANGES,CONCLUSION,CONTROL,JAPAN,LABEL,METHODS,OSAKA,OVERALL,PREFECTURE,PROGRAM,RESULTS
MACINTOSH,THERE,UNDER
DESPITE,EXCESSIVE,HOWEVER
169,ACUTE,ADAPTED,DISEASE,GRADE,III,JAPAN,NSCLC,PBT,PHASE,PRESS,PUBLISHED,RADIATION,RBE,SIX,SOCIETY,STAGE,UNIVERSITY
HOUNTIS,INTENSITY,NSCLC
001,002,177,MALIGNANT,THESE
001,169,474,713,978,AFRICAN,AFTER,AMERICANS,BACKGROUND,END,LABEL,METHODS,RESULTS,SOCIETY,THESE
100,120,169,958,BACKGROUND,END,HNSCC,LABEL,METHODS,RESULTS,ROUTINE,SOCIETY,SPM,SURVIVORS,THERE
01A,169,183,33258,956,AIM,CHINA,CONCLUSION,COPYRIGHT,FURTHER,HOCHEST,LABEL,METHODS,MTT,OBJECTIVE,PUBLISHED,RESULTS,SPC,UNIVERSITY
169,AKT,COPYRIGHT,INC,NSCLC,SEVERAL,THESE,WHILE
001,006,020,026,169,967,COCHRAN,COPYRIGHT,EXPRESSION,GTPASES,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RAL,RESULTS,SINCE,THERE,WESTERN
169,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MICRORNAS,OBJECTIVE,OBJECTIVES,RESULTS,TET
100,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LESIONS,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PARAMETERS,PET,PUBLISHED,RESULTS,ROYAL
293FT,947,CD3,CD4,CD8,IFN,LEWIS,RESULTS,VSIG4
169,AMP,LTD,METFORMIN,PUBLISHED,THESE,WILEY
169,231,B16,COPYRIGHT,F10,FURTHER,HOWEVER,INC,MDA,NEOPLASIA,PRESS,PUBLISHED,THESE
119,956,THEIR,THREE
169,INC,PUBLISHED,THERE,THEREFORE
OPTICAL,VOC
169,ASIAN,FOGARTY,HOWEVER,PACIFIC,SOCIETY
169,ACUTE,AHA,ALR,ANR,ASSOCIATED,COPYRIGHT,DIC,DISEASE,FEBRILE,FFP,FNHTR,FRESH,GRAFT,HEMOLYTIC,LTD,NON,OTHER,PLATELETS,REACTIONS,RELATED,THEREFORE,TRALI,TRASFUSION,TTB,WILLEBRAND
160,ADDITIONAL,CANDIDATE,CO2
169,945,946,956,COPYRIGHT,THEIR
001,120,140,150,155,169,309,349,469,531,540,608,695,AMONG,ORS,SYNERGY,THERE
001,013,014,017,039,945,EBC,IIA,NSCLC,TNF
HOWEVER,TARGETING,THEREFORE
001,002,003,014,018,020,027,COX,DFS,NSCLC,PRE
274,988,CHINESE,CLPTM1L,HOWEVER
BACKGROUND,CHINA,CHINESE,DISCUSSION,ELDERLY,EORTC,IDENTIFIER,III,LABEL,LONGHUA,MEANWHILE,METHODS,NSCLC,PFS,QLQ,RESULTS,SEVENTY,TCM,TRIAL
HENCE,HYPOXIC
169,183,200,722,947,COPYRIGHT,D50,D98,DVH,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,USING
169,BBB,BRAIN,COPYRIGHT,CURRENTLY,IRELAND,LTD,NSCLC,TKI,WOULD
169,CHRONIC,COPYRIGHT,DISEASE,GPS,HOWEVER,LTD,PULMONARY
169,239,APC,ATTACKING,CASC1,NON,NOTABLY,NSCLC
169,CPG,CSS,GISTS,KIT,PGL,SDH,SOCIETY,STRATAKIS
ALK,BIOMARKER,DAVID,FUNCTIONAL,MCL,NETWORK,THEREFORE,THESE,TK1
CHINA,GIVEN,KNOWLEDGE,MARCH,ROC,SUMMARY
000,414,BACKGROUND,BRONCHITIS,FALLS,INCIDENCE,IRS,LABEL,METHODS,RATES,RESULTS,UNLABELLED,USING,WOMEN
000,001,100,110,160,169,221,508,800,956,BACKGROUND,CHILE,CONCLUSION,LABEL,METHODS,ORS,RESULTS
174,177,COX,ERCC1,JANUARY,MASSARRAY,NSCLC
239,ALK,APART,BREAK,EMA,FDA,GIVEN,III,JANUARY,KIT,MEDICINES,NSCLC,PROBE,VYSIS
160,231,954,AKT,COX,MDA,MMP,THEREFORE
ARHGDIA,FUNCTIONAL,GTPASES,HCC,LOW,RHO,TTR
160,169,ASSOCIATES,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,FOLLOWING,HOWEVER,LABEL,LTD,METHODS,PUBLISHED,SMALL,SURGERY,SUV
119,169,CHINA,CHINESE,COPYRIGHT,COS,DIAGNOSIS,DOS,INC,OVERALL,PRESENTLY,TCM
160,174,377,986,COX,RADON,SMR
BECAUSE,MCF,MDR,THESE
178,BACKGROUND,BCL,CONCLUSION,CRA,DESPITE,LABEL,METHODS,PBMCS,PFS,RESULTS,THERE,TREATMENT
AMONG,BASIC,PPI,THERE
100,956,AMONG,IC50S,THESE,VI5,VI7
160,946,ACE,ANG,ANGII,EXPRESSION,HOS,MAS,RAS,THESE
BASED,DESPITE,FAK,FAS,GEF,RHO,SINCE
946,947,ALZHEIMER,NCI,NOTCH,PS2,STAT3,TAKEN,THEREFORE
169,954,AUTHORS,COPYRIGHT,H1299,HRP,INC,MYC,PUBLISHED,ROS,SUBSEQUENT
BASED,BMICS,BMS,BRAIN,BTICS,DESPITE,SIMILAR,THESE,TIC
169,19DEL,ADDITIONAL,AFTER,ALK,COPYRIGHT,E542K,ION,IRELAND,L858R,LABEL,LTD,METHODS,NGS,NSLAS,OBJECTIVE,PCR,PURPOSE,RESULTS,RET,TKI,TORRENT
169,177,3DCRT,BECAUSE,COPYRIGHT,DOSIMETRIC,HOWEVER,INC,MEDICAL,OAR,PTV,PUBLISHED,TOMODIRECT
169,COPYRIGHT,HODGKIN,INC,MEDICAL,OWING,PRIOR,PUBLISHED,UNIVERSITY,WASHINGTON
148,169,488,545,954,960,AIM,CALCULATED,CCC,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PERCENT,PUBLISHED,RESULTS,ROYAL,USING
183,DISCUSSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTEEN
169,55933,945,947,AT5,ATM,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,DSB,HOWEVER,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,S1981,WESTERN
169,BASED,COPYRIGHT,CRC,HCT,KDS,LTD,SELEX,W14
150,177,319,COX,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SRS,THERE,THESE
CLINICIANS,III,LARGE,SUPPLEMENT,VITAMIN
11P15,16Q,COG,GROUP,PEDIATRIC,PROGNOSTIC,REMARKABLY,SOCIETY,WHEREAS,WILMS
NON
ASPIRATOR,DIFFERENT,GIVEN,LIVER,PRINGLE,ULTRASONIC
ALCHEMIST,ALK,INITIATIVE,INSTITUTE,MATCH,NCI,NETWORK,RESPONDERS,THESE
169,COPYRIGHT,OPTIMUM,SOCIETY,THERAPY
BTB,POZ,ROS,THEREFORE,ZBTB3
160,169,COPYRIGHT,INC,PROGNOSIS,PUBLISHED,SOCIETY,TREATMENT
125,169,4T1,945,947,ASIAN,BESIDES,COPYRIGHT,IFN,MMP,THESE,TNF
169,CHOLINE,COPYRIGHT,PARTIAL,PLS,THESE,TOF
ADVERSE,ALK,CERITINIB,NSCLC,ONGOING,PHASE
169,COPYRIGHT,LTD,WHILE
EVALUATION,THEREFORE,TREATMENT
169,AFTER,BACKGROUND,END,HOWEVER,LABEL,METHODS,PROGRAM,RESULTS
CYS,ROS
AMONG,III,LABEL,METHODS,OBJECTIVE,RESULTS
366,946,BRCA1,COX,ERCC1,HOWEVER,III,NSCLC,TUBB2,TUBB3
BACKGROUND,FGFR1,LABEL,OBJECTIVE,SCC,SEVERAL
113,177,178,213,BACKGROUND,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,RESULTS,VIDEO
001,002,003,032,155,162,169,311,319,479,611,BACKGROUND,COX,DESPITE,III,LABEL,METHODS,MIR,NSCLC,OBJECTIVE,PCR,RESULTS,THERE,TOTAL
281,BACKGROUND,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
ANALYZE,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THEREFORE
001,017,028,ACADEMY,AMONG,BACKGROUND,CHINESE,DEC,GEFITINIB,INSTITUTE,JAN,LABEL,MEDICAL,METHODS,OBJECTIVE,PFS,RESULTS,UNKNOWN
001,002,009,011,014,017,040,046,110,114,500,535,945,BACKGROUND,COX,DCR,ELISA,ERLOTINIB,KREBS,LABEL,LDH,MEIER,METHODS,MMP,MOLECULAR,OBJECTIVE,ORR,PFS,RESULTS,SERUM,TGF,THESE,TPS
177,192,AFTER,BACKGROUND,BIM,CISPLATIN,DDP,LABEL,METHODS,MIR,NSCLC,OBJECTIVE,PCR,RESULTS,UTR,WESTERN
100,946,AFTER,AKT,BACKGROUND,EXOGENOUS,LABEL,LK2,METHODS,OBJECTIVE,PCR,RESULTS,SPC,WESTERN
945,954,BACKGROUND,LABEL,METHODS,MTT,NUCLEAR,OBJECTIVE,PCR,RESULTS,TRANSWELL,WESTERN,XHO
954,AFTER,APOPTOSIS,BACKGROUND,CISPLATIN,DDP,IKBKB,IKK,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THEREFORE
169,CHINESE,CONCLUSION,COPYRIGHT,COX,HOWEVER,INDIVIDUAL,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WHETHER
031,110,169,237,443,474,CONCLUSION,COPYRIGHT,COX,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
004,007,169,916,CHANGES,CONCLUSION,COPYRIGHT,FDG,IRELAND,LABEL,LTD,METABOLIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PATHOLOGY,PET,PREDICTIVE,PTL,REMAINING,RESULTS,SST,SUV,TTL
100,951,956,H2O,RH2,THESE
729,730,820,910,AMONG,BACKGROUND,CONCLUSION,FURTHER,HOWEVER,INSURANCE,LABEL,METHODS,RESULTS,THEIR,THERE
001,004,253,320,633,BEIJING,CHEST,CHINA,CHINESE,COX,DCR,ORR,OVERALL,PFS,THERE,TKI
000,100,ACCORDING,ACS,CGA,GEP,GERMANY,NET,SERUM,TCS,TNM,WORLD
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NSCLC,TKI
169,COPYRIGHT,CRP,DISCUSSION,HOWEVER,LTD
AID,IGG,INHIBITION,METASTASIS,THESE
003,007,018,049,169,183,473,549,ALVEOLI,BACKGROUND,BLOOD,COPYRIGHT,FUNDING,HEART,INSTITUTE,INSTITUTES,LABEL,LTD,METHODS,RESULTS
063,783,ADP,ARG399GLN,ASIAN,BACKGROUND,CONCLUSION,HOWEVER,LABEL,PRINCIPAL,RESULTS,THESE,VAL762ALA,XRCC1
BACKGROUND,DIAGNOSTIC,LABEL,METHODS,NSCLC,PET,RESULTS,SPN
169,847,ALPHA,COLORECTAL,FINLAND,LEUKOCYTE,ORS,OVARIAN,PREVENTION,SCREENING,TOCOPHEROL,TRIAL,WOMEN
001,192,AKT,FURTHER,H3K27,HOX,HOXB7,NSCLC,THESE,TNM,UNIVARIATE
169,ALK,HOWEVER,INCREASED,NSCLC,SOCIETY
002,169,BACKGROUND,E2M,LABEL,MEIER,METHODS,MLN4924,NAE,NEDD8,PRESS,PUBLISHED,RESULTS,UBC12,UNIVERSITY
169,961,BACKGROUND,CHANGES,CONTOURING,COPYRIGHT,CROWN,EUD,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,PLANS,PTV,PUBLISHED,PURPOSE,RESULTS,SEVEN,TCP,VOLUMES
169,BASEL,GUIDELINES,IMAGE,ULTRASOUND
169,COPYRIGHT,NETWORK
169,CONFERENCE,COPYRIGHT,GUIDELINES,LEORA,NETWORK,NSCLC
329,BACKGROUND,FGFR1,LABEL,METHODS,NSCLC,RESULTS,SCC,TMA
ADJUSTING,BACKGROUND,GENERAL,LABEL,METHODS,NET,RESULTS,USING
196A2
169,COPYRIGHT,PUBLISHED,SOCIETY
0MGML,169,945,946,AMONG,AMR,AMRUBICIN,BACKGROUND,CBDCA,COPYRIGHT,HOWEVER,LABEL,METHODS,NON,ORR,PFS,PUBLISHED,RESULTS,SOCIETY
169,415,BACKGROUND,CONCURRENT,COPYRIGHT,GRADE,HOWEVER,III,JANUARY,LABEL,METHODS,MST,NSCLC,PUBLISHED,RESULTS,SOCIETY
100,101,169,780,BACKGROUND,EXCLUDING,LABEL,MARCH,MASSIVE,METHODS,OTHER,PUBLISHED,RAPID,RESULTS,SOCIETY
18F,BACKGROUND,FDG,LABEL,METASTASES,METHODS,OBJECTIVE,PET,RECURRENT,RESULTS
ASIAN,SUBSEQUENT
18F,18FDG,AFTER,CEA,ERLOTINIB,GEFITINIB,HOWEVER,L858R,PET,THREE
ASIAN,BECAUSE,HCC
100,ALDH1A1,BACKGROUND,BETWEEN,DETECTION,ELISA,LABEL,METHODS,NSCLC,RESULTS
ACADEMY,ADVERSE,ASSESSMENT,BACKGROUND,BETWEEN,DEPARTMENT,EVALUATION,GULHANE,LABEL,MEDICAL,METHODS,OBJECTIVE,RADIATION,RESULTS,SOLID
002,005,007,158,171,173,248,296,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,V10,V20
087,248,295,326,444,567,575,634,685,785,922,967,AFTER,BACKGROUND,CAUSE,CVD,LABEL,METHODS,NORWEGIAN,RESULTS
148,BACKGROUND,CASES,FURTHER,GSTM1,GSTT1,LABEL,METHODS,RADON,RESULTS,SEVEN,SIMILAR,THESE
345,828,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POTENTIAL,RESULTS
190,537,745,MCF
338,ATP7B,CHINESE,HAN
MULTIMODAL,PULMONARY
18FDG,PET
AHL,PQS,THESE,VFR
III,PHASE
169,947,COPYRIGHT,HDACS,IIA,MYC,REPORTS,YY1
BRM,FDG,LABEL,MET,OBJECTIVE,PURPOSE,RADIOLOGIC,RESULTS,SEVERAL,SUMMARY
BACKGROUND,CONCLUSION,HHV,LABEL,METHODS
002,013,023,026,132,CEA,CONCLUSION,FDG,FURTHER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC
HOWEVER
000,101,143,AUC,BASED,CONCLUSION,GGN,GGO,GROUP,IAC,LABEL,METHODS,MIA,OBJECTIVE,RESULTS,ROC,THROUGH
HOWEVER,INCREASED,THEREFORE
001,016,095,169,312,328,ALK,FGFR1,FGFR2,FGFR3,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,RET,SIX,TACC3
101,169,945,AZD2171,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VEGFR
BMJ,GROUP,LTD,PUBLISHING
AREAS,BACKGROUND,CHRONIC,COVERED,EPIGENETIC,LABEL,METHODS,OPINION
BCS,FDG,NOC,PET,PULMONARY,TOC
169,18F,COPYRIGHT,FDG,LTD,PET,WILEY
100,239,53BP1,800,ADVERSE,AMONG,AMUVATINIB,CONCLUSION,FORTY,KIT,LABEL,METHODS,MTD,NSCLC,OBJECTIVE,PURPOSE,RAD51,RESULTS
100,150,215,ALP,C57BL,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS
95D,AUTOPHAGY,BECLIN1,CONCLUSION,EARLE,LABEL,LC3,MDC,METHODS,OBJECTIVE,RESULTS,THESE,WESTERN
EGF,ERK,IQGAP,THESE
160,169,956,AMONG,AMPICILLIN,COPYRIGHT,DU145,HOWEVER,NMR,SAS,SKOV3

120,169,177,CONCLUSION,COPYRIGHT,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,DISRUPTION,ECM,FAK,MPM,NF2,SCIENCE,THESE,WHEREAS
BACKGROUND,BAL,CCL19,CCL21,CHRONIC,DESPITE,EXPRESSION,LABEL,METHODS,RESULTS
169,326,AUTHORITY,DISTRICTS,ENGLAND,LOCAL,MOTIVATED
260,ERK,FINALLY,HOWEVER,KMT,MAP,MEK,RAF,RAS,SET,SMYD3,USING
AKT,H1299,INHIBITION,NSCLC,OVERALL,PEMETREXED,PREVIOUSLY,THESE,TREATMENT
121,351,APC,CRC,EIF3E,FINALLY,PCR,PTPRK,RSPO2,RSPO3,THESE
AFTERWARDS
CHOROIDAL,EARLY,OVERALL
169,95C,95D,ALTERED,COPYRIGHT,FOXJ3,INC,KEY,LABEL,METHODS,MIR,OBJECTIVE,RESULTS
169,ADDITIONAL,AWARENESS,CASES,CD117,COPYRIGHT,ERG,HOWEVER,IHC,INC
AFTER,BLOOD,CISPLATIN,CONCLUSION,GFR,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
169,CMC,DOX,ME2MO,OEGYLATED,TOWARDS,VCH,WILEY
169,COPYRIGHT,CSLCS,IRELAND,LTD,SCREENING,SUCCESSFUL
101,680,ADC,AIS,AUC,LABEL,METHODS,MIA,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,ROC
155,169,AUC,BACKGROUND,COMPARABLE,COMPARISON,CONCLUSION,COPYRIGHT,CURVE,DPH,DPN,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,SHOWING,SUPPORT,SYSTEMS,THESE,UNDER
114,16063,MICRORNAS,THESE
DESPITE,MICRORNAS,NSCLC,THEREFORE
006,122,182,260,275,318,466,733,ACTIONABLE,ALK,AMONG,BACKGROUND,CONSORTIUM,ERBB2,IDENTIFIER,IMPORTANCE,IQR,LABEL,MET,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,SETTING,TARGETING,TRIAL
169,CYTOMETRY,FIRST,HOWEVER,PCA,PRINCIPAL,SOCIETY
DESPITE,GGN,LABEL,LIMITED,METHODS,OBJECTIVE,PURPOSE,REGARDING,RESULTS,SOLID
150,ACCORDING,EORTC,EVALUATION,FDG,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RADIOLOGIC,RESULTS,SIXTY,SOLID,SUV,THREE,TKI,TREATMENT
169,ATO,COPYRIGHT,INC
169,946,ASSOCIATED,B16,COPYRIGHT,ECM,INC,LAMP1,PROTEIN
157,169,296,COX,HOWEVER,NUTRITION,PAH,PRESS,PUBLISHED,SPANISH,THERE,UNIVERSITY
CHINESE,FINALLY,HOWEVER,NSCLC,SNL,SOLANUM,STAT3
CAUCASIAN,DRC,FURTHER,GLN,LYS,OCTOBER,REDUCED,XERODERMA,XPD
000,169,COPYRIGHT,DICOM,ELECTRICAL,LTD,SAD,VOJVODINA
131,169,BACKGROUND,INVENTORY,LABEL,METHODS,ORR,PFS,QUALITY,RESULTS,SECONDARY,SOCIETY,SYMPTOM
FURTHER,HOWEVER,METABOLIC,OBESE,THESE
169,243,BRITISH,COPYRIGHT,INFECTION,IPA,IQR,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,PUBLISHED,RESULTS,TEN
473,AKT,ATP,CAV,CDC42,DENDROBIUM,HACAT,SER,WESTERN
000,029,169,446,454,CONCLUSION,COPYRIGHT,COSTS,FEE,FFS,HMO,HODGKIN,IMAGING,LABEL,MATERIALS,METHODS,MRI,NETWORK,NHL,OBJECTIVE,PET,PURPOSE,RATES,RESULTS,SOCIETY,THERE
BOEHRINGER,CHEMICALLY,INGELHEIM,L858R,NSCLC,PRESENTLY,UNION,USA,USFDA
945,PEMETREXED,TCELL,V1801,VARIOUS
174,181,480,FDA,ROCHE,THESE
500,ALTERED,CHINESE,FURTHER,LABEL,LOW,MASSARRAY,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCC,SNP,WNT
169,441,504,BACKGROUND,CONVERSELY,END,LABEL,MEN,METHODS,PROGRAM,RESULTS,SIR,SIRBLADDER,SIRRECTAL,SOCIETY,THERE
169,470,610,BACKGROUND,CIS,COPYRIGHT,HOWEVER,INC,JOURNAL,LABEL,METHODS,OBJECTIVE,PREVENTIVE,PROLONGED,PUBLISHED,PURPOSE,RESULTS,SMOKING,THERE
947,ALK,CTL,H2228,HLA,IFN,RLSALESRV,THESE
COX,STUDIES,THESE,TRIGGERING
169,638,COPYRIGHT,FEDERATION,HOWEVER,NSCLC,PUBLISHED,SILENCING,SOCIETIES,UTR
197,AKT,ANNEXIN,ARQ,ERK,FINALLY,H1975,MEK,MET,MTT,PATHWAY,T790M,TKI
146,HRM,L858R,MEC,PCR,T790M,TKI
160,ANNEXIN,COCL2,EGR,HRE,INFECTION,MTT,PLASMID,USING
495,578,CLUSTER,CPG,FDR,FURTHER,PATHWAY
100,307,5A4,ALK,IHC,THEREFORE
BMJ,GROUP,LTD,PUBLISHING
BMJ,GROUP,LTD,METASTASES,PUBLISHING,RENAL
AFTER,BMJ,GROUP,LTD,PUBLISHING,THESE
018,025,072,079,161,1ST,2ND,BACKGROUND,EPITHELIAL,LABEL,MALIGNANT,METHODS,OVERALL,RESULTS
109,150,151,169,CONCLUSION,ERLOTINIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY,SOCIETY
AURKA,BAX,BCL,H1688
169,945,AUTHORS,E7820,H1650,H1975,L858R,LTD,NSCLC,PTY,PUBLISHING,SCIENCE,T790M,TKI,TREATMENT,TUNEL,WILEY
100,215,945,946,HISTOLOGIC,KERATIN,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SMA,WHETHER
BASED,DONOR

BACKGROUND,CONCLUSION,DELAYED,DUE,LABEL,LITERATURE,METHODS
ASP,ASP312ASN,ASP312ASP,CDA,GLN,HOWEVER,LYS,LYS751GLN,NSCLC,THERE,THESE,TTP,XERODERMA,XPD
013,BXPC3,FINALLY,HENCE,HOWEVER,OVERALL,PANCREATIC,USING,USP9X
160,169,219,292,304,651,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SIXTY,SOCIETY,SYSTEMATIC
160,591,962,980,BACKGROUND,COX,END,HOWEVER,IQR,LABEL,MEIER,METHODS,MPM,OVERALL,RECEIPT,RESULTS
001,106,215,238,402,BACKGROUND,BIOMEDICAL,CAREFULLY,CHINESE,CIS,CONCLUSION,CRUDE,ERCC1,FUNCTIONAL,HOWEVER,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,ORS,OVERALL,REMOVAL,RESULTS,SEVERAL,SIXTEEN
169,ASPC1,BIOLOGY,DUE,FAB,GA201,IGF,IGG,INC,MOLECULAR,OASCFAB,R1507,SOCIETY
100,181,840,945,ATP,BASED,E2F,HOWEVER,SNU
945,CK2,GST,L22,RPL22,RPS,TAP
160,AKT,CURRENTLY,MTT,NSCLC,PC9,SYNERGISM,TKI
124,169,LABEL,LTD,MDT,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THESE,WILEY
169,HOWEVER
AYURVEDIC,COX,CURCUMA,LOX,SEVENTY
123,169,ADC,CAVITATION,COPYRIGHT,DIFFERENT,IMAGE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREVALENCE,RESULTS
100,135,160,CTC,PCR

160,NDRG2,THESE
108,169,CAF,COPYRIGHT,FEDERATION,FURTHER,NCF,PUBLISHED,SOCIETIES,THESE,WNT
001,069,085,106,144,169,191,472,799,ADJUSTING,ANALOGOUS,CAREFIRST,CONCLUSION,COPYRIGHT,CSF,ESA,FREQUENCY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SOCIETY
001,169,177,183,AFTER,BARTH,FRANCONIA,GEORG,LABEL,METASTASES,METHODS,OBJECTIVE,STUTTGART
000,100,956,ANNEXIN,APOPTOSIS,DOX,JC1,ROS,WESTERN
362,CUTTING,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,BECAUSE,COPYRIGHT,IFN,INFLUENZA,IRF,NADPH,RSV,SOCIETY,THESE,WHILE
169,COPYRIGHT,HOWEVER,SOCIETY,THOSE
WJOG4607L
701,727,947,HOWEVER,IFN,MALIGNANT,MPM,SIX,SOCS1,STAT1,STAT3,WESTERN
945,HCC,HIF,MHCC97L,THESE
001,002,008,013,019,029,622,ASC,THESE
001,005,CONCLUSION,CTV,DRT,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRT,V20,V30
003,169,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THEREFORE
100,131,169,COPYRIGHT,LABEL,MALIGNANT,METHODS,MPM,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY
150,169,230,400,945,AJS,BRITAIN,CIGARETTE,COPYRIGHT,EMT,GREAT,HBE,IRELAND,LTD,PUBLISHED,SIMILARLY,SMK,SMOKE,SOCIETY,SRC,USING,WILEY
169,CIS,CSC,DECREASED,FOLLOWING,H1299,SOX,SQE,THEREFORE
169,338,BACKGROUND,COPYRIGHT,COX,DENMARK,INC,LABEL,METHODS,NEPHROTIC,RESULTS,SIR,THEREFORE
116,169,183,BSA,CH3COOH,CH3OH,COPYRIGHT,FURTHER,H2L,HCT,INC,NI2,ONO,THREE,VIS
169,ARK,CPG,INK4A,INK4B,PBMCS,RESULTS
DIFFERENT,HOWEVER,LABEL,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,SCREENING,SUMMARY
177,18F,370,ABDOMINAL,AFTER,FDG,LABEL,MBQ,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVMEAN
169,368,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,INC,KAOHSIUNG,LABEL,METHODS,POTENTIAL,RESULTS,SIR,TOTAL,UNION,WORKERS
169,AUTHORS,LTD,MEDICAL,NETWORK,NSCLC,PTY,PUBLISHING,SCIENCE,THERE,UNIVERSITY,WILEY,ZOLEDRONIC
169,CONVERSELY,COPYRIGHT,DLBCL,END,LTD,RESULTS,USING
001,002,006,037,132,169,175,177,COPYRIGHT,GROUP,INC,LABEL,MEIER,METHODS,NEOPLASTIC,OBJECTIVE,OVERALL,PREVALENT,PUBLISHED,RESULTS,SURGERY,THERE,TREATMENT
169,945,BACKGROUND,COPYRIGHT,HIF,IRELAND,LABEL,LTD,METHODS,NSCLC,NTG,REDUCTION,RESULTS,SIXTY
169,COPYRIGHT,HOWEVER,INHIBITION,LPS,NSCLC,TRIGGERING,UTILIZING
130,177,945,EPG,NATURALLY,NCI,NSCLC,PEITC
001,128,160,169,177,AIM,BMI,CNR,COLLEGE,CONCLUSION,COPYRIGHT,CTDIVOL,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SEVENTY,SNR
169,CETUXIMAB,COPYRIGHT,LTD,TAXANES,TTF
169,818,AML,CCS,CONCLUSION,COPYRIGHT,END,HODGKIN,INC,INCREASES,IRR,LABEL,METHODS,NHL,OBJECTIVE,OCCURRENCE,REGARDING,RESULTS,SPT

017,029,032,183,233,BACKGROUND,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PROPENSITY,REPORTS,RESULTS
002,003,042,151,295,305,311,463,537,689,695,958,BACKGROUND,EVALUATION,LABEL,MEIER,METHODS,NANJING,NSCLC,PFS,RESULTS,SOLID,TKI
169,215,956,CONFERENCE,COPYRIGHT,CZT,ICH
VARIOUS
BMJ,GROUP,IMAGING,LTD,PUBLISHING
BMJ,GROUP,ISM,LTD,PUBLISHING
104,231,EXCISED,LABEL,LM2,MATERIALS,MDA,METHODS,MRI,OBJECTIVE,ORTHOTOPIC,PRIMARY,RESULTS
169,185,CCL,COPYRIGHT,DU145,HTB,LTD,MBC,PROMISING,SHARPLESS
BASED,FURTHER,QOL,WHILE
036,048,076,169,728,954,956,AIN,COPYRIGHT,COX,H1975,IKB,INC,NON,NSCLC,WESTERN
FOLLOWING,FUSED,HOWEVER,IMPORTANT,SNS,SPECT
102,104,169,177,AMPLITUDE,AVERAGE,D95,DCT,FTV,JAPAN,PRESCRIBED,PRESS,PUBLISHED,RADIATION,RBE,SOCIETY,UNIVERSITY
184,BASED,ERBB2,L858R,S310F
169,COPYRIGHT,DEV,DVH,LABEL,LTD,METHODS,OBJECTIVE,PBI,PDF,POPULATION,PTV,PURPOSE,RESULTS,SMALL
128,177,183,208,CHEST,FBP,HENCE,HOUNSFIELD,INSURANCE,IRT,LABEL,MATERIALS,METHODS,NOISE,OBJECTIVE,OVERALL,PHILIPS,PURPOSE,RESULTS,SPS,WRITTEN
100,169,ADVERSE,AFTER,DCMAT,FURTHER,GRADE,JAPAN,PRESS,PTV,PUBLISHED,RADIATION,SOCIETY,TOXICITIES,UNIVERSITY,USING
100,169,AUSTRALIA,ERS,IPF,SEVEN,TELOMERASE,THESE,WHILE
169,ATLAS,CLOSING,LARGE,PRESS,PUBLISHED,THESE,UNIVERSITY
003,005,023,14Q32,169,356,370,411,ACS,DIFFERENT,IASLC,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
169,368,889,CLUSTERING,CRMP5,IGG,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIGNATURE
169,DIAGNOSTIC,FOUNDATION,MRI,WESTERN
AMERICA,EARTH,GROUP,INSTITUTES,OCTOBER,POPULATION,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
ADC,JANUS,NSCLC,SCC,SIAH2,STAT1,STAT3
111,147,164,169,184,241,355,954,COHEN,CONCLUSION,FDG,FLT,III,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SOCIETY,THERE,UNLABELLED
ADP,BAX,BCL,HOWEVER,LTE,MEANWHILE,MMP,RGC32,TAKEN,WESTERN
169,277,635,CIRCLES,COPYRIGHT,DVH,ECLIPSE,EUD,HOWEVER,INC,MEDICAL,MLC,OVERALL,PUBLISHED,SEVERAL,SQUARES,TRS,TUBES,WEAVE
AMONG,MALIGNANT,MESOTHELIN,THEREFORE
120,EASTERN,GROUP,SERUM
160,435,DIETARY,MDA,PTX,RESULTS,USING
AKT,CONSISTENT,ESTRADIOL,EXPRESSION,FDG,GLUT1,GLUT4,LAM,MOLECULAR,NADPH,PET,TARGETING,USING
AXL,CCNB1,MICRORNAS,NSCLC,THESE,TKI,WNT5A

ANOTHER,AWARENESS,CK5,CLEAR,DIFFUSE,EPSTEIN,HISTOLOGIC,SMARCB1,TREATMENT
002,122,137,153,412,DRS
017,022,031,129,134,142,143,150,169,183,500,714,APRIL,BACKGROUND,COPYRIGHT,EASTERN,FEB,FUNDING,GROUP,ITALIAN,ITALY,LABEL,LTD,METHODS,RESULTS,THERE
169,COPYRIGHT,HIV,LTD,SCREENING,THEREFORE,THROUGH
000,001,017,048,105,160,250,BACKGROUND,CMV,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCT,THERE
133,177,208,ASSESSMENT,ERLOTINIB,EVENTUALLY,HOWEVER,LITERATURE,TDM,THESE
037,090,106,133,241,273,299,348,379,387,507,531,570,630,643,647,774,858,ACCORDING,BMI,CHINESE,CONCLUSION,CONTROL,COX,FURTHER,GUIDELINES,HBSAG,HOWEVER,HRS,LABEL,MAY,MEANWHILE,METHODS,OBESITY,OBJECTIVE,OVERWEIGHT,PREVENTION,RESULTS,STRATIFIED,THERE
169,ASIAN,PACIFIC,SOCIETY,THERE

169,CCR,PREDICTIVE
169,317,945,APRIL,CHINESE,CONCLUSION,COPYRIGHT,EORTC,IRELAND,KARNOFSKY,KPS,KRUSKAL,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,QLQ,QOL,QUALITY,RESULTS,SHORT,TIANJIN,TREATMENT
001,005,120,169,95D,COPYRIGHT,III,LABEL,METHODS,MMP,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,STAGE,TRANSWELL,WESTERN
181,CDK,E2F,E2F3A,E2F3B,H1299,HLM006474,NSCLC,SINCE,TAKEN
141,169,186,212,257,398,COLORECTAL,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,QOL,RESULTS,WILEY
160,280,MA148,THESE
169,342,496,609,625,DENMARK,JOURNAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,POPULATION,RESULTS,SETTING,SIR
EXTRA,FDG,MALIGNANT,PET
169,200,946,AKT,EMT,TGF,TKI
169,CONSISTENT,POLYOMA,SNAI2
169,CHRONIC,CONVERSELY,IL6,MCL,OVERALL,THESE
138,141,181,DALTONICS,HOWEVER,MALDI,MICROFLEX,SAMPLES,SPECTRA,TOF
ADDITIONAL,INC,PRIMARY,PUBLISHED
HDAC1,HOWEVER,LAD,PREVIOUSLY,SP1,TAKEN
PACLITAXEL,PEG,PTX,RED
947,HHD,HLA,HSPCS,NOD,NSG,USING
169,COPYRIGHT,HBECS,PUBLISHED,SOCIETY,THESE,WHILE
ANOTHER,WHILE
509,PNA,UTR
100,169,181,GSI,JAPAN,MARCH,PRESS,PUBLISHED,RADIATION,SOCIETY,UNIVERSITY
001,030,118,125,150,227,792,848,904,937,961,963,990,AUC,BACKGROUND,CEA,HE4,LABEL,METHODS,MRI,RESULTS,ROC
100,177,954,BACKGROUND,DISCREPANT,FLAIR,GADOLINIUM,GRE,LABEL,METHODS,MRI,RESULTS,SEVENTY
335,CRC,HOWEVER,MEIER,MICRORNAS,THESE
403,533,651,BACKGROUND,DIAGNOSTIC,LABEL,METHODS,PET,RESULTS
DISCOIDIN,PROMISING
ALK,BACKGROUND,CBL,LABEL,METHODS,MYCL1,RB1,RESULTS,SCLCS
528,AMONG,BACKGROUND,CONCLUSION,FINNISH,KIT,L858R,LABEL,METHODS,MUTATIONS,OVERALL,PCR,RESULTS,WESTERN
AMONG,BACKGROUND,CTC,GRADING,LABEL,METHODS,RADIATION,RESULTS,THREE
100,406,ADVERSE,BACKGROUND,CAREFUL,DISEASE,HOWEVER,LABEL,MEIER,METHODS,OVERALL,RESULTS,THERE,THREE,TREATMENT
AKT,BACKGROUND,CONCLUSION,ECH,HOWEVER,KEAP1,KIRSTEN,LABEL,METHODS,RESULTS,STK11
115,BACKGROUND,CONCLUSION,CRIZOTINIB,HGF,LABEL,MET,METHODS,RESULTS,TAS,THESE,THREE,TKI
130,224,678,BACKGROUND,BESIDES,CD4,DESPITE,HIV,LABEL,METHODS,RESULTS,THERE
231,234,AMONG,B02,DEBIO0719,EGF,ELISA,HOWEVER,KI16425,LPA,MCF,MDA,PC3,THEREFORE
124,AGE,CONCLUSION,FBP,FORTY,LABEL,METHODS,OBJECTIVE,OPTIMIZED,RESULTS,SIMILARLY,SNR
107,165,201,956,ABOUT,AFFYMETRIX,BUFALIN,CASP9,CCAR1,CCPG1,CONSOLE,DDIT4,EXPRESSION,GADD45B,HOWEVER,NCI,RMA,THAP1,THESE
CONTEXT,EARLY,HOWEVER,INCREASED,ROS,THESE,VITAMIN
163,167,174,190,ABSTRACTS,ASSESSMENT,ASSUMPTION,BACKGROUND,BRANCHBURG,CARIBBEAN,CENTRAL,CIC,CIS,CITATIONS,CONCLUSION,CONTROLLED,DAILY,DIAGNOSTIC,EFFECTS,ESTIMATES,FUNDING,HTA,INC,INDEX,INDEXED,INSTITUTE,KIT,LABEL,LATIN,LITERATURE,MEDLINE,METHODS,MOLECULAR,NON,NSCLC,OBJECTIVE,OTHER,PCR,PROCESS,QALYS,RANDOMISED,RESULTS,REVIEWS,ROCHE,SCI,SCIENCE,SIX,SOURCES,SYSTEMATIC,SYSTEMS,TECHNOLOGY,TESTING,THERE,TKI,USA,VENLO
BARRETT,BMJ,CAUCASIAN,ENDOSCOPY,GROUP,LTD,PET,PUBLISHING,SUBSEQUENT
100,181,AMONG,DOCKING,HOP,HOPEFULLY,INSTITUTE,LOG10GI50,LOG10LC50,MAESTRO,NCI,NON,NSC,PDB,TGI,USA
OPINION,THERE
CHEST,T1AN0M0,VIDEO
169,BRITAIN,COPYRIGHT,DEPLETION,GREAT,IRELAND,LTD,PCR,PIN,PUBLISHED,SOCIETY,TAKEN,THESE,WILEY
169,AUTHORS,LTD,MET,PTY,PUBLISHING,SCIENCE,SU11274,THESE,WILEY
150,169,BACKGROUND,CONCLUSION,LABEL,MEDICAL,METHODS,ORR,PRESS,PUBLISHED,RESULTS,SEQUENTIAL,SOCIETY,UNIVERSITY
AUTOMATION,DEVELOPING,DNASE,LUNGS
AKI,DIAGNOSIS,ENGLISH
GTPASES,HOWEVER,RAS
BASED,CEA,CONCLUSION,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,QALYS,RATIO,RESULTS,THERE,TUFTS
105,169,247,269,659,668,727,777,782,793,796,869,880,921,BIOLOGY,INC,MOLECULAR,PKC,PRKCE,SER,SOCIETY,SP1,STAT1
BMJ,GROUP,LTD,PUBLISHING
AMERICANS,CALIFORNIA,DETROIT,END,HISPANICS,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,PROGRAM,RESULTS
169,3DCRT,COPYRIGHT,CRT,DMEAN,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PRESCRIBED,PTV,PURPOSE,RESULTS

518,ABC,BACKGROUND,FLUID,LABEL,METHODS,SOMETIMES
112,1790G,CAUCASIAN,HIF,HOWEVER,OVERALL,SNP,THESE
AGE,ELISA,NSCLC,SERUM
ALONGSIDE,BACKGROUND,CONCLUSION,DISCUSSION,FINALLY,LABEL,THERE
001,129,169,170,199,365,938,BACKGROUND,BRUSH,LABEL,METHODS,NEG,NPV,PPV,RESULTS,SOCIETY,SPECIMENS,THERE
047,169,INDUCTION,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,POTENTIAL,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVARIATE,UNIVERSITY
HOWEVER,ISSUE,LABEL,METHODICAL,METHODS,OBJECTIVE,PRACTICAL,SCREENING,TRIAL
SPN
945
100,110,532,AMONG,KIRSTEN,NSCLC,RAF,THREE,USING
001,009,136,HAI,RFA,SIXTY,THESE
169,945,946,C57BL,COPYRIGHT,ERK,EXCESSIVE,INC,NOTABLY,PP1,REDUCED,SRC,U0126
169,200,767,810,ATLAS,EXOME,FINALLY,LABORATORY,PAN,PRESS,PROJECT,PUBLISHED,TRANSPOSEQ
160,169,ANCHORAGE,COPYRIGHT,INC,SHC
169,COPYRIGHT,GOD,GREEK,INC
120,145,183,197,24H2O,335,894,CUTLM,LNCAP,RAMAN,SEVERAL
CLEAR,DRESLER,HOWEVER,SOCIETY,USING
001,169,432,677,COPYRIGHT,END,FACTORS,INC,LABEL,METHODS,METRICS,OBJECTIVE,OBJECTIVES,PATIENT,PUBLISHED,READMITTED,RESULTS,SURGERY,THERE
NON,NSCLC
CONCLUSION,CONSISTENT,FORTY,IMPORTANT,KEY,LABEL,MCC,METHODS,OBJECTIVE,PURPOSE,RESULTS
004,160,BRAZILIAN,CIRCADIAN,CLOCK,DISRUPTION,NOCTURNIN,NSCLC,SNP
160,ADDITIONAL,BACKGROUND,EWING,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,RESULTS,THERE,WILMS
169,231,233,COPYRIGHT,PUBLISHED,SAS,THESE
169,INC,PPB,SERTOLI,WILEY
169,599,CENTRAL,CONTROLLED,EIGHT,FURTHER,MEDLINE,PEDRO,PRESS,PUBLISHED,REVIEWS,SEVEN,STUDIES,SURGERY,UNIVERSITY
000,AUC,CONCLUSION,FORTY,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE

169,AMONG,ASIAN,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,MAY,METHODS,OBJECTIVE,ORBITAL,PUBLISHED,PURPOSE,RESULTS,THEREFORE,THREE,TOTAL,UNIVERSITY
001,005,026,125,169,276,476,820,962,AFTER,AMONG,BACKGROUND,BECAUSE,COPYRIGHT,INC,LABEL,MARKETSCAN,METHODS,PUBLISHED,RESULTS,SOCIETY,STRATEGIES,TOTAL,VIDEO
087,102,169,177,237,249,311,435,477,560,610,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,OVERALL,PROPENSITY,PUBLISHED,RESULTS,SOCIETY
041,095,169,177,AFTER,BACKGROUND,COPYRIGHT,INC,INSTEAD,LABEL,LNS,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SOCIETY
006,015,058,169,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
APPLY,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAY,RESULTS,THEIR
001,169,946,BECAUSE,IHC,IMS,INHIBITION,MALDI,NSCLC,THESE,USING
169,ANTIBODIES,ANTIGEN,BASED,COPYRIGHT,LTD,SCCHN
001,008,009,012,023,127,169,183,220,393,967,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARAMETRIC,PUBLISHED,PURPOSE,RESULTS,SIR,SOCIETY,STUDENT,SURROGATE,THERE,THERMAL
229,61A,693,ALLELIC,EGF,ILD,THREE,WHILE
100,111,119,475,630,AMONG,GTN,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WOMEN
946,ALTOGETHER,MES,NCI,NSCLC
169,380,435,570,653,781,814,AFTER,CONCLUSION,FOM,IMAGING,INC,LABEL,METHODS,MOLECULAR,NAF,NUCLEAR,ONCOLOGIC,OVERALL,PET,POM,RESULTS,SOCIETY,UNLABELLED
039,040,487,516,AFTER,ATM,BACKGROUND,CHINESE,LABEL,METHODS,RESULTS
160,CD4,CD8,DFS,HOWEVER,III,NSCLC,THERE,THESE,TNM,UNIVARIATE
946,EMT,FAK,INDUCER,INDUCTION,INHIBITION,NSCLC,PCBP1,PCR,TGF
ALK,RESISTANT,THESE,USING
160,169,ACADEMY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,COX,END,HOSPICE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RANDOMIZED,RESULTS
001,166,99M,CLINICALLY,CONCLUSION,ESTIMATION,LABEL,MAA,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SPECT
169,COPYRIGHT,DIFFERENT,INVERSE,LTD,OAR,POTENTIAL,PUBLISHED
158,169,665,COPYRIGHT,FINAL,INC,KEY,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
169,16S,177,215,AFTER,CFU,EIKENELLA,GEMELLA,LTD,OLSENELLA,PTY,PUBLISHING,SOCIETIES,THESE,USING,WILEY
160,945,946,CCRCC,CLEAR,CXCR4,DESPITE,FINALLY,HIF,HOWEVER,IL6,MIG,MMP,RCC,RENAL,TAM,TGF,TH1,THESE,TKI,TNF,VHL
160,COX,HOWEVER,NON,NSAID,ROS
169,COPYRIGHT,INC,LIPOMAS
178,936,945,946,AIF,ANNEXIN,BASED,BAX,BCL,CA2,CTD,GRP78,HOWEVER,RESULTS,ROS,WESTERN,XBP
734AA,BELARUS,GSTM1,GSTT1,IMBALANCE
BOERL,MB231,MCF,MDA,MRC,SKI
ETT,VAP
006,008,009,011,019,020,029,031,044,048,211,215,343,494,697,AFTER,ATS,DFS,ERS,EXPRESSION,HISTOLOGIC,IASLC,THYROID
100,823,BGC,CARDIAC,NSCLC,PCR,SEVEN,THESE
169,CANCERS,CHALLENGES,HOWEVER,SOCIETY,THEREFORE,WHILE
105,169,286,AMONG,BACKGROUND,BJS,CONCLUSION,CRLMS,DFS,DSS,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SEVENTY,SOCIETY,TEN,VARIOUS,WILEY
169,4T1,946,EMT,LUC,NEU,TGF
000,100,327,684,ANNUALIZED,CASES,HOWEVER,KOREA,LABEL,METHODS,NTM,OBJECTIVE,PURPOSE,RESULTS,SOUTH
001,004,012,025,414,436,AMONG,LABEL,METHODS,NSCLC,OBJECTIVE,PLC,PURPOSE,RECURRENCE,RESULTS,TNM
169,191,271,298,AZA,CONVERSELY,H23,HOWEVER,HOXA9,INC,NSCLC,PCR,TRANSIENT,WILEY
118,177,210,219,240,252,303,501,578,954,AVC,CTS,HOWEVER,ICC,INTER,KEY,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VOLUMETRIC
001,002,017,019,037,038,046,129,DFS,LAPTM4B,MEIER,MVD,NSCLC,THESE,TNM
AKT,IGF,MICRORNAS,MIR,NON,TGF
067,949,AMONG,BMJ,GROUP,LABEL,LIMITED,METHODS,MINNESOTA,MORTALITY,OBJECTIVE,OTHER,PUBLISHED,PUBLISHING,RESULTS,SMR,SRR
103,169,CELLS,CONCLUSION,HNSCC,LABEL,METHODS,OBJECTIVE,RESULTS,SCC,SIMILARLY
100,169,AMONG,BECAUSE,COPYRIGHT,GATA3,GCDFP,INC,SIXTY,WT1
001,002,003,009,014,112,AIM,BACKGROUND,CONCLUSION,III,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RCAS1,RESULTS
ALLOGRAFTS,BACKGROUND,CLARIFYING,CONCLUSION,LABEL,MATERIALS,METHODS,PANCREATIC,RESULTS,THEREFORE,THESE
169,183,234,APRIL,AUG,BACKGROUND,COPYRIGHT,COX,EARLY,FUNDING,H1N1PDM09,JAN,LABEL,LTD,MARCH,METHODS,RESULTS,ROCHE,THERE,THESE

169,26B,AUTHORS,COPYRIGHT,HOWEVER,PUBLISHED,VARIOUS
001,003,004,006,022,043,230,460,BACKGROUND,GST,GSTM1,INDIA,LABEL,MATERIALS,METHODS,MIZORAM,RESULTS,WOMEN
HOWEVER,MECHANISMS,TAKEN,USING
60S,BACKGROUND,L39,LABEL,MATERIALS,MDR,METHODS,PCR,RESULTS,RPL39,TDR,TOTAL,VIABILITY
001,018,496,511,813,831,BACKGROUND,FURTHER,JANUARY,LABEL,MEDICAL,METHODS,OTHER,POP,RESULTS
001,017,267,AGE,ALK,ANAPLASTIC,BACKGROUND,IHC,JANUARY,LABEL,MAI,MATERIALS,METHODS,NSCLC,RESULTS,THERE,UNIVERSITY,VENTANA,VPI
0000001,333,400,800,BACKGROUND,CIS,CONSUMING,HOWEVER,LABEL,MATERIALS,METHODS,ODD,ORS,OTHER,PAKISTANI,RESULTS,SMOKING,STRONGEST
E2C,ECTOPIC,MMP,MTT,THESE,UBE2C,USING
001,005,129,149,177,219,276,325,956,ARSENIC,BACKGROUND,CADMIUM,LABEL,MATERIALS,METHODS,RESULTS,SCC,THERE,TNM
169,COPYRIGHT,INC,MOLECULAR,PATHOLOGY,PUBLISHED,SOCIETY
160,169,ALK,HCT,IMT,LTD,PUBLISHED,WILEY
144,169,COLLEGE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS
007,160,169,AUTHORS,HOWEVER,LTD,PTY,PUBLISHING,SCIENCE,WILEY
169,698,946,956,AFTER,COPYRIGHT,H22,HEP,HOWEVER,INCREASING,LTD,NEITHER,THESE,USING
AKT,BIM,CISPLATIN,KNOCKDOWN,THR32
7TH,8TH,BASED,HOWEVER,PROJECT,STAGING,THEREFORE,TNM
BACKGROUND,CONCLUSION,LABEL,LOBES,MATERIALS,METHODS,RESULTS,TC99M
001,164,169,209,250,AFTER,BACKGROUND,COPYRIGHT,IMPORTANT,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SEPAR
021,027,2GY,372,4CM,ACUTE,COX,CTCAE,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STAGE,THREE
169,AUTHORS,COPYRIGHT,INC,LUADS,NF2,PUBLISHED,THESE,TKI
169,956,AKR1B10,COMPARISON,COPYRIGHT,INC,INHALATION,PCR,ROS
169,945,COPYRIGHT,LTD
SMALL,THESE
177,AFTER,BACKGROUND,CONCLUSION,GIVEN,HAART,HIV,LABEL,METHODS,NON,RESULTS,THERE,VIRUS
169,ACADEMY,ADDITIONAL,BACKGROUND,BECAUSE,CD4,CD8,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,STAGING
169,ALK,AMONG,COPYRIGHT,CREST,FURTHER,HYDRA,INC,KMT2A,MLL,MOLECULAR,PATHOLOGY,PUBLISHED,SOCIETY,STUDIES,USING

169,BACKGROUND,BML,INFERRING,LABEL,LANDSCAPE,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,BACKGROUND,LABEL,MAP,METHODS,MOTIVATION,NON,NSCLC,PRESS,PUBLISHED,RESULTS,TKI,UNIVERSITY
150,169,CONCLUSION,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SEVEN,SOCIETY,SUV,TREATMENT,UNLABELLED
GUIDELINES,PANEL
015,037,100MG,148,155,165,169,193,BACKGROUND,LABEL,LOWER,METHODS,PRESS,PUBLISHED,RESULTS,SIMILAR,SMOKING,SOCIETY,TOBACCO,UNIVERSITY,WEEKS
001,007,011,027,032,169,200,450,838,956,BACKGROUND,BETWEEN,COPYRIGHT,FORTY,INC,JANUARY,LABEL,MCT,METHODS,PUBLISHED,RESULTS,RJC,SOCIETY,UNIVARIATE
AEA,AKT,CB1,EGF,ERK,FATTY,FURTHER,MET,NSCLC,SINCE,TAKEN
001,496,BACKGROUND,DFS,LABEL,METHODS,N2A,NODAL,NSCLC,OVERALL,RESULTS,THERE
ADC,LABEL,LCC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
DESPITE,LABEL,LCNEC,OBJECTIVE,PURPOSE,REGARDING,RESULTS,SCC,SUMMARY
100,AAH,ADC,AIS,FURTHER,LABEL,LPA,MIA,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THEREBY
REMARKABLY,SAC,TAKEN
BMJ,EPIDERMAL,GROUP,LEU747PRO,LIMITED,PCR,PUBLISHED,PUBLISHING,RGQ,THERE,TKI
945,BIOLOGICAL,RANDOMIZED,TNF
MMP,WHILE
169,956,COPYRIGHT,DYSOXYLUM,ECD,HEPG2,INC,MCF,MO2,NMR,OAC,THEIR,THREE
120,169,BPP,COPYRIGHT,LTD,MEANWHILE
365,COX,III,INSTITUTE,LABEL,LNR,MEDICAL,MEIER,METHODS,OBJECTIVE,PEARSON,RESULTS,THERE,TIANJIN,TNM,UNIVERSITY
G4NH2,HFA,HOWEVER,PAMAM,SILENCING,SMALL,THEIR
CEVARIX,HOWEVER,HPV
169,945,946,954,BASED,BECAUSE,BIOLOGY,EXOGENOUS,HOWEVER,IKK,INC,MOLECULAR,NME1L,SOCIETY,TNF
MRI
002,011,027,048,11Q22,707,CASKI,CLASS,HIPPO,LITERATURE,OVERALL,WARTS
231,CXCR4,FURTHER,HOWEVER,MDA,MTT,PCR,THESE,TNM,WESTERN,YET
001,066,916,CHEST,FOLLOWING,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SPO,SURGERY,THERAPY
177,183,CONCLUSION,GEORG,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STUTTGART,SURGERY
169,CELLS,COPYRIGHT,DISRUPTION
169,ASIAN,BAYES,FOLLOWING,IDEALLY,MODALITIES,PACIFIC,SOCIETY
BECAUSE,COPYRIGHT,MALIGNANT,SLACK
231,549,EMT,MCF,MDA,THESE,ZEB
214,229,ALK,III,LUNGCARTA,LUNGFUSION,MASSARRAY,MET,MUTATIONS,NSCLC,PANEL,RET,STK11

ADDITIONAL,AREAS,BACKGROUND,COVERED,INHIBITORS,LABEL,METHODS,OPINION,PATENTS,SCIFINDER,TRK
022,023,031,032,10878,118,123,205,239,255,ADDITIONAL,ALK,BACKGROUND,BUNDANG,DFS,HOWEVER,LABEL,METHODS,MYC,RESULTS,SEOUL,UNIVERSITY
INSTITUTE,LABEL,METHODS,MWA,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
106,129,131,133,137,140,153,AFB,CONCLUSION,LABEL,METHODS,NBI,OBJECTIVE,RESULTS,THERE,WLB
100,CONCLUSION,EIGHT,HOWEVER,ICE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TECHNICAL,TRANSIENT
CTC,GENOMIC,INSTEAD,USING
260,APRIL,CONCLUSION,JAPAN,LABEL,LTD,METHODS,OBJECTIVE,OLYMPUS,OVERALL,PURPOSE,RESULTS,SEPTEMBER,TOKYO
100,178,200,956,AUC,BACKGROUND,LABEL,LINIFANIB,METHODS,NSCLC,PARTIAL,RESULTS
947,AFTER,FATIGUE,FINALLY,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS
419,541,583,586,621,715,802,892,BSO,CONCLUSION,LABEL,LEVEL,METHODS,NUTRITION,OBJECTIVE,PREVENTION,RESULTS
001,108,188,AMONG,BACKGROUND,CONCLUSION,CRT,FOLLOWING,HRQOL,III,LABEL,METHODS,RESULTS
400,550,627,906,BACKGROUND,COMMITTEE,CONCLUSION,COX,LABEL,MEIER,METHODS,REFINEMENT,RESULTS,STAGING,THREE,TNM,WBC
002,004,149,154,ABIGAIL,AVASTIN,BACKGROUND,BIOMARKERS,CONCLUSION,EVALUATION,INNOVATIVE,LABEL,METHODS,NRP,RESULTS,SOLID,VEGFR
100,159,165,215,369,ATLAS,BACKGROUND,CONCLUSION,CPG,FINALLY,GATA2,HOWEVER,LABEL,METHODS,NNK,NSCLC,RESULTS,SIMILARLY
110,111,221,396,BACKGROUND,CONCLUSION,COX,EASTERN,GROUP,III,LABEL,METHODS,NSCLC,RESULTS
AFTER,BECAUSE
060,114,283,377,481,555,557,635,664,665,869,969,ASIAN,BSC,EPIDERMAL,NSCLC,PFS,SCIENCE,THROUGH,WEB
EPA,FIRST,HOWEVER,IUR,LIBBY,MARYSVILLE,PROTECTION,RFC
315,322,673,STRIKINGLY,THESE,THOSE,WGD
169
246,AFTER,HODGKIN,INCREASED,LABEL,LIMITED,METHODS,OBJECTIVE,RESULTS
EXPOSURES,LABEL,METHODS,OBJECTIVE,OTHER,RESULTS
169,946,956,EMT,FINALLY,TAKEN,TBE,TGF
001,015,041,177,210,270,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,365,954,CXCR4,HOWEVER,MSC
012,013,169,600,786,EGFRS,MOABS
120,160,648,CPG,GATAD2B,KNOCKDOWN,LEUCINE
003,005,010,015,043,183,BACKGROUND,CONCLUSION,COX,LABEL,LOG,MEDICAL,METHODS,NSCLC,PCR,RESULTS,STUDENT,TIANJIN,UNIVERSITY
128,303,BASED,RNASE
ARIZONA,CARRINGTON,CHARLES,DEPARTMENT,DIP,LABORATORY,MALIGNANT,NUCLEAR,PATHOLOGY
242,325,BASED,H1703,H1755,NCI,NSCLC,PROTEOMIC
107,152,153,156,158,580,ADC,HISTOLOGIC,SQC
016,240,543,HOWEVER,NSCLC
HOWEVER,RESULTS,SIMULATION,WEIBULL
165,177,214,235,COMPATIBLE,GFP,KDR,PET
177,215,ACTIVATION,BBB,GTPASES,LEWIS,MNSOD,RHO,THERE
100,267,DOX,SLN
169,COMBINING,COPYRIGHT,HOWEVER,LTD,THEREFORE,WILEY
BIC,DOX,MTX,TAKEN
269,769,GLU,GNP,PEG,RESULTS
036,181,203,230,950,AMONG,BACKGROUND,CLINICALLY,FURTHER,HOWEVER,HSP27,LABEL,METHODS,NSCLC,RESULTS
192,HOWEVER,MCNPX
AFTER,AKT,HOWEVER,IGF,MTT,NSCLC,PCR,SILENCING,WESTERN
003,004,110,169,AROMATASE,HCC4006,INHIBITORY,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
160,169,945,AKT,AQUAPORIN,ATP,AUTHORS,EXPRESSION,H1299,NON,NSCLC,NSCLS,PHYSIOLOGY,SOCIETY
100,169,BACKGROUND,DIAGNOSIS,INC,LABEL,METHODS,MUCORALES,PROCEDURE,RESULTS,WILEY
177,180,246,250,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRADESH,RESULTS,SOUTH
106,120,144,169,945,946,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PURPOSE,RESULTS,STATE,THESE,YKL
162,578,858,864,ARG,ARG415GLN,ASP,ASP1104HIS,BACKGROUND,GLN,LABEL,OVERALL,PRINCIPAL,RESULTS,XPF,XPG
DIGITAL
947,B16,F10,GCR,GCS,GSH,NADPH,TAKEN
043,156,157,220,BACKGROUND,BANGLADESH,CHRONIC,CIS,COX,CREATININE,FURTHER,LABEL,METHODS,OCTOBER,PERSONS,RESULTS,THERE
100,126,155,169,20B,34A,BACKGROUND,BASEL,HCC,LABEL,METHODS,NSCLC,OVERALL,PCR,RESULTS,TREATMENT
APRIL,BACKGROUND,BETWEEN,GRADE,LABEL,METHODS,RECURRENCE,RESULTS,THERE
169,BASEL,CURRENTLY
169,AFFYMETRIX,INC,USING,WILEY
001,016,025,026,029,031,033,041,120,COX,MEIER,PFS,ROC,SERUM,THESE,UNIVARIATE,YKL
169,AMINO,AMONG,HEPG2,MCF,VCH,WILEY
945,946,BLOOD,CD105,HOWEVER,NON,NSCLC,SMALL,THESE,TNM,USING
100,162,BACKGROUND,CONCLUSION,DIAGNOSTIC,EUS,FINAL,FNA,HOWEVER,LABEL,LNS,LYMPH,METHODS,OBJECTIVE,RESULTS,THEREFORE
169,209,639,909,AFTER,DFS,HOWEVER,JAPAN,PRESS,PUBLISHED,RADIATION,SETUP,SOCIETY,UNIVERSITY
28049,3LL,CEM,CHANGES,CO38P,E1000,LABEL,LEWIS,METHODS,NZM10,NZM52,OBJECTIVE,PURPOSE,RESULTS,RETENTION,WHILE
001,009,013,245,AFFAIRS,AMONG,ARIZONA,BACKGROUND,FDG,JANUARY,LABEL,MARCH,METHODS,PET,RESULTS,SUV
10878,3A4,400,800,BACKGROUND,CYP,LABEL,METHODS,MTR,OTHER,PAZOPANIB,RESULTS
177,181,945,946,AKR1B10,ANNEXIN,NCI,TAKEN
EMT,HOWEVER,KNOCKDOWN,KYSE150,THESE
231,549,MDA
120,177,949,INGENUITY,MRMAP,PET,PHILIPS,SUV
115,141,CONCLUSION,LABEL,METHODS,OBJECTIVE,PTC,RESULTS,SIX,THERE,ULTRASOUND
231,CXCR3,CXCR6,MDA,PRODUCTION,THESE
BRAIN,CHEST,METASTATIC,MRI,SUBSEQUENT
169,573,ATS,CONCLUSION,ERS,HISTOLOGIC,IASLC,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,SOCIETY,SOLID,TNM
005,014,169,AFTER,AUTHORS,LTD,RADIATION,SERUM,TREATMENT,WILEY
002,048,056,206,368,425,544,593,599,677,680,690,784,811,956,967,NRS,RETRACTOR,SEVENTY
100,465,945,AFTER,ANIMALS,FRESH,LABEL,METHODS,OBJECTIVE,RESULTS,ZEALAND
AFTER,AUC60,CHANGES,CONCLUSION,DYNAMIC,EVALUATION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SOLID
FURTHER,III,PHASE,TKI
169,NAD,SILYBIN,SIRT1
BACKGROUND,BETWEEN,CIS,HODGKIN,HRS,ITALIAN,LABEL,METHODS,PWA,RESULTS
169,CIGARETTE,CSC,H1299,INC,NADPH,NOX,NSCLC,TREATMENT,USING,WILEY
100,169,215,991,996,AUC,CNS,CSF,FURTHER,MRI,OVERALL
000,100,126,140,145,260,263,BACKGROUND,BLOOD,CONCLUSION,DISEASE,FUNDING,HEART,HORIZON,INITIATIVE,INSTITUTE,LABEL,LIMITATION,METHODS,OBJECTIVE,OUTCOME,PAYER,POPULATION,PRIMARY,RESULTS,SOURCES,THESE,WHI,WOMEN
BRIEF,DUTCH,ILLNESS,KARNOFSKY,PERCEPTION,PRINCIPAL,QUALITY,TREATMENT
INSTITUTE
144,169,561,758,956,AMBIENT,COPYRIGHT,DTT,HEPG2,INDIA,PAH,STEEL,TAMIL,THEIR,THERMAL,WHILE
956,C10,C11,COMPOUNDS,NOESY,YMJ1179
CA2,EFFECTIVE,ORAI1
000,008,084,132,144,178,443,550,FIG,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RANDOMIZED,REF,RESULTS,TAB
000,130,152,169,177,183,188,364,BACKGROUND,CHANGES,COPYRIGHT,DECREASES,FOUNDATION,FUNDING,GATES,HIV,LABEL,LTD,MDG,MELINDA,METHODS,MILLENNIUM,REMARKABLE,RESULTS,SAHARAN,SHAPLEY,SINGAPORE,WITHOUT
037,109,169,191,400,ASIAN,BACKGROUND,LABEL,METHODS,NSCLC,OBJECTIVE,PACIFIC,RELATIVELY,RESULTS,SCC,SOCIETY,SURGICALLY,VDT
169,582,ASSESSMENT,BACKGROUND,CTX,LABEL,LOW,METHODS,RESULTS,SCALE,SOCIETY,SYMPTOM,THESE,THREE
ART,CXCR4,FIRST,HIV,HOWEVER,SEVERAL,THIRD
010,016,022,028,032,040,169,303,AMONG,BACKGROUND,CHINESE,COPYRIGHT,COX,FURTHER,HAN,HORMAD2,LABEL,LOG,LTD,MASSARRAY,MATERIALS,METHODS,NSCLC,RESULTS,SIMILARLY,THESE
169,ASIAN,PACIFIC,SOCIETY
179,245,489,500,504,528,946,956,AMONG,BSI,CURRENT,EARLY,INADEQUATE,JANUARY,KLEBSIELLA,MDR
100,132,BAL,BDG,GROUP,IFI,INSTITUTES,LABEL,LTD,METHODS,MYCOSES,NIH,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,TEN,TREATMENT,USING
109,114,BACKGROUND,DFI,DUE,JAPAN,LABEL,MEIER,METHODS,PULMONARY,RESULTS,TORANOMON,UNIVARIATE
946,CHANGES,ECLIA,LABEL,METHODS,NSE,OBJECTIVE,PERHAPS,RESULTS,USING
CONCLUSION,FMK,HOWEVER,LABEL,METHODS,MTT,NDV,NEWCASTLE,OBJECTIVE,PBS,RESULTS,RVG,TUNEL,VAD,WESTERN
169,969,ADP,COPYRIGHT,HUA,INC,NAC,NSCLC,ORYZA,PBA,ROS,TAKEN
169,709,716,CHINESE,COPYRIGHT,CRE,CREB1,HOWEVER,INC,MDR,THESE
118,244,ACC,DUE,EXPRESSION,LABEL,METHODS,OBJECTIVE,RESULTS
ANOTHER,IHC,LABEL,METHODS,MSP,OBJECTIVE,RESULTS,THERE
019,101,138,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE,UNIVARIATE
105,124,177,240,262,268,273,276,290,313,326,327,335,537,570,608,615,617,645,669,686,735,947,FE2O3,HOWEVER,LABEL,METHODS,MRI,NPS,OBJECTIVE,RESULTS,STERILE,T2W
001,003,004,006,007,009,011,020,023,024,048,049,053,BACKGROUND,CONCLUSION,LABEL,METHODS,PREDICTORS,RESULTS,THESE
946,BACKGROUND,CONCLUSION,CPG,FINALLY,LABEL,METHODS,NSCLC,RAR,RESULTS
THERAPIES,TIM
001,033,139,169,16Q21,215,946,998,BACKGROUND,COLORECTAL,CSNK2A2,HEART,INC,LABEL,METHODS,OVARIAN,RESULTS,SCREENING,SIKHS,SOUTH,TRIAL,UKCVD
177,AFTER,AMONG,BMJ,GROUP,LABEL,LIMITED,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEVEN,THREE,TREATMENT
169,177,BACKGROUND,COLLEGE,COPYRIGHT,FIFTEEN,FVC,INC,INDIVIDUAL,LABEL,METHODS,PATIENT,PUBLISHED,RESULTS,TLC,TOTAL
169,174,331NM,595ML,955,CH2,GEFITINIB,INC,P450S,SEVERAL
169,231,956,COPYRIGHT,MDA,SAR,SAS,STRUCTURE,THESE
169,423,ALU,AUTHORS,COPYRIGHT,INC,OLDER,PREVALENCE,PUBLISHED,THERE
100,148,169,COPYRIGHT,FOLLICULAR,IRELAND,LABEL,LTD,METHODS,MOTOL,MTC,OBJECTIVE,OBJECTIVES,PTC,RESULTS,RET,THYROID,TSH
169,201,231,COPYRIGHT,PUBLISHED,REGARDLESS,SAS
169,CONCLUSION,COPYRIGHT,INC,INCREASED,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,SOURCES
015,110,119,121,129,169,176,442,729,844,ARSENIC,BACKGROUND,ESTIMATING,LABEL,METHODS,PROTECTION,RESULTS,THESE,WHILE,WORLD
169,946,COPYRIGHT,EMT,GINSENG,HOWEVER,IRELAND,LTD,PANAX,RG3,SMAD2,SNAIL,TAKEN,TGF
169,946,956,COPYRIGHT,DU145,FURTHER,MTT,SAS
169,945,AKT,CCK,COPYRIGHT,HIF,HOWEVER,INC,NSCLC,THESE
10058,160,ASIAN,JQ1,LIVER,MYC
020,029,169,ASA,COPYRIGHT,EVLWI,GROUP,INC,LABEL,METHODS,OBJECTIVE,OLV,OPERATING,RESULTS,SETTING
001,023,169,457,880,AMONG,BACKGROUND,COPYRIGHT,INC,INFLATION,INPATIENT,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,STATE,WASHINGTON
001,006,014,040,117,169,184,204,253,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,MAJOR,MAY,METHODS,MWA,PUBLISHED,RECORDS,RESULTS,SOCIETY
000,100,160,169,282,394,750,800,862,BACKGROUND,COPYRIGHT,DESPITE,INC,LABEL,MAJOR,METHODS,OCTOBER,PUBLISHED,RESULTS,ROBOTIC,SOCIETY
169,BED10,COLLEGE,COPYRIGHT,HOWEVER,III,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
047,160,BRAZILIAN,FIFTY,L858R,NSCLC,UNICAMP,WESTERN,WHITE
HCC,HOWEVER,NSCLC,RFS,THEREFORE,TNM
001,020,169,317,355,672,APPLIED,BACKGROUND,BIOSYSTEMS,BMI,CHINESE,COPYRIGHT,HAN,KIT,LABEL,METHODS,MULTIPLEX,OBJECTIVE,ORS,RESULTS,SMOKING,USA
549,CONCLUSION,DEVELOPED,LABEL,METHODS,NAKED,OBJECTIVE,PRE,PURPOSE,RESULTS,THESE
003,004,006,087,093,099,100,ARTIFICIAL,BETWEEN,FOM,KEY,LABEL,METHODS,OBJECTIVE,PULMONARY,RESULTS,THREE
169,954,COPYRIGHT,ESPECIALLY,H23,LPS,LTD,NCI,SAR
LABEL,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,SUMMARY,THERE,THESE
100,169,AFTER,APART,CARDIOLOGY,DESPITE,FINALLY,PUBLISHED,SOCIETY
169,ALK,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,USING
001,009,016,058,169,AFRICAN,AMERICANS,BACKGROUND,CAUCASIANS,COPYRIGHT,EXPRESSION,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
000,001,022,038,169,234,COPYRIGHT,FDG,FIRSTLY,IRELAND,LABEL,LAC,LSCCS,LTD,METHODS,NPV,OBJECTIVE,OBJECTIVES,PET,PPV,RESULTS
169,COPYRIGHT,FDG,HOWEVER,INC,PET,PUBLISHED,SOCIETY,USING
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY,TNM
169,233,COPYRIGHT,GBS,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SIX,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,215,COPYRIGHT,EVALUATION,INC,LABEL,METHODS,NSCLC,OBJECTIVE,ONTARIO,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,UNDER
004,145,169,177,238,244,492,637,AWARENESS,BACKGROUND,BUNDLED,CENTERS,COPYRIGHT,INC,INITIATIVE,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
BCG,DESPITE
200,PRDX2,SESN1
CALGB,MINIMALLY,REGARDING,WJTOG4607L
000,005,100,161,775,BACKGROUND,CAUSE,CONTROL,DISEASE,LABEL,MEDICAL,METHODS,PREVENTION,RESULTS,THERE,WHILE
169,ERS
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
100,145,205,549,620,AMONG,CNS,FURTHER,H23,HEP,HOLARRHENA,HOWEVER,IMR,MCF,NCI,NIH,OVCAR,SRB
DISCUSSION,FDG,FOLLOWING,PET
142,147,183,184,215,956,ACCEPTABLE,AGNO3,AGNPS,AGRIMONIAE,FOURIER
MDSCS,MYELOID,TARGETING,TNF,TRAIL,TREATMENT
169,204,248,APART,BACKGROUND,HRS,LABEL,METHODS,RESULTS
120,169,BACKGROUND,BLEOMYCIN,HODGKIN,INC,JANUARY,LABEL,METHODS,NON,PFT,RESULTS,WILEY
169,17A,239,947,DCS,DENDRITIC,IFN,LNS,MEANWHILE,PROFILING,STRIKINGLY,TAKEN,USING
143,160,239,CNS,NSCLC,PCR,T790M,THERE,TKI
AKT,CCK,ERK,HOWEVER,PROTEIN
CISPLATIN,CONVERSELY,EMT,NSCLC,SNAIL
ELISPOT,MARKERS,PADRE,THESE,WHILE
160,ERBB2,ERBB3,H1975,HSP90,T790M
163,169,CAREGIVER,CONCLUSION,COPYRIGHT,FCG,III,LABEL,LTD,METHODS,OBJECTIVE,QOL,RESULTS,SCALE,SECONDARY,THESE,VERSION,WILEY
100,26S,H1299,HOWEVER,MG132,MMP,NSCLC,TAKEN,UPS
BACKGROUND,LABEL,METHODS,QOL,RESULTS,SURVIVORS,THESE,WHILE
169
028,031,036,109,210,360,537,653,716,782,ALTERED,BACKGROUND,COX,DFS,DISEASE,DSS,HAZARDS,HOWEVER,LABEL,MEIER,METHODS,NSCLC,RATIO,RESULTS
133,591,FACTORS,KPS,LOCAL,OVARIAN
ELISA,EMT,EPITHELIAL,HOWEVER,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,STAT3,WESTERN
169,882,CEC,EOF,ESI,OVERALL,THREE,VCH,WILEY
THEREFORE
ASSESSMENT,BACKGROUND,CAD,CHEST,DIGITAL,HOWEVER,LABEL,METHODICAL,METHODS,RESULTS
169,ABL,ALK,BCR,EGF,HOWEVER,MECHANISMS,OFTEN,RESISTANCE
111,ANDALUSIA,ATNEA,FINALLY,LABEL,METHODS,NET,OBJECTIVE,PURPOSE,RESULTS,SEX
CD137,CPG,CPG1826,HOWEVER,ORTHOTOPIC,RENCA
00001,563,604,AMIFOSTINE,BACKGROUND,CENTRAL,CONCLUSION,GRADE,HNSCC,HOWEVER,LABEL,MEDLINE,METHODS,RESULTS,SEVENTEEN
104,169,172,BACKGROUND,DISEASE,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMALL,TKI,WILEY
GIANT,GLY34,H3F3A,HISTONE,LABEL,LEU,MALIGNANT,OPINION,RANKL,STATEMENT,SURGERY,TRP,UNASSIGNED
26A,AKT,CPG,EXPRESSION,MICRORNAS,ODN,TCN,THESE
160,181,CELLS,LC3,THESE
177,181,BASED,DDP,GROUP,MTT,TRANSWELL
169,COPYRIGHT,HISTOLOGIC,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,SIR,THERE
004,039,169,IGG,IGM,L1210,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,TREATMENT
013,215,409,ACCORDING,ADC,AUC,DCE,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,PARAMETERS,PERFUSION,PET,RESULTS,ROC
001,041,092,AUROC,CAPILLARY,ELISA,III,INTRA,MEIER,MVD,NSCLC,THESE,TSP,WHITNEY
100,5A4,ABCAM,ALK,ANTIBODIES,BACKGROUND,CUTOFFS,DETECTION,FIFTEEN,IHC,INTENSITY,LABEL,METHODS,OCCASIONAL,RESULTS,VENTANA
BACKGROUND,CONCLUSION,GEFITINIB,LABEL,LITERATURE,METHODS,PIS,RESULTS,THERE
18F,BACKGROUND,CONCLUSION,FDG,HOWEVER,HRS,LABEL,METHODS,NSCLC,PET,PRIMARY,RESULTS,STATA,SUV,VERSION
101,104,121,701,777,BACKGROUND,LABEL,METHODS,RESULTS,SEVENTY,SOLID
500,ALDH1,AUC,BMI,CD133,CHINA,CSC,EPCAM,FURTHER,HOWEVER,MUSASHI,ROC,USING
116,169,215,COMMUNITY,COPYRIGHT,EASTERN,HOWEVER,INC,LABEL,METHODS,MINOR,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,WESTERN
FAB,IGG,SDS,SEVERAL
169,COPYRIGHT,SAS
ALCAM,AUC,MPE,MRM,PES,QCONCAT,SIS,SVEP1,THBS4
001,105,169,AFTER,BACKGROUND,CHEST,CONCLUSION,CONFIRMED,COPYRIGHT,GGO,HOWEVER,LABEL,LTD,METHODS,MILIARY,RESULTS,THEREFORE
110,946,953,954,955,BECAUSE,FUNCTIONAL,IDC,IL1,OVERALL,PKC,TGF
100,169,GLYCOLYTIC,INCREASED,INHIBITION,K100Q,NADPH,PGAM2,SIRT2,THESE
120,BETWEEN,MAG,SPECT,THEIR
504,AFTER,BACKGROUND,CIS,COLORECTAL,COX,HRS,LABEL,METHODS,OVARIAN,RESULTS,SCREENING,TRIAL,USING
120,ABO,DISEASE,EMR,IKZF1,SIMILARITY,SIMILARLY,VARIMED
033,266,307,AIM,CHINESE,CONCLUSION,GSTP1,HAN,LABEL,METHODS,MOP,MPO,OBJECTIVE,PCR,PHASE,RESULTS,SNP
001,003,ADC,CONCLUSION,CRS,DWI,JAPAN,KNOWLEDGE,LABEL,MCNEMAR,METHODS,MRI,NSCLC,OBJECTIVE,PULMONARY,RESULTS,THERE,UNIVERSITY,WHITNEY
ESS
140,293,450,BACKGROUND,CONCLUSION,HEK,LABEL,METHODS,RAMOS,RESULTS,XRCC4
100,130,131,AFTER,CSF,DISTANT,FFP,HISTOLOGY,HOWEVER,LABEL,LOCAL,METHODS,OBJECTIVE,PERMANENT,RESULTS,SECONDARY,SRS,THERE,THESE
177,178,185,BASED,DSA,EVERY,LABEL,METHODS,NRS,OBJECTIVE,RESULTS,TPS,UNDER
000,001,002,007,008,017,032,035,050,124,125,6TH,AMONG,CRT,DFS,DISTANT,JANUARY,LABEL,LRC,MAY,METHODS,N2B,OBJECTIVE,RESULTS,SCCHN,TNM,UNIVARIATE
117,AMONG,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,THEIR
705,814,AAH,AIS,AUC,CONCLUSION,GGN,IAC,LABEL,METHODS,MIA,OBJECTIVE,RESULTS,THERE
169,205,577,896,944,ACS,COPYRIGHT,EVALUATING,FEDERATION,NON,NSCLC,PCR,PUBLISHED,SCC,SEVEN,SOCIETIES,SOCS4
258,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEX,SUV,THERE,UNIVARIATE
BACKGROUND,CONCLUSION,FIFTY,HOWEVER,HRS,LABEL,MATERIALS,MAXIMAL,METASTASIS,METHODS,MVM,MVN,MVT,OVERALL,PET,RESULTS,SUV,SUVWB,TLG,TLGWB
263,656,677,697,702,717,732,741,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RATIONALE,RESULTS,VARIOUS
ANTISENSE,BRCA2,IDO,NAD
001,25X,975,LABEL,LINAC,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
EQA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBA
174,BOT,DESPITE,HT1,HT2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSS
029,103,177,538,ADDITIONAL,BLOCKED,CARLO,LABEL,LAR,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TESTICULAR
945,954,CONSISTENT,IFN,INTERFERON,MMP,MMP12,THESE,WHEREAS
ENDOSCOPIC,HAMARTOMAS
163,263,444,507,AFTER,ALTERED,PATIENT,RPE
100,BACKGROUND,LABEL,METHODS,RESULTS,THERE,VAS,WHITNEY
350,370,BLOOD,CA242,CA724,CEA,CRC,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,THESE,TNM
003,284,285,546,630,731,945,946,PCR,PI3KS
181,AFTER,GIVEN,THESE,TUNEL
EASTERN,GASTRIC,HOWEVER,THERE,THESE
139,169,477,COX,HEMATOLOGY,MINNESOTA,OLMSTED,RECURRENCE,SOCIETY,VTE
169,FINALLY,FIRST,MEDICAL,PRESS,PUBLISHED,SOCIETY,THERE,THROUGH,UNIVERSITY
169,482,CHINESE,FUNCTIONAL,INC,MEIER,NON,NSCLC,SNP,WILEY
169,174,BACKGROUND,CONVERSION,COPYRIGHT,LABEL,LTD,MAY,METHODS,RESULTS,VINCI,WILEY
378,46T,ARG194TRP,ARG399GLN,BLOOD,ERCC5,GENOMIC,HIS1104ASP,HRS,JANUARY,KIT,NSCLC,PFS,RESULTS,SIMILARLY,XRCC1
160,169,183,ESPECIALLY,GEORG,IPILIMUMAB,IRAES,STUTTGART
185,200,DIGESTION,ECL
ATP,CHLAMYDIA,CPN,IGA,III,MEIER,NSCLC,TESTING
145,169,AKT,SERUM,SOCIETY
175,177,196,472,III,MDR,NH3,RESULTS,RUCL2,TAKEN
001,237,956,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
150,200,420,AFRICAN,ALK,AMERICANS,CYP3A,ERLOTINIB,LOW,NSCLC,OSI,TTP
169,ASIAN,BASED,COMMUNITY,CONCLUSION,COPYRIGHT,FORTY,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,PROGRAM,PURPOSE,RESULTS,SOCIETY
008,009,022,048,0GY,10878,169,362,65YEARS,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FURTHER,HOWEVER,III,LABEL,LARGE,LIN28,LTD,METHODS,MLD,NSCLC,PUBLISHED,RESULTS
169,PRESS,PUBLISHED,PULMONARY,SURGERY,UNIVERSITY
169,758,847,AAL,AGP,ALEURIA,AUROC,BIOLOGICAL,COPYRIGHT,ELISA,LABEL,MRM,THEREFORE,UNASSIGNED,UNLABELLED
169,COPYRIGHT,IDIOPATHIC,IPF,LTD
169,COPYRIGHT,SAS,VISIBLE
279,DUTCH,HOWEVER,OFFERMANS
169,COPYRIGHT,INC,SEVERAL
169,COPYRIGHT,INC,INITIAL,ROBOTIC
169,COPYRIGHT,INC,ROBOTIC
169,COPYRIGHT,INC,ROBOTIC,TECHNICAL,THERE
169,ADVANTAGES,COPYRIGHT,HOWEVER,INC,LOBECTOMY
169,COPYRIGHT,ENTRY,INC,STUDIES
152,169,COPYRIGHT,FEDERATION,MICRORNAS,NSCLC,PUBLISHED,SOCIETIES
169,BACKGROUND,CETUXIMAB,CISPLATIN,COPYRIGHT,DOCETAXEL,FREQUENCY,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,REGULATORY,RESULTS
00001,169,491,499,990,BACKGROUND,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,ORR,PFS,RANDOMIZED,RESULTS,SIX,TKI,WHETHER
169,BRITISH,FMF,MYCOSIS,STUDIES,THESE
001,006,011,020,074,131,340,342,AOPPS,BACKGROUND,CRP,LABEL,METHODS,MLR,PAB,PCO,RESULTS
00001,101,AMONG,BACKGROUND,CRC,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,RESULTS
100,ADR,BACKGROUND,III,LABEL,MEDICAL,METHODS,NAC,OBJECTIVE,PLADO,PRETEXT,RESULTS,TEN,THP
089,094,095,106,177,99MTC,AIM,AMONG,BACKGROUND,CONCLUSION,CURRENTLY,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,RESULTS
001,003,6007C,938,BMP,III,NSCLC
100,160,169,200,208,ASSESSMENT,CHRONIC,CNS,CONCLUSION,FACIT,FATIGUE,FUNCTIONAL,ILLNESS,LABEL,METHODS,MODAFINIL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SOCIETY,THERAPY,THERE
169,3LL,ANTIBODIES,FINALLY,GAPDH,HSP90,LOWER,TAA,USING
169,947,950,CD2,CD3,NUCLEAR
MICRORNAS,SIX,TNRC6,TRIPARTITE
181,217,418,HOWEVER,NADPH,TRP14,TRX,TRXR1,TXNDC17,TXNL5
ALK,BACKGROUND,CONCLUSION,LABEL,MALIGNANT,MATERIALS,METHODS,RESULTS
CONCLUSION,CTC,LABEL,MALIGNANT,METHODS,MPM,RESULTS,UNLABELLED
001,036,150,AIM,CONCLUSION,EARLY,III,LABEL,METHODS,NSCLC,OBJECTIVE,PET,RESULTS,SRR
001,002,014,028,041,131,215,AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
112,AIM,CONCLUSION,FDG,LABEL,METHODS,MTV,NSCLC,OBJECTIVE,PFS,PRIMARY,RESULTS,TLG
013,015,031,036,209,328,BACKGROUND,CONCLUSION,LABEL,METHODS,MIE,PCS,PULMONARY,RESULTS
100,205,217,29B,29C,375,552,592,617,AIM,BACKGROUND,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PROMINENT,RESULTS,SCLCS
LEWIS,NATURAL,THESE,THROUGH
ALPHA,ATP,OUABAIN,SINCE
792,ASSAY,BACKGROUND,CONCLUSION,ELISA,FORTY,LABEL,MATERIALS,METHODS,RESULTS,THYMIDINE,TK1
106,145,34B,34C,486,BACKGROUND,BMP,CONCLUSION,LABEL,LDN,MATERIALS,METHODS,MICROARRAY,REDUCED,RESULTS,THREE
169,HODGKIN,INC,PET,PRIMARY,WILEY
001,GEFITINIB,HOWEVER,L858R,MAY,MEIER,OBJECTIVE,PFS,THEREFORE
01910,169,AUTHORS,LTD,MDS,PROGNOSTIC,REVISED,RIGOSERTIB,SCORING,TRIAL,WILEY
CIMAVAX,COMBINING,EGF,HOWEVER,THEREFORE
117,119,MANAGEMENT
107,124,131,167,169,COMMISSION,GBQ,IEC,MBQ,PET,PHANTOM,RIT
169,DESPITE,THESE
ADP,ARA,GAL,GAS,GLC,LDH,MTT,RHA,TAKEN
107,169,207,212,243,245,261,276,281,295,488,CONCLUSION,COX,FDG,IMAGING,INC,LABEL,MEIER,METHODS,MOLECULAR,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,THERE,UNLABELLED
169,177,ADC,CONCLUSION,FDG,FLT,GLUCOSE,H1975,HOWEVER,HTB56,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,THESE,THYMIDINE,TK1,UNLABELLED,WESTERN,XENOGRAFTS
169,BACKGROUND,BASEL,CONCLUSION,HOWEVER,IMAGING,LABEL,METHODS
CD11B,CXCR4,FURTHER,STUDIES
160,169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PANEL,PUBLISHED,RESULTS,SOCIETY
026,142,225,239,956,ART,BACKGROUND,CD4,HIV,HODGKIN,HOWEVER,JAPAN,LABEL,MALIGNANT,METHODS,NON,RESULTS
006,017,022,169,793,ALK,ANAPLASTIC,CHINESE,COPYRIGHT,INC,LIMITED,SRC
130,169,COPYRIGHT,INC,PRMT5
169,194,201,3CM,COPYRIGHT,DIAGNOSTIC,FDG,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PLC,RESULTS,TBB,VBN
169,AUTHORS,BIOLOGY,CELLS,DEPLETION,JAPAN,LTD,MOLECULAR,NSCLC,PTY,PUBLISHING,SOCIETY,WILEY
169,BASIL,BAY86,COPYRIGHT,ERK,FURTHER,HOWEVER,INC,MEK,NEXAVAR,RAF,RAS,SORAFENIB,VEGFR
100,174,179,196,199,621,BACKGROUND,BLOOD,CONCLUSION,INC,LABEL,MARCH,METHODS,MOLECULAR,MUTATIONAL,PAIRS,PCR,RESULTS,ROCHE,SIX,SYSTEMS,TRIAL,USA
BACKGROUND,CONCLUSION,DISTANT,LABEL,MALIGNANT,METHODS,SEVEN
956,COMPOUNDS,FCM29,PLASMODIUM,TURRAEA
CD40L,THROUGH
BML
ALK
MPNST

169,178,197,253,268,292,422,633,CASES,EMPHYSEMA,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PRESS,PROLONGED,PUBLISHED,RESULTS,SIX,SURGERY,THERE,TREATMENT,TRIAL,UNIVERSITY
DISCOID,PULMONARY
BACKGROUND,DOX,LABEL,METHODS,RESULTS,SABOURAUD,THERE
169,958,AMONG,METABOLIC,URINE,VCH,WILEY
169,AMONG,ATLAS,FGFR1,GCN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC,TKI
001,011,044,169,202,EMT,EPITHELIAL,NSCLC,SEPTEMBER,TKI
CURRENTLY,LCNEC,NGS,WHILE
133,169,202,639,851,944,BACKGROUND,BJS,CONCLUSION,COUNCIL,ENGLAND,LABEL,LTD,METHODS,NETWORK,ORGAN,PUBLISHED,RESULTS,SHARING,SOCIETY,TRANSPLANT,WILEY
100,169
169,PRESS,PUBLISHED,SURGERY,UNIVERSITY
ATP,MET,SINCE
282,289,744,DIAGNOSTIC,END,FACTORS,HRQOL,INTERVIEW,LABEL,MDD,METHODS,OBJECTIVE,POR,PROGRAM,PURPOSE,RESULTS,SURVIVORS,UNASSIGNED
FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
004,010,013,016,050,125,146,205,263,291,346,431,474,659,676,818,854,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,THEREFORE,TKI,YAP,YES
150,BACKGROUND,GRADE,IMO,LABEL,METHODS,NSCLC,RESULTS,TEAES
000,009,015,021,547,ADAM9,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,PEARSON,RESULTS,SIXTY,THESE
177,AFTER,APC,BACKGROUND,FORTY,LABEL,METHODS,PHONE,RESULTS,THEIR
100,DETECTION,HOWEVER,L858R,PAP,PCR,T790M
536,609,737,ABT,BH3,CONVERSELY,H1299,K48,MCL,MEF,THESE
HEALTHCARE,LABEL,LOUISVILLE,METHODS,NURSING,OBJECTIVE,OBJECTIVES,OUTPATIENT,PURPOSE,RESULTS,SETTING,VARIABLES
001,008,169,AFTER,AMONG,BACKGROUND,CADMIUM,COPYRIGHT,CROSS,HOWEVER,INC,KOREA,LABEL,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,RESULTS
169,453,CONVERSELY,FOS,HOWEVER,NCOA1,SRC
001,169,COPYRIGHT,EXACT,EXPRESSION,H69AR,HOWEVER,INC,INHIBITION,KNOCKDOWN,LUCIFERASE,MEIER,UTR
12A,13A,13K,13L,169,549,AMONG,ATP,COPYRIGHT,MCF,MDR,MTT,SAS
169,COLORECTAL,COMMITTEE,COPYRIGHT,CRC,ENDOSCOPY,ENGLAND,FIT,GROUP,INC,PUBLISHED,SCREENING,SOCIETY,SPH,SUCCESSFUL,WORKING,WORLD,WORLDWIDE
169,200,492,500,956,970,BACKGROUND,CHINA,CONCLUSION,COPYRIGHT,HBE,HOWEVER,IRELAND,LABEL,LTD,METHODS,PATHWAY,PM2,RESULTS,THESE,WUHAN
169,174,181,368,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,OTHER,RESULTS,RRS,SMR,THERE
169,BRD,CONCLUSION,COPYRIGHT,DAD,III,INC,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS
169,BIOLOGICAL,COPYRIGHT,DB1,DJ1,ESI,FTL,GDP,HSP27,LABEL,PROTEOMICS,PSME1,REMARKABLY,RHO,SH3BGRL,THERE,UBE2N,UNASSIGNED,UNLABELLED
169,945,946,9NM,ABELSON,ABL,ASP,ATP,COPYRIGHT,DDR,DFG,EXCESSIVE,GLY,LTD,PHE,PONATINIB,PUBLISHED,WHEREAS
169,17F,841,C57BL,CCD,CON,COPYRIGHT,EBP,ERLOTINIB,IEC,INC,INTESTINAL,KNOCKDOWN,NSCLC
001,169,177,1MM,COPYRIGHT,EVEROLIMUS,EXPRESSION,INC,L858R,MTT,THESE,TRANSGENIC
INC,PUBLISHED
169,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STAGE
034,169,213,AIM,CONCLUSION,COPYRIGHT,DETECTION,INCIDENCE,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,PFS,PRIMARY,RESISTANCE,RESULTS,SIXTY,T790M,TKI,WHETHER
016,018,077,145,147,169,175DAYS,233DAYS,338,505,534,917,AMONG,AUTHORS,BACKGROUND,BECAUSE,CAUCASIAN,COPYRIGHT,EASTERN,GROUP,III,LABEL,LTD,METHODS,PFS,PUBLISHED,RESULTS,WHILE
116,169,946,BAL,COPYRIGHT,CROWN,IFD,INC,IPA,PCR,PUBLISHED
169,177,7NM,947,99M,BACKGROUND,COPYRIGHT,EPH,EPHA2,HYNIC,INC,LABEL,METHODS,OCM,PRE,RESULTS,SATURATION,SPECT,SWL,THEREFORE,THESE
169,904,ALK,AMONG,BACKGROUND,COPYRIGHT,HISTOLOGIC,HOWEVER,IRELAND,LABEL,LTD,METHODS,MIB,PCR,RESULTS
001,101,121,160,169,177,196,821,BACKGROUND,BETWEEN,COPYRIGHT,INC,INCIDENCE,JANUARY,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
001,002,010,021,033,114,169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CULLIN1,IHC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,THESE
169,COPYRIGHT,IRELAND,LTD,TREATMENT
169,945,AFP,COPYRIGHT,GASTRIC,HEPATOCYTE,INC,PLUNC,SAL,SALL4,THERE
114,169,226,COPYRIGHT,E318K,INC,V320I
160,248,BACKGROUND,DISCUSSION,ESOPHAGEAL,LABEL,METHODS,PREPARE,SECONDARY,TRIAL,WHILE
10878,169,2MONTHS,6MONTHS,BACKGROUND,COPYRIGHT,EHD,JANUARY,LABEL,LTD,METHODS,PRIMARY,RESULTS
ANNEXIN,APOPTOSIS,BACKGROUND,CLUSTERIN,HEP,LABEL,METHODS,MTT,PCR,RESULTS,TUNEL,WESTERN
137,141,169,177,AUSTRALIAN,AVERAGE,BACKGROUND,COLLEGE,CONCLUSION,GTV,LABEL,METHODS,MID,NSCLC,RESULTS,ROYAL,ZEALAND
169,ACADEMY,ALLERGY,BECAUSE,COPYRIGHT,DESPITE,HOWEVER,IMMUNOLOGY,INC,LARGE,MOSBY,PUBLISHED,STUDIES
33258,945,946,BACKGROUND,BBR,BERBERINE,CHINESE,CONCLUSION,EXOGENOUS,FOXO3,HOECHST,LABEL,METHODS,MTT,NSCLC,PD98059,PIFITHRIN,RESULTS,SILENCING,WESTERN
001,003,005,008,016,046,160,169,376,COPYRIGHT,GENERAL,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PPOFEV1,PUBLISHED,RESULTS,SIMILAR,SOCIETY,SURGERY,THESE,UNIVARIATE
945,BACKGROUND,BLOOD,BUFFALO,CXCR3,HCC,HO1,HOWEVER,IL6,LABEL,MAJOR,MCA,METHODS,RESULTS,TNF,TREGS
169,624,ACADEMY,AMONG,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,DYSPNEA,HOSPICE,INC,LABEL,METHODS,MINIMAL,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RESULTS,YOUNGER
170,500,BACKGROUND,CONCLUSION,III,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,ORR,OVERALL,PFS,RESULTS,TRIAL
144,169,340,AHI,HISTOLOGIC,III,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,NOS,NSCLC,OBJECTIVE,PCE,PPV,PUBLISHED,PUE,PURPOSE,QUALITY,RADIATION,RESULTS,SOC,SOCIETY,THESE
169,ALIGNRT,COPYRIGHT,DRR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE,THREE,VARIATIONS
001,007,012,016,017,034,040,049,169,BETWEEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SIMILARLY,V10,V20,V30
003,169,ABC,FORTY,FURTHER,HODGKIN,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V20
169,177,FIRST,INC,ITV,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SIMPLIFIED,THESE
001,AP2,BACKGROUND,ERK,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,THESE
177,946,99M,ALZHEIMER,CUR,DAC,GALLIUM,NMR
945,CURRENT,FOLLOWING,LNS,NPC,NTP,PBS
443,AREAS,BACKGROUND,COVERED,DEPENDING,INVENTION,LABEL,METHODS,OPINION
140,C57BL,CPA,CYPB6TM,E7CD8,EXPRESSION,GDEPT,HPV,NADPH,RED,TC1,THESE
383,AFP,AFTER,AIM,ALPHA,CONCLUSION,GLISSONEAN,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS,SEGMENT,SELECTIVE,THERE
HEREAFTER,HOWEVER,RESECTION
ACTL8,ATLAS,CTS,CURRENT,CXORF61,HORMAD1,PRAME,THESE
INCREASED,PBMCS,PROGRAMMED,RCC,WHILE
001,169,BAL,COMPARING,HOWEVER,INC,MICROSCOPY,PCR,WESTERN,WILEY
001,AFP,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
000,011,270,COX,MEIER,NSCLC
BRMS1,EXPRESSION,HBEC3,NSCLC,RAS,THESE
BACKGROUND,ISTAT,LABEL,METHODS,OVERALL,RESULTS,SMR
160,169,956,CNS,COMPOUNDS,COPYRIGHT,SAS
JANUARY,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OFF,PURPOSE,RESULTS,THREE,UNIVERSITY
916,968,AKT,BCL,ERK,HOWEVER,INHIBITORS,ROS,SEC,TAKEN,TRXR1
ALDH1A1,ALDH3A1,ALDH7A1,BACKGROUND,DU145,LABEL,METHODS,PCSCS,PIN,RESULTS,WHEREAS,XENOGRAFT
000,136,145,147,152,177,525,596,AFFILIATED,CONCLUSION,DEPARTMENT,DNMT1,ELISA,FIRST,HDAC1,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIXTH,THERE,UNIVERSITY,ZHENGZHOU
000,001,113,198,239,612,CHI,DCR,JANUARY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,THEIR,THREE,XINQIAO
000,006,021,049,946,BACKGROUND,CHINESE,ERCC1,III,INCREASED,LABEL,METHODS,NSCLC,RESULTS,SEVENTY,TUBB3,WHITNEY
169,372,716,AMONG,BACKGROUND,COMMUNITY,LABEL,METHODS,ORS,RESULTS,SEPP1
100,210,218C9,300,6B6,CAUCASIAN,COPENHAGEN,EXTRACTED,HOWEVER,NSCLC,PCR,POSITIVITY,PROTEIN,REFINEMENT,SEVEN,SIGNALING,TECHNOLOGY,USA
115,143,191,225,347,368,385,406,FGFR1,LOW,THERE

105,242,BACKGROUND,LABEL,MATERIALS,METHODS,MTS,PATIENT,RESULTS
231,540,BACKGROUND,CONCLUSION,COR,EPSILON,LABEL,MDA,MTT,MTX,RESULTS,SURFACE,THESE
183,200,945,BTC,EMT,EPITHELIAL,ERBB2,GATA3,GATA6,KNOCKDOWN
HOWEVER
160,ACT,FIRST,STIMULATED,THIRD
104,BACKGROUND,LABEL,MAJOR,MATERIALS,METHODS,NSCLC,PFS,RESULTS,TKI
017,043,117,174,334,518,557,681,979,980,BACKGROUND,CHINESE,CLPTM1L,CONCLUSION,LABEL,METHODS,RESULTS,SIMILAR
COBAS,CONCLUSION,HOWEVER,HOWOVER,KIT,LABEL,METHODS,MOLECULAR,OBJECTIVE,PCR,RESULTS,ROCHE
BACKGROUND,CD3,CD4,CD8,HOWEVER,LABEL,MATERIALS,METHODS,NKG2A,NKG2D,NSCLC,RESULTS,TNM,UNBALANCED
001,002,148,245,BACKGROUND,LABEL,MATERIALS,METHODS,MPV,NLR,OBJECTIVE,PLR,RESULTS,TNM
000,746,BACKGROUND,JAPAN,LABEL,MATERIALS,METHODS,RESULTS,SENDING,USING,WESTERN
001,027,033,042,048,111,298,ADP,CONCLUSION,COX,ERCC1,LABEL,METHODS,OBJECTIVE,PARP1,PURPOSE,RARP1,RESULTS,SIMILALRY,THROUGH
339,391,ADDITIONAL,ASIAN,BACKGROUND,CAUCASIANS,CIS,FURTHER,GLU,GLU589LYS,HOWEVER,JANUARY,LABEL,LYS,MATERIALS,METHODS,ORS,OVERALL,PUBLISHED,RESULTS,SCIENCE,WEB
001,002,003,004,145,CA2,DECREASED,FRESH,IHC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PATIENT,PCR,PURPOSE,RESULTS,SIMILAR,TRPV5,TRPV6,USING
DHA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THEREFORE
107,110,203,BACKGROUND,LABEL,MARCH,MATERIALS,METHODS,RESULTS,SCC,SMOKING
177,928,DDP,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,RESULTS
001,004,021,122,18F,7TH,BACKGROUND,COMMITTEE,COX,EASTERN,EFS,GROUP,III,JOINT,LABEL,MATERIALS,METHODS,NSCLC,PET,RESULTS,THERE,VARIABLES
003,004,006,AMOUNTS,CHANGES,CONCLUSION,CONVERSELY,FDG,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVMEAN,TOTAL,WHITNEY
CHEST,DESPITE
169,285,925,AMERICANS,BACKGROUND,BRONX,CENTRAL,CHICAGO,COMMUNITY,CONCLUSION,DIEGO,DOMINICANS,HISPANICS,INSTITUTE,LABEL,LATINOS,METHODS,MIAMI,NUTRITION,OBJECTIVE,OVERALL,RESULTS,SAN,SOCIETY,SOUTH,VARIATIONS
169,EUS,FNA,LOOKING,SOCIETY
083,169,328,HPV,HPV11,HPV16,HPV31,THREE
001,002,012,013,016,017,138,169,346,382,522,552,594,995,AMONG,EPIDERMAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POTENTIAL,PRESS,PRS,PUBLISHED,RESULTS,SURGERY,TKI,UNIVERSITY
AMONG,DAG,ESI,H1975,MALDI,NCI,PCS,PIS,SMS,TAG,THREE,UHPLC
AGS,H1650,HDAC3,HOWEVER,NCI,STAT3
AIM,INCREASED,ITALY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REFERENCE,RESULTS,SMR,SPATIAL,TARANTO
045,127,154,169,174,945,947,COPYRIGHT,HIF,INC,PROLASTIN,UO126
001,017,177,388,431,435,ADC,CD4,CONTROL,COX,DISEASE,EIGHT,HIV,HODGKIN,ITALIAN,JANUARY,LABEL,LOW,LOWER,MEIER,METHODS,MULTI,NADCS,NON,OBJECTIVE,OBJECTIVES,RECURRENCE,REGARDING,RESULTS,SEPTEMBER,SURVIVALS
036,132,18F,BACKGROUND,CHILD,FDG,HCC,HOWEVER,LABEL,LYMPH,METHODS,PET,RESULTS
737,ION,PANEL,SINCE,TORRENT,UNTIL,USING,WHILE
108,152,195,223,232,460,464,479,595,648,820,ADC,MATTHEW,MCC,SCC,SCLCS
169,COPYRIGHT,LTD,NSCLC,PROGNOSTIC
169,COPYRIGHT,DIFFERENT,FIRST,HOWEVER,LTD,NON,NSCLC,SMALL,TKI
FDA
000,100,138,169,250,323,500,581,600,742,BACKGROUND,FIGURES,GERMANY,ITALY,LABEL,MEDICAL,METHODS,NOTABLE,PANCREATIC,POPULATION,PRESS,PROJECTED,PUBLISHED,RESULTS,SOCIETY,SPAIN,UNION,UNIVERSITY,WORLD
180,CYSTOSCOPY,HOWEVER,IVB,SERUM,SHELDON,THEREFORE
CYSTOSCOPY,JAPAN
140,169,1950S,1970S,5MG,BRITISH,CLYDACH,HYGIENE,PRESS,PUBLISHED,SOCIETY,UNIVERSITY,WALES,WHILE

BIGH3,HYALURONAN,SINCE,THESE
956,GLN,PHE,TRUNCATION
100,128,BETWEEN,DISTANT,GTV,LOCAL,SRS,SRT
169,AUTHORS,BASED,COPYRIGHT,CTS,DESPITE,INC,PUBLISHED,REPORTING
HOWEVER,NSCLC,THEREFORE,TKI
NSCLC,RADIATION,THEREFORE
NSCLC
100,ADVERSE,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,RELATIVELY,RESULTS,THREE
012,182,813,ANOVA,BACKGROUND,BLAND,LABEL,METHODS,OBJECTIVE,RESULTS
001,010,107,121,134,276,311,318,386,450,478,810,887,918,972,BACKGROUND,CBM,LABEL,LIBRARY,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVEN,STATA,THEREFORE,VIP,WANFANG
001,005,007,039,116,BACKGROUND,DCR,EPIDERMAL,GNAS1,HOWEVER,LABEL,METHODS,NCSLC,NSCLC,OBJECTIVE,PCR,PFS,RESULTS,T393C,TKI,UNIVARIATE
104,946,BACKGROUND,ITF,LABEL,METHODS,OBJECTIVE,RESULTS,SCC
946,AAP,AFTER,BACKGROUND,DENSITY,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SPECIES,TGF
BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,TCF21,TRANSWELL,WESTERN

CONCLUSION,ILC,KNOWLEDGE,LABEL,OBJECTIVE
BLAND,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PET,RESULTS,THERE
100,177,COMPLEX,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PPV,RESULTS,ROUND
169,6TN,946,947,AUTHORS,FOUNDATION,JOURNAL,LTD,MOLECULAR,RADIATION,RLE,SMAD3,SNAIL,TGF,TH1,TH2,WILEY
BACKGROUND,CHINESE,CONCLUSION,LABEL,METHODS,PAROTID
169,BRITISH,DLBCL,DLCBL,EBV,EPSTEIN
007,043,100,162,225,250,400,BACKGROUND,CHINESE,LABEL,METHODS,RESULTS,SOX,THERE,THESE
160,BACKGROUND,III,IVB,LABEL,METHODS,PULMONARY,RESULTS,THERE
003,017,026,039,049,345,832,BACKGROUND,BASED,CONCLUSION,COX,ELISA,LABEL,MALIGNANT,MEIER,METHODS,MPE,NSCLC,PFS,RESULTS,ROC,SPECIMENS,WHITNEY
946,BACKGROUND,CATENIN,EMT,GLI,INHIBITION,LABEL,METHODS,PROTEIN,RESULTS,SCC,SHH,VISMODEGIB,WESTERN
AKT,BCL,FRAGILE,HOWEVER,MTT,PCR,PROTEIN,THESE,TREATMENT
169,COPYRIGHT,COX,DETECTION,HOWEVER,LTD,RESULTS,WILEY,YET
174,BCC,EMA,FDA,GDC,JANUARY,MEDICINES,SMO,VISMODEGIB
AMONG,DUE,EMA,FDA,HIV,MEDICINES,SEVERAL,SINCE
HODGKIN,NOTABLE,NPI,PROTEOSOME
ACTIVATION,ATP,ERK,III,MEK,PLX4032,RAF,RAS,UNDER,V600E,V600K
ALK,ATP,CRIZOTINIB,HOWEVER,MET,NSCLC,ROS,RTK,THERE,TOXICITIES
INHIBITORS
757,ASIAN,CIS,HOWEVER,HRS,ISI,LOW,SCIENCE,WEB
OVERALL,TEN,THERE
100,112,160,169,177,183,81S,CONCLUSION,FEWER,GEORG,GUIDELINES,KEY,LABEL,MATERIALS,METHODS,MULTISLICE,OBJECTIVE,PURPOSE,QUALITY,REDUCED,RESULTS,STUTTGART,TOMOGRAPHY,WHITNEY
CONCURRENT,LABEL,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,TACC3
ADVANTAGES,BACKGROUND,CONCLUSION,DUE,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
CENTRAL,DIAGNOSTIC,FNA,ISSUE,LABEL,METHODICAL,METHODS,OBJECTIVE,PRACTICAL,RESULTS,SEVERAL
000,049,398,500,575,700,744,929,AMONG,ASIAN,BACKGROUND,BANGLADESH,CHINA,EDITORS,INDIA,JAPAN,KOREA,LABEL,METHODS,RESULTS,SINGAPORE,SUMMARY,TOBACCO
001,169,488,AMONG,CONCLUSION,COPYRIGHT,COSTS,END,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STUDIES,TEXAS,THOSE
335,371,502,946,DOB,HARVARD,HLA,KLRK1,NSCLC,SNP,UNIVERSITY
017,239,250,500,AUC,CURRENT,NPR,NSCLC,ORR,PFS,PREDEFINED,SECONDARY,TKI,TREATMENT
AFTER,RCC
169,197,ALK,BACKGROUND,LABEL,MEANWHILE,METHODS,RESULTS,SHS,THESE
AUC,DUE,EARLY,HALOTAG,LUMINEX,THERE,THEREFORE
BECN1,NON,NSCLC,PACLITAXEL,T24,TXR,UTR
A40,A41,DISTANT,GREATER,INNOV,LABEL,MEIER,METHODS,OBJECTIVE,PATHOLOGIC,PATIENT,RESULTS,THERE,VATPS,VIDEO
001,011,018,026,029,047,331,ANOVA,BLOOD,EXHALED,FORTY,LABEL,LOWER,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE
BACKGROUND,CONCLUSION,LABEL,METHODS,PULMONARY,VIDEO
CHINESE,REPORTS
169,190,272,413,468,NCN,RRS,SCREENING,SPATIALLY,TRIAL
BACKGROUND,CHINESE,FURTHER,HAN,KNOCKDOWN,LABEL,METHODS,MMP,PCR,RESULTS,SP1
169,ADP,CDK,COPYRIGHT,THESE,WESTERN
169,ACADEMY,AFH,BACKGROUND,CFH,COPYRIGHT,CUTANEOUS,FATAL,INC,LABEL,METASTASIS,METFH,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SEVEN
RADIATION
160,BACKGROUND,JAPAN,LABEL,METHODS
169,ENDOSCOPIC,FORCE,HOWEVER,JAPAN,LTD,PLEURAL,PTY,PUBLISHING,SIXTEEN,SOCIETY,SURGERY,WILEY
133,169,390,ENDOSCOPIC,FORCE,JAPAN,LTD,PTY,PUBLISHING,SOCIETY,SURGERY,WILEY
101,327,428,646,BACKGROUND,DESPITE,DETAILS,DUTCH,III,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,REASONS,RECURSIVE,RESULTS,RPA,THEREFORE
956,COMPOUNDS,HCC44,NSCLC,THREE
160,168,169,240,AGE,BACKGROUND,BOS,CASES,CONCLUSION,ENGLISH,FURTHER,LABEL,LTD,MEDLINE,METHODS,NON,OBJECTIVE,PUBLISHED,RELAPSE,RESULTS,SEVENTY,TOTAL,WILEY
000,100,ANS,CHSDA,COMPARISON,EFFORTS,IHS,INDIANS,LABEL,METHODS,NATIVES,OBJECTIVE,OBJECTIVES,RESULTS,SERVICE,SOUTHWEST,WHITE
ATP,EGF,ERBB3,ERBB4,HOWEVER,III,LUX,NSCLC,PHASE,TKI
ALK,FIRST,NSCLC
SMALL
160,169,956,AUTHORS,H2052,H2452,H28,HRK,LTD,NCI,PTY,PUBLISHING,SCIENCE,TAKEN,WILEY
954,J774A,LPS,SIMILAR,SLC15A3,THESE,THP,USING
169,ABOVE,IGA,IGG,INC,WILEY
001,215,450,854,INITIAL,NSCLC,TNM
169,321,615,DIFFUSE,DLBCL,EPSTEIN,HODGKIN,INC,MATCH,NON,POISSON,SIR,THEREFORE,TRANSPLANT,WILEY
169,954,FINALLY,HOWEVER,LABEL,NSCLC,REL,TAKEN,UNLABELLED
169,AUTHORS,BACKGROUND,ERCC1,INC,LABEL,METHODS,PROTEIN,RESULTS,SECONDARY,SOCIETY,TREATMENT,WILEY
183,997,AMONG,BACKGROUND,BECAUSE,CONCLUSION,FORTY,GEORG,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,SIXTY,STUTTGART,THEIR,THERE
ASSESSMENT,CONCLUSION,GENERATED,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SIXTY,SMELL,SUBJECTIVE,TASTE,TSS
169,947,ABS,ACUTE,AFTER,BECAUSE,COPYRIGHT,HOWEVER,IFN,IGA,IGG2A,INC
169,277,AES,BACKGROUND,CRS,LABEL,LAR,METHODS,NET,ORR,PRIMARY,PRS,RESULTS,SDS,SIMON,SOCIETY,TREATMENT
169,SOCIETY,STRATEGIES
BECAUSE,BMP
CD3,CD8,DCS,HMGB1,NSCLC
945,947,CD4,CD8,CEA,CONCLUSION,CSF,CTL,DCS,IFN,LABEL,METHODS,MHC,OBJECTIVE,RESULTS,THESE,TNF
CONCLUSION,LABEL,LCSCS,METHODS,NANOG,NCI,OBJECTIVE,PCR,RESULTS
169,230,AMONG,CHILDHOOD,CONCLUSION,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR,SOCIETY
169,MODEL,PRESS,PUBLISHED,ROMANIA,UNIVERSITY
000,004,013,169,BIOLOGICAL,COMMITTEE,EFFECTS,ERR,PRESS,PUBLISHED,RADIATION,UNIVERSITY,WLM
169,473,AKT,BACKGROUND,BASEL,DDP,HOWEVER,INHIBITION,LABEL,METHODS,OBJECTIVE,RESULTS,SER,SEVERAL,U0126,WHEREAS
001,002,967,ANY,CONCLUSION,IMPAIRMENT,LABEL,MEASURE,METHODS,OBJECTIVE,RESULTS,SCALE,TOKUHASHI
SINCE
CONCLUSION,CSF,DIAGNOSIS,EVOLUTION,IAM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RAPID,RESULTS,SETTING,TREATMENT,VESTIBULAR
004,120,169,177,CNR,COPYRIGHT,GTV,IMAGING,INC,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER
169,COPYRIGHT,DESPITE,HOWEVER,INC,PULMONARY
100,169,243,970,BACKGROUND,BETWEEN,COPYRIGHT,INC,JANUARY,LABEL,LYMPH,METHODS,MORBIDITY,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY,SPECIALTY,THERE
001,111,139,154,169,177,215,335,728,AMONG,BACKGROUND,COPYRIGHT,DSP,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,SEQ,THEIR
001,100,169,215,AFTER,CONCLUSION,COPYRIGHT,FSE,III,IRELAND,JANUARY,LABEL,LCR,LTD,MATERIALS,METHODS,MTS,OBJECTIVE,RESULTS,SPECIMENS,WHITNEY
169,COPYRIGHT,HOWEVER,LIVER,PUBLISHED,SAS
169,COPYRIGHT,HOWEVER,PUBLISHED,SAS,THESE
169,COPYRIGHT,DIFFERENT,HOWEVER,MAJOR,MINIMALLY,PUBLISHED,SAS


ACC,ADENOID
160,169,ALK,ANAPLASTIC,APMIS,CRIZOTINIB,JUN,KRUSKAL,LTD,NPM,NSCLC,PDGFR,PUBLISHED,THESE,WILEY
160,169,AUTHORS,EGF,LTD,MEK,NSCLC,PTY,PUBLISHING,SCIENCE,TKI,WILEY
MATERIALS,REFERENCE
945,946,BPA,DDT,DIVERSE,EDC,ENDOCRINE,MECHANISMS
100,300,ADR,CSF,DOX,FINALLY,FIRST,FURTHER,MCF,MDC,THIRD,TNF
CONCLUSION,LABEL,METHODS,OBJECTIVE,PFS,PSC,RESULTS,THEIR
202,ACCORDING,CHEST,CHINA,CONCLUSION,DEPARTMENT,LABEL,METHODS,OBJECTIVE,RESULTS,SICHUAN,STAGE,SURGERY,UNIVERSITY
001,013,041,167,616,CHINA,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SICHUAN,UNIVERSITY
CONCLUSION,H1975,IHC,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,SIMILARLY,WESTERN
100,AFTER,BAD,CONCLUSION,EF1,LABEL,METHODS,OBJECTIVE,PCR,PFU,RESULTS,TEASY,TOTAL,WESTERN
AFTER,CCK,CONCLUSION,GFP,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SEQUENCES,WESTERN

1ST,2ND,3RD,AVERAGE,MORTALITY,THERE,TOMSK
154,177,794,BACKGROUND,BMI,LABEL,METHODS,NUTRITION,OBJECTIVE,OVERALL,RESULTS
169,CHEST,PRESS,PUBLISHED,SURGERY,UNIVERSITY
CEA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,UNIVARIATE
169,AMONG,COMMISSION,COUNCIL,COUNTRIES,DIRECTIVE,EURATOM,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
100,125,132,ACUTE,APREPITANT,APRIL,BEIJING,HT3,LABEL,METHODS,OBJECTIVE,RESULTS
024,036,COX,FINALLY,MEIER,NSCLC,TNM,VASH1,VASOHIBIN
158,ADX,HOWEVER,NSCLC,ORR,TKI
176,181,300,DISTILLED,DUE,MOL,MORINGA,ROS,SINCE,THESE,WATER
DESPITE,MODULATION,NSCLC
BESIDES,DESPITE,VTE
945,954,BBS,GLI,GTPASES,PAR,RHO,SHH,SMALL,SONIC
ALZHEIMER,EMT,FURTHER,HUNTINGTON,SNAIL,TAKEN,THESE,UBIQUILIN1,UBQLN
DISEASE,HOWEVER,LABEL,LIFESTYLE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,GENERAL,HEPARANASE,ISSUE,LABEL,METHODS,RESULTS,SPECIAL,TNM
HENCE,HOWEVER,STAGE
945,946,954,RTK,THESE
125,BACKGROUND,CEA,CEACAM1,COLORECTAL,CYFRA,HOWEVER,LABEL,METHODS,NSE,OPG,OPN,OVARIAN,PRL,RESULTS,SCREENING,SEVERAL,SIXTY,TRIAL
001,036,160,946,ASIAN,BACKGROUND,CONCLUSION,CONTEXT,DEVELOPING,HOWEVER,INC,LABEL,LOWER,METHODS,OBJECTIVE,OBJECTIVES,PACIFIC,PUBLISHED,RESULTS
109,160,169,ACADEMY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,HOSPICE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PATIENT,PUBLISHED,RESULTS,SYMPTOM,THERE
169,956,COMPOUNDS,COPYRIGHT,DR5,EWG,H1792,INC,THESE
169,COPYRIGHT,FURTHER,HENCE,INC,NAD,NSCLC,NUCLEAR,PREVIOUSLY
169,COPYRIGHT,INC,MALIGNANT,MPM,SRC,WHILE
160,169,BACKGROUND,COPYRIGHT,INC,LABEL,MARCH,METHODS,MOLECULAR,MOSBY,PUBLISHED,RESULTS,SURGERY,THERE,THESE
169,212,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PFT,PUBLISHED,RESULTS,SURGERY,T1A,T1B
169,COPYRIGHT,FURTHER,INC,INSTITUTE,THESE
001,160,169,177,BACKGROUND,CONCLUSION,COPYRIGHT,EPA,FATIGUE,LABEL,LBM,LTD,METABOLISM,METHODS,NSCLC,NUTRITION,OBJECTIVE,ONS,REGISTERED,RESULTS,SOCIETY,THERE
169,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,MEDLINE,METHODS,PULMONARY,REGARDING,RESULTS,SINCE,THEREFORE
001,002,100,169,COPYRIGHT,CSF,INC,LYM,PMN,THESE
102,169,956,COPYRIGHT,IMR,INC,LTR,STUDIES
169,976,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,CONCLUSION,COPYRIGHT,CSANZ,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,THESE,ZEALAND
169,231,233,COMPARABLE,COPYRIGHT,HUANG,PUBLISHED,SAS
169,AKT,BECAUSE,CONCLUSION,COPYRIGHT,EXPRESSION,H1975,INDUCTION,IRELAND,KNOCKDOWN,L858R,LABEL,LTD,MATERIALS,MET,METHODS,NANOG,NSCLC,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,T790M,THESE,TKI
169,285,AFRICAN,COLLEGE,COPYRIGHT,EIGHT,FIFTEEN,LABEL,LOCALLY,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,295,296,486,487,496,500,CONCLUSION,COPYRIGHT,GUIDELINES,LABEL,METHODS,OVERALL,RESULTS,SAS,UNLABELLED
169,ATP,COPYRIGHT,INC
169,COPYRIGHT
169,946,APOPTOSIS,BACKGROUND,CHROMATIN,COPYRIGHT,HFL,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,MITOTIC,NSCLC,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,SENESCENCE
001,10878,169,301,ATC,BACKGROUND,CONCLUSION,COPYRIGHT,COX,ELEVATIONS,FURTHER,IRELAND,LABEL,LTD,MASSARRAY,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR
169,1MM,2MM,3MM,4MM,7MM,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,TEN
160,169,COPYRIGHT,FURTHER,INC
160,169,2N0,BACKGROUND,COPYRIGHT,INC,LABEL,METASTATIC,METHODS,PUBLISHED,RESULTS,SOCIETY
169,BRAIN,COPYRIGHT,GENERAL,INDIA,MRI,SAS,TYPICALLY

GASTRODIA,HSP,HSP27,HSP70,MARKERS,NCI,THESE
143,169,967,COPYRIGHT,CURRENT,GATA3,INC,SINCE
001,100,169,177,AMONG,COPYRIGHT,INC,NSCLC,OWING,THESE
100,169,946,AUTHORS,BECAUSE,CASES,COPYRIGHT,E12,INC,PUBLISHED
169,CK5,COPYRIGHT,HOPKINS,INC,JOHNS,NSCLC,SQCCS
085,120,134,169,239,AMONG,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
001,002,027,169,768,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,HOSPITALS,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NON,NSCLC,RESULTS,SMALL,THERE,UNIVARIATE,UNIVERSITY
AUTOIMMUNE,CONCLUSION,EEG,EIGHT,HASHIMOTO,LABEL,MARCH,MAY,METHODS,MRI,OBJECTIVE,RESULTS,SIX,THEIR,THERE
ACTIVATING,ALK,AREAS,BACKGROUND,COVERED,EIGHT,III,LABEL,METHODS,NSCLC,OPINION,PHASE,TKI
169,370,435,CONVERSION,COPYRIGHT,INC,MDA,MODULATION,RESULTS,THEREFORE
025,169,181,304,COPYRIGHT,IGF1R,INC,MEMBRANOUS,REGARDING,SNP,THESE
125,BAX
EXPRESSION,HTB,INHIBITION,THESE
BECAUSE,DEPENDING,REGULATION,UTR
BAX,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TFT,TRAIL,WESTERN
7B7,MAB,MIA,USING
CLINICIAN,HOWEVER,JUDGING,SOUTH
132,169,192,194,212,363,381,ARRAY,ERS,EXPRESSION,MICRORNAS,THESE
104,946,DACH1,DACHSHUND,ED2,KYSE150,KYSE510,NETWORK,PCR,RETINAL,TGF
160,BRITISH,KNOWLEDGE,LABEL,METHODS,NAVIGATOR,OBJECTIVE,PURPOSE,RESULTS,VANCOUVER,VOLUNTEERS
AMONG,FORMULA,NON,NSCLC,SCC
169,DESPITE,PRESS,PUBLISHED,THERE,UNIVERSITY
001,111,165,AREAS,BACKGROUND,HETES,HOWEVER,LABEL,METHODS,RESULTS,SERUM,THERE
4T1,EPITHELIAL,TAKEN,TWIST
08975,391,AFTER,BACKGROUND,C30,COX,EORTC,EVERY,HRQOL,HRS,LABEL,METHODS,NSCLC,QLQ,RESULTS
BACKGROUND,FINALLY,LABEL,MALIGNANT,METHODS,MPM,PTP,RESULTS,SHP,SST,SSTR4
153,ACTIVATING,BACKGROUND,E545K,LABEL,METHODS,NSCLC,RESULTS,T790M,THESE,TKI
956,987,CONCLUSION,EDI,HEIDELBERG,HRA,LABEL,METHODS,OBJECTIVE,OCT,OUTER,OVERLYING,PURPOSE,RESULTS,SPECTRALIS,SUBRETINAL
AMERICANS,BACKGROUND,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,STRATEGIES,THOUSANDS,USING
001,003,177,184,192,216,223,238,317,320,385,388,945,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SECONDARY,THREE
SINCE,THERE
177TH,AVR,CAREFUL,MEDICAL,MVR
135,169,253,496,BCL,HNSCC,OVERALL,PRESS,PUBLISHED,SCC,SINCE,TARGETING,UNIVERSITY
B2A,CHEST,RIGHT
DESMOID,SEVENTEEN,SINCE,WHILE
001,008,121,141,262,402,636,664,967,APRIL,CONCLUSION,FINALLY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,RESULTS,THERE,TTF
AFTER,BETWEEN,TEN
210,CHEST,NON,RECURRENCE,THERE
FURTHER,GEFITINIB,NSCLC,THESE,TKI
340,343,683,699,ADR,AMONG,B75,JAPAN,MAY,NSCLC,PATIENT,PEM,PERIPHERAL,STAGE,THESE
000,146,172,CIA,JAPAN,SEPTEMBER,SOCIETY,THERAPY,THEREFORE,THESE
AFTER,BECAUSE,INDUCTION,LAR,MILES,QOL,SOX
120MG,200MG,AFTER,LEUCOVORIN,QOL,STAGE
THERE,THESE
FUNCTIONAL,HT3,INDEX,QOL
200ML,AUC,CREATININE,CSF,HOWEVER,TOTAL
11Q21,BRANDWEIN,FEW,FORTY,MAML2,PULMONARY,THESE,TTF
AFTER,BECAUSE,EIGHT
AVAIL,BASED,HOWEVER,III,JAPAN,NOTCH,THESE
946,EXPRESSION,POLII,SCC,USING,WHILE
160,169,BESIDES,CLC,COPYRIGHT,CURRENTLY,LTD,MMP,THESE,U87
ANNEXIN,JNK,MAPKS,PARP1,TREATMENT
GIVEN,PRECISION
169,191,322,513,COPYRIGHT,INC,JANUARY,RESULTS,SPANISH
169,CANCERS,COPYRIGHT,DISRUPTION,HEART,INC,NON,PUBLISHED,SOCIETY
AFFYMETRIX,CONSISTENT,HOWEVER,MYC,PCR,TAKEN
404,ADC,ALK,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VENTANA
ACCORDING,ATLAS,FURTHER,MMP,PROTEIN,THEREFORE,WESTERN
169,956,ACADEMY,AGILENT,BIOLOGICAL,BIOLOGY,CHINESE,EDITORIAL,EXPRESSION,INSTITUTE,INSTITUTES,MGX,PANAX,PRESS,PRIMEVIEW,PUBLISHED,THESE,UNIVERSITY
100,BACKGROUND,CONCLUSION,DOTATOC,LABEL,MCC,METHODS,NOTABLY,PET,RESULTS
ABOUT,CONCLUSION,LABEL,LITERATURE,METHODS,OBJECTIVE,RESULTS
006,486,686,BACKGROUND,CANCORS,CONSORTIUM,ENHANCING,FEW,HOWEVER,LABEL,METHODS,OBJECTIVE,PHYSICIANS,PROGNOSIS,RESULTS,SETTING
393,BACKGROUND,CHANGES,END,INSTITUTE,LABEL,METHODS,RESULTS,SIR,THERE
DYSPNEA,OFTEN,PALLIATIVE,THEREFORE
103,117,212,AMONG,EIGHT,ELISA,ILD,THESE
021,036,066,120,128,140,152,ADR,ADULT,BMI,CONCLUSION,EASTERN,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILAR
169,BECAUSE,DESPITE,FINALLY,LABEL,MOLECULAR,UNLABELLED
100,113,135,169,177,BASED,ICU,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,TEN,THERE,UNIVERSITY
169,AFTER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
169,CO2,FIRSTLY,HOWEVER,MIE,PRESS,PUBLISHED,SURGERY,UNIVERSITY
169,AKT,DU145,FABP4,FATTY,SEVERAL,THESE
169,DESPITE,DISCOIDIN,H1299,JM2,TAKEN
195,HCC,HOWEVER,SRC,THEREFORE,UTR
CURRENT,EVALUATION,HOWEVER,LDH,NSE,SOLID
093,169,215,312,398,412,502,BACKGROUND,BONFERRONI,COLORECTAL,DIETARY,GIVEN,INTRACLASS,LABEL,LARGE,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OTHER,OVARIAN,PEARSON,RESULTS,SCREENING,SOCIETY,TRIAL,USUAL
323,ESI,MALDI,PANTHER,POTENTIAL,SCC,TOF
105,129,169,250,400,499,500,999,AMERICA,AUSTRALIA,BACKGROUND,BETWEEN,COPYRIGHT,EASTERN,FEB,GRADE,GROUP,LABEL,LTD,METHODS,NORTH,RESULTS,SOUTH,USING
EARLY
CHRONIC,RICHTER
ENGLISH,PRIMARY

ADDRESSED,CHINESE,CONCLUSION,FATALISTIC,ISSUE,KNOWLEDGE,LABEL,LIMITED,METHODS,NSW,OBJECTIVE,RESULTS,SEVEN,SOUTH,THERE,VIETNAMESE,WALES


CUSHING,ECTOPIC
103,105,BACKGROUND,CBCTS,ENB,INCIDENCE,LABEL,METHODS,PATIENT,RESULTS,THROUGHOUT
BACKGROUND,LABEL,METHODS,RESULTS,VIRTUAL
ADVOCATES,CLM,CONGENITAL,INCREASES,LABEL,MRI,OBJECTIVE,PROPONENTS,PURPOSE,RESULTS,SUMMARY,THERE
105,185,AIM,AMONG,BMJ,CNB,DIAGNOSTIC,EIGHT,FNA,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PROMINENT,PUBLISHED,PUBLISHING,RESULTS,UNIVARIATE
086,169,896,AGING,AGREEMENT,AMSTERDAM,CONCLUSION,COPYRIGHT,CROSS,INC,LABEL,METHODS,MULTILEVEL,OBJECTIVE,OBJECTIVES,OLDER,RESULTS,UNDER
BECAUSE
177,931,963,BACKGROUND,CONCLUSION,DAILY,IMAGE,INTRA,LABEL,MATERIALS,METHODS,RESULTS
BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,RENAL,WORLD
BACKGROUND,CONCLUSION,CZECH,LABEL,METHODS,RESULTS,USING
169,ALTOGETHER,AUTHORS,HOWEVER,JOURNAL,OCT4A,PATHOLOGY,THESE
9GR,AKT,EEF,EPIMEDIUM,H1975,NAKAI,NSCLC,SIMILARLY,T790M
BACKGROUND,LABEL,RESULTS
EMT,NSCLC,THESE
001,169,518,573,ADHERENCE,AUDIT,CONCLUSION,COPYRIGHT,FLORIDA,III,INITIATIVE,LABEL,MEDICAL,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,QUALITY,RESULTS,SIXTEEN,SOCIETY,THERE,WHETHER
063,121,169,AMONG,CONCLUSION,COPYRIGHT,COX,ESA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,SINCE,SOCIETY
004,100,121,169,BETWEEN,BRONCHIAL,DISEASE,FINAL,HISTOLOGY,III,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESECTION,RESULTS,STAGE,SURGERY,UNIVERSITY
120,169,197,240,360,ARQ,BACKGROUND,CONCLUSION,DIFFERENT,EARLY,FIFTY,GRADE,IDENTIFIER,LABEL,MEDICAL,MET,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,TEN,THERE,TIVANTINIB,UNASSIGNED,UNIVERSITY
001,002,003,016,166,169,352,BACKGROUND,BCL,BIM,CHINESE,COX,EPIDERMAL,LABEL,METHODS,NSCLC,PFS,RESULTS,SOCIETY,TKI
169,INC,MMP,MMP1A,VARIATION,WILEY
001,009,018,065,124,169,AMONG,BACKGROUND,EPIDERMAL,GENOTYPING,HOWEVER,LABEL,METHODS,RESULTS,SOCIETY,T790M
002,005,012,018,024,108,109,115,116,ACCORDING,AMONG,COX,DFS,III,JANUARY,NSCLC,TNM
169,215,250,308,558,AFFYMETRIX,AFTER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS,SNP
151,ADHERENCE,AES,BCS,CONCLUSION,GERMANY,LABEL,LAD,METHODS,OBJECTIVE,PTV,PURPOSE,QOL,RESULTS,SIB,WBI
145,786,FOLLOWING,MMP,MTT,RCC,THESE
100,101,102,103,159,169,486,BACKGROUND,EFFECTIVE,ERA,LABEL,METHODS,PARTICULAR,PRESS,PUBLISHED,RADIATION,RESULTS,UNIVERSITY
BACKGROUND,CONCLUSION,JAPAN,LABEL,METHODS,MORTALITY,REGARDING,RESULTS,SURGERY
169,916,MINERAL,RGD,SOCIETY,THEREFORE
FURTHER,ISSUE,LABEL,METHODICAL,METHODS,OBJECTIVE,PULMONARY,RESULTS
169,231,BECAUSE,GGA,JAPAN,LPA,MDA,REMARKABLY,RHO,ROCK1,THESE,TUNEL
000,038,229,257,510,522,567,735,952,AFTER,ALA499VAL,ASIAN,BACKGROUND,CAUCASIAN,CIS,CONCLUSION,EGGER,GLN939GLN,HOWEVER,LABEL,LYS939GLN,METHODS,ORS,PAT,PUBLISHED,RESULTS,XERODERMA,XPC
001,004,008,016,021,447,BACKGROUND,FGFR1,INCREASED,LABEL,METHODS,NSCLC,RESULTS,SCC
10878,143,183,BACKGROUND,LABEL,METHODS,MIB,RESULTS,UNIVARIATE
174,BACKGROUND,CXR,LABEL,LOCAL,METHODS,OUTCOME,PATIENT,RESULTS,ROUTINE,THERE
00001,025,048,169,469,500,536,IUPAC,SMALL
BESIDES,CASES,INFECTION,NS3,RESULTS,SPLEENS,STUDIES,THESE,TISSUES
018,021,150,400,COX,NSCLC,OVERALL,TTP
160,AMONG,DISTANT,III,IMF,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,FGFR1,FOCAL,LABEL,METHODS,RESULTS,THERE
ALK,ANAPLASTIC,BACKGROUND,LABEL,METHODS,MULTIPLEX,RESULTS,SEVERAL,TPR,TRK,TRP
120,BACKGROUND,CONCLUSION,FIFTY,LABEL,METHODS,NORTH,PRIMARY,RESULTS,TTP
ACTIVATING,T790M
ALK,CH5424802,NSCLC,RO5424802
001,140,229,BACKGROUND,CUMULATIVE,III,INCOMPLETE,LABEL,MASAOKA,METHODS,OUTCOME,RECURRENCE,RESULTS,SOCIETY,WORLD
107,157,176,472,AMONG,BACKGROUND,FORTY,LABEL,METHODS,PTV,RESULTS
945,946,BACKGROUND,EIGHT,FURTHER,LABEL,METHODS,NSCLC,PEMETREXED,RESULTS
001,200,300,374,900,BACKGROUND,BETWEEN,CHANGES,LABEL,METHODS,RESULTS,TREATMENT
056,121,147,228,242,305,375,431,507,575,BACKGROUND,CONCLUSION,EASTERN,GEFITINIB,GROUP,L858R,LABEL,METHODS,NSCLC,PFS,RESULTS,THERE,TKI
001,005,006,304,383,AFTER,AMONG,BACKGROUND,CONCLUSION,CUSHING,CUSHINGPS,LABEL,METHODS,OTHERPS,REDUCED,RESULTS,WORLD
705,APOPTOSIS,BACKGROUND,ECTOPIC,LABEL,METHODS,NSCLC,PTP,RESULTS,SHP,SORAFENIB,SRC,STAT3,TARGETING
001,227,533,547,864,BACKGROUND,BCL,BIM,COX,JANUARY,LABEL,METHODS,PFS,POLYMERASE,RESULTS,THERE
945,AZA,BACKGROUND,BISULFITE,CYP24A1,EXPRESSION,H3K4ME2,H3K9ME2,LABEL,METHODS,NCI,RESULTS,THESE,TREATMENT,TSA,VDR
177,634,712,GGO,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTEEN,THESE
100,142,152,154,178,179,217,228,230,ALK,BACKGROUND,CONCLUSION,DETECTION,IHC,LABEL,METHODS,NSCLC,ONCOGENIC,PET,RESULTS,TREATMENT
BACKGROUND,CONCLUSION,HEREDITARY,LABEL,METHODS,RESULTS,T790M,THERE
131,ADHERENCE,BACKGROUND,DIAGNOSIS,END,FEW,HOWEVER,LABEL,METHODS,OVERALL,QUALITY,RESULTS,STAGING,SUPPORTIVE,TREATMENT
ADRENAL
BELOW,CESSATION,COMMITTEE,CONTROL,SMOKING,TOBACCO
169,AKT,CHRYSOTILE,COPYRIGHT,FINALLY,INC,JNK,JUN,LC3,NOTABLY,THESE
BACKGROUND,BRAIN,COLORECTAL,CONCLUSION,CRC,DUE,LABEL,METHODS
107,160,176,210,300,754,HODGKIN,LABEL,LAD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,V20,V30
169,198,AFTER,AIS,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNTIL,UTILIZING
001,169,COPYRIGHT,III,INHIBITING,IRELAND,JNK,JUN,LTD,NSCLC,OXIDATIVE,THERE,VNR
169,COPYRIGHT,HOWEVER,LTD,PTB,SH2
000,100,386,390,507,GEOGRAPHIC,LABEL,METHODS,OBJECTIVE,RADON,RESULTS,THESE
169,945,BCL,COPYRIGHT,COX,DEX,GCS,HOWEVER,INC,NOS,TNF
169,COPYRIGHT,FINALLY,H1993,H2073,INC,LXR,NRS,PHA665752,TAKEN
CALOTROPIS,COMPOUNDS,NMR,THEIR,THREE
263,ABT,BCLXL,FINALLY,FIRST,LUMINEX
ADULT,CONCLUSION,EES,EWING,FDG,IMAGING,KNOWLEDGE,LABEL,METASTASES,METHODS,OBJECTIVE,RESULTS
ATP,BCL,COMPLEX,ECM,NPS,SOD,ZNO
EUS,HOWEVER,NSCLC,PET,SINCE,SMALL
000,010,036,042,500,AFP,EIGHT
100,181,462,700,780,ARNEBIA,GAE,LPO,TPC
480,BCA,BINDING,RHAMM
THERE
149,157,BASED,CHINALUNG,CONSORTIUM,HOWEVER,IMAGE,SINCE
FINALLY
119,169,BACKGROUND,BLOOD,ETOPOSIDE,FURTHER,III,LABEL,MALDI,METHODS,OBJECTIVE,RESULTS,TOF
169,BACKGROUND,CHINA,CONCLUSION,GENOTYPING,GST,GSTM1,GSTT1,LABEL,METHODS,PCR,RESULTS
169,BASEL,DAH,DIFFUSE,THERE
169,COPYRIGHT,HOWEVER,INC,PRDM2,VASH1
169,ADP,ATP,COPYRIGHT,EG5,INC,THESE
018,023,034,048,10878,136,EXOME,FOLR3,GGH,SLC19A1
99M,ASSESSING,DIFFERENT
001,169,287,538,AUSTRIA,BACKGROUND,BESIDES,CONCLUSION,COPYRIGHT,CURRENT,DEPARTMENT,HOMEOPATHY,HOWEVER,LABEL,LTD,MALIGNANT,MEDICAL,METHODS,OUTPATIENT,PATIENT,RESULTS,UNIVERSITY
169,CHINA,COMMISSION,COPYRIGHT,INDIA,LTD,USA
169,COPYRIGHT,FOLLOWING,PRECURSOR,PRP19,SAS
128,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM
100,10Z,11Z,160,200,946,RED,SEA,TME
002,008,045,169,200,945,AIM,BACKGROUND,BARCELONA,FDG,FOUNDATION,HCC,HEPATOLOGY,JOURNAL,LABEL,LIVER,LTD,METHODS,MILAN,OBJECTIVE,OPTIMALLY,PET,PLS,PTY,PUBLISHING,RESULTS,WILEY
APLASIA,FGF,FGF10,FGFR2,THESE
CTC,FINALLY,HOWEVER,THEREFORE,THESE

NOTABLY
109,169,490,789,APRIL,INTENSITY,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
101,17A,946,947,B16,B7H,BECAUSE,BHT,C57BL,ECS,F10,FINALLY,FOXP3,HEPG2,HOWEVER,JR8,M14,NOD,PCF,PIX,THEREFORE
125,169,226RA,337,METHODS,PRESS,PUBLISHED,THERMAL,UNIVERSITY
001,003,005,009,015,023,141,169,235,326,399,691,718,730,929,ARG399GLN,ASP148GLU,BER,NSCLC,PFS,SER326CYS,XRCC1
169,945,946,AUTHORS,BCA,CNS,INC,PUBLISHED,SCN1B,VGSCS,VOLTAGE,WILEY
116,956,ANNEXIN,CAM,H2DCFDA,HCT,MTT,R24,ROS
001,002,155,169,443,658,CONCLUSION,COX,GIVEN,HNC,HYPOTHESIS,INC,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,SOCIETY,SPC
961,A313G,ASIAN,CAUCASIAN,CAUCASIANS,GSTM1,GSTP1,INCLUSION,NSCLC
AFTER,THERE
200,300,400,PERFORM,SEVENTEEN,THERE,VORINOSTAT
105,160,BECAUSE,CRIBRIFORM,NST
BACKGROUND,CONCLUSION,CYTOTOXIC,DOCETAXEL,H1650,HOWEVER,LABEL,METHODS,MITOGEN,NCI,RESULTS
215,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,UNDER,V30
AFTER,AGING,AIM,BACKGROUND,CHILE,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SCREENING
10Q,11Q,12P,13Q,16P,17Q,18Q,20Q,20Q13,ACCORDING,ARRAY,BAC,CGH,GENOMIC,PAC,PCR
160,CXCR4,MMP,SDF,TAKEN
000,215,250,576,HISEQ,ION,PGM,POOLING
177,400,ADVERSE,CONCLUSION,DTC,EIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OFF,RESULTS,SORAFENIB,THERAPY,THESE
000,181,250,4T1,500,AFTER,DIMENSIONS,METASTASIS,MIGRATION,MMP,MTT,THESE,ZYMOGRAPHY
176,AFTER,BAX,BCL,H1299,HDAC6,HOWEVER,SIRTUIN,TAKEN,TARGETING,THESE,TSA
169,ALK,ANOTHER,BASEL,DESPITE,ERBB2,HOWEVER,OVERCOMING,RET,SEVERAL,THEREFORE,THESE
026,043,177,956,AIM,BAX,BCL,CONCLUSION,LABEL,LC3,LDM,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,WESTERN
AKT,AMONG,ERK,HOWEVER,NNK,NOTABLY,STAT3,TRP53
ACCORDING,AIM,CONCLUSION,DETECTION,DIFFERENT,FIFTEEN,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,THESE
ASSESSMENT,BACKGROUND,FAILURE,FURTHER,HOWEVER,LABEL,METHODS,ORGAN,RESULTS,SEQUENTIAL
448,AFTER,BACKGROUND,HEALTHY,HRS,LABEL,METHODS,RESULTS,RRS
169,COPYRIGHT,DIGITOXIN,HOWEVER,NSCLC
169,COPYRIGHT,NMR,SAS
100,138,160,162,AMONG,CARLO,COV,CTDIVOL,CTDIW,ELSCINT,FDA,FIRST,GENERAL,HITACHI,KINGDOM,MONTE,PHILIPS,SCREENING,SIEMENS,TOSHIBA,TRIAL,VOLUMETRIC
160,169,BLOOD,BOS,COPYRIGHT,HCT,OTHER,PATIENT,SOCIETY
169,ERBB4,EZR,IMA,LABEL,METHODS,OBJECTIVE,ONCOGENIC,PURPOSE,RESULTS,RET,SIGNALING
169,COPYRIGHT,HOWEVER,INC,TELOMERES,THERE
169,199NM,217NM,946,ANXA2,CLG,COPYRIGHT,CSC,DIR,H1650,HOWEVER,MYC,PCR,PUBLISHED,S100A10,SRC,TARGETING,THESE,WESTERN
169,64328,BACKGROUND,COPYRIGHT,DCI,ECR,ESTONIA,HODGKIN,LABEL,LTD,METHODS,RESULTS,RSR
169,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PRIMARY,PUBLISHED,SOCIETY,ZEALAND
160,169,AMD3100,CHEMOKINE,COPYRIGHT,CXCR4,DESPITE,LTD,PLERIXAFOR,SDF
001,160,169,188,545,643,COPYRIGHT,FURTHER,GENERAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,SURGERY,WOMEN
ABC,ABCB1,ABCC1,ABCG2,ATP,HOWEVER,LINSITINIB,LTD,MDR,OVERALL,PUBLISHED
169,5MM,CONCLUSION,COPYRIGHT,COX,EVALUATION,LABEL,LTD,METHODS,MODELLING,OBJECTIVE,PURPOSE,REGARDLESS,RESULTS,SOLID,THESE,TUMOURS
160,169,192,237,302,BACKGROUND,COPYRIGHT,FORTY,HILAR,INC,LABEL,METHODS,NSCLC,PATHOLOGIC,PUBLISHED,RESULTS,ROBOTIC,SOCIETY
117,136,169,213,271,373,518,BACKGROUND,COPYRIGHT,EPP,INC,INDUCTION,ITALY,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
169,CONCLUSION,COPYRIGHT,INC,KIRSTEN,LABEL,METHODS,MUTATIONS,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,RESULTS,SOCIETY,TESTING
160,169,COPYRIGHT,FINALLY,INC,LDH,NSCLC,RAS
169,AUTHORS,COPYRIGHT,INC,PUBLISHED
169,233,AICAR,AUTHORS,BHD,COPYRIGHT,CRE,DUB,INC,PUBLISHED
169,177,CARLO,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RANGE,RESULTS,TPS,V10
CEREBELLAR,HODGKIN,LTD,PUBLISHED
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,NLP,PUBLISHED,RESULTS,SAS
169,6MONTHS,BACKGROUND,COPYRIGHT,DIARRHOEA,LABEL,LTD,LUX,METHODS,NAMED,NPU,NSCLC,PATIENT,PFS,RESULTS
017,019,055,085,089,100,160,AFTER,BACKGROUND,CONCLUSION,GENOMIC,LABEL,METHODS,NSCLC,ORR,OVERALL,PFS,RESULTS,SNP,UTR
160,169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
120,169,177,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NODULES,PUBLISHED,REMOVAL,RESULTS,SIXTY,SOCIETY
169,99M,COPYRIGHT,FIFTEEN,INC,INDIVIDUAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
001,169,COPYRIGHT,FIFTEEN,FL1,FL2,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SPECT,V20
106,169,COPYRIGHT,FDG,GTV,INC,LABEL,MATERIALS,METHODS,MMR,OBJECTIVE,PET,PURPOSE,RESULTS,VOI
169,DDR,INC
002,017,025,035,041,063,084,169,219,244,421,785,928,CLUSTER,CONCLUSION,COPYRIGHT,DFS,IRELAND,LABEL,LTD,MATERIALS,METHODS,MUC5B,OBJECTIVE,OBJECTIVES,RESULTS,TRU,TTF
000,001,002,004,008,129,169,346,491,726,968,AGE,CA125,CEA,COPYRIGHT,COX,III,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,NSCLC,NSE,OBJECTIVE,PURPOSE,RESULTS
HOWEVER,THEREFORE
AFTER,CAF,CEA,CHINESE,CTM,DECOCTION,ECT,FEI,FOLLOWING,PFS,SEP,TTP
001,CIS,ILD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
ANTWERP,BELGIUM,EPIDERMAL,FLEMISH,L858R,NSCLC,RESULTS,TAT,THERE,TKI

177,BACKGROUND,C57BL,CONCLUSION,DESPITE,LABEL,METHODS,P53,RESULTS,SIXTY,TEN,THEREFORE
169,ALK,ANAPLASTIC,INC,NSCLC,PRIOR,SEVERAL,WILEY
169,H1975,HOWEVER,L858R,NSCLC,T790M,THESE
169,246,ALK,AMP,ANAPLASTIC,APRIL,BACKGROUND,CAP,COLLEGE,GUIDELINE,IASLC,LABEL,METHODS,MOLECULAR,MTG,PATHOLOGY,RESULTS,SOCIETY,SUBTYPING,TESTING
169,HOWEVER,INC,SIMULATION,WILEY
169,950,BASED,HRP,MCE,NSE,VCH,WILEY
221,222,30B,BACKGROUND,DICER,HOWEVER,III,KNOCKDOWN,LABEL,METHODS,NSCLC,PC9,RESULTS,SILENCE,SILENCING,THESE,WESTERN
578,ABBOT,ARCHITECT,C28,CHINESE,HAN,INSTITUTE,LABEL,LABORATORY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RIS,STANDARDS
169,ALPHAGUARD,BRAZILIAN,COMMITTEE,DOSEMAN,EFFECTS,HOWEVER,NATIONS,PRESS,PUBLISHED,RADIATION,SCIENTIFIC,THERE,UNIVERSITY
169,PRESS,PUBLISHED,UNIVERSITY
100,125,CHEST,CONCLUSION,GROUP,JANUARY,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS
169,902,AIM,COX,INSURANCE,LABEL,METHODS,NHI,OBJECTIVE,PHYSICIANS,PRESS,PUBLISHED,RESULTS,UNIVERSITY
001,031,042,045,146,CHINESE,FORTY,GLU185GLN,HOWEVER,MEIER,NSCLC,RAD51,THR9ILE
EBT,FORTY,NSCLC
001,160,189,945,ASSESSMENT,CONTINUING,DISCLOSURE,LABEL,LIMITATION,METHODS,OBJECTIVE,PEARSON,PURPOSE,QSC,R10,RESULTS,SUBSEQUENT
181,EEG,GLASGOW,ROUTINE,SCALE,SERUM,VALPROATE

169,232,605,996,ALTOGETHER,PRESS,PUBLISHED,SURGERY,THERE,UNIVERSITY,USING
029,954,AKT,ECM,MMP,MT1,PDZ,SMALL,SP1,THESE
20A,20B,946,DDP,EMT,MICRORNAS,NSCLC,TGF,THESE
37LRP,EMT,EPITHELIAL,PCR,THESE
946,AKT,CSF,CSF1R,INHIBITION,MPM
123,ADP,ADR,BCL,FINALLY,FURTHER,MCL,METHOXY,NCI,RES,THESE,TUBULIN,TYR15
HOWEVER,NOTCH,QKI,SF1,TAKEN
CONVERSELY,DELTA,DNP73,FINALLY,JUN,TAP73
CARD9,CASPASE,TAKEN,USING
047,116,124,169,183,194,214,BACKGROUND,LABEL,METHODS,PFS,RESULTS,SECONDARY
ALK,BACKGROUND,CK5,CK7,LABEL,METHODS,RESULTS,SRY
001,006,114,420,735,896,967,ASIAN,BACKGROUND,EPIDERMAL,HOWEVER,LABEL,MET,METHODS,MUTATIONS,NSCLC,RESULTS,THESE,WHETHER
177,250,400,BACKGROUND,BETWEEN,CONCLUSION,CRT,III,LABEL,METABOLIC,METHODS,OCTOBER,RESULTS,SEPTEMBER,WORLD
100,BACKGROUND,GIVEN,JANUARY,LABEL,METHODS,RESULTS,SIXTEEN,THERE
003,006,010,100,BACKGROUND,CONCLUSION,LABEL,METHODS,MUTATIONS,RESULTS,SOCIETY,THESE,WORSE
ACTIVATED,ALK,BACKGROUND,CLEVELAND,CRIZOTINIB,HGF,HOWEVER,IHC,JANUARY,LABEL,MET,METHODS,NSCLC,RESULTS
100,103,ALK,ANAPLASTIC,BACKGROUND,DAB,EXCELLENT,IHC,INC,LABEL,MEDICAL,METHODS,NSCLC,OVERALL,RESULTS,SIMILAR,SPECIMENS,SYSTEMS,THERE,THESE,VENTANA
671,BACKGROUND,GENOMIC,LABEL,METHODS,ONCOGENIC,RESULTS,RET
001,200,339,979,BACKGROUND,BECAUSE,BETWEEN,CAUCASIANS,CRS,LABEL,METHODS,NSCLC,PATIENT,RESULTS,THERE
CAPILLARY,COL15A1,COL18A1,DYSPLASIA,FOXF1,FSCN1,GRINA,MATN2,PRKCDBP,PULMONARY,RASL11B,SIMILAR,SIRPA,THESE,VEINS
169,956,AMONG,COPYRIGHT,FURTHER,HOECHST,LTD,OVERALL
BACKGROUND,IHC,LABEL,METHODS,RESULTS,SIX,SIXTY
212,AFTER,BACKGROUND,CHEST,CONCLUSION,LABEL,METHODS,PTH,PTHRP,SEMINOMAS,SERUM
14035,169,270,351,38581,762,AUSTRALIA,CENTRES,COLLEGE,COPYRIGHT,FRIESLAND,LABEL,LEEUWARDEN,LIVERPOOL,LTD,MACARTHUR,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,QUEENSLAND,RESULTS,RIF,ROYAL,SOUTH,THERAPY,WALES,WOMEN
169,366,756,CCK,COPYRIGHT,EXPRESSION,INHIBITION,MICROARRAY,PCR,SAS
169,639,712,947,956,CHIDAMIDE,COPYRIGHT,H2A,HDAC1,NCI,NSCLC,PARP1,SAS,SER10
116,137,145,169,BACKGROUND,CHINA,COPYRIGHT,DISCUSSION,KRUSKAL,LABEL,LTD,METHODS,RESULTS,SMOKY,THESE,XRF,XUANWEI
169,337,359,AIM,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,FAILURE,FNA,JOURNAL,LABEL,METHODS,MOLECULAR,NSCLC,OBJECTIVE,OCTOBER,PARTNERING,PHYSICIANS,RESULTS,ROYAL,SAMPLES,THERE,TKI,TREATMENT
BRUNN,CHEST,DIAGNOSIS,IMT
329,BACKGROUND,FACTORS,JANUARY,LABEL,METHODS,NSCLC,RESULTS,RIGHT,SMOKING
750,961,BACKGROUND,BETWEEN,CONCLUSION,LABEL,METHODS,NSCLC,OVERALL,RESECTABLE,RESECTION,RESULTS
CLASSIC,DIAGNOSTIC
CIGARETTE
BACKGROUND,BEV,LABEL,METHODS,OBJECTIVE,RESULTS,TTP
160,169,945,946,ALIKE,BIOLOGY,CIGARETTE,COMMONS,INCREASED,LICENSE,NEUROD1,OSBORNE,SHARE,SOCIETY,THESE
BECAUSE,LARGE,LCNEC
BACKGROUND,CRS,LABEL,MALIGNANT,METHODS,MPM,MTS,ONCOLYTIC,RESULTS,THESE
169,CONFERENCE,CONSENSUS,MAY,MEDICAL,NSCLC,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
001,005,COX,EIGHT,KPS,MAY,OCTOBER,OVERALL
100,160,231,FN1,GANODERMA,GLE,IDENTIFIED,MDA,PCR
RPLND
18F,ANNEXIN,BAX,BCL,FDG,MTT,NSCLC,PARIS,PSI,RHIZOMA
169,COPYRIGHT,GEMMS,GIVEN,LTD
169,283,544,COLORECTAL,IGE,IMMUNOCAP,ORS,OTHER,OVARIAN,OVERALL,SCREENING,THERE,TRIAL,USING
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NTS,OBJECTIVE,PARAMEDIAN,RESULTS,SUMMARY
177,183,BACKGROUND,CONCLUSION,JANUARY,LABEL,LEVEL,LOS,METHODS,OBJECTIVE,ORS,RESULTS,SUMMARY,THEIR,THERE
CARDIAC,FLUID,IMAGING,MALIGNANT
LABORATORY,SSC,VAD
HODGKIN,WHILE
IATROGENIC
030,117,119,123,128,129,130,169,180,212,250,400,500,BACKGROUND,CETUXIMAB,COPYRIGHT,FEB,LABEL,LTD,METHODS,NOV,RESULTS,SURGERY,THERE
AMERICA,BRAIN,CENTRAL,METASTATIC,SOUTH
GUIDELINES,III,PANEL,THESE
600,CONVERSELY,GLU,TAKEN,TARGETING,V600E,VAL
HOWEVER,NUTRITION
109,118,288,AMONG,CASES,FEWER,HIV,MACCALLUM,MARCH,OVERALL,PETER,PJP
000,001,002,005,102,176,CHINESE,COX,GENERAL,LABEL,LCNEC,MAR,MATERIALS,METHODS,OBJECTIVE,OCT,PLA,RADICAL,RESULTS,THERE,TNM
24H,48H,72H,BAX,BCL,HDAC1,MATRINE,MICROARRAY,MTT,SOPHORA,WESTERN
916,968,BAX,BCL,PCR,THEREFORE
040,116,148,160,177,196A2,351,360,383,446,467,524,625,726,737,827,873,887,990,BACKGROUND,HOWEVER,LABEL,SNP
001,018,025,048,270,299,AGE,BACKGROUND,BESIDES,EASTERN,GROUP,LABEL,MATERIALS,METHODS,NLR,PRIOR,RESULTS,THERE
000,001,003,004,018,026,030,177,300,BACKGROUND,LABEL,LDH,MATERIALS,METHODS,MPM,NLR,OVERALL,PLR,RESULTS,THERE,WBC
276,CHINESE,DAUGHTERS,WOMEN
008,009,014,020,022,040,272,544,ARG399GLN,BACKGROUND,GLN,INDIA,LABEL,LYS751GLN,MATERIALS,METHODS,NORTH,RESULTS,XPD,XRCC1
BESIDES,DEC,HENCE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
138,COX,GLASGOW,GPS,HRS,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,UNIVARIATE
BACKGROUND,BLADDER,ENDOSCOPIC,LABEL,METHODS
000,013,019,500,BASED,COSTS,III,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
CHF,CONGESTIVE,EMERGENCY,RESULTS
169,CD133,DESPITE,LNA,NOVEL,OVERALL,PRESS,SILENCING
001,006,100,103,108,169,430,437,531,AGE,FRACTURES,HOUNSFIELD,MINERAL,SOCIETY,UNITS
10001,333,MEDICAL,OSSEOUS,PATIENT,PET,PUBLISHERS,SEVENTH,USA
160,166,178,EHE,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PLEURAL,PURPOSE,RESULTS
252,BACKGROUND,CONCLUSION,CTV,DEGRO,DISCUSSION,DISTANT,ESPECIALLY,GROUP,GTV,LABEL,PTV,RADIATION,RESULTS,SOCIETY,SRS,WORKING
AFTER,THREE
001,002,009,036,042,043,044,160,AKT,EMT,FOX,FOXM1,HOWEVER,NSCLC,OTHER,PCR,THEREFORE,TMA,TNM
160,296,AMONG,AOR,CAM,CAUCASIAN,CONCLUSION,GIVEN,GREATER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCANT
540,549,AMONG,CIS,CURRENT,EXTRACTION,HOWEVER,HRS,IMPORTANCE,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,RELEVANCE,RESULTS,SELECTION,SOCIETY,SOURCES,SYNTHESIS,TKI
160,AAV,C57BL,LEWIS,LLC,MVD,PIGMENT,THESE
786,FOLLOWING,MMP,RCC,THESE
160,486,COX,DROPOUT,LIVERPOOL,LLP,MEIER
001,169,EXPRESSION,LABEL,MEMBRANOUS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RCC,RES,RESULTS,THESE
10A,231,946,BACKGROUND,EMT,EXPRESSION,FAK,H1299,LABEL,MCF,MDA,MECHANISMS,METHODS,NADPH,NOX,R175H,R280K,REMARKABLY,RESULTS,ROS,SMAD3,TGF
008,100,107,115,141,169,182,645,813,BLOOMBERG,ENGLAND,HOPKINS,JOHNS,MORTALITY,PRESS,PUBLISHED,THESE,UNIVERSITY,WALES
660,GENOMIC,MGA
001,002,023,035,COX,GENECARDS,M38,MEIER,THESE
002,AFTER,CD3,CD4,CD8,CIK,THERE
DIAGNOSIS,PULMONARY
169,ADC,ANTITUMOR,BAY,BINDING,DM4,EFFECTS,MESOTHELIN
100,121,169,196,247,LERMONTOV,NORTH,PRESS,PUBLISHED,UNIVERSITY
8G7G3,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPT24,TTF
ALW,ATP,BAD,EPHA2,INDUCTION,KNOCKDOWN,NSCLC,RTK,TARGETING
076,100,181,299,318,400,566,921,BACKGROUND,CIS,CONCLUSION,FINALLY,LABEL,LIBRARY,OVERALL,PRINCIPAL,RESULTS,SEPTEMBER,STUDIES
169,BECAUSE,COPYRIGHT,INC,PATHOLOGY,PUBLISHED,SOCIETY
AIDED,BACKGROUND,BASED,CHALLENGES,DETECTION,DISCUSSION,FURTHER,HOWEVER,IEEEXPLORE,LABEL,METHODS,SCIENCE
ANTIBODIES,BACKGROUND,BRAIN,LABEL,METHODS
11124,ADK,AFTER,CHINESE,IHC,NSCLC,PCR,SCC,TAKEN,TNM,WESTERN
AFTER,HOWEVER,MEANWHILE,MIRNA,NCI,NSCLC,TAKEN,THESE
BRONCHIAL,HODGKIN,SJOGREN
DESPITE
EARLY,HOWEVER,PATIENT,RAPID,TOKUHASHI
BACKGROUND,FVC,INCREASED,IPF,LABEL,METHODS,REGARDLESS,RESULTS,TLC
169,BASED,CIGARETTE,PRESS,PUBLISHED,SMOKING,UNIVERSITY
HODGKIN,LANGERHANS,LAOTIAN
HODGKIN,PARKINSON,SPS,STIFF
001,002,025,169,204,338,ALASKAN,ANS,BACKGROUND,DISEASE,EFFORTS,END,FEWER,INDIANS,LABEL,METHODS,NATIONALLY,NATIVES,NONRECEIPT,RATES,RESULTS,SOCIETY,TREATMENT
169,AUTHORS,C3A,C5A,HOWEVER,LTD,SEVERAL,WILEY
169,FGF,LTD,NSCLC,OTHER,TARGETING,THERE,WHILE,WILEY
019,025,326,945,946,967,978,COX,MEIER,NSCLC,SMA,TGF,THERE
169,189,H1975,INC,THEREFORE,WILEY
HGF,MET,NSCLC
109,134,147,197,277,300,AFFAIRS,AMONG,FLEISCHNER,FORTY,GUIDELINES,IMPORTANCE,LABEL,METHODS,NOTABLY,OBJECTIVE,OTHER,PULMONARY,RELEVANCE,RESOURCES,RESULTS,SETTING,SOCIETY,SYSTEMS
160,FIFTY,GLI,PCR,SHH,THESE
160,177,DRR,FINALLY,THESE
279,946,BACKGROUND,BECAUSE,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,THERE,THESE,USING
169,196,355,ALTERED,CLDN6,CLDNS,COX,NOTEWORTHY,NSCLC,PROTEIN,THESE,TTF
169,G2M,HOWEVER,III,K48,NRAGE,PRESS,PUBLISHED,UNIVERSITY,USP10
176,177,178,215,CARLO,MEDICAL,MLC,MONTE,PHYSICS
178,DVH,DYNALOG,ECLIPSE,MILLENNIUM,MLC
001,007,DVH,FINALLY,GROUP,IMN,OAR,OVERALL,RADIATION,SCV,THERAPY,TREATMENT,TVS,V10GY,V20GY,V30GY,V90,V95
FBP,GGO
169,483,946,ALCAM,EMT,GDP,RHO,RHOGDI1,SNAIL,WNT
100,118,122,200,400,800,CONCLUSION,METHODS,QALYS,RESULTS
169,ATM,CELLS,COPS5,COPYRIGHT,FINALLY,JUN,PEA15,RAS,REGULATION,SOCIETY
RESULTS
HOWEVER,LABEL,NGS,OBJECTIVE,PURPOSE,RESULTS,SEQUENCING,SUMMARY
000,009,019,100,112,448,560,BACKGROUND,BETWEEN,FURTHER,HOWEVER,INSURANCE,LABEL,METHODS,OBJECTIVE,PROPENSITY,PURPOSE,RESULTS,THREE
13Q,15Q,17P,22Q,ESPECIALLY,NOVEL,RB1,SOMATIC,THESE,WGS
HOWEVER,OVERALL,THERE
169,956,AFRICAN,COMPOUNDS,COPYRIGHT,HEP,LTD,NMR,PENINSULA,PUBLISHED,ROESY,SAR,THEIR,YUCATAN
BACKGROUND,BRAIN,CONCLUSION,CXORF66,LABEL,MATERIALS,METHODS,ORF,RESULTS
169,231,468,COPYRIGHT,HOWEVER,INC,MDA,NEOPLASIA,NOTABLY,OPN,PRESS,SEVERAL,USING
144,169,946,CONVERSELY,COPYRIGHT,FURTHER,INC,NEOPLASIA,PRESS,RAS,TAKEN,THEREFORE,TRCP1,UBCH5
160,169,BAPTA,BAX,BPC,CA074,COMPLEX,COPYRIGHT,LMP,LYSOSOMAL,SAS,THESE
100,160,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PNB,PUBLISHED,RADIATION,RESULTS,ROYAL,THERE,TOTAL,ULD
100,200,AAH,BACKGROUND,CHINESE,DETECTION,FOLLOWING,HENCE,LABEL,METHODS,MICROARRAY,RESULTS,SCD,SEQUENCING,TOTAL
100,160,177,203,206,390,BACKGROUND,CHINA,CHINESE,ICU,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,OPERATIVE,RESULTS,TNM,VABSL
160,HOWEVER,VIDEO
178,239,400,8TH,BACKGROUND,CRT,GRADE,HLA,HOWEVER,LABEL,METHODS,PEPTIDE,RESULTS,SIX,TRIAL,TTK
100,BACKGROUND,CAUCASIAN,KINGDOM,LABEL,METHODS,SERVICE,THESE
001,034,036,145,CONCLUSION,COX,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOTAL
167,176,177,EFFECTS,GEL,OPTIMAL,SIRNA
072,EGGER,PRIOR,SEPTEMBER,STATA11,THERE
AKT,COMPOSITAE,H1299,NSCLC,S6K
PRINGLE,TSC
014,150,945,94INS,954,ACCORDING,BIA,HOWEVER,NSCLC,PCR,TURKISH,UTR
197,945,946,ALK,EML,HSP90,MAPPING,RECURRENT
HOWEVER,KLEBSIELLA
169,252,945,956,AZ521,B16,BAX,BCL,CHIMICA,COPYRIGHT,HELVETICA,MELIACEAE,MSH,SIAMESE,SIX,TRP,VALETON,WESTERN
169,252,63743,946,956,AZ521,CHIMICA,COPYRIGHT,EBV,EPSTEIN,HELVETICA,THESE,TPA,WESTERN
115,169,AUTHORS,CSF,DOCUMENTED,III,LTD,RDI,WHILE,WILEY
169,ETS,FINALLY,MMT,THESE
001,012,015,BCSG1,MAM,PCR,RESULTS,THESE
AIM,BACKGROUND,EAGLE,INCREASING,LABEL,LC3,MATERIALS,METHODS,OBJECTIVE,RAPAMYCIN,RESULTS
023,327,617,633,674,716,766,831,928,DESPITE,MBC,THESE
222,954,CONCLUSION,ERCC1,ERRC1,FIRST,GENZYME,LABORATORY,METHODS,NSCLC,RESULTS,THIRD
001,946,ASIAN,BACKGROUND,CAUCASIAN,EFS,HOWEVER,IHC,III,LABEL,METHODS,NSCLC,ORR,PCR,RESULTS,THEREFORE,TUBB3
000,200,BRAIN,CHEST,EMERGENCY,MRA,WHILE
AKT,EGF,FOXO1,JUN,NSCLC,TAKEN
738,833,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,ROC
242,555,932,ARG,ASIAN,CIS,CLU,GLU,ORS,OVERALL
MED,NH2,SURFACTANT
009,042,047,100,11000,D21
AFTER,HIV
218,ADAM9,BECAUSE,LUCIFERASE,MIR,SLIT2
DUE,PROFILING,SPE,VARIOUS
END,RESULTS
100,FINALLY,NSCLC,SEQ
169,215,400,EXNER,HPF,MITOTIC
ESS,EWING,HPF,THREE
CATHEPSIN,EMMPRIN,HOWEVER,MMP,PCR,TCA8133,USING,WHILE
000,100,160,290,463,BIOLOGICAL,CRT,EFFECTS,LAR,ORGAN,PLD,RADIATION,VII
169,COPYRIGHT,INC,RET
001,014,COX,HOWEVER,LAC,MMP,MTT,TAKEN,TRANSWELL
169,945,947,948,954,969,CONSISTENT,COPYRIGHT,HOWEVER,INC,STAT3,THESE,TOCOPHEROL
038,169,16PTS,19PTS,460,662NM,AFTER,COPYRIGHT,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PDT,RESULTS,THERE
169,ARS,ARTHRALGIA,BOHAN,COPYRIGHT,ILD,JO1,LABEL,MEDLINE,METHODS,MI2,OBJECTIVE,PETER,RAYNAUD,RESULTS,RNP,RPH,SCL,SRP
160,169,177,956,ACCORDING,ADP,ALDER,C57BL,COPYRIGHT,CUPRESSUS,DIELS,E0771,EPITHELIAL,MCF,SAS,THESE
169,COPYRIGHT,DNASE,E1B,GENOMIC,PREVIOUSLY,SFN
169,AESTHETIC,BRITISH,COPYRIGHT,EATON,III,LAMBERT,LEVEL,LTD,PLASTIC,PRE,PUBLISHED
10878,135,169,177,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,DFI,LABEL,LTD,METHODS,PATIENT,RECURSIVE,RESULTS,RPA,STS
169,ALK,COPYRIGHT,IRELAND,LTD
100,169,400,CAS,COPYRIGHT,HSNSS,LTD,MRI,RGD
169,COPYRIGHT,INC,MYC,TERRY,VIRUS
019,150,159,165,169,2ND,500,B12,BACKGROUND,COPYRIGHT,EASTERN,EVALUATION,GROUP,III,LABEL,LTD,METHODS,NSCLC,PEMETREXED,PFS,RESULTS,SECONDARY,SOLID
12MINUTES,131,169,26M,CHARTERED,COPYRIGHT,EORTC,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PUBLISHED,QLQ,RANDOMISED,REGARDLESS,RESULTS,SECONDARY,SETTING,SHORT,SHUTTLE,SOCIETY,THERE,TREATMENT
169,302,853,947,AUR,AUTOMATIC,BETWEEN,COPYRIGHT,FORTY,HOWEVER,INC,INTRA,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,TODAY
169,201,231,COPYRIGHT,PUBLISHED,SAS
169,ABCB1,BASED,COPYRIGHT,D16,DOC,HOWEVER,MDR
100,169,239,COPYRIGHT,ESTIMATED,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,T1A,T1B,TECHNICAL
169,ASSOCIATED,BACKGROUND,CONCLUSION,COPYRIGHT,IMAGING,LABEL,METHODS,RESULTS,SAS,THESE,WORLD
169,BACKGROUND,CONCLUSION,COPYRIGHT,GRADE,HOWEVER,IRELAND,LABEL,LTD,METHODS,NCSLC,NSCLC,RESULTS
169,COPYRIGHT,EGFRI,INC,MEDICATION,MOSBY,NSCLC,SURVIVING
049,280,417,429,778,ACCORDING,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BASED,FDG,HOWEVER,PET
AREAS,BACKGROUND,COVERED,DESPITE,FURTHER,IPILIMUMAB,LABEL,METHODS,NSCLC,OPINION
117,215,CONCLUSION,HOWEVER,LABEL,METHODS,PATIENT,RESULTS,UNLABELLED
001,739,822,887,904,960,988,ALS,NON,PTB
215,AMONG,BACKGROUND,CENTRAL,CLINICIANS,CONTROLLED,ENGLISH,LABEL,LIMITED,MAY,MEDLINE,METHODS,OBJECTIVE,RATIONALE,RESULTS,REVIEWS,SYSTEMATIC,THREE
000,001,009,081,127,CENTRAL,CIS,CONTROLLED,DCR,HRS,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PFS,RESULTS,SUB
352,ALONG,BACKGROUND,HISPANICS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,STRUCTURAL,USING
169,955,HOT,THESE,VCH,WILEY
169,ANTITUMOR,HCC,HGF,LABEL,MET,METHODS,NOTABLY,OBJECTIVE,PURPOSE,RES,RESULTS,TOTAL
169,CONSISTENT,FURTHER,INC,MET,MTT,THESE,TUNEL,WILEY
169,945,FOXC2,HUVEC,INC,INCREASED,OPN,THESE,WILEY
169,223,411,ALK,BACKGROUND,BETWEEN,CONCURRENT,FGFR1,FGFR2,JANUARY,LABEL,MET,METHODS,RESULTS,RET,SOCIETY,SURGICALLY,THESE
107,160,177,CISPLATIN,HOWEVER,LIPOSOMES
BACKGROUND,CHEST,COLLEGE,COMMITTEE,IDEALLY,LABEL,METHODS,NETWORK,PHYSICIANS,PREDEFINED,QUALITY,RESULTS,THREE

372,ATLAS,AZA,DDP,GDA,ICAM1,LOW,LOXL1,NSCLC,S100P,TEN,TIMP4,TSA,WISP2
CEA,HOWEVER,LEWIS,METASTASIS,OH1,USING
521,910,AIRFLOW,ATS,BACKGROUND,CONCLUSION,EMPHYSEMA,ERS,FVC,HOUNSFIELD,LABEL,MATERIALS,METHODS,PERCENT,RESULTS,SPIROMETRY,UNITS
169,177,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PRESS,PUBLISHED,RECURRENCE,RESULTS,SURGERY,UNIVERSITY
100,945,APTAMER,EMPLOYING,EOL,EVOLUTION,LIGANDS,SDA,SELEX,SYSTEMATIC,TNF,UNDER
693,ACCORDING,DESPITE,MVD,SMA
100,AGE,FORTY,HOWEVER,KARNOFSKY,KPS,MRI,NSCLC,PROGNOSIS,RPA,SRS,TCR
169,COPYRIGHT,EMT,H1299,HOWEVER,THEREFORE,THP
169,946,947,9ER,9ZD,AKT,AUTHORS,ELISA,EPIDERMAL,HOWEVER,IMMUNOBLOT,LTD,NSCLC,PCR,PTY,PUBLISHING,SCIENCE,SMAD2,T790M,TGF,THESE,TKI,WILEY
BACKGROUND,CHEST,CONCLUSION,LABEL,METHODS,MRI,MULTI,PET,PPV,RESULTS,SCHOLAR,THERE
169,303,ASIAN,BACKGROUND,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBTAINING,PACIFIC,RESULTS,SAMPLES,SOCIETY
169,173,300,379,552,ASIAN,BACKGROUND,CRMP5,LABEL,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,THREE
003,CONCLUSION,DESPITE,DSS,HOWEVER,LABEL,METHODS,PFS,RESULTS,STS,UNLABELLED
CHINA,COMPOUNDS,FURTHER,GLY,HEPG2,ILE,NMR,PRO,SEA,SOUTH,THR
CONCLUSION,CONSCIOUS,KNOWLEDGE,KRUSKAL,LABEL,METHODS,OBJECTIVE,RESULTS

ATS,CK7,ERS,IASLC,PEACS,PULMONARY,SOCIETY,TTF

BAL,HOWEVER,ISD,PAP,TEM,THEREFORE
BACKGROUND,COX,FURTHER,ICH,LABEL,MEIER,METHODS,NOTABLY,PCR,PROTEIN,RESULTS,THESE,WESTERN
169,945,BIOLOGY,CARDIAK,EPHA2,FGFR2,INC,LYN,MOLECULAR,NOVEL,PDGFR,SOCIETY,TAKEN,THESE,YES
169,BHV,COPYRIGHT,HSV,IFN,IMPORTANCE,LABEL,NCI,OBJECTIVE,ONCOLYTIC,OVERALL,OVS,SOCIETY,STRIKINGLY,THESE,UNLABELLED
945,946,FURTHER,GAL,REGARDING
003,006,125,167,169,193,318,LABEL,METHODS,MUTATIONS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
005,137,177,344,ELISA,SERUM,TNC
005,ACCORDING,CHINA,KNOWLEDGE,REFERENCES,VIP,WANFANG,XPA
BETWEEN,CONCLUSION,EIGHT,IIP,ILD,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
139,146,169,ACCORDING,AIM,CONCLUSION,FORTY,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
000,127,134,214,230,ACADEMY,CHINESE,DEPARTMENT,INSTITUTE,JANUARY,MAY,MEDICAL,PREVENTION
16HBE,946,ALTOGETHER,ERK,FURTHER,H23,HOWEVER,NCI,NSCLC

H1299,HBE,HOWEVER,NSCLC,PCR,THESE,WESTERN
177,BETWEEN,FIFTY,LABEL,MARCH,METHODS,OBJECTIVE,PPL,RESULTS,SEVENTY,TENTH
AMERICA,CHINA,CHINESE,NORTH
BBB,BRAIN,CNS,FDG,FINALLY,PET,THERAPY,USING,USUALLY
369,FDG,MEDLINE,PET,WHOLE
AFTER,PAH,PROVIDING
169,BLOOD,COPYRIGHT,INC,PUBLISHED,SECONDARY,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,946,COPYRIGHT,INC,PATHOLOGIC,PUBLISHED,SOCIETY
009,187,BACKGROUND,CONTEXT,INCREASED,KIRSTEN,LABEL,METHODS,OBJECTIVE,RAS,RESULTS,SOCIETY
109,169,FDG,LABEL,METHODS,MRI,OBJECTIVE,PET,PHANTOM,PHYSICISTS,POISSON,PSF,PURPOSE,RESULTS
169,COV,DERENZO,DISCOVERY,FBP,FDG,FINALLY,HILBERT,LABEL,METHODS,OBJECTIVE,PET,PHYSICISTS,POISSON,PURPOSE,RADON,RESULTS,SRT,USING
169,177,CONSORTIUM,HAUSDORFF,IMAGE,LABEL,METHODS,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,UNDER
169,BETWEEN,CARLO,EXCELLENT,IDENTICAL,LABEL,METHODS,MONTE,OBJECTIVE,PHYSICISTS,PTV,PURPOSE,RESULTS
001,100,169,177,AFTER,BDE,BMR,FURTHER,LABEL,MARGINS,METHODS,OBJECTIVE,PHYSICISTS,PROCRUSTES,PURPOSE,RESULTS,SMALL,THESE,USING
118,177,BACKGROUND,CTV,DIFFERENT,DOSIMETRIC,LABEL,METHODS,OCTOBER,OVERALL,RESULTS,V98
144,41BBL,947,AFTER,CD152,CD274,CD275,CHANGES,CONVERSELY,CTL,DU145,ELISPOT,EPITHELIAL,FINALLY,ICOSL,IFN,LNCAP,OX40L,PC3,PCA,THESE
006,ACCORDING,AIM,CONCLUSION,III,LABEL,METHODS,NAC,OBJECTIVE,RESULTS,UNIVERSITY
018,100,110,150,198,242,342,419,442,540,BACKGROUND,BETWEEN,CONCLUSION,DCR,ERLOTINIB,GEFITINIB,JANUARY,LABEL,METHODS,NSCLC,PRIOR,RESULTS,SEPTEMBER
AIM,CONCLUSION,FORTY,LABEL,METHODS,NSCLC,OBJECTIVE,PS0,PS1,RESULTS,THEIR,TREATMENT,UNTREATED
BACKGROUND,BECAUSE,CONCLUSION,DENDROBIUM,EMT,LABEL,MATERIALS,METHODS,RESULTS,SNAIL,TDB
041,112,AIM,AXL,BACKGROUND,CONCLUSION,ERK,LABEL,METHODS,NSCLC,OBJECTIVE,PC9,PHOSPHO,RESULTS
100,956,ACTIVITIES,AIM,BACKGROUND,CONCLUSION,H28,LABEL,MATERIALS,MET5A,METHODS,MTT,NCI,OBJECTIVE,PP1,PPS,PTP1B,RESULTS,TUNEL
BACKGROUND,DIETARY,FURTHER,HCC,HEPG2,LABEL,MATERIALS,METHODS,MTS,Q3G,QUERCETIN,RESULTS,USING
24H,CONCLUSION,ICP,LABEL,MATERIALS,MCF,MDR,METHODS,RESULTS,THERE,UNLABELLED
956,AIM,BACKGROUND,CONCLUSION,DTS,HEN,LABEL,MATERIALS,METHODS,OBJECTIVE,PETIVERIA,RESULTS,WST
123,231,BACKGROUND,COMPOUNDS,CONCLUSION,EFFECTS,LABEL,MATERIALS,MDA,METHODS,PC3,RESULTS,THESE
CURRENTLY,NSCLC
946,AKT,ANP,CATENIN,CONCLUSION,ERK,FOS,JNK,JUN,LABEL,MAPK9,MEK,RAS,RAT,STAT1,STAT3,THEIR,THERE,THESE,UNLABELLED,WNT
169,ANCILLARY,INC,THERE,WILEY
169,ENB,FNA,INC,LOGIC,PATHOLOGIC,WILEY
169,AUTHORS,CSF,GIVEN,LTD,RAPID,SIMILARLY,WILEY
ACC,ADENOID,BACKGROUND,CONCLUSION,ENGLISH,LABEL,METHODS
036,053,169,901,956,AUTHORS,COX,FOLLOWING,III,LTD,NSCLC,RFS,UNTIL,WILEY
169,292,BACKGROUND,COX,CRT,DEFINITIVE,III,LABEL,METHODS,NSCLC,RESULTS,SOCIETY,THESE
138,169,723,NERVOUS,OVERALL,SIR,SWEDISH
002,022,027,056,169,187,8F1,945,BACKGROUND,CCT,CHOLINE,ERCC1,HNSCC,LABEL,METHODS,NSCLC,PROTEIN,RAS,RESULTS,SIMILARLY,SOCIETY
160,181,ARSENIC,ATO,H23,NSCLC,USING
138,947,SENP1,SENTRIN

156,200,222,251,285,382,DISCUSSION,FRANKEL,KPT,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,UPT
FINALLY,HOWEVER,LFCIN,MEANWHILE,NCI,PCR,THESE,WESTERN
ARSENIC,SEVERAL,STUDIES
BECAUSE,EMAST,MSI
169,COPYRIGHT,WHEREAS
CONCLUSION,EFFECTS,LABEL,METHODS,RESULTS,UNLABELLED,XCV
945,946,954,ADP,CCAR1,DISULFIRAM,DSF,INHIBITORY,MPM,SAPKS
SEVERAL
169,356,759,803,925,AMONG,CONCLUSION,COPYRIGHT,COX,FACTORS,FEDERATION,GYNECOLOGY,INC,LABEL,METHODS,OBJECTIVE,OBSTETRICS,OSS,OVERALL,RESULTS,SOCIETY
169,ADVERSE,COPYRIGHT,FDA,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MPM,OBJECTIVE,OBJECTIVES,PEMETREXED,RESULTS,SIXTY,THESE,VERSION
18F,AFTER,AUTHORS,FDG,PET,ROSAI,TOTAL
002,005,027,033,043,053,095,169,177,324,911,916,ASIAN,BACKGROUND,CAVITATION,CHRONIC,LABEL,MAC,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY
100,140,EDC,MCF,MTT,NHS,NPS,PCL
169,ASIAN,COX,MEIER,PACIFIC,POPULAR,SOCIETY
102,169,205,INC,MAJOR,OTHERWISE,PATHOLOGY,WILEY
001,ASK,DESPITE,MMP,MVD
BECAUSE,BENEFITING,ECL,HOWEVER,MICRORNAS,THROUGH
177,5GY,BACKGROUND,CARDIAC,CRT,CTS,DMEAN,LABEL,METHODS,MHD,NON,PTV,RESULTS
BISABOLOL,DLD,ESSENTIAL,POPULUS
004,100,ADC,DWI,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,ROC,SOLID
AHI,BACKGROUND,EFFECTIVE,FUNCTIONAL,HOWEVER,LABEL,METHODS,NETWORK,OSA,RATIONALE,RESULTS,TREATMENT
239,500,AMONG,GRADE,LABEL,LEVEL,LIVER,METHODS,OBJECTIVE,RESULTS,SIX
169,AFTER,PRESS,PUBLISHED,THESE,UNIVERSITY
169,MICROARRAY,MYC,NSCLC
169,519,BIOMARKERS,EGF,ELISA,FURTHER,HGF,IHC,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN
169,AUTOPHAGY,BRITAIN,COPYRIGHT,GREAT,HOWEVER,IRELAND,LTD,PC9,PUBLISHED,SOCIETY,THEREFORE,WILEY
183,GEORG,NON,STUTTGART,THESE
215,HEPG2,HSV,PCR,SYNCO,THESE,UL38P
169,ANOTHER,BATCH,COPYRIGHT,LTD,WILEY
250,EORTC,LABEL,LOW,METHODS,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,TREATMENT
1236T,2677T,3435T,AFRICAN,ASIAN,CAUCASIANS,FURTHER,SNP,THERE,THREE
001,007,013,049,056,131,140,154,176,301,826,956,CONCLUSION,DOSIMETRIC,DTC,EORTC,FUNCTIONAL,LABEL,METHODS,NON,OBJECTIVE,OVERALL,PURPOSE,QOL,QUALITY,RESULTS,TREATMENT,TSH
AFTER,MYELOID,RECIPROCAL
AMP,CURRENTLY,GMP,HOWEVER,PDE
115,120,182,JANUARY,SURGERY,TOMOGRAPHY
171,187
024,032,039,15Q25,301,318,945,ADC,CHINESE,GWASS,III,TNM
169,COPYRIGHT,EPIGENETIC,INC
007,052,083,112,11H,160,169,215,3T3,956,COPYRIGHT,HCL,MV4,SAS
BACKGROUND,CONCLUSION,EHE,LABEL,METHODS
000,117,136,138,427,549,672,767,AFTER,BACKGROUND,BIOLOGICS,BMJ,BRITISH,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RATES,RESULTS,SOCIETY,THERE,TNF,TREATMENT
BMS,MPDL3280A,NSCLC
169,945,954,AKT,COPYRIGHT,EGF,HOWEVER,INC,TGF
001,100,169,601,COPYRIGHT,GRADE,GROUP,INC,LABEL,MATERIALS,MAXIMUM,METHODS,NSCLC,OBJECTIVE,PULMONARY,PURPOSE,RADIATION,RESULTS,THERAPY,V45,V50,V55,V60
087,169,581,COMMISSION,COPYRIGHT,CRT,FURTHER,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS
122,169,ADDITIONAL,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,III,INC,JURAVINSKI,LABEL,METHODS,NSCLC,ONTARIO,OUTCOME,REASONS,RESULTS,THESE
002,044,169,311,689,894,BACKGROUND,CONCLUSION,CONTINUOUS,COPYRIGHT,INSTITUTE,IRELAND,LABEL,LTD,MARCH,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,T790M,TKI,UNIVERSITY
169,CARCINOID,COPYRIGHT,LCNEC,OVERALL,PNT,PUBLISHED,PULMONARY,SEPAR,SEVERAL,TNM
169,AUTHORS,BAD,BIM,COPYRIGHT,DRUGS,ERBB2,ERBB3,INC,MEK,MYC,PUBLISHED,RAS,THERE,THESE,USING
169,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,PURPOSIVE,REDUCTIONS,RESULTS
143,162,916,APRIL,EOD,FORTY,JAN,LABEL,METHODS,OBJECTIVE,PFT,RESULTS,SCT
001,177,LABEL,METHODS,NPV,OBJECTIVE,PPV,RESULTS,SPECT,TNM
002,008,018,037,177,D95,D99,D994D,D99CONV,GTV,LABEL,METHODS,MHD,MHD4D,MHDCONV,MLD,MLD4D,MLDCONV,OBJECTIVE,PTV,PTV4D,PTVCONV,RESULTS,THERE,V10,V104D,V10CONV,V15,V20,V30,V304D,V30CONV,V40
001,1ST,2ND,500,BASED,CHINA,CHINESE,CONSISTENT,DOC,LABEL,METHODS,NSCLC,OBJECTIVE,PEM,PFS,RESULTS,SIMILARLY
100,177,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN,XUANWEI
169,997,AMONG,COPYRIGHT,ITALIAN,ITALY,LTD,MALIGNANT,RENAM,THERE
946,BACKGROUND,ESOPHAGEAL,EXPRESSION,FURTHER,LABEL,LYSINE166,METHODS,RESULTS,SCF,SCFFBXL19,TGF
AFTER,BACKGROUND,COX,DEPRESSION,EASTERN,FINLAND,FINNISH,HOWEVER,LABEL,LABORATORY,METHODS,POPULATION,RESULTS,SLEEP
ADJUSTMENT,AFTER,AGING,ALBANIA,BACKGROUND,BATTERY,EARLY,LABEL,METHODS,RESULTS,SHORT
CHRONIC,HOWEVER,NOTABLY,SRC,WHILE
BACKGROUND,CHEST,DESPITE,DTC,FTC,LABEL,MALIGNANT,METHODS,MPE,PATIENT,SUMMARY
154,160,169,184,338,CHINESE,HMGB1,HMGB2,LTD,PTY,PUBLISHING,THREE,WILEY
001,005,BACKGROUND,BASED,CONCLUSION,EXAMINING,INCIDENCE,LABEL,METHODS,MONTENEGRO,NSCLC,OBJECTIVE,RATIO,RESULTS
169,800,954,AUTHORS,BASED,DICER,LTD,MODULATION,MYC,RAS,SWISS,TGF,WILEY
ATM,MRI,WHILE
CHINA,FOLFIRI,HOWEVER,MAY,OVERALL,PFS,TEN
067,909,CIS,GSTM1,HOWEVER,ORS
120,160,177,CONCLUSION,HOWEVER,LABEL,METHODS,PET,RESULTS,THOSE,UNLABELLED
014,038,136,DROSOPHILA,FURTHER,HIPPO,HOWEVER,LARGE,LATS1,NSCLC,SER,THESE,THR,TNM,YAP
009,487,588,838,CHEST,ESOPHAGEAL,HNSCC,HOWEVER,SYSTEMATIC
001,004,011,023,035,148,246,277,APRIL,BETWEEN,HOWEVER,JANUARY,MUTATED,STUDIED
110,BASED,HOWEVER,INSULIN,MVS,NSCLC
BMJ,CSA,FEF25,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,RRS,SCD,THERE,TLC
178,AMONG,BACKGROUND,CONCLUSION,DOCETAXEL,III,JAPAN,LABEL,METHODS,NSCLC,RESULTS,SECONDARY
BUNGE,THESE
620,CPG,THESE
169,177,ALLOGENEIC,BACKGROUND,DONOR,HEART,HLA,INC,KEY,LABEL,LVADS,METHODS,MPC,RESULTS,SUCCESSFUL,TRIAL,URL
100,126,160,215,BACKGROUND,HOWEVER,LABEL,METHODS,PULMONARY,RESULTS,SEVERAL
BAX,FURTHER,H1975,NCI,SPC,TAKEN,THESE,THO,THOC1,WHILE
001,109,327,714,958,DENMARK,FURTHER,ICELAND,INCREASED,MEN,MRR,POISSON,WOMEN
945,STAT3,STRUCTURAL
AKT,GEFITINIB,MTT,NSCLC,TKI
CD104,CD24LOSCA1,CD49F,EPCAM,TGF
LYG,MRI,MTX
SMACS,TAXOL
028,169,199,554,PRESS,PUBLISHED,THESE,UNION,UNIVERSITY
CIC,FINALLY,GOF,MUTATIONS,ONCOGENIC,SEVERAL,SLC25A1
165,18023,215,60543,BACKGROUND,BONFERRONI,CDKN2BAS1,LABEL,METHODS,POPULATION,RESULTS,SNP,TRICL
124,169,177,602,670HU,705,7HU,AFTER,CASES,CONCLUSION,COPYRIGHT,GGN,HOUNSFIELD,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
109,115,136,169,174,300,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
001,006,009,169,196,AIM,CONCLUSION,CONTROL,COPYRIGHT,CSS,DFS,DISEASE,FIFTY,GTV,IRELAND,LABEL,LOCAL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PRIMARY,RECURRENCE,RESULTS,TOTAL
165,169,967,BACKGROUND,COPYRIGHT,COX,INC,LABEL,LNM,LYMPH,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY,SYSTEMATIC
159,169,258,ADVERSE,BACKGROUND,COPYRIGHT,EFFECTS,INC,LABEL,MAY,MEDICAL,METHODS,PUBLISHED,RESULTS,SEVEN,SOCIETY,SURGERY,THERE,VIDEO
160,169,231,AGI,COMPLEX,COPYRIGHT,DOCKING,ERS,ESI,GSH,LOX,MCF,MDA,MIXED,MOLECULAR,MRC,NMR,OAW,SAS,SRB,TPP,VIS
169,COPYRIGHT,FOLLOWING,H1299,NSCLC,SEGMENT,SP1,SP3,SP4,THEREFORE
169,947,COPYRIGHT,HENCE,HOWEVER
019,169,ACADEMY,ADJUSTING,ASSESSMENT,BACKGROUND,COGNITIVE,CONCLUSION,CONTEXT,COPYRIGHT,FUNCTIONAL,HOSPICE,HOWEVER,INC,INDEX,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,PALLIATIVE,PUBLISHED,RESULTS,THERAPY,THOSE,TRIAL
169,BACKGROUND,BRONCHIOLO,CONCLUSION,COPYRIGHT,EARLY,LABEL,METHODS,PUBLISHED,SAS
160,169,1ST,702,AMONG,BACKGROUND,BELGIAN,BELGIUM,CONCLUSION,COPYRIGHT,JANUARY,LABEL,METHODS,PATIENT,PUBLISHED,RESULTS,SAS,SEPTEMBER,THERE,THESE
150,169,BACKGROUND,COPYRIGHT,LABEL,MATERIALS,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SAS,THESE
001,139,169,BACKGROUND,CONCLUSION,COPYRIGHT,EVALUATION,LABEL,MAY,METHODS,PUBLISHED,RESULTS,SAS,THERE
065,169,ADH1B,ADH1C,ALDH2,BLOOD,COPYRIGHT,FULLY,LABEL,LTD,MATERIALS,METHODS,MOUTHWASH,OBJECTIVE,ORS,RESULTS,WHETHER
000,001,005,011,027,031,032,115,140,167,169,296,306,361,702,754,815,971,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MIA,OBJECTIVE,OBJECTIVES,RESULTS
001,002,169,564,AFTER,AMERICA,BACKGROUND,CLPTM1L,CONCLUSION,COPYRIGHT,COX,GSV,III,IRELAND,LABEL,LTD,METHODS,NORTH,NSCLC,PFS,RESULTS,STAGE,THESE
169,APRIL,BACKGROUND,COPYRIGHT,FORTY,HGNEC,HOWEVER,IIB,IRELAND,LABEL,LARGE,LCNEC,LTD,METHODS,RESULTS,RFS,SEPTEMBER
106,169,18F,264,618,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RECURRENCE,RESULTS,RFS,SOCIETY,T1B
169,5GY,COPYRIGHT,INSTITUTE,KYOTO,LTD,RADIATION,REACTOR,UNIVERSITY
004,110,169,222,COPYRIGHT,DESPITE,EXCLUSION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PURPOSE,RADIATION,RESULTS,SRS,THERE
169,176,500,BACKGROUND,COPYRIGHT,INFECTIOUS,LABEL,LTD,OTHER,OVERALL,PUBLISHED,SOCIETY,SUPPORTIVE,THERE,TRIAL,UNLABELLED
131,169,195,222,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,CURRENT,INDEX,IRELAND,LABEL,LTD,METHODS,MORBIDITY,RESULTS
034,139,227,234,269,314,750,NSCLC,OCTOBER,PRE,STAGE,THESE
BMI,BRAZILIAN,CONCLUSION,COPYRIGHT,CROSS,DIETARY,EDICIONES,INADEQUACY,INDEX,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,VITAMIN
160,162,250,280,956,BACKGROUND,CONCLUSION,CYTOTOXIC,ELISA,HIV,HOP,LABEL,LOWER,METHODS,NON,POLAR,PRESENT,RESULTS,REVERSE,ROCHE,SEVERAL,SOLANACEAE,SOLANUM,SOXHLET,SRB,THP,TLC,TOTAL
BACKGROUND,FOCUS,GLASGOW,GPS,LABEL,METHODS,RECRUITING,RESULTS,THREE
BACKGROUND,CONCLUSION,CONTROL,DISEASE,III,LABEL,METHODS,NSCLC,ORR,OVERALL,PFS,RESPONDING,RESULTS,SEVENTY,TRIAL
017,030,036,077,100,224,234,280,690,CONCLUSION,ERR,INHALATION,LABEL,LEVEL,LOW,METHODS,OBJECTIVE,POISSON,PURPOSE,RESULTS,WLM,WORKING
005,956,CALOTROPIS,CISPLATIN,EGYPT,NMR,THEIR
AFTER,PULMONARY,THESE

16HBE,945,946,ACH,BACKGROUND,CARBACHOL,DECREASED,EMT,EPITHELIAL,ERK,LABEL,METHODS,RESULTS,SMA,SMAD2,TGF
AMERICA,NORTH,SURGERY,THROUGHOUT,VIDEO
169,945,AUTHORS,BECAUSE,LTD,SOMATIC,THOSE,WHETHER,WILEY
413,946,956,BASED,BURKITT,CF3,HSA,MRC,NMR,RAMOS
169,BID,GRANZYMES,HOWEVER,PROTEOMIC,THESE,VCH,WILEY
169,GHR,VCH,WILEY
250,3A1,956,ALDH1A1,ALDH1A2,ALDH1A3,ALDH1B1,ALDH2,ALDH3A1,CCD,COMPOUNDS,HOWEVER,IFM,KINETIC,SF767
002,050,702,ADJUSTING,EFFORTS,ELDERLY,END,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
EPIDERMAL,HOWEVER
BACKGROUND,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESOLUTION,RESULTS,USING
500,CHINESE,CIS,NSCLC,ORS,SCC,SNP
882,BACKGROUND,BETWEEN,BMJ,DETAILS,DISEASE,EASTERN,FURTHER,GROUP,LABEL,LIMITED,METHODS,PATIENT,PUBLISHED,PUBLISHING,RESULTS,THERE
AAD,AMONG,DIFFERENT,FURTHER,HSP,HSP70,HSP90,NSCLC,THESE,VER
CONCLUSION,DEFECTIVE,EARLY,EL4,LABEL,METHODS,UNLABELLED
AKT,HOWEVER,IHC,MMP,SP1,SPARC
HOWEVER,MVD
001,037,076,722,734,855,946,COX,LAPTM4B,NSCLC,PCR,THESE
JEGHERS,MYC,PCR,PEUTZ,PJS,STAT3,TE1
107,247,280,495,693,993,BACKGROUND,CTM,INDWELLING,IPC,LABEL,METHODS,RESULTS,SEVEN
003,104,107,131,189,275,288,378,407,ATS,BACKGROUND,CONTROL,ERS,HISTOLOGIC,HOWEVER,IASLC,III,LABEL,LOW,METHODS,RESULTS,SOCIETY,UNION
268,424,469,622,6TH,737,7TH,ACCORDING,CONCLUSION,IIA,IIB,LABEL,M1A,M1B,METHODS,OBJECTIVE,PURPOSE,RESULTS,TNM
001,673,BACKGROUND,BLOOD,CEA,DVT,FORTY,JANUARY,LABEL,METHODS,RESULTS,VTE
HRT,UTERINE
945,947,BETWEEN,CD8,EBV,HLA,HSV,RESPONSES,VARICELLA,VIRUS,VZV
AIM,CONCLUSION,FATIGUE,FIFTY,INVENTORY,LABEL,METHODS,OBJECTIVE,PEARSON,RESULTS,SYMPTOM,TAIWANESE

HOWEVER,NSCLC,T790M,TKI
FIFTEEN
BACKGROUND,CONCLUSION,FURTHER,LABEL,METHODS,OBJECTIVE,REDUCED,RESULTS,TAKEN
BACKGROUND,CHINA,CONCLUSION,COX,LABEL,METHODS,NSCLC,OBJECTIVE,OLDER,RESULTS
001,012,57B,BACKGROUND,ESO,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
AIM,LABEL,LDH,METHODS,OBJECTIVE,RESULTS,WBC
044,18F,ADVERSE,BACKGROUND,CONCLUSION,CTCAE,FDG,IMAGE,LABEL,LCR,METHODS,NSCLC,OBJECTIVE,OVERALL,PET,RESULTS,SEVENTY
000,BACKGROUND,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,THESE,WHILE
940,ALTOGETHER,JNK,KNOCKDOWN
100,175,181,947,ADDITIONAL,AS3,CD61LOW,CSC,MYC,NOD,TAKEN,THESE
169,BCL,BIM,MEK,NSCLC,PI3KI,THESE,USING,WHILE
169,EXTENSIVE,H2O,INITIATION,NOTABLY,PRUDENT,USING,YET
169,III,PPB,RNASE,SOMATIC
ADMIRAL,BORIS,COINCIDING,DEPARTMENT,EDUCATION,GENERAL,JANUARY,MPH,SMOKING,SURGEON,WELFARE,YEARS
235,AIM,CONCLUSION,CRS,DIFFUSE,FURTHER,HIPEC,LABEL,METHODS,OBJECTIVE,PCI,RESULTS,SEVERAL
032,BACKGROUND,FIFTEEN,LABEL,LEVEL,METHODS,PATIENT,PREDNISONE,RESULTS,TRANSPLANT,UNIVARIATE
169,177,956,ALZHEIMER,BENZYLOXY,CONTROLLED,COPYRIGHT,EEL,SAS
169,231,562,BAD,BAX,BCL,BID,BIM,CEM,CNE,COPYRIGHT,FAS,HEPG2,HSP27,IGF,IGFBP,LIVIN,MCF,MDA,NH2,SAS,TRAIL
169,621,634,662,ALK,ALTOGETHER,HOWEVER,ISSUE,KHURI,LABEL,NON,NSCLC,RAMALINGAM,THESE,TKI,UNLABELLED
129,359,488,494,533,961,CHINA,CHINESE,SMOKING
ADDITIONAL,HOWEVER
600,AKT,BACKGROUND,CONCLUSION,FURTHER,LABEL,METHODS,MOLECULAR,OBJECTIVE,RAS,RESULTS
160,169,474,COPYRIGHT,INC,PUBLISHED,SOCIETY
005,007,009,039,055,169,175,177,30MIN,60MIN,781,798,ATM,BCC,BCT,BTT,COPYRIGHT,DRC,DSR,HOWEVER,MRE11,OLIVE,OTM,RAD50,SSR,XRCC1,XRCC4
102,169,177,1ST,660,812,AIM,CONCLUSION,COPYRIGHT,DAKAR,DEPARTMENT,DRE,GENERAL,GLEASON,GRAND,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SAS,THERE,UNLABELLED,UROLOGY
100,169,171,454,729,ALK,CONCLUSION,COPYRIGHT,H1299,H2228,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTIPLEX,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RECURRENT,RESULTS,WHILE
001,020,169,BECAUSE,COPYRIGHT,EXCLUSION,GIVEN,III,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,REGARDLESS,RESULTS,THREE
169,AMONG,COPYRIGHT,IRELAND,LTD,THERE
METASTATIC,SCC
100,169,BECAUSE,COMET,COPYRIGHT,HOWEVER,NPS,PUBLISHED,TIO
161,169,382,AUTHORS,III,LTD,MORTALITY,NUTRITION,PTY,PUBLISHING,SCIENCE,THIRD,USA,WILEY
169,ALK,ATLAS,CAP,COLLEGE,CONFERENCE,GROUP,IASLC,LTD,MEETING,NSCLC,OCTOBER,PTY,PUBLISHING,WILEY,WORKING,WORLD
169,ALK,EML,LTD,PRECISION,PTY,PUBLISHING,WHERE,WILEY
CONTROL,CONVENTION,ESPECIALLY,FORUM,FRAMEWORK,LARGE,SOCIETIES,THERE,TOBACCO,WORLD
DISEASE,FORUM,REALITIES,SOCIETIES,TODAY,WORLD
169,APMIS,EPI64,GAP,HOWEVER,LTD,PUBLISHED,RAB27,TAKEN,WILEY
169,50S,CK5,CLARA,HOWEVER,SOCIETY,THEIR,TTF
001,101,1ST,CBM,CRUDE,EBSCO,LABEL,LIBRARY,METHODS,NSCLC,OBJECTIVE,ORS,RESULTS,SCHOLAR,SCIENCE,SEVEN,STATA,T309G,WEB
790,AREAS,ATP,BACKGROUND,COVERED,GREAT,III,LABEL,METHODS,NSCLC,OPINION
HOWEVER,SINCE
916,CONCLUSION,EWING,EWS,LABEL,M51,METASTATIC,METHODS,ONCOLYTIC,RESULTS,UNLABELLED,VSV
001,042,687,COX,GASTRIC,H19,MEIER,MTT,MYC,PCR,PEARSON
AVERAGE
AMONG,CHINA,ELSHOLTZIA,ESI,NMR
169,224,COPYRIGHT,CRC,GSE,IHC,MOLECULAR,NOTABLY,PCR,TTF,VIS
PSIP1,PULMONARY,RB1,SNF,SWI,THESE
800,BRITISH,THESE,VITAL
008,009,169,AKI,AT1,AT3,AT5,BACKGROUND,KIM,LABEL,METHODS,RESULTS
CARCINOMA,HOMOLOGOUS,NSCLC,RAD51,RPS,THEREFORE
BINDING,NSCLC,TOWARDS,WIDESPREAD
METASTATIC
114,130,400,750,ALK,AMONG,BACKGROUND,CERITINIB,LABEL,METHODS,NON,NSCLC,RESPONSES,RESULTS
140,155,947,BACKGROUND,HIV,HODGKIN,ILD,LABEL,METHODS,MSA,NXP,RESULTS,SEVEN,SEVENTEEN,TIF
119,159,172,177,290,332,509,558,628,873,945,959,BACKGROUND,CNS,CONCLUSION,COSTS,IRELAND,LABEL,METHODS,PREMATURE,RESULTS,TOTAL,VALUATION,YPPLL
100,THESE
PLC,PRIMARY,PULMONARY
ILS,INCREASED,INHIBITION,LOCAL,MMP,PRO,THERE,THESE
169,2ND,CONFERENCE,CONSENSUS,MAY,MEDICAL,NSCLC,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,BACKGROUND,IHC,LABEL,MALIGNANT,MATERIALS,MEDICAL,METHODS,MPM,NETWORK,OVERALL,PCR,PRESS,PUBLISHED,RESULTS,REVERSE,SOCIETY,UNIVERSITY
169,188,486,AUTHORS,IHC,LTD,WILEY
001,169,206,272,478,931,945,ALB,COPYRIGHT,INC,PAH,THESE,WILEY
100,147,925,99M,CONCLUSION,DEPREOTIDE,DICHOTOMY,DIFFERENT,IMAGING,LABEL,METHODS,NSCLC,OBJECTIVE,REGARDING,RESULTS,SIXTY,SPECT
169,306,AFFAIRS,AMONG,BACKGROUND,CENTRAL,CIS,COMMITTEE,COX,DESPITE,III,JOINT,LABEL,METHODS,NSCLC,RESULTS,SOCIETY,THERE
10001,333,CTD,DIFFERENT,FINALLY,MEDICAL,PUBLISHERS,PULMONARY,SEVENTH,USA
945,946,STAT3
951,956,ICP,PF6,THESE
111,185,AMONG,ASSESSMENT,BASED,BED,CONCLUSION,DOTATOC,GFR,LABEL,MBQ,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
ABP1P,ADF,AFFYMETRIX,FUNCTIONAL,HIP,HOWEVER,SRC
160,171,BACKGROUND,BETWEEN,LABEL,MATCHED,METHODS,RESULTS
CSC,IGF,IGF1R,NANOG,NSCLC,USING

931,AMONG,DESPITE,DISCUSSION,FINALLY,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL,WHEREAS
AFTER,DESPITE,GIVEN,SUBSEQUENT
001,002,003,008,220,BACKGROUND,COX,GLASGOW,LABEL,LVI,METHODS,NLR,NSCLC,PLR,PROGNOSTIC,RESULTS,RFS,SCORE,UNIVARIATE,VPI
000,014,018,033,177,79869,CUMULATIVE,EXCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SHR
001,BACKGROUND,INCLUSION,LABEL,METHODS,RESULTS
945,946,FURTHER,MYC,SCIENCE,SIGNALING,THEIR,TNBCS
100,282,333,368,410,ALK,BASED,CASES,HOWEVER,IHC,PCR,RIGHT,THREE
BLP25,CIK,CTLA4,III,NSCLC,THESE
HENCE,HOWEVER
MICRORNAS

100,215,500,ALB,BACKGROUND,DIMER,GENERAL,LABEL,MALIGNANT,MEDICAL,MEIER,METHODS,PO2,PTE,RESULTS,TEN,THESE,TIANJIN,UNIVERSITY,WBC
049,227,945,946,AMONG,BACKGROUND,BCL,ERCC1,LABEL,METHODS,RESULTS,STAGE,TTF,UNIVARIATE
BACKGROUND,BIM,HRM,LABEL,METHODS,PCR,RESULTS
BACKGROUND,LABEL,METHODS,NLT,RESULTS,STATA,WANFANG
525,ALK,BACKGROUND,IHC,LABEL,METHODS,RESULTS,WHILE
001,068,070,117,206,221,414,520,650,791,794,967,BACKGROUND,CHI,COX,FINALLY,JANUARY,LABEL,LOG,MEIER,METHODS,MICRORNAS,MIRNA,NSCLC,PCR,RESULTS,TNM
967,AMONG,BACKGROUND,BINZHOU,LABEL,METHODS,RESULTS,THERE
001,012,177,215,BACKGROUND,C30,EORTC,LABEL,METHODS,NSCLC,QLQ,QOL,QUALITY,RESULTS,THEREAFTER,TREATMENT
000,100,410,BACKGROUND,CHINA,DIFFERENT,LABEL,LOG,METHODS,PERMANENT,RESULTS
069,112,505,BACKGROUND,CA2,CELLS,CONCLUSION,LABEL,LASER,METHODS,OBJECTIVE,RESULTS
196,945,946,99M,99MTC,BACKGROUND,LABEL,METHODS,NCI,RESULTS,SPECT
BACKGROUND,CONCLUSION,H118F,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,S120G,THERE,WESTERN
200,BACKGROUND,BOM,BRM,FINALLY,L9981,LABEL,LNM,LUC,LUM,METHODS,RESULTS,UNDER
169,MARSHFIELD
110,169,AMONG,BIOLOGICAL,CD109,COPYRIGHT,ELISA,LABEL,NSCLC,SWATH,THESE,UNASSIGNED,UNLABELLED
169,COPYRIGHT,INC,LIVER
169,COPYRIGHT,INC,PULMONARY
006,007,019,022,035,169,344,733,COPYRIGHT,COX,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,T1B
084,117,169,189,350,548,618,727,731,761,933,ACR,BACKGROUND,BSL,CCC,COMPARISON,CONCLUSION,COPYRIGHT,FDG,FIFTY,INC,IRB,LABEL,METHODS,PET,RESULTS,SUV,THEREFORE,TIA,TLG,TLG42,VOI,VOLUMES
BACKGROUND,DISCUSSION,EARLY,HOWEVER,LABEL,MEDLINE,METHODS,SOCIO,SYSTEMATIC,TRIAL
EXPRESSION,GST,HOWEVER,LOCAL,NAT,UGT,XME
AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION,THEIR,TREATMENT
239,CFD,CYP,HEC,NOAEL
010,014,127,169,HOWEVER,INC,NSCLC,PCR,SIX,THEREFORE,WILEY
169,ERK,H1299,HBE,HOWEVER,INC,MMP,PCR,PD98059,THERE,THESE,TREATMENT,WESTERN,WILEY
169,ADDITIONAL,AFFAIRS,BACKGROUND,CENTRAL,COX,EPIGENETIC,LABEL,METHODS,RESULTS,SAS,SOCIETY,VPA
169,BETWEEN,HYPOTHESIS,IAC,INC,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,SOCIETY,THREE
169,191,CA9,CNA,COPYRIGHT,EFT,EWING,HOWEVER,INC,MFH,MUTATIONS,NGS,RUSC2,WILEY
ACCORDING
CTS,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRE,PULMONARY,RESULTS,TIL
019,021,105,138,148,512,699,ACCORDING,BACKGROUND,DESPITE,HOWEVER,LABEL,METHODS,NSCLC,PFS,RESULTS
945,ANNEXIN,AUTOMATION,BACKGROUND,COLO699,CONCLUSION,IHC,LABEL,LOWER,METHODS,NSCLC,PROPIDIUM,RESULTS,SEM,SMA
001,059,100,134,ADDITIONAL,BACKGROUND,CONCLUSION,FREEDOM,HOWEVER,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPA,SCALE,SRS,THREE
169,ATM,ATR,CHEK1,ERCC1,ERCC4,NOTABLY,OVERALL,XPF,XRCC1
AKT,BASED,DAMGO,EGF,EMT,FURTHER,GAB,IGF,MOR,NSCLC,SRC,STAT3
946,AKT,BCL,FGFR3,HCC1954,HOWEVER,INHIBITION,MET,MKN45,PATHWAY,SAIT301,TREATMENT
946,ACCORDING,ALZHEIMER,HOWEVER,TGF
AFFAIRS,BACKGROUND,CENTRAL,CISPLATIN,COX,DEPARTMENT,LABEL,METHODS,RESULTS,WHILE
006,010,013,039,057,945,ACCORDING,BACKGROUND,CELLS,LABEL,METHODS,RESULTS,SMA,SMOKING,WESTERN
112,118,342,620,624,725,BACKGROUND,BLOOD,CHRONIC,CONSORTIUM,HEART,HOWEVER,INSTITUTE,LABEL,METHODS,PRIMARY,RESULTS
002,023,083,158,230,591,945,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,NODAL,NSCLC,RESULTS,TTR
124,133,200,300,970,971,BACKGROUND,III,L858R,LABEL,METHODS,MUTATIONS,RESULTS,T790M,TREATMENT
AKT,BAX,BCL,CELASTROL,CHINESE,H1650,H1975,HSP90,NSCLC,TAKEN
169,947,COPYRIGHT,EARLY,GABAB,HOWEVER,KOREA
169,215,ART,ATS,COPYRIGHT,DHA,HEPG2,HOWEVER,HSA,INCREASED,MEANWHILE
001,006,011,805,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,THESE,TIAM1,TNM,UNASSIGNED,VIRTUAL
001,100,169,AMONG,COPYRIGHT,ENDPOINTS,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OTHER,PURPOSE,RESULTS,THREE,V20,V30
100,169,ACTUARIAL,COPYRIGHT,D10,DOSIMETRIC,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STUDENT
169,215,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,MEIER,METHODS,NORTH,NSCLC,OBJECTIVE,PFT,PULMONARY,PURPOSE,RADIATION,RESULTS,THERAPY,V10,V20,WHOLE
169,ASIAN,BACKGROUND,BRONCHIAL,DETECTION,LABEL,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,SP1
BECAUSE,EVALUATION,SOLID,STATE,WORLD
001,160,169,183,COX,DISCUSSION,HRS,INSURANCE,JANUARY,KNOWN,LABEL,LTD,METHODS,NHI,OBJECTIVE,PRIOR,RESULTS,TZD,USING,WILEY
CONCLUSION,DETECTION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
CONCLUSION,EWING,FDG,FORTY,HOWEVER,JANUARY,LABEL,MATERIALS,MDP,METHODS,OBJECTIVE,PATHOLOGY,PET,RESULTS,SIXTY,STUDIES
181,946,954,COX,IKK
ASKIN
CHEST,HODGKIN,NHL
BAX,BIN,MTT,RESULTS,THESE,WESTERN
ANOVA,BACKGROUND,FIELD,HODGKIN,LABEL,LYL,METHODS,PROCEDURE,RADIATION,RESULTS,YEARS
METASTASIS,PRIOR
169,27632,JAPAN,PRESS,PUBLISHED,RADIATION,RHO,S19,SER19,SIMILARLY,SOCIETY,THESE,UNIVERSITY,WESTERN,WST
121,177,99M,BETWEEN,CONCLUSION,DUE,FDG,LABEL,MDP,METHODS,NPV,OBJECTIVE,PET,PPV,PURPOSE,RESULTS,SUV
001,AGE,C00,C96,DISEASE,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS,TREND
001,005,016,018,095,145,150,244,416,652,CONCLUSION,EASTERN,EPP,GROUP,LABEL,LOG,METHODS,MPM,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
033,AKT,CONCLUSION,LABEL,METHODS,NSCLC,NSCLL,OBJECTIVE,PFS,PKB,PURPOSE,RESULTS
CIS,CONCLUSION,LABEL,LITERATURE,METHODS,NSCLC,NSE,OBJECTIVE,PURPOSE,RESULTS
APOPTOSIS,CALU1,CASPASE,INCREASED,JAK,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,STAT3,WESTERN
ENGLISH,PULMONARY
CRC,DESPITE,NOTCH,NSCLL,OBVIOUSLY,PRIMARY,RCC,TARGETING
17P,947,954,BCR,BTK,CHRONIC,CLL,ERK,IBRUTINIB,PLC
FORCE,INITIATIVE,LEGAL,MANAGEMENT,QUALITY,THERE
099,357,477,519,531,533,551,671,AGE,CEA,COX,HOWEVER,MEIER,OTHER,OVERALL,VPI
001,027,BIOMEDICAL,CAUCASIANS,CBM,CHINESE,CRUDE,ISSUE,LIBRARY,MEDLINE,NSCLC,SCIENCE,STATA,WEB
127,COLON,COX,LABEL,MEIER,METHODS,PURPOSE,RESULTS,UNIVARIATE,UNLABELLED
FAK,FINALLY,FURTHER,LABEL,LPS,METHODS,NEDD9,OBJECTIVE,PURPOSE,RESULTS
169,DUE,HOWEVER,PRESS,PUBLISHED,SURGERY,UNIVERSITY
106,169,PRESS,PUBLISHED,RIGHT,SURGERY,UNIVERSITY
937,G719S,HOWEVER,L858R,NSCLC,T790M
100,160,630,800,CNR,CONCLUSION,CTS,GGO,INCREASING,ITERATIVE,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,PATIENT,RESULTS,SLICE,STUDENT
4T1,ELISA,LPS,PBS,PULMONARY,TREATMENT
100,BACKGROUND,CONCLUSION,GLASGOW,INFIRMARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WESTERN
ASO,MICRORNAS,THESE
169,215,370,591,CHINESE,HAN,HOWEVER,PRESS,PUBLISHED,TOBACCO,UNIVERSITY

CRKII,L858R,MAMTH,USING
169,COPYRIGHT,SOCIETY
ERK,GBC,HOWEVER,KNOCKDOWN,METASTASIS,THESE
INCREASED,NON,NSCLC,PEMETREXED,PHASE,RAPAMYCIN
EGF,HOWEVER,ONCOGENIC,RAB25,TAKEN,THEREFORE
AHR,HOWEVER,IDO,INHIBITION,STAT3
HEPIN,HPN,THESE,WHILE
169,4T1,947,COPYRIGHT,GABAB,GABAERGIC,GAD65,IRELAND,LTD,MCF
169,823,AMB,BGC,COPYRIGHT,HOWEVER,MEANWHILE,MTT,NUR77
141,193,262,956,BETWEEN,CONCURRENT,INC,IQR,PUBLISHED
169,945,947,AFTER,COPYRIGHT,EVALUATION,IFN,IGG,IL2,INC,MSC,NOD,NSG,TNF,WHILE
169,946,BCMO1,COPYRIGHT,IRELAND,LTD
169,COPYRIGHT,DISULFIRAM,HOWEVER,INC,INHIBITION,MTT,NON,NSCLC,PCR
169,ALK,BETWEEN,CONCLUSION,COPYRIGHT,E542K,E545K,E545Q,FGFR1,FGFR2,G719A,GENOMIC,HOWEVER,IRELAND,JANUARY,LABEL,LTD,MATERIALS,MET,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RET,SAMPLES,SCLCS
169,COPYRIGHT,LTD
103,125,169,177,183,308,CONCLUSION,COPYRIGHT,INCIDENTAL,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
169,COPYRIGHT,ECM,INC,PERIOSTIN
169,COPYRIGHT,DEPARTMENT,EMERGENCY,FIFTEEN,HEMATOLOGY,ITEMS,LABEL,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,RESULTS,SELECTION,THERE
169,BACKGROUND,CONCLUSION,COPYRIGHT,CRT,GRADE,INC,LABEL,LOCAL,METHODS,PFS,RESULTS,TOTAL,TRT
169,AFTER,CONCLUSION,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,UNASSIGNED
169,AIM,CLINICALLY,CONCLUSION,COPYRIGHT,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS
160,169,ADRENAL,COPYRIGHT,CUSHING,ECTOPIC,SAS,TREATMENT
100,129,169,221,325,COPYRIGHT,INC,IRE,LABEL,METHODS,OBJECTIVE,OVERALL,PANCREATIC,PUBLISHED,PURPOSE,RESULTS,SIR
BACKGROUND,LABEL,RESULTS,WHOLE
001,032,037,040,143,169,260,AIM,CONCLUSION,COPYRIGHT,COX,HOWEVER,LABEL,LLR,LRR,LTD,METHODS,OBJECTIVE,RESULTS,SIMILARLY
BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,ONTARIO,PGS,RESULTS,SURVEYS,THERE
946,AML12,BACKGROUND,CPG,DNMT1,EMT,HOWEVER,LABEL,METASTATIC,METHODS,RESULTS,TGF,UNASSIGNED,VIRTUAL
BACKGROUND,CONCLUSION,LABEL,RESULTS
113,693,APOPTOSIS,BACKGROUND,BANCR,CONCLUSION,ECTOPIC,EMT,EXPRESSION,HISTONE,HOECHST,HOWEVER,LABEL,METHODS,MTT,NSCLC,PROTEIN,REDUCED,RESULTS,THESE
BACKGROUND,BETWEEN,BRAZILIAN,IIB,JANUARY,LABEL,METHODS,NSCLC,REGARDING,RESULTS
ELDERLY
DESPITE,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RADIATION,RESULTS,V20
NSCLC,USING
ALTERED,AREAS,BACKGROUND,COVERED,KIRSTEN,LABEL,METHODS,OPINION,RAT,SARCOMA,TARGETING,VIRAL
169,AMONG,FURTHER,JNK,NSCLC,SIX
PRIMARY,SEVILYA,THERE
177,388,CONCLUSION,DIXON,FDG,FORTY,FULLY,HOWEVER,LABEL,METHODS,OVERALL,PET,PULSE,RESULTS,SUV,THERE,UNLABELLED
169,264,823,BACKGROUND,BASED,BGC,CHANG,CONCLUSION,CURRENTLY,HEPG2,HGC,LABEL,NSCLC,PLEUROTUS,RAW,RESULTS,SOCIETY
DIR,THERE
945,986,ASSESSMENT,BRAZILIAN,C30,EORTC,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,QUALITY,RESULTS,SYMPTOM,TREATMENT
006,282,ANXIETY,ASSESSMENT,BACKGROUND,CHANGES,COMPARING,DEPRESSION,FUNCTIONAL,GREEK,LABEL,MATERIALS,METHODS,NSCLC,QOL,QUALITY,REGARDING,RESULTS,SCALE,SHORT,THERAPY
FBP,IMR,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,THERE,VISIBILITY
BAP,BSA,DHA,DIETARY,FURTHER,THEREFORE
MMP,THESE
169,AMD3100,CDC42,CXCR4,EWING,GTPASES,LABEL,MIGRATION,PCR,RHO,SDF,UNLABELLED
AKT,FURTHER,JNK,THESE
001,055,AUDIT,BACKGROUND,ENGLISH,LABEL,METHODS,PATIENT,RECIPROCAL,RESULTS
CURCUMA,HOWEVER,HSP90,ROS,SIMILARLY,T63,THESE,USING
110,OVERALL,PAM50
169,218,BASED,CONCISE,CONCLUSION,COPYRIGHT,HOUNSFIELD,INC,LABEL,LYMPH,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROC,UNASSIGNED,USING
169,COPYRIGHT,INC,LABEL,NPS,UNASSIGNED,UNLABELLED
169,444,537,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,NSCLC,RESULTS
169,181,280,400,450,956,AFTER,AUTOMATED,BIOMARKER,COLLEGE,COPYRIGHT,FDG,GENERATOR,H2O,LTD,MARCH,MEV,RCY,UNIVERSITY,USP
169,COPYRIGHT,INC,THERE
100,177,ABERRATION,AFFYMETRIX,BACKGROUND,CNV,CONCLUSION,HDAC9,LABEL,LOH,MCNEMAR,RESULTS,SINCE,SNP
CASPASE,CCK,H1299,LABEL,METHODS,MYRICETIN,OBJECTIVE,RESULTS,UNASSIGNED,VIRTUAL
CASTLEMAN,LABEL,UNASSIGNED,UNICENTRIC,UNLABELLED,VIRTUAL
22RV1,BACKGROUND,CHO,CONTEXT,DISCUSSION,H1299,HEPG2,HILDEBR,LABEL,MATERIALS,METHODS,NCI,OBJECTIVE,RESULTS,THEIR,WST
DEBATES,HNSCC,HOWEVER,MRI,PET,THEREFORE
CLINICALLY,EPIGENETIC,REVERSIBLE
HBV,HCC,HOWEVER
000,028,088,145,169,177,312,331,371,392,421,426,APRIL,BETWEEN,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,UNIVERSITY
169,180,313,369,387,426,493,ALK,ANAPLASTIC,BACKGROUND,BECAUSE,FIFTY,LABEL,METHODS,NSCLC,RESULTS,SOCIETY
254,255,BIOMARKERS,COLORECTAL,OVARIAN,PRESS,PUBLISHED,UNIVERSITY
169,945,CHROMATIN,DSB,ERK,HOWEVER,MEK,NSCLC,PKC
169,AFTER,ARF,BRITAIN,COPYRIGHT,CUL4A,GENOMIC,GREAT,H2170,IHC,INCREASED,INK4A,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
124,160,169,177,179,183,196,203,224,314,423,619,724,AMONG,CARDIAC,CONCLUSION,EXTRA,GEORG,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,PVI,RESULTS,STUTTGART
FINALLY,JNK,MICRORNAS,NOTABLY,PCR
HOWEVER,SP1
00001,239,363,876,ASSESSING,HOWEVER,NSCLC
009,099,169,238,268,398,636,721,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TIL,YTMA128,YTMA201
007,012,013,041,047,229,ADDITIONAL,BACKGROUND,DCR,LABEL,METHODS,NSCLC,PFS,RESULTS
104,HOWEVER,MRI,NUCLEAR,THEREFORE,UNIVARIATE
CONSORTIUM,DIGITAL,IMAGE,USING
112,169,304,484,BACKGROUND,COPYRIGHT,INNSBRUCK,IRELAND,LABEL,LDH,LTD,METHODS,OVERALL,PARAMETERS,RCT,RESULTS,UNIVERSITY
169,187,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HOWEVER,III,IRELAND,IVA,IVB,LABEL,LTD,MASAOKA,MEIER,METHODS,OVERALL,RESULTS,STAGE
AFTER,AUTOPSY,CANDIDA,ESPECIALLY,STAGE
169,4CM,7CM,BACKGROUND,BPB,CHEST,CLASSIC,CONCLUSION,COPYRIGHT,LABEL,METHODS,PAN,PATIENT,PPB,PULMONARY,SAS,TTF
169,4MONTHS,COPYRIGHT,SAS,THERE
945,HOWEVER,NNK,UDP
001,2M0,4N0,BACKGROUND,COX,FURTHER,LABEL,MEIER,METHODS,MVI,NSCLC,OBJECTIVE,RESULTS,TNM,VPI
340,422,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS
HOWEVER,MRI,THEREFORE
ARRAY,ERK,IGF,KIT,LABEL,MATERIALS,MEK,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RTK,SIGNALING,STAT1,TIC,TOTAL,WESTERN
ABC,BACKGROUND,HOWEVER,LABEL,METHODS,PEARSON,PRE,PTV,RESULTS,THESE,USING
AREAS,BACKGROUND,COVERED,ERBB3,JAPAN,LABEL,LUX,METHODS,NSCLC,OPINION,TKI
000,019,033,177,EASTERN,GROUP,MALIGNANT,MARCH,MPM
143,169,HOWEVER,LTD,NSCLC,PUBLISHED,SSX,WILEY
069,130,620,BACKGROUND,CMM,FACTORS,FURTHER,LABEL,METHODS,NORWEGIAN,RATES,RESULTS,SCC,SIR
FREEDOM,FRESH,MODEL,RADON,SHS,SMOKING,TEACHABLE
129,CURRENT,KNOWING,PERCEIVED,PROGRAM,RADON,THOSE
007,066,106,122,BACKGROUND,INVENTORY,LABEL,METHODS,MLR,OBJECTIVE,RESULTS,SMALL,SYMPTOM,THESE
105,ADDRESSING,BACKGROUND,CONCLUSION,DESPITE,III,ILLNESS,LABEL,METHODS,OBJECTIVE,QOL,RESULTS
PCI
TEN
169,CONCLUSION,EGF,EMT,FINALLY,LABEL,METFORMIN,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,STAT3,STUDIES,TKI,WESTERN
169,HOWEVER,NSCLC
169,PET
946,AKT,ERK,HOWEVER,NSCLC,THESE
003,011,160,DFS,LABEL,METHODS,MUTATIONAL,OBJECTIVE,PURPOSE,RESULTS,WHETHER
177,HOWEVER
138,177,ASIAN,PEARSON,SIXTY
039,GEOGRAPHIC,ICU,SES,URBAN,WHITE
ALDH1,CONCLUSION,DEPARTMENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURGERY,THREE
945,CAPER,HOWEVER,MTT,NSCLC,THESE,TMA,WESTERN
ANOTHER,APRIL,AVAILABLE,BASED,COLORECTAL,CONTROLLED,ERSPC,HARMS,HEART,IMPORTANCE,JANUARY,LABEL,MEDLINE,METHODS,OBJECTIVE,OTHER,OVARIAN,PSA,RANDOMIZED,RELEVANCE,RESULTS,SCORING,SCREENING
000,042,118,120,168,169,177,886,942,962,989,BACKGROUND,CONCLUSION,COPYRIGHT,JANUARY,LABEL,LYG,METHODS,NSCLC,RESULTS,SOCIETY,USING,VARYING
001,169,ACE,ADULT,COPYRIGHT,DISEASE,EVALUATION,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SOCIETY,STRATIFIED
797,803,805,ERBB4,SEVERAL,T790M
DTX,FH535,LAD,MEANWHILE,SFRP1,SPC,TAKEN,TAXANES,TREATMENT,WNT
2000S,ALK,ASIAN,FINALLY
WGCNA
338,LRP,TMEM205
169,ATTRIBUTES,BASEL,HPV,THESE
HOWEVER,MCF,RAD50,REMARKABLY,SKBR3,THESE
SOLUBLE
023,146,296,374,617,670,889,GTP,MUTATIONS,RAS
GEFITINIB,NSCLC,PULMONARY
DIFFUSE,DPL,HOWEVER
177,231,945,956,GELATIN,HOWEVER,MCF,MDA,NOS,NOSCAPINE
181,945,BACKGROUND,CRC,LABEL,LVD,METHODS,MVD,RESULTS,SMA,THEREFORE,USING
003,007,048,BACKGROUND,BRMS1,DFI,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,TOWARDS
946,BACKGROUND,C509T,CAUCASIANS,CHINESE,CIS,CONCLUSION,DATABASES,G915C,LABEL,MEDLINE,METHODS,ORS,PNEUMONIA,RADIATION,RESULTS,SEPTEMBER,SUMMARY,T869C,TGF,ULTIMATELY
BACKGROUND,ENV,GAG,LABEL,METHODS,OPA,PCR,RESULTS,SEVERAL,WHILE
231,946,ATLAS,BACKGROUND,CONCLUSION,FINALLY,HCC1428,III,JNK,JUN,KNOCK,LABEL,MDA,METASTASIS,METHODS,NUCLEAR,PROCESSES,RESULTS,THESE,WESTERN
HDL,RCT,RHEUMATOID,TNF,TREATMENT
257,269,526,BACKGROUND,LABEL,MEDLINE,METHODS,NSCLC,RESULTS,THERE
100,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SEVENTEEN,THERE
AFTER,CTC,DGM,EPCAM,PCR,TOS
HOWEVER
AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION,PHASE,THERE
ICT2588,MMP,PRODRUG,VDA,WILLEBRAND
BER,BERBAMINE,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
183,956,AKT,BAX,BCL,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,NSCNC,OBJECTIVE,RESULTS,WITHAFERIN
109,177,AMONG,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PACLITAXEL,RESULTS
177,245,466,711,981,AMONG,CONCLUSION,DVT,ELISA,INCREASING,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,FURTHER,GLUCOSE,LABEL,LDH,MATERIALS,METHODS,PLEURAL,RESULTS
000,100,600,CANCERS,CHINA,GUANGXI,HOWEVER,THEREFORE
BACKGROUND,GROSS,HELICAL,KOREA,LABEL,MATERIALS,METHODS,NSCLC,PUBLISHED,RESULTS
CTC,FDA,SINCE
100,ACT,BRAIN,CONCLUSION,IMAGING,INSURANCE,KNOWLEDGE,LABEL,METASTASES,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS
233,BROWN,RADIATION
115,185,288,672,AIM,ATT,BACKGROUND,FIRST,FORTY,LABEL,METHODS,OBJECTIVE,POPULATION,PULMONARY,RESULTS
NOVALIS,PALLIATIVE,RESULTS,SRT
ACUTE,ADJUNCTIVE,RECURRENCE
000,225,ACCORDING,FOUNDATION,PRECISE,THERE,USA,WORLD
EPP,MALIGNANT,MPM,THERE
169,946,ONCOGENIC,VEC,VEGFA,WNT,WNT7B
169,CSC,CSF,IFN,RESISTANCE
169,EMT,EXPRESSION,HCC,HNRNPAB,SNAIL
169,BESIDES,DESPITE,EORTC,GERIATRIC,MEDICAL,NON,NSCLC,PRESS,PUBLISHED,SINCE,SOCIETY,TREATMENT,UNIVERSITY,WESTERN
001,215,ACUTE,AFTER,BACKGROUND,CHRONIC,CRITICALLY,DESPITE,DVT,EVALUATION,ICU,IDENTIFIER,IMPORTANCE,LABEL,METHODS,NLDVT,OBJECTIVE,PHYSIOLOGY,RELEVANCE,RESULTS,SETTING,THROMBOSES,TRIAL
OCCURRENCE,SINCE
HPV,PAPILLOMA,PCR,VIRUS
280,341,BACKGROUND,BIVARIATE,INCLUSION,INDEX,LABEL,MDS,METHODS,NSCLC,RESULTS,SMALL,TREATMENT
BASAL,CETUXIMAB,CRIZOTINIB,EGF,EIGHT,ERBITUX,ERLOTINIB,FINALLY,HGF,HOWEVER,MSD,OVERALL,SPHEROIDS,THEREFORE,THREE
142,284,ADVERSE,CONCLUSION,III,JAPAN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
127,150,344,CONCLUSION,ERCC1,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SECONDARY
005,007,017,150,886,924,FIRST,PCR,SMALL,THESE
ALANINE,BIK,BIKDD
DNMT1,HOWEVER,SEVERAL,UHRF1
169,COPYRIGHT,FINALLY,HSA,LEVEMIR,TRESIBA,VICTOZA
169,878,945,AML,APL,CONVERSELY,LABEL,LINC00478,MOL,PML,RAR,RARES,RES,RESPONSIVE,THEREFORE,THESE,UNLABELLED
001,169,177,BACKGROUND,LABEL,METHODS,MORTALITY,OCTOBER,PULMONARY,RESULTS,SIXTY
150,169,400MG,AMONG,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PFSR12W,PRE,RESULTS,STILL,T790M,TKI,VORINOSTAT
169,COPYRIGHT,IRELAND,L858R,LTD,NSCLC,TKI
109,119,169,ASIAN,BACKGROUND,BECAUSE,CAUCASIAN,CHINESE,CONCLUSION,COPYRIGHT,FURTHER,IHC,IRELAND,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,PKCIOTA,PUBLISHED,RESULTS,TAKEN
160,169,204,253,255,281,317,511,954,AAA,AGREEMENT,AVAILABLE,CAPTURING,CAS,CENTERS,CONVERSELY,COPYRIGHT,ESTIMATED,FIFTEEN,INC,INITIATIVE,LABEL,METHODS,MOSBY,OBJECTIVE,PAD,PUBLISHED,RESULTS,WHI,WOMEN
146,169,COPYRIGHT,EXTENSIVE,IRELAND,LOCAL,LTD,RECURRENCE
001,183,AMERICANS,AMONG,APPROACHES,CROSS,DIETARY,LABEL,METHODS,MEXICAN,NATIONALLY,NUTRITION,OBJECTIVE,PDQ,RESULTS,SETTING,USA
001,028,169,482,947,BACKGROUND,FDG,FIFTY,LABEL,LOW,METHODS,NSCLC,PEARSON,PET,PUBLISHED,RESULTS,SOCIETY,WHETHER
142,169,215,306,597,BACKGROUND,CISPLATIN,HOWEVER,LABEL,METHODS,MPM,OVERALL,PUBLISHED,RESULTS,SOCIETY
169,ACTIVATION,COPYRIGHT,EMT,HGF,HOWEVER,INHIBITION,MET,NSCLC,PUBLISHED,SOCIETY,T790M
AIR
283,3BP,ACCORDING,AFTER,CONCURRENT,GSH,LACTATE,LDH,THERE,WARBURG
008,169,320,AFTER,BACKGROUND,COPYRIGHT,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS
169,CLINICIANS,COPYRIGHT,INC,PULMONARY,RCC
112,169,345,749,COPYRIGHT,HOWEVER,INC,METASTASIS,WHITNEY
169,AUTHORS,BASED,BETWEEN,COPYRIGHT,GROUP,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,RPA,SURGICALLY,THERAPY
335,BECAUSE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,TRANSPLANT
215,FATTY,RIGHT,TEN
111,127,169,189,239,300,812,841,AUC,AVERAGE,BERBAUM,CAD,CONCLUSION,DORFMAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,READERS,RESULTS,SELECTION,STAND,STILL,THREE,WITHOUT,WRITTEN
137,144,321,446,467,496,BACKGROUND,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,USING
00157,136,ABSENCE,BACKGROUND,CONCLUSION,EXPRESSION,IHC,LABEL,METHODS,OTHER,P53,REGARDING,RESULTS
THEIR,THEREFORE
169,MAY,PRESS,PROLENE,PUBLISHED,SURGERY,UNIVERSITY
261,ASIAN,CLPTM1L,DUE,LABEL,RESULTS,UNASSIGNED,UNLABELLED
169,177,99M,COPYRIGHT,H1299,LTD,PORPHYRINS,TECHNETIUM,THEREFORE,WILEY
112,169,252,63743,945,956,958,AMONG,AZ521,B16,CHIMICA,COPYRIGHT,EBV,EPSTEIN,HELVETICA,MSH,SEVENTEEN,TPA,WESTERN
1846C,185,AFTER,CRP,FIFTY,HOWEVER,LYMPH,USING
143,196A2,673,CAUCASIANS,CIS,HOWEVER,MICRORNAS,ORS,OVERALL
ALTOGETHER,NSCLC,PCR,RHO,ROBO1,ROCK1,SUZ12,WESTERN
001,005,042,093,605,CNS,CONCLUSION,EARLY,FURTHER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TKI
100,AMONG,CURRENTLY,DETECTION,DUE,KIT,PCR,SEPT9
152,157,160,185,234,313,622,818,881,896,AMONG,BACKGROUND,COX,EASTERN,GROUP,LABEL,METHODS,RESULTS
021,023,100,103,141,IQR,LDH,LOCALIZED,RADIATION,STAGE,THERE
215,ALK,BACKGROUND,LABEL,METHODS,PTC,RB1,RESULTS,RET,THERE,THESE,TRAPP,WHOLE
AAD,BAK,BAX,CONCLUSION,DBD,FINALLY,H1373,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
120,BACKGROUND,BCP,COX,HMO,HOWEVER,IQR,LABEL,METHODS,NETWORK,RESULTS,USING
ALZHEIMER,HENCE,HOWEVER,INCREASED
AMONG,ATLAS,NON
DIAGNOSIS,DISTRICTS,DPC,IWATE,JAPAN,LABOR,MEDICAL,MORIOKA,PREFECTURE,PROCEDURE,SECONDARY,SMD,WELFARE
SCC,SEVEN,SMALL,THEREAFTER
AFTER,DESPITE,III,PAH,RIGHT,WORLD
004,008,100,BACKGROUND,EUS,FNA,LABEL,METHODS,RESULTS
BACKGROUND,LABEL,MESSAGE,METHODS,OUTCOME,RESULTS,UNASSIGNED
945,ANG,CSF,E47,EMT,EPITHELIAL,LOXL2,TFS,TNF
H1299,H23,PEP,PEPCK,STILL,UNDER
ALK,HIF1A,HOWEVER,MMP,NCL,NUCLEOLIN,TFG
100,169,8AMOL,956,BENZENE,COPYRIGHT,IRELAND,LTD,PHG
169,945,947,954,COPYRIGHT,DEPLETING,EXPRESSION,GST,INC,KNOCKDOWN,RAD,RAS,TNF
169,268,COPYRIGHT,CURRENT,HOWEVER,INC,LABEL,LLO,PEG,UNASSIGNED,UNLABELLED
100,169,24H,956,AFTER,COPYRIGHT,LABEL,MDR,METHODS,MTT,OBJECTIVE,PTX,PURPOSE,RESULTS
100,169,956,BECAUSE,COPYRIGHT,HOFFMAN,IRELAND,KNOWLEDGE,LTD
100,169,COPYRIGHT,CROSS,HBL,LEAVE,RECON,SAS,STRUCTURE,VALIDATION
169,COPYRIGHT,INC
150NM,169,177,5NM,COPYRIGHT,DEVELOPED,PEGYLATED,THESE
00001,169,AFTER,ANN,COPYRIGHT,HOWEVER,LTD
169,956,CNS,COPYRIGHT,FURTHER,SAR,SAS,THESE
169,COPYRIGHT,EXPRESSION,MICRORNAS,THESE
169,COPYRIGHT,EGF,EPIREGULIN,ERBB1,ERBB2,ERBB3,ERBB4,LTD,NEU,THEREFORE
169,946,AKT,COPYRIGHT,HOWEVER,INC,NSCLC,OVERALL,SIMILAR,STATINS,T790M,THESE,TKI
007,122,169,945,BACKGROUND,COPYRIGHT,ELECTRONIC,FURTHER,HIF,HYPOXIA,IHC,III,LABEL,METHODS,NSCLC,RESULTS,STUDIES,TAKEN,TOTALLY,VARIOUS
169,COPYRIGHT,EXPANSION,INC,INHIBITION,LYMPHATIC,LYMPHATICS,MYCOPLASMA,PATHOLOGY,PUBLISHED,SOCIETY,SPROUTING,TREATMENT,VEGFR
169,947,C57,CD3,COPYRIGHT,HOWEVER,IFN,INC,LEWIS,LLC,NK1,NSCLC,SEP,THESE
169,BCL,CARDIAC,COPYRIGHT,EARLY,H1975,III,INC,JNK,LC3,OUABAIN,THESE
000,001,169,177,188,458,921,922,COMPLETING,CONCLUSION,COPYRIGHT,DIFFICULTY,JAPAN,KNOWLEDGE,LABEL,LTD,METHODS,MPM,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
169,CHR19,COPYRIGHT,FINALLY,GEMMS,INC,RB1,SMALL,TRP53,USING
100,143,169,177,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR
169,AFTER,COPYRIGHT,INSTITUTE,MAJOR,SAS,TENPATH,THESE
160,169,COPYRIGHT,PERITONEAL,SAS
105,10877,10878,113,123,125,132,164,169,180,188,197,205,210,483,505,BED10,COPYRIGHT,D99,GTV,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,ROC,SHORTER,THERE
006,169,211,AGGREGATE,BACKGROUND,CARDIAC,COPYRIGHT,END,HEART,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,STATISTICS,TRANSPLANT
169,8MM,ANOTHER,COPYRIGHT,PUBLISHED,RADIOLOGIC,SEPAR,SPN
169,BACKGROUND,CHRISTIANA,CONCLUSION,COPYRIGHT,HEALTHCARE,LABEL,LTD,METHODS,RESULTS,THERE,UNINSURED
017,169,AIM,COLLEGE,CONCLUSION,COPYRIGHT,ELISA,GGO,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OTHER,PUBLISHED,RESULTS,ROYAL
169,COPYRIGHT,DESPITE,EPONYMS,HOWEVER,INC
001,003,012,016,020,033,169,222,CIGARETTE,COPYRIGHT,DCR,IRELAND,L858R,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,ORR,PFS,RESULTS,SMOKERS,THERE,TKI
001,169,195,445,640,APRIL,BACKGROUND,CARCINOMA,CONCLUSION,COPYRIGHT,GROUP,IASLC,IRELAND,LABEL,LTD,M1A,M1B,METHODS,NON,NSCLC,PNEUMOLOGY,RESULTS,SOCIETY,SPANISH,SURGERY,TNM
001,007,147,169,444,ALK,BACKGROUND,CHINESE,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,PCR,RESULTS,RET,THERE
169,177,549,945,946,956,COPYRIGHT,FID,SENECIO
169,COPYRIGHT,DISCUSSION,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
108,150,353,567,BACKGROUND,ERM,EZRIN,HOWEVER,INCREASED,LABEL,MEIER,METHODS,NSCLC,PCR,RESULTS,THR,TYR
945,AKT,ALIVE,BACKGROUND,BIO,BTC,CHX,CONCLUSION,CXCL8,EGF,ERBB1,ERBB4,ERK,ERLOTINIB,IMAGE,LABEL,MATERIALS,METHODS,MONITORING,RESULTS,TNF,TREATMENTS
254,BACKGROUND,CONCLUSION,FURTHER,HGF,HOWEVER,IHC,LABEL,MET,METHODS,NON,NSCLC,PA8,RESULTS,RON,RTK,SU11274,SUBSEQUENT,USING,UTILIZING
BACKGROUND,BASAL,CONCLUSION,CXR,III,LABEL,LUMINAL,LUS,METHODS,RESULTS,THESE
169,APMIS,CIK,FURTHER,HOWEVER,HYPOXIA,LTD,METRONOMIC,NSCLC,PUBLISHED,WILEY
BACKGROUND,CANCERS,CONCLUSION,DUE,ENGLISH,EPSCC,ESPCC,HOWEVER,LABEL,METHODS,OCTOBER,PCI,RESULTS,SCC,SCOPE,SMALL,SOCIETY,THEREFORE
FDA,GEFITINIB,HENCE,HOWEVER,IDENTIFIED,INTENSIVE,NSCLC,PHASE,THESE
CBM,EBSCO,FURTHER,LIBRARY,NSCLC,OCTOBER,SCHOLAR,SCIENCE,SERUM,STATA,THERE,TNM,WEB
ANATOMICAL,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PHASE,PTV,RESULTS,THERE,TREATMENT,V10,V20,VOLUMETRIC
1990S,450,CYP,DME,GST,HENCE,HOWEVER,LEBANON,NAT,PHASE,THERE
000,169,AUTHORS,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,VITAL
100,169,176,ACCORDING,CO2,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SFR,SRF,STAT3,SURGERY,THREE,UNIVERSITY,VINFLUNINE
954,CHRONIC,HOWEVER,QUIESCENT,STAT3,TREATMENT
4YL,INHIBITORS,LTU27,THERE
169,ACIDS,EPIDERMAL,MET,NUCLEIC,PRESS,PUBLISHED,SEVERAL,SYNTH,UNIVERSITY
946,ATP,RELEASE,TGF,THESE,TREATMENT
33258,946,ANNEXIN,APOPTOSIS,BAD,BCL,CONSISTENT,CURCUMA,CYTOSOLIC,DDP,ELE,GSH,HOECHST,MTT,THESE
BRCA2,CHINESE,DSB,INHIBITION,SAS,THESE,XRCC2
NSCLC,THESE
ANNEXIN,AUTOPHAGY,HOWEVER,LC3,MTT,PEMETREXED,PTX,TAKEN
GEFITINIB,GENOMIC,HOWEVER,MRI,OWING
699,ATPFQEG,AVPIAQK,FURTHER,NSCLC,TAKEN,THERMAL,TREATMENT
145,156,239,CHEST,COLLEGE,FEV1PPO,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PCS,PHYSICIANS,PREDICTED,RESULTS
EARLY,ICH,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
335,349,INFECTION,MUTANTS
169,CEC,CEP,CTECS,FOLLOWING,TEM,THESE
169,946,CONSISTENT,CONVERSELY,NOTABLY,SILENCING
HOWEVER,NSCLC,VARIOUS
001,015,131,144,169,976,984,993,AIM,CEA,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,TDR
ADMISSION,FORTY,HOWEVER,MACCALLUM,OVERALL,PCR,PETER,PJP,SHORTNESS,TODAY
169,CMT,CONFORMAL,ENDORECTAL,GERIATRIC,INTENSITY,LEVEL,MEDICAL,NSCLC,PATIENT,PRESS,PUBLISHED,SHORT,SHORTER,SOCIETY,UNIVERSITY,WHERE
160,169,BACKGROUND,BETWEEN,COPYRIGHT,DISSECTION,FIFTEEN,INC,LABEL,MARCH,METHODS,OCTOBER,OVERALL,PUBLISHED,RESULTS,SIXTEEN,SOCIETY,THREE
AFTER,ATS,ATTAINMENT,BECAUSE,COMMITTEE,EXECUTIVE,SOCIETY
215,CARLO,CONVERSELY,LABEL,MATERIALS,METHODS,MONTE,OAR,OBJECTIVE,PHILIPS,PTV,PURPOSE,RESULTS,THERE
100,ADVERSE,BACKGROUND,CTCAEV4,ELEVATION,FDG,LABEL,MATERIALS,METHODS,NSCLC,PET,RESULTS,SUV,USING
006,100,111,128,137,300,824,834,AUC,CAD,CLEARREAD,CONCLUSION,JACKKNIFE,KNOWLEDGE,LABEL,METHODS,MIAMISBURG,OBJECTIVE,RESULTS,SIX
150,BACKGROUND,CD105,ENG,KDR,LABEL,METHODS,PCR,RESULTS,TAKEN,TBP,THESE,VEFR2,VEGFA,VEGFR
CHANGES
FINALLY
BECAUSE,C10,CYS,EXPRESSION,GFP,SEC,SRX,THESE,TR1,TR2,TRX,TYPICAL
023,135,141,161,169,184,276,278,583,782,861,BACKGROUND,CONCLUSION,INSURANCE,JANUARY,LABEL,MALIGNANCY,MATERIALS,METHODS,PHYSICIANS,PRESS,PUBLISHED,RESULTS,SPM,UNIVERSITY
127,160,174,ALTOGETHER,CRIZOTINIB,LABEL,MCF,METHODS,MICELLE,OBJECTIVE,PEG,PLA,PURPOSE,RESULTS,SILDENAFIL
MUTATIONAL,PCR,RAS,THESE,WHILE
HOWEVER,MUTATIONS
169,BIOLOGY,MEETING,PRESS,PUBLISHED,SOCIETY,SURGERY,TODAY,UNIVERSITY
003,007,222,596,ADDITIONAL,CIS,FTR,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OPERATIVE,RELEVANCE,RESULTS,SES,SETTING
160,591,605,683,863,904,BLOOD,DATABASES,HOWEVER,STUDIES,SUMMARY
177,99M,BINDING,BT474,IMAGING,ISOLINK,LABEL,MEMBRANOUS,METHODS,OBJECTIVE,PURPOSE,RESULTS
000,169,181,200,400,500,600,679,749,946,CARET,COX,HOWEVER,HRS,RAE,RETINOL,TOTAL,TRIAL
046,554,DEC,FURTHER,HNPCC,HOWEVER,MEDLINE,OVERALL
EXAMINING,OVERALL,WHILE
947,EGF,GSI,NOTCH,WESTERN
945,BMP,CAKUT,ECM,GBM,INSTEAD,ITGA3,NEP,NEPHROTIC,PULMONARY,TGF,WNT
02X,169,177,COMPARISON,COPYRIGHT,INC,LABEL,MATERIALS,MAX,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,R4DCT,RADIATION,RESULTS,RMV,SOCIETY,THESE
169,250,751,COPYRIGHT,FONAR,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY
019,039,169,470,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PRIOR,PUBLISHED,PURPOSE,RADIATION,RESULTS,SIXTY,SOCIETY
109,169,AUTOMATIC,BOARD,COPYRIGHT,DAILY,INC,ITV,LABEL,MATCHES,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,ROI,SOCIETY,USERS,VOI
028,470,BACKGROUND,BASED,C3B,C4B,CHINESE,CIS,COMPLEMENT,CONCLUSION,CR1,HAPLOVIEW,HOWEVER,LABEL,METHODS,NSCLC,ORS,RESULTS,SIMILARLY,SNP
169,5A4,AIM,ALK,BECAUSE,BENCHMARK,LABEL,LTD,METHODS,OBJECTIVE,PRE,RESULTS,TESTING,VENTANA,WILEY
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
CONCLUSION,CONVERT,FEW,GTV,III,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PATIENT,PHASE,RESULTS,SEPTEMBER,THERE
AREAS,BACKGROUND,COVERED,FINALLY,FIRST,LABEL,LATER,METHODS,OPINION
243,AFRICAN,BIOST,COLLEGE,EASTERN,FP7,FRAMEWORK,HUSSEIN,IRELAND,ISO,KHCCBIO,MANAGEMENT,NORTH,PROGRAMME,QMS,QUALITY,SEVENTH,TRINITY,UNION,VALIDATION
AFTER
169,COLLEGE,INC,MOLECULAR,PATHOLOGY,THEREFORE,UNTIL,WILEY
003,081,107,122,169,179,193,384,825,957,BACKGROUND,CONCLUSION,INC,LABEL,LNI,METHODS,PULMONARY,RCC,RESULTS,SYSTEMATIC,WILEY
NANOSIZED
MICRORNAS,PCR
CLEARLY,ERBB2,INITIAL,NSCLC
181,18F,200,ADP,ANNEXIN,AVERAGE,ERCC1,HOWEVER,NSCLC,PC9,PET,THERE
956,BAX,HOWEVER,NCI,PRDX6,SEVERAL,THESE
ATM,CUT,LOH,RAS,ROS
001,006,194,211,946,BACKGROUND,CONCLUSION,H1299,LABEL,LENTIVIRAL,MES,METHODS,NSCLC,RESULTS,THESE
ADT,HRPCA,NOS,PCA,SEQUENCING
231,500,945,954,AKT,FURTHER,LFG,MDA,MEANWHILE,MMP,STAT3,TAKEN,TNF
AKT,ERK,HSP,HSP27,JNK,MEIER,NSCLC,PCR
169,843,946,BCL,BIM,ERK,LABEL,MOL,NON,NSCLC,RAS,RES,THESE,UNLABELLED
169,ARF,ATLAS,CDKN2AB,HOWEVER,INK4A,LABEL,PRIMARY,THESE,UNLABELLED
WDPMS
183,189,18F,190,254,357,375,378,ABSTRACTS,CANCERS,EVALUATION,FDG,HOWEVER,PET,SOLID,SYMPOSIUM
169,NOTABLY,SCC
169,AKT,COPYRIGHT,LTD,POLD4,PREVIOUSLY,THESE
CEACAM5,MYC,PTBP3,SCC
169,COPYRIGHT,CPSF4,FEDERATION,HOWEVER,MEIER,PUBLISHED,SOCIETIES
169,174,CONCLUSION,CONSORTIUM,COPYRIGHT,INITIATIVE,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,QUALITY,RESULTS,SOCIETY,SYMPTOM,USING,WHERE
001,006,153,169,174,AFTER,CELLSEARCH,CTC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
215,AMONGST,GCT
169,BESIDES,DIGITAL,DTS,HOWEVER
169,7TH,COMMITTEE,III,JOINT,RADIOLOGIC,TNM
160,169,945

008,120,NON,PRIMARY
002,107,115,160,169,172,177,237,AGE,GROUP,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,UNIVERSITY
001,005,006,169,CHEST,FEW,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESECTIONS,RESULTS,SURGERY,UNIVERSITY
114,183,4TH,CDC,HOWEVER,THERE
169,AFT,INC,SIMULATION,WILEY
169,183,GEORG,MALIGNANT,STUTTGART
169,183,ACCEPTANCE,AGNOR,DEFINITIVE,EMPLOYERS,GEORG,HODGKIN,INSURANCE,LIABILITY,NHL,NON,PLEURAL,STUTTGART
141,258,401,AFTER,CHINA,CIS,DATABASES,HOWEVER,ISI,KNOWLEDGE,MEDLINE,ORS,OVERALL,SCIENCE,SEVERAL,WEB
277,COX,HOWEVER,NSCLC,PFS,SIMILARLY,XPG
ELISA,FCM,LEWIS,LLC,MDSCS
169,177,BACKGROUND,BETWEEN,CONCLUSION,FOUNDATION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR,TRANSIENT
GRIA1,GRP78,RCN,SRC,THESE
169,176,184,276,504,AMONG,CONSORTIUM,ILCCO,WHILE
178,206,APRIL,BEIJING,CHINESE,CONCLUSION,COX,HOWEVER,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE,VARIABLES,WESTERN
169,954,FDA,HOWEVER,TAKEN
006,BACKGROUND,CONCLUSION,FDG,GTV,JOINT,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SFS
001,160,419,986,BACKGROUND,CONCLUSION,COX,HOWEVER,LABEL,LAC,MEIER,METHODS,RESULTS
101,108,109,129,132,138,163,169,183,200,ALB,CARLO,CRP,CTRLS,EARLY,MONTE,SAMPLES
946,MTT,TGF,WESTERN
771,ASIAN,CIS,FURTHER,IGF,IGFBP,MAY,ORS,STATA
967,FIFTY,SMALL,THESE
GIVEN,SRS
215,OWING
161,241,554,BACKGROUND,EVENTUALLY,LABEL,METHODS,OVERALL,PSA,RESULTS
001,006,026,169,BACKGROUND,GREEK,LABEL,METHODS,PRESS,PREVALENCE,PUBLISHED,RESULTS,SAMPLES,SES,SMOKING,THESE,UNIVERSITY
160,BEAMNRC,DESPITE,DOSXYZNRC,LINAC,PHASE
12469,169,COPYRIGHT,FE3O4,GPX,HEL,IRELAND,LTD,PEG,ROS,SOD,UNDER
169,APOPTOTIC,COPYRIGHT,EPIDERMAL,IRELAND,LTD,NSCLC,THESE
ARD,LABEL,NOA,OBJECTIVE,OPHIOLITES,PURPOSE,RESULTS,SUMMARY,THERE
185,FDG,HIV,HOWEVER,LABEL,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,SUMMARY
100,188,ABI3130XL,APPLIED,BIOSYSTEMS,MDX,PCR,Q24,RGQ,ROTOR,SEVERAL
12Q13,ARMSS,BCR,DDIT3,DICER,FOXO1,GAINS,IGF1R,LRP1B,THERE
DESPITE,HAART,HIV,HOWEVER,LYMPHOMAS,OTHER
169,263,737,945,ABT,BAK,BAX,BCL,BH3,COMBINING,HIF,PDX,RAPAMYCIN,THESE,WHILE
169,177,411,434,514,597,BACKGROUND,CONCLUSION,HHD,LABEL,METHODS,NSCLC,QOL,RESULTS
001,012,029,169,277,343,ACADEMY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,HOSPICE,III,INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PALLIATIVE,PUBLISHED,RESULTS,SCALE,STAGE
169,CONCLUSION,COPYRIGHT,CYP,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVERAL
169,COPYRIGHT,HOX,LTD
169,954,981,B16,BECAUSE,COPYRIGHT,F10,FINALLY,INC,MACROPHAGE,MEL
160,169,ACTIVATED,AKT,AUTHORS,COMPLEMENT,COPYRIGHT,INC,PUBLISHED,THESE
160,169,AUTHORS,COPYRIGHT,FINALLY,INC,PUBLISHED,TREATMENTS
169,COPYRIGHT,INC,KRUPPEL,ROS
000,148,169,233,355,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,INCIDENCE,LABEL,METHODS,MORTALITY,RESULTS,SAS
169,231,ANTAGONISM,COPYRIGHT,ECTOPIC,FDA,IIA,INC,MCF,MDA,THESE
169,COPYRIGHT,HNSCC,LTD,PLC,PUBLISHED,PULMONARY,T2N2BMX
160,169,177,193,221,APRIL,COPYRIGHT,INC,LABEL,LEVEL,METASTASES,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCIENCE,SOCIETY,SURGERY,THERE
002,007,179,341,BACKGROUND,CCRCC,CRP,HOWEVER,LABEL,METHODS,ORGAN,RCC,RESULTS
001,009,150,160,177,BACKGROUND,COX,DKK,ELISA,LABEL,MEIER,METHODS,NSCLC,NUMERICAL,RESULTS,SERUM,TNM,UNASSIGNED,VIRTUAL
150,AFTER,ERLOTINIB,PHYSICIANS
400,600,800,AST1306,AUC,BACKGROUND,BASED,BID,DLT,FIBONACCI,FURTHER,LABEL,METHODS,MTD,RESULTS,SEVENTY,TID,UNDER
106,956,BACKGROUND,CONCLUSION,EWING,HOWEVER,LABEL,METHODS,MMP,RESULTS,THEREFORE,THESE,ZOLEDRONIC
169,AIM,BACKGROUND,IMS,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,RESULTS,THESE,WILEY
169,303,5A4,ALK,ALK01,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SP8,THESE,THREE,WILEY
169,ASIDE,GIVEN,INC,WHILE,WILEY
ABCG2
DOX,MAL,NON,NSCLC,PEG,PEG2000
169,AEROSOL,BACKGROUND,CONCLUSION,INC,LABEL,MATERIALS,METHODS,PBS,RESULTS,TREATMENT,WILEY
169,ADDISON,INC,WILEY
169,CAROTID,FNA,HEPATIC,INC,MRI,PRIMARY,WILEY
169,ATPASES,CARDIAC,CGS,HOWEVER,INC,KNOCKDOWN,NKA,NSCLC,PP2,ROS,SRC,THESE,WILEY
18F,CILIARY,FDG,MRI
HAART,HIV,HODGKIN,JANUARY,LABEL,METHODS,NON,OBJECTIVE,PRE,PURPOSE,RESULTS
169,CHILDHOOD,DISEASE,EARLY,FORUM,GREATER,INC,PEDIATRIC,PNEUMONIA,REALITIES,SOCIETIES,TODAY,WILEY,WORLD
ALZHEIMER,CHASE,CHEVY,INCIDENCE,SMALL,WAR,WASHINGTON,WORLD
000,146,172,ACCORDING,CIA,JAPAN,SEPTEMBER,THERE,THEREFORE,WELFARE
ACCORDING,BACKGROUND,GRADE,ILD,LABEL,METHODS,REGARDING,RESULTS,SIXTY
BRITISH,MEETING,SOCIETY
005,160,200,248,478,967,ADS,CAV,CHINA,KNOWLEDGE,NSCLC,SCC,SCIENCE
ADP,BYK,NCI,PARP1,POLYMERASE,ROS
C3H10T1,HEK293A,MBOAT,SHH,SONIC
125,CHO,EGF,III,SURFACTANT,THESE
00128,945,946,CHINA,NPC,THESE
H1299,HOWEVER,MRC,NCI,PDSS2,PEARSON,TAKEN,THERE
000,169,200,AMONG,BACKGROUND,CANCERS,CONCLUSION,END,FEW,HODGKIN,LABEL,METHODS,ORS,RESULTS,SHORT,STRONGEST,USING,VTE,WHILE
169,946,CONVERSELY,CRC,EXPRESSION,PRESS,PUBLISHED,STAT5,UNIVERSITY
169,CSC,DEPLETION,EPHA2,HOWEVER,JNK,JUN,KNOCKDOWN,NH2,NSCLC,RES,TREATMENT
169,LABEL,METHODS,OBJECTIVE,PLACE,REDUCED,RESULTS,ROYAL,SINCE,SMOKING,SOCIETY,TOTAL
000,169,BAYES,COPYRIGHT,LTD,SVM
169,254,ADR,ADRB2,BACKGROUND,COPYRIGHT,HCC,HOWEVER,LABEL,LIVER,METHODS,MONOAMINE,NOTABLY,OBJECTIVE,PCR,PUBLISHED,RESULTS,TAKEN
120,169,177,674,800,947,956,COPYRIGHT,NIH,OVCAR,PDT,THESE
120,169,170,209,215,362,AMONG,COPYRIGHT,HCT,IDIOPATHIC,INC,IPS,PUBLISHED,TEN,THERAPY
169,954,COPYRIGHT,FEDERATION,PUBLISHED,RAS,RASSF,SOCIETIES
000,001,031,141,169,653,7TH,963,BACKGROUND,CA125,CONCLUSION,COPYRIGHT,EPCAM,ICC,LABEL,METHODS,RESULTS,ROC
169,ASSESSMENT,AUC,BACKGROUND,COPYRIGHT,DIAGNOSTIC,ENGLISH,HOWEVER,LABEL,MARCH,METHODS,MPM,QUALITY,RESULTS,SIX,STUDIES,USING
13R,169,945,COPYRIGHT,GOLGI,TUNEL,U87
BACKGROUND,BETWEEN,LABEL,LOCAL,MEIER,METHODS,PULMONARY,RESULTS,REVISIONS,SCORE,THERE,THESE,THOUGHT
123,169,COPYRIGHT,FURTHER,HOWEVER,LTD,MRC,MTT,PCR,PLEUROTUS,PN50G,RDAMINE,SEM,THESE
169,COPYRIGHT,LIU,LTD,STRUCTURE
172,237,264,APRIL,BACKGROUND,CONVERSION,HOWEVER,LABEL,MAY,METHODS,PSP,REASONS,RESULTS,THEIR
001,002,100,169,947,ADP,COPYRIGHT,EFFECTS,GEFITINIB,H1975,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PC9,PURPOSE,RADIATION,RESULTS,T790M,TKI,WESTERN
169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
DOX,GLU,LYS,MAXIMUM,MTD,NPS,PHE
ALONGSIDE,HOWEVER,THC
000,100,111,137,145,170,765,BACKGROUND,CHINA,DCO,DIAGNOSIS,ICD,INCIDENCE,JIANGXI,LABEL,MATERIALS,METHODS,RESULTS,SIMILARLY
CURRENTLY,EXPRESSION,FINALLY,FURTHER,MET,NON,NSCLC,THESE,UTR
000,BACKGROUND,EGGER,LABEL,METHODS,NSCLC,PCI,RESULTS,SIX
BACKGROUND,CIS,CONCLUSION,ENGLISH,LABEL,METHODS,ORS,REFERENCE,RESULTS,THERE,WHILE
008,012,021,100,ADC,ASIAN,BACKGROUND,CONCLUSION,COX,EXPRESSION,HOWEVER,LABEL,MEIER,METHODS,PCR,PEARSON,RESULTS,STUDENT,UNIVARIATE
001,008,020,037,043,098,362,BACKGROUND,BMD,CAUSE,CONTEXT,COX,JANUARY,LABEL,LOW,METHODS,OBJECTIVE,OUTCOME,RESULTS,ROTTERDAM,SETTING
HOWEVER,MICRORNAS,THERE
945,LUNGS
134,194,226,246,284,311,357,362,AMONG,CONCLUSION,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SAKARYA,THERE
ASBESTOSIS,DIFFUSE,SUBPLEURAL
SURGERY
100,181,220,KDA,MALDI,MTT,PEPTIDE,PYROCOCCUS,SDS,TOF
130,BACKGROUND,BECAUSE,EIGHT,LABEL,METHODS,RESULTS
244,956,COFILIN,HOECHST,RESULTS,RHODAMINE,THESE
017,CRT,PLANS,PTV,V10,V13,VOB
010,015,030,BACKGROUND,CONCLUSION,FORTY,FURTHER,IMT,LABEL,LOS,MAXIMAL,METHODS,OTHER,RESULTS
160,945,954,AFTER,FURTHER,H1299,MMP,PCR,TNF
003,012,023,048,18F,FDG,PET,SUV,VALIDATION
160,500,804,CONCLUSION,HOWEVER,LABEL,LAD,LADSUPINE,METHODS,NONTARGET,OBJECTIVE,PRONE,PURPOSE,RCA,RESULTS,SPARING,TREATMENT,V20SUPINE,WBI
006,169,177,BACKGROUND,CONCLUSION,KINKING,LABEL,METHODS,RESULTS,THERE
AFTER,DUE,GATA3,PET,S100P
ALONG,BEV,HOWEVER,NSCLC,SCM,SIX,TREATMENT
169,500,750,ALT,CBR,CHINA,IIA,IIB,PFS,PHASE
EFFICIENT,INHIBITION,RNAIMAX
945,947,DUE,GCS,GSH,GSS,HIF,HOWEVER,THEREFORE
FAS,THESE
169,215,AIC,BACKGROUND,CURRENT,GIVEN,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
BMP,HOWEVER,ID1,ID2,ID3,NSCLC,SMALL
166,BACKGROUND,EUS,LABEL,LNS,METHODS,NSCLC,RESULTS,SMS,TRIAL,URL
BAK,BCL,EPIGENETIC,IDIOPATHIC,IPF,THESE
213,849,ASP353GLU,CBMDISC,CHINESE,CHONGQING,CIS,EGGER,ENGLISH,GLU353ASP,HOWEVER,HWE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,ORS,RESULTS,SCIENCE,TP53BP1,VIP,WEB
CECAL,FURTHER,HDL,LABEL,OBJECTIVE,RESULTS,THERE,THYMOCYTE,USING
947,MEANWHILE,MMP,MTT,PCR,TAKEN
006,007,012,071,169,307,656,COX,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,THESE,UNIVERSITY
ASC,ASCT2,BACKGROUND,IHC,LABEL,METHODS,NSCLC,RESULTS
001,002,004,005,021,127,BACKGROUND,BMJ,DISTANT,GROUP,LABEL,LIMITED,METHODS,NODAL,PROGNOSTIC,PUBLISHED,PUBLISHING,RESULTS,SEVERAL
096,097MM,169,177,490,499,COPYRIGHT,PHANTOM
169,COPYRIGHT,DIVERSE,LTD,MCF
169,945,946,AKT,CONVERSELY,ECTOPIC,GASTRIC,HIF,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,PUBLISHED,SAS
100,120,160,169,COPYRIGHT,HOWEVER,PUBLISHED,SAS
160,169,CHIVA,COPYRIGHT,HIV,MANAGEMENT,PUBLISHED,SAS
169,AFRICAN,ART,COPYRIGHT,HIV,INITIALLY,PUBLISHED,SAS
111,140,148,795,ADDITIONAL,FLORIDA,SERVICE
169,COPYRIGHT,DESPITE,EPP,HOWEVER,IRELAND,LTD,MALIGNANT,PALLIATIVE,RADICAL,VARIOUS
169,352,BACKGROUND,COPYRIGHT,FEW,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,SALVAGE,THERE,THREE
169,AFRICAN,AGE,AMERICANS,BACKGROUND,CONCLUSION,COPYRIGHT,COX,EASTERN,IRELAND,LABEL,LTD,METHODS,NORTH,OLDER,PATIENT,PRIVATELY,RESULTS,SAS,UNIVERSITY
ACC,ACCORDING,AUTOPSY,LABEL,SLOOTEN,UNASSIGNED,UNLABELLED,VAN,VIRTUAL,WEISS
001,038,090,168,169,295,969,COPYRIGHT,F20,F21,F23,F25,ICD,INC,LABEL,METHODS,MORTALITY,OBJECTIVE,OVERALL,PHYSICIANS,PRESS,RESULTS,USING
100,181,239,468,MDA,NCI,RESULTS,USA
APGAR,GRAVIDA,LAM
GIVEN,JANUARY,JAPAN,METASTASIS
182,BACKGROUND,LABEL,METHODS,MICROARRAY,PCR,RASA1,RESULTS
BACKGROUND,CEA,CYFRA21,FINDING,LABEL,METHODS,NSE,RESULTS,SERUM
169,FUNCTIONAL,INCREASED
169,AKT,ID1,IGF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TARGETING
010,016,026,125,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,PULMONARY,RESULTS,SOCIETY,VAGUE
169,PRESS,PUBLISHED,SFTPS,SURGERY,UNIVERSITY
060,180,405,450,605,709,741,956,ENROLLMENT,JANUARY,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,SMR,THESE
001,002,016,253,CIS,HOWEVER,HRS,METASTASIS,OCTOBER,ORS,OVERALL
103,129,154,169,AGILENT,AUTHORS,INC,MICRORNAS,PUBLISHED,STILL,WILEY
003
300,AFTER,CHEST,III,SEVEN
11Q,169,17P,AURANOFIN,CHRONIC,CLL,RIDAURA,TCL
002,005,ALLOCATION,BACKGROUND,CENTRAL,CONCLUSION,CONTROLLED,HOWEVER,INCREASED,LABEL,MEDLINE,METHODS,RESULTS
ADS,ARG,ASP,GLY,HOWEVER,ONCOLYTIC,PEG,RGD
945,946,954,ABIN1,APOPTOSIS,CFM,INHIBITORY,JNK,MALIGNANT,MPM,PARP1,SAPKS,TREATMENTS
013,113,183,215,441,BACKGROUND,BIOVU,CLL,CONCLUSION,DLBCL,HODGKIN,INITIATIVE,LABEL,METHODS,NHL,OBJECTIVE,POPULATION,RESULTS,SLL,WOMEN
197,945,946,AFTER,AKR1B10,COMPARISON,K125R,TYR48,V301L
100,100SN,120,150SN,192,215,DIAGNOSTIC,FORCE,HIGHEST,IMAGE,LABEL,METHODS,OBJECTIVE,PROTOCOLS,PURPOSE,RESULTS,SOMATOM
169,ALK,AP26113,CNS,COPYRIGHT,III,IRELAND,LTD
001,008,089,155,169,217,AUTOMATED,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,THERE
169,445,APC,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RASSF1A,RESULTS,SET
CAREFUL,FALSE,WHOLE
116,160,200,211,ACTIVATION,AKT,AMONG,BACKGROUND,BCL,H1650,H1975,HCT,HFF,INCREASED,IST,LABEL,M14,MET5A,METHODS,MPP89,NCI,RESULTS,SKRB3,THESE
169,CD163,COPYRIGHT,SCC
4MM,SEVERAL
HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
AREAS,BACKGROUND,COVERED,III,LABEL,MEDLINE,METHODS,NINTEDANIB,NSCLC,OPINION,PDGFR,PHASE,VEGFR
HOWEVER,JAPAN,NCD
EVALUATION
035,231,947,BRMS1,CONCLUSION,FINALLY,KEY,KNOCKDOWN,LABEL,MATERIALS,MCF,MDA,METHODS,PLC,RESULTS,UNLABELLED,USING
12A,946,AKT,BAX,BCL,H1299,MCF,NITROSO,PREVIOUSLY
CRT,OCTOBER,V20
BACKGROUND,FIFTEEN,LABEL,PEMETREXED,PREVENTION
FORCE,PREVENTIVE
FGFR2
AGGRESSIVE,DISCOVERY,LABEL,MECHANISMS,MURUGAESU,ST6GALNAC2,SUMMARY
DISCOVERY,LABEL,MAX,MYC,SUMMARY,TAKEN
APRIL
044,100,EGGER,ERCC5,SCIENCE,WEB
ALZHEIMER,CHRONIC,RTI
160,169,183,GEORG,HOWEVER,NON,NSCLC,STAGE,STUTTGART,THERE
GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,THREE
ACTIVATING,CHINESE,DELETIONS,GLEASON,IHC,L858R,MUTATIONS,PCA,THERE
11Q13,29A,FINALLY,HOWEVER,HSP47,PCR,TAKEN,THEREFORE
LARGELY,TUMOURS,WORLD
AMNLM,ANATOMICAL,HOWEVER,NLM,PET,SNR
293,945,HEK,HIF,NEIL2,PCR,ROS,SECONDHAND,SHS,SSS,TAKEN,THESE
34A,H1299,MICRORNAS,NSCLC
185,276,BACKGROUND,CHROMOSOME,FURTHER,H1650GR,H1975,KPT,LABEL,METHODS,NOD,NSCLC,RESULTS,TKI
23S,CL1,FTSJ1,FTSJ2,FTSJ3,HOWEVER,NSCLC,RIBOSOMAL,TE671
001,135,231,352,BACKGROUND,LABEL,MARKERS,METHODS,MIF,MIGRATION,MPM,PROTEIN,RESULTS
120,200,BACKGROUND,CD8,CONCLUSION,FOXP3,HOWEVER,LABEL,METHODS,NOVEL,RESULTS,WHOLE
NSE,THEREFORE
EVEROLIMUS,ILD,RCC
141,169,330,773,877,APRIL,ASIAN,BIRTH,CONCLUSION,COPYRIGHT,HCV,HIV,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
177,227,705,946,BMJ,BRITISH,GROUP,HOWEVER,IFN,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,STATISTICS,THERE,USING,VITAL
169,372,475,602,639,719,AUR,COPYRIGHT,EXP,FOM,INC,KINGDOM,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SPECT
003,005,007,038,169,AUR,CONFIDENCE,COPYRIGHT,EYE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
100,136,169,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,FORTY,INC,INCIDENTAL,LABEL,LOW,MARCH,METHODS,MLNSS,NSCLC,PET,RESULTS,SEPTEMBER
102,117,BACKGROUND,BETWEEN,CONCLUSION,INC,LABEL,MARCH,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,TEN,UNIVERSITY
169,COPYRIGHT,LAN,PDA,PUBLISHED,THESE
183,750,ACTIVATING,AKT,BRAZILIAN,INTER,NSCLC,SCC,SOMATIC,TTF
169,192,CHANGES,CONSISTENT,COPYRIGHT,CXCL1,ELV,FEDERATION,ISOLATION,PUBLISHED,SOCIETIES,WESTERN,YET
166,992,AKT,BACKGROUND,LABEL,MAP,METHODS,NSCLC,RESULTS,SCC,THERE,THESE,TSC,TYR,UNASSIGNED,VIRTUAL
169,183,233,947,BCG,BRITISH,EFFECTIVE,IFN,IMMUNOLOGY,INDUCTION,LUC,PBS,REMARKABLY,S12,SOCIETY,TH1,THESE,TREATMENT
APPEARANCE,AUC,GGO,IDM,LABEL,METHODS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,TEXTURE,THREE
001,177,BASED,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,WHILE
CARLO,CTV,ECLIPSE,FINALLY,FURTHER,LABEL,MEDICAL,METHODS,MONTE,OAR,OBJECTIVE,PTV,PURPOSE,REGARDING,RESULTS,SWISS,SYSTEMS,V95
001,002,039,111,128,150,177,264,269,2SD,600,CI100,COMPARISON,DELTA,DOSIMETRIC,DUE,FFF,LABEL,METHODS,OBJECTIVE,PARAMETERS,PTV,PURPOSE,RESULTS,SCANDIDOS,THESE,UTILIZING,V12,V20,WHILE,X6FFF,YET
136,161,947,EIGHT,HOUNSFIELD,LABEL,METHODS,OBJECTIVE,OVERALL,PTV,PURPOSE,REGARDING,RESULTS,USING
177,FIRST,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS
063,069,092,107,BASED,BIMODAL,CTS,GEOMETRIC,LABEL,LEIBLER,METHODS,NOVEL,OBJECTIVE,PURPOSE,RESULTS
169,LTD,PUBLISHED,WILEY
BACKGROUND,BCG,CONCLUSION,HOWEVER,LABEL,METHODS
001,CD3,CD4,CXCR3,CXCR5,FURTHER,III,NSCLC,RESULTS,TFH,TH1,TH2
138,167,169,687,962,AMONG,LABEL,LTD,METHODS,MONOCLONAL,OBJECTIVE,RESULTS,WILEY
169,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,GTV,INCREASES,INITIAL,LABEL,METHODS,RESULTS,ROYAL,THERE,V95,ZEALAND
LOW,REFLECTING,SCREENING,TOMOGRAPHY,TRIAL
001,007,945,BACKGROUND,CRP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OSI,RESULTS,SERUM,TAC,TOL
BACKGROUND,CONCLUSION,DETAILS,LABEL,METHODS,PRIMARY,SECONDARY
001,007,021,045,046,048,967,980,AIM,BRCA1,CHINESE,CONCLUSION,ERCC1,ERCCL,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS
HOWEVER,IPF
III,NSCLC,SEVERAL
FGF,FINALLY,HOWEVER,III,NSCLC,THERE
BARCELONA,SOCIETY,SPAIN,VARIOUS
LAM,PIVOTAL,THESE,TSC
949,FURTHER,LSL,PLC,RAM,RAS,TAKEN
COA,FINALLY,K333Q,LARGE,SERUM,THESE
012,169,ASTN1,AUTHORS,HOX,LTD,NTM,PTK2B,SBC,SMALL,WILEY
277,AIM,APPRAISAL,BACKGROUND,DUE,FINALLY,LABEL,LIBRARY,MEDLINE,NSCLC,OBJECTIVE,PEMETREXED,PROGRAM,RESULTS,REVIEWS,SPAIN
001,002,152,203,245,413,CONCLUSION,DESPITE,III,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,PURPOSE,RESULTS
001,009,183,BACKGROUND,CLOSE,CONCLUSION,DFS,DISTANT,GEORG,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,STUTTGART
169,BACKGROUND,LABEL,METHODS,NNK,PRESS,PUBLISHED,RESULTS,SOCIETY,THREE,TOBACCO,UNIVERSITY
947,ABOUT,ADDITIONAL,CSF,CURRENT,DESPITE,GABAB,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE
462,715,ASIAN,CAUCASIAN,CIS,ORS,SCIENCE,THEREFORE,THESE,WEB
210,876,ARG,ARG194TRP,HENCE,HOWEVER,ORS,SEPTEMBER,TRP,XRCC1
280,420,CURRENT,FLEISCHNER,RADIATION,SCREENING,THESE,TRIAL
169,FGF19,HCC,HOWEVER,III,MEK,MET,MOLECULAR,NOVEL,RAS,REASONS,SORAFENIB,THESE
114,MORTALITY,THERE,UTERINE
BMI,CIS,COX,FOLLOWING,HOWEVER,HRS,LITHUANIAN,SMOKING
292,300,786,794,CTL,EF292,EF786,HLA,HNSCC,HODGKIN,IGG,KNOCKDOWN,NHL,PBMCS,THESE
ASM,ATLAS,DMR,FURTHER,USING
CHINESE
004,008,016,018,023,024,028,038,048,324,CONCLUSION,CXCR4,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,TNM
125,CTS,MAY,THEIR,THREE
125,169,177,AIM,AMONG,COLLEGE,CONCLUSION,COPYRIGHT,HCC,LABEL,LTD,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS,ROYAL,UNDER
001,169,AIM,CHI,CONCLUSION,COPYRIGHT,CTC,DIAGNOSTIC,LABEL,LTD,METHODS,NPV,OBJECTIVE,OVERALL,PPV,PUBLISHED,RESULTS
025,032,048,049,169,ALK,ANAPLASTIC,COPYRIGHT,LTD,SEVENTEEN,THYROID
169,300,BENZENE,CHRONIC,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SCHOLAR
COLLISION,GROSS,HISTOLOGIC
156,169,BRONCHIAL,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MAXIMUM,METHODS,OBJECTIVES,RESULTS,UNLABELLED
2009H,ANTITUMOR,AREAS,BACKGROUND,BPI,CHINA,CHINESE,CONMANA,COVERED,III,LABEL,METHODS,OPINION,PHASE,STATE
BACKGROUND,COMPETENCE,EARLY,FOCUS,HOWEVER,LABEL,METHODS,RESULTS
ADVERSE,APRIL,CONCLUSION,GRADE,JANUARY,KNOWLEDGE,LABEL,LANSCLC,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,SIB,TREATMENT
956,ADP,BCL,CDK,COSMOSPORA,LC3,MMP,TAKEN,VAD
174,99MTC,BACKGROUND,CEACAM5,CK7,DETECTION,LABEL,METASTATIC,METHODS,NANOCOL,NAVIGATOR,PLUNC,RESULTS
169,BCR,BRITAIN,COPYRIGHT,FGFR1,FGFR2,FGFR3,GREAT,IRELAND,LTD,PUBLISHED,SOCIETY,WILEY
CRC,HOWEVER,RECURRENCE
016,036,798,ANG,ATTENDING,LOG,NON,NSCLC,PCR,THESE
BACKGROUND,GENERALLY,LABEL,METHODS,MPE,MPTTS,RESULTS
CL1,WHILE,YOUNG
231,ASC,BACKGROUND,EMT,FAT,GFP,HOWEVER,LABEL,MDA,MMP,PRINCIPAL,RESULTS,RFP
DDP
500,CL1,MRC,SPR
487,ASIAN,BASED,CAUCASIAN,LDT,NSCLC,PCR,SAMPLES,TKI
203,206,505,658,832,BACKGROUND,DIFFERENT,LABEL,METHODS,POISSON,REGARDLESS,RENTING,RESULTS
001,055,513,AGE,AUDIT,BACKGROUND,CONCLUSION,ENGLAND,LABEL,METHODS,RESULTS,SINCE,THERE
177,BACKGROUND,FITNESS,HOWEVER,LABEL,METHODS,MYC,PCR,POISSON,RESULTS,REVERSE
001,040,041,BACKGROUND,CONCLUSION,FURTHER,HODGKIN,HOWEVER,LABEL,METHODS,ORS,RESULTS,SCIENCE,WEB
184,214,215,308,328,349,829,ASIAN,BACKGROUND,CHINA,CHINESE,DECREASING,LABEL,LOG,METHODS,NSCLC,PFS,RESULTS,WEIBULL,WTP
BACKGROUND,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TKI,USING
181,DEPENDING,NEURITE,RGD,SCLCS,SMALL
231,DECREASED,ECM,EMT,EPITHELIAL,HOWEVER,KNOCKDOWN,MDA,MET,THESE
ALZHEIMER,CANCERS,CENTRAL,CNS,COLORECTAL,NERVOUS,P53,PARKINSON,THERE,THESE,WNT
100,117,FORTY,OVERALL,THEREFORE
EXPRESSION,RAS,STRIKINGLY,THESE
183,946,DAP12,INSTEAD,NKP44,TGF

HODGKIN,PULMONARY
EBSTEIN,PULMONARY
003,017,177,206,258,BACKGROUND,LABEL,METHODS,RESULTS,THERE
1A1,BACKGROUND,CONCLUSION,CYTOCHROME,FINDING,LABEL,METHODS,RESULTS,SPECIMENS,THERE,THESE,TOBACCO
032,044,144,BACKGROUND,CONCLUSION,FIFTY,LABEL,MAI,METHODS,NON,OBJECTIVE,RESULTS,SEPTEMBER,THEREFORE,UNIVERSITY
177,CONCLUSION,HODGKIN,LABEL,METHODS,OBJECTIVE,RESULTS,TOTAL
215,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SECONDARY,SPECIALIST
125,128,253,376,500,AVAPERL,BACKGROUND,CONCLUSION,DISEASE,III,LABEL,METHODS,PFS,RESULTS
BECAUSE,PATHOLOGY
457,BACKGROUND,COX,FURTHER,LABEL,MEIER,METHODS,OVERALL,RESULTS,SPECIMENS
001,266,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,PROPENSITY,RESULTS,UNIVARIATE
105,109,127,169,LABEL,METHODS,NON,OBJECTIVE,OBJECTIVES,OPERATIVE,PRESS,PUBLISHED,RESULTS,SURGERY,THREE,UNIVERSITY
169,600,CADM1,CDH13,DESPITE,EPIGENETIC,FURTHER,HOWEVER,IL4,JAPAN,MEV,MOUSE,MTHFR,PRESS,PUBLISHED,RADIATION,SFRP1,SOCIETY,UNIVERSITY
169,BACKGROUND,GROUP,INC,LABEL,METHODS,PROCEDURE,RESULTS,TREATMENT,WHILE,WILEY,WILMS,WLI
169,GDP,HOWEVER,INHIBITION,RHO,RHOGDI2
014,076,160,250,500,AUC,BACKGROUND,DFS,EPIDERMAL,L858R,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER
001,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
125,169,183,300,327,ACUTE,BACKGROUND,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,USUAL
946,AIM,AKT,EGF,EMT,HOWEVER,PULLIAT,TGF,THEREFORE,VITIS
183,18F,CTS,FDG,GEORG,INTEGRATED,PET,STUTTGART,THEREFORE
183,GEORG,NSCLC,PULMONARY,STUTTGART,T1A
000,239,315,CHINA,CHRONIC,CIGARETTE,FINALLY,OTHER,ROS,YET
313,342,394,971,FGFR1,HLA,LLA,PEARSON
946,A549CELLS,ANIP973,ERK,HDLEC,JAM,LNM,NSCLC,OVERALL
181,946,954,EP1,HOWEVER,NSCLC,STATA,TARGETING,TREATMENT
BACKGROUND,CONCLUSION,ENHANCING,FIFTEEN,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,SIXTEEN
BECAUSE,ILD,SSC
125,E746_A750,EPIDERMAL,H1650,H1975,H3255,L858R,NSCLC,PHY,SPECT,T790M,THEREFORE,WESTERN
169,NSCLC,PROTEIN
HOWEVER,IMAGE,RFA
001,CD8,CONCLUSION,CRT,FOXP3,IIA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
HOWEVER,ROBOT,SINCE,VINCI
945,947,AEROBIC,PGC,WARBURG
130,AMD3100,ANOIKIS,CXCR4,HOWEVER,MFE,SDF,SKBR3
173,943,963,AFTER,AIM,AMONG,BACKGROUND,HUNGARY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,VOLUNTEERS
ADENOVIRUS,AUTOPSIES
MPM
169,AFTER,CAT,CL1,COPYRIGHT,HOWEVER,INC,ROS
116,169,18B,969,COPYRIGHT,EARLY,HCT,PC3,SAS,THESE
169,956,CHANGES,COPYRIGHT,HOWEVER,KOREA,LTD,WESTERN
169,BACKGROUND,BAX,BCL,CHINESE,CME,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MARSDENIA,MATERIALS,METHODS,MTT,MVD,PBMCS,RELEVANCE,RESULTS,THESE,TUNEL,WESTERN
169,BECAUSE,COA,COPYRIGHT,FTASE,GIVEN,HMG,HMGCR,INC,INITIALLY,MVA,RHO
160,169,AUTHORS,COPYRIGHT,HOWEVER,INC,METASTASIS,PUBLISHED,THESE,TNC,USING
169,946,COPYRIGHT,HBV,HBX,HCC,INC,LINE1,WNT
138,169,COPYRIGHT,EPIDERMAL,H1975,HOWEVER,INC,KNOCKDOWN,MICRORNAS,MIRNA,NSCLC,PC9,PC9GR,TKI
169,AKT,COPYRIGHT,FIRST,INC,JNK,NAC,ROS,SEVERAL,STAT3
160,169,COPYRIGHT,DOX,LTD,MEANWHILE,MSURVIVIN,PCL,PEI,THESE
169,COPYRIGHT,HOWEVER,IRELAND,LTD,NON,NSCLC,SURGERY
001,169,177,258,613,871,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THESE
001,169,217,425,642,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,NSCLC,PRIMARY,PUBLISHED,RESULTS,SOCIETY,SURGERY
169,COPYRIGHT,GERIATRIC,SAS
169,COPYRIGHT,INC
169,BACKGROUND,CONCLUSION,CONCURRENT,COPYRIGHT,IRELAND,LABEL,LTD,LYMPH,METHODS,NSCLC,PET,RESULTS,SUV,SUVPT,USING
169,BRAIN,COPYRIGHT,INC,L1CAM,PLASMIN
177,BACKGROUND,CRC,GYE,LABEL,LCR,MAY,METHODS,OCTOBER,OVERALL,PTV,RESULTS,TREATMENT,USING
025,100,169,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SECONDARY,SIR
100,169,177,AMONG,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THERE,TNABS
100,169,177,COPYRIGHT,GGO,INC,LABEL,LOCAL,MAJOR,MATERIALS,MAY,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SIR
00069,014,BACKGROUND,CAG,DXS1047,LABEL,LOH,METHODS,RESULTS,SEVENTY,TAIWANESE,XCI
250,500,AFTER,BACKGROUND,EBB,FOLLOWING,IIT,LABEL,METHODS,RESULTS,TEA,TRANEXAMIC,TRIAL
100,946,AKT,BACKGROUND,BASED,BUFALIN,CERTAIN,CONCLUSION,HCC,IHC,INHIBITION,LABEL,METHODS,ORTHOTOPIC,RESULTS,SIMILAR,THESE,TUNEL
100,162,199,308,361,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SCM,TOTAL
084,177,373,439,567,633,733,739,BACKGROUND,CHINA,EDUCATION,FIELD,LABEL,METHODS,OBJECTIVE,OIL,ORS,RESULTS,TIANJIN
BACKGROUND,EPIDERMAL,III,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,THEREFORE,TKI
123,154,183,954,956,AKT,BACKGROUND,BCL,CONCLUSION,DDP,FINALLY,LABEL,MDR,METHODS,MTS,OBJECTIVE,PCR,RESULTS,SNAIL,TWIST,WESTERN
177,BACKGROUND,BASED,CASPASE,CONCLUSION,COX,FAS,GFP,LABEL,METHODS,OBJECTIVE,PBS,RESULTS,SPC,THEIR,TUNEL
169,COPYRIGHT,ICD,INDIA,PUBLISHED,SOCIETY
169,AUSTRALIAN,COLLEGE,ROYAL,ZEALAND
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
FIRST,FOLLOWING
BACKGROUND,BASED,BRIEFLY,FDR,LABEL,RESULTS,SNP,SSCAD,THESE
001,005,008,020,027,031,062,098,103,114,169,170,183,252,405,618,709,726,824,946,AMONG,BRITISH,CYTOKINES,FURTHER,IMMUNOLOGY,LUMINEX,SOCIETY,THROMBOSIS,VTE
CPG,EPIGENETIC,THESE,WHILE
CONTROL,SERUM,STAGE
PEG
AFTER,EPP
1BB,950,CAR,CD3,OFF,THESE
115,181,BAK,BCL,BOERL,MCL,MRC,TRIHYDROXY,WESTERN,WRL
EUS,FNA,IASLC,NSCLC,PET,SOCIETY,THEREFORE,VIDEO
100,169,COPYRIGHT,GATA3,INC,WILEY
160,HOWEVER,III,NON,NSCLC,VEGFR
032,998,APRIL,FIFTEEN,INDUCTION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEPTEMBER
101,FACTORS,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SETTING,VARIABLES
174,BREATHING,BRIEF,CLASS,INDEX,LABEL,MEDICAL,METHODS,NSCLC,NURSING,OBJECTIVE,OBJECTIVES,PITTSBURGH,POTENTIAL,PROFILE,PURPOSE,QOL,QUALITY,RESULTS,SETTING,SLEEP,VARIABLES
CHALLENGES,DAILY,ENROLLMENT,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PATIENT,PURPOSE,RESULTS,SETTING,SYMPTOM,VARIABLES
169,BACKGROUND,COLORECTAL,FINAL,HOWEVER,IMPUTATION,INITIALLY,LABEL,LCS,METHODS,OVARIAN,RESULTS,SCREENING,SOCIETY,TRIAL
956,BESIDES,BLOOD,HOWEVER,STA,THESE,TTS
18F,BACKGROUND,FDG,LABEL,METHODS,NSCLC,PET,RESULTS
002,008,401,AGE,BACKGROUND,BLOOM,CONCLUSION,ELDERLY,LABEL,METHODS,RESULTS,RICHARDSON,THESE
AFTER,PRIOR
151,153,199,230,BACKGROUND,CONCLUSION,GPA,HIF,LABEL,LOW,METHODS,MVD,NSCLC,RESULTS
002,021,047,063,298,384,464,944,967,COX,DCR,KDR,MO19390,NSCLC,PCR,PFS,RAS,THEREFORE
136,BACKGROUND,COX,DFS,IL8,LABEL,METHODS,PCR,RESULTS
4T1,DISULFIRAM,DSF,METASTASIS,THESE
002,007,169,183,BACKGROUND,COPYRIGHT,COUNCIL,FUNDING,GROUP,INDIVIDUAL,JANUARY,LABEL,LTD,MEDICAL,METHODS,NSCLC,PUBLISHED,RECURRENCE,RESULTS,SECONDARY,THERE,TOXIC,UPDATED
169,233,COPYRIGHT,PARTIAL
108,139,141,169,180,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,USING
101,169,682,959,BACKGROUND,BETWEEN,COLLEGE,COPYRIGHT,FALSE,FDG,FINAL,GROUP,INC,LABEL,METHODS,NSCLC,PET,PUBLISHED,RESULTS,SOCIETY,Z4031
169,239,376,ASSESSMENT,CHEMO,CHINA,CHINESE,CLOUD,CONCLUSION,COPYRIGHT,FUNCTIONAL,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,QOL,REGRESSION,RELATIVELY,RESULTS,THERAPY
945,947,956,AFTER,AKT,BACKGROUND,CALCIUM,CELLS,EXPRESSION,JNK,LABEL,METHODS,NPS,PCR,PLC,RCC,RESULTS,WESTERN
169,ACTIVATING,AIM,CAUCASIAN,DELETIONS,G719X,L861Q,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,POLYMERASE,PTY,PUBLISHING,RESULTS,WILEY
003,020,042,048,182,335,945,BACKGROUND,CONCLUSION,IHC,ISH,LABEL,METHODS,MMP,NSCLC,RESULTS,SCC
511,570,EUROPEANS,HOUSING,MALIGNANT,MORTALITY,NUMBERS,POPULATION,WORLD
177,178,183,805,ASSESSMENT,CHINA,FEMALES,FUNCTIONAL,INVENTORY,LABEL,MDASI,METHODS,OBJECTIVE,QOL,RESULTS,SYMPTOM,THERAPY,THERE,THREE
123,ACL,DOX,HEPG2,MCF,MDR,MULTIDRUG,RHODAMINE,THESE,VERAPAMIL
VTE
OTHER,RANDOMIZED,RFA,SHORT
100,DIPNECH
169,239,CD4,CD8,DEREG,FOXP3,HOWEVER,INHIBITION,REMOVAL,THESE,TREGS
732,938,COMBINING,COX,E3N,HRS
169,CRP,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
104,169,600,900,EFFECTIVE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SECONDARY,SURGERY,UNIVERSITY
DDX58,EDM,EDMONSTON,IMPORTANCE,LABEL,MEASLES,NSCLC,OBJECTIVE,RIG,THESE,UNLABELLED
169,ADENOID,HOWEVER,INC,THEREFORE,WILEY
001,008,150,169,174,400,AUTHORS,COX,DIFFERENCE,EIGHT,GRADE,LTD,PFS,VERISTRAT,WILEY
169,205,600,FET,HOWEVER,LOD,MICRORNAS,VCH,WILEY
013,121,145,155,169,198,211,252,325,34A,362,430,502,583,610,678,801,822,870,926,BACKGROUND,CLASSICAL,INTEGRITY,LABEL,METHODS,RESULTS,RIN,SOCIETY,THEREFORE,UNDER
169,HENCE,INC,PULMONARY,WILEY
155,181,200,300,LABEL,METHODS,MORTALITY,NLR,OBJECTIVE,RDW,RESULTS
002,041,109,204,275,311,385,GROUP,NSCLC,SEVERAL,ZOLEDRONIC

AUSTRALIAN,CLINICIANS,CONCLUSION,CPG,FIFTY,GROUP,LABEL,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,SEVENTY
000,022,100,169,200,215,BECAUSE,CD4,FOXP3,HENCE,LABEL,METHODS,MRD,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN,TREGS,ULD
119,136,169,250,ALK,APART,BREAK,FDA,INC,KIT,MOLECULAR,NSCLC,ORR,PROBE,VYSIS,XALKORI
33258,945,AGS,ANNEXIN,BAX,BID,CASPASE,FAS,HOECHST,MMP,PFT,TANGERETIN,WESTERN
CDC20,CYTOSCAPE,DAVID,EXPRESSION,FINALLY,OMNIBUS,OVCAR,PCR,PPI,RAS,RASSF1A,STK
COX,ERK,HOWEVER,MEIER,MIG,MITOGEN,NSCLC
178,COX,GIVEN,IHC,III,MEIER,USING
ANCTS,CCK,ERK,FIRST,HOWEVER,IHC,LOX,LYSYL,MMP,SIMILARLY
946,AG490,EMT,EPITHELIAL,H1650,HOWEVER,JAK,PAI,SMAD3,SNAIL,STAT3,TGF
135,AKT,HOWEVER,IGF,IGFBP,USING
169,464,AMONG,BLC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,UNIVERSITY
304,585,587,CPG,THESE
ENGLISH,FURTHER,HOWEVER,MEDLINE,THERE
100,169,630,800HU,CONCLUSION,COPYRIGHT,FBP,IMR,IRELAND,LABEL,LTD,MATERIALS,METHODS,NOISE,OBJECTIVE,PURPOSE,RESULTS
FDG,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS
001,200,AMONG,ATS,BACKGROUND,BASED,CONTEXT,EPIDERMAL,ERS,HOWEVER,IASLC,L858R,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
259,355,614,ATLAS,BACKGROUND,LABEL,METHODS,NOTABLY,NSCLC,PCR,RESULTS
946,AKT,BACKGROUND,COMPLEX,COMPONENTS,EMT,GSK,H2009,IGF,INCREASED,LABEL,METHODS,NSCLC,PCR,RESULTS,SNAIL,THESE
169,588,BACKGROUND,BRITISH,CONCLUSION,K16,KEY,LABEL,LYS,METHODS,MOF,MOUSE,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SAMPLES,SOCIETY
000,100,ASR,BACKGROUND,CANCERS,CASABLANCA,CONCLUSION,FEW,HODGKIN,LABEL,METHODS,MOROCCO,RESULTS,STAGE,THESE,TUMOURS
056,100,CONCLUSION,III,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,THESE,UNIVERSITY
6TH,BACKGROUND,COX,CRUDE,LABEL,LOBECTOMY,METHODS,PROPENSITY,RESULTS,THREE,WEDGE
AFTER
APRIL,BACKGROUND,CONCLUSION,INCOMPLETE,LABEL,METHODS,RESULTS,SHORTER,THERE
BACKGROUND,CONCLUSION,IIB,JANUARY,LABEL,MAY,METHODS,NSCLC,RESULTS,SURGERY,THEIR
117,119,129,608,727,AGE,BACKGROUND,ELDERLY,JANUARY,LABEL,METHODS,RESULTS,SEPTEMBER,THOSE,WHILE
100,177,AIM,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS
169,PHYSICIANS,PRESS,PUBLISHED,THROUGH,UNIVERSITY
ERS,HMB,LAM,OVERALL,PRS,SMA,SPECIMENS,THEREFORE,THESE,TSC
231,453,ARV,ATT,CE3,CE9,EXPRESSION,GTT,HEPG2,ILE,LNCAP,MCF,MDA,SEQUENCING,VAL
739,CAUCASIAN,COMPARISON,HOWEVER,IIB,SMC
916,ONCOLYTIC,OVS,VSV
ATLAS,ATM,BRCA1,ERCC1,HRM,NEIL1,NSCLC,XPC
BACKGROUND,FINALLY,HOWEVER,LABEL,METHODS,RESULTS
946,BACKGROUND,CONSISTENT,EMT,EXPRESSION,FINALLY,LABEL,MET,METHODS,PCR,RESULTS,SMAD2,SMAD3,TGF,THESE,TREATMENT
ADDITIONAL,S214C,THESE,WHOLE
001,007,013,019,021,026,169,388,395,AMONG,BACKGROUND,CONCLUSION,COX,LABEL,LOW,METHODS,NSABP,PREDICTORS,RESULTS,THERE,WOMEN



TREATMENT
177,206,253,258,400,522,708,BACKGROUND,BETWEEN,III,LABEL,MEIER,METHODS,OPERATING,RESULTS,SEPTEMBER
100,155,158,173,216,246,365,489,7TH,BACKGROUND,IIA,IIB,LABEL,METHODS,PROGNOSTIC,RESULTS,TNM,VALIDATION
130,169,COPYRIGHT,ECO,EUCAN,EUREG,EUROCIM,EUROCOURSE,EXCELLENCE,INCIDENCE,LTD,MORTALITY,POPULATION,REGISTRIES,SCIENTIFIC
ADMISSION,CHEST,CONCLUSION,DEMOCRATIC,FURTHER,GERMANY,HISTORY,LABEL,LABORATORY,METHODS,RHEUMATOID,THESE,TREATMENT
169,COPYRIGHT,INFECTIONS,LOWER,PUBLISHED,SEPAR
2YL,549,CELLS,MTT,NIGELLA,NRU,NSE,NSO,THEREFORE
003,384,621,696,CONCLUSION,CRP,GLASGOW,GPS,INDEX,LABEL,LYMPHOCYTE,METHODS,NEUTROPHIL,NLR,OBJECTIVE,PLR,PNI,PROGNOSTIC,PURPOSE,RATIO,RESULTS,SCORE,UNIVARIATE
500,EXPRESSION,GROUP,HOWEVER,PAM,SIMILARLY
294,325,619,ACCORDING,CONCLUSION,DCR,DDP,III,LABEL,MATERIALS,METHODS,NDP,NSCLC,OBJECTIVE,ORR,RESULTS,THERE
102,304,BACKGROUND,EMERGENCY,LABEL,MATERIALS,METHODS,RESULTS,SOUTHWEST,STUDENT
00036,047,111,114,148,177,BACKGROUND,CONCERNING,GGO,LABEL,MATERIALS,MAXIMUM,METHODS,RESULTS,THERE
AA8,CHINESE,CYTOTOXIC,ETHANOLIC,MP1,MP2,MP3,MTT,PRO,TUNEL,WHILE
CTL,DCS,DENDRITIC,ELISA,LABEL,LVS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PCR,PERIPHERAL,RESULTS,TAA
CONVERSION,HCC,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPECIAL,THERE
945,947,948,954,ATM,B56,BACKGROUND,EXPRESSION,H1299,KU55933,LABEL,METHODS,PKA,RESULTS,TRANSIENT,TREATMENT
008,012,085,169,554,ATP,FINALLY,HSP,LABEL,NSCLC,THESE,TNF,TRAP1,UNLABELLED
1ST,2ND,3RD,4TH,5TH,809,BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS

011,043,250,255,379,632,725,970,ALK,AMONG,CCO,CONCLUSION,COSTING,COSTS,FUNDING,INITIATIVE,LABEL,METHODS,MOLECULAR,NETWORK,NSCLC,OBJECTIVE,ONTARIO,PROGRAM,PURPOSE,QALYS,RESULTS,TRANSITION,UNIVERSITY
BMJ,FINALLY,GROUP,LIMITED,MALIGNANT,MSC,PUBLISHED,PUBLISHING,TRAIL
ALTOGETHER,AMONG,NOD,NSG,PAM50,THESE,THREE,TME
494,945,COX,HIF1A,HOWEVER,HYPOXIA,NSCLC,RFS,THERE
001,116,H1299,HBE,NSCLC,TNM
AKT,BCL,H1299,HBE,NSCLC,SNF,SWI,TNM
114,HOWEVER,III,LABEL,LOCALLY,MASAOKA,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,SIXTY,SPARING,STAGE,THERE
169,AMONG,CLEAR,FORTY,HOWEVER,JANUARY,LABEL,LNS,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RECURRENT,RESULTS,SURGERY,UNIVERSITY
084,092,304,729,CAUCASIAN,EGGER,GSTP1,ILE105VAL,OVERALL,SCC,ULTIMATELY
181,CHRONIC,EPIRUBICIN,HBV,HOWEVER,NOTABLY
181,956,AGS,DHA,HOWEVER,J82,MES,MRC,UNDER
574,ERH
142,16S,177,316,441,508,787,920,935,ARSENIC,FIRMICUTES,GEMELLA,INDUCED,ION,MACHINE,METASTATS,MICROBIAL,NEISSERIA,PREVOTELLA,QIIME,TORRENT
169,COPYRIGHT,HOWEVER,LVI,LYMPH,LYMPHATIC,NSCLC,SAS
169,ALK,COPYRIGHT,RET,ROS,SAS,SINCE
169,COPYRIGHT,INCIDENCE,SAS,THESE,VTE
169,COPYRIGHT,SAS
169,COPYRIGHT,ONGOING,SAS
169,ANATOMY,COPYRIGHT,HOWEVER,INITIALLY,SAS,SINCE,TNM
001,002,005,126,169,177,564,669,733,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,SAS,THERE,UNLABELLED
169,COPYRIGHT,SAS
169,ALK,ATU,COPYRIGHT,FINALLY,PUBLISHED,RET,SAS,TODAY
169,COPYRIGHT,FVC,IDIOPATHIC,IPF,NON,PULMONARY,SAS,SEVERAL,UIP
169,COPYRIGHT,H3K9ME3,INC,PACLITAXEL,PTX,SUV39H1
169,ACADEMY,ALLERGY,COPYRIGHT,IGA,IGG,IGM,IMMUNOLOGY,INC,LIMITED,PUBLISHED
169,COPYRIGHT,HOWEVER,INC,NSCLC,ONGOING,OTHER,SALVAGE,SMALL
169,COPYRIGHT,CURRENTLY,EARLY,HOWEVER,III,INC
169,ALK,COPYRIGHT,INC,MET,NSCLC,PARTICULAR,RET,SEVERAL
169,COPYRIGHT,HOWEVER,INC,NSCLC,PFS,TARGETING
169,COPYRIGHT,INC,NON,NSCLC
169,ALK,COPYRIGHT,CURRENTLY,EPIDERMAL,INC,NSCLC,THERE,TKI
169,COPYRIGHT,INC,LOCALLY,NSCLC
169,COPYRIGHT,DESPITE,IIB,INC,NEWER,NSCLC
169,COPYRIGHT,INC,NSCLC,THESE,WHILE
INC,PET,PUBLISHED
169,1990S,945,946,COPYRIGHT,CYP19,ERS,INC
085,125,169,177,446,679,697,BACKGROUND,COPYRIGHT,GENERAL,INC,LABEL,MAJOR,METHODS,PUBLISHED,RESULTS,SCORE,SOCIETY
028,169,177,BACKGROUND,BOARD,CONCLUSION,COPYRIGHT,COX,DIAGNOSIS,HOWEVER,INCIDENTAL,LABEL,LTD,MATERIALS,MEIER,METHODS,PET,RESULTS,VTE
022,030,169,BASED,COX,HNSCC,MEIER,OVERALL
169,AEC,AFTER,BACKGROUND,BRASILEIRA,COPYRIGHT,CXR,EDITORA,ETT,EXCHANGING,ICU,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,SOCIEDADE
BACKGROUND,LABEL,METHODS,POLYGENIC,RESULTS
003,100,178,956,ARM,BACKGROUND,CSF,ELISPOT,LABEL,METHODS,NCI97C0141,PFS,RAS,RESULTS,THERE,TRIAL,WHILE
947,ASCITES,BACKGROUND,BINDING,CD3,CD8,DCS,HSP70,IFN,LABEL,METHODS,MTB,RESULTS
BACKGROUND,LABEL,ONCOGENIC,RESULTS,SYK,WGCNA
AMONG,BACKGROUND,DUE,LABEL,METHODS,RESULTS
AMONG,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS
EARLY,HMGA1,HNRPD,HOWEVER,NSCLC,SUV39H1,TFDP1
241,643,AMONG,DTX,EIGHT,HAMAMATSU,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SALVAGE,SIX,TRANSITORY,UNIVERSITY
004,102,143,162,173,276,CAMPANACCI,CHINA,DEPARTMENT,FIFTY,III,METASTASES,RECURRENCE,SICHUAN,THERE,THEREFORE,TREATMENT,UNIVERSITY
BACKGROUND,DISCUSSION,HENCE,KEEPING,LABEL,OBJECTIVE
CONCURRENT,HOWEVER
001,194,299,422,AFFYMETRIX,BACKGROUND,EARLIER,LABEL,LAPTM4B,METHODS,MIXED,NSCLC,ORDINAL,PROFILING,RESULTS,WHOLE
169,CHINESE,CHO,EGF,HEMOGLOBIN,KIRSTEN,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERIOUS,SILTUXIMAB,TEN
CEA,COX,HGF,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCATTER,SCC
BLOOD,COX,D4W,HOWEVER,NSCLC,PCR,TKI,TTP
ATG12,BORTEZOMIB,LC3,NSCLC
780,ASSESSMENT,CONCLUSION,FIFTY,FUNCTIONAL,III,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PHASE,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SYMPTOM,THERAPY,THERE,TREATMENT
ANCILLARY,EMPIRIC,FURTHER,TRICUSPID,TVE
095,150,186,237,288,3N0,4N0,542,900,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,NAC,NSCLC,PRIMARY,RESULTS
001,015,FACTORS,FLT,HOP92,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SKOV3,THD,THESE,THYMIDINE,TK1
003,5TH,AMONG,CONCLUSION,DEFINITIVE,FDG,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RCT,RESULTS,RTEP2
001,019,048,124,787,AMONG,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIX,TKI
150,CONCLUSION,FACTORS,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIXTY,THESE
169,2ND,CONFERENCE,CONSENSUS,MAY,MEDICAL,NSCLC,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
MALIGNANT
001,002,003,004,013,019,100,169,177,18F,GGO,IIA,IIB,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PRESS,PUBLISHED,RECURRENCE,RESULTS,SERUM,SURGERY,UNIVERSITY
A1C,BACKGROUND,FURTHER,LABEL,MCC,METHODS,NORTH,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,SECONDARY

18F,99MTC,AFTER,CHEST,FDG,MDP,MRI,PET
ACTIVATION,HOWEVER,RET
169,CHEST,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,SEVEN,THOSE,ULTRASOUND,UNIVERSITY
169,COPYRIGHT,SAS
169,BACKGROUND,CCS,CLEAR,COPYRIGHT,EIGHT,INSTITUTE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIXTEEN
169,297,2MM,314,3MM,4MM,5MM,8MM,AFTER,COPYRIGHT,CTV,IRELAND,ITV,LABEL,LARGE,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,USING,VOLUMES
169,5MM,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,002,10878,169,285,APR,BACKGROUND,BASED,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OPTIMAL,ORS,PURPOSE,RADIATION,RESULTS,UNIVARIATE
108,127,169,COPYRIGHT,FDG,IMAGING,INC,LABEL,METHODS,OBJECTIVE,PET,POSTMORTEM,RESULTS
169,193,209,COPYRIGHT,HOWEVER,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NINTH,OBJECTIVE,PREDICTORS,RESULTS,SAH
169,COPYRIGHT,INC
169,CAF,COPYRIGHT,EARLY,FAP,FOXF1,HOWEVER,LTD,PDGFR,SEVERAL,SIMILARLY,SPARC,THESE,USING
000,169,215,368,736,BLOOD,BONFERRONI,COPYRIGHT,DBP,H19,HLA,INC,MAP,NFAT5,NUCB2,PDE1A,PUBLISHED,SBP,SOCIETY,VCL
103,169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,GAL,HOWEVER,III,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,STAGE
169,ADDITIONAL,BACKGROUND,COPYRIGHT,INC,LABEL,MATERIALS,MEDLINE,METHODS,NSCLC,RESULTS,SIXTY,THYROID
169,CARCINOMA,COPYRIGHT,EXTRALOBAR,IRELAND,LTD,MALIGNANCY,WHILE
169,COPYRIGHT,IRELAND,LTD
169,1980S,AGE,AGGREGATED,AMONG,APART,APC,CHINESE,CONCLUSION,COPYRIGHT,INDIANS,IRELAND,LABEL,LTD,MALAY,METHODS,OBJECTIVE,OBJECTIVES,POISSON,RESULTS,SINGAPORE,THERE,WHILE
102,140,144,150,169,284,AFTER,BACKGROUND,BETWEEN,CHARLSONS,CONCLUSION,COPYRIGHT,ERLOTINIB,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,PFS,PRIMARY,RESULTS,SCS,SECONDARY,TARGETING
003,169,1CM,916,CON,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,AKT,CELLS,COPYRIGHT,INC,MOLECULAR,SANIDAS
160,169,CHEST,COPYRIGHT,FURTHER,INC,PUBLISHED,THREE,TROUSSEAU
169,ADVERSE,AES,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,GROUP,INC,LABEL,M30,METHODS,NSCLC,PFS,PRIMARY,RESULTS,SECONDARY,TRAIL
001,169,701,AGE,BACKGROUND,COLLEGE,COPYRIGHT,COX,END,INC,INCREASING,LABEL,METHODS,OVERALL,PUBLISHED,RESULTS,SHORT
001,100,169,COPYRIGHT,EXACT,EXPRESSION,H69,H69AR,HOX,HOXA1,INHIBITION,LOW,LTD,LUCIFERASE,MEIER,MICRORNAS,PCR,SEVERAL,UTR
169,183,228,233,393,461,ASSESSMENT,BACKGROUND,CARES,CHRONIC,COPYRIGHT,DEC,END,EVALUATION,FACIT,FAMCARE,FEB,FUNCTIONAL,FUNDING,GROUP,ILLNESS,LABEL,LTD,MEDICAL,METHODS,MIS,ONTARIO,P16,QUALITY,RESULTS,SECONDARY,SOCIETY,SPIRITUAL,SYMPTOM,THERAPY,TORONTO
AMONG,COX,FEW,INSURANCE,LABEL,METHODS,NHI,OBJECTIVE,OBJECTIVES,RESULTS,TAIWANESE
103,118,273,AMONG,BACKGROUND,CEA,CHEST,GGO,INCIDENCE,JANUARY,LABEL,METHODS,RESULTS,T1A,T1AN0M0,THERE
174,AREAS,BACKGROUND,COVERED,CREMOPHOR,III,LABEL,MBC,MEDICINES,METHODS,NSCLC,OPINION,PHASE
002,ALBUMIN,ASSESSMENT,CONCLUSION,COPYRIGHT,CRP,EDICIONES,INDEX,INI,LABEL,MAY,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SGA,STATA,SUBJECTIVE
078,090,137,349,355,381,614,ASIAN,BACKGROUND,CIS,FAS,HOWEVER,LABEL,METHODS,ORS,RESULTS,SCIENCE,SIMILARLY,STATA,WEB
H1299,LIMITED,MTS,THESE,TREATMENT
001,ADC,DWMRI,MRI,SEVERAL
142,169,946,FASEB,HOWEVER,NSCLC,SMAD3,TGF,THESE,UTR
110,177,304,414,AFTER,BACKGROUND,CHI,FACTORS,III,LABEL,METHODS,RESULTS
021,113,308,623,CDA,CONCLUSION,HOWEVER,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
99MTC,ASC,FSC,FURTHER,LABEL,LYMPH,MBQ,METHODS,NSCLC,OBJECTIVE,RESULTS,SPECT,THERE
001,013,027,196,517,946,AFTER,CRT,ELISA,FIFTY,HOWEVER,NSCLC,SERUM,TGF,THERE
COLONIC,DEPENDING,METASTATIC
BREATHING,EUCLIDEAN,EVENTUALLY,INCREASING,LOG,MRI,THESE
108,154,177,BACKGROUND,BAE,BRONCHIAL,CHINESE,GENERAL,IMMEDIATE,JANUARY,LABEL,LIBERATION,METHODS,RESULTS
ACTIVATION,AKT,ALK,H3122CR,PF02341066
169,BACKGROUND,BASEL,BDU,LABEL,MEIER,METHODS,MIR,MTT,NSCLC,PCR,RESULTS,USP14,WESTERN
ATS,ERS,HISTOLOGIC,IASLC,LABEL,METHODS,OBJECTIVE,RESULTS,SAS,SOCIETY,THEREFORE
ADENOVIRUS,BACKGROUND,CONCLUSION,DISCOIDIN,EMT,HNSCC,METHODS,PCR,RESULTS,RTK
246,CONCLUSION,EIGHT,FDG,JANUARY,LABEL,METHODS,PET,RESULTS,SEVENTEEN,TEN,UNLABELLED
169,BACKGROUND,BASEL,CONCLUSION,EIA,H23,LABEL,METHODS,MTS,NCI,OBJECTIVE,PCR,RESULTS,THEREFORE,THESE
169,BACKGROUND,CONCLUSION,COPYRIGHT,HNSCC,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METASTATIC,METHODS,PUBLISHED,RESULTS,SABRT,SURGERY
151,169,CONVERSELY,COPYRIGHT,CYS,HOWEVER,INC,KEAP1
000,001,005,015,023,033,034,036,048,060,069,081,087,089,103,106,113,128,130,152,160,166,185,186,196,199,233,242,245,252,265,292,313,316,370,378,388,544,549,CAUCASIANS,EGGER,ERCC2,FINALLY,LYS751GLN,THESE
001,003,007,021,039,046,099,164,169,199,296,570,670,COPYRIGHT,EPC,IAP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PPC,PUBLISHED,RCC,RESULTS,SMC,TIANJIN
946,B16F1,BACKGROUND,DIFFERENT,LABEL,METHODS,PKA,RESULTS,SUNITINIB
639,ALA,ANORG,ATR,CH1,CL5,COMPOUNDS,ESI,GLY,NMR,PRO,RUCL3,SER,SW480,THR,TYR,VAL
100,472,CONCLUSION,GGN,LABEL,OBJECTIVE
11C,18F,CONCLUSION,CURRENTLY,FDG,INCIDENTAL,LABEL,OBJECTIVE,PET
CONCLUSION,LABEL,MRI,OBJECTIVE
001,100,157,177,BLAND,CONCLUSION,FORTY,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,SMALL
CONCLUSION,HOWEVER,LABEL,OBJECTIVE,SCREENING,TRIAL
CLINICIANS,CONCLUSION,LABEL,MRI,OBJECTIVE
AFFAIRS,BECAUSE,CONCLUSION,FDG,FIFTY,LABEL,LOW,MATERIALS,METHODS,NET,OBJECTIVE,OUTCOME,PET,RESULTS
100,954,CONCLUSION,LABEL,MCNEMAR,METHODS,MRA,NSCLC,OBJECTIVE,PULMONARY,RESULTS
1990S,239,ACCOUNT,PIONEERING,SINCE,TECHNICAL,THESE
AES,BACKGROUND,CONCLUSION,CONTEXT,INJECTION,LABEL,METHODS,OBJECTIVE,RESULTS
13C,205,ALPINIA,COMPOUNDS,DCM,NCI,NMR,SHARPLESS
169,322,BECAUSE,HOWEVER,HSP,HSP70,HSP90,LABEL,UNLABELLED
NFKB2,R175H,R273H
169,GUIDELINES,HOWEVER,INC,THESE,WILEY,WORLD
169,183,AIT,GEORG,HOWEVER,MATRINE,NPC,OVERALL,SOPHORA,STUTTGART,THEREFORE
001,005,012,018,030,043,114,132,406,482,499,613,704,811,995,COX,DESPITE,JANUARY,LDH,MEIER,NLR,NSE,THESE
111IN,139,177,237,285,374,381,423,513,522,BACKGROUND,CONCLUSION,DOTATOC,ENETS,FIRST,IMAGING,IQR,LABEL,METHODS,NEN,OVERALL,PET,RESULTS,SRS,SWISS
ADVERSE,GRADE,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VERSION
003,004,006,026,041,045,2R3RG,2R6,3RG,ACCORDING,NSCLC,PORTUGUESE,SNP

34B,34C,34S,5MM,LUC,MPM,NCI,PBS
169,206,210,BIOMEDICAL,BOARD,CDC,CHINA,CONCLUSION,COPYRIGHT,EDITORIAL,LABEL,METHODS,NNK,OBJECTIVE,PCR,PUBLISHED,RESULTS
117,169,427,909,ACADEMY,ADC,BIOMEDICAL,BOARD,CDC,CHINA,CHINESE,CONCLUSION,COPYRIGHT,EDITORIAL,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCC,SMOKE
945,956,ANEMONE,ESIMS,HEPG2,NMR,THEIR
1910S,1940S,1960S,1970S,1990S,BOWEN,RESIDENTS,SEVERAL,THERE
181,NOTABLY,SNP,UTR,WHILE
558,607,GTPASES,H1703,NCI,NSCLC,ONCOGENIC,RAS,RHO,SILENCING,THESE
169,231,646,979,ALK,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,UNIVERSITY,V600E
947,ADULT,C57BL,HOWEVER,IFN,PTERIDIUM,TAKEN
HOWEVER,SPERMINES,THEREFORE,THESE
AKT,ARF,BMI,INK4A,MLV,SPC,THESE
BACKGROUND,HOWEVER,LABEL,METHODS,NON,RESULTS
248,523,545,BACKGROUND,BRONI,CAUSE,ITALIAN,ITALY,LABEL,LAW,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PAVIA,RESULTS,SIMILARLY,SIN,SMR,THESE
100,239,610,BACKGROUND,COX,GGO,LABEL,METHODS,PET,RESULTS,RFS,T1A,T1B,THERE
005,006,007,009,017,CBP,COX,DFS,LABEL,METHODS,MLL,OBJECTIVE,PURPOSE,RESULTS
34A,HCC,HOWEVER,MAXIMAL,NSCLC,SYNERGY,TKI,USING
001,061,237,272,CONCLUSION,LABEL,METHODS,MINIMAL,NSCLC,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,THEREFORE
945,946,954,ELK,ETR,ETS,FINALLY
000,AKT,EGF,HOWEVER,JUN,NSCLC,ONCOGENIC,RAF,THESE,V600E
100,169,696,716,AFTER,COPYRIGHT,DIFFERENT,INC,WILEY
169,503,946,ECTOPIC,IKK,NSCLC,TAKEN
BACKGROUND,BMJ,CIS,FURTHER,GROUP,LABEL,LIMITED,METHODS,MOLECULAR,PUBLISHED,PUBLISHING,RESULTS,THESE,USING
111,236,289,435,661,D03,ERBB2,G03,LABEL,MDA,METHODS,NON,OBJECTIVE,PHAGE,PROCEDURES,PURPOSE,RESULTS,SPECT
415,AFTER,EGYPT,LABEL,METHODS,OBJECTIVE,RESULTS,SHS,SMOKE,THESE
001,AKT,EPIDERMAL,ERBB3,ERK,HOWEVER,PCR,PEM,STAT3
946,ABCG2,ATP,CD133,CSC,FINALLY,NOTCH,WNT
BCL,COX,CXB,ERK,MEK,NSCLC,SOR,TAKEN,VEGFR
100,127,160,956,DOCKING,INDIA,KLEBSIELLA,MARAPALAM,SALMONELLA
BLADDER
113,ACTIVATION,CONCLUSION,COX,DFS,EFFECTS,EXPRESSION,H1299,H1975,JANUARY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SPC,XIANGYA
183,20S,231,947,956,FURTHER,H2O,HK1,HONE1,HOWEVER,MDA,NALMAWA,NCI60,NO3,NPC,PC9,ROS,SKOV3,SW480,THESE
ASSESSMENT,C30,EORTC,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,QLQ,QUALITY,RESULTS
CONCLUSION,FDG,LABEL,METHODS,PEARSON,PET,REGARDLESS,RESULTS,SUV,TEXTURE,THREE,TLG,UNLABELLED,YET
9AC,CDK,CDK4I,CDKIS,CPT,HOCPT,MODULATION,NCI,PD0332991,SCLC26A,TPT,WHEREAS
001,136,499,514,879,906,929,AUC,III,LOW,NSCLC,SERUM,VALIDATION
189,340,LABEL,METHODS,POISSON,RESULTS,SIR,UNLABELLED
001,002,100,144,169,235,367,544,916,ATG,BLOOD,CAMBRIDGE,CASES,CHANGES,COPYRIGHT,GENZYME,INC,INSTITUTES,IQR,PUBLISHED,SCT,SOCIETY,SPIROMETRY,TRANSPLANT,TREATMENT
AKT,APOPTOTIC,BACKGROUND,BCL,HOWEVER,LABEL,METHODS,RESULTS
149,158,169,227,COMMISSION,COMPARING,ITALIAN,SEPTEMBER
10878,163,169,ALK,BACKGROUND,CEA,COPYRIGHT,KIRSTEN,LABEL,LTD,MATERIALS,METHODS,PROGRAMMED,RESULTS,RFS,THERE,TUMOURS
AIRWAYS,BACKGROUND,CONCLUSION,GIVEN,ITALY,LABEL,METHODS,RESULTS
000,001,021,057,108,136,147,177,238,302,344,545,768,811,928,967,997,AFFILIATED,DEPARTMENT,DNMT1,ELISA,FIRST,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIXTH,UNIVERSITY,ZHENGZHOU
028,035,152,169,17A,17F,239,258,7488G,CHAIN,COPYRIGHT,HOWEVER,LTD,PCR,POLYMERASE
000,019,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SYK,TRANSFERED
001,002,005,112,210,LABEL,METHODS,OBJECTIVE,RESULTS,UNC
000,006,169,215,767,BACKGROUND,BED,BED10,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMALLER
3DCRT,BACKGROUND,CONVERSELY,EARLY,HODGKIN,LABEL,LAR,METHODS,PTV,RESULTS
006,303,RATIO
359,412,ACUTE,BACKGROUND,CCI,EARLY,INDEX,INSURANCE,LABEL,METHODS,NHI,NONCANCER,RESULTS,SEPTEMBER,UNLABELLED
CBD,KDS,PAH,POLYCYCLIC,PREVIOUSLY,SEPARATELY
167,252,294,384,549,THP
000,169,DANGEROUS,DISCUSSION,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHN,RADON,RESULTS,WILEY
384,AKT,AXL,H1299,MER,NCI,TAM,THESE,TYSO3,USING
18F,BASED,FDG,OTHER,PET
004,169,370,401,CIS,COLORECTAL,DIETARY,HOWEVER,OVARIAN,PRESS,PUBLISHED,SCREENING,SEVERAL,TRIAL,UNIVERSITY
III,MPM,SURGERY
AIM,CONCLUSION,CSF,LABEL,METHODS,MRI,OBJECTIVE,OTHER,RESULTS,SERUM
001,330,680,CAUCASIAN,CAUCASIANS,CIS,CLPTM1L,HOWEVER,ORS,OVERALL,SUMMARY,TEN
00001,002,004,464,869,CAUCASIANS,CHINA,CIS,DATABASES,KNOWLEDGE,ORS,OVERALL,WANFANG
169,BACKGROUND,BILIARY,DEFINITIVE,ENDOSCOPIC,EUS,FNA,LABEL,METHODS,PANCREATIC,RESULTS,SOCIETY,SPN,SURGERY
027,030,239,COX,NSCLC,SEVERAL,SLC29A3,SULT1E1,THREE
130,A22,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,NMC,NODAL,NSCLC,OBJECTIVE,PET,RESULTS,SUV,VIDEO
001,143,530,825,APRIL,CONCLUSION,FRANKEL,HOWEVER,KARNORFSKY,LABEL,METHODS,OBJECTIVE,RESULTS
487,945,CA2,DAG,IL3,IP3,MYB,PKC,PLC,PROGNOSCAN
AML,AUSTRALIAN,COX,HCT,HODGKIN,INDEX,POPULATION,RECIPIENT,RECIPIENTS,SCT,SIR,TRANSPLANT
954,BAY11,CONVERSELY,GFP,LC3,VAD
145,AKT,EPIDERMAL,STAT3,THESE
AFFILIATED,AMONG,DEPARTMENT,JANUARY,PRPFS,SIXTH,SRS
133,18272,18279,183,INCREASED,NADPH,OVERALL,ROS,SOC,SOD,TREATMENT,WEEKLEY
NOVEL
BASED,CXC,MC3T3,RESULTS
000,169,180,556,COPYRIGHT,EPITHOR,INC,JANUARY,LABEL,LOW,METHODS,MODEL,MOSBY,MULTILEVEL,OBJECTIVE,PUBLISHED,RESULTS,SINCE,SURGERY
001,066,117,169,194,230,665,872,BACKGROUND,COLLEGE,COPYRIGHT,GROUP,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE
001,169,850,884,AMONG,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,DIRECTORS,FRAILTY,FRIED,INC,LABEL,MEDICAL,METHODS,OLDER,PUBLISHED,RATES,RESULTS,WOMEN
169,225,BACKGROUND,COPYRIGHT,DFS,FIFTEEN,JANUARY,LABEL,LRACC,LTD,METHODS,MVR,NEO,RESULTS,SECONDARY,SHORT
000,146,468,661,ACADEMY,AMONG,CHINESE,COLLEGE,INSTITUTE,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,TKI,UNION
026,177,478,BACKGROUND,CHEST,LABEL,METHODS,PULMONARY,RECORDS,RESULTS,THREE
101,528,BACKGROUND,CONCLUSION,FALSE,INTEGRATED,LABEL,LYMPH,METHODS,NODAL,NSCLC,PET,RESULTS
144,169,285,COPYRIGHT,IRB,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,VARIABLES
BECAUSE,COMPELLING,HRQOL,SMOKING
169,AE105,CONCLUSION,COPYRIGHT,FAVORABLE,INC,LABEL,MBQ,METHODS,PET,RELATIVELY,RESULTS,UNLABELLED,VOI
001,003,004,022,033,141,99M,CONCLUSION,HCC,LABEL,LSF,MAA,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BESIDES,CDK,ERK,H1299,HOWEVER,MEANWHILE,THEREFORE,TREATMENTS
945,BACKGROUND,FLOTILLIN,LABEL,METHODS,NSCLC,PCR,RESULTS,STS,WESTERN
916,AFTER,ALI,EXPRESSION,HOWEVER,KNOCKDOWN
001,004,024,043,108,463,945,AKT,ALK,AMONG,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,ONCOGENIC,PURPOSE,RESULTS
00001,BACKGROUND,ERLOTINIB,HOWEVER,III,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS,SEVERAL,TREND
34A,HOWEVER,TAKEN,UTR
150,NON,NSCLC
169,ACH,CHOLINE,COPYRIGHT,LTD,MRS,PCR,PET,SLC44,USING,WILEY
169,177,CHEST,DESPITE,INC,PRIMARY,THERE,WILEY
001,004,011,241,428,494,APRIL,DFS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PLC,RESULTS
FURTHER,INITIAL,MRI,SUBSEQUENT
169,ERK,FURTHER,HISTONE,INC,KAZAL,MMP,REVERSION,SP1,TAKEN,WILEY
197,212,LABEL,LOCALLY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
205,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
001,150,BACKGROUND,CDT,COLLEGE,CONCLUSION,FOB,IHC,INADEQUATE,INDIA,LABEL,LATUR,MEDICAL,METHODS,MIMSR,MINOR,OTHER,PATHOLOGY,RESULTS,SEPTEMBER,TOTAL,VARIOUS,YIELD
FANCONI,ML323,PROTEIN,USING
BASED,COLORECTAL,ERSPC,OVARIAN,RANDOMIZED,SCREENING
COLON,DETAILS,ERSPC,HOWEVER,OVARY,PSA,RANDOMIZED,SCREENING,USA
000,1990S,COLORECTAL,DRE,OVARIAN,PSA,SCREENING,TRIAL
004,012,153,212,HOWEVER,MEIER,NSCLC,PCR,RESULTS,WESTERN
CAR,CME,DESPITE,LABEL,METHODS,OBJECTIVE,PURPOSE,QID,RETINAL,SINCE
004,006,012,018,021,600,CARCINOMAS,REDUCTION,REMARKABLY,TRP53,TUMOURS
169,COPYRIGHT,H1299,INC,NCI,RV1
174,960,CAREFUL,CLINICALLY,ERK,GTP,THERE,V600E
100,169,257,393,956,BASED,COPYRIGHT,DOCKING,EVALUATION,INSTITUTE,NCI,OVARIAN,RENAL,RXF,SAS
792,956,AFTER,ARIZONA,BACKGROUND,CADMIUM,HEART,HRS,INDIANS,LABEL,LOW,METHODS,NORTH,OBJECTIVE,RESULTS,SOUTH
ADC,LINEAGE,LOX,NOTABLY,SCC
001,19B,223,ABERRANTLY,NSCLC,PCR,SERUM,THESE,THREE,TNM
131,169,210,215,260,471,BLOOD,COPYRIGHT,HODGKIN,INC,NHL,PUBLISHED,SOCIETY
169,252,947,BCG,BESIDES,CD4,CD8,COPYRIGHT,IFN,INC,MTB,PPE68,PUBLISHED,SOCIETY,TH1
169,946,COPYRIGHT,INHIBITION,MMP,MUTATIONS,PUBLISHED,S2A,SER1038,SER2039
169,956,ANTICANCER,COPYRIGHT,EVALUATION,GI50NCI,H322M,NSC,SAS
169,181,COMBINING,COPYRIGHT,H1703,HOWEVER,HSP90,INC,MKK6E,NSCLC
169,945,946,ANGIOSTAMP,BASED,COPYRIGHT,INC,MRI,NIR
169,956,ANTICANCER,COPYRIGHT,NON,THESE,WST
034,169,AMR,AUTHORS,BETWEEN,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,ORR,PFS,PUBLISHED,RESULTS
169,BACKGROUND,BLACK,CONCLUSION,CONTROLLED,COPYRIGHT,DOWNS,HOWEVER,LABEL,LTD,MEDLINE,METHODS,NCSLC,NON,NSCLC,OBJECTIVE,PSYCHINFO,PURPOSE,RANDOMISED,RCT,REGARDING,RESULTS,SMALL,SURGERY
169,780,COPYRIGHT,CURRENT,LEWIS,LTD,NIR
169,956,ADP,BASED,BK10040,COPYRIGHT,LTD,MTT,VAD
169,CHEST,COPYRIGHT,LTD,METASTATIC,MPC,THREE
001,160,169,531,COPYRIGHT,FURTHER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,OPERATIVE,OVERALL,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,SURGERY
019,169,201,916,CCC,COPYRIGHT,D99GITV,HOWEVER,INC,LABEL,LOCAL,MATERIALS,METHODS,NOVALIS,OBJECTIVE,PTV,PURPOSE,RESULTS,THERE,TPS,TREATMENT,V90GITV
104,10L,10R,112,169,173,250,3N2,COPYRIGHT,CTV,INC,LABEL,LRF,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,169,177,AUTHORS,BECAUSE,COPYRIGHT,CRT,D99,IDEAL,III,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS
010,020,169,177,189,1ST,201,321,528,645,674,COPYRIGHT,INCIDENCE,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SRE
106,121,122,169,177,193,196,222,227,321,COPYRIGHT,CYBERKNIFE,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SIR,SOCIETY,TECHNICAL
169,BOERHAAVE,COPYRIGHT,EPF,FISTULA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PLACEMENT,PUBLISHED,PURPOSE,RESULTS,SIR,STENT,TECHNICAL
169,946,ACTIVATION,COPYRIGHT,ECM,HOWEVER,IDIOPATHIC,INCREASED,IPF,LTD,SMAD2,TGF,UIP,WHWTS
169,COPYRIGHT,INC
169,200,241,400,BACKGROUND,COPYRIGHT,DEPARTMENT,LABEL,METHODS,OBJECTIVE,PNEUMOLOGY,RESULTS,SALAMANCA,UNIVERSITY
000,100,BACKGROUND,CONCLUSION,DRUGS,FVC,IDIOPATHIC,IPF,LABEL,METHODS,RESULTS,SELECTIVE,UIP
215,258,377,391,427,464,509,511,515,554,593,606,622,685,686,688,694,696,700,706,741,752,781,836,856,967,AMONG,CHI,COLLEGE,CONCLUSION,CONTROL,CONVENTION,CURRENT,FACTORS,FRAMEWORK,GUANGDONG,GUANGZHOU,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,TOBACCO
160,169,916,COPYRIGHT,III,INC,PA7,PROTEOMIC,VIRULENCE
ADC,BACKGROUND,CONCLUSION,IFP,LABEL,LOW,METASTATIC,METHODS,MRI,RESULTS,THERE
169,ARONJ,COPYRIGHT,ENGLISH,INC,MOSBY,PUBLISHED,THERE
001,122,159,686,BACKGROUND,CCA,DMEAN,FORTY,GRADE,GROUP,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,RADIATION,RESULTS,SEVENTY,THERAPY,UNIVARIATE,V20,V30,V40,V50,V60
100,160,177,BACKGROUND,CONCLUSION,LABEL,METHODS,NON,NSCLC,PARP3,PCR,RESULTS,SMALL,TELOMERASE,WESTERN
493,BACKGROUND,CONCLUSION,CONTEXT,LABEL,METHODS,MMP40,OBJECTIVE,OBJECTIVES,RESULTS,RPP40
160,169,183,901,FINLAND,HODGKIN,LTD,NHL,POISSON,RRS,WILEY
001,004,027,029,133,BETWEEN,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BAX,BCL,COX,WESTERN
000,001,173,ANTITUMOR,BACKGROUND,EASTERN,GROUP,JANUARY,LABEL,METHODS,PATIENT,RESULTS,SOLID
AKT,BACKGROUND,BCL,LABEL,MATERIALS,METHODS,MV4,RESULTS,THERE,THESE,WESTERN
LDR,MDR,SEARO
412,AIM,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
000,100,177,206,AGE,AMONG,APC,ASR,BACKGROUND,CONTINUING,EDUCATION,LABEL,MATERIALS,MEDICAL,METHODS,MOSUL,POISSON,REGISTY,RESULTS,SCC,SINCE
593,652,716,726,740,780,787,812,838,858,872,884,888,923,974,AFP,AUC,CA125,CA153,CA199,CEA,HENCE,KRUSKAL,THERE,WHITNEY
107,AIM,BACKGROUND,GROUP,GUIDELINES,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,STUDENT,TURKISH
545,AMONG,CHINESE,MPM,THERE
001,002,072,151,ASIAN,BACKGROUND,LABEL,MALAYSIAN,MATERIALS,METHODS,MUTATIONS,NEVER,NSCLC,RESULTS
011,038,194,ADJUSTMENT,CHECKLIST,CHINA,CHINESE,CIGARETTE,LABEL,MAC,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROTTERDAM,SICHUAN,SMOKERS,SMOKING,SYMPTOM
000,120,839,BACKGROUND,CONCLUSION,LABEL,METHODS,MODERATELY,MVD,NSCLC,OBJECTIVE,OPN,RESULTS,WHILE
100,946,CAM,IHC,LOW,MUC18,NPC,PCR,TGF,THESE
ERLOTINIB,NSCLC,TKI
11E,15E,191,69E,71E,79E,COX,INFLUENCE,LONELINESS,MEIER
100,177,365,6TH,7TH,AVERAGE,BACKGROUND,LABEL,MATERIALS,METHODS,NEPAL,OCTOBER,RESECTION,RESULTS,SEVENTY,SURGERY,THERE,THOSE,THREE
956,AKT,C57BL,ERK,FAK,JNK,MAPKS,THESE,WESTERN
155,CD133,CD338,EXPRESSION,HSA,NSCLC
2YEAR,ACCORDING,BACKGROUND,EASTERN,FORTY,GROUP,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,PATIENT,RESULTS,SCC,TURKISH
001,006,177,200X109,COX,EXPRESSION,GAPDH,III,JANUARY,MEIER,MOUSE,NSCLC,SPC,TNM,USING
008,034,377,CHINESE,GWASS,HAN,HENCE,HOWEVER
000,073,100,159,200,210,238,270,681,939,977,AMONG,CLL,COX,MOUND,OTHER,RUSSIAN,SMR,THERE,VITAL
113,451,559,AFTER,APRIL,CONCLUSION,JAPAN,KIRSTEN,LABEL,METHODS,OBJECTIVE,RESULTS
ACUTE,CTEPH,HOWEVER,LABEL,MEDICAL,OBJECTIVE,RESULTS,SEVERAL
160,3M0,4N0,754,814,BACKGROUND,CONCLUSION,FDG,GASTRIC,GROUP,ITALIAN,LABEL,METHODS,PET,RESULTS
177,428,478,557,577,954,BACKGROUND,INITIATIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,REFINED,RESULTS,THERE,WHEREAS,WHI,WOMEN
737,ABT,BCL,BH3,MCL,MUTATIONS,RESULTS
17I,COLO320DM,EPCAM,HOWEVER,PCI
947,ANTIGEN,CD4,CD8,CONCLUSION,CTL,DCS,DENDRITIC,ELISA,ELISPOT,IFN,LABEL,METHODS,OBJECTIVE,PROTECTION,PURPOSE,RESULTS,VEGFR,WHILE
000,180,330,383,457,802,956,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SCREENING,THERE
169,946,BACKGROUND,BASEL,CONCLUSION,GANODERMA,LABEL,METHODS,MTT,OBJECTIVE,PHA,RESULTS,TGF
169,280,BASEL,PAS,PET,PULMONARY,UNDER
169,DUE,ERS,FURTHER,HOWEVER
169,AGE,BASED,ERS,SCREENING,TREATMENT,TRIAL
169,953,COPYRIGHT,INC,PKC,PRIMARY,PRKCI,PROTEIN
160,169,953,COPYRIGHT,GLI,GROWING,INC,JUSTILIEN,PKC
002,100,CONCLUSION,FDG,HISTOLOGIC,HOUNSFIELD,LABEL,LYMPH,METHODS,PET,RESULTS,SIXTY,THEREFORE,THESE,THREE,UNLABELLED
100,169,945,946,COPYRIGHT,ESTRADIOL,INC,MALAT,MB231
002,003,006,007,008,012,013,015,021,025,032,035,036,037,039,040,045,177,248,762,AMERICA,BMI,EXCLUDING,FOUNDATION,FURTHER,GROUP,IIA,IIB,III,JANUARY,LABEL,METHODS,MYASTHENIA,OBJECTIVE,OBJECTIVES,PACO2,RESULTS,THYMECTOMY,UNIVARIATE,VITAL
169,ANNEXIN,COPYRIGHT,LNC,MTT,THESE,TRETINOIN,TTN
169,363,AMONG,CAUCASIANS,COPYRIGHT,INC,MASSARRAY,NSCLC,PUBLISHED
007,169,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,ENTERPRISE,GUIDE,INC,LABEL,METHODS,NSCLC,RESULTS,SAS,THESE
169,1980S,ADC,AMERICA,AUSTRALIA,CONTINENTS,COPYRIGHT,DENMARK,EARLY,FURTHER,ICELAND,INCIDENCE,IRELAND,LABEL,LTD,METHODS,NORTH,OBJECTIVE,OBJECTIVES,OCEANIA,RESULTS,SCC,VOLUMES
001,002,004,008,028,029,037,055,114,169,991,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NLR,NSCLC,RESULTS,VTE
177,945,946,99M,CYSTINE,H2O,HCC4006,RENAL,S02,SPECT,THEREFORE
123,177,183,195,881,937,956,ABCB1,ASP,ICC,NCI,NCL,OCT,OCTN1,OCTN2,RH123,SLC22A1,TEA,THESE,WESTERN
169,BSA,DOX,FINALLY,MTT,NPS,WILEY
967,BACKGROUND,EDI,INDEX,LABEL,METHODS,PAF,POISSON,POPULATION,RESULTS
CONFERENCE,COPYRIGHT,IASLC,PROUS,SCIENCE,WORLD
CYCLE,DESPITE,HOWEVER,MRI,PATIENT,THESE
004,019,021,107,BACKGROUND,LABEL,METHODS,MVD,NSCLC,PCR,RESULTS,WESTERN
29C,429,534,723,727,ALTERED,BACKGROUND,LABEL,METHODS,NSCLC,PCR,RESULTS,ROC
135,188,249,295,311,855,BLOOD,CARDS,DIETARY,DIGESTIVE,FYS,HEART,HNRIM,INSTITUTE,MANAGEMENT,NIH,NUTRITION,ODS,THEREFORE
AMERICA,AMONG,CENTRAL,FURTHER,HPV,HPV16,HPV18,NORTH,PRESS,PUBLISHED,SOUTH,UNIVERSITY,WHITE
945,946,BACKGROUND,BRONCHO,LABEL,LUMINEX,MCP,METHODS,MIP,RESULTS,SERUM
002,AIM,BACKGROUND,C30,CONCLUSION,INDWELLING,ITEMS,LABEL,MALIGNANT,METHODS,OBJECTIVE,QLQ,QUALITY,RESULTS,SPAIN,TREATMENT
169,LTD,SF3B1,SF3B155,SRSF2,THESE,U2AF1,URP,WILEY,ZRSR2
169,353,AFTER,AKT,COPYRIGHT,FINALLY,HRS,III,MEDLINE,NSCLC
023,038,ASP148GLU,BER,CAUCASIANS,HOWEVER,ORS
001,013,032,160,179,187,338,355,492,902,915,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,PFS,RESULTS,SEVENTEEN,SURGERY,TREATMENT
002,208,315,549,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,PCR,RESULTS,SAM68,TNM,WESTERN
169,916,961,AAA,BOARD,D95,ECLIPSE,JAPAN,MEDICAL,PBC,PRESS,PTV,PUBLISHED,RADIATION,SOCIETY,SYSTEMS,THESE,UNDER,UNIVERSITY
169,750MG,AML,COPYRIGHT,LTD,NOVEL,PRIOR,WHILE
THESE
169,207,231,438,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,RESULTS,RFS,WHILE
007,039,467,ACUTE,ANZDATA,AUSTRALIAN,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,RECIPIENTS,RESULTS,THERE,TRANSPLANT,USING,ZEALAND
200,CD133,GBM,THESE
GATA2,HOWEVER,NPSIGATA2,NSCLC,SYNTHETIC
001,177,72H,956,ANNEXIN,BAX,BCL,CHRYSIN,CONCLUSION,HONEY,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,REACTIVITY,RESULTS
COMPOUNDS,GSTP1
003,005,012,199,BACKGROUND,BUNDANG,DFS,KOREA,LABEL,MAY,METHODS,NSCLC,RESULTS,SEOUL,SPECIAL,UNIVERSITY
BECAUSE,BRM,DECODER,DEFECTS,DEPLETION,H3K9ME3,SMARCA2,SMARCA4,SNF,SWI
121,169,AKT,ECD,EGF,ERK,FIRST,RAS
250,300,400,ATP,HOWEVER,KINASES,LARGE,MRM,THEREFORE
CRITICALLY,ST6GALNAC2,THESE,USING
182,ADAM9,FOXO3,KNOCKDOWN,REPRESSION,SP1
169,562,741,993,AUTHORS,BRM,LTD,THERE,THESE,WILEY
100,EXPRESSION,FMG,HFL,HSV,VIRAL
160,693,CONCLUSION,FOURIER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
156,BETWEEN,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
008,BAL,EARLY,NON,NSCLC,PCR
169,BACKGROUND,DNB,LABEL,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,LABEL,METHODS,MICRORNAS,PRESS,PUBLISHED,SURVMICRO,THEIR,THEREFORE,UNIVERSITY,UNLABELLED
3AB,3AC,945,946,956,BEL,HEPG2,NCI,SKOV3
100,142,149,AICHI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,THEREFORE
001,007,108,1471G,253,276,361,CRS,LABEL,PCR,TAKEN,UNASSIGNED,UNLABELLED,XRCC1
887,HOWEVER,MTC,SRM
169,COPYRIGHT,FURTHER,HSP90,SAS,THESE,WESTERN
215,SCLEROSING,TOMOGRAPHY
002,005,177,439,481,683,BACKGROUND,CONCLUSION,HPF,LABEL,MATERIALS,MCD,MEASURING,METHODS,MVD,RESULTS,TOLOUIDINE
ADDITIONAL,CONCLUSION,GRADE,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,V10
128,177,967,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SEM,WINDOWS
200,AIM,ASIAN,CHINESE,GENOTYPING,LABEL,MASSARRAY,MATERIALS,METHODS,NSCLC,OBJECTIVE,PSMA4,RESULTS,SETTING,THERE
CLINICALLY,HSP90
ACTIVATION,GPCRS,S1P,SIGNALING
215,BACKGROUND,COMMITTEE,JOINT,LABEL,LOW,M1B,M1C,METHODS,RESULTS
273,ACS,AFFYMETRIX,AMONG,BACKGROUND,CEACAM1,EXPRESSION,IHC,LABEL,METHODS,PCR,RESULTS,TCS
111,167,169,244,BACKGROUND,COPYRIGHT,IIA,IIB,INC,LABEL,METASTASIS,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY

NSCLC
200,946,ECM,TGF,THESE,ZEB
169,BASED,COPYRIGHT,EARLY,EVALUATION,FDG,INC,PET,SOLID
ALK,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,REVERSE
009,063,AMONG,APC,BACKGROUND,CONCLUSION,FORTY,HOPKINS,JANUARY,JOHNS,LABEL,MEIER,METHODS,PATHOLOGY,RESULTS
100,178,DL1,DL2,EASTERN,EIGHT,GRADE,GROUP,PRIMARY,SECONDARY
100,132,156,BACKGROUND,FURTHER,GROUP,IDL,LABEL,MALIGNANCY,MASAOKA,METHODS,RESULTS,THESE
172,202,230,301,313,401,503,596,690,ACCORDING,AFTER,BACKGROUND,EPP,LABEL,METHODS,MPM,RESULTS,SURGERY
048,ANALYZING,BACKGROUND,HOWEVER,III,LABEL,METHODS,NSCLC,PET,RESULTS,SUV,TNM
001,036,131,177,198,273,70YRS,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MARCH,METHODS,OLDER,PROCEDURE,RESULTS
BACKGROUND,CANDIDATE,CONCLUSION,IHC,INGENUITY,LABEL,MAP,METHODS,PATHWAY,PRINCIPAL,RESULTS,RUVB1,SCLCS,SMALL,SUBSEQUENT,THESE,WESTERN
150,ALK,ANAPLASTIC,BACKGROUND,CRIZOTINIB,IHC,LABEL,METHODS,NSCLC,RESULTS,STRIKINGLY
MIB
AAP,BACKGROUND,ESTIMATING,HOWEVER,IER,IHD,LABEL,METHODS,OBJECTIVE,PAF,PM2,RESULTS
346,945,EGF,LY3016859,TGF
169,COPYRIGHT,FIFTY,INC,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SMOKERS
169,301,441,535,AFTER,COX,EARLY,JOINT,NSCLC,PRESS,PUBLISHED,RESULTS,SNP,UNIVERSITY,WNT,WNT16
125,ACTIVATING,ARTIFICIAL,BACKGROUND,LABEL,MATERIALS,METHODS,PCR,RESULTS,T790M,THESE,TKI,UNTIL
001,012,028,032,114,188,BACKGROUND,DEVELOPING,FEW,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES
100,BACKGROUND,CONCLUSION,INCREASING,LABEL,LOS,METHODS,NCSLC,OBJECTIVE,PCU,RACFS,RESULTS
AFTER,BACKGROUND,CONCLUSION,CTCAE,GRADE,LABEL,METHODS
ENDOSCOPIC,METASTASES
000,155,53000,ACCORDING,DANTE,DLSCT,INTERIM,LOW,PRESCRIRE
945,ALDH1,CD133,EMT,EPITHELIAL,HOWEVER,HYBRIDS,NANOG,NOD,NSCLC,SMA,THESE
121,183,300,CURRENT,NGS,RESTART,THESE,UTILIZING,VARWALKER
176,177,216,HEPG2,NPS,REALGAR
070,BCL,CD4,CD8,FOXP3,PBMCS,TAKEN,THESE,TREGS
169,EARLY,GENERAL,NSCLC,SURGEON
ABOUT,HOWEVER
480,CONCLUSION,COX,DCR,EVALUATION,LABEL,METHODS,METRICS,MODEL,OBJECTIVE,PURPOSE,REGARDLESS,RESULTS,SOLID,TRITR
001,169,297,AUDIT,AUTHORS,DIAGNOSIS,ENGLISH,INC,IQR,PRIMARY,PUBLISHED,ROUTINELY,THESE,USING,WILEY
EPA,EPM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PLA,RESULTS,TTF
100,160,ALK,CYTOLOGIC,HISTOLOGIC,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE
ASIAN,CHINESE,FORTY,GSTM1,HAN,P73,XRCC1
001,222,AMONG,CHINA,COX,PFS,SPECIMENS,XELOX
177,ADVERSE,CAUTIONARY,CONTROL,CTCAE,ELECTRONIC,EPR,LABEL,MAY,METHODS,OBJECTIVE,OSCIR,PATIENT,RESULTS,SUNNYBROOK,SYMPTOM,USING
FNA,INITIAL,SUBSEQUENT,TREATMENT,ULTRASOUND
GASTRIC,UPPER
945,AMP,KNOCK,THEREFORE,THESE
AFTER,EIGHT,ENDOSCOPY,PRIMARY
A2780,A2780CP70,BDI,CANCERS,REMARKABLY
169,946,ECTOPIC,INHIBITOR,NEDD9,RAC,TCF,TRANSITION
HOWEVER,LABEL,RAS,REDUCED,THESE,TREATMENT,UNLABELLED,WNT5A
002,027,148,364,CBCT1,CBCT2,CBCT3,CBCT4,CBCT5,GTV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
ACUTE,ADH,DESPITE,SIADH
156,ATP,DFG,FGF,FGFR1,FIBROBLAST,GENERALLY
169,ADSQS,BACKGROUND,CEA,COPYRIGHT,IRELAND,LABEL,LTD,MAML2,MEC,METHODS,RESULTS,THEREFORE,THESE,TTF
021,024,169,381,ALK,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
10A,12810,169,178,66027,956,ATCC66027,CANDIDA,COPYRIGHT,HEPG2,HVS,LTD,MCF,MIC,THERE
141,169,208,CHS,COPYRIGHT,LABEL,METHODS,NPV,OBJECTIVE,PPV,PUBLISHED,RESULTS,SEPAR,SIX,THESE
384,460,ATM,ATMATRDNA,ATR,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,OIS,RESULTS,RNF43,TELO2,THROUGH
169,COPYRIGHT,GPX,INC,NCI,PRDX6,THEREFORE,WESTERN
160,169,200,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,EVALUATION,GANETESPIB,GROUP,HOWEVER,HSP90,INC,LABEL,MBC,METHODS,ORR,REPONSE,RESULTS,SIMON,SOLID,THERAPY
100,BACKGROUND,LABEL,METHODS,PET,RADIATION,RESULTS,TEN
174,ATM,ATR,BACKGROUND,EUTDA,GENERALLY,H23,LABEL,METHODS,NCI,NKG2D,NSCLC,PCR,PREVIOUSLY,RESULTS,SURFACE,THEREFORE
177,ACCORDING,BACKGROUND,LABEL,METHODS,QUICKLY,RESULTS,SEVENTY,UNDER
EARLY,III,NSCLC,PHASE,PROGRAMMED,THEIR,WHILE
13794,160,956,CONVERSION,DEPOSIT,DIFFERENT,EMP,GIVEN,HYGIENE,INSTITUTE,ISO,JOURNAL,MICRO,MINNESOTA,MOUDI,NIOSH,ORIFICE,RANGE,THEREFORE,UNIFORM
002,036,BACKGROUND,CONCLUSION,DEPARTMENT,LABEL,METHODS,NUTRITION,OBJECTIVE,RAJAVITHI,RESULTS,SIXTY,STUDIED,THEREFORE,WHITNEY
100,ACETATE,AERVA,ALEAF,CHLOROFORM,ETHYL,SRB,THERE
PULMONARY
1ST,2ND,3RD,7TH,CD133,HCC,HOWEVER,LIVER
001,039,067,071,266,GIVEN,NON,NSCLC
305,AIM,CONCLUSION,DIFFERENCE,INTENSITY,LABEL,METHODS,NUMERICAL,OBJECTIVE,OVERALL,RESULTS,SCALE
316,BACKGROUND,CONCERNING,CONCLUSION,LABEL,METHODS,RESULTS,THREE
500,600,ANTIGEN,BACKGROUND,CONCLUSION,DISEASE,KARNOFSKY,LABEL,METHODS,PRIMARY,RESULTS,REVIA,TEN,THESE,THIOCTACID
177,285,AIM,CONCLUSION,III,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVENTEEN
579,EASTERN,GROUP,MAXIMUM,PRT,RPA
BACKGROUND,DISCUSSION,EMA,LABEL,LOCATIONS,METHODS,THERE,THREE
001,354,AIM,AMONG,CEA,CONCLUSION,CYFRA,FDG,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PET,RESULTS,SCC,WHITNEY
BACKGROUND,BECAUSE,CONCLUSION,DESPITE,EXAMINING,LABEL,MALIGNANT,METHODS,MPNST,OVERALL,RESULTS,THEREFORE
004,019,036,AIM,BACKGROUND,HSP90B1,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,TURKISH
AIM,CONCLUSION,KIRSTEN,LABEL,METHODS,MUTATIONAL,OBJECTIVE,RESULTS,SMALL
AMONG,BACKGROUND,CONCLUSION,EUKARYOTIC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,THERE
CRC,EPIDERMAL,KIRSTEN,L858R,NSCLC,T790M
169,PHASE,UNTIL
169,COPYRIGHT,DESPITE,INC,MOUSE,WILEY
040,042,169,AUTHORS,CASES,COX,GAMMA,III,INCREASED,KNIFE,LOCAL,LTD,PROGNOSTIC,SRS,WILEY
169,954,AUTHORS,CHRONIC,H2052,H28,IMD,LTD,NCI,THESE,WILEY
422,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,THERE
FUSOGENIC,GNHU5,HFL,HSV,PROTEIN,UL38P,WESTERN
001,012,302,304,409,HAPLOTYPES,JANUARY,KAZAL,NSCLC,SEPTEMBER
183,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,ROS,USING
001,121,124,321,420,CHINESE,CYP,CYP2C19,CYTOCHROME,PCR
HOWEVER,WESTERN
002,003,009,018,037,042,138,COX,ELISA,KLK11,MEIER,NSCLC,PFS,SERUM,UNIVARIATE
011,100,160,280,524,BLD,ELISA,LMTK3,MEIER,NSCLC,ROC
169,442,946,CELLS,EMT,PRESS,PUBLISHED,RSF,SIMILAR,THESE,UNIVERSITY,UTILIZING
CHANGES,LEWIS,PRESS,PUBLISHED,THESE,UNIVERSITY
16Q23
946,DUSP1,HOWEVER,NOTCH,NSCLC,RAS,THESE,USING
001,002,100,BACKGROUND,DNP63,FORTY,LABEL,METHODS,P63,PCR,RESULTS,SIX,TAP63,THERE,THEREFORE
ASSOCIATED,DIAGNOSIS,HOWEVER,MALT1,PROGNOSIS,PULMONARY
CAM,CAR,CD171,CE7,OVERALL
175,437,874,ARP,BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,ORS,PUBLISHED,PUBLISHING,RESULTS
CK7,FIRST,HOWEVER,METASTASES,PSA,SHIELDS,THESE,TTF,UVEAL
ALK,BECAUSE,PRESENTLY
169,CARDAMONIN,COPYRIGHT,FK506,HOWEVER,INC,KEY,LABEL,MEANWHILE,METHODS,MTT,OBJECTIVE,RAPAMYCIN,RESULTS,TREATED,WESTERN
169,COPYRIGHT,INC,RAPAMYCIN
00001,001,004,006,169,895,CAD,COPYRIGHT,HOWEVER,MAX,PLEKHG5,PPI,SMAD3,T2D,THESE,TIAM1
169,947,BED,CONCLUSION,COPYRIGHT,DAH,IRELAND,LABEL,LOW,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,241,APAAP,COPYRIGHT,ERCC1,EXPRESSION,FNABS,III,LABEL,METHODS,NSCLC,OBJECTIVE,PORTUGUESA,PUBLISHED,PURPOSE,RESULTS,SOCIEDADE
169,BACKGROUND,COPYRIGHT,DECORIN,GENERAL,ISSUE,LABEL,MAJOR,METHODS,PARTICULAR,SCOPE,SLRPS,SMALL,SPECIAL
169,786,COPYRIGHT,HUH,IRELAND,LTD,MEK,MKN28,PP2AC,TAKEN,TUNEL
000,108,169,177,AVERAGE,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THREE
005,118,145,160,169,174,204,AMONG,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METASTASIS,METHODS,MOSBY,PREDICTORS,PUBLISHED,PULMONARY,RECURRENCE,RESULTS,SURGERY
100,160,169,177,COPYRIGHT,INC,LABEL,METHODS,MOSBY,MRI,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
001,108,111,122,160,169,230,COPYRIGHT,COX,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,RESULTS,SURGERY,UNIVARIATE
151,160,169,177,458,ADULT,AGE,COPYRIGHT,DFS,EVALUATION,INC,LABEL,METHODS,MOSBY,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY
001,008,024,031,037,045,169,568,609,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
100,169,946,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,INC,THESE
169,CHRONIC,COPYRIGHT,INC,OXIDATIVE,TREATMENT
005,084,157,169,221,302,554,COPYRIGHT,GWASS,INC,LDL,PCSK9,PUBLISHED,SOCIETY
000,1511G,169,200,208,330,538,AFRICAN,ANGPTL8,ARG504HIS,ARRAY,CHD,COL18A1,COPYRIGHT,EXOME,GLY111ARG,HDL,INC,LDL,LOW,PCSK7,PCSK9,PUBLISHED,SER161LEU,SOCIETY
169,CHEMOKINES,COPYRIGHT,CXCR6,EWING,INC,UNIVARIATE,USING
169,171,187,COPYRIGHT,HOWEVER,PUBLISHED,SEPAR
AMONG,BACKGROUND,CAREFUL,CHINA,CONCLUSION,DEPARTMENT,EIGHT,LABEL,MEC,METHODS,RESULTS,SEVEN,SICHUAN
033,160,169,479,557,COPYRIGHT,COX,INC,JANUARY,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SUCCESSFUL,SURGERY,USING
169,BACKGROUND,COPYRIGHT,HOWEVER,INSTITUTE,LABEL,MANAGEMENT,METHODS,OBJECTIVE,PRIOR,RESULTS,SAS,SINCE
037,CLARK,LABEL,METHODS,OBJECTIVE,RESULTS,TNM
AMONG,CHINESE,CHM,CONCLUSION,JANUARY,KARNOFSKY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SEVENTY,UNDER,UNIVARIATE,UNIVERSITY
100,177,181,CD3,CD8,CONCLUSION,LABEL,METHODS,MULTI,OBJECTIVE,RESULTS
260,AMONG,CHINA,CONCLUSION,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,XUANWEI

107,137,160,169,177,205,BACKGROUND,CONCLUSION,ESTIMATION,JANUARY,LABEL,LTD,MARCH,METHODS,PUBLISHED,RADIATION,RESULTS,WILEY
112,CTV,DESPITE,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNDER,UNIFORM,V20,V40,V55
COM,EUCLIDEAN,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE
208,266,ACA,CNA,NSCLC,SCC
000,150,BACKGROUND,CONCLUSION,FOUNDRY,LABEL,METHODS,RESULTS,SMR
BACKGROUND,CHINESE,CHUANXIONG,CONSISTENT,CXCR4,HOWEVER,LABEL,PCR,PRINCIPAL,RESULTS,SDF,THESE,TMP,USING,WHOLE
BACKGROUND,HOWEVER,KEAP1,LABEL,NUCLEAR,PRINCIPAL,RESULTS,SKI,USING
963,ATM,CUC,NAC,ROS,STAT3,TAKEN,THESE
946,AKT,CL1,ERK,FDA,JNK,NAD
001,CELLS,DESPITE,EMT,H1299,LK2,MEANWHILE,NSCLC,SPC
450,545
CLINICALLY,INCREASED,SILENCING,TAKEN
177,185,CONCLUSION,CURVE,FDG,LABEL,METHODS,NON,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,ROC,THREE,UNDER,VALUE
BACKGROUND,BAL,LABEL,MANAGEMENT,PR8,PRINCIPAL,RESULTS,SERUM,THROUGH
METASTASES
AGNO3,AGNPS,B16,CHINESE,CHO,FINALLY,FIRSTLY,HUVEC,THIRDLY
111,177,945,946,99M,AAT,CONCLUSION,GIVEN,IHC,LABEL,MBQ,METHODS,MTD,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,RGD,TRT,U87MG
AMONG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,SPECIAL,THERE
033,CCAT2,CEA,NSCLC,SILENCING
011,048,177,703,ADJUSTING,AMONG,BMI,CONCLUSION,HOWEVER,KNOWLEDGE,LABEL,METHODS,MISSING,OBESITY,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
163,197,230,ALK,ERG,ESRRA,III,PCR,SALZMAN,TMPRSS2
020,AFTER,CHANGES,CONCLUSION,FLT,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,SIMILAR,SIXTEEN,SUV,THESE
013,134,600,CAUSE,GAMMA,KNIFE,LOCAL,OVERALL,UNIVARIATE
FINALLY,FIRST,FURTHER,LABEL,NSCLC,OPINION,PATIENT,PD1,RCC,STATEMENT,THESE,UNASSIGNED,VARIOUS
128,387,414,956,AILUROPODA,FURTHER,GIANT,HEP,HISTOLOGY,L22,MEANWHILE,MTT,PANDA,PCR,PRIMARY,RPL22
21Q22,AFTER,ALK,AML,CAREFUL,MTX,MYELOID,SUBSEQUENT
421,835,843,AUSTRALIA,BACKGROUND,BRITISH,HOUSEHOLD,LABEL,METHODS,MIDLIFE,MODEL,PANEL,RESULTS,RETIREMENT,SIBLING,THESE,WISCONSIN
001,038,051,203,ADC,AMONG,BACKGROUND,CCDC6,CELLS,KIF5B,LABEL,METHODS,NSCLC,PCR,RESULTS,RET
001,BACKGROUND,BETWEEN,FORTY,GROUP,JANUARY,LABEL,METHODS,RESULTS,THREE
120,1ST,4TH,8TH,947,AIM,AKP,CONCLUSION,DAILY,DAO,III,LABEL,METHODS,OBJECTIVE,RESULTS
FDG,HOWEVER,PET,SUV
100,177,BLAND,COMMITTEE,CONCLUSION,FDG,JOINT,LABEL,METHODS,NSCLC,PET,RESULTS,SUV,THERE,THESE,UNLABELLED
118,918,99M,BESIDES,CARLO,CONCLUSION,DVH,FINALLY,HOWEVER,LABEL,MAA,MCNPX,METHODS,MIA,MONTE,NORMALIZED,NTL,OAR,RESULTS,SPECT,THOSE,UNLABELLED
416,422,838,BACKGROUND,CROSS,GROUP,LABEL,LOBECTOMY,METHODS,NSCLC,RESULTS,SCIENCE,WEB
AMSRS,ASMRS,AVOIDABLE,COMMUNITY,CONCERTED,FURTHER,MORTALITY,WORLD
945,954,ADENOVIRAL,BACKGROUND,CLIC4,CONCLUSION,INCREASED,LABEL,METHODS,RESULTS,SIMILARLY
945,ADC,CILC4,CLIC4,S100A11,THESE
VARIOUS
AFTER,JANUARY,PTC,RET,V600E
AIM,C30,CHARACTER,EORTC,HRQOL,INVENTORY,LABEL,METHODS,OBJECTIVE,QLQ,QOL,RESULTS
001,012,014,412,426,AIM,BACKGROUND,IIB,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,WOMEN
049,123,125,151,157,180,196,200,213,273,275,298,309,316,330,376,401,BACKGROUND,III,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,THERE
249,BACKGROUND,FEW,III,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
142,206,26E,401,543,850,89E,ANNOTATION,DISCOVERY,EXPRESSION,FINALLY,GATA2,HLA,INTEGRATED,MYBL2,OMNIBUS,RAMP1,WISP1
177,178,181,198,209,269,349,476,482,590,591,795,954,955,AFFILIATED,COLLEGE,DEPARTMENT,ELISA,FLC,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SURGERY,THEIR
160,169,320,BACKGROUND,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SOCIETY,SURGERY
169,ACCURAY,COPYRIGHT,CYBERKNIFE,INC,LTD,PUBLISHED,SUNNYVALE,USA
103,143,169,246,COPYRIGHT,INC,MEDICAL,MEV,PUBLISHED,THERE,V10,V30,WITHOUT
169,947,CD133,COPYRIGHT,CSC,DPP,FEW,FINDING,GSI,INC,NOTCH,THESE
DVT

110,154,THEREFORE,ZAPOROZHYE
BMPMS,PERITONEAL
DISCOVERY,FGF,FGFR1,MYC,RECURRENT
EMT,EPITHELIAL
024,035,039,042,AMONG,BILATERAL,FVC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,THERE
NOVEL
169,372,AUTHORS,BACKGROUND,EASTERN,GROUP,INC,LABEL,METHODS,NSCLC,ORR,RESPONDERS,RESULTS,SIX,SOCIETY,TKI,WILEY
169,910,CD166,CSC,DUE,EXPRESSION,FEW,FURTHER,GRADING,NSCLC,PRESS
169,180,AUTHORS,E545K,GLY972ARG,IRS,LTD,PDPK1,REGARDING,SCC,SSC,WILEY
1A1,ADC,CD133,DC101,HOWEVER,NSCLC,SCC
109,AGFG1,AMONG,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,CXCL9,CXCR3,CXCR4,EXPRESSION,IL6,IL8,ITGA5,ITGB1,ITGB3,NSCLC,PCR,TNF
001,004,006,007,024,029,048,150,158,169,222,BACKGROUND,BOARD,BROAD,CONVERSELY,COX,EARLY,FURTHER,LABEL,METHODS,RESULTS,SOCIETY,UNDER
AUGMENTED,C57BL,HOWEVER,MELANOMAS,SIMILAR,THESE
005,035,066,BIOMARKERS,CONCLUSION,EBC,LABEL,METHODS,MEXICAN,OBJECTIVE,RESULTS
945,948,EARLIER,EPITHELIAL,GOLGI,HYPOXIA,PKC
18F,ACCORDING,CLINICALLY,CUP,FDG,IMAGING,ISSUE,LABEL,METHODICAL,METHODS,MODALITIES,MRI,OBJECTIVE,PET,PRACTICAL,RESULTS,SUBSEQUENT,WHOLE
219,691,BACKGROUND,BASED,CIS,CONCLUSION,GENERATION,HOWEVER,HPV,LABEL,METHODS,MULTI,POISSON,REGISTERS,RESULTS,RRS,SWEDISH,THROUGH,WHILE
160,371,BACKGROUND,CLM,LABEL,METHODS,RECURRENCE,RESULTS,RFS,TSF
ASSESSING,ECM,TGFBI
174,D95,LABEL,MARGINS,METHODS,MULTI,OBJECTIVE,PURPOSE,RESULTS,SINUSOIDAL,SNS,TARGETS,THESE
EPR,FIRST,HOWEVER,THESE
270,ASIAN,BACKGROUND,BASED,CHRONIC,DISEASE,HOWEVER,INITIATIVE,LABEL,METHODS,RESULTS,UNIVERSITY
COMPOUNDS,HEP,NMR,THEIR,VARIOUS
1HR,AFTER,DEX
268,631,963,HENCE,OVERALL
166,19Q13,676,EGLN2,LTBP4,MASSIVE,SINCE,STRIKINGLY,TGFB1,THESE
102,237,256,PRE,SCREENING,TRIAL
200,BIP,CAR,CONCLUSION,DKK,GRP78,JNK,JUN,LABEL,MATERIALS,METHODS,MOI,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,TKI
946,AZA,BACKGROUND,BASED,CHROMATIN,CPG,HOWEVER,KAISO,LABEL,METHODS,PCR,RESULTS,SPC
946,AKT,BACKGROUND,CONVERSELY,EFFECTS,LABEL,METHODS,NSCLC,RESULTS
CELLS,CIGARETTE,FPG,GREEN,HENCE,NCI,PAH,PROTEIN
131,167,182,369,AML,ATLAS,CAG,CONSISTENT,SEQ,U2AF1,UAG,USING
4T1,CTC,METASTASIS,THESE,USING
500,740,760,860,COX,DETECTION,HOWEVER,IGG,LUMINEX,NSCLC,SOMATIC

ACCORDING,AWARENESS,HOWEVER,TYPICAL
HIPPO,KNOCKDOWN,METASTASIS,TAZ,THESE,TPC,YAP
169,AFFYMETRIX,AUTHORS,CIGARETTE,FINALLY,HNC,INGENUITY,IPA,LTD,NSCLC,PAM,PATHWAY,SMOKING,SNC,WILEY
FINALLY,FIRST,GIVEN
174,177,189,204,210,215,226,230,232,234,304,331,367,CONTINUOUS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHETHER
945,BAX,BCL,HENCE,THESE,WESTERN
160,CONCLUSION,DISTANT,EXTREMITY,HIPAA,IRB,LABEL,LMS,MATERIALS,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS,THERE
FOLLOWING,HOWEVER,MNPSICDK4,NSCLC
FOREIGN
000,010,035,068,090,124,155,162,177,216,230,382,433,513,AIM,AMONG,CONCLUSION,COX,FIFTEEN,FVC,LABEL,METHODS,NIS,NSCLC,OBJECTIVE,OCTOBER,RESULTS,THERE
MPM
ASK,BACKGROUND,DUTCH,LABEL,METHODS,OBJECTIVE,PHYSICIAN,RESULTS,SINCE
INHIBITION
ERK,H1299,H89,INC,KEY,LABEL,METHODS,NCI,NSCLC,NTS,NTSR1,OBJECTIVE,PKA,PUBLISHED,RESULTS,SR48692,THESE,TIRON,TREATMENT,WESTERN
132,485,BACKGROUND,CONCLUSION,COX,DETROIT,END,HRS,INCREASED,INTERVIEW,LABEL,METHODS,NSCLC,OCTOBER,POPULATION,RESULTS,THESE
100,ADDITIONAL,AES,BACKGROUND,BID,CONCLUSION,FORTY,LABEL,METHODS,MTD,RESULTS,SAR245409
ALK,ALKAS,BACKGROUND,DISCOVERY,EXPRESSION,FINALLY,LABEL,METHODS,NANOSTRING,NSCLC,PDX,RESULTS,SCREENING,SEQ
134,845,BACKGROUND,LABEL,LY2,LYMPHATIC,METHODS,NSCLC,RESULTS,SINCE,THERE
BACKGROUND,H1299,LABEL,METHODS,NSCLC,OPG,RANKL,RESULTS,THESE
ANXIETY,BACKGROUND,BECAUSE,CONCLUSION,DEPRESSION,FORTY,IES,LABEL,METHODS,RESULTS,SCALE
158,182,523,652,ALK,AMONG,BACKGROUND,LABEL,METHODS,NSCLC,PCR,RESULTS,SIX
577,BACKGROUND,END,LABEL,LIMITED,METHODS,NSCLC,OVERALL,RESULTS,VIDEO
000,100,388,493,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,FINALLY,LABEL,METHODS,RESULTS,SAP,USING
169,956,COPYRIGHT,DECREASED,INC,LEWIS,PATHOLOGY,PUBLISHED,SOCIETY,TAKEN
001,003,008,169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PURPOSE,RESULTS,SRS,TRT
169,AFTER,COPYRIGHT,COX,CRT,CSS,END,III,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PROPENSITY,PURPOSE,RESULTS,USING
169,ASSESSMENT,BACKGROUND,CGA,COPYRIGHT,FIT,FRAIL,GERIATRIC,HOWEVER,INC,LABEL,MATERIALS,METHODS,NCI,RESULTS,SEVERAL,VULNERABLE
169,221,524,COPYRIGHT,COX,DFS,DISEASE,FEDERATION,HOWEVER,MUTATIONS,NSCLC,OVERALL,PREDICTIVE,PUBLISHED,SOCIETIES,T53,TRIAL
181946C,8227G,EPIDERMAL,SHORT,THERE
159,500,ADDITIONAL,DESPITE,NSCLC,SOCIETY
NON,NSCLC,THERE
BACKGROUND,BASED,CONCLUSION,CONTEXT,III,LABEL,METHODS,NSCLC,OBJECTIVE,OTHERWISE,RESULTS,TLF
5TH,600,800,AFTER,CONCLUSION,CUMULATIVE,FVC,ITBVI,LABEL,METHODS,OBJECTIVE,PEF,PRIMARY,PURPOSE,RESULTS,SECONDARY,THERE
000,169,BCL,BCL2L11,BIM,EGF,LABEL,LOW,METHODS,NSCLC,OBJECTIVE,OVERALL,PCR,PFS,PURPOSE,RESULTS,T790M
169,AFRICAN,AGE,AMERICANS,AMHR2,BRSK1,HK3,PRESS,PRIM1,PUBLISHED,UNIVERSITY,USA
945,GRAMICIDIN,HIF,IONOPHORES,PREVIOUSLY,RCC,TAKEN,VHL
110,123,164,165,169,COPYRIGHT,EFFORTS,LABEL,LTD,METHODS,MIDWESTERN,OBJECTIVE,OLDER,RESULTS,SEVENTY,WILEY
135,173,189,261,347,425,564,584,598,607,673,863,898,A683C,C626G,DR4,G422A,THEREFORE
001,029,050,067,106,202,235,478,893,957,CHINA,EGGER,IL6,KNOWLEDGE,ORS,THEREFORE
3T3,951,954,CISPLATIN,NCI
ENGLISH
113,AIP,CONCLUSION,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,STATISTICS,THERE,VITAL
108,HOWEVER,PD1,PD2,SEVERAL,SINCE,THERE
BLOOM,CELLS,H391Y,K422R,REMARKABLY,THESE
946,EP2,EP4,FINALLY,NOSCAPINE,PKA,PKI,TGF
181,BCL,ENDIANDRA,MCL,NMR,THEIR,THESE
DM1
949,BACKGROUND,CONCLUSION,DUE,IGE,LABEL,METHODS,RESULTS,RII,THESE
ANTIGEN,DESPITE,IGG,RNASE,SERUM,SIMILARLY,TAKEN,TRANSIENT
AFTER,EMERGENCY,PULMONARY,RAPID,SEH,TH4,TH7
HOWEVER,JAPAN,PULMONARY,THERE,THREE
CHEST,RIGHT
BECAUSE,NSCLC,PLEURAL
PULMONARY
AUTOPSY,F18,HOWEVER,SEVERAL
001,006,009,013,045,169,600,945,BACKGROUND,CONCLUSION,COPYRIGHT,DLT,EASTERN,FURTHER,GROUP,IHC,INC,LABEL,METHODS,MPM,MTD,PDGFR,PFS,RESULTS,SEVENTEEN
169,CELLS,COPYRIGHT,HUVEC,LTD,MTT,UMBILICAL
169,549,APOPTOTIC,BACKGROUND,CHINESE,COPYRIGHT,EFFECTS,IRELAND,LABEL,LTD,MATERIALS,MCF,METHODS,RELEVANCE,RESULTS,THESE
169,5A1,954,956,CADMIUM,CDCL2,COPYRIGHT,INC,NOTABLY,SUBSEQUENT,TAKEN,THEREFORE
169,ARF,BCL,COPYRIGHT,HIPPO,INK4A,LATS2,MALIGNANT,NF2,RAS,SAV,SEVERAL,WNT
945,947,954,ABC,BCL10,BCR,DLBCL,LABEL,LUBAC,MALT1,MYD88,Q622L,RBCK1,RNF31,THESE,UNLABELLED
169,BACKGROUND,CCC,COLLAPSED,COPYRIGHT,LABEL,LTD,METHODS,MUS,PBC,PTV,PUBLISHED,RESULTS,SWT,THERE,V95
169,CONCLUSION,COPYRIGHT,CTS,GEORGIA,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTILEVEL,NSCLC,OBJECTIVE,RESULTS,RURAL
169,ACE,AUTHORS,BACKGROUND,COMBINING,CONTEXT,COPYRIGHT,ELAC2,FEW,GSTM1,JANUARY,LABEL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,REVIEWERS,SUMMARY,SYNTHESIS,VDR
002,003,008,119,169,239,BACKGROUND,COPYRIGHT,CROSS,LABEL,MAY,MEN,METHODS,OBJECTIVE,OUTCOME,PATIENT,PFS,PSA,PUBLISHED,RESULTS,SETTING,SUMMARY,TAXANES,UROLOGY
017,022,169,237,243,272,345,410,500,BACKGROUND,CIENT,CONCLUSION,INSTITUTO,LABEL,METHODS,NAVARRA,RESULTS,THERE,UNIVERSITY
95D,CGG,CONCLUSION,FINALLY,LABEL,MEANWHILE,METHODS,MTT,OBJECTIVE,PCR,RESULTS

176,233,ADVERSE,BCG,BSD,EFFECTIVE,EORTC,FIFTEEN,FOLEY,HEATING,LABEL,MATERIALS,METHODS,MMC,NMIBC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,TREATMENTS
160,ALK,SINCE
ALK,CONCLUSION,CRIZOTINIB,ID1,KNOCKDOWN,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PCR,PHA,RESULTS,SRC
024,CURRENTLY,DIFFERENT,ENOBOSARM,FDA,GTX,HIV,III,INC,PHASE,SARMS,SEPTEMBER,USA
AFTER,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TAXUS,WESTERN
AFTER,CONCLUSION,DEX,LABEL,METHODS,MKP,MTT,OBJECTIVE,PCR,RESULTS,SGK,USING
ACTUARIAL,AIM,BASED,COSTS,DEPARTMENT,FORECASTS,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,SLI,STATISTICS,STRUCTURAL,THESE,UNLABELLED
A50,AUC,CTPET,LABEL,LESIONS,METHODS,NON,OBJECTIVE,OBJECTIVES,PET,RESULTS,REUSING,SOLID,SUV,TLG,VOI
945,ALDH1A1,CD133,CXCR4,FINALLY,IGF1R,KNOCKDOWN,NANOG,NSCLC,PC9,SEVEN,TARGETING
CIGARETTE,SECONDHAND,SHS,THESE,THIRDHAND,THS
AKT,BRAFV600E,C40,CRE,E38,ERK,G37,HOWEVER,MEK,NSCLC,RAF,RAL,S35,THESE,V12
134,168,169,188,223,30D,376,544,939,940,FUNCTIONAL,HOWEVER,INGENUITY,IPA,MIR,NORMFINDER,PATHWAY,RNU6B,SEVEN
275,BESIDES,CEBPB,E2F,ETS,EXPRESSION,FINALLY,FIRSTLY,GEO,GSE2378,LABEL,MAP,MATERIALS,METHODS,OBJECTIVE,OMNIBUS,POTENTIAL,RESULTS,SMALL
169,19P,200,205,945,COPYRIGHT,HOWEVER,INC,WILEY
169,176,240,956,BGE,FOLLOWING,INTER,TWEEN,VCH,WILEY
176,177,189,AVERAGE,CO2,CONCLUSION,HIPEC,ICU,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
945,947,GRIP1,H3K4ME3,IFN,MERM1,THESE,TNF,WBSCR22
197,BH3,BMF,LNA,NIH,NSCLC
945,946,AZD8931,EPCAM,FIBROBLAST,NSCLC,SERPINE,SPHK1,TGF
001,008,026,029,103,220,221,ACTIVATION,AKT,EPIDERMAL,NSCLC,TISSUES
178,319,618,829,837,918,AIM,CEA,CHINESE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,SIXTY
014,177,499,789,813,ANN,AUTOMATED,CAD,CONSORTIUM,EFFECTIVE,IMAGE,ROI,TEXTURE,USING
514,AFRICAN,BILATERAL,BLACK,CIS,COX,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,USING,WOMEN
946,EVALUATION,MUTATIONS,MYO10,SEVERAL,THESE
INACCURATE,ITV,MIP
CLONALITY,SEQUENTIAL
BOLUS,CARLO,MEV,MONTE,SFF,STUDIES
946,AKT,CRC,MOUSE,ORT
946,954,CHROMATIN,CHRONIC,HBE,NCI,P50
100,ACCOUNTING,BACKGROUND,FURTHER,HOWEVER,JANUARY,LABEL,METHODS,RESULTS,WEIBULL
ALCOHOL,AMONG,BACKGROUND,FINLAND,FINNS,LABEL,METHODS,RESULTS,WITHOUT
000,600,LOCAL
169,BEADCHIPS,LA1,LABEL,METHODS,MICROARRAY,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THESE
100,169,300,ATLAS,CONCLUSION,CPG,FOLLOWING,HOXA9,LABEL,METHODS,NON,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,USING
001,169,503,BISULFITE,BSP,COBRA,COPYRIGHT,FANCA,FANCONI,HOWEVER,INC,NSCLC,PCR,TAKEN,UTR
169,178,231,315,916,COPYRIGHT,HOWEVER,INC,RRM,THESE
169,COPYRIGHT,GLO,INC,PROMEGA,PROTEASOME
169,COPYRIGHT,GLI,INC,IRREGULAR,KEY,PATCHED,PTC,RND,SMO,SMOOTHENED
169,2341066,ALK,APOPTOSIS,BCL,COPYRIGHT,CRIZOTINIB,LTD,MCL,NPM,STAT3,THESE
169,174,BACKGROUND,COPYRIGHT,COX,DIAGNOSIS,HOPKINS,IIB,INC,JOHNS,LABEL,METHODS,PUBLISHED,REASONS,RESULTS
169,946,BACKGROUND,CONCLUSION,COPYRIGHT,CXCR4,EXPRESSION,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIXTY,STUDIES,THEREFORE,THESE
169,195,COPYRIGHT,FINALLY,IRELAND,LTD,MYB,NSCLC,PUBLISHED,TAKEN,USING
169,16S,946,API,COPYRIGHT,INFECTIOUS,LTD,PUBLISHED,SOCIETY,THERE
10M,169,AIM,AMONG,COPYRIGHT,DISCUSSION,FDG,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SAS,SIX,SUV
169,AKT,COPYRIGHT,INCREASING,MICRORNAS,MIGRATION,MIR,NSCLC,PCR,SAS,THESE,TRANSWELL
169,AFTER,COPYRIGHT,EMERGENCY,PUBLISHED,SAS
169,178,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,USING
169,ALK,ANY,COPYRIGHT,EXPERTS,FIRST,INC,ITALIAN,MAY,MEETING,NSCLC,PANEL,PANELISTS,TKI
160,169,AFTER,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY,THEREFORE
100,169,ADDITIONAL,BECAUSE,COPYRIGHT,INC,LABEL,MAP,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,VAL,VIRTUAL
001,009,163,169,189,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MCPYV,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,THESE
169,954,COPYRIGHT,HISTONE,MMP,NSCLC,ROMIDEPSIN,SAS,SUB
109,169,203,AGT,BENJAMINI,COPYRIGHT,FOLR3,INC,LMS,MASP1,NLGN1,PCR,SHMT1,SLITRK4,THBS1,TNNT1,TSPAN10
100,169,CONCLUSION,COPYRIGHT,CURRENT,EMC,EPITHELIAL,IRELAND,KOREA,LABEL,LTD,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SAMSUNG,SEOUL,THEREFORE,TTF
169,352,ADC,BACKGROUND,CONCLUSION,COPYRIGHT,IGF,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SCC,THESE
169,ADRIAMYCIN,AFTER,BACKGROUND,CAP,CONCLUSION,COPYRIGHT,EASTERN,EVALUATION,GROUP,INC,LABEL,MASAOKA,METHODS,MYASTHENIA,RESULTS,SOLID,SURGERY,THYMOMA,WORLD
001,004,005,012,013,029,036,058,169,383,BACKGROUND,CONCLUSION,COPYRIGHT,INC,JCO,JOURNAL,LABEL,METHODS,PFS,RESULTS,SMALL,THERE,THROUGH
169,316,541,CONCLUSION,COPYRIGHT,EDUCATION,FOUNDATION,HEART,INC,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SMOKING
169,176,1GY,5CC,MEDICAL,OVERALL,PTV,PUBLISHED,SMALL,TREATMENT,V20
169,400,CLOSE,COPYRIGHT,CROSS,IATROGENIC,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SYMPTOM
177,18F,ACCORDING,AFTER,BACKGROUND,CONCLUSION,FDG,LABEL,MAY,METHODS,PET,RESULTS,THESE,TOTALLY,USING,WHILE
116,169,549,956,AMONG,COPYRIGHT,HCT,HUISGEN,LTD,MCF,MICHAEL
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,FVIII,INC,PUBLISHED,SOCIETY,TAKEN
169,368,ADDITIONAL,CONCLUSION,DUTCH,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS
005,169,461,CONCLUSION,ELDERLY,LABEL,LTD,METHODS,OBJECTIVE,PHASE,PUBLISHED,REASONS,RESULTS,THERAPY,THERE,UNASSIGNED
169,311,AMONG,BACKGROUND,BASED,COX,LABEL,METHODS,PERIPHERAL,RESULTS
200,280,343,AMP,BACKGROUND,CHINESE,CRTC2,HAN,LABEL,METHODS,NOTABLY,PCR,PROM1,R379C,RESULTS,S281R
169,AIM,CHINA,COMPOUNDS,CONCLUSION,COPYRIGHT,EUPHORBIA,LABEL,METHODS,MTT,NMR,OBJECTIVE,PUBLISHED,RESULTS,UNIVERSITY
169,AIM,CHINA,CONCLUSION,COPYRIGHT,DAD,ESI,HEPG2,KP4,LABEL,METHODS,MTT,NCI,OBJECTIVE,PANAX,PPD,PUBLISHED,RESULTS,RG3,RH2,SGC,TSF,UNIVERSITY
169,183,435,945,956,AIM,CHINA,CONCLUSION,COPYRIGHT,HIF,LABEL,MDA,METHODS,OBJECTIVE,OPHIOPOGON,PCR,PUBLISHED,RESULTS,UNIVERSITY,WESTERN
16913,20005,20359,25910,46269,AGE,AMONG,BACKGROUND,CHANGES,FEDERAL,HODGKIN,LABEL,METHODS,RESULTS
HOWEVER,NSCLC,OBJECTIVE,OBTAINING,THREE
BACKGROUND,CONSISTENT,DCS,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,TLS
169,ARRAY,AUTHORS,LTD,PCR,PTY,PUBLISHING,SCIENCE,SIX,THESE,WILEY
AFTER,BACKGROUND,CONTEXT,CUSHING,HISTOLOGY,IMAGING,LABEL,METHODS,RESULTS,THERMAL
THESE
MALIGNANT,THERE
178,AMONG,FINALLY,GRADE,LABEL,METHODS,OBJECTIVE,OTHER,RESULTS,THEREFORE
001,002,009,014,018,022,041,044,112,140,169,193,252,EPD,EPP,FACTORS,LABEL,METHODS,MPM,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SEVENTY,SURGERY,THERE,THESE,UNIVERSITY
169,LABEL,MCR,SMALL,UNLABELLED
H3K36,HDAC3,KDM2A,NSCLC,SIMILAR,THESE
004,169,AGE,ANGELES,BACKGROUND,CONCLUSION,FEF25,HODGKIN,INC,LABEL,LOS,METHODS,OLDER,PFT,PROCEDURES,RESULTS,TLC,TOTAL,WILEY
169,215,430DUPG,759,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCN,WILEY
138,13Q,169,214,230,AMONG,CNA,MET,NON,NSCLC,STAGE,STK11
277,491,718,762,AFTER,BACKGROUND,FACILITIES,FDG,HOWEVER,JAPAN,LABEL,METHODS,OSAKA,PET,PREFECTURE,RESULTS,SCREENING,WHOLE
CSE,CYTOMETRY,GSH,HOWEVER,LABEL,MTT,NAD,ROS,UNASSIGNED,UNLABELLED
FDG,PET
10001,333,CURRENTLY,MEDICAL,PET,PUBLISHERS,SEVENTH,USA
000,10001,159,228,333,HYPOXIA,MEDICAL,PUBLISHERS,SEVENTH,USA
10001,1960S,1970S,333,ADDITIONAL,CURRENTLY,FURTHER,HOWEVER,MEDICAL,PUBLISHERS,RANDOMIZED,SCREENING,SEVENTH,TRAIL,USA
10001,1980S,333,HOWEVER,MEDICAL,MRI,PET,PUBLISHERS,SEVENTH,SINCE,STATE,UNTIL,USA
10001,333,HOWEVER,MEDICAL,PUBLISHERS,SEVENTH,STUDIES,THERE,USA
062,123,169,683,BACKGROUND,LABEL,METHODS,PFS,RESULTS,SOCIETY,THERE
EATON,GROUP,ITALIAN,LAMBERT,MYASTHENIC,SYNDROMES,WORKING
ETS,GABPA,HOWEVER,R273H,SEQ,STRIKINGLY
ENBA1,FURTHER,MYC,YET
HSP70,IBUPROFEN
AKT,CSC,H1975,NSCLC,OVERALL,REGULATION,SRY
106,218,620,AFFILIATED,BACKGROUND,CONCLUSION,DCA,EASTERN,FACTORS,FIRST,HCC,LABEL,MEDICAL,METHODS,PMS,PULMONARY,RESULTS,SURGERY,UNIVERSITY
001,026,030,122,242,364,946,BACKGROUND,COX,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,SCC,TGFBI,USING
001,102,139,188,305,676,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,RESULTS,VDT
646,ADSQLCS,ALK,BACKGROUND,CHINESE,ERBB2,GENOTYPING,HOWEVER,KIF5B,LABEL,METHODS,RESULTS,RET,SEVENTY
177,BECAUSE,SCC
400,480,PCR,POISSON,SPC,USING
004,104,111,112,117,130,BACKGROUND,EBB,GRANULOMAS,HOWEVER,LABEL,METHODS,RESULTS,TRIAL,URL
FURTHER,III,RNASE,WILMS
074,DATABASES,DETECTION,HOWEVER,LABEL,LIBRARY,METHODS,OBJECTIVE,RESULTS,SCIENCE,SCREENING,SEVEN
169,AFTER,APRIL,BACKGROUND,BASEL,CONCLUSION,FREQUENTLY,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,SIXTEEN,THERE
169,946,ERK,FIBULIN,HOWEVER,MMP,PRESS,PUBLISHED,UNIVERSITY,WNT
169,CLARA,DOX,GOF,HOWEVER,MYC,PRESS,PUBLISHED,SRC,THESE,UNIVERSITY
ATP,AUGMENTED,CTL,HMGB1,RADIATION,THESE
169,COPYRIGHT,HOWEVER,INC,THEREFORE
BACKGROUND,CONCLUSION,LABEL,METHODS,RENAL,RESULTS,RETRO,ULTRASOUND
169,COPYRIGHT,LTD,SMALL,SYSTEMATIC
169,183,COPYRIGHT,LTD,OPIUM
169,COPYRIGHT,HOWEVER,HYPERICIN,PDD,PDT,PVP,STICS,WHEREAS
169,AIM,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
111,130,169,177,2N0,315,621,707,BASED,COPYRIGHT,CRT,INC,MAT,MEDICAL,MUS,OVERALL,PUBLISHED,QUALITY,SEVERAL,THESE,V10,V20
169,177,2MM,3MM,CONTROL,COPYRIGHT,GAMMA,INC,LINAC,MEDICAL,MELBOURNE,MONITOR,NUCLEAR,OVERALL,PATIENT,POINT,PUBLISHED,SNC,SUN
009,014,075,080,108,169,304,335,435,532,639,678,682,747,812,846,962,966,973,989,CONCLUSION,COPYRIGHT,COX,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RECURRENCE,RESULTS,SETTING,UNIVARIATE
001,169,182,184,207,916,975,BACKGROUND,CAPITAL,COPYRIGHT,INC,KEY,KNOWLEDGE,LABEL,LESSENING,METHODS,OPERATIVE,PUBLISHED,RESULTS,ROBOTIC,SOCIETY,THERE
124,160,169,390,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,ROUTINE,SOCIETY
169,686,787,BACKGROUND,BECAUSE,COPYRIGHT,CURRENTLY,END,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE
THERE
100,169,INITIAL,LTD,PUBLISHED
169,CONTENT,COPYRIGHT,LTD
169,ILD,INC,LANGERHANS,PUBLISHED
169,IMPORTANT,INC,POTENTIAL,PUBLISHED,UIP
169,204,BACKGROUND,CONCLUSION,COPYRIGHT,EIA,EXPRESSION,LABEL,METHODS,NSCLC,RESULTS,SERUM,TMA,TXS,WHILE
169,CDK,COPYRIGHT,LOW,LTD
003,008,024,027,030,032,045,057,059,092,256,BACKGROUND,COX,DEFINED,FDG,KPS,LABEL,LOCAL,MEIER,METHODS,NSCLC,PET,PFS,RESULTS,SUV
BACKGROUND,LABEL,METHODS,RESULTS,SCATTERED,THERE,THYROID,TLD,TPS
106,136,160,169,945,BACKGROUND,HEPG2,HUH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PODOPLANIN,RESULTS,SOCIETY,THESE,THROMBOSIS
001,160,169,CK7,FIFTY,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THESE,TTF,WILEY
149,34B,34C,AGILENT,ALDOA,BACKGROUND,CELLS,CONCLUSION,G4470,HNF4A,HUMANHT,KCO,LABEL,MICRORNAS,MIR,MIRNA,RESULTS
11PATIENTS,149,165,ACCORDING,BACKGROUND,CONCLUSION,GRAWITZ,LABEL,METHODS,RESULTS,SCHWANNOMA,SURGERY,THERE,XII
ANNEXIN,ANX,AREAS,BACKGROUND,CCC,COVERED,LABEL,METHODS,OPINION
008,025,027,048,055,090,105,160,ALBERTA,LIMIT,OEL,POTENTIAL,THERE,THESE,TOTAL
DIAGNOSIS,EATON,KNOWLEDGE,LAMBERT
239,BACKGROUND,COMPILING,L858R,LABEL,METHODS,RESULTS,T790M,TKI
120,194,ALK,AMONG,BACKGROUND,CONTINUING,COX,CRIZOTINIB,LABEL,METHODS,NSCLC,RESULTS
169,FURTHER,HOWEVER,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SUBJECTIVE,WILEY
442,628,815,ATS,ERS,IASLC,SOCIETY
945,946,CD103,CD8,CTL,HOWEVER,ITGAE,OVERALL,SMAD2,TCR,TGF,USING
BACKGROUND,INTERVIEWS,LABEL,METHODS,OBJECTIVE,RESULTS
001,048,169,286,327,610,COX,FDG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PET,PRESS,PUBLISHED,RESULTS,RFS,SURGERY,THERE,UNIVERSITY
BACKGROUND,DENMARK,LABEL,METHODS,OBJECTIVE,RESULTS,USING
THREE
AVASTIN,PALLIATIVE
169,CMA,COGNATE,DED,HSC70,INC,KFERQ,PEA,PED,PROTEIN,SHOCK,THEREFORE,USING,WILEY
001,003,169,EMT,FUNCTIONAL,FURTHER,SYK,TAKEN
169,293,FINALLY,HOWEVER,PCR,SQC
001,159,170,998,ALK,ASIAN,NSCLC,SINCE,VTE
MUTATIONS,NOTABLY,TFE
BECAUSE,HOWEVER,NAC,RAF,RAS,ROS
100,169,BACKGROUND,CONCLUSION,COPYRIGHT,CRT,INC,LABEL,METHODS,PACLITAXEL,RESULTS
CJONEDITOR,JOURNAL,NURSING,SELECTION
AFTER,CHEST,INADEQUATE,PROGNOSTIC
AWARENESS,BACKGROUND,CONTEXT,DIFFICULTY,LABEL,LITERATURE,METHODS,OBJECTIVE,OTHER,SOMETIMES,SOURCES
BACKGROUND,CNS,CONTEXT,CURRENTLY,KI67LOW,LABEL,MEIER,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILARLY
174,ALK,ANAPLASTIC,AREAS,BACKGROUND,COVERED,CRIZOTINIB,FDA,KEYWORD,LABEL,METHODS,NOVEL,OPINION,SCIFINDER,SEPTEMBER,SMALL
945,BACKGROUND,CONCLUSION,FURTHER,HISTOLOGIC,HOWEVER,LABEL,LABORATORY,METHODS,THROUGH
181,BACKGROUND,CHRONIC,CONCLUSION,COX,DESPITE,LABEL,METHODS,NSCLC,RESULTS,T2A,UNIVARIATE
001,028,034,100,177,196,323,475,633,733,766,AMONG,CONCLUSION,DIAGNOSTIC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PTNBS,PURPOSE,RESULTS,VARIABLES,VIRTUAL
033,838,894,AVERAGE,CONCLUSION,EIGHT,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RATINGS,RESULTS
500,750,964,ACCORDING,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESOLVING,RESULTS
16HBE,410,766,ARG10,H2126,HOWEVER,NRE,PRE,THESE
ALK,AMONG,PCR,SUBSEQUENT,THESE,THYROID
ALTOGETHER,KNOCK,MMP,RUNX3,STRIKINGLY,TMA,TNM
011,048,427,ASSOCIATED,BACKGROUND,BRITISH,COMPLEX,CONCLUSION,END,GENERAL,LABEL,METHODS,OVERALL,PRS,RESULTS,SHIPMAN,THESE,WORLD
001,005,119,175,CONCLUSION,INITIATIVE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,QUALITY,RESULTS,USING
220,III,JAPAN,MARCH,PHASE,STAGE
169,285,448,AFTER,AMONG,AYA,BACKGROUND,LABEL,METHODS,RESULTS,SOCIETY,WILMS,ZIP
169,CANCERS,COPYRIGHT,LTD,SWISS,WILEY
160,265,AIM,LABEL,METHODS,OBJECTIVE,PRE,PULMONARY,RESULTS,RFA,TTR,UNI
AFTER,CANCERS,IRELAND,OTHER,RISKS,VARIATIONS
006,009,015,046,085,103,18F,BETWEEN,DESPITE,FDG,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESULTS,THERE,TOTAL
150,450,600,BECAUSE,CYP,DOSES,ERLOTINIB,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,URINARY
945,HIF,HOWEVER,HRE,LNM35,NSCLC,SILENCING,TAKEN,USING
169,ORTHOTOPIC,OVERALL
HOWEVER,ILD
108,119,120,154,AMONG,COX,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,WHITE
COMBINING,LABEL,METFORMIN,METHODS,MTT,NCI,OBJECTIVE,RESULTS
1377G,248,297,844,CHINA,FAS,PCR,SNP,SOUTH
001,005,009,010,ASSAY,BACKGROUND,CD105,CD146,CEC,CELLSEARCH,ELISA,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,THESE
177,956,ANNEXIN,CHAMP,FURTHER,GPX,NON,NSCLC,RH123,ROS
CAM,CDS,GEN,GENISTEIN,RESULTS
000,JEM,OVERALL
001,003,022,103,344,610,899,ACCORDING,AIS,ATS,CIR,CUMULATIVE,ERS,IASLC,MIA
KHORANA,PATIENT,PRIMARY,VTE
169,242,243,AMONG,ASIAN,BACKGROUND,CONCLUSION,HOWEVER,ILLNESS,INSURANCE,LABEL,METHODS,PATIENT,PHYSICIANS,PRESS,PUBLISHED,RESULTS,SEVERAL,THROUGH,UNIVERSITY,VTE,WESTERN
145,1522B,AGO,CATCHESIDE,CLINICALLY,CONCLUSION,KNOWLEDGE,LABEL,LEA,METHODS,OBJECTIVE,RESULTS,SINCE,THERE,THESE
169,201,AKT,BIM,COPYRIGHT,DR4,HOWEVER,INC,KNOCKDOWN,S3I,STAT3,TRAIL,TREATMENT
111,169,ANOTHER,CGA,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,RESULTS,SEPTEMBER
124,169,ASA,CONCLUSION,FACTORS,FEDERATION,GERIATRIC,GYNECOLOGY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OBSTETRICS,RESULTS,SOCIETY
001,120,169,322,AGING,BETWEEN,CHI,CONCLUSION,COPYRIGHT,GROUP,INC,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
133,169,377,386,ADDITIONAL,AFRICAN,ASIAN,CONSORTIUM,COPYRIGHT,INC,LABEL,LOS,MATERIALS,METHODS,MORTALITY,OBJECTIVE,PRIMARY,PROLONGED,RESULTS,THERE,UNIVERSITY
169,COPYRIGHT,FDA,FINALLY,GENERATION,HOWEVER,IRELAND,LTD,NGS,SEQUENCING,TESTING,WHILE
BACKGROUND,CONCLUSION,FURTHER,HIBERNOMAS,LABEL,MALIGNANT,METHODS
ANAMORELIN,HELSINN,IGF,III,NSCLC,PHASE
011,169,8G7G3,946,ADS,AUTHORS,E12,HGNEC,LCNEC,LTD,PATHOLOGY,PTY,PUBLISHING,SCC,SOCIETY,SPT24,SQS,TTF,WILEY
MALIGNANT,OVERALL,SPECIMENS,THERE
002,169,180,BACKGROUND,CONCLUSION,JOURNAL,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PCD,PURPOSE,RESULTS,YET
169,AKT,BACKGROUND,BECAUSE,BRITISH,CCK,CONCLUSION,EGF,HSP90,KEY,KIT,L858R,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMALL,SOCIETY,T790M,TKI,WESTERN
132,956,BMI,COROLLARY,LABEL,METHODS,OBJECTIVE,RESULTS,THERAPY
043,215,250,299,ASSESSING,BACKGROUND,BASED,CONCLUSION,COX,FRANKEL,HARRELL,KARNOFSKY,LABEL,MEDICAL,MEIER,METHODS,PREDICTIVE,RESULTS,SBM
169,NON,SUBSEQUENT
169,ACCURATELY,COPYRIGHT,EOL,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THESE,WILEY
169,DUE,FAP,FIBROBLAST,HOWEVER,VCH,WILEY
001,002,003,045,208,505,CAUCASIANS,FINALLY,XRCC1
FURTHER,PATHWAY,TAKEN
946,INCREASED,KINDLIN,KNOCKDOWN,TWIST
100,HOWEVER,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
HOX,LABEL,MALAT,METHODS,NFPAS,OBJECTIVE,PURPOSE,RESULTS,THERE
169,COX,EXPRESSION,KNOCKDOWN,LABEL,MYC,NSCLC,SIMILARLY,THESE,UNLABELLED
169,550,954,BCL,DEPLETION,FGF,LABEL,MCL,MOL,NSCLC,RES,TKI,TNF,TNFRSF12A,TWEAK,UNLABELLED

INHIBITION,MICRORNAS,NSCLC,REVERSION
102,946,AKT,ECTOPIC,EGF,ERBB2,ERBB3,III,LABEL,UNLABELLED
AKT,DECREASED,EMT,ERBB4,NSCLC,SPC,TNM
ERK,MEK,NAD,RAF,RAS,RESISTANCE,SIRT2,THESE,USING
ALK,ECTOPIC,ERBB2,HOWEVER,MEK,RAS,RET,RTK,THESE
AKT,MTC,RAPAMYCIN
156,506,954,ECTOPIC,ROS
143,DNMT1,H3K9ME2,HBECS,MAL,OLIG2
100,BSA,CONCLUSION,FDG,GLC,LABEL,LBM,METHODS,OBJECTIVE,PET,RESULTS,SPN,SUVMEAN,THERE
CSF1R,NOD,RESULTS
946,947,EMT,FINALLY,GSK,HOWEVER,INDUCTION,WESTERN
169,946,ANGIOMOTIN,COPYRIGHT,HOWEVER,INC,SRSF1,TAKEN,TCF,YAP,YES
123,DEPRESSION,EPL,LABEL,METHODS,OBJECTIVE,PHQ,RESULTS,ROC,SADNESS,SEVENTY,STAGE,USING
048,060,169,AKT,AMONG,CONCLUSION,COPYRIGHT,IRELAND,L858R,LABEL,LTD,MATERIALS,METHODS,MUTATIONS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,STK11,T790M,TKI
160,169,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTY,HOWEVER,INC,INHIBITION,LABEL,METHODS,RESULTS
169,945,COPYRIGHT,EPIDERMAL,INC,SNS
001,002,007,016,022,029,160,177,AUC,COMBINING,CONCLUSION,FDG,FIFTY,III,LABEL,MAXIMUM,METHODS,NORMALIZED,NSCLC,OBJECTIVE,PET,PURPOSE,RATIO,RESULTS,SUV
BACKGROUND,DOSIMETRIC,ELECTRONS,LABEL,METHODS,PTV,RESULTS,TODAY
185,NMR,PACLITAXEL,PTX,THESE
BCL,BESIDES,CHINESE,FUR,FURTHER,LC3,RHIZOMA,TAKEN,TRANSWELL
130,174,FDA,III,NSCLC,PHASE
EARLY,HOWEVER,USING
BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,RCC,RENAL,THEIR
BACKGROUND,CONCERNING,CONCLUSION,LABEL,LNR,LNS,METHODS,RESULTS,RLN,TNM
ANT,ERK,FETMPYP,JNK,MAP,ROS,STUDIES,TREATMENT
790,961,AFTER,ASIAN,BACKGROUND,CAUCASIANS,CHINESE,CIS,HOWEVER,ISI,KNOWLEDGE,LABEL,METHODS,ORS,RESULTS,SEVERAL,SIMILAR
DESPITE,III,NON
945,946,ACC,CAS,CD9,CONSISTENT,FAK,FINALLY,MESO1,SIRNA
ALK,FINALLY,FIRST,ION,MYC
BASED,CHINESE,CHO,LNCAP,NEOPLASTIC,THEREFORE,WHILE,XENOPUS
150,ADAMS,ECM,ELISA,H1688,HOWEVER,SILENCING,SMALL,THEREFORE
H2373,H28,HOWEVER,ISTMES2,MET5A,MPM,NCI
ALDOA,ATP,DEPLETION,NCI,THESE
CD8,OXP,UTILIZING
DEPREOTIDE,ROC
ECS,FINALLY,HSPB1,MMP,PREVIOUSLY,THESE
ASSAY,BACKGROUND,CTC,DESPITE,LABEL,METHODS,NON,NSCLC,ONCOGENIC,PCR,RESULTS,SEQUENTIAL
CCP,FEW
147,150,172,267,424,439,AMONG,BACKGROUND,CAUSE,CURRENT,EIGHT,FACTORS,GENERAL,HOWEVER,JANUARY,KAOHSIUNG,LABEL,MAJOR,MALIGNANCY,METHODS,RESULTS
EPCAM,EPICD,LABEL,MEMBRANOUS,METHODS,MOC,OBJECTIVE,REGULATED,RESULTS,TMA
169,EMT,ERK,FINALLY,FRAGILE,LABEL,MMP,PD98059,PP1,SRC,THESE,UNLABELLED,USING
169,COPYRIGHT,EATON,INC,LAMBERT,WILEY
001,003,242,274,391,399,663,681,C609T,CHINESE,III,LABEL,NAD,NSCLC,UNASSIGNED,UNLABELLED
046,169,720,BACKGROUND,BRITISH,COX,DFS,JOURNAL,LABEL,METHODS,NLR,PRESS,PUBLISHED,RESULTS,SIMILARLY,UNIVERSITY
HCC,OPN,USING
BACKGROUND,LABEL,LARGE,METHODS,RESULTS,THERE,TPP
INTRINSIC,PDIA4,PDIA6,USING
AGREEMENT,INSTITUTES,NIH,THERE
10H,10I,169,549,COPYRIGHT,MDA,SAR,SAS
1990S,CREMOPHOR,DOCETAXEL,NAB,NSCLC,PACLITAXEL,TAXANES
EBV,EPSTEIN,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
504,AKT,ALK,HSP90,IPI,LABEL,NSCLC,OBJECTIVE,ONGOING,PURPOSE,RAF,RESULTS,SUMMARY
ASIAN,LABEL,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY,THERE,TKI
169,956,COPYRIGHT,CUAAC,INC,PDE4B,THESE,THREE
169,COPYRIGHT,DTX,EDB,FINALLY,LLC,TAKEN,TWEEN,U87MG
169,AUTHORS,BESIDES,COPYRIGHT,HCC,IRELAND,LTD,NANOSECOND,NSPEF,PUBLISHED
169,CISPLATIN,COPYRIGHT,DESPITE,IRELAND,LTD,NER,NUCLEOTIDE
034,100,169,181,200,543,915,ADDITIONAL,AUTHORS,COPYRIGHT,IRELAND,LTD,PUBLISHED,WHILE
169,ACCORDING,COPYRIGHT,PUBLISHED
001,004,169,248,602,966,AFTER,BACKGROUND,COPYRIGHT,HEART,INC,ISHLT,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE,TRANSPLANT
001,169,185,238,COPYRIGHT,CRC,HOWEVER,ILL,LABEL,LTD,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,296,382,COPYRIGHT,DDR,FEDERATION,PUBLISHED,SEVERAL,SOCIETIES,STRIKINGLY,THEREFORE
169,COPYRIGHT,COX,DEC,FORTY,HOWEVER,IPF,JAN,LTD,SEOUL,UNIVERSITY
12H,169,239,ASIAN,CAUCASIAN,COPYRIGHT,DCR,DESPITE,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,OVERALL,RESULTS,TTP
169,557,AMONG,COPYRIGHT,INFECTIOUS,JAPAN,LTD,MARCH,PUBLISHED,SEPTEMBER,SOCIETY,THERE
100,169,ANAPLASTIC,COPYRIGHT,CRIZOTINIB,INC,LABEL,LAT,LOCAL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OPD,PURPOSE,RESULTS
115,127,169,173,207,215,406,ACADEMY,ADDITIONAL,ASSESSMENT,COPYRIGHT,DIETETICS,EASTERN,GENERATED,GIVEN,GROUP,INC,NUTRITION,PATIENT,PUBLISHED,SGA,SUBJECTIVE,SYMPTOM
BACKGROUND,CNS,CONCLUSION,CSF,EATON,HOWEVER,LABEL,LAMBERT,METHODS,PUBLISHED,RESULTS,SERUM,TEXAS,UNIVERSITY
160,169,AKT,COPYRIGHT,INC,K36,MRG15,POL,PTB,SETD2,THESE
004,169,183,649,653,BACKGROUND,BLOOD,CLARA,COPYRIGHT,COX,FUNDING,HEART,INDEX,INSTITUTE,JAN,LABEL,LTD,METHODS,MORTALITY,RESULTS,SERUM,USA
077,119,169,183,263,391,786,827,946,AFTER,BACKGROUND,CHUNG,COPYRIGHT,FOUNDATION,FRAMEWORK,FUNDING,HEART,INSTITUTE,LABEL,LOCAL,LTD,METHODS,MORTALITY,PROGRAMME,PUBLISHED,REGIONS,RESULTS,SEVENTH,SWEDISH,TRUST
169,COPYRIGHT,LTD,NSCLC
169,501,529,945,BACKGROUND,BETWEEN,COPENHAGEN,COPYRIGHT,FOUNDATION,FUNDING,FVC,GENERAL,HOWEVER,HRS,IQR,LABEL,LLN,LTD,METHODS,NEVER,NOV,POPULATION,RESULTS,UNIVERSITY
169,AMONG,APRIL,COLLEGE,COPYRIGHT,DESPITE,MEDICAL,OVERALL,PUBLISHED,SIX,THERE
169,1CM,AFTER,COPYRIGHT,PUBLISHED,PULMONARY,REMOVAL,SAS
169,BACKGROUND,CONCLUSION,COPYRIGHT,DEFINITIVE,FDG,LABEL,LOBECTOMY,METHODS,NODULAR,PET,PUBLISHED,SAS
169,BACKGROUND,COPYRIGHT,DISCUSSION,HOWEVER,LABEL,METHODS,PUBLISHED,SAS
169,ANY,BACKGROUND,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SAS,THERE
169,COPYRIGHT,EHE,IRELAND,LTD,PLEURAL
006,120,169,ALK,BAC,BETWEEN,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RAS,RESULTS
169,184,237,238,BACKGROUND,CONCLUSION,COPYRIGHT,GUIDELINES,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
169,945,946,948,ADP,BCL,CONVERSELY,COPYRIGHT,ERK,JNK,JUN,LTD,NCI,NH2,NSCLCCS,OVERALL,PKC,PMA,TUNEL
001,100,169,588,774,99M,HCC,LABEL,MAA,MATERIALS,MEIER,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,PVT,RESULTS,SIR,SPECT
210,BOSUTINIB,KNOCKDOWN,NSCLC
945,HOWEVER,LPT,NSCLC,PCR,PEP,TRAF2,UPR,WESTERN
BACKGROUND,CURRENT,HOWEVER,INDICATORS,INSTITUTE,IOM,LABEL,MEDLINE,METHODS,NON,PROMS,RESULTS,THERE,THESE,USING
342,AFFYMETRIX,APOPTOSIS,BACKGROUND,DUE,HYPOXIA,LABEL,METHODS,MME,NON,NSCLC,RESPONSES,RESULTS,VIABILITY,WHILE
ASSESSING,NOVEL
CONCLUSION,GSH,HOWEVER,LABEL,METHODS,OBJECTIVE,OTM,RESULTS,ROS,SOD
946,INSULINOMA,MEDICAL,OTHER,THESE,TIH
169,177,215,AIR,NSCLC,PRESS,PUBLISHED,SURGERY,THERE,UNIVERSITY
001,017,020,031,059,223,237,322,508,534,981,CEA,COX,FORTY,TKI,UNIVARIATE
169,EPIDERMAL,IGF1R,MET,NVP,TKI
160,169,177,183,COMPARING,CONCLUSION,FRAUNHOFER,GEORG,GERMANY,HEALTHCARE,KEY,LABEL,MATERIALS,METHODS,MEVIS,OBJECTIVE,PHILIPS,PROTOTYPE,PURPOSE,RESULTS,SIEMENS,STUTTGART,UNTIL,VOLUMETRIC
169,BASED,BASEL,HOWEVER,SCREENING,SWISS,TRIAL
ANOTHER,FDG,OSTEOLYTIC,PET
DROSOPHILA,ECTOPIC,HIPPO,HPO,TDU,TEADS,VGLL4,YAP
013,229,577,ALS,ALZHEIMER,BACKGROUND,CNS,CONCLUSION,HUNTINGTON,INCREASED,ISI,KNOWLEDGE,LABEL,MARCH,MEDLINE,METHODS,PARKINSON,RESULTS,SCZ,SOURCES,THERE,WEB
34A,THESE,UTR
945,OCS,PENTRAXIN,THESE,TNF
169,ABCB1,ABCG2,BACKGROUND,BASEL,CPT,DESPITE,GEFITINIB,LABEL,METHODS,RESULTS
100,B2M,FAU,GAPDH,HPRT1,NORMFINDER,PCR,RPLP0,RPS11,RPS14,SEQ,TBP,UBC,YWHAZ
169,947,BASEL,CATENIN,EMT,FEW,MPM,TWIST
DUE
AFTER,CEA,HASHIMOTO,LABEL,LCNEC,METHODS,MTC,OBJECTIVE,SERUM,THERE
100,150,18F,420,840,BACKGROUND,CONCLUSION,FDG,LABEL,METHODS,NSCLC,PET,RESULTS
177,227,280,453,476,FNA,LABEL,METHODS,MFB,OBJECTIVE,RESULTS,THERE
001,022,169,APRIL,BACKGROUND,BASEL,CONCLUSION,FURTHER,L858R,LABEL,MAJOR,MARCH,METHODS,NSCLC,PFS,PREDICTORS,RESULTS,SEVENTY,TKI
025,067,096,ADVERSE,CCS,GRADE,GTV,MEIER,PTV,REGARDING,TOXICITIES,V10,V15,V20,V25
169,945,946,954,956,COPYRIGHT,IKK,SAS,TNF
23A,27A,BACKGROUND,BISULFITE,CONCLUSION,EPIGENETIC,LABEL,MET,METHODS,MPM,PCR,RESULTS
125,133,199,208,322,347,360,478,526,537,635,648,663,683,746,BACKGROUND,CONCLUSION,CRT,DUTCH,HOWEVER,HRT,LABEL,METHODS,NMB,NSCLC,QALYS,RESULTS,THEREFORE
173,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,T1BN0M0,VARIOUS
009,120,126,ACS,BACKGROUND,BCS,CONCLUSION,DISTANT,JANUARY,LABEL,LYMPH,METHODS,RESULTS,SMOKE,THERE
001,428,BACKGROUND,COX,ELDERLY,END,FACTORS,LABEL,METHODS,RESULTS
BACKGROUND,CONCLUSION,HOWEVER,L858R,LABEL,MARIE,METHODS,MOLECULAR,RESULTS,SCLCS,SEVEN,SIX,THERE,TKI
001,002,003,114,122,200,436,945,BACKGROUND,IHC,III,INHIBITION,LABEL,METHODS,PEMETREXED,RESULTS,THERE,THYROID,TTF
376,501,697,BACKGROUND,CIS,COMMUNITY,CONCLUSION,COX,FEW,HRS,LABEL,MARCH,METHODS,RESULTS,SEPTEMBER,SOUTHEAST,THESE,USING
000,BACKGROUND,CONCLUSION,GROUP,LABEL,METHODS,RESULTS
BACKGROUND,BASED,CHEST,COLLEGE,CONCLUSION,DEVIATIONS,LABEL,METHODS,NETWORK,ONTARIO,PHYSICIANS,PROGRAM,RESULTS,SCREENING,SOCIETY
MINIMALLY,REFERRING
001,133,169,530,AUDIT,BACKGROUND,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,RESULTS,STAGE,THESE,WESTERN
EXUBERANT
169,747,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,FURTHER,IHC,INC,LABEL,METHODS,NUT,RESULTS,SMALL
CARCINOMA,PET
150,169,COPYRIGHT,ERK,FAK,FINALLY,H1975,LTD,PCR,RAS,SCHMIDT,SRC,TAKEN,USING,UTR
169,298,398,599,BACKGROUND,CHINESE,COPYRIGHT,FURTHER,HAN,HOWEVER,LABEL,LCINS,LTD,METHODS,RESULTS,SNP
100,BETWEEN,CIS,CONCLUSION,HNB,KIT,LABEL,LOCAL,MATERIALS,MELAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE,T1B,T2B,T4B,TIS
177,3DCRT,AFTER,BACKGROUND,EPP,INTENSITY,LABEL,METHODS,MPM,OVERALL,RECURRENCE,RESULTS
946,BACKGROUND,BBR,BERBERINE,EMT,LABEL,METHODS,PCR,QRT,RESULTS,SINCE,TGF,WESTERN
AFTER,BACKGROUND,CHINESE,CONCLUSION,LABEL,METHODS,MFH,RESULTS,THERAPY,UNASSIGNED,VIRTUAL
169,CAUCASIAN,LABEL,LTD,METHODS,MOLECULAR,NSCLC,OBJECTIVE,RESULTS,SIXTY,WILEY
ANTIGEN,AREAS,BACKGROUND,COVERED,FURTHER,III,LABEL,METHODS,OPINION,OUTCOME,PHASE
003,402,833,CANCERS,PLAIN,SIMAV,SINCE
100,BACKGROUND,H1299,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS
177,AFTER,CASES,EMERGED,FIFTEEN,HOWEVER,LABEL,LARGE,LDDMM,MAPPING,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOMOGRAPHY
146,946,ADP,HOWEVER,NSCLC,STUDIES,WNT
147,415,549,AFFYMETRIX,AKT,BACKGROUND,CONCLUSION,EMT,LABEL,MET,METHODS,PLUS2,RESISTANCE,RESULTS,SW480,TGF
ITALY,MORTALITY,NPCSS,PROJECT,SITES,TARANTO,THESE
036,177,GTV,GTV3D,III,MLD,NSCLC,PLANEOE,PTV3D,THERE,V10,V20,V30,V40,V55,V60,V66
CURRENTLY,FDA,GUIDELINES,MUTATIONAL,NSCLC
025,169,361,500,CAUCASIAN,LABEL,MEIER,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,THERE,UNIVERSITY
169,ADC,NSCLC,PXD000438,SCC,SILAC,THERE,THESE,VCH,WILEY
076,174,227,272,ANXA1,DDX53,HOWEVER,IGG,III,NSCLC,STUDENT
11Q21,169,ANOTHER
320,584,904,BACKGROUND,EXPRESSION,FURTHER,GENOMES,KYOTO,LABEL,MATERIALS,METHODS,MICROARRAY,NSCLC,OMNIBUS,RAW,RESULTS,WEBGESTALT
AFTER,AIM,ANNOTATION,ARCHIVE,BASED,CUFFLINKS,EXPRESSION,FCGBP,GSM718709,GSM718710,KOBAS,LABEL,MATERIALS,METHODS,OBJECTIVE,OMNIBUS,ORTHOLOGY,RESULTS,SRA,THESE
231,600,FE3O4,FOURIER,III,PEI,TEM,VSM,XPS,XRD
MICRORNAS,NSCLC,SIMILARLY,SINCE,USING,WHILE
160,NIN,NON,NSCLC,PCR,RPN12,THEREFORE,THESE
MANAGEMENT,THERMAL
AKT,BIM,FOXO1,H1299,JNK,MTT,NUCLEAR,THESE,USING
190,214,FGFR3,INCREASED,LCS,PCR,R248C,R248H,R273C,TACC3
CUG,FINALLY,FURTHER,ISG15,ROS,SINCE,STAT1,TAKEN,UNDER,VSV
754,EFFORTS,ESTIMATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PSOAS,PURPOSE,RESULTS,SONOGRAPHY
ADX,BACKGROUND,COX,LABEL,MEIER,METHODS,OVERALL,RESULTS
001,109,484,BRCA1,CHINESE,ERCC1,FURTHER,HOWEVER,NSCLC
945,HIF
LABEL,LARGE,MMMFS,NEWLY,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE,UNASSIGNED,VIDEO
169,ACCORDING,COPYRIGHT,DESPITE,DISEASE,ENGAGEMENT,LTD
177,986,987,995,BLAND,CONCLUSION,FDG,ICC,INTRACLASS,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,RESULTS,THERE
CONCLUSION,JANUARY,KIDNEYS,LABEL,MALIGNANT,MATERIALS,METHODS,MRI,OBJECTIVE,PECOMAS,PRIMARY,RESULTS
ADDITIONAL,HOWEVER,MALIGNANT,MPM
169,AUTHORS,COLLEGE,JOURNAL,PHYSICIANS,ROYAL
100,BACKGROUND,CK7,CONCLUSION,LABEL,LANGERHANS,LCH,LIGHT,METHODS,TTF
107,137,375,CPG,MICRORNAS,NSCLC,PCR
ADPGK,ALDOA,ATP,GAPDH,GLYCOLYSIS,GPI,HK1,PCR
916,HEK293T,HEL,HEP,HOWEVER,HSV,IFI16,IFN,STING,US3
169,946,CONCLUSION,EMT,FINALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TGF,THESE
AKT,BASIC,ERBB3,JAK,JANUS,MEK,TKI
004,351,976,977,CONCLUSION,EVALUATING,HOWEVER,LABEL,METHODS,OVERALL,PET,RESULTS,THEREFORE,UNLABELLED
160,ADC,COX,HAG,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,169,183,ADMISSION,GEORG,HISTORY,LABEL,METHODS,STUTTGART,TREATMENT,UNLABELLED
12Q15,169,COPYRIGHT,DAVID,INC,SOMATIC,THESE,WILEY
047,127,415,490,COLORECTAL,EARLIER,HRS,OLDER,OVARIAN,SCREENING,TRIAL,USING
001,004,005,009,150,ACCORDING,AMONG,CERTAIN,EASTERN,GROUP,HOWEVER,ICU,KOREA,MECHANICAL,REFRACTORY
DESPITE,FAK,SRC,TREATMENT,USING
169,622,946,APC,COX,JEGHERS,LABEL,MOL,MYC,PEUTZ,PJS,RES,STK11,SUBSEQUENT,TCF,UNLABELLED,WNT
000,750,AES,AZD7762,CARDIAC,FORTY,GRADE,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS
967,AMONG,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TNM
DESPITE,FURTHER
M1B,MRI
10B,128,134,192,273,502,662,677,ABOUT,BACKGROUND,CURRENTLY,EXPRESSION,LABEL,METHODS,NLP,NSCLC,PCR,RESULTS,SCC
001,033,043,320,333,496,674,696,891,940,959,APRIL,BACKGROUND,CFI,CONCLUSION,COX,GAMMA,IDL,KNIFE,LABEL,METHODS,NON,OBJECTIVE,PER,PERFEXION,RESULTS,VARIABLES
146,169,BASED,COPYRIGHT,CROWN,ELF,INC,NBT,NON,NSCLC,PCR,PROGNOSTIC,PUBLISHED
169,HGSDC,PRIMARY
169,774,AKT,COPYRIGHT,ERLOTINIB,H1975,HOWEVER,INC,NSCLC,OSI,TAMOXIFEN,TARCEVA,THESE,THYMIDINE,TREATMENT
169,COPYRIGHT,FORMATION,LTD,SEVERAL
169,946,COPYRIGHT,EMT,HOWEVER,JNJ7777120,LTD,NSCLC,SNAIL,TGF,THEREFORE
169,177,AUTHORS,BIG,COPYRIGHT,ELISA,INC,KEY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERUM,THESE
110,19Q,234,BACKGROUND,CNS,CONCERNING,DETECTION,HOWEVER,LABEL,METHODS,OGD,RESULTS,UNASSIGNED,VIRTUAL
AGE,AMONG,DISTANT,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
125,945,946,CD117,CK5,CKPAN,E12,LABEL,METASTASIS,METHODS,OBJECTIVE,RESULTS,SMA,TEN,THESE
001,150,COX,KPS,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
181,ERLOTINIB,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,SERD0
945,946,957,APN,CLN,CNR,CONCLUSION,DEXTRAN,FE3O4,HUVEC,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,RGD10,ULTRASMALL,USPIO
001,002,021,177,CHINESE,LABEL,METHODS,MHCC97L,OBJECTIVE,ORTHOTOPIC,RESULTS,SONGYON,SONGYOU,THREE,YIN
100,169,177,949,956,COPYRIGHT,DOX,ECM,LNCAP,LRP,LTD,MDR,NPS,OVERALL,PCA,PCL,PEG,SEPARATELY,THREE
ACC,AMONG,AMP,APOPTOSIS,BAX,BCL,COA,DCM,ERICACEAE,H2O,HEMSL,NSCLC,RFL,URSOLIC
334,BACKGROUND,CONCLUSION,HPV,LABEL,METHODS,PCR,RESULTS
DIETARY,GSH,TAKEN
658,ADHERENCE,ECS,FAK,SRC,VEC,Y658F
312,375,711,ARG156ARG,ARG194TRP,ARG280HIS,ARG399GLN,ASN,ASP,ASP312ASN,ASP711ASP,COX,HRS,INDIVIDUAL,LYS751GLN,NSCLC,PCR,XPD,XRCC1
ADC,EXPRESSION,GENOMES,KYOTO,NON,NSCLC,OMNIBUS,SCC,THEREFORE
961,EXPRESSION,GIVEN,HOWEVER,NANOSTRING,NGS,OVERALL,PCR,THESE
169,560,ATP,EHF,LABEL,MOL,NSCLC,RES,SMARCA4,SNF,SWI,UNLABELLED
177,3N0M0,AFTER,BACKGROUND,EPP,III,LABEL,METHODS,MPM,OCTOBER,RADIATION,RESULTS,SMART,SURGERY,THERAPY
001,003,005,015,039,061,846,967,HCC,LABEL,LITERATURE,METHODS,OBJECTIVE,PITUITARY,PURPOSE,RESULTS
145,IRINOTECAN,THERE
CBL,DUE,EGF,MODEL
169,956,AMONG,COPYRIGHT,NOVEL,SAS,THESE
169,954,AKT,COPYRIGHT,CROWN,HBE,INC,ISG15,PUBLISHED,THESE,UBE1L
169,946,956,COPYRIGHT,CURCUMA,GTPASES,HOWEVER,INC,LASER,MEANWHILE,MMP,RHO
169,956,COMPOUNDS,COPYRIGHT,LOBELIA,NCI,NMR,THEIR,THREE
000,100,169,COPYRIGHT,LTD,RESULTS,SES,STATISTICS,THESE
949,954,IKK,JAK,JANUS,MEK,RAS,THESE
169,COLLISION,COPYRIGHT,INC
169,34A,BAX,BCL,COPYRIGHT,FEDERATION,FUNCTIONAL,NSCLC,PUBLISHED,SOCIETIES
001,100,10878,169,232,356,CONCLUSION,COPYRIGHT,DAILY,GFR,IRELAND,JANUARY,LABEL,LTD,METHODS,NPH,NSCLC,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SERUM,SINCE,SIXTY
006,200,BACKGROUND,CONCLUSION,IRELAND,LABEL,LTD,MANAGEMENT,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,TREATMENT,UVA
169,231,BACKGROUND,COPYRIGHT,GNP,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MDA,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,BACKGROUND,CHEMO,CONCLUSION,COPYRIGHT,CRT,CTCAEV3,III,INDAR,IRELAND,LABEL,LTD,MEIER,METHODS,NON,NSCLC,OVERALL,RESULTS
169,440,956,BACKGROUND,CONCLUSION,COPYRIGHT,ESOPHAGEAL,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
113,123,131,169,177,CONCLUSION,COPYRIGHT,CRT,EAR,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OED,PURPOSE,RESULTS,THREE
169,956,COPYRIGHT,H1299,LTD,MOM,MTT
169,COPYRIGHT,DIGITAL,INC,USING
945,AKT,ATP,CONCLUSION,FOXO1,H28,HOWEVER,INNOVATION,LABEL,MET5A,OBJECTIVE,RESULTS,SINCE,THESE
CRP,EVALUATION,HOWEVER,METASTATIC,RCC,UPPER,WHOLE
945,946,947,BACKGROUND,CONCLUSION,IFN,LABEL,METHODS,MIC,NKG2D,RESULTS,SKOV3,THESE,TNF
ACUTE,ARF,BACKGROUND,BURKITT,DIAGNOSIS,HMS,HODGKIN,ICU,LABEL,METHODS,NHL,RESULTS,THREE
111,LABEL,M5A,METHODS,OBJECTIVE,PURPOSE,RENAL,RESULTS,T84,TISSUES,UPTAKES,YET
100,125,151,BACKGROUND,CUP,EXPRESSION,LABEL,METHODS,POSITIVITY,RESULTS
221,481,506,AETNA,CONCLUSION,FEWER,IPA,LABEL,LEVEL,MAY,METHODS,OBJECTIVE,PATHWAY,PATIENT,PROGRAM,PSS,PURPOSE,RESULTS,SPECIALTY,SUPPORT,TEXAS,TOTAL,TXO
169,BACKGROUND,BON,HOWEVER,LABEL,MEK,METHODS,NCI,NET,PD0325901,PEPTIDE,QGP,RAS,RESULTS,THEREFORE
169,336,977,ALK,CHINESE,CONCLUSION,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,TEN,TKI,WESTERN
108,169,DESPITE,EMT,EPITHELIAL,LABEL,METHODS,MOLECULAR,MPM,NF2,OBJECTIVE,PATHWAY,PCR,PURPOSE,RESULTS,SIMILAR
15B,169,177,252,63743,945,946,956,ARTEMISIA,CHIMICA,COPYRIGHT,DDP,DOX,HELVETICA,MDR,NMR,SPS
BRONCHIAL
017,019,089,189,282,947,NSCLC,UNIVARIATE
967,BRCA1,COX,ERCC1,HRS,JANUARY,NSCLC,PFS,XPG
001,BACKGROUND,BMJ,DLCST,GROUP,LABEL,LIMITED,METHODS,MISSING,OVERALL,PUBLISHED,PUBLISHING,RESULTS,SCREENING,SMOKING,THERE,TRIAL
160,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
ALTOGETHER,AML,AUSTRIA,LABEL,METHODS,OBJECTIVE,PROPORTION,PURPOSE,RESULTS,TYROL
160,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SIMULATION,VIDEO
001,105,215,218,320,329,387,573,686,ASSOCIATED,DISEASE,LABEL,LYMPH,METHODS,OBJECTIVE,OBJECTIVES,RESECTION,RESULTS,THERE,WHILE
001,002,006,115,170,220,592,CONCLUSION,FDG,INITIAL,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,TEXAS,UNIVERSITY
APRIL,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RADICAL,RESULTS,SPT
169,GENERAL,OWING,PERHAPS,SMOKING,SURGEON,TOBACCO
001,149,332,ALK,L858R,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
DCA,FURTHER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SYNERGY,UNDER
ATR,NSC746364
3KT,DNMT1,FINALLY,HDAC1,HDAC2,HDAC3,HDACS,SFRP2,TARGETING,THESE,TREATMENT,VPA
001,452,50S,794,897,AMONG,KEY,KINGDOM,LABEL,LIVERPOOL,OVERALL,RESULTS,SCREENING,THOSE,UNLABELLED
129,155,172,1980S,CK5,CK7,HOWEVER,MAJOR,MINOR,OVERALL,TTF
CURRENTLY,LABEL,MAJOR,OBJECTIVE,OPTIMIZED,PURPOSE,RESULTS,SCREENING,SUMMARY,THREE,TRIAL
LABEL,NGS,OBJECTIVE,PURPOSE,RESULTS,SQCCS,SUMMARY
LABEL,MALIGNANT,MPM,OBJECTIVE,PROGNOSIS,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE
ANTIGENIC,BLP25,III,LABEL,NSCLC,OBJECTIVE,PURPOSE,RCT,RESPONSES,RESULTS,SEVERAL,START,SUMMARY,TRIAL
AXL,THEREFORE,USING,WHILE
ACCORDING,BACKGROUND,CONTEXT,EBV,EPH,EPSTEIN,FOLLOWING,LABEL,LMP,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SCC
169,1MG,CAO,COPYRIGHT,MGO,RER,SEM,THESE,WHILE
00001,500,ASIAN,III
169,947,AZA,COPYRIGHT,CPG,DAC,FINALLY,HLA,IFN,MEIOB,TAKEN
169,AKT,COPYRIGHT,ERK,INC,PC9,SRC,TKI,U0126
169,490,CCND1,COPYRIGHT,INC,MICRORNAS,THESE,UTR
169,ACTIVATION,ANNEXIN,APOPTOSIS,BBB,CASPASE,COPYRIGHT,FAILURE,IRELAND,LTD,OVERALL,PEI,PROPIDIUM,STAT3
169,400MG,622,665,AIM,BCL,BIM,CONCLUSION,COPYRIGHT,DCR,HFS,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PFS,PRIMARY,RESULTS,SECONDARY,SORAFENIB,TKI
100,169,COPYRIGHT,IHC,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS
001,002,004,005,016,123,169,CENTROMERE,COPYRIGHT,P53,PCR,WESTERN
978,BACKGROUND,CD133,DSB,FINALLY,H1299,IRELAND,LABEL,LENTIVIRAL,LTD,MATERIALS,METHODS,PCR,PRIOR,PUBLISHED,RAD51,RESULTS
169,AUTHORS,BASED,COPYRIGHT,IRELAND,LIMITED,LTD,PUBLISHED,RNI,SUBSETS,WBI,WHILE
113,122,169,183,239,242,364,910,AFTER,ASIAN,BACKGROUND,BOEHRINGER,CHINA,CLINICIANS,COMMITTEE,COPYRIGHT,FIRST,FUNDING,INGELHEIM,JOINT,KOREA,LABEL,LEU858ARG,LTD,METHODS,NSCLC,RESULTS,SOUTH,TREATMENT
169,INC,USING
001,169,232,AOM,COPYRIGHT,DSS,NSCLC,PROTEIN,SAS,SHP,TNM
169,340,BACKGROUND,BETWEEN,COPYRIGHT,COX,DCR,GUSTAVE,IRELAND,LABEL,LTD,MEIER,METHODS,MUT,NSCLC,PFS,RESULTS
145,148,149,150,169,174,BACKGROUND,COPYRIGHT,IRELAND,IVD,KIT,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,RGQ,SINCE,THEREFORE,THREE
105,129,145,169,177,BACKGROUND,COPYRIGHT,JANUARY,LABEL,METHODS,MHZ,OBJECTIVE,PPL,PUBLISHED,RESULTS,SEPAR
169,CEREBELLAR,MRI
169,486,ALLERGY,BACKGROUND,CIS,COLLEGE,CONCLUSION,COPYRIGHT,HAY,HISTORY,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,ORS,PUBLISHED,RESULTS
ASIAN,BACKGROUND,BETWEEN,JOURNAL,LABEL,METHODS,OBJECTIVE,PACIFIC,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS,RURAL,THERE
169,243,493,AFTER,BACKGROUND,COPYRIGHT,DVT,ENFERMEDAD,INC,LABEL,METHODS,MOSBY,PUBLISHED,RESULTS,RIETE,SOCIETY,SURGERY,THESE,TROMBOEMB
169,183,215,AAV,BACKGROUND,CHM,COPYRIGHT,DEPARTMENT,DESPITE,FUNDING,LABEL,LTD,MAXIMAL,METHODS,RAB,RESULTS,THESE,TRUST
002,110,169,BACKGROUND,COPYRIGHT,EXCLUSIVE,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR
001,100,169,249,932,COMPLEX,CRIBRIFORM,DISEASE,PATHOLOGIC,SOCIETY,THESE
169,176,177,APN,ASPARAGINE,COPYRIGHT,INC,LABEL,MB231,MBQ,MDA,METHODS,NGR,PET,RESULTS,UNLABELLED
197,205,978,985,ACSL1,AUC,AXIN2,BACKGROUND,CHINESE,CURRENTLY,FOXO3,GENOMES,KYOTO,LABEL,METHODS,PCR,PPP1R3A,PREDICTED,RESULTS,RUNX1,SMAD4,TBL1XR1,TEN
105,149,BACKGROUND,CHINESE,COX,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,UNIVARIATE
169,946,AUTHORS,CALU3,EXPRESSION,H23,KNOCKDOWN,LTD,NCI,NOD,PTY,PUBLISHING,SB208,SCIENCE,SMAD2,TGF,THESE,WILEY
786,ADR,ANTICANCER,EHRLICH,ERS,MODULATORS,NCI,OVCAR,PSIDIUM,RECEPTORS,RES,SELECTIVE,SERMS,SOLID
169,177,AFTER,AUSTRALIAN,COLLEGE,CONCLUSION,DELAYED,FDG,LABEL,METHODS,NON,OBJECTIVE,PET,PURPOSE,RESULTS,ROYAL,SUL,SUV,WHILE,ZEALAND
160,945,946,947,EMSAS,IFN,LXR,LXRES,SEVERAL,TAKEN
012,100,177,BACKGROUND,LABEL,METHODS,OBJECTIVE,PCU,RESULTS,SETTING,THERE,UNIVARIATE
945,A12,AKT,BACKGROUND,BECAUSE,COX,HIF,IGF,IMC,LABEL,METHODS,MTT,NSCLC,RESULTS,TAKEN,USING
CONCLUSION,HEALTHY,HOWEVER,LABEL,METHODS,OBJECTIVE,OUTCOME,RESULTS,RETIREMENT,THESE,USING
20S,BACKGROUND,DIRECTIONS,DISSECTING,LABEL,THERE,WHEREAS
BACKGROUND,BRAIN,LABEL,METHODS,RESULTS,USING,WITHOUT
169,CONSISTENT,ILLNESSES,SMOKING
IIA,SCC,SEVEN
1950S,COMMITTEE,GENERAL,SURGEON,THESE
005,007,022,027,045,COX,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,TNFSF13
169,181,5MC,945,ALU,AMBIENT,BEIJING,CHINA,COPYRIGHT,EFFECTS,HOWEVER,INC,MEASURING,OVERALL,PM2,SAT,THERE,WILEY
169,AKT,BCL,CD133,CSC,NOTABLY,PKB,SMALL
150,515,983,AMONG,BACKGROUND,EASTERN,GROUP,INVENTORY,LABEL,METHODS,RATINGS,REGRESSION,RESULTS,SYMPTOM
148,327,ASA,DUE,PCR,SER326CYS,SIMILARLY
169,CARLO,LABORATORY,MCNP5,MONTE,OAK,PRESS,PUBLISHED,RIDGE,UNIVERSITY
100,177,BASED,CONCLUSION,DOTATOC,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
131,APRIL,CONCLUSION,EIGHT,FDG,FURTHER,GBQ,HODGKIN,LABEL,MARCH,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RIT,SIP,SPECT,TENARAD
174,239,FDA,GIOTRIF,III,L858R,LUX,NSCLC,TKI
169,CHRONIC,DESPITE,ERS,EUROPEANS,USING
009,023,034,313,ADC,ATS,EASTERN,ERS,FACTORS,GROUP,IASLC,OVERALL,PFS,PROGNOSTIC,SINCE,SOCIETY
169,BASEL,BIOLOGICAL,HOWEVER,USING
AUTOPHAGY,MDR
02E,23E,40E,946,AUGMENTED,EGF,FGF,FINALLY,HOWEVER,RHO,TGF,THESE
160,DUE,LINAC
169,AKT,CLINICALLY,COPYRIGHT,DISRUPTION,IRELAND,JNK,LTD,NSCLC,STAT3,TAKEN
100,112,160,176,200,CATPHAN,RMG
169,AMPLATZER,AVP,BACKGROUND,BASEL,BPF,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SHORT
169,181,190,APRIL,BACKGROUND,BASEL,DISCUSSION,EUS,INFECTIOUS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SAE,SERIOUS
255,CDT,CYTOLETHAL,LEWIS,LFN
231,4T1,BCL,CAM,HOWEVER,JNK,JUN,MCL,MDA,SCF,T24,TRAIL,TUBULIN,UNRAVELING
100,DUE,FNA,HPC,LABEL,METHODS,OBJECTIVE,RESULTS,SIX
205,945,BACKGROUND,CONCLUSION,H2170,HOWEVER,LABEL,LUCIFERASE,METHODS,NSCLC,RESULTS,TMPRSS4
034,138,154,176,177,390,627,750,BACKGROUND,FIBRINOGEN,LABEL,METHODS,MPM,RESULTS
231,BACKGROUND,CARIPORIDE,LABEL,MCF,MDA,METHODS,PD98059,RESULTS,TAKEN
128,169,CAD,COPYRIGHT,THEREFORE
947,LTD,PUBLISHED
150,169,956,AFM,BSA,CBM,CNP,COPYRIGHT,MTT,MTX,SEM,THESE
169,460,COBRA,COPYRIGHT,HOWEVER,NCI,RAS,RASSF,RASSF10,SAS,TAKEN,TREATMENT
169,189,300,300CC,BACKGROUND,CONCLUSION,COPYRIGHT,EFS,FURTHER,III,IRELAND,LABEL,LTD,MAGNITUDE,METHODS,NSCLC,OTHER,PTV,RESULTS,THREE
000,001,003,021,105,112,116,161,166,177,181,271,541,644,967,CEA,GGO,JANUARY,LABEL,METHODS,OBJECTIVE,PET,RESULTS,T1A,THERE
HOWEVER,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OCTOBER,PLE,RESULTS
169,183,189,APPLIED,AUG,BACKGROUND,BANKS,COPYRIGHT,DEC,ENGLAND,FUNDING,INSTITUTE,LABEL,LTD,METHODS,OTHER,PROGRAMME,PUBLISHED,RESULTS,SELECTION
100,181,460,956,ACD,CHEMSKETCH,DOCKING,GIVEN,MCF,MOLECULAR,NCI,TELOMERASE
BMPR2,BRCA1,ECS,OCCLUSIVE,PAH
023,107,162,240,453,490,492,502,617,CONCLUSION,ETHNICITY,FURTHER,HISPANICS,ICD,LABEL,MEDICAL,METHODS,OBJECTIVE,PANEL,RESULTS,SMOKING
946,954,ABSENCE,HMGB1,NAC,PCR,TLR,USING
003,100,101,137,181,AHI,AKERN,BACKGROUND,BCM,BIA,BMI,CRP,ECW,ELISA,FFM,GRASS,ICW,ITALY,LABEL,METHODS,MODEL,OBJECTIVE,OBJECTIVES,PSG,RESULTS,RJL,TBW
308,335,670,916,AFTER,ERS,LABEL,MAYBE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER
CUTANEOUS,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE,SERPENTINE,THESE,WHILE
ALONG,CAP,CURRENT,ENETS,FURTHER,MOLECULAR,NET,NORTH,OTHER,PANNETS,PER,PREVIOUSLY,SOCIETIES
954,BIM,CRL,E3S,MLN4924,SAG,TREATMENT,USING
006,100,169,ADVERSE,DISEASE,DL3,EGF,ERLOTINIB,FPB,FURTHER,LABEL,LOW,METHODS,MTD,NSCLC,OBJECTIVE,PFS,PURPOSE,QTC,RESULTS
100,169,L858R,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,T790M
COMMITTEE,JOINT,LABEL,MEANWHILE,OPINION,PAP,RADIATION,RESULTS,STATEMENT,UNASSIGNED
119,AMONG,CHINA,FURTHER,HOWEVER,THEREFORE,TODAY,TOTAL,YADANZI
100,HMB,THEREFORE
ACUTE,COCAINE,VARIOUS
BACKGROUND,CLARA,DESPITE,LABEL,LYMPHATIC,METHODS,OBJECTIVE,RATIONALE,RESULTS,VEGFR
169,64257,AUNBS,COPYRIGHT,LTD
CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SIR,SLE
CONCLUSION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
945,BACKGROUND,IMMUNOBLOT,LABEL,METHODS,OPTICAL,RESULTS
AKT,CD226,CLAUDIN,ERBB2,ERK,HDL,HOWEVER,LDL,MICROARRAY,OCLUDIN,THESE
185,HIF1A,MAJOR,PIR,SRSF2,VEGFA
AKT,CL1,HSP90,INHIBITION,NATURAL,PBT,TAKEN
CIGARETTE,HPHCS,WHOLE
169,AUTHORS,BALLANTYNE,CMN,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY,VARIOUS
QOL,WHITE
119,136,347,ALK,CRIZOTINIB,FURTHER,HOWEVER,OTHER,THESE,XALKORI

BMT,EBV,LABORATORY,THESE,THREE
0X3,100,8X3,AE1,AE3,CAM,GROSSLY,MEANWHILE,ZELLBALLEN
130,AMONG,HDAC9,THESE
100,496,954,AKT,ERK,HOWEVER,INGENUITY,IPA,NSCLC,PATHWAY,PCR,THEREFORE
BAX,BCL,FURTHER,GAMBOGE,GAMBOGENIC,GFP,GNA,HOWEVER,LC3,MDC,SIMILAR
IAP,INHIBITION,ROS,SCAVENGING
300,3LL,6NTAC,954,AIM,BACKGROUND,C57BL,CHAIN,CONCLUSION,LABEL,LEWIS,MATERIALS,METHODS,OBJECTIVE,PCR,POLYMERASE,RESULTS,SRS,TBI,WHILE
080,169,235,BLOOD,CONCLUSION,FEDERATION,HCC,HEART,HOWEVER,INSTITUTE,JANUARY,LABEL,LIMITED,LIVER,METABOLIC,THERE,UNLABELLED
CHINESE,COX,EASTERN,GROUP,MEIER,NON,NSCLC,PCR,PFS
160,58CPG,946,95C,95D,AHR,AZA,DCN,DECORIN,HOWEVER,NSCLC,PCR,SMAD3,TAKEN,TGF,UTR
001,006,023,148,310,419,DOCUMENTED,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS
173,177,AFTER,AXL,CY5,LABEL,METHODS,NCI,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,SELECTIVE
169,CARLO,CONFORMITY,COPYRIGHT,D95,IRELAND,ITV,LABEL,LTD,MATERIALS,METHODS,MONTE,NSCLC,OBJECTIVE,PLANNED,PTV,PURPOSE,RESULTS,SIB,TOMOPEN,TVS
252,AGE,AMONG,DTC,LABEL,MEN,METHODS,MTC,OBJECTIVE,PFS,PRIMARY,RESULTS,SEQUENTIAL,THERE,TKI
169,ADJUSTING,BACKGROUND,COPYRIGHT,HRS,INC,LABEL,LVI,MEDLINE,METHODS,NSCLC,PUBLISHED,RESULTS,RFS,SOCIETY
100,169,AFTER,APRIL,BACKGROUND,BETWEEN,COPYRIGHT,III,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE
160MG,427,AFTER,AMONG,CAB,CENTRAL,DISTANT,M1B,NODAL,PCA,PSA,RADICAL,T1C,TREATMENT
THESE
650,775,BACKGROUND,CONCLUSION,CSI,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,USING,WHETHER
CURRENTLY,ITV,MIP,PET,PREDICTED,SUV,VMSBR
947,ARC,DQA,DTA,ECLIPSE,PHANTOM,RAPID,THESE
3MM,6MM,DIBHS,THERE
215,AAA,AXB,ECLIPSE,GROUP,NSCLC,PTV,R50,RADIATION,SIMILARLY,THERAPY,TPS,V20
177,3MM,NSCLC
0TO,100,CARLO,D95,D99,FIFTY,GTV,MONTE,PRESCRIBED,PTV,SIMILAR
029,068,281,385,596,750,756,795,967,ADVERSE,CLASS,DCR,ERCC1,FURTHER,III,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,ORR,PFS,RESULTS,THERE
ANTIBODIES,IGE,TH2
169,CONCLUSION,GDC,GLI,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMO,SMOOTHENED,XENOGRAFTS
169,956,CIGARETTE,COPYRIGHT,HNE,INC,SCAVENGER
BACKGROUND,BREATHING,CONCLUSION,DELIVERING,EIGHT,HEART,LABEL,LAD,METHODS,RESULTS,TCP
001,026,033,132,16HBE,497,703,868,ACCORDING,ATS,BACKGROUND,COX,ERS,IASLC,LABEL,LAD,MEIER,METHODS,MPA,NOTCH,PCR,PPA,RESULTS,REVERSE,SOCIETY,SPA,WESTERN
004,135,298,BACKGROUND,JANUARY,LABEL,MARCH,METHODS,RESULTS
BACKGROUND,BV6,C16,CONCLUSION,CONSISTENT,FAS,HOWEVER,IAP,LABEL,LCL85,METHODS,RESULTS,SILENCING
169,AFTER,AUTHORS,BECAUSE,LTD,PATHOLOGY,PTY,PUBLISHING,S10,SOCIETY,WILEY
023,045,104,169,507,ALDH1,AUTHORS,LTD,NSCLC,PATHOLOGY,PROGNOSTIC,PTY,PUBLISHING,SOCIETY,WILEY
100,297,ALK,ASIAN,BACKGROUND,CHINESE,EIGHT,HOWEVER,IHC,LABEL,METHODS,PCR,RESULTS,THREE,UNASSIGNED,VENTANA,VIRTUAL
231,549,956,ACCORDING,DYSIDEA,MCF,MDA,MRC
BACKGROUND,CRT,DEC,LABEL,MEIER,METHODS,NON,NSCLC,ORR,PFS,RESULTS,SEP,SMALL
III,KINETIC,TI2TF
AFRICAN
HOWEVER,SMALL
COMMENTARY,ERM,INCREASING,MEMBERS,SIMILARLY
177,24H,293,48H,945,AFTER,BAMHI,CMV,CONCLUSION,ELISA,GFP,HIF,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SHUTTLE
169,BACKGROUND,GATA3,GCDFP,LABEL,METHODS,RESULTS,SOCIETY
160,169,183,CAUCASIAN,END,GEORG,STUTTGART,USA
EPIDERMAL,FGFR1,HOWEVER,MET,NUT,OTHER,OWING,STAGING,THESE
CONCLUSION,GAMMA,HOUNSFIELD,ICE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TPS,TRE,VALIDATION,WHILE
001,029,046,177,183,211,BACKGROUND,GEORG,JANUARY,LABEL,LOBECTOMY,MATERIALS,METHODS,NSCLC,RESULTS,SEPTEMBER,STUTTGART
200,400,ACCRUAL,GRADE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PDGFR,PREVIOUSLY,RAF,RESULTS,SORAFENIB,VEGFR
169,540,COX,DIFFERING,FRAMINGHAM,HISTOLOGY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PROPENSITY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY,WEDGE
106,127,159,169,286,DIAGNOSTIC,EUS,FALSE,FNA,FOLLOWING,JANUARY,LABEL,METHODS,NPV,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STATION,SURGERY,TEMLA,UNIVERSITY
106,COX,CSS,DMS,FOLLICULAR,FTC,MEIER,PROGNOSTIC,THEIR,UNIVARIATE
740,ADJUSTING,BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PACKS,PICTORIAL,PUBLISHED,PUBLISHING,RESULTS,SMOKERS
001,039,040,552,602,HOWEVER,NSCLC,TELOMERASE,THESE
015,019,126,HOWEVER,NSCLC,PCR,RAF,TNM
001,007,009,016,032,045,086,AKT,ASIAN,ERK,L858R,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
215,AGREEMENT,BMI,FORTY,FURTHER,LABEL,MDS,METHODS,MPS,NRS,OBJECTIVE,PURPOSE,RESULTS,SGA
ASIAN,DISEASE,HAP,HOUSEHOLD,INITIATIVE,LABEL,NONSMOKERS,OBJECTIVE,PREVALENCE,PURPOSE,RESULTS,SMOKING,SPIROMETRY,SUMMARY,THERE
000,118,ADULT,ENGLAND,ENGLISH,EPISODE,HODGKIN,INCIDENCE,JANUARY,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STATISTICS,STRATEGIES,THERE
107,ALK,AMONG,CHINESE,HOWEVER,LIVER,RET,ROS,THESE
270,A20,ALK,ANAPLASTIC,BACKGROUND,E13,I1171FS,LABEL,METHODS,NSCLC,RESULTS,T1312FS
124,197,APRIL,BACKGROUND,CONCLUSION,FACTORS,FORTY,LABEL,METHODS,NEWLY,NSCLC,PREDICTIVE,RESULTS,SRE,TREATMENT
026,500,BACKGROUND,CONCLUSION,DFS,EASTERN,GGH,GROUP,LABEL,METHODS,PATHOLOGIC,RESULTS,SLC19A1,THERE
125,130,225,APRIL,BACKGROUND,BETWEEN,CONCLUSION,LABEL,METHODS,NSCLC,PEMETREXED,PFS,PRIMARY,RESULTS,SEPTEMBER,THERE
500,539,BACKGROUND,EASTERN,GROUP,III,LABEL,METHODS,OTHER,PARAMOUNT,RESULTS
145,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,PFS,RESULTS,SOMATIC,TKI,TTR
001,005,026,029,079,133,138,314,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS
001,002,111,114,225,358,BACKGROUND,COX,G719X,HOWEVER,L858R,L861Q,LABEL,METHODS,OVERALL,RESULTS
BACKGROUND,CD14CD204,CD204,CONCLUSION,LABEL,METHODS,RESULTS
148,AKT,BACKGROUND,CHRONIC,CONCLUSION,L78,LABEL,M3R,METHODS,MUSCARINIC,NSCLC,RESULTS,WESTERN
199,BACKGROUND,BIOMARKER,COMPOUNDS,CONCLUSION,JANUARY,LABEL,METHODS,NSCLC,PHYSICIANS,RESULTS,SIX
001,009,016,704,746,ASIAN,BACKGROUND,CONCLUSION,COUNTRY,INDIA,LABEL,METHODS,PIONEER,RESULTS
DESPITE,NSCLC,THESE
125,200,ASIAN,AUC,BACKGROUND,CONCLUSION,GRADE,III,LABEL,METHODS,NSCLC,ORR,PFS,PRIMARY,RESULTS,TRIAL
MANAGEMENT

IMAGE,LOCAL
INDIA,LAM,THERE
BACKGROUND,HOWEVER,LABEL,METHODS,NPV,RESULTS,SINCE
044,FURTHER,MACINTOSH,PLL,THERE,VIRTUAL
BACKGROUND,CYTOLOGIC,LABEL,METHODS,RESULTS,THERE
001,287,652,870,939,967,CONCLUSION,DETECTION,DIAGNOSTIC,HOWEVER,ITALIAN,LABEL,METHODS,MSC,OBJECTIVE,PURPOSE,RESULTS
001,136,242,721,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHS,TORONTO
BETWEEN,CONCLUSION,CVD,END,FALLING,LABEL,MEASURING,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS
HOWEVER,TSG
ACTIVATION,ALK,ASP3026,ATP,ECHINODERM,FINALLY,H2228,MET,NCI,NSCLC,TAKEN
AFTER,BRAIN,MAY,MRI
130,FURTHER,GIVEN,HPV,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEQUENCING,USING
THREE,THYROID,TTF
169,COPYRIGHT,FURTHER,LTD,MCF,MTT,SW480
100,169,179,295,ALK,COPYRIGHT,IHC,INC,MOLECULAR,NSCLC,PATHOLOGY,PCR,PUBLISHED,RET,SOCIETY,USING
947,ATP,FIRST,H2A,MRS2578,P2Y12,PCR,SINCE,TAKEN,THEREFORE,UTP
169,BACKGROUND,COPYRIGHT,ELDERLY,III,INC,ITALIAN,LABEL,METHODS,MILES,NSCLC,PRIMARY,SECONDARY
169,219,30B,340,502,945,954,CASP9,CELLS,COPYRIGHT,HEPG2,HOWEVER,SEQ,THEREFORE,THESE,TNF
169,567,590,750,CONCLUSION,COPYRIGHT,DLCST,EUR,EUROS,IQR,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SEPTEMBER,TOTAL
169,AZD7762,BACKGROUND,COPYRIGHT,H1299,H1993,INC,LABEL,METHODS,NSCLC,RESULTS,TARGETING,THERE,WESTERN
169,CONCLUSION,COPYRIGHT,FDG,FRACTAL,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
169,AUC,CAD,COPYRIGHT,FPR,LTD,ROC
000,004,040,044,047,050,229,426,631,967,COX,JINLING,LABEL,LOG,MEIRE,METHODS,NSCLC,OBJECTIVE,OCTOBER,PTP1B,RESULTS
003,006,014,015,018,025,031,036,044,100,166,177,213,387,410,500,618,623,AMONG,ANOTHER,CONCLUSION,DEPARTMENT,HOWEVER,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,THEIR,THERE,THIRD,UNIVERSITY,XINQIAO
177,232,347,484,AMONG,FDG,LABEL,METHODS,OBJECTIVE,OCTOBER,PET,RESULTS,ZHONGSHAN
000,177,708,CONCLUSION,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
015,034,222,864,AFFILIATED,AMONG,CEA,CONCLUSION,FUDAN,GGN,GGO,LABEL,METHODS,NSE,OBJECTIVE,OTHER,RESULTS,SCC,THERE,UNIVERSITY,ZHONGSHAN
009,047,ASA,BACKGROUND,CRC,LABEL,METHODS,PULMONARY,RESULTS,SEX,SIXTY,SOCIETY
AFTER,CNP,DEVELOPING,FPF,RESULTS,SPC,THEREFORE,USING
169,172,954,BACKGROUND,BRITISH,FUNCTIONAL,LABEL,OPIOIDS,SOCIETY,THESE,UNLABELLED
946,AMONG,INHIBITION,TGF
4T1,BCL,CLEAVED,DISCOVERY,FAK,FDA,FURTHER,MCL,MDSCS,MVD,NOTABLY,SRC,STAT3,TAKEN,WESTERN
BEIJING,CARLO,CHINA,MONTE,PAF,PAH,PIF,SEVERAL,THEIR
4T1,946,947,CD11B,CD4,FOXP3,GR1,IFN,MHC,TAKEN,TGF,TREGS
235,311,546,BACKGROUND,LABEL,METHODS,RESULTS,SIX,THERE,THESE
004,AUC,BACKGROUND,BETWEEN,CONCLUSION,EARLY,IRB,JANUARY,LABEL,METHODS,OCTOBER,PSN,RESULTS,TEXTURE
117,119,136,215,522,689,730,831,862,BACKGROUND,BASED,CHINA,CHINESE,IHD,LABEL,LCD,LER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SHS,SMOKING,THESE
032,188,290,408,447,472,490,717,803,ABOUT,KIRSTEN,LPS,NETWORK,NOTABLY,NSCLC,THESE
BMJ,CANCERS,COLORECTAL,GROUP,LIMITED,PUBLISHED,PUBLISHING,PULMICC,PULMONARY,SARCOMA,THERE,THESE
001,101,165,169,260,290,304,362,691,823,996,EARLY,FATIGUE,FIFTEEN,RCC,SUMMARY,TREATMENT
278,AFTER,CONCLUSION,ENGLAND,ENGLISH,FITTING,INCREASING,LABEL,MECHANICAL,METHODS,MODELLING,OBJECTIVE,OUTCOME,RESULTS,SETTING
169,2DE,AMONG,INGENUITY,LABEL,MALIGNANT,METHODS,MPM,OBJECTIVE,OVERALL,PURPOSE,RELEVANCE,RESULTS,VCH,WESTERN,WILEY
169,ELISA,GELATIN,GROUP,LABEL,METHODS,MMP,OBJECTIVE,PURPOSE,RELEVANCE,RESULTS,SERUM,THERE,VCH,WILEY
169,183,AFTER,BACKGROUND,ENDOSCOPIC,EUS,FALSE,FNA,GEORG,LABEL,MALIGNANT,METHODS,OBJECTIVE,RESULTS,STUTTGART
103,160,960,MAXIMUM,QUALITY
001,100,967,BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY
013,HOWEVER,IMMUNOBLOT,MEIER,NSCLC,RING1,TNM
ARG,ASN,ASP,CA1,CA2,GLY,MAGNEVIST,MRI,NGR,RGD
114,119,120,176,211,424,BEGINNING,HOWEVER,RISKS,SWEDISH
114,120,160,215,ACUTE,APRIL,BACKGROUND,CONCLUSION,LABEL,MARCH,METHODS,NSCLC,RESULTS
100,160,AIM,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RADIATION,RESULTS

ABSENCE,MRI
AKT,FURTHER,LEWIS,LLC,MMP,NSCLC,THERE,WESTERN
043,12H,178,183,185,250,261,398,542,813,AUC,FURTHER,LABEL,LSS,METHODS,OBJECTIVE,PURPOSE,RESULTS
AMONG,BACKGROUND,HLA,LABEL,MOTIVATION,RESULTS
ALTOGETHER,ATP,CRE,DEPLETION,FOXP3,SUBSEQUENT,TREGS
418,ACTIVATING,GNA11,HENCE,HOWEVER,MEK,PKC,UMS,UVEAL
954,AKIP1,AP2,HENCE,HOWEVER,SP1
100,160,169,47D,956,COPYRIGHT,HBL,OVERALL,SAS,THESE
169,COPYRIGHT,IRELAND,LTD,NSCLC,TKI
111,125,169,240,ACTIVATING,CONCLUSION,COPYRIGHT,E746_A750,IHC,IRELAND,L858R,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SP111,SP125,THEREFORE,VARIOUS,WHILE
169,176,181,24H,BACKGROUND,CONCLUSION,COPYRIGHT,HENCE,IRELAND,ISOLATION,LABEL,LTD,METHODS,MIA,MTT,NMR,PETROLEUM,RELEVANCE,RESULTS,STRUCTURE,THREE
100,160,169,COPYRIGHT,FNA,HENCE,INC,MOLECULAR,PATHOLOGY,PCR,PROGNOSIS,PUBLISHED,SOCIETY
169,215,CARTESIAN,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,SLR
169,178,COPYRIGHT,EBP,HACAT,HOWEVER,IRELAND,LTD,ROS,SOLUBLE,THESE,THREE
169,2OHOA,CDK,COPYRIGHT,ISSUE,MLT,PATHOLOGY,PHYSIOLOGY,PKC,RAS,RELEVANCE,SMS,SPECIAL,STRUCTURE,THERAPY,THESE
160,169,176,AFTER,BIOLOGY,COPYRIGHT,FEDERATION,INC,MHZ,PUBLISHED,RAYLEIGHS,SPEED,ULTRASOUND,WORLD
137,169,BESIDES,COPYRIGHT,KIT,MDR,MIR,PUBLISHED,RESULTS,SAS
150,169,AMONG,FOCAL,HOWEVER,IMT,INSULIN,OTHER
169,945,946,BAIBA,COPYRIGHT,INC,PGC
169,183,199,200,206,211,322,336,652,655,659,714,AFTER,BACKGROUND,BETWEEN,BOEHRINGER,COPYRIGHT,DEC,FEB,FUNDING,GRADE,INGELHEIM,IQR,LABEL,LTD,METHODS,NINTEDANIB,NSCLC,PFS,RESULTS,SIMILAR
001,040,169,177,399,696,789,AMONG,AUC,BACKGROUND,BED,COPYRIGHT,INC,ISO,KARNOFSKY,LABEL,LOCAL,MATERIALS,METHODS,NSCLC,RESULTS,ROC,SEVERAL,SVM,TCP,THESE
003,164,169,215,366,956,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OPTIMAL,ORS,PURPOSE,RADIATION,RESULTS,UNIVARIATE,V20,WBC
163,169,180,BETWEEN,CONCLUSION,COPYRIGHT,FDG,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,STAGE,THERE
169,231,233,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,ECG,LABEL,METHODS,PUBLISHED,SAS,SNFMI,SYSTEMATIC
169,177,956,ACCORDING,CDX,COPYRIGHT,LTD,MCF,NCI,TEA,THF
000,004,040,274,517,586,CTV,GRADE,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PTV56,PURPOSE,RESULTS
99A,BACKGROUND,CONCLUSION,ECTOPIC,IGF1R,INHIBITORS,INSERTION,LABEL,METHODS,MICRORNAS,OVERALL,PCR,RESULTS,UTR
AFTER
001,002,031,032,035,261,ACCORDING,AMONG,BACKGROUND,CEA,DESPITE,JANUARY,LABEL,METHODS,NSCLC,OVERALL,RESULTS,THERE
947,CD4,CD8,FAS,HUPBL,MHC,NOD,STAT1,VEGFR
ACUTE,AFTER,AIP,ALT,AST,BAL,BLOOD,CHEST,CLINICIANS,FACTS,INSIGHT,LDH,NOVEL
100,864,HOWEVER,PLEURAL
000,060,119,120,260,338,361,399,518,536,553,635,699,754,807,813,880,881,979,AMONG,CONFIDENCE,DISCUSSION,EAR,FIRST,HODGKIN,HOWEVER,ICD,INCIDENCE,INCREASED,ISLANDS,ITALIAN,LABEL,LIFESTYLE,METHODS,MPS,NON,NORTH,OBJECTIVE,OBJECTIVES,OVERALL,RATIO,RESULTS,SIR,SOUTH,WOMEN
EXOME,HOWEVER,WGA
HOWEVER,LIVER,POSTMORTEM,PRIMARY,THERE
ALD,CURRENTLY,THEREFORE
CTC,VARIATION
NNK,PAH,THERE,THESE,TOBACCO
169,ACT,AFFORDABLE,CME,CNE,INC,INTERVIEW,PATIENT,PROTECTION,SOCIETY
000,100,215,956,ASSAY,ERLOTINIB,MRM,NSCLC,RSD,SIMOTINIB
001,004,008,012,021,025,109,164,169,239,267,385,481,AUTHORS,EPIDERMAL,LTD,NSCLC,TKI,WILEY
00001,004,CHINA,DATABASES,HOWEVER,IL6,KNOWLEDGE,OVERALL,SEVERAL,WANFANG
001,011,015,024,028,030,046,164,CCTTT,GENOTYPES
154,169,489,CSNK1A1,FN1,KNOCKDOWN,LOW,MACC1,NBN,NFAT5,NOTABLY,PCR,SOX17,SRY,USING
000,100,169,181,215,AIR,AMERICA,BACKGROUND,COHORTS,EFFECTIVE,EFFECTS,HARVARD,INC,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,POLLUTION,RESULTS,SIX,SOCIETY,SPAIN,SPANISH
NCI,NUCLEAR,ORTHOGONAL
131,MEASURING,PTC
169,AGREEMENT,BACKGROUND,JOURNAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCENARIOS,SMALLER,THERE,THESE
181,189,AGS,AMONG,MRC,MTT
CETUXIMAB,CRIZOTINIB,III,IMPORTANT,LABEL,NINTEDANIB,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY
169,947,ACCESSORY,CD11B,CLP,IFN,NKT
169,APOPTOSIS,COPYRIGHT,E2F,HOWEVER,LNCAP,P53,PCR,TFDP3
GIVEN,TUMOURS
114,177,332,338,396,CONCLUSION,EFFECTS,LABEL,LENTI,LENTIVIRUS,METHODS,OBJECTIVE,PBS,RESULTS,TUNEL,WESTERN,XENOGRAFT
169,617,946,FINALLY,KNOCKDOWN,LTD,OVERALL,PATHWAY,PKC,PUBLISHED,TAKEN,WILEY
947,BACKGROUND,CONCLUSION,H3K27,H3K4ME3,H3K56,H4K16,H4K20,LABEL,METHODS,PTM,RADIATION,RESULTS,WESTERN
162,169,242,576,656,818,CTV,IBR,RADIATION,V95
169,233,945,947,AFTER,BCG,CD3,CD4,CD8,COPYRIGHT,CXCR3,HOWEVER,IFN,LTD,PBMCS,PFMCS,TAKEN
169,681,APRIL,COPYRIGHT,JANUARY,KOREA,NON,PRIMARY,PULMONARY
138,169,FINALLY,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE,UNDERLYING,UTR,WILEY
169,223,5MG,CMCTS,COPYRIGHT,DERIVED,FAK,FGFR3,FIBROBLAST,FOCAL,INTESTINAL,IRELAND,KIT,LCK,LTD,LYMPHOCYTE,LYN,MASITINIB,MCS,STROMAL,YES
027,221,232,275,33X,43X,624,961,BACKGROUND,COMPARISON,GENERALLY,HBV,HCC,LABEL,METHODS,RESULTS,SVS
231,946,AGILENT,BACKGROUND,CHANGES,DAVID,ELISA,FAK,GENESPRING,IL1,LABEL,MAPKK,MDA,METHODS,NCI,PCR,PD98059,RESULTS,TGF
001,002,139,490,900,BACKGROUND,BECAUSE,CHRONIC,CMH,FURTHER,LABEL,LSC,METHODS,MSP,PCR,PITTSBURGH,PLUSS,RESULTS,SCREENING,SMOKERS,SULF2,THESE
400,BACKGROUND,CHRONIC,CVD,GOVERNMENT,KATHMANDU,LABEL,METHODS,NCD,NEPAL,NON,OVARIAN,POPULATION,RESULTS,SOUTH,UNIVARIATE
169,ACCEPTABLE,BACKGROUND,COPYRIGHT,IMPLANT,INC,LABEL,LARGE,LOCAL,MAY,METHODS,OCTOBER,PUBLISHED,RADICAL,RESULTS,SOCIETY,THERE,THREE
003,169,BACKGROUND,CLINICIANS,CONCLUSION,COPYRIGHT,DPD,HOWEVER,INC,LABEL,METHODS,NSCLC,RESULTS
001,017,029,046,164,170,20A,258,375,406,537,945,MICRORNAS,NSCLC,THESE
381,382,826,ASIAN,CLINICIANS,INC,INSURANCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SDS,SIR
026,122,166,171,173,ALK,BACKGROUND,IHC,LABEL,METHODS,NSCLC,PCR,PFS,RESULTS,SELECTIVE
916,ACTIVATING,MODEL,NSCLC,PC9,PET,REFERENCE,SIMPLIFIED,SW620,U87,XENOGRAFTS
110,125,949,BCL,DIFFERENT,EARLIER,FURTHER,HOWEVER,MMP,NPS,PCL,PVP,TET,THEREFORE,WESTERN
200,2C9,956,AMERICA,BACKGROUND,CYP2C19,GOVERNMENT,INFECTIOUS,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVERSITY
BASED,BRCA1,BREST,CROSS,CURRENTLY,DUE,ERCC1,NSCLC
1960S,AMONG,HOWEVER,III,THESE
ALK,BASED,DESPITE,NSCLC,ONGOING,RET,ROS,TKI
956,BRCA1,CHINESE,CISPLATIN,DCP,MOLECULAR,PATIENT,PHASE,PRE,USA
A751C,C118T,ERCC1,NSCLC,THESE,XERODERMA,XPD
001,107,150,AIM,BACKGROUND,CONCLUSION,IHC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
250,AFTER,CRF,FDG,GEFITINIB,NSCLC,PET
200,AIM,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS
AIM,BETWEEN,CONCLUSION,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,RESULTS
BACKGROUND,BECAUSE,CONCLUSION,GRADE,LABEL,MALIGNANT,METHODS,PEMETREXED,PFS,PLM,RESULTS,SELECTION,SIX,THREE,TOXICITIES,TREATMENT,TREATMENTS
150,AIM,CONCLUSION,FIFTY,FOLFIRI,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TREATMENT
AIM,BACKGROUND,BETWEEN,CEA,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SINCE,SOX,THREE,XELOX
100,153,319,775,854,AIM,AMONG,CONCLUSION,FDG,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PPV,RESULTS
169,231,DDR,ECTOPIC,EMT,H1299,KNOCKDOWN,MDA,PRESS,PUBLISHED,SENESCENCE,TAKEN,UNIVERSITY
NNK,ODN,RESULTS,SILICOSIS,SUP,SYNTHETIC,THERE,THESE
169,956,HOWEVER,SCCHN,TU212
169,GENERAL,SURGEON
000,024,033,039,169,700,989,AUTHORS,COMPARISON,CONCURRENT,COX,DESPITE,III,LTD,MEIER,NSCLC,OTHER,RADIATION,RECORDS,SEVENTY,WILEY
150,160,162,169,253,AUTHORS,COX,FDG,IRB,LTD,MBC,MEDICAL,MTV,PET,TLG,WILEY
169,AUTHORS,GERMANY,HODGKIN,LTD,SPC,SWEDISH,WILEY
160,169,AUTHORS,BPH,DU145,GLEASON,LNCAP,LTD,PC3,PCR,PEARSON,PSA,TNM,WILEY
169,945,ANTITUMOR,ATP,AUTHORS,BAY,FURTHER,HIF,HOWEVER,III,LTD,NSCLC,VHL,VON,WILEY
169,ALK,AUTHORS,FEW,GGO,LTD,NSCLC,OVERALL,WILEY
169,181,300,870,ECT,FINALLY,INC,WILEY
145,255,863
AUSTRALIA,BRISTOL,CONFERENCE,MERCK,MYERS,WORLD
169,AUTHORS,EARLY,FOURIER,HHE,ICR,LTD,NSCLC,VOC,WILEY
FUNCTIONAL,IVS,MIB,SDH
CDC,CHANGES,END,INSTITUTE,PROGRAM,REGISTRIES,RESULTS
191,244,BOARD,CONCLUSION,EVALUATION,GERIATRIC,HOWEVER,JANUARY,KAPPA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PILOT,RESULTS,SETTING
511,AFTER,BAX,FINALLY,FIRST,PCR,TRIB2
AMONG,COMPARISON,FDA,MEDICAL,NCLSC,NSCLC,THESE,TOWARDS
120,328,354,529,611,852,901,BACKGROUND,CONCLUSION,FORTY,LABEL,METHODS,NOTABLY,NSCLC,PFS,RESULTS,SEVENTY,THOSE
CELLS,EMBRYONIC,ENGINEERED,ESC,FLP,GEMMS,MOUSE,MYCL1,SMALL,THREE
139,160,200,956,ASSOCIATED,BACKGROUND,CD4,CONCLUSION,EMPHYSEMA,HIV,HOWEVER,LABEL,METHODS,RESULTS,SCREENING,THERE,THESE,TRIAL
HAART,HIV,HODGKIN,INCREASING,NADCS
ACCORDING,CONCLUSION,LABEL,METHODS,NSCLC,NUMBERS,OBJECTIVE,RESULTS,THERE
169,536,676,715,BASEL,ELISA,IQR,LABEL,MALIGNANT,METHODS,OBJECTIVE,OTHER,RESULTS,SOLUBLE
169,320,355,956,AFTER,CZE,HEP,HEX,HEXANAL,PUBLISHED,RSD,UNDER
ENGLISH,MALIGNANT,MMS
174,ABC,ACTUARIAL,AFTER,BACKGROUND,BED,BREATHING,CAUSE,CONCLUSION,EQUIVALENT,INTENSITY,LABEL,METHODS,NSCLC,OUTCOME,OVERALL,PFS,RESULTS
169,954,COX,EPIDERMAL,HOWEVER,IKK,INHIBITING,NSCLC,SH2,STAT3,THEREFORE,TKI
CPB,METICULOUS,VARIOUS
033,BACKGROUND,CLEARLY,ENB,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
DETECTION,ELISA,HOWEVER,THESE,WHILE
ABCC2,BCL,DDP,MODULATION,NSCLC
007,174,ABI,ALBUMIN,CREMOPHOR,HOWEVER,III,NON,NSCLC,PACLITAXEL,PHASE
177,INDIVIDUAL,ITV,PERSPEX,WHILE
AUC,BACKGROUND,CONCLUSION,EFFECTS,LABEL,METHODS,OBJECTIVE,RESULTS
100,108,115,159,212,247,254,267,405,506,879,BACKGROUND,COX,END,LABEL,MEIER,METHODS,PRISM,RESULTS,THERE
160,AKT,ANNEXIN,PREVIOUSLY,TKI
100,956,BAX,BCL,MCF,TERMINALIA,THESE
160,BAX,BCL,CASPASE,HOWEVER,KANK1
160,400,HOWEVER,SINCE,SORAFENIB,WHEREAS
PC3,RHO
4T1,BAX,BCL,CD4,CD8,FGF,MCL,MDSCS,MEANWHILE,THEREFORE,WESTERN
500,ADVERSE,CONCLUSION,EVALUATION,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,PEMETREXED,PHASE,RATES,RESULTS,SOLID,THERE,TKI,TUMOURS
169,947,AKT,ATM,ATR,BECAUSE,CSS,H3S10,H3S28,JNK,MRC,PRESS,PUBLISHED,THESE,TREATMENT,UNIVERSITY,USING
002,003,230,252,468,504,CIS,COLORECTAL,ORS,OVARIAN,PCR,RCC,RESULTS,SCREENING,THESE,TRIAL
001,110,122,169,AFTER,AMONG,CPEB1,EMILIN2,KNOCKDOWN,PRESS,PUBLISHED,ROBO3,STAGE,STUDIES,UNIVERSITY
091,AUDIT,BACKGROUND,COX,HES,LABEL,METHODS,RESULTS,STATISTICS,THESE
169,1990S,945,946,CYP19,ERS
169,945,946,AKT,ARS,RAS,SRC,THESE,TOBACCO
NON,NSCLC,PATHOLOGY,PDGFR
III,NOVEL,NOW,NSCLC
MMP,NON,NSCLC,THEREFORE
020,022,031,163,199,703,AFTER,BACKGROUND,BLOOD,HOWEVER,LABEL,METHODS,MMP,NSCLC,OBJECTIVE,OCTOBER,RESULTS,SERUM,THESE,TOS,USING
109,160,BACKGROUND,BESIDES,COX,LABEL,MEIER,METHODS,MST,OBJECTIVE,PCI,RESULTS,SMALL
001,003,006,021,041,394,919,ACCORDING,BACKGROUND,CBP,COLLEGE,COX,DDP,HOWEVER,KPS,LABEL,MEDICAL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,SMALL,TOTAL,UNION,UNIVARIATE
123,206,503,954,AFTER,AKT,APOPTOSIS,BACKGROUND,BCL,CISPLATIN,DDP,ERCC1,LABEL,METHODS,MIR,MTS,OBJECTIVE,PCR,RESULTS,WESTERN
BACKGROUND,FIXED,GENOMIC,LABEL,METASTATIC,METHODS,NON,NSCLC,PCR,RESULTS,SMALL
001,005,148,169,240,548,COX,DISEASE,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RCC,RESULTS,STAGE,THESE,UNIVARIATE
169,COPYRIGHT,EARLY,LTD,NRP1SIR,SLUGSIR,THROUGH
THESE
121,122,123,124,125,134,135,138,169,1B7,APC,CD4,COPYRIGHT,EBV,ESO,LTD,MINIMAL,PBMCS,TCR,USING
BACKGROUND,CAM,DU145,GIVEN,HCC1143,HCC1937,LABEL,METHODS,MISTLETOE,NCI,RESULTS,VAE

ABOUT,HOWEVER,III,NON,USA
100,AIM,BACKROUND,CEA,CK5,CK7,CONCLUSION,EMA,INSTITUTE,LABEL,METHODS,MOC31,PATHOLOGY,PULMONARY,RESULTS,SREMSKA,UNLABELLED
001,003,015,2ND,COX,KEY,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TTP
019,100,30002,30206,39808,BACKGROUND,CALGB,CONCLUSION,CURRENT,LABEL,METHODS,PATIENT,PREDICTORS,RESULTS,THEREFORE,V10,V20,V60
080,081,CONCLUSION,ERK,FERRETS,LABEL,METHODS,MUSTELA,NNK,OBJECTIVE,PREVIOUSLY,RESULTS,WESTERN
BIOMARKERS
MRI,PRIMARY,THERE
CSN,NETWORK,SENTIMENT,SOCIETY,SURVIVORS,THREADS,USING
HOWEVER,SCREENING
000,200,250,BURKITT,DAUDI,PCR,USING,WESTERN
METASTASIS,TNF,TRAIL
169,CAF,CELLS,PRESS,USING
MES,PCR,PRDM5,TAKEN,WESTERN
169,INC,SIMULATION,WILEY
CONSISTENT,DIFFERENT,DR4,DRS,HOWEVER,JNK,MYCELIA,NCI,THESE,TRAIL
169,ADP,ARCTIGENIN,ECTOPIC,INC,NSCLC,WILEY
001,027,150,169,24CPM,330,337,98CASES,AGE,CONCLUSION,COPYRIGHT,COX,CRUDE,III,IRELAND,LABEL,LTD,MALIGNANT,METHODS,MPM,NCR,OBJECTIVE,RESULTS,ROI,THERE
001,169,177,ANNEXIN,CONVERSELY,H2052,HOWEVER,ISTMES2,LABEL,MET,MET5A,METHODS,OBJECTIVE,PRESS,PUBLISHED,PVP,RESULTS,SURGERY,UNIVERSITY
FDG,HOWEVER,IMAGE,PET,SINCE,THEREFORE
215,LABEL,METHODS,SUMMARY,SURGERY,THERE
THEREFORE
260,PERIPHERAL,PTX
AFTER,CEF,HOWEVER,IIB,III,STAGE,VNR
HOWEVER,LOCAL
AFTER,BEI,SCC,THREE
AFTER,FDG,PET,RIGHT,SIX,SMALL,STEROID
215,AFTER,CEA,GRADE,IIB,SIX,SST,TREATMENT
AFTER,CSF,LABORATORY
188,HOWEVER,IIB,JANUARY,NSCLC
GGO
100,500,BAL,CHEST,STEROID,THESE
AFTER,BECAUSE,LYM,PUL
100,AFTER,ENDOSCOPIC
CPT,EVIDENTLY,HOWEVER,SEPTEMBER,STAGE,T4A

50S,60S,CONCLUSION,HEMOSTASIS,HOWEVER,LABEL,SHOCK,TAE,UNLABELLED
ADM,CPT,FOLLOWING,THEREAFTER
ENDOSCOPY,FOLFIRI,SIGMOID,UFT
AFTER,LIVER,XELOX
AFTER,CARCINOMA,COLORECTAL,FOLFIRI,LEUCOVORIN,OKAYAMA,RFA,UNIVERSITY
AFTER,BASED,CURRENTLY,LEUCOVORIN,PET
000,100,133,890,APRIL,BETWEEN,EASTERN,EIGHT,ERLOTINIB,GEM,GRADE,GROUP,III,JAPAN,OCTOBER,OTHER,PANCREATIC
AFTER,CHEST,JANUARY
178,AFTER,CBD,CURRENTLY,EIGHT,LEUCOVORIN,PYLORUS,RECURRENCE,THEREFORE
HCC,ILEOCECAL,MARCH,OCTOBER,PET
226,SEPTEMBER
172,SEPTEMBER
001,006,008,011,079,085,088,107,169,177,BREASTSIB,COPYRIGHT,CROWN,CRT,D98,DOSIMETRIC,INC,OVERALL,PTV,PUBLISHED,RADIATION,SIB
250,7TH,8TH,ACCORDING,AFTER,AMONG,BACKGROUND,FIFTY,HISTOLOGY,LABEL,LINAX,METHODS,NSCLC,PATIENT,RESULTS,T1A,T1B,T2A
160,169,CURRENT,GOING,HOWEVER
177,901,ACTIVATION,AUC,BACKGROUND,CEA,ELISA,III,LABEL,RESULTS,ROC,TAKEN,TRX
160,176,177,AFTER,BACKGROUND,BSA,HOWEVER,LABEL,METHODS,RESULTS,THERE
169,COPYRIGHT,DDS,DTX,LTD,NG2,PBS,TAASGVRSMH
SEVERAL
125,33258,956,997,ABOUT,AFTER,APOPTOSIS,BACKGROUND,CASPASE,CONCLUSION,CONTEXT,DIELS,DISCUSSION,HOECHST,LABEL,MATERIALS,MCF,METHODS,MTT,OBJECTIVE,PREVIOUSLY,PROTEIN,RESULTS,SGC,WESTERN
FURTHER,INVENTORY,PROBLEM,PROFILE,RESULTS,REVISED,SOLVING,SPS,TOTAL
198,1A1,ADDITIONAL,ASIAN,BACKGROUND,CAUCASIANS,CIS,CYTOCHROME,FURTHER,ILE462VAL,LABEL,METHODS,OVERALL,RESULTS
007,102,946,95C,DFS,HOWEVER,NSCLC,PCR,TAB,TAKEN,WESTERN,WNT
231,CONTROL,LUC,MDA,THEREFORE,THESE,UDP
156,177,426,APE,BACKGROUND,BEIJING,CTEPH,JANUARY,LABEL,METHODS,PACTA,PAS,RESULTS
001,013,069,152,272,349,434,622,INCLUSION,NSCLC,OUTCOME,STAGE,TESTS
FURTHER,SINCE,UNDER
000,100,777,AMONG,BACKGROUND,KNOWLEDGE,LABEL,LOW,METHODS,PLCSP,PLN,POMERANIAN,PROGRAM,RESULTS,SCREENING
001,125,129,130,135,159,290,449,BACKGROUND,DEPARTMENT,LABEL,METHODS,NSCLC,PULMONARY,RESULTS,THERE
169,239,AUTHORS,CD8,DSR,INC,KHT,NKT,PUBLISHED,WILEY
BLOOD,COX,NSCLC,PCR,PFS
094,216,352,445,518,CAUCASIANS,LEU,NOV,OVERALL,PHE,ULTIMATELY
AKT,CURRENT,CXCR4,ERK,HOS,PCR,REPETITIVE,STUDIES
223,680,CAUCASIANS,HOWEVER,USING
181,AMONG,CERTAIN,NCI,NPC,STUDIES
104,123,337,AES,BACKGROUND,IGF,LABEL,MAB,METHODS,ORR,PRS,R1507,RESULTS,THREE
000,169,300,BETWEEN,CARDIOLOGY,CAREFUL,CONCLUSION,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCD,SINCE,SOCIETY,USA
001,005,014,119,CUB,EGF,EMT,NSCLC,RESULTS,SCUBE3D,TNM
106,206,CDC42,HSPA5,HSPD1,MIR,POLA1,SMARCA4
BMP,HOWEVER,TIE
CK7,CRIBRIFORM,MOLECULAR
27B,ECTOPIC,FINALLY,LIM,LIMK1,NON,NSCLC
DHC,MTT,NCI,PMA
193,332,400,461,AMONG,INITIATION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRE,USING
11Q13,LOH,MENIN,MUTATIONS,NATURAL,NET,PREVALENCE,PULMONARY
000,001,002,004,006,011,018,029,039,042,045,067,071,082,129,518,ACC,BACKGROUND,CHINA,DFS,EMC,INTENSIVE,JANUARY,LABEL,MAY,MEC,METHODS,OVERALL,RESULTS,THEIR
018,096,BACKGROUND,CONCLUSION,EVALUATION,LABEL,METHODS,OVERALL,PARTIAL,PFS,RESULTS,SCS,SOLID,THERE
ALK,ANAPLASTIC
BACKGROUND,CONCLUSION,GGO,LABEL,METHODS,RESULTS,T1A,T1B,T2BN0M0,TNM
027,051,BACKGROUND,COUNCIL,COX,EVERY,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,THERE
003,009,012,048,140,151,1990S,AFTER,BACKGROUND,FORTY,INDUCTION,LABEL,METHODS,OVERALL,PATHOLOGIC,RESULTS,TOTAL
106,150,500,800,B12,BACKGROUND,CONCLUSION,LABEL,METHODS,PFS,RESULTS,THERE,TREATMENT
200,555,ADVERSE,BACKGROUND,CONCLUSION,LABEL,METHODS,PRIMARY,RESULTS,TTP
001,002,004,120,150,197,268,300,306,332,BACKGROUND,COX,FURTHER,LABEL,METHODS,NSCLC,PTC,RESULTS,SB3
189,337,BACKGROUND,CONCLUSION,DEPLETION,GTPASES,HOWEVER,LABEL,METHODS,NSCLC,OVERALL,RAL,RAS,RESULTS,USING
946,BACKGROUND,BECAUSE,CSC,LABEL,METHODS,RESULTS,ROS
000,GROUP
147,169,558,BACKGROUND,COPYRIGHT,DESPITE,EVALUATION,FEDERATION,HOSPICE,LABEL,METHODS,NCS,OVERALL,PALLIATIVE,PUBLISHED,RESULTS
169,947,CD4,CD8,EPITOPE,HOWEVER,IFN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TAA,THREE
ACTIVATING,AMONG,EPIDERMAL,NSCLC,THESE
169,COPYRIGHT,HOWEVER,STAT3,STATS,THERE
169,CHP,COPYRIGHT,GTPASES,INC,NSCLC,RHO
169,BACKGROUND,CONCLUSION,COPYRIGHT,INK4A,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR,SHOX2
005,169,244,289,460,537,946,ALPES,BAX,BRCA1,CONCLUSION,COPYRIGHT,DCR,ERCC1,FAS,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TUBB3
004,169,946,956,BIOLOGICAL,COPYRIGHT,ERLOTINIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEVERAL,THESE
001,150,169,1ST,2ND,3RD,462,467,CONCLUSION,COPYRIGHT,ERLOTINIB,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,S768I,SECONDARY,SEVEN
001,169,CONCLUSION,COPYRIGHT,III,IRELAND,LABEL,LTD,METHODS,MSP,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TET,THERE,THEREFORE
169,946,COPYRIGHT,ELISA,EMT,FEDERATION,M30,PRE,PUBLISHED,RESULTS,SOCIETIES,TGF,TUNEL
169,ALK,BACKGROUND,BETWEEN,COPYRIGHT,JANUARY,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY
169,BACKGROUND,COPYRIGHT,CRP,DESPITE,HOWEVER,LABEL,LABORATORY,METHODS,PAS,PUBLISHED,RESULTS,SOCIETY,WBC,WHILE
150,169,BASED,COPYRIGHT,DINACICLIB,ERLOTINIB,EVALUATION,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,RESULTS,SCH,TTP
169,231,233,947,COPYRIGHT,HMGCR,MDA,MI2,PUBLISHED,SAS,SNFMI,SRP
125,169,174,177,600,CATPHAN,CONCLUSION,COPYRIGHT,FOV,IMAGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,XVI
112,117,169,251,368,BACKGROUND,COPYRIGHT,HCC,HEPATIC,HRE,INC,LABEL,METHODS,MLC,OTHER,RESULTS,RFA,THERE
ANNEXIN,APOPTOSIS,BACKGROUND,CFLAR,CONCLUSION,DDIT3,DR5,EIF2A,HOWEVER,HSPA5,KNOCKDOWN,LABEL,METHODS,MTT,NSCLC,PTL,RESULTS,SILENCING,SRB,TNFRSF10B,WESTERN
231,COMPOUNDS,HRESIMS,MDA,NMR,THESE
177,961,963,DIFFERENT,HOUNSFIELD,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,VHU
176,532,749,960,AUTOMATED,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIMILAR
CAUTION,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SYSTEMS,THESE,VARIATIONS,VOLUMETRIC
103,125,131,BRACHYDOSE,CARLO,DESPITE,DOSES,LABEL,METHODS,MONTE,NOTABLY,OBJECTIVE,PURPOSE,RESULTS,STR,VOXEL
CARLO,LABEL,LINAC,LORENTZ,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TESLA,V20
176,LABEL,MATERIALS,METHODS,MUS,OBJECTIVE,PURPOSE,RESULTS
134,BACKGROUND,FIFTY,KARNOFSKY,LABEL,METHODS,OVERALL,RESULTS,SIXTY
ABDOMINAL,BACKGROUND,LABEL,METASTASES,METHODS,MRI,VATER
956,ALDH1A1,ALDH1A2,ALDH1A3,ALDH1B1,ALDH2,ALDH3A1,CB7,STRUCTURAL
046,ABSENCE,ARM,BACKGROUND,CANDIDATE,EGFRI,EIR,LABEL,METHODS,NSCLC,PRE,RESULTS
BACKGROUND,BASED,DISCUSSION,LABEL,METHODS,REDUCTION,SECONDARY,TAU,THEREFORE
ADHERENCE,ADVERSE,BACKGROUND,CONTROLLED,CURRENT,IQR,LABEL,METHODS,NSCLC,QUADRICEPS,RESULTS,SECONDARY,THERE,TRIAL
568,716,852,AMONG,BACKGROUND,CHINA,COLLEGE,CONCLUSION,DESPITE,HBV,HCC,HCV,HOWEVER,LABEL,MEDICAL,METHODS,PERKING,RESULTS,THEREFORE,UNION
CRIZOTINIB,EGF,HGF,HOWEVER,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,T790M,TKI
026,031,114,129,290,355,392,479,558,624,625,635,726,734,740,753,782,786,860,897,908,910,972,978,BACKGROUND,CHINESE,CLPTM1L,HAN,HOWEVER,LABEL,METHODS,RESULTS
001,022,028,181,362,400,509,ACTIVATION,AIM,BAL,CCL,CHEMOKINE,CONCLUSION,FVC,INCREASED,LABEL,METHODS,PRO,PROTEIN,PULMONARY,RATIONALE,REGULATED,RESULTS,SECRETORY,SFTPB,SHORT,SURFACTANT,UNASSIGNED
CLINICALLY,CSLCS,LAC,LACSLCS,MMP,THESE
159,DOX,FUNCTIONAL,NSCLC,SP5
031,100,120,127,177,CAD,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
130,ADP,CONCERNING,DOX,MIAPACA,TAKEN
ROS,THESE
GROUP,JAPAN,PRIOR,THESE,USING
AMONG,BIOMARKERS,PREDICTIVE
160
177,956,BICKEL3,CONCLUSION,DTATEGF,LABEL,METHODS,MTT,MVD,NSCLC,OBJECTIVE,PC9,RESULTS,SUBG0
707,BASAL,THESE
BACKGROUND,CONCLUSION,COX,ELISA,LABEL,METHODS,MTS,PCR,RESULTS,THEREFORE,TXA2R,VARIOUS,WESTERN
AFTER,NSCLC,THESE
160,BLASTIC,BPDCN,CUTANEOUS,DUE,HODGKIN,SCT
LABEL,OBJECTIVE,OCCASIONAL,PURPOSE,RESULTS,SMOKING,SUMMARY,THERE,WHILE
169,CBL,COPYRIGHT,HGF,INC,MET,RTK,VEGFR
169,ADDITIONAL,COPYRIGHT,LTD
169,ALLOGENEIC,COPYRIGHT,HOWEVER,LDF,LTD,METASTATIC
169,203,967,COPYRIGHT,COX,FURTHER,GAC,HOWEVER,INC,MEIER,NAD,PCR,THROUGH
169,956,BAP,CAM,CGS,CONDURANGO,COPYRIGHT,MMP,NSCLC,OVERALL,ROS
169,COPYRIGHT,DIFFUSE,DIPNECH,INC,PUBLISHED,SOCIETY
BACKGROUND,DAP,DIAGNOSTIC,DISCUSSION,EMPIRICAL,ICC,INTER,INTERVIEWS,LABEL,METHODS
945,BACKGROUND,CONCLUSION,CONTROL,EXPRESSION,GLY,HOWEVER,III,INCREASED,LABEL,METHODS,P4HA2,PRO,REDUCED,RESULTS,SILENCING,THEREFORE,THESE,THREE,USING,WESTERN
169,SOCIETY
169,185,2NM,ABT,AFM,AGNPS,CCL,COPYRIGHT,EDS,FOURIER,FURTHER,HTB,MCF,PUBLISHED,SEM,TEM,VISIBLE
169,COPYRIGHT,ELISA,HOWEVER,INC
169,223,COPYRIGHT,HARMANE,HOECHST,HUVEC,PEGANUM
100,121,169,ALK,CONCLUSION,COPYRIGHT,IHC,IRELAND,LABEL,LTD,MATERIALS,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RAPID,RESULTS,THESE
293,CRE,THESE,TPC
945,CISPLATIN,FETAL,HIF,STUDIES,VEGF165
037,142,602,858,COMPONENT,CONCLUSION,CSE,DIFFERENT,GCG,GSH,LABEL,METHODS,MTT,OBJECTIVE,PCA,PRINCIPAL,RESULTS
FIBROUS
115,140,242,250,BRUSHINGS,FIBEROPTIC,FOB
GANODERMA,LEWIS,TERNARY,THESE,TME
945,956,ALTOGETHER,BECAUSE,FURTHER,NAD,SIRT1,SIRT2,SIRT3,SIRTUIN,THESE
246,DUE
BAL,DESPITE,HOWEVER
CYCLOSPORA,MEXICAN,SIX
239,GRADE,LABEL,LEVEL,METHODS,OBJECTIVE,PHASE,RESULTS
CCK,FOXM1,GENISTEIN,PCR
081,450,CONVERSELY,VEGFR,WHETHER
954,956,APO3L,BAX,BCL,BEE,DR3,DR6,FAS,FURTHER,HENCE,NCI,NSCLC,PREVIOUSLY
157,REGRESSION,THESE,TYPES
000,100,177,190,426,497,550,575,576,862,910,BACKGROUND,COLORECTAL,CONCLUSION,END,FUNDING,GENERATOR,HARMS,HISTORY,HORIZON,INSTITUTE,LABEL,METHODS,OBJECTIVE,OUTCOME,OVARIAN,POPULATION,PRIMARY,RESULTS,SCENARIOS,SCREENING,SMOKING,SOURCES,TRIAL,UNASSIGNED
100,116,145,160,172,181,231,2OS,500,549,786,872,A2058,CA2,ECM,FBS,HCC,HCT,HEP,MCF,MDA,MIA,MMP,PMA
FORCE,LABEL,METHODS,POPULATION,PREVENTIVE,SCREENING
LABEL,METHODS,OBJECTIVE,RESULTS
082,091,101,234,276,459,494,634,698,FINALLY,GSI,IMAGING,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SEVENTY
DESPITE
169,239,COPYRIGHT,HOWEVER,PET,THESE
4T1,916,936,ANNEXIN,BASED,DDP,DOX,FURTHER,MTT,PREVIOUSLY
169,COPYRIGHT,INC,OPS,PLS,SAR
134,169,945,946,BACKGROUND,COPYRIGHT,LABEL,METHODS,NSCLC,RESULTS,TGF
119,COX,FOLLICULAR,LABEL,LOG,MEIER,METHODS,OBJECTIVE,RESULTS
146,177,192,213,251,306,344,348,368,437,492,540,564,ASC,BAC,FDG,HISTOLOGIC,III,JANUARY,LABEL,LARGE,METHODS,NSCLC,OBJECTIVE,OCTOBER,OTC,PATHOLOGIC,PET,PRIMARY,RESULTS,SCC,SUV,THERE,TNM
181,290,APRIL,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,TIANJIN
151,177,215,945,AKT,ELISA,EMT,ERK,H1975,HGF,LABEL,MET,METHODS,MRC,MTT,OBJECTIVE,RESULTS,TGF,WESTERN
169,COMMISSION,COPYRIGHT,GROUP,HOWEVER,IRELAND,ITMIG,JOINT,LTD,MALIGNANCY,THEIR,UNION
BACKGROUND,CASES,CONTEXT,INCORRECT,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
200,BACKGROUND,CONTEXT,GASTRIN,GRPRS,III,LABEL,METHODS,NON,OBJECTIVE,RESULTS
001,AGE,BACKGROUND,CONTEXT,DTA,LABEL,LITERATURE,METHODS,OBJECTIVE,POPULATION,RESULTS,SIXTEEN,STUDIES,THERE
001,493,COLLEGE,COMPARISON,CONTEXT,FNA,NSCLC,OBJECTIVE,OVERALL,PROGRAM,RESULTS,SCC,SUBTYPING,THERE
169,320,COMPOUNDS,COPYRIGHT,GIVEN,HOWEVER,INC
169,BECAUSE,COPYRIGHT,DISORDERED,ESPECIALLY,EXPECTEDLY,GREATER,INC,WARBURG
103,159,177,220,236,925,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,RESULTS,TDT,TUNEL
001,011,043,546,BACKGROUND,CIS,DATABASES,FATAL,LABEL,METHODS,RESULTS,RRS,SCIENCE,SOCIETY,SUMMARY,TKI,VEGFR,WEB
500,ADVERSE,EIGHT,EVALUATION,JANUARY,JIANGSU,LABEL,METHODS,NCI,OBJECTIVE,OTHER,PEMETREXED,PURPOSE,RESULTS,SEPTEMBER,SOLID,THEIR
100,120,BACKGROUND,FURTHER,HRM,LABEL,METHODS,RESULTS,THERE
001,177,BACKGROUND,ETS,GLUCS,LABEL,MATERIALS,METHODS,RESULTS,WHITNEY
140,AFTER,ANTIGEN,CARCINOMA,CEA,CEACAM5,CONCLUSION,GASTRIN,GMP,GRANULE,GRP,KRT,KRT19,LABEL,METHODS,OBJECTIVE,PEPTIDE,PROTEIN,RELEASING,RESULTS,SFTPB
130,BACKGROUND,ELISA,III,LABEL,METHODS,NSCLC,NSE,RESULTS,SCC,SERUM
011,030,033,059,260,318,ASIAN,BACKGROUND,CHINESE,CIS,CONCLUSION,HOWEVER,LABEL,METHODS,ORS,PCR,RESULTS
240,CHINA,DAUGHTERS,DISEASE,MEN

AKT,HOWEVER
100,150,ITALY,L858R,MUTATIONS,R831H,SELECTION,SPECIMENS
004,008,015,028,046,107,945,ALDH1,AMONG,BACKGROUND,CD204,CIC,CSC,LABEL,METHODS,NANOG,PRIMARY,RESULTS
001,002,104,124,239,580,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,NOTABLY,NSCLC,PFS,RESULTS,THEREFORE,TKI,TREATMENT
007,119,130,177,292,2AM,5AM,BMI,COLORECTAL,MELATONIN,OVARIAN,PEARSON,SCREENING,SERUM,TRIAL
003,195,422,HOWEVER,ION,LNA,MACHINE,NSCLC,PCR,PGM,PNA,TKI,TORRENT
169,945,FL3,T24,VCH,WILEY
160,AGE,CGA,COX,FIFTY,NSE,SIXTY,THERE,UNIVARIATE
169,CSC,EMT,ESC,INSIGHT,NANOG
001,004,021,044,146,CDK,COX,HOWEVER,NSCLC
218,219,263,270,329,605,882,ALA499VAL,ASIAN,EBSCO,HOWEVER,LYS939GLN,MEDLINE,XERODERMA,XPC
APJ,THESE,UNDER
169,400,BACKGROUND,CELECOXIB,CONCURRENT,COX,CRT,GRADE,III,INC,LABEL,METHODS,RESULTS,SPHINCTER,SURGERY,WILEY
169,AKT,BAX,COPYRIGHT,ERK,IGF1R,TKI
019,032,074,096,159,164,173,199,221,366,409,502,517,579,580,809,816,825,870,933,CHINESE,HAN,NSCLC,SIMILAR,SNP,THEREFORE,UTR
131,177,CONCLUSION,DTC,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE
169,BACKGROUND,COPYRIGHT,HOT,HOWEVER,IGF,IRELAND,LABEL,LTD,MAP,METHODS,OBJECTIVE,OCTOBER,PI3,RESULTS,ROS,THERE
169,946,COPYRIGHT,FH535,GSK,IRELAND,LTD,SURGERY,THEREFORE,TRANSWELL
169,474,945,AKT,AUTHORS,C18,C22,COX,DHA,ENRICHMENT,FURTHER,HOWEVER,INCREASED,LTD,MMP,PUBLISHED,TGF,THESE,TREATMENT,WESTERN
002,003,012,109,147,169,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,ENDOSTATIN,INC,KDR,LABEL,METHODS,NSCLC,REGARDING,RESULTS,THEREFORE
169,176,200,24H,48H,956,ABOUT,AFTERWARD,APTAMER,BACKGROUND,CONCLUSION,LABEL,METHODS,PERCENT,PET,RESULTS
169,COPYRIGHT,GIVEN,HOWEVER,III,IRELAND,LTD
003,005,169,346,497,AUSTRALIAN,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,LABEL,METHODS,MTS,OCTOBER,OVERALL,RESULTS,SOUTH,STS,THESE,WHETHER
AFTER,AIS,BACKGROUND,CONCLUSION,IMPAIRMENT,LABEL,METHODS,NCT,NSCLC,RESULTS,SCALE,THEREFORE,THREE,TRIAL
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,INHIBITION,LABEL,METHODS,NSCLC,RESULTS,TEN,THERE
169,COPYRIGHT
035,093,160,169,225,592,645,BLACK,CAD,COPYRIGHT,FINALLY,FIRST,INC
169,AUSTRALIAN,BACKGROUND,BECAUSE,COLLEGE,DFH,DVH,LABEL,METHODS,MLD,PERFUSION,RESULTS,ROC,ROYAL,SPECT,V20,V30,ZEALAND
169,AFP,AFTER,BEP,GCT,HOWEVER,ICE,LTD,MRI,PBSCT,PUBLISHED,TIP,WILEY
009,160,169,180,ACUTE,ALT,AMB,AST,BACKGROUND,BETWEEN,BLACKWELL,CANDIDA,CENTRES,IFD,ITALIAN,JANUARY,LABEL,ORR,PMN,UNLABELLED
169,HBV,HCC,LTD,NAS,PUBLISHED,SINCE,STUDIES,WILEY
039,046,054,100,111,ASSOCIATED,CHARLES,CONCLUSION,DEPARTMENT,FACULTY,GYNECOLOGY,III,KRALOVE,LABEL,LRP,MED,MEIER,METHODS,MULTIDRUG,OBJECTIVE,OBSTETRICS,PFS,PGP,PROTEIN,RELATED,RESISTANCE,RESULTS,SETTING,UNIVERSITY
004,ADULT,AIM,BAL,CD4,CD8,ENGLISH,LABEL,METHODS,MTX,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,THESE
177,209,227,232,BINDING,EFIMOVA,EPR,GSH,MET,OVERHAUSER,PEDRI,PROBE,RESON,VRF
127,177,BULGARIAN,INSTITUTE,JANUARY,NET,SOCIETY

ID1,STANKIC,UNDER
100,455,479,567,737,ACQUITY,BEH,C18,DAH,DBD,DIACT,ESI,HCL,MRM,SPD,SPM
EBSCO,FURTHER,PROLONGED,SCIENCE,WEB
GCDFP,THESE
BECAUSE,IFOSFAMIDE,RMS,VINCRISTIN
001,002,003,007,PRO,STATE,T309G
IGE
VTC
METASTASIS,PLEURAL,WHEREIN
110,152,260,430,ANY,BESIDES,FREQUENCY,HENCE
NSCLC
100,HOWEVER,INHALATION,PARTICLES,PROPERTIES,THERE
HOWEVER,USUALLY

003,006,013,AKT,ERCC1,EXPRESSION,HISTOLOGIC,STAT3,THERAPIES,THERE
BACKGROUND,CONCLUSION,FNA,INDIA,LABEL,MATERIALS,METHODS,NORTH,OBJECTIVE,OBJECTIVES,PRESENT,RESULTS,TTFNA
169,INC
001,007,191,204,208,249,282,311,378,395,427,482,967,983,DESPITE,HOP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OFF,RESULTS,TREATMENT
MET
100,169,FUNCTIONAL,IQCB1,PCR,SRSF1,THESE,TUBD1
100,169,177,200,638,800,834,956,982,MALIGNANT,NCI,OBJECTIVE,RIT,YTTRIUM
169,AMP,COX,FUNCTIONAL,GPR109A,HOWEVER,NEU,THESE
216,952,HOWEVER,SIMILARLY,TNM
00011,00074,016,028,036,039,043,289,GASC1,NUCLEAR,PERCENTAGE,SIMILARLY,SMOKERS,SMOKING
106,967,COX,ERCC1,MEIER,NSCLC,XPF
169,177,946,AFTER,CHO,COPYRIGHT,FBS,MCF,MDA,PLH,RECHARGING,SKOV3,SPC,THESE
169,2573_2574,COPYRIGHT,GREEN,INC,MUTATIONS,PCR,THESE
FINALLY,RIGHT,SCC,SCCRF
169,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CVD,HOWEVER,LABEL,METHODS,OBJECTIVE,OMEGA,RESULTS,TXA,UTXB2
CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS
002,026,139,169,ATS,BAC,CHINESE,COPYRIGHT,ERS,IASLC,IHC,MEANWHILE,SPA
001,030,041,169,223,253,9TH,BACKGROUND,COPYRIGHT,HEALTHCARE,ICD,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,POISSON,PROJECT,PUBLISHED,RESULTS,SOCIETY,THERE
169,CAUSE,COPYRIGHT,CSS,EXCLUSION,IRELAND,ITALIAN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SURGERY,THREE
169,COPYRIGHT,EPIDERMAL,IRELAND,LTD,NSCLC,TKI
169,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,INC,KIRSTEN,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,TESTING,THERE
169,956,COMPOUNDS,COPYRIGHT,DICHROISM,LTD,MCF
169,388,459,956,COPYRIGHT,ED50S,ESI,LTD,QCC,THEIR
020,10F,160,177,215,5GY,985,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,PRV,RESULTS,SEQUENTIAL,SEVENTEEN
BACKGROUND,CHINA,CIS,LABEL,METHODS,ORS,RESULTS,SNP,TAIYUAN,VARIANT
331,CONCLUSION,DENMARK,DEPARTMENT,LABEL,METHODS,NON,NSCLC,RESULTS,UNIVERSITY,UNLABELLED
700,BACKGROUND,COX,LABEL,RESULTS,SHEDDEN,TREMENDOUS
19DEL,AMONG,ASIAN,AXL,BACKGROUND,CONCLUSION,DESPITE,EMT,KOREA,KOREANS,L858R,LABEL,MET,METHODS,PANEL,RESULTS,SECONDARY,SEVEN,T790M,TKI,WESTERN
BACKGROUND,BESIDES,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,PRIOR,RESULTS
BACKGROUND,BETWEEN,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
170,BACKGROUND,CONCLUSION,CPG,EPIGENETIC,FOXG1,GRIK3,HAND2,HLA,HOX,III,LABEL,NEUROG1,PATHWAY,PRKCB,PTGDR,RAP1A,RESULTS,STAGE,UBC
100,181,ALC,BACKGROUND,HCT,LABEL,LRD,LYMPHOCYTE,METHODS,PRE,RESULTS,RSV,URI
001,016,BACKGROUND,BECAUSE,LABEL,METHODS,MPLCS,MUTATIONAL,NOTABLY,OBJECTIVE,RESULTS
FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,THERE
BACKGROUND,CSF,CYCLE,DLT,EVEROLIMUS,LABEL,METHODS,PRIMARY,RESULTS,SECONDARY
150,177,BACKGROUND,DCR,EVEROLIMUS,GRADE,LABEL,METHODS,NSCLC,PFS,PRIMARY,RESULTS
HOWEVER,RAS,THEREBY,WESTERN,WHILE
169,194,280,312,399,751,CAUCASIANS,COPYRIGHT,ERCC2,HOWEVER,LABEL,LYS751GLN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SCIENCE,STATA,THREE,WEB,XPD,XRCC1
169,177,BLADDER,COPYRIGHT,INC,PFS,THERE
004,006,008,012,014,029,037,043,120,130,169,400,916,945,BACKGROUND,BCL,CONCLUSION,COPYRIGHT,FDG,FORTY,HIF,INC,LABEL,LDH,LIMITED,MAXIMUM,METHODS,ORR,PET,RESULTS,RFS,SEX,SUV
132,169,187,1MM,ALBUMIN,COPYRIGHT,GLYCATION,HEYNS,HSA,NBT,NITROBLUE,SEM,SERUM,TEM,THESE
169,COPYRIGHT,INC,RIGHT
126,169,ADAM9,COPYRIGHT,CRK,EGFL7,HOXA9,INC,IRS,SOX,THROUGH
BACKGROUND,CONCLUSION,LABEL,METHODS,PNS
CHIR99021,NOTCH,NSCLC,OVERALL,WNT
001,749,763,892,APOPTOSIS,BACKGROUND,CONCLUSION,EXPRESSION,LABEL,METHODS,PCR,PERCENTAGE,PRE,RESULTS,THESE,WESTERN
715,ADDITIONAL,ANXA3,CADM1,CCNE1,COX,ERCC1,GEO,MEIER,NSCLC,OPN,RAD51,UNIVARIATE
004,177,215,CISPLATIN,H1975,LCL,NSCLC,SNP,THEREFORE
COMPONENT,PCA,PRINCIPAL,SPE,URINARY,URINE,WHITNEY
106,761,CONCLUSION,INADEQUATE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
001,388,430,444,467,555,961,AFTER,BACKGROUND,COMPELLING,HODGKIN,HOWEVER,LABEL,METHODS,PCR,RESULTS,RTL,STRATIFIED
458,CD8,HOWEVER,TAKEN,TH1,THESE,TLS
169,AKT,BCL,CLPTM1L,RAS,TAKEN
000,063,100,391,AGE,ALZHEIMER,CAUSE,DESPITE,INDIANS,ISLANDERS,MORTALITY,NATIVES,PACIFIC,POISSON,POVERTY,RESIDENTS,USA
LNCAP,PCA,PCR,PNT1A,THESE
169,209,370,CONCLUSION,COX,CXCR2,EPCAM,EXPRESSION,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS
947,NATURAL,PERIPHERAL
CL1,CYTOSCAPE,DAVID,FINALLY,GEO,GNG11,GSE9315,GSM234967,GSM234968,HMGB2,THP,TME,WNT
3758309,946,954,AMONG,ECM,MIGRATION,MMP,THROUGH
160,AKT,EGF,SHORT
003,009,145,151,262,607,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OUTCOME,PATIENT,PTX,PURPOSE,RESULTS,SEVEN,TRACT,WITHOUT
001,002,006,112,156,535,588,BACKGROUND,CONCLUSION,DIAGNOSTIC,GENERAL,GUIDELINE,GUIDELINES,LABEL,METHODS,RESULTS,SUSPECTED,TESTS,THERE,USING
AMONG,BBB,BRAIN,METASTATIC,SINCE,TJS
ALA,ATP,COX,THESE,WARBURG
160,BECAUSE,CLOFILIUM,FIRST,SIMILARLY,THEIR
947,DSB,H71,HSP90,RAD51,THESE
100,956,BACKGROUND,LABEL,METHODS,RESULTS
MALIGNANT,NOTABLY
ABDOMINAL,AFTER,HOWEVER,THEREFORE
015,090,100,166,169,230,BACKGROUND,COPYRIGHT,FURTHER,HOWEVER,INC,LABEL,MEDLINE,METHODS,PCR,PUBLISHED,RESULTS,THERE
0009433,029,320,500,BACKGROUND,BONFERRONI,COLOMBIAN,CROHN,LABEL,MASSARRAY,METHODS,OBJECTIVE,PTB,RESULTS,SNP
006,017,026,028,036,169,185,555,695,819,897,AFTER,COX,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SIR,SOCIETY,UNADJUSTED
169,FINALLY,HOWEVER,PNS
169,BRAIN,MRI,OVERALL,SEVERAL
169,EARLY,EATON,LAMBERT,METASTASIS,NEUROLOGIC,THERE
169,660,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,VTE
033,120,169,AMONG,BACKGROUND,BETWEEN,COPYRIGHT,INC,JANUARY,LABEL,LCT,METHODS,NPO,PUBLISHED,RESULTS,RIGHT,SOCIETY
102,134,169,211,234,AFTER,BACKGROUND,BECAUSE,COPYRIGHT,III,INC,LABEL,METHODS,NSCLC,PATHOLOGIC,PUBLISHED,RESULTS,RML
120,169,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,EASTERN,FACTORS,FEW,GROUP,INC,LABEL,LDH,METHODS,RESULTS,SIX,SMALL
169,BACKGROUND,CONCLUSION,COPYRIGHT,DISEASE,FURTHER,INC,LABEL,METHODS,NSCLC,PBT,RADIATION,RBE,RESULTS,SEVENTY
002,007,169,177,954,AVERAGE,CNR,CONCLUSION,COPYRIGHT,DUE,INTER,IRELAND,LABEL,LTD,METHODS,MRI,NOISE,OBJECTIVE,OVERALL,RATIO,RESULTS,SCREENING,THERE,TRIAL
PROPONENTS
400,HAUSDORFF,JACCARD,PLATE,SNAKE,SPEEDED,THREE,TPS
916,CRC,DETECTION,EPIDERMAL,NSCLC,PCR,RGQ,SEQUENCING
000,185,BIS,MEG,MORPHOLOGY,NMR,PCL
023,EVALUATION,FDG,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,P53,PET,RESULTS,TIGAR
051,ACCORDING,DUE,NETWORK,ORGAN
133,177,ABCG2,ALDH1,CD133,CELLS,CSC,EGF
GEFITINIB
ALK,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC
160,BACKGROUND,CONCLUSION,DIR,LABEL,METHODS,NEITHER,RESULTS,THESE,VOLUMETRIC
169,CONVERSELY,ERBB2,FATTY,HNSCC,MMP,OTSCC,SCC,THESE,VEGFA165B,ZSGREEN
169,BCL,HOWEVER,IRR,JAK,JANUS,STAT3,THESE
032,945,BASED,FLICE,HOWEVER,MCL,PIK,PRIMARY,SNS,TRAIL
HOWEVER,NSCLC,TAKEN,TDCLS,V600E
FINALLY,MAX,MGA,MYC,SNF,SWI
254,GAPDH,HDAC5
946,AKT,CABYR,CONVERSELY,GSK,HOWEVER,LABEL,NCI,TAKEN,UNLABELLED
124,169,BACKGROUND,COPYRIGHT,FUNCTIONAL,LABEL,MICRORNAS,RESULTS,THP,UL112
169,946,COPYRIGHT,CROWN,DICKKOPF1,INC,NSCLC,PUBLISHED,RUNX2,TAKEN,WNT
300,MALIGNANT,PXD000531,SEVEN
BASAL,BCC
169,BIOLOGY,COPYRIGHT,DISCOIDIN,PUBLISHED,SELECTIVE,SOCIETY,WHILE,YET
110,133,169,330,945,946,954,ACORN,AT2,B1R,COPYRIGHT,ILE,INC,NAL,OIC,OVERALL,PHE
169,ADDITIONAL,AKT,AURKA,AUTHORS,BIOMARKERS,CHALLENGE,COPYRIGHT,ERBB2,ERK,FIRST,HOWEVER,ISSUE,MEK,NSCLC,PROTEOMIC,PUBLISHED,RAF,RAS,SPECIAL,VX680
169,177,956,BESIDES,COPYRIGHT,MMS,MNU
169,32YEARS,40YEARS,78YEARS,93YEARS,AUTHORS,COPYRIGHT,INC,PUBLISHED,RRS,THERE
169,946,956,AUTHORS,BALTIMORE,CHRISTI,COPYRIGHT,COX,CRUMP,GERMANY,HAYNE,INC,LEVERKUSEN,POISSON,PUBLISHED,UERDINGEN,URF
100,116,169,261,437,AUTHORS,COPYRIGHT,EPIDERMAL,HISTOLOGY,HOWEVER,III,IPASS,IRELAND,LABEL,LTD,METHODS,MUTATIONS,OBJECTIVE,OBJECTIVES,ORR,PAN,PUBLISHED,RESULTS
100,146,169,479,553,822,ACCORDING,ACT,BACKGROUND,CONCLUSION,COPYRIGHT,COX,EVALUATION,HIPAA,III,INC,INSURANCE,LABEL,MATERIALS,MEIER,METHODS,NSCLC,PATIENT,RESULTS,SOLID
001,003,414,967,AFFAIRS,AFRICAN,BACKGROUND,CAUCASIAN,CENTRAL,CONCLUSION,COX,GRADE,INC,JANUARY,KRUSKAL,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS
130,169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OVERALL,RESULTS,THESE
001,004,007,012,021,160,169,440,ALK,AMONG,BACKGROUND,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS
077,169,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEPAR,THREE
133,169,246,522,BACKGROUND,COPYRIGHT,DISCUSSION,DISEASE,FDG,HYPOTHESIS,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PUBLISHED,RESULTS,SEPAR,TREATMENT,USING
100,110,135,169,CARCINOMAS,CATEGORIES,CK7,COPYRIGHT,HOWEVER,IHC,INC,RESULTS,SEVEN,SPB,TTF
169,280,4T1,CNP,COPYRIGHT,HOWEVER,LTD,RFP,WESTERN
LNCAP,LTD,NAD,PUBLISHED,SAR,TOP
169,ALK,COPYRIGHT,FBXW7,IRELAND,LTD
169,946,CONCLUSION,COPYRIGHT,DIANA,FAK,HUVEC,IRELAND,LABEL,LTD,MATERIALS,METASTATIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCP,RESULTS,SRC,TARGETSCAN,TGF,THESE,THREE,WNT
169,241,COPYRIGHT,CPG,PCR,PORTUGUESA,PUBLISHED,SOCIEDADE,TNM
001,10877,169,170,200MG,260,306,BACKGROUND,CEDIRANIB,COPYRIGHT,DAILY,LABEL,LTD,METHODS,PFS,RESULTS
169,AUSTRALIAN,CONCLUSION,COPYRIGHT,CROWN,HRQOL,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,PUBLISHED,RESULTS
169,ALK,COPYRIGHT,FURTHER,IRELAND,LTD,NSCLC
169,513,632,BACKGROUND,COMPARISON,COPYRIGHT,ENDPOINTS,EPP,IRELAND,LABEL,LTD,MALIGNANT,METHODS,MPM,RESULTS,SEVEN
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
128,177,217,BACKGROUND,CONCLUSION,ELDERLY,LABEL,METHODS,NEITHER,PET,RESULTS
135,176,ABC,BACKGROUND,DOSIMETRIC,FIFTEEN,GROSS,HOWEVER,LABEL,METHODS,PTV,RESULTS,THEREFORE,V10,V20,V30
116,169,183,945,946,956,AIM,CANDIDA,CHINA,COPYRIGHT,EUPHORBIA,HCT,LABEL,METHODS,MTT,NMR,OBJECTIVE,PUBLISHED,RESULTS,TARAXEROL,TRITERPENE,UNIVERSITY
BACKGROUND,CANCEROUS,CONCLUSION,HOWEVER,LABEL,METHODS,SEVERAL,THESE
CYRUS,DORMANT
BACKGROUND,BAX,BCL,BESIDES,BIP,J82,LABEL,METHODS,PEE,RESULTS,T24,TAIWANESE
160,386,IMPROVING,PERCEIVED,USING
520,APPRAISAL,BACKGROUND,BRITISH,FURTHER,HODGKIN,LABEL,METHODS,MINIMISING,NHS,PROGRAMME,RESULTS,SEVEN,SIX,THERE,ZEALAND
CSC,PCR,THESE
BASED,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PECOMAS,RESULTS,SEVEN
CONCLUSION,DIR,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
001,AKT,CPSF4,HOWEVER,JNK,KNOCKDOWN,MECHANISM
116,BSA,CF770,EPR,HCT,HLA,HOWEVER,IGG2A,JCK,NIR,PDX,THEREFORE,THESE,XENOLIGHT
130,177,181,BAX,BCL,CDK,FURTHER,MCF,PARMOTREMA,WST
440,BACKGROUND,DESPITE,LABEL,METHODS,RESULTS
BACKGROUND,IPILIMUMAB,KIR,LABEL,LAG,METHODS,MPDL3280A,RESULTS,SEVERAL,THESE
BACKGROUND,LABEL,METHODS,PREDICTIVE,RESULTS
BACKGROUND,ERLOTINIB,LABEL,METHODS,MOLECULAR,NON,NSCLC,RESULTS,TKI,USING
886,AMONG,BACKGROUND,CLINICIANS,HOWEVER,LABEL,METHODS,RESULTS,SIMILARLY,SOCIETY,TEN
038,249,3N2,534,BACKGROUND,INT,JANUARY,LABEL,METHODS,NSCLC,RESULTS,STAGE,THERE
001,997,AMONG,BACKGROUND,COX,III,LABEL,MEIER,METHODS,MOFFITT,NSCLC,RESULTS
ADDRESSING,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS
ADDITIONAL,ALK,BACKGROUND,GENOMIC,IMPORTANT,LABEL,METHODS,MULTIPLEX,NSCLC,RESULTS
BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,THREE,WHILE
BACKGROUND,CONTINUED,CURRENT,EUS,FNA,LABEL,METHODS,NSCLC,RESULTS
ADVERSE,BACKGROUND,FALSE,GUIDELINES,HOWEVER,LABEL,METHODS,RESULTS,SCREENING,TRIAL
160,ALTOGETHER,FACTORS,NSCLC,PATIENT,THESE
169,198,FGFR1,HENCE,INC,NCI,RESTORING,WILEY
BACKGROUND,CHANGES,DISCUSSION,GERMANY,INSTITUTE,LABEL,MATERIALS,METHODS,RESULTS
086,252,447,578,AOK,BACKGROUND,DETMOLD,DISCUSSION,DISEASE,LABEL,MANAGEMENT,METHODS,PROGRAM,RESULTS,SIR,T2D
300,429,477,900,DCO,DESPITE,GERMANY,INCLUSION
169,INC,MEANWHILE,NSCLC,PCR,TAKEN,TNM,WILEY
009,169,1ST,215,748,893,AFTER,BACKGROUND,IMBALANCES,KTR,LABEL,METHODS,NUTRITION,OR5TH,ORS,RESULTS,TRYPTOPHAN
001,009,160,190,382,572,AHR,ARG,BACKGROUND,CCND1,EPHX1,ILE,LABEL,LYS,MESTIZO,METHODS,MEXICAN,RESULTS,STUDENT,TYR,VAL
169,949,APOPTOSIS,CD11C,CD3,COPYRIGHT,LTD,NSCLC,PLCE1,WESTERN,WILEY
169,AKT,CD133,CISPLATIN,ECTOPIC,HOWEVER,HTRA1,INC,LAC,THEREFORE,WILEY
169,CLINICALLY,CRK,INC,SH2,SH3,WILEY
165,169,HPB,THESE,UN1
945,946,947,956,ATP,B16,CXCL8,F10,IFN,JNK,JUN,LY2228820,MK2,MYC,TED,TNF,WESTERN
169,183,BECAUSE,CALVERT,THEREFORE
003,118,182,BACKGROUND,CHRONIC,DISEASE,ETS,EXCLUSION,INITIATIVE,LABEL,METHODS,PASSIVE,RESULTS
200,676,AUC,BACKGROUND,C30,EORTC,LABEL,METHODS,NSCLC,OBJECTIVE,PATIENT,Q3W,QLQ,RESULTS
169,954,ASSAY,AZA,BACKGROUND,BASEL,H1703,H1915,H1975,H1993,H2073,LABEL,MCL,METHODS,MICRORNAS,MTT,NCI,NSCLC,PCR,PDT,RESULTS,TREATMENT,WESTERN
371,742,AFTER,EDUCATION
001,177,MPG,OMA,THESE
001,004,169,210,AFTER,APRIL,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INC,LABEL,METHODS,RESULTS,SEOUL,TNM,UNIVERSITY
169,COPYRIGHT,METHODS,PUBLISHED,SEPAR
050,126,169,83YEARS,COPYRIGHT,ELISA,INC,KRUSKAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PUBLISHED,RESULTS,SERUM,SOCIETY
ABSENCE,ANTICANCER,K292E,NCI,PUBLISHED,TYROSYL
171,177,INC,PUBLISHED,THESE
160,169,COPYRIGHT,FLORIDA,KNOWLEDGE,LTD,MOFFITT,PROGRAM,RAPID,RTD,TAMPA,USA,WHILE
3RD,6TH,945,BASED,CD4,CD8,CSF,ELISPOT,FINALLY,FIRST,HLA,IDO,IFN,IL2,INTERFERON,KYN,LDH,MONTANIDE,NSCLC,OVERALL,PET,SINCE,SW480,TMZ,TREGS,TRP
454,493,BACKGROUND,CONCLUSION,CTS,DENMARK,FOUNDATION,FUNDING,JANUARY,LABEL,METHODS,NORDISK,RESULTS,SOCIETY,THERE,TRIAL
169,AMONG,ANALYZING,COPYRIGHT,HOWEVER,IHC
169,ALK,COPYRIGHT,FOLLOWING,IRELAND,LTD,MET,NSCLC,SEVERAL,THESE
169,395,BACKGROUND,COPYRIGHT,DESPITE,III,INC,LABEL,METHODS,RESULTS,WHETHER
169,BACKGROUND,CELLS,CONCLUSION,COPYRIGHT,DESPITE,LABEL,METHODS,NOVEL,RESULTS,THESE
179,290,298,CUMULATIVE,EPIDEMIOL,JOURNAL,VLAANDEREN

169,COPYRIGHT,IRELAND,LTD
169,177,CONCLUSION,COPYRIGHT,GIVEN,IRELAND,LABEL,LTD,MATERIALS,METHODS,NONSMOKING,OBJECTIVE,OBJECTIVES,RESULTS
169,177,355,365,954,ANOVA,BACKGROUND,COPYRIGHT,COX,CPH,FDG,IHC,INCREASED,INCREASING,IRELAND,LABEL,LTD,MEIER,METHODS,MICROARRAY,NSCLC,PET,RESULTS,STAGE,SUVMEAN,THESE
169,177,COPYRIGHT,CREKA,DIM,INC,LABEL,NCS,NTA,PCNCS,PEGYLATED,UNASSIGNED,UNLABELLED
447,ANONYMOUS,BACKGROUND,DARTMOUTH,FLEISCHNER,HITCHCOCK,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SOCIETY
000,007,018,142,158,161,307,817,BACKGROUND,BLINDED,COMBINING,HEREDITARY,HHT,IQR,LABEL,METHODS,OVERALL,RESULTS,THESE
013,072,077,353TT,791,940,BACKGROUND,EMT,EPITHELIAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SEVEN,SNAI1,THERE,VAL118ALA
169,AVM,BRAGG,JAMES,LINDA,MEDICAL,TREATMENT,UNIVERSITY,WHILE
V95
MLC
177,DEDICATED,IQR,MPH,RESULTS,TCS
AAK,ALK,AREAS,BACKGROUND,COVERED,FGFR1,LABEL,MEK,MET,METHODS,NSCLC,OPINION,RET,VEGFR,WHILE
THEREFORE,TNM,YET
1960S,EARLY,SURGERY
ENGLISH,NON,NSCLC
000,245,273,370,440,607,618,815,985,AFTER,BACKGROUND,CXR,ITALY,LABEL,LCS,METHODS,NHS,RESULTS,SERVICE
RIGHT
EPIDERMAL,G719X,HOWEVER,L858R,L861Q,NSCLC,TKI
AIM,BACKGROUND,DYSPNEA,HOSPICE,LABEL,LUKAS,METHODS,OBJECTIVE,PERCEIVED,RESULTS,RMD,SANKT,SCALE,SCM,VAS
183,230,251,ADDITIONAL,LABEL,METHODS,OBJECTIVE,PCP,PURPOSE,QUESTIONS,RCT,RESULTS,STATE,SURVIVORS,THOSE,WASHINGTON
100,CHARLESTON,HOWEVER,SOUTH
150,AES,ERLOTINIB,III,LABEL,METHODS,NSCLC,OBJECTIVE,PFR,PRIMARY,PURPOSE,RESULTS,SECONDARY,SIXTY,TTP
ALTERED,BASED,CISPLATIN,FDG,HKI,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,THREE,UNDER
145,181,268,ATTEMPTING,HCT,MCF,N13,SGF,SIF
99MTC,AIM,CONCLUSION,ECT,LABEL,METHODS,NUCLEATED,OBJECTIVE,RESULTS,SUPPRESSED,ZEALAND
DESPITE,HOWEVER,RIGHT,SPECIAL,SUBSEQUENT,SVC
132,166,279,AFTER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,USING
001,047,155,235,282,293,697,CHINESE,G719A,G719C,G719S,G719X,L858R,L861Q,NSCLC,REFRACTORY,T790M
HOWEVER,PULMONARY,SEVERAL,THESE,V10,V15,V20,VS5
AFTER,EBV,EPSTEIN,LMP,NPC
178,ANSELIN,ARABIAN,EASTERN,GWR,HODGKIN,MORAN,NHL,OLS,POPULATION,SAUDI,THESE
165,252,321,868,BASED,COCHRAN,CONCLUSION,FINALLY,FIRSTLY,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,REVIEWS,URINARY,WEB
556,ACCORDING,AIS,AMONG,BETWEEN,CTR,GGN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEVERAL,SOCIETY,STAGE
109,157,158,AFTER,AIM,ALARM,BACKGROUND,CONCLUSION,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,SETTING,THREE
103,AKT,CONVERSELY,EXPRESSION,HNSCC,MEK,NSCLC,PD98059,RAS,RASWT,SIMILAR
141,169,177,ABDOMINAL,COPYRIGHT,DESPITE,EVERY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TUKEY
169,BASED,MEDICAL,NSCLC,PRESS,PUBLISHED,SEVERAL,SOCIETY,UNIVERSITY
AFTER,AMONG,APC,DUE,HOWEVER,IMIDS
001,160,352,493,BACKGROUND,BDC,CURRENT,HOWEVER,LABEL,METHODS,NSCLC,PERFORMING,RESULTS,STAGE
ACCORDING,AFTER,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LAPATINIB,METHODS
007,008,073,945,946,BED,NSCLC
000,100,185,265,455,INCIDENCE,JANUARY,KOREA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,VIETNAM,WAR
100,215,3GLCNAC,4GLCNAC,945,946,BECAUSE,EBC,FURTHER,MILLETTIA,THESE,WJA
127,338,AFTER,BECAUSE,CHRONIC,COX,JAPAN,MEIER,SPIROMETRY,WESTERN
300,956,ARSENIC,MTE,THESE
HCC78,HOWEVER,NSCLC,PREVIOUSLY
1940S,ADDITIONAL,BIRTH,HOWEVER,REANALYSIS,THEREFORE
AKT,CHINA,CONCLUSION,HOWEVER,KNOWLEDGE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
001,101,29C,378,483,BACKGROUND,CONCLUSION,FOLLOWING,LABEL,METHODS,PCR,RESULTS,ROC,USING
BESIDES,DESPITE,EPH,EPHA2,EPHA3,EPHB4,GPI,THESE
HOWEVER,SEVERAL,TMPRSS2
945,AFTER,H1299,HIF,KNOCKDOWN,MICRO,RADIATION,RBE,TAKEN,THESE
AIM,BACKGROUND,CHECKLISTS,CONCLUSION,CUMULATIVE,CURRENT,EXCELLENCE,GENERALLY,GUIDELINES,HOWEVER,INDEX,INSTITUTE,LABEL,LITERATURE,MEDLINE,METHODS,NETWORK,NURSING,QUALITY,REPORTING,RESULTS,THEREFORE
037,112,152,ELISA,FOXP3,IGG,STUDENT
169,230,BACKGROUND,BEHAVIORAL,COPYRIGHT,F2F,INTENTION,LABEL,LTD,METHODS,MODEL,RESULTS,VULNERABLE,WILEY
169,HOWEVER,IMT,INC,WILEY
158,169,455,GAP,HENCE,RAS,RHO,THESE
169,AKT,CXCL5,EGF,ERK,FOS,HSP27,INHIBITING,KNOCKDOWN,RSK,SNAIL,TARGETING,THESE
ALK,CD4,EMA,HISTOLOGY,PRIMARY,PROGNOSIS

000,700,934,AFRICAN,COX,EFFECTS,GEORGIA,MEDICAL,NHW,NON,NSCLC,SOUTHWEST,THERE,TREATMENT,WHITE
FIFTEEN,FORTY,HYPOXEMIA,MEDICAL,PES,PRE,THERE,THESE,UNIVERSITY
953,BHD,DUB,PRIMARY,TAIWANESE
952,PCR,RASGRP3,REGIONS,RNF20,SCA,SNP,SSBP2,WIDESPREAD
NSCLC,RADIOMICS,THEREFORE
BRCA1,HSP90,LABEL,LARGE,MUTATIONS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SUMMARY,TNBCS
195,200,600,BACKGROUND,EASTERN,GROUP,LABEL,METHODS,PFS,RESULTS
070,215,BACKGROUND,BCL,LABEL,MAXIMUM,METHODS,NSCLC,OBATOCLAX,OVERALL,RESULTS,THREE
240,947,BACKGROUND,CCDC6,CONCLUSION,HODKGIN,KIF5B,LABEL,METHODS,NCOA4,RESULTS,RET
CHANGES
ALK,APRIL,BACKGROUND,BREAK,CLINICIANS,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER
003,012,130,201,225,BACKGROUND,DETECTION,DISCREPANT,GENOMIC,LABEL,METHODS,REFRACTORY,RESULTS,THERE,THESE,TKI,WHETHER
001,002,005,ASSESSMENT,BACKGROUND,CONCLUSION,FUNCTIONAL,INSTITUTE,LABEL,METHODS,PACLITAXEL,PATIENT,PHYSICIANS,RESULTS,THERAPY
100,BACKGROUND,CONCLUSION,FIFTY,LABEL,METHODS,RESULTS,THERE
001,005,283,2N0M0,BACKGROUND,BETWEEN,DFS,LABEL,LOCAL,MEIER,METHODS,NSCLC,PROGNOSTIC,RESULTS,T1A
AKT,BACKGROUND,ERK,FURTHER,LABEL,MAP,METHODS,NCI,NED,NSCLC,RESULTS,U0126,USING
371,ABCG5,ALDH1,BACKGROUND,BER,CD133,CD166,CONCLUSION,CSC,EP4,ESA,EXTENSIVE,LABEL,METHODS,MOC,NSCLC,RESULTS,SEX
134,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,RESULTS,RET
001,104,109,188,200,ALK,BACKGROUND,BETWEEN,LABEL,METHODS,NORTH,NSCLC,PCR,RESULTS,SEPTEMBER,THESE,V5A
CSC,DESPITE,PROVIDING
160,ALTOGETHER,ARF,ARG249SER,CONVERSELY,H2052,H2452,H28,HMC,IST,MALIGNANT,MES,NCI
169,ANOVA,CD4,CD8,COPYRIGHT,FOXP3,III,LSD,NSCLC,THERE,THESE,TREGS
NON,NSCLC
000,400,ALK,AMONG,FGFR1,MAJOR,SQCLC,THESE
ALK,CRIZOTINIB,FURTHER,NSCLC
AFTER,BACKGROUND,C30,ELDER,EORTC,GROUPED,LABEL,METHODS,NAUSE,OBJECTIVE,QLQ,QUALITY,RESULTS,SIXTY
009,032,557,AFTER,AUG,BACKGROUND,ESS,EUTHYROID,FT3,FT4,LABEL,METHODS,NSCLC,OBJECTIVE,OCT,POD,RESULTS,THERE,TOS,TSH,VIDEO
091,BACKGROUND,BRAIN,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,USUAL
041,108,121,131,152,189,209,310,3N2M0,4N1M0,4N3M0,BACKGROUND,BETWEEN,CHI,COLLEGE,HOWEVER,III,LABEL,MARCH,MEDICAL,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PFS,RESULTS,SURGERY,THERE,THREE,TNM,UNION
001,008,035,077,087,123,178,277,931,967,978,BACKGROUND,BCL,BIM,DCR,JANUARY,LABEL,METHODS,MULTI,NON,NSCLC,OBJECTIVE,OCTOBER,PCR,PFS,RESULTS,TKI,UNIVARIATE
181,BACKGROUND,CETUXIMAB,KDR,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THEIR,WESTERN
ABC,ANTITUMOR,ATP,GIVEN,NSCLC,SINCE,TRAIL
169,49009,AKT,COPYRIGHT,H1975,HSP70,HSP90,LTD,MET,PU3,SUBSEQUENT,VER
100,203,436,BACKGROUND,CIS,COLLECTED,CONCLUSION,ETS,LABEL,METHODS,ORS,OVERALL,RESULTS,SES,THERE,WHILE
169,AMONG,BRITISH,HOWEVER,SOCIETY,TRP,TRPA1
169,ASIAN,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,LTD,MEDICAL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SELECTION,SUBJECT,WILEY
BACKGROUND,CONCLUSION,COULD,HOWEVER,LABEL,METHODS,RESULTS
169,AUTHORS,EMT,LTD,PTY,PUBLISHING,SCIENCE,THESE,WILEY,WNT,WNT5B
ABSTRACTS,BACKGROUND,BIOLOGICAL,BRITISH,C30,CAB,CD3,CD4,CD8,CHINESE,CQVIP,EBSCOHOST,EORCT,FURTHER,HOWEVER,INDEX,ISI,KARNOFSKY,LABEL,LIBRARY,MEDICAL,MEDLINE,METHODS,NURSING,QLQ,RESULTS,SCIENCE,WANFANG,WBC,WEB
001,021,399,COX,OPTIMAL,WORLD
39351,3RD,CANCERS,CHILDHOOD,CONCLUSION,DEC,EDITION,GENERAL,HACETTEPE,HOSPITALS,JAN,LABEL,MEDICAL,METHODS,OBJECTIVE,PEDIATRICS,PURPOSE,RADIATION,RESULTS,SURGERY,UNIVERSITY,UROLOGY
000,129,177,209,AMONG,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SPN
815,CONCLUSION,DYNAMIC,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TAC
432,989,CONCLUSION,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
100,CONCLUSION,COX,HSP,HSP27,LABEL,LCNEC,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLCS,SURGICALLY,THERE
COX,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PURPOSE,RESEARCHES,RESULTS
001,012,031,034,040,073,233,CONCLUSION,IIIIV,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
169,293,GREEN,H1299,INC,NSCLC,POLYPHENON,TAM67,WILEY
169,AUTHORS,LTD,STATISTICS,WILEY
FEWER,PATHOLOGY,RCC,SOCIETY,THEIR,TLF,UROLOGICAL,WORLD
GISTS,GIVEN,THESE,TREATMENT
BMJ,GROUP,INDWELLING,IPC,LIMITED,MPE,PUBLISHED,PUBLISHING,SUSPECTED,THERE,THESE
001,100,CD146,EMA,GLUT1,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RMC
OCT
000,047,AFFILIATED,CHINA,CONCLUSION,III,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PROVINCIAL,RESULTS,UNIVERSITY
945,CSA,CYP,DOX
BASAL,BCC
169,ACS,AMONG,BACKGROUND,CDC,CENTERS,CENTRAL,CONTROL,DISEASE,END,ESTIMATES,INSTITUTE,LABEL,METHODS,NCI,NORTH,OVERALL,PREVENTION,REGISTRIES,RESULTS,SOCIETY,THROUGH
116,285,353,994,AOS,CELLS,FOXM1,HOWEVER,NADPH,ROS,THEREBY,THEREFORE
001,169,244,AMONG,BACKGROUND,CNS,COPYRIGHT,INC,LABEL,METHODS,MIXED,RECORDS,RESULTS,TTP
169,17A,945,947,ACADEMY,ALLERGY,BACKGROUND,CHRONIC,CONCLUSION,COPYRIGHT,EXPRESSION,HOWEVER,IFN,IMMUNOLOGY,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,POLYP,PUBLISHED,RESULTS,SPLUNC1,TLR
169,562,ATP,BACKGROUND,CALCIUM,CARCINOMA,CHINESE,COPYRIGHT,GENERAL,LABEL,LEWIS,METHODS,PUBLISHED,RESULTS,THEREFORE
169,1GY,225,2GY,5GY,991,AVERAGE,CONCLUSION,COPYRIGHT,CTC,DOSIMETRY,GRADE,ILD,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,NCI,OBJECTIVE,PURPOSE,RESULTS,WHOLE
169,INC,MOLECULAR,PUBLISHED
169,ALK,INC,NON,NSCLC,SEVERAL
002,016,152,169,COPYRIGHT,DPM,FURTHER,GASTRIC,JANUARY,LABEL,LTD,METHODS,MSI,OBJECTIVE,RESULTS,THEREFORE
946,AKT,CKS,EMT,GSK,INHIBITION,PLATYCODON,SMAD2,SMAD7,SNAIL,TGF,THESE
BACKGROUND,DGE,HOWEVER,JOINT,LABEL,RESULTS,TOP
00004,NSCLC,STAGE,UNIVARIATE
205,CHINA,POLLUTION,RESULTS,WORLD,XUANWEI
003,131,178,BACKGROUND,CONCLUSION,INC,LABEL,MEDICAL,MERIT,METHODS,RESULTS,SOUTH,SYSTEMS,THERE
FILAMIN,FILIP1L,FURTHER,OVERALL,REDUCED
148,707,METASTASIS,SUBSEQUENT,TNM
361,608,769,946,AKT,BCL,ERK,LU1,SHORT,TGF,WNT
177,DESPITE,ELISA,IGF,IGFBP,SERUM,TKI,WESTERN
947,BACKGROUND,BECAUSE,CONCLUSION,DEN,EBP,HCC,IFN,LABEL,OBJECTIVE,RESULTS
005,009,196,376,AGE,CONCLUSION,EASTERN,GROUP,IFD,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
169,300,350,BACKGROUND,FIFTY,LABEL,METHODS,PLK,RESULTS,SEVEN,SOCIETY,VOLASERTIB
000,001,031,043,446,ASIAN,CAUCASIANS,MMP,NSCLC,SEVEN
407,ASN,ASP312ASN,C118T,CHINA,ERCC1,ERCC2,GLN,KNOWLEDGE,LYS751GLN,NSCLC,PFS,SNP
169,ALDRICH,AUTHORS,B16,DCS,IMMUNOLOGY,JOURNAL,VCH,WILEY,WISKOTT
169,PIC,PPC,RATIONALLY,USING,VCH,WILEY
BASED,CHEST,TEN,THEREAFTER
BASED,BECAUSE,GRADE,GROUP,III,JAPAN,LABEL,METHODS,OBJECTIVE,OTHER,PHASE,RESULTS,TEN
133,169,321,563,686,881,945,946,ALPHA,FINNISH,NEITHER,PREVENTION,TOCOPHEROL
169,BACKGROUND,CONCLUSION,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM,WILEY
BESIDES,FUNCTIONAL,LABEL,MATERIALS,METHODS,MICROARRAY,OBJECTIVE,OBJECTIVES,PROTEIN,REFERENCE,RESULTS
142,537,BESIDES,CLUSTER,CONCLUSION,DAVID,EXPRESSION,FUNCTIONAL,GENECODIS,GSE3268,LABEL,MATERIALS,METHODS,MIR,OBJECTIVE,OMNIBUS,RESULTS,SLC,THESE,WEBGESTALT
000,003,006,008,011,021,054,074,172,224,559,644,675,COX,FORTY,IHC,MEIER,THESE
100,101,177,215,DEMODEX,RESULTS
036,403,527,COX,FIFTY,GROUPINGS,NSCLC,OBJECTIVE,PCR,PFS,THERE,TKI
945,954,LPS,SIMILARLY,SNO,THESE,TNF,TRX,TXNIP
115,946,947,AK301,CELLS,EMPLOYING,FAS,THESE,TNF,TNFR1,TRAIL
COLORECTAL,DESPITE,HOWEVER,THEREFORE,TYPICALLY
200,931,COMPOUNDS,ESTIMATED,PM2,USEPA
HIF,HOWEVER,METASTATIC,RCC,VHL,VON
177,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
BAK,BCL,DHA,FAS,GEM,ROS
040,045,15Q25,200,210,ADDITIONAL,CAUCASIANS,CHINESE,HAN,HOWEVER
236,385,945,956,AKT,BP1,H1975,MTT,NVP,PCR,T790M,THERE,THESE,THR70,WESTERN
233,DANDY
ACTIVATION,ASIAN,ATP,BACKGROUND,CONCLUSION,DCR,GRADE,HGF,LABEL,MET,METHODS,MGC,PRE,RESULTS,TIVANTINIB
129,818,935,953,AUC,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESENTING,PUBLISHED,RESULTS,ROC,THESE,UNIVARIATE,USING
231,ALDH1,MDA
150,177,225,227,333,367,CONCLUSION,DIXON,FDG,FIFTY,INTRACLASS,LABEL,MBQ,METHODS,PET,RESULTS,THERE,THREE,UNLABELLED
000,100,120,177,240,300,500,956,99M,B12,CONCLUSION,DYNAMIC,LABEL,MBQ,METHODS,PREDOSING,RENAL,RESULTS,SIX,SPECT,TARGETING,TEN,UNLABELLED
BUTEA,COX,THESE
967,BACKGROUND,LABEL,LOS,MEIER,METHODS,RESULTS,WHITNEY
ATP,CONVERSELY,ROS,THESE,TRAIL
231,ALTOGETHER,MCF,MDA,VGSCS,VOLTAGE
ACTIN,ESPIN,FAK,GTP,HOWEVER,LABEL,MEL,RET,UNLABELLED
127,191,AIM,BACKGROUND,CHARING,CONCLUSION,CROSS,DESPITE,DETAILS,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,ONGOING,RESULTS,TREATMENT
124,173,177,237,363,AGE,APRIL,JANUARY,LABEL,METHODS,MORBIDITY,MORTALITY,OBJECTIVE,OBJECTIVES,PAF,RESULTS,UNIVARIATE,WHILE
630,HOWEVER,PDT
AJUBA,HIPPO,HOWEVER,LATS2,LIM,MALIGNANT,MMS,NF2,TAKEN,YAP,YES
100,HOWEVER,MOLECULAR,THERE
32P,AIM,CONCLUSION,INSTEAD,LABEL,METHODS,OBJECTIVE,RESULTS,ROI,SPECT
007,106,127,224,345,CONVERSELY,ELISA,FORTY,IPF,MMP,NSCLC,PCR,SERUM
5FU,BAX,CONVERSELY,HOWEVER,KNOCKDOWN,PATZ1,THEREFORE
491,CONVERSELY,EGF,FAK,LOWER,MICRORNAS,OSCCS,USING
AGILENT,APPLIED,BACKGROUND,BIOSYSTEMS,CONCLUSION,FLA,LABEL,METHODS,PCR,RESULTS,STR
010,11C,889,955,ATP,COMBINING,EGF,GBM,IHC,MRI,PET,ROI,THERE,TKI
001,018,145,169,277,674,676,BASEL,FDG,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PET,PFS,RESULTS
116,435,956,HCT,HNY29,MDA,MTT,PHOMOPSIS,THREE
001,177,BACKGROUND,CONCLUSION,HOWEVER,KBP,LABEL,METHODS,RESULTS
ASIAN,AUSTRALIA,CHINA,COLORECTAL,HOWEVER,JAPAN
001,002,137,169,177,APRIL,DEFINITION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PREDICTORS,PRESS,PUBLISHED,RESULTS,SAA,SEVERAL,SURGERY,THERE,THREE,UNITS,UNIVERSITY,VIDEO
162,169,311,430,741,945,A588T,AIM,BASEL,CONCLUSION,HIF,LABEL,METHODS,NSCLC,OBJECTIVE,P582S,PFS,RESULTS
109,169,AMP,BACKGROUND,BASEL,CONCLUSION,ECA,ESOPHAGUS,HOWEVER,LABEL,METHODS,RESULTS,THESE,TREATMENT
AGE,AMD,AREDS,BECAUSE,DISEASE,EYE,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATED,RESULTS
169,BECAUSE,CPG,HTB56,LABEL,METASTASIS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,WIDESPREAD
001,169,209,ADC,III,INCREASED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS
MANAGEMENT,THERE
BMJ,EMT,EPITHELIAL,GROUP,LIMITED,PUBLISHED,PUBLISHING
AKP,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,REGARDING,RESULTS,THERE,TOS
AMONG,EIGHT,ENGLISH,FURTHER,HOWEVER,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,RATIONALE,RESULTS
ACUTE,CONCLUSION,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,NORTH,NSCLC,OBJECTIVE,PET,PURPOSE,REASONS,RESULTS,THESE,TREATMENT,WHILE
DDM,ECLIPSE,EMT,ITV,PTV,THEREFORE
CEA,CELLSEARCH,CTC,FISCHER,SIX
954,AGREEMENT,CASES,COHEN,DOM,GREATER,JEM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISKS,TORONTO
169,BESIDES,COPYRIGHT,HOWEVER,PDCD4,PROGRAMMED
169,177,COPYRIGHT,IRELAND,LTD,MICROARRAY
169,BEL7404,COPYRIGHT,HEPG2,RIBOSOMAL
118,174,200,233,AIM,BACKGROUND,BRONCHIAL,CENTRAL,CONCLUSION,HUNGARY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OTHER,PDS,PROLONGED,RESULTS,THERE,THESE
FINALLY,FIRST,THERE,THESE
169,COPYRIGHT,FURTHER,IRELAND,LTD,RADON,STUDIES
169,COPYRIGHT,INCREASING,INHIBITION,IRELAND,LEWIS,LLC,LTD,PCR
169,COPYRIGHT,GALECTINS,HUVEC
169,COMPOUNDS,COPYRIGHT,NCI,PALLADIUM,SAS,THESE
169,946,AKT,CISPLATIN,CONVERSELY,EMT,FINALLY,HOWEVER,INCREASED,KNOCKDOWN,NSCLC,PUBLISHED,SNAIL,TAKEN,TWIST
169,COPYRIGHT,DESPITE,GROUP,III,LTD,NSCLC,RADIATION,STRATEGIES,THERAPY,THESE
001,169,375CM,677,AAA,AXB,COPYRIGHT,CROWN,ECLIPSE,INITIAL,MEDICAL,MUS,NSCLC,OVERALL,PUBLISHED,RADCALC,USING
169,COLLEGE,COPYRIGHT,DIGITAL,LTD,PUBLISHED,ROYAL
169,BACKGROUND,COPYRIGHT,HOWEVER,III,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,STAT3
169,233,COMPANY,COPYRIGHT,JANUARY,JOURNAL,LABEL,LTD,METHODS,OBJECTIVE,OCTOBER,ONCOLOGIE,PEDIATRIC,PUBLISHED,RADICAL,RESULTS,SEVENTEEN,SIXTEEN,UROLOGY,WILMS
169,ASIAN,CAUCASIAN,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THESE
169,CARCINOMAS,COLLECTIVE,COPYRIGHT,INC,K14
037,169,BMI,CONCLUSION,COPYRIGHT,ESTIMATED,FVC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SEPAR,SMIRNOV,STUDENT,VARIABLES,VO2,WHITNEY
169,549,COPYRIGHT,LTD
169,D50,FIF,MEDICAL,PUBLISHED,THREE
169,946,AUTHORS,COPYRIGHT,EMT,ID1,INC,KNOCKDOWN,MET,PUBLISHED,TGF
006,041,169,618,CIS,CONCLUSION,COPYRIGHT,GEFITINIB,ILD,IRELAND,JANUARY,LABEL,LTD,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,RESULTS,RRS,SOCIETY,SUMMARY,TREATMENT
001,009,045,169,CONCLUSION,COPYRIGHT,COX,HRS,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NEITHER,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,TESTS
169,177,99M,BETWEEN,FINAL,JANUARY,LABEL,MAA,MATERIALS,MBQ,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THERE
001,006,169,COLLEGE,COPYRIGHT,HOWEVER,KUTCHER,LABEL,LKB,LTD,LYMAN,MAASTRO,MATERIALS,METHODS,OBJECTIVE,PLANS,POTENTIAL,PTV,PUBLISHED,RESULTS,ROYAL,THERE
169,COPYRIGHT,INC,NEOPLASTIC,PRIMARY,SECONDARY
169,COPYRIGHT,INC,NOTCH,RBM10
008,140,169,CONCLUSION,CONSORTIUM,COPYRIGHT,FINALLY,IMAGE,LABEL,METHODS,OBJECTIVE,RESULTS
160,169,396,428,437,492,646,861,AMONG,COPYRIGHT,EARLY,ELCAP,INC,LABEL,MEIER,METHODS,MOSBY,OBJECTIVE,PROGRAM,PUBLISHED,RESULTS,SCREENING,SURGERY,TRIAL,VIDEO
000,091,100,101,137,153,157,183,199,200,264,685,LABEL,METHODS,MORTALITY,OBJECTIVE,PRAIS,RESULTS,SPYLL,STATA,THERE,WINSTEN
001,140,169,200,209,295,297,309,322,330,342,398,651,945,946,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,SCLCS,SIX,THERE
001,002,006,036,058,100,106,CETUXIMAB,COX,DCR,LABEL,METHODS,OBJECTIVE,ORR,PCR,PERIPHERAL,PFS,PNA,RESULTS
169,COPYRIGHT,INC
007,024,034,062,075,105,116,120,129,169,570,ACUTE,CHRONIC,EVALUATION,III,LABEL,METHODS,NETWORK,OBJECTIVE,PHYSIOLOGY,RESULTS
169,ACCEPTANCE,ADS,BANGLADESH,CHINA,COPYRIGHT,EGYPT,GRAPHIC,INDIA,INDONESIA,LTD,MESSAGE,PERCEIVED,SMOKERS,VIETNAM
169,961,COPYRIGHT,DESPITE,DIXON,FDG,IRELAND,LABEL,LTD,METABOLIC,METHODS,MRI,MTV,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,SUVMEAN
100,169,AE1,AE3,CASES,CK5,OSCAR,SMA,THERE,TTF,WT1
160,169,ABC,BREATHING,COPYRIGHT,EIGHT,INC,ITV10,LABEL,MANAGEMENT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIFORM
169,945,946,COPYRIGHT,INC,LABEL,MATERIALS,MCFRT,METHODS,MSBRT,OBJECTIVE,PURPOSE,RESULTS
160,169,AIP,COPYRIGHT,DYNAMIC,INC,LABEL,MATERIALS,METHODS,MIP,OBJECTIVE,PURPOSE,RESULTS,STATIONARY
169,ABOUT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PURPOSE,RESULTS
001,008,010,036,048,169,AFTER,COMPETING,COPYRIGHT,COX,INC,KARNOFSKY,KPS,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SRS
169,COPYRIGHT,PECOMAS,THESE
169,AKT,ANNEXIN,ASO,BACKGROUND,CONCLUSION,COPYRIGHT,INHIBITING,IRELAND,LABEL,LENTIVIRAL,LTD,METHODS,MIR,MTT,NSCLC,OBJECTIVE,PC9,PCR,PDCD4,PURPOSE,RESULTS,TKI,WESTERN
169,954,AKT,CONCLUSION,COPYRIGHT,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,S6K,THESE
001,169,838,ASP,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,GGT,GLY,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,TGT
169,ALLERGY,BACKGROUND,CASPASE,CD4,CD8,COLLEGE,CONCLUSION,COPYRIGHT,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS
FOLLOWING,WIDESPREAD
367,BACKGROUND,DEPARTMENT,EDS,EMERGENCY,INCREASING,JANUARY,LABEL,MATERIALS,METHODS,NATIONWIDE,NORTHEAST,RESULTS
169,400,AAH,AUR,COMBINING,COPYRIGHT,ENTROPY,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PPV,PUBLISHED,RATIONALE,RESULTS,TDR,THREE,USING
160,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SIX,THREE
160,169,322,753,801,828,843,853,855,862,909,931,AUC,AUR,CHINA,CHINESE,CONCERNING,COPYRIGHT,DEEKS,DIAGNOSTIC,DOR,DWI,ENGLISH,INC,JANUARY,KNOWLEDGE,LABEL,LIBRARY,MATERIALS,MAY,MEDLINE,METHODS,NLR,OBJECTIVE,OBJECTIVES,PLR,POTENTIAL,PUBLISHED,RATIONALE,RESULTS,SEVENTEEN,STUDIES,SUMMARY,THERE
169,INC
016,123,142,169,268,274,291,300,410,477,507,538,806,829,956,BACKGROUND,COPYRIGHT,DARMSTADT,EFFECTIVE,FEB,FUNDING,GERMANY,GRADE,HOWEVER,III,INJECTIONS,LABEL,LTD,MERCK,METHODS,NOV,RESULTS,SERIOUS,START
169,7TH,COPYRIGHT,INC,M1A,THESE,TNM
169,AFTER,EARLY,INC,PUBLISHED,V20
169,INC,THESE
169,COPYRIGHT,INC,SURVIVORS
22Q12,ABDOMINAL,BACKGROUND,CONCLUSION,EWING,LABEL,METHODS,PAKISTANI,PRIMARY,SARCOMA,STAGING
BACKGROUND,CROHN,EARLY,LABEL,METHODS,RESULTS,SCREENING,UNIVERSAL,UST
BACKGROUND,EXPRESSION,FREQUENTLY,FUNCTIONAL,III,LABEL,MAPPING,METHODS,NOTABLY,ORTHOTOPIC,PROTEOMIC,RESULTS
946,ANGPTL4,BACKGROUND,EXPRESSION,FST,GST,LABEL,METHODS,PTHLH,RESULTS,SINCE,SMAD3,TGF
22Q13,BACKGROUND,BRCA1,LABEL,PPP2R2A,PRKDC,RESULTS
606,BACKGROUND,CONCLUSION,DENMARK,HOWEVER,LABEL,METHODS,RESULTS,SEAFARING
169,AUTHORS,BASED,COLLEGE,JOURNAL,PHYSICIANS,ROYAL,SUBSEQUENT
160,169,BECAUSE,JANSSEN,JAPAN,LTD,MEDICAL,PANEL,PTY,PUBLISHING,SCIENCE,WILEY
GREEN
172,CIS,CONCLUSION,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SIMILARLY,SMOKING
CUTANEOUS,LIGHT,PDT
AFTER,FURTHER,PROMISING
CONCLUSION,LABEL,LOW,MATERIALS,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS
HNSCC,HOWEVER
169,PATIENT
169,JAHCHAN,THEIR
169,AKBAY,DISCOVERY,EGF
015,169,H82,HGF,HOS,MET,PREVIOUSLY,SIMILAR,SMALL,SU11274,TOP
169,946,FILAMIN,FILIP1L,MMP,MODULATION,NUCLEAR,OVERALL,PROTEIN,USING,WNT
160,169,183,ANTARES,BACKGROUND,CONCLUSION,GEORG,GERMANY,LABEL,METHODS,MHZ,RESULTS,RTE,SIEMENS,STUTTGART
169,OTHER,SOCIETY
169,FIRST,INC,SOCIETY,THERE,THIRD
169,239,ALK,CONCORDANT,HSP90,III,LABEL,METHODS,OBJECTIVE,OVERALL,PEMETREXED,PURPOSE,RESULTS
154,BACKGROUND,CONCLUSION,FOLLOWING,LABEL,MALIGNANT,METHODS,MPM,NDC80,PROGNOSIS,PROTEIN,RESULTS,THESE,USING,UTILISING
18F,298,345,435,855,CONTROL,FDG,III,NSCLC,PET,PFS,SUV,THERE,UNION,UNIVARIATE,ZPS
018,043,375,838,CEA,CYFRA21,HOWEVER,NSE
DESPITE,HOWEVER
AFTER,NTM,PET,RCC,THESE
16S,BACKGROUND,CONCLUSION,CUTANEOUS,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS
128,129,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,THERE
001,018,069,239,BACKGROUND,FEBRILE,LABEL,METHODS,OBJECTIVE,OVERALL,PARTIAL,RESULTS
132,BACKGROUND,COMPOSTELA,COX,GSTM1,GSTT1,LABEL,METHODS,OBJECTIVE,RESULTS,SPAIN,UNIVERSITY
001,010,033,046,047,100,120,133,145,179,193,540,702,ADS,ADSQC,ALK,IHC,III,NOS,NSCLC,PFS,SQC,WHETHER,WHILE
148,1M0,200,2M0,3N0,4N0,583,628,ANTIBODIES,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,NAC,NSCLC,RESULTS
ALPPS,BACKGROUND,LABEL,METHODS,RESULTS,SEVEN,SIX,STILL,TEN,THREE
100,169,220,945,947,956,AZA,CK1,CK2,COPYRIGHT,LTD,NCI,SIK,THESE,WHEREAS
169,945,BLOOD,BRB,CAV,COPYRIGHT,INC,NG2,PATHOLOGY,PUBLISHED,SMA,SOCIETY,THESE,VEINS
169,945,946,ABH,COPYRIGHT,ENDOGENOUS,GALECTINS,GM3,HNK,K176L,KEY,LNT,LTD,THESE
215,BPF,NSCLC,RESULTS,RFA,THERE,THEREFORE,VIRTUAL
133,229,BACKGROUND,CONCLUSION,IMMUNOBLOT,LABEL,METHODS,NET,NSCLC,PRMT5,PROTEIN,RESULTS,SLIDE,THERE,UNASSIGNED,VIRTUAL,WESTERN
215,392,BEIJING,BOOLEAN,BOOST,CHINESE,GUANGZHOU,HAN,HOWEVER,LRM,OPERATION,PAIRS,SCREENING,TESTING,USING
THESE,TYPICAL
001,009,122,160,169,ASSESSMENT,BACKGROUND,CLINICALLY,CONCLUSION,COPYRIGHT,GENERATED,LABEL,LTD,METABOLISM,METHODS,NUTRITION,OBJECTIVE,PATIENT,RESULTS,SOCIETY,SUBJECTIVE
BOARD,GENERALLY,THESE
199,230,500,ABOUT,BASED,HOWEVER,LAM,METHODS,OBJECTIVES,OESTROGEN,RESULTS,TSC
001,002,004,169,177,DOSIMETRIC,EFFICIENCY,GTV,KUTCHER,LYMAN,OAR,PTV,USING,WHILE
169,PET,RESULTS,TESTS
152,169,215,300,ABS,AVERAGE,BRAGG,BRCA1,BRCA2,CCNB2,DNMT1,GADD45A,GOLGI,GTSE1,HLE,IFNB1,JUN,PCR,PERCENTAGE,PTTG1,RAD51,SIAH1,STUDIES,TDR,TNF,WT1,XRCC2,XRCC3
33258,CONCLUSION,HOECHST,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
100,AKT,FCM,GEFITINIB,H1975,LABEL,MET,METHODS,MTT,OBJECTIVE,RESULTS,THEIR,WESTERN
BAC,CHINESE,INF,LABEL,MEANWHILE,METHODS,OBJECTIVE,QSPSS,RESULTS,TH1,TH2,THL,TOTALLY
CD3,CD4,CD8,FURTHER,LABEL,METHODS,NKA,NSCLC,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,TLC
177,BASED,BNS,CAMML,ENGLISH,HOWEVER,ROC
AMONG,BRAIN,CURRENT,FURTHER,INHIBITING,MMP
ALTOGETHER,BASAL,CCM,FINALLY,FIRSTLY,HOWEVER
AFTER,BACKGROUND,CONCLUSION,CTC,III,LABEL,METHODS,NSCLC,PCR,RESULTS
001,231,4T1,CONVERSELY,DESPITE,FINALLY,MDA,PACLITAXEL,THESE,THREE,TIX
ASC,NSG,PRIMARY,TAKEN,THERE,THESE
BLOBS,HOWEVER,THESE
000,600,ADDITIONAL,INCREASED,PAH,POISSON,RRS,SES,SIR,THEREFORE
ADC,CNV,CTC,THESE
398,AIM,APRIL,BETWEEN,CONCLUSION,CONCURRENT,DEFINITIVE,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVERSITY
BACKGROUND,BMS,BRAIN,CONCLUSION,FIFTEEN,LABEL,METHODS,RESULTS
946,AIM,AMONG,BACKGROUND,CONCLUSION,DOCETAXEL,EPIDERMAL,ERCC1,III,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PCR,RESULTS
215,239,500,AFTER,AIM,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
001,167,AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,YKL
100,693,AIM,CONCLUSION,GIP,KARNOFSKY,LABEL,METHODS,NSCLC,OBJECTIVE,PRIMARY,RESULTS,UNTREATED,WHILE
33342,AKT,ANNEXIN,BACKGROUND,CONCLUSION,HOECHST,LABEL,MATERIALS,METHODS,MTT,RESULTS,THESE
11A,14C,239,945,946,AIM,BACKGROUND,CERV196,CONCLUSION,EVEROLIMUS,EXPRESSION,FURTHER,HIF,HNSCC,HPV,INCIDENCE,INCUBATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PDGFR,RAF,RESULTS,RET,THESE
BACKGROUND,CELLS,CONCLUSION,LABEL,MATERIALS,METHODS,OCT4B,OCTAMER,PROPIDIUM,RESISTANCE,RESULTS,SILENCING
BACKGROUND,BAX,CONCLUSION,H1650,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,ZOL
184,659,956,BACKGROUND,CISPLATIN,CONCLUSION,LABEL,MATERIALS,METHODS,MTC,MTN,NSCLC,NUCLEAR,RESULTS
22Q11,9ER,AIM,AKT,AMONG,BACKGROUND,CONCLUSION,LABEL,MATERIALS,MECHANISMS,METHODS,NSCLC,NVP,OBJECTIVE,PCR,RESULTS,TKI
169,HOWEVER
100,169,BACKGROUND,ENB,FNA,LABEL,LITERATURE,METHODS,PET,RESULTS,SOCIETY,TBX,THERE
100,101,169,183,64257,DISCLOSING,FURTHER,GEORG,HOWEVER,LABEL,METHODS,OBJECTIVE,PHYSICIAN,RESULTS,STUTTGART,TREATMENT
160,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
002,043,AMONG,BLACK,CONCLUSION,COVARIATES,DEPRESSION,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,STUDIES,WHITE
104,261,CONCLUSION,CURRENTLY,FGFR3,KEAP1,LABEL,METHODS,NORTH,OBJECTIVE,PURPOSE,RB1,RESULTS,SCC,SEVEN,TACC3,THESE
160,200,AKT,CONCLUSION,DLT,LABEL,METHODS,OBJECTIVE,OTHER,PURPOSE,RESPONSES,RESULTS,SIXTY
009,160,177,BACKGROUND,CONCLUSION,COX,ELISA,GTV,HYPOXIC,LABEL,METHODS,NSCLC,OPN,RESULTS
025,384,731,954,AGREEMENT,AMONG,BACKGROUND,LABEL,MDX,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SDX,TREATMENT
MFP,MRI,SUCCESSFUL
D422N,G186R,G333C,G423V,KEAP1,ONCOGENIC,PROTEOMIC,R320Q,R470C,R554Q,S243C,SOMATIC,THESE,V155F,W544C
ADHERENCE,BACKGROUND,CONCLUSION,FOS,LABEL,METHODS,RESULTS,SKOV3,USING
FDG,PET,PRIMARY,THEREFORE
HARMS,IMPORTANCE,LABEL,OBJECTIVE,RELEVANCE,RESULTS
320,452,969,CXR,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE,RESULTS,SCREENING,SETTING,THESE,TRIAL
00001,BACKGROUND,CHI,COX,CRS,HIPEC,III,LABEL,MAJOR,MEIER,METHODS,MPM,PATHOLOGIC,RESULTS
946,INF,PANCREATIC
138,215,945,BECAUSE,BLOOD,ERAND,HMB45,LAM,PGR
FURTHER,IIB,LYMPH,MARCH
ACC,ANY,CHEST
CHEST,METASTATIC,SCLEROSING,SINCE
HOWEVER,INITIALLY,LAD,LCX,OFF,RCA
1ST,3RD,6TH,7TH,FIBER,TORSION
001,007,123,169,945,946,AMONG,ANOTHER,COX,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
001,002,011,169,550,EARLY,HRS,LOBECTOMY,MEDLINE,PRESS,PUBLISHED,STAGE,SURGERY,THESE,UNIVERSITY
001,169,945,ACCORDING,CA9,CRC,FORTY,HIF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,PULMONARY,RESULTS,STAT3,SURGERY,UNIVERSITY
945,AUTOPHAGY,CCL20,HOWEVER,IL6,K63,LPS,LYS63,MCP,MIP,REMARKABLY,THESE,TLR,TNF,TRAF6,VEGFA
10MIN,169,176,AMONG,CAR,COPYRIGHT,HEADSPACE,KETONES,PLEURAL,STUDENT,THREE
014,031,169,BACKGROUND,COPYRIGHT,DCR,EORTC,FIFTY,FORTY,IRELAND,LABEL,LTD,METHODS,MPM,PARTIAL,PEMETREXED,PFS,PS0,RESULTS,TREATMENT
169,945,946,COPYRIGHT,MCF,NMR,PARONYCHIA,PUBLISHED,STRUCTURES
160,199,3N1M0,BACKGROUND,CONVERSELY,FURTHER,IMD,LABEL,METHODS,MLN,NSCLC,RESULTS,THESE,UNIVARIATE
169,INC,TREATMENT
169,947,ADC,COPYRIGHT,EXTENSIVE,FEDERATION,PUBLISHED,SOCIETIES,THESE
169,181,215,25CELLS,BACKGROUND,COX,HOWEVER,INC,LABEL,LDH,MEIER,METHODS,PFS,PUBLISHED,RCC,RESULTS,THESE,THREE,UNIVARIATE
BACKGROUND,CONCLUSION,CXCR2,LABEL,LEUKOCYTES,NEUTROPHIL,RESULTS,SIMILARLY,THESE
283,826,APRIL,BACKGROUND,JANUARY,LABEL,MEDICAL,METHODS,OCTOBER,RESULTS,SPANISH,THERE
435,MCF,MDA,NMR,PORTULACA,THEIR
169,APMIS,LTD,PUBLISHED,WHILE,WILEY
215,850,HUS,INCREASED,LABEL,METHODS,MID,OBJECTIVE,ORGAN,PET,PURPOSE,RESULTS
AFTER,BETWEEN,DSC,GROSS,GTV,HISTOGRAMS,HOUNSFIELD,IMAGE,JACCARD,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,REDUNDANT,RESULTS,THREE
AVERAGE,FFMCT,FLUENCE,IQMSD,LABEL,METHODS,MODULATED,OBJECTIVE,PURPOSE,RESULTS,THESE
177,215,954,BASED,BREATHING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,THREE,TYPES
176,946,CARLO,COMPARING,FINALLY,HOWEVER,LABEL,METHODS,MONTE,OBJECTIVE,PCC,PEARSON,PET,PURPOSE,REGARDING,RESULTS,ROTATIONAL,SETUP
DIR,FIRST,HOWEVER,JOHNSON,LAB,LABEL,MCPHAIL,MED,METHODS,OBJECTIVE,PURPOSE,RESULTS
100,177,5GY,963,CARLO,D99,EUD,HOWEVER,LABEL,METHODS,MLD,MONTE,OBJECTIVE,PURPOSE,RBE,RESULTS,THESE,V90,V95
200,III,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TEN,THEREFORE
FDK,HOWEVER,LABEL,METHODS,OBJECTIVE,PICCS,PURPOSE,RESULTS
136,176,177,360,AFTERWARD,DIFFERENT,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,USING,VPD
ANZAI,FINALLY,FMISO,INTEX1D,INTEX3D,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THESE,THREE
100,150,300,CARLO,CRITERION,DUE,FOV,LABEL,METHODS,MONTE,OBJECTIVE,OEC,PCXMC,PURPOSE,RESULTS,SDD,SNR,THESE,USING
625,FBP,LABEL,METHODS,OBJECTIVE,PRECISION,PURPOSE,RESULTS
001,947,BEV,LABEL,METHODS,MLC,OBJECTIVE,PEARSON,PURPOSE,RESULTS
3DCRT,FINALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,ORBIT,PTV,PURPOSE,RAYSEARCH,RESULTS,V20
EXACT,ITV,LABEL,LIGHTSPEED,METHODS,MIP,OBJECTIVE,PURPOSE,RESULTS
169,BACKGROUND,CONTEXT,KEILLOR,LABEL,METHODS,MILBANK,RESULTS,WOBEGON
MARCH,RANDOMIZED,THERE,THESE
237,363,BACKGROUND,CONCLUSION,ICD,ICU,JANUARY,LABEL,METHODS,RESULTS,SEVEN,THERE
AFTER,NOR
169,244,632,AMONG,BACKGROUND,CHINA,CIGARETTE,CIS,CONCLUSION,COX,HRS,LABEL,METHODS,RESULTS,THESE

953,955,LAC,THESE
NOW,PULMONARY
EMT,ERK,HOWEVER,MEK,NSCLC,NSCLS,THEREBY,THESE
CHEST,GADOLINIUM,JAPAN,MRI,OCCURRENCE,SHRINKAGE,SPE
001,002,009,012,021,022,026,528,572,BREATHING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
129,196,AFTER,BLACK,CLEVELAND,CPR,GREATER,LABEL,METHODS,OBJECTIVE,PURPOSE,RECEIPT,REGRESSION,RESULTS,RRR,WHITE
900,D52,PCR,STRONGEST,THESE,TPD52
USING
12QF1,ACTIVATION,APOBEC1,GNAO1,PRKG1,TAKEN,THESE
BCL,MET,SMASE,STUDIES
253,AKT,BECAUSE,G660D,USING,V659E
AZD0530,AZD6244,DORMANT,SFK,SRC,THESE
100,BACKGROUND,BETWEEN,CEC,CEP,CONCLUSION,EMA,FDG,LABEL,MARCH,METHODS,NSCLC,PARTIAL,PET,RESULTS,THOSE
351,634,717,BACKGROUND,BLACK,CONCLUSION,COX,EASTERN,HOWEVER,JENKINS,LABEL,LEO,METHODS,NORTH,RESULTS
250,450,BIOMARKERS,BLOOD,EVALUATION,INCLUSION,NON,NSCLC,OVERALL,SIXTY
215,299,391,580,676,778,AFTER,ALPHA,CIS,COLORECTAL,FINNISH,LINE1,ORS,OVARIAN,PREVENTION,SCREENING,THESE,TOCOPHEROL,TRIAL
HENCE,HOWEVER,TNF,TRPM7
169,AID,AMONG,COPYRIGHT,FLS,INC
790,EPIDERMAL,HGF,IGF,MET,NSCLC,SEVERAL,T790M,THERE,TKI
169,945,946,A1080,A1170,COPYRIGHT,SERUM,THESE
169,236,53BP1,640,685,BACKGROUND,CHINESE,COPYRIGHT,HAN,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PUBLISHED,RESULTS,SEVERAL,SNP
169,COPYRIGHT,GLU,INC,LTD,MATERIALIA,PHE,PTX,PUBLISHED,TSR
169,177,231,233,ADVERSE,COPYRIGHT,EFFECTS,HELICAL,HOWEVER,LABEL,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SAS,SIX,THERE,V20,V30,V95
169,CA125,COLORECTAL,COPYRIGHT,INC,KINGDOM,OVARIAN,PUBLISHED,ROC,SCREENING,TRIAL,UKCTOCS
000,169,COLLEGE,COPYRIGHT,FLEISCHNER,INC,INCIDENTAL,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,WHETHER
169,954,ACCORDING,BACKGROUND,CONTEXT,COPYRIGHT,DENOSUMAB,DEPARTMENT,FDA,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RADIOLOGY,RANKL,RESULTS,STATE,THEREFORE,UNIVERSITY,XGEVA
169,ASSESSMENT,C30,COPYRIGHT,DISCUSSION,EORTC,INC,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,QLQ,SCALE,SECONDARY,SYMPTOM
169,BACKGROUND,COPYRIGHT,CZECH,HOWEVER,LABEL,LTD,METHODS,RESULTS
001,169,496,AVAILABLE,BLOOD,CLINICIAN,CONFERENCE,CONSENSUS,COPYRIGHT,COX,INSTITUTES,NIH,NRM,PFT,PRO,SOCIETY,WORSENING
001,003,005,007,047,160,169,183,BETWEEN,BLOOD,COPYRIGHT,ESTIMATED,FLU,FLUBU,HCT,INC,MEL,PUBLISHED,SOCIETY,TBI
169,18F,288,AIM,CARDIFF,COLLEGE,CONCLUSION,COPYRIGHT,DIAGNOSTIC,FDG,LABEL,LTD,MATERIALS,MAX,METHODS,NSCLC,OBJECTIVE,PET,PETIC,PUBLISHED,RESULTS,ROYAL,SUV,SUVMEAN,TLG,TNM,TOMOGRAPHY
133,169,COPYRIGHT,SIX,TWEEN,UNDER
026,169,336,CONTAINING,COPYRIGHT,HCC,LTD,PCR,RESULTS,SH2,TMA
160,169,947,BLOOD,COPYRIGHT,CTC,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,186,COPYRIGHT,GTV,INC,INITIAL,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTP,PTV,PTVORIG,PTVPRED,PURPOSE,RESULTS
169,AML,COPYRIGHT,FEDERATION,FGFR1,FGFR1OP,IL3,MPD,OTHER,PMF,PUBLISHED,REARRANGED,RET,SOCIETIES
160,169,BETWEEN,COMPARISON,CONCLUSION,COPYRIGHT,GROUP,LABEL,MARCH,MDA,METHODS,NEUTROPHIL,OBJECTIVE,OLV,PMN,PUBLISHED,RESULTS,SOD
008,169,BACKGROUND,BETWEEN,COPYRIGHT,IMPALPABLE,INC,LABEL,METHODS,PATHOLOGIC,PRIMARY,PUBLISHED,RESULTS,SOCIETY
169,ANZSCTS,AUSTRALIA,AUSTRALIAN,BRONCHIAL,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,THERE,ZEALAND
001,131,134,155,160,169,214,369,691,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MOSBY,NSCLC,OVERALL,RESULTS,SECONDARY,SURGERY,THERE,THESE
169,CENTRAL,COPYRIGHT,DUE,EIGHT,IRELAND,ISSUE,LEVEL,LIBRARY,LTD,MEDLINE,MPM,STUDIES
CUTANEOUS,HOWEVER,VARIOUS
SOT
107,169,2000S,BACKGROUND,CARIPLO,COMMISSION,COMPAGNIA,COPYRIGHT,FOUNDATION,FUNDING,FURTHER,HODGKIN,IRELAND,ITALIAN,LABEL,LTD,MAJOR,METHODS,PAOLO,RESULTS,SAN,UNIFORM,VARIATIONS
169,GIVEN,INC,RADIATION
SWEDISH,WHETHER
001,AFTER,BACKGROUND,CHINESE,FMK,LABEL,METHODS,MTT,NEC,RESULTS,VAD,WESTERN
177,DEC,FIFTY,H2O,HOWEVER,JAN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
146,AFTER,JANUARY,LABEL,METHODS,NPC,OBJECTIVE,RESULTS
040,070,079,946,CBR,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,TTP
AMONG,BEV,CPT11,DCR,INTESTINAL,LABEL,METHODS,OBJECTIVE,ORR,RESULTS,SEVENTY,VARIOUS
001,164,302,376,420,542,640,COX,LABEL,METHODS,NPC,OBJECTIVE,RESULTS,THERE
ACADEMY,CHINESE,DEPARTMENT,FIFTY,FNA,FOB,JANUARY,LABEL,MEDICAL,METHODS,MUTATIONS,NSCLC,OBJECTIVE,PCR,PLE,POLYMERASE,RESULTS
125,135,177,AFTER,BCL,BESIDES,CCK,FOXM1,FOXM1SIRNA,FOXML,LABEL,METHODS,MYC,NSCLC,OBJECTIVE,PCR,RESULTS,TKI,WESTERN
078,100,169,389,BACKGROUND,CONCLUSION,EFS,EIGHT,HOWEVER,LABEL,LMD,METHODS,OVERALL,RESULTS
BACKGROUND,CONCLUSION,FPS,GERMANY,HOWEVER,LABEL,METHODS,POISSON,RESULTS,ROC,THERE,THEREFORE
113,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SEGMENTAL,THERE
BACKGROUND,DIAGNOSTIC,DUE,LABEL,NSCLC,RESULTS
006,124,155,230,279,710,BACKGROUND,HOWEVER,LABEL,LEWIS,METHODS,NSCLC,RADICAL,RESULTS,ROC,SLX
GIVEN,PRO
169,KARNOFSKY,KPS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,UNIVERSITY,WILEY

396,956,ACTIVATION,ATO,BACKGROUND,CASPASE,CEL,CONCURRENT,COX,DEX,ERK,IC50S,LABEL,METHODS,RESULTS,TREATMENT
945,946,CRC,GAL,ST6
946,CATENIN,NSCLC,STAT3,WNT,XANTHATIN
001,009,499,AMONG,BACKGROUND,CONCLUSION,COX,DISEASE,GERMANY,LABEL,LDH,MEIER,METHODS,PROGNOSTIC,RESULTS,S100B,SERUM,TUEBINGEN
GMP,MOUSE,PDE
001,012,016,017,169,293,511,CIS,COX,HRS,INSTITUTES,USING
001,020,028,033,124,180,905,DFS,DISEASE,MACC1,NSCLC,TNM
956,DISCUSSION,ICFIS,ICG,LABEL,METHODS,MSA,OBJECTIVE,PURPOSE,RESULTS,SLN
000,013,030,039,103,105,191,197,224,300,332,376,413,441,719,744,776,809,831,832,834,844,849,862,882,893,902,958,959,962,968,ASIAN,HOWEVER,IGFBP,INSULIN
CLO,HOWEVER,NCI,THESE
000,007,165,438,ASP,ASP148GLU,CAUCASIANS,GLU,OCTOBER,OVERALL,ULTIMATELY
100,CRETE,GP5,GP6,HPV,NSCLC,PCR,SIXTEEN
002,AGE,AMD,AREDS,BACKGROUND,CONCLUSION,DISEASE,DOCUMENTED,EYE,IDENTIFIER,IMPORTANCE,LABEL,MEASURE,METHODS,OBJECTIVE,RELATED,RELEVANCE,RESULTS,SETTING,TRIAL
037,177,183,1ST,2ND,5TH,BACKGROUND,BIFOCAL,CONCLUSION,GEORG,IIA,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,STUTTGART
CPT
ERK,GTP,JNK,KNOCKDOWN,MOLECULAR,NAC,NCI,NOVEL,RAF,RAS,ROS,SPR,TAKEN
HDAC1,NON,NSCLC,TARGETING,TRAIL,TREATMENT
ACCORDING,ALDH1A1,COA,CSC,M30,MPE,THESE
100,BETWEEN,EFS,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY
005,163,264,AVERAGE,BRCA1,COLORECTAL,CONSORTIUM,END,MAMMOGRAM,MRI,NUTRITION,OVARIAN,PREVENTION,RESULTS,SCREENING,THESE,TRIAL
4T1,945,946,CHRONIC,CSF,DEX,DMI,EMOTIONAL,ISO,MIP,NEITHER,SHG,SNS,THESE,TREATMENT
169,BAL,COPYRIGHT,DIAGNOSTIC,HOWEVER,LTD
947,ATM,AUTOMATED,BECAUSE,DDR,DIGITAL,MOLES
169,204,COPYRIGHT,PCR,TAKEN
100,101,120,129,169,258,281,AFTER,AHTRT,BACKGROUND,C000000095,COPYRIGHT,EASTERN,FUNDING,GROUP,IRINOTECAN,JAPAN,LABEL,LTD,METHODS,OCT,RESULTS,THERE,WELFARE
169,417,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,GROUP,IRELAND,KMLCG,L858R,LABEL,LTD,METHODS,MOLECULAR,NSCLC,PPS,RESULTS,SITES,SMOKING,THERE,TKI,TTP
946,APC,CONVERSELY,DACT2,DKK,HDPR1,NSCLC,OVERALL,PORCUPINE,RUNX3,TCF,WIF,WNT
DISEASE,SURGERY
ADDITIONAL,EGF,PROSE,VERISTRAT
169,215,AFTER,ENDOSCOPIC,FORCE,FURTHER,JAPAN,LTD,MIB,PET,PTY,PUBLISHING,SOCIETY,SURGERY,WILEY

004,956,HEPG2,MTT,MXN,PEGYLATED,THESE,VSS
137,177,314,455,456,535,599,771,787,998,AFTER,BACKGROUND,BETWEEN,EUROQOL,INSURANCE,LABEL,METHODS,OWING,QOL,RESULTS,THESE
001,100,BACKGROUND,LABEL,METHODS,OBJECTIVE,PROCEDURE,RESULTS,THERE
BACKGROUND,EXPRESSION,LABEL,METHODS,MOTIVATION,RESULTS,TRAIT
089,1661A,1722T,388,49A,CYTOTOXIC,HOWEVER
056,272,593,CAUCASIANS,HENCE,INDIANS,OVERALL
169,945,946,947,BRITAIN,CONVERSELY,COPYRIGHT,ECM,GREAT,IDIOPATHIC,IPF,IRELAND,LTD,PUBLISHED,SIMILAR,SMAD4,SOCIETY,TGF,WILEY
169,AUTHORS,BRITAIN,CRE,FOLLOWING,GEM,GIVEN,GREAT,IRELAND,JOURNAL,LTD,PATHOLOGY,SOCIETY,WILEY
001,002,BACKGROUND,JAMES,LABEL,METHODS,OBJECTIVES,QUESTIONS,RESULTS,ROCHESTER,SCP,SURVIVORS,TSS,UNIVERSITY
160,HOWEVER,NON,NSCLC
164,215,446,512,718,ANC,CSF,DAILY,FEBRILE,ITALIAN,ITALY,PRIMARY
ALCOHOL,BACKGROUND,LABEL,METHODS,RESULTS,STUDIES
ALK,NSCLC,THEREFORE,THESE
001,352,622,AFTER,BACKGROUND,LABEL,METHODS,NSCLC,PET,RESULTS
CAUCASIAN,HEPATIC
001,033,956,AUC,EIGHT,FURTHER,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS
ALK,CBL,LY2801653,MET,NSCLC,PAMGENE,RON,ROS,STAT3,TAKEN,THESE,USING
115,THESE

004,BACKGROUND,BRONCHIAL,CARCINOIDS,FDG,LABEL,METHODS,PET,REGARDING,RESULTS,SIXTY,SPN
946,ARGONAUTE,FINALLY,HMGA2,INTEGRATED,NON,NSCLC,TAKEN,TGF,THESE
008,010,011,039,169,210,335,COPYRIGHT,DSS,EXPRESSION,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
012,014,018,045,058,127,181,BACKGROUND,CONCLUSION,COX,CTG,EXPRESSION,JBR,LABEL,MEIER,METHODS,NETWORK,NSCLC,RESULTS,UNIVERSITY
210,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NOTABLY,RESULTS,USING
LATER,PRIMARY
000,061,091,100,103,104,107,126,132,156,160,166,181,199,216,564,573,901,956,991,CENTRAL,CHINA,CHINESE,CONCLUSION,HENAN,LABEL,LINZHOU,METHODS,OBJECTIVE,RESULTS,SHENQIU,THERE
000,100,107,116,139,161,176,207,272,320,346,424,560,613,699,763,848,920,954,AGE,CHINESE,CONCLUSION,LABEL,MEANWHILE,METHODS,OBJECTIVE,RESULTS
000,207,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,SMOKING
001,024,169,278,347,584,AUSTRALIAN,AUTHORS,BACKGROUND,BASED,BLAND,CAV,COLLEGE,DTS,IMAGING,INTER,JOURNAL,LABEL,LTD,MEDICAL,METHODS,PTY,PUBLISHING,RADIATION,RCDIAMETER,RESULTS,ROYAL,WILEY,ZEALAND
178,BACKGROUND,BIACORE,LABEL,MEIER,METHODS,RESULTS,SEC61,SEC62,TARGETING,TFP,THEREFORE,TREATMENT,USING
001,005,010,011,033,AFTER,FURTHER,GIVEN,MEIER,PULMONARY,THERE,TUKEY
EUROQOL,KOREA,LABEL,METHODS,NUTRITION,OBJECTIVE,RESULTS,THOSE
CSC,KULCHITSKY
029,039,040,169,506,AUTHORS,CHINESE,COX,EPCAM,FURTHER,HOWEVER,INSTEAD,LTD,MEIER,NSCLC,PTY,PUBLISHING,SCIENCE,SNP,WILEY
007,023,026,169,183,947,954,BRITISH,IMMUNOLOGY,NSCLC,SOCIETY
BASED,PEARSON,STRUCTURE,THESE
BACKGROUND,CONCLUSION,ITALY,LABEL,METHODS,MORTALITY,RESULTS
HISTORY,INCIDENCE,ITALIAN,ITALY,RATIO,SIR,THERE
183,200,400,EVEROLIMUS,FOLLOWING,GEORG,GERMANY,LAM,RAPID,SIROLIMUS,STUTTGART,TEN,THERAPY,THESE,TSC
PULMONARY
HCG,PRIMARY
135,149,153,157,441,675,746,750,AFTER,FINALLY,IHC,L858R,PCA,PRINCIPAL,RAMAN,SOMATIC,SVM,T790M
BLACK,DOWNS,HRQOL
643,945,CYP2C,CYP2C44,EET,NON,NOTABLY,NSCLC,RAS,THESE,WYETH
FGFR1,HOWEVER,LABEL,MYC,UNLABELLED
945,EMT,ERBB3,LABEL,UNLABELLED
ACCORDING,AUC,BASED,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,127,AIM,DIFFERENT,EXPRESSION,HPV,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,BACKGROUND,INC,LABEL,LCNEC,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,TNM,USING,WILEY
954,BACKGROUND,BAX,BCL,CONCLUSION,FAS,H1299,IAP,INCREASED,LABEL,METHODS,MTT,NCI,NSCLC,PCR,RESULTS,ROS
PREVENTION,SENSORY
003,BENCHMARK,DESPITE,GCN,THERE,ULTRA,VENTANA
945,PRODUCTION
ADC,APC,BASED,CONCLUSION,FALLING,HIV,HODGKIN,LABEL,MATCH,METHODS,NADCS,NHL,OBJECTIVE,POISSON,POPULATION,RESULTS
215,946,971,ETT,GROSS,PET,SERUM,THERE
ABCAM,CCL39,CHINESE,GLUCOSE,HOWEVER,LS174,TITRATION
177,BACKGROUND,INTER,JANUARY,PET,SUV,VOI,VOIBG,VOITUMOUR
CHEST,FDG,PET,PRIMARY,VIDEO
18F,FDG,MALIGNANT,PET
18F,FDG,HISTOLOGIC,METASTATIC,PET
110,AMONG,CEA,CONCLUSION,CYFRA21,ELISA,GRP,LABEL,METHODS,NSCLC,NSE,OBJECTIVE,PRO,SCC
192,ACCORDING,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,BCL,COPYRIGHT,ERK,IRELAND,JNK,JUN,LTD,MAP,MMP,ROS,STAT3,TAKEN,TIMPS,TREATMENT
118,177,180,ACCORDING,BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VAS
102,108,169,231,ALK,AMONGST,ANAPLASTIC,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,NANOSTRING,NEVER,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
160,169,BACKGROUND,COPYRIGHT,FURTHER,INC,LABEL,METHODS,PLRCS,QOL,RESULTS
169,476,AFTER,BACKGROUND,BASED,COPYRIGHT,FRANCISCO,FURTHER,INC,LABEL,MATERIALS,METHODS,RESULTS,SAN
001,012,018,021,033,036,037,087,161,177,BACKGROUND,CONCLUSION,FIFTY,HISTORY,LABEL,LEAKAGE,LEVEL,METHODS,OBJECTIVE,RESULTS,SUMMARY,VERTEBRAL
123,800,944,BACKGROUND,GREM1,INTEGRATED,LABEL,LCC,METHODS,NDRG1,NON,NSCLC,PDGFB,RESULTS,SCC,USING
APRIL,BETWEEN,NSCLC,PFS,PPS,THESE
101,AUTOPHAGY,BCL,BH3,INHIBITION,TARGETING
CD133,GOT,GPT
140,ANXIETY,BACKGROUND,BETWEEN,CHINESE,CONCLUSION,FATIGUE,INITIAL,INVENTORY,LABEL,METHODS,OBJECTIVE,PIPER,PURPOSE,RESULTS,SCALE,STATE,TRAIT
001,042,BETWEEN,CONCLUSION,GPS,LABEL,METHODS,OBJECTIVE,OUTCOME,PRIMARY,RESULTS,SETTING
OVERALL,SEVERAL,THESE
HCC,HOWEVER,SORAFENIB,THEREFORE,TREATMENT
AMONG,REGARDLESS,WHILE
113,150,160,377,BCL,DOSES,FATIGUE,LABEL,LYMPHOCYTE,MAXIMUM,METHODS,OBJECTIVE,PNT2258,PURPOSE,RESULTS
002,139,173,183,386,BACKGROUND,GEORG,HOWEVER,LABEL,LOW,MEIER,METHODS,NSCLC,RESULTS,STUTTGART
001,002,114,177,183,203,236,260,293,439,490,553,623,BETWEEN,CONCLUSION,GEORG,LABEL,LNS,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCM,SML,STATION,STUTTGART,VAM
169,L858R,LAC,PFS,THERE
121,124,AGE,CNB,EXCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
ABC,ABCC4,H1993,H2073,MET,SNP,STK11,WHILE
160,177
HGF,MET,NSCLC,TAKEN,TEXAS,USING,WESTERN
945,AKT,ERK,HIF,LCC,NCI,THESE
ADDITIONAL,BID,MALIGNANT,SBL,THESE,TRAIL
A598T,ASIAN,BACKGROUND,CONCLUSION,G464E,G466R,G469A,G596R,G606R,K601E,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,V600E
302,372,BACKGROUND,CONCLUSION,LABEL,LOW,METHODS,PPV,RESULTS,THESE,USING
169,BASEL,HOWEVER
FAR,H1650,L1210,SMR
177,223,365,AIANS,ALASKAN,AMONG,BACKGROUND,BECAUSE,CALIFORNIA,COMPARING,CONCLUSION,IHSCS,INDIANS,LABEL,METHODS,NATIVES,REGISTRIES,RESULTS,SERVICE,STATE,USING,WASHINGTON
ERK,NF1,RAS,T654I,THESE
241,HCC,MPZL1,NOTABLY,SRC,TAKEN
169,ACTIVATED,ALK,AMONG,DESPITE,LABEL,SLC34A2,UNLABELLED
ANOTHER,MRI,PET,VARIOUS
001,117,169,200,347,956,CHILE,COPYRIGHT,DMA,INC,MMA,OVERALL
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,IIA,INC,PUBLISHED,SOCIETY,T2BN0M0
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,AMYLOIDOMA,COPYRIGHT,INC,PUBLISHED,SOCIETY,T11
160,169,ADDITIONAL,COPYRIGHT,INC,PUBLISHED,SOCIETY
DIFFERENT,RET
001,002,003,005,012,013,016,020,106,169,595,663,959,AGE,COPYRIGHT,IIA,IIB,IRELAND,JAPAN,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVEN
169,COLLEGE,COPYRIGHT,EARLY,INC,PROGRAM,PUBLISHED,RADIOLOGY,SCREENING,THERE,TRIAL
001,169,359,COPYRIGHT,METASTATIC,PUBLISHED,UROLOGY
0B1,945,946,ERB,FUNCTIONAL,NR0B2,NR1D1,NR2C1,NR2C2,NR2E1,NR2E3,NR2F1,NR2F2,NR2F6,NR4A1,NR4A2,NR4A3,NR6A1,NUR77,NURR1,PNR,RESULTS,REV,TFI,THESE
169,526,AFTER,BACKGROUND,COPYRIGHT,CRC,DUE,III,LABEL,LTD,METHODS,RESULTS
169,AOM,COPYRIGHT,LTD
169,CARINAL,COPYRIGHT,INC
169,COPYRIGHT,EWING,FEDERATION,GD2,PUBLISHED,SEVERAL,SINCE,SOCIETIES
141,376,CIS,DISEASE
4GY,ERK,GATA3,ID2,PC3,PCR,THROUGH
HOWEVER,ONGOING,THEREFORE
131,PULMONARY
CD117,DESPITE,FURTHER,KIT,SUNITINIB
BACKGROUND,CONCLUSION,FURTHER,INTRA,LABEL,METHODS,TREATMENT
ANOTHER,COA,FURTHER,HMG,RAC,RAS,REGARDING,RHO,STATINS

262,AMONG,INCIDENCE,KNOWLEDGE,VIRGINIANS
CONCLUSION,FINALLY,FIRST,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,V10,V20
EBV,EPSTEIN,FURTHER,MOLECULAR,PET,PRIMARY,PTLDS,SUV,WESTERN
001,031,042,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OCCLUDENS,PCR,RESULTS,TNM
005,013,014,027,030,041,222,ACCORDING,BESIDES,FGFR1,INCREASED,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,RFS,SEX,SPECIMENS,TNM
110,189,273,NSCLC
122,945,946,CNS,CONCLUSION,ECM,INHIBITORS,LABEL,METHODS,OBJECTIVE,RESULTS
000,298,ASSISTANT,BATCH,LUNGCAGXE
100,DOTAP,EPHA2,LNP,MICRORNAS,MPM,NSCLC,PEG,RAS
100,173,175,181,215,AIM,ALK,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SAMPLES,STAINED
CHEST
PULMONARY
275,287,BRCA1,ERCC1,III,INITIAL,LARGE,NSCLC,PREDICTION,THEREFORE
TOBACCO
AKT,CELASTROL,CIP2A
495,HOWEVER,MIR,MTA,NSCLC,PCR,THESE,USING
001,009,160,320,CAUCASIANS,HOWEVER,THESE
169,BRITAIN,COPYRIGHT,DISCOIDIN,ECS,GREAT,HENCE,IRELAND,LTD,PUBLISHED,RTK,SOCIETY,THESE,WILEY
169,AUTHORS,CISPLATIN,DCC,LTD,PACLITAXEL,PUBLISHED,UNC5H,WILEY
160,956,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PURPOSE,RESULTS,WESTERN
169,240,2D6,ADVERSE,BLOOD,COLLEGE,CYP,FORMATION,WHILE
ALK,GIVEN,MANAGEMENT,MET,NSCLC,RAS,ROS
224,263,ABT,ATN,BCLXL,CURRENTLY,MUTATIONS,NSCLC,P38,TREATMENT
016,024,AMONG,BASED,DFI,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS
AKT,ATXN3,DUB,HDACI,HISTONE,HOWEVER,INSTEAD,JOSD1,SIMILARLY,VORINOSTAT
947,THESE
CURRENTLY,PET,SINCE,WESTERN
BACKGROUND,CLUSTER,CONCLUSION,EXPRESSION,LABEL,METHODS,MMP,PROTEIN,RESULTS,THESE,UNIVARIATE
500,BACKGROUND,CASES,CAUCASIAN,CONCLUSION,EASTERN,GROUP,LABEL,METHODS,NSCLC,ORR,PFS,PLANNED,RESULTS,TEAES
142,169,177,207,239,330,550,675,AMONG,BACKGROUND,BETWEEN,CONCLUSION,JANUARY,LABEL,METHODS,RESULTS
ASSESSMENT,FUNCTIONAL,GENERAL,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SURVEYS,SYMPTOM,THERAPY,WHILE
169,BLOOD,COPYRIGHT,MRD,RELAPSE,SOCIETY
169,956,COMPOUNDS,COPYRIGHT,EUPHORBIA,MCF,NMR,NOESY,SIX,THEIR
169,ATM,ATR,BACKGROUND,BAX,COPYRIGHT,DSB,GENERAL,GIVEN,LABEL,MAL,METHODS,RESULTS
169,ATLAS,AX1,AX2,BACKGROUND,CONCLUSION,COPYRIGHT,D95,GROUP,INC,LABEL,MATERIALS,METHODS,PLANS,RADIATION,RESULTS,STF,THERAPY,V10,V20,V25,V30
169,24H,AMONG,ARSENIC,COPYRIGHT,FURTHER,H2A,HOWEVER,THESE,USING
169,239,CD8,COMBINING,COPYRIGHT,HOWEVER,INC,THEREFORE
145,146,169,202,946,956,CHANGES,COPYRIGHT,IRELAND,LTD,SER,THESE,THR
169,CANCERS,CD8,COPYRIGHT,DCS,IGG,INC
015,169,409,440,542,578,686,967,AMONG,COLLEGE,COPYRIGHT,COX,GROUP,INC,LABEL,LOCAL,LOG,METHODS,MOSBY,OBJECTIVE,OVERALL,PROPENSITY,PUBLISHED,RESULTS,SEVEN,SURGERY,THERE,Z0030
100,169,AGREEMENT,BLOOD,COPYRIGHT,DIAGNOSTIC,INC,LABEL,MARCH,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,OCTOBER,PUBLISHED,RESULTS,SURGERY
014,102,169,6MONTHS,BACKGROUND,BETWEEN,CASES,DEC,DIAGNOSIS,EXCLUSION,JAN,LABEL,METHODS,NSCLC,RESULTS,SINCE,THESE,UNDERLYING,VTE
169,4T1,946,COPYRIGHT,DHA,FAS,FEEDING,HOWEVER,INC,MCF,THESE,WNT
169,323,360,907,AUC,COPYRIGHT,DOR,EIGHT,FDG,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PET,RESULTS,ROC,SUB
169,COLLEGE,COPYRIGHT,DESPITE,LTD,PUBLISHED,ROYAL,THESE
703,BACKGROUND,BRITISH,BTS,CARDIAC,INDEX,LABEL,METHODS,RESULTS,REVISED,ROC,SOCIETY
118,156,BACKGROUND,III,LABEL,METHODS,NSCLC,PULMONARY,RESULTS,TECHNIQUES,THERE
169,206,215,EXPRESSION,LTD,MIR,PUBLISHED,THESE,UTR,WESTERN,WILEY
061,095,183,184,367,CONCLUSION,GLM,LABEL,MAE,METHODS,OBJECTIVE,OLS,RESPONSES,RESULTS
169,AUTHORS,DCE,FUNCTIONAL,IMAGING,LTD,MRI,NUCLEAR,OTHER,PET,PHYSIOLOGY,SOCIETY,WILEY
130,145,169,655,AIM,CONCLUSION,GROUP,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PET,PTY,PUBLISHING,RESULTS,VICTORIAN,WHILE,WILEY
BAX,BCL,MMP,ROS,WESTERN
ACTIVATED,ANNEXIN,MTT,SAFFRON,WORLDWIDE
161,595,CEF,CHINESE,SYNERGY,TCM,THERE
CYP27A1,LXR
174,ALK,CRIZOTINIB,III,KEY,MET,NSCLC,PROFILE,THOSE,XALKORI
140,ARM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PET,PIE,PURPOSE,RESULTS,SEQUENTIAL,THERE
FUNCTIONAL,HMG,SOX,SRY
PESTICIDES,PPE,THERE
179,443,451,EPIDEMIOL,JOURNAL,ONTARIO,THESE,TORONTO,VILLENEUVE
181,425,445,523,948,EXPOSURES,FEW,FURTHER,ONTARIO,SIMILARLY,TORONTO
134,169,406,540,621,AFTER,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THEREFORE,THREE
001,014,143,150,260,834,885,951,AUC,BACKGROUND,LABEL,METHODS,MIR,NSCLC,PCR,RESULTS,ROC,SENSITIVE,SMALL,THERE
103,203,221,222,30B,30C,ABERRANTLY,BACKGROUND,CONCLUSION,LABEL,MEIER,MET,METHODS,NSCLC,RESULTS
174,BACKGROUND,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,RESULTS,THERE,WEGENER
15A,AP4,EMT,MET,UTR
169,190,945,COPYRIGHT,HIF,SAR,THEREFORE,VCH,WILEY
946,AKT,DEPLETION,EGF,EPHA2,ERBB2,H1792,H1975,HEIGHTENED,HOWEVER,MET,PTP,RET,RTK,SHP
169,207,218,516,525,532,539,598,604,755,769,946,954,CAM,EBP,FUS,MMP,MUTATIONAL,SW872
001,015,019,129,64257,HOWEVER,HOX,PCR
001,102,117,BACKGROUND,BETWEEN,ERMETIC,INSTITUTE,L858R,LABEL,METHODS,NSCLC,RESULTS,THERE,UNDER
1990S,CASES,CRC,HOWEVER,STUDIES
177,18F,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEVENTY
352,423,967,BACKGROUND,COMMITTEE,CONCLUSION,JOINT,LABEL,MEIER,METHODS,NSCLC,ONTARIO,PREDICTORS,RESULTS,THERE,TNM,WEDGE
169
169,2MG,630,COPYRIGHT,KPS,LABEL,METHODS,OBJECTIVE,PDT,RESULTS
127,131,169,COPYRIGHT,HLF,HYPERICIN,LED,PDT,PVP
169,240,820,946,ANTIBODIES,LABEL,METHODS,MOLECULAR,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCC,SIGNALING,THESE,TMA
169,2341066,CONCLUSION,EMT,HGF,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
BACKGROUND,BCL,CONCLUSION,CONTEXT,ELISA,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS
BIOACTIVE,BMP,EPIGENETIC,THREE,TREGS
BACKGROUND,CONTEXT,ELASTIN,LABEL,METHODS,OBJECTIVE,PERFUSION,RESULTS
177,BACKGROUND,CONCLUSION,LABEL,LASER,LIVER,METHODS,MORBIDITY,RECURRENCE,RESULTS,RFA,THEIR
ATM,CK2,GIVEN
BACKGROUND,CHINA,CHINESE,CIS,ISI,KNOWLEDGE,LABEL,METHODS,ORS,RESULTS,SCIENCE,SIX,WANFANG,WEB
001,100,169,AUSTRALIAN,BACKGROUND,BREATHING,COLLEGE,GTV,HOWEVER,LABEL,METHODS,POTENTIAL,RESULTS,ROYAL,V20,ZEALAND
169,283,434,AIM,AUSTRALIAN,AUTHORS,CNB,COLLEGE,CONCLUSION,CUMULATIVE,IMAGING,JOURNAL,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,RADIATION,RESULTS,ROYAL,THREE,ZEALAND
CIGARETTE,THESE
ATLAS
CIE,ENDOSOMES
010,018,105,122,195,215,707,ASIAN,AUC,COX,LABEL,MEASURING,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,ROC,USING
AKT,AMONG,DESPITE,H1650,NCI,NON,NSCLC,SHOGAOL,STAT3,THEREFORE
954,HOWEVER,SECRETORY
945,947,CSE,ERK,EXPRESSION,SIMILARLY,TNF
169,MALIGNANT,MPNST,PRESS,PUBLISHED,SURGERY,UNIVERSITY
160,1970S,817,932,ADDITIONAL,AUTHORS,BACKGROUND,BSC,CENTRAL,COLLECTION,CONTROLLED,EXPERTS,HOWEVER,IFOSFAMIDE,III,ISSUE,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PARTIAL,PHASE,QUALITY,RESULTS,SELECTION,THREE,TREATMENT
100,125,140,278,2RA,ALG,ASSESSMENT,ATG,AUTHORS,BACKGROUND,CD3,CENTRAL,CLEAR,COLLECTION,CONSENSUS,EVALUATION,FEW,FURTHER,GROUP,HOWEVER,LABEL,MARCH,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RENAL,RESULTS,SELECTION,STUDIES,THREE,TRIAL
177,ABDERAHMAN,BACKGROUND,BMI,CONCLUSION,JANUARY,LABEL,MAY,METHODS,NRI,RESULTS,SEVERAL
160,BETWEEN,FDG,HOWEVER,LABEL,MAY,METHODS,MPM,OBJECTIVE,PET,RESULTS,THERE
078,102,306,419,431,485,582,619,773,798,ASIAN,COMPARING,CONCLUSION,ERLOTINIB,III,IPASS,LABEL,METHODS,OBJECTIVE,OPTIMAL,RESULTS,SETTING,THOSE,WJTOG,WORLD
013,035,037,047,BACKGROUND,CRC,DISCUSSION,KIRSTEN,LABEL,METHODS,MTS,PMS,PULMONARY,RESULTS,THESE,V600E
160,210,CONCLUSION,LABEL,MEASURING,METHODS,MICRORNAS,OBJECTIVE,PCR,PURPOSE,RESULTS
169,AIR,BASEL,DESPITE,MRI,SEVERAL
187,281,CONCLUSION,DEPRESSION,INVENTORY,LABEL,MDASI,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,STUDIES,SYMPTOM
BACKGROUND,CONCLUSION,H1299,HOWEVER,LABEL,METHODS,NSCLC,PA28GAMMA,PCR,RESULTS,TOTAL
169,294,347,AMONG,COPYRIGHT,COX,EARLY,INC,LABEL,MEIER,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PROGRAM,PROPENSITY,PUBLISHED,RESULTS,SURGERY
169,AKT,COPYRIGHT,H23,INHIBITION,IRELAND,LTD,NSCLC,PLB,PLUMBAGIN,THERE,THESE
ACTIVATING,CURRENT
AKT,EPIDERMAL,HOWEVER,SOCS3,STAT3,TAKEN
169,177,396,967,ACCORDING,COPYRIGHT,LABEL,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEPAR,THERE
169,CONCLUSION,COPYRIGHT,DIFFERENT,DUE,LABEL,LTD,MAXILLO,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,THESE
ANAPLASTIC,BACKGROUND,CAUCASIAN,CONCLUSION,HOWEVER,KIRSTEN,LABEL,MET,METHODS,T4N3M1B,TREATMENT
169,BACKGROUND,CHO,COPYRIGHT,DTI,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PARAMETRIC,PURPOSE,RESULTS,SOCIETY,THESE,WHOLE
BEAGLES,CASP3,CASPASE,CHAIN,FAS,FASLG,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PCR,PLUTONIUM,POLYMERASE,PURPOSE,RESULTS,REVERSE,THESE,TUNEL,UTILIZING
409,PCI
ASIDE,BACKGROUND,CURRENTLY,DISCUSSION,EXCELLENCE,GPS,INSTITUTE,LABEL,METHODS,TRIAL
000,100,155,DETECTING,TKI
946,EMT,EXPRESSION,HOWEVER,TAKEN,TGF
BESIDES,FINALLY,FIRST,FUNCTIONAL,PDB,PPI,PROTEIN
124,125,149,200,ANALYZING,HOWEVER,MICRORNAS,USING
001,311,344,379,399,691,797,935,986,AGREEMENT,BACKGROUND,BLAND,CONCLUSION,LABEL,METHODS,NODULES,RATIONALE,RESULTS,SSN
000,054,BEADCHIPS,CABYR,CLDN2,CURRENT,EXPRESSION,FDR,HABP2,HCC,HUMANHT,IGLL1,INTEGRITY,NUMBERS,OVERALL,RIN,SCL13A5,USING
ALDEFLUOR,ALDH1A1,CD11B,CXCR4,H1299,LLC,SDF,TARGETING,THESE
AFTER,FDG,MRI,PET
HOWEVER,LOBECTOMY,PULMONARY
160,III
HOWEVER,OTHER,SPANISH
014,169,AZD3965,EXPRESSION,KINGDOM,LABEL,METHODS,OBJECTIVE,PROOF,PURPOSE,RESISTANCE,RESULTS,TMA,WESTERN
AIM,AUSTRALIA,BACKGROUND,CONCLUSION,FIFTY,GPS,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,SEVEN,THERE
106,FLOT1,FURTHER,HOWEVER,NSCLC,TAKEN
CD4,FOXP3,GBS,USING
AMONG,BACKGROUND,BETWEEN,CONCLUSION,HRS,III,ITT,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,THERE
118,133,251,852,ASSESSMENT,AUTOMATED,CHRONIC,CONCLUSION,CUMULATIVE,FUNCTIONAL,GENERAL,ILLNESS,INSTITUTE,LABEL,METHODS,NURSE,OBJECTIVE,PACIC,PATIENT,PURPOSE,QUALITY,RESULTS,THERAPY,THERE
AIF,DDH,EXPRESSION,FAK,HGF,MET,MMP,NOTEWORTHY,NSCLC,OSMRS,THESE
00010,035,039,BACKGROUND,CONCLUSION,CONTEXT,HGNEC,LABEL,METHODS,OBJECTIVE,RESULTS
181,969,DHA,EPA,MTT
100,215,945,946,NSCLC,VEGFR
ABC,ABCG2,ATP,MULTIDRUG,MXR,THESE
945,954,EGF,FINALLY,TNF,TRAF2,V12
540,FINALLY,LSL,NSCLC,RAS,SCRIB
MALIGNANT,TSC
IFS,INFANTILE,NTRK3
IVA,NPC
100,177,215,500,800,ADC,ADCMEAN,ADCMEDIAN,CONCLUSION,COV,DIFFUSION,INTER,INTRA,KEY,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,REGIONS,RESULTS
169,619,638,AGE,AIM,ASR,AUSSIEDLER,COPYRIGHT,DISCUSSION,GERMANY,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SIR,STOMACH,UNION
169,COPYRIGHT,HOWEVER,INC,MCL,MMP,OVERALL,QUERCETIN,STAT3
169,183,COPYRIGHT,FORCE,LTD,PREVENTIVE,SCREENING,TRIAL,USA
160,CONDUCTING,HOWEVER,PETER,REEVE,THESE
100,174,204,457,799,820,952,BACKGROUND,CONCLUSION,FORTY,JANUARY,KARNOFSKY,KPS,LABEL,MATERIALS,MEIER,METASTATIC,METHODS,RESULTS,SIX,SRS,THERE,UNASSIGNED
CURRENT,FINALLY,TAKEN,TREATMENT
EGF,FIP,FLAMMULINA,HOWEVER,MTT,PCR,RACGAP1,RED,SILENCING,TEXAS,WESTERN
169,200,CEA,IDE,NPS,PUBLISHED,THESE
947,BACKGROUND,CONCLUSION,CXCL5,CXCL8,ELISA,EMT,EPITHELIAL,EXPRESSION,JAK,LABEL,METHODS,NSCLC,PRODUCTION,RESULTS,SELECTIVE,SNAIL,STAT1,STAT3,STATTIC,THESE,WESTERN
162,CHR,CHROMOSOME,CONSORTIUM,FINALLY,HPP,PROJECT,PXD000603,SNP,TABLE
AIM,BACKGROUND,BELFAST,CONCLUSION,INCREASED,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,USING
HOWEVER
000,00055,00061,00098,100,200,689,956,BACKGROUND,BASED,DEE,ERC,ESTIMATED,LABEL,METHODS,OBJECTIVE,RESULTS
014,030,034,042,047,065,115,121,169,196,212,945,AIR,BEIJING,CHINA,COPYRIGHT,DISCOVERY,ELEMENTAL,FALSE,FDR,GAMES,GEE,INC,OLYMPIC,PM2,POLLUTION,SAT,TRUCK,WILEY
AMONG,ESTIMATES,NUTRITION
NIN,NSCLC,PCR,THERE,TNM,WESTERN
BML,HOWEVER,TAE
002,004,169,MEN
945,AFTER,CTP,INTRA,LABEL,MATERIALS,METHODS,MTT,NON,NSCLC,OBJECTIVE,PEI,PRECISION,PURPOSE,RESULTS,WCV
916,BECAUSE,FINDING,NAD,VDAC1
BAX,BCL,BESIDES,TAKEN,VAD
020,062,147,177,785,H1299,HOWEVER,MTT,NSCLC,PCR,THERE,WESTERN
160,DISTANT,HPV,OPSCC,PCR,SEVENTEEN,THESE
CIK,HOWEVER,HYPOXIA,NSCLC
127,201,322,337,399,558,CAUCASIANS
H1299,NADPH,PPP,TAP73,THESE,THROUGH
AFTER,AMERICA,LABEL,METHODS,NORTH,NSCLC,OBJECTIVE,PURPOSE,STAGE
116,181,COLON,COMPOUNDS,ESI,HCT,KLEBSIELLA,MIC,NMR
CLINICIANS,HIV,WORSENING
945,954,AKT,BCL10,HOWEVER,LATIN,MALT1,SMALL,THERE
100,169,215,301,BACKGROUND,CAD,CONCLUSION,DERIVED,DETECTION,FOUNDATION,LABEL,METHODS,OBJECTIVE,PHANTOM,PURPOSE,RADIATION,RANDO,RESULTS,SEVENTY,SINCE
000,169,177,24H,72H,7NM,COPYRIGHT,EPR,PHPMA,THP
169,945,947,AKT,CANCERS,CETUXIMAB,COPYRIGHT,DOWNSTREAM,ERBB1,ERBB2,ERBB3,ERBB4,FOLLOWING,GEFITINIB,LAPATINIB,LTD,MEK,PKB,PLC,RAF,RAS,SEVEN,SEVERAL,THESE
169,947,AKT,COPYRIGHT,DICKKOPF1,INC,ROMO1,ROS,THEREAFTER,WNT
100,169,174,209,ACTIVATING,BACKGROUND,CHINA,CONCLUSION,COPYRIGHT,G719X,JAPAN,L747P,L858R,LABEL,METHODS,PCR,PUBLISHED,RESULTS,RGQ,S768L,THEREFORE,USING
100,169,946,956,AFM,COPYRIGHT,EMT,H1299,INC,STUDIES,TREATMENTS,YOUNG
169,COPYRIGHT,SAFFRON,TAKEN,TH1,TH2
169,237,241,COPYRIGHT,DISCUSSION,LABEL,METHODS,OCT,OFTALMOLOG,PUBLISHED
169,BACKGROUND,COPYRIGHT,DENMARK,DESPITE,GENERALLY,GIVEN,ICELAND,LABEL,LTD,METHODS,MIXED,PREVENTION,RESULTS,SMOKING,THERE,TRUNCATED,WORLD
100,160,169,231,233,2GY,BETWEEN,CLINICALLY,CONCLUSION,COPYRIGHT,HELICAL,LABEL,LOW,MAY,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SAS,V10,V13,V15,V20
INC,MALIGNANT,MEH,PUBLISHED,SEVERAL
169,241,COPYRIGHT,PORTUGUESA,PUBLISHED,SOCIEDADE
169,ABOUT,AKT,COPYRIGHT,ERK,H1975,HOWEVER,MEK,NSCLC,RAS,SAS,T790M,TAKEN
169,COPYRIGHT,GIVEN,LTD
169,231,233,246,945,CONCERNING,COPYRIGHT,HODGKIN,OTHER,PUBLISHED,SAS,SNFMI,TNF
120,169,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,COX,GGO,HRS,IRELAND,LABEL,LTD,METHODS,PULMONARY,RESULTS,SMOKING,THESE
11L,13L,169,178,CENTRAL,CONTROLLED,COPYRIGHT,HRQOL,LABEL,LTD,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PEDRO,RESULTS,SMD,SOURCES
169,174,AUTHORS,COPYRIGHT,HIPAA,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PUBLISHED,RESULTS,SIX,SIXTY,STAGING
169,180,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,EBC,IRELAND,LABEL,LTD,METHODS,MSP,NON,NSCLC,P16,PUBLISHED,RESULTS
169,183,258,GAD,LAP,LEAVING,LTD,MEANING,PATIENT,PHQ,PROFILE,REVISED,SIX,SOURCES,WILEY
132,169,177,956,APOPTOTIC,BAX,CONCLUSION,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,ROS,THUJA,TUNEL,WILEY
001,160,164,169,ACUTE,COPYRIGHT,INC,JANUARY,JAPAN,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS,SURGERY,UNIVARIATE
169,BACKGROUND,BRONCHIAL,COMMENT,CONCLUSION,COPYRIGHT,LABEL,PUBLISHED,SAS,THEIR
160,169,AMONG,BACKGROUND,COPYRIGHT,DIAGNOSTIC,JANUARY,LABEL,METHODS,PUBLISHED,RESULTS,SAS,THERE,THESE
169,AGAINST,CHANGES,COMMITTEE,COPYRIGHT,INC,JOINT,PET,THERE,UNION
169,CHEST,COLLEGE,COPYRIGHT,FINALLY,FLEISCHNER,INC,PARTICULAR,PHYSICIANS,SOCIETY
169,ADHERENCE,COPYRIGHT,CURRENT,INC,SCREENING
169,18F,AWARENESS,COPYRIGHT,INC,PET
169,945,946,CET,CETUXIMAB,GFP,IGG,INF,ORGAN,SPECT,STRIKINGLY,TARGETING,VIRAL
ADM,FIFTEEN,GENERAL,GOTTRON,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PLA,RESULTS,SIX,THERE,THREE
001,169,650,BACKGROUND,COPYRIGHT,END,FORTY,INC,LABEL,LYMPH,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
160,169,173,888,ANTIBODIES,CONCLUSION,LABEL,LCNEC,LTD,METHODS,OBJECTIVE,PCR,RESULTS,THREE,WILEY
169,ACTIVATION,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,VALID,WILEY
118,169,289,2M0,4N0,707,913,DISCORDANT,LABEL,LTD,MATERIALS,METHODS,NAC,NSCLC,OBJECTIVE,RESULTS,SAMPLES,TEN,WILEY
001,003,174,AIM,CONCLUSION,FRA,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE
NMR,RHIZOMA,SGC,USING
549,MCF,RAUVOLFIA,SEVEN,SW480
BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,RCC
005,009,193,298,324,961,AZA,BACKGROUND,CPG,EXOGENOUS,H23,HRM,LABEL,NSCLC,PRINCIPAL,RESULTS
100,177,994,CURRENTLY,EARLY,GFP
945,946,AFTER,AIF,APOPTOTIC,FURTHER,HDAC1,HDAC2,HOWEVER,MCL,MG132,MYC,PCR,PROTEIN,THR58,WESTERN,WOGONIN
007,021,JAM,NSCLC,TNM,WESTERN
945,ABSENCE,AKT,DIFFERENT,ERK,NON,RAS,SCA,THESE,WESTERN
111,152,267,433,586,AFFYMETRIX,AGILENT,ATLAS,FINALLY,NON,PCR,PROTEIN,RAF
024,068,072,073,098,102,130,145,173,177,215,291,354,446,721,764,844,871,CONCLUSION,EIGHT,ILD,LABEL,LED,LOW,MATERIALS,METHODS,OBJECTIVE,RADIANT,RESULTS,SENSE,THERE
008,095,142,458,AGE,EASTERN,FACTORS,GEFITINIB,GROUP,NSCLC,PEMETREXED,PPS,TKI
250,420,CDC42,CONCLUSION,CORTACTIN,FINALLY,HOWEVER,LABEL,OBJECTIVE,RESULTS,SPA
BECAUSE,EARLY,FGFR1,FGFR2,FGFRS,VEGFR
CASES,DIAGNOSIS
001,006,455,471,6TH,AKT,COMMISSION,CONVERSELY,COX,EXPRESSION,JOINT,LABEL,LEVEL,MEIER,METHODS,NSCLC,OBJECTIVE,PATHOLOGY,RESULTS,TNM
FURTHER,HOWEVER,PML,SCT
ACTA2,DU145,ERBB2,FAS,HOWEVER,IFNA1,IFNB1,IL6,IL8,ITGA1,ITGB3,LNCAP,PC3,PDGFB,TAGLN,TEK,TNF
BCL,DECREASED,EMP,H1299,MEANWHILE,MEIER,MMP,MTT,NSCLC,PCR
293,544,HCC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
002,029,119,320,400,745,956,996,AU400,BACKGROUND,BSA,INSTITUTE,LABEL,LABORATORY,LINEARITY,LOWER,METHODS,NSCLC,OLYMPUS,PACLITAXEL,PRECISION,PTX,RESULTS,STANDARDS,TAXOL,TDM,THREE
177,400,689,956,ADDITIONAL,AU400,AU640,BACKGROUND,BECKMAN,COULTER,DOCETAXEL,DTX,INSTITUTE,LABEL,LABORATORY,LINEARITY,METHODS,RESULTS,STANDARDS,TESTING
169,AFTER,CHINESE,COPYRIGHT,PPL,PRIMARY,PUBLISHED
BH3,BIM,CCL39,CONSISTENT,ERK,FTY720P,HOWEVER,INSTEAD,MCL,PKB,PKC,RESISTANCE,S1P
106,118,250,784,803,859,AES,BACKGROUND,CAUCASIAN,CONCLUSION,CTC,DCR,FIRST,LABEL,METHODS,NSCLC,ORR,PFS,PHASE,PRE,PRIMARY,RESULTS,SECONDARY,TREATMENT
113,131,169,347,573,931,AGE,ASIAN,BACKGROUND,COPYRIGHT,COX,IRELAND,LABEL,LTD,METHODS,MORTALITY,RESULTS
437,65291,946,AFTER,CPT,III,JUA,MEA,VIP
169,956,COPYRIGHT,FURTHER,MIAPACA,NCI,SAS,SIMILARLY,THESE
064,111,118,147,177,181,202,268,389,620,643,722,786,872,928,945,946,AFFILIATED,BLOOD,CHEST,COLLEGE,DEPARTMENT,ELISA,FIRST,HMGB1,III,LABEL,MEDICAL,METHODS,OBJECTIVE,PCR,RESULTS,SERUM,SIXTY,SURGERY,TNF,ZUNYI
000,100,133,16T,236,238,252,643,8505C,BACKGROUND,CMV,FTC,IL2RG,LABEL,METHODS,MOUSE,NEO,NOD,PRKDC,RESULTS,SIMILARLY,SZJ,THJ,V600E,XENOGEN,XTC
946,AKT,API,BACKGROUND,ECTOPIC,FBXW7,HOWEVER,KNOCKDOWN,LABEL,MCL,MG132,RESULTS
120,350,AFTER,GUERBET,HEALTHCARE,HISTORY,LABORATORY,LIGHTSPEED,MILWAUKEE,TECHNICAL,VCT,WHITE,WIS,XENETIX
004,CONCLUSION,MARCH,METHODS,OBJECTIVE,PET,RESULTS,THERE,THREE,USING
220,AMONG,CONCLUSION,JANUARY,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,RFA,THERE
103,228,254,316,482,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
MESOTHELIN,MONOCLONAL,NCI,OVCAR,SS1
945,AKT,CCL,FURTHER,HOWEVER,NSCLC,STAT3,TAKEN,TNF
AKT,NF2,THESE
946,ALTERED,ALTOGETHER,AMINO,FINALLY,WNT,WNT5A
100NG,169,249,7NG,9NG,APPARENTLY,BACKGROUND,INDUCTION,LABEL,METHODS,MYOSTATIN,RESULTS,THEREFORE,WESTERN
028,160,1772C,1790G,945,BACKGROUND,CAUCASIANS,HIF,LABEL,PRINCIPAL,RESULTS
001,105,108,111,216,IHC,NSCLC,PFS,ROC
120,137,177,183,215,240,320,760,AMONG,CONCLUSION,ESR,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SERUM,TOTAL
001,014,122,879,ASP312ASN,CAUCASIANS,CIS,FURTHER,HOWEVER,HRS,LABEL,LYS751GLN,METHODS,NER,NSCLC,OBJECTIVE,ORS,PFS,PRIMARY,RESULTS,XERODERMA,XPD
129P2,C57BL,ELL,FVB,OLA,PIN,POL,STROMAL,THESE
013,016,025,028,539,627,ASIAN,BACKGROUND,CAUCASIANS,CHINESE,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
916,BACKGROUND,METHODS,RESULTS
316,328,BACKGROUND,COMPARING,CONCLUSION,LABEL,METHODS,RESULTS,THESE
002,218,317,AZA,H23,NSCLC,TRANSIENT
CHEMOKINES
052,169,798,AFTER,ALK,AMONG,BACKGROUND,CHRONIC,DISEASE,INCREASED,LABEL,METHODS,RESULTS,SOCIETY
10001,333,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,THESE,USA
10001,333,HOWEVER,MEDICAL,PUBLISHERS,SEVENTH,USA
10001,333,ALK,DIFFERENT,MEDICAL,MET,MULTIFOCAL,PUBLISHERS,SEVENTH,T790M,TKI,USA
10001,333,ALK,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,USA
10001,333,MEDICAL,PUBLISHERS,SEVENTH,SEVERAL,THESE,USA
10001,333,EASTERN,FIT,GERIATRIC,GROUP,III,MEDICAL,PUBLISHERS,SEVENTH,USA
10001,1960S,333,450,MEDICAL,PUBLISHERS,SEVENTH,SMOKING,USA
10001,333,HOWEVER,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,USA
10001,333,AMONG,MEDICAL,PUBLISHERS,SEVENTH,THESE,USA,USING
10001,333,MEDICAL,PUBLISHERS,SEVENTH,SPN,USA
10001,333,BAYES,KNOWLEDGE,MEDICAL,PATIENT,PUBLISHERS,SEVENTH,THEIR,USA
10001,333,CTS,MEDICAL,PUBLISHERS,RADIATION,SEVENTH,USA
10001,333,MEDICAL,PUBLISHERS,SCREENING,SEVENTH,TRIAL,USA
001,18F,BACKGROUND,EORTC,ERLOTINIB,FDG,FIFTY,LABEL,METHODS,NSCLC,PET,PFS,PMD,PMR,RESULTS,SMD
134,14Q32,655,946,EMT,EPITHELIAL,MAGI2,NSCLC,PCR,PDZ,TGF,TKI
670,956,CONJUGATE,FURTHER,STRUCTURAL
001,021,045,ASIAN,DFS,FURTHER,HCC,WESTERN
404,499,974,CAUCASIANS,HOWEVER,OVERALL,SEVENTEEN,THEREFORE
100,160
000,100,103,361,376,AGE,AMONG,APRIL,COX,ENGLAND,EPISODE,MARCH,STATISTICS,THERE
EDA
003,011,038,044,194,AMONG,CLARIFYING,COX,LABEL,LOG,MEIER,METHODS,OBJECTIVE,RESULTS,TIANJIN
ABC,CT0,CTEEH,CTEIH,DIS,GTV,GTV50,LABEL,METHODS,OBJECTIVE,RESULTS,WHETHER
AAA,AXB,BASED,NPC,NSCLC,PLANS,PRO,PRO10,PRO10_AIR
D90,ECLIPSE,FFF,GTV,HOWEVER,MLC,PTV,SIX
4MM,BASED,DIR,DMP,DVF,FEM,FOURIER,PATIENT,REGIONS,SINUSOIDAL
037,100,177,199,200,947,987,999,BELLOWS,EIGHT,LATENCY,MANAGEMENT,MAXIMUM,MEDICAL,MIP,NEGLIGIBLE,PEARSON,PHILIPS,RPM,SYSTEMS,THEREFORE
000,009,100,375,483,576,667,770,ALONG,CONCLUSION,ESTIMATION,HENAN,HENNA,INSTITUTES,LABEL,METHODS,OBJECTIVE,PER,RESULTS,TOBACCO,TREND
019,271,551,606,638,800,AMONG,BETWEEN,CHINA,CHINESE,CONCLUSION,DIFFERENCE,LABEL,METHODS,OBJECTIVE,RESULTS,STATISTICS,TRAFFIC,WOMEN
001,002,177,967,COX,DESPITE,FURTHER,JANUARY,LABEL,LWR,MEIER,METHODS,OBJECTIVE,RESULTS,SIMILARLY
176,AD5,FAM176A,H1299
001,103,COX,DCR,EPIDERMAL,JANUARY,L858R,LTD,MEIER,NSCLC,ORR,PFS,PUBLISHED
BINDING,EFFORTS,GDP,GTP,ONCOGENIC,RAF,RAS,SOMATIC,THESE
160,945,946,BACKGROUND,BED10,CTCAE,DESPITE,FACTORS,FFF,FLATTENING,FURTHER,LABEL,METHODS,NERVE,PULMONARY,RESULTS,SIX,SIXTY
001,231,CXCR4,EMT,MDA,MMP,SILENCING,THESE
100,BACKGROUND,GRADE,HCC,LABEL,LOCAL,MATERIALS,METHODS,OVERALL,RESULTS
025,142,203,AFTER,BACKGROUND,DISCUSSION,FGFR1,LABEL,MATERIALS,METHODS,NSCLC,PCR,PRIOR,RESULTS,THERE,THESE,THOSE
RAS,SOMATIC,THESE
169,BML,COPYRIGHT
001,006,111,120,187,242,344,615,BACKGROUND,DECREASING,FORTY,LABEL,METHODS,RESULTS,SERUM,THERE,TIE
15Q25,742,967,AFRICAN,AFTER,CAUCASIANS,HOWEVER,OVERALL,SEVERAL
219,232,685,690,ASIAN,CHINESE,CIS,FURTHER,HOWEVER,KNOWLEDGE,MICRORNAS,ORS,SNP
231,ABC,ABCC1,ABCG2,AMONG,LRP,MCF,MDA,MDR,PREVIOUSLY,RESULTS,THESE
124,131,309,AKT,CHINESE,ERK,GCS,HCC95,LCS,OKA,PPME1,PROTEIN
120,AHNAK,H2052,H2452,H28,KNOCKDOWN,MESO1,MESO4,MET,PCR,SINCE,THESE
169,29B,946,DEFINITION,EMT,ERK,INHIBITION,MAP,MEK,MIR,NSCLC,SNAIL,SPARC,TGF,TREATMENT
001,131,169,206,259,CHEST,COLLEGE,COPYRIGHT,COX,CURRENT,GROUP,INC,LABEL,METHODS,MOSBY,NSCLC,OBJECTIVE,PFT,PHYSICIANS,PUBLISHED,RADIATION,RESULTS,SURGERY,THERAPY,THERE,THESE,USING,Z4099
001,123,134,140,169,172,COPYRIGHT,INC,LABEL,METHODS,MORBIDITY,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,ROBOTIC,SURGERY,THERE
100,ACUTE,BEIJING,CHINA,CONCLUSION,CTV,DEPARTMENT,GENERAL,GTV,JANUARY,LABEL,LIBERATION,LOCAL,METHODS,NSCLC,OBJECTIVE,PTV,QGD,RADIATION,RESULTS
946,963,DESPITE,EPOB8,HEY,MIA,MSA,WESTERN
NMR,PHE,PRO
169,BAE,CUMULATIVE,IMMEDIATE,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RECURRENCE,RESULTS,SIR,SOCIETY
001,002,100,111,177,759,844,AMONG,AVERAGE,III,LABEL,LHS,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESECTION,RESULTS,THERE,TOTAL,TOTALLY
000,100,BACKGROUND,HOWEVER,ITALIAN,ITALY,LABEL,METHODS,RESULTS,USING,YET
080,160,169,392,569,AMERICA,ASIAN,BASED,CHI,COPYRIGHT,HPV,IRELAND,LTD,NON,NORTH,NSCLC,SEPTEMBER,SOUTH,THERE
001,169,177,COPYRIGHT,INCREASED,LTD,WHITNEY
100,169,UROLOGICAL
169,AUTHORS,FDA,FOUNDATION,JOURNAL,LTD,MOLECULAR,MUCOSITIS,PALIFERMIN,SEVERAL,WILEY
169,ADRENAL,BACKGROUND,CONCLUSION,ENDOSCOPIC,FORCE,JAPAN,LABEL,LTD,METHODS,OCTOBER,PTY,PUBLISHING,RESULTS,SEPTEMBER,SOCIETY,SURGERY,THERE,WILEY
155,160,167,169,206,222,941,954,CONCLUSION,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WILEY
169,241,6B6,EPIDERMAL,L858R,LABEL,LTD,METHODS,OBJECTIVE,PCR,RESULTS,SP111,SP125,WILEY
18F,AGGRESSIVE,DIFFERENT,FDG,FIFTY,OPERATORY,PET,SUV
BACKGROUND,BETWEEN,CONCLUSION,DISCUSSION,FIFTEEN,FUNCTIONAL,ILIAC,LABEL,MATERIALS,METHODS,MINIMUM,RESULTS,SIXTEEN,VARIOUS
1RA,526,592,BACKGROUND,BCA,CCL17,CCL22,COLORECTAL,CONTROL,COX,CRP,CXCL5,CXCL9,DESPITE,ENA,LABEL,LUMINEX,MDC,METHODS,MIG,ORS,OVARIAN,RESULTS,SAA,SCREENING,SERUM,TGF,TRIAL
160,178,500,AUTHORS,BACKGROUND,DFS,GUIDELINES,JANUARY,LABEL,LEVEL,METHODS,OBJECTIVE,PATIENT,QUESTIONS,RESULTS,THREE,WHETHER
169,945,954,CHINESE,INC,THESE,TREATMENT,WILEY
169,18B,CPG,INC,NOTABLY,PCR,THESE,WILEY
021,029,048,056,100,131,533,564,967,COX,DFS,HOWEVER,PCR,SMOKING
001,BASED,CONCLUSION,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC
120,270,340,750,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,PURPOSE,RESULTS
001,220,485,604,620,669,683,696,717,727,741,761,783,853,AUC,CARET,CONCLUSION,DETECTION,EARLY,LABEL,METHODS,OBJECTIVE,PAN,PRO,PURPOSE,RESULTS,RETINOL,SFPTB,SFTPB,TRIAL
001,005,018,022,325,618,CONCLUSION,HODGKIN,LABEL,METHODS,OBJECTIVE,PDMMS,PURPOSE,RESULTS,SEVEN,SEVENTEEN,STUDIES
224,AMONG,AUSTRALIA,CONCLUSION,CONTINENTS,DENMARK,ESTONIA,HPV,INCIDENCE,JAPAN,KINGDOM,LABEL,METHODS,OBJECTIVE,OPC,PURPOSE,RESULTS,THESE,USING,VOLUMES
160,181,730,APOPTOSIS,ATP,CELLS,DRB,EAGLE,EFFECTS,PREVIOUSLY,THEREFORE,THESE,TUNEL,UNTREATED
IMT,PRIMARY
160,181,ANNEXIN,BAD,BAX,BCL,CHINESE,HOWEVER,PAB
160,946,AKT,ANNEXIN,BAX,BCL,GSK,LACTATE,LIQUIRITIN,RAF,THESE,WESTERN
218,FUNCTIONAL,HMGB1,MICRORNAS
956,AKT,ALDH1,CD133,FRUCTUS,FURTHER,MMP,VITICIS
III,PREVIOUSLY
FINALLY,GPS,HOWEVER,PRIMARY,SEVERAL
169,335,BASEL,CMV,DESPITE,PATIENT
110,146,ALK,JAN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VYSIS
000,008,590,946,983,AB2,CONCLUSION,FLASH,LABEL,METHODS,OBJECTIVE,PC9,RESULTS,TOP,WESTERN,WNT
CEA,EMA,ENDOSCOPIC,LABEL,METHODS,MUC,OBJECTIVE,PSA,RESULTS,THESE,THREE,VILLOUS
169,COPYRIGHT,IRELAND,JNK,LTD,NSCLC,THESE,TNM
100,150,169,200,300,500,BACKGROUND,CENTRAL,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,GROUP,III,INC,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,PHASE,PUBLISHED,QALYS,QUALITY,RESULTS,TREATMENT
124,135,137,150,169,BACKGROUND,COPYRIGHT,ERLOTINIB,GRADE,LABEL,LTD,METHODS,NSCLC,OVERALL,RESULTS
008,117,160,169,177,CARDIAC,COPYRIGHT,EVALUATION,FORTY,HODGKIN,INC,INCREASING,LABEL,METHODS,MOSBY,OBJECTIVE,OPERATIVE,PUBLISHED,RESULTS,SURGERY
169,CONCLUSION,COPYRIGHT,EMD,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SUPERVISED
125,140,169,AICHI,BACKGROUND,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RAS,RASSF,RASSF1A,RESULTS,TEN,UNIVERSITY
169,AUC,CONCLUSION,COPYRIGHT,GRADE,III,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PATIENT,RESULTS,SECONDARY,THREE,TTR,TUESDAY,WEDNESDAY
100,169,295,COPYRIGHT,ENGLAND,LTD,THERE
10YEARS,169,214,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,DUE,LABEL,LTD,METHODS,OBJECTIVE,OSJ,OSP,RESULTS,WHEREAS
169,215,510,894,AMONG,BASILIC,CONCLUSION,COPYRIGHT,CRT,LABEL,LTD,METHODS,OBJECTIVE,PICCS,PURPOSE,RESULTS
147,AFTER,CONCLUSION,CSNK2A1,KYOTO,LABEL,MENIN,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,SILAC
1195G,247,271,956,994,ACADEMY,AMONG,CHINESE,CONCLUSION,HAN,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SCIENCE,THERE,TOTALLY,WHILE
EXPRESSION,PCR
007,169,379,503,623,648,659,791,THESE
006,021,285,ANCOVAS,ANGER,ANXIETY,CAREGIVERS,CHESS,CQOLI,DEPRESSION,LABEL,METHODS,OBJECTIVE,RESULTS,SUPPORT,WEB,WRITTEN
954,ABCB1,ADM,CHINESE,HOWEVER
DOX,GPC,NMR,PNH
118,300,CK5,CK7,IHC,MEIER,NSCLC,SCC,TTF
001,002,040,122,141,259,332,BACKGROUND,CONCLUSION,COX,DIVIDED,KRUSKAL,LABEL,MEIER,METHODS,RDW,RED,RESULTS,UNIVARIATE
COMPARING,COX,HOWEVER,LEWIS,LLC,PGF2A,TME,USING
CD4,CPG,DNMTS,HOWEVER,SPC,STUDIES
000,350,ATLAS,BRCA1,BRCA2,FUNCTIONAL,HOWEVER,LUDLU,PARP2,SCC
946,ASSOCIATED,CHINESE,CRC,METASTASIS,MMP,MYC,POLYGONUM,TRANSCRIPT,USING,WNT
ABC,ABCC1,CD133,CONTROL,CTL,EMT,HCC,INCREASED,MIGRATION,NOD
FINANCIAL,IRELAND,THESE
CIC,CSC,HOWEVER,PCR,RAPID,TAKEN,THEREFORE
AMONG,DECREASED,HOWEVER,LABEL,LUL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RUL,UPPER
169,225,BISPECIFIC,EPIDERMAL,ERBITUX,INDUCED

169,959,CONSISTENT,NNK,NNN,URINARY
137,CURRENTLY,HOWEVER,NSCLC,PXN,TAKEN
956,ARBUTUS,NCI,THESE
AFRICAN,CONDUCTING,LAGOS,NIGERIA,PRE,STATE,UNIVERSITY
169,ANCHORING,CONTEXT,COPYRIGHT,HOWEVER,INC,NLRP3,NSCLC,THESE
BESIDES,BRITAIN,COUNTRIES,MORTALITY,PREVALENCE,PREVENTION,SMOKING,SURVEYS
CLDN7,ERK,MEK,NCI,NSCLC,STUDIES,TNFRSF10B,TRAIL
117,135,153,169,215,234,419,572,689,954,AFTER,AGREEMENT,CASES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
018,036,038,044,139,BETWEEN,COX,DIAGNOSTIC,IFI,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN
006,126,BACKGROUND,CYP19A1,FIFTY,LABEL,METHODS,OTHER,PCR,RESULTS,SNP,THREE
30C,786,BACKGROUND,HOWEVER,LABEL,METHODS,MICRORNAS,PCR,RESULTS,THERE,TOTAL
200,BACKGROUND,DISEASE,LABEL,MAY,METHODS,RESULTS,SEPTEMBER,SIXTEEN,THESE,TSH
051,169,398,954,AFTER,AGE,CWP,INSURANCE,SIR
ASIDE,EPIGENETIC
945,946,954,AUTOPHAGY,H5N1PPS,SINCE,THESE,TNF
GAO
ACTIVATION,ATM,ATR,CDK,E2F,FURTHER,HNO,MRN,THESE,XLF
120,852,AML,COX,CUMULATIVE,ELF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,USING
ACTIVATION,ATR,DDR,FURTHER,HNO
215,EIGHT
542,ECTOPIC,EGF,SER,STAT3,TAKEN,THR
AMP,BECAUSE,NAD,NOTABLY,NSCLC,SIRT1,SRT1720,TAKEN
DEPLETION,EMT,FURTHER,HOWEVER,KIF2A,KIF2C,RAS
145,INCREASED,MPM,TREATMENT,UTR
757,AFTER,BACKGROUND,CARLO,CHAIN,CONCLUSION,ESTIMATION,LABEL,METHODS,MONTE,NUTRITION,RESULTS
AFTERWARDS,CARDIAC,SAPHENOUS
169,4989216,945,BIM,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLCS,TGI,THESE
169,COPYRIGHT,L61,PLURONICS,TBC
169,COPYRIGHT,HIV,HOWEVER,RETINOIDS,THERE
169,COPYRIGHT,FET,FPTRP,H69,LAT,NCI,PET,SAS,SMALL
001,169,3DCRT,BDVHS,COPYRIGHT,DVH,INC,MEDICAL,NSCLC,OAR,PUBLISHED,SCHEDULES,V20
002,169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SYSTEMATIC,THREE
169,AUTHORS,COPYRIGHT,CRE,DDR,INC,MK2,NSCLC,PUBLISHED
169,ANTITUMOUR,CEM,COPYRIGHT,HOWEVER,LTD,NCI,NON,SMALL
169,COPYRIGHT,HCC,INC,PUBLISHED,WESTERN
131,142,169,AGE,BACKGROUND,COPYRIGHT,FDG,LABEL,MALIGNANCY,MALIGNANT,METHODS,MRI,OCTREOSCAN,PET,RESULTS,SAS,SDH,THESE
001,033,169,CONCLUSION,COPYRIGHT,FGF,FIBROBLAST,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
169,AUSTRALIA,COPYRIGHT,COX,FINNISH,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
169,231,233,359,AMONG,APRIL,BAROMETER,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADON,RESULTS,SAS
169,3MM,BACKGROUND,CONCLUSION,COPYRIGHT,E90,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PAN,PURPOSE,RESULTS
020,074,120,149,169,APRIL,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,III,INC,LABEL,MATERIALS,METHODS,NSCLC,PET,RADIATION,RESULTS,SUV,TNM
001,100,169,197,COPYRIGHT,D95,DVH,HEART,IMN,INC,MEDICAL,MVA,PTV,PUBLISHED,REFINEMENT,UNIVARIATE,UVA,V20GY,V25GY
169,919,BACKGROUND,CONCLUSION,COPYRIGHT,ENDPOINTS,GLEASON,GRADE,INC,LABEL,METHODS,PSA,RESULTS,SERIOUS
169,COPYRIGHT,LTD,MICRORNAS
100,AMONG,BACKGROUND,HOWEVER,LABEL,MARCH,METHODS,RESULTS,SEPTEMBER
169,COPYRIGHT,HOWEVER,IRELAND,LTD,PLC,PUBLISHED,TNM,VARIOUS
001,106,169,177,1MM,217,AZD1480,CONCLUSION,COPYRIGHT,EFFECTS,ER3,GROUP,IRELAND,JAK,LABEL,LTD,MATERIALS,MEIER,METHODS,MTT,OBJECTIVE,OVERALL,PROTEIN,RESULTS,RPC,STAT3,STUDENT,THREE,VAN
177,550,BACKGROUND,CONCLUSION,DIAPHRAGM,LABEL,METHODS,RESULTS
169,CURRENTLY,INC
169,176,INC
169,8505C,8505CBRAF,956,AZA,BACKGROUND,BCPAP,BRAFV600E,CONCLUSION,COPYRIGHT,CPG,DAC,EXPRESSION,INC,LABEL,LATER,MAGEA,MEK,METHODS,MOSBY,PLX,PLX4720,RESULTS,TPC,TREATMENT
017,038,169,213,317,ADRENAL,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MOSBY,NON,NSCLC,RESULTS,SURGERY
169,COPYRIGHT,INC,PUBLISHED,SURGERY
000,012,021,033,045,239,286,321,327,499,508,582,586,605,644,BACKGROUND,CONCLUSION,DRUGS,ERCC1,FDG,HOWEVER,LABEL,MED,METHODS,MONIT,NSCLC,ONCOL,PET,RESULTS,ROC,SCI,SUPPL
169,AIM,AUSTRALIA,BACKGROUND,CONCLUSION,KEY,LABEL,LTD,OBJECTIVE,PENDING,RATIONALE,RESULTS,SEVERAL,THESE,WILEY
HOWEVER
101,125,198,655,799,841,AUSTRALIA,CRITICALLY,HOWEVER,JANUARY,LABEL,MDM,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,PATIENT,RESULTS,SETTING,SMOKING,VICTORIAN
945,EPR,MDR,MULTIDRUG,P85,PTX,TAXOL,THEREFORE
DESPITE
AIM,CER,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
368,439,715,724,BLACK,CXR,EVALUATION,MED,RESULTS,SCREENING,TRIAL
504,FGFR3,ION,MET,PGM,SMAD4,STK11,THEREFORE,TORRENT
001,009,ASIAN,EIGHT,HRS,NSCLC,OVERALL,THEREFORE
127,157,CD146,ECS,FIRST,GENOMIC,IHC,THY,VWF
CDA,FDG,FIRST,NSCLC,PET,THERE
FINALLY,YET
946,GATA3,SMAD3,SMAD4,TGF
METASTASIS

10001,333,ASSOCIATED,CERTAIN,MEDICAL,PUBLISHERS,SEVENTH,USA
100,CONCLUSION,LABEL,MATERIALS,METHODS,MTS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFA,TTP
002,004,009,ABC,BREATHING,CONCLUSION,CRT,LABEL,LTD,MATERIALS,METHODS,MLD,OBJECTIVE,PTV,PURPOSE,RESULTS,SEVERAL,SRT,SYSTEMS,V20
100,EVIDENT,LABEL,LESIONS,LTD,MATERIALS,METHODS,MICROWAVE,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,TECHNICAL
945,CLINICALLY,EVALUATION,PCR
485,805,HOWEVER,IMPROVING,MAJOR,OCCURRENCE,VTE
233,290,300,ACL,FURTHER,IHC,LESER,SKS,USUALLY
100,947,AMONG,FURTHER,IDIOPATHIC,PCR,THESE
277
90Y
945,BACKGROUND,CONCLUSION,CURRENTLY,HNSCC,LABEL,METHODS,RESULTS,USING
BACKGROUND,CONCLUSION,FDG,FIFTY,LABEL,METHODS,MTV,NSCLC,PET,RESULTS,SUV,THERE,TLG,UNDER
18WEEKS,500MG,AUC,BEV,CBDCA,PEM,THEREFORE,THESE,UFT
000,FIRST,ICHUSHI,JAPAN,OTHER
CHINA,MISREPAIR,RADIATION
HOWEVER,JAPAN,PM2,SARIHIDIR
EPIGENETIC,RIGHT
119,121,166,167,169,183,250,289,292,301,304,333,400,500,605,938,939,AVAILABLE,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,ELI,FEB,FUNDING,HOWEVER,IMCLONE,INITIALLY,JAN,LABEL,LILLY,LLC,LTD,METHODS,NSCLC,RESULTS,SYSTEMS,USA
169,1S159,945,946,ANOIKIS,BCL,COPYRIGHT,GSK,INC,MCL,NSCLC,SCREENING,THESE
001,ADJUSTMENT,AFTER,AMONG,BACKGROUND,BLACK,COX,END,FURTHER,LABEL,METHODS,RESULTS,UNADJUSTED
160,169,COPYRIGHT,CRC,F56,HCT,HOWEVER,HUVEC,LTD,PBS,VCR
160,169,956,BMDL0,COPYRIGHT,LTD,RIVER,THESE
169,5AR,8AR,BAX,BCL,COPYRIGHT,LTD,ROS,THESE
916,946,CD8,CONVERSELY,HIV,PERIPHERAL
10A,169,17A,23A,COPYRIGHT,HEPG2,MCF,PYRAZOL,SAR,SAS,THEIR
101,198,1ST,BACKGROUND,COLORECTAL,HEALTHY,LABEL,LTD,MATERIALS,METHODS,OVARIAN,PCR,PUBLISHED,RESULTS,RTEL1,RTL,SCREENING,THERE,THEREFORE,TRIAL
100,106,133,169,215,BED,CARLO,CONCLUSION,COPYRIGHT,D95,EPL,HOWEVER,IRELAND,LABEL,LTD,MARSDEN,METHODS,MONTE,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,TCP,TREATMENT
169,945,AUTHORS,COPYRIGHT,HOWEVER,INC,MEK,PI3,PUBLISHED,RAS,TOTAL
169,ARF,CIP,COPYRIGHT,INC,RAS,RUNX3,THESE,WAF
160,169,COPYRIGHT,INC,LUCHINO
169,945,CASTELLANO,COPYRIGHT,HOWEVER,INC,RAS
NSCLC,RET
ALK,FGF,HOWEVER,SINCE,TARCEVA

001,108,151,3N2M0,4N1M0,ACCORDING,BACKGROUND,BETWEEN,COLLEGE,COX,LABEL,MARCH,MEDICAL,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PFS,RESULTS,THERE,UNION,UNIVARIATE
BACKGROUND,ELISA,EXPRESSION,LABEL,MEANWHILE,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SERUM
021,024,147,225,266,491,925,BACKGROUND,COX,LABEL,LOG,LYMPHATIC,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS
013,046,177,531,600,604,632,669,718,822,903,AAH,AIS,AUC,BACKGROUND,BETWEEN,BLAND,GGO,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,ROC,STUDENT,THEREFORE,WHILE
001,004,005,011,017,019,028,034,181,293,914,967,BACKGROUND,COX,CPT,CURRENTLY,DXL,HOWEVER,IFO,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,SMALL,TAX,THERE,TPT,UNIVARIATE
177,956,ARTESUNATE,BACKGROUND,HOWEVER,LABEL,METHODS,MMP,MTT,OBJECTIVE,RESULTS,WESTERN

BACKGROUND,CONCLUSION,DVH,ELECTRONIC,EXTRA,HISTOGRAM,IMN,LABEL,MAJOR,METHODS,MLD,RESULTS,SCF,SMOKING,TAMOXIFEN,TEN,V20GY,VDOSE
HOWEVER,MRI

CD133,CONCLUSION,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,WANFANG

BAC,CAREFUL,CONGENITAL,POLYMERASE,THEREFORE,THESE
161,THERE
946,ALTOGETHER,H1299,MTT,NSCLC,SINCE,ZFX
945,946,DDX,DHT,THESE
153,BRAIN,KDM5B,NSCLC,SIRT1
177,916,DFS,III,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
100,210,300,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
104,122,169,BACKGROUND,CYTOPATHOL,FNA,HOWEVER,LABEL,METHODS,MOLECULAR,MULTIPLEX,NGS,NON,NSCLC,RESULTS,SOCIETY,THERE,THESE
142,CNA
181,945,ALKALOIDS,ANNEXIN,ASL,BCL,C57BL,ELISA,LEWIS,MTT,NSCLC,THEIR,THESE,TNF,WESTERN
ALK,ANTIBODIES,ERG,ETS,HMG,LANGERHANS,SALL4,SCHWANN,SOX10,SOX11,SRY,TREPENOMA
948,954,956,B16,DAMGO,HUVEC,KOR,LEWIS,LLC,OPIOIDS,SNC80,THESE,TREATMENT,U50
102,169,250,400,ARM,BACKGROUND,BETWEEN,CETUXIMAB,CISPLATIN,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MAY,METHODS,NSCLC,RESULTS
BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
445,AMERICA,AUSTRALIA,FINAL,INTERGROUP,MALIGNANT,MPM,NORTH,PEMETREXED,PLEURAL,SURGERY
169,ESOPHAGUS,HIROSHIMA,INC,SOCIETY,WILEY
600,AFTER,CONTROL,LABEL,METHODS,NSCLC,RESULTS,ROS,THEIR,UNLABELLED
046,146,AMACR,BACKGROUND,COA,CONCLUSION,LABEL,METHODS,RESULTS,SCC
BACKGROUND,CSP,LABEL,METHODS,RESULTS,THREE
252,APART,DGP,GROUP,HEIDELBERG,MAY,NSCLC,PATHOLOGIE,PATHOLOGY,PULMONARY,SOCIETY,TNM,WORKING
LABEL,METHODS,MFS,MICROARRAY,OBJECTIVE,OBJECTIVES,RESULTS,SURVIVING
001,005,BACKGROUND,CSSCD,DISEASE,HDL,LABEL,METHODS,RESULTS,SCA,TRIAL,TRV,VOC
295,AIM,CONCLUSION,COX,DFS,III,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PFS,RESULTS,SIRT1,SIRTUIN
ACCORDING,BACKGROUND,CENTRAL,CIS,CNS,HOWEVER,INCIDENCE,IRR,LABEL,METHODS,NATIONWIDE,RESULTS,THERE,THEREFORE
H2170,MET,NSCLC,PFS,SIMILAR,SU11274,THEREFORE,TKI,WNT
947,CURRENTLY,HLA,HOWEVER,IFN,MHC,MQLMPFGCLL,NSCLC,T790M,TKI,TREATMENT
011,027,545,BACKGROUND,CIS,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,RRS,SCIENCE,WEB
KNOWN,RBP,STRA6,THESE,VITAMIN
FINALLY,HOWEVER,SMAD5
001,27A,576,BACKGROUND,CHINESE,CONCLUSION,COX,FURTHER,LABEL,LOG,METHODS,NSCLC,RESULTS,SNP
AMONG,ANNEXIN,ANXA4
ABOUT,AFTER,BACKGROUND,CONCLUSION,GERMANY,LABEL,METHODS,RESULTS,SMOKING
BASED,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VALIDATION
169,AUTHORS,ENDOGENOUS,INC,KNOCKDOWN,MBT,PUBLISHED,THESE,WILEY
128,BACKGROUND,COLLEGE,CONCLUSION,GSTM1,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
157,181,474,509,625,662,AILUROPODA,FURTHER,HEP,L24,PRIMARY,RPL24
001,002,005,191,BACKGROUND,CONCLUSION,COR,DFS,FDG,LABEL,METHODS,NSCLC,PET,PRE,PVE,RESULTS,SUV
471,BACKGROUND,CONCLUSION,DESPITE,ERBB2,LABEL,METHODS,NSCLC,ONCOMAP,RESULTS
104,BACKGROUND,CONCLUSION,ERLOTINIB,LABEL,MEDICAL,METHODS,NSCLC,PFS,RESULTS,THERE,TKI
208,BACKGROUND,CONCLUSION,CONFIDENCE,FIFTY,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
100,AES,AIM,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
120,140,174,BACKGROUND,CONCLUSION,GRADE,HOWEVER,LABEL,MBC,METASTATIC,METHODS,RESULTS,TAXOL
AIM,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
FDG,FLT,HOWEVER,NSCLC,PET,THESE
126,148,169,183,BACKGROUND,BASED,DEVIATION,GEORG,HALLE,JANUARY,LABEL,METHODS,OTHERWISE,RESULTS,SAALE,STUTTGART,THERAPY
002,169,183,469,BACKGROUND,CONCLUSION,CRYOPROBES,DIFFERENT,GEORG,HOWEVER,LABEL,METHODS,RESULTS,STUTTGART
661,ABOUT,CONCLUSION,LABEL,METHODS,ONCOLOGIC,PET,PLANNED,RESULTS,UNLABELLED
945,AKT,AUGMENTED,CONCLUSION,CONVERSELY,FDG,FINALLY,HENCE,HIF,LABEL,LEWIS,METHODS,MG132,PET,RESULTS,ROS,SCAVENGING,UNLABELLED
121,ALK,CK5,CK7,EXPRESSION,KIRSTEN,L858R,LCC,LLC,MOLECULAR,TTF
100,115,135,150,160,BACKGROUND,CONCLUSION,ERLOTINIB,LABEL,METHODS,MTD,NON,NSCLC,RESULTS,THERE
022,124,169,3N0,414,4N0,ANOTHER,BACKGROUND,CLASS,CONCLUSION,III,LABEL,MATERIALS,METHODS,NAC,NSCLC,POTENTIAL,RESULTS,TUBB3
016,246,817,BACKGROUND,FURTHER,LABEL,METABOLITE,METHODS,ORS,RESULTS,SWEDISH,WHOLE
945,946
954,BAY11,F14,MDR,NAM,SINCE,SIRT1,TAKEN
954,AKT,COX,ERK,MCF,METASTASIS,MMP,OVERALL,SIMILARLY,SUBSEQUENT,TPA
021,174,AMONG,BACKGROUND,HIV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
METASTASIS
00099,001,169,215,945,BACKGROUND,CDC53,CONCLUSION,COPYRIGHT,DIEGO,HAPLOTYPE,INC,LABEL,MACROPHAGE,METHODS,MIF,NSCLC,RESULTS,SAN,SCF
FUKUI,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THREE
100,900,947,956,ALLEIASCL,CD8,ELISPOT,HLA,IDO,IFN,III,KYN,LABEL,METHODS,MONTANIDE,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,TRP
001,APRIL,BACKGROUND,LABEL,METHODS,PULMONARY,RESULTS
169,176,956,BACKGROUND,CONCLUSION,DUE,GENOMIC,INC,LABEL,METHODS,MGCL2,PCR,POLYMERASE,RESULTS,WILEY
CELLSEARCH,CTC,DETECTION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
117,152,169,193,215,CODES,COMPARISON,CONTINUUM,COPYRIGHT,DEPARTMENT,GROUP,HEALTHY,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,RURAL,RURALNESS,URBAN,WILEY
131,218,733,ASSOCIATED,CUMULATIVE,LABEL,LOWER,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNU,SIMILAR
195,298,515,ESCCS,EXPRESSION,LABEL,METHODS,NOTCH,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
324,653,658,946,ABSTRACTS,BACKGROUND,CENTRAL,CONCLUSION,CONTROLLED,CVD,EFFECTS,EXTRACTION,FUNDING,HEALTHCARE,JANUARY,LABEL,LIMITED,MEDLINE,METHODS,NEITHER,OBJECTIVE,PRIMARY,PURPOSE,QUALITY,RESULTS,REVIEWS,SELECTION,SOURCES,STUDIES,SYNTHESIS,SYSTEMATIC,VITAMIN
16S,CARIBBEAN,ESI,NMR,SMENAMIDES,STRUCTURES,THEIR
027,036,204,340,5H1,CD274,EXPRESSION,FURTHER,GREEK,NSCLC,QIF,TMA,UNIVERSITY
001,030,CLONOGENIC,DIRECTION,H1299,MLC
169,COPYRIGHT,DUE,ERK,FLOTILLIN,FLOTILLINS,HOWEVER,INC,INCREASED,THESE
ASIAN,BACKGROUND,CONTEXT,ENGLISH,EUS,FNA,FOLLOWING,LABEL,METHODS,PANCREATIC
169,COPYRIGHT,INC,MALIGNANT,OFTEN,PUBLISHED,THERE,WHETHER
169,COPYRIGHT,INC,STUDIES,WAR,WORLD
169,ANY,COPYRIGHT,FDG,IRELAND,LABEL,LRC,LTD,MATERIALS,MEIER,METHODS,MPM,OBJECTIVE,PFS,PURPOSE,RESULTS
10B,252,BACKGROUND,CCK,CONCLUSION,EXPRESSION,KIT,LABEL,METHODS,NSCLC,PCR,RESULTS,WESTERN
001,019,160,169,239,277,BASED,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PMD,RESULTS,SMD,THERE,WHILE
001,169,200,736,ADJUSTMENT,COLORECTAL,COPYRIGHT,COX,GROUP,LABEL,LTD,MAY,METHODS,OBJECTIVE,PATHOLOGY,PATIENT,RESULTS
1970S,1980S,CHINA,RESIDENTS,THERE
443,BACKGROUND,ELISA,LABEL,METHODS,NSCLC,OPN,PCR,RESULTS,SERUM,SNP,THERE
486,NSCLC,RCA
ALPINIA,BACKGROUND,JOHOR,LABEL,LC1,LC4,MEANWHILE,METHODS,MRC,PENINSULAR,RC1,RC5,RESULTS,SUB,TEN,TERENGGANU,THERE,VLC17
ANALYTICAL,CPT,HVGGSSV,NPS,PTX,RESULTS,TEM
945,946,HOWEVER,MET,NSCLC,SUBSEQUENT,TIVANTINIB
169,945,H1299,MTT,NMR,PEG,VCH,WILEY
169,CONCLUSION,EGR,EMT,HCC,LABEL,LIVER,M2B,RRM2B,THESE,UNLABELLED
169,CPT,EXPRESSION,HOWEVER,KNOCKDOWN,NOXIN,THESE,TSA
160,ADP,ANTITUMOR,H1299,LDH,NSCLC,ULMUS
954,ACTIVATING,FOXM1,IKBKB,JNK,JUN,MYC,NFKB1,NFKB2,PTTG1,RAS,SFTPC,TRANSGENIC
STAGE,THERE
160,181,BAX,H1975,NCI,NSCLC,SORAFENIB,THESE,WESTERN
177,243,BRITISH,DIAGNOSIS,EXCELLENCE,FURTHER,INSTITUTE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY
AMONG,BACKGROUND,CONCLUSION,CZECH,DENMARK,HUNGARY,ITALY,LABEL,METHODS,RESULTS,SMOKING,SPAIN
001,045,136,141,ALK,BACKGROUND,CNG,DFS,LABEL,MET,METHODS,RESULTS
9TH,CODES,CONCLUSION,JANUARY,LABEL,METHODS,RESULTS,THOSE,UNLABELLED,VTE
169,264,4T1,945,954,956,AIV,AMERICA,BACKGROUND,BIO,CENTRAL,COX,ELISA,GMELL,IRELAND,LABEL,LPS,LTD,MACROPHAGE,MATERIALS,METHODS,PUBLISHED,RAW,RELEVANCE,RESULTS,RUBIACEAE,SOUTH,SUB,TNF,UNCARIA
ACM,GGO,PULMONARY
3CM,DIR
169,AKT,FEDERATION,PUBLISHED,SOCIETIES,THESE
100,169,47D,945,946,956,COPYRIGHT,HBL,OVERALL,SAS
169,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,ADP,AMONG,CONSISTENT,COPYRIGHT,INC,PAR,RADIATION,THESE
169,215,500,COPYRIGHT,FINALLY,INC,MOLECULAR,NGS,PATHOLOGY,PUBLISHED,SOCIETY,TOOLKIT
001,156,169,95D,COPYRIGHT,FURTHER,IRELAND,LTD,THESE
169,CARCINOMAS,CARM1,COPYRIGHT,H1299,NEUROMEDIN,NON,NSCLC,PRMT1,PROTEIN,SAS,SMALL,TARGETING,THEIR
012,018,028,036,117,169,ATS,COPYRIGHT,ERS,GGO,IASLC
040,160,169,476,502,592,600,837,BACKGROUND,COPYRIGHT,INC,INPATIENT,LABEL,METHODS,MOSBY,NINTH,PREMIER,PROCEDURES,PUBLISHED,RESULTS,SURGERY,USING,VIDEO
169,BACKGROUND,BYM,CLASSIC,CONCLUSION,COPYRIGHT,DIC,ISERE,LABEL,MAPPING,METHODS,MORAN,POISSON,RESULTS,SAS
006,012,025,027,160,169,ADHERENCE,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
169,177,288,947,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TRANSIT
160,169,331,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FORTY,HOWEVER,LABEL,LTD,MBC,METHODS,PFS,RESULTS,SEVENTY,TTP
005,028,169,184,ADC,BACKGROUND,CONCLUSION,COPYRIGHT,EXPRESSION,IGF1R,IHC,INC,LABEL,METHODS,NSCLC,RESULTS,SCC,WESTERN
169,CONVERSELY,COPYRIGHT,LTD,MHC,MICROBIAL,NATURAL,NKT
001,005,169,241,442,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,NSCLC,PFS,PORTUGUESA,PUBLISHED,RESULTS,SOCIEDADE,STAGE,UNIVARIATE
001,005,011,021,100,169,185,ADVERSE,BETWEEN,COPYRIGHT,CURRENTLY,GROSS,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,THESE
130,240,878,946,BACKGROUND,CANCERS,CONCLUSION,LABEL,METHODS,RESULTS,SIRNA,THESE,WNT,WNT3A
160,BACKGROUND,CONCLUSION,LABEL,METHODS,RENAL
BACKGROUND,CYP,DESPITE,ECTOPIC,H2DCFDA,LABEL,METHODS,RESULTS,ROS,THESE,UPR
169,CONCLUSION,COPYRIGHT,EVALUATION,LABEL,METHODS,NPV,NUCLEAR,OBJECTIVE,P63,PPV,PRODUCTION,PURPOSE,RESULTS,SCC,SIMILARLY,TTF
169,177,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,NSCLC,PERFORMING,PUBLISHED,RESULTS,SOCIETY
001,005,012,040,169,923,ASC,BACKGROUND,COPYRIGHT,FIFTY,GGO,INC,LABEL,METHODS,PERIPHERAL,PUBLISHED,RESULTS,SCC,SOCIETY
001,004,130,408,529,NPC,THEREFORE,UNIVARIATE
156,169,ADDITIONAL,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LEBANON,LTD,METHODS,ORA,PUBLISHED,RESULTS,SAUDI,WATERPIPE
169,9MONTHS,COPYRIGHT,LTD,PUBLISHED
169,ALK,AMONG,BECAUSE,BIOMARKERS,COPYRIGHT,MET,SAS
157,160,191,348,ADELPHI,BACKGROUND,DISEASE,DSP,GERMANY,ITALY,LABEL,MAY,METHODS,OVERALL,PROGRAMME,RESULTS,SPAIN,WHILE,WORLD
AREAS,BACKGROUND,COVERED,DUE,LABEL,METHODS,OPINION,WHILE
AMONGST,CNS,CXCR4,MOLECULAR
H23,MMR,NCI
113,12P12,134,16P,192,210,21Q,309,413,457,914,BACKGROUND,GENOMIC,LABEL,METHODS,RESULTS,SEVERAL,SUPERVISED
001,002,007,009,112,129,153,161,185,219,723,791,860,AUC,BACKGROUND,CONCLUSION,FACTORS,FDG,HOWEVER,INTEGRATED,LABEL,LYMPH,METHODS,NODAL,NPV,NSCLC,PET,PPV,RESULTS,ROC,SUV,UNIVARIATE
013,030,181,HMSH2,HOWEVER,MMR,MUTATIONS,NSCLC
BESIDES,EMT,FCM,MICRORNAS,MIR
051,053,060,107,177,682,786,810,AGE,AUC,CEA,CHINA,CYFRA21,FRIENDSHIP,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,ROC,SERUM,SPN,UNIVARIATE,UNIVERSITY
AUC,CENTRIFUGE,EVALUATION,HOWEVER
CIS,FIXED,FURTHER,HOWEVER,JANUARY,MEDLINE
005,100,101,106,177,244,BACKGROUND,BRCA1,CONCLUSION,ERCC1,LABEL,METHODS,NOS,NSCLC,OFTEN,OVERALL,RESULTS,SAMPLES,THERE
048,2641773,CHINESE,CONSISTENT,GGC,MUCIN
215,AFTER,CHINESE,FURTHER,HOWEVER,LABEL,PPP2R1A,PPP2R1B,PPP2R2A,PPP2R2B,PPP2R5C,PPP2R5E,PROTEIN,SNP,UNASSIGNED,UNLABELLED
945,947,EARLIER,FRIZZLED9,HOWEVER,Q212L,TAKEN,WNT,WNT7A
CETUXIMAB,CTX,NCI,THESE
618,FINALLY,GNE,NAD,NAMPT,WHILE
169,BRAFV600E,STROHECKER
008,022,125,AMONG,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,STAGE
169,33258,956,BAX,BCL,COPYRIGHT,HOECHST,METHOXY,MOLECULAR,THESE,VCH,WILEY
516,945,946,CKD,CONCLUSION,ESPECIALLY,EXTENSIVE,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
169,DEPLETION,LABEL,MMP14,NEDD9,SIMILARLY,TIMP2,UNLABELLED
226,CHOROIDAL,FURTHER,HOWEVER,JANUARY,KAOHSIUNG,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,TREATMENT,UNIVERSITY
001,316,BACKGROUND,END,GUIDELINE,GUIDELINES,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS,SECONDARY,TEXAS,THERE
HERCULEAN
ACC,NOTABLY,PCR,PIT,RETROVIRAL,RRV,THESE
AFTER,APL,BACKGROUND,CD117,CONCLUSION,CYTOTOXIC,LABEL,LEUKAEMIC,METHODS,MTT,NOD,PHO,PML,RESULTS,SYNTHETIC
CONCLUSION,CRT,D95,FURTHER,HOMOGENOUS,HOWEVER,INTENSITY,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE
100,956,THESE
169,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,IVL,PBM,PUBLISHED,SOCIETY,ZEALAND
100,177,186,200,DYNALOG,ECLIPSE,HOWEVER,PTV,RMS,SIX,TEN,TPS
169,COPYRIGHT,GLUT1,H1299,LTD,PUBLISHED
DUSP3,EPIGENETIC,H3K36,HISTONE,KDM2A,NSCLC,THESE
169,MEDICAL,PTV,PUBLISHED,THESE,V10,V20,V30,XIO
T1BN0M0,VIDEO
10908,AES,CENTRAL,CONCLUSION,GROUP,JAPAN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,SURGERY,TOTAL
THESE
945,CHEST,CSF,TNF
ENGLISH,SINCE
PAP,PULMONARY,THERE,THESE
TEN,THERE

169,ALK,AUTHORS,CHINESE,COPYRIGHT,CRC,FORTY,G719A,INC,INTRATUMOR,LOW,MET,NSCLC,PUBLISHED,THREE,ULTRADEEP
100,169,956,COPYRIGHT,CTC,FNA,INC,LABEL,NMR,UNASSIGNED,UNLABELLED
169,AUR,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,RATIONALE,RESULTS,THERE
COPYRIGHT,FIFTEEN,SLACK,SURGERY,T12
169,924,BACKGROUND,BETWEEN,COPYRIGHT,ERF,ESOPHAGEAL,INC,LABEL,METHODS,OVERALL,PUBLISHED,RESULTS,SOCIETY,TEN
946,APC,APCMUTANT,FAP,GIVEN,HOWEVER,MUTATIONS,POLYPOSIS,SEVERAL,WNT
402,BMI,CAP,CIS,CONCLUSION,COX,FACTORS,ICS,LABEL,MEIER,METHODS,OBJECTIVE,PNEUMONIA,RESULTS,SETTING
DMAPT,GIVEN,MCL,STAT3,THESE,WESTERN
570,590,BACKGROUND,LABEL,MYC,NFKB1,RB1,RESULTS,TFS
BACKGROUND,BILATERAL,LABEL,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS
ALVEOLI,BACKGROUND,CONTEXT,FRESH,LABEL,METHODS,MPM,OBJECTIVE,RESULTS
200,946,A549M,BACKGROUND,CSC,EARLIER,ECTOPIC,EMT,EPCAM,EPIDERMAL,EPITHELIAL,GDC,H1299,HOWEVER,INHIBITION,LABEL,METHODS,NANOG,NON,NSCLC,RESULTS,TGF,THEREFORE
001,002,004,016,160,169,196,207,511,ACCORDING,COPYRIGHT,DFS,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SURGERY,UNIVARIATE
169,956,A20,ALK,BACKGROUND,COPYRIGHT,CRIZOTINIB,E13,ERBB2,H3122,IRELAND,LABEL,LTD,METHODS,NCI,NSCLC,RESULTS,THESE,TKI
100,169,998,AMONG,COPYRIGHT,EARLY,IRELAND,LTD
ARG,ASN,CYS,FINALLY,GLY,ILE,LEU,PHE
169,183,GEORG,SEVERAL,SOCIETY,STUTTGART
001,10B,128,160,201,634,720,COX,FIRSTLY,HOWEVER,MEANWHILE,NSCLC
100,136,248,594,BRAIN,CHINA,MEIER,NSCLC,PFS,SOUTH,THEREFORE,TKI
001,115,53BP1,BRCA1,MMSET,NSCLC,PCR,PIAS4,UBC13
001,508,916,AMONG,CONVERSELY,IMPORTANCE,INPATIENT,JANUARY,LABEL,METHODS,NATIONWIDE,OBJECTIVE,RELEVANCE,RESULTS,SETTING,THERE,VTE
BH4,NDP,REMOVAL,RNR
177,AFTER,B16,CHEMOKINE,CLL,ERDR1,F10,LABEL,MAP2K,MEF,PMC,THEREFORE,U0126,UNLABELLED
160,ANOVA,AVECT,CONCLUSION,EXP,EXPCT,INSPPET,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RIGHT,SPECT,THESE,TUKEY
BLP25,DESPITE,HOWEVER,NSCLC,REMARKABLE
100,105,177,CONCLUSION,FINALLY,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,TECHNICAL,TEMPORARY
CEA,FOLFIRI,HOWEVER,OCTOBER,THERE
CD4,HIV,MAY,OCTOBER,THEREFORE
150,ADL,FINALLY,FIRST,HOWEVER,OWING,QOL,THEREAFTER
EMT,HOWEVER,QIN,SMALL
AMRUBICIN,BACKGROUND,ERLOTINIB,GIVEN,L861Q,LABEL,LEWIS,METHODS,SERUM,SEVEN,SMALL,STAGE,WHOLE
001,002,008,015,023,026,028,213,253,361,685,899,ALK,HOWEVER,KNOWLEDGE,MOLECULAR,SPATIAL
31811,36333,611,BACKGROUND,BESIDES,CHINESE,CONCLUSION,HOWEVER,LABEL,NSCLC,ORS,RESULTS,SNP
CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VALUE,VOI
001,006,027,106,160,215,600,AFTER,ASSESSMENT,FDG,III,LABEL,METHODS,MTV,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,TLG,UNIVARIATE,WHOLE
945,954,FURTHER,LC3,OEL,ROS,THESE
450,700,DIAGNOSTIC,HTPWS
002,003,012,109,147,CONCLUSION,KDR,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SINCE,THESE
001,013,024,029,239,307,354,947,CD11B,CD8,CHANGES,CONCLUSION,FINALLY,IFN,III,LABEL,MDSCS,METHODS,NON,NSCLC,OBJECTIVE,PBMCS,PURPOSE,RESULTS
250,305,ADVERSE,AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
AIM,CONCLUSION,ENB,FORTY,LABEL,METHODS,OBJECTIVE,PNS,RESULTS
167,179,346,ABSORBABLE,AIM,AIR,CONCLUSION,LABEL,METHODS,OBJECTIVE,OCCURRENCE,RESULTS
L858R,LEU858ARG,PCR
110,HOWEVER,LAC,PATIENT,RAS,THERE,Y1173
827,DETECTION,H1975,HCC,INCREASED,NCI,NSCLC,TKI
169,203,3T3,DCUN1D5,KNOCKDOWN,LABEL,METHODS,NIH,NLS,OBJECTIVE,PCR,PURPOSE,RESULTS,STRUCTURE,WESTERN
AIR,EASTERN,GOF,GWR,HOWEVER,NO2,OVERALL,SAUDI,THESE
169,BACKGROUND,BASEL,CONCLUSION,LABEL,MATERIALS,METASTASES,METASTATIC,METHODS,PRIMARY,RESULTS,THEIR,THERE,UNUSUAL
011,248,931,AMONG,SWEDISH,USING
169,1V270,BASEL,CD11C,HOWEVER,PULMONARY,THEREFORE,TLR,VENEZUELAN
169,250,ALK,CAUCASIAN,COPYRIGHT,IRELAND,LTD,MAJOR,MET,PET
169,4D8,956,AUTHORS,B10,COPYRIGHT,EPIDERMAL,HOWEVER,IRELAND,LTD,NSCLC,PUBLISHED,RESISTANT,T790M
169,548,ASIAN,BACKGROUND,BRITISH,COPYRIGHT,IPASS,IRELAND,LABEL,LTD,MARCH,METHODS,NORTH,NSCLC,RESULTS,SIXTY
160,229,APOPTOSIS,BACKGROUND,CELLS,LABEL,METHODS,NICOLETTI,RADIATION,RBE10,RESULTS,SMALL,TREATMENT
ADDITIONAL
ALK,CTLA4,EGF,NSCLC,PD1
132,150,169,174,220,290,916,BACKGROUND,BASEL,BGA,COX,CPX,CVB,DECLINE,FVC,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PULMONARY,RESULTS,TLC,TREAT
009,520,540,BACKGROUND,COX,END,HEREDITARY,HHT,LABEL,MEIER,METHODS,RESULTS,THERE
BRCA1,NSCLC,TREATMENT
DRUGS,EPIDERMAL,HOWEVER,III,NSCLC,PRE,SEVERAL,VEGFR
BMCHF,HOLOPTELEA,PLANT,THESE
001,177,FBS,GNC,MTT,S6S,STAT6
HCC,HDAC5,HOWEVER,MES,PTP,PTP1E,PTPL1,PTPLE,STAT3,USING
CNA,THESE,USING
146,ASTRO,CNS,FIRST,MEDLINE,QOL,THERE
CRYSTAL,HETERACTIS,MTT,THESE,VENOM
125,155,639,688,722,889,CEA,OOP,PCR,ROC,USING
176,AIM,BACKGROUND,CONCLUSION,LABEL,LEIOMYOMAS,METHODS,OBJECTIVE,OPERATIONS,OTHER,TECHNIQUE
BACKGROUND,COMMITTEE,CONCLUSION,ENDOSCOPIC,EUS,HOWEVER,III,JOINT,LABEL,METHODS,RESULTS,THERE
024,CANCER1,COMPLETED,ENOBOSARM,GTX,III,LABEL,LGD,MAY,OBJECTIVE,PHASE,PREVENTION,PURPOSE,RESULTS,SARMS,SUMMARY,WASTING
000,009,032,138,140,228,255,469,662,757,CAUCASIANS,GSTT1,HOWEVER,THERE
1940S,HOWEVER,PACKHAM
AFTER,BACKGROUND,CLINICIANS,CONCLUSION,DESPITE,E2Z02,EASTERN,GROUP,LABEL,METHODS,QOL,RESULTS,SOAPP,SYMPTOM,THESE,UNIVARIATE
200,250,400,BACKGROUND,CETUXIMAB,CONCLUSION,HOWEVER,III,LABEL,METHODS,MOLECULAR,NSCLC,RESULTS,S0819,SECONDARY,THERE
169,947,954,COPYRIGHT,IRELAND,LTD,NSCLC,TAKEN
263,ARHG5,CD11A,CD11B,CELLS,GLU2B,TKI
100,181,183,946,CYANOPHORA,FLASH,THESE
169,235,268,271,397,501,668,72492,AUC,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MPV,MST,NSCLC,PUBLISHED,RESULTS,ROC,THESE,UNIVARIATE
169,COPYRIGHT,INC,OVERALL,STUDIES
CNV,THESE,THREE
001,011,015,134,136,169,187,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METASTATIC,METHODS,NSCLC,RESULTS
169,COPYRIGHT,INC,NSCLC
131,245,BACKGROUND,CAUCASIAN,EPICLIN,HEALTHCARE,LABEL,MANAGEMENT,METHODS,NSCLC,PATTERN,RESULTS,SURGERY,THERE
AFTER,CHINESE,CONCLUSION,COX,INTEGRATED,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,RESULTS,WESTERN
LUGOL
COX,HRK,LABEL,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,RESPIRABLE,RESULTS,SMR,UNDERLYING
004,017,018,023,032,034,169,AOI,AOS,INC,THERE,THESE,WILEY
106,547,BETWEEN,LABEL,LVI,MAY,METHODS,OBJECTIVE,OVERALL,RESULTS
945,CNA,EMT,METASTATIC,NOTABLY
ACTIVATION,ATP,GLS,GSH,HOWEVER,METABOLIC,PHGDH,TAP73,TCA,THESE
150,240,253,260,300,EZR,SIMILAR
001,002,020,042,214,824,ATS,CRIBRIFORM,ERS,HOWEVER,IASLC,SOCIETY
34A,946,CD133,CONVERSELY,CRC,ECTOPIC,EMT,MET,MYC,SNAIL,TAKEN,ZBP
INHALATION,SEVERAL
006,105,626,636,659,679,771,800,CEA,EBC,MARKERS,NSCLC,NSE,ROC,SCC
160,945,AMONG,ASYMMETRIC
002,003,004,014,024,029,033,038,043,EGYPT,FURTHER,NSCLC,SCC
15Q14,19P13,DESPITE,HPV,NCS,NUT
169,174,177,213,231,300,945,956,ASP,CONGO,D9K,E6K,GLU,HEPG2,MDA,NH2,PIPIDAE,PRO,STRUCTURE
AIM,CONCLUSION,LABEL,MAGLUMI,METHODS,OBJECTIVE,RESULTS,ROC,THERE,THESE
001,HOWEVER,KUHNIGK,MEASURING,OVERALL
169,COPYRIGHT,LTD
001,169,COPYRIGHT,EPIDERMAL,FALSE,G179A,HOWEVER,INC,INSTITUTE,L858R,L861Q,MOLECULAR,MUTATED,PATHOLOGY,PCR,PUBLISHED,SOCIETY
169,231,250MG,BASED,COPYRIGHT,GSH,HEPG2,MCF,MDA,MTT,RESULTS
100,169,AFTER,BECAUSE,COPYRIGHT,FOLLOWING,INITIALLY,PUBLISHED,SAS
163,169,5MM,BACKGROUND,CHANGES,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
008,009,021,041,044,073,135,140,169,175,204,457,COPYRIGHT,DFS,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,POCRT,RESULTS
169,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RST,SCANNED,TCS,THEREFORE
007,063,100,150,169,868,945,946,CONCLUSION,COPYRIGHT,CTCAEV4,EQD,FACTORS,GRADE,IRELAND,ITV,LABEL,LTD,METHODS,MLD,OBJECTIVE,PREDICTORS,PTV,PURPOSE,RADIATION,RESULTS,RPA,SEVENTY,TOTAL,V10,V50
169,COPYRIGHT,HCC,HOWEVER,IRELAND,LTD
012,169,240,242,245,267,295,577,773,904,AUSTRALIA,BACKGROUND,COPYRIGHT,HODGKIN,LABEL,LTD,METHODS,OTHER,RESULTS,THERE
138,169,463,CLINICALLY,COPYRIGHT,DIAGNOSIS,DISCUSSION,ENGLISH,HOWEVER,LABEL,METHODS,MIM,OBJECTIVE,OBJECTIVES,PAGET,RESULTS,SAS,SUPPORT
001,130,169,175,ALK,CHI,CONCLUSION,COPYRIGHT,FGFR1,HIF1A,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE
169,ABDOMINAL,COPYRIGHT,IMAGING,PUBLISHED
169,COPYRIGHT,ERLOTINIB,SAS
122,169,ALK,CONCLUSION,COPYRIGHT,GENOTYPING,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,169,395,945,946,BACKGROUND,BAYES,BED,BFS,CONCLUSION,COPYRIGHT,GENERALLY,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,TCP,THERE,USING
000,169,1YEAR,COGNITIVE,COPYRIGHT,PUBLISHED,SAS,SMOKING,TOBACCO
169,ASYMMETRIC,COPYRIGHT,INC,PUBLISHED,SOCIETY,SOUTHEAST
APC,AUSTRALIA,AUSTRALIAN,JANUARY,LABEL,METHODS,OBJECTIVE,OUTCOME,POPULATION,RESULTS,SETTING,STATISTICS
347,BACKGROUND,CIS,COX,CPB,FURTHER,GIVEN,HOWEVER,LABEL,METHODS,RESULTS,THESE
153,186,188,223,PHOSPHORUS,RHENIUM,STRONTIUM
ALTOGETHER,BACKGROUND,CURRENT,LABEL,RESULTS,XENOGRAFT
BACKGROUND,ITALIAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,THERE,THESE
174,400,AFTER,PEG,SOLUTOL,SPRAGUE,THESE
169,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
AWARENESS,BACKGROUND,BELIEFS,CONCLUSION,LABEL,METHODS,RESULTS,STRATEGIES
COMMUNITY,END,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SES
001,002,003,008,010,014,160,CONVERSION,FIFTY,PCR,PFS,SMALL
BACKGROUND,HOWEVER,LABEL,NSCLC,THERE
009,017,038,043,118,177,CONCLUSION,CTV,LABEL,METHODS,OBJECTIVE,PET,PTV,PURPOSE,RESULTS,STUDENT,UNGATED
954,BASED,LIN,MEC,SNAIL
EARLY
169,946,COPYRIGHT,NMR,SAS,SHARPLESS
18F,CONCLUSION,FDG,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,RESULTS,TREATMENT
169,AKT,COPYRIGHT,ERK,H1299,INC,NCI,NSCLC,TXL,VCS
169,945,946,956,CD133,COA,COPYRIGHT,FAK,FURTHER,H1152,HMG,INC,MYPT1,RHO,ROCK1,THESE,WESTERN
168,199,ABCC3,COX,EXPRESSION,MDR,MTT,MULTIDRUG,NSCLC,PCR,TNM
DMAPT,FINALLY,FLIPS,JNK,JUN,LC3,MB231,MDA,NADPH,PROLONGING,RIP,ROS,TAKEN,TNBCS,VAD
169,COPYRIGHT,ECM,LTD,METASTASIS,METASTATIC,MICRO,NON,NSCLC
169,COPYRIGHT,HOWEVER,INC,TKI
946,BACKGROUND,CD8,CMV,FIXED,HLA,INC,LABEL,METHODS,MLR,OBJECTIVE,PUBLISHED,RESULTS,SEB,TRANSWELL
BACKGROUND,CISPLATIN,CONCURRENT,DOCETAXEL,III,IMAGE,LABEL,METHODS,NON,PFS,RESULTS,SMALL,STAGE
AREAS,BACKGROUND,COVERED,LABEL,METHODS,NEWER,OPINION,PET,SPECT,THERE
3MG,FDA,IPILIMUMAB,MARCH,SINCE,TYPICALLY
003,175,397,CONTROL,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN,SEVENTY,SMALL,THERE
953,ERK,FINALLY,GENOMIC,HOWEVER,LABEL,MEK,PKC,PROTEIN,THESE,TIC,UNLABELLED
160,244,APMAX,BACKGROUND,CONCLUSION,CONVERSELY,CVP,FLOTRAC,H2O,LABEL,METHODS,PACO2,RESULTS,THESE
169,AUTOMATED,NSCLC,PCR,PGR,RESULTS,THERE
AIM,BACKGROUND,LABEL,MATERIALS,METHODS,NOW,OBJECTIVE,RESULTS,THEREFORE
169,CCCTC,CHROMATIN,CHROMOSOME,DEPLETION,TELOMERASE
169,EMT,HOWEVER,METASTASIS,NEDD9,TAKEN
ALK
170,510,945,947,954,C57BL,IFN,MMP,PCVAD,PMA,SINCE,TNF
LRP,MAJOR,MVP,SP1,SW620,THESE,USF,USING
160,3LL,CD4,CD40L,DCS,EXO,HOWEVER,LEWIS,THESE
160,954,CA2,DMS,SPHK1,THESE
140,148,185,230,392,DPD,FDG,MPM,MVD,NSCLC,PET,PMT,SUV
100,215,ADCHIGH,CONCLUSION,DCE,DWI,FIRST,KEY,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,SPL,TESLA,THESE,USING
169,CONCLUSION,GANETESPIB,HSP90,LABEL,METABOLIC,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
181,ANNEXIN,AUTOPHAGIC,AUTOPHAGY,FOLLOWING,H1299,HOWEVER,LC3,LOW,MTT,NCI
DIAGNOSIS,ORGAN,SLAUGHTER
181,968,ANNEXIN,BASED,BAX,GSH,HOWEVER,MMP,MTT,NAC,ROS,TRX,VAD
ADCY2,ADCY9,APC,COLORECTAL,HDAC6,ION,JAZF1,METASTASIS,PGM,SIGNALING,TORRENT,WHOLE
008,016,101,148,160,245,431,742,754,BACKGROUND,DIAGNOSTIC,EUS,FNA,GROUP,HOWEVER,LABEL,METHODS,RESULTS,THERE,TRIAL,USING
198,267,359,465,873,BACKGROUND,COX,ENGLAND,LABEL,MEIER,METHODS,NSCLC,RESULTS,THESE
064,169,BLAND,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,VIBRATION
CURRENT,LARGE
ATL,BAX,BCL,WESTERN
169,945,BACKGROUND,BRITISH,CONCLUSION,COX,GRS,HENCE,HIF,HOWEVER,HYPOXIA,KEY,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,RU486,SOCIETY,TAKEN,WESTERN
001,280,ALZHEIMER,HIV,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SUBSTANCE
THESE
707,BACKGROUND,CHINA,CHINESE,CNIPR,CONCLUSION,CURRENT,HOUSE,HOWEVER,LABEL,METHODS,NET,OBJECTIVE,PUBLISHING,RESULTS,RIGHT,STATE,TCM,THERE,THEREFORE,THESE


100,945,946,948,AKT,BAY,BECAUSE,IC50S
HOWEVER,RIGHT
ATP,ERLOTINIB,GREATER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TKI,TREATMENT,VANDETANIB
169,BRONCHIAL,LABEL,METHODS,NURSE,OBJECTIVE,PULMONARY,PURPOSE,SOURCES
11I,11S,599,725,CONCLUSION,INTRA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,186,BETWEEN,CONCLUSION,GROUP,HEPATIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
120,123,160,279,KRUSKAL,LABEL,MESOTHELIN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM
160,BACKGROUND,BASED,CHEST,DUE,HISTOLOGIC,HOWEVER,LABEL,METHODS,PRIMARY,PULMONARY,RESULTS,TRU
12Q13,169,261,CONVERSELY,NSCLC,TAKEN,THESE
III,THEREBY,THEREFORE
FETAL,MRI
160,668,946,CD142,CD144,CD62P,EMV,LABEL,METHODS,OBJECTIVE,PMV,PURPOSE,RESULTS,ROC
946,956,CISPLATIN,ESI,ICP,OES,REACTIONS,THEIR,THESE
001,007,017,022,119,374,381,536,597,CONCLUSION,KRUSKAL,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PTC,RESULTS
106,109,288,BACKGROUND,IMMEDIATE,JANUARY,LABEL,LIVERPOOL,METHODS,RESULTS,SEVENTY,UVEAL
240,360,AES,AMONG,ASIAN,ATP,BACKGROUND,BID,CONCLUSION,CYP2C19,DOSES,EMS,GRADE,LABEL,MET,METHODS,NSCLC,PMS,RESULTS,THREE,TIVANTINIB,WESTERN
CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,TRPC1,WESTERN
169,BACKGROUND,CONCLUSION,COPYRIGHT,DISRUPTION,EXPRESSION,INC,LABEL,LOW,METHODS,MUTATIONS,RESULTS
169,175,BACKGROUND,COPYRIGHT,FURTHER,INC,LABEL,METHODS,NSCLC,RESULTS,SIX,THERE
734,BACKGROUND,CENTRAL,EFFORTS,EXCLUDING,LABEL,MEASURING,METHODS,NORTH,OBJECTIVE,RESULTS,USING,WORKFORCE
001,110,169,176,177,34B,BAP,COPYRIGHT,GREEN,HVS,IRELAND,LABEL,LTD,MALIGNANT,MATERIALS,METHODS,MPM,MSP,OBJECTIVE,OBJECTIVES,PCR,RESULTS,ROC
239,500,EASTERN,FORTY,GRADE,GROUP,LABEL,METHODS,OBJECTIVE,PEMETREXED,PHASE,RESULTS,STAGE
ABOUT,AIM,DECREMENT,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SURFACTANT,THERE,TNM,WESTERN

169,JAPAN,SUNITINIB,UNIVERSITY,UROLOGICAL
ADVERSE,AES,BACKGROUND,EPICLIN,JANUARY,KEY,LABEL,MANAGEMENT,MARCH,METHODS,NSCLC,PATTERN,RESULTS,THROUGHOUT,WORLD
176,177,227,250,AKT,BACKGROUND,EMT,ERK,HCC,HOWEVER,LABEL,METHODS,MIGRATION,MMP,MOLECULAR,MTT,PD98059,RESULTS,RFA
BRAIN,DESPITE,HOWEVER
CEA,CHINA,CYFRA21,HOWEVER,MEANWHILE,NSE
DESPITE,EMT,GR5,H1975,MET,NSCLC,SRC,STAT5,T790M,THEREFORE
001,012,026,027,103,264,COX,NSCLC
031,045,AMONG,APRIL,BACKGROUND,CONCLUSION,EDMPS,LABEL,METHODS,MPS,PDMPS,RESULTS
002,003,005,009,015,CONCLUSION,CONFORMITY,CRT,DMEAN,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,STAGE,THREE,V20,V95
169,BACKGROUND,ICC,LABEL,METHODS,PC9,RED,RESULTS,SOCIETY,THESE
100,119,166,169,174,956,COPYRIGHT,EQUAL,INC,LBC,WILEY
169,INC,WILEY
012,026,048,105,169,954,AMONG,APPROACHES,BIOMARKER,CONCLUSION,DCR,EIGHT,INCREASED,INTEGRATED,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RAF,RAS,RESULTS,SORAFENIB,SSS,THERAPY,THESE
400,4EBP1,600,AKT,CDD,EIGHT,ERK,LABEL,MEK,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SAR245408,SIXTY
169,916,ADC,CK5,COPYRIGHT,FNA,IHC,INC,SIX,WILEY
ERBB2,OVERALL
956,AAG,CASPASE,DEPLETION,DESPITE,EXPRESSION,GANETESPIB,MTS,SMALL,TNFR1,USING
946,FUNCTIONAL,FURTHER,HDAC4,HMS,PITX1,PTHRP,ROBO1,SMAD2,TGF,THESE
160,247,406,601,611,ANGELES,BAYES,COX,INDEX,LABEL,LOS,METHODS,MORTALITY,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RHR,SNP,USING
160,300,CD200,CD200KO,CD200R1KO,CD4,CD8,CPG,DLN,FOLLOWING,WHILE
110,184,AUC,CHEMONAIVE,CONCLUSION,CONCURRENT,HOWEVER,III,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,THEREFORE
169,375,AEG,HOWEVER,IGF1R,MICRORNAS,MIR,REDUCED
BACKGROUND,FIFTY,METHODS,RESULTS,SCREENING
LOW
DESPITE,SEVERAL,THERE
000,324,408,BACKGROUND,BEHAVIORAL,BRFSS,CHRONIC,CONCLUSION,LABEL,METHODS,NORTH,PREDNISONE,RATES,RESULTS,THESE
169,275,FBXW7,LABEL,MCR,MYC,NON,NSCLC,TOP2A,UNLABELLED
215,ADDITIONAL,ANIMALS,ECTOPIC,FURTHER,LABEL,LIVER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPRAGUE,WHEREAS
005,007,160,169,BACKGROUND,COMPARISON,ELECTRONIC,LABEL,LIBRARY,LTD,METHODS,NSCLC,ORR,RESULTS,RRS,SEVEN,WILEY
HOX,LNCRNAS
AKT,AXL,HCC78,MET,NPS,NSCLC,T790M,THERE,TKI
169,DFG,ERK,MEK,MOLECULAR,RAF,RAS,V600E,WILEY
105,110,CONCLUSION,DMEAN,DVH,EIGHT,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,V10,V13,V20,V30,V40
H2A,HISTONE
001,169,945,946,BRITAIN,BUDESONIDE,GREAT,IRELAND,PRE
AKT,FINALLY,PKB,THEREFORE
COMPARING,FURTHER,H1299,MRC,PARTIAL,PLS,THESE,TOF
183,GEORG,SMALL,STUTTGART
100,150,176,177,183,AFTER,APRIL,BACKGROUND,BSA,EARLY,GEORG,HOWEVER,LABEL,LOCAL,MASAOKA,METHODS,OPERATIVE,RESULTS,SEPTEMBER,STUTTGART
183,301,AFTER,BACKGROUND,CONCLUSION,DESPITE,GEORG,JANUARY,LABEL,METHODS,REGRESSION,RESECTION,RESULTS,STUTTGART,YAG
183,GEORG,NSCLC,STUTTGART,THEREFORE
183,AFTER,FIRST,GEORG,HOWEVER,ILP,SINCE,STUTTGART,USING
183,DUE,GEORG,GERMANY,RADIATION,SOCIETY,STUTTGART,THEREFORE
100,183,AAH,AIS,ATS,ERS,GEORG,IASLC,IMA,LPA,MIA,SIMILARLY,STUTTGART,THEREBY
183,FIRST,GEORG,SCREENING,STUTTGART,TRIAL,USA
177,181,BRCA1,CHINESE,CONCLUSION,ERCC1,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,STMN1,TOP2A,TUBB3
177,CONCLUSION,FURTHER,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,RESULTS
BESIDES,EMT,EPITHELIAL,HOWEVER
EMT,EPITHELIAL,HOWEVER,THESE
PKC,THERAPIES,THESE
GIVEN,JANUS,STAT3
ANOTHER,HOWEVER
AES,AFTER,GEFITINIB
028,CHI,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
135,155,161,177,180,CONCLUSION,DFS,GGO,LABEL,MATERIALS,MEANWHILE,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
305,500,ACCORDING,BANGLADESH,CONTROL,HEPATITIS,STATISTICS,WORLD
002,004,106,122,136,151,169,182,183,214,229,350,BOS,DLT,EDS,ERS,GROUP,LABEL,LTS,METHODS,OBJECTIVE,OBJECTIVES,ODS,ORS,PGD,PRESS,PUBLISHED,RECIPIENTS,RESULTS,SLT,SURGERY,THERE,THREE,UNIVERSITY
PARTIALLY
048,076,160,30610,BID,BRIGHAM,CALGB,COX,DERMATITIS,GRADE,INSTITUTE,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,STUDENT,WOMEN
MPRIP,NTRK1,TREATMENT
92B,EXPRESSION,INHIBITION,NSCLC,REVERSION
BACKGROUND,CONCLUSION,CONTACT,FURTHER,HKDC1,LABEL,MOTIVATION,OWING,RESULTS
MRI,THERE,THYROID
HOWEVER
DMM,MPM,WHILE
THESE
ATLAS,AZA,INNOVATIVE,NON,NSCLC,SMALL
101,169,803,BAD,BCL,BEL,COPYRIGHT,FURTHER,INC,MCG,MOLECULAR,NCI,TAKEN
169,AMONG,COPYRIGHT,HOWEVER,IRELAND,LTD,OXIDATIVE,WESTERN
004,169,AUC,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CROWN,DIAGNOSTIC,DIFFERENCE,HYALURONIC,IRELAND,LABEL,LIVER,LTD,MALIGNANT,MATERIALS,METHODS,PUBLISHED,RESULTS,SERUM
1970S,FIFTY,FORUM,NURSING,ONF,REVIEWING
169,413,ACEIS,ADVERSE,COPYRIGHT,COX,III,INC,LABEL,MATERIALS,METHODS,MLD,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,196,AGA,BACKGROUND,COPYRIGHT,CROHN,IBD,INC,INSTITUTE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,VITAMIN
169,956,ADP,BCL,CORDYCEPS,JNK,JUN,MAPKS,MILITARIN,ROS,TREATMENT
169,ICP,MDR,MULTIDRUG,NIR,NPS,OVERCOMING,PCR
169,ANALYSING,COPYRIGHT,FIRST,IMPORTANT,LTD,RESULTS,SES,SMOKING,THIRD
169,COPYRIGHT,INC,MOSBY,PEDIATRIC,PRIMARY,PUBLISHED,STRABISMUS,UVEAL
DESPITE,OPERATIVE,ROBOTIC,THERE
215,SYNTHETIC,THEIR
100,109,119,FAR,FORTY,GAMMA,GKS,HOWEVER,KARNOFSKY,KNIFE,KPS,LABEL,METHODS,MRI,OBJECTIVE,OCTOBER,RESULTS
BACKGROUND,BMP,CONCLUSION,ID1,ID3,INHIBITION,LABEL,METHODS,MICROARRAY,NSCLC,PCR,RESULTS,SMALL,THESE
231,946,956,BACKGROUND,BAX,BCL,CIP1AND,FURTHER,LABEL,MDA,METHODS,RESULTS,THESE,WHEREAS,WHILE
100,169,183,ABOUT,GEORG,GERMANY,MANAGEMENT,MET,METASTATIC,NEN,OUTCOME,STUTTGART
BACKGROUND,CONCLUSION,EFFECTIVE,EVEROLIMUS,FINAL,INITIAL,LABEL,METHODS,NSAIS,OVERALL,PFS,RESULTS,THESE
BACKGROUND,BETWEEN,CONCLUSION,GRADE,LABEL,MALIGNANT,MARCH,METHODS,MPM,OCTOBER,PFS,RESPONSES,RESULTS
132,ALZHEIMER,HOWEVER,MIR,NSCLC,TAKEN
169,956,ANTITUMOR,AZD1480,FINALLY,H82,IC50S,JAK,JANUS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLCS,TREATMENT
160,16F,25M,AMONG,BACKGROUND,LABEL,MEIER,METHODS,PROGNOSIS,RESULTS,SEVEN
FINALLY,HOWEVER,TTF
177,207,248,530,945,AFTER,BESIDES,CONCLUSION,FEDERATION,INSTITUTE,LABEL,MEASURING,METHODS,OBJECTIVE,RESULTS,THESE,THOSE,UNLABELLED,WAITING
298,IHC,L858R,PCR,SWEDISH,THREE
946,AKT,CPG,ECTOPIC,THROUGH,TSG,WNT,WNT5A
CONSISTENT,SMOKING
007,BACKGROUND,CISPLATIN,HIPEC,LABEL,MARCH,METHODS,MPM,RESULTS,THERE
SURGERIES,THREE
046,118,133,138,1990S,ACTUARIAL,HOWEVER,INSTITUTE,IQR,LABEL,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESECTION,RESULTS,RFS,RIZZOLI,SURGERY
001,215,310,ALK,BACKGROUND,LABEL,METHODS,RESULTS,RET,SQCCS,TEN,THREE
B16,BL6,C57,HVJ,IIA,JAPAN,MEDICAL,OSAKA,SINCE,UNIVERSITY
954,ERK,FAK,H1299,KNOCKDOWN,MMP,SRC
AFP,AUTOPHAGY,BECN1,CRE,EMT,FURTHER,HCC,METASTASIS,MOUSE
95D,BCL,HOWEVER,LIM,PCR,THESE,TREATMENT
169,AVATARS,COPYRIGHT,GEMMS,GIVEN,IRELAND,LTD,MOUSE,THESE,TRIAL
APART,CRP,LABEL,OBJECTIVE,OVERALL,PURPOSE,RESULTS,STUDIES,SUMMARY,THERE
346,361
001,009,100,177,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PGA,RESULTS
169,1A2,2C9,2D6,3A4,ARN,BACKGROUND,CHINA,CLINT,CONCLUSION,CYP,CYP2C19,CYP450S,GEFITINIB,HEPG2,IRELAND,LABEL,LTD,MARSDENIA,MEANWHILE,METHODS,MTE,NSCLC,PUBLISHED,RELEVANCE,RESULTS,WIGHT
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NODAL,NSCLC,RESULTS
045,109,115,122,139,162,945,BACKGROUND,BETWEEN,BLOOD,CONCLUSION,COX,EASTERN,ELISA,EXPRESSION,JANUARY,LABEL,MAY,MEIER,METHODS,NSCLC,RESULTS,SERUM,THEIR,THESE,TNF,TTP
AFTER,APRIL,BACKGROUND,BECAUSE,CELSIUS,DUE,FURTHER,HCC,HOWEVER,JANUARY,LABEL,METHODS,MILAN,NORWEGIAN,OCTOBER,PET,SINCE,SIROLIMUS,SUBSEQUENT,THEIR,TOR
169,ALK,COPYRIGHT,DESPITE,FDA,IRELAND,LTD,NON,NSCLC,SMALL,USA
169,174,AOD,BACKGROUND,CONCLUSION,COPYRIGHT,ESSEN,GAPDH,HOWEVER,HPRT1,INSTITUTE,LABEL,MATERIALS,METHODS,PATHOLOGY,PSMA1,THREE,UNIVERSITY
945,AKT,AT13387,BACKGROUND,CONCLUSION,CSC,EBV,EPSTEIN,HDAC6,HSP90,LABEL,NPC,RESULTS
113,B82,BACKGROUND,FINALLY,FURTHER,LABEL,METHODS,MTT,NSCLC,RESULTS,TREATMENT,WESTERN
ADDITIONAL
STUDIES
945,ADC,BECAUSE,EFFECTS,EPO,H1975,HOWEVER,III,NSCLC
160,COMPLEX,DDP,FURTHER,HOTAIR1,HOWEVER,KNOCKDOWN,LAD,REPRESSIVE,SPC,TAKEN
418,946,BRCA1,JANUARY,NSCLC,SIMILARLY
169,181,BCL,BIM,BIOLOGY,FEDERATION,H1299,NSCLC,OVERALL,PFT
008,149,300,967,BACKGROUND,BESIDES,CONCLUSION,HOWEVER,LABEL,METHODS,PCR,PEARSON,RESULTS,THERE
AKT,GLUT1,HK2,OVERALL,TRAF4
4TH,BER,NER,NSCLC,SIMILARLY
947,CTL,ELISPOT,GRB,HLA,IFN,NSCLC,PRAME,RHAMM,TAA,TAKEN,WT1
160,DFNA5,HEPG2,THROUGH,UNDERLYING
127,137,157,224,347,829,ADULT,CSF,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
AKT,JNK,LC3,MDR,MEANWHILE
160,PROGRAM,SCREENING,STUDIES
001,027,174,177,BACKGROUND,BLOOD,CEA,CELLSEARCH,COLORECTAL,CRC,CTC,DIFFUSE,EPCAM,FDA,IMAGING,KRUSKAL,LABEL,METHODS,RESULTS,SEM
231,468,47D,945,946,ANNEXIN,BACKGROUND,BRAIN,CLONOGENIC,FOLLOWING,INTEGRINS,LABEL,MCF,MDA,METHODS,MTS,RESULTS,THESE
BECAUSE,CANCERS,CURRENT,FDG,FDOPA,NAF,PET,WHILE
ERK,HOWEVER,LABEL,MAP,MUTATIONAL,RAF,TAKEN,UNLABELLED,V600E
FDG,PET,THESE
FDG,PATHOLOGIC,PET
GIANT,ORBITAL,SFT
116,BACKGROUND,FNA,HENCE,ICC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
GPCRS,GPR65,H1299,INSTEAD,MYC,TDAG8
BACKGROUND,ICARE,LABEL,METHODS,RESULTS
DROSOPHILA,DUE,EXPLOITING,FURTHER,PARKINSON,SANJEEVANI,SEVERAL
007,169,261,BELGIUM,EASTERN,ERLOTINIB,GROUP,LTD,NSCLC,PFS,SEVERAL,TRUST,WILEY
169,231,COPYRIGHT,LTD,MDA,MDR,VAL,WILEY
169,BACKGROUND,EFFECTS,KEY,LABEL,METHODS,PREDICTORS,RESULTS,SOCIETY
CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV
169,AMONG,BACKGROUND,EMT,LABEL,METHODS,RESULTS,SOCIETY,TWIST
183,AFTER,CONCLUSION,EMPLOYING,GEORG,INDICATION,LABEL,METHODS,OBJECTIVE,STUTTGART
160,169,183,GEORG,REGULAR,STUTTGART,THERE,THEREFORE
000,001,034,136,160,BACKGROUND,COX,INSURANCE,LABEL,METHODS,RESULTS
713,AVERAGE,BACKGROUND,CONCLUSION,EBS,FRANKEL,HOWEVER,LABEL,LEVEL,METHODS,MULTILEVEL,OBJECTIVE,PATIENT,RESULTS,SIX,SUMMARY,THERE,THREE
103,112,141,206,AIM,ASIAN,BOARD,CMDHB,CONCLUSION,ISLANDERS,LABEL,MANUKAU,MAORI,METHODS,NSCLC,OBJECTIVE,PACIFIC,RESULTS,SOUTH,THERE,ZEALAND
006,114,169,532,945,946,CONCLUSION,EXPRESSION,LABEL,METHODS,MMP,OBJECTIVE,PCR,PRIMARY,PURPOSE,RESULTS,TGF,THESE
4T1,GEM,HOWEVER,THESE,WHILE
211,226,230,277,338,417,496,614,967,FAILURE,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERE
001,005,029,031,039,121,215,290,415,706,LABEL,METHODS,MPM,OBJECTIVE,PNI,PURPOSE,RESULTS,THESE,UNIVARIATE
BACKGROUND,BUTTERFLY,KRIESEL,LABEL,METHODS,MOTIVATION,RESULTS,SUPPORTING

105,116,169,177,431,549,946,956,ARTEMISIA,BASED,COLON,COPYRIGHT,CRL,DAD,DECNE,EXCELLENT,FINALLY,HCT,LEUKAEMIA,MTT,THP
244,CHINESE,EXPOSURES,PAH,PHE,URINARY
174,181,72H,914,954,ENTACAPONE,H1299,PARKINSON,TREATMENT
BACKGROUND,BCL,CCND1,EXPRESSION,LABEL,MALIGNANT,MATERIALS,MET,METHODS,MPM,REDUCED,RESTORING,RESULTS,USING,XENOGRAFT
169,239,BACKGROUND,COPYRIGHT,DR5,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,RESULTS,SECONDARY
160,KEY,RELAPSE,SMOKERS,SMOKING,SUCCESSFUL,TOBACCO
001,002,014,018,177,916,BACKGROUND,CHRONIC,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIOR,RESULTS,SMOKERS,SMOKING,THERE,TWISP
169,AFTER,CAD,CONSORTIUM,COPYRIGHT,FINALLY,IMAGE,IRELAND,LTD
515,611,COX,ERR,HOWEVER,LSS,RADIATION
169,BLACKWELL
ADDITIONAL,BACKGROUND,DIRECTIONS,EARLY,LABEL,RESULTS,WHILE
CONCLUSION,DESPITE,FURTHER,HENCE,HYPOXIA,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SIX,THESE
001,148,149,159,199,229,241,268,290,305,CONCLUSION,DIAGNOSTIC,FINAL,GGO,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
531,556,572,660,695,754,772,789,803,818,874,900,921,946,954,AXIAL,CONCLUSION,ICC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PREDICTION,RADIOLOGIC,RESULTS,T1A,T1B,T2A,T2B
3T3,CEM
ACCORDING,ELISA,HOWEVER,IGG2A,NIEMANN,REGARDING,THESE,WESTERN
AKT,AMP,NSCLC,TUSC2
001,007,031,192,502,576,BACKGROUND,CONCLUSION,FUNCTIONS,FURTHER,LABEL,LOG,LOWER,LUCIFERASE,METHODS,NSCLC,RESULTS,SET,USING
HEPATIC,PORCINE,SAA,SERUM,THESE
001,009,568,BACKGROUND,HHT,LABEL,PRINCIPAL,RESULTS,THERE
GATEWAY,USING
ACTIVATION,CCL22,CD11B,CD79A,ERK,FINALLY,GR1,MDSCS,STAT3,SYK
300,IVC,MANAGEMENT,RESECTION
175,2578C,634,LABEL,UNASSIGNED,UNLABELLED
233,BASED,DUB
IOF,TREATMENT,USA
947,CD4,CD9,CURRENTLY,DCS,GTPASES,HOWEVER,HSP,HSP90,IFN,RAB,RAB27
MITOSIS,NSCLC,SGOL1,SHUGOSHIN,THESE
175,BACKGROUND,COX,HIF1A,LABEL,METHODS,RESULTS,TTP,UNIVARIATE,VEGFA,VEGFA165B,VEGFB,VEGFC,VEGFD
215,LABEL,METHODS,OBJECTIVE,RESULTS
BECAUSE,BSD,LABEL,METHODS,OBJECTIVE,OPERATIVE,RESULTS
CTC,HOWEVER
160,945,946,947,EMT,MMP,NANOG,NOTABLY,NRF,NSCLC,OCTAMER,OVERALL,PARIS,PARKINSON,PCR,PGC,TWIST,ZEB
BLOOD,EORTC,GROUP,JANUARY,MSG,MYCOSES,TREATMENT
100,460,823,AMONG,GATA3,GCDFP,L50,LEICA
000,139,180,956,LEUKEMOID
012,200,467,472,500,949,BEV,CONCLUSION,EASTERN,GROUP,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PAC,PACCBEV,PEM,PEMCBEV,PEMETREXED,PFS,POINTBREAK,PURPOSE,RESULTS,SMALL
004,CONCLUSION,ESCALATION,HOWEVER,LABEL,LOCAL,METHODS,MTD,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
169,ACP,AUSTRALIAN,BACKGROUND,CAREGIVERS,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EARLY,GIVEN,HINDRANCES,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
169,BCF,CHINESE,FAO,ICP,POTENTIAL,TCR,THEREFORE,THQ
169,ADC,BACKGROUND,CONCLUSION,ENGLISH,HOWEVER,LABEL,MAY,METHODS,NSCLC,RESULTS
169,AMONG,COPYRIGHT,LTD,NMR,SINULARIA,STRUCTURES
001,169,954,BACKGROUND,LABEL,METHODS,MICRORNAS,MIR,RESULTS,THESE
102,126,203,257,465,485,584,744,CONCLUSION,III,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM
169,CURRENTLY,DUE,INC,OVERALL
169,33258,AZN,COLLEGE,COPYRIGHT,HOECHST,INHIBITION,LABEL,MDA,MEDICAL,METHODS,METHYLENE,MTT,OBJECTIVE,PUBLISHED,RESULTS,SOD,SUPEROXIDE
BLP25,FIRST,III,MODULATION,NSCLC,PHASE
AMIDE,APT
100,788,956,AFTER,LCD,MESOPOROUS
177,190,203,674,857,HNSCC,HOWEVER,HPV16,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,USA
028,152,403,813,858,928,930,938,993,CONSISTENT,LABEL,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SMR,THERE
162,AIR,ICD,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMR,TEM
497,954,COHEN,JEM,JOB,LABEL,METHODS,OBJECTIVE,REFERENCE,REGARDING,RESULTS,TBQ
ITV,WEL
169,CINCINNATI,DISEASE,III,INITIAL,LIVER,MEDICAL,OLT,PRETEXT,THREE
HOWEVER,NSCLC,THEREFORE
FCM,HRS,WESTERN
945,CONCLUSION,EBP,LABEL,LPT,MATERIALS,METHODS,OBJECTIVE,PCR,PEP,PKR,PURPOSE,RESULTS,TRAF2,XTT
CONCLUSION,FXIII,III,IQR,LABEL,LOEWY,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE,TNM
677TT,C677T,CHINESE,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,MTHFR,NSCLC,OBJECTIVE,PURPOSE,RESULTS,WANFANG
001,002,COX,EPP,HOWEVER,LNR,MALIGNANT,MEIER,METASTATIC,MPM
HOWEVER,MMP,MTT,THEREFORE,TRANSWELL
001,160,495,497,582,991,ADDITIONAL,DISCHARGE,DUE,ICD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPI,TEXAS,USING
HOWEVER,VAD
115,122,157,160,224,502,563,779,AFTER,GROUP,HISTOLOGY,LABEL,METHODS,MPM,OBJECTIVE,PLT,PROGNOSTIC,PURPOSE,RESULTS,STAGE,WBC
946,COMET,DCF,FURTHER,HOWEVER,NSCLC,ROS
500,CONCLUSION,DCR,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,ORR,PEMETREXED,PFS,PURPOSE,RESULTS,THERE,TREATMENT
946,CINNAMOMI,EMT,FINALLY,TGF,TNM
177,33342,945,946,C57BL,CHINA,ELISA,HOECHST,LEWIS,MCP,PARIS,PRS,ROS,SMITH,TGF,THESE,TNF,WESTERN
169,BACKGROUND,BRAIN,COPYRIGHT,INC,LABEL,LASER,METHODS,THERE,TREATMENTS
169,ALK,CRIZOTINIB,MET,THEREFORE,THESE,UVEAL
169,946,954,AKT,EMT,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,SNAIL,TGF,WHETHER
AFTER,CHEST
004,005,006,169,19Q13,339,358,772KB,BACKGROUND,CD3EA,CHINESE,CHROMOSOME,COPYRIGHT,ERCC1,ERCC2,LABEL,LTD,MDR,METHODS,PPP1R13,RESULTS,SNP
169,24H,956,ADP,AGS,B25,COPYRIGHT,DAIRY,GASTRIC,HOWEVER,INC,LC3,PUBLISHED,SCIENCE,THEREFORE,THESE,WESTERN
169,945,946,BSP,CURRENT,HOWEVER,OPG,OPN,PTHRP,RANKL,SPARC,TGF
169,954,COPYRIGHT,LTD,MMP,THESE
169,COPYRIGHT,DEFICIENCY,INC,ROS,SIRT5,THESE
169,BACKGROUND,COPYRIGHT,LABEL,LTD,METASTATIC,METHODS,REGRESSION,RESULTS,THESE
169,AMR,AMROL,COPYRIGHT,IRELAND,LTD,PEM
007,160,169,271,AFTER,BETWEEN,COPYRIGHT,CXR,INC,LABEL,METHODS,MNDCT,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY
169,COPYRIGHT,HOWEVER,INC,NR4A1,SEMAPHORIN,THESE
169,ALK,AMONG,ANAPLASTIC,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,MEDICAL,METHODS,NSCLC,PERUGIA,PFS,RESULTS,STUDIES
169,AUTHORS,COPYRIGHT,H3K27,INC,PUBLISHED,REDUCTION
169,946,AUTHORS,COPYRIGHT,INC,PUBLISHED,TNC,WNT
LUNGS
BACKGROUND,CARLO,CYBERKNIFE,HOWEVER,LABEL,METHODS,MONTE,OAR,RAY,RESULTS,THEIR,TPS,TRACING
250,500,GEFITINIB,PARKINSON,PREVIOUSLY
AGREEMENT,BACKGROUND,CARCINOMA,DEFORMABLE,DIR,GROSS,GTV,HAUSDORFF,LABEL,METHODS,NON,NSCLC,PRE,RESULTS,SMALL
160,169,BACKGROUND,BMI,COPYRIGHT,DISCUSSION,FINALLY,FURTHER,INS,LABEL,METHODS,OVERWEIGHT,RESULTS,SAS,STEROID
058,169,379,462,945,946,COPYRIGHT,CRP,IL6,LTD,MPO,THERE,THEREFORE
001,003,169,190,195,200,220,AFTER,COX,HRS,PRIMARY,STUDIES,THESE
169
BACKGROUND,CATHEPSIN,ESI,HOWEVER,LABEL,RESULTS,SCC,SHH,THESE,TOF
169,AUTHORS,BACKGROUND,COMPLEX,CONFERENCE,CONSENSUS,COPYRIGHT,INC,LABEL,MAMMALIAN,METHODS,MONRO,PUBLISHED,SCLEROSIS,VARIOUS
169,AFTER,CONCLUSION,COPYRIGHT,GEFITINIB,H1703,IRELAND,LABEL,LTD,MATERIALS,METFORMIN,METHODS,MKK6E,MTS,OBJECTIVE,OBJECTIVES,PCR,PROTEIN,RESULTS,TRANSIENT,WESTERN
945,AMONG,BACKGROUND,ELISA,HIF,INHIBITION,LABEL,METHODS,PROGNOSIS,PROTEOMIC,RAF,RESULTS
ALK,GROWING,MICRORNAS,NSCLC,THERE
HOWEVER,NSCLC,SIMILARLY
ALK,NSCLC

ATLAS,NETWORK
ALK,MET,NSCLC
100,AMONG,DESPITE,FINALLY,KEEPING,NSCLC,RAS,THESE,THREE
AKT,ERK,MEK,NSCLC,RAF,RAS,TARGETING,THEREFORE
ERLOTINIB,HOWEVER,NON,NSCLC
CHRONIC,COA,HMG,WHILE
ADJUNCTIVE,EVENTUALLY,WHILE
BAX,BCL,PAR
A2A,A2B,FINALLY,JUN,LEWIS,LLC,USING
174,270,472,798,ASSAY,BACKGROUND,CHAIN,CONCLUSION,EPI,GERMANY,LABEL,MATERIALS,METHODS,MPE,PCR,POLYMERASE,RESULTS,SHORT,SHOX2,STATURE
DISCUSSED,PREDICTIVE,THESE
103,169,AEROSOL,BACKGROUND,COMBINING,CONCLUSION,INC,LABEL,METHODS,NKG2D,PROCEDURE,RESULTS,THERE,WILEY
001,CD4,CD8,NSCLC,PCR,RESULTS,SIMILARLY,THESE,TNFAIP8,WESTERN
001,006,008,120,177,BDCA2,CD123,CD4,III,NSCLC,RESULTS,THESE
169,947,948,CD8,EUR,HOWEVER,IMMUNOL,IMMUNOLOGY,JOURNAL,MHC,NKG2D,TCR,TRAIL,ULBP2,VCH,WILEY
177,CONCLUSION,FEB,JAN,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SIX,VAS
102,119,150,286,395,AFTER,AVERAGE,CONCLUSION,CPS,FACTORS,KARNOFSKY,KPS,LABEL,MDT,MEIER,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,RTT,SUMMARY,THERE
BACKGROUND,CONCLUSION,D269H,DR5,E195R,LABEL,METHODS,OVCAR,P53,RESULTS,TNF,TRAIL
556,AMONG,BETWEEN,HOWEVER,III,JAPAN,LABEL,METHODS,NODAL,OBJECTIVE,OBJECTIVES,PHASE,RESULTS,SEVERAL,STAGE,T1A,USA
947,CD3,EPHA2,HOWEVER,ONCOLYTIC,TEA,VVS
4G5,5B6,947,956,EXPRESSION,FGF,NCA,TNF
945,947,ALTOGETHER,B16F1,CD4,CD8,IFN,TNF
000,100,169,946,BASEL,BECAUSE,CHMTF,PTD
CRITICALLY,THESE,THOSE
435,BASED,CNS,DUE,FURTHER,GHR,III,INC,INSTITUTE,MDA,MEL,NCI60,PRL,PUBLISHED,STAT5,STRIKINGLY,WHILE
169,946,COPYRIGHT,EMT,INC,METASTASIS,SILENCING,SPARC,TAKEN,TGF
4T1,BLI,CREMOPHOR,MIP,NPS,PEG,PTX,PTXMIP_SQ,TAXOL,USING
169,946,AUTHORS,FETAL,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
BACKGROUND,EXTENSIVE,LABEL,METHODS,PCD,PET
LTQ,MALDI,MEETING,MSI,TARCEVA,THESE
011,012,017,034,169,177,3N0M0,EIGHT,ESOPHAGUS,FITCHBURG,FURTHER,HEALTHCARE,INC,PHILIPS,PTV,SOCIETY,USA,WILEY
FURTHER,LIBBY
169,BECAUSE,FOUNDATION,LTD,PUBLISHED,WILEY
EGF,EGFR2,NSCLC
EGF,HOWEVER,NSCLC,ONGOING,THESE
WHILE
BECAUSE,BML,PATHOLOGY
036,042,046,HOWEVER,MEIER,NSCLC,RESULTS,SH2,SHIP2,TNM
945,AKT,HOWEVER,NSCLC,TGF,THERE,TOTAL
001,008,027,028,EXPRESSION,NSCLC,SEVENTY,THEREFORE,VARIOUS
MES,NCI,NSCLC,PCR,WESTERN
001,103,195,AFTER,CHINESE,HOWEVER,LIMITED,LOG,NSCLC,RESULTS,THESE
001,003,009,020,10F,150,GRADE,PFS,THEREAFTER
156,ALK,CCDC6,KIF5B,KOREANS,NSCLC,RET
CID,HOWEVER,SEVERAL
100,174,BACKGROUND,CELLSEARCH,CTC,LABEL,METHODS,RESULTS,THERE
169,BECAUSE,COPYRIGHT,LOD,LTD,ROC,SUPPOSE,WILEY
001,147,169,177,436,BACKGROUND,CONCLUSION,EARLY,FOUNDATION,INITIAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SYSTEMATIC,VDT
169,826,BACKGROUND,CONVERSELY,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,OVERALL,PCA,RESULTS,THERE,THESE,WILEY
104,143,371,AHR,BECAUSE,FOS,MRM,MYC,NF2L2,NPV,USING,VALIDATION
031,H3K27,HISTONE,KNOCKDOWN,TAKEN
105,109,117,177,181,230,345,396,HISTOLOGY,INDUCTION,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,279,ADULT,LABEL,LOBECTOMY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,PULMONARY,RESULTS,SURGERY,THERE,TTE,UNIVERSITY
COMET,E2F,EXPRESSION,HOWEVER,SAC
100,123,160,169,ATS,COPYRIGHT,ERS,IASLC,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE
600,ANOVA,BACKGROUND,BRITISH,BSC,BSM,CLASS,COX,EXPOSURES,FUELS,HOWEVER,LABEL,METHODS,NSF,RESULTS,SMOKELESS,STEEL,THESE,WORKERS
102,126,169,183,184,BACKGROUND,COPYRIGHT,LABEL,LTD,LUXEMBOURG,METHODS,RESULTS,THESE,UNION
649,964,CRC,FINLAND,FINNISH,IBD,INSURANCE,METHODS,OBJECTIVE,OVERALL,RESULTS,SIR
220,390,DOX,H1299,HBA,IONPS,MCF,MCS,MRI,USING
19A,19B,205,20A,30B,AMONG,HOWEVER,SCC,THESE
ECS,TDECS,THESE,XENOGRAFTS
BURKITT,C57BL,COX,DLBCL,FOXM1,MYC
231,4T1,MCF,MDA,MMP,THESE
COMMITTEE,CONCLUSION,CONFERENCE,CONSENSUS,FIFTY,LABEL,LOBECTOMY,MEETING,METHODS,NSCLC,OBJECTIVE,RESULTS,SCIENTIFIC,STATEMENT,VIDEO
033,036,268,351,AFRICAN,AMERICANS,ASIAN,ASSESSMENT,FUNCTIONAL,GENERAL,LABEL,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,THERE,TREATMENT,TRIAL
100,AFTER,TAG
140,169,34B,ECTOPIC,EPIGENETIC,EXPRESSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,947,BRCA1,DNAPK,EGF,RAD50,TAKEN,USING
169,AKT,BECAUSE,ECTOPIC,ELISA,FAK,IGF,IGF1R,INSULIN,MEK,MOLECULAR,NSCLC,SRC,TREATMENT,WESTERN
10A,169,252,CHIMICA,COPYRIGHT,HELVETICA,MTT
030,BPF,BRONCHIAL,CENTRAL,GENERALLY,GROUP,HOWEVER,JAPAN,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY,TRS
ANY,FSH,SERTOLI,THERE
BECAUSE
BACKGROUND,CONCLUSION,ENGLAND,INCOMPLETE,LABEL,METHODS,OVARIAN,RESULTS,SCREENING,TRIAL,WALES
2B7,ADDITIONAL,ALTERNATE,ASE,CONCLUSION,LABEL,MATERIALS,METHODS,NOVEL,OBJECTIVE,RESULTS,THESE,UDP,UGT2B7S
169,BACKGROUND,COPYRIGHT,FORTY,GRADE,IASLC,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,STAGE,SYSTEMATIC,THERE
039,100,125,169,177,COPYRIGHT,GTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RBE,RESULTS,THROUGH
150,169,BACKGROUND,CLINICALLY,COPYRIGHT,DISCUSSION,EXTENSIVE,IMAGE,IMAGING,IRELAND,LABEL,LTD,METHODS,MODALITIES,OAR,RESULTS
AMERICA,ARSENIC,BACKGROUND,BECAUSE,HISEQ,HOWEVER,LABEL,LUSCS,METHODS,NORTH,RESULTS
451,ALK,ASIAN,BACKGROUND,LABEL,MET,METHODS,NSCLC,RESULTS,SIXTY
207,ALK,BACKGROUND,KIRSTEN,LABEL,METHODS,NSCLC,RESULTS
127,140,226,279,BACKGROUND,EASTERN,FURTHER,GROUP,LABEL,METHODS,RESULTS,SEVERAL,SIMILAR,THREE
006,121,BACKGROUND,CONCLUSION,GENOMIC,HOWEVER,LABEL,METHODS,MPM,RESULTS,THERE
BACKGROUND,BIOMARKER,CONCLUSION,FOUNDATION,IMAGING,KEY,LABEL,METHODS,NINTH,PREVENT
056,096,126,140,195,200,208,229,249,625,884,BACKGROUND,BMI,JANUARY,LABEL,METHODS,NINTH,REGARDLESS,RESULTS,THERE
4T1,BACKGROUND,BE1,CCK,ENDOSTATIN,EVIDENTLY,LABEL,LDM,LDP,LIDAMYCIN,METHODS,RESULTS,TARGETING,THEREFORE
160,169,CONCLUSION,LABEL,LTD,METHODS,NUCLEAR,OBJECTIVE,RESULTS,SCC,THERE,WILEY
169,APOPTOSIS,FAS,LAK,LTD,NSCLC,PCR,THESE,WESTERN,WILEY,ZB4
174,452,500,ADVERSE,BACKGROUND,CIMAVAX,CTC,EGF,FURTHER,IMMUNOLOGY,INSTITUTE,LABEL,MEDICAL,METHODS,MOLECULAR,NCI,RESULTS,THESE
HSP90,INHIBITING,NOVOBIOCIN,PRESTWICK,UTILIZING
270,956,MEMBERS,PDT,THESE
949,HOWEVER,INHIBITION,INRF2,INRF2S602A,KEAP1,MOLECULAR,PKC
BRENT,CAMBRIDGE,CARLO,CENTRAL,COUNCIL,DEPARTMENT,GROUP,HODGKIN,HOWEVER,JAGER,MEDICAL,MEIER,MONTE,NATURAL,NOE,NORTH,NSERC,STATISTICS,TREATMENT,UNIVERSITY,VAN,VARIOUS,WELLNER
100,377,AMONG,CONCLUSION,COX,HCT,ICU,INDEX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
000,169,653,ADULT,BACKGROUND,CHILDHOOD,CNS,CONCLUSION,CSI,INC,INCIDENCE,LABEL,MEDICAL,METHODS,POISSON,RATES,RESULTS,SURVIVORS,WILEY
FURTHER,HISTOLOGY
169,BACKGROUND,C30,COX,EORTC,HRQOL,LABEL,METHODS,QLQ,QUALITY,RESULTS,SOCIETY,TREATMENT,WORLD
001,006,066,165,169,187,260,304,362,447,599,691,CIS,MAY,RCC,SUMMARY,TREATMENT,VEGFR
100,107,169,203,356,420,593,BACKGROUND,FNA,HISTOLOGIC,LABEL,LTO,METHODS,RESULTS,SAT,SOCIETY,UNSAT
169,63742,BECAUSE,COPYRIGHT,HOWEVER,VCH,WILEY
160,CHEMOKINE,CHEMOKINES,CXCR4,CXCR7,EWING,SDF
001,010,012,031,078,102,140,HOWEVER,PCR,ROC,SERUM,SEX,TAKEN,TNM
029,133,145,193,194,874,967,ADC,ARHGEF5,HOWEVER,NSCLC,SCC,SRC,THEREFORE
127,198,325,443,757,954,CK7,IHC,MATCHED,NSCLC,TEN,TTF
719,AFFAIRS,CENTRAL,FEW,IMPORTANCE,LABEL,METHODS,NOTABLE,OBJECTIVE,OUTPATIENT,OVERALL,RELEVANCE,RESULTS,SETTING,THESE,USING
AKT,CURRENTLY,LC3,NSE,THESE
131,158,177,231,AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAPILLARY,PMC,RESULTS,SURGERY,TOTAL
169,ACCORDING,COLLEGE,COPYRIGHT,CRUDE,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,OVERALL,PROQEST,PUBLISHED,RESULTS,ROYAL,SCIENCE,SMOKERS,WEB
DIMINISHED
004,006,008,157,300,ACUTE,ARP,BACKGROUND,CONCLUSION,CTR,FEV,INDUCTION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,V13,V20,V25
018,100,BACKGROUND,LABEL,MATERIALS,METHODS,NPV,PET,PPV,RESULTS
169,BORTEZOMIB,BTZ,CASPASE,COPYRIGHT,FINALLY,H1299,HMSNS,HOWEVER,LTD,NSCLC,THEREFORE
100,169,CUTANEOUS,ERG,MMP,THESE,WHILE
DPC,INSIGHT,LIGHT,MICROSCOPY,SWISS
400,6NHSD,956,C57BL,GFP,LD100
100,945,956,HRS
014,049,178,811,892,967,BACKGROUND,BASED,CONCLUSION,CRT,III,LABEL,MARCH,METHODS,PFS,RESULTS,WHOLE
001,BACKGROUND,HOWEVER,IDO,LABEL,METHODS,PLEURAL,RESULTS,TBP,THESE
CONCLUSION,FURTHER,INCISIONAL,LABEL,METHODS,OBJECTIVE
H1975,L858R,STRUCTURAL,T790M,THESE
1RM,216,AMERICA,BACKGROUND,DISCUSSION,HOWEVER,HRQOL,LABEL,METHODS,NORTH,NSCLC,PRIMARY,SECONDARY,TRIAL,WESTERN
BETWEEN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEPTEMBER,SURGERY,THERE,VIDEO
181,AKT,BAK,BASED,BAX,BCL,EPIDERMAL,MAPKS,MCL,MES,NCI,NSCLC,USING
907,AFRICAN,AMERICANS,ASIAN,BACKGROUND,CAUCASIANS,CENTRAL,CHINESE,CONSISTENT,EASTERNERS,EPIDERMAL,EUROPEANS,FREQUENCY,HOWEVER,INDIA,KOREANS,LABEL,NON,NORTH,NSCLC,PRINCIPAL,RESULTS
400,PEG,PEGYLATED
1970S,2000S,326,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,BCC,CARDIAC,INC,NBCCS,PTCH1,WILEY,WILMS
169,BACKGROUND,COPYRIGHT,INDIVIDUAL,LABEL,LTD,METHODS,NEVER,RESULTS,WILEY
NSCLC,OVERALL,USP17
169,945,ALA,BINDING,BIOLOGICAL,COPYRIGHT,HLH,ID1,LTD,MALDI,MCF,MTT,PEPTIDE,SAR,SOCIETY,SPR,TOF,WILEY
169,ALK,COPYRIGHT,EPH,EPHA1,EPHB1,EPHB6,INC,KDR,MET,NON,NSCLC,RET,WILEY
001,101,174,288,386,517,538,AMERICA,BASED,CENTERS,III,LABEL,MEASURE,METHODS,NSCLC,OBJECTIVE,OUTCOME,OVERALL,PATIENT,RESULTS,SETTING,SEVEN,SIX,TREATMENT
169,549,ALA,ALDER,DIELS,GLU,GLY,MCF,PHE,VCH,WILEY
200,239,AIM,ASSESSMENT,AUC,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PFS,RESULTS
127,215,239,252,445,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
176,180,360,AIM,ARC,BACKGROUND,CONCLUSION,INTENSITY,LABEL,METHODS,MODULATED,MODULATION,NSCLC,OBJECTIVE,PTV,RESULTS,THERAPY,VOLUMETRIC,WHILE
100,CONCLUSION,CONCURRENT,FURTHER,LABEL,METHODS,RESULTS,SIX,THEREFORE,UNLABELLED
945,947,ADSCS,DESPITE,EMT,NOTCH,SMA,THESE
418,705,BACKGROUND,BEN,CONCLUSION,CONFLUENCE,H1299,LABEL,MATERIALS,MES,METHODS,NSCLC,RESULTS,SHP,SINCE,SRC,STAT3
945,AKT,BACKGROUND,CONCLUSION,FDG,GLUT1,GLUT3,HIF,HOWEVER,LABEL,LCNEC,MATERIALS,METHODS,MVD,PET,PNETS,RESULTS
AIM,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SCIENTISTS,THREE
CAREFUL,SUCCESS,THERE
100,110,169,176,996,COPYRIGHT,LTD,SPM,THEREFORE,WILEY
169,FEW,INC,METASTASES,RENAL,TREATMENT,WILEY
169,198,878,CHINESE,COLLEGE,COVARIATES,DCR,DISEASE,NSCLC,PFS,PREDICTIVE,THERE,WESTERN
124,BACKGROUND,FOXO3,LABEL,METHODS,OBJECTIVE,PULMONARY,RATIONALE,RESULTS
169,862,BACKGROUND,BRIGHAM,COX,EASTERN,GROUP,LABEL,LES,METHODS,PREDICTING,RESULTS,SOCIETY,WOMEN
169,BRITAIN,COPYRIGHT,GREAT,INSTEAD,IRELAND,ISSUE,JOURNAL,LTD,PATHOLOGY,PUBLISHED,SOCIETY,WILEY
169,HOWEVER,INC,NOD,THEIR,WILEY
001,002,013,10Q22,169,197,945,AE1,AE3,AUTHORS,BRITAIN,CNS,COPYRIGHT,GENOMES,GENOMIC,GREAT,IRELAND,JOURNAL,KIT,LTD,MAJOR,PATHOLOGY,PGR,SOCIETY,THERE,WILEY
036,BACKGROUND,CARCINOMA,EPSCC,EXTRA,LABEL,METHODS,RESULTS,USA
153,177,EDTMP,THESE
001,016,056,146,205,226,236,967,BASED,ELISA,IGA,IGG,NSCLC,PEARSON,STUDENT
DGIDB

DTC,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,PATHOLOGIC,PURPOSE,RESULTS,THREE
946,AKT,EMT,ERK,MET,NRP,TGF
945,946,F666D,HEK,INHIBITION,NOTABLY,PKC,PLD,PROTEIN,THESE
044,094,150,301,968,BACKGROUND,CONCLUSION,ERLOTINIB,GRADE,JANUARY,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS,SEPTEMBER
HAI,KNOCKDOWN,PCA,THESE
169,COPYRIGHT,HCT15,HEPG2,MCF,NCI,RESULTS,SAS
169,956,COPYRIGHT,NSCLC,SAS
100,191,208,CK7,GATA3,HOWEVER,III,REMAINING,THEREFORE,UCS
100,ALT,ANCILLARY,CPM,HMGA1,HMGA2,HOWEVER,LIPOMATOUS,SEVEN,THREE,WDL
AUTOPHAGY,B16,BASED,CA755,LEWIS,LLC,OVERALL,P62,RAS,S37
001,BACKGROUND,EINDHOVEN,GASTRIC,LABEL,METHODS,ORADJ,RESULTS,YOUNGER
169,AML,FINALLY,INHIBITION,THESE
169,ERK,MEK,RAF,RAS,TARGETING
001,169,263,309,328,349,351,392,426,430,470,550,605,805,AMONG,BACKGROUND,CONCLUSION,CVD,LABEL,METHODS,REGISTERED,RESULTS,SIMILAR,SUMMARY,WHILE
100,169,946,ALX,COPYRIGHT,EMT,EPITHELIAL,EXPRESSION,GPR32,H1299,H1703,HOWEVER,LTD,RESOLVINS,TGF,THEREFORE,THESE,WESTERN
169,NOVEL,PUBLISHED
169,COPYRIGHT,CTC,DFS,INC,MOSBY,NSCLC,RESULTS
169,210,338,BIOLOGICAL,HOWEVER,ILGGHLDAK,LABEL,MRM,NPANPVQ,NSCLC,PUBLISHED,SECRETION,SERUM,SID,THREE,THROUGH,UNASSIGNED,UNLABELLED
169,AGA,BACKGROUND,COPYRIGHT,DGCR8,FUNCTIONS,HMGA2,INC,INSTITUTE,KNOCKDOWN,LABEL,METHODS,NUCLEAR,OBJECTIVE,PANCREATIC,PDACS,PUBLISHED,REDUCED,RESULTS,THESE,TNFRSF10A,TNFRSF10B,TRAIL
169,327,COPYRIGHT,COX,MEN,PUBLISHED,TAX,THESE
BDUMP,CAR,EIGHT,GENERAL,LABEL,LIBERATION,MARCH,METHODS,OBJECTIVE,OCTOBER,OTHER,PNS,PON,RESULTS
169,241,AIM,BACKGROUND,COMPARING,CONCLUSION,COPYRIGHT,FEMALES,LABEL,METHODS,OBJECTIVE,PORTUGUESA,PUBLISHED,RESULTS,SOCIEDADE
169,600,AMERICA,COPYRIGHT,LATIN,PUBLISHED,SEPAR
169,ACD,ACRYLIC,COPYRIGHT,DIFFERENT,DVT,FEMORAL,LATERAL,LTD,PATHOLOGIC,PFN,QOL,RESULTS,SIX,SYNTHES,THERE
169,MMP,PRIMARY
PULMONARY
169,COPYRIGHT,SAS,SMOKING,TROUSSEAU
169,2CM,CARLO,EARLY,HOWEVER,MEDICAL,MONTE,MUS,PTV,SIMILAR,THESE
160,215,AUC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
120,160,169,177,AUR,CONCLUSION,COPYRIGHT,DES,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,ROC
001,169,177,5GY,AFTER,AUSTRALIAN,AUTHORS,BACKGROUND,BTV,COLLEGE,CRT,FIF,HOWEVER,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,RADIATION,RESULTS,ROYAL,TOTAL,V47,WHILE,ZEALAND
100,169,AUSTRALIAN,BACKGROUND,COLLEGE,COMBINING,CONCLUSION,FAT,LABEL,METHODS,RESULTS,ROYAL,ZEALAND
001,169,AES,BACKGROUND,CHINA,CONCLUSION,COX,EASTERN,FURTHER,GROUP,JANUARY,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SUNITINIB,TKI,UNIVARIATE,WILEY
169,177,184B5,956,AAD,MCF,SOCIETY
169,FINALLY,LTD,WILEY
000,001,007,014,038,063,160,201,BACKGROUND,LABEL,METHODS,MST,NSCLC,RADIATION,REGISTERED,RESULTS,TNC,TREATMENT,TRIAL
002,160,169,333,951,955,BACKGROUND,BRITISH,CONCLUSION,HOWEVER,INFORMING,LABEL,METHODS,OBJECTIVE,READING,RESPONSES,RESULTS,SMOKERS,SOCIETY,STATEMENT,THERE,UNASSIGNED,WILKS
AKT,EGFR1,ERK,GENOMIC,NSCLC,PROTEIN,RAS,STAT3,TKI
AKT,AMONG,FINALLY,HTD,TAKEN
123,169,ADRIAMYCIN,BACKGROUND,BRITISH,CDC,EGF,FACSCAN,H1299,INSTITUTE,KEY,LABEL,MCL,METHODS,NSCLC,OBJECTIVE,PROTEIN,PURPOSE,RESISTANT,RESULTS,SOCIETY,TYR15,WESTERN
004,082,087,116,261,453,476,564,696,892,929,968,ASIAN,BACKGROUND,CAUCASIAN,CIS,HRS,LABEL,MATERIALS,MET,METHODS,NSCLC,ORS,RESULTS,THESE,THR,THR241MET,XRCC3
K2P,K2P10,K2P12,K2P16,K2P18,POTASSIUM,THEIR,WHILE
101,169,946,ANTIBODIES,ATLAS,BACKGROUND,CALIF,EFFUSIONS,INC,LABEL,METHODS,RESULTS,SANTA,SOCIETY,STOCKHOLM
335,454,COLORECTAL,FORCE,INSTITUTE,INSTITUTES,OVARIAN,PREVENTIVE,SCREENING,TRIAL
169,947,AFTER,ATM,CONSISTENT,CYTOMETRY,DDS,EDU,SER15,SER1981,SOCIETY,THESE,THR68,TK6
34B,945,946,954,COX,ERK,NNK,TOBACCO

0SH,0SHCONTROL,169,916,BASED,CL1,HOWEVER,SEVERAL,VCH,WILEY
169,FOS,INC,JUN,TAKEN,WESTERN,WILEY
089,292,451,ACTIVITIES,AMONG,DAILY,ERLOTINIB,III,INITIAL,NSCLC,THERE
10B,10C,10E,10H,10M,10P,10R,11B,169,181,MKN,PAC,VCH,WILEY
575,945,946,HEK293T,SEX,STIM1,STROMAL,THESE
169,EATON,LAMBERT,THERE
BCG
169,1A2,2A6,ATR,BAX,BRCA1,CASPASE,CYP2A13,CYTOCHROME,HOWEVER,INHIBITION,MRE11,P30,P40,P50,RAD50,RAD51,THESE
169,ACTIVATING,ALK,AUTHORS,BRITAIN,FGFR1,GREAT,IRELAND,JOURNAL,LTD,MEK,MET,NSCLC,PATHOLOGY,RET,SOCIETY,THESE,WILEY
CETUXIMAB,EARLY
CCNB1,EXPRESSION,GEO,GSE3268,MCM,MEANWHILE,OMNIBUS,OTOLOGY,PTTG1,PUBLISHED,RFC
009,169,CALORIC,OVERALL,SIR,SMR,WOMEN
AMP,IGF,METFORMIN,NOTABLY,SUPPORT,THERE
198,SNP,THESE
CONTINUOUS,CUP,INSTITUTE,PROJECT,WORLD
837,BACKGROUND,CGH,CONCLUSION,HOWEVER,LABEL,OBJECTIVE,RESULTS,TMA,VEGFA
100,300,SINCE
CONSISTENT,H2A,INHIBITION,LY2603618,TREATMENT
169,BACKGROUND,EASTERN,FATIGUE,GROUP,LABEL,METHODS,RESULTS,SOCIETY,USING
00001,002,005,ASIAN,CIS,DFS,ELISA,FINALLY,HRS,INITIAL,LATEX
054,057,060,064,100,104,201,230,238,308,BACKGROUND,LABEL,LC1,LC2,METHODS,NSCLC,RESULTS,SIMILAR,TNF
DISEASE,HOWEVER,JAPAN,MALIGNANT,THERE
RESULTS
169,946,954,ECM,H1299,INC,INHIBITING,RHO,THESE,WHILE
169,ACCORDING,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LOCAL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,PFS,RESULTS,THERE,THREE,USING
169,442,AFFYMETRIX,COPYRIGHT,ELISA,H1299,H1437,H1993,H23,INHIBITION,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,PMX,RESULTS,THESE,U133A,WESTERN,WST
169,HOWEVER,THESE
004,111,124,136,169,189,855,883,AUC,BSI,CLEARREAD,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTI,OBJECTIVE,OBJECTIVES,OBSERVERS,OPERATING,RESULTS,ROC
169,231,956,COPYRIGHT,MCF,MDA,SAS,TBAHS,THESE
169,COPYRIGHT,HCT15,MEL,PSA,SALMONELLA,SAS,STRUCTURE
169,176,956,BINDING,COPYRIGHT,DIXON,HUVEC,MTA,SAS,TARGETING
100,754,AUC,BACKGROUND,CONCLUSION,DENSITY,DIAGNOSIS,DISCOVERY,LABEL,LOW,METHODS,NSCLC,PCR,RESULTS,ROC
100,169,CONCURRENT,COPYRIGHT,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THOSE
169,177,215,402,931,963,BECAUSE,COPYRIGHT,CTV,FILLING,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SDS,TCP
169,176,270,956,BRAGG,COPYRIGHT,FIT,FNTDS,INC,LABEL,MATERIALS,METHODS,MEV,OBJECTIVE,PURPOSE,RESULTS,RIF
ALK,COMBINING,SCC,THESE,WHILE
HOWEVER,RANDOMIZED,SCREENING
004,006,038,BACKGROUND,CONCLUSION,E21,KIRSTEN,LABEL,MEANWHILE,METHODS,NSCLC,OBJECTIVE,RESULTS,STMN1,TUBB3
BACKGROUND,BLM,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,PCR,PEPT2,PEPTIDE,PULMONARY,RESULTS,SPRAGUE,THERE
EPIDERMAL,HOWEVER,INTENSE,NOW,NSCLC,THEIR,THERE
004,011,012,030,041,460,466,634,666,832,960,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,ORR,PFS,RESULTS,SUBSEQUENT
BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
AMONG,BACKGROUND,CDD,CONCLUSION,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SUNITINIB,TREATMENT
AMONG,BACKGROUND,CONCLUSION,DIFFERENT,EPIDERMAL,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,TKI
AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESISTANCE,RESULTS,TKI
169,AMONG,COPYRIGHT,DUE,LTD,MBC,NSCLC
160,169,ELISA,HOWEVER,MMP,MT1
801,ACTIVATION,ALTERED,BACKGROUND,CHROMATIN,ERK,EXPRESSION,FOXO1,HEPG2,HLF,HOWEVER,HUH,INDUCTION,KNOCK,LABEL,METHODS,MTT,PCR,RESULTS,THR24,TXNIP,WESTERN
169,INC,WILEY
169,945,A2780,GLUT1,HIF,HOWEVER,OVCAR,THESE,TRANSWELL,WARBURG
BACKGROUND,DIRECTIONS,LABEL,MICRORNAS,RESULTS,SINCE
004,BASED,CRT,ELISA,MAB,PAB,THEREFORE
001,147,149,160,169,208,839,8G7G3,905,IBC,LABEL,LTD,METHODS,NUCLEAR,OBJECTIVE,RESULTS,SPT24,TMA,TTF,WILEY
218,DLCST,MEASURING,SCREENING,SMOKING,TRIAL,USUALLY
945,AZD,CIGARETTE,EGF,FURTHER,MCP,SAE,SIMILARLY,SRC,THESE,TNF
CIGARETTE
AFTER,FIBEROPTIC,IMAGING,PALLIATIVE
239,946,CONSISTENT,EGF,EMT,ERK,MAPK3,MEK,NSCLC,OVERCOMING,TGF,THESE
100,200,ALLERGY,EORTC,FRESH,GROUP,IFD,INFECTIONS,INFECTIOUS,INSTITUTE,MSG,MYCOSES,PCR,TREATMENT
CAVERNOUS,CHOROIDAL,HOWEVER,IMAGING,MELANIN,NEOPLASMS,ORBITAL
CARCINOID,CARCINOIDS,DIFFUSE,DIPNECH,LARGE,LOCAL,THESE

005,017,098,167,169,184,370,427,907,BACKGROUND,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,STATISTICS,USING,WILEY
001,005,015,135,169,APART,BACKGROUND,BEP,CUMULATED,GCC,LABEL,METHODS,OCTOBER,RESULTS,SOCIETY,TREATMENT
HOWEVER,UNDER
600,EXPRESSION,IMP,MYC,SMALL
742,EXHAUSTIVE
169,947
169,BACKGROUND,CONCLUSION,HIV,LABEL,METHODS,PRESENTING,REPORTS,THEREFORE,THESE
206,ALTOGETHER,C2C12,CCND1,TARGETING
000,006,118,133,134,516,865,BACKGROUND,CONCLUSION,HOWEVER,III,LABEL,METASTASIS,METHODS,NSCLC,PCR,RESULTS,THERE,TNM,UNASSIGNED,VIRTUAL
ADDITIONAL,AMONG,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
HAZARDS,IMPAIRMENT,INDUSTRIAL,JAPAN,LAW,ORDINANCE,PREVENTION,SPECIFIED,SUBSTANCES
100,916,CK5,CONCLUSION,FNA,IHC,LABEL,MEDICAL,METHODS,NSCCA,OBJECTIVE,RESULTS,UNIVERSITY,WASHINGTON
160,176,1ST,327,775,880,BACKGROUND,CD4,COX,CUMULATIVE,FACTORS,HIV,HODGKIN,INCIDENCE,JANUARY,LABEL,LATER,MEIER,METHODS,MODIFIABLE,NON,RESULTS,USING
169,FINALLY,LTD,MALIGNANT,PUBLISHED,WILEY
APRIL,BACKGROUND,CHINA,D15S822,D22S689,D2S1363,D6S1056,D7S1824,DEPARTMENT,GENOMIC,LABEL,METHODS,PCR,RESULTS,SICHUAN,SINCE,SURGERY
115,170,300,AFTER,INDIA,KARNATAKA,SEVENTY,SSNTD
001,002,100,145,177,BACKGROUND,DUE,LABEL,MEDICAL,METHODS,RESULTS,RIGID
169,B16,BASED,BSA,HOWEVER,THESE,VCH,WILEY
006,169,490,ALCOHOLIC,HODGKIN,JANUARY,LIVER,SIR
CHECKPOINT,CHEK2,I157T,LOW,MEDICAL,MUTATIONS,STUDIES
001,120,148,169,743,BACKGROUND,BETWEEN,CONCLUSION,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOLID,THOSE,UNIVARIATE,WHILE,WILEY
001,169,211,ANXIETY,AUTHORS,DEPRESSION,LABEL,LTD,METHODS,OBJECTIVE,PREVALENCE,RESPECTIVE,RESULTS,SCALE,STUDIES,WILEY
000,169,AICHI,ALDH2,ASIAN,JAPAN,MULTI,THERE,THESE
III,LARGE,MEDICAL,MEDLINE,METHODS,MPDL3280A,NON,NSCLC,RESULTS,SOCIETY,START,VALIDATING
169,CSLCS,THEREFORE,USING
169,FINALLY,SOCIETY
946,AFTER,AIM,AKT,CHINA,CHINESE,CONCLUSION,DDP,FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,PROFESSOR,RESULTS,WESTERN,WNT
169,BACKGROUND,HOWEVER,LABEL,METHODS,PPS,RESULTS,SOCIETY,T790M,THR790MET,TKI,VARIOUS
000,001,006,160,BEL,FINALLY,HCC,OVERALL,SERPINB,UNIVARIATE
1ST,BUCHMAN,ENGLISH,PERIPHERAL,THESE
215,4TH,ASKIN,BECAUSE,CHEST,MRI
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,UNLABELLED
CONCLUSION,DYSPNEA,LABEL,METHODS,OBJECTIVE,PCU,RESULTS
001,002,ACCORDING,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE
001,004,022,215,472,AGE,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCORE
HCC,HOWEVER,JUN,MYC,TNF
CD3,CIK,CIKIL,FURTHER,GENERATION,HOWEVER
AMONG,MUCOSAL,NKT,THEIR,WHETHER
244,253,EIGENIMAGE,IMAGING,MED,ONCOL,USING,WHILE
169,BACKGROUND,CONCLUSION,ESO,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
169,3LL,945,COPYRIGHT,EPH,EPHA2,INC,THEREFORE,TNF
ACUTE,BASED,CONCLUSION,CTV,FORTY,HEART,LABEL,LAD,MATERIALS,METHODS,OBJECTIVE,PRESCRIBED,PRONE,PTV,PURPOSE,RESULTS,STUDENT,V10,V20,V95
BACKGROUND,EXPRESSION,HOX,HOXA5,INHIBITION,LABEL,METHODS,MTT,NSCLC,PCR,PROTEIN,RESULTS,STUDENT
001,110,300,ABOUT,ADMISSIONS,AEQ,ASIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,OUTCOME,POISSON,POPULATION,RESULTS,RISKS,SETTING,SMALL,SOUTH
169,COPYRIGHT,CROSS,ELEVATION,EVENTHOUGH,LTD,PLD,PUBLISHED,RAS,TGF
001,005,021,169,198,377,4DCTS,653,AUSTRALIAN,BACKGROUND,COLLEGE,COUCH,LABEL,METHODS,MID,RESULTS,ROYAL,ZEALAND
177,5TH,8TH,AFTER,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,STENT,THERE
169,BACKGROUND,COLLEGE,CONCLUSION,LABEL,METHODS,PULMONARY,RESULTS,ROYAL,SEVENTY,SURGERY,THREE
169,916,968,ACTIVATION,BAX,BCL,CONCLUSION,ERK,FINALLY,FIRST,INHIBITION,KEY,LABEL,LC3,MET,METHODS,OBJECTIVE,RESULTS,ROYAL,SOCIETY,SUBSEQUENT,VAD
HNO,NSAID,STRUCTURAL
584,CONCLUSION,EASTERN,ELDERLY,GROUP,LABEL,METASTATIC,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,XELOX

200,350,945,HIF,HYPOXIA,P3971,STAT3
AFTER,MBS,PCR
486,CURRENT,EBC,MICRORNAS,NSCLC,THERE,WESTERN
169,945,954,BACKGROUND,BAX,BCL,BID,BIS,BRITISH,COX,FURTHER,KEY,LABEL,METHODS,MMP10,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SOCIETY,THESE,TNF

AGAIN,DEFICIENCY,NCS,THESE
MINIMAL

945,946,COX,HIF,HOWEVER,MET,P53,TGF,THEIR,THEREFORE,TNF
THESE
001,150,AES,CONCLUSION,III,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SEVEN
002,004,137,CONCLUSION,CONVERSELY,COPRIMARY,IHC,INCIDENCE,INCREASED,ITT,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,THESE
ALK,DESPITE,NSCLC,THESE,TKI
053,128,961,COX,FOLLOWING,G10398A,HOWEVER,NON,NSCLC,PCR,ROS,WARBURG
384,DECREASED,MTT,SNP,THESE,TRANSWELL,WESTERN
946,HOWEVER,IHC,JCV,K19,PULMONARY,THESE,USING
003,016,019,150,178,300,525,CURRENT,DOSES,FORTY,INTRA,MTD,TTP
CD133,HOWEVER,METFORMIN,TARGETING
BLOOD,CRC,HOWEVER,PCA,PLSDA,THREE
ALK,EXPRESSION,IGG,IMT,IPT,SINCE,SMA
A2058,AMONG,CONSISTENT,JAK,JANUS,MCL,MLS,MYC,SRC,STAT3,TAKEN
AKT,ERK,GEP,HSP,HSP70,HSP90,IGF,INHIBITION,NCI,THESE,TREATMENT
100,169,COPYRIGHT,EIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
169,238,COPYRIGHT,GTV,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MDE,METHODS,OBJECTIVE,PURPOSE,RESULTS
105,169,357,AUTHORS,BACKGROUND,COPYRIGHT,III,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,PUBLISHED,RESULTS
ATS,ERS,FLEISCHNER,HOWEVER,IASLC,PULMONARY,SOCIETY
100,160,169,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GENERAL,GGO,HOWEVER,JANUARY,LABEL,METHODS,PUBLISHED,RESULTS,SURGERY,THERE
169,ABCB9,COPYRIGHT,DDP,HOWEVER,IRELAND,LTD,NOTABLY,NSCLC,UTR
169,BAX,COH,COPYRIGHT,GST,HENCE,INC,MAP,SR4,TREATMENT,WESTERN
169,92B,COPYRIGHT,FEWER,INC,MICRORNAS,NSCLC,PCR,THESE

001,002,008,123,124,136,181,200,247,369,7TH,ACS,AGE,COX,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SURG1,SURG2,SURG3,SURG4,SURGERY,THERE,TNM,UNITS
169,467,904,COPYRIGHT,FORTY,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,AMONG,BACKGROUND,COPYRIGHT,DISEASE,IIA,IIB,IRELAND,LABEL,LTD,MATERIALS,METHODS,NEITHER,RESULTS,SEVENTY,SMOKERS,TEN
MATSUSAKA,PRIMARY
FOXP3,HOWEVER,IDO,LEWIS,LLC,THREE,TREGS
AUSTRALIA,COMMITTEE,DRUGS,FIRST,NSCLC
160,169,COPYRIGHT,HEPATOCYTE,HGF,MET,MMP,NK1,NK2,NK3,NK4,PUBLISHED,RESULTS
BACKGROUND,BISULFITE,EXPRESSION,HOECHST,HOWEVER,LABEL,METHODS,MTT,NSCLC,PCR,PROTEIN,RESULTS,STUDENT
DOCETAXEL,HOWEVER,OWING
CHINESE,HAN,HOWEVER,IBS,LKM,MAF,PCA,SIMULATION,SNP
AGE,ASR,BACKGROUND,HBV,HEPATITIS,HIV,HODGKIN,HOWEVER,HPV,INCIDENCE,LABEL,METHODS,NCR,NHL,RATES,RESULTS,SAHARAN,SIMILARLY
223,946,COX,EMT,EP1,EP4,EXOGENOUS,TGF,THESE,TREATMENT
2578C,571,664,BACKGROUND,CIS,CONCLUSION,CRUDE,LABEL,METHODS,OBJECTIVE,ORS,RESULTS,SCC
131,AHASA,BACKGROUND,BECAUSE,CONCLUSION,CONTEXT,DTC,LABEL,OBJECTIVE,PEDIATRIC,RAI,RESULTS
009,025,169,221,265,320,541,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS,SCC,TNM,TTF
169,CSB
ATP,USING,WASHING
131,947,AFTER,DISTANT,INF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TES,THREE
FOLLICULAR,FTC,PTC
FDG,PET
STUDIES
001,163,CASES,LABEL,LESSONS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY
507,956,AIM,CONCLUSION,ELISA,ERLOTINIB,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SPC,THERE,WESTERN
CROSS,EYA4S,NSCLC,TSG
10A,231,252,945,954,ECTOPIC,EPITHELIAL,MCF,MDA,THESE,USING,VCP
BCL,CL1,ERK,H23,MEK,NSCLC,PXN,RAF,SRC,THEREFORE,Y31
221,249,3N0M0,823,DUE,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,DOCETAXEL,PUBLISHED,SPECIALIST
169,AMONG,BACKGROUND,CSE,HBE,HSP70,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PERIPHERAL,RESULTS
177,AMONG,ASSESSMENT,BACKGROUND,COLLECTED,DAS28,DISEASE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCORE,SYSTEMATIC
169,ASA,COX,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SETTING,UNIVARIATE
169,181,215,231,500,ASTERACEAE,BACKGROUND,BENTH,CONCLUSION,FURTHER,IRELAND,LABEL,LTD,MATERIALS,MCF,MDA,METHODS,MIA,RELEVANCE,RESULTS,WST
100,169,241,COPYRIGHT,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,THERE
169,AMONG,COPYRIGHT,HEPG2,MCF,SAS
169,33258,945,COPYRIGHT,DHA,HEPG2,HOECHST,MTT,NCI,SAS,SKOV3,THEIR,TUNEL
169,BACKGROUND,BASED,CHEST,EICHINGER,HELBICH,HRCTS,ICC,INTRACLASS,LABEL,METHODS,MRI,REGARDING,RESULTS
169,956,BASED,COPYRIGHT,KNOWN,LIBRARY,LTD,NSCLC,PC9,T790M
043,160,169,177,ATO,COPYRIGHT,GDC,GLI,LABEL,METHODS,MPM,MTT,OBJECTIVE,RESULTS,SELECTIVE,SMO,SURGERY,THESE
021,119,125,169,COPYRIGHT,HGF,HOWEVER,IRELAND,LTD,MET,MPP,PHOSPHO,SCI,STAGE,THESE
169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,NAIDS,PUBLISHED,SAS,STILL
001,131,169,173,177,COPYRIGHT,HISTOLOGY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,REGARDING,RESULTS
169,176,BACKGROUND,CONCLUSION,COPYRIGHT,DIGITAL,DTS,GTV,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,609,BACKGROUND,BASIC,CAMBRIDGE,CARDIFF,CONCLUSION,COPYRIGHT,GLASGOW,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SHEFFIELD,THESE
169,7TH,AFTER,AIM,BACKGROUND,BLOOD,CONCLUSION,FVIIA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SAMPLES,TFA,VTE
169,COPYRIGHT,CRT,EIGHT,INC,MEDICAL,NSCLC,OAR,PUBLISHED,QUALITY,VMATH
001,002,005,021,032,062,160,169,785,ADENOID,APRIL,BACKGROUND,BRONCHIAL,CHEST,COPYRIGHT,COX,INC,LABEL,MARCH,MEIER,METHODS,PRIMARY,PUBLISHED,RESULTS,SOCIETY
007,169,204,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,REDUCED,RESULTS,SOCIETY
001,159,169,967,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,NSCLC,OPN,PUBLISHED,RESULTS,SOCIETY
160,169,215,BACKGROUND,CD3,COPYRIGHT,DESPITE,FIFTEEN,INC,INFUSIONS,LABEL,METHODS,NATURAL,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,THERAPY,THREE
169,488,635,COPYRIGHT,CY5,FAM,LIF,MICRORNAS,THESE
169,AUTHORS,COPYRIGHT,HOWEVER,IRELAND,LTD,NSCLC,PUBLISHED
086,169,255,336,956,AMONG,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,LVI,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SVI
169,956,AFTER,CYTOMETRY,FCM,HOWEVER,SLN,TEM
169,176,AMF,FE3O4,FOURIER,PEG
002,177,99M,CONCLUSION,DIAGNOSIS,LABEL,METHODS,RESULTS,SPECT,UNLABELLED
AMONG,BACKGROUND,CHROMATIN,FGA,FGB,FGG,FOXA1,FOXA2,FURTHER,LABEL,RESULTS,SEQ,SEVERAL,SNAIL
BAC,CONGENITAL
DIFFERENT,HYDROXY,MTT,P85,TEM
126,186,HACAT,MALIGNANT
30S,NCI,NSCLC,ROS,WHILE
HOWEVER

027,323,584,816,AMONG,BACKGROUND,COX,HOWEVER,IIP,LABEL,METHODS,RESULTS
001,133,209,636,903,945,946,957,AKT,BACKGROUND,HNSCC,IGF,III,INCREASED,LABEL,METHODS,NSCLC,RESULTS,SEVERAL,SRC,STUDENT,TARGETING,WESTERN
ADT,COLORECTAL,ERSPC,MAJOR,OVARIAN,PSA,RANDOMIZED,SCREENING,THESE
169,945,946,947,DSB,EGF,HOWEVER,SHORT,STUDIES,THESE,TKI
169,AUTHORS,EMT,FXS,HOWEVER,LTD,PUBLISHED,THERE,WILEY
009,014,031,309,310,CHINA,CURRENT,HAN,OVERALL,SNP
157,ACCORDING,ACS,AFTER,COX,DEPARTMENT,ITALY,JANUARY,LABEL,LCNCS,METHODS,NET,OBJECTIVE,OBJECTIVES,OLDER,RESULTS,SCLCS,SURGERY,TCS,TURIN
100,104,532,946,CRC,GROUP,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,THESE,VARIABLES,VIDEO
168,AMBER,OVERALL

NEWLY,PCA
CHEMISTRY,GFP,H2B,NOBEL,NUCLEAR,PRIZE,RES,RFP
METASTATIC,THERE

024,037,047,11P15,12Q23,160,16Q22,967,COMMITTEE,FAL,FRACTIONAL,III,JOINT,KRUSKAL,LOH,MSI,NSCLC,STAGING,THESE,TOTAL
115,124,386,COLORECTAL,COX,DIETARY,FURTHER,HOWEVER,OVARIAN,SCREENING,THESE,TRIAL
101,163,350,679,771,AMONG,CONCURRENT,HOWEVER,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,THERE,THREE
160,175,DESPITE,ENGAGEMENT,IMPORTANT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,217,CHINA,CHINESE,DEPRESSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
ALK,AP26113,CH5424802,HOWEVER,III,NSCLC,SEVERAL
001,316,AMONG,BACKGROUND,END,GUIDELINE,GUIDELINES,LABEL,METHODS,RESULTS,TEXAS
1ST,3RD,ACCORDING,BACKGROUND,BETWEEN,C30,CONCLUSION,EORTC,LABEL,METHODS,QLQ,QOL,RESULTS,THESE
307,BACKGROUND,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,TIMELINESS
AALDH,FURTHER,INHIBITION,LIMITED,NOTCH,TIC
BASED,DESPITE,IFOSFAMIDE,SERUM
BECAUSE,CSF,GIVEN,IRF,MDSCS,MYELOID,OVERALL,STAT3,STAT5
169,CIP,COLLECTED,CONCLUSION,COPYRIGHT,EIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREGNANCY,RESULTS
001,004,027,169,CELLSEARCH,COPYRIGHT,CSF,DEB,DETECTION,GRADE,LABEL,LTD,MBC,METHODS,OBJECTIVE,ORR,PRIMARY,PURPOSE,RESULTS,THERE,UNASSIGNED,WOMEN
ALCAM,ASCL1,ATP,CD151,CD166,CXCR4,FGFRS,GLUT1,GPCRS,IGF1R,INC,MYC,NANOG,PHASE,PUBLISHED,RECURRENT,RTK,SEVERAL
169,947,AFLATOXIN,BAX,BCL,COPYRIGHT,FAS,HOWEVER,JNK,LTD,NAC,PRE,ROS
142,183,227,789,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
003,016,095,169,238,427,430,BACKGROUND,COPYRIGHT,DATABASES,INC,INPATIENT,LABEL,METHODS,PUBLISHED,RESULTS,ROBOTIC,SID,SOCIETY,STATE,USING
001,169,177,BACKGROUND,COMPONENT,COPYRIGHT,DIRECTORS,FOCUSED,GIVEN,IMMEDIATE,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
500,BACKGROUND,DISCUSSION,EASTERN,ENROLMENT,GROUP,LABEL,LITERATURE,METHODS,TRIAL
FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
DUE,DVF,FDK,IMAGE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMEIR
177,ARTIFACTS,DSC,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,REDUCTION,RESULTS,SPECT
176,177,DYNAMIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
003,110,113,146,215,372,541,564,741,837,BLOCKED,CARLO,HIP,LABEL,METHODS,MONTE,OBJECTIVE,ORGAN,PURPOSE,RESULTS
AFTER,BACKGROUND,DESPITE,DIL,DU145,FURTHER,HOWEVER,INDIVIDUAL,LABEL,LNCAP,METHODS,RESULTS,SW620,USING,WASF3
945,GATA4,GATA6,SCC,SP1
000,100,124,133,149,169,259,392,542,746,759,ABC,AGE,BACKGROUND,COLORECTAL,CONCLUSION,COX,EFFECTIVE,LABEL,METHODS,NOMOGRAMS,OVARIAN,RESULTS,USING
BACKGROUND,CANDIDATE,CONCLUSION,DTC,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,SERUM
MDP,SPECT
AFTER,CLOSURE,FGCCP,SANJO,SAPPORO,THERE,THREE,THROUGH
126,16403,AES,BETWEEN,CENTRAL,CONCLUSION,GENERALLY,GROUP,HOWEVER,JANUARY,JAPAN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURGERY,TOTAL

GENERALLY,NLH,SLT
ADDITIONAL,AFTER,THERE
60400,CRP,MALIGNANT,WBC
001,114,160,191,CONCLUSION,GGO,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
215,6TH,CHEST,GROUP,S4B,T1AN0M0
CD4,HOWEVER,MDSCS,SHP,SIMILARLY,SRC
AFFILIATED,BACKGROUND,COX,DUE,FIRST,HENAN,JANUARY,LABEL,LOG,MEIER,METHODS,PSC,PULMONARY,RESULTS,THERE,TNM,UNIVERSITY,ZHENGZHOU
169,BECAUSE,COPYRIGHT,INC,PUBLISHED,SOCIETY
160,169,BRONCHIAL,BSF,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,CARDIAC,COPYRIGHT,INC,PUBLISHED,SOCIETY,THESE
060,177,272,331,729,BACKGROUND,LABEL,MAY,METHODS,RESULTS
ALK,AREAS,BACKGROUND,COVERED,DESPITE,FURTHER,HOWEVER,LABEL,METHODS,NON,NSCLC,OPINION
CLINICALLY,COPYRIGHT,EPIDERMAL,HNSCC,HOWEVER,LUX,NSCLC,PROUS,SCIENCE,T790M,TKI
CTS,FDG,HOWEVER,ICT,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
001,009,014,019,027,035,048,ASIAN,BACKGROUND,CAUCASIAN,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,THESE
001,053,081,108,233,234,581,591,678,702,727,735,750,AMONG,CONCLUSION,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS
EXOME,HOWEVER,NGS,SEQ,USING
AMP,JEGHERS,PEUTZ,STK11
160,970,BACKGROUND,CONCLUSION,HOWEVER,ISI,LABEL,METHODS,MSP,NSCLC,POTENTIAL,RESULTS,SCIENCE,WEB
103,169,19DEL,APRIL,CONCLUSION,COX,EVALUATION,L858R,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SMALLER,SOLID,TKI
2HEXNAC,ALEURIA,ELISA,HLE,IGG,INCREASED,LEWIS,SCLCS,SMALL,WESTERN
105,720,946,CONSISTENT,CURRENT,EXPRESSION,KNOCKDOWN
945,954,AKT,APO10LA,C57BL,HCC,HFD,NAD,OBESITY,SIRT1,STAT3,TAKEN,TNF
CONCLUSION,FDG,FINALLY,GLG,III,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RADIATION,RESULTS,SUVMEAN
106,116,271,706,BANGLADESH,CHAIN,INDIVIDUAL,POLYMERASE,THEREFORE
008,013,022,220,284,ASIAN,CBM,CIS,CYS,DESPITE,MEDLINE,ORS,SER,SER326CYS,THESE
115,160,211,491,832,918,939,952,AUC,CEA,CYFRA,LABEL,METHODS,MODEL,MPE,NSE,OBJECTIVE,PURPOSE,RESULTS,TPS
FMK,HOWEVER,MEA,METASTASIS,RSK,TAKEN,THEREFORE
341,514,945,946,954,AKT,COX,FMK,GSK,HOWEVER,IKK,MG132,PIS,PROTEASOME,S9A,THEIR,TREATMENT
MCF,NTP,NUCLEOSIDE,PPASE
AREAS,BACKGROUND,COVERED,LABEL,METHODS,OPINION,TODAY
AKT,HOWEVER,THESE
BASED,NNK,SERUM,THESE
205,HOWEVER,LUCIFERASE,NON,NSCLC,PCR,UTR
CHROMATIN,FDA,HDACI,HISTONE,IDIOPATHIC,III,IPF,PCR,WESTERN
018,160,169,AGGRESSIVE,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,HIPEC,INC,LABEL,LIVER,METHODS,MORTALITY,MOSBY,NET,OBJECTIVE,OVERALL,RESULTS
PCA
165,288,AB1,AB2,AIM,CONCLUSION,ELISA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CONVERSELY,CURRENTLY,LABEL,MALIGNANT,METHODS,MMP14,MPM,PCR,RESULTS
001,033,034,181,450,945,946,BACKGROUND,BRAIN,EXPRESSION,KRUSKAL,LABEL,METHODS,RESULTS,THERE,THREE
169,AFTER,COPYRIGHT,GROWING,HOWEVER,IRELAND,LNCRNAS,LTD,SILENCING,THESE
001,169,BACKGROUND,COPYRIGHT,CTS,DETECTION,GGN,INC,LABEL,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SCREENING,SOCIETY,THERE,THREE,TRIAL
100,169,19K,200,956,ALP,ALT,AST,BESIDES,COLLEGE,COPYRIGHT,FILGRASTIM,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
000,002,003,004,006,010,013,023,033,050,074,076,082,095,096,101,109,174,212,229,270,285,323,382,460,500,518,535,596,697,712,755,795,824,838,841,936,942,948,949,ASP312ASN,CAUCASIANS,CIS,ERCC2,ORS,THEREFORE
CLEAR
BACKGROUND,CHINA,CONCLUSION,GREEN,H2DCFDA,LABEL,METHODS,RED,RESULTS,TRACKER,WESTERN
094,116,177,946,ALPINIA,BACKGROUND,CIOCALTEU,FOLIN,HCT,LABEL,METHODS,MRC,RESULTS,SKI,SOD
100,945,956,A2058,CAT,CL1,SIMILAR,THESE
APART,OTHER
CRL4A,FBXW5,FINALLY,GTP,NSCLC
239,CHEMO,CISPLATIN,CREATININE,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,TEN
000,001,004,143,237,444,450,CONCLUSION,CPG,HOXA9,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PCDHGB6,PURPOSE,RESULTS,RFS
112,210,967,BACKGROUND,LABEL,MEIER,METHODS,OVERALL,PEARSON,RESULTS,WHETHER
ARF,HOWEVER,INK4A,TAKEN
000,005,102,18FDG,273,BACKGROUND,CONCLUSION,DOR,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,SUMMARY
EJ1,ERBB1,ERBB2,ERBB3,FINALLY,OVERALL,TREATMENT,WHILE
169,BASEL,COPYRIGHT
102,301,352,398,775,797,843,ADVERSE,BACKGROUND,COU,CYP17,HRS,LABEL,METHODS,ORR,PSA,RESULTS,TREATMENT
036,151,169,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,FACTORS,LABEL,METHODS,RESULTS,SMOKERS,SMOKING
BECAUSE,HAART,HIV,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE,SIMILAR
169,HDACI,VPA
EXPRESSION,FURTHER,INSULIN,THERE
063,335,COX,LABEL,METHODS,N2A,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESECTION,RESULTS,SINCE,TNM
003,169,AFFAIRS,AMONG,CLINICIANS,COLLEGE,COPYRIGHT,COX,DEPRESSION,ICD,III,INCREASED,LABEL,MATERIALS,METHODS,NETWORK,NORTHWEST,NSCLC,OBJECTIVE,RESULTS,ROYAL,THERE
HOWEVER,SCREENING,TRIAL,UNTIL
100,169,BECAUSE,COPYRIGHT,HPD,PUBLISHED
ASIAN,BACKGROUND,CONCLUSION,LABEL,METHODS,NODULAR,PULMONARY,SUBSEQUENT
ALK,BACKGROUND,HOWEVER,LABEL,MARCH,METHODS,NOS,NSCLC,RESULTS,SAMPLES
BACKGROUND,CAARRAY,CONCLUSION,DNMT2,EPIGENETIC,GEO,HDAC4,HIGHEST,LABEL,METHODS,RESULTS,SIGNATURES,SIRT1,TGF,USING
946,CDS,DOX,MOLECULAR,MTT
III,PPB
169,CTL,EGF,EXPRESSION,LABEL,THESE,UNLABELLED
169,239,FDA,LABEL,SMALL,THESE,UNLABELLED
BACKGROUND,COLLECTING,HOWEVER,LABEL,METHODS,MOTIVATION,RESULTS,THESE,USING,WEB
169,BACKGROUND,CONCLUSION,FOUNDATION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL
104,ARF,ASAP3,GTP,INCREASED,LTE,NSCLC,THESE,TNM,WESTERN
CONCLUSION,DIR,FINALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
132,139,271,BRONCHIAL,CERTAIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PPL,RESULTS,TBB
320,842,CIS,NORWEGIAN,PAF,POISSON,RRS
AFTER,BACKGROUND,CONCLUSION,DRUGS,LABEL,MONITORING,NON,PROMISING,RATIONALE,STEROIDAL
005,008,019,153,232,247,265,312,99M,ACCORDING,CONCLUSION,EDTMP,LABEL,LBM,MDP,METHODS,OBJECTIVE,PATIENT,PLT,PURPOSE,RESULTS,ROC,USING,WBC
016,080,113,BACKGROUND,COX,ICU,LABEL,METHODS,PRIMARY,RESULTS,SECONDARY,SEVEN
EARLY,FIFTY,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS
106,ADVERSE,BACKGROUND,BETWEEN,COX,GRADE,LABEL,LOCAL,MEIER,METHODS,NSCLC,RESULTS,V30
100,121,135,BACKGROUND,CONCLUSION,FGFR1,FIBROBLAST,LABEL,LIMITED,METHODS,RESULTS,SIMILARLY,SQCCS,USING
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,STK11
BACKGROUND,DENMARK,EUS,FNA,HOWEVER,LABEL,METHODS,RESULTS
AVAPERL,BACKGROUND,DESPITE,EXCEPTIONS,HRQOL,III,LABEL,METHODS,PATIENT,QUALITY,RESULTS,TREATMENT
000,169,673,AZD,BMN,ELISA,INHIBITION,LABEL,METHODS,OBJECTIVE,PAR,PARP1,PROTEIN,PURPOSE,RESULTS,SMALL,THESE
002,003,006,010,168,169,199,200,259,317,860,875,885,902,933,AKT,COX,FRAP1,HRS,LABEL,MEIER,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SNP
946,ABS,JNK,JUN,MMP,SMAD1,SMAD2,TGF,THERE,TRACON105
945,954,DISRUPTION,THEREFORE,TSC
100,BLACK,HMB,INDEX,LABELLING,MELANOTIC,MRI,SIX
HOWEVER,PET
570,95C,95D,BESIDES,DEG,EGR,HOWEVER,METASTASIS
105,120,140,160,D99,DIFFERENT,GEOMETRIC,GYE,NON,THESE
004,SPAIN,SPANISH,SURVEYS
177,HOWEVER,THESE
100,AMONG,CHRONIC,CMV,FEW
169,BASED,HOWEVER,SEVERAL,SILTUXIMAB
000,169,DESPITE,HOWEVER
947,ANTITUMOR,BIOMARKERS,INC,NOTCH,PUBLISHED
107,169,177,BOOST,CONCERNING,COPYRIGHT,D95,GAI,LABEL,LTD,MATERIALS,METHODS,MUS,OBJECTIVE,PLANS,PTV,PUBLISHED,PURPOSE,RESULTS,TEN,V10,V18,V20,V30
002,003,169,421,708,ADULT,COPYRIGHT,INC,LABEL,MEIER,METHODS,OBJECTIVE,RECURSIVE,RESULTS,RPA,THESE
169,ASIC1,CANCEROUS,COPYRIGHT,FINALLY,IRELAND,KNOWLEDGE,LTD,NGF,TRPV1
169,HOWEVER,MICRORNAS,VIRAL
169,225,956,BMDL0,CENTRAL,COPYRIGHT,ESTIMATED,HUNGARY,LTD,THREE,WATER
169,IMPORTANT,INC,LASSO,MOTIVATED
183,239,250,AFTER,AUC,NSCLC,ORR,PFS
001,10172,160,169,229,ACUTE,AMONG,BACKGROUND,COPYRIGHT,INC,INSTITUTES,ISP,LABEL,METHODS,NORSTROKE,NORWEGIAN,ORG,PUBLISHED,RESULTS,SCALE,TREATMENT,TRIAL
142,154,169,231,COPYRIGHT,CUSUM,FAILURE,INC,INDIVIDUAL,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PREVALENCE,PUBLISHED,RAPID,RESULTS,SURGERY
160,169,COPYRIGHT,INC,LABEL,MARCH,METHODS,MOSBY,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SURGERY
169,CCAML,CONCLUSION,COPYRIGHT,III,LABEL,METHODS,MOLECULAR,OBJECTIVE,PUBLISHED,TSC
169,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,RESULTS
169,ALK,COPYRIGHT,IRELAND,LTD
169,ARB,BACKGROUND,BBS,CCB,COPYRIGHT,COX,HOWEVER,LABEL,LTD,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,PROGRAM,PROVINCIAL,PUBLISHED,RESULTS,TDS,THERE
105,147,169,210,293,945,946,CONCLUSION,COPYRIGHT,EQD,GY3,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRESCRIBED,PURPOSE,RESULTS,SEVENTY
169,177,BECAUSE,CHANGES,COPYRIGHT,DVH,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,171,ACUTE,AET,BACKGROUND,CIS,COPYRIGHT,COX,EORTC,EQUIVALENT,EUD,IRELAND,KUTCHER,LABEL,LKB,LTD,LYMAN,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,V76
169,174,177,34G,ABCG2,ATP,CAUCASIANS,CHINA,CHINESE,COPYRIGHT,SAS,UHPLC,XINZE
169,215,AFTER,COPYRIGHT,PERIPHERAL,SAS
169,757,CONCLUSION,EVALUATION,FURTHER,INT,JUN,KEY,LABEL,MAHALIK,MATERIALS,MEDLINE,METHODS,MULLICK,NARASIMHAN,OBJECTIVE,OCT,OVERALL,PEDIATR,PURPOSE,RAO,RATAN,RESULTS,SODHI
016,063,100,120,169,CAD,COMBINING,COPYRIGHT,HIGHEST,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
009,021,029,034,036,116,136,208,228,967,BESIDES,CONCLUSION,FUDAN,HUADONG,LABEL,METHODS,OBJECTIVE,RESULTS,TAM,UNIVERSITY
105,111,169,2ND,616,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MODEL,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,VERISTRAT
169,BASED,HOWEVER,HPV,INC,INFECTION
AREAS,BACKGROUND,BECAUSE,COVERED,LABEL,METHODS,OPINION,SELECTINS
160,169,258,383,606,777,ABOUT,ACCORDING,AMONG,CONCLUSION,FDI,FEDERATION,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RAJASTHAN,RESULTS,RISKS,UNLABELLED,WORLD
HOWEVER,JANUARY,MARCH,MAY,RCC
946,ACTIVIN,BACKGROUND,CD133,CD9,FGFR2,HONE1,IL6ST,LABEL,NANOG,RB1,RESULTS,SIGNALING,SLMT1,TGF,THERE,USING,WNT
12P,AVASTIN,BACKGROUND,KLH,LABEL,RESULTS,VEGFR
854,9G8,ALY,ASF,FURTHER,HOWEVER,PROTEIN,REF,SF2,SRSF3,UAP56,USING
20S,PULMONARY
000,AUTOSOMAL,BECAUSE,E8SJM,GIVEN,LABEL,LDLRAP1,MENDELIAN,OBJECTIVE,RESULTS
007,140,662,BRAZILIAN,CAUCASIANS,GSTT1,HOWEVER,LIBRARY,THERE
B16,CIN85,HOWEVER
108,BPE,CEA,ELISA,MPE,PLEURAL
946,DESPITE,EMT,MODULATION,PCBP1,TGF,THESE
ECM,MMP,OPIOIDS
106,111,160,194,306,308,349,351,AFTER,AMONG,CEA,ELEVATION,JANUARY
DENOSUMAB,GIANT,RANKL
001,945,946,CD3,CONCLUSION,III,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PBMCS,PERIPHERAL,PURPOSE,RESULTS,TIP,TNF
AFTER,CONCLUSION,EPIDERMAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEVENTY,THERE,TKI
170,528,ADL,DIAGNOSIS,DPC,LABEL,MARCH,METHODS,OBJECTIVE,PROCEDURE,RESULTS
AIM,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,NEWLY,OBJECTIVE,PRIOR,RESULTS,THREE
273,808,CONTRARILY,IMMUNOCRIT
956,AKT,CALU1,CALU3,COA,ERK,GEFITINIB,HMG,NSCLC,RAF,SIMILAR,THEREFORE,THESE
LOW,OTHER,SCREENING,TRIAL
169,945,946,947,BCMO1,COPYRIGHT,INC,RXR,THESE
131,148,149,152,169,CURRENTLY,IHC,RAF,THERE,V600E,VE1
BESIDES
143,169,949,COPYRIGHT,FEDERATION,NON,NSCLC,PKC,PUBLISHED,SOCIETIES,TREATMENT,UTR
169,CURRENT,INC,MOSBY
001,038,044,109,134,169,283,501,CONCLUSION,COPYRIGHT,COX,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,ALK,COPYRIGHT,CURRENTLY,ELDERLY,GIVEN,INC,NON,NSCLC
169,70YEARS,ASSESSMENT,BSA,CGA,CONCLUSION,COPYRIGHT,COX,DESPITE,ECP,GDS,GERIATRIC,INC,INDEX,LABEL,MATERIALS,METHODS,MPI,OBJECTIVE,PROGNOSTIC,PROGRAM,RESULTS,ROC
13Q,13Q14,162,169,COPYRIGHT,GLEASON,HOWEVER,INC,OLFM4,PATHOLOGY,PUBLISHED,SOCIETY
106,269,708,ABOUT,COX,DISCUSSION,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PRIMARY,RCC,RESULTS,RPA,STUDENT,THESE
001,002,003,045,102,BACKGROUND,CONCLUSION,EXPRESSION,KPNA2,LABEL,METHODS,NSCLC,RESULTS,SMALL,TNM
AKT,GNA,ISO,RHO
003,005,008,012,047,064,143,179,213,283,293,343,416,457,505,859,898,983,ABSTRACTS,ASSESSMENT,BACKGROUND,BETWEEN,CENTRAL,CITATIONS,CONCLUSION,CONFERENCE,CONTROLLED,CURRENT,EED,EFFECTS,EVALUATION,FUNDING,GLEASON,HTA,INDEX,INDEXED,INSTITUTE,LABEL,MEDLINE,METHODS,MRI,NETWORK,NHS,NON,OBJECTIVE,OBJECTIVES,OTHER,OVERALL,PORTFOLIO,PROCESS,PROGRAMME,RESULTS,REVIEWS,SCC,SCIENCE,SERVICE,SEVENTEEN,SEVERAL,SOURCES,SYSTEMATIC,TECHNOLOGY,THERE,TYPES,UKCRN,WEB
002,006,016,140,231,409,491,523,708,895,ADULT,DISCUSSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
20S,21S,945,C21,HOWEVER,LACTONE
946,ACCORDING,BACKGROUND,CK5,E12,LABEL,METHODS,RESULTS,SEVERAL,SQCCS,TTF
082,161,525,835,988,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TOTAL
181,946,EMT,SEVERAL,TAKEN,TGF,THESE,WITHAFERIN,WRE
001,038,128,160,164,172,177,219,261,388,BACKGROUND,BLOOD,III,LABEL,PRINCIPAL,RESULTS
4T1,947,CD8,CONTROL,CTL,IFN,MMC,TRF
217,ATM,CAUCASIANS
260,ENDOTHELIN,IIB,POCCS,PULMONARY
116,CONCLUSION,CSF,GABAB,GAD65,LABEL,METHODS,NMDAR,OBJECTIVE,OMS,RESULTS,SERUM,SEVENTEEN,SMALL,TREATMENT
APOPTOSIS,HOWEVER,INHIBITION,KNOCKDOWN,OVERALL,SER15,SIMILAR
169,215,900,CBV,CONCLUSION,COPYRIGHT,DSC,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGIONS,RESULTS,WILEY
956,AZD6244,BIM,EPIDERMAL,ERK,H1650,H1975,MEK,NSCLC,PC9,RAF,TKI
BESIDES,CIS,HOWEVER,ORS,VDR
RPA,TEN
ANOTHER,LABEL,METHODS,NON,OBJECTIVE,RESULTS,SEVEN,WHITE
167,170,369,674,CHINA,CONTROL,EFFECTS,INCREASED,JOINT,OVERALL,STUDIES,ZEALAND
209,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAULO,PUBLICO,RESULTS,SAO
921,923,924,995,EDITORS,GEBEL,MORFELD,TOXICOL
EIGHT,HOWEVER,JANUARY,LABEL,LIBRARY,MAY,MEDLINE,METHODS,NSCLC,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESULTS,THERE
B55,H1299
002,004,007,009,012,036,FURTHER,IPF,NSCLC,PCR,TELOMERASE
028,956,AKT,BIM,DISRUPTION,LNCAP,THESE,TRAMP
BACKGROUND,CHEST,GIVEN,LABEL,METHODS,SINCE
2O2,BASED,DESPITE
100,160,169,BACKGROUND,COPYRIGHT,DETECTION,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE
2013A,39000
010,732,983,AUC,BIOMEDICAL,CENTRAL,CHINA,CHINESE,CONTROLLED,DIAGNOSTIC,DOR,HOWEVER,LITERATURE,MED,MEDLINE,NLR,NON,NSCLC,PLR,PUB,SCIENTIFIC,SEN,SPE,STUDIES
BETWEEN,ESOPHAGEAL,III,NSCLC,PFS
HOWEVER,TGI,THEIR
696,CRYOBIOPSY,FORCEPS,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,UNLABELLED
BOLTZMANN,CARLO,EXTENSIVE,MONTE
CD11B,GRI,HOWEVER,LPS,MDSCS,MYD88,THESE,TLR
000,130,BIOLOGISTS,JAVASCRIPT,JSP,MYSQL,PHYSICIANS,THEREFORE,VALIDATION
144,BACKGROUND,FINALLY,FINDING,FURTHER,LABEL,METHODS,NON,NSCLC,PRINCIPAL,RELATED,RESULTS,ZFX
001,004,009,012,256,ATM,LABEL,METHODS,NSCLC,NUCLEAR,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
HOWEVER,LEWIS,LLC,THESE,VASH1,VASOHIBIN
169,AKT,EGF,HOWEVER,LABEL,MINIMAL,NSCLC,T790M,THESE,UNLABELLED
00388,AUSTRALIA,PRICE,SOUTHEAST,THEIR,THESE
002,006,072,BMI,CONCLUSION,DESPITE,LABEL,METHODS,NLR,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERUM,SIR,THESE,TLR,WHILE
AMONG,CONCLUSION,HOWEVER,LABEL,METHODS,METOHIA,OBJECTIVE,POISSON,PURPOSE,RESULTS,TREND
1980S,1990S,NSCLC
210,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,THESE
001,003,BACKGROUND,COX,HCT,LABEL,LRD,METHODS,RESULTS,RSV,TREATMENT
APRIL,COLORED,HOWEVER,JANUARY,LABEL,MATERIALS,METHODS,MTT,NON,OBJECTIVE,OBJECTIVES,PERFUSION,RESULTS,ROI,THERE,TTP
AKT,ALK,DESPITE,ERK,MEK,RTK
160,945,946,DSS,EBC,HIP,HLC,III,PAP,PCR,REG,SCC,THEREFORE
001,258,433,661,665,670,685,691,697,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,MPS,NSCLC,OVERALL,RESULTS,STAGE
001,110,346,665,AVERAGE,DOSIMETRIC,GTV,HOWEVER,LABEL,METHODS,MLD,OBJECTIVE,OBJECTIVES,PTV,RESULTS,SIXTY,THERE,V10,V20,V30
110,CHRONIC,CROSS,CRP,FVC,NORFOLK,SERUM
ASTER,BELGIUM,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,THEREFORE
169,AKT,AXL,CL1,FINALLY,FURTHER,HOWEVER,INC,PERSISTENT,ROS,USING
169,COX,CPH,MOTIVATED
169,COPYRIGHT,PUBLISHED,SEPAR,TREATMENT
001,169,308,452,668,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,EPIDERMAL,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,TKI
CURRENT,EIGHT,FRV,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE
169,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARTIAL,PATIENT,PBI,PURPOSE,RESULTS
154,169,598,ALZHEIMER,END,FILES,INDIVIDUAL,LOWER,MULTI,PARKINSON,RESULTS,SERVICE,USING
AMONG,CONCLUSION,CWP,III,LABEL,METHODS,OBJECTIVE,RESULTS
104,215,710,870,873,926,954,980,CONCLUSION,FVC,LABEL,METHODS,OBJECTIVE,PAM,RESULTS,SIX,WLL
177,CENTROSOME,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS
001,002,015,CONCLUSION,COX,LABEL,LTD,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY
169,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,FRANCIM,LABEL,LTD,METHODS,NET,RESULTS
169,EGF,L858R,T790M,THESE
BLOOD,CHEMISTRY,FDA,HEART,IMPORTANT,INSTITUTE,NCI,NHLBI,PROTEIN
135,613,751,761,BACKGROUND,GEO,H19,LABEL,METHODS,RESULTS,ROC,TNM,TOTAL
677,763,ALLELIC,BACKGROUND,FIFTY,LABEL,METHODS,MTHFR,NSCLC,PCR,RESULTS,SAH,SAM,SNP
500,ABRUZZO,ADMISSIONS,BACKGROUND,COMMITTEE,COX,DISCUSSION,LABEL,METHODS,MIXED,SECONDARY,TRIAL,UNIVERSITY,WHILE
174,CIS,DRI,MTT,NSCLC
179,AFFAIRS,AGREEMENT,AUC,BACKGROUND,CLINICIANS,ICC,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OBJECTIVES,PHYSICIAN,RATIONALE,RESULTS,THERE,VIGNETTES
ALK,AZD6244,CURRENTLY,ERK,HOWEVER,MEK,NSCLC,RAF,RAS

ALTOGETHER,ISOXAZOLE,USING
182,500,CTC,H1650,NCI
MMP,PEG,PEG1000,PEGYLATION,SEVERAL,USING
001,260,734,889,898,CONCLUSION,COX,END,HODGKIN,LABEL,MARRIED,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
001,002,005,635,857,AMONG,BMI,DESPITE,EPITHOR,LABEL,METHODS,OBESITY,OBJECTIVE,OBJECTIVES,OPERATIVE,RESULTS,SOCIETY,SURGERY,THEIR
177,FORTY,LABEL,M1A,MALIGNANT,METHODS,OBJECTIVE,OBJECTIVES,PLEURAL,RESULTS,THERE
169,945
CFA,COMPETENCE,CONFIDENCE,CONSTRUCT,FACIT,HIV,ITEMS,LABEL,METHODS,NURSE,OBJECTIVE,PHYSICIAN,PURPOSE,RESULTS,STAFF,TECHNICAL,TREATMENT,TRUST
177,AFTER,CONCLUSION,CRT,LABEL,METHODS,OBJECTIVE,PULMONARY,RESULTS,SUN,UNIVERSITY,YAT
956,AS2O3,BAP,GSH,TAKEN
185,463,BSA,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DIAGNOSIS,FURTHER,METASTATIC
001,002,003,004,012,015,025,026,033,BLD,CTC,DISEASE,EPCAM,NSCLC,PCR,SIXTY
176,EMA,FEWER,FOCAL,HMB45,HPF,KIT,METASTASES,PECOMAS,SEVENTEEN,SIXTEEN,THREE
BCL,FOCAL,SIX,TEN
TEN,THERE
60S,RPL11,RPS
172,246,BACKGROUND,FIFTY,FORTY,IMPORTANT,LABEL,MATERIALS,METHODS,RESULTS
102,127,165,193,2N0M0,AFTER,BACKGROUND,BETWEEN,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PET,PFT,PTV,RESULTS,SURGERY,THERE
001,325,578,600,900,AFTER,BACKGROUND,COX,CSS,CUMULATIVE,DOSES,EFS,FIRST,FORTY,INCIDENCE,LABEL,MEIER,METHODS,NEUTROPHIL,NRM,OBJECTIVE,RELAPSE,RESULTS
300,317,956,CTC,EPCAM,FINALLY,FIRST,PET
FOURIER,ROI,THEREFORE,WHILE
1990S,255,ANDALUSIA,SPAIN,THERE
BELGIAN,DUTCH,EVALUATION,RANDOMIZED,SCREENING,TRIAL
BAC,PULMONARY,SOCIETY,SSN
BIOMARKERS,LABEL,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY
169,954,ABC,BCR,CD79B,CHRONIC,COPYRIGHT,DESPITE,DLBCL,HEPATITIS,LTD,MECHANISMS,PUBLISHED
ALK,NSCLC,TKI
CLEAR,HMB45,SEVERAL
169,185,CCL,COPYRIGHT,DU145,HTB,LTD
169,375,500,ASIAN,BACKGROUND,CONCLUSION,COPYRIGHT,DECREASED,LABEL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,TAIWANESE,THERE,THESE,WESTERN
169,24H,947,ADP,ATM,BACKGROUND,CASPASE,COPYRIGHT,DLD,ECM,HDACS,INHIBITION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,POLYMERASE,PURPOSE,RESULTS,SCC15,THESE
131,169,387,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,169,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREAFTER
169,177,COPYRIGHT,EFFICIENT,FDG,GTV,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SBR,SUV
100,CATHEPSIN,EXTRA,HMB,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
001,004,034,046,079,127,146,259,399,524,901,CONCLUSION,DCR,GENERALLY,GIVEN,HOWEVER,JANUARY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,TTP
002,022,123,1394T,142,487,501,643,842,CHINESE,CONCLUSION,G135C,LABEL,METHODS,OBJECTIVE,PCR,RAD51,RESULTS,XRCC4
001,002,007,008,011,014,019,021,026,028,035,046,120,131,184,ATP7B,BACKGROUND,BRCA1,ERCC1,ERCCI,LABEL,LDH,METHODS,MYC,PFS,RESULTS,SMALL,THESE,TOPOI,TOPOIIA,TOPOIIB
B16,C57,CXCR4,PES43,PROOF,SN12C,THREE
158,216,AUTOPHAGIC,AUTOPHAGY,BACKGROUND,FURTHER,GFP,HCC,LABEL,LC3,METHODS,RESULTS,TEM
AKT,NSCLC,ORAI3,THESE
DYNAMIC,HOWEVER,MRI
CHEST,GGO
169,945,947,CURRENT,STUDIES,THEIR,THEREFORE,THESE
013,024,038,051,058,060,CONCLUSION,FDG,JANUARY,LABEL,MALIGNANT,METHODS,MPM,MTV,OBJECTIVE,OVERALL,PET,PROGNOSTIC,PURPOSE,RESULTS,SUV,THEREFORE,TLG
PRIMARY
140,945,946,956,H1975,HEP,MTT,RESULTS
954,956,ASS,EPM,H2S,MPM,NSAID,RNS,ROS
239,AES,BACKGROUND,CAUCASIAN,EASTERN,FIFTY,GROUP,LABEL,METHODS,NEWLY,NSCLC,ORR,PFS,PRIMARY,RESULTS
6TN,945,946,BSA,GAPDH,LOW,RLE,THESE
26A,NOTABLY,THESE,ZCCHC11
000,149,AMONG,HODGKIN,INFECTIONS,POISSON,USA
001,133,169,ANN,CONCLUSION,FDG,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
130,135,169,753,760,835,895,956,AUC,BACKGROUND,BAP,LABEL,METHODS,NEWLY,RESULTS,ROC,SERUM,TRACP
169,916,947,CIITA,CLASS,COPYRIGHT,HLA,IFN,INC,MHC,TAG,THESE
100,15KDA,169,176,20KDA,70KDA,956,BLUEHC650M,COPYRIGHT,GEL,HOP62,HOWEVER,LCL,LOTUS,SDS,THEREAFTER,THP
036,141,169,201,769,993,BACKGROUND,CONCLUSION,COPYRIGHT,GEFITINIB,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS,SEM,TKI,USING
169,CHINA,COPYRIGHT,G719X,GIVEN,L858R,LTD,XUANWEI
169,BACKGROUND,CONCLUSION,COPYRIGHT,DISCUSSION,DUKES,LABEL,METASTASIS,METHODS,MILES,OTHER,SAS,TREATMENT
111,169,APRIL,BACKGROUND,CIT,COPYRIGHT,GYE,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,169,CDCP1,COPYRIGHT,CUB,FEDERATION,HOWEVER,PUBLISHED,SOCIETIES,SRC,TRIGGERING,WESTERN
169,201,231,COPYRIGHT,FIBROVAKIM,PUBLISHED,SAS,SYSTEMATIC,THESE
169,AKT,COPYRIGHT,INHIBITION,LTD,NSCLC
004,157,165,169,175,COPYRIGHT,INC,LABEL,LMD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,VARIABLES
169,BACKGROUND,CONVERSELY,CRC,ENGLISH,HOWEVER,INC,LABEL,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,REFERENCE,RESISTANCE,RESULTS,SEVERAL,T790M
169,COPYRIGHT,IRELAND,JEGHERS,LKB,LTD,PEUTZ,PJS
100,103,124,169,COPYRIGHT,DOSIMETRIC,GRADE,ILD,IRELAND,LABEL,LTD,MATERIALS,METHODS,MLD,OBJECTIVE,PURPOSE,RESULTS,V10,V15,V20,V25
169,183,200,956,AMONG,ANTICANCER,ATP,COPYRIGHT,H2O,HEP3B,LTD,MTT,NMR,PC3
169,BESIDES,COPYRIGHT,LATER,SMARCB1,THESE
ICU,THESE,UNTIL
EGFRS,L858R,T790M
BECAUSE,GRADE,PEDIATRIC,PMA
120,169,345,661,AMONG,BJU,BLACK,CANCERS,COLORECTAL,CONCLUSION,GOVERNMENT,LABEL,METHODS,MORTALITY,OBJECTIVE,OVARIAN,PUBLISHED,RATES,RESULTS,SCREENING,USA
BACKGROUND,CONCLUSION,FREQUENCY,GERMANY,INTERVIEWS,LABEL,METHODS,OBJECTIVE,RESULTS
AFTER,CONCLUSION,EVALUATION,HCC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SINCE,SOLID,THERE
177,956,CASPASE,POLYPORUS,PRW,SENPS,SURFACE
COMPARISON,FINALLY,HDL,ICG,NCI,NIR
C34,ICD10,OPOLE
AMONG,SF3B1,THEIR,THESE
024,031,056,067,471,854,COX,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PPO,RESULTS
123,160,165,201,283,446,AMONG,APRIL,INITIATIVE,LABEL,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEOUL,THERE,UNIVERSITY
388,427,483,568,930,994,ANOTHER,CHINA,OVERALL,SEVERAL,SYNERGY,ZEALAND
947,AKT,EPIDERMAL,ERLOTINIB,HOWEVER,MET,RAS,TAKEN,TARCEVA,THESE
120,745,AUDIT,BACKGROUND,CONCLUSION,COX,ENGLAND,HRS,LABEL,METHODS,NORTH,NSCLC,RESULTS,USING
205,22RV1,691,945,BACKGROUND,CONCLUSION,CWR22,DLKPA,DU145,EL102,LABEL,METHODS,MULTIDRUG,RESULTS,TAXANES,TUBULIN
252,BASED,BSC,DEGRO,DEUTSCHEN,GROUP,NSCLC,RADIATION,SOCIETY,THESE,WORKING
017,300,303,739,868,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,HOWEVER,III,LUX,NON,NSCLC,SINCE
003,045,169,277,BACKGROUND,LABEL,LNS,METHODS,NSCLC,PET,RESULTS,THERE
169,BASEL,COPYRIGHT
266,FIRST,HOWEVER,NOD,STAT3,THESE,TWIST
001,144,169,239,398,BACKGROUND,BROOKMEYER,COPYRIGHT,COX,CROWLEY,EARLY,LABEL,LTD,METHODS,PFS,RESULTS,SIXTY,TTR
169,COPYRIGHT,DSCR1,HOWEVER,IRELAND,LSL,LTD,THESE,USING
169,COPYRIGHT,RFA,SAS
007,025,169,202,ADVERSE,CASES,COLLEGE,CONCLUSION,COPYRIGHT,COX,EASTERN,FACTORS,GROUP,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,ROYAL
000,100,169,946,AMONG,BEP,COLLEGE,CONCLUSION,COPYRIGHT,EMA,GRADE,GTN,LABEL,LTD,MATERIALS,METHODS,MTX,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SALVAGE,TREATMENT,WORLD
HPV,SCC
169,535,596,812,843,969,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HOWEVER,INITIAL,INSURANCE,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCC,THERE
169,947,COPYRIGHT,HOWEVER,INC
169,BACKGROUND,BAX,BCL,CDK,COPYRIGHT,INCUBATION,INHIBITION,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,PHASE,PROPIDIUM,PUBLISHED,RESULTS,VPA
100,169,COPYRIGHT,DEFINITIVE,FORTY,IRELAND,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SRS
169,841,921,BACKGROUND,CONCLUSION,COPYRIGHT,COX,IRELAND,JANUARY,LABEL,LTD,METHODS,NSCLC,RESULTS,SCORE,SCS,SIMPLIFIED,THERE,USING,VICTORIAN,VICTORIANS
169,883,AMONG,COPYRIGHT,FINALLY,INC,PATHOLOGY,PCR,PUBLISHED,SOCIETY,WHSC1L1
245,497,698,835,873,BACKGROUND,BID,DCR,ITT,LABEL,METHODS,NSCLC,PFS,RESULTS,SEVEN,THERE,TREATMENT
ABCC1,ATP,GSH,PHASE
100,110,162,210,5MM,BACKGROUND,CHANGES,GTV,HAUSDORFF,ISOTROPIC,ITV,LABEL,METHODS,OVERALL,PTV,RESULTS,TEN,THESE
000,162,349,470,BACKGROUND,DISCUSSION,FEMALES,LABEL,METHODS,RESULTS,SEVENTY,SHORT
001,455,612,COX,FURTHER,THESE
HODGKIN,PRIMARY
PULMONARY,SFT
BRAIN,CURRENT,LABEL,OPINION,PCI,QOL,STATEMENT,UNASSIGNED
180,AFRICAN,AGE,AHF,BUN,CONCLUSION,DESPITE,FAILURE,HEART,HIV,LABEL,METHODS,NIGERIA,NORTH,OBJECTIVE,PREDICTORS,PROGNOSTIC,RESULTS,SAHARAN,SOUTH
CUSHING
00014,00033,169,381,CCP,CONSORTIUM,COX,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
179,185,956,AMONG,HEPG2,MCF,MTT,NMR,STRUCTURE
104,166,258,AFFAIRS,CONCLUSION,IMPORTANCE,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PRIMARY,RELEVANCE,RESULTS,SETTING
945,AMP,IMR,LC3
137,JAPAN,RFA
AFTER,BRAIN,LARGE,LCNEC,MRI
159,AFTER,CBDCA,CEA,DOC,PTX,SRS,T2AN0M0,T2AN1,UFT
BECAUSE
000,010,024,BMS,CA184,CD152,IGG1K,IPILIMUMAB,JAPAN,MARCH,MDX,UNION
FDG,GLUT1,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV,THREE
174,44K,916,AGILENT,ALDEFLUOR,ALDH1,ALDH1A3,CSC,NOTABLY,NSCLC,TKI,USING,WHOLE
TAT,THREE,VII
149,220,AVAI3,AVAI4,BACKGROUND,COX,FDG,GTV,IVH,LABEL,MAXIMUM,METHODS,MTV,NSCLC,PET,PRIMARY,REGRESSION,RESULTS,SUV,THESE
18F,BESIDES,CONCLUSION,FDG,FIFTEEN,ICC,LABEL,LESIONS,METHODS,NSCLC,OBJECTIVE,OVERALL,PET,PURPOSE,RADIOMICS,RESULTS,SIMILARITY,SUV,SUVMEAN
ANA,DESPITE,FDG,HODGKIN,INTENSIVE,PET
1A3,2B7,MICHAELIS,PAH,PCR,POLYCYCLIC,PROXIMATE,ROS,UDP,UGT
181,231,945,MDA,THEIR
293,367,BACKGROUND,DUKES,HEPATIC,LABEL,LOCAL,METHODS,MILES,OBJECTIVE,RESULTS
AKT,AMONG,NUCLEAR,TAKEN
102,177,BACKGROUND,FDG,LABEL,LAD,METABOLIC,METHODS,MTV,PET,RESULTS,THEREFORE,TLG,UNIVARIATE
056,682,841,945,C111A,CHINA,FURTHER,HIF,HOWEVER,KNOWLEDGE,OVERALL,THEREFORE
001,169,422,479,810,858,943,AUC,BLOOD,CA125,CEA,CYFRA21,EFFECTIVE,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
THERE
CURRENT,HOWEVER
676,ADDITIONAL,CEE,CHD,CVD,HOWEVER,HRS,INITIATIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIMILARLY,WOMEN
BACKGROUND,CONCLUSION,ENGLAND,EPS,LABEL,METHODS,RESULTS
19Q13,CPD,EGLN2,THESE
LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
ADC,CALM1P2,HOXA4,HOXA5,HOXA6,HOXA7,HOXA9,LOC442282,LOC442586,LOC442589,LOC442651,MBP,NOTABLY,VARIATIONS
AFTER,LABORATORY,NSCLC,OCTOBER,PET,TYPICALLY
231,956,CXCR4,MDA,THESE,THREE
118,169,239,37C,524,8092C,BASED,CISPLATIN,CONCLUSION,COPYRIGHT,CUSTOMIZED,ERCC1,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PFS,PRIMARY,RESULTS,SIMON,TREATMENT
001,005,007,169,BACKGROUND,COMPARISON,COPYRIGHT,IRELAND,LABEL,LAD,LTD,MATERIALS,METHODS,OBJECTIVE,PRONE,PURPOSE,RESULTS,SECONDARY,WBI
001,169,259,AUC,AUTHORS,CARDIAC,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PRIOR,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE
169,BACKGROUND,COPYRIGHT,FDG,IRELAND,ITV,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,177,AUTHORS,BACKGROUND,CNR,COPYRIGHT,HX4,IRELAND,LABEL,LTD,MATERIALS,MAXIMUM,METHODS,NSCLC,OBJECTIVE,OPTIMAL,PEARSON,PET,PUBLISHED,PURPOSE,RESULTS,SUV,TBR
171,443,776,833,AFFAIRS,AMERICA,AMONG,ARA,DDI,DEPARTMENT,HOWEVER,MARKETSCAN,NORTH,PPI,REUTERS,SARFARI,THERE,THESE,THOMSON,WESTERN
000,100,524,706,BACKGROUND,CAUSE,DISEASE,FURTHER,LABEL,METHODS,RESULTS,SEYLL,USING,YEARS
H1299,TAKEN,THESE
177,956,AUTOPHAGIC,BACKGROUND,CELLS,CONCLUSION,CONTEXT,GFP,HBC,LABEL,LC3,MATERIALS,MDC,METHODS,OBJECTIVE,RESULTS,WESTERN
001,014,020,041,087,166,173,226,250,COLLEGE,CONCLUSION,COX,FDG,GROUP,HOWEVER,III,IMAGING,INSTITUTE,LABEL,METHODS,NETWORK,NSCLC,OBJECTIVE,PET,PURPOSE,RADIATION,RADIOLOGY,RESULTS,SUV,SUVPEAK,THERAPY
160,ADDITIONAL,BECAUSE,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS
100,ADVERSE,CYTOTOXIC,INDIVIDUAL,THERE
001,018,546,CHINA,COX,CUMULATIVE,MONOTONIC,THESE
VIRTUAL,VRT
OVERCOMING,RAS,SMALL,THESE,TKI
B16,DCA,HISTOLOGY,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN
100,624,FOLLOWING,MEL,MOI,THEREFORE
100,115,177,BETWEEN,CONCLUSION,FDG,LABEL,LOCAL,MAXIMUM,MEIER,METHODS,NCT,NPV,OBJECTIVE,OVERALL,PET,PPV,PURPOSE,RESULTS,RFA,ROC
LOW,NAD,NSCLC,SCREENING,SIRT3,TAKEN
FDG,PET

ASSESSMENT,FATIGUE,FUNCTIONAL,IIA,INVENTORY,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PATIENT,PURPOSE,QUALITY,RESULTS,THERAPY,THOSE
169,215,ALLICIN,BACKGROUND,FOURIER,GENERAL,LABEL,METHODS,MTT,RESULTS
008,169,17YEARS,5CM,BACKGROUND,COPYRIGHT,GROUP,III,ITALY,KINGDOM,LABEL,LESIONS,LTD,METHODS,PAEDIATRIC,PFS,PPB,RESULTS,SIXTY,THESE,TUMOURS
169,COPYRIGHT,ING,IRELAND,LTD,NSCLC,TSP
169,AKT,B08,COPYRIGHT,EGF,FINALLY,GIVEN,H1975,INC,L858R,NSCLC,T790M
169,COPYRIGHT,GEFITINIB,IRELAND,LTD,NSCLC,PUBLISHED,THEREFORE,THESE
169,956,APOPTOTIC,ARSENIC,ATO,BACKGROUND,COPYRIGHT,DMS79,EXPRESSION,GSH,H69,IRELAND,LABEL,LTD,MATERIALS,METHODS,MMD,RESULTS,SMALL,SYNERGISM,TALALAY,THERE,WESTERN
116,155,30A,377,423,ACUTE,HCT
169,COPYRIGHT,INC,TTE
169,AFTER,CONCLUSION,COPYRIGHT,DCE,FOURIER,HOWEVER,IMAGE,IRELAND,LABEL,LTD,METHODS,MRI,NON,NSCLC,OBJECTIVE,OVERALL,RESULTS,SMALL
000,169,842,937,978,COPYRIGHT,EXTENSIVE,INC,ISPOR,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,REDUCED,RESULTS,SOCIETY,UNIVERSITY
114,BECAUSE,CURRENTLY,METASTASIS,USING
177,215,ABSL1,BLOOD,CFU,CONIDIA,FECES,HOWEVER,LUNGS,SABOURAUD,SAMPLES,SPF,THEREFORE,ZEALAND
001,166,956,BACKGROUND,CONCLUSION,KDA,LABEL,METHODS,MOE,MORINGA,RESULTS,SOUTH,TBARS,WESTERN
100,150,181,INORGANIC,METABOLISM,MOA,PROGRAMME,PROTECTION,USEPA
273,BACKGROUND,CHANGES,GTV,HOWEVER,LABEL,METHODS,PRE,PTV,RESULTS,TEN,THESE
BASED,H1299,HOWEVER,MCF,NCI,NIR,RAMAN,THEREFORE

113,118,125,140,204,251,A743V,L718M,L815P,NSCLC,PCR,V819E
10A,155,195,203,30A,30C,885,946,ARHGAP5,CXCR3,CYP27B1,GNA13,GP5,HIST1H2BF,HLF,IGSF3,IKBKB,MAF,NON,NSCLC,RAB23,RAP2A,SLC11A1,WNT
GLUCOSE,INHIBITION
00001,007,798,BACKGROUND,HENCE,LABEL,LARGE,LIBRARY,LOW,METHODS,NSCLC,RESULTS,THERE
000,480,ATLAS,BESIDES,CHG,CPG,FASTDMA
946,CXCR4,CXCR7,HUVEC,THESE
203,945,FINALLY,HOWEVER,PKC,PRKCA,USING
021,147,216,387,700,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SNP
001,004,015,111,GRADE,HOWEVER,HRQOL,III,QOL,QUALITY,REDUCED,RIT,TRM
945,954,BRCA1,DESPITE,FANCONI,NCI,NSCLC,PROTEASOME,PSMA1,RAD51,RADIATION,THESE
140,IGF1R,INTEGRATED,KNOCKDOWN,MICRORNAS,NSCLC
ACTIVATING,BASED,KIRSTEN,NSCLC,VEGFA
946,CDH17,HCC,STRIKINGLY,TGI,TREATMENT,WNT
021,029,042,046,047,15Q25,174,405,460,BACKGROUND,BLOOD,LABEL,MASSARRAY,MATERIALS,MEIER,METHODS,NSCLC,PFS,PORTUGUESE,RESULTS,SNP,THEREFORE,THREE
169,177,BACKGROUND,CONCLUSION,DUE,EIGHT,INC,LABEL,METHODS,RESULTS,WILEY
169,BACKGROUND,FLUID,LABEL,METHODS,RESULTS,SOCIETY,THERE,THOSE,UNIVERSITY
169,ARTEMISIA,CHINESE,COPYRIGHT,DHA,DUE,GEL,INC,THESE,WILEY
169,HOWEVER,INC,NSCLC,THESE,WILEY
169,495,ATP7A,FINALLY,INC,NSCLC,PCR,USING,WESTERN,WILEY
HISTOLOGY,SURGERY
169,197,DISCHARGE,HBV,HEPATITIS,HODGKIN,INC,OUTPATIENT,SIR,SWEDISH,THESE,WHILE,WILEY
169,INC,LITERATURE,PREVENTION,THERE,WILEY
169,INC,MINIMAL,WILEY
169,BACKGROUND,COPYRIGHT,CXR,LABEL,METHODS,MORTALITY,POISSON,RESULTS,RRS,SCREENING,SOCIETY,TRIAL
129,946,EMT,HOWEVER,TAKEN,USING
CTL,LEWIS,LLC,TRP,TRPA1,TRPM8,WESTERN
169,ABCB1,ABCG2,ALK,AUC,CRIZOTINIB,NSCLC
169,COPYRIGHT,INC,PANCREATIC,WILEY
169,ARISTALESS,BCL,CPG,HOWEVER,PCR,THESE,USING,WESTERN
10001,333,MEDICAL,PUBLISHERS,PULMONARY,SEVENTH,USA
USING,UTR
141,200,429,DESPITE,INSTEAD,THESE
007,037,367,ASCL1,IHC,RET,THESE
AGC,AKT,GSK2334470,NOTABLY,PKC,SELECTIVE,V600E
201,NUCLEAR,P53
ADO,H1299,INDUCTION
001,044,ASIAN,BLACK,CONSORTIUM,HISPANICS,OVERALL,USING
ACTIVATION,AKT,C57BL,ERK,FAK,FVB,HOWEVER,MGAT3,POLYOMA,PREVIOUSLY,SRC,TEC
ATLAS,NBS,SOMATIC
ALZHEIMER,BACKGROUND,CONCLUSION,EVIDENTLY,JAPAN,LABEL,MECHANISMS,METHODS,OBJECTIVE,RESULTS,WESTERN
160,603,657,AFTER,APOC1,CIS,COX,CRP,GRS,HNF1A,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
177,6MM,AFTER,AUDIO,FIRST,MHI,PREVIOUSLY,TOTAL
007,BHCTS,DEVIATIONS,FIFTEEN,INTRA,OVERALL,RADIO
001,003,007,CRT,DOSIMETRIC,PTV,RESULTS,TEN,V10,V13,V20
1SD,CYBERKNIFE,STATISTICS
AAA,DUE,ECLIPSE,KUTCHER,LKB,LYMAN,PBC,PUBLISHED,THREE
177,2CM,ANOTHER,CI100,HOWEVER,NMT,PTV,REDUCTION,THEREFORE,V20
AFTER,APART,CARLO,CYBERKNIFE,DESPITE,DEVIATION,FRACTIONAL,HOWEVER,MONTE,NSCLC,OAR,PTV,RAT,RAY,TRACING
260,28049,334,956,AUC,C57,COLON,CONCLUSION,LABEL,LEWIS,LL3,METHODS,NZM10,NZM52,OBJECTIVE,PURPOSE,RAG,RESULTS,THESE
HDACS,HISTONE,III,LABEL,METHODS,OBJECTIVE,ONGOING,PHASE,PURPOSE,RESULTS,THEREFORE
116,169,8NM,AFTER,COLO205,COPYRIGHT,HCT,SECRETORY,TWEEN
181,335,538,640,BACKGROUND,CHILE,INDICES,LABEL,METHODS,ORS,RESULTS,ROTHMAN,SYNERGY,THESE
202,DDR,ERCC1,FANCONI,FINALLY,HDR,HOWEVER,RPA,THESE,XPA,XPF
153,737,ABT,BAD,BCL2L11,BIM,COR,DMS,L42,NEITHER,NOVEL,SMALL
169,B16,COPYRIGHT,CXC,CXCR4,F10,HOWEVER,INC,METASTASIS,MMP,SACCHARINA,TAKEN
169,HOWEVER
956,AFTER,DCM,JACARANDA,MCF,PC3
000,033,053,078,102,147,169,192,247,255,259,359,413,419,563,736,746,761,BECAUSE,CD4,CHINESE,FOXP3,HAN,NSCLC,PCR,SNP
000,100,101,169,179,872,BACKGROUND,BRAZILIAN,COPYRIGHT,DALYS,DESPITE,HOSPITALS,LABEL,LTD,METHODS,RESULTS,SANTA
169,946,BACKGROUND,CASES,CONCLUSION,COPYRIGHT,HCG,LABEL,METHODS,NSCLC,PUBLISHED,REPORTS,SAS
131,169,BACKGROUND,COPYRIGHT,DFI,DISCUSSION,JANUARY,LABEL,LTD,METHODS,OVERALL,PET,PRIMARY,RESULTS,SPN
169,COPYRIGHT,G469L,IRELAND,LTD,V600E
142,169,252,425,COPYRIGHT,CRT,FOLLOWING,INC,INTERGROUP,LABEL,LRPFS,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PRE,PRESENT,PURPOSE,RESULTS
169,185,348,AFTER,AMERICA,AUSTRALIA,CLINICALLY,CONCURRENT,COPYRIGHT,EFFORTS,FACTORS,INC,LABEL,MATERIALS,METHODS,NORTH,OBJECTIVE,PURPOSE,RECURSIVE,RESULTS,THERE,V60,VALIDATED
160,169,177,393,620,ACCORDING,BACKGROUND,COPYRIGHT,ESL,FUNCTIONAL,INC,JANUARY,LABEL,METHODS,NSCLC,OKADA,OVERALL,PUBLISHED,RESULTS,SOCIETY,THERE
100,169,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY,THERE
160,169,AFTER,BACKGROUND,BLOOD,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,SPIROMETRY,TEMPORARY,THEREFORE
169,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,T790M,THERE
169,956,CNS,COPYRIGHT,LTD
INC,OCTREOTIDE,PUBLISHED
CHINA,CURRENTLY,EARLY,HOWEVER
AFTER,CHINA,NON,NSCLC
151,156,170,177,178,179,188,671,736,AFFILIATED,BACKGROUND,FIRST,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SOOCHOW,THERE,UNIVERSITY,VAS,VIDEO
BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SVCOS
117,177,23R,BACKGROUND,CD3,CD4,CSF,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,THERE
140,465,704,APRIL,BACKGROUND,COX,IRINOTECAN,LABEL,MEIER,METHODS,OBJECTIVE,PFS,PROGNOSTIC,REGRESSION,RESULTS,THEREFORE
AKT,BACKGROUND,GEFITINIB,HGF,LABEL,MET,METHODS,MTT,NSCLC,OBJECTIVE,PC9,RESULTS,STAT3,WESTERN
008,177,BACKGROUND,BASIC,DIFFERENT,LABEL,LEWIS,LUMINEX,METHODS,OBJECTIVE,RESULTS
BACKGROUND,CELLS,DIFFERENT,H1299,HOWEVER,LABEL,METHODS,MICROCT,OBJECTIVE,PERIODICAL,RESULTS,SPC
BACKGROUND,CHINA,INCIDENCE,LABEL,MEANWHILE,METHODS,OBJECTIVE,POISSON,RESEARCHES,RESULTS,STRATIFIED
169,201,231,COPYRIGHT,GREAT,PUBLISHED,SAS
BETAHCG
169,LTD,MWA,PUBLISHED,THRESHOLDS
100,160,169,ASIAN,BIOCAST,COPYRIGHT,HOWEVER,LCINS,PUBLISHED,SAS
169,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,EPIDERMAL,LABEL,METHODS,NSCLC,PUBLISHED,SAS,T790M,TKI
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PUBLISHED,SAS
106,169,1ST,BACKGROUND,CARIBBEAN,CONCLUSION,COPYRIGHT,FEW,GUADELOUPE,III,JANUARY,LABEL,METHODS,NON,NSCLC,PUBLISHED,RESULTS,SAS,STAGE
169,323,562,812,961,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SAS,SEX
169,COPYRIGHT,INC,NSCLC,TKI,VPS34
104,169,COPYRIGHT,OVERALL,RECIPIENTS,SOCIETY,TRANSPLANT
169,205,225,AFTER,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DNT,INC,JANUARY,LABEL,METHODS,MMF,OLT,RESULTS,TACROLIMUS,THERE
100,104,169,CIS,COPYRIGHT,HODGKIN,INC,ITALIAN,ITALY,LABEL,METHODS,NHL,OBJECTIVE,OLT,PYS,RESULTS,SIR,THESE
100,161,169,228,567,653,878,AMONG,ASIAN,AUTHORS,BACKGROUND,CHIBA,DETECTION,GODDARD,JAPAN,LABEL,METHODS,OBJECTIVE,PACIFIC,PFT,RESULTS,SOCIETY
169,GEFITINIB,MET,NEITHER,NON,T790M,TKI
169,4T1,LTD,TH2,THESE,TSLPR,WILEY
001,013,169,240,894,ACS,BILIARY,COLLEGE,DESPITE,ELDERLY,FACTORS,GIVEN,LABEL,METHODS,NSQIP,OBJECTIVE,OBJECTIVES,PANCREATO,PROGRAM,QUALITY,RESULTS,THESE
NIH,NUR77,SEVERAL,TREATMENT
144,155,169,BRITISH,INCREASING,MECHANISMS,OMM,SOCIETY
007,032,058,ASSESSMENT,BACKGROUND,DIETARY,HARVARD,HISPANICS,HOWEVER,LABEL,METHODS,NAA,NHW,OBJECTIVE,OBJECTIVES,OVERALL,RATIONALE,RESULTS,SMOKERS,SMOKING,UNIVERSITY
DIFFUSE,FEWER,THEIR
945,946,AKT,BECAUSE,ERS
100,174,967,AFTER,CRAIG,GRADE,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PEARSON,REPORTS,RESULTS,STAPLER,THERE,USA
EGF,FOS,FURTHER,JUN,MITOGEN,NOTABLY,RAS,TAKEN
945,AFP,CEA,CK5,CK7,CK8,EPCAM,HEPPAR1,MOC31,THREE,TTF
002,009,013,014,032,048,059,185,AML,DFS,DOWNSTREAM,FMS,ITD,LRP,MDR,MLL,MRP,PTD
CL1,GUANINE,TBA,THESE
169,945,CONCLUSION,CRC,DC101,EVALUATION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMA,SOLID,VEGFI
029,204,206,218,415,BMI,CHINA,HOWEVER,TAIXING,THESE
169,BECAUSE,MOLECULAR,WORLD
100,169,340,BACKGROUND,BASED,COPYRIGHT,DMD,LABEL,LTD,METHODS,PROCEDURES,RESULTS
001,002,004,005,010,011,169,CONCLUSION,COX,DFS,FDG,LABEL,MATERIALS,MAXIMUM,METHODS,MTV,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SEVENTY,SUV,T2AN0M0,TLG,TLG50,TLG60
001,084,CONCLUSION,DCE,FIRST,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROI,THIRD,USING
169,AMONG,COPYRIGHT,IRELAND,LTD,NSCLC,PROGRAMMED,RCC
100,945,946,FORMULA,HOWEVER,QUADRATIC,WIF,WITHERS
CNS,T790M
001,026,169,177,360,3MM,4FP,ANN,CAD,CONSORTIUM,COPYRIGHT,FEATURE,FRAMEWORK,GENERATION,GREEN,IMAGE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEARCHING,SVM
140,169,183,280,BACKGROUND,COPYRIGHT,DEC,ELDERLY,FUNDING,LABEL,LTD,METHODS,RESULTS,ROCHE,TREATMENT
VARIETIES
101,160,BETWEEN,HPC,LABEL,MATERIALS,METHODS,MHZ,MPM,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS,THERE
169,AUTHORS,LTD,STATISTICS,WILEY
001,100,145,204,265,450,946,ASSESSMENT,DISEASE,FUNCTIONAL,LABEL,METHODS,NSCLC,OBJECTIVE,PATIENT,PURPOSE,REGRESSION,RESULTS,SCALE,SYMPTOM,THERAPY,USA
113,133,160,CRP,HOWEVER,HRV,NSCLC,PSA,THEREFORE
946,CIGARETTE,III,IMR,PGC,SIRT1,THESE
139,266,HOWEVER,TNM
105,154,916,BACKGROUND,BASED,HOWEVER,LABEL,METHODS,NPV,PCR,RESULTS,SHOX2
135,202,AMONG,ANTITUMOR,GUIDELINES,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
205,CNS,ESTIMATES,HODGKIN,LABEL,MEDLINE,METHODS,ORS,RESULTS
145,160,214,23A,718,720,AGILENT,PCR,SPC,THESE
AIT,FIRSTLY,HOWEVER,NAC,NON,NSCLC,ROS,SOPHORA
169,CHEMOKINES,CXCR4,CXCR7,HOWEVER,LABEL,NSCLC,TARGETING,THESE,UNLABELLED
DDP,TAKEN,THESE
001,002,30C,339,370,390,550,566,616,656,939,ADC,AUC,CONVERSELY,EARLY,NSCLC,OVERALL,SIX
001,106,114,190,AFTER,CONCLUSION,HE4,III,LABEL,METHODS,NSCLC,OBJECTIVE,PTB,RESULTS,SERUM,STAGE,USING
BMJ,DUTCH,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RAPIDLY,RESULTS,SCREENEES,THERE
169,279,LABEL,LAK,LTD,METHODS,NSCLC,OBJECTIVE,PBK,PDZ,RESULTS,TNM,UNIVARIATE,WILEY
159,656,929,END,HOWEVER,IIA,LABEL,LIMITED,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SIMILAR,USING
169,ESS,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,VARIOUS,WILEY
CURRENTLY,HOWEVER,THERE,THESE
CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TNF
CHINESE,CONCLUSION,ERBANXIAO,LABEL,MEDICINES,METHODS,OBJECTIVE,RESULTS,SIXTY,THERE,THESE,TNF
BACKGROUND,DOSIMETRY,FIF,LABEL,LDC,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN
946,AKT,BACKGROUND,CK2,EMT,ERK,FAK,LABEL,MATERIALS,METHODS,MMP,PCR,RESULTS,SMAD2,SNAIL,SRC,TGF,TWIST,WESTERN,WNT
ANG,HOWEVER,THESE,TIGHT
001,428,7TA,7TB,BACKGROUND,BASED,DFS,GUIDELINES,LABEL,LN0TA,LN0TB,LN1,LN7,LNS,METHODS,NSCLC,RESULTS
017,103,118,150,158,175,181,455,464,667,BACKGROUND,FOLLOWING,HOWEVER,LABEL,METHODS,OUTDOOR,PM2,RESULTS,SHS,SUCCESSFUL,WHILE
003,018,172,302,414,432,665,BACKGROUND,CENTRAL,CONTROLLED,HOWEVER,LABEL,MEDLINE,PFS,PRINCIPAL,RESULTS
ENV,HIV,HKENV,MVA,PROTECTION,RENCA,RLZ,THESE
358,716,AIM,ATM,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TAIWANESE
239,945,BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,RESULTS
001,407,714,837,AHR,BACKGROUND,CONCLUSION,L858R,LABEL,METHODS,MST,NSCLC,NUCLEAR,RESULTS
CAV,PULMONARY,SURGERY
001,003,005,155,AIM,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS,SIX
233,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,REGRESSION,RESULTS,SYMPTOM
946,947,BACKGROUND,CONCLUSION,LABEL,LEWIS,LLC,LOCAL,MATERIALS,METHODS,NOD,NOG,RESULTS,SMAD3,TGF,TIG
945,946,EMT,FAP,GLI,HOWEVER,NSCLC,PCR,SMA,SMAD3,SNAI1,SNAI2,TGF
LARGE,LCNEC,NCI,SINCE,THEREFORE,THESE
945,946,ALTERED,GFP,LM4,RFP
AIM,CONCLUSION,EPIDERMAL,LABEL,MATERIALS,METHODS,MTD,NEITHER,OBJECTIVE,RESULTS
ALK,ANAPLASTIC,ATP,DESPITE,HOWEVER,NSCLC
961,HOWEVER,THESE
169,174,279,956,ALK,BACKGROUND,CLINICALLY,COPYRIGHT,FURTHER,HOWEVER,INCREASES,LABEL,METHODS,NEITHER,NSCLC,OTHER,OVERALL,RESULTS,SOCIETY
946,CONVERSELY,FUNCTIONAL,HOWEVER,MYC,PCR,TNM,WNT,WNT3A
946,EMT,EPITHELIAL,HEPATOCYTE,HOWEVER,KNOCKDOWN,TGF
160,169,183,BLOOD,CONCLUSION,DIAGNOSTIC,GEORG,HCT,HISTORY,LABEL,LAM,METHODS,REFRACTORY,SERUM,STUTTGART,TREATMENT,VOIDING
AKT,HIF1A,MIR,NSCLC
366,AMONG,BACKGROUND,CIS,CONCLUSION,ERR,LABEL,MAYAK,METHODS,POISSON,PRODUCTION,RESULTS,THERE
267,BACKGROUND,CONCLUSION,CPF,END,HIV,LABEL,METHODS,NSCLC,RESULTS,STAGE,USING
AFTERWARDS,BAP,PAH,PMF,SPAIN
169,AMRUBICIN,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,CURRENTLY,FEBRILE,GRADE,JANUARY,LABEL,METHODS,NSCLC,RESULTS,THEIR,THERE,UNIVERSITY
389,495,AMONG,BACKGROUND,CONCLUSION,DATABASES,FORTY,HOPKINS,JOHNS,LABEL,MEDICAL,METASTATIC,METHODS,RENAL,RESULTS,STATE,UNIVERSITY
018,160,169,199,474,995,AFTER,BACKGROUND,COPYRIGHT,INC,LABEL,MARTINI,MELAMED,METHODS,PUBLISHED,RESULTS,SMPLC,SOCIETY,TNM,TREATMENT
001,160,169,610,BACKGROUND,COPYRIGHT,COX,GGO,INC,LABEL,METHODS,PATHOLOGIC,PET,PUBLISHED,RESULTS,SOCIETY
169,26S,COPYRIGHT,DSB,FEDERATION,PUBLISHED,RAD51,SOCIETIES,THESE
ALK,BACKGROUND,CTC,H2228,HOWEVER,LABEL,METHODS,NCI,PCR,RESULTS
223,270,300,ATLAS,BACKGROUND,BLOOD,CHD,GATA4,GENOMIC,HEART,INSTITUTE,LABEL,METHODS,MYH11,PATHOGENIC,PUTATIVELY,RESULTS,SEVERAL
003,025,169,250,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,FAVORABLE,FORTY,GEFITINIB,IRELAND,L858R,LABEL,LTD,MATERIALS,METHODS,RESULTS
169,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,THESE,TRICHROME
12DYN,169,177,HEP3B,HOWEVER,LAMINAR,LSS,MECHANICAL,OSS,SCC25,SMAD1,SMAD5
169,AKT,ARCTIUM,ARG,COPYRIGHT,GSH,THESE
247,BACKGROUND,CONCLUSION,ICU,JANUARY,LABEL,METHODS,OUTCOME,PCP,RESULTS,STAGE
34A,ADENO,CARCINOMA,CELLS,CSC,MPE,NCI,SINCE
197,ASYMMETRIC,EGFRS,L834R,MUTATED,T766M,TKD
110,121,129S1,159,175,AKR,C3H,C57BL,CBA,DBA,DEPARTMENT,GEM,LABORATORY,MAMMARY,NEWLY,NOVEL,SVW,WOM
169,297,AMONG,INC,WILEY
169,947,948,CROSS,NKG2D,SOLUBLE,TRAIL,VCH,WHETHER,WILEY
001,002,013,116,COX,EXPRESSION,HOWEVER,LABEL,MEIER,METHODS,MIR,OBJECTIVE,PCR,PFS,PURPOSE,RESULTS,TNM,UNIVARIATE
COLORECTAL,CRC,SPAIN
169,555,600,COPYRIGHT,INC,KIT,KITLG,LCNEC,PCR,POSITIVITY,SCF,WILEY
183,HRQOL,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,ROC
00001,00002,002,945,BACKGROUND,CBM,DATABASES,HIF,HOWEVER,HYPOXIA,III,LABEL,MAY,METHODS,NSCLC,RESULTS,STUDIES,VIP,WAN
ICR,NSCLC
001,152,270,ATS,BACKGROUND,COMMITTEE,CONCLUSION,ERS,IASLC,JOINT,LABEL,MEIER,METHODS,RESULTS,SOCIETY,USING

001,002,005,181,193,BACKGROUND,CLM,HOWEVER,LABEL,LIVER,METHODS,OBJECTIVE,RAS,RESULTS,RFS,SOMATIC
169,945,AKT,COPYRIGHT,IRELAND,LTD,MAMMALIAN,NSCLC,RAPAMYCIN
125,160,176,180,215,360,3CM,CARLO,COUNCIL,D95,DESPITE,DOSXYZNRC,FURTHER,HOWEVER,LED,MONTE,PTV,RESULTS,SMALL,THESE,V20
HOWEVER,MHC,NKG2D,TRAMP
ERK,ONCOGENIC,OVERALL,RAS,TSP,USING
945,AGP,BACKGROUND,COMPARISON,DISCUSSION,ELISA,LABEL,MAA,METHODS,NSCLC,RESULTS,TYPICAL
ALLOGENEIC,BIOLOGY,DLI,INC,INSTITUTE,PREVENTION,PUBLISHED,RELAPSE,SCIENTIFIC,SESSION,TREATMENT
100,169,6PGDS,COPYRIGHT,DE3,INC,MICHAELIS,THREE,USING
169,BACKGROUND,BMI,FVC,LABEL,MATCHED,METHODS,PREGNANCY,PUBLISHED,RESULTS,SOCIETY
001,163,169,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,NANOG,OBJECTIVE,PCR,RESULTS
169,COPYRIGHT,PUBLISHED
001,018,028,169,173,177,482,596,AMONG,BRAIN,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,MLR,NOTABLY,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,TREATMENT
169,ALTERNATE,CONFERENCE,COPYRIGHT,DYNAMIC,GROUP,IMAGING,IRELAND,LTD,MPM,MRI,PET,SEPTEMBER,THESE,USA
001,169,335,774,BACKGROUND,BPD,COPYRIGHT,GEFITINIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OCTOBER,RESULTS,SIXTY,TKI
001,169,3DCRT,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,END,ESOPHAGUS,III,INTENSITY,IRELAND,KEY,LABEL,LTD,METHODS,PATIENT,PREDICTORS,RESULTS,THESE
169,COPYRIGHT,DNX,DOX,LTD,NDS,NDX,PEG
169,177,AUTOMATED,COPYRIGHT,DCE,FOURIER,IRELAND,LABEL,LLA,LTD,MATERIALS,METHODS,OBJECTIVE,PERFUSION,PURPOSE,RESULTS,ULA
169,247,COPYRIGHT,FINAL,IRELAND,KAPPA,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREVALENCE,RESULTS,RIGHT,SMALL,VOLUMETRIC
169,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,INCREASED,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,BACKGROUND,COPYRIGHT,CTCAE,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OPTIONS,PBT,PURPOSE,RATES,RBE,RESULTS
169,COPYRIGHT,DESPITE,LTD
111,DISTANT,III,NPC,SIB
HEPG2,ICR,NMR,STEMONA,THEIR,THESE,THREE
APRATOXIN,AQABA,MANGROVES,NCI,NMR,RED,SEA
169,AUTHORS,BLACKWELL,CURRENT,JOURNAL
1990S,2000S,AMONG,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,RESULTS,RII,THESE
ADDITIONAL,BACKGROUND,EASTERN,EIGHT,GROUP,LABEL,LOBECTOMY,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RATIONALE,RESULTS,SEVENTY,THERE
001,037,045,FURTHER,LABEL,METHODS,OBJECTIVE,OHP,PURPOSE,RESULTS,THERE,VARIOUS
500,554,592,64257,ASIAN,BACKGROUND,CAUCASIANS,CYP2C19,HOWEVER,LABEL,METHODS,OVERALL,PMS,RESULTS
MOLECULAR,PAM50,THESE
FINALLY,HOWEVER
176,945,946,C57BL,CONVERSELY,EMT,FURTHER,LEWIS,LLC,MNU,SIMILARLY,TGF,THESE,TNF
102,114,115,116,117,174,945,946,AKT,AMONG,HSP,MET,OTHER,REGARDING,SEVERAL,T790M,TAIHO,TAS,UFT,USING
320,LABEL,MCNEMAR,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
088,104,160,613,736,APART,DESPITE,EIGHT
AIR,THERE
215,225,CONCLUSION,FINAL,LABEL,METASTATIC,METHODS,OBJECTIVE,PET,PTH,RESULTS
100,156,218,468,956,CONCLUSION,CTS,DESPITE,EAS,ECTOPIC,FUNCTIONAL,LABEL,METHODS,MRI,NOTABLY,OBJECTIVE,PET,RESULTS,SUSPICIOUS,TSS
131,215,945,CALCIUM,CONCLUSION,FURTHER,GISTS,LABEL,METHODS,OBJECTIVE,OH2,PTH,PTHRP,RESULTS,THERAPY
180,220,260,500,BACKGROUND,BASED,DESPITE,LABEL,METHODS,MTD,NSCLC,PEMETREXED,PHASE,PLANNED,PRIMARY,RESULTS,THREE,TREATMENT
001,002,125,CASES,COX,DFS,EXPRESSION,MEIER,NSCLC,THERE
160,AMPUTATIVE,CURRENT,METASTASES,TREATMENT
033,114,150,373,713,MMP,NSCLC,SIRNA,TRANSIENT
149,159,FDA,IBC,SUM,THESE,TIC,WNT
DUE,FAB,INDUCTION,KEY,LABEL,MESSAGE,MET,TET,THESE,UNLABELLED
AIM,BACKGROUND,CONCLUSION,CURRENTLY,EEA,FURTHER,LABEL,MAINZ,MEDICAL,METHODS,MIE,MINIMALLY,OBJECTIVE,ORVIL,RESECTION,RESULTS,THERE,TRANSORAL,UNIVERSITY
001,002,AICHI,BACKGROUND,CIGARETTE,LABEL,LCS,METHODS,ORS,RESULTS
109,158,160,186,641,APRIL,CTS,FDG,LABEL,METHODS,NPV,OBJECTIVE,PET,PPV,PURPOSE,RESULTS,SPN,USING
946,AKT,CSC,EMT,FBLN3,FBLNS,IGF,IGF1R,OVERALL,SNAIL,THESE
B16,HCI,LNM35
002,020,046,5YR,ACCORDING,CD204,CONCLUSION,FOXP3,HGNEC,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,TREGS
169,COPYRIGHT,CVD,INC,PUBLISHED,SIX,THREE
169,COPYRIGHT,HBE,HUVEC,IRELAND,LTD
100,169,531,AFRICAN,BACKGROUND,BENIN,CONCLUSION,LABEL,LEONE,METHODS,MOZAMBIQUE,NIGER,OVERALL,PREVALENCE,RESULTS,SAHARAN,STEPS,SUB,SWAZILAND,USING
169,224,448,954,BESIDES,CHINA,CHINESE,COPYRIGHT,HAPLOTYPE,LABEL,LTD,METHODS,OBJECTIVE,POL,PURPOSE,RESULTS,TLS
160,169,674,CONVERSELY,COPYRIGHT,HOWEVER,INC,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY
169,AUTHORS,BIOMARKERS,COPYRIGHT,HRP,INC,KNOCKDOWN,PUBLISHED,ROS,THEREFORE
169,231,ETS,HGF,MDA,ORF
169,946,EMT,OVERALL,SILIBININ,T24
100,134,169,CONCLUSION,COPYRIGHT,DFS,FDG,IRELAND,LABEL,LTD,MATERIALS,MCNEMAR,METHODS,MRI,NSCLC,OBJECTIVE,PET,PURPOSE,QUICK,RESULTS,ROC
169,AFTER,COPYRIGHT,IRELAND,LTD,NSE,SECONDARY,TKI
946,INC,PUBLISHED,TGF
169,AKT,CK2,COPYRIGHT,LTD,MMP
169,946,BACKGROUND,CONCLUSION,COPYRIGHT,EMT,IRELAND,LABEL,LTD,METHODS,NCI,NSCLC,RESULTS,TGF,THESE
169,AUTHORS,COPYRIGHT,HOWEVER,IRELAND,LTD,MICROARRAY,NSCLC,PUBLISHED,WHILE
100,169,200,956,AUC,BACKGROUND,BBB,CONCLUSION,COPYRIGHT,CSF,GEFITINIB,ICA,INCREASED,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS,THEREFORE
169,COPYRIGHT,D40,HENCE,HIPPOCAMPI,NSCLC,PUBLISHED,SAS,SPARING
169,376,636,COPYRIGHT,COX,ELDERLY,END,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NCSLC,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THESE,USING
169,DPYSL,THESE
PRIMARY
CD147,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
ASXL1,JAK2V617F,R693X,USING
160,169,700,727,839,BAL,BLACKWELL
169,COPYRIGHT,CURRENT,INC,PET
MEIER
001,127,326,843,AGS,BACKGROUND,BINDING,LABEL,METASTASIS,METHODS,RESULTS,SGC,SP1,TNM
ALTERED,BACKGROUND,FOLLOWING,INCREASED,LABEL,LUNGS,METHODS,MMP13,OTHER,RESULTS,THEREFORE,THESE,WHITNEY
945,946,EXAMINING,H2009,HOWEVER,THEREFORE,THESE
100,563,607,898,BACKGROUND,FURTHER,GENOMIC,LABEL,MALAY,METHODS,PRINCIPAL,RESULTS,THESE
117,231,282,386,397,611,806,AMONG,BACKGROUND,BASED,CUSHING,HOUNSFIELD,JANUARY,KOREA,LABEL,MALIGNANT,MEDICAL,METHODS,OBJECTIVE,RESULTS,SAMSUNG,SCS,SEOUL,SOUTH
109,169,897,ADDITIONAL,AREVA,BACKGROUND,BASED,CONCLUSION,COX,HRS,INC,LABEL,METHODS,MORTALITY,NUCLEAR,RESULTS,WILEY
928,934,AUC,CXR,HOWEVER,NCN,ROC,SCREENING,THESE,TRIAL
107,140,239,642,AGE,AMONG,ASIAN,CANCERS,COX,FURTHER,ICD,INCREASED,INSURANCE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,USING
100,945,956,BACKGROUND,CONCLUSION,ELISA,HIF,IGF,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
CD133,CSC,FURTHER,HOWEVER,NANOG,NSCLC,OCT4A
002,003,007,330,572,902,AMONG,BACKGROUND,BMI,COEXISTING,COX,HRADJ,IIB,LABEL,METHODS,NSCLC,PFS,RESULTS,SCC
AFTER,BASEL,CLU,CLUSTERIN,CONCLUSION,LABEL,METHODS,MMP,OBJECTIVE,PCR,RESULTS,WESTERN
CEA,CEP,CHEST,FDG,PET,S10,SEPTEMBER

CHRONIC,SINCE
600,800,AFTER,IPF,KREBS,LDH,PULMONARY
246,FDG,IGA,PET,SCH,SEGMENT
CHEST,COLON,SEVERAL,THESE,TTF
000,100,358,BACKGROUND,COMPLEX,III,LABEL,METHODS,PONTEVEDRA,RESULTS
160,CM5,EARLY,HOWEVER,PROTEIN,WESTERN
160,ACC,ADENOID,ASSAY,QCMTM,THERE
945,AKT,CK2,MOLECULAR,PKB,TCF,WNT
954,HOWEVER,OPN,PTM
104,152,283,BETWEEN,LABEL,LOW,METHODS,NPV,NSCLC,OBJECTIVE,OBJECTIVES,PPV,RESULTS,STAGE,THEREFORE
169,COPYRIGHT,HOWEVER,INC,PHYSICIANS,PUBLISHED,TROUSSEAU
000,100,169,ALTERED,COPYRIGHT,CURRENT,DUE,ENT,JAPAN,PUBLISHED,SAS,UNTIL
100,169,215,24H,661,955,956,AFTER,ASSAY,COPYRIGHT,METAL,MTT,PDT,RESULTS
254,507,BACKGROUND,BECAUSE,ESTIMATED,HRS,LABEL,METHODS,MID,OBJECTIVE,RESULTS
001,100,124,149,169,1ST,29C,375,424,COPYRIGHT,COX,DENSITY,IRELAND,KARNOFSKY,LABEL,LOW,LTD,MEIER,NSCLC,UNLABELLED,USING
CURRENT,SEVERAL
954,BACKGROUND,CONCLUSION,DIR,KAPPA,LABEL,METHODS,RESULTS,RTT
100,177,99M,GIVEN,LABEL,METHODS,MODEL,NODULES,OBJECTIVE,OBSERVERS,PURPOSE,RESULTS,SPECT,THREE
145,CBCTS,DEPENDING,FARADAY,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
176,DTS,FINALLY,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,REFERENCE,RESULTS,SHORT,SYSTEMS,THREE,TOOLKIT
177,ABDOMINAL,AFTER,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
215,963,CURRENT,FURTHER,HERETOFORE,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
D99,FINALLY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,TEN,WHILE
CARLO,LABEL,METHODS,MONTE,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THESE
110,160,EBD,LABEL,MEANWHILE,METHODS,MHI,OBJECTIVE,PDETECT,PIR,PURPOSE,RESULTS
632,956,AMONG,BACKGROUND,HEM,HENCE,HOWEVER,LABEL,RESULTS
200,500,APRIL,CISPLATIN,FORTY,GRADE,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS
4T1,946,EMT,MAMMARY,TGF
177,181,COA,DU145,HMG,RAS
034,037,CIK,DENDRITIC,NSCLC,SIXTY,TTP
160,945,DIPNECH,GRP
169,ATS,BAC,CURRENTLY,ERS,GGO,IASLC,INC,PET,SEVERAL,SOCIETY,TNM,WILEY,WORLD
169,183,BESIDES,GEORG,NSCLC,STUTTGART,TKI
CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
160,CONCLUSION,FDG,ILD,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEPTEMBER,SIX,SUV,THERE
956,AMONG,H1299,SIX,THEIR,THESE

AUTOPSY,HOWEVER,KYODO,SAITAMA
BACKGROUND,EXPRESSION,FGF,FGF10,LABEL,METHODS,PBB,PPB,RESULTS,SHH,THEIR,THESE
769,786,ADDITIONAL,BACKGROUND,EPO,HOWEVER,LABEL,METHODS,RCC,RESULTS,RPTEC,TMA,USING
CCNE1,LABEL,METHODS,OBJECTIVE,OVCAR,PURPOSE,RESISTANT,RESULTS,THESE
169,ASSESSING,DCUN1D1,SENP2
160,956,AIR,ANGELES,BACKGROUND,CONCLUSION,COX,END,HAZARDS,HOWEVER,LABEL,LOS,MEIER,METHODS,RESULTS,SIMILAR,WHITE
AMONG,BACKGROUND,III,INSTITUTE,LABEL,LOW,METHODS,RESULTS,SCREENING,THESE,TRIAL
102,AMONG,BACKGROUND,BRITISH,DETECTION,EARLY,FOX,INSTITUTE,LABEL,MAJOR,METHODS,PAN,PREDICTIVE,PREDICTORS,RESULTS,TERRY
169,238,BACKGROUND,CONCLUSION,FDG,FOUNDATION,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
107,195,198,AES,ASIAN,BACKGROUND,BEV,CHEMO,CHINESE,ITT,LABEL,METHODS,MO19390,NSCLC,OBJECTIVE,RESULTS,SECONDARY,TTP
169,3SI,4T1,945,946,HOWEVER,LABEL,LAMA5,UNLABELLED
423,BACKGROUND,CONCLUSION,INCIDENTAL,LABEL,METHODS,RESULTS,SIXTY,THEIR,THERE,THOSE
001,005,160,223,400,421,BACKGROUND,LABEL,LNR,METHODS,RESULTS
ADX,AMONG,NEITHER,NSCLC,PLEURAL,REFRACTORY,THREE,TKI,TREATMENT
001,ACTIVATING,ASIAN,BACKGROUND,CAUCASIAN,CONCLUSION,GERMANY,LABEL,METHODS,MUTATIONS,NON,NSCLC,RESULTS,THESE,THYROID
BACKGROUND,CHEMOKINES,CONCLUSION,CXCR7,LABEL,METHODS,RESULTS
BACKGROUND,BMI,CONCLUSION,CONSORTIUM,HOWEVER,HRT,LABEL,METHODS,POTENTIAL,RESULTS
0325901,178,AAG,AZD6244,BACKGROUND,CONCLUSION,EBC,FURTHER,IRINOTECAN,LABEL,METHODS,PACLITAXEL,PF2341066,RESULTS,THESE,TOPOTECAN
100,946,AZA,HOWEVER,MTS,PCR,TNM,TREATMENT
160,215,420,CARLO,CCE,CLOUD,COMPUTE,EC2,ELASTIC,MONTE,STX,THREE,TVR,UNITS
039,082,085,AMONG,BLACK,CONCLUSION,DRUGS,EFFORTS,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RECEIPT,RESULTS
100,200,224,294,561,956,COMPLIANCE,CONCLUSION,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SPT
115,160,181,CARLO,CURVE,EAHY296,EAHY926,HRS,MONTE,POISSON,RESULTS,THREE
160,215,DEFORMABLE,DIR,DVF,FEM,PEARSON,SIX
BACKGROUND,CAUCASIAN,CONCLUSION,FDA,LABEL,METHODS
169,ALK,ATN,COPYRIGHT,FOLLOWING,IRELAND,LTD,NSCLC,URINARY
ISCHAEMIC
169,946,AKT,CCL18,CHEMOKINE,COPYRIGHT,EMT,HOWEVER,LIN,LTD,MEC,SNAIL
HOWEVER,OBSERVING,PET
947,CBCTS,CONCLUSION,LABEL,METHODS,PDM,RESULTS,UNLABELLED
174,BMETS,COMMERCIAL,CUMULATIVE,IVB,KEY,LABEL,MARKETSCAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,USA
180,CAUCASIAN,FURTHER,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STOMATITIS,THEIR
ACRIN,BACKGROUND,COGNITIVE,COLLEGE,CONTENT,CURRENT,IMAGING,LABEL,METHODS,MODEL,NETWORK,NVIVO,RADIOLOGY,REGULATION,RESULTS,SCREENING,SMOKING,SOCIETY,TRIAL

945,AMONG,CSC,EMT,EPITHELIAL,INCREASED,K15,SCC,SMAD4
169,231,ANIMALS,COPYRIGHT,MDA,PUBLISHED,THESE
169,COMPOUNDS,COPYRIGHT,CRATAEGUS,HRESIMS,LTD,NMR
169,177,6CM,AMACR,CDC,CK5,CK7,COPYRIGHT,GATA3,IHC,MSA,RCC,RENAL,SEVEN,SIMILAR,SIX,TEN
100,COMBINING,METASTATIC,THERE
166,177,199,228,255,945,947,ACCORDING,CD28MAB,CHANGES,CIK,EFFECTS,ELISA,GRANB,HYPACUE,IFN,INF,MFC,PBMNC,PERIPHERAL,TNF
955,FURTHER,HNSCC,NSCLC,SCC1483,THESE
148,160,169,ANESTHETIC,BACKGROUND,COPYRIGHT,INC,INTUBATED,LABEL,METHODS,OPERATIVE,PUBLISHED,RESULTS,SOCIETY,THERE
169,211,APRIL,BACKGROUND,COPYRIGHT,III,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,190,BACKGROUND,COPYRIGHT,GRADE,HOWEVER,INC,IPSLR,LABEL,LOCAL,METHODS,PUBLISHED,RESULTS,SOCIETY,T1A,T1B,T2A,TREATMENT
002,132,143,160,169,177,302,BACKGROUND,COPYRIGHT,COX,CURRENT,IIA,IIB,INC,LABEL,LNR,MEIER,METHODS,NODAL,NSCLC,PUBLISHED,RESULTS,SEVERAL,SOCIETY,THERE,TNM
169,178,BACKGROUND,CONCURRENT,COPYRIGHT,FORTY,FURTHER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE,THREE
169,211,605,699,756,813,AUC,BACKGROUND,COPYRIGHT,ESTIMATION,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
006,135,153,169,210,ACOSG,AMONG,BACKGROUND,COLLEGE,COPYRIGHT,GROUP,HOWEVER,INC,LABEL,METHODS,NOTABLY,PUBLISHED,RESULTS,SECONDARY,SOCIETY,THERE,Z4032
160,169,ACC,ATS,BACKGROUND,COPYRIGHT,EIGHT,FIFTY,INC,LABEL,METHODS,PUBLISHED,RESULTS,SCC,SOCIETY,TRANSITORY
BETWEEN,DEFINITIVE,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
103,BETWEEN,COMMITTEE,HIGHEST,IRELAND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RCS,RESULTS,SCIENTIFIC,SIXTY,TWA
III,LARGE,SURGERY
HOWEVER,IPF
ACCORDING,IDIOPATHIC,IPF,VIEWING
473,946,AKT,AMONG,EARLIER,EMT,HEP3B,HOWEVER,MH2,PA1,SER,SEVERAL,SMAD3,TGF
EVALUATION,HOWEVER,PET,SOLID
99M,BLOOD,CONCLUSION,LABEL,MBQ,METHODS,OBJECTIVE,RESULTS,SPECT
AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TRANSGENIC,WESTERN
33258,APOPTOSIS,BAX,BCL,CONCLUSION,HOECHST,LABEL,METHODS,MTT,NCI,OBJECTIVE,RESULTS,WESTERN
946,AXIN1,CONCLUSION,LABEL,METHODS,OBJECTIVE,PC3,PCR,RESULTS,SMAD3,TGF,WESTERN
169,ALTOGETHER,HGF,HSP27,MK2
ABC,ABCG2,ATP,BINDING,KNOCKDOWN,SP1,SP3
ERLOTINIB,GIVEN,LABEL,ONGOING,OPINION,SCC,STATEMENT,UNASSIGNED
169,INC,LOW,WILEY
CTC,DESPITE,FACTORS,HOWEVER,LABEL,NSCLC,OPINION,STATEMENT,THERE,UNASSIGNED
169,COPYRIGHT,LTD,WILEY
APRIL,BASED,COX,NSE,THESE
CONCLUSION,FIRST,LABEL,METHODS,OBJECTIVE,ORGAN,PROMISING,PURPOSE,RESULTS
263,945,ACTA2,CONSISTENT,EXPRESSION,FAK,LABEL,MET,METASTATIC,METHODS,OBJECTIVE,PC14PE6,PURPOSE,RESULTS,THEREFORE,THESE
001,967,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
019,025,041,048,050,ACCORDING,BARTHEL,BETWEEN,CONCLUSION,EORTC,INDEX,LABEL,METHODS,OBJECTIVE,PURPOSE,QLQ,QUALITY,RESULTS,SCALE,TREATMENT,WHITNEY
231,ERK,INHIBITION,LM2,MDA,MEK,RAS,THESE,UO126
ASIAN,COX,HOWEVER,RFS,SIMILAR,SP1,TAIWANESE,THEREFORE
946,AKT,HGPIN,HOWEVER,MUTATIONS,TGF
000,100,543,555,BACKGROUND,BIOLOGICAL,CONCLUSION,CTO,EFFECTS,LABEL,LAR,METHODS,MINIMAL,PCI,RADIATION,RESULTS,STEMI,VII
498,DOX,DOXOL,HCT,HEPG2,MCF,MTT,NCI,OVCAR,OVERALL,THEREFORE,WESTERN
DESPITE,JANUARY,SINCE
B5B,CK7,F18,FDG,MALIGNANT,MIXED,PET,THEREFORE,THYROID
101,150,215,300,CD8,CSF,DESPITE,OCTOBER,OVERALL
169,COPYRIGHT,EXPRESSION,INC,NSCLC,PCR
145,169,956,COPYRIGHT,LTD,NCI,OXI8006
169,HOWEVER,TELOMERASE,THEREFORE
066,169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PPN
169,COPYRIGHT,INC,PET
169,COPYRIGHT,EARLY,INC
169,COPYRIGHT,HOWEVER,INC,SCREENING,TRIAL
169,COPYRIGHT,IASLC,INC
001,169,943,947,981,982,984,992,993,997,AMONG,CCC,ICC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
154,169,308,445,900,AFTER,COLORECTAL,COPYRIGHT,DIAGNOSTIC,IRELAND,LTD,METHODS,OVARIAN,SCREENING,TRIAL
150,169,500,BACKGROUND,COPYRIGHT,EPIDERMAL,ERLOTINIB,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
009,051,059,169,COPYRIGHT,ERCC1,HOWEVER,III,IRELAND,LTD,NSCLC,TTP
160,169,684,946,ALK,AXL,COPYRIGHT,EMT,EPITHELIAL,FEDERATION,H2228,HSP90,PHENOTYPIC,PUBLISHED,SOCIETIES,TAE,TGF
169,956,AMONG,COPYRIGHT,LTD,MOLECULAR
169,AKT,BECLIN1,COPYRIGHT,GSH,LTD,NELUMBO,PREVIOUSLY,ROS,TAKEN
160,169,AUTHORS,COPYRIGHT,INC,PUBLISHED,REPORTS
001,002,169,241,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DEPARTMENT,DICLE,FDG,LABEL,MEDICAL,METHODS,PET,PORTUGUESA,PUBLISHED,RESULTS,SEPTEMBER,SOCIEDADE,THERE,UNIVARIATE,UNIVERSITY
085,169,C30,COPYRIGHT,DYSPNEA,EORTC,FIFTY,GRADE,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,QLQ,QOL,RESULTS,SECONDARY
169,956,COPYRIGHT,LTD,MAP,MCF,RESULTS,SINCE,THESE
169,AMONG,BSA,COPYRIGHT,HEPG2,LTD
169,ACC,AFTER,ATS,AUTOLOGOUS,BACKGROUND,CONCLUSION,COPYRIGHT,DAILY,DESPITE,LABEL,METHODS,NEOPLASMS,PRIMARY,RESULTS,SAS,SCC,THROUGH
102,169,267,633,799,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS
021,046,101,118,151,160,169,177,188,223,258,292,326,403,BACKGROUND,BETWEEN,COPYRIGHT,FURTHER,H2O,HOWEVER,INC,LABEL,LOW,METHODS,MIE,MINIMALLY,MOSBY,PUBLISHED,PULMONARY,RESULTS,SURGERY
169,177,927,955,BACKGROUND,COPYRIGHT,FDG,IRELAND,LABEL,LTD,MASAOKA,METHODS,PET,RESULTS,ROC,THERE
124,150,169,200,ADVERSE,AUTHORS,BACKGROUND,COMBINING,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,PLANNED,PUBLISHED,RESULTS,SECONDARY,SEPTEMBER
169,COPYRIGHT,INC,PUBLISHED,SOCIETY,THEREFORE
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
001,169,357,531,726,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,NOTABLY,RESULTS
001,006,013,048,111,169,945,APOPTOTIC,COPYRIGHT,NSCLC,OPN,PROLONGED,THERE,TNM,TUNEL
169,CIS,HISTORY,JAPAN,ORS,THESE
100,169,956,ANP,BACKGROUND,CONCLUSION,ELISA,ERK,FOS,FOUNDATION,JOURNAL,JUN,LABEL,LTD,MATERIALS,MEK,METHODS,PUBLISHED,RAS,RESULTS,SOCIETY,STICHTING,THESE,WILEY
ALK,HGF,HOWEVER,MET,THERE,THESE
124,263,629,BACKGROUND,D10,GRADE,LABEL,METHODS,MHD,MLD,NSCLC,PARAMETERS,RESULTS,UNIVARIATE,V65
169,49G,CONCLUDING,LTD,PROTEUS,PUBLISHED,WILEY
BACKGROUND,CONTEXT,DESPITE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,SEVERAL,SOURCES
954,AGGREGATES,CRYSTAL,FOCAL,THESE
ALK,BIOMARKER,COLLEGE,CURRENT,GUIDELINE,INHIBITORS,MOLECULAR,PATHOLOGY,SELECTION,TESTING
169,ALK,INHIBITORS,LADCS,RET,XL184
FURTHER,INSTITUTE,RESULTS,SHOWS
650,BAX,BCL,FURTHER,INCREASING,LAD,SILENCING,UNIVARIATE
100,CHINA,CONCLUSION,HOWEVER,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS,SMOKERS,SMR,THERE
007,040,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,RESULTS
141,659,ATP,HOWEVER,USING
156,211,426,487,557,560,576,603,667,763,77T,ARG194TRP,ARG280HIS,ARG399GLN,CAUCASIANS,HENCE,T241M,XRCC1,XRCC3
001,138,31G,B3LYP,BACKGROUND,BASED,COMPOUNDS,CONCLUSION,EPIDERMAL,FINALLY,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS,T790M,THEREFORE,THESE
001,007,008,945,946,BIOMARKERS,CHF,CKD,FRAMINGHAM,HEART,KIM,NRI,PRIMARY,SECONDARY,TFF,WHETHER
339,410,480,514,OVERALL,SEVEN,THERE,THEREFORE,THR241MET,XRCC3
001,146,173,CAUCASIANS,LABEL,SUPEROXIDE,UNASSIGNED,UNLABELLED
004,011,178,BMI,COX,HOWEVER,IGF,THERE,THEREFORE
EARLY,LABEL,NSCLC,OPINION,STATEMENT,UNASSIGNED

169,216,B16,LEWIS,LLC,PAI,SIMILARLY,THESE
001,069,110,113,120,132,138,154,158,168,177,203,215,219,257,336,354,407,540,LABEL,METHODS,NEITHER,OBJECTIVE,OPERATION,OPERATIVE,RESULTS
B16,CONPS,F10,METAL
169,H1299,LABEL,LY2801653,MET,NCI,NSCLC,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,SUSTAINED,THESE,TREATMENT
614,AFTER,BACKGROUND,BRITAIN,CONCLUSION,GREAT,LABEL,METHODS,RESULTS,THERE,TOTAL,TRS
203,BACKGROUND,HENCE,HOWEVER,INCIDENTAL,LABEL,METHODS,OTHER,OVERALL,RESULTS,SIXTY,SUBSEQUENT
106,133,164,BACKGROUND,CRP,KETTERING,LABEL,METHODS,MSKCC,RESULTS,SLOAN,TREATMENT,UNIVARIATE
177,C30,EORTC,FATIGUE,LABEL,METHODS,MULTIMODAL,OBJECTIVE,PURPOSE,QLQ,RESULTS,SCALE,TREATMENT
18F,FDG,PET
001,002,014,ANXIETY,ASSESSMENT,DEPRESSION,FUNCTIONAL,IMPROVING,INDEX,KNOWLEDGE,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PITTSBURGH,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SETTING,SLEEP,TREATMENT,VARIABLES
AIM,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,MHZ,OBJECTIVE,RESULTS
AIM,BACKGROUND,CHRONIC,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THERE
354,ADULT,AFTER,BACKGROUND,BMJ,CHINA,CHINESE,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,TOBACCO
021,046,425,ADC,KIRSTEN,MORPHOLOGY,RAF,THESE,TTF
169,30C,BACKGROUND,BASEL,COMPARING,CONCLUSION,HOWEVER,LABEL,METHODS,NSCLC,PCR,QRT,RESULTS,UTR
083,169,354,5MM,BACKGROUND,BASED,COPYRIGHT,FDG,IASLC,IRELAND,JANUARY,LABEL,LTD,MARCH,MATERIALS,METHODS,PET,RESULTS
001,100,169,COPYRIGHT,INC,MOLECULAR,PATHOLOGY,PUBLISHED,RAF,SOCIETY,SOMATIC,T790M,THESE
169,176,COPYRIGHT,ENDOGENOUS,INC,MOLECULAR,PATHOLOGY,PCR,PUBLISHED,SOCIETY,USING
169,233,5MM,ATS,COPYRIGHT,DIPNECH,ERS,IASLC,INSTITUTES,PATHOLOGY,THESE,UNIVERSITY
169,823,ADP,ANEMONE,AUTHORS,BAX,BCL,BESIDES,BGC,COPYRIGHT,HOWEVER,INC,KAZAL,MKN,MMP,PCR,PUBLISHED,RADDEANIN,REGEL,SGC,TRANSWELL,WESTERN
169,COPYRIGHT,CTV,EORTC,FINALLY,GTV,ITV,PET,PUBLISHED,RUYSSCHER,SAS,TREATMENT
009,014,016,034,163,169,311,ACUTE,AMERICANS,CAT,COPYRIGHT,FIM,INC,INVENTORY,LABEL,MEASURE,METHODS,NEITHER,NRS,OBJECTIVE,OLDER,OUTCOME,PAC,PUBLISHED,RESULTS,SES,SETTING
169,33258,945,COPYRIGHT,DHA,HEPG2,HOECHST,LTD,MTT,NCI,PUBLISHED,SKOV3
169,256,BACKGROUND,CARLO,CTP,INDIVIDUAL,LABEL,LAR,METHODS,MONTE,RESULTS,TOTAL
004,009,043,050,117,138,172,196,226,330,442,BACKGROUND,BOTLING,CONCLUSION,GAPDH,GLYCOLYSIS,LABEL,LEE,METHODS,NSCLC,OKAYAMA,PCR,PET,RESULTS,ROEPMAN,SHEDDEN
169,194,229,374,ACADEMY,CHOROIDAL,CILIARY,COPYRIGHT,CURRENT,DIAGNOSIS,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,PURPOSE,RESULTS,THERE
CNS,HOWEVER
169,438,BACKGROUND,COPYRIGHT,FINALLY,INC,LABEL,METHODS,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY
001,169,289,296,BACKGROUND,COPYRIGHT,FACTORS,INC,LABEL,LOS,METHODS,PREMIER,PUBLISHED,REGRESSION,RESULTS,SOCIETY
125,BACKGROUND,BASED,LABEL,MANAGEMENT,METHODS,RESULTS,SIADH,TEN,THESE
BACKGROUND,CANDU,CONCLUSION,COX,HOWEVER,LABEL,METHODS,ONTARIO,PICKERING,RESULTS,SIR,TRITIUM
FIRST,THESE
133,ABC,ABCG2,ALDH1,ATC,ATP,BACKGROUND,CD133,CSC,CXCR4,GP1,LABEL,LRP,METHODS,OBJECTIVE,PTC,RESULTS,THESE,THYROID
945,CRUCIALLY,EGF,EXPRESSION,HOWEVER,INHIBITION,NAV,NSCLC,TTX,VARIOUS
AMONG,CCAAT,DR5,HOWEVER,KNOCKDOWN,ROS,TAKEN,TRAIL
THERE,VIDEO
115,116,150,AFTER,BACKGROUND,EPIDERMAL,ERLOTINIB,HOWEVER,LABEL,METHODS,NSCLC,NSQ,PFS,PRIMARY,RESULTS,UNASSIGNED
FIRST,THERE
300,AFP,HCC,PIVKA,UFT
BACKGROUND,BECAUSE,CEREBELLAR,CHEST,CONCLUSION,CYBERKNIFE,LABEL,MARCH,THEREFORE
ERLOTINIB,GEFITINIB,MARCH,MAY,T790M
BECAUSE,RADIATION
150,3RD,4TH,ANXIETY,CBDCA,CPT,OCTOBER,SINCE
HDL,LOW
CELLS,INHALABLE,PULMONARY,RNS,ROS
169,176,AMONG,ASSOCIATED,COPYRIGHT,CXCL8,CXCR4,DFS,FRESH,III,LTD,MIF,PUBLISHED
181,AKT,COMPOUNDS,ERK,H1299,INHIBITORY,MTT,PFBR2,PFBR3,PFBR4

001,112,169,967,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PET,PURPOSE,RESULTS,SUV
AREAS,ATP,BACKGROUND,COVERED,DESPITE,LABEL,METHODS,NSCLC,OPINION,T790M
954,HOWEVER,IKK
HOWEVER,PULMONARY
000,012,014,100,921,III,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,UNASSIGNED,VIRTUAL
947,BACKGROUND,CONCLUSION,LABEL,METHODS,ORGAN,RESULTS,SCANDIDOS,TRILOGY
120,400,BR5,DISCOIDIN,NMR,USING
AFTER,AIM,LABEL,METHODS,NSCLC,RESULTS,ROS,UNLABELLED
COMPLIANCE,ERLOTINIB,GRADE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,THESE
B12,CLINICALLY,HOWEVER,MTA,NSCLC,PEMETREXED
AKT,ATP,CAV,CDC42,FAK,NOTABLY
000,001,024,041,053,093,109,167,313,572,884,SCC,STUDIES,THERE,THREE,UNIVARIATE
DESPITE,GAD,PNS
130,169,BACKGROUND,FINDING,LABEL,METHODS,RESULTS,SOCIETY,SOSLC
169,BAD,BAX,BIOLOGY,LOTUS,MAPKS,MOLECULAR,NELUMBO,THESE,UNION
169,956,AMONG,CO2,FUNCTIONAL,HOWEVER,MICROWELL,VCH,WILEY
946,EMT,GSK,THESE,USING
169,196,481,719,ADDITIONAL,AFTER,BONFERRONI,CHRONIC,CIS,NADPH,NAPDH,SCREENING,TRIAL,WHILE
039,100,200,233,686,847,LABEL,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RADON,RESULTS,THERE
778,869,CAUCASIANS,CIS,HOWEVER,ORS,OVERALL,XRCC3
2578C,676,861,CAUCASIANS,CBM,CIS,CRUDE,HOWEVER,LIBRARY,MAY,ORS,SCC,SCIENCE,WEB
ASIAN,FURTHER,HOWEVER,OVERALL
169,CXR,INC,MORTALITY,SCREENING,TRIAL,WHILE,WILEY
310,AFTER,ALOKA,ANATOMICAL,BACKGROUND,BECAUSE,BICLAMP,ETHICON,GERMANY,HITACHI,INC,JAPAN,LABEL,LAP,LTD,METHODS,OLYMPUS,RESULTS,SURGERY,TOKYO,TUEBINGEN,VII,VIO300D
001,103,122,159,274,BACKGROUND,CALGB,CONCLUSION,COX,EORTC,III,LABEL,METHODS,MPM,NLR,RESULTS,UNIVARIATE
174,239,ASIAN,BOEHRINGER,COMMITTEE,FDA,GIOTRIF,INGELHEIM,JAPAN,L858R,MEDICINAL,MEDICINES,NSCLC
019,047,37C,473,581,967,COX,ERCC1,MECHANISM,NSCLC,PCR,THERE
160,181,64258,ANNEXIN,CBF,K16,LDH,LEWIS,LYS16,TEM,THESE
001,288,552,AFTER,ASIAN,PTV,SWT,TANGENTIAL,V20
001,258,818,BACKGROUND,CONTINUED,GAMMA,GKS,IMAGING,JANUARY,KNIFE,LABEL,MEDICAL,METHODS,RESULTS,SEIZURE
169,EMT,F191G,FINALLY,HOXA9,LABEL,STRUCTURE,TARGETING,THEREFORE,THESE,TWIST,UNLABELLED
169,ATLAS,CXCR4,DEPLETION,DUE,INSPECTION,LABEL,RCC,SIMILARLY,TAKEN,UNLABELLED
006,011,114,124,161,177,FORTY,LABEL,MAJOR,METHODS,OBJECTIVE,PREDICTED,RESULTS
E2F,LENTIVIRAL
EPIGENETIC,FINALLY,HOWEVER,RUNX3,SLIT3,THESE,UHRF1,UTR
ACCORDING,LIMITED,PCI,SMALL,WHEREAS
BACKGROUND,BECAUSE,GRADE,HOWEVER,LABEL,METHODS,PCB,PRIMARY,RESULTS,THERE
BACKGROUND,BAYES,COLON,CONCLUSION,FEATURE,ITERATIVE,LABEL,MACHINE,MULTI,NAIVE,NCI,RECURSIVE,RESULTS,RFE,SUPPORT,SVM
APRIL,DESPITE,JANUARY,NSCLC,THESE
169,237,341,AFTER,AMONG,COPYRIGHT,ECTOPIC,H1299,INC,INSP3,ITPKA,MEPTT,TAKEN
180,BACKGROUND,CMTM7,COX,LABEL,METHODS,NSCLC,RESULTS,TSG,UNIVARIATE,WESTERN
169,COPYRIGHT,DIFFERENT,HOWEVER,INHIBITION,IRELAND,ITGB3,LTD,MICRORNAS,NSCLC,TNM
169,22YEARS,COPYRIGHT,IRELAND,LTD,P53,SEQUENCING,THESE,V157D
169,AUSTRALIAN
169,362,454,753,950,AIM,ALT,AST,BRITISH,DESPITE,III,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
ALK,NGS
174,AEROSOL,FINALLY,UNTIL,USA
AKT,EMT,FINALLY,IFS,THERE
100,BETWEEN,DOPPLER,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER
486,IGF,IGF1R,MICRORNAS
169,KEAP1,NVP
242,250,251,252,344,395,503,ADVERSE,CONCLUSION,DFS,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERIOUS,SIMILARLY
001,105,110,122,140,268,331,380,AICHI,APRIL,CEA,COX,III,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS
022,023,029,313,728,CAUCASIANS,CIS,G463A,MPO,ORS,OVERALL,SIMILAR,STRATIFIED,WANFANG
000,169,956,DEVELOPING,EGF,ERK,HOWEVER,IEF,MEK,NANOPRO,NSCLC,WESTERN
ICB,LRP,WESTERN
001,004,AFTER,BACKGROUND,ELISA,ILK,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM
001,003,032,036,620,AS1,CHINA,NSCLC,PEARSON,UNIVARIATE
522,6XA,6XC,6YB,6YC,6YE,6ZA,6ZC,6ZE,7XA,7XD,7YD,7YE,7ZA,7ZC,7ZD,7ZE,COMPOUNDS,HCT,NCL
BAMH1,BARTS,EBV,EPSTEIN,NPC,REPORTS,STUDIES,THESE
BECAUSE,CASP3,CASP7,CASPASE,PPI,THESE
515,810,CIS,CROHN,DENMARK,HODGKIN,IBD,JUTLAND,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SIR
065
169,PUBLISHED,SFT,SOCIETY
131,133,169,177,791,BACKGROUND,CIGARETTE,HOWEVER,ILD,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
015,046,0ML,101,115,127,169,190,5NG,8ML,BACKGROUND,FVC,HOWEVER,LABEL,LAM,LOW,METHODS,PUBLISHED,RESULTS,SIROLIMUS,SOCIETY,THESE
169,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,WHILE
169,362,405,411,491,583,909,BOS,KANKREJ,NUCLEOTIDE,PCR,SCC,SNP,VALIDATION
169,HOWEVER,JNK,PREVIOUSLY,SP1,SP3,THESE,TMPRSS4
204,215,688,CNTNAP1,COX,FAM156A,FRMD8,GALNTL1,SEQ,SNTB1,SNX10,TEN,THESE,TXNDC12
956,BIOSPIN,COMBRETUM,COMPOUNDS,ESIMS,NCI,TCI,THEIR,UTI89
REGULATION
ABOUT,AUC,BACKGROUND,HENCE,IGHG1,IGHG3,LABEL,PDIA6,PRINCIPAL,RESULTS,SDCCAG3,SEQUENCING,TAA
038,261,315,435,550,619,726,781,986,APRIL,ASIAN,ASN,ASP,ASP312ASN,ASSESSMENT,BACKGROUND,CAUCASIAN,DATABASES,HOWEVER,LABEL,LYS751GLN,MEDLINE,METHODS,NEWCASTLE,NSCLC,QUALITY,RESULTS,THESE,XPD
945,CRGDK,HOWEVER,MEANWHILE,RGD
005,007,010,016,017,027,036,038,043,242,BCL,CHINESE,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THREE,UTR
581,THERE,TRUNCATING,WHOLE
102,16HBE,BACKGROUND,HOWEVER,LABEL,METHODS,NBE,RESULTS,WESTERN
BAC,BACKGROUND,COX,GINS3,LABEL,MEIER,METHODS,MSP,MTS,PCR,PFS,RESULTS,S100P,TGFB3,WOUND
ALU,AML,BACKGROUND,EXPRESSED,LABEL,MEASURING,RESULTS,THESE
BACKGROUND,ENGLISH,HOWEVER,INCIDENCE,LABEL,METHODS,OVERALL,RESULTS,WHILE
HOWEVER,INHIBITION,MDK,MIDKINE,PTN,THEREFORE
200,CURRENTLY,EXPRESSION,LNCRNAS,MALIGNANT,MPM,NCODE,PLEURAL,ROC,THESE
947,AKT,BACKGROUND,FINDING,LABEL,MCF,PRINCIPAL,RESULTS,WESTERN

HLA,KIRSTEN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
363,945,GASTRIC,III,MBP,MICRORNAS,MYC,SNU,TAKEN
AKT,CONVERSELY,EMT,ERBB2,ERK,NEU,SNAIL,THESE
EVALUATION,MALIGNANT,MPM,PCR
245,CRE,HOWEVER,III,LTE,NCI,THESE,TNM
160,ADULT,ADVERSE,CONCLUSION,LABEL,METHODS,MPD,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,SIXTY
100,141,158,177,198,215,956,BACKGROUND,FIBROBLAST,LABEL,MATERIALS,METHODS,RESULTS
160,AMONG,BESIDES,BUN,FORTY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SELDINGER
160,GRADE,III,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SECONDARY
160,4T1,980,NIR,SWNTS
IMAGING
001,178,255,967,EOC,III,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
956,BAX,CCND1,GAPDH,HALLMARKS,MYC,PCR,THESE
011,119,181,229,233,336,531,538,795,917,ACCORDING,BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
18G,1970S,21G,5MM,CURRENTLY
947,ALA,ASP,CD133,CD4,CSC,DDX3X,GLU,IFN,SINCE,THESE
222,HOWEVER,METFORMIN,MIR,NCI,THEREFORE
002,028,134,AMONG,ATS,BACKGROUND,ERS,IASLC,L858R,LABEL,METHODS,PFS,RESULTS,SOCIETY,TKI
169,4T1,BSA,BXPC3,COPYRIGHT,DYNABEADS,EPCAM,EXFOLIATED,INC,MBS,PBS
IMT,ORIGINALLY
169,212,COPYRIGHT,LTD,TAKEN
169,COPYRIGHT,FAK,FOLLOWING,INC,STRIKINGLY
169,COPYRIGHT,HOWEVER,INC,USING
169,177,240,COPYRIGHT,DLS,DOX,DTA,NSCLC,PCL,SEM,THESE
169,COPYRIGHT,INC,MET,PPP,THEREFORE
001,106,126,134,137,160,169,218,271,298,300,841,946,BEV,CARBO,COPYRIGHT,COX,IRELAND,LTD,MEIER,NSCLC,PAC,PEM,PFS,THREE
001,004,169,215,BESIDES,CONCLUSION,COPYRIGHT,FACTORS,FAVORABLE,HOWEVER,IRELAND,LABEL,LOCATIONS,LTD,MATERIALS,METASTATIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PTV,RADICAL,RESULTS,SEPTEMBER,TREATMENT
005,169,215,AMONG,BIRC5,BRCA1,CASP8,COPYRIGHT,ERCC2,IRELAND,LTD,NSCLC,SEVENTY,THREE,XRCC1
169,21G,COPYRIGHT,LTD
169,190,COPYRIGHT,ERBB2,INC,MASSIVE,MOLECULAR,MPS,PATHOLOGY,PUBLISHED,SOCIETY,USING
13R,160,169,945,946,AKT,AUTHORS,COPYRIGHT,HOWEVER,INC,MEMBERS,PUBLISHED,TGF,WNT
160,169,205,ALK,APRIL,BACKGROUND,COPYRIGHT,INC,KIRSTEN,LABEL,MARCH,METHODS,MOLECULAR,PUBLISHED,RESULTS,SOCIETY
169,183,COPYRIGHT,LTD,PREVENTION,SCREENING,THESE,TRIAL
169,AXL,COPYRIGHT,CROSSTALK,LTD,MED12,NON,THR790MET
169,COPYRIGHT,FINALLY,LTD,NON,THEREFORE
169,CARDIAC,COPYRIGHT,HOWEVER,POTENTIAL,PUBLISHED,SAS,V20,V30
169,945,946,AG490,AG658,AKT,COPYRIGHT,CYTOKINES,DR4,DR5,FDA,IGF,INCREASED,INHIBITION,INSTEAD,JANUS,LTD,SINCE,SIRT1,TGF,TNF,TRAIL
169,5TH,AUTHORS,BASIC,COPYRIGHT,INITIATIVE,LMICS,LTD,PUBLISHED,REGULAR,THESE,WHILE
169,200,300,AUTHORS,BACKGROUND,COPYRIGHT,HRS,IHC,III,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,THESE
169,ARCHIVE,ATLAS,BLOOD,COPYRIGHT,EXOME,GENOMES,HEART,HOWEVER,INSTITUTE,LARGE,LTD,NHLBI,PROJECT,READS,SEQUENCING,THERE,THESE
CRICK,KRAS2,PNA,USING
PET
000,001,007,015,064,091,111,122,133,137,143,160,161,163,184,187,261,399,429,475,543,649,705,732,739,798,850,982,986,BIOMEDICAL,CAUCASIANS,CBM,CHINESE,CONCLUSION,LABEL,LITERATURE,MATERIALS,MAY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SCIENCE,SER326CYS,SIMILARLY,UNASSIGNED,VIRTUAL,WEB
231,BACKGROUND,IDC,IMAGING,LABEL,MDA,METHODS,MSP,PCR,PRE,PRKD1,RESULTS,USING
018,026,046,COMMITTEE,CONTROL,HISTOLOGIC,JOINT,SOCIETY,THERE,TNM,UNION
087,BLAND,COMPARISON,CONCLUSION,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PERCENTAGE,RESULTS,SOLID
877,AFTER,AMONG,CONCLUSION,FOV,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
EARLY
231,4T1,945,946,954,CSC,ERBB2,HCC1806,HMGB1,MDA,SMAD3,STAT3,TGF,THEREFORE,THESE
237,CD4,DEPARTMENT,FORTY,HIV,JANUARY,PNEUMOLOGY,SPAIN
169,RSK
AFTER,FINALLY,MAGOH,RBM8A,THESE,Y14
098,169,202,210,239,408,765,AUTHORS,CMT,DEE,IIA,INC,JOURNAL,PUBLISHED,STAGE,WILEY
005,008,015,177,665,946,ETT,FEDERATION,FINALLY,GYNECOLOGY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OBSTETRICS,RESULTS,THESE,WOMEN
ACS,LCS,NCI,OCTREOSCAN,PCR,SSTR2,SSTR3,SSTR5,SSTRS,TCS,THEREFORE
169,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,METASTATIC,METHODS,RESULTS,THERE,TOXICITIES
002,066,187,531,EPIGENETIC,MEIER,NSCLC
160,4T1,945,CHRYSIN,CURRENT,DAILY,DR5,HIF,IMMUNOBLOT,PCR,STAT3,TRAIL
DETECTION
802,BACKGROUND,DESPITE,EDINBURGH,FURTHER,INFIRMARY,LABEL,METHODS,PET,RESULTS,ROUTINE,ROYAL
169,COPYRIGHT,DEFORMABLE,DSC,GERMANY,NORMALIZED,PUBLISHED,THESE,THREE
001,169,24H,945,AUC,DEPRESSION,HPA,INCREASING,ROC,THESE,TNF,VAR
167,169,239,478,735,774,AMONG,BACKGROUND,COPYRIGHT,DISEASE,INC,LABEL,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SOCIETY,THEIR,THERE
160,169,BACKGROUND,BETWEEN,COPYRIGHT,FORTY,INC,JANUARY,LABEL,METHODS,NEITHER,PUBLISHED,RESULTS,SOCIETY
231,AAD,ANNEXIN,BAK,BAX,BCL,DBD,H1373,MBD,MCF,MDA,MTS,PRD,TAKEN,TUNEL,WHILE
BACKGROUND,CONCLUSION,DUE,FURTHER,INDIVIDUAL,LABEL,METHODS,MPC,RESULTS
AIM,BACKGROUND,CONCLUSION,FACTORS,GREENLAND,LABEL,METHODS,OBJECTIVE,PREVENTION,RESULTS,SERIOUS,SMOKERS,SMOKING
398,COX,DRUGS,FCA,NON,NSAID,PARTICULAR,PETRI,STEROIDAL,THEREFORE
E2F,SMALL,THROUGH
000,001,033,042,069,178,403,442,656,BMI,CIS,EGGER,HOWEVER,HRT,LIBRARY,MAY,ORS
C57BL,CCL12,LLC,MOUSE,MPE,THESE,USING
947,ATPASES
169,29A,335,BECAUSE,EXPRESSION,IGF,LABEL,RANKL,SBC,SMALL,THESE,UNLABELLED
002,196,368,BACKGROUND,BMI,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SEX
100,128,400,779,800,956,AMONG,BACKGROUND,CALCIUM,COX,HOWEVER,HRS,INITIATIVE,LABEL,LOWER,METHODS,OBJECTIVE,OBJECTIVES,PRIOR,RESULTS,TRIAL,VITAMIN,WOMEN
BACKGROUND,BECAUSE,CONCLUSION,IMT,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE,THREE
169,BAF,BCL,HOWEVER,LUC,MDR,PTX,VCH,WILEY
169,945,946,RCC,STS
169,CONSISTENT,EGF,FANCONI,HOWEVER,HRR,ICL,RAD51
FOXO1,FOXO3,NOTABLY
AFTER,BACKGROUND,BIOMEDICAL,CHALLENGE,DIAGNOSTIC,EXPRESSION,FIFTY,LABEL,MOTIVATION,OMNIBUS,RESULTS,SIGNATURE,TEAMS
120,945,956,BCL,CHINESE,GANODERMA,GLK,KARST,LEWIS,LEYSS,TNF
169,AUTOPHAGIC,AUTOPHAGY,BRAFV600E,LABEL,TRP53,UNLABELLED
CHINA,KIT,STUDIES,T801I,THERE
CLINICALLY,H19,H3K9ME3,MINERAL,SILENCING,TAKEN
215,HOWEVER,THEREFORE
176,AL2O3,FIT,FNTDS
169,AFTER,DLT,INC,WHILE
956
183,193,203,559,AMONG,BACKGROUND,DISCUSSION,LABEL,MEDICAL,METHODS,RESULTS,SCR,SWEDISH
HOWEVER
200,250,945,947,956,IFN,NOTABLY,PBMCS,PERIPHERAL,SEA,SEG,SEI,TNF
946,AFTER,EMA,HOWEVER,PRIMARY,RFA,SEVEN,SIX
INHIBITION
WIEDEMANN
123,BRCA1,FURTHER,MPM
001,1A1,500,76A,946,956,AIN,AKT,ALDEFLUOR,ALDH1A1,ESCIN,NNK,THREE
183,400,500,AUC,CDD,GRADE,LABEL,METHODS,MTD,NSCLC,OBJECTIVE,OBJECTIVES,PEMETREXED,RESULTS,SUNITINIB
CURRENT,PRIMARY,TCM
169,956,ADP,AKT,BAD,BAX,BCL,COPYRIGHT,FADDR,FAS,IGF,IGF1R,LTD,NIMBOLIDE,WILEY
469,956,CELLS,DEG,NAVO3,WHILE
948,AKT,CCAAT,EBP,ERK,EXPRESSION,HOWEVER,LEP,MEK,NRF,STAT3
150,169,250,AMENDMENT,EGF,LABORATORY,OVERALL,THERE,THEREFORE,TKI,TTF
191,BACKGROUND,CONCLUSION,ENROLMENT,FOLLOWING,HRQOL,III,LABEL,METHODS,NORWEGIAN,RESULTS
175,AMONG,BACKGROUND,CONCLUSION,DLT,EVEROLIMUS,LABEL,METHODS,RESULTS
001,002,032,112,666,BACKGROUND,CONCLUSION,DFS,DSS,FIB,LABEL,METHODS,MVD,RESULTS,WBC
169,COLLEGE,CONCLUSION,COPYRIGHT,FINALLY,INCREMENTS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PEARSON,PREDICTED,PUBLISHED,RCT,RESULTS,ROYAL,SCATTER,SEVERAL,TOTAL
AKT,FURTHER,HGF,MET,MRC,PF02341066,THEREFORE
953,ATM,BLOOD,FIFTEEN,MTD,PKC,PROTEIN,SIX,THERE
AKT,BECN1,LC3,TAKEN,USING
169,946,ACC,ADENOID,CONCLUSION,COPYRIGHT,EMT,EXPRESSION,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RIIDN,SMAD2,TGF
169,CTC,HOWEVER,MES
111IN,CMV,DOTAP,GAMMA,NSCLC,SPECT,SSTR2,TUSC2,WESTERN
169,COPYRIGHT,IRELAND,LTD,NSCLC,TMA
169,945,954,AKT,CHINESE,COPYRIGHT,CXCR4,HIF,IRELAND,LTD,POLYGONAM,RHEUM,STAT3
169,CARLO,FINALLY,GORFINE,HOEFFDING,KENDALL,MONTE,PEARSON,PRESS,PUBLISHED,SYSTEMATIC,UNIVERSITY
169,413,BACKGROUND,CONCLUSION,COPYRIGHT,COSTS,DESPITE,DIAGNOSTIC,IRELAND,LABEL,LTD,METHODS,NON,OBJECTIVE,RESULTS
169,AD5,CAR,H2052,HOWEVER,NCI,ONCOLYTIC
169,JAK,NSCLC,PC9,STAT3,THESE
AFP,BACKGROUND,BUN,CONCLUSION,CONTROL,DOX,ERK,HCC,HEMATOLOGY,LABEL,METHODS,PLT,RESULTS,SERUM,WBC
120,169,710,800,AUSTRALIA,AUSTRALIAN,CONCLUSION,INDIGENOUS,INSTITUTE,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,REGISTRIES,RESULTS,WELFARE,WILEY
280,AFTER,CALIFORNIA,CONCLUSION,COX,FOREIGN,HISPANICS,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
ATP,CDC42,FRAX597,GROUP,KNOCKDOWN,NF2,PAK,RAC,THESE
000,CPS,HOWEVER,PEGYLATED
169,DUE,INC,MALIGNANT,THEREFORE,WILEY
001,009,195,305,CHRONIC,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SIXTEEN,THERE,UNASSIGNED
169,VCH,WILEY
169,ADP,BCL,MICROARRAY,PIAS3,PROTEIN,STAT3
002,767,890,CAUCASIANS,SIMILAR,SINCE
136,945,B55,FURTHER,HOWEVER,MICRORNAS,NSCLC,PPP2R2A
FURTHER,HBE,HIPPO,HOWEVER,KNOCKDOWN,NSCLC,WWTR1
ENGLISH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTK,SCC
FAO,GEMMS,NSCLC,TRP53,USING
CD133,EPCAM,EXPRESSION,HOWEVER,LCSCS,SINCE
140,169,183,COPYRIGHT,DLC,DOX,GLU,HCL,INC,LTD,MATERIALIA,MAXIMUM,MTD,PEG,PHE,PUBLISHED
AIM,CD117,CD5,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,PAX,POSITIVITY,RESULTS
102,109,817,854,920,933,934,BACKGROUND,CK7,LABEL,METHODS,PLC,RESULTS,TTF
169,COPYRIGHT,HOWEVER,LTD,MCF
CHINESE,EBV,EPSTEIN,EXTRANODAL,HOWEVER,LABEL,PGK,PRIMARY,TCR,UNASSIGNED,UNLABELLED,VIRTUAL
464,ALONGSIDE,BACKGROUND,CELSIUS,CHERNOBYL,FIFTY,FOLLICULAR,INCREASING,LABEL,MEDULLARY,METHODS,RESULTS,SEVEN,SURGERY
001,003,004,009,010,011,022,275,698,699,HOWEVER,NSCLC,UNIVARIATE
100,169,175,220,BACKGROUND,BMI,CONCURRENT,COPYRIGHT,CTX,ESPAT,INDUCTION,IRELAND,LABEL,LTD,LTS,METHODS,NOS,NSCLC,PUBLISHED,RESULTS,RTX,SURGERY
215,LCNEC
SCC
AFTER,FOLFIRI,FURTHER,HOWEVER
169,ADP,AUTHORS,BECAUSE,EMBRYONIC,INVASIONS,LTD,NOTABLY,PATHOLOGY,PTY,PUBLISHING,SINCE,SOCIETY,WILEY
AMONG,BACKGROUND,CBP,DLT,HOWEVER,III,LABEL,METHODS,MTD,NSCLC,NVB,PREVIOUSLY,RESULTS,THEREFORE
177,951,954,956,A2780,BF4,MEG,MRC,NMR,OH2,PF6,PO3
AAA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
006,101,190,319,435,BACKGROUND,BETWEEN,CON,CONCURRENT,CRT,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,SEQ
006,103,947,BACKGROUND,CONCLUSION,D50,INDIVIDUAL,LABEL,METHODS,QUANTEC,RESULTS
177,CONCLUSION,CTV,ECLIPSE,ESTIMATED,ESTIMATES,FIELD,GROUP,IMN,LABEL,METHODS,OAR,OVERALL,RESULTS,UNLABELLED
BACKGROUND,CONCLUSION,EXHALED,LABEL,METHODS,RESULTS
002,BACKGROUND,BASED,COMPARISON,CONCLUSION,EIG,LABEL,METHODS,RESULTS,SEVENTEEN,THESE,TREATMENT,V20
177,BACKGROUND,DEFORMABLE,HOUNSFIELD,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS
104,AMONG,BACKGROUND,C1Q,ECS,HOWEVER,HSP,IGA,LABEL,METHODS,MGN,OTHER,RESULTS,SCHOENLEIN,SINCE,SLE,TRI
124,131,DIFFERENT,H1299,HOWEVER,L858R,MORPHOLINO,MUTATIONS,NSCLC,PET,USING
HOWEVER,SCENT,STUDIES
001,013,AFTER,AGE,BASED,CHINA,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THREE
MALIGNANT,MPM
002,178,AMONG,BACKGROUND,COX,LABEL,METHODS,RESULTS
DAH,DIFFUSE
121,CD3,CD4,CD8,CIK,HCC
AIM,BACKGROUND,CONCLUSION,FURTHER,IRELAND,LABEL,LINCOLN,METHODS,NCR,OBJECTIVE,REGISTRIES,RESULTS
002,015,018,166,181,962,ADC,CIR,CUMULATIVE,GROUP,JAPAN,KETTERING,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SLOAN,T1AN0M0
CD11C,DCS,HIRSCHHORN,INDUCTION,KNOCKDOWN,TADCS,THESE,TWIST,WHSC1
945,956,ANACARDIC,BECAUSE,BECLIN1,BIP,GADD153,GFP,GRP78,HOWEVER,LC3,TEM,UPR
011,100,CONCLUSION,ITERATIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SOLID
001,007,008,122,132,137,139,160,ALK,IHC,NSCLC,OPTIMISED,PCR
129X1,953,C57BL,CRICK,DISRUPTION,NOTABLY,POL,SVJ
AKT,ALANINE,HOWEVER,SUBSTRATE,THESE
160,169,AUTHORS,COPYRIGHT,DSCR1,FURTHER,HOWEVER,INC,INCREASED,PUBLISHED
169,170,200,BESIDES,COPYRIGHT,NCI
169,945,946,947,ABSENCE,BRONCHIAL,ELISA,INC,MDA,OXIDATIVE,REGARDLESS,STUDIES,TGF,TNF
169,H1299,TEROXIRONE
169,COPYRIGHT,ECTOPIC,FEDERATION,MICRORNAS,NSCLC,PUBLISHED,SOCIETIES
169,APEX1,COPYRIGHT,CPG,FEDERATION,GUANINE,PUBLISHED,S326C,SOCIETIES
026,044,169,904,945,COPYRIGHT,HOWEVER,INC,THESE,WORLD
169,COPYRIGHT,FGF23,INC,MCT,PMT,TEN
169,CASES,CONCLUSION,COPYRIGHT,GGA,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,THERE
100,115,163,169,338,453,981,BACKGROUND,COPYRIGHT,INC,LABEL,LYMPH,METHODS,PUBLISHED,RESULTS,SOCIETY,SYSTEMATIC,THERE
160,169,177,178,BACKGROUND,COPYRIGHT,FINAL,GRAFT,INC,LABEL,METHODS,MOSBY,NSCLC,OVERALL,PUBLISHED,RESULTS,SURGERY,THERE,THREE
044,060,104,109,BACKGROUND,CHI,FEW,LABEL,METHODS,RESULTS
001,133,169,COPYRIGHT,CROWN,CYBERKNIFE,HISTOLOGY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THERE
169,CLEAR,COPYRIGHT,CREB1,EWS,EWSR1,SEVERAL,SINCE,THERE,THESE
169,ACCORDING,COPYRIGHT,IRELAND,LARGE,LCNEC,LTD,THERE
001,100,169,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,HRF,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS
000,100,169,COPYRIGHT,CROWN,CRUMP,DEPENDING,HOWEVER,MINES,PUBLISHED,THESE,USING
112,BACKGROUND,EBL,HEMOPTYSIS,LABEL,METHODS,REGARDLESS,RESULTS,THERE,VARIABLES
BACKGROUND,EVALUATING,EVERY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THEIR
002,005,022,424,877,940,BACKGROUND,CHEST,DETERMINE,DIMENSION,EUROQOL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RATIONALE,RESULTS,THOSE
004,005,019,126,139,177,265,339,BACKGROUND,CTS,LABEL,MAC,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,WITHOUT
11H,183,CH1,COO,COOET,CU2,ESI,ETOOC,H2O,MEOOC,MTT,NMR,SW480,ZN2
160,169,177,609,AIM,BASED,DIFFERENT,LTD,PUBLISHED,TRANSPLANT,WHETHER,WILEY
169,TEMPO
AKT,CL1,COMMERCIAL,EGF,ERBITUX,RTK,WESTERN
181,945,CMP,DLD,DMB,DP3,HOWEVER,POLYSIALIC,ST8IAII,STX,USING,UTILIZING
ANTICANCER,ASP,TAKEN
276,543,640,658,814,856,871,CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,ORS,PUBLISHED,RESULTS
001,003,045,279,326,410,ADPRT,ASP148GLU,BACKGROUND,CHINESE,CYS,LABEL,METHODS,RESULTS,SER,SER326CYS,THREE,VAL762ALA
945,946,AKT,EPIDERMAL,INHIBITION,KNOCKDOWN,MEK,SIGNALING,TREATMENT,U0126
312,ALK,AMONG,BACKGROUND,CAUCASIAN,CHINESE,ECHINODERM,HOWEVER,IHC,INCLUDING,LABEL,METHODS,NSCLC,PCR,RESULTS,REVERSE
BACKGROUND,BEL,CARCINOMAS,CY5,FIRSTLY,LABEL,LS2,PRINCIPAL,RESULTS,SELEX,TCA8113,THEIR,ZY8
BACKGROUND,LABEL,PRINCIPAL,RESULTS,THEREFORE
001,215,386,BACKGROUND,FDA,INCLUDING,LABEL,METHODS,RESULTS
EGF,GIVEN,TAKEN
169,FOLLOWING,GENOMIC,HER2V659E,LABEL,UNLABELLED
001,237,ASSOCIATED,BACKGROUND,ILC,LABEL,NUCLEAR,PROTEIN,RESULTS,SINCE,YAP,YES
000,160,220,AUTHORS,BACKGROUND,CENTRAL,CISPLATIN,COLLECTION,CONTROLLED,III,ISSUE,JANUARY,LABEL,MARCH,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RANDOMISED,RESULTS,SELECTION,SOCIETY,THERE,THEREFORE,TRIAL
100,125,231,400,680,CTC,MCF,MDA,SMALLER,T24,USING
CURRENT,EXOGENOUS,FGF10,FIBROBLAST,III,MEK,PCR,UROTHELIAL,WESTERN
000,150,221,BACKGROUND,LABEL,MEDICAL,METHODS,NAGELKERKE,RESULTS,SCREENING,SEVERAL,SOUTH,SWENSEN,THREE,TRIAL,UNIVERSITY
008,035,115,194,CONCLUSION,COX,FDG,III,LABEL,MEIER,METABOLIC,METHODS,MTV,NSCLC,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,ROC,TLG
169,243,311,374,BASEL,CARDIAC,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHILE
169,BASEL,COPYRIGHT,EXTENSION
001,006,014,027,031,169,782,BACKGROUND,CONCLUSION,COPYRIGHT,DISEASE,FDG,LABEL,LTD,METHODS,MTL,MTV,PET,RESULTS,TLG,UNIVARIATE
169,ACH,AUTHORS,CHOLINE,COPYRIGHT,DMA,H69,HOWEVER,LTD,NCI,NHE,PCR,PUBLISHED,THESE,VARIOUS
169,AUCL3,GIVEN,III
169,946,BACKGROUND,CELLS,COPYRIGHT,CURRENTLY,CXCL4,ELISA,IRELAND,LABEL,LTD,MALIGNANT,MCP,METHODS,MMP,MPE,PLEURAL,RESULTS,TGF,TH2,THERE,THESE
026,CONCLUSION,LABEL,MDR,METHODS,NSCLC,OBJECTIVE,RESULTS,RRM
033,046,121,125,140,169,183,196,199,200,250,395,400,BACKGROUND,CHINA,CHINESE,COPYRIGHT,FEB,LABEL,LTD,METHODS,NOV,RESULTS,TRC,TRIAL
154,169,BASAL,BPLER,COPYRIGHT,EXPRESSION,HMLER,INC,MCL,PROTEASOME,TNBCS
001,161,169,CIK,COPYRIGHT,CURRENTLY,INC,NSCLC
008,016,034,059,169,172,177,241,306,540,945,ACCORDING,BACKGROUND,COPYRIGHT,HIF,LABEL,METHODS,OBJECTIVE,RESULTS,STUDIES,THERE,TNM
AFRICAN,AMERICANS,AMERINDIAN,CALIFORNIA,DECREASED,EDUCATION,LABEL,LATINOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SES
BACKGROUND,CHINA,COLLEGE,CONCLUSION,EXPRESSION,LABEL,MEDICAL,METHODS,MTF,NRF,NUCLEAR,PCR,RESULTS,SURGICALLY,THESE,TOTAL,ZUNYI
5GY,946,COMBINING,CSC,EMT,NON,NSCLC,OCT,PDFGR,PDGFR,SNAIL,THESE
ATS,BACKGROUND,ERS,LABEL,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,RESULTS,SOCIETY
CURRENTLY,HOWEVER,NCD,WORLD
FURTHER,JAPAN,SMALL,UNION,USA
215,560,BLOOD,CUSHING,PLEURAL,TREATMENT,URINARY
169,4T1,946,HOWEVER,INSTEAD,JAK,SEVERAL,STAT3,TAKEN,WHILE
009,031,169,233,AFTER,ATLAS,LABEL,MARKERS,METHODS,MIR,NOTABLY,OBJECTIVE,PCR,PURPOSE,RESULTS
116,CANDIDA,HCT,KOREA,NMR,SEPARACENE
139,141,BACKGROUND,BRAIN,CONCLUSION,DISEASE,EPSCC,IRELAND,LABEL,MANAGEMENT,METHODS,PATIENT,PCI,RESULTS
137,AFRICAN,ASIAN,BACKGROUND,CONCLUSION,EPIDERMAL,FURTHER,LABEL,METHODS,MUTATIONS,NORTH,RESULTS
176,ATS,BACKGROUND,CHEST,CHINA,CONCLUSION,COX,DFS,ERS,IASLC,LABEL,MEIER,METHODS,RESULTS,SOCIETY,UNIVARIATE
001,007,027,313,625,938,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,MODEL,PET,RESULTS
159,BACKGROUND,H1568,H1650,LABEL,METHODS,NSCLC,RESULTS,VIA,WILMS,WOUND,WT1
100,105,139,154,30A,379,629,742,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS,SIX,THERE
012,021,034,090,170,192,219,298,445,452,903,980,BACKGROUND,BESIDES,DIFFERENT,HOWEVER,L858R,L861Q,L861R,LABEL,METHODS,PFS,RESULTS,TKI
161,364,919,BACKGROUND,CONCLUSION,III,INSURANCE,LABEL,METHODS,RESULTS,TNM
CONGO,THERE,THESE
P53
012,113,178,220,292,336,967,BACKGROUND,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS
058,076,BACKGROUND,BLOOD,CAT,CATHEPSIN,COX,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,STUDIES,TNM,UNIVARIATE
AES,BACKGROUND,DCR,FORTY,GEFITINIB,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PEMETREXED,QOL,RESULTS
ABCG2,BACKGROUND,CD133,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
185,BACKGROUND,BBB,CHINESE,CPA,FDG,LABEL,METHODS,MRI,OBJECTIVE,PET,RESULTS,YANG1
ECS,EGFL7
004,109,111,118,215,ABSENCE,BACKGROUND,CHRONIC,CTCAE,LABEL,LLN,METHODS,NSCLC,OBTAINING,RESULTS,WHETHER
160,169,365,698,708,ACTIVATION,DOX,IBSEN,LED,LOCALIZED,PCB,PHOTOBIOL,PHOTOCHEM,PRODRUG,SOCIETY
017,215,438,948,CONCLUSION,DESPITE,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
004,064,494,502,587,713,906,BLUECROSS,BLUESHIELD,BROADLY,CAREFIRST,COMPLIANCE,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,PER,PURPOSE,RESULTS,SAVINGS
001,610,AMONG,BLACK,CONCLUSION,END,FORTY,INEQUALITY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
281,CONCLUSION,DRUGS,FIFTY,HEMATOLOGY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
CONCLUSION,FINALLY,LABEL,MEDICAL,METHODS,OBJECTIVE,PHASE,PURPOSE,RDI,RESULTS
178,181,185,398,916,947,AMONG,APOPTOTIC,CELECOXIB,COX,FINALLY,PGD,PGJ,PGS
11047,169,275,ECH,KEAP1
946,EMT,ETS,FGFR4,FGFRS,FURTHER,TAF
NOTCH,NSCLC,THESE
143,160,377,902,CONCLUSION,INPATIENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPANISH,SRE
ADP,AKT,ASIAN,BAX,BID,HBECS,JNK,NON,NSCLC
029,035,048,433,681,752,CAUCASIANS,MARCH,MPO,ORS,OVERALL,THERE,WANFANG
ASIAN,CAUCASIAN,HOWEVER,MPO
399,AFRICAN,ASIAN,CAUCASIAN,CHINESE,HOWEVER,ORS,XRCC1
169,279,361,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,RATIONALE,RESULTS,USING,WILEY
ALLOGENEIC
169,ACTIVATION,COPYRIGHT,EXPRESSION,LTD,MET,PC9,RESISTANCE,STUDIES,T790M,THEREFORE,THESE,WILEY
169,200,ADC,ATS,BACKGROUND,CONCORDANT,ERS,IASLC,LABEL,METHODS,RESULTS,SOCIETY
003,005,103,104,118,175,255,627,BACKGROUND,CHI,CONCLUSION,LABEL,METHODS,RESULTS,UNLABELLED,USING
500,895,ACCEPTANCE,BACKGROUND,DISCUSSION,INTUITIVE,LABEL,MEDLINE,METHODS,RESULTS,ROBOTIC,SUNNYVALE,VINCI
005,098,120,CURRENTLY,LABEL,LOW,METHODS,OBJECTIVE,ONCOLOGIST,PURPOSE,RESULTS
000,133,148,368,956,965,BACKGROUND,CENTERS,JANUARY,LABEL,MARCH,METHODS,RESULTS
145,6TH,7TH,BACKGROUND,EDITION,LABEL,LYMPH,METHODS,NSCLC,RESULTS,THERE,THESE,TNM
HIV,LABEL,LIVER,MSM,OBJECTIVE,PLWHA,PURPOSE,RESULTS,SCREENING,SUMMARY,TRIAL
HIV,LABEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE
169,COPYRIGHT,INC,PUBLISHED
169,BACKGROUND,BASEL,BIO,COPYRIGHT,GP5,GP6,HOWEVER,HPV,ISH,LABEL,METHODS,MEXICAN,OBJECTIVE,PCR,RESULTS
BACKGROUND,CONCLUSION,LABEL,METHODS,PCG,RESULTS
001,177,759,850,BACKGROUND,CONCLUSION,COX,E4599,EVALUATION,LABEL,METHODS,NSCLC,PFS,RESULTS,SOLID,THERE
BACKGROUND,BLOOD,CONCLUSION,CTC,GPG,LABEL,METHODS,NSCLC,RESULTS
152,234,252,296,AE1,AE3,BACKGROUND,CONCLUSION,DTC,EARLY,EPCAM,ICC,IMS,LABEL,METHODS,MOC31,NSCLC,RESULTS
946,AFTER,BACKGROUND,BCC,E12,HOWEVER,LABEL,METHODS
185,198,240,284,985,BACKGROUND,DISCUSSION,LABEL,METHODS,QALYS,RESULTS,SCREENING,TRIAL
AMONG,BACKGROUND,COX,ERCC1,LABEL,METHODS,NSCLC,PFS,RESULTS
954,B16,DU145,EXPRESSION,JAK,PDCD4,TAKEN
158,415,532,BMI,COX,NIH,OVERWEIGHT,WORLDWIDE
144,AFTER,BACKGROUND,COMPARING,HOWEVER,INTERFERON,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THERE
072,099,112,198,356,509,539,618,651,710,939,960,BACKGROUND,LABEL,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,THR241MET,XRCC3
INDUCED,INTRACRINE,LOCALLY,PITUITARY,PREMATURE
001,435,4T1,CONVERSELY,MDA,USING
001,133,158,177,181,190,BACKGROUND,C1Q,C4D,COMPLEMENT,LABEL,METHODS,RESULTS,THERE,WHITNEY
BRESLOW,CLARK,EASTERN,FIG,GROUP,HMB45,HOWEVER,K642E,KIT,PATHOLOGY
687,CONCLUSION,GROUP,INTERGROUP,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,RMS,STAGING
169,PRESS
068,134,644,678,863,ASIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SPM,THERE,THYROID,USA,WESTERN
JOINT,NON,NSCLC,TAM
001,694,732,841,CMTM8,CONCLUSION,INCREASED,LABEL,METHODS,OBJECTIVE,RESULTS,THERE

NON
4DDCS,DIFFERENT,EXTENSIVE,HOWEVER,ITV
169,29A,29B,29C,29S,946,COPYRIGHT,DNMT1,DNMTS,HOWEVER,INC,MIR,NSCLC,PCR,TAKEN,WESTERN,WIF,WNT
945,956,CL2,H2O,RESULTS
HCC4006,THESE,TKI
MES,NSCLC
158,169,186,215,219,522,664,CONSENSUS,CONSISTENT,GENOMIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAM,SUBGROUPS
BASED
169,COPYRIGHT,LTD
BACKGROUND,CONCLUSION,LABEL,METHODS
169,COPYRIGHT,CROWN,IRELAND,LTD,NSCLC,PERSISTENT,PUBLISHED
001,123,215,338,981,BACKGROUND,JANUARY,LABEL,MCNEMAR,METHODS,REGARDING,RESULTS,SCORE
100,FINALLY,NSCLC,REVERSIBLE
169,ARALIACEAE,ASTERACEAE,COPYRIGHT,LAM,LTD,NMR,THEIR
BACKGROUND,CBP,CONCLUSION,GRADE,HOWEVER,III,INCREASING,LABEL,METHODS,NSCLC,NVB,RESULTS,THERE,UNTREATED
100,169,241,BACKGROUND,COPYRIGHT,LABEL,LAM,MEIER,METHODS,OBJECTIVE,RESULTS,THREE
947,950,BACKGROUND,BECAUSE,CAR,CD3,CD8,CONCLUSION,EXPRESSION,F19,FAP,FIBROBLAST,IFN,LABEL,MALIGNANT,METHODS,MPM,RESULTS,TAA,THEREFORE
185,947,AFTER,BACKGROUND,GEFITINIB,H1975,HOWEVER,IFN,L858R,LABEL,LC3,METHODS,MHC,MPR,NATURAL,NKG2D,NKP44,NKP46,NOTABLY,RESULTS,T790M,ULBP1,ULBP2
AFRICAN,AMERICANS,BACKGROUND,CONCLUSION,CONTEXT,FIRST,HISPANICS,HOWEVER,LABEL,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SAMPLES,SMOKING
AREAS,BACKGROUND,COVERED,LABEL,METFORMIN,METHODS,NSCLC,OPINION,RAF,RAS
GFR,NSCLC,RTKIS
49A,CYTOTOXIC,HOWEVER,NSCLC,PCR
029,248,25307,312,365,389,410,561,595,742,836,847,871,APRIL,HYPOTHESIS,JANUARY,LABEL,MEDLINE,METFORMIN,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,THERE
158,202,360,ALK,BACKGROUND,IHC,LABEL,METHODS,PCR,RESULTS,SCREENING,THERE
HOWEVER,NSCLC,WILMS,WT1
174,GMP,OVCAR,PCR,PER,PHASE,REBMAB200
MESOTHELIA,TAKEN,YET
4T1,ATTENTION,GFP,MSC,RFP,THESE,TME,USING
AFM,CON,CONCLUSION,DOCETAXEL,GEL,HOWEVER,LABEL,MATERIALS,METHODS,MMP,MMPIS,NPS,OBJECTIVE,PCL,RESULTS,TEM
008,023,138,BACKGROUND,FREQUENCY,HRV,LABEL,METHODS,RESULTS,ROC
COA,DECREASING,ENDOGENOUS,HOWEVER,THESE,WESTERN
945,954,HOWEVER,HSP70,SIMILAR,TNF
002,222,CIK,CONCLUSION,COX,LABEL,MEIER,METHODS,MHC,OBJECTIVE,RESULTS
100,AKT,BLINDED,TKI
946,954,CIC,EMT,KIT,NSCLC,SNAI1,SNAI2,TGF,TNF
008,046,199,267,980,AFFYMETRIX,BACKGROUND,CTA,ESO,EXPRESSION,FURTHER,JBR,LABEL,METHODS,NAC,NSCLC,ONCOCARTA,RESULTS,SIMILAR,THERE
BACKGROUND,BMI,COLORECTAL,EDITORS,INSTITUTES,LABEL,METHODS,MHT,NIH,OVARIAN,RESULTS,SCREENING,SUMMARY,THESE,TRIAL,USING,WHILE
006,169,492,954,EXPRESSION,FINALLY
DESPITE,GIVEN,HOWEVER,III,LABEL,LARGE,NON,NSCLC,OPINION,STATEMENT,UNASSIGNED
002,009,045,1239C,1239G,2E1,526,CHINESE,CYTOCHROME,HOWEVER,ORS,TNM
233,237,BACKGROUND,CAIBARI,CARTESIAN,CIFUENTES,CLARA,LABEL,METHODS,OBJECTIVE,RESULTS,SAGUA,SANTA,VARIABLES,VILLA
AKT,CONCLUSION,GSK690693,LABEL,MDR,METHODS,MULTI,NCI,OBJECTIVE,PURPOSE,RAS,RESULTS,SNP,THEIR,THEREFORE,TIPIFARNIB,TXR,U87
100,160,BETWEEN,END,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OVERALL,PROPORTION,PURPOSE,RESULTS
145,179,218,300,322,403,820,ACTIVATING,CAUCASIAN,FINALLY,JANUARY,L858R,MUTATED,PCR,SIMILAR,THEREFORE,TTF,USING
EPITHELIAL,METASTASIS,NOVEL,TME
202,673,ADP,AZD,BMN,ERCC1,HOWEVER,NSCLC,PARP1,RAD51
505,916,BMS,CDC42,EX2,INHIBITION,LIM,LIMK1,LIMK2,LIMKS,MSC,NF2,PAK,RAC,SCHWANN,SCS,SIMILARLY
006,018,946,BIOMARKERS,COL11A1,ETS,MICROARRAY,PCR,SMALL,TGF
1LONG,ADP,BAX,BCL,FURTHER,HOWEVER,MCL,TANKYRASE,TELOMERES
DESPITE
169,COPYRIGHT,DZNEP,H3K4ME3,H3K9ME3,HMTASES,INC,PCR,REDUCED,SUV39H1
005,006,160,169,389,ARTESUNATE,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METASTASIS,METHODS,MOLECULAR,MOSBY,OBJECTIVE,RESULTS,TGF,USING,WNT
169,BRUCINE,CHINA,COPYRIGHT,H22,HCC,HEPG2,HIF,HYPOXIA,IRELAND,LTD,STRYCHNOS,THERE
169,540,546,554,ATP,CBP,CONVERSELY,COPYRIGHT,INC,INCREASED,SIRT2
100,169,99M,APART,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,TECHNETIUM
001,032,169,986,988,995,998,COPYRIGHT,EVALUATION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,REVISED,SOLID,THERAPY,WORLD
169,207,252,359,381,ALK,ASIAN,BACKGROUND,BLACK,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,THESE,WHITE
165,169,CAM,CONVERSELY,COPYRIGHT,FEW,GIVEN,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,177,514,BACKGROUND,CONCLUSION,COPYRIGHT,FEW,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
169,18F,FDG,INC,PET
001,169,300,COPYRIGHT,DFS,E2F,HDAC1,IRELAND,KNOCKDOWN,LTD,NSCLC,SNIP1,THESE,TMA
100,169,ALK,COPYRIGHT,HOWEVER,IHC,IRELAND,KIF5B,LTD,PCR,PRIMERS,RET,THREE
169,COPYRIGHT,IRELAND,LTD
003,017,026,169,209,239,245,307,AMONG,BACKGROUND,COMPLETELY,COPYRIGHT,COX,HOWEVER,INC,LABEL,LOBECTOMY,MEIER,METHODS,MUTATIONS,NSCLC,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,THREE
169,CALCIUM,GMP,LCP,LIPID,LTD,NSCLC,PHOSPHATE
169,CONCLUSION,COPYRIGHT,HOPKINS,JOHNS,LABEL,LTD,METHODS,OBJECTIVE,PROBLEM,PROJECT,PUBLISHED,RESULTS,SAUDI,STATEMENT,USING
169,ALK,AMONG,COPYRIGHT,CRIZOTINIB,CURRENTLY,FDA,HOWEVER,HSP90,LTD,MET,NSCLC
169,945,ADC,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,ECS,INC,LABEL,MALIGNANT,METHODS,MPE,MVD,PCS,PDGFR,RESULTS,SMA
169,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,CRIZOTINIB,CROSS,INC,LABEL,METHODS,NEITHER,NSCLC,OBJECTIVE,OVERALL,PEM,PEMETREXED,PFS,RESULTS,THERE
167,169,FE3,FER,NSCLC,PE1,PREVIOUSLY,SEVERAL,THEREFORE
AMERICA,FINALLY,LATIN,NORTH,PACIFIC,PREVENTIVE,WESTERN
AREAS,BACKGROUND,COVERED,FINALLY,INTRA,LABEL,METHODS,OPINION,SELECTING
169,COPYRIGHT,EARLY,INC,PALLIATIVE
169,COPYRIGHT,INC,QOL,QUALITY
169,COPYRIGHT,INC,PUBLISHED,SURGERY,THERE
169,COPYRIGHT,INC,PUBLISHED
169,COPYRIGHT,INC
160,169,COPYRIGHT,EFFORTS,III,INC,NSCLC
169,COPYRIGHT,INC
169,COPYRIGHT,EARLY,HOWEVER,INC,SURGERY,THERAPIES
169,COPYRIGHT,FURTHER,INC,SLN
169,COPYRIGHT,INC
169,COPYRIGHT,INC
169,COPYRIGHT,INC
169,COPYRIGHT,INC
169,COPYRIGHT,INC,JAPAN,LARGE
169,COPYRIGHT,ESTIMATION,INC
169,COPYRIGHT,III,INC,STAGE
ACTIVATING,ALK,AREAS,BACKGROUND,COVERED,FGFR1,LABEL,MET,METHODS,NSCLC,ONCOGENIC,OPINION,RET,SCC,SEVERAL
COX,HODGKIN,HRS,MEIER,NHL,WHILE
100,150,200,722,AMONG,ENDPOINTS,HRS,PFS,SCC,THERE
HOSPITALS,HOWEVER,NSCLC,THESE,UNIVERSITY
169,214,ALPK2,COPYRIGHT,HOWEVER,INC,NSCLC,THEREFORE,THESE,THROUGH,TNFAIP3,WILEY
169,25K,GFP,INC,LA1,MICHAEL,PDCD4,PEG,PEI,SPE,THESE,WILEY
956,AKT,DHA,HOWEVER
945,946,AKT,COX,EDA,EMT,ERK,OVERALL,PI3
00017,11Q,BIRC5,CPC,FANCONI,KLK12,OTP,PCR,PULMONARY
002,042,160,AGE,FIFTY,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,TKI
001,024,113,139,147,150,160,AIM,ALA,ARG,BACKGROUND,ETS,EXONS,GENOTYPING,HOWEVER,LABEL,METHODS,MNSOD,OBJECTIVE,RESULTS,TYR,VAL
169,LABEL,LIU,SUMMARY
CYSTEIN,DROSOPHILA,HIPPO,MAMMALIAN,NSCLC,OVERALL,PHOSPHO,STE20,YAP,YES
AKT,BCL,BRCC2
BACKGROUND,CCC,CONCLUSION,CONTROL,IMPROVING,LABEL,METHODS,PROTECTION,RADON,RESULTS,THREE
100,110,120,169,238,406,434,CONCLUSION,COPYRIGHT,DESIGNING,EFFECTIVE,FBP,IMAGE,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THERE,THREE
AKT,CULTURING,ECM,ERK,EXPRESSION,INHIBITION,LABEL,MEK,NCI,RE1,REPRESSING,SMALL,SRRM4,TAKEN,U0126,UNLABELLED
169,5MM,956,ALK,ATS,BACKGROUND,CK5,COPYRIGHT,ERS,IASLC,IRELAND,JANUARY,LABEL,LTD,MARCH,METHODS,P63,RESULTS
100,169,239,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
169,CONCLUSION,COPYRIGHT,DEPENDENT,EPIDERMAL,IRELAND,LABEL,LTD,MATERIALS,MELTING,METHODS,NEITHER,OBJECTIVE,OBJECTIVES,PANEL,PCR,PST,RESOLUTION,RESULTS,TECHNOLOGY
100,169,599,ALK,CONCLUSION,COPYRIGHT,DETECTION,IHC,IRELAND,KIF5B,LABEL,LTD,METHODS,MUTATIONS,N581I,OBJECTIVE,PURPOSE,RESULTS,RET,V600E,VE1
CONCLUSION,GUIDELINES,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL,THERE,TREATMENT
160,BACKGROUND,EPIDERMAL,FORTY,GROUP,KMLCG,L858R,LABEL,METHODS,MOLECULAR,NSCLC,PCR,PNA,RESULTS,THERE
343,BACKGROUND,BASED,FDG,LABEL,LITERATURE,MEDLINE,METHODS,MRI,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
MCF,MOLECULAR,THREE
169,293,HEK,KEY,LABEL,METHODS,MTT,OBJECTIVE,OBJECTIVES,OTF,RESULTS,ROYAL,SOCIETY,THF
169,AML,KEY,LABEL,METHODS,MINIMAL,OBJECTIVE,RESULTS,ROYAL,SOCIETY,USING
DUE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SELECTING,THESE
103,112,177,266,277,ADF,IMAGE,LABEL,MCE,METHODS,MRE,OBJECTIVE,PET,PROCESS,PURPOSE,RESULTS,SOI,TBR,THEREFORE,TRANS
177,215,HOWEVER,LABEL,LTM,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROI,THESE,VALIDATION,VTM
111,240,311,CURRENT,DESPITE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
148,AREAS,DEFORMABLE,EVALUATING,FORTY,GTV,LABEL,METHODS,OBJECTIVE,PURPOSE,REGIONS,RESULTS,THERE
CARLO,EVALUATION,FITCHBURG,GTV,HEALTHCARE,HOWEVER,LABEL,LINAC,LOR,METHODS,MONTE,MOSEK,OBJECTIVE,PET,PHILIPS,PINNACLE3,PTV,PURPOSE,RADIATION,RESULTS
106,AIR,BACKGROUND,CONCLUSION,DENSITY,GGO,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
111,150,AGG,FINALLY,KDM6A,UTUCS,WHOLE
169,5DT,CDC,CDK,CONCLUSION,H1299,LABEL,METHODS,NSCLC,RESULTS,SCOPE,TAN,TANGERETIN,THESE,VCH,WILEY
001,007,1CM,258,2CM,476,734,ADC,ATS,BACKGROUND,CIR,CUMULATIVE,ERS,IASLC,KETTERING,LABEL,METHODS,MIP,RESULTS,SLOAN,SOCIETY
160,177,223,239,326,513,633,BETWEEN,BEV,MPE,NSCLC,SEPTEMBER,SIXTEEN
BESIDES,GREAT
956,MAXF401NL
169,CURRENT,DACOGEN,DNMTI,EPIGENETIC,THEREFORE,THESE
507,662,CHINESE,ETS,HAN,NSCLC,XRCC3,XRCC4
HOWEVER,SCIENCE,SOCIETY
174,181,357,AFFYMETRIX,AMONG,ARRAY,ASIATIC,ERK,EXPRESSION,MEK,PC9,RAF,RAS,WESTERN
BACKGROUND,FACTORS,FEW,HISTORY,HRQOL,LABEL,MCS,METHODS,PCS,RESULTS
CNT,KNOCKDOWN,MALIGNANT,MMP,PCR,WESTERN,WHOLE
BACKGROUND,DENSITY,ITALIAN,ITALY,LABEL,LT4,METHODS,OXIDATIVE,REGIONS,RESULTS,SEQUENTIAL,THERE
WHILE
ACTC1,CCNB1,CCNE2,ERRB4,FUNCTIONAL,IL6,KIT,NCI,NSCLC,PCR,SHH
353,946,AKT,EMT,ERK,INGENUITY,IPA,NCI,NSCLC,PATHWAY,SUBSEQUENT,TEC,U1752,WNT
442,BACKGROUND,CONCLUSION,FOLLOWING,GUIDELINES,LABEL,METHODS,NSCLC,PATIENT,RESULTS,TKI
GENERATION,NGS,PCR,SEQUENCING
ALK,CHINESE,IHC,PCR,SIGNALING,TECHNOLOGY,THEREFORE
CTS,DRILLER
169,CXCR4
007,ABL,BACKGROUND,CCL19,CHEMOKINES,CONCLUSION,CRK,LABEL,METHODS,RESULTS
128,ABCG2,ALDH1A1,BACKGROUND,BMI,CONCLUSION,IHC,LABEL,METHODS,NSCLC,PCR,RESULTS
169,439,COLLEGE,DDI,DESPITE,MET,NSCLC
001,015,169,405,BACKGROUND,LABEL,LOG,METHODS,NSCLC,RESULTS,SOCIETY,TKI
ATTENUATED,SALMONELLA,THEREFORE
AFTER
169,FINALLY,FIRST,GLS,RESISTING,RIG,ROS,TAKEN
028,032,138,169,BACKGROUND,COX,END,LABEL,MEIER,METHODS,OVERALL,PCI,RESULTS,SOCIETY,USING
169,NSCLC
FINALLY
000,100,112,124,1980S,1990S,2000S,235,AFTER,BACKGROUND,DENMARK,HODGKIN,HOWEVER,HUNGARY,LABEL,METHODS,RESULTS,SPAIN,UNION,WORLD
AFTER,CONCLUSION,COX,EIGHT,LABEL,MAY,MEIER,METHODS,MTV,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV,THERE,TLG
169,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,PFS,REGARDING,RESULTS,THESE
231,FUNCTIONAL,MDA,MICRORNAS,NOTCH,TAKEN,UTR
100,169,300,BACKGROUND,BAE,HEMOPTYSIS,IMMEDIATE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SUCCESS
169,CISPLATIN,COPYRIGHT,CURRENT,EVALUATION,HENCE,INC,JANUARY,MEDICAL,NSCLC,PEMETREXED,SOCIETY,SUPPORTED,THEREFORE,THESE
186,AMONG,BNP,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
FAK,HSP90,METABOLIC,THESE,UNC,USING
FURTHER
179,185,206,CONVERSELY,ECH,HDAC4,KEAP1,NADPH,PPP,ROS,SUSTAINED,TCA,USING
169,COPYRIGHT,HPV,IRELAND,LTD,OTHER
005,169,176,ARC,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PASSIVE,PURPOSE,RBE,RESULTS,THEREFORE,V20,V30
005,104,119,147,169,223,3DCRT,ACUTE,COPYRIGHT,COX,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THEIR
002,004,150,169,351,780,AMONG,ANITA,BACKGROUND,CALGB,COPYRIGHT,COX,DFS,HISTOLOGY,IRELAND,JBR,LABEL,LTD,METHODS,MUCIN,NSCLC,PROGNOSTIC,RESULTS
BASED,MIP,QUALITY,SINCE,THEREFORE
169,775,EMP,EPITHELIAL,HOWEVER,INC,NSCLC,TNM,WHILE
169,945,ALPHA,COPYRIGHT,FURTHER,GROUP,INC,PREVENTION,TOCOPHEROL,TRIAL,VITAMIN
139,267,BACKGROUND,BAL,ELISA,HOWEVER,LABEL,METHODS,MPO,PERIPHERAL,RESULTS,ROS
301,EASTERN,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL
106,110,ALK,BACKGROUND,CHINA,CHINESE,HUNAN,KIRSTEN,LABEL,MET,METHODS,PCR,RESULTS,TEN
CBCTP10,CRT,DIR,ECLIPSE,HOWEVER,NSCLC,PTV,THESE,TPS
001,144,425,850,CONCLUSION,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,TOXICITIES
000,100,170,250,460,490,BACKGROUND,CHINA,CHINESE,COX,HRS,LABEL,METHODS,MORTALITY,PEF,RESULTS,WESTERN
169,BL6,C57,HISTOLOGY,LEWIS,LLC,RENCA,SUNITINIB,TOPOTECAN,TREATMENT
DNMT1,FURTHER,MAMMARY,THESE
ASC,CCRL2,CSF,CXCR4,EMT,OBESITY,THEIR
003,BETWEEN,CPB,INCOMPLETE,IVC,LABEL,METHODS,MORBIDITY,OBJECTIVE,OBJECTIVES,RADICAL,RESULTS
001,215,954,CONCLUSION,FDG,FLT,FMISO,LABEL,METHODS,NSCLC,NUCLEAR,PET,RESULTS,SOCIETY,SUV,TEN,UNLABELLED
086,110,215,225,999,CONCLUSION,FDG,LABEL,METHODS,PET,RESULTS,SUV,SUVMEAN,TLG,UNLABELLED
169,1970S,1980S,CXR,EFFORTS,ELCAP,INC,THESE,WILEY
169,947,948,INC,MAJOR,MHC,VPA,WILEY
180,DFS,NSCLC,SPHK2,USING
DESPITE,NSCLC
169,945,947,AUTHORS,CURRENTLY,FCGAMMA,IGA,IGG,LTD,PUBLISHED,THESE,USING,WILEY
ALK,NSCLC,TKI
160,BELOTECAN,CONCLUSION,GRADE,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS
100,110,173,181,196,359,460,AFTER,CALIFORNIA,CHILE,KINGS
HCC
946,AVAILABLE,C57BL,CD8,CONCLUSION,FOXP3,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS
A2A,ANTAGONISM,ATP,CAF,NSCLC,PC9,THESE,WARBURG
HOWEVER,III,NSCLC,PHASE
AKT,COLON26L5,CUG,ERK,INHIBITION,STAT1,TAKEN,VEC
DUE,HOWEVER,POD,PTE,PULMONARY,THEREFORE
S10
FIFTY,THREE
000,200,500,AFTER,DUE,PRE
SSP,THEREFORE
1ST,2ND,THROUGHOUT
HOWEVER,SITES
VNR
7TH,8TH
BLOOD,CEA,SCC,SUV,VIDEO
3T3,EXPRESSION,MCP,MET,PCR,TAKEN,THESE
200MG,CYP2A13,KINETIC,MICHAELIS,NNK,THESE
HMB,JAPAN,SINCE
000,SITUS,UNIVENT
PARTIAL
169,COPYRIGHT,CROWN,EMT,FINALLY,HOWEVER,LTD,MET,NOTCH,NSCLC,PUBLISHED,SILENCING,TKI
169,INC,SIX,STEAP,THESE,USING
113,157,169,270,ASSESSMENT,COPYRIGHT,COUGH,FEW,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OLDER,RESULTS,SCALE,SHORTNESS,SYMPTOM,THESE
001,004,018,038,169,177,305,862,958,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PET,PUBLISHED,RESULTS,SIXTY,SOCIETY
169,231,946,954,ECTOPIC,EMT,MCF,MDA,TAKEN,TGF,WHILE
160,APO,APOA1,ASSESSMENT,BACKGROUND,CHRONIC,CONCLUSION,CONTEXT,FATIGUE,FUNCTIONAL,ILLNESS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THERAPY,THESE,TTR,WESTERN
169,COPYRIGHT,PUBLISHED,SIMILAR,THESE
169,COPYRIGHT,CROWN,ECTOPIC,H1299,HOWEVER,INC,PUBLISHED,TAKEN,TSA,USING
169,173,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,FURTHER,LABEL,METHODS,PROTEOMICS,RESULTS,SAS
007,027,031,169,427,504,582,655,677,736,805,806,932,AFP,COPYRIGHT,EDMONDSON,HCC,LABEL,LTD,MEIER,METHODS,OBJECTIVE,PERIOSTIN,POSTN,RESULTS,RFS
169,BECAUSE,CONCURRENT,COPYRIGHT,EMT,LTD,NSCLC,SILIBININ,SILYBUM,TKI
169,ADDITIONAL,COPYRIGHT,LTD,NCI,STRUCTURE
169,ADP,CISPLATIN,COPYRIGHT,FURTHER,H1299,HOWEVER,IRELAND,LTD,NAD,NSCLC,PUBLISHED,ROS,SEVEN,SIRT1,SIRT2,SIRTUIN,TAKEN
025,026,033,042,169,266,AMONG,BACKGROUND,CDX,COPYRIGHT,COX,GPR49,HOWEVER,III,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,RESULTS,TNM,TTF
003,129,160,169,177,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,LOBECTOMY,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY
169,291,337,AFTER,BACKGROUND,CONVERSELY,COPYRIGHT,GIVEN,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,TYPICAL
BACKGROUND,CONCLUSION,ELISA,FINALLY,FOXA2,GSH,HOWEVER,LABEL,METHODS,MUC5B,PCN,PCR,PREVIOUSLY,RESULTS,RNS,ROS,STAT6,THESE
AMONG,AVERAGE,BACKGROUND,CENTERS,CHINA,CHRONIC,CONTROL,DISEASE,HUBEI,LABEL,METHODS,PREVENTION,RESULTS,SRR,WHILE,YLL
843,946,AFFYMETRIX,BACKGROUND,FIBROBLAST,ILD,IPF,LABEL,METHODS,MHC,MICROARRAY,PCR,RESULTS,SSC,STAT1,TGF
FURTHER,MAB,MRC,RESULTS,SELECTIVE,TEM
2GY,946,AFTER,AXIN1,BACKGROUND,DNMTS,LABEL,LTE,MECP2,METHODS,MMP,PCR,RESULTS
277,ABC,BACKGROUND,CONSISTENT,FTASE,FTI,FURTHER,GILFORD,HUTCHINSON,LABEL,METHODS,PAK,PDR10,RAS,RESULTS,THESE,USING
000,024,034,CONCLUSION,EMT,EXPRESSION,IGF,LABEL,METHODS,MST,NSCLC,OBJECTIVE,ORR,RESULTS
HOWEVER
ARD,BACKGROUND,BARCELONA,DISCUSSION,HOWEVER,LABEL,METHODS,PLEURAL
160,BACKGROUND,ELISA,FINALLY,LABEL,METHODS,NON,NSCLC,PRDX1,RESULTS,TIF,WESTERN
CONCLUSION,END,EXCEPTIONS,HOWEVER,LABEL,METHODS,NON,OBJECTIVE,OVERALL,PROGRAM,RESULTS,SETTING
169,FINALLY,USING
169,ACC,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,FGFR1,HPV,INC,LABEL,METHODS,RESULTS,SCC,SNUCS,WILEY
169,300,ADULT,AMONGST,ENGLISH,HISTOLOGIC,INC,WHILE,WILEY,WILMS
129,169,277,342,366,635,728,90401,ASI,BACKGROUND,CALGB,COPYRIGHT,GROUP,LABEL,METHODS,ORR,PFS,POISSON,PSA,RESULTS,SOCIETY,THERE
169,ADC,BIO,HOWEVER,III,LA1,LIGANDS,LKR13,NSCLC,PERIPHERAL,SYNGENEIC,THESE
169,COPYRIGHT,LTD,MOTIVATED,WHILE,WILEY
169,ALPHA,CARLO,CHAIN,COPYRIGHT,FINLAND,LTD,MONTE,PREVENTION,TOCOPHEROL,WILEY
174,CARBOLYZER,CO2,HOWEVER,INC,JAPAN,LABEL,METHODS,OBJECTIVE,OSAKA,RESULTS,TAIYO
160,177,AREAS,BCG,CK5,DESPITE,GROUP,IHC,THERE
001,005,015,046,160,CK5,CK7,DONOR,HOWEVER,TTF
17R,954,BV8,CSF,ERK,THESE,WHILE
150,153,177,189,300,956,CYP3A,EFAVIRENZ,ERLOTINIB,HIV
001,269,306,431,BACKGROUND,EXONS,HOWEVER,L858R,LABEL,METHODS,NSCLC,PCR,PFS,RESULTS,T790M,THERE,TKI
DESPITE,JNK,JUN,NH2,NON,NSCLC
956,COMBINING,ERCC1,EXPRESSION,H1975,MKK6E,NSCLC,TREATMENT
039,150,926,BACKGROUND,FURTHER,LABEL,METHODS,NSCLC,PFS,RESULTS,RFC,THESE
ILD,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
169,ALK,BIOLOGICAL,HOWEVER,LABEL,MEK,NCSLC,NON,NSCLC,RAF,RAS,SILAC,SITES,SUPER,THROUGH,UNASSIGNED,UNLABELLED
169,COPYRIGHT,H1299,IRELAND,LTD,RAS,REGULATOR,RGS19,RGS20
169,PCR
026,169,AIM,BACKGROUND,CENTRAL,CISPLATIN,CONTROLLED,COPYRIGHT,EPIRUBICIN,ETOPOSIDE,HOWEVER,LABEL,LARGE,LTD,METHODS,ORR,RESULTS
366,415,437,473,501,528,606,670,BACKGROUND,DISCUSSION,LABEL,METHODS,OCCUPATION,ORS,RESULTS,SYNERGY
169,177,AFTER,COPYRIGHT,FORTY,INC,NSCLC,PFS
205,BACKGROUND,CONCLUSION,HOWEVER,JANUARY,LABEL,METHODS,RESULTS,SOCIETY,THEREFORE,UNIVARIATE,UNIVERSITY
169,BACKGROUND,FUNCTIONAL,GENERAL,LABEL,MAPK1,METHODS,MIR,PCR,RESULTS,SNAI2,WESTERN
169,BAYES,CPG,EUCLIDEAN,LTD,PUBLISHED
169,ATP,DUE,INCREASING,MME,REN
169,ACTIVATING,AXL,COPYRIGHT,IGF1R,IRELAND,LTD,NSCLC,T790M,TKI,YET
169,COPYRIGHT,ERBB2,HEXOKINASE,HK1,HK2,INC,SIMILARLY,USING
ALK,APART,BECAUSE,FGFR2,FINALLY,GASTRIC,MET,RTK,WHILE
169,CGA,CKPAN,CONCLUSION,EMA,LABEL,LTD,METHODS,OBJECTIVE,P63,POLYGONAL,RESULTS,SMA,SPB,SYN,THERE,TTF,WILEY
123,149,169,176,259,316,335,346,631,678,774,BACKGROUND,BSC,CONCLUSION,COPYRIGHT,DEFINITION,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,THERE
001,169,CONCLUSION,COPYRIGHT,COX,EXACT,GRADE,IRELAND,LABEL,LTD,METHODS,MONTHLY,OBJECTIVE,OBJECTIVES,PFS,RESULTS
301,437,632,BACKGROUND,COX,HENCE,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,THERE,WHETHER
102,150,169,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,CTI,ERLOTINIB,ILD,IRELAND,JAPIC,L858R,LABEL,LTD,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,SIX,T790M
038,169,BECAUSE,COPYRIGHT,IRELAND,LTD,MAINE,NSCLC,POISSON,POPULATION,WHILE
169,CA9,CAXII,COPYRIGHT,H1975,IRELAND,LTD,NSCLC,THESE
169,COPYRIGHT,FACULTY,HERNIATION,LEGAL,LTD,PPR,PRIMARY,RMS,SUBSEQUENT
169,AFTER,COPYRIGHT,CURRENT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
169,AAB,III,MEDICAL,PAB,PTV
160,169,BACKGROUND,COPYRIGHT,END,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE
169,FDG,FEDERATION,PET,PUBLISHED,THESE
169,241,250MG,AFTER,ALK,BID,CHEST,COPYRIGHT,CRIZOTINIB,PORTUGUESA,PUBLISHED,SOCIEDADE
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,215,AFTER,CHEST,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
117,169,268,AFRICAN,BACKGROUND,CAUCASIAN,CONCLUSION,COPYRIGHT,DCR,INC,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,TOOLS
121,165,169,220,640,AMT,BECAUSE,COPYRIGHT,COX,GROUP,HISTOLOGIC,INC,LABEL,MEIER,METHODS,NOS,NSCLC,OBJECTIVE,OVERALL,PFS,RESULTS,S0003,S9308,S9509,S9806,SOUTHWEST
008,028,031,033,169,229,AMONG,BACKGROUND,CONVERSELY,COPYRIGHT,EPIDERMAL,HOWEVER,INC,LABEL,METHODS,NSCLC,PFS,RAS,RESULTS,THEREFORE,THESE
169,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IMAGING,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,SCANS,SEVENTY
DESPITE,FURTHER,NSCLS,SILAC,VORINOSTAT
169,183,380,BACKGROUND,BRITISH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STATA,WMD
POTENTIAL,RADIATION
MENDS
3T3,EAGLE,EXPRESSION,FGF,LPA,LPAR3,THESE
ADDRESSING,MAB,THERE
022,035,351,404,ADIPOSE,BACKGROUND,BESIDES,EPIDERMAL,HGF,INCREASED,LABEL,METHODS,NSCLC,OSAKA,OVERALL,PREVIOUSLY,RESULTS,TKI,UNIVERSITY
377,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,SRE,TKI
003,032,107,BACKGROUND,CYFRA,CYFRA21,ELITE,LABEL,METHODS,QSTAR,RESULTS,SCC
231,468,BCS,CDK,EGFR2,ERBB2,ERK,FPD,G464V,MCF,MCL,MDA,MEK,ONCOGENIC,RAF,RAS,RTK,SFN,SKBR3,THESE
213,AGE,LABEL,LAG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPIROMETRY,THESE
448,CONCLUSION,LABEL,MEASURING,METHODS,OBJECTIVE,RESULTS,WEANING
169,593,CHROMOSOME,CONCLUSION,DCUN1D1,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC,SENP2,THROUGH,UBXN7
001,007,177,AMONG,CONCLUSION,EVALUATING,KNOWLEDGE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TTP,TUMOURS,WORLD
169,215,316,483,502,894,912,CHINESE,CLPTM1L,HAN,HAPLOTYPE,HOWEVER,INC,THESE,WILEY
169,177,181,AMONG,B16,COPYRIGHT,DOCKING,F10,INC,WILEY
001,006,048,169,ADC,ATS,CONCLUSION,COPYRIGHT,DFS,DISEASE,DWI,ERS,FORTY,IASLC,INC,LABEL,MATERIALS,MEIER,METHODS,MRI,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,WILEY
169,BASED,C70,COPYRIGHT,FULLERENE,PDT,R13,ROS,VCH,WILEY
AFTER,CSF,THERAPY
ESS,METASTASES
169,181,ALKYLATION,COPYRIGHT,DUE,HOWEVER,INC,THESE,WILEY
711,AMONG,BACKGROUND,CONCLUSION,JOINPOINT,LABEL,METHODS,OVERALL,PROGRAM,REGRESSION,RESULTS,SUSTAINED,TOBACCO
018,169,272,641,869,BMI,CIS,COLORECTAL,COX,OVARIAN,RRS,SCREENING,THEREFORE,THESE,TRIAL,TVU
120,169,231,4T1,945,DOCETAXEL,MDA,SMA,STUDIES,THESE
001,009,012,021,108,123,373,486,532,687,771,837,965,DFS,HOWEVER,NSCLC,THERE
5CM,AFTER,CRANIOTOMY,MCA,PYOKTANIN,STA,TEARING,USING
105,METASTATIC,RPA,SEPTEMBER,TREATMENT
CHALLENGES,CNS,DABRAFENIB,FURTHER,III,INCREASING,LABEL,LIMITED,MOLECULAR,NEWER,NSCLC,OPINION,PHASE,RANDOMIZED,STATEMENT,UNASSIGNED
398,BACKGROUND,COLORECTAL,CONCLUSION,GREATER,INSTITUTE,LABEL,METHODS,OVARIAN,RESULTS,SCREENING,SIMILARLY,SIX,THESE,TRIAL
123,230,946,AMONG,ANNEXIN,HOWEVER,JANUARY,JUP,LABEL,METHODS,OBJECTIVE,PLEURAL,PROTEOMIC,PURPOSE,RESULTS,SDS,SEPTEMBER,SEQUEST,SEVEN
100,178,BACKGROUND,LABEL,METHODS,NSCLC,OAS,RCT,RESULTS,TMZ,TREATMENT,TTP
169,BECAUSE,COPYRIGHT,LTD,PROGRAMMED,THESE
945,HIF,HIF1A,LABEL,LSL,PLOD2,TRP53,UNLABELLED,UPS
169,CONCLUSION,FAK,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM
169,185,216,348,405,656,760,ADVERSE,COX,EVALUATED,EVALUATION,III,INSTITUTE,INTRA,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,SIR,SOLID,TTP
169,947,ANALYZING,BLM,BMG,COPYRIGHT,NCI
169,209,350,568,AUSTRALIA,BRAIN,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,RESULTS,ROYAL,SEVENTEEN,WHOLE
169,17A,1ST,7TH,947,ANOTHER,ASSAY,COPYRIGHT,ELISPOT,IFN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,TH1,THESE
233,EXTUBATION
THESE
118,129,ACUTE,BACKGROUND,CONCLUSION,CONTEXT,CPE,LABEL,METHODS,OBJECTIVE,RESULTS,WATERPIPE,WTS
001,024,042,152,AIM,CONCLUSION,CYFRA21,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,015,100,169,179,AHR,BLACKWELL,COX,LDH,PULMONARY,SEVERAL
ANATOMICAL,BACKGROUND,CONCLUSION,CT1,CT2,CTV,LABEL,METHODS,NSCLC,RESULTS,SIXTEEN,TYPICALLY
143,ACCORDING,AMONG,BACKGROUND,FINALLY,HOWEVER,LABEL,MICRORNAS,NSCLC,PCR,RESULTS
100,196,ADC,ALK,AMONG,BACKGROUND,CST,DAB,IHC,LABEL,METHODS,PCR,RESULTS,SIGNALING,TECHNOLOGY,ULTRAVIEW,VENTANA
178,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DECREASED,ELECTRONIC,HRQOL,ISSUE,LABEL,LIBRARY,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PEDRO,RESULTS,SCIENTIFIC,SELECTION,SMD,THREE
180,200,CHROMATIN,NOTABLY
169,946,BASED,BESIDES,IHC,INC,NLK,NSCLC,TCF,WESTERN,WILEY,WNT
001,177,188,1BB,215,246,947,CD137,CD3,CD8,ELISA,FEWER,IFN,MHC,TIL
001,007,150,508,ATLAS,BCAR1,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SIMILAR
006,011,622,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,THEREFORE
BACKGROUND,BASED,COHORTS,ICRUCUMAB,IMC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PHASE,RESULTS,SIX,VEGFR
160,209,ASSESSMENT,AVERAGE,DED,DETECTION,EMOTIONAL,FURTHER,ILLNESS,INTERVIEW,LABEL,MEASURE,METHODS,OBJECTIVE,PICTORIAL,PRISM,PURPOSE,RESULTS,SPANISH,STRUCTURED,SUFFERING,SYMPTOM,VAS
160,CEA,CEACAM1,CEACAM5,CEACAM6,CEACAMS,THESE
HOWEVER,METASTASIS
PHG,PULMONARY
EARLY
946,954,AKT,AUTOPHAGY,BACKGROUND,DESPITE,E1B,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
34A,954,H1299,NCI,NOTCH,NSCLC,RHAMNETIN,TAKEN,TREATMENT
132,945,BASED,FINALLY,FURTHER,HIF,OVERALL,SUPERVISED,VDAC1
015,100,2N0M0,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LOCAL,METHODS,NSCLC,RESULTS,UNIVERSITY
AEROSOL,FINALLY,SEVERAL,THEREFORE
AGAINST,AMONG,AREAS,BACKGROUND,CONCERNING,COVERED,LABEL,METHODS,OPINION,SMALL
DMT,HILIC
100,956,ALTOGETHER,DUE,SIXTY,THEREFORE,WHILE

080,794,801,ACCORDING,AMONG,FURTHER,PET,SURGERY,THEREFORE
AFTER,PEC
012,CONCLUSION,GGN,HEALTHCARE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIEMENS,SUCCESSFUL

164,200,945,947,AMONG,BLOOD,CD3,CD4,CD8,CONCLUSION,HOWEVER,IFN,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,AFTER,CRYOPROBES,PERIPHERAL
BASED,EXCLUSION,FINAL
169,COPYRIGHT,LTD,MEIER,PARAMETRIC,WILEY
AIM,BACKGROUND,CONCLUSION,CSC,EMT,FINALLY,LABEL,OBJECTIVE
PULMONARY
DESPITE,ERK,MEK
046,AFTER,AGGRESSIVE,CRC,DESPITE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
CD176,THEREFORE,THOMSEN
ALK
945,SEVERAL,SIRT1,SIRT2,TOXOFLAVIN
318,ALTOGETHER,FATIGUE,MORBIDITY,NSCLC,OVERALL,SLR,STAGE,THERE,TREATMENT
169,954,AIF,AUTHORS,BAX,BAY,CONVERSELY,COPYRIGHT,DEPLETION,EB1,H1299,IRELAND,LTD,NSCLC,PUBLISHED,ROS
177,BACKGROUND,DYNAMIC,FDG,FEW,FURTHER,INCREASED,LABEL,METHODS,PAH,PULMONARY,RESULTS
169,1970S,80S,CNT,CURRENT,THERE,THESE
215,290,543,ACTN4,BACKGROUND,COX,HOWEVER,LABEL,METHODS,RESULTS
169,AUC,CONCLUSION,LABEL,METHODS,NPV,OBJECTIVE,OBJECTIVES,PCR,PREDICTIVE,RESULTS,ROC,TELOMERASE,VALUE
169,174,HOWEVER,LTD,NON,NPS,PRINT,TEMPLATES
AREAS,BACKGROUND,BIOMARKER,COVERED,EARLY,LABEL,METHODS,NSCLC,OPINION,PEMETREXED,PHASE
946,BACKGROUND,CONTEXT,E12,ESOPHAGEAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THOSE,TTF
AGAINST,BACKGROUND,COLLEGE,CONTEXT,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REPORTING,RESULTS,ROYAL
000,ALK,FURTHER,H3122,OVERALL,REPLICATE,SILAC
126,288,AMONG,HOWEVER,M1A,TNM
RESECTION,SEVEN,SIX
HOWEVER,THEREFORE
BASED,FACTORS,SIMILARLY,TNM
ACCORDING,AFTER,AMONG,CAREFUL,GENERAL,JAPANEASE,MINIMALLY,RECORDS,RESECTION,RULES,SOCIETY,SURGERY,SVC
A870G,CCND1,HOWEVER,PCR,THERE
AGAINST,CISPLATIN,EASTERN,FINALLY,GROUP,INITIALLY,STRATEGIES,THESE,TNM,UNION
009,026,BACKGROUND,BLOOD,CONCLUSION,DISEASE,LABEL,METHODS,NSCLC,PCR,RESULTS
006,029,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,PEMETREXED,PFS,RESULTS
239,500,ALK,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,NSQ,OBJECTIVE,PFS,RESULTS,TOXICITIES
008,BACKGROUND,CONCLUSION,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,THERE
006,039,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,OVERALL,PFS,RESULTS
HSE,HSV,PCI,SMALL
BACKGROUND,CONCLUSION,H19,HOX,LABEL,MATERIALS,METHODS,PCR,RESULTS
GAPDH,H69,H82,HENCE,PCR,PROX1,THREE
ALA,ASP,DDX39,FINDING,GLU,HOWEVER,HSP27,INTRINSIC,PROTEOMIC,STUDENT,THESE
140,AIM,CONCLUSION,LABEL,MATERIALS,METHODS,MULTI,OBJECTIVE,OXIDATIVE,PAH,RESULTS,TAC,URINARY
AKT,ARTOCARPUS,ARTONIN,BACKGROUND,CDC42,CONCLUSION,FAK,H23,KNOWLEDGE,LABEL,MATERIALS,METHODS,MIGRATION,MTT,RESULTS,THESE
SINCE
134,150,293,862,CONCLUSION,ENGLAND,HRS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STUDIES,THERE
169,HLA,MHC
001,105,139,164,169,239,469,ALK,BETWEEN,COX,EGF,HOWEVER,LABEL,LOCAL,METHODS,MOLECULAR,NON,NSCLC,OBJECTIVE,PURPOSE,RATES,RESULTS
BACKGROUND,CROSS,ENGLISH,FLORIDA,HISPANICS,LABEL,METHODS,NOTABLE,POISSON,RESULTS,THERE,WHITE
188,337,AMONG,BACKGROUND,CASES,CONCLUSION,ELISA,LABEL,METHODS,PHS,PHYSICIANS,PRO,RESULTS,SFTPB,THESE
HIPPO,INVERSELY,TAZ,TEA,YAP
241,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,BECAUSE,CENTRAL,CONCLUSION,CONTROLLED,ENGLISH,EXTRACTION,FORCE,FUNDING,HARMS,HEALTHCARE,INCIDENTAL,LABEL,MAY,MEDLINE,METHODS,OBJECTIVE,PREVENTIVE,PRIMARY,PURPOSE,QUALITY,RESULTS,REVIEWS,SELECTION,SMOKING,SOURCES,SYNTHESIS,SYSTEMATIC,THREE
003,005,ACT,BACKGROUND,DSS,INSURANCE,LABEL,LOCAL,LTP,MEIER,METHODS,PATIENT,RESULTS,TREATMENT
COLORECTAL,CRC,DESPITE,DISEASE,MANAGEMENT,WESTERN
897,904,AIM,BONFERRONI,CDP,GTPASES,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,RHO,SIX
MIB,NSE,OVARIAN,ROSETTE
HOWEVER,THESE,VITAMIN
160,IPM,RCC
001,169,183,185,217,BACKGROUND,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR
AKT,ANTIBODIES,ERBB3,HENCE,HOWEVER,NSCLC,TKI
169,COPYRIGHT,IRELAND,LTD,ZOL
DESPITE,EHMES,IGF,MPM,NCI,PAPPA
169,ALK,COPYRIGHT,HSP90,INHIBITION,LTD
169,227,946,COPYRIGHT,MUTATIONAL,NET,NUCLEAR
169,BCL,COPYRIGHT,DPT,FIRST,HOWEVER,III,NCI,NSCLC,SAS
169,COPYRIGHT,IRELAND,LTD,TAKEN,WHEREAS
001,008,013,028,169,177,261,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,HEAVY,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,SMOKING,THERE
169,COPYRIGHT,GCS,JAPAN,PUBLISHED,SOCIETY,THEREFORE
001,160,169,177,178,322,417,500,BACKGROUND,COPYRIGHT,INC,INSERTION,JANUARY,LABEL,METHODS,PROCEDURE,PUBLISHED,RESULTS,SOCIETY,VARIOUS,VIDEO
CESSATION,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SRS
2ND
174,946,AFTER,AKT,ALISO,AMENDMENTS,BACKGROUND,BROWN,CAMBRIDGE,CARIS,CCND1,CGH,CKS1B,DELETIONS,EXPLORING,FOUNDATION,GATA3,HOUSTON,LAB,LABEL,LABORATORY,MEDICAL,METHODS,MYC,PHYLLODES,RB1,RESULTS,SPARC,TEXAS,THERE,TLE,UNIVERSITY,USA,VIEJO,WHOLE
695,AKT,CYTOSOLIC,ERK,HUVEC,LLC,NSCLC,PLA,TREATMENT,UTILIZING
CDC42,FINALLY,HCC,IHC,PRIOR
945,BASED,ENOLASE,TREATMENT
169,BCL,BECAUSE,EGF,JANUS,NSCLC,PTPMEG2,SRC,STAT3,THESE
169,183,DOX,HCL,RAPID,VCH,WILEY
102,795,BACKGROUND,LABEL,METHODS,POISSON,PREVENTIVE,RESULTS,SMOKING,SPC,THESE
106,169,ANXIETY,CONCLUSION,COPYRIGHT,DEPRESSION,FCS,FIRST,LABEL,LTD,MANAGEMENT,METHODS,OBJECTIVE,RESULTS,SCALE,SYMPTOM,WILEY
100,169,287,AMONG,BACKGROUND,FNA,GENOMIC,HISEQ,LABEL,METHODS,NOS,NSCLC,RB1,RESULTS,SCLCS,SMAD4,SOCIETY
169,215,219,226,871,882,BAYES,CONSORTIUM,EHB,EPIDEMIOL,GENET,GWASS,INC,INFERENCES,MURCRAY,THESE,WILEY
113,169,ADC,FDG,MRI,PET
169,INC,OPENING,RESULTS,SCREENING,TRIAL,WHILE,WILEY
169,BACKGROUND,CONCLUSION,COPYRIGHT,FACTORS,INC,LABEL,METHODS,PRIMARY,PULMONARY,RESULTS,WILEY
000,169,INC,WILEY
169,ACRIN,HOWEVER,INC,SCREENING,TRIAL,WILEY
259,365,ERK,H1299,MAP,PKA,RAF,RAS,SER,THESE
169,99A,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FUNCTIONAL,INC,LABEL,LOW,MEIER,METHODS,MIR,MTT,PCR,RESULTS,WESTERN,WILEY
008,230,299,463GA,MPO,SP1
AKT,CMTM6,CMTM7,CPG,ECTOPIC,TSG
001,BACKGROUND,CONCLUSION,DISEASE,HCC,LABEL,METHODS,RESULTS,SIXTY
000,160,AES,AZD7762,CTCAE,GRADE,LABEL,METHODS,OBJECTIVE,OVERALL,PHASE,PURPOSE,RESULTS,THERE
100,177,CARLO,CTS,HENCE,HOWEVER,MONTE,PTV,RESULTS,THEREFORE,TREATMENT
100CM,176,177,235,435,500,700,788,BACKGROUND,LABEL,METHODS,NNK,POTENTIAL,RESULTS,THIRDHAND,WHILE
PROGNOSIS
CARCINOID,LABEL,OPINION,STATEMENT,UNASSIGNED
143,ASP,CNS,FLA,L858R,LNA,NSCLC,PCR,PNA,THERE
CD4,CONCLUSION,HAART,HIV,IRR,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCHOLAR,SCIENCE,SIR,SIXTY,USA,WEB
00001,001,177,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRP,RESULTS,STRATEGIES,THERE,TNM,VO2
169,314,330,339,549,956,AIM,BACKGROUND,CAI,CHINA,CHINESE,COMPOUNDS,ETOAC,IRELAND,LABEL,LTD,MATERIALS,MCF,METHODS,NIU,OBJECTIVE,RELEVANCE,RESULTS,SW480,TCM,WEI
001,169,946,AGILENT,NSCLC,PCR,ROC
169,177,946,956,AUTHORS,BIS,COPYRIGHT,DIM,MET,MYC,NUR77,PUBLISHED,RESPIRABLE,TR3
169,946,AKT,CONVERSELY,COPYRIGHT,LTD,RUNX3,TAKEN
945,CKD,INC,PUBLISHED,SEVERAL
109,169,COPYRIGHT,ECA,ERK,INC,JNK,PD98059,SPC,TEA,TF3
231,233,234,DIC,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS
002,100,115,169,207,BACKGROUND,COPYRIGHT,COX,INC,INCIDENTAL,JANUARY,LABEL,MEIER,METHODS,RESULTS,ROCHESTER,UNIVERSITY,VTE
169,COPYRIGHT,HOWEVER,IRELAND,LTD,MUTATIONS
169,COPYRIGHT,IRELAND,LTD
169,498,634,CHINA,CIS,COPYRIGHT,HISTORY,IRELAND,LTD,ORS,THESE,USING,XUANWEI
169,ALK,COPYRIGHT,CSS,FFPET,IRELAND,KIF5B,LTD,NSCLC,RET
00001,169,904,ADC,AIS,ATS,BACKGROUND,COPYRIGHT,COX,EPIDERMAL,ERS,IASLC,IDI,IRELAND,LABEL,LEPIDIC,LTD,METHODS,MIA,RESULTS,SOCIETY
158,169,AMONG,BACKGROUND,CD4,COPYRIGHT,CROWN,FOXP3,IRELAND,LABEL,LTD,METHODS,NSCLC,PBL,PUBLISHED,REGULATORY,RESULTS,TREGS
064,139,169,468,607,BACKGROUND,COCHRAN,COPYRIGHT,IRELAND,LABEL,LTD,MEDLINE,METHODS,NSCLC,PEM,PEMETREXED,PFS,RESULTS,STUDENT,STUDIES
160,169,192,AMONG,BACKGROUND,COPYRIGHT,COX,INC,LABEL,METHODS,PREDICTORS,PUBLISHED,RESULTS,SOCIETY,STS
169,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,THEIR,ZEALAND
169,500,BACKGROUND,COPYRIGHT,FORTY,III,IRELAND,LABEL,LOW,LTD,METHODS,NSCLC,PROMISING,RESULTS,SIX,THERE
008,100,130,132,134,164,169,197,209,332,352,BACKGROUND,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,METHODS,NOS,NSCLC,RESULTS,SIX,SMALL
169,189,428,BACKGROUND,COPYRIGHT,EASTERN,ELDERLY,FACTORS,GROUP,HOWEVER,III,INC,JANUARY,LABEL,METHODS,NSCLC,RECORDS,RESULTS
169,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NOTCH,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS
169,8505C,945,ACTIVATION,AUTHORS,BACKGROUND,COPYRIGHT,FAK,GDC,GTPASES,HIF,HYPOXIA,IRELAND,LABEL,LTD,METHODS,MIGRATION,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,RHO,WESTERN
169,COPYRIGHT,LTD,PUBLISHED,THESE
169,174,ACR,COLLEGE,COPYRIGHT,INC,PUBLISHED,RADIATION,RADIOLOGY,SEQUENTIAL
169,COPYRIGHT,PUBLISHED,SEPAR,THREE
115,141,169,256,BACKGROUND,COPYRIGHT,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,PUBLISHED,RESULTS,SEPAR,THERE
111,411,416,COLORECTAL,COX,DIETARY,INC,LABEL,METHODS,OBJECTIVE,OVARIAN,PUBLISHED,PURPOSE,RESULTS,SCREENING,THESE,TOTAL,TRIAL
002,003,005,150,169,240,500,ASIAN,BACKGROUND,COPYRIGHT,COX,EASTERN,FIRSTLY,GROUP,LABEL,LTD,METHODS,NSCLC,PEMETREXED,PFS,RESULTS
169,392,ASIAN,AUTHORS,BACKGROUND,EASTERN,GROUP,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,THERE,USING,VO2PEAK
DYNAMIN,GTPASES,THESE
FOXO1,THESE
100,IHC,LABEL,MATCHED,METHODS,MPE,NSCLC,OBJECTIVE,RESULTS
169,INCREASED,INTERPLAY,MDSCS,OSTEOLYSIS,RES,THEREFORE,THESE
200,BACKGROUND,BORTEZOMIB,DLT,LABEL,METHODS,MTD,PHASE,RESULTS,SORAFENIB,VEGFR
750,BACKGROUND,GRADE,HOWEVER,LABEL,METHODS,NON,RESULTS,THERE
181,954,ACTIVATION,BESIDES,CASPASE,CONTENT,HOWEVER,MMP,SCREENING,THESE,TREATMENT
632,AMONG,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS
145,900,ALTOGETHER,BAX,BESIDES,CCAAT,EBP,EGF,GLUCOSE,GRP78,INSTEAD,PDT,PHOTOFRIN,UPR,VAD
041,299,770,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,ORS,PRESCRIBED,RESULTS,SWEDISH,TNM
160,4A4,916,PHAGE,SFI,TAP63,THESE,WESTERN
ALK,APART,BREAK,COLOR,PCR,Q24,VYSIS
307,400,FGFR1,HOWEVER,SCLCS,SMALL,THEREFORE
005,100,CONVERSELY,METASTATIC,TTF
001,100,MOLECULAR,THERE
100,200,250,302,ASIAN,BACKGROUND,BASIC,BETWEEN,CONCLUSION,GEFITINIB,LABEL,MARCH,METHODS,RESULTS,THERE,WEB
001,BACKGROUND,BMI,CONCLUSION,COX,EASTERN,GROUP,LABEL,METHODS,OBESITY,RESULTS
BACKGROUND,CONCLUSION,EPHB2,H2595,INHIBITION,LABEL,MALIGNANT,METHODS,MMP,RESULTS,USING
100,167,ACA,ALK,IHC
169,BASEL,COPYRIGHT,LTD,VEVEY
017,028,146,169,173,204,841,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,EUR,INDICATORS,INDWELLING,IPC,LABEL,METHODS,MPE,OBJECTIVE,OBJECTIVES,RANDOMIZED,RESULTS
C34,EMERGENCY,FACTORS,HUNDRED,ICDO2,III,IRELAND,LABEL,LOS,METHODS,NCR,NSCLC,OBJECTIVE,OBJECTIVES,PATIENT,POISSON,RESULTS,STAGE
169,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GRADE,INC,LABEL,LOCAL,METHODS,RESULTS
160,169,454,BACKGROUND,CCI,CONCLUSION,COPYRIGHT,III,INC,INDEX,LABEL,METHODS,NON,NSCLC,RESULTS
001,005,023,039,169,394,476,594,961,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,EPCAM,FCM,HOWEVER,INC,LABEL,LEWIS,METHODS,NSCLC,PCR,RESULTS
005,169,956,A2780,COPYRIGHT,LTD,LUBELUZOLE,MTT
116,11R,169,549,945,947,956,COPYRIGHT,DIETHYL,DIVERSE,FEW,HCT,LTD,MICHAEL,MORPHOLINE,THP
169,205,AKT,CHEMICALLY,KLN,RESULTS
004,005,169,BACKGROUND,CONCLUSION,EPIDERMAL,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,T790M
000,163,174,AES,ASSESSMENT,BACKGROUND,BRITISH,CELGENE,CIS,COMPANY,DOC,ELI,EXCELLENCE,FABRE,FEW,FORMULARY,FUNDING,GEF,GEM,HOWEVER,INC,INSTITUTE,LABEL,LIBRARY,LILLY,MEDLINE,METHODS,NAVELBINE,NSCLC,OBJECTIVE,OBJECTIVES,PAX,PEM,PFS,RESULTS,SOURCES,TECHNOLOGY,THREE,USING
ACCORDING,BACKGROUND,CEACAM1,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,SERUM
169,COPYRIGHT,INC,PUBLISHED,SEVERAL,SIR
134,178,AEC,BCL,FINALLY,IRE,THESE,USING
946,BACKGROUND,CD3,CD4,CD8,INADEQUACY,LABEL,MDSCS,METHODS,MYELOID,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THESE
946,ANOVA,BACKGROUND,CONCLUSION,CRT,EARLY,III,LABEL,METHODS,NSCLC,RESULTS,TGF,TRIAL,USING,VARIATIONS
001,016,029,032,043,046,049,053,956,BACKGROUND,INCREASED,LABEL,METHODS,PAH,PCR,POLYCYCLIC,RESULTS,WHETHER,WORKERS
945,946,956
169,AKT,E278A,ECTOPIC,K276R,PIAS1,PROTO,SENP1,STRIKINGLY,SUMO1,SUMOYLATED
101,138,558,581,686,BACKGROUND,BETWEEN,CONCLUSION,FDG,HALLE,IMAGING,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PREVIOUSLY,PURPOSE,RESULTS,SMM,SUV,THERE
BACKGROUND,CONTEXT,DFS,LABEL,OBJECTIVE,PERSISTENT,RECURRENCE,RESULTS,SIXTY,THYROID
100,177,BLAND,CONCLUSION,DIFFERENT,HOUNSFIELD,INTER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS
009,048,227,255,357,BACKGROUND,COX,KETOROLAC,LABEL,METHODS,NLR,RESULTS

ADS,EVENTUALLY,NOTABLY,PCSCS,STAGE,THESE,TRAMP
183,BACKGROUND,CONCLUSION,EMG,GEORG,LABEL,METHODS,POSTERIOR,RESULTS,STUTTGART,VIDEO,VINCI
013,029,835,ARARG,ARG,ARG399GLN,CHINESE,GLN,OVERALL,THERE,XRCC1
001,046,160,ALONGSIDE,BLOOD,FIFTY
CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,477,621,721,BEGINNING,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATIVELY,RESULTS
160,CATALAN,EXPERTS,FIRST,GERMANY,HEIDELBERG,IMPPC,MEDICAL
956,AGS,COMPOUNDS,J82,MES,MRC
104,107,110,112,150,169,183,222,540,702,BACKGROUND,COPYRIGHT,ERLOTINIB,HOWEVER,ITALIAN,LABEL,LTD,METHODS,NSCLC,RESULTS
146,278,AFTER,BACKGROUND,BMP,CONCLUSION,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,SUMMARY,THERE
AKT,BACKGROUND,BECAUSE,CONCLUSION,ERK,ERLOTINIB,FINALLY,LABEL,METHODS,NSCLC,RESULTS,SERUM,TKI
BACKGROUND,CCT,COLLECTED,CONCLUSION,FORTY,III,LABEL,METHODS,NSCLC,PREDICTED,RESULTS,THERE,THESE
AFTER,BACKGROUND,CONCLUSION,EMERGENCY,ESPECIALLY,LABEL,METHODS,MRI,PALLIATIVE
169,2DG,AMP,ATP,BCL,EGF,H1975,III,MCL,NSCLC,PC9,T790M,THESE,TKI,TREATMENT
443,CHI,CONCLUSION,III,LABEL,MEIER,METHODS,OBJECTIVE,OPN,PURPOSE,RESULTS,THREE,TNM
CONCLUSION,LABEL,LARGE,OBJECTIVE
120,256,APE,CONCLUSION,KRUSKAL,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,WHITNEY
DIAGNOSTIC
001,011,014,018,032,106,177,182,239,446,580,776,946,EPC,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,STAGE
169,4T1,945,B16LACZ,CONCLUSION,IFN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURGERY,THESE,USING
ACP,CENTRAL,ENGLISH,FLORIDA,KNOWLEDGE,LATINOS,SPANISH,USA,VENEZUELA
160,174,233,DABRAFENIB,FDA,III,PHASE,PRE,V600E
138
001,002,011,014,033,120,205,541,553,NSCLC,OBJECTIVE,OCTOBER,PCR,SEPTEMBER,SERUM,SIMILARLY
ALK,III,PROFILE

946,EMT,HOWEVER,TGF
945,APS,NATURALLY,NSCLC,RENIERA
222,249,CHRONIC,RADON,SUGGESTED,THERE

C56BL,C57BL,HOWEVER
106,147,169,946,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,MTT,RESULTS,THEREFORE,TNM,WNT
169,APART,FAILURE,MDR
120,169,300,370,BSA,COPYRIGHT,FDG,HOWEVER,IRELAND,LABEL,LTD,MAXIMUM,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV
100,956,BAX,H1975,HOWEVER,JAK,JANUS,STAT3,T790M
APERT,FGF,FGFR1,FGFR2,FGFR3,FGFR4,FIBROBLAST,FINALLY,ONTOLOGIC,SOMATIC,THESE
001,004,100,138,160,187,214,281,509,920,AFTER,ARF,BACKGROUND,BASED,DIAGNOSTIC,LABEL,LOG,METHODS,RESULTS
169,BECAUSE,CD163,COPYRIGHT,FOLR2,HOWEVER,LPL,NSCLC,THESE
100,253,AUC,PROJECTION,REMOVAL
035,169,215,625,956,APOPTOSIS,COPYRIGHT,ELISA,H69,IRELAND,LTD,MDR,PGP,PRE,SILIBININ,SILYBUM,SMALL,THESE,VPA17
000,100,110,118,129,150,BACKGROUND,BED,CHI,COX,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,SRS,UNIVARIATE
CIGARETTE,CKD,CVD,NAFLD,SMOKERS,SMOKING
188,CONCLUSION,DOF,INTRA,LINAC,NSCLC,PTV,RESULTS
ADVERSE,LABEL,LAM,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING,TSC
008,036,121,163,284,2NG,BACKGROUND,CEA,CONCLUSION,COX,CYFRA,HOWEVER,LABEL,METHODS,MST,NSCLC,PCV,RESULTS,SERUM,TKI,UNIVARIATE
APC,BACKGROUND,CHAMORROS,CIS,GUAMANIANS,HAWAIIANS,INSTITUTE,LABEL,METHODS,NHOPI,OTHER,PACIFIC,POPULATION,RESULTS,SAMOANS,UTILIZING
AMONG,APC,ASIAN,BACKGROUND,CHINESE,CIS,DECREASES,END,FILIPINAS,FILIPINOS,INCIDENCE,INDIANS,JOINPOINT,KAMPUCHEAN,KOREANS,LABEL,LAOTIAN,METHODS,PAKISTANI,PAKISTANIS,RATES,RESULTS,THESE,VIETNAMESE
100,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS
METICULOUS,ROUTINE
015,017,025,039,144,1A1,205,ALDH1A1,BACKGROUND,CD133,COX,EXPRESSION,LABEL,METHODS,NSCLC,RESULTS,THESE
144,169,16Q12,423,AMONG,AUTHORS,BRITAIN,CHINA,EBF,EBV,EPSTEIN,GREAT,IRELAND,JOURNAL,KNOCK,LTD,NOTABLY,NPC,PATHOLOGY,SOCIETY,THESE,WILEY
169,COPYRIGHT,DOCYANINE,ICG,VCH,WILEY
HOWEVER,MIYAURA,PKH26,POLARIC,THEREFORE,THESE
HOWEVER,METFORMIN,RAS,SIMILARLY,THESE
217,BACKGROUND,ENTRY,FIFTY,GRADE,LABEL,MARCH,MBQ,METASTRON,METHODS,NRS,REGARDING,RESULTS
BASED,FDG,HISTOLOGY,PET
EXTRA,FDG,PET,PRIMARY
99M,MRI,NAF,PET
CXCR4,DESPITE,HAART,HIV,HOWEVER,TODAY
114,ALK,EZR,KIF5B,NSCLC,RET,SLC34A2
182,FINALLY,HOWEVER,PDCD4,PROGRAMMED,SPC,THESE,TRANSWELL
200,CONCLUSION,EARLY,HOUNSFIELD,IMAGE,LABEL,METHODS,NOISE,OBJECTIVE,PARTITION,PROGRAM,PURPOSE,RESULTS,TBE
100,HOWEVER,SEVEN,SUNITINIB
160,CML,ILD,NILOTINIB
10R,11R,13S,14R,866,AKT,BECLIN1,CELLS,EXPRESSION,FLICE,GFP,KNOCKDOWN,LAMP2,LC3,LC3II,SIMILAR,TREATMENT
124,162,271,327,AMONG,BACKGROUND,CHEST,CONCLUSION,LABEL,MAY,METHODS,NSCLC,RESULTS,THERE
169,1T1,956,AFFYMETRIX,CELLS,COPYRIGHT,DMA,HBE,III,INCREASING,INORGANIC,IRELAND,LTD,MMA,THESE
169,188,267,ALK,CONCLUSION,COPYRIGHT,CRC,ESTIMATED,EUR,FGFR1,JANUARY,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PREEMPTIVE,PURPOSE,RESULTS
169,241,BACKGROUND,CNS,COPYRIGHT,LABEL,MATERIALS,METASTASIS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,101,BETWEEN,BLOOD,CONCLUSION,JANUARY,LABEL,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PERFUSION,RESULTS,VALIDATION
100,160,169,AIM,ALK,CD117,CENTRAL,CONCLUSION,COPYRIGHT,CROWN,HEPATIC,HOWEVER,IMT,LABEL,LTD,MATERIALS,MAY,METHODS,MRI,OBJECTIVE,PATHOLOGY,PUBLISHED,RESULTS,SEPTEMBER,SMA,SOUTH,TEN,THEREFORE,UNIVERSITY,XIANGYA
011,100,138,142,AMONG,BACKGROUND,ICU,INSURANCE,IQR,LABEL,METHODS,MORTALITY,PALLIATIVE,PMV,QUALITY,RESULTS
200,383,956,ART,BACKGROUND,CD4,CURRENTLY,HIV,HOWEVER,LABEL,METHODS,OTHER,RESULTS
H23,HOWEVER,ROS,THEREFORE
145,BACKGROUND,HSV,ICP27,LABEL,METHODS,MICRORNAS,NON,NSCLC,ONCOLYTIC,RESULTS
AKT,APOPTOSIS,COX,IC5,LABEL,LEWIS,LLC,MATERIALS,METHODS,MTT,OBJECTIVE,PAEONOL,PROTEIN,PURPOSE,RESULTS,TUNEL,WESTERN
DESPITE,HACAT,LEWIS,THESE
0063794,AKT,ATP,CONCLUSION,EPIDERMAL,FOXO1,H1650,H1975,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PC9,PC9GR,RESULTS,TKI
004,005,006,009,803,819,BACKGROUND,CHINA,CHINESE,FURTHER,GENOTYPES,GIVEN,HAN,HAPLOTYPE,HARDY,LABEL,MDR,METHODS,OVERALL,PALLELE,PGENOTYPE,QIQIHAR,RESULTS
591,929,ANOVA,BACKGROUND,CHI,CONCLUSION,JANUARY,LABEL,METHODS,OVERALL,RBC,RESULTS,TRANSFUSED
005,007,III,YIN,YMR
AKT,ATP,CDC42,FAK,HOWEVER,OUABAIN,ROS
009,077,184,371,809,910,BACKGROUND,CONCLUSION,FURTHER,INSURANCE,LABEL,METHODS,PAP,RESULTS,RNS,SIR,TAIWANESE
946,BACKGROUND,CONCLUSION,HFE,INHIBITION,LABEL,RESULTS,SINCE,THEREFORE,USING
676,BACKGROUND,LABEL,METHODS,OBJECTIVE,PAL,RANDOMIZED,REGARDING,RESULTS,SPR,STUDIES,SUCTION,SUMMARY,SYSTEMATIC,THERE,WHETHER
AFTERWARDS,APPL1,ARHGEF9,BIRC5,CCNA2,CCNB2,CDC27,CDC42,CDCA5,CDCA8,CGH,CLPTM1L,FOXP1,FUS,KIF15,KIF2C,LPP,MACF1,MYBBP1A,MYO10,PGF,PRKAR2A,PRPF6,PSMD2,RAB5A,SENP2,SMARCC1,SNP,SOX18,SP4,SRC,SYCE2,TAF15,TFDP1,TRA2B,TTK
469,916,FOLLICULIN,K508R,SERINES,SIMILARLY,THESE
CONVERSELY,FURTHER,METASTASIS,THESE,TKS5SHORT
500,ASSURANCE,CENTRES,CONSORTIUM,EFFECTIVE,GROUP,QUALITY
177,BACKGROUND,CHEST,CONCLUSION,LABEL,METHODS,OBJECTIVE,PFT,PULMONARY,PURPOSE,RESULTS,RHEUMATOID,THERE,THEREFORE
169,ACUTE,BER,CHRONIC,EXPRESSION,H1299,H1975,UNG
169,COPYRIGHT,HOWEVER,NPS,OCA,OLEYL,VCH,WILEY
000,SCREENING,TRIAL
057,151,169,200,208,AMONG,COPYRIGHT,FEW,GERMANY,INSTITUTE,SMOKING,TOBACCO
160,FDG,PET,SINCE
ASIAN,BESIDES,CCND1,G870A,MEDLINE,OVERALL,SEVERAL
377,LITERATURE,SEVERAL
GENERATION,HOWEVER
DUFFY,HOWEVER,RESULTS,TAKEN
120,160,176,203,BMI,BRIEF,EASTERN,FATIGUE,GROUP,HGS,INVENTORY,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,QUALITY,RESULTS,WHETHER
117,295,400,CASES,JANUARY,MEDICAL,THEREFORE,UNIVERSITY
19Q12,HERVS,HML,LTR,NOVEL,PCR,SEQUENCES
103,169,ALK,BRM,FGFR1,HOWEVER,NSCLC,SMARCA2,SMARCA4,SNF,SWI
169,945,946,AKT,EGF,HOWEVER,INCREASED,SRC
15Q25,EMSAS,PUBLISHED,RESULTS,SNP
100,169,267,946,ABS,COPYRIGHT,EGFR237,EGFRS,EPIDERMAL,LEWIS,LLC,MVF,THEREFORE
001,002,005,009,033,139,169,180,505,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EPIDERMAL,FURTHER,IRELAND,JANUARY,LABEL,LTD,METHODS,RESULTS
001,169,172,ACCORDING,COPYRIGHT,KARNOFSKY,LABEL,METHODS,MONTH,OBJECTIVE,PRIMARY,RESULTS,SCORE
169,AUTHORS,COPYRIGHT,EPIDERMAL,HOWEVER,IHH,INC,MUTATIONS,PUBLISHED,STRIKINGLY,USING
169,CCAMS,COPYRIGHT,HOWEVER,LTD,MEDICAL,WHICHEVER
001,003,009,017,036,042,114,130,169,ACTIVITIES,ASSESSMENT,CAUCASIAN,CHALLENGES,CHRONIC,COGNITIVE,COPYRIGHT,DAILY,FUNCTIONAL,ILLNESS,INC,INSTITUTE,KARNOFSKY,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PROGRAM,PROJECT,QOL,RESULTS,SIXTY,SUPPORT,THERAPY,TOTAL
016,034,049,135,160,169,BACKGROUND,CA9,COPYRIGHT,DUSP6,ERBB3,EXPRESSION,FRESH,III,INC,LABEL,LCK,METASTASIS,METHODS,MMD,NSCLC,PCR,RESULTS,SCC,SEVERAL,STAT1,THERE
048,169,177,COPYRIGHT,LTD,PUBLISHED
156,169,177,AMONG,AVERAGE,BACKGROUND,COPYRIGHT,INC,LABEL,MAY,METHODS,PUBLISHED,REPORTS,RESULTS,SOCIETY,THERE
169,ADIPOKINES,ADIPOSE,AIM,BACKGROUND,COPYRIGHT,FEW,INCREASING,LABEL,LTD,MATERIALS,MEDLINE,METHODS,OBJECTIVE,RESULTS,SEVERAL
120,AMONG,BACKGROUND,CTA,LABEL,METHODS,RESULTS,SEVENTY
012,169,AUSTRALIAN,BACKGROUND,COLLEGE,DFS,EIGHT,FDG,INTRA,LABEL,METHODS,NSCLC,PET,RESULTS,ROYAL,SEVENTEEN,THERE,ZEALAND
169,AUSTRALIAN,AUTHORS,COLLEGE,CONCLUSION,IMAGING,JOURNAL,LABEL,LOCAL,MATERIALS,MEDICAL,METHODS,MWA,OBJECTIVE,PURPOSE,RADIATION,RESULTS,ROYAL,TREATMENT,ZEALAND
001,169,183,211,223,272,328,553,787,824,888,COPYRIGHT,COX,INC,INDEX,LABEL,METHODS,MOSBY,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
HOWEVER,SCREENING,TRIAL
105,160,169,547,BOARD,COPYRIGHT,DISTANT,INC,INSTITUTE,LABEL,MEIER,METHODS,MOSBY,OBJECTIVE,PATHOLOGIC,PET,PROGNOSTIC,PUBLISHED,RESULTS,SURGERY,THOSE
163,300,700,APRIL,ASSESSMENT,BACKGROUND,BPS,BSC,CONCLUSION,CONFERENCE,DATABASES,DENOSUMAB,FUNDING,GENERALLY,INSTITUTE,ISSUE,LABEL,LIBRARY,MARCH,MAY,MEDLINE,METHODS,NMA,NSCLC,OBJECTIVE,OBJECTIVES,OWING,PAS,RESULTS,SCIENCE,SOURCES,SRE,STUDIES,SYSTEMATIC,TECHNOLOGY,WEB,WITHOUT
160,169,954,AKT,ALA,CELLS,EFFECTS,EGFRS,H1299,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OFTEN,PDT,RESULTS,TKI,WILEY
945,946,954,AKT,BAX,BBR,BCL,BERBERINE,CHINESE,COX,ERK,FURTHER,HIF,HOWEVER,KNOCKDOWN,MEK,NSCLC,RAF,TAKEN,TREATMENT
KRT15,MEIER,METASTASIS,NON,NOVEL,NSCLC,OVERALL,SMALL,TNM
ERK,SPRY2,THESE
002,110,412,945,946,COX,FDG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,RFS,T1A,T1B
169,215,293,HEK,SELECTIVE,VCH,WILEY
169
EMS,FINALLY,HOWEVER
109,125,129,BACKGROUND,CONCLUSION,GRADE,LABEL,METHODS,RESULTS
001,009,556,845,BACKGROUND,CONCLUSION,LABEL,METHODS,QRESEARCH,RESULTS,THERE
BESIDES,DESPITE,EARLY
15A,921,BCL,DLEU2,FINALLY,HDAC3,HDACS,HISTONE,HOWEVER,THEREFORE,TSA
000,001,002,160,BACKGROUND,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,POPULATION,PULMONARY,RESULTS
169,BRCA2,CELLS,COPYRIGHT,IRELAND,LTD
169,BASEL,ILD,PHYSICIANS
DISCUSSION,LABEL,METHODS,OBJECTIVE,RESULTS,RETIREMENT,THESE
120,169,177,240,4CK,945,946,99M,BAC,COPYRIGHT,INC,MOSBY,NCI,RGD
169,48H,COPYRIGHT,HCC,IRELAND,LTD,MIGRATION,THEREFORE
DELTA
169,FGF,FGFR3,FIBROBLAST,NSCLC,SCA,SFTPC,THESE
011,017,019,023,049,160,169,170,329,543,897,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MEIER,METHODS,NSCLC,RESULTS
287,33342,956,ACTIVATION,ADP,ANNEXIN,CONCLUSION,HOECHST,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,THESE,TUNEL
945,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LUCIFERASE,METHODS,MTT,NAC,NSCLC,RESULTS,SILENCING,SMALL,TRANSIENT,WESTERN,WHILE
001,169,208,672,AFTER,BACKGROUND,COPYRIGHT,COX,DFS,HOWEVER,INC,LABEL,MEDICAL,METHODS,NSCLC,PATIENT,PUBLISHED,RESULTS,SOCIETY,VIDEO

954,NOW,TRIPTOLIDE
BACKGROUND,CHEST,LABEL,MAY,METHODS,OBJECTIVE,PULMONARY,RESULTS
AMONG,BACKGROUND,CONCLUSION,DCR,LABEL,NSCLC,OBJECTIVE,ORR,RESULTS
BACKGROUND,FVC,LABEL,METHODS,MVV,PEF,RESULTS,THERE,VITAL
001,288,ASIAN,BACKGROUND,CAUCASIAN,HOWEVER,LABEL,MARCH,MEDLINE,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE
008,011,046,071,097,102,140,224,237,262,300,317,494,705,713,984,BACKGROUND,ERLOTINIB,GEFITINIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,TKI
AFTER,BACKGROUND,COBROTOXIN,LABEL,LC3,METHODS,MTT,P38,P62,RESULTS,USING,WESTERN
AIS,MIA,SOCIETY
223,ACTIVATION,BACKGROUND,CALU3,CBP,LABEL,LYN,METHODS,PAG,PKC,RACK1,RESULTS,SILENCING,SRC,WESTERN
APRIL,BACKGROUND,BML,LABEL,METHODS,RESULTS,THREE,VIDEO
2J2,CYP,CYTOCHROME,EET,FURTHER,SEVERAL
168,BACKGROUND,DESPITE,LABEL,METASTASES,METHODS,MTT,NSCLC,PYGO2,PYGOPUS,RESULTS,USING,WNT
169,AUTHORS,ENGLISH,LTD,PATHOLOGY,PTY,PUBLISHING,PULMONARY,SOCIETY,WILEY
BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SER,SHORT,SIXTEEN,THEREFORE
916,CONCLUSION,EARLY,EVALUATION,FDG,LABEL,METHODS,MTV,NSCLC,PARAMETERS,PET,PFS,RESULTS,SOLID,SUV,TLG,UNLABELLED
001,013,111,122,126,146,221,228,BETWEEN,FIFTY,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PLT,PULMONARY,RESULTS,TEN,THERE
11A,11E,11I,PROLINE,THEIR,UGI
160,947,BACKGROUND,CONCLUSION,EXPRESSION,FOXF1,LABEL,METHODS,NANOG,PROTEIN,PTCH1,RESULTS,SEVERAL,SMO
INITIALLY
420,438,BLAND,CONCLUSION,GGN,INTERSCAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WRITTEN
100,113,120,138,174,APRIL,AUTOMATED,B30,B70,BACKGROUND,BETWEEN,CONCLUSION,GERMANY,JANUARY,LABEL,LMS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SENSATION,SIEMENS,SOMATOM,THERE,VME
AMD3100,CHEMOKINES,CXCR4,DIL,ELISA,HOWEVER,MSC,THESE,TRANSWELL,USING
231,916,936,BAD,BAX,BCL,BIM,CHO,FMK,HPV,MDA,VAD
002,004,160,169,243,COPYRIGHT,COX,DESPITE,HOWEVER,IDC,ILC,LTD,MEIER,ORIGINALLY,STATISTICS,TAMPERE,TNM,UNIVERSITY
166,464,500,644,856,AMONG,CASES,DISULFIRAM,SIMILARLY
EYE,HOWEVER
AFTER,SOX,STAGE,UFT
2MM,AFTER,STAGE
AFTER,APRIL,CEA,CPT,FDG,JANUARY,MAY,OCTOBER,PET,VIRCHOW
APRIL
ACD,ANTICANCER,DRUGS,HOWEVER,QOL,THEREFORE,TREATED
177,EFFECTIVE,SRE,ZDA,ZOLEDRONIC
AFTER,FOLFIRI
120MG,CEA,GEM,HOWEVER,III,PEM,PEMETREXED,STAGE
104,970,AFTER,CRP,CSF,III,LABORATORY,STAGE,WBC
4MG,AFTER,HOWEVER,PGR
CENTRAL,FDG,IBARAKI,PET,PGR,PTX
APREPITANT,CIC,HOWEVER,HT3,NK1

138,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THREE
169,FINALLY,NANOVIN,PEG,POLYMERIC,USING
169,CH5164840,EPIDERMAL,ERK,H1975,HOWEVER,HSP90,INHIBITION,NCI,NSCLC,STAT3,T790M,TAKEN
000,147,181,554,604,BACKGROUND,INSTITUTE,LABEL,METHODS,RESULTS,SCREENING,THESE,TRIAL
621,BIOMEDICAL,CENTRAL,CHINA,CHINESE,CONTROLLED,DOR,LITERATURE,MED,MEDLINE,NLR,NSCLC,NUMBERS,PLR,PUB,REFERENCE,SCIENTIFIC,SELDI,SEN,SPE,TOF
BETWEEN,CYBERKNIFE,DISRUPTING,IRT,LARGE,LIVER,SERVICE,SPINE,TBF,TECHNICAL,TIMES,TREATMENT,WEIBULL
NIR,NRS,PTT
GTV,RPM
ENRICHMENT,PATHWAY,SET
A82,AKT,EPO,HOWEVER,MCF,NCI,PCR,STAT3,STAT5,TAKEN,WHILE
00001,ABSTRACTS,CENTRAL,CONCLUSION,CONTROLLED,LABEL,MANAGER,MEDLINE,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RESULTS,VANDETANIB,WANFANG
BACKGROUND,CTC,DEFINITION,EPCAM,EPITHELIAL,FDG,IQR,LABEL,MATERIALS,METHODS,NSCLC,PET,RESULTS
CH2PH,CHPH2,COMPLEXES,ESI,H1666,NCI,NHC,NMR,OPH
001,160,169,177,178,183,187,18F,215,ADC,ADCMEAN,CONCLUSION,DWI,FDG,GEORG,LABEL,MATERIALS,METHODS,MRI,NSCLC,OBJECTIVE,PEARSON,PET,PURPOSE,REGIONS,RESULTS,ROI,STUTTGART,SUV,SUVMEAN
ANOTHER,ERG,FAF,IHC,LABEL,METHODS,OBJECTIVE,OCT,PURPOSE,RESULTS,SDOCT,THREE,WESTERN
101,120,AFTER,AST,BACKGROUND,BID,GRADE,LABEL,METHODS,MTD,NSCLC,PRS,RESULTS
147,BACKGROUND,CONCLUSION,DISEASE,EMPLOYEES,ICD,JEM,LABEL,METHODS,OBJECTIVE,PADUCAH,REPORTS,RESULTS
200,239,945,BACKGROUND,BID,CONCLUSION,LABEL,METHODS,MTD,NSCLC,RESULTS
169,BACKGROUND,BASEL,COPYRIGHT,FIFTY,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPECIMENS,THREE
000,040,139,169,260,343,408,ATS,BECAUSE,BETWEEN,CONCLUSION,COPYRIGHT,ERS,GGO,IASLC,III,IRELAND,JANUARY,LABEL,LTD,MARCH,MATERIALS,METHODS,NOGUCHI,OBJECTIVE,PURPOSE,RADIOLOGIC,RESULTS
AREAS,BACKGROUND,COVERED,DNMTS,EPIGENETIC,FURTHER,HDACS,LABEL,METHODS,OPINION,PRIMARY
GENOTYPIC,HIF,MYC,WARBURG
946,956,BUTYL,CHINESE,EPS72,FURTHER,SEPHAROSE
400,ARG,ASP,DUE,GLY,H1299,HOWEVER,ICP,MAL,MNC,OES,PLA,RGD,SUBSEQUENT,THEREFORE,USING
ALT,NPS,OVERALL
200,BACKGROUND,BROMIDE,CONCLUSION,FORTY,LABEL,METHODS,NSCLC,PFS,RESULTS,TREATMENT,TRIAL
169,ACTIVATION,PRESS,THESE
000,200,BACKGROUND,BAD,CONCLUSION,GIVEN,LABEL,METHODS,RESULTS,SCLCS,WESTERN
AVERAGE,BACKGROUND,BED,CONCLUSION,DOSIMETRY,GBQ,LABEL,LESIONS,METHODS,PET,PRIMARY,RESULTS,SST,SSTRS
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS
100,AFTER,BACKGROUND,CONCLUSION,FIFTY,LABEL,METHODS,NSCLC,RESULTS,SECONDARY,SIX
ASO,HBE,MEANWHILE,NCI,TRANSWELL,WESTERN
DUMON,EMERGENCY,MALIGNANT
DESPITE,DIAGNOSTIC
HOWEVER,OPTIMAL
EXAMINING,RECURRENT

200,500,BACKGROUND,CHEST,LABEL,MALIGNANT,METHODS,PLEURAL,RESULTS
160,BESIDES,CCK,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERUM,SMALL,THESE,WESTERN
FURTHER,METABOLIC,THESE
AHF,FOLLOWING,STAGE
400,BECAUSE,CHILD,THERE
503,BCL,MICRORNAS,TAKEN
FDG,METASTASIS,PET,THESE
124,198,ASPECTS,FNA,JANUARY,LABEL,MARCH,MATERIALS,METHODS,MPR,OBJECTIVE,PURPOSE,RESULTS,TTFNA
001,021,022,100,431,451,682,876,BACKGROUND,COLORECTAL,CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,POSTTRIAL,RESULTS,SETTING,THERE,WOMEN
169,COPYRIGHT,FINALLY,FIRST,LTD
169,171,187,759,AGE,BACKGROUND,BMI,COPYRIGHT,FACTORS,FVC,LABEL,LATIN,METHODS,PLATINO,PUBLISHED,RESULTS,SEPAR
012,038,207,BACKGROUND,CELLSEARCH,LABEL,METHODS,PERIPHERAL,RESULTS,WHITNEY
169,946,INHIBITION,LOX,OVERALL,POLYOMA,RES,TGF
CXCR4
169,AKT,CONVERSELY,ECTOPIC,HOWEVER,RES,SH4
205,954,AKT,CONVERSELY,HOWEVER,NSCLC,PHLPP,TAKEN
169,889,BOARD,COPYRIGHT,DISEASE,INC,INSTITUTE,LABEL,LVI,MEIER,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RECURSIVE,RESULTS,RPA,SURGERY,THERE,THESE
169,BOX,COPYRIGHT,EMT,FOXM1,IRELAND,KNOCKDOWN,LTD
169,AUTHORS,CCDC6,COPYRIGHT,IRELAND,KIF5B,LENVATINIB,LTD,NCOA4,PUBLISHED,RET,THESE
1A1,945,946,AHR,CYP,INCREASING,WHEREAS
LAM,LIMITED,MILES
013,102,120,240,300,330,954,AMONG,DISEASE,NSCLC,PFS,SIMILARLY,TG2,TKI
001,003,005,006,007,010,013,015,017,020,027,040,101,122,204,471,490,508,524,634,697,852,926,946,967,COX,DECREASED,DFS,EFFECTIVE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,TUMOURS
011,684,985,994,BACKGROUND,BMJ,CONTROL,CONVENTION,FRAMEWORK,GROUP,INCREASING,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,TOBACCO,USA
RENAL,TSC
763,ACCORDING,AIM,BACKGROUND,CUFFLINKS,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SHANNON,THESE
ACCORDING,AFRICAN,AMERICANS,C609T,CAUCASIANS,HISPANICS,LABEL,MAY,NAD,REFERENCES,THERE,UNASSIGNED,UNLABELLED
169,500,974,AFP,ALPHALISA,ASSAY,BACKGROUND,CEA,CK8,CYFRA,DONOR,ECLIA,HOWEVER,INC,LABEL,METHODS,NSE,RESULTS,ROCHE,THERE,WILEY
183,ACCORDING,BACKGROUND,BASED,CDH,CONCLUSION,END,ENGLISH,GEORG,HOWEVER,LABEL,LEVEL,MATERIALS,METHODS,PCO,RANDOMIZED,RCS,RESULTS,STUTTGART,SYSTEMATIC,TEF,THEREFORE,VIDEO
242,ADVERSE,IRR,MAMMALIAN,PULMONARY,WHILE
EHE,METASTATIC,TREATMENT,VARIOUS
431,ALF,ASP,CNS,EXPRESS,L858R,PCR
183,196,31C,599,ARG,GLU,LABEL,LYS,MET,METHODS,OBJECTIVE,PPI,PTGS2,PURPOSE,RESULTS,SYMPTOM,TNFR2,USING
CURRENT,NEWER,PCI,SMALL
247,680,954,ATLAS
000,800,NOTABLY,THOUSANDS
PEMETREXED
945,949,IFN,INCUBATION,STUDIES,UTR
947,BECAUSE,CD4,CD8,FOXP3,HOWEVER,IFN,NSCLC,TAG,TREGS
001,006,015,046,BACKGROUND,CCK,EXPRESSION,HCC,HOWEVER,LABEL,METHODS,RESULTS,SHOX2,TNM
30A,ECTOPIC,FURTHER,TAKEN
231,946,HOWEVER,MDA,MMP,TGF,THESE
DICER,DISRUPTING,III,INK4A,P16,P27,RNASE
4SA,946,EMT,HSC70,KNOCKDOWN,PROTEOMIC
169,257,600,746,COPYRIGHT,HODGKIN,HOWEVER,INC,NADPH,PUBLISHED,USING
169,945,COPYRIGHT,EBP,FEDERATION,FIRST,MICRORNAS,SOCIETIES,TRIB2
169,BLOOD,CHROMOSOME,COPYRIGHT
169,946,CELASTROL,COPYRIGHT,DARBY,EMT,INC,MADIN,MIGRATION,SNAIL,TGF,THESE
169,25K,25KDA,ADP,ATP,COPYRIGHT,H1299,PEI,POLYCATION,STUDIES,THESE,THROUGH,UNRAVELING
169,COPYRIGHT,ERG,HOWEVER,INC,SMALL,THEREFORE,TMPRSS2,URINARY
169,ASXL1,BRCA1,COPYRIGHT,DESPITE,DROSOPHILA,H2B,HOX,INC,P19,UCH
148,169,194,577,COPYRIGHT,DEPRESSION,GENERAL,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCALE,SDS
169,179,241,372,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,PORTUGUESA,PUBLISHED,RESULTS,SOCIEDADE
169,241,COPYRIGHT,PORTUGUESA,PUBLISHED,SOCIEDADE,THESE
048,160,169,COPYRIGHT,HDR,INC,LABEL,METHODS,OBJECTIVE,OFS,OVERALL,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE
100,131,160,169,AFRICAN,AFTER,COMMITTEE,COPYRIGHT,IIA,INC,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,STAGE
169,AMONG,AUTHORS,COPYRIGHT,HOWEVER,LTD,NSCLC,OPHTHALMIC,PUBLISHED
169,185,239,797,ARG,CD4,CD8,COPYRIGHT,IRELAND,LTD,MYELOID,NSCLC,PCR,PMN,THERE,UNTIL
169,423,449,453,622,BACKGROUND,CAUCASIANS,CENTRAL,CNV,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,PCR,RESULTS,THERE,UGT2B17
125,169,AFTER,AIM,CONCLUSION,COPYRIGHT,FURTHER,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,VIDEO
169,393,495,BACKGROUND,BETWEEN,CONCLUSION,CONTEXT,COPYRIGHT,DRG,LABEL,LTD,METHODS,PATIENT,RESULTS,SPATIAL,THERE
000,005,006,016,066,078,121,169,COPYRIGHT,COX,GPA,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBM,THERE
169,BACKGROUND,CETUXIMAB,COPYRIGHT,FORTY,III,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,TAKEN,THREE
013,100,131,169,183,312,944,956,AIR,AMBIENT,BACKGROUND,COHORTS,COMMUNITY,COPYRIGHT,COX,EFFECTS,FRAMEWORK,FUNDING,HRS,LABEL,LTD,METHODS,PM2,POLLUTION,PROGRAMME,RESULTS,SEVENTH
169,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESECTION,RESULTS,SOCIETY,SUBCLAVIAN,THERE
160,169,BASAL,BCC,COPYRIGHT,LTD,MAXILLO,PUBLISHED,SURGERY
020,044,132,169,473,491,617,709,926,934,938,CLARA,DIFFUSION,DWI,SHIMOSATO,SUV
BACKGROUND,BTV,DIFFERENT,FDG,GTV,LABEL,METHODS,PERCIST,PET,RESULTS,TLG
HOWEVER,THESE
169,BACKGROUND,CONCLUSION,ERCIYES,GROUP,LABEL,LTD,MAY,METHODS,NPV,OBJECTIVE,PPV,RESULTS,UNIVERSITY,WILEY
946,EMT,THESE

BACKGROUND,CD4,CD8,LABEL,METHODS,NKC,NSCLC,RESULTS,TEN,TTP
FDA,OTHER,SEVERAL,SMALL
138,BACKGROUND,BOARD,CLYDE,GLASGOW,GREATER,LABEL,METHODS,NHS,OBJECTIVE,RESULTS,SERVICE,THESE
169,252,956,AMONG,AZ521,CHIMICA,COPYRIGHT,HELVETICA
ARGENTINA,FDA,III,JAPAN,MEK,OCEANIA,ORIGINALLY,PHASE,SEVERAL,TOBACCO,TRAMETINIB,V600E,V600K
ACTIVATING,L861Q,PCR,T790M
MTT,NOTABLY,THR62
001,362,954,AGREEMENT,BACKGROUND,LABEL,METHODS,RAPID,RESULTS,TBNAS,THERE
001,007,BACKGROUND,CA125,CCR,DIFFUSE,DPM,EXTRA,III,LABEL,METHODS,NON,PAX,PCI,RESULTS,SEVEN,SIXTY,THERE,TUMOURS
156,284,321,831,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
006,169,CENTRAL,COPYRIGHT,DSS,ENDPOINTS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,PULMONARY,PURPOSE,RESULTS
CTV,DVH,DVHPC,GTV,INC,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,RP2,THERE,V20
018,104,154,169,289,365,444,688,704,967,AFTER,COPYRIGHT,CRT,INC,KRUSKAL,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,PBT,PURPOSE,RESULTS,WHILE
169,450,FANCC,FANCONI,MICROARRAY,THESE
160,169,946,C57BL,CARCINOMA,COPYRIGHT,HOWEVER,LEWIS,LLC,SAS
200,400,458,500,SEVERAL
160,169,CONCLUSION,COPYRIGHT,JANUARY,LABEL,LTD,MANAGER,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE,VIDEO,WEATHER
169,COPYRIGHT,CXCR4,INC,METASTASES,METASTASIS,OSTERIX,RANKL,RB1
160,169,174,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MALAT,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TRANSWELL,UROLOGICAL
131,169,241,COPYRIGHT,MRI,SPECT
049,166,ENETS,GEP,LCNEC,NEC,NEN,NET,SHORT,WDNET
169,COPYRIGHT,INC,ITGB4,NOTCH,NSCLC,SUSTAINED,TPC,WHILE
160,BACKGROUND,CD3,EBV,LABEL,LITERATURE,METHODS,THERE
DESPITE,EPHB4,TAKEN
024,029,840,866,952,BACKGROUND,BECAUSE,CHINESE,CPD,KRUSKAL,LABEL,METHODS,RESULTS,THESE
LUCIFERASE,NICOTINIC,PCR,SEVERAL,THEREFORE,UTR
DECREASED,DNMT1,DUE,H1299,NON,NSCLC
946,AHR,SINCE,YET
227,AMONG,BRAZILIAN,ICD,MORTALITY,PAULO,STATE,UNDER,UNDERLYING
BIOMARKERS,METASTASIS,PCR,SEVERAL,THESE
AIF,ANNEXIN,FINALLY,HOWEVER,NAD,ROS,SIRT3
100,133,139,177,251,349,384,399,3MM,BACKGROUND,CONCLUSION,FNA,LABEL,MATERIALS,METHODS,RESULTS,THERE,TRAVERSED
105,118,BACKGROUND,BETWEEN,CONCLUSION,HNSCC,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SPM
187,291,5TH,6TH,AGE,ALZHEIMER,AMONG,DALYS,DISABILITY,DISEASE,HEALTHY,HOWEVER,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,YEARS,YLD,YLL
008,025,027,057,138,271,552,ACA,BACKGROUND,BETWEEN,CONCLUSION,GAMMA,KNIFE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC
BACKGROUND,DEL,FGFR1,FINALLY,GEFITINIB,HOWEVER,LABEL,METHODS,NSCLC,PATIENT,RESULTS,TEN
001,100,167,200,208,310,323,372,593,680,721,814,890,966,AUC,BACKGROUND,CONCLUSION,FIRST,III,LABEL,METHODS,NSCLC,ORR,PRIMARY,RESULTS,RRR,SCC
BACKGROUND,CONCLUSION,LABEL,LOW,METHODS,NSCLC,PET,PFS,RESULTS,SIXTEEN,TREATMENT
BACKGROUND,CYLIND1,LABEL,METHODS,NSCLC,RESULTS,SH2
004,169,177,295,827,943,APRIL,COPYRIGHT,F20,F21,F23,F25,GENERALLY,ICD,INC,LABEL,MARCH,METHODS,OBJECTIVE,PHYSICIANS,PLACE,PRESS,RESULTS
100,BACKGROUND,BECAUSE,DUE,LABEL,METHODS,PULMONARY,RESULTS,SIMULATED,SONOGRAPHY,THERE,TUMOURS
100,215,BACKGROUND,BECAUSE,BOOTSTRAP,CONCLUSION,HOWEVER,JEFFERSON,LABEL,METHODS,NETWORK,RESULTS,UNIVERSITY
169,175,177,AIM,ANZDATA,ASIAN,AUSTRALIA,AUTHORS,CONCLUSION,CREATININE,FIFTY,INACCURATE,LABEL,METHODS,NEPHROLOGY,NON,OBJECTIVE,PACIFIC,PRIMARY,RESULTS,SOCIETY,TRANSPLANT,ZEALAND
118,166,200,236,680,826,956,ALPINIA,BACKGROUND,CHINESE,CIOCALTEU,CONCLUSION,CONTEXT,DISCUSSION,FOLIN,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TPC
ALK,MET,NSCLC,RET
FINALLY,HOWEVER,RAMAN
INHIBITION,NSCLC,PCR,TRPC1,TRPC3,TRPC4,TRPC6,TRPCS,WESTERN
291,BACKGROUND,CELLSEARCH,CTC,EPCAM,EPITHELIAL,HOWEVER,LABEL,MCA,METHODS,NSCLC,RESULTS
215,BACKGROUND,CONCLUSION,DIFFERENT,FDG,HOWEVER,LABEL,LIPOSOMAL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,VX2,ZEALAND
263,341,AGE,BACKGROUND,COX,CURRENT,CVD,LABEL,METHODS,RESULTS,SMOKING
20S,BACKGROUND,CELLS,ERCC1,EXTENSIVE,LABEL,MALIGNANT,MATERIALS,METHODS,MRP,PGP,RESULTS,VIABILITY
520,600,BACKGROUND,CIS,HOWEVER,LABEL,METHODS,MPO,ORS,OVERALL,RESULTS,ROS,UNASSIGNED
055,177,931
127,136,167,252,253,287,386,420,AIM,CONCLUSION,FIFTY,III,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
169,437,ASSESSMENT,BACKGROUND,COPYRIGHT,COX,KARNOFSKY,LABEL,LOUIS,MATCHED,MEIER,METHODS,NSCLC,PROGNOSTIC,RESULTS,SOCIETY,SRS,UNIVERSITY,WASHINGTON
ANIMALS,BACKGROUND,CONCLUSION,DIFFUSION,EWING,GD2,LABEL,METHODS,MRI,NOVEL,RESULTS,SEQUENTIAL,WHOLE
954,H1299,TAKEN
10B,651,BIOMARKERS,COX,HAPLOTYPE,NSCLC,PRESENTLY,SNP,THESE,TNF,TNFRSF10B,VALIDATED
HOWEVER,PHASE,Y90
001,169,188,BACKGROUND,BASEL,COPYRIGHT,DESPITE,ELDERLY,LABEL,METHODS,NSCLC,OPTIMAL,PATIENT,RESULTS,THERE
EXTENSIVE,HOWEVER,MRI,NSCLC,PET,SEVERAL
192,COX,DFS,LVS,NSCLC,SPECIMENS
169,AMONG,CHEST,COMMITTEE,COPYRIGHT,IASLC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SEPAR,SOCIETY,SPAIN,SPANISH,STAGING,SURGERY,TNM
BACKGROUND,DESPITE,KNOWN,LABEL,PALLIATIVE,SUPPORTIVE,THERE,UNKNOWN
124,147,HOWEVER,LABEL,METHODS,NNT,NPV,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
169,947,ANTIGEN,CONCLUSION,ELISPOT,IFN,INSTITUTE,LABEL,METHODS,NCI,OBJECTIVE,PERIPHERAL,PRAME,PURPOSE,RESULTS,STRATEGIES,WT1
169,200,5MG,946,ANIMALS,AT1,FPNPS,FURTHER,LOS,MVD,TEL,TGF
169,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THREE
169,193,541,566,784,IMAGING,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
136,145,247,436,768,811,889,926,AFTER,CONCLUSION,LABEL,LOG,METHODS,OBJECTIVE,RESULTS
177,NNK
DRUGS,NSCLC
002,004,007,010,028,031,035,040,055,057,065,103,946,BACKGROUND,CONCLUSION,ESTROGENS,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,THEREFORE,TMN,TNM
160,169,231,233,468,956,AKT,INHIBITION,LTD,MDA,MTT,PUBLISHED,USING,WILEY
007,019,048,169,COPYRIGHT,ELISA,FACTORS,FURTHER,HPV,SOCIETY,SOLID,TRANSPLANT
EAC,LABEL,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN,THESE
945,BH4,HIF,M14,THESE,USING
ERK,FGFR4,GENOMIC,MUTATIONS
080,385,477,568,621,954,AKT,BASAL,HOWEVER,METADHERIN,PLK,SER,THESE

169,COPYRIGHT,LTD,THESE,WILEY
160,177,ACROMEGALY,AGE,IGF,MALIGNANCY,RENAL,THEREFORE,THYROID
148,156,169,183,190,731,BACKGROUND,CLINICIANS,GEORG,JANUARY,LABEL,METHODS,NSCLC,RESULTS,STUTTGART
AVERAGE,FIFTY,LABEL,LAPLACIAN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECIST1,RESULTS
003,010,030,046,FIFTY,LABEL,LNS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
034,160,945,BACKGROUND,FAP,FIBROBLAST,GRADE,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,OVERALL,RESULTS,TARGETING,THEREFORE
1400W,ACC,ACCIM,AMD3100,CXCR4,NOS,PBS,TUNEL
001,125,128,376,500,ANY,AVAPERL,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THOSE
001,180,234,285,359,397,500,539,939,945,AFTER,CONCLUSION,EASTERN,GROUP,III,LABEL,LOG,METHODS,NSCLC,OBJECTIVE,PARAMOUNT,PEMETREXED,PURPOSE,RESULTS
ADDITIONAL,AFTER,EASTERN,FIG,GROUP,MOLECULAR,NSCLC,PET,TREATMENT
730,BCL,CASPASE,FAS,IHC,LDH,MTT,NCI,NLCLC,NSCLC,PCR,REDUCED
169,945,956,AMONG,COPYRIGHT,R16,SAS,THESE
4MC,CARLO,D98,DPE,GTV,INVERSE,MONTE,OCE,V20,VARIATIONS
CHANGES,CTCAE,NSCLC,PTV,V50,V55,V60,V65,V70
177,916,BLAND,DEFORMABLE,DEPENDENCE,DIR,DSC,HOUNSFIELD,THREE
177,CARLO,CYBERKNIFE,GTV,HOWEVER,MONTE,V10,V30,V50,V80
ECLIPSE,ESOPHAGEAL,SES,TEN,THREE,TREATMENT,V10,V40,WHILE
100,119,177,AFTER,IEC,MELBOURNE,NUCLEAR,OSLDS,SUN,TPS
INCREASING,MPM,OAR,PTV,ROBUSTNESS,SIX,USING,V90,V95
177,AFTER,ELITETM,INTRA,OPTICALLY
ARRAY,CI100,DOSIMETRIC,DTA,EIGHT,MUS,PLANS,PTV,PTW,R50
169,ART,BACKGROUND,CONCLUSION,COPYRIGHT,GIVEN,HOWEVER,LABEL,PUBLISHED,SAS,SCIENTIFIC,STATE,THERE
169,AMONG,BACKGROUND,COPYRIGHT,GROUP,GSTSG,LABEL,MRI,PET,PUBLISHED,RESULTS,SAS,SPINE,TOKUHASHI,VIEWPOINTS
169,178,188,215,BACKGROUND,CCI,CONCLUSION,CONCURRENT,COPYRIGHT,GRADE,III,INC,INDEX,INTENSITY,LABEL,MEIER,METHODS,MLD,NSCLC,RESULTS,TREATMENT
001,011,029,144,169,424,967,AFFILIATED,CONCLUSION,COPYRIGHT,FINAL,INC,LABEL,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUV,UNIVERSITY
160,169,956,DOCKING,MATRILYSIN,MTT,NMR,WILEY
169,195,208,CHINA,CHINESE,ENGLISH,INCLUSION,JANUARY,LTD,MEDLINE,SCIENCE,WEB,WILEY
169,4T1,ATP,INHIBITION,KD317,KD5,KD9,LABEL,LACTATE,LDH,METASTASES,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS
169,AXL,BCL,CONVERSELY,HOWEVER,MERTK,TAM,THESE,TYRO3
169,257,297,883,ALK,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,USING,V600E
215,CONCLUSION,D95,HOWEVER,KNOWLEDGE,LABEL,METHODS,MINIMUM,OBJECTIVE,PCR,RESULTS,TREATMENT
229,325,AGE,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PET,RESULTS,UNIVARIATE
100,AFRICAN,MRI,THROUGH
153,ALTOGETHER,DESPITE,HOWEVER
117,AFTERNOON,ALONG,ASA,ASAII,GROUP,HRV,III,LABEL,METHODS,NIGHT,OBJECTIVE,OBJECTIVES,RESULTS,RMSSD,SD1
946,AKT,ERK,NSCLC,SEVERAL,TGF
177,737,ABT,AIM,BACKGROUND,BCL,HTB,LABEL,MATERIALS,METHODS,MMP,MTT,OBJECTIVE,PCR,RCC,RESULTS
169,945,946,ACTIVATION,ALDEFLUOR,C5A,CD49F,EPCAM,LIN,PRIMARY,WNT
689,CAUCASIANS,ILE,ULTIMATELY,VAL
001,036,105,113,210,693,910,LABEL,METHODS,OBJECTIVE,OVERALL,PULMONARY,RESULTS,THERE
033,040,679,876,BIOMEDICAL,CHINA,FINALLY,G463A,LITERATURE,MPO,OVERALL,THERE,WANFANG
041,160,203,514,895,934,AMONG,FIRST,III,KOREA,SIMILAR,THERE,TKI
108,CONCLUSION,DIFFERENT,GGN,IAC,III,LABEL,METHODS,MIA,MULTI,OBJECTIVE,RESULTS,TYPES
160,250,500,956,HOWEVER,HRAS128,SINCE,TRACING,TREATMENT,ZNCL2,ZNO
169,215,365NM,COPYRIGHT,FURTHER,HOWEVER,PDT
233,AMONG,BETWEEN,DESPITE,FIFTY,JANUARY
BCL,ERK,HOWEVER,JNK,KILLING,THESE
100,169,177,215,3MG,937,956,COPYRIGHT,H69AR,RELEASE,SMALL,SOLUBILITY
100,169,183,945,AFTER,AUC,BACKGROUND,COPYRIGHT,FUNDING,LABEL,LTD,METHODS,ONCOSUISSE,OTHER,RESULTS,TREATMENT
169,947,CD8,COPYRIGHT,CTL,IFN,LTD,MYD88,TAS,THESE
003,004,169,170,225,COPYRIGHT,INC,NSCLC,PCR,PUBLISHED,SOCIETY
169,177,241,335,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTEEN,HISTOLOGY,IRELAND,LABEL,LTD,METHODS,OVERALL,RECIPIENT,RESULTS,SIX
000,119,169,181,200,500,AIM,COPYRIGHT,ETOAC,III,IRELAND,JIRADEJ,LABEL,LANNA,LTD,MATERIALS,MCH,METHODS,OBJECTIVE,RELEVANCES,RESULTS,SRB,UNASSIGNED
169,COLLEGE,COPYRIGHT,ESTIMATING,LABEL,LARGE,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,231,COPYRIGHT,MDA,MMP,SNAIL,THEREFORE
ECM,FAS,LTD,MIGRATION,PUBLISHED
001,005,100,169,177,215,500,ADC,CONCLUSION,COPYRIGHT,DWI,EPI,FDG,IRELAND,LABEL,LTD,METHODS,MRI,NON,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,ROI,STUDENT,SUV,VOI
169,COPYRIGHT,CTC,EMT,IRELAND,LTD
169,COPYRIGHT,INC
A2BP1,DUSP7,FAM190A,HDS,INC,MMT,PUBLISHED,RPL29,SKY
001,040,169,242,BACKGROUND,COPYRIGHT,GPS,HOWEVER,INC,LABEL,LDCTS,MATERIALS,METHODS,PUS,RESULTS,SCREENING,THESE,THREE,TOS
001,169,AUR,CONCLUSION,COPYRIGHT,CTP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
105,132,160,954,CONCLUSION,EXCELLENT,ICC,INC,LABEL,METHODS,OBJECTIVE,PERCENT,PUBLISHED,PURPOSE,RESULTS
169,241,BAD,COPYRIGHT,ONJ,PORTUGUESA,PUBLISHED,SOCIEDADE
160,APRIL,BACKGROUND,CONCLUSION,HORMONE,HOWEVER,IIB,JANUARY,LABEL,MARCH,MAY,METHODS,PACLITAXEL,SEPTEMBER,SINCE,THEREAFTER,THEREFORE
142,169,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,LVI,METASTASIS,METHODS,NSCLC,RESULTS,T1A,T2A,VPI
125,169,177,CONCLUSION,COPYRIGHT,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TPS
169,COPYRIGHT,IRELAND,LTD,NUCLEAR,WHILE
169,AEC,COPYRIGHT,OTHER,PUBLISHED,THERE,TREATMENT
169,COPYRIGHT,HOWEVER,LTD,NSCLC,SEVERAL,TKI
169,A11,A24,A26,A31,A33,CTL,HLA,IGG,PEPTIDE,PPV,REFRACTORY,TAKEN
945,946,BACKGROUND,BEL,CONCLUSION,CONVERSELY,EMT,HCC,LABEL,MET,METHODS,MRC,PCR,RESULTS,SNAIL
LOCAL,NSCLC,SINCE

150,178,200,400,AREAS,BACKGROUND,COVERED,III,LABEL,METHODS,NSCLC,OPINION,PHASE,PICOPLATIN,RESULTS
BACKGROUND,FURTHER,III,LABEL,PC3,RESULTS,THESE
FINALLY,MB231,MDA
HOWEVER,LEWIS,LLC,LOXL2,LYSYL,SMALL
FURTHER,TAKEN
114,229,308,386,389,611,614,945,AIM,BACKGROUND,CONCLUSION,GASTRIC,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TNF
169,BACKGROUND,BKV,CONCLUSION,COPYRIGHT,DIFFUSE,DMM,INC,IRANIAN,JCV,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,THERE,WILEY
AKT,APOPTOSIS,BCL,CHRONIC,DESPITE,INCREASED,NICL2
444,467,777,BACKGROUND,COX,DIFFERENT,HOWEVER,HRS,LABEL,METHODS,RESULTS,RISKS
111,BACKGROUND,CONFIRMING,LABEL,METHODS,OCT,OPTICAL,RESULTS,SIX,SPN
185,DISTANT,FDG,PET,STM,THESE
177,335,HOWEVER,IMA,LABEL,METHODS,NED,OBJECTIVE,RESULTS,SEVENTEEN,WBS
945,AIM,CD4,CD8,CYTOKINES,III,LABEL,MATERIALS,METHODS,MIP,OBJECTIVE,PCR,RESULTS
BREATHING,HATHA,NSCLC,STAGE,SURVIVORS,WHILE
III,NOTABLY,THESE
282,370,APRIL,BACKGROUND,DISEASE,FIFTEEN,HOWEVER,LABEL,LOBECTOMY,METHODS,NSCLC,PET,RESULTS,THERE
BACKGROUND,EARLY,FURTHER,H2052,LABEL,METHODS,MPM,PHENOTYPIC,RESULTS,TAKEN
160,CTC,HOWEVER,L858R,LCM,PCR,SEQUENCING,T790M,USING,WHOLE
AFTER,JANUARY,RCC
169,215,480,AUC,CHEST,CONCLUSION,COPYRIGHT,FPD,IRELAND,ISS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROC,SIMULATED,SIX,THERE
169,COPYRIGHT,INC
001,002,004,169,376,513,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,GROUP,HOWEVER,INC,INDEX,LABEL,MAY,METHODS,MOLECULAR,NEITHER,NSCLC,RESULTS,UNIVERSITY
006,015,029,101,123,126,130,145,163,189,352,AFFAIRS,BACKGROUND,CONCLUSION,HEALTHCARE,III,INC,JANUARY,LABEL,METHODS,NSCLC,OCTOBER,PUBLISHED,RESULTS,TIMELINESS,VACHS,VARIABLES
002,019,169,BACKGROUND,COPYRIGHT,GLASGOW,INC,LABEL,METHODS,RESULTS
169,172,ALTOGETHER,ATP,COPYRIGHT,GPINH5A,HBSMC,LTD,REGULATOR,USING
169,203,367,392,428,508,778,ADDITIONAL,AUSTRALIA,AUSTRALIAN,COPYRIGHT,CRTAM,HOWEVER,IRELAND,ITALIAN,ITALY,LTD,MALIGNANT,PUBLISHED,RASGRF2,THESE,WESTERN
001,008,126,169,AFTER,COPYRIGHT,FINALLY,MIR,NSCLC,PCR,TNM
169,231,956,COPYRIGHT,MCF,MDA,RUTHENIUM,SAS,THESE
171,CONCLUSION,CONCURRENT,LABEL,METHODS,OBJECTIVE,ORR,PFS,RESULTS,TNM
100,BACKGROUND,BPS,GROSS,HDR,LABEL,METHODS,NPC,PLATO,RESULTS
AAA,LABEL,METHODS,NTCPAAA,NTCPPBC,OBJECTIVE,PBC,PURPOSE,RESULTS,STUDENT
945,AKT,ATP,AZ12253801,IGF1R,III,IR3,NSCLC,NVPAWD742,PHASE,SIGNALLING
MAP,THESE,V600E
END,OTHER,RESULTS
169,340,680,BACKGROUND,FNA,LABEL,LOUIS,MEDICAL,METHODS,RAPID,REPORTS,RESULTS,SOCIETY,THERE,UNIVERSITY,WASHINGTON
120,745,785,847,884,886,924,928,929,933,941,942,943,945,947,951,954,955,957,961,963,966,975,AGREEMENT,BLAND,CONCLUSION,DEPENDING,HIPAA,INTRACLASS,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
005,160,177,945,FDG,FIFTY,LABEL,MEAIB,METHODS,OBJECTIVE,OBJECTIVES,PET,PURPOSE,RESULTS,SETTING,WHOLE
737,ABT,BAK,BAX,BCL,BFL,BH3,BXI,MCL,NCI,TREATMENT
169,AKT,FINALLY,INTRINSIC,JNK,KEAP1,MAPK8,NH2,NSCLC,USING
004,109,140,230,674,BACKGROUND,BANGKOK,CONCLUSION,DESPITE,FURTHER,LABEL,LYMPH,METHODS,NODAL,NSCLC,RESULTS,SHP
177,183,BECAUSE,BRCA2,GEORG,STUTTGART
001,013,028,041,160,213,CLL,CNS,HGG,HRQOL,LGG,MCS,NHL,NSCLC,SHORT,SOS
954,ACTIVATION,BAY11,CIGARETTE,CSE,EMT,FINALLY,HBE
110,112,257,382,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,MIXED,RESULTS
DUE,HOWEVER,MANAGEMENT,NCI,NSCLC
128,BACKGROUND,CONCLUSION,EBV,EIGHT,EPSTEIN,HOWEVER,LABEL,METHODS,RESULTS,TEN,THEREFORE,THREE
107,640,BACKGROUND,CAO,CENTRAL,CONCLUSION,EIGHT,HEIDELBERG,HOWEVER,JANUARY,LABEL,MAY,METHODS,PLACEMENT,RESULTS,STENT
051,181,192,DESPITE,FMS,HOWEVER,INSTEAD,NSCLC,TAKEN
424,945,946,G505S,I638F,LYN,PIK3C2A,PLCL2,SCC,SH2,SHP,SRC,TAKEN
075,151,229,346,826,902,AFFAIRS,ARB,BACKGROUND,CONCLUSION,DEPARTMENT,LABEL,METHODS,RESULTS,THERE
177,215,397,BRAGG,CTV,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
CARLO,DVF,DVH,HOWEVER,LABEL,METHODS,MONTE,NEGLECTING,OBJECTIVE,PURPOSE,RESULTS,USING
176,945,947,952,DTA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
177,DMR,KNOWN,LABEL,METHODS,OBJECTIVE,OUTSIDE,PURPOSE,RESULTS,SSD,VRE
166,177,LABEL,METHODS,MODEL,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,SUCCESSIVE
10001,333,AMONG,CANDIDA,HOWEVER,MEDICAL,OTHER,PUBLISHERS,PULMONARY,SEVENTH,THERE,USA
160,BACKGROUND,BASED,CONCLUSION,DES,EQUATIONS,LABEL,METHODS,OBJECTIVE,RESULTS
METAZOANS
000,ACT,CANCERS,DTP,EXCELLENCE,NCI,PROGRAM,SPORE,THERE,THROUGH
CSC,EVALUATING,HOWEVER
023,046,MICRORNAS,MIR,NOTEWORTHY,NSCLC,PCR,RAS
HOWEVER,JNK,LRP,MAJOR,MVP,SP1,SW620,THEREFORE,UNDER
174
169,COPYRIGHT,ECH,INC,KEAP1,KELCH,NUCLEAR,OWING
102,108,125,437,521,589,623,848,AMONG,BACKGROUND,COLORECTAL,CONCLUSION,COX,INSTITUTES,LABEL,METHODS,OVARIAN,RESULTS,SCREENING,TRIAL,WHILE
201,92A,BACKGROUND,CONCLUSION,CONVERSELY,GELATIN,H1299,LABEL,LUCIFERASE,METHODS,MMP,PCR,PROTEIN,RESULTS,S3I,STAT3,TRANSWELL,UTR
169,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OLDER,RESULTS
001,002,011,937,ASIAN,CONCLUSION,CUMULATIVE,ELDERLY,HNSCC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,SPM,UNIVARIATE,UNIVERSITY
169,COPYRIGHT,DEPLETION,ISSUE,LTD,MOLECULAR,SINCE,THESE
ALK,APART,BECAUSE,FGFR2,GASTRIC,MET,RTK,WHILE
172,214,A140D,CAUCASIAN,GSTO1,NSCLC,PCR,TURKISH,UNTIL
169,177,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,FIFTY,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS
230,330,500,CARLO,CONVERSELY,ION,MEV,MONTE,THERE
102,CONTROL,CRT,CSS,LOCAL,OVERALL,PFS,PRIMARY,SECONDARY,SEVEN,THESE,TREATED
AEC,CROSS,HNF4A,INHIBITION,RXR,WNT
AFTER,MOTIVATED,TTF
H1299,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS
200,CONCLUSION,CONTINUOUS,FIFTY,FOLFOX7,LABEL,METHODS,OBJECTIVE,PFS,PREVIOUSLY,PURPOSE,RESULTS
003,160,EGFRS,IGF,JANUARY,UNIVERSITY
008,036,13C,31P,ATP,GENOMIC,LEWIS,NMR,TAKEN,TCA,TEM,THESE,WORKING
170,AMONG,BACKGROUND,BECAUSE,CD8,CTL,EVERY,HLA,LABEL,METHODS,RESULTS,SINCE
160,212,331,603,660,738,ALTERED,CONCLUSION,EXPRESSION,HOWEVER,LABEL,LSCCS,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,440,BACKGROUND,LABEL,METHODS,ONCOMAP,RESULTS,THESE
169,DOCETAXEL,SENSORY
001,005,007,177,793,961,ANATOMICAL,CONCLUSION,DESPITE,DIXON,IMAGE,LABEL,MBQ,METHODS,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,THERE,THESE
001,100,120,177,200,211,BACKGROUND,CONCLUSION,CTDIW,DLP,HOWEVER,IMAGE,LABEL,METHODS,NPV,OBJECTIVE,PPV,PURPOSE,RESULTS,STUDENT
000,100,160,FNA,L858R,PCR,T790M
435,CH2,CL2,DU145,MCF,MDA,MTS,NMR,SEVERAL
ALI,BACKGROUND,FIFTEEN,LABEL,MCP,METHODS,OBJECTIVE,RESULTS,STATINS,THERE
000,004,155,160,EGGER,LABEL,METHODS,OBJECTIVE,RESULTS
HOWEVER
ALK,BACKGROUND,CONCLUSION,IHC,LABEL,METHODS,NSCLC,RESULTS
106,164,582,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,RADIATION,RESULTS,SIXTEEN,SOCIETY
100,169,786,956,BASEL,COPYRIGHT,DU145,H2052,H2452,H28,HEPG2,HUH,LNCAP,MKN,NCI,SBC,T24,VHL
000,169,ASSESSMENT,BACKGROUND,BASEL,COPYRIGHT,DIAGNOSTIC,FIFTY,KNOWLEDGE,LABEL,MAJOR,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,STAGE,STUDIES
169,BACKGROUND,BRAIN,COPYRIGHT,HOWEVER,LABEL,LTD,MEETING,METHODS,RESULTS,THEREFORE
001,004,007,010,015,C30,CONCLUSION,FATIGUE,III,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,QOL,QUALITY,RESULTS,THREE,TREATMENT
100,AES,CONCLUSION,ERBB1,FIFTY,L858R,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY,T790M,TREATMENT
001,269,308,345,ASIAN,CONCLUSION,ERBB1,ERBB2,ERBB4,III,L858R,LABEL,LUX,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY
177,CONCLUSION,FDG,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SEVENTY,THESE
169,AVAILABLE,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GRADE,INC,ISG15,LABEL,METHODS,PATIENT,PFS,RESULTS,THERE
001,169,413,483,559,BASEL,BECAUSE,CAUCASIAN,COPYRIGHT,FEW,LABEL,LCS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
141,169,BACKGROUND,BASEL,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PES,PULMONARY,RESULTS
169,178,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,LABEL,METHODS,NSCLC,RESULTS,SEVENTEEN,TREATMENT
ACUTE,DIAGNOSIS,HOWEVER,IDIOPATHIC,IPF,PROGNOSTIC,UIP
160,169,BACKGROUND,COPYRIGHT,FEDERATION,HOS,IMR,KCCF1,LABEL,METHODS,ONCOLYTIC,PUBLISHED,RESULTS,SKNAS,SOCIETIES
001,116,456,588,797,936,AFTER,ASIAN,CAUCASIAN,FIFTEEN,III,MEDLINE,NSCLC,PBC,THESE,USING
169,CARLO,COPYRIGHT,LOW,LTD,MONTE,NOISE,SNR,USING
CHRONIC,FURTHER,IRANIAN,IRELAND,LTD,PUBLISHED,THERE,WAR
169,CONCURRENT,COPYRIGHT,INC,PUBLISHED,SOCIETY,VSD
169,BILATERAL,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
BACKGROUND,BLOOD,CD4,CD8,COMPARING,FURTHER,HOWEVER,LABEL,MALIGNANT,METHODS,MPE,MPM,RESULTS,WHEREAS
AKT,BACKGROUND,COLON,CYQUANT,ERK,FINALLY,FURTHER,HOWEVER,INHIBITION,LABEL,MAP1D,MEK,METHODS,PDF,PROTEIN,RESULTS
293,946,AMONG,BACKGROUND,FOP,INHIBITION,LABEL,METHODS,NSCLC,PCR,RESULTS,STUDENT,TCF,TOP,WNT
169,ADP,AKT,ERK,HOWEVER,RAS,SHC,SRC
AREAS,BACKGROUND,COVERED,DESPITE,LABEL,MALIGNANT,METHODS,MPM,OPINION,PHASE,THEREFORE,THESE
160,AIMP2,DX2,DXI01,TAKEN
632,MTT,RAMAN,SERRS
INSTEAD
AFTER,BACKGROUND,CURRENTLY,FLAIR,GADOLINIUM,LABEL,METHODS,MRI,RESULTS,SRS,STEROID
FINALLY
ALK,NOTABLY,NSCLC,RET,THESE
169,CRITICALLY,CRT,KNOCKDOWN,LABEL,OVERALL,PREVIOUSLY,PTP1B,THESE,UNLABELLED
215,301,ADDITIONAL,BCA,BONFERRONI,COLORECTAL,HODGKIN,NHL,OVARIAN,SCREENING,TRIAL
397,FAK,FINALLY,GDP,GTP,MIGRATION,PRECISELY,TAKEN
BACKGROUND,LABEL,METHODS,RESULTS,SCIENCE,THERE,WEB
001,031,167,169,AKT,DIX,HBE,INC,MEIER,NSCLC,THESE,TNM,WILEY
169,COPYRIGHT,GLYCOLYSIS,PFK,VCH,WILEY
169,231,ADP,CONVERSELY,COPYRIGHT,ERK,IIA,KBM,LC3,LTD,MDA,NCI,OVERALL,PD98059,RAF,RSK,S6K,SALVIAE,TAN,WILEY
AFTER,CRMP5,GAD,MA2,RITUXIMAB
EWING,PRIMARY,THERE
169,406,COPYRIGHT,LTD,WILEY
177,CONCLUSION,LABEL,UNLABELLED
001,160,CALIBRATED,FLT,IDIFS,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PEARSON,PROCEDURES,PURPOSE,RESULTS,SUV,VOI
METASTASES,TCC
CASES,DIAGNOSTIC,DISCUSSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCP,RESILIENT,RESULTS,WHILE
549,FORMULA,HEPG2,HUCCA
002,160,430,CIS,CISPLATIN,NSCLC,PRIMARY,RRS,SUMMARY
WHILE
956,BAX,BCL,CDK,MCF,NMR,P21,PC3,TREATMENT
100,799,873,BACKGROUND,COLORECTAL,CONCLUSION,GENERALLY,GROUP,LABEL,MEDLINE,METHODS,RESULTS
18Q,AMONG,INTEGRATED,LABEL,LOW,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THEREFORE
HOWEVER,TSLC1
001,924,929,ARG,ASIAN,CIS,HOWEVER,ORARG,ORS,PRO,SIMILAR
215,PIT,PRIMARY
946,ALI,ALTERATION,FAS
AKT,FOLLOWING,HIF,PASMC,THESE,WHILE
CRAMP,LEWIS,TAKEN
252,946,FAK,INHIBITION,MMP14,TAKEN,USING
AKT,EGF,FINALLY,HGF,MET
100,BACKGROUND,CONCLUSION,CURRENT,G3BP1,KLAKLAK,LABEL,LTVSPWY,MATERIALS,MDA,METHODS,RAS,RESULTS,THEREFORE,TOX
219,ANALYZING,APRIL,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,BETWEEN,CLEAR,EIGHT,LABEL,LEVEL,METHODS,PLANNED,RESULTS,SIX,SOCIETY
160,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SQCLC
169,945,946,ARSENIC,HBE,HIF
169,956,CADMIUM,CCT,CELLS,EXPRESSION,HIF,HPL,MMP,OVERALL,OXIDANT,RAS,SLC38A3,ZIP,ZNT
169,ALPINIA,ATG,CALYXIN,COPYRIGHT,IRELAND,JNK,LTD,NCI,THEREFORE
169,804,ABL,BCR,COPYRIGHT,HOWEVER,IRELAND,LTD,PONATINIB,RET,V804M,VANDETANIB
100NM,169,COPYRIGHT,DUE,HOWEVER,INC,THESE,THROUGH
136,FORTY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,RFI,SEVENTY,STAGE,TYPES,UNIVARIATE
116,169,549,COMPOUNDS,COPYRIGHT,HCT,HUISGEN,MCF,NMR,SAS,THEIR,THP
100,169,183,300,400,ADP,ANTITUMOUR,BACKGROUND,BETWEEN,BRCA1,BRCA2,COPYRIGHT,DOHME,EASTERN,EIGHT,ETS,EVALUATION,FUNDING,GROUP,JAN,LABEL,LTD,MERCK,METHODS,NIRAPARIB,RESULTS,SHARP,SOLID,TOXIC,USA
169,COMPARISON,COPYRIGHT,CPG,INC,MOLECULAR,NGS,PATHOLOGY,PUBLISHED,SOCIETY
001,114,153,160,169,BACKGROUND,COPYRIGHT,EMPHYSEMA,INC,LABEL,METHODS,NON,NSCLC,RESULTS,THERE
CARDIAC,DISTANT,INC,PUBLISHED,SINCE
147,169,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,RESULTS,TKI
169,ATP,COPYRIGHT,INC,THESE
001,008,150,169,177,2CM,CHEST,D50,DESPITE,MEDICAL,MLD,NOMINAL,NSCLC,OAR,PTV,R50,V10,V20,V30
169,BTG3B,COPYRIGHT,FUNCTIONAL,INC,THESE
125,169,BACKGROUND,CONCLUSION,COPYRIGHT,DETECTION,INC,LABEL,METHODS,OVERALL,PCR,PERIPHERAL,PTHRP,RESULTS,SAMPLES
169,232,BACKGROUND,COMPARING,CONCLUSION,COPYRIGHT,COX,JANUARY,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM,VTE
169,COPYRIGHT,INC,PUBLISHED,SIR
015,018,047,067,132,163,169,BACKGROUND,BRC,CD163,CLUSTER,CONCLUSION,COPYRIGHT,DAP12,INC,LABEL,MATERIALS,METHODS,RESULTS
169,AUTHORS,COPYRIGHT,CURRENTLY,CYBERKNIFE,GAMMA,IDEALLY,KNIFE,LINAC,LOCAL,LTD,PUBLISHED
013,160,169,825,AMONG,CIS,COPYRIGHT,EPIDERMAL,HOWEVER,INCIDENCE,LTD,RRS
032,103,118,169,946,BACKGROUND,COPYRIGHT,ENZYMES,ERCC1,III,INC,LABEL,METHODS,MPM,MSH,PRE,RESULTS,THEIR,THEREFORE
169,225,241,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,THERE
169,ASIAN,CARCINOID,CONCLUSION,COPYRIGHT,IIA,LABEL,LLC,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RECURRENCE,RECURRENT,RESULTS,SEVEN,SIX
160,169,171,296,325,462,496,COPYRIGHT,COX,DFS,INC,LABEL,LOBECTOMY,MEIER,METHODS,MOSBY,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SEX,SURGERY,SURVIVALS
169,814,CONCLUSION,COPYRIGHT,ICERTDT,ICLINDT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SETTING,THERE
169,609,AMONG,BACKGROUND,COPYRIGHT,COX,INC,LABEL,METHODS,RESULTS,THERE
BACKGROUND,COLORECTAL,CONCLUSION,CRC,DENMARK,DIVERSITY,FUNDING,GROUP,HOPEFULLY,LABEL,METHODS,POS,QUESTIONS,RESULTS,TRIAL
0CM,150,169,250CM,3DCRT,CHANGES,EFFECTS,EMD,INCREASING,MEDICAL,OAR,TOMODIRECT,USING,V20GY
215,BACKGROUND,E2F,KNOCKDOWN,LABEL,LIVER,LXR,METHODS,PCR,PUBLISHED,RESULTS,TAKEN
169,COPYRIGHT,III,IRELAND,LTD,NSCLC
169,ALK,COPYRIGHT,IRELAND,LTD,NSCLC
002,019,101,169,250,989,BSA,COPYRIGHT,GEFITINIB,IRELAND,LTD,NSCLC,OKAYAMA,PFS,UNIVERSITY
117,AGREEMENT,BACKGROUND,BLAND,BPI,BRIEF,CHECKLIST,CONCLUSION,FIRST,INVENTORY,LABEL,METHODS,OBJECTIVE,OUTCOME,PALLIATIVE,POS,QOL,RESULTS,ROTTERDAM,SCALE,SECONDARY,SETTING,SPANISH,SYMPTOM,THERE
169,INC,PRIMARY,WILEY
172,1ST,289,2ND,CONTROL,EH3,EH4,EXB,HARDY,MAYAK,PHASE,THERE,TYR113HIS
001,004,015,777,ADC,AMONG,BACKGROUND,CIR,LABEL,METHODS,RESULTS,T1A,T1B,T2A,TNM,VPI
100,160,717,AFTER,DUTCH,HOWEVER,LABEL,METHODS,OBJECTIVE,PALGA,PATHOLOGY,PURPOSE,RESULTS,SURGERY
100,126,200,300,317,400,797,BACKGROUND,CONCLUSION,EUS,FNA,HRM,KIRSTEN,LABEL,METHODS,RESULTS
946,DESPITE,LSL,N1ICD,NSCLC,SNAIL,WNT
160,ARYTENOID,HOWEVER,USING
160,239,500,AUC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
ACL,ATP,BECAUSE,EMT,FINALLY,H1650,H1975,HMLER,INDUCIBLE,RAS,SIMILAR,SNAIL
200,500,CONSISTENT,HOWEVER,PHOSPHO,TWEEN
948,EXPRESSION,HEL,KNOCKDOWN,PTGIS,SINCE,THESE,TIG
169,COPYRIGHT,FIFTY,INC,THERE
169,174,AFTER,COPYRIGHT,LOCAL,MEANWHILE,NAVELBINE,RESULTS,TAKEN
001,169,497,513,AFA,AFRICAN,AMERICANS,BACKGROUND,BASED,CAUCASIAN,COPYRIGHT,INDEX,IRELAND,LABEL,LTD,MAY,METHODS,MUTATIONS,NSCLC,RESULTS,UNIVERSITY
100,169,215,COPYRIGHT,CROWN,IRELAND,LTD,NSCLC,PCR,PUBLISHED,RARB2,RASSF1A,USING
169,304,AMONG,COPYRIGHT,COX,FGFR1,FIBROBLAST,IRELAND,ISH,LCC,LTD,NSCLC,SCC
169,AFTER,CDK,COPYRIGHT,ERK,INC,MAPKS,PMA,RESULTS
169,COPYRIGHT,CURRENT,HOWEVER,IMAGE,INC,PUBLISHED,SIR
169,946,947,AMAXA,COPYRIGHT,DNT,HENCE,HOWEVER,IFN,NATURAL,RII,TGF,THESE
100,169,ASIAN,BACKGROUND,CAUCASIAN,COPYRIGHT,DISTANT,FORTY,GGO,IIA,INC,LABEL,M1A,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE
EIGHT,GBM,GMB,HOWEVER,IHC,MRI,PET
0665752,ALK,AREAS,BACKGROUND,COVERED,LABEL,MET,METHODS,NPM,NSCLC,OPINION,PHA,STUDIES
711,BACKGROUND,CALIFORNIA,COX,LABEL,METHODS,NO2,OBJECTIVE,OBJECTIVES,PREVENTION,RATIONALE,RESULTS,SOCIETY,USING
013,215,CHINESE,MITOGEN
169,AXL,FGFR1,FGFR2,FGFRS,MER,MET,MOL,VEGFR
169,945,946,HOWEVER,INDUCTION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
140,169,204,DESIGNS,DTF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
154,DECREASED,FURTHER,NSCLC,PCR,THEREFORE
143,945,ACCORDING,TNF,UTR
012,BACKGROUND,CONCLUSION,CYTOLOGIC,FURTHER,GEFITINIB,LABEL,LMC,METHODS,NSCLC,RESULTS,SEOUL,TEN,TKI,UNIVERSITY
00004,379,489,945,946,ALPHA,BACKGROUND,FIFTY,FINNISH,LABEL,METHODS,OBJECTIVE,PREVENTION,RESULTS,THESE,TOCOPHEROL
MANAGEMENT
003,215,451,694,696,935,AMONG,BPI,CIS,COLORECTAL,INHERITED,ITGB2,LBP,MYD88,ORS,OTHER,OVARIAN,SCREENING,SIXTEEN,TRIAL
000,100,117,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
110,ECM,LABEL,METHODS,NPV,OBJECTIVE,OBJECTIVES,PRECAUTION,RESULTS,SELECTIVE,STAGING,VAMLA
163,CALIFORNIA,CAREGIVER,CAREGIVERS,CURRENT,INSTITUTE,KNOWLEDGE,LABEL,METHODS,NSCLC,NURSING,OBJECTIVE,OBJECTIVES,OUTCOME,OVERALL,PERCEIVED,PURPOSE,QOL,RESULTS,SETTING,VARIABLES
169,AFRICAN,AMERICANS,CARDIAC,INC,PRIMARY,WILEY
AFRICAN,ALK,AMERICANS,BACKGROUND,BIOMARKER,CALIFORNIA,CONTEXT,DIEGO,HOWEVER,LABEL,MET,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SAN,STAT3,TARGETABLE
REGULAR,SEVERAL,THEREFORE
001,435,AKT,MDA,MMP,PI3
AMONG,BAL,BPI,CATHEPSIN,ELISA,LAMP2,NEUTROPHIL
946,EMT,EPITHELIAL,FH535,HOWEVER,NSCLC,TGF,THESE,WNT
954,BAY,FINALLY,HOWEVER,ILK,MMP,PREVIOUSLY,TAKEN
206,207,BACKGROUND,CONCLUSION,LABEL,MET,METHODS,N375S,PREVIOUSLY,RESULTS,SU11274,TAIWANESE,THERE
BACKGROUND,CRP,LABEL,METHODS,PCR,PROTEIN,RESULTS,SA4,SAA,THERE,THESE
CPG,MAFUCCI,TET,THESE
ALK,OTHER,THERE
BECAUSE,BETWEEN,COMBINING,EARLY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PAS,PET,PULMONARY,PURPOSE,RESULTS
DESPITE,NSCLC
CRS,DIFFUSE,EXPRESSION,GLUT1,HIPEC,LABEL,MEDICAL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS
181,CHEST,IGA,LABORATORY
169,BACKGROUND,BISULFITE,CHROMATIN,COPYRIGHT,CPG,EPIGENETIC,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RUNX3,SOCIETY,THERAPY,THESE
169,386,932,956,ARIZONA,ARSENIC,BACKGROUND,HEART,HRS,INDIANS,INORGANIC,LABEL,LOW,METHODS,NORTH,RESULTS,SOUTH,THESE
ACCORDING,CONCLUSION,DEPARTMENT,GENERAL,INC,LABEL,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SPAIN,SURGERY,TEN,THERE,UNIVERSITY
169,215,AIM,CHERNOBYL,CONCLUSION,COPYRIGHT,FINLAND,FINNISH,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THERE
002,946,BACKGROUND,EMT,HOWEVER,LABEL,METHODS,NOTCH,RESULTS,SNAI1,TGF,WNT,YOUNG
439,BACKGROUND,CONCLUSION,JAPAN,LABEL,LIVER,METHODS,OSAKA,RESULTS,THESE
001,600,BACKGROUND,DOSES,DOSIMETRY,EARLY,LABEL,METHODS,PRONE,RESULTS,WBI,WTF
5GY,AAA,ALGORITHM,ANALYTICAL,AXB,BACKGROUND,D98,DVH,ECLIPSE,III,LABEL,METHODS,MLD,PTV,RESULTS,THERE
2000S,AFTER,AUSTRALIA,BACKGROUND,CONCLUSION,COUNTRIES,GEOGRAPHIC,ITALY,LABEL,METHODS,RESULTS,THESE,USA,WESTERN
ACC,BACKGROUND,BASAL,BBC,COMPARISON,CONCLUSION,DIAGNOSTIC,FOXA1,GIVEN,GPM6B,LABEL,MEL,METHODS,MIA,PCR,RESULTS,ROPN1,SOX10,TRIM2
ASA,ASPIRIN,BCL,COX,FAS,MTX,NOTABLY,SRB
020,101,C10ORF137,CATALOGUE,EP300,LPHN2,MS4A3,NSCLC,SIXTEEN,SOMATIC,TAKEN
373,ERR,MAYAK,POISSON,THERE
174,185,247,252,FDG,PET,PHYSICIANS,TREATMENT
100,BACKGROUND,CAV,HOWEVER,INDIANA,LABEL,METASTATIC,METHODS,NED,RESULTS,RPLND,SIX,TREATMENT,UNIVERSITY
113,171,228,FNA,FORTY,LABEL,METASTASES,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROCHESTER
PAX3C,PAX3D,PAX3E,TAKEN,WHILE
BACKGROUND,CIK,HOWEVER,HYPOXIA,INTRAVITAL,LABEL,METHODS,MHC,RESULTS
AKI,ATN,BACKGROUND,HOWEVER,INHIBITORS,LABEL,METHODS,THEIR,THESE,WITHDRAWAL
047,101,169,BACKGROUND,HOWEVER,LABEL,METHODS,OTHER,PFS,RESULTS,SOCIETY,TREATMENT
120,169,ASP148GLU,CERTAIN,EPHX1,HIS139ARG,INC,NAD,PRO187SER,WILEY
005,006,024,025,029,318,411,LOWER,NSCLC,THERE,TNM,UNIVARIATE
002,022,023,026,169,COX,HPV,TAIWANESE
60S,ELISA,FURTHER,HOWEVER,L22,NSCLC,RIBOSOMAL,RPL22,WESTERN
005,160,161,ATS,EPIDERMAL,ERS,HOWEVER,IASLC,SOCIETY
CHEST,DIFFUSE,HISTOLOGIC,ILD,INITIAL,LANGERHANS,MALIGNANT
006,012,169,BACKGROUND,HOWEVER,HPV,HPV16,LABEL,METHODS,RESULTS,SOCIETY,TAIWANESE
BASED,FDG,HISTOLOGY,PET
111,CAUCASIAN
023,034,035,042,945,HIF,LABEL,MARCH,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE
169,BASEL,COPYRIGHT,DIFFUSE,MPMNS
169,COPYRIGHT,INC,LITERATURE,PUBLISHED,SIR
169,BASED,CEA,CGA,COPYRIGHT,FINALLY,LDH,NSE,PUBLISHED,SCC,THEREFORE
009,049,172,177,300,CONCLUSION,INORGANIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,THERE,THREE,WORKERS
169,26YEARS,COPYRIGHT,HODGKIN,MALIGNANT,SAS
100,169,200,233,245,445,ASIAN,AUTHORS,BACKGROUND,BASED,CURRENTLY,L858R,LABEL,METHODS,OBJECTIVE,PACIFIC,PCR,RESULTS,SCREENING,SOCIETY
946,956,COMBRETUM,COMPOUNDS,ETOAC
CISPLATIN,RESISTANCE
169,AUTHORS,COPYRIGHT,CTS,DMS53,PCC,PUBLISHED,SCHIP
169,954,955,CD3,CD79A,COPYRIGHT,EMA,HIV,HMB45,HOWEVER,INC,LCA,PBL,VMT,VS38C
169,COPYRIGHT,FHF,FULMINANT,NEOPLASTIC,PUBLISHED,SOCIETY,THESE
000,000NG,007,100,101,120,152,169,200,230,334,500,600,630,700,765,800,832,898,900,950,BACKGROUND,BAP,COPYRIGHT,III,LABEL,METHODS,MPM,OMC,PLEURAL,PUBLISHED,RESULTS,ROC,SOCIETY
CONCLUSION,GIVEN,HOWEVER,LABEL,OBJECTIVE
954,970,CONCLUSION,EVALUATION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVENTY,SOLID,STUDENT,TTP
002,CONCLUSION,COX,FDG,IMAGING,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PET,RESULTS
013,038,052,136,157,454,733,ADDITIONAL,APRIL,CARLO,CONCLUSION,LABEL,METHODS,MONTE,OBJECTIVE,RESULTS,SCREENING,SEPTEMBER,TRIAL
258,759,CANCERS,CASES,CONCLUSION,DETECTION,DIFFUSE,LABEL,MATERIALS,METASTASES,METHODS,OBJECTIVE,PATIENT,RESULTS,TEN
015,089,EASTERN,ENDPOINTS,GERIATRIC,GROUP,III,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY
32D,EGF,ERBB3,ERBBS,FINALLY,HOWEVER,MET,NSCLC,OVERALL,USING
312,321,ADC,ALK,CK5,THERE,TTF
CONVERSELY,PCR,THEIR
169,34A,INC,KIT,MICRORNAS,NSCLC,PCR,PEMETREXED,TARGETSCAN,WILEY
160,453,965,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,HOWEVER,ISSUE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,PREMEDLINE,RESULTS,RRS,SELECTION,THERE,WHERE
169,EPIDERMAL,INC,THEREFORE,WILEY
115,211,CHINESE,GSTT1,REVMAN4,STATA10,WANFANG
026,435,461,HISTONE,HOWEVER,JUN,KNOCKDOWN,MICROARRAY,NFKB1,PATHWAY,TAKEN,THESE
APOPTOSIS,BACKGROUND,CONCLUSION,DCA,FURTHER,HOWEVER,HUVEC,INHIBITION,LABEL,MATERIALS,METHODS,PDK,RESULTS,TK6,TUNEL
100,CONCLUSION,DETECTION,FALSE,INITIAL,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
BACKGROUND,CONCLUSION,IIB,LABEL,MAY,METHODS,RESULTS,SECONDARY,SIX
001,177,320,AMONGST,DIAGNOSTIC,DIFFERENT,FIFTY,FORMULA,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,ROC
028,033,038,145,160,177,217,ADRENAL,BACKGROUND,DFI,LABEL,MEIER,METHODS,NON,NSCLC,PRIMARY,RESULTS,SHORTER
000,A2058,ATX,AUTOTAXIN,B16,C57BL,CINCINNATI,COMPOUNDS,DISCOVERY,F10,LPA,NPP,THESE,UNIVERSITY
1970S,EMP,HOWEVER,INSTITUTE,LIMIT,NIOSH,RANGE,REL,SEG,SIMILAR,SINCE,USING
BAX,BCL,CDK,CINK4,H23,NOVEL,THESE
150,3512676,PFS,SALIENT
293,A127T,AMONG,BCL,D399N,DRP,DYNAMIN,E423K,FURTHER,G105D,GFP,HEK,K506R,MFN,MITOFUSION,P233L,P487L,PROTEIN,PXN,T255I,UTILIZING
BURKITT,E2F,FURTHER,PEGYLATED,PEP,TREATMENT
BASED,COLORECTAL,FDA,FOLFIRI,FURTHER,SEPTEMBER,SORAFENIB,V600E
AFTER,COLORECTAL,CRC,FOLFIRI,PRO,TRAIL,V600E
ACTIVATING,AKT,ANTICANCER,CPG,HOWEVER,MPE,PTGS2,QUESTIONS,REGULAR,THEREFORE
172,231,AKT,ANXA2,DEPLETION,EGF,JNK,JUN,KNOCKDOWN,MDA,S3A,S3E
169,954,COPYRIGHT,DOX,FURTHER,HSP70,IRELAND,LTD,MDR,PCR,TAKEN,USING
120,169,320DM,549,945,956,AMBERLITE,BLOOD,COLON,COPYRIGHT,H23,NCI,SAS
001,002,007,023,032,104,169,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,GROUP,INC,LABEL,METHODS,PFS,RESULTS,SCALE,THEREFORE
140,169,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,LARGE,LCNEC,LYMPHATIC,METHODS,NEC,RESULTS,THERE
169,HOWEVER,IHC,III,INC,MEANWHILE,MIGRATION,MMP,MSF,MTT,NSCLC,PCR,PUBLISHED
169,COPYRIGHT,IRELAND,LNCRNAS,LTD
001,142,151,169,173,249,457,967,COPYRIGHT,INC,LABEL,LLNRS,LPARS,LPERS,METHODS,OBJECTIVE,OVERALL,PFI,PRS,RESULTS,SCS,SECONDARY
169,182,183,AMONG,BLADDER,COPYRIGHT,FURTHER,MIR,THEREFORE
169,COPYRIGHT,GENERALLY,HOWEVER,IRELAND,KNOWLEDGE,LTD,MRI,THOSE
001,012,160,177,219,405,ADA,ELISA,GROUP,III,LABEL,LDH,LTD,METHODS,MPE,PUBLISHED,RESULTS,ROC,THERE,TPE,UNLABELLED
151,169,171,BACKGROUND,COMPETING,COPYRIGHT,CTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS
169,COPYRIGHT,PUBLISHED,SEPAR,WHILE
169,177,APRIL,BACKGROUND,BLOOD,COPYRIGHT,INC,JANUARY,LABEL,METHODS,MRI,PUBLISHED,RESULTS,SIXTEEN,SOCIETY,SVC
169,ALK,COPYRIGHT,CRIZOTINIB,III,INC,NSCLC
045,169,177,916,COPYRIGHT,D30CC,DOSIMETRIC,FORTY,INC,ITV,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PERCENTAGE,PURPOSE,RESULTS
169,COLLEGE,COPYRIGHT,EPSCC,LTD,PET,PUBLISHED,ROYAL,SMALL
169,COPYRIGHT,LTD,MRI,PCD
109,113,169,250,400,500,AES,CONCLUSION,COPYRIGHT,GRADE,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PEMETREXED,PFS,RESULTS,SECONDARY,SEVENTY,STAGE,THERE
169,214,249,415,878,COPYRIGHT,EDS,IRELAND,LTD
169,600,956,COPYRIGHT,EARLY,FURTHER,ICG,INC,LABEL,METASTATIC,METHODS,MOSBY,NIR,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SLN,SURGERY
115,146,169,186,310,315,329,334,369,644,BACKGROUND,BETWEEN,COPYRIGHT,INC,INCLUSIVE,JANUARY,LABEL,METHODS,MORTALITY,PUBLISHED,RESULTS,SOCIETY,UNIPORTAL
12S,169,BECLIN1,COPYRIGHT,IRELAND,LA1,LTD,MARKERS,PROLONGED,SUCCESSFUL,TAKEN,TOTAL
169,COPYRIGHT,INCREASING,IRELAND,LTD,MALIGNANT,MPM
169,CAUCASIAN,CHINESE,COPYRIGHT,NON,NSCLC,PEMETREXED,PFS,SAS,TAKEN,THERE
AREAS,BACKGROUND,COVERED,HOWEVER,III,LABEL,METHODS,NSCLC,OPINION,PDGFR,PHASE,SEVERAL,THESE,THOSE
008,105,208,ALK,ASIAN,BACKGROUND,GIVEN,LABEL,METHODS,ORR,PFS,RESULTS
066,150,321,617,898,AES,BACKGROUND,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SUNITINIB
019,089,610,BACKGROUND,FDG,LABEL,METHODS,PET,RECURRENCE,RESULTS,RFS
001,008,027,156,180,242,263,404,426,702,936,967,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STATION,THEREFORE
005,169,239,619,951,998,BACKGROUND,CONSISTENT,COPYRIGHT,INC,LABEL,METHODS,RESULTS,RRS,WILEY
125,131,BRACHYDOSE,CAESIUM,CALCULATED,CARLO,MONTE,RESULTS,SINCE,TREATMENT
ALTOGETHER,BRACHYURY,CHROMATIN,FINALLY
BRESLOW,COX,LOG,MEIER,SEVERAL
263,AUSTRALIA,BACKGROUND,CONCLUSION,EUROQOL,HRQOL,LABEL,METHODS,NON,NSCLC,OVERALL,RESULTS,THREE,VAS
161,BACKGROUND,CONCLUSION,KIRSTEN,LABEL,METHODS,NSCLC,PFS,RESULTS,SECONDARY
172,AMONG,BACKGROUND,CONCLUSION,FORTY,LABEL,METHODS,NSCLC,RESULTS,TKI,USING
CUMULATIVE,GIVEN,INDEX,LABEL,METHODS,MWS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
271,ILD,INCREASED,LABEL,METHODS,OBJECTIVE,RESULTS
PRIMARY,THYROID,TTF
169,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,ALK,ANAPLASTIC,COPYRIGHT,HOWEVER,IRELAND,LTD
169,AES,BNC105P,COPYRIGHT,GRADE,IRELAND,LTD,MALIGNANT,MPM,PLEURAL,THERE
043,169,BACKGROUND,CONCLUSION,COPYRIGHT,EPIDERMAL,HOWEVER,INC,INTRATUMOR,LABEL,METHODS,RESULTS
946,ANGIOGENIC,ARG,ASP,BACKGROUND,GLY,LABEL,METHODS,NH3,RESULTS,RGD,TEM,USPIO
145,238,316,468,AFTER,BACKGROUND,CNS,COLLEGE,HOWEVER,III,LABEL,LIVER,MEDICAL,METHODS,NSCLC,OCTOBER,OTHER,PATIENT,PFS,RESULTS,SEPTEMBER,SUBSEQUENT,TKI,UNION
001,002,011,023,049,946,BACKGROUND,COX,DFS,LABEL,MEIER,METHODS,PCR,PDZ,RESULTS,THESE,WESTERN
FURTHER,HOWEVER,PCL
FGFR2,FGFR3,SCC,THESE,USING
100,200,384,500,956,COMPLEX
004,007,016,033,106,169,945,CD204,FIRST,LARGE
FBLN2,FIBULIN,HOWEVER
001,140,912,920,BACKGROUND,CONCLUSION,EMPHYSEMA,FVC,GROUP,LABEL,LLN,METHODS,RESULTS,THERE
946,HUVEC,ILK,PROTEOMIC,THESE
002,008,169,192,BECAUSE,CD8,DENSITIES,LABEL,METASTASES,METHODS,NKP46,OBJECTIVE,PURPOSE,RCC,RESULTS,TH1
169,COPYRIGHT,LABELLING,NCI,PET,THESE,VCH,WILEY
007,015,169,188,224,605,644,AMONG,BMI,CRP,HCC
008,010,015,169,ANNEXIN,COPYRIGHT,ELISA,ILK,SOCIETY,THESE
130,160,169,177,185,424,ACUTE,CONCLUSION,EXPERIENCE,FIFTY,III,INC,INSTITUTE,LABEL,METHODS,OBJECTIVE,PARTIAL,RESULTS,SETTING,TREATMENT
954,ROS
FIRST,USA
31T,511,HOWEVER,SEVERAL
946,ALK,ATAD2,EMT,GENOMIC,IBC,IBC02,MYC,REMARKABLY,SINCE,THESE,TSPAN24
233,ALTERATION,BHD,DUB,SINCE,WNT
BCL,BID,HOWEVER,IAP,KOREA,MMP,VED
001,007,009,364,487,717,851,HOSPITALS,IMPORTANCE,LABEL,LEWIS,MCKEOWN,METHODS,MORBIDITY,OBJECTIVE,PROJECT,PULMONARY,QUALITY,RELEVANCE,RESULTS,SETTING
DECREASED,KISS1,PCR
946,IKK,MAGNESIUM,NK2,SOD,SP1
344,519,CAUCASIAN,EFFECTS,ERLOTINIB,LDH,MOLECULAR,NSCLC,OBJECTIVE,PFS,TKI
100,177,183,206,COMBINING,FIFTY,KEY,LABEL,METHODS,NAVIGATION,OBJECTIVE,OBJECTIVES,PNX,RESULTS,TECHNICAL
133,160,ACCORDING,H1299,HOWEVER,MMP,NCI
AKT,BCL,CISPLATIN,STRIKINGLY,THESE
150,169,183,215,222,225,226,451,APRIL,BACKGROUND,COPYRIGHT,FASTACT,FUNDING,LABEL,LTD,METHODS,PFS,RESULTS,ROCHE,SERIOUS,TREATMENT
061,169,175,479,684,BACKGROUND,BPF,COPYRIGHT,INC,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE,THREE,UNIVARIATE
007,289,339,622,674,729,943,992,AGE,BACKGROUND,CARCINOMA,CHINA,DESPITE,FAO,FINLAND,FURTHER,HOWEVER,JAPAN,KINGDOM,LABEL,METHODS,NPC,PEARSON,PER,RESULTS,SINGAPORE,STATISTICS,THERE,TRADE
FINALLY,LIFESTYLE,SINCE
169,COX,HNC,ILLNESS,INSURANCE,LTD,NHIRD,RATIO,SPC,WILEY
000,345,600,AMONG,BACKGROUND,CONCLUSION,GCMAF,HOWEVER,LABEL,MARCH,METHODS,MIRAI,RESULTS
160,ANTITUMOR,BACKGROUND,CONCLUSION,DG3,GCMAF,GROUP,LABEL,LEWIS,MATERIALS,METHODS,RESULTS,SEPHAROSE
169,ACADEMY,HOWEVER,MOLECULAR
100,169,318,364,BACKGROUND,EPIDERMAL,HOWEVER,L858R,LABEL,METHODS,PFS,RESULTS,SOCIETY,TKI
169,183,AFTER,BACKGROUND,CONCLUSION,ENT,GEORG,INSERTION,LABEL,MALIGNANT,METHODS,OBJECTIVE,PEG,RESULTS,STUTTGART,THEREFORE
BECAUSE,CONCURRENT,III
ANOTHER,THEIR
AGILITY,DELTA,MLC,SCANDIDOS,STOCKHOLM,UPPSALA
129,160,LABEL,LESIONS,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS
109,111,169,COPYRIGHT,FORTY,HMB,LAM,SEVEN,SIXTY
001,002,008,011,012,019,028,051,056,061,134,160,169,190,780,912,CONTROL,COPYRIGHT,COX,ESPECIALLY,INC,JANUARY,LABEL,LYMPHATIC,MEIER,METHODS,MOSBY,NSCLC,OBJECTIVE,PATHOLOGIC,PUBLISHED,RESULTS,SURGERY,THERE,TNM,UNION
001,002,009,026,068,169,603,COPYRIGHT,COX,HOWEVER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PUBLISHED,RESULTS,SURGERY,THERE
001,160,169,344,433,BETWEEN,COPYRIGHT,INC,LABEL,MAY,METHODS,MOSBY,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY,VAMLA
039,169,BACKGROUND,BROWN,COPYRIGHT,CSF,DEFINITION,ERASMUS,FACTORS,IMAGING,IMBCM,LABEL,MED,MEDLINE,METHODS,OBJECTIVE,PUB,RESONANCE,RESULTS,SEQUARD,TREATMENT
100,139,708,715,887,978,AUC,BACKGROUND,CEA,COMPARISON,CONCLUSION,LABEL,METHODS,MPM,RESULTS,SOLUBLE,WHEREAS
BACKGROUND,COX,DECREASED,EXPRESSION,LABEL,MATERIALS,METHODS,MIRNA,NSCLC,RESULTS
DCA
BACKGROUND,HOWEVER,INDEX,LABEL,METHODS,OTHER,RESULTS,SCOPE,SPM
ADP,NSCLC,ROS,THESE
CANDIDATE,SUPPRESSOR,TAKEN,TUSC1
109,946,954,FURTHER,H1299,HBE,HOWEVER,MTT,MYC,NSCLC
169,449,CASES,CONCLUSION,COPYRIGHT,HRS,INC,LABEL,METHODS,OBJECTIVE,PARTIALLY,PFT,PURPOSE,RATES,RESULTS,SIXTY,STUDIES,WILEY,WILMS
945,946,EP2,EP4,HOWEVER,THESE
154,ANXIETY,CONCLUSION,DEPRESSION,FEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,WHILE
001,032,205,500,APRIL,CONCLUSION,EASTERN,GROUP,III,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIMILAR,THERE
384,CONCLUSION,CONSORTIUM,HOWEVER,LABEL,METHODS,OBJECTIVE,OLDER,PURPOSE,RESULTS,SEVENTY
169,HOWEVER,NUCLEAR,SUBSEQUENT
169,215,COMPARISON,COPYRIGHT,THESE,USING
169,385,BACKGROUND,BLOCKER,COPYRIGHT,EIGHT,LABEL,METHODS,RESULTS,SOCIETY
160,173,185,945,BACKGROUND,LABEL,METHODS,NON,NSCLC,RESULTS,SEVERAL
001,024,075,143,336,354,370,692,736,758,788,804,955,AAA,ALK,ANCCA,BACKGROUND,COX,HOWEVER,LABEL,METHODS,RESULTS
002,169,19Q13,328,483,CONCLUSION,LABEL,LUCIFERASE,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,SNP
AGE,ASSESSMENT,BONFERRONI,C30,EORTC,FURTHER,HRQOL,INCREASED,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QLQ,RESULTS,UNIVARIATE
3T3,946,947,CBP,CEBPG,COVALENTLY,EBP,NIH,OIS,RAS,V12
BER,CLAUDIN,EP4,HOWEVER
ANN,ARBOR,ENGLISH,IMAGING,MUM,PRIMARY,STERNBERG
344,497,ABOUT,LITERATURE,NSE
945,EFFICIENT,LPH
ANTITUMOR,GMP,LCP,MVD,NSCLC,THERE,VEGFS
169,956,ANEMONE,COPYRIGHT,HEPG2,THEIR,U87MG
278,376,654,CONCLUSION,COX,GROUP,LABEL,LYMPH,MEIER,METHODS,MLN,NLS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE,UNIVARIATE
RIGHT,THEREFORE
103,BACKGROUND,BIOLOGICAL,CISPLATIN,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,WESTERN
047,178,BACKGROUND,CPT,FORTY,JANUARY,LABEL,LCNEC,METHODS,RESULTS,SMALL
BACKGROUND,BECAUSE,CONCLUSION,HOWEVER,LABEL,METHODS,PATHOLOGY,RESULTS,THEIR
774,ACTIVATION,CBL,EGF,OVERALL,SRC
140,169,191,192,215,391,946,COX,MIR,NSCLC,PCR,SERUM,TGF,THOSE
169,231,233,BACKGROUND,CONCLUSION,COPYRIGHT,DIAGNOSIS,HISTOLOGY,LABEL,METHODS,PRIMARY,PUBLISHED,SAS,SNFMI
169,946,BACKGROUND,CAF,COPYRIGHT,EXPRESSION,INC,LABEL,METHODS,NCI,NSCLC,PUBLISHED,RESULTS,SOCIETY,TARGETING,TGF,THESE
160,169,ADDITIONAL,ADJUSTING,AGGREGATE,BACKGROUND,COPYRIGHT,CURRENT,END,ESTIMATES,INC,INSURANCE,LABEL,MATERIALS,METHODS,OVERALL,POPULATION,RESULTS,SMALL,THEREFORE,UNIVARIATE
169,AKT,ATK,COLORECTAL,COPYRIGHT,CRC,DLD,INC,MMP,PCR,PROTEOMIC,SW480,TAGLN
169,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,FAILURE,GREAT,IRELAND,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SINCE,SWEDISH,THERE,TNM
131,151,169,181,CONCLUSION,COPYRIGHT,DFS,EASTERN,ESTIMATED,GROUP,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SCORE
HOWEVER,THESE
110,169,BACKGROUND,COPYRIGHT,ESTIMATED,IRELAND,LABEL,LOCAL,LTD,METHODS,OBJECTIVE,OMD,OVERALL,PME,PURPOSE,RESULTS,SECONDARY
169,176,224,244,400,CONCLUSION,COPYRIGHT,DYNAMIC,EBT,FFF,GAFCHROMIC,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS,SEVEN,UNDER
169,19Q13,235,BACKGROUND,CNV,CONCLUSION,COPYRIGHT,DFS,ERCC1,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
ALK,THERAPY
000,160,169,ACADEMY,AFTER,AUTHORS,CONSISTENT,EVALUATION,III,INC,IPILIMUMAB,THESE,WILEY
009,965,ARS,AUTHORS,BASED,PTB,RRS,SEOUL
001,025,027,285,293,440,455,495,546,744,794,SNP,THEREFORE
407,426,BESIDES,H22,HDM,HSP70,HUVEC,THESE
038,532,CONCLUSION,COX,HORDALAND,LABEL,METHODS,NORWEGIAN,OBJECTIVE,PURPOSE,RESULTS,SUB
120,413,AIM,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS
339,AIM,AMONG,BACKGROUND,BESIDES,CYTOSCAPE,ERBB4,EXPRESSION,FUNCTIONAL,FURTHER,LABEL,MATERIALS,METHODS,MICRORNAS,OBJECTIVE,OMNIBUS,PATHWAY,PPI,RESULTS,THREE
ALK,DRUGS,FURTHER,NSCLC,ONGOING
179,185,200,550,BASED,BECAUSE
026,033,145,160,177,215,217,677,945,946,955,963,AHF,CHF,D88,FAKIRIS,FINALLY,INT,NSCLC,OERAH,OERCH,ONCOL,PALMA,TCP
100,177,946,956,HEP,HSC,LPS,M21,MTT,SOLANUM,THEIR
001,002,003,COLORECTAL,ERSPC,OVARIAN,PSA,RANDOMIZED,SCREENING,SINCE
CAVIN
DISRUPTION,HOWEVER,OVERALL
945,946,ACR,CHROMATIN,NOTABLY
083,MAJOR,THESE
169,CERTAIN,COPYRIGHT,ISSUE,LTD,MOLECULAR,THERE,UPP
169,174,ALBUMIN,ANOTHER,CONTINUED,COPYRIGHT,DESPITE,MBC,NSCLC,PACLITAXEL,SPARC,TAXANES
033,169,446,523,COPYRIGHT,GLN223ARG,OBESITY,POLYCYSTIC,PRO1019PRO
169,ASC,ASIAN,BACKGROUND,CONCLUSION,COPYRIGHT,JANUARY,L858R,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,TKI
000,440,CONCLUSION,EARLY,EPC,INC,LABEL,METHODS,MODEL,OBJECTIVE,ORS,PUBLISHED,QALYS,QOL,RESULTS
155,169,470,AMONG,COPYRIGHT,INDUCTION,IRELAND,LCC,LCNEC,LTD,NSCLC,PATHOLOGIC,THERE,THEREFORE,TNM
118,145,169,589,648,725,834,AGE,BACKGROUND,CARDIOLOGY,COLLEGE,COPYRIGHT,COX,FOUNDATION,GIVEN,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
730,ALK,CHINESE,KIRSTEN,NSCLC
AFTER,ALK,NSCLC,PHASE
CURRENT,NSCLC,T790M,TKI

001,014,178,370,967,BACKGROUND,EPIDERMAL,LABEL,METHODS,NSCLC,PFS,RESULTS,TKI
137,AFI,BACKGROUND,LABEL,METHODS,NBI,OLYMPUS,RESULTS,WLB
100,132,162,199,216,348,361,BACKGROUND,BETWEEN,COMPARING,LABEL,METHODS,RESULTS
ADM,BACKGROUND,DDP,DELTA,FIRSTLY,H69,H69AR,LABEL,LIKE1,MDR,METHODS,NOTCH,PCR,RESULTS,WESTERN
169,ANNEXIN,ATG,ATG12,AUTOPHAGIC,AUTOPHAGY,AVO,COPYRIGHT,ERLOTINIB,H1975,HCC4006,INHIBITION,IRELAND,L858R,LABEL,LC3II,LTD,METHODS,MTT,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,T790M,TKI,WESTERN
169,BACKGROUND,COPYRIGHT,HOWEVER,IASLC,IRELAND,LABEL,LTD,METHODS,RESULTS,THESE
169,ALK,COPYRIGHT,IRELAND,LTD,NSCLC
004,125,169,177,50S,APART,CONCLUSION,COPYRIGHT,CTP,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,RESULTANT,RESULTS
100,160,169,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,TEN
169,ACTIVATION,AUTHORS,COMPLETED,COPYRIGHT,CURRENTLY,HOWEVER,LTD,NSCLC,PUBLISHED,TKI
169,BACKGROUND,CONCLUSION,COPYRIGHT,DUE,HOWEVER,III,LABEL,LTD,METHODS,RESULTS,RFA,TREATMENT
048,160,169,408,687,792,BACKGROUND,CHRONIC,CONCLUSION,COPYRIGHT,HOWEVER,ICS,INDEX,JANUARY,LABEL,LTD,METHODS,RESULTS
057,071,169,206,282,384,500,827,COLLEGE,COPYRIGHT,DISCUSSION,ENGLAND,ENGLISH,GROUP,LABEL,LTD,MALTHUS,MATERIALS,METHODS,OBJECTIVE,PCT,PRIMARY,PUBLISHED,RESULTS,ROYAL,TRUST
BACKGROUND,LABEL,METHODS,NSCLC,RBE,REDUCTIONS,RESULTS,V10,V20,V30,V40
ACADEMY,OTHER,PHYSICIANS,PROTECTION,SOURCES,WRITTEN
001,433,HOWEVER,IIA,IIB,LABEL,LVI,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,RFS,STAGE,T2AN1,T2BN0,T2BN1,VPI
169,259,297,410,ASN,FOURIER,IGG,VCH,WILEY
169,BACKGROUND,COPYRIGHT,EIGHT,EWING,INC,INITIAL,LABEL,METHODS,PROCEDURE,RESULTS,RMS,THERE,WILEY,WLI
121,209,CK5,FIFTEEN,IHC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,P63,RESULTS,THYROID
100,EXTRACTED,FIFTY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,REFRACTORY,RESULTS,RGQ,SCORPIONS,USING
169,BACKGROUND,COMPANY,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,RESULTS,SDC,WILEY
1H209,1H210,GFP,GLV,RBC,TAKEN
001,954,CONCERNING,DIAGNOSTIC,F18,FDG,KEY,LABEL,LNS,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,PET,RESULTS
EVIDENTLY,JANUS,KALLIKREIN,KLK,REGARDING
000,001,122,181,300,400,640,860,CASES,CHILE,HOWEVER
062,209,BACKGROUND,JOHNSON,LABEL,MEDICAL,METHODS,RALPH,RESPONSES,RESULTS,SMOKERS
AFB,AFI,REGARDING,SEVERAL,WLB
169,DDX3X,EXPRESSION,INCREASED,LABEL,PROTEOMIC,SEC62,SNAI2,THESE,TLOC1,UNLABELLED
110,169,300,432,500,COPYRIGHT,INC,LABEL,MARCH,METHODS,MOSBY,OBJECTIVE,OCTOBER,PUBLISHED,RESULTS,SURGERY,THESE
169,BAK,BAX,BCL,BID,CASPASE,COPYRIGHT,DIOSCIN,HOWEVER,LTD,NCI,WESTERN
100,106,169,50YEARS,AUTHORS,COPYRIGHT,ESTIMATES,GIVEN,HOWEVER,INC,MODEL,PUBLISHED,RRS
169,194,231,400,956,COMPOUNDS,COPYRIGHT,LTD,MCF,MDA,PEG,WHILE
160,169,COPYRIGHT,DESPITE,INC,TTF
169,COPYRIGHT,GATA6,INC
004,015,145,169,281,503,CHT,GROUP,KARNOFSKY,LTD,TRT,WILEY
169,AUTHORS,BRITISH,CANONICAL,JOURNAL,KNOWN,LTD,POTENTIAL,SOCIETY,THERE,THESE,TRANSIENT,TRPC1,TRPC3,TRPC4,TRPC5,TRPC6,TRPC7,WILEY
001,004,006,008,013,025,177,533,869,880,ABC,AFTER,AMONG,CANDIDATE,CHECK,ENRICHMENT,JNK,NRAGE,NSCLC,PARTP,PATHWAY,PGSEA,POINT,PRODUCT,SET,SIGNALING,SIGNALS,SNP,TRUNCATED
181,30X
945,946,IL1,IL8,PBMCS,THESE
18F,BACKGROUND,CONCLUSION,FDG,FOURIER,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,THEIR,TNM
105,115,119,130,177,418,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
339,352,691,ADDITIONAL,BACKGROUND,CONCLUSION,HENCE,LABEL,LAR,METHODS,NORMALIZED,OBJECTIVE,PURPOSE,RESULTS,SUMMATION,USING,VII
PLEURAL
101,169,HEMOPHILUS,INC,SEVENTY,TREATMENT,WILEY
ACTIVATION,ARF,HOWEVER,NOTABLY,PCR,THESE
16S,LEGIONELLA
946,AKT,LEUCINE,LZTS2,NSCLC,THESE,WNT
239,2ND,BACKGROUND,DCR,EXCLUSION,III,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OTHER,PFS,PRIMARY,QOL,RESULTS,SECONDARY,STAGE,SUNITINIB,TREATMENT,TTP
ATM,ATR,ATRIP,DDR,DISABLING,FINALLY,FURTHER,RPA,THESE,USING
DISCOIDIN,HOWEVER,III,MMP,NSCLC
169,200,320,549,COPYRIGHT,DSC,ESI,INC,MTT,NGI,TGA,WILEY
CAUCASIANS,HOWEVER,ILE143VAL,LEU,LYS178ARG,PHE,RESULTS
478,BACKGROUND,III,LABEL,METHODS,OBJECTIVE,PATIENT,PCI,PFS,RESULTS,WHITFIELD
160,167,227,LABEL,MAJOR,MEDICAL,METHODS,NSCLC,OBJECTIVE,OPERATIVE,PURPOSE,RESULTS,THERE
947,HLA,HOWEVER,IFN,MDSCS,NADPH,NSCLC,ROS,THESE
BACKGROUND,CONCLUSION,LABEL,MIGHT,RADICAL,SURGERY
BASED,CBI,HOWEVER,L1210,NOTABLY,PREVIOUSLY
945,946,AKT,CETUXIMAB,CTX,DESPITE,IKK,INHIBITION,IRS,NCI
001,002,177,NLR,NSCLC,PFS,UNIVARIATE
CHEST
205,375,HOWEVER,NSCLC,PCR,SCC,THEREFORE,THESE,THREE
602,AFTER,AMONG,BACKGROUND,CHINA,CIS,COX,IRR,LABEL,METHODS,RESULTS
11C,945,AMT,MRI,PET,SUV,THESE,TUMORAL
169,239,ANORECTIC,COPYRIGHT,INC,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SPM,THESE
012,037,039,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,OCTOBER,RESULTS
010,011,043,049,119,177,428,AMONG,BACKGROUND,EASTERN,GROUP,LABEL,METHODS,NSCLC,RESULTS,T2AN0M0
001,028,045,160,AFTER,BACKGROUND,CLINICALLY,HENCE,HOWEVER,LABEL,METHODS,NSCLC,PFS,RESULTS,RFA
100,106,209,922,BACKGROUND,CEA,CONCLUSION,FURTHER,HOWEVER,LABEL,LDH,METHODS,PCR,PULMONARY,RESULTS,ROC
001,004,012,115,432,BACKGROUND,CHINESE,ERCC1,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS
001,003,004,023,029,048,114,11A,30A,967,ASSESSING,BACKGROUND,GENOMIC,HOWEVER,IIB,LABEL,NSCLC,RESULTS,SCC
HOWEVER,THEREFORE,THESE
PULMONARY,THERE
BACKGROUND,CONCLUSION,LABEL,METHODS,PRIMARY,THESE
185,270,560,AMONG,BACKGROUND,BRAGG,CALCEIN,DII,FIT,FNTDS,HDS,HOECHST,LABEL,METHODS,MEV,NEITHER,PC3,RESULTS,SMA,U87
131,152,164,AMONG,BACKGROUND,COX,DISTANT,DTC,KOREA,LABEL,METHODS,OLDER,RESULTS,SEOUL,UNIVERSITY
169,CRC,CXCR2,CXCR4,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WILEY
III,SPM
945,CERTAIN,HORMONE,INITIATIVE,THEREFORE,WOMEN
CONCLUSION,EIGHT,HODGKIN,LABEL,MEDICAL,METASTATIC,METHODS,OBJECTIVE,RESULTS,SECONDARY,SEVENTY,UNIVERSITY
004,019,780,AUC,CTCAE,HOWEVER,HRT,ROC,UNIVARIATE,V10,V15,V20,V25
169,DLT,FDG,HSP70,LABEL,METHODS,MTD,OBJECTIVE,PET,PURPOSE,RESULTS,SECONDARY,THERE
FDG,GLUCOSE,ONCOCYTIC,PET
169,239,BLOOD,EXOME,HEART,INC,INSTITUTE,PROJECT,RVA,SEQUENCING,WILEY
EXPRESSION,OATP1B1,OATP1B2,OATP1B3
ADULT,AGE,AMONG,IMPORTANCE,LABEL,METHODS,OBJECTIVE,OCTOBER,RELEVANCE,RESULTS,SETTING,THESE,USING
100,204,2573T,AIM,IHC,L858R,LABEL,LEU858ARG,METHODS,OBJECTIVE,RESULTS,THERE
CYP,CYP2A,CYP2A13,CYP2B,LABEL,METHODS,NNK,OBJECTIVE,PURPOSE,RESULTS
028,954,BACKGROUND,COHEN,CURRENTLY,INCREASING,KNOWLEDGE,LABEL,METHODS,RESULTS,WEB
947,AFTER,ATM,DIFFERENT,ERK,EXOGENOUS,HBE,MRE11,NOTABLY,PCR,U0126,XRCC1
001,169,3MM,550,694,716,810,909,ADVANCE,CONCLUSION,COPYRIGHT,DLR,INVERSE,IRELAND,KNOWLEDGE,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,ROC,UNASSIGNED
009,131,169,APMIS,BONFERRONI,CHI,FIFTY,FURTHER,LTD,NSCLC,PUBLISHED,SIXTY,WILEY
001,002,010,012,022,037,045,048,050,065,10A,126,145,169,30D,30E,320,451,732,ACCORDING,COPYRIGHT,DFI,HOWEVER,IRELAND,LTD,LUMINEX,NSCLC
003,005,006,007,009,012,016,023,024,025,026,031,041,169,BLD,CONCLUSION,COPYRIGHT,DFS,FIFTY,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS
13D,169,COPYRIGHT,DU145,HBA,LTD,PDGFR
169,177,956,COPYRIGHT,DOX,INHALABLE,LTD,TRAIL
C10,MAP,MEA,PCR,POLYCYCLIC,THEREFORE,THESE
A50,ACR,COLLEGE,CONCLUSION,CTN,ELECTRICAL,FDG,HOWEVER,LABEL,METHODS,NETWORK,NUCLEAR,OBJECTIVE,PET,PHANTOM,PURPOSE,RADIOLOGY,RESULTS,SNM,SOCIETY,SUV,THESE,VOI
ADDITIONAL,ASIAN,ESPECIALLY,SEVERAL
169,177,257,956,A2780,ANISOCYCLA,COMPOUNDS,COPYRIGHT,LTD,MCF,NMR,WILEY
005,023,169,799,835,AFTER,AMONG,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADIOLOGIC,RECURRENCE,RESULTS,VARIABLES,WILEY
183,AMONG,BACKGROUND,CONCLUSION,GEORG,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,STUTTGART
181,DRECHSLERA,MDR,NICOTIANA,OPHIOBOLIN,TBY
160,183,1990S,215,770,BETWEEN,LABEL,METHODS,MINIMALLY,OBJECTIVE,OPERATIVE,OTHERWISE,PROCEDURAL,PURPOSE,RESULTS,SHORTER,SINCE,THERE

001,002,055,CONCLUSION,FDG,FHV,HOWEVER,III,LABEL,METHODS,NSCLC,PARTIAL,PET,RESULTS,THERE,THEREFORE,UNLABELLED
ANTISENSE,ETE,LOX,OXER1,SEVERAL,STUDIES
916,968,BAX,BCL,FUCOIDANS,GSH,IAP,LIVIN,MMP,ROS,THESE,UNDARIA
GIVEN,HOWEVER,HSVTK,USING,VSV
100,178,HEPES,TAQ
AP4,BESIDES,CONVERSELY,CRC,EMT,FN1,INHIBITION,MYC,SNAIL,TFAP4,THEREBY,THESE,VIM
231,ALDRICH,FIRST,MCF,MDA,PLD,THESE,THIRD,WISCOTT
946,AGS,EMT,EPH,EPHA2,MODULATION,MYC,SGC7901,SNAIL,THESE,WNT
112,169,COPYRIGHT,CYP2A13,IHC,LTD,NSCLC,TSNAS
ADHERENCE,BLACK,CONCLUSION,LABEL,METHODS,OBJECTIVE,PRIOR,PURPOSE,RESULTS,THESE,THROUGH,VHA
CONCLUSION,CPG,GUIDELINES,INSTITUTE,IOM,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TRUST
FDG,PET
007,177,ASC,CENTRAL,CONCLUSION,FDG,LABEL,MARGINS,MEIER,METHODS,OBJECTIVE,PET,PROPORTION,PURPOSE,RESULTS
001,DELAYED,FACTORS,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
116,169,BESIDES,COPYRIGHT,FURTHER,HCT,INC,MSC,NOTCH,TAKEN,THESE
001,008,206,AIM,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS
169,ACUTE,BESIDES,CONCURRENT,COPYRIGHT,III,INC,JANUARY,LIBRARY,MEDLINE,NSCLC,PATIENT,RCT,SEVENTEEN
018,035,049,177,178,457,535,ASM,AVERAGE,SARCOPENIA
231,DOX,FURTHER,INCLUSION,LEWIS,LLC,MDA,MMP,ND2,NDS,PXL,R221A,RSV,WHILE
078,181,200,625,946,956,BACKGROUND,CHANGES,CHINESE,CONCLUSION,CONTEXT,DISCUSSION,GIVEN,HANCE,HMECS,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SALVICINE
146AG,ASIAN,CHINESE,CIS,CRC,HCC,HOWEVER,INDIA,KOREA,MICRORNAS,NORTH,ORS,WHEREAS,WHILE
100,105,108,110,136,740,BACKGROUND,H37RV,LABEL,METHODS,MTB,MTC,NTM,PCR,RESULTS,THEREFORE
252,272,280,323,331,553,CD8,CTL,HLA,NCI,WHILE
148,358,716,APEX1,ASP,GLU,PCR
022,033,138,201,215,247,422,482,884,943,BACKGROUND,CIN,CONCLUSION,DFS,EARLY,LABEL,METHODS,NSCLC,RESULTS
1082A,439,ADC,ATA,BACKGROUND,CONCLUSION,COX,LABEL,MATERIALS,MEIER,METHODS,PCR,RESLUTS,RFS,SCC
001,858,AIM,BACKGROUND,BIO,BNG,CIS,CONCLUSION,DIAGNOSIS,DOR,ELISA,GIF,LABEL,MATERIALS,METHODS,MPM,MTS,OBJECTIVE,RESULTS,ROC,SOLUBLE,USING
002,008,058,126,215,239,305,931,AMONG,BACKGROUND,BSP,CONCLUSION,CONVERSELY,LABEL,MATERIALS,METHODS,MOLECULAR,OPN,RCC,RENAL,RESULTS
2C4,AIM,CONCLUSION,INC,KIT,LAB,LABEL,METHODS,NEWMARKET,OBJECTIVE,RESULTS,TELOMERASE,TEX,THERE,UNIVERSAL,USA
AIM,CONCLUSION,LABEL,MBC,METHODS,OBJECTIVE,PACLITAXEL,RESULTS
001,003,177,402,443,945,956,AUC,BECAUSE,BMS,CEA,CTX,CYFRA,NSCLC,SIXTEEN
024,351,887,ALA,ASP,DDX39,GLU,H2052,H2452,H28,MALIGNANT,MET,MPM,NCI,SINCE,THESE
AIM,BACKGROUND,CONCLUSION,EMT,EPIDERMAL,ESC,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,RESULTS,TKI
CURRENT,THESE
BBB,BRAIN,JUNCTIONAL,THERE,TIGHT,TJS
006,100,169,176,BACKGROUND,LABEL,METHODS,ORS,RESULTS,S1P,THESE,WASHINGTON
LANGERHANS
001,113,135,160,195,215,236,244,345,480,FINALLY,LABEL,METHODS,NODAL,NSCLC,OBJECTIVE,RESULTS
169,946,ERK,OVERALL,PRX,SILENCING,SRC
100,150,916,ACCORDING,CTS,HOUNSFIELD,INDEX,THEREFORE
169,DISCOVERY,NSCLC,RET
019,027,045,252,300,363,398,426,439,BESIDES,C241T,CHINA,CHINESE,CIS,KNOWLEDGE,ORS,ORT,SCIENCE,SEVEN,WEB,XRCC3
BASED,BIRC5,GNT,NCI
118,ACCORDING,BACKGROUND,EMT,LABEL,MEIER,METHODS,NSCLC,RESULTS,THERE
006,212,DECREASED,DUSP4,INCREASED,THERE
121,124,133,160,753,792,BACKGROUND,EPIDERMAL,FINALLY,INSTITUTE,LABEL,METHODS,PFS,RESULTS,SUBSEQUENT,THERE,TKI,UNIVERSITY
800,BACKGROUND,GIVEN,GRADE,JANUARY,LABEL,METHODS,RESULTS,UNIVARIATE
EXPRESSION,GCT,GIANT,GIVEN,GPX,LOH,MECHANISMS,MUTATIONS,NON,SECONDARY
144,HOWEVER,SECONDARY
EGF,ERBB2,ERBB3,HOWEVER,KNOCKDOWN,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RTK,TESTING
143,945,954,ERK,HEXAVALENT,HOWEVER,IGF,THESE
100,11A,12A,13A,13I,145,169,176,COPYRIGHT,FURTHER,MTT,OXO,SAS
169,200,COPYRIGHT,LTD,PERVASIVE,ROLES,THESE
001,177,182,186,190,BLAND,COMPARISON,CONCLUSION,ESTIMATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,RESULTS,UNENHANCED
PRIMARY,WESTERN,WHILE,WORLD
946,ALP,MTX,WNT
116,169,COPYRIGHT,HTC,MCF,NCI,SAS,SEVERAL
169,549,562,AFRICAN,COPYRIGHT,FIELD,FOURIER,MDA,PLEUROTUS,THESE
128,169,AGA,BACKGROUND,CD110,CDCP1,COPYRIGHT,CRC,FUNCTIONAL,INC,INSTITUTE,LABEL,MCSCS,METHODS,MICROARRAY,MIGRATING,OBJECTIVE,PUBLISHED,RESULTS,THESE
150,169,COPYRIGHT,FEDERATION,INHIBITION,PUBLISHED,SOCIETIES,UTR
100,169,185,956,ALA,ASP,COPYRIGHT,ECHIS,HUVEC,LTD,MALDI,MIC,PLA,SER,TOF,VAL
001,146,168,169,241,COPYRIGHT,FDG,HOWEVER,LABEL,MATERIALS,METABOLIC,METHODS,MTV,NSCLC,OBJECTIVE,OBJECTIVES,OTHER,PET,RESULTS,TLG
169,500,BACKGROUND,COPYRIGHT,CROWN,EIGHT,FDG,LABEL,LTD,MEDLINE,METHODS,OVERALL,PET,PUBLISHED,RESULTS
CD8,LTD,PUBLISHED
000,024,032,169,183,231,300,500,600,700,774,846,934,948,AGE,AMBIENT,BACKGROUND,CHINA,COPYRIGHT,DALYS,DIETARY,FACTORS,FOUNDATION,FUNDING,G20,GATES,GBD,LABEL,LEADING,LTD,MELINDA,METHODS,POPULAR,REDUCTION,RESULTS,THESE,USA,YLD
169,BACKGROUND,COPYRIGHT,CURRENT,FOLLOWING,IRELAND,LABEL,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
BESIDES,CHI,CONCLUSION,ENG,HBE,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,WESTERN
CURRENT,DESPITE,FINALLY,OVERALL
001,177,ARC,GROSS,MODULATED,SIB,THERAPY,USING,V10,V20,VOLUMETRIC
ACCORDING,DIFFERENCE,DISTANCES,DSC,ESTIMATION,LEVEL,METRICS,PPV,PREDICTIVE,SIMILARITY,SURFACE,TRUTH,VALUE
103,169,183,533,728,BRAZILIAN,CALCITONIN,CCH,CEA,FORTY,GLY533CYS,LABEL,LTD,MEN2A,METHODS,MTC,OBJECTIVE,PTH,RESULTS,RET,REVIEWING,WILEY
003,004,031,035,037,038,177,33258,3LL,732,956,980,AIM,C57,CONCLUSION,HCT,HOECHST,LABEL,LEWIS,METHODS,MTT,NOTABLY,OBJECTIVE,RESULTS,SPP,SW480
GUIDELINES,NON,SMALL,THESE
169,INC,NSCLC,PALB2,WILEY
169,AML,CSC,INC,THESE,WILEY
177,BACKGROUND,CHINA,COUGH,EARLIER,JANUARY,LABEL,METHODS,RESULTS,THERE
117,187,326,CONCLUSION,COX,FDG,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,TLGWB,UNIVARIATE,USING
206,BACKGROUND,CHEST,CHINESE,COMMISSION,CONTROL,COX,DFS,HOWEVER,JOINT,LABEL,LNR,LNS,MEIER,METHODS,NSCLC,OVERALL,PERIPHERAL,RESULTS,STRATIFIED,T1A,T2BN1M0,UNION
BACKGROUND,CONCLUSION,LABEL,MALIGNANT,METHODS,STAGING
000,323,AFRICAN,AMERICANS,BLACK,BMI,CONCLUSION,CONTROL,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USA,WHR,WOMEN
215,780,980,HOWEVER,NIR,PEGYLATED,PTA
001,100,ALK,CURRENTLY,HOWEVER,RED
100,470,594,5A4,ALK,NSCLC,PCR,THESE
947,KETOCAL,KETOGENIC,LABEL,METHODS,NCI,OBJECTIVE,PURPOSE,RESULTS,THESE
169,946,AMONG,CIP2A,CONCLUSION,COX,EBP,HOWEVER,HPV,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,TL1,TL4
DEFINITIVE,PRIMARY,PULMONARY
100,169,AKT,COLCHICINE,COPYRIGHT,ERBB2,HSP90,INC,NSCLC
ESTIMATION,FOURIER,SIMULATION
10878,169,COPYRIGHT,INC,NSCLC,PCR,THESE
104,119,169,229,280,AFTER,CARCINOMAS,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR,THEREFORE
169,COPYRIGHT,FOURIER,HACC2,HACCS,MGC80,NIR,NMR
113,169,191,4CM,7MONTHS,BRITISH,COPYRIGHT,DIAGNOSIS,IRELAND,JANUARY,KARNOFSKY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,THERE
008,050,160,169,379,382,423,680,682,AUTHORS,BLACKWELL,FOUNDATION,JOURNAL,LTD,MOLECULAR,OVERALL,PUBLISHED,PUBLISHING,SCCHN,SNP,USING
AFB,CELLS,EPHX1,GLUCOSE,GSH,HOWEVER,NADPH
BACKGROUND,GOLGI,HOWEVER,LABEL,METHODS,PCR,RESULTS,WESTERN
000,081,100,109,147,249,261,263,269,342,555,659,929,ADDITIONAL,AMONG,ASMRS,AVOIDABLE,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SEYLL,THERE
063,169,177,215,961,976,EGF,LABEL,METHODS,MSI,OBJECTIVE,PURPOSE,RESULTS
775,ATLAS,DETECTION,EBV,EPSTEIN,HEPATITIS,HPV,SEQ,VIRAL,WHILE
335,BCL,FINALLY,H1299,HOWEVER,LUCIFERASE,MICRORNAS,NSCLC,PCR,SP1,THEREFORE,THESE,WESTERN
AMONG,CLOSE,HOWEVER,MORPHOLOGY,NOS,NSCLC,TTF
001,177,BAK,BH3,HOWEVER,TAT,THESE,TIU
CONCLUSION,CONTINUOUS,DYNAMIC,FURTHER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,VOLUMES
160,CK7,JAW
160,257,514,BACKGROUND,CONCLUSION,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THREE
223,369,689,BACKGROUND,FURTHER,HOWEVER,LABEL,LNS,METHODS,N2A,N2B,NSCLC,RESULTS
007,021,042,088,160,238,258,527,673,734,842,882,907,AMONG,ASIRS,CATALAN,CATALONIA,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN,TARRAGONA,THESE
CRS,HIPEC,HOWEVER,III,INDEX,PCI,PERITONEAL
177,947,APOPTOSIS,CHANGES,CONCLUSION,EARLY,EF5,HYPOXIA,LABEL,METHODS,PET,RESULTS,SN30000,THEREFORE,THESE,UNLABELLED
IIA,MST
EAC,EHRLICH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
145,181,BLOOD,CHOLINE,DECREASED,FOURIER,GNP,ICP,LABEL,METHODS,MTT,OBJECTIVE,PEI,PURPOSE,RESULTS,TEM,USING,XPS
393,HOP,INSTITUTE,RXF
ADC,ALK,BACKGROUND,CONTEXT,IHC,LABEL,LCC,METHODS,OBJECTIVE,OTHER,PULMONARY,RESULTS,SEVERAL,SOLID,THERE,WORLD
001,010,018,020,035,038,049,767,BACKGROUND,LABEL,METHODS,RESULTS
001,010,018,039,137,310,BACKGROUND,EARLY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,002,008,CONCLUSION,FDG,HIPAA,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PEARSON,PERCENTAGE,PET,PURPOSE,RESULTS,THERE
KNOCKDOWN,NAD,SIRT1,THESE
946,BACH1,INSTEAD,KNOCKDOWN,SMADS,TGF
169,947,BEIGE,HOWEVER,NOD,NSG,OVERALL,THESE,XENOGRAFTS
169,330,AVAILABLE,BACKGROUND,COPYRIGHT,FURTHER,III,INC,INITIAL,LABEL,METHODS,RECURRENCE,RESULTS,SEVENTY,THERAPIES,WILEY,WILMS
169,4T1,COPYRIGHT,CSF,CXCL5,CXCR2,FINALLY,HOWEVER,INCREASING,KRUPPEL,MDSCS,NOD,REDUCED,TAKEN
020,022,025,050,074,109,112,180,254,354,357,488,500,556,668,797,961,999,CAUCASIANS,CHINESE,E375G,SNPSCAN
169,BASED,COPYRIGHT,EHE,FUSIONSEQ,INC,PCR,WILEY,WWTR1
105,BESIDES,NSCLC,THESE,VPS4B,WESTERN
CNS
001,100,160,169,362,529,590,634,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NBL,OAR,PROCEDURE,RADIATION,RESULTS,WILEY
001,245,BACKGROUND,COLLEGE,LABEL,METHODS,PROGRAM,QUALITY,RESULTS,SIX,UNIVARIATE
169,CARLO,COPYRIGHT,DCART,HOWEVER,IBM,IMRT2,IMRT5,LTD,MONTE,OAR,PBC,PTV,PUBLISHED,SEVEN
169,CH2,CHN,COPYRIGHT,DFT,LTD,MB231,MDA,MEG,SME
001,169,215,261,267,3RD,4TH,528,COPYRIGHT,HOWEVER,HYPOTHESIS,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PRE,RESULTS,THERE,THREE
160,OVERALL
AFTER,BACKGROUND,CONCLUSION,DIAGNOSIS,LABEL,METHODS,OPTIMAL,PRIMARY
200,550,CRCLS,GMP,LABEL,MATERIALS,METHODS,NETWORKING,NTA,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,SDS,TEM
LABEL,LIPID,OBJECTIVE,OBJECTIVES
ATP,HSP90,THEREFORE
945,GIVEN,GPCRS,INCREASED,LIGANDS,RGS,RGS17
ACUTE,ANY,IDIOPATHIC,PRIMARY,SECONDARY
FURTHER,SMALL
AMONG,BACKGROUND,BRAIN,DTC,LABEL,MEIER,METHODS,OVERALL,PATIENT,RESULTS,SRS,SURGERY,THEREFORE,WORLD
USING
CNV,COMPARING,COMPARISON,EMT,MET,SOMATIC,T790M,THESE,TKI
001,416,496,797,CALIFORNIA,CONCLUSION,END,GIVEN,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,USING
214,286,BETWEEN,COMPLIANCE,CONCLUSION,GREATER,LABEL,METHODS,MONTHLY,OBJECTIVE,PATIENT,PRIOR,PURPOSE,RESULTS,SEPTEMBER,WEB
169,200,ANXIETY,ASSESSMENT,C30,CONCLUSION,COPYRIGHT,DEPRESSION,LABEL,LTD,METHODS,NEEDS,OBJECTIVE,QUALITY,RESULTS,SCALE,THERE,TREATMENT,WILEY
001,160,2A6,595,607,BIOMEDICAL,CHINESE,FURTHER,KNOWLEDGE,OVERALL,THEREFORE
946,AFTER,BACKGROUND,EMT,EPITHELIAL,LABEL,METHODS,NSCLC,RESULTS,TGF,THESE,WESTERN
169,231,AHR,AKT,APOPTOSIS,COPYRIGHT,MDA,NOTABLY,PAH,PAS,PER,SIM,SUBSEQUENT,THEREFORE
100,CRMP5,LOW,ONCONEURAL,PNS,SPR,THERE
012,016,280,660,736,924,ARG,EUROPEANS,HOWEVER,OVERALL,THEREFORE,XRCC1
293,300,EASTERN,FORTY,GROUP,INSTITUTE,RESULTS,SOUTH
ALK,BACKGROUND,CONCLUSION,LABEL,MET,METHODS,NON,NSCLC,OTHER,OVERCOMING,RESULTS,SCIENCE,SEVERAL,T790M,WEB
945,CAR,COMBINING,EPHA2,FAP,FIBROBLAST
AIR,BOYLE,BRITISH,SIMILARLY,SOCIETY
BECAUSE,CURRENT,PROCEDURAL
945,AFTER,HIF,HOWEVER
ACCOUNTING,BACKGROUND,BECAUSE,CONTACT,CPG,LABEL,MOTIVATION,RESULTS
169,CONCLUSION,COPYRIGHT,DESPITE,GIVEN,INC,LABEL,LOPEZ,LOWER,METHODS,OBJECTIVE,PHASE,PREVALENCE,PREVENTION,RATIO,RESULTS,SIR,SMOKING,VIETNAM,VIETNAMESE
ANTONIO,BACKGROUND,CDC,LABEL,SAN,SOCIETY,SYMPOSIUM,THESE
169,1AE,AES,BACKGROUND,CELGENE,COPYRIGHT,CRU,FUNDING,LABEL,LTD,METHODS,OVERALL,RESULTS,SERIOUS
001,007,013,015,132,169,428,804,CONCLUSION,COPYRIGHT,EXT,FDG,IRELAND,LABEL,LTD,MATERIALS,METABOLIC,METHODS,MTV,OBJECTIVE,PET,PURPOSE,RESULTS,THESE,TRX,UNI
169,A750DEL,ALK,COPYRIGHT,IRELAND,LTD
003,012,016,108,116,169,177,BACKGROUND,COPYRIGHT,COX,FORTY,INC,ITLNM,JANUARY,LABEL,MEIER,METHODS,OVERALL,PARTIAL,PATIENT,PUBLISHED,PULMONARY,RESULTS,SOCIETY
100,101,131,169,170,BACKGROUND,COPYRIGHT,DESPITE,INC,LABEL,MAY,METHODS,PUBLISHED,RAPID,RESULTS,SOCIETY
169,237,241,ABC,COPYRIGHT,FFL,NEUROCIRUG,PUBLISHED
DDS
169,AVOIDANCE,C30,CES,CHARACTER,DEPRESSION,DEPRESSIVE,EORTC,FIFTY,INVENTORY,LTD,QLQ,QUALITY,SCALE,STUDIES,TCI,THESE,TREATMENT,VARIATIONS,WILEY
169,FURTHER,LTD,WHILE,WILEY
000,127,169,257,AIM,AUSTRALIA,AUTHORS,DALYS,DUE,LABEL,METHODS,OBJECTIVE,RESULTS,USING
AREAS,BACKGROUND,COVERED,HENCE,HOWEVER,LABEL,METHODS,OPINION,THERE,ULTIMATELY
145,946,A2780,ANNEXIN,H1299
169,353,ANXIETY,ASSESSMENT,CHINESE,DEPRESSION,FUNCTIONAL,FURTHER,GENERAL,HRQOL,LTD,PTY,PUBLISHING,THERAPY,WILEY,YOUNGER
945,946,BINDING,GDP,HENCE,HOWEVER,KNOWLEDGE,NMR,SPR,STD,THEREFORE
METASTASIS,PAPILLARY
MTS,TORRE
118,181,19A,270,945,AFTER,HADV3,HADV4,LABEL,METHODS,MTS,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE
121,208,260,CONCLUSION,GROUP,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SIX,THERE
001,103,110,471,663,AMS,BAC,COMMITTEE,JOINT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGARDING,RESULTS,SOCIETY,STAGE,WHILE,WORLD
BIOMARKERS,DESPITE,PULMONARY,REGARDLESS,THEREFORE
160,MARCH
169,DESPITE,EMT,HOWEVER,NG2,SIGNALING
169,BECAUSE,COX,MALIGNANT
ABOUT,AML,BILATERAL,LAM,THEREFORE
100,169,239,301,465,683,ALK,AMONG,ANAPLASTIC,FUNCTIONAL,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SECONDARY,SUFFICIENT,WESTERN
001,005,100,169,BACKGROUND,COMPANY,CONCLUSION,COPYRIGHT,HNSCC,INC,IPN,LABEL,METHODS,PFS,RESULTS,WILEY
000,005,006,250,MBC,PFS
ENGLISH,PRIMARY
178,ATLAS,CAREFULLY
400,BACKGROUND,BORTEZOMIB,LABEL,METHODS,NSCLC,PFS,PRIMARY,RESULTS,THERE
THESE
946,BCC,TGF,THESE
DESPITE,LCA,TREATMENT
C8161,DESPITE,FINDING,GRP78,IGM,PAT,SM6,THESE
ALK,BACKGROUND,DISCUSSION,HOWEVER,LABEL,MATERIALS,METHODS,PREDICTIVE,RESULTS,THERE
102,160,945,947,AKT,BP1,E545K,NSCLC,RAS,UNIVARIATE
160,947,CLONOGENIC,GCS,GSH,GSS,NAC,OLEANOLIC,THEREFORE,UNDER
007,013,043,169,C118T,COPYRIGHT,ERCC1,FURTHER,III,NSCLC,OVERALL,STAGE,THERE,THESE
007,120,162,169,177,6MM,APE,COPYRIGHT,FBP,IRELAND,LABEL,LTD,MATERIALS,METHODS,NOISE,OBJECTIVE,OBJECTIVES,RESULTS
169,24H,956,COPYRIGHT,HOWEVER,LTD,NAASO
169,488,AUC,COPYRIGHT,IRELAND,LASSO,LTD,ROC,SVM
003,020,040,116,118,168,169,215,308,558,946,BACKGROUND,CONCLUSION,COPYRIGHT,CYFRA21,ELISA,LABEL,LTD,METHODS,NSE,PRESENT,RESULTS,SCC,SERUM,TGF
169,192,BRITISH,CLAVIEN,COPYRIGHT,DINDO,FACTORS,III
169,945,APOPTOTIC,CO2,COPYRIGHT,DESPITE,HIF,HYPOXIA,INC,LM8,MMP,THESE
169,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,JO1,LABEL,METHODS,PL7,PUBLISHED,SAS
169,COPYRIGHT,EATON,IGG,LAMBERT,PCD,THESE
100,169,954,COPYRIGHT,IRELAND,LTD,NSCLC,PCR,PEPTIDE,PLEURAL,PNA,TKI
001,038,169,ACUTE,COPYRIGHT,CURRENT,IRELAND,LTD,NSCLC,RCT,TREATMENT
001,008,027,031,117,169,220,538,BACKGROUND,COPYRIGHT,CROWN,EPIDERMAL,IRELAND,LABEL,LTD,MAY,METHODS,NSCLC,PUBLISHED,RESULTS
001,169,192,867,AUC,COPYRIGHT,EXAMINING,FURTHER,HOWEVER,LTD,MALAT,PCA,PCR,ROC
008,111,147,169,ADVERSE,BACKGROUND,COPYRIGHT,DOSIMETRIC,ILC,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,UNIVARIATE
007,0MM,169,1MM,2MM,5MM,8MM,931,963,COPYRIGHT,DAILY,EPI,FOLLOWING,HEART,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,POPULATION,PURPOSE,RESULTS,THERE
109,169,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,V22,V30,VDOSE
011,169,657,COPYRIGHT,HEART,HOWEVER,HRV,LTD,PUBLISHED,THESE,WHILE
100,132,169,18FDG,3DCRT,BOT,COPYRIGHT,CTPET,CURRENT,FFF,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,CAREFUL,COPYRIGHT,LTD
001,169,COPYRIGHT,ENGLISH,HODGKIN,HOWEVER,LABEL,LTD,METHODS,NHL,OBJECTIVE,OBJECTIVES,POTENTIAL,RAYNAUD,RESULTS,SIR,SSC

293,296,378,DESPITE,INTERPLAY,JAMES,MAHIN,MASON,REBOUND,REDOX,RPR,SIGNALING
947,ACUTE,BACKGROUND,CLONOGENIC,HBECS,HZE,LABEL,PHASE,RBE,RESULTS,SIGNALING,THEREFORE,THESE,WHILE
ALK,CRIZOTINIB,RESISTANCE
001,250,347,500,ALK,BACKGROUND,CRIZOTINIB,LABEL,METHODS,RESULTS,WHETHER
ADC,ALK,ANOTHER,ASIAN,BACKGROUND,ERBB2,FURTHER,LABEL,METHODS,NSCLC,POTENTIAL,RESULTS,WESTERN
104,169,ACTIVATING,GEF,HDAC6,LABEL,RAS,SIRT2,THESE,UNLABELLED
ENGINEERED,H1299,NCI,PCR
034,163,738,DM2,DMP,ENROLMENT,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,PANCREATIC,POISSON,RESULTS,SIR,THERE
010,012,016,032,040,472,AIS,BACKGROUND,DISEASE,LABEL,METHODS,MIA,RESULTS,THERE
169,231,945,946,AKT,ERBB2,INDUCED,LUC,MDA,MDR,TNF,TNFRSF12A,TNFSF12,TREATMENT,TWEAK
169,946,EXPRESSION,ITGB1,KDM5A,TAKEN
004,AGS,AKT,BACKGROUND,BCL,COBRA,CONCLUSION,EBV,EPSTEIN,EXPRESSION,IL8,KNOCK,LABEL,MET,METHODS,MKN28,MYC,PLAUR,RESULTS,SSTR1
001,177,956,CRP,FVIII,HODGKIN,IIA,MEIER,UNDERLYING,WILLEBRAND
008,015,021,178,967,BACKGROUND,COX,FURTHER,IHC,LABEL,MAXIMAL,MEIER,METHODS,PFS,RESULTS,TREATMENT
500,960,A43,CONJUGATED,RED,TEXAS,USING
169,790,MASSARRAY,NSCLC,PFS,SABER,T790M,TKI

EBC,H1373,H1993,MET,NSCLC,RTK
THESE
000,093,094,107,169,216,487,500,BACKGROUND,COPYRIGHT,DISEASE,GIVEN,LABEL,METHODS,NSCLC,RESULTS,SOCIETY
169,COPYRIGHT,CURRENTLY,TKI
AKT,IGF,NSCLC
160,207,248,334,694,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
AMONG,ARF,BACKGROUND,CONCLUSION,DIAGNOSTIC,GOLDMAN,ICU,LABEL,METHODS,RESULTS
ART,FINALLY,MRI,PET
169,NSCLC,TARGETING,THESE
169,BCL,HNSCC,KNOCKDOWN,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS

100,EIT,ELECTRICAL,THERE,THREE
LABEL,METHODS,MIP,OBJECTIVE,OUTSIDE,PURPOSE,RESULTS
104,110,114,118,CTV,GTV,LABEL,METHODS,MLD,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,V20
HOWEVER,PET
169,COPYRIGHT,FOCAL,HOWEVER,INC,MYC,MYCL1,NOTABLY,RLF,SCLCS,WILEY
169,BECAUSE,CME,CNE,COPYRIGHT,CURRENT,HOWEVER,INC,SOCIETY,THESE
169,567,COPYRIGHT,INCREASED,MEIER,NSCLC,SERUM,THESE
150,169,COCULTURE,CONTINUED,COPYRIGHT,COR,CYTOMETRY,DRAQ7,ENRICHMENT,H69,HOWEVER,INITIAL,NCI,POLYSIA,SHP,SOCIETY
177,231,282,331,380,480,821,828,COLLATERAL,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE
140,146,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SSN
GPR54,KISS1,NSCLC,PCR
001,002,227,973,AFTER,AVAILABLE,CHINESE,DISEASE,FORTY,NSCLC,PREVALENCE,THERE,TKI
12B,HCC,SUPPLEMENT,THESE,VEGFR
128,459,AES,BACKGROUND,III,LABEL,METHODS,NSCLC,PFS,RESULTS,SEPTEMBER
215,947,ADVANTAGE,CD3,FINALLY,GITRL,IFN,LIGHT,OX40L,SINCE,TNF
954,BAY,EMT,FUNCTIONAL,HOWEVER,MMP,PCR,RGC32,SNAIL,TAKEN,WESTERN
001,048,049,ACCORDING,ARG,BASED,CAUCASIANS,CONCERNING,ORS,PRO,SCIENCE,SIMILAR,WANFANG,WEB
233,BHD,CERTAIN,DUB,DUE,RECURRENT
BACKGROUND,CONCLUSION,HEALTHCARE,KEY,LABEL,METHODS,NEUTRAL,OBJECTIVE,PHYSICIAN,PHYSICIANS,RESULTS,SHARING,SPS,SUPPORTIVE,THESE
156,COX,ESTROGENS,MCR,NETWORK,NSCLC,PROGRAM,SEX,USING
CIS,GEM,NSCLC,RESULTS
COMPONENTS,HOWEVER,MARIJUANA,STUDIES,THC,USA
122,248,254,454,AFTER,CONCLUSION,DFI,DFS,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,THESE
213,752,966,BMI,CIS,COLORECTAL,CONCLUSION,HRS,LABEL,METHODS,OBESITY,OBJECTIVE,ORS,OVARIAN,PURPOSE,RESULTS,SCREENING,TRIAL,WHETHER
AS02B,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
AGNTS,ATP,NIR,RAMAN,THEIR,THERE
020,043,215,BASED,CD133,COX,FUNCTIONAL,SNP
160,177,230,948,LINAC,UNIVERSITY,WASHINGTON
124,151,SCREENING,SYSTEMATIC,THERE,TRIAL
023,30002,30206,39808,BACKGROUND,CONCLUSION,COX,GRADE,GROUP,LABEL,METHODS,OVERALL,PFS,PROGNOSTIC,RESULTS
LABEL,OBJECTIVE,PALLIATIVE,PURPOSE,RESULTS,SPECIALTY,SUMMARY,THERE
ALK,LABEL,MUTATIONS,NSCLC,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SUFFICIENT,SUMMARY,THESE
100,177,181,7TH,AFTER,DAR,EHRLICH,PAC,PCL
AUTONOMIC,GATA3
DTYMK,STK11
BRESLOW,PRIMARY,THREE,V600E
169,MRI,PET
169,APB,CIS,CISPLATIN,COPYRIGHT,NSCLC,STIM1,STROMAL,THESE
169,ACTIVATING,AMONGST,ATF,CONVERSELY,COPYRIGHT,HOWEVER,INC,JNK,SOLUBLE,TAKEN,THESE
256,A1SCI,CPNE3,H1299,III,NSCLC,SPC,TAKEN,THROUGH,TNM
THESE
945,954,956,HMGB1,HOWEVER,JNK,JUN,MCP,NSCLC,TNF,WESTERN
100,169,174,231,233,300,AFTER,CONCERNING,CONCLUSION,COPYRIGHT,DEPARTMENT,FDG,LABEL,MAY,METHODS,NOVALIS,OBJECTIVE,OCTOBER,PET,PUBLISHED,PURPOSE,RESULTS,SAS,SEVENTEEN,STRASBOURG,STRAUSS,SUV,V20
002,120,169,COPYRIGHT,FURTHER,H1299,IRELAND,JNK,LTD,NSCLC,SPAG9,TNM
18F,215,CHEST,FDG,LOCAL,PULMONARY,SEVEN,SFT
001,917,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RDW,RED,RESULTS,UNIVARIATE
169,AIR,CHEST,CONCLUSION,COPYRIGHT,FOP,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,KRT15,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WILEY
169,1960S,1980S,LTD,WILEY
945,947,BGC,INSTITUTE,ONX
001,011,120,200,435,537,CIGARETTE,CONCLUSION,COX,LABEL,MATERIALS,METHODS,NEVER,OBJECTIVE,PURPOSE,RESULTS
001,008,317,3RGCC,3RGGC,677,680,680CC,CONCLUSION,FURTHER,GARFT,LABEL,MATERIALS,METHODS,MTHFR,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
139,164,165,166,ABCG2,ATP,BACKGROUND,GLI,HOWEVER,LABEL,METHODS,RESULTS,SHH,SONIC
160,BACKGROUND,EIGHT,IFS,INFANTILE,LABEL,METHODS,NON,PRIMARY,RESULTS,SEVEN
AIR,BETWEEN,JANUARY
DESPITE,THESE
MENDELIAN,MMP1A,SILENCING,TAKEN
13C,140,166,946,956,MCF,NMR
173,945,AKT,HOWEVER,NSCLC,SINCE,TAKEN,THEREFORE
100,BACKGROUND,CONCLUSION,EGYPT,ENDOCAN,HOSPITALS,LABEL,METHODS,MVD,OBJECTIVE,OVERALL,RESULTS,SETTING,UNIVERSITY,ZAGAZIG
945,ALEXANDER,FXR,LABEL,METHODS,OATP1B1,OBJECTIVE,OWING,PURPOSE,RESULTS,RXR,SVCT1,SVCT2
BCL,MCL,MMP,NAC,PDT,ROS,WESTERN
200,EMT,H1299,HFE,HNRNPA3,HNRNPR3,INGENUITY,IPA,NOVEL,NSCLC,PCR,REINFORCED,THESE
65308,AGE,BACKGROUND,CANCERS,COX,END,HRS,LABEL,LIFESTYLE,MEN,METHODS,RESULTS,VITAL
169,946,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,NUCLEAR,PC9,PUBLISHED,RESULTS
169,ADC,COPYRIGHT,GATA6,INC,MOLECULAR,THESE
169,COPYRIGHT,ERK,HEPG2,INC,INHIBITION,KEAP1,METFORMIN,PD98059,RAF,RESISTANCE,THESE
169,COPYRIGHT,FAA,FERULIC,H1299,LTD,MMP,RESULTS,SIMILARLY,TAKEN
169,186,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MSKCC,PFS,RCC,RESULTS,SUNITINIB,UNIVARIATE
140,169,177,916,COPYRIGHT,IRELAND,LTD
122,160,169,177,625,750HD,919,AIM,CNR,COLLEGE,CONCLUSION,CONVERSELY,COPYRIGHT,DISCOVERY,FBP,GGO,IMAGE,LABEL,LTD,MATERIALS,METHODS,NIS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,USING,VEO
169,COPYRIGHT,INC,INSTEAD,PUBLISHED,SOCIETY,THESE
169,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,COPYRIGHT,INC,PUBLISHED,PULMONARY,SOCIETY
169,COPYRIGHT,FACTORS,INC,PUBLISHED,SOCIETY
169,BACKGROUND,CONCLUSION,COPYRIGHT,DMS53,EXPRESSION,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,THERE,THEREFORE
001,012,019,082,169,208,407,614,COPYRIGHT,FINALLY,IHC,IRELAND,LTD,NSCLC,TMA
112,169,467,COPYRIGHT,LTD,PUBLISHED
001,H69,H82,MCA,NCI,THEREFORE,UNDER
177,CCK,CPG,FURTHER,KIT,ODN,ODN7909,THESE,TLR,WESTERN
AREAS,BACKGROUND,COVERED,HOWEVER,III,LABEL,METHODS,NON,NSCLC,OPINION,PHASE

001,ACTIVATION,BACKGROUND,DECREASED,DISRUPTION,EMT,EPITHELIAL,HYPOXIA,III,LABEL,METHODS,PIASY,PROTEIN,RESULTS,SIRT1,SP1
169,945,MOUSE,THESE,TNF
169,CONVERSELY,UNDERLYING
169,256,293,327,ATXN7L2,HOUSTON,ITIH2,LEMD3,NSCLC,NUDT5,ROCHESTER,TAIWANESE,TEXAS,THESE,TMBIM,UNIVERSITY
169,ASD,CHINA,COPYRIGHT,DUE,IMAGING,INC,SCHENZHEN,WILEY
108,177,BACKGROUND,CONCLUSION,GUIDELINE,LABEL,METHODS,QUALITY,RESULTS
154,160,270,517,816,CAUCASIAN,ERG,GLEASON,SEVENTY,SPANISH,THREE
AIM,BACKGROUND,CAREGIVER,CAREGIVERS,CROSS,INCLUSION,INTERVIEW,LABEL,METHODS,OBJECTIVE,OUTCOME,PALLIATIVE,RESULTS,SCALE,SETTING,SHORT,THOSE,ZARIT
132,222,CRCCS,FUHRMAN,HOWEVER,PRCCS,RCC
ADC,EVALUATION,SCC,STROMAL,WESTERN
BACKGROUND,DECREASED,DISCUSSION,GFR,LABEL,METHODS,MPM,RESULTS
169,BST,COPYRIGHT,HOWEVER,INC,MCF,STAT3,TAKEN,THEREFORE,TRM
GROUP,INTERGROUP,LABEL,OBJECTIVE,PURPOSE,RESULTS,RUSCH,SINCE,SOUTHWEST,SUMMARY,VIDEO
144,169,AIS,COPYRIGHT,CORTACTIN,LARGE,NSCLC,SIRT1
169,COPYRIGHT,HOWEVER,LABEL,LOCAL,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SALVAGE,STUDIES
169,COPYRIGHT,FINALLY,HIV,HODGKIN,INC
169,200,CHRONIC,CIGARETTE,COPYRIGHT,LTD
169,954,COPYRIGHT,EXPRESSION,HEP,HISTOLOGIC,INC,MICROARRAY,PATHOLOGY,PCR,PUBLISHED,SOCIETY,THEREFORE
169,FURTHER,LABEL,LTD,METHODS,OBJECTIVE,PEARSON,RESULTS,THESE,WILEY
100,106,107,108,109,114,117,122,132,133,137,143,146,149,165,170,BLAND,CONCLUSION,INTRA,LABEL,METHODS,OBJECTIVE,OVERALL,PERFUSION,RESULTS,VOI
AREAS,CONCLUSION,DYNAMIC,FIFTY,FINALLY,LABEL,MCNEMAR,METHODS,OBJECTIVE,PET,RESULTS
001,100,177,954,CONCLUSION,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,RESULTS
001,033,038,128,177,210,735,763,773,AGE,CONCLUSION,FOV,IMAGING,LABEL,LATERAL,METHODS,OBJECTIVE,RESULTS
176,ARTIFACTS,COBRA,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
001,003,007,031,395,426,708,ADULT,ADVANTAGE,ANOVA,APR,BRAIN,CHI,INCLUSION,JAN,POISSON,TOTAL
AF802,ALK,CH5424802,ROCHE,SPECIALLY
201,326,399,751,ADC,CHINA,CHINESE,GENOMIC,HAN,HOWEVER,HUNAN,THERE,XPD,XRCC1
185,BACKGROUND,BAL,FDG,GLUCOSE,HERMANSKY,HPS,IPF,LABEL,METHODS,PET,RESULTS,THERE
169,172,952,EPIDERMAL,FER,GTP,H1299,LABEL,MOL,NSCLC,RAC,RES,UNLABELLED
001,010,045,AUSTRALIA,BACKGROUND,GOLDFIELDS,GREAT,LABEL,METHODS,MIXED,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,SIXTY,THERE,THESE,WESTERN
233,257,264,947,BCG,CD11C,CD4,CD8,COINFECTED,FOLLOWING,IFN,MHC,OVA
418,435,ABS,CETUXIMAB,EGF,EPIDERMAL,FVB
006,309,813,COLORECTAL,OVARIAN,SARCOSINE,SCREENING,TRIAL
169,CONVERSELY,EGF,HSP70,HSP90,LOW
NEOPLASTIC
456,BACKGROUND,BECAUSE,IGF,LABEL,LABORATORY,METHODS,NICTH,NON,PATIENT,THESE,WESTERN
169,COUNTER,HOWEVER,PES,THEIR,THESE,VCH,WILEY
ALK,ANAPLASTIC,SINCE,WHILE
169,946,AKT,AZD4547,BECAUSE,DOVITINIB,EMT,FGF,FGFR1,FGFR2,FGFR3,FGFR4,FGFRS,FIBROBLAST,INC,KI23057,NOTCH,RAS,TACC1,TACC3,TGF,WHOLE,WILEY,WNT
19S,954,DUB,IKK,PROTEASOME,THESE
167,216,327,ADIPOKINE,ADIPOKINES,BACKGROUND,BMI,CIS,COLORECTAL,CONCLUSION,LABEL,METHODS,MHT,ORS,OVARIAN,RESULTS,SCREENING,THESE,TRIAL
169,COPYRIGHT,FMT,NON,VCH,WILEY
002,026,201,324,AFTER,BACKGROUND,CONCLUSION,END,LABEL,LNR,METHODS,NSCLC,RESULTS
000,161,500,BARCELONA,CATALONIA,FEW,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPAIN
CLEARLY,DESPITE,NSCLC,TARGETING
169,EGF,HOWEVER,LABEL,METFORMIN,METHODS,MTT,NSCLC,OBJECTIVE,PURPOSE,RAF,RAS,RESULTS,TKI,TREATMENT,WESTERN
169,AMONG,CONCLUSION,CSC,EXPRESSION,LABEL,METHODS,NOTCH,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE,WNT
150
000,100,116,142,181,AMONG,ARSENIC,BACKGROUND,CESSATION,COOKING,INORGANIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROXARSONE
169,COPYRIGHT,GIVEN,MER,SAS,THROUGH,UNC1062
PET
169,COPYRIGHT,PAH
107,169,BACKGROUND,CHEMONAIVE,COPYRIGHT,LABEL,LTD,METHODS,MTD,OBJECTIVE,ORR,PERIPHERAL,RESULTS,SAGOPILONE,SECONDARY
000,169,174,200,COPYRIGHT,GERMANY,LIPID,LTD,MPL,REDUCED,SINCE,TLR
169,AKT,BLACKWELL,CONCLUSION,FCM,LAA,LABEL,LTD,LYCORIS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PUBLISHING,RESULTS,THESE,TUNEL,WHILE
169,INHIBITION,LTD,NATURAL,WILEY
169,4T1,ACUTE,ALI,AMD3100,CXCR4,FINALLY,LABEL,LPS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UBIQUITIN
275,331,CONCLUSION,ERCC1,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
DESPITE,THERE,THESE
BACKGROUND,DSS,FIFTY,LABEL,METASTATIC,METHODS,PRIMARY,RESULTS,SAMPLES,THREE,UNIVARIATE,UNUSUAL
014,018,028,041,129,967,ABC,ABCG2,ATP,COX,LABEL,MDR,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
100,158,300,AFTER,BACKGROUND,CONCLUSION,EASTERN,FIFTY,GIVEN,GROUP,LABEL,METHODS,NEITHER,PFS,RESULTS,TOXICITIES
100,5A4,ALK,ANY,BACKGROUND,BIOSYSTEMS,CONCLUSION,EVALUATION,FIFTEEN,FORTY,ICC,LABEL,LEICA,METHODS,NOVOCASTRA,NSCLC,RESULTS
169,COPYRIGHT,CPG,FURTHER,HOWEVER,IRELAND,KNOCK,LTD,SHC
COLLISION,ENGLISH,RIGHT
160,200,BCT,BOARD,D95,FURTHER,HOWEVER,IMAGING,LCT,PCT,PHILIPS,PTV,SIMILARLY,THEREFORE,THESE
100,167,177,215,963,964,CARLO,EUD,LARGE,MONTE,RBE,TREATMENTS
169,228,BACKGROUND,COPYRIGHT,LABEL,LAM,LTD,LYMPHEDEMA,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,UNIVERSITY,YET
169,BACKGROUND,CONCLUSION,CONCURRENT,COPYRIGHT,FIFTEEN,INC,LABEL,MATERIALS,METHODS,NSCLC,PBT,PHASE,RBE,RESULTS,SEPTEMBER
169,600,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,ADULT,CHILDHOOD,COPYRIGHT,LYMPHANGIO,MRI,PRIMARY,SAS,THESE
169,COPYRIGHT,FOXP3,H3K27,NOW,THESE
046,169,BACKGROUND,COPYRIGHT,COX,EPP,IRELAND,LABEL,LTD,MCR,MEIER,METHODS,MPM,RESULTS,THERE
169,4T1,946,956,COPYRIGHT,INC,NADPH,NOX,ROS,SCH,SEVERAL,SIMILAR,TGF
CONCLUSION,DFS,ELISA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
169,BECAUSE,COPYRIGHT,CYTOLOGIC,IHC,INC,KAPPA,MAY,MGG,NSCLC,SQC,WILEY
334,647,991,AGE,AUDIT,BACKGROUND,ENGLISH,LABEL,METHODS,NSCLC,RESULTS,THREE
EGF,FIRST,HOWEVER,K295R,L858R,NSCLC,PREVIOUSLY,SRC,TKI,Y527F
177,956,AMD3100,CXCR4,ELISA,PCR,THEREFORE,THESE,VEGFA,WESTERN
ANNEXIN,CHINESE,HOWEVER,IHC,RO5203280,SECURIN,THESE,WESTERN
H23,HDACI,HISTONE,HOP62,LKR,NOTABLY,OTHER,THEREFORE,THESE,VORINOSTAT
100,169,177,215,217,357,BOOTSTRAP,COPYRIGHT,EDI,EMPEY,HYPOTHESIS,INC,LABEL,LTS,METHODS,OBJECTIVE,OTOLOGICAL,PEARSON,RESULTS,ROC,SOCIETY
169,341,ERK,LABEL,NSCLC,RAS,RASEF,UNLABELLED,USING
CDC,COLLECTING,RCC,THESE
250,3A4,450,ALK,CONCLUSION,CRIZOTINIB,CYP,INC,LABEL,MET,NSCLC,OBJECTIVE,PHASE,PURPOSE,SUMMARY,XALKORI
169,COPYRIGHT,INC,WILEY
947,948,ABS,B16,IFN,STRIKINGLY,TCR,TIL
090,160,168,258,798,CONCLUSION,COX,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
139,ACCORDING,FURTHER,HOWEVER,MEIER,PCR,RESULTS,USING,WNT
124,239,AFTER,BSC,GPA,HOWEVER,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
001,177,AIS,LGP,LVD,LYMPH,PULMONARY,USING
ERK,GP130,JANUS,LIF,OSM,STATS
FN1,GLI,TBP
310,945,954,BDS,JQ1,TNF
946,CLUSTERED,DEPLETION,EPH,EPHA1,HOWEVER
207,767,BACKGROUND,COX,HOWEVER,LABEL,METHODS,NSM,RESULTS,THERE
BACKGROUND,CONCLUSION,DIFFUSE,HMGB1,LABEL,METHODS,MPM,RESULTS,THEREFORE
185,ADDITIONAL,CONCLUSION,FDG,HIV,LABEL,METHODS,MRI,OBJECTIVE,PCNSL,PET,PURPOSE,RESULTS,TEN,THREE
FINALLY,PULMONARY,TUMOURS
169,956,BECLIN1,CAT,COPYRIGHT,CROWN,LC3,LDH,LTD,PM2,PUBLISHED,ROS,SOD,THESE
160,169,COPYRIGHT,COUNTRIES,DIETS,INC,MOSBY,NUTRITION,SEVEN,SURVEYS,TAKEN,THESE
169,BECAUSE,COPYRIGHT,INC,JAPAN,MOLECULAR,S0424
169,COPYRIGHT,HISTOLOGIC,LTD,METASTASES,SEVERAL,THREE,TREATMENT
169,COPYRIGHT,IRELAND,LTD,MALIGNANT
169,200,AKT,AXL,COPYRIGHT,ERK,HOWEVER,INC,MMP
169,COPYRIGHT,IRELAND,LTD
001,169,281,513,717,796,BACKGROUND,COPYRIGHT,COX,INC,LABEL,LOBECTOMY,METHODS,NODAL,NSCLC,OVERALL,PATIENT,PUBLISHED,RESULTS,SOCIETY,STS,SURGERY
169,BACKGROUND,BRONCHIAL,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE
169,CONCURRENT,COPYRIGHT,INC,NSCLC,SEVERAL
169,1970S,BETWEEN,CENTRAL,COPYRIGHT,DISEASE,EARLY,INC,MEDLINE,SEVENTEEN
101,169,215,BETWEEN,BRAIN,COPYRIGHT,COX,INC,KARNOFSKY,LABEL,LOCAL,MARCH,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SRS
100,160,169,BACKGROUND,CAUCASIAN,COPYRIGHT,FINALLY,INC,JANUARY,LABEL,METHODS,RESULTS,THREE
169,956,ATP,COPYRIGHT,DOCKING,LTD
169,ALK,COPYRIGHT,IRELAND,LTD,NSCLC
169,COPYRIGHT,IRELAND,LTD,NSE,TKI
169,294,350,B12,COPYRIGHT,IRELAND,LTD,NSCLC,THERE
169,945,946,COPYRIGHT,FURTHER,H1299,HOWEVER,INK4A,IRELAND,LTD,NSCLC,PFT,TAKEN
647,99M,AF488,ALEXA,ASCITES,CNT,EAT,EHLRICH,LYSOSOMAL,MCF,MTX,OVERALL,TECHNITIUM
AGT,ESI,NNK,NNN,OVERALL,POB,SYNTHETIC,TAKEN,TOBACCO
131,BACKGROUND,BILATERAL,DESPITE,DISTANT,INITIAL,LABEL,METHODS,PAPILLARY,PATIENT,SUMMARY,TREATMENT,UNILATERAL
AREAS,BACKGROUND,BECAUSE,COVERED,CURRENTLY,HISTOLOGY,LABEL,LIMITED,METHODS,NON,NSCLC,OPINION,PEMETREXED
177,OWING,QDS
AKT,CONCLUSION,FINALLY,INNOVATION,LABEL,METHODS,MM2,NADPH,OBJECTIVE,ONCOGENIC,PDCD4,RESULTS,ROS,THESE,USING
176,CYP4B,EVALUATION,MTT,PET,THESE
FURTHER,YET
MOLECULAR,NON,NSCLC
001,169,232,EAGLE,FDR,HFE,HPX,INC,MTHFR,SIXTY,THRESHOLD,TNF,TPO,U133A,WILEY,WNT
ERK,FOS,H1299,HBE,JNK,JUN,MMP,THESE,U0126
BIOMARKERS,MMP
954,DROSOPHILA,HOWEVER,MTT,NCI,NUMBL,RESULTS,TRAF6,TRANSWELL
BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
NSCLC
277,338,AMONG,BACKGROUND,COMBINING,LABEL,METHODS,RESULTS,TNM
000,184,230,871,BACKGROUND,DESPITE,END,LABEL,METHODS,RESULTS,SMR,SUICIDE
946,LEWIS
100,HOWEVER,THREE,TTF
125,BACKGROUND,HOWEVER,HPF,IASLC,LABEL,LPA,MITOTIC,USING
042,156,157,BACKGROUND,CCL15,CHEMOKINE,CIS,LABEL,MATERIALS,METHODS,ORS,RESULTS,SMOKING,THESE
169,ALGORITHMS,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SMALL,USING
169,241,BECAUSE,COPYRIGHT,FDG,MALIGNANCY,PET,WEGENER
169,COPYRIGHT,INC,SCF,UPS
169,COPYRIGHT,DESPITE,PUBLISHED,SEPAR
169,ACTIVATION,AKT,COPYRIGHT,HOWEVER,TAKEN
071,169,961,AVENTIS,BACKGROUND,BRITISH,COPYRIGHT,COUNCIL,DFS,FUNDING,LABEL,LIGUE,LTD,MEDICAL,METHODS,NATIONALE,PFS,PROGRAMME,RECHERCHE,RESULTS,SURROGATE
134,169,ASIAN,BACKGROUND,FEW,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDENT,THESE,WILEY
169,ANAEMIA,CHRONIC,DESPITE,LOW,LTD,WILEY
172,563,BACKGROUND,HRS,LABEL,METHODS,RESULTS,SIR,SMOKING,THESE,VAT
3LL,945,CD4,CD8,CURRENTLY,D1222,FOXP3,NK1,RELEVANTLY
946,ADC,BASED,COX,LNM,PNLTS
IPC,MPM,TREATMENT,WHERE
002,008,012,026,108,166,172,177,268,526,CONCLUSION,COX,FDG,LABEL,MEIER,METHODS,MTV,OBJECTIVE,PET,PFS,RESULTS,TLG
169,22RV1,ABNORMALLY,AGAIN,BASAL,COPYRIGHT,INDUCTION,SIMILAR,WHILE
PROGRAMMED,SCS,THESE,USING
122,177,954,BACKGROUND,CONCLUSION,EIGHT,LABEL,MEIER,METHODS,NOGUCHI,NUCLEAR,RESULTS
AGK,JAK,JH2,STAT3,THESE
181,215,BACKGROUND,LABEL,LOCAL,METHODS,PM2,RESULTS
100,390,507,956,BACKGROUND,FURTHER,LABEL,METHODS,NO2,ORS,PM2,RESULTS,STILL,THERE
169,ACADEMY,EPHA7,NOTABLY
549,THESE
ASIAN,BOTANICALS,CURIS,CURRENTLY,DUE,FDA,GENENTECH,GLI,SOUTHEAST,THESE
169,INC,WILEY
160,176,ARRHENIUS,FINALLY,RFA,VARIOUS
3PO,945,AKT,F26BP,IND,LEWIS,PFK15,PREVIOUSLY,RAS
135,231,287,540,BETWEEN,BRONCHIAL,CASES,HISTOLOGY,HOWEVER,IIA,IIB,INTEGRITY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE
BECAUSE,FDG,FLT,FURTHER,PET,RAPID,SEVERAL,THYMIDINE
271,AFTER,THESE
000,160,1980S,230,MUTATIONS,THESE
160,945,CSF,DUE,ERK,EXPRESSION,HOWEVER,THEREFORE,TNF,TREATMENT,U0126
260,719,931,NMR
AUSTRIA,PNEUMOLOGY,RADIOLOGY,SCREENING,SOCIETY,TRIAL
136,AKT,COX,MMP,PCR,S100P,STR,TRANSWELL
TRAIL,WHILE
CIGARETTE,FACTORS,SMOKELESS
005,160,379,382,761,AFTER,ARG,ARG399GLN,CYS,GENOTYPES,GLN,HOWEVER,LYS,LYS751GLN,LYS939GLN,SER,SER326CYS,XPC,XPD,XRCC1
174,506,ALB,ALK,LABEL,METHODS,MONOLIX,OBJECTIVE,PANCREATIC,RESULTS,ZALTRAP
002,004,013,015,036,068,129,220,325,CEP17,EASTERN,FIFTY,GROUP,IHC,LABEL,MBC,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,USING
169,497,COPYRIGHT,INC,INTEGRATED,MICRORNAS,MIRNA,NSCLC
169,946,CISPLATIN,CONVERSELY,COPYRIGHT,DDP,GSK,HOWEVER,IRELAND,LOW,LTD,MTT,NSCLC,TOTAL,WNT
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,OUTCOME,PALLIATIVE,PATHOLOGIC,PUBLISHED,RESULTS,SEPTEMBER,SIXTY,SOCIETY
169,770,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PREDICTIVE,PUBLISHED,RECORDS,RESULTS,SOCIETY
100,18F,ADDITIONAL,BACKGROUND,CONCLUSION,FDG,IMAGE,LABEL,METHODS,PET,PRIMARY,RESULTS,SIXTY,USING
169,AEC,AUTHORS,BLACKWELL,FOUNDATION,FURTHER,GRE,HOWEVER,INHIBITING,JOURNAL,LTD,MOLECULAR,PUBLISHED,PUBLISHING,TAKEN
ALTOGETHER,CSE,ECH,KEAP1,SCAL1
100,945,946,CHINESE,SALMONELLA
186,AKT,EGF,LIN,MEC,NSCLC,PTTG1,REDUCTION
169,CANCORS,COPYRIGHT,LTD,THESE,USA,WILEY
116,169,954,HCT,INC,NSAID,RKO,SP1,SP3,SP4,SW480,THESE,TOLFENAMIC,WILEY
183,AFTER,CONCLUSION,GEORG,HISTOLOGY,LABEL,METHODS,MRI,STUTTGART,THERE,THEREFORE,UNLABELLED
169,177,956,COPYRIGHT,INC,OATP2B1,OCTN1,ORGANIC,REGARDING,SIXTEEN,THESE,WILEY
EMT,FUNCTIONAL,KNOCKDOWN,NSCLC,ROCK1,THESE
CONCLUSION,LABEL,METHODS,OBJECTIVE,PRIMARY,PRIOR,PURPOSE,RESECTION,RESULTS,RFA,THERE,TREATMENT
10A,148,150,182,184,34A,34C,HOWEVER,NSCLC,PCR,TARGETSCAN,THESE,UTR
EPIGENETIC,NUCLEOSIDE,RASSF1A,RUNX3,TSG
DDIT3,NSCLC,TRIB3
169,241,BACKGROUND,CARCINOID,CONCLUSION,COPYRIGHT,CUSHING,FIFTY,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE,THREE

169,177,200,500NG,945,947,999,COPYRIGHT,NSE,RSD,SRM,TIAPALVSK
529,567,ACA,AFTER,CCA,CYP19A1,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PERIPHERAL,RESULTS,THERE
ALK,CONCLUSION,CTC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,VARIATIONS
169,ALK,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,DISCORDANT,IHC,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS
169,376,873,ADDICTION,AIM,COMMUNITY,COX,HRS,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,SETTING,SEX,SOCIETY,SWISS,THERE
007,029,047,12A,12K,954,956,E746_A750,FINALLY,H1975,L858R,NSCLC,OVERALL,T790M
133,143,169,ADVERSE,BETWEEN,CONCLUSION,LABEL,MAY,METHODS,OBJECTIVE,REACTIONS,RESULTS,THERE,WILEY
169,214,ALCAM,CONVERSELY,MALIGNANT,OVERALL,SILENCING,TFAP2,THESE

HOWEVER,THERE,THEREFORE
183,557,BACKGROUND,CBW,GEORG,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,SCC,STUTTGART,THERE
233,DIFFUSE,DUB,FOCAL,LANGERHANS
002,138,378,ARSENIC,CIS,CONCLUSION,COX,HOWEVER,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOTAL
945,954,BASED,CD4,DCS,DUE,HLA,TPT

169,BCL,CRL5908,LABEL,THREE,TREATMENT,UNLABELLED
EUKARYOTIC,MCF
VIDEO
003,162,984,ANOVA,AXIAL,BRAIN,FLAIR,MRI,THERE,TSE,WMH
BACKGROUND,CHINA,DISCUSSION,GOING,LABEL,OBJECTIVE,OBJECTIVES,WHETHER
008,023,047,169,177,32P,3PACKYEARS,956,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NNK,RESULTS,THERE,TOBACCO
169,COPYRIGHT,GD3,HOWEVER,INC,LAM,NKT,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY
116,169,956,COPYRIGHT,FURTHER,HCT,MCF,SAS
169,954,BAL,BIOLOGICAL,COPYRIGHT,INGENUITY,LABEL,MALDI,MAPPING,PROTEIN,TOF,UNASSIGNED,UNLABELLED
11D,169,BIOLOGICAL,COPYRIGHT,LTD
169,780,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,LABEL,LTD,MEDLINE,METHODS,OVERALL,PET,RESULTS,STUDIES
024,029,169,BACKGROUND,CONCLUSION,COPYRIGHT,CYP,ERLOTINIB,EXISTENCE,GEFITINIB,HOWEVER,INC,LABEL,METHODS,NSCLC,REDUCED,RESULTS
001,169,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,EVALUATION,III,INC,LABEL,MEDLINE,METHODS,RESULTS,SEVEN,SIXTEEN
169,ALTOGETHER,COPYRIGHT,LAMIACEAE,LTD,MOROCCO
001,002,108,120,169,CALU1,COLO699,COPYRIGHT,CURRENTLY,ECFCS,ECSCR,FIRST,FURTHER,HBEPC,IRELAND,LTD,NSCLC,PCR,ROBO4,TEM,THEREFORE,WESTERN
169,ATP,COPYRIGHT,HOWEVER,IRELAND,L858R,LTD,LUX,MET,NSCLC,REVERSIBLE,T790M,THESE
159,169,BACKGROUND,CONCLUSION,COPYRIGHT,D19S878,D19S886,HOWEVER,IRELAND,LABEL,LIVER,LOH,LTD,METHODS,MUTATIONS,RESULTS,THESE
169,ALK,COPYRIGHT,CRIZOTINIB,IRELAND,LTD,NSCLC
169,C32,COPYRIGHT,ERK,FAK,HETES,LOX,LTD,NOD,PD98059,SEVERAL,THESE,TREATMENT
001,009,169,201,347,591,694,7TH,BACKGROUND,BETWEEN,BVI,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MEDICAL,METHODS,NSCLC,RESULTS,T1A,T1B,T2A,TNM,TOKYO,UNIVERSITY
169,189,2N0M0,BACKGROUND,COPYRIGHT,CROWN,FDG,IRELAND,JANUARY,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,PUBLISHED,RESULTS,SUV,THESE
169,945,947,FURTHER,GOTTRON,SERUM,TIF
DEPARTMENT,FUNCTIONAL,GRADE,GROSS,GTR,HUASHAN,LABEL,MEDICAL,METHODS,OBJECTIVE,PSAES,RESULTS,THERE
004,074,089,AGE,CNS,FIFTY,GAMMA,KARNOFSKY,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTY,SIXTY,SRS,UNIVARIATE
ACT,CER,INSTITUTE,MAY
2000S,ALK,ASIAN,FINALLY
169,181,916,936,BAX,BCL,GSH,HPF,INC,MMP,NAC,ROS,TRXR1,WHILE,WILEY,ZEB,ZEBULARINE
012,037,169,CHINESE,HOWEVER,INC,RAS,SIPA1,SNP,THREE,WILEY
169,ADDITIONAL,LABEL,MCF,THESE,UNLABELLED
006,169,195,469,986,BACKGROUND,EPIDERMAL,KIRSTEN,LABEL,METHODS,NSCLC,RESULTS,SOCIETY,THERE,TTP
100,169,ALK,AUTHORS,BRITAIN,DIAGNOSTIC,FGFR3,GREAT,IRELAND,JOURNAL,LTD,ONCOGENIC,PATHOLOGY,SOCIETY,WILEY
AIF,BAK,BAX,BID,ROS
001,169,945,946,COPYRIGHT,INHIBITORS,INTEGRINS,LABEL,SIMILARLY,UNLABELLED
160,936,NAC,PREVENTION,ROS,THESE
A683C,C626G,DR4,G422A,PCR,POLYMERASE,REFRACTORY
142,178,390,COX,GRADIENTS,MORTALITY,SWISS,THERE
100,181,936,GSH,HOWEVER,JNK,MEK,MMP,ROS,TREATMENT
387,AAH,AMONG,BACKGROUND,CONCLUSION,COX,III,IPF,LABEL,METHODS,RESULTS
002,025,CRUDE,DISCUSSION,LABEL,LOUISVILLE,MATERIALS,MEDICALLY,METHODS,OBJECTIVE,OBJECTIVES,PET,PRIMARY,RESULTS,THERE,UNIVERSITY
169,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,EXCELLENT,FORTY,INC,LABEL,METHODS,NSCLC,PET,RESULTS,THREE,TOTAL,TREATMENT
149,CONCLUSION,DPS,GRADE,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,RPG,SEPTEMBER,THERE,V10
140MG,169,50G,549,850MG,CHINESE,COPYRIGHT,FINALLY,HPCCC,LEWIS,NMR
169,177,21G,956,COPYRIGHT,DANSHEN,IIA,INDUCTION,JAPAN,NATURAL,NOTEWORTHY,PUBLISHED,SKOV3,SOCIETY,TOV,TRAIL,VAD
001,002,003,021,169,177,COX,DCE,FDG,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OPTIMUM,PET,PURPOSE,RESULTS,THESE,UNIVARIATE,USING
001,009,169,201,AFFYMETRIX,CONCLUSION,HGF,IHC,LABEL,LOW,MEIER,MET,METHODS,NSCLC,OBJECTIVE,PATIENT,PURPOSE,RESULTS
169,300,COPYRIGHT,EDUCATION,GUIDELINE,INC,LABEL,MATERIALS,METHODS,MODELED,OBJECTIVE,OUTSIDE,PANEL,PSA,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,177,ASA,BISPECTRAL,CD4,CD8,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,TH1,TH2,TOTAL,UNIVERSITY
100,160,169,300,ACADEMY,FDA,III,ONGOING
10C,110,11C,11T,12C,12T,13C,183,410,CH1,CHCL3,ESI,H2IND,HBZIM,HPZ,NMR,OSCL4,RUCL4,RUTHENIUM,SW480
001,169,424,543,AFTER,CHINESE,EFFECTIVE,ORS,PROTECTIVE,ROR
001,016,121,COMPLETION,HISTOLOGY,JANUARY,LABEL,MARTINI,MELAMED,METHODS,MORBIDITY,OBJECTIVE,OBJECTIVES,OVERALL,REGARDING,RESULTS
120,THROUGH
BASED,FDG,HISTOLOGY,HODGKIN,OTHER,PET
830,AGE,AMONG,BACKGROUND,FATIGUE,LABEL,METHODS,OBJECTIVE,QUALITY,RESULTS,THESE,TREATMENT
039,115,169,946,AMONG,COPYRIGHT,INC,MALIGNANT
019,ANOTHER,DIFFERENT,EIGHT,THREE
CSC,EMT,K252A,MPE,NTS,THESE,TREATMENT,TRK
ALK,BACKGROUND,COMPANION,CONTENT,KIRSTEN,LABEL,NSCLC,SUMMARY,THESE
132,169,177,273,363,427,457,APMIS,ELISA,GPNMB,LTD,OVERALL,PUBLISHED,SCLCS,THESE,WILEY
AKT,BCS,BRONCHIAL,FINALLY,MAPK3,NVP,REBOUND,RESISTANT,RPS6KB2,THESE
IHC,OVERALL,REVERSE,RPPAS
003,049,146,385,545,AFTER,ARG194TRP,CHINESE,HAN,HOWEVER,THERE,THEREFORE,THOSE,XRCC1
ENGLISH,TYPICALLY
IMAGING
008,214,CAUCASIANS,CCND1,G870A,HOWEVER,INCREASING,MAY,MIXED
468,786,ATP,BASED,CFU,EVALUATION,H23,MCF,MDA,NCI
000,160,956,ADDITIONAL,MALDI
108,457,592,ANOTHER,BRCA1,CHEK2,DUE,NORTH,SCREENING,THREE,WOMEN
160,BACKGROUND,BASED,GROSSLY,LABEL,METHODS,RESULTS
256,530,866,AFTER,BACKGROUND,CONCLUSION,HODGKIN,INSURANCE,LABEL,METHODS,RESULTS,SIR
001,002,008,169,245,COPYRIGHT,COX,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SAS,SHORT,SURGERY
177,209,210,956,963,DUE,HCL,ROMANIA,TEN
169,239,737,ABT,APPROACHES,BACKGROUND,BCL,BH3,BRITISH,ERK,H1688,KEY,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SOCIETY,THESE,WESTERN
160,169,945,AUTHORS,BLACKWELL,CK2,CONVERSELY,FINALLY,FOUNDATION,H1299,JOURNAL,LTD,MOLECULAR,PROTEIN,PUBLISHED,PUBLISHING
160,169,BACKGROUND,CAL27,HOWEVER,LABEL,LTD,METHODS,OSCCS,PUBLISHED,REPRESSION,RESULTS,WESTERN,WILEY
ADDITIONAL,ALTOGETHER,BACKGROUND,CONCLUSION,CONTEXT,DISCUSSION,GLC1M13,IEF,LABEL,M13,MATERIALS,METHODS,OBJECTIVE,RESULTS,SDS,SMALL,THEREFORE,WESTERN
169,ACH,CONVERSELY,CTL,H82,KNOCKDOWNS,SOCIETY,SUPPORTING,SYNTHESIS,THESE
100,169,956,C57BL,COPYRIGHT,INC,INJECTION,LEWIS,MACROPHAGE,PAMPS,TH1,TH2,THREE,WILEY
169,AXL
954,A1E,ADP,AKT,ASIAN,BCL,H1299,NCI,NSCLC,PCR
AFTER,CCL19,CHROMATIN,FOLLOWING,GGGGC,HOWEVER,NSCLC,SP1,THESE
203,275,2A6,359,444,522,596,607,668,672,713,715,720,760,761,769,838,839,861,869,886,AMONG,ASIAN,CIS,CYTOCHROME,EIGHT,HOWEVER,LITERATURE,ORS,OVERALL
169,COPYRIGHT,ERK,FAK,MACRONB,MICRONB,THESE,UTILIZING
BACKGROUND,CPG,HOWEVER,LABEL,MASSIVELY,METHODS,PANEL,RESULTS,UDG
169,AFTER,COPYRIGHT,NLC
16HBE,RHO,SER,THR
001,010,023,169,BASED,COPYRIGHT,INC,SMALL,THERE
152,154,169,170,196,235,243,436,556,606,649,799,803,965,BACKGROUND,COPYRIGHT,GENOA,INSTITUTE,IRELAND,ITALY,LABEL,LTD,METHODS,RESULTS,SERVICE,SPONSORED
169,COA,COPYRIGHT,GIVEN,HMG,HNSCC,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,RHO,STAT3,STATINS,THESE
001,002,018,169,176,211,BACKGROUND,BETWEEN,COMPARING,COPYRIGHT,CPS,DESPITE,INC,JANUARY,LABEL,MAJOR,METHODS,PUBLISHED,RESULTS,SOCIETY,TEN
153,169,AET,BACKGROUND,CAUCASIAN,COPYRIGHT,DATES,ESOPHAGUS,INTENSITY,IRELAND,LABEL,LTD,MAXIMUM,MEDICAL,METHODS,MODULATED,NSCLC,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE,V50
115,123,169,363,590,CONCLUSION,COPYRIGHT,EIGHT,GY3,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,V20
001,169,AFTER,ARG,COPYRIGHT,IIB,III,INC,ISA51,MONTANIDE,NSCLC,PARIS,SECONDARY,TYR,VX001
169,COPYRIGHT,HOWEVER,IMMEDIATE,LTD,PKP
176,AFTER,HMGB1,HOWEVER,ROS
001,108,125,BACKGROUND,ENGLISH,GINGIVA,LABEL,METHODS,RESULTS
AKT,EGF,ERK,MEK,PHOSPHO,RAF
ACTIVATION,BCS,CLARA,EXPRESSION,REMARKABLE,THREE
001,145,COX,GCE,LOG,MEIER,METASTATIC,SMALL,THERE
100,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THESE
215,CHILD,KIT,NEITHER,RADIO,SERUM
000,106,178,200,650,956,FATIGUE,KAHALALIDE,LABEL,METHODS,MTD,OBJECTIVE,PROLONGED,PURPOSE,RESULTS
AN1,NCI,THESE
33258,946,956,AIM,COMPOUNDS,CONCLUSION,HOECHST,HOWEVER,LABEL,LDH,MAP,METHODS,MTT,NOR,OBJECTIVE,RESULTS,ROS,WESTERN
120,125,239,BACKGROUND,HEC,LABEL,METHODS,RESULTS,TRIPLET
042,215,798,HOWEVER,THESE
115,127,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UNDER
100,129,206,335,AMONG,BETWEEN,DFS,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,SND,THERE
001,300,600,DENMARK,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PASCART,RESULTS,SURGERY,THERE,UNIVERSITY
134,136,176,KNOWLEDGE,LABEL,METHODS,MUTATIONAL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,DEL,IHC,L858R,LABEL,METHODS,MOLECULAR,OBJECTIVE,PRIMARY,RESULTS,SIA
169,2GY,2IN,954,COPYRIGHT,OXIDATION,THESE
169,16HBE,205,620,956,CEM,CNS,COLON,COPYRIGHT,LAN,MCF,MTT,NCI,NON,SAS,SMALL
124,136,155,169,177,180,207,267,2NG,442,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,HCC,HOWEVER,LABEL,METHODS,RESULTS,SERUM
169,176,60MIN,COPYRIGHT,CYTOTOXIC,GENOTOXIC,SHORT,USING
169,BAX,COPYRIGHT,FOS,HOWEVER,INC,JNK,JUN,MAPKS,NH2,PRDX6,THESE
135,169,ACP,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PARKINSON,PUBLISHED,RESULTS,THERE
169,CONCLUSION,COPYRIGHT,EATON,EMG,FEDERATION,HENCE,IRELAND,LABEL,LAMBERT,LTD,METHODS,MUP,OBJECTIVE,PUBLISHED,RESULTS
002,003,043,116,139,157,169,190,464,BACKGROUND,CHEST,COPYRIGHT,FURTHER,HOWEVER,III,INC,LABEL,METHODS,NSCLC,PUBLISHED,REGARDING,RESULTS,SOCIETY
166,169,952,AFTER,BACKGROUND,BETWEEN,COPYRIGHT,DFS,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,T1A,T1B,T2A,T2B,USING,VPI
169,946,COPYRIGHT,GAPDH,HOWEVER,IRELAND,LTD,NON,NORMFINDER,PCR,SMALL,TBP,USING
169,BACKGROUND,CHALLENGES,COPYRIGHT,GROWING,LABEL,LTD,METHODS,RESULTS,THERE,WHILE
017,039,169,285,CAPPA,COPYRIGHT,IRELAND,LTD,NSCLC,PFS,PRIMARY,PS2,TNM
169,400,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,GRADE,III,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,TRT,UFT
169,COPYRIGHT,PNS
011,013,015,018,021,035,042,080,136,158,159,169,248,409,508,625,669,992,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,UNIVARIATE
169,ACC,ADP,AKT,AMP,COA,CONVERSELY,COPYRIGHT,JNK,JUN,LTD,OVERALL,ROS,S6K,WILEY
169,COPYRIGHT,MOLECULAR,SEVERAL,VCH,WILEY
BP1,FGF,REDUCTION,THEREFORE
TAKEN
FDG,IMAGING,PATHOLOGY,PET
ANALYZING,FINALLY,H69,IGF,INNOVATIVE,INSULIN,R1507
183,215,956,FINALLY,FURTHER,MCF
945,946,NUCLEAR,OVCAR,STAT1,THYROID
100,177,185,487,489,956,963,BASED,CCL,CRL
148,169,291,BRCA1,COX,EXPRESSION,HIF1A,JAPAN,MIR21,PCR,PROGNOSTIC,RFS,SEVEN
169,190,2651A,3551C,604,739,782,ALK,AMONG,COPYRIGHT,DUE,IRELAND,LTD,RET,USING
169,177,192,255,359,447,479,494,662,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,PPL,RESULTS,TBB,THESE
177,EARLY,III,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STAGE,TREATMENT
169,COPYRIGHT,CROWN,III,LTD,PPB,PUBLISHED
CAD,CHRONIC,CONCLUSION,DISEASE,HOWEVER,INITIATIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SCREENING,TRIAL
169,300,ALK,APRIL,BACKGROUND,CH5424802,COPYRIGHT,CURRENTLY,DLT,FUNDING,JAPAN,LABEL,LTD,METHODS,MTD,NSCLC,RESULTS,SERIOUS,TREATMENT
169,946,BACKGROUND,CLINICALLY,CONCLUSION,COPYRIGHT,ERCC1,III,INTRA,LABEL,LTD,MATERIALS,METHODS,NSCLC,PROGNOSTIC,RESULTS
169,COPYRIGHT,INC,PANCAKE,RENAL,RMS,TREATMENT
169,956,APOPTOSIS,BESIDES,COPYRIGHT,DDP,HOWEVER,MMP,MTT,SAS,TAKEN,TRANSWELL
025,032,041,102,103,111,175,186,207,956,CISPLATIN,FDT,FIFTEEN,FUNCTIONAL,HFA,LABEL,METHODS,OBJECTIVE,OCT,PACLITAXEL,PSD,PURPOSE,RESULTS,THERE,THREE
033,169,956,BACKGROUND,BCL,BRITISH,COMPOUNDS,CONSISTENT,GREEN,HEP3B,HMJ38,HSC,JNK,KEY,LABEL,M21,METHODS,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,SOCIETY,TREATMENT,USING,WESTERN
001,004,005,ALK,THESE,TREATMENT,TTF
169,FNA,GCT,GIANT,HOWEVER,INC,WILEY
169,COPYRIGHT,FORTY,HOPKINS,IHC,INC,JOHNS,PTC,TGB,THYROID,TTF,WILEY
109,169,COPYRIGHT,CRR,INC,OVERALL,RED,TRIPATH,WILEY
100,169,COPYRIGHT,INC,MOC,WILEY
169,946,947,B16,DCS,DU145,IFN,STAT1,VCH,VIRAL,WILEY
AFTER,BACKGROUND,BECAUSE,CONCLUSION,HOWEVER,LABEL,METHODS,TMD,WESTERN
AMONG,PRIMARY,THROUGH
METASTASIS,THESE,USING,WHILE
100,AMONG,BETWEEN,CONCLUSION,ELEVATION,FACTORS,FDG,LABEL,METHODS,OBJECTIVE,OCTOBER,PET,RESULTS
MEDICAL
177,ANESTHESIA,CO2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
954,AMONG,IMMUNOBLOT,MCL,PCR,STAT3,TRAIL
511,ALONG,COX,KIM,PGE
954,THESE,USING
120,166,23C,23D,32A,32B,498,FINALLY,MONOPOLAR
AES,CENTRAL,EIGHT,GENERALLY,GROUP,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SURGERY
ALTOGETHER,ERK,HBECS,JNK,MAPKS,ROS,SCAVENGING
160,HOWEVER,NOTCH,NSCLC,THESE
037,066,177,ALTOGETHER,COA,CONCLUSION,FDG,LABEL,MAXIMAL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS
001,069,117,160,177,BOARD,FDG,FORTY,FURTHER,HIPAA,LABEL,LOW,METHODS,MRI,OBJECTIVE,PET,PROCEDURES,PURPOSE,REGIONS,RESULTS,SUV,SUVMEAN,USING
003,169,256,440,973,996,COPYRIGHT,IRELAND,LTD,MPC,PULMONARY,THESE,TKI
000,001,169,BMI,CIS,COLORECTAL,CONCLUSION,COPYRIGHT,CVD,HRS,INC,LABEL,METHODS,OBESITY,OBJECTIVE,OVARIAN,OVERWEIGHT,RESULTS,SCREENING,TRIAL
169,AFTER,ANKLE,COLLEGE,COPYRIGHT,INC,PUBLISHED,THEREAFTER
721,CLINICIAN,CONCLUSION,FORTY,INTEGRATED,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,002,005,275,300,543,763,780,ACT,AMONG,CONCLUSION,COX,HRS,LABEL,METHODS,NSCLC,OBJECTIVE,OBS,PURPOSE,RESULTS,THERE
182,230,248,311,AMENDMENTS,AMONG,CONCLUSION,GENOMIC,LABEL,LABORATORY,METHODS,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
116,126,169,AFTER,ASSAY,BLOCKED,CBMNCYT,COPYRIGHT,INC,NNK,SEVERAL,WILEY
169,C57BL,CATHEPSIN,COPYRIGHT,FURTHER,TAKEN
001,169,181,AKT,COPYRIGHT,EVALUATION,FINALLY,FOLLOWING,H1975,HCT15,MEK,PI3KI,RAF,RAS,SELECTIVE,THEREFORE,THESE
514,FOLIC,FRS,RAMAN,REDUCED,RGO
JAZF1,SIX
945,CDX,HISTOLOGIC,HOWEVER,LAFMS,LOW,THESE
151,281,675,835,BECAUSE,NSCLC,SMALL
100,PCR
004,013,014,024,169,1ST,420,993,ASIAN,BACKGROUND,BIOMEDICAL,CAUCASIAN,CHINESE,COPYRIGHT,CROWN,FORTY,FURTHER,HOWEVER,LABEL,METHODS,PUBLISHED,RESULTS,SCIENCE,SEPTEMBER,STATA,WEB
001,002,169,COPYRIGHT,H4K16,INC,MICROARRAY,NSCLC,THESE
177,BRONCHIAL,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
011,014,023,028,169,BACKGROUND,CASES,COPYRIGHT,EXPRESSION,IHC,IRELAND,LABEL,LTD,METHODS,NSCLC,NUCLEAR,PFS,RESULTS
123,131,169,AUNPS,COPYRIGHT,LTD,MICROSPECT,PEG,PUBLISHED
107,33F,BACKGROUND,CONCLUSION,CTV,GTV,HOWEVER,INCREASED,LABEL,METHODS,NSCLC,PTV,RESULTS,T1B,TCP,THESE,V74GY
183,CCK,CNE,ESIMS,HEPG2,NCI,NMR,USING
33A,EMT,FUNCTIONAL,HMGA2,TTF,UTR
231,ADP,III,MDA,PUF,XENOGRAFT
169,946,ADC,INC,NSCLC,RII,SCC,TGF,THESE,WHETHER,WILEY
110,169,177,BACKGROUND,CR2,LABEL,METASTASIS,METHODS,PREFS,PRS,RESULTS,RL1,SOCIETY,SURGERY,THESE
169,945,947,948,954,ERK,GCS,INC,MES,SIMILARLY,WILEY
DEPENDING
CHT,CURRENT,III,PCI
231,4T1,945,956,BAX,BCL,MDA,REDUCED
373,ACS,ADC,ALK,BACKGROUND,CONCLUSION,DETECTION,IHC,LABEL,METHODS,MULTIPLEX,PCR,RESULTS
945,AKT,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,THESE,TKI,WESTERN
160,283,792,952,COLORECTAL,COX,INSTITUTES,NIH,OVARIAN,SCREENING,SIMILAR,TRIAL,WOMEN
LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
956,ABL,KINASES,MET,PHA665752,THESE
ATOX1,IHC,KNOCKDOWN,NSCLC,THESE
DICER,POLARIZED,THESE,USING
AFTER,HOWEVER,PAH,PULMONARY,STILL
916,968,BCL,HOWEVER,JNK,MMP,RU486,TAKEN
AMONG,H2452,MALIGNANT,MPM,NCI,NOTCH,THESE
108,169,177,19Q13,CHINESE,COPYRIGHT,GENOTYPING,LDR,PCR
100,169,215,945,946,COPYRIGHT,D50,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,NTD,OBJECTIVE,PURPOSE,RESULTS,SPECT
169,COLLEGE,COPYRIGHT,CURRENTLY,INC,NETWORK,PUBLISHED,RADIOLOGY,SCREENING,TRIAL
169,956,A2058,A2780,COMPOUNDS,COPYRIGHT,LTD,MADAGASCAN,NMR
169,COPYRIGHT,DUE,LTD,METASTASIS
160,169,COPYRIGHT,INC,MTCH2,PATHOLOGY,PUBLISHED,RELEVANTLY,SOCIETY,THEREFORE
100,169,AKT,BACKGROUND,COPYRIGHT,CRC,FEW,GREEN,HOWEVER,INC,LABEL,METHODS,MUTATIONAL,RESULTS,SEVEN
169,ABOUT,COPYRIGHT,GISTS,KIT,LTD,RAS,TUMOURS
169,193,BACKGROUND,COPYRIGHT,INC,LABEL,LUL,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVARIATE
169,COPYRIGHT,INC,LOCAL,ONGOING
004,010,169,183,239,715,800,961,AUC,DOCETAXEL,LABEL,METHODS,NET,OBJECTIVE,PET,PURPOSE,RESULTS
947,AG490,FINALLY,MMP,PCR,RESULTS,STAT3
DIAGNOSTIC,FDG,INTENSE,PET,PLC
BACKGROUND,BECAUSE,CNS,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
CLARA,HOWEVER,SFTPA,SFTPB,SFTPC,SFTPD,THEREFORE,TREATMENT,YET
100,BACKGROUND,HOWEVER,IGF,IGR,IHC,LABEL,METHODS,NEITHER,NSCLC,PPV,RESULTS,SEVEN,SEVENTEEN,SINCE,TKI,TOTAL
LOCAL,MORTALITY,PRIMARY
DUTCH,GENERALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIR,SMR,SURINAMESE
001,022,033,177,180,AMONG,PCR,SOLID,TTF,WHETHER
147,264,555,ELISA,FIBROBLAST,MOLECULAR,PCR
183,BACKGROUND,FVC,GEORG,HOWEVER,LABEL,METHODS,PFT,RESULTS,SEVENTY,STUTTGART
100,115,183,BACKGROUND,CONCLUSION,GEORG,JANUARY,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,STUTTGART,THERE
150,510,945,HIF,HOWEVER,HUR,HUVEC,NOTABLY,SIMILAR,TAKEN
135,169,946,CONCLUSION,COPYRIGHT,IHC,INHERITED,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
AML,BRITISH,PULMONARY
BACKGROUND,CRT,FIELD,HODGKIN,HOWEVER,LABEL,LYL,METHODS,RESULTS
120,169,COPYRIGHT,INC,MBC,OVERALL
000,100,128,DUE,ISS,NSCLC,PCR,RUNNING
106,227,ALK,LABEL,METHODS,NEITHER,OBJECTIVE,RESULTS,SENSITIVE
169,COPYRIGHT,INC,MOSBY,TELOMERES
132,156,169,248,291,701,883,ABOUT,BMD,BMI,COPYRIGHT,HRT,INCLUSION,IRELAND,LOW,LTD,NORWEGIAN,NSCLC,USING
169,187,242,2N0M0,335,383,565,621,677,740,785,810,829,848,886,AMONG,BACKGROUND,COPYRIGHT,DFS,DIGITAL,GGO,IMAGING,INC,LABEL,METHODS,NSCLC,PROPORTION,PUBLISHED,REGARDLESS,RESULTS,ROC,SOCIETY
121,185,199,320,BACKGROUND,BETWEEN,BMI,COLLEGE,INC,LABEL,MEDICAL,METHODS,MILWAUKEE,MOSBY,OBESITY,OVERWEIGHT,PUBLISHED,RESULTS,THERE,WISCONSIN
293,296,378,5AC,ADENOVIRAL,ANG,CONCLUSION,HMOX1,INNOVATION,JAMES,LABEL,MAHIN,MASON,NCI,NSCLC,OBJECTIVE,REBOUND,REDOX,RESULTS,TRACK
ADC,DCE,GTV,MRI,OAR,THERE,TPS,WHILE
005,009,028,CRT,CUMULATIVE,DVH,PTV,SHORTENED,TEN,TREATMENT,V20,V48,VOLUMETRIC
001,049,115,COX,LOG,LYS751GLN,NSCLC,PFS,WHILE,XPA,XPA23,XPD
100,GRADE,HCSRT
187,220,251,296,370,440,780,805,830,940,ICG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,185,197,206,31G,946,C2GNT,COPYRIGHT,DFT,M06,O6H,THESE,THREE,VCH,WILEY
169,COPYRIGHT,LTD,RAS,SPROUTY,THESE,WILEY
100,131,134,141,147,229,234,368,956,AFTER,BACKGROUND,BELARUSIAN,CHERNOBYL,CONTEXT,EXPERIENCE,GBQ,GERMANY,LABEL,MBQ,METHODS,OUTCOME,RESULTS,RIT,TSH
160,905,CONCLUSION,FIF,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS,THERE,WBI
001,005,023,028,048,074,110,160,251,CONCLUSION,CYTOMETRY,DFS,DISEASE,GREATER,HOWEVER,IHC,INCREASED,LABEL,LNS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
AKT,FOXO1
176,200,DIAGNOSIS,IMAGING,MOLECULAR,PCR
BACKGROUND,DISCUSSION,HEARTBURN,LABEL,USA
33342,AFFYMETRIX,ALK,ATP,CRIZOTINIB,FDA,HOECHST,LEWIS,LLC,NSCLC,OVERALL,SMAD3
177,BETWEEN,EUS,FNA,HOWEVER,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STAGE
946,DEPLETION,EMT,IRS,REMARKABLY,ROS,TGF
CD8,COCULTURE,DCS,TH0,TREGS
200,BID,FIFTY,GRADE,LABEL,MAXIMUM,METHODS,OBJECTIVE,PFS,PURPOSE,RCC,RESULTS
169,HEC1A,HOWEVER,LYMPH,THESE
945,AAT,CHANGES,CONCLUSION,FGA,KRT10,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SERUM,THESE,TKI,WESTERN
169,COPYRIGHT,FINALLY,ICP,III,MRI,PEG,PSQ,VCH,WILEY
027,029,081,083,121,159,631,982,AFTER,BETWEEN,CEA,COX,CRC,DISEASE,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,YOUNG
117,120,131,142,149,183,378,BACKGROUND,CONCERNING,CONCLUSION,GEORG,JANUARY,LABEL,METHODS,RESULTS,SEVEN,STUTTGART,THERE
177,BACKGROUND,INDURATION,ISA,LABEL,LYMPHOCYTE,METHODS,MONTANIDE,RESULTS,THREE
150,945,946,ACTIVATING,ATP,ERBB2,NOTABLY,TAKEN,USING
117,AFTER,ALK,AMONG,BACKGROUND,H2228,H3122,IHC,LABEL,METHODS,NSCLC,PCR,PLA,RESULTS,THESE,WESTERN
66KDA,945,946,BAX,BCL,GAL,GLC,GM3,IGG,MAACKIA,NSCLC
600,CGH,CNV,FOCUSED,KDM1A,LFS,REMARKABLY,SIRT3,TRRAP,USING
132,268,ACCRUAL,BACKGROUND,CONCLUSION,DIGITAL,FIRST,LABEL,METHODS,OVERALL,OWING,PULMONARY,RESULTS,SOS
18F,741,BACKGROUND,FDG,ITALUNG,LABEL,MANAGEMENT,METHODS,PET,POSITIVITY,RESULTS,SURGERY,TEN,THREE
003,100,102,BACKGROUND,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SCORE,SOCIETY,THERE,UNIVARIATE
034,120,150,BACKGROUND,CONCLUSION,CTS,DESPITE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
102,160,169,BACKGROUND,BCN,CATALAN,CLASSICAL,COPYRIGHT,IBERIAN,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PENINSULA,RELEVANCE,RESULTS,VOUCHER
946,AKT,JUN,RAS,RAT,THEIR,THESE,WNT
CD8,RON,TREATMENT
000,108,169,215,293,956,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PUBLISHED,RESULTS,SERUM,SOCIETY,TNM
950,DESPITE,HOWEVER,SHORT,THEREFORE,TREATMENT
169,1CC,1GY,351,6CC,AMONG,BETWEEN,COPYRIGHT,EIGHT,GTV,INC,MEDICAL,MLD,NSCLC,PUBLISHED,SIMULATED,STAGE,THERE,V20
169,AEU,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,FOLLOWING,ISC,LABEL,METHODS,OBJECTIVE,PUBLISHED,SUMMARY,TUMOURS,UNASSIGNED
158,169,AUC,CONCURRENT,COPYRIGHT,HOWEVER,III,IRELAND,LTD,MAY,NSCLC,ORR,TRT
002,169,423,716,AMONG,BACKGROUND,CONVERSELY,COPYRIGHT,E1594,III,IRELAND,LABEL,LCC,LOGRANK,LTD,MEN,METHODS,NOS,NSCLC,PFS,RESULTS,SCC
169,946,COLON,DDB,DEPLETION,EMT,METASTASIS,TGF,XPE
100,800,CONCLUSION,DCR,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE
106,BACKGROUND,III,LABEL,MAXIMUM,METHODS,MTD,RESULTS,TAS,TOLERATED,WHILE
111,250,945,946,ARG,ASP,CONCLUSION,FOLLOWING,GLY,JAPAN,LABEL,LYS,METHODS,NOGUCHI,OBJECTIVE,PHE,PREVIOUSLY,RESULTS,RGDFK,SPECT
139,169,BACKGROUND,COPYRIGHT,EOC,IHC,INC,LABEL,METHODS,PFS,RESULTS,UNIVARIATE,WESTERN,WILEY
LANGERHANS,LCH,WHILE
001,004,006,007,017,046,052,103,169,19A,201,438,CONCLUSION,COPYRIGHT,EXPRESSION,INC,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SERUM,TNM,WILEY
001,007,009,013,015,023,025,030,160,CONCLUSION,HISTOLOGY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVMEAN,THESE
CTC,EPCAM,HOWEVER,MET,MIC,THESE
HMGB3,HOWEVER,MEIER,NSCLC,PCR,WESTERN
122,149,160,256,354,CONCLUSION,DFS,FIFTEEN,HOWEVER,LABEL,METHODS,MUTATIONS,OBJECTIVE,PURPOSE,RESULTS,THERE,TKI
CALCITONIN,HOWEVER,IMAGING,MEDULLARY,MTC,THESE
001,006,032,037,042,336,359,655,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
III,PRESENT,STUDIES,THESE
004,022,215,663,AGE,BACKGROUND,COMMITTEE,JAPAN,JOINT,LABEL,METHODS,REASONS,RESULTS,THERE
001,008,140,945,946,BACKGROUND,FINALLY,LABEL,METHODS,RAS,RESULTS,THERE,THESE
242,ADULT,BACKGROUND,CIS,COLLEGE,COMMISSION,CONCLUSION,COX,CRT,LABEL,MEIER,METHODS,NSCLC,OPTIMAL,RESULTS,TREATMENT
BACKGROUND,CONCLUSION,COX,FORTY,JANUARY,LABEL,MEIER,METHODS,PET,RESULTS
169,ADDITIONAL,COPYRIGHT,HCC,SAS,SEVEN
169,AFTER,CIS,COPYRIGHT,HRS,IRELAND,LTD,NSCLC,PCR,RAS
100,EIGHT,JAPAN,TECHNICAL
169,ALK,COPYRIGHT,FEW,HOWEVER,LTD,MET,NSCLC,ONCOGENIC,RAS,RET,ROS,THESE
169,COPYRIGHT,IMAGE,OVERALL,PUBLISHED
120,160,4HU,967,BACKGROUND,DYNAMIC,LABEL,MALIGNANT,METHODS,RESULTS,SMALLER,THERE,WHITNEY
018,140,ARNAU,CONCLUSION,CONTINUED,DIFFERENT,ERLOTINIB,HOWEVER,LABEL,LANGONE,MEDICAL,METHODS,NSCLC,NYU,OBJECTIVE,PFS,PURPOSE,RESULTS,THESE
160,PROTEOMIC,SILAC
169,ASSESSMENT,COPYRIGHT,MCF,VCH,WILEY
500,BACKGROUND,CONCLUSION,DESPITE,III,LABEL,METHODS,OBJECTIVE,PARTIAL,RESULTS,THERE
AMONG,MMP,MT1,THESE,TJS
132,137,169,BACKGROUND,LABEL,LRC,METHODS,NSCLC,RANDOMIZED,RESULTS,SLR,SOCIETY,TRC,UNIVARIATE
125,131,160,177,215,99M,CLEAR,SSTR2
178,CONCLUSION,DLT,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS
945,946,CYR61,MCP,NOTABLY,TAKEN,THESE
118,160,ACCURAY,ACTUARIAL,BETWEEN,CBK,CONCLUSION,CSS,CYBERKNIFE,EORTC,EVALUATION,FURTHER,GROUP,INC,INCLUSION,LABEL,MAY,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RADIATION,RESULTS,SCALE,SOLID,SRT,SUNNYVALE,THERAPY,TREATMENT,USA
FOXM1,HCC,HOWEVER,TRANSWELL
945,946,BASCS,CONVERSELY,FINALLY,ID1,LA2,LSL,NSCLC,PKC,PRKCA,PROTEIN,TGF
1980S,998,CHINA,FURTHER
100,250,956,HYOGO,JAPAN,LABEL,LNS,METHODS,OBJECTIVE,RESULTS
100,138,18F,BAC,DFS,FDG,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,PET,PURPOSE,RESULTS
AML,CCT,CLEAR,NEITHER,PECOMAS,THEREFORE,THESE
FDG,METASTASES,MRI,PET
SPECT
FDG,HOWEVER,MRI,PET
CPB,FDG,HISTOLOGY,PET
103,HOWEVER,LOCAL,ORGAN,RADIATION
169,288,403,COPYRIGHT,IRELAND,JUMONJI,LTD,PCR
100MG,100MM,169,174,249NM,331NM,956,9ML,COPYRIGHT,FOLLOWING,INTER,SAMPLES
169,ACADEMY,CLEAR,COPYRIGHT,INC,MOSBY,PUBLISHED
116,169,956,AMONG,COPYRIGHT,HCT,LTD,SUNITINIB
000,002,017,105,169,196,208,341,457,520,539,632,762,789,794,811,904,CD147,COPYRIGHT,CROWN,NSCLC,PUBLISHED,TNM,UNIVARIATE
169,241,CHEST,COPYRIGHT,PORTUGUESA,PUBLISHED,SOCIEDADE
169,COPYRIGHT,ECT,LTD,MICROWAVE,MWA,RFA,SURGERY,THERMAL
169,CONCLUSION,COPYRIGHT,DCAIR,FDG,INC,ITV,LABEL,MATERIALS,METHODS,MIP,OBJECTIVE,PET,PURPOSE,RESULTS
100,169,BRITISH,COPYRIGHT,DETAILS,DISEASE,IQR,LTD,PUBLISHED,SCC,SPECIALIST,THERE,THOSE,TNM
039,069,105,133,176,240,312,331,394,409,490,496,548,577,608,636,868,910,945,BECAUSE,COMPETING,GROUP,HOWEVER,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SCALE,SRS,THERE,THESE,ULTIMATELY
000001536,004,043,047,173,334,350,BACKGROUND,BECAUSE,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THERE,VBN
150,AFTER,ERLOTINIB,HOWEVER,JANUARY,LABEL,MAJOR,METHODS,OBJECTIVE,RESULTS
011,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,PULMONARY,RESULTS,SARCOMA,SEVENTY
145,252,293,300,A750DEL,FALSE,L858R,MOLECULAR
EARLIER,IDIOPATHIC,IPF
001,120,AFTERWARDS,FIFTY,GGO,LABEL,LOBECTOMY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,SIXTY,THERE,VBN,WWR
001,100,169,CONCLUSION,COPYRIGHT,DESPITE,F18,FDG,IRELAND,LABEL,LTD,MBQ,METHODS,NSCLC,PET,RESULTS,SOR,THERE,THEREFORE,UNLABELLED
169,174,AVASTIN,COPYRIGHT,NSCLC,SAS
002,169,173,410,C30,COPYRIGHT,DECLINE,DELAYED,EORTC,GROUP,HOPKINS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PURPOSE,QLQ,QUALITY,RADIATION,RESULTS,THERAPY,TREATMENT
005,169,203,283,AES,APEX1,CENPE,CONCLUSION,COPYRIGHT,GSTP1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,SNP
BACKGROUND,CONTEXT,LABEL,LITERATURE,METHODS,OBJECTIVE,OBJECTIVES,SOURCES
THESE,USING
177,186,813,AIM,BACKGROUND,BASED,CONCLUSION,LABEL,METHODS,NYT,OBJECTIVE,RESULTS,TIMES,YOUNGER
100,174,ANOVA,BACKGROUND,CONCLUSION,KEY,LABEL,METHODS,OBJECTIVE,OBTAINING,PGY1S,RESULTS,SIXTY,UNIVERSITY
THERE,USUALLY
LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,THERE,THEREFORE,WANDERING
001,008,391,647,BACKGROUND,CAUCASIANS,HOWEVER,LABEL,METHODS,PRO,PRO72,RESULTS,STRATIFIED
160,177,214,384,FACBC,FDG,LABEL,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,TEN,THERE
ADP,CK2,DIFFERENT,H2030,INHIBITION,PML,SER,TBB,THESE,THR,WESTERN
001,003,004,014,106,149,245,JANUARY,LABEL,METHODS,OBJECTIVE,OSAKA,OVERALL,PURPOSE,RESULTS,THERE
169,527,618,EXPOSURES,HUNGARY,ROMANIA,THERE,WORKPLACE
001,003,005,012,154,HOWEVER,JMJD6,MEIER,PCR,WESTERN
001,012,030,048,100,177,AMONG,CONCLUSION,COX,FDG,LABEL,MAXIMUM,METHODS,MTV,NSCLC,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,ROC,SUV,TLG
169,260,386,BACKGROUND,BASEL,BETWEEN,COPYRIGHT,FDG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEPTEMBER
114,160,271,366,DEPENDING,NORWEGIAN,SIR,USING
150,169,183,BACKGROUND,BRITISH,ERK,KEY,LABEL,MAP,MEK,METHODS,OBJECTIVE,PURPOSE,RAF,RESULTS,SOCIETY,SPC,VEGF165,YL529
100,126,160,177,AGGREGATE,CONCLUSION,FPR,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCREENING,THERE,TRIAL
169,886,924,946,NCI,SMALL,TGF
143,152,177,315,364,410,EVALUATION,III,LABEL,MAJOR,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STAGE,THERE
DISCUSSION,HOWEVER,LABEL,METHODS,MINIMALLY,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OTHER,RESULTS,TRT
169,COPYRIGHT,INC,MET,NSCLC,T790M,THESE,TKI,WILEY
EDNRA,GATA2,HOWEVER,KNOWN
100,956,DISPASE,PATIENT
1ST,BACKGROUND,CONCLUSION,IDIOPATHIC,IPF,JANUARY,LABEL,METHODS,PFS,RESULTS
235,280,661,BACKGROUND,LABEL,METASTASES,METHODS,NET,RESULTS,THERE,UNIVERSITY,UPPSALA
215,945,CYTOGLOBIN,DESPITE,NSCLC,TSG,VEGFA
BIOLOGICAL
169,COPYRIGHT,FURTHER,HOWEVER,LTD,NSCLC,OVERALL
114,116,130,360,464,AES,BACKGROUND,GRADE,LABEL,METHODS,NSCLC,PEMETREXED,PFS,RESULTS,STAGE
001,002,104,160,242,BACKGROUND,CEA,CYFRA,LABEL,METHODS,NSCLC,PFS,RESULTS,TKI
169,BACKGROUND,BLACK,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,174,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,MINDSTORMS,PUBLISHED,RESULTS
LITERATURE,MET,THEREFORE
ECH,HYPOXIA,KEAP1,KELCH,NUCLEAR,OXIDATIVE,RVH,THESE
243,339,377,ASBESTOSIS,BACKGROUND,INDEX,INSULATOR,INSULATORS,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,PREVENTION,RATIONALE,RESULTS,SMOKING
103,205,607,835,956,BACKGROUND,COX,ENGLISH,HOWEVER,HRS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THERE,THESE
200,946,ADVERSE,AUC,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
169,223,237,286,631,854,AMONG,CONCLUSION,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,WILEY
ACTIVATION,ARSENIC,KEAP1,LC3
ACUTE,GAS41,THESE
013,116,145,169,209,414,956,ANTITUMOR,B16,BCA,C38,C51,GXF,HCT,LABEL,LEWIS,METHODS,MIA,N87,NCI,OBJECTIVE,P02,P03,PURPOSE,RESULTS,SR475,TAXANES,THESE,TXT,XRP6258
160,947,BTG,ERK,H1975,HOWEVER,NCI,TOB,TRANSDUCER,WESTERN
124,169,271,800,BACKGROUND,EHE,FIFTEEN,FURTHER,LABEL,METHODS,RESULTS,SEVEN,SOCIETY,THERE
BECAUSE,EIGHT,HNSCC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,COPYRIGHT,INC,ROS,THESE,WILEY
177,PET,SUV
137CS,946,967,CCK,CENTRUM,DUE,GAL,KAROLINSKA,RCR,THESE,U1690
160,EMT,HOWEVER,SBC,TAKEN,THEREFORE,USING
PATHOLOGY,PPB
320,532,BLOOD,HOWEVER,THEREFORE
947,MCL
024,026,028,151,208,FURTHER,WILMS
RIGID
AFTER,EWING,PET
AKT,BAX,BCL,EPIDERMAL,H1975,HOWEVER,NSCLC,SINCE,T790M,THESE,TKI,USING
100GY,CIVCO,GROUP,INC,LOK,NOVALIS,PRO,PUBLISHED,RADIATION,STAGE,THERAPY
060,1151T,169,93G,ASIAN,BACKGROUND,CBM,COPYRIGHT,FINALLY,FURTHER,HOWEVER,ISI,LABEL,MANAGER,MED,METHODS,OVERALL,PUB,RESULTS,VAL384ASP
003,004,169,ASIAN,AUTHORS,BACKGROUND,BETWEEN,BRONCUS,INC,LABEL,LUNGPOINT,MAY,METHODS,MHZ,NOTABLY,OBJECTIVE,PACIFIC,PPL,RESULTS,SOCIETY,UNIVARIATE,USA
149,215,221,241,288,956,CVS,H69,H69AR,MRM,SINCE,SIS,SMAD4,STAT1,STAT2,TFS
169,ASIAN,AUTHORS,CD133,CSC,EMBRYONIC,NOTCH,PACIFIC,SIMILAR,SOCIETY,WNT
002,135,171,190,201,239,402,AMONG,GRADE,HOWEVER,III,JAPAN,LABEL,METHODS,NEJ,OBJECTIVE,PHASE,RESULTS,SMOKING,THREE,WJTOG
169,912,MVS,NSCLC,SDS,THESE,THREE,USING,VCH,WILEY
169,183,ELISA,GEORG,H1299,JNK,MTT,PROCASPASE,STUTTGART,TUNEL
001,003,012,017,018,105,180,183,246,263,469,576,605,659,927,CONCLUSION,COX,GEORG,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STUTTGART,VIDEO
169,ALBUMIN,ALK,BACKGROUND,COPYRIGHT,CRIZOTINIB,FSH,LABEL,LLN,MET,METHODS,RESULTS,SOCIETY
AFTER,CSC,HNSCC,HPV,LABEL,METHODS,NOD,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,UNIVERSITY
102,169,COPYRIGHT,EWING,INC,RMS,WILEY
267,400,824,CHINA,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WOMEN
194,946,MICRORNAS,TGF,THESE
CONSISTENT,CONVERSELY,H1299,P53,SP1
169,BACKGROUND,CHINESE,COPYRIGHT,ERK,GENERAL,GINSENG,LABEL,METHODS,MMP,MTT,NAC,RESULTS,ROS,THESE,TREATMENT,TUNEL,WESTERN
169,185,COPYRIGHT,FDG,JANUARY,OCTOBER,PET,SAS
169,33342,ABCB1,ABCC1,ABCG2,COPYRIGHT,HOECHST,INC,MDR,MTT,SAD,THESE
10877,169,1MG,2MG,5MG,BETWEEN,CONCLUSION,COPYRIGHT,EASTERN,GROUP,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SECONDARY
120,169,ADDITIONAL,COPYRIGHT,EATON,ELISA,GFP,INC,LAMBERT,PUBLISHED,SEVERAL,SOCIETY
005,006,007,062,116,160,169,208,242,BACKGROUND,COPYRIGHT,COX,END,INC,LABEL,MATERIALS,MEIER,METHODS,NRT,NSCLC,PST,RESULTS,THERE
169,871,ALPHA,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CROWN,CRYAB,FOLLOWING,LABEL,METHODS,MORTALITY,NSCLC,PUBLISHED,RECURRENCE,RESULTS,THERE
002,019,169,177,215,945,AGE,COPYRIGHT,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THERE,TNF,UNIVARIATE,WHOLE
001,002,003,004,007,169,777,CONCLUSION,COPYRIGHT,ECM,GPA,III,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,RPA
169,COPYRIGHT,HOWEVER,INC,INITIALLY,OTHER
160,169,CENTRAL,COLLEGE,CONCLUSION,CONTROLLED,COPYRIGHT,ENROLMENT,III,LABEL,LTD,MATERIALS,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,REGRESSION,RESULTS,ROYAL,SEPTEMBER,SRE
169,COPYRIGHT,MRI,SAS
169,CONCLUSION,HOWEVER,LABEL,LTD,METHODS,MUCUS,OBJECTIVE,PCR,PUBLISHED,RESULTS,SHP,SOCIETY,WILEY
169,IMAGING,INC,MALIGNANT,STAGING,WILEY
000,001,002,057,090,131,138,179,AUTHORITY,BRESCIA,CD4,HIV,HOWEVER,IRR,LHA,LOCAL,NADCS,POISSON,SIR
169,POL,STAT3
003,008,024,088,138,169,248,701,ACT,COPYRIGHT,EXPRESSION,JBR,NSCLC
169,945,DISEASE,INCREASED,TERMS,VCH,WILEY
169,COPYRIGHT,HOWEVER,IKZF1,INC,WILEY
ADJUSTMENT,CML,DETERMINE,LABEL,METHODS,OBJECTIVE,PROTECTIVE,REMAINING,RESULTS,RRS,ZEALAND
ANAMORELIN,DAILY,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,ONO,PURPOSE,RESULTS,THEREFORE,THESE
118,160,AFTER,CONCLUSION,DIAGNOSTIC,IQR,LABEL,LCRDU,METHODS,OBJECTIVE,PURPOSE,RAPID,RESULTS,TNM
005,012,059,946,ALTERED,BACKGROUND,EIGHT,EPIDERMAL,LABEL,MET,METHODS,NSCLC,ORR,RESULTS,THESE,TKI
177,200,AUC,BACKGROUND,CYCLE,DLT,END,FIFTY,LABEL,METHODS,NEITHER,NSCLC,PRIMARY,RESULTS,SECONDARY
001,021,035,169,4T1,945,COX,FINALLY,JAPAN,MEDICAL,SAPPORO,SEVENTY,THEREFORE,THESE,UNIVERSITY
169,AKT,CCDC6,EXPRESSION,HOWEVER,LAD,MUTATIONS,RET,VANDETANIB
947,AFTER,EXPRESSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RAD51,RESULTS,WESTERN
169,BROMO,HOWEVER
108,173,360,640,AFTER,H2RBS,HISTAMINE,INSURANCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC
121,145,169,354,360,956,BACKGROUND,CYTOPATHOL,GIVEN,LABEL,METHODS,RESULTS,SOCIETY,USING
178,336,AMONG,COX,HAZARDS
001,100,177,CONCLUSION,DYSPNEA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
462,509,708,BACKGROUND,CONCLUSION,CTCAE,EIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFA,THESE,THREE
169,COLLEGE,CONCLUSION,COPYRIGHT,CUMULATIVE,HODGKIN,INDEX,JANUARY,LABEL,LITERATURE,MAY,MEDLINE,MEN,METHODS,NURSING,OBJECTIVE,POPULATION,RESULTS,SCIENCE,SIR,SIX,SSC,THERE,WEB
143,169,317,566,945,CONCLUSION,DISCOVERY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
ASSESSMENT,BACKGROUND,CCO,CONCLUSION,DIAGNOSTIC,DISEASE,DPM,EIGHT,FUNDING,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OBJECTIVES,ONGOING,ONTARIO,PATHWAY,RESULTS,SYMPTOM,THROUGH,UNITS,WEB
956,ATG,AUTOPHAGY,BACKGROUND,ERLOTINIB,INHIBITION,LABEL,METHODS,NSCLC,RESULTS
ACCORDING,BACKGROUND,CONCLUSION,EIGHT,EQA,ITALIAN,LABEL,MEDICAL,METHODS,OVERALL,PATHOLOGY,PCR,POLYMERASE,RESULTS,SOCIETY,TEN
001,211,321,591,812,AMONG,ASIAN,BACKGROUND,BECAUSE,CHINESE,CONCLUSION,DARBY,DESPITE,LABEL,MALAY,MALAYSIAN,MEDICAL,METHODS,MUTATIONS,RESULTS
001,039,319,374,384,434,593,BACKGROUND,CONCLUSION,COX,CURRENTLY,GROUP,JAPAN,LABEL,METHODS,NSCLC,OVERALL,RESULTS,SMOKING
FINALLY,PARTIAL
FEW,THEREFORE
461,AFTER,CONCLUSION,DESPITE
AFTER,C57BL,HOWEVER,HPV,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,RTB,THEREFORE
004,008,AMONG,BACKGROUND,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SUMMARY
100,169,5A4,ANAPLASTIC,COPYRIGHT,INC,INTERPHASE
001,004,006,030,144,169,177,256,720,789,948,954,956,964,967,COPYRIGHT,COX,DOR,EC109,HOWEVER,INC,KENDALL,KOR,KYSE150,KYSE180,MOR,WESTERN
819,AMONG,BMJ,COX,GROUP,INDEX,INTERVIEW,LABEL,LIMITED,METHODS,MORTALITY,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SMOKING
169,BAGE1,BAGE2,BAGE4,BAGE5,BORIS,CSC,CTS,D40,GAGE1,GAGE8,LTD,MAGEA12,PCR,PLU,SGY,SPA17,SPANXA1,SPANXB1,SW480,TDRD1,TEX15,THEREFORE,WILEY,XAGE1,XAGE2
ALK,COMPANION,FDA,HOWEVER,KIT
169,178,BORTEZOMIB,GRADE,HOWEVER
ECH,KEAP1,KELCH,SNP,THESE,WHILE
203,954,CMR,CONCLUSION,EORTC,EVALUATION,FDG,INDIVIDUAL,LABEL,METHODS,PERCIST,PET,PMD,PMR,RESULTS,SMD,SOLID,THERE,TREATMENT,UNLABELLED
HCC44,HUR,PCR,PTHRP,THESE,WESTERN
160,ADDITIONAL,BACKGROUND,BETWEEN,LABEL,METHODS,REDUCED,RESULTS,WEDGE
951,DEPLETING,DGK,LABEL,METHODS,OBJECTIVE,PURPOSE,RAS,RESULTS,SINCE
177,AFTER,MKR,MTB,NEU,TAN
ESPECIALLY,HNC,INDWELLING,IRELAND,LABEL,OBJECTIVE,PROSTHETIC,PULMONARY,PURPOSE,RESULTS,SUMMARY,TLR,TOTAL
178,180,4TH,BACKGROUND,BRONCHIAL,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,THERE,THREE,VIDEO
945,AFTER,CASES,HCC,HEP,LIVER,PAR,PARTIAL
STAGE
100,145,175,211,223,BACKGROUND,DUTCH,GP5,HPV,HPVE7,INFECTION,LABEL,METHODS,RESULTS,SINCE,THESE,WHEREAS
001,177,212,222,235,383,534,709,BACKGROUND,COX,END,INCREASING,INDEX,LABEL,MEIER,METHODS,NSCLC,OLDER,OVERALL,RESULTS,SURGERY,TREATMENT,YOUNGER
112,DEK,DEPLETING,GTP,MEIER,MLC,NSCLC,TAKEN,TNM
135,169,245,380,ACCORDING,ADC,CD151,COPYRIGHT,DFS,HOWEVER,IRELAND,LTD,NSCLC,SCC
169,ACORN,BACKGROUND,CONCLUSION,COPYRIGHT,IMD,IRELAND,LABEL,LOW,LTD,METHODS,RESULTS,SES,SIMILARLY,STAGE,THERE
169,500,AUTOMATIC,CLRRS,CONCLUSION,COPYRIGHT,HYPOTHESIS,IRELAND,LABEL,LABORATORY,LTD,METHODS,OBJECTIVE,OLDER,REPORTS,RESULTS,THESE
109,169,2N0M0,BETWEEN,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
945,AGREEMENT,BACKGROUND,CONTEXT,LABEL,METHODS,OBJECTIVE,RESULTS
SRC
321,CHINESE,CIS,HRS,OVERALL,SINGAPORE,THERE
039,CONCLUSION,EIGHT,IMMEDIATE,LABEL,MAY,METHODS,OBJECTIVE,OCTOBER,OUTCOME,RESULTS,SETTING
400,DESPITE,THESE
000,150,CURRENT,FURTHER,MALIGNANT,MPE,THEREFORE
177,478,581,AFTER,CPG,FOURIER,ODN,PDI,SDS,THEIR,TRANSFORM,XTT
011,012,015,020,030,032,058,077,177,240,299,300,ASSESSMENT,BAY,BECAUSE,CONCLUSION,FDG,IMAGE,LABEL,MBQ,METHODS,PET,RADAR,RADIATION,RESULTS,UNLABELLED
021,174,ADDITIONAL,CONCLUSION,FDG,IMAGING,INCIDENTAL,JANUARY,KNOWLEDGE,LABEL,MALIGNANCY,METHODS,OBJECTIVE,PET,REPORTING,RESULTS,TESTS
GATED,GTV,GUNMA,HEAVY,IMS,ION,MEDICAL,UNIVERSITY
239,AUC,CONCLUSION,GRADE,IRINOTECAN,LABEL,MAJOR,MARCH,METHODS,NON,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,TREATMENT
169,COPYRIGHT,IRELAND,LTD,TAKEN,TW01001
169,COPYRIGHT,INC,MLR,NSCLC,PCA,PLSDA
100,169,956,CLARA,COPYRIGHT,DEP,PM2,ROS,SERUM,SRM
BACKGROUND,CONCLUSION,EFFECTIVE,LABEL,METHODS,OXYCODONE,RITODRINE
001,005,335,409,475,500,645,BACKGROUND,FID,LABEL,METHODS,PARAMETERS,RESULTS
169,COPYRIGHT,HOWEVER,IRELAND,LTD
0KB,169,COPYRIGHT,LABEL,LUCIFERASE,METHODS,OBJECTIVE,PCR,RESULTS,VDR
169,AXL,EMT,HOWEVER,NSCLC,USING
FINALLY,PREDICTIVE,SOCIETY,THERE
001,177,990,CTV,DIS,GTV,ITV,NSCLC
148,155,257,296,CONCLUSION,FDG,FURTHER,LABEL,MATERIALS,MBQ,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SPLIT
INCREASING,SELECTIVE,SINCE
178,490,945,946,947,954,ASM,ASMCS,BAPTA,CONFLUENT,CONVERSELY,CXCR3,CYTOMIX,DESPITE,ELISA,JAK,JNK,NEITHER,PCR,SERCA,SIGNALING,STAT1,TNF
169,318,AMONG,BACKGROUND,COPYRIGHT,COX,END,IQR,LABEL,METHODS,NSCLC,OVERALL,RANDOMIZED,RESULTS,SOCIETY,STRATIFIED,THEIR
019,160,175,608,BACKGROUND,COX,HRS,LABEL,METHODS,NSCLC,PFS,RESULTS,THESE,TTF
037,177,BACKGROUND,EVALUATION,FINALLY,LABEL,METHODS,MOLECULAR,PRIMARY,RESULTS
195,BLAND,CONCLUSION,EORTC,LABEL,METHODS,NSCLC,NUCLEAR,OBJECTIVE,OVERALL,PET,PSF,PURPOSE,RCS,RESULTS,SUV,TEN,THESE,TREATMENT,USING
100,181,250,500,549,ECM,HOWEVER,MMP,PMA,PROTEASES,THESE,TIMPS
FGFR1,NSCLC,PCR,PONATINIB
AKT,BCL,BMAL1,MMP,SINCE,THEREFORE,THESE
FINALLY,FINDR,FOURIER,RAMAN,SVM
001,249,287,CONCLUSION,DESPITE,JANUARY,LABEL,LRC,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS
916,946,954,CIGARETTE,LEWIS,SMOKING,WNT
BESIDES,CCND1,EPIDERMAL,HDAC1,HOWEVER,PML,PMLIV
169,AKT,BCL,DTX,ECTOPIC,FURTHER,H1299,LAD,PREVIOUSLY,SPC,UTR
169,24H,946,956,CAO,CHINESE,COPYRIGHT,ECM,ERK,FURTHER,HOWEVER,INCREASING,IRELAND,LTD,PCR,TAKEN,WESTERN
169,177,COPYRIGHT,D95,FIFTEEN,INC,ITV,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PTV,PURPOSE,RESULTS,TREATMENT
157,169,584,861,CAUCASIANS,COPYRIGHT,HENCE,OVERALL,T241M,XRCC3
337,BACKGROUND,CONTINUED,ENGLISH,III,INCLUSION,INCREASED,IRELAND,JANUARY,LABEL,LTD,MEDLINE,METHODS,NSCLC,PUBLISHED,QOL,RESULTS,THREE
108,145,164,169,193,295,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LTD,NSCLC,SCC,TNM
169,AMONG,BACKGROUND,CIS,COPYRIGHT,FURTHER,LABEL,LIBRARY,LTD,METHODS,NEWCASTLE,RESULTS,SCALE,SEPTEMBER
169,COPYRIGHT,FBXW7,IRELAND,LTD,MCL,NVP,PI3,TRAIL
169,CDC42,COPYRIGHT,GTPASES,INC,PATHOLOGY,PREVIOUSLY,PUBLISHED,RHO,SMK,SOCIETY,THESE,USING
169,521,ALK,ALREADY,COLLEGE,CONSENSUS,COPYRIGHT,INC,INITIAL,JANUARY,LABEL,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PROCESS,PUBLISHED,SOCIETY,THREE,WRITING
169,COPYRIGHT,LTD,METASTASIS,OVERALL,PRIMARY,SURGERY,WHILE
001,100,118,122,145,169,170,600,613,946,AGE,ASSESSMENT,BACKGROUND,CAUCASIAN,CONCLUSION,COPYRIGHT,DISEASE,EUROQOL,FATIGUE,FUNCTIONAL,GERMANY,HRQOL,IRELAND,LABEL,LTD,METHODS,NSCLC,PATIENT,RESULTS,SCALE,SYMPTOM,THERAPY
169,956,ADM,AMONG,AMONGST,COPYRIGHT,HOWEVER,LEISHMANIA,LTD,MICROMELUM
AREAS,BACKGROUND,COVERED,FTM,LABEL,METHODS,NSCLC,OPINION,QOL
COMPOUNDS,ESPECIALLY,THEIR
001,006,156,164,169,AMONG,BACKGROUND,COPYRIGHT,END,ESTIMATES,HODGKIN,LABEL,MATCH,METHODS,RESULTS,SOCIETY,SOLID,SUBGROUPS,TRANSPLANT
169,AMONG,BACKGROUND,COLORECTAL,COPYRIGHT,LABEL,MEN,METHODS,NON,OVARIAN,PSA,RESULTS,SOCIETY
197,239,AMONG,BACKGROUND,BCL,BIM,HOWEVER,LABEL,METHODS,NSCLC,PFS,RESULTS,SEOUL,T790M,TKI,TREATMENT,UNIVERSITY
BACKGROUND,COX,HSB,III,LABEL,LOW,LSB,METHODS,NSCLC,PFS,RESULTS
001,516,950,991,CHINESE,FURTHER,HOWEVER,KNOWLEDGE,PUBLISHED,T188C,WANFANG
AFTER,BECAUSE,FGFR2,FGFR3,THROUGH
177,390,CONCLUSION,EWING,FDG,LABEL,LOCAL,METHODS,NPV,OBJECTIVE,OVERALL,PET,PPV,PURPOSE,RESULTS
E14,E15,EMT,HOWEVER,ID1,INHIBITOR,MAMMARY,MYC,TMA
169,BACKGROUND,COPYRIGHT,FORTY,LABEL,METHODS,NSCLC,RESULTS,SOCIETY
BACKGROUND,DETECTION,FURTHER,LABEL,METHODS,MINIMAL,MRD,PCR,TNM
575,945,ADDITIONAL,ANTITUMOR,PDGFR,THESE
169,ALK,CAUCASIAN,COPYRIGHT,FDG,IRELAND,LTD,PET,RAS,RET,WHILE
CHEST,CURRENTLY,FDG,PET
AFTER,UNKNOWN
169,6MV,CARLO,COPYRIGHT,EBT,GAFCHROMIC,HOWEVER,INC,MEDICAL,MONTE,PUBLISHED,V95
467,CEA,DFS,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
COX,III,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PRETHERAPY,RESULTS,SALVAGE,STAGE,THERE
150,165,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESERVING,RESULTS,SEPTEMBER,THERE,THREE
HCP,INCREASING,PHYSICIANS,RTD
169,COPYRIGHT,LIVER,OTHER,PUBLISHED,PULMONARY
169,INC,WILEY
169,175,391,BACKGROUND,BCC,CONCLUSION,COPYRIGHT,CUTANEOUS,INC,LABEL,METHODS,ORGAN,RESULTS,SCC,SOLID,WILEY
169,BIOLOGY,COPYRIGHT,DR5,EBP,FLIPL,FURTHER,INC,MOLECULAR,NATURAL,ROS,UNION
169,946,BIP,CHINESE,COPYRIGHT,FUR,LTD,MYC,RHIZOMA,TAX,WILEY
169,200,239,AES,ALK,EIGHT,GANETESPIB,HSP90,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PCR,PFS,PURPOSE,RESULTS,SECONDARY
1204831,1214063,169,242,EMD,HGF,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR
169,945,946,COPYRIGHT,IMMUNOBLOT,INC,NSCLC,SILENCING,USING,WILEY
100,233,BLOOD,COMBINING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMOKING,TOBACCO
015,CONCLUSION,EARLY,EVALUATION,GROUP,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PERFUSION,RESULTS,SOLID,TEF,TUMOURS,TVV
076,169,439,AMONG,BMI,CIS,CONVERSELY,CSI,ORS,REVERSE,SMOKING,THERE
160,219,CENTRAL,OPHIOLITIC,SIVAS,YET
417,914,AFTER,BACKGROUND,CHINESE,CIS,COX,CVS,FFQ,HRS,LABEL,METHODS,RESULTS,WOMEN
001,890,CIS,HRS,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS
AKT,AUTOPHAGY,DIOSCIN,H1299,LC3,MEANWHILE,RESULTS,TAKEN,TREATMENT
CHINESE
95D,APOPTOSIS,BAX,BCL,FURTHER,LACTATE,PCR,TREATMENT,WHILE
250,400,500,AMONG,BEXAROTENE,GEFITINIB,HOWEVER,TARGRETIN,THREE
521,ALK,ALREADY,COLLEGE,CONSENSUS,INITIAL,JANUARY,LABEL,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PROCESS,THREE,WRITING
160,169,ALK,IHC,KIRSTEN,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SAMPLES,WILEY
001,005,169,AIM,BAL,CEA,CONCLUSION,CYFRA,CYFRA21,LABEL,LTD,METHODS,NSE,OBJECTIVE,PTY,PUBLISHING,RESULTS,SCC,WILEY
ACCOUNT,HOWEVER,INITIALLY,OBATOCLAX,SIMILAR,THESE
521,ALK,ALREADY,COLLEGE,CONSENSUS,INITIAL,JANUARY,LABEL,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PROCESS,THREE,WRITING
169,223,AE1,CK7,E12,EPSTEIN,LTD,PUBLISHED,WILEY
BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,NODULES,OBJECTIVE,PURPOSE,RESULTS,SMALL,SWENSEN,THESE
954,GINSENG,HOWEVER,KOREA,KWG,NH2,RB1,SCC,SWISS,THESE,TREATMENT,WESTERN
017,088,160,493,931,BACKGROUND,LABEL,METHODS,PATTERN,RESULTS
008,011,022,029,110,169,954,AKT,CONCLUSION,ECTOPIC,EXPRESSION,FINALLY,HCC,LABEL,MEIER,METHODS,MYD88,OBJECTIVE,PURPOSE,RESULTS,RFS,TLR,UNIVARIATE
126,130,ERK,FURTHER,HGF,MET,NSCLC,THROUGH,VARIOUS
ANY,BETWEEN,CONCLUSION,EARLY,FDG,III,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS
956,RHO,ROCK1,ROCK2,SER,THEREFORE,THR
169,CARDIAC,CISPLATIN,COPYRIGHT
169,AKT,ARSENIC,ATO,BRCA1,COMPARABLE,DSB,EGF,FINALLY,HOWEVER,MEK,RAD50,RAD51,SUBSEQUENT
018,021,024,035,038,041,045,1208T,169,174,209,506,785,CAUCASIAN,CHI,COPYRIGHT,DFS,ENDOSTATIN,GENOMIC,GENOTYPING,INS,IRELAND,IVS,LTD,MEIER,NSCLC,PAR,PCR
EPIRUBICIN,FE3O4,MAGNETITE,PVP,TEM,TGA,VIS
001,140,AFTER,CONCLUSION,FVC,LABEL,MATERIALS,METHODS,OBJECTIVE,PREDICTED,PURPOSE,RESULTS,SPECT,SUM
SINCE
001,158,ASSESSMENT,BRIEF,CAREGIVER,CAREGIVING,CONCLUSION,COUPLES,HOWEVER,INVENTORY,LABEL,METHODS,MULTILEVEL,OBJECTIVE,PURPOSE,RESULTS,SYMPTOM,TARGETS,WHILE
160,945,946,ANG,DX600,EMT,EPITHELIAL,FINALLY,FURTHER,RAS,SMA,TGF
945,CYTOHESIN,DFS,HCC,HEPG2,IGF,INHIBITION,PCR,SECINH3,TKI,TNM,VEGFR
100,130,149,169,200,318,845,930,AUC,CA031,CONCLUSION,COPYRIGHT,III,IRELAND,JAPAN,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,ORR,PURPOSE,RESULTS
131,200,239,250,500,AFTER,BACKGROUND,DUE,EIGHT,HOWEVER,LABEL,METHODS,PAPILLARY,PATIENT,PTC,SORAFENIB,TREATMENT
AFTER,HODGKIN,HOWEVER,PET
264,ERK,HOWEVER,OVERALL,RAW,ROS
160,BACKGROUND,BCC,BLOOD,BOARD,FORTY,JANUARY,LABEL,METHODS,RESULTS,SEPTEMBER,SEVENTY,STATE,UNIVERSITY
AKT,ALK,HGF,MET,RAS,RTK,STAT3
ADDITIONAL,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE
001,034,049,164,16HBE,176,329,AMONG,COE,CPG,FURTHER,PAH,PCR,THESE
026,047,954,CONCLUSION,FLT,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIXTY,SUV,THREE
500,OVERALL
001,169,584,ASSESSMENT,BASED,BLOOD,COPYRIGHT,FEWER,FUNCTIONAL,HAP,HGS,HOWEVER,INC,INSTITUTES,LEE,MOS,PROFILE,PUBLISHED,SCALE,SHORT,SOCIETY,SYMPTOM,THERAPY,USING
104,SOCIETY
EPB41L3,FINALLY,III,PCR,RAS,TAKEN
AFTERWARDS,DOTATOC,MRI,PET,THREE
169,BACKGROUND,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR,THESE,VTE
169,205,215,412,420,COLLEGE,COPYRIGHT,FLEISCHNER,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY
LTD,PUBLISHED,SINCE
000,100,169,BECAUSE,COPYRIGHT,CRS,LTD,OVERALL
104,137,169,177,1ST,COLLEGE,COPYRIGHT,GENERAL,IRELAND,JANUARY,KBP,LTD,PHYSICIANS,THESE
169,177,COPYRIGHT,FIFTEEN,LTD,PAH,PNEUMOLOGY,ROMANIA,SIMILARLY
100,169,BRONCHIAL,COPYRIGHT,HDREB,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SEVENTY,SOCIETY,THERE
100,120,169,COPYRIGHT,GRADE,III,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS
002,049,101,169,215,335,BACKGROUND,CD163,CD66B,COPYRIGHT,CRP,ENDPOINTS,FURTHER,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,RFS,WBC
169,262,ASSESSMENT,BACKGROUND,COPYRIGHT,EFQ,EFS,FUNCTIONAL,HRQOL,INDEX,IPASS,IRELAND,ITT,LABEL,LCS,LTD,METHODS,NSCLC,OBJECTIVE,ORR,OUTCOME,PFS,RESULTS,THERAPY,THERE,TOI,TRIAL
007,021,027,057,169,177,890,BACKGROUND,COPYRIGHT,FEV,FORTY,HEART,INC,LABEL,MAY,METHODS,MORBIDITY,MORTALITY,OPERATIVE,OVERALL,PORTSMOUTH,PUBLISHED,RESULTS,SCORE,SOCIETY
038,263,704,ACTUARIAL,ASSESSMENT,BETWEEN,CLASS,GAMMA,GKS,KNIFE,LABEL,METHODS,MRI,NSCLC,OBJECTIVE,OVERALL,PROGNOSTIC,RECURSIVE,RESULTS,RPA
CONVERSELY,HOWEVER,KNOCKDOWN,MICRORNAS,MMR,NSCLC
000,ADVERSE,BACKGROUND,CONCLUSION,DLT,LABEL,METHODS,MTD,RESULTS
BLAND,FIFTY,LABEL,LOBAR,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
001,353,LABEL,METHODS,NSCLC,PFS,RESULTS,TESTS,UNASSIGNED
C16,C17,C18,EXIGUOLIDE,LEWIS,NCI
169,AIMP2,COPYRIGHT,DX2,HOWEVER,MOLECULAR,PCR
100,136,169,177,1MM,956,AGNO3,COPYRIGHT,FOURIER,OREGANO,SEM,XRD
169,COPYRIGHT,HDACI
100,169,AKT,NATURAL,PI3,PRODUCT,RESULTS,SIXTY,TAKEN
137,169,ELEVATION,ELISA,MET,NEITHER,NSCLC,OA5D5V2
101,169,AXL,EGF,MET,PREVIOUSLY,TAKEN
169,239,EXPRESSION,FGFR1,NSCLC,PC9,THESE,TKI
169,BLADDER,CONVERSELY,CRITICALLY,GSN,TAKEN,THESE
169,ALK,BACKGROUND,CBS,CONCORDANT,COPYRIGHT,CRIZOTINIB,LABEL,METHODS,RESULTS,REVERSE,SOCIETY,STAINED
120,154,191,386,455,765,AMONG,MAY,NSCLC
001,002,M30,M65,NSCLC,PFS,SERUM,SEVERAL,STAGE
001,260,ABOUT,HOWEVER,III,NSCLC,THEIR
AMPULLA,III,REPETITIVE,VATER
169,BACKGROUND,CHANGES,COLORECTAL,COPYRIGHT,CRS,ITALIAN,ITALY,JOINPOINT,JOINPOINTS,LABEL,LTD,METHODS,PERCENT,PROGRAM,REGISTRIES,REGRESSION,RESULTS
001,169,177,AAA,AIR,BESIDES,CARLO,COPYRIGHT,ECLIPSE,INC,MAPES,MEDICAL,MGS,MONTE,PUBLISHED,XIO
CONFIRMED,KIF5B,RET
ALK,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS
946,AKT,ERK,GTP,JNK,JUN,MAPK9,MEK,RAS,STAT1,STAT3,THEIR,THERE,THESE,WNT
004,169,CGI,COBRA,COPYRIGHT,H293T,HCC,HEPG2,INC,MASSARRAY,PTPRO,TAKEN,TREATMENT,TYROSYL,VCP,WILEY
001,014,031,035,037,058,1236C,150,160,2677G,3435C,420,6986A,ABCB1,ABCG2,BACKGROUND,CSF,EARLY,ERLOTINIB,ILD,LABEL,METHODS,NSCLC,OSI,POPULATION,RESULTS
001,003,AUC,CEA,CONVERSELY,CYFRA,LOW,MPM,PES,RESULTS,ROC
123,169,956,BACKGROUND,CHRYSOTILE,CONCLUSION,INC,LABEL,METHODS,RESULTS,WILEY,WORLD
019,020,021,160,747,891,HOWEVER,NUTRITION,OCM,SEM,SEVERAL
169,962,AMONG,BACKGROUND,COPYRIGHT,HOWEVER,INC,KAOHSIUNG,LABEL,METHODS,RESULTS,SMR,THOSE,UNION,WILEY,WORKERS
10001,333,HOWEVER,MEANINGFUL,MECHANISMS,MEDICAL,PUBLISHERS,SEVENTH,USA
MRI,NASAL
AFTER,MULTIPLEX,SDS,SMARTPHONE
023,054,058,280,ALTOGETHER,ANOTHER,SOCIETY
038,100,BEV,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRE,THEREFORE,TTP,VEGFR
000002452,500,APRIL,BACKGROUND,CTR,FURTHER,GRADE,III,JANUARY,LABEL,METHODS,NON,NSCLC,PARTIAL,RESULTS,SEVENTEEN
002,004,009,028,039,074,283,ATS,ERS,IASLC,LABEL,LEPIDIC,METHODS,OBJECTIVE,OLDER,PL2,RESULTS,SOCIETY,THEIR
711,AMONG,GISTS,SDH,THERE,THREE
8G7G3,CSA,SPT24,TTF
FDG,MRI,PET
150,SPECT
017,14M,177,18F,CONCLUSION,DIFFERENCE,DISEASE,FDG,GBQ,HCC,LABEL,MAY,MEIER,METHODS,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,THERE,WHILE
FDG,MPT,NSCLC,PET
FDG,PET
549,NSCLC,OVERALL,PLK,REGARDING
130,270,ASO,BACKGROUND,DCS,DOX,LABEL,METHODS,RESULTS
139,AMONG,CXCLS,DECREASED,FURTHER,HIF1A,IL6,IMPDH,ORIGINALLY,PAI,U87,USING
ADC,ANNEXIN,CONCLUSION,COX,LABEL,LSC,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
160,529,APRIL,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,SURGERY
HENCE,NEAT2
026,053,177,967,979,ACCORDING,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OPERATIVE,RESULTS,THERE,THREE
005,169,916,946,COPYRIGHT,E12,HOWEVER,INC,TEN,THESE
169,AKT,COPYRIGHT,IRELAND,LTD,PERIFOSINE,PP242,REDD1,THEREFORE
169,AKT,COPYRIGHT,CYR61
18F,18FDG,415,430,AUC,BACKGROUND,CBM,CHINESE,CONCLUSION,DOR,FDG,LABEL,LIBRARY,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SCIENCE,SUMMARY,VIP,WANFANG,WEB
001,114,245,267,506,733,960,994,BACKGROUND,CNB,CONCLUSION,DIAGNOSTIC,FNA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
017,576,AUC,BACKGROUND,CONCLUSION,CXR,DIGITAL,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,THREE
169,COPYRIGHT,HOWEVER,LTD,SWISS,THEREFORE
COMMISSION,FINALLY,PES,PROTECTION,THESE
169,AUSTRALIA,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RRS
111,169,ANZ,AUTHORS,BACKGROUND,COLLEGE,DISCUSSION,JOURNAL,LABEL,METHODS,RESULTS,ROYAL,SURGERY,THERE
169,AFM,AFTER,INC,PCR,WESTERN,WILEY
004,009,052,076,089,169,318,322,612,988,BACKGROUND,COPYRIGHT,III,KIRSTEN,LABEL,METHODS,RESULTS,RFS,SOCIETY,THERE
153,169,AFP,CONCLUSION,FINALLY,H19,HCC,HEPG2,LABEL,LIVER,NAD,SIRT6,SIRTUIN,UNLABELLED
001,950,BECAUSE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS
BLM,FINALLY,IPF,NOTABLY,THESE
124,AMP,AS2,CISPLATIN,HOWEVER,JSI,METFORMIN,PC14PE6,ROS,S3C,STAT3
HOWEVER,MIF,PRDX1,THESE
100,CHEST
047,089,123,145,168,256,360,659,663,675,857,862,877,896,956,AFRICAN,CAUCASIANS,CHINA,CIS,ELECTRONIC,HOWEVER,KNOWLEDGE,ORS,REFERENCES,SINOMED,XRCC3
160,ABOUT,CULTURALLY,FURTHER,SIXTY,THREE
294,376,571,CONCLUSION,FORTY,HODGKIN,LABEL,MAY,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,ROYAL,THERE
EMERGENCY,NSCLC,SUBSEQUENT
100,160,197,BACKGROUND,CHART,CONCLUSION,ELECTRONIC,EPC,IVATR,JANUARY,LABEL,METHODS,OBJECTIVE,PATIENT,RADIOLOGY,RESULTS,TATTOOING,TECHNICAL
001,00375,239,LABEL,LRP,MALIGNANT,METHODS,OBJECTIVE,OVARIAN,PURPOSE,RESULTS
001,010,021,040,118,BACKGROUND,DFS,LABEL,METHODS,PFS,RESULTS,TKI,TTF
AMONG,BPF,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OWT,PURPOSE,RESULTS,SUCCESSFUL
AKT,HOWEVER,IMMUNOBLOT,MTT,NCI,NSCLC,TKI,TREATMENT
160,300,CEA,ELISA,HOWEVER,III,MALIGNANT,MPE,NSCLC,PLEURAL,THERAPY,THERE
130,215,BACKGROUND,LABEL,METHODS,RADICAL,RESULTS,SURGERY,TOXIC
945,947,BRCA1,EB1,HOWEVER,PTX,TAKEN
480,ALGORITHMS,BACKGROUND,CRC,GENERIC,ICD,INCLUSION,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
169,COPYRIGHT,EP4,INC
105,160,169,748,AUC,BACKGROUND,COPYRIGHT,HOWEVER,INCREASED,LABEL,METHODS,MPE,NSCLC,RESULTS,SAMPLES
001,003,004,015,037,105,169,COMBINING,COPYRIGHT,ERCC1,INCREASED,IRELAND,LOW,LTD,PFS,PROTEIN
001,169,286,320,7TH,880,CONTROL,COPYRIGHT,FURTHER,HOWEVER,IRELAND,JANUARY,LTD,MARCH,THERE,TNM,UNION
044,160,169,278,332,ASSESSMENT,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,CST,FUNCTIONAL,GENERAL,HRQOL,III,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,QUALITY,RESULTS,STAGE,SURVIVING,THERAPY,THERE
169,CALYPSO,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNDER
001,002,169,960,COPYRIGHT,GIVEN,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PTV,PURPOSE,R50,RESULTS,USING,V10,V20
169,AFTER,COPYRIGHT,CTV,CUMULATIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TCP
100,169,ALK,ANAPLASTIC,COPYRIGHT,DETECTION,HOWEVER,ICC,IHC,IRELAND,LABEL,LTD,RESULTS,THEREFORE,UNIVERSITY,UNLABELLED
169,434,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,COX,HOWEVER,III,INC,LABEL,METHODS,NSCLC,RESULTS,SEVEN,THREE,VDR
169,CLINICIANS,COPYRIGHT,INC,INSTITUTE,LANGONE,MANAGEMENT,MEDICAL,NURSING,PUBLISHED,SOCIETY,UNIVERSITY
169,AMPLATZER,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,THEREAFTER,ZEALAND
127,128,169,AES,BACKGROUND,CONCLUSION,COPYRIGHT,EIGHT,IRELAND,LABEL,LTD,METHODS,RESULTS,SAGOPILONE,TREATMENT,WORLD
169,AFTER,COPYRIGHT,GENERALLY,IRELAND,LTD,MPM,NEC
169,177,COPYRIGHT,INC,NON,THERE,THEREFORE,THESE,VASOHIBIN
169,ASIAN,AUTHORS,BACKGROUND,ENB,FACTORS,HOWEVER,LABEL,LESIONS,METHODS,OBJECTIVE,PACIFIC,PERIPHERAL,RESULTS,SIXTY,SOCIETY,TECHNICAL
206,BETWEEN,CLASS,CONTINUOUS,HOWEVER,IOM,LABEL,MEP,METHODS,MOTOR,OBJECTIVE,REDUCTION,RESECTION,RESULTS,SINCE
169,183,BACKGROUND,BCC,BRITISH,HOWEVER,LABEL,MEIER,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,PFS,PRIOR,RESULTS,TEN,UNIVERSITY,USING
114,133,169,ASIAN,AUTHORS,BACKGROUND,FURTHER,LABEL,LACERATION,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,THESE
169,AFTER,ASIAN,AUTHORS,BACKGROUND,CAO,DEBAKEY,HOUSTON,LABEL,LESIONS,MALIGNANT,MEDICAL,METHODS,MICHAEL,OBJECTIVE,PACIFIC,PRE,RESULTS,SOCIETY
001,162,397,700,DISEASE,NSCLC,PROGNOSTIC,RECURRENCE,THERE,USD32
177,CURRENT,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
AFTER,APRIL,BACKGROUND,CONCLUSION,CPP,CVP,DOPPLER,H2O,ICP,LABEL,MAP,METHODS,PACO2,PARTIAL,RESULTS,RRS
232,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMOKING,UNIVARIATE
18F,AFTER,FINAL,GGO
BAC,L861Q,LCNEC
DFI,SECONDARY,SSP

169,18F,18FDG,429,BACKGROUND,COPYRIGHT,CURRENT,HOWEVER,III,IRELAND,JANUARY,LABEL,LTD,METHODS,MRI,NSCLC,PET,RESULTS,SEPTEMBER,STAGE,THREE
111,BOARD,CONCLUSION,DOSIMETRY,DOTANOC,DOTATOC,LABEL,METHODS,ORGAN,PET,REPORTING,RESULTS,THERE,UNLABELLED
100,118,160,180,224,287,372,441,876,AES,CENTRAL,CONTROLLED,DCR,HOWEVER,MEDLINE,NSCLC,ORR,RANDOMIZED
NOS,PECOMAS,THESE,TREATMENT
006,169,906,956,AKT,ERK,IGF,INSULIN,NCI,OSI,TAKEN
174,177,EYE,HAMAMATSU,ICG,IMF,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHOTONICS,RESULTS
114,160,169,175,177,BACKGROUND,COPYRIGHT,FOCAL,FORTY,GGO,LABEL,LARGE,LTD,METHODS,RESECTION,RESULTS
041,392,BACKGROUND,CHINESE,LABEL,LOWER,METHODS,NSCLC,PCR,RESULTS,THERE
33342,ABCG2,AMONG,BAX,BCL,CD133,FINALLY,HOECHST,HOWEVER,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,WESTERN
001,102,884,967,CONCLUSION,HIPAA,ILA,IMAGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCREENING,TRIAL
169,901,COPYRIGHT,DESPITE,INC,MAY,MEDLINE,REPORTING,REVIEWS,STUDIES,SYSTEMATIC,THREE,WILEY
130,169,236,446,495,598,AMONG,BMI,CLEAR,COLORECTAL,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBESITY,OBJECTIVE,OVARIAN,RESULTS,SCREENING,SOCIETY,TRIAL
175,800,AUC,FORTY,III,NSCLC,ORR,PFS,PRIMARY,SECONDARY
105,EXPRESSION,NSCLC,RHO,TAKEN
954,AEG,ALTOGETHER,EMT,FIRST,FURTHER,THESE,URSOLIC
ABDOMINAL,EPITHELIAL,FDG,PET
PET
131,DTC,FALSE,SPECT
CHEST,EPSTEIN,FDG,PET
006,107,10877,112,127,132,169,239,AHF,BACKGROUND,COPYRIGHT,CRUDE,CTX,III,LABEL,LDH,LTD,METHODS,NSCLC,RADIATION,RESULTS,RTX,THERE
100,160,169,177,AGE,BLOOD,COLLEGE,COPYRIGHT,CPB,EDINBURGH,FUHRMAN,IRELAND,IVC,LABEL,LAPAROTOMY,LTD,METHODS,OVERALL,PUBLISHED,RADICAL,RCC,RENAL,RESULTS,ROYAL,SAVER,THERE,UNLABELLED
169,COPYRIGHT,DISTANT,INC,PRIMARY
169,AIM,COPYRIGHT,ITALIAN,ITALY,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,RESULTS,ROMAGNA,STAGE,THREE
169,5MG,ADVERSE,BELOTECAN,COPYRIGHT,CTCAE,EVALUATION,FEBRILE,INSTITUTE,IRELAND,LTD,NCI,SOLID,TREATMENT
012,169,663,755,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,SUBSEQUENT
013,106,108,378,390,700,967,ATTENDING,CONCLUSION,EOV,LABEL,METHODS,OBJECTIVE,PCS,RESULTS,SETTING,THERE
169,948,C1R,C1S,CDCP1,CUB,EXPRESSION,FYN,HOWEVER,INHIBITION,LC3,PKC,PP2,SRC,THESE
APC,CDC20,HOWEVER
104,BASED,DISEASE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTY
001,CONCLUSION,COX,KINGDOM,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OVERALL,PATIENT,PROPENSITY,RESULTS,SEPTEMBER,SERVICE,SEX,STAGE,STRATEGIC,SUB,TRACING,UNIVARIATE
100,169,ALS,ALZHEIMER,COPYRIGHT,HUNTINGTON,INC,PARKINSON,THESE,TODAY,WILEY
AMONG,FIFTY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VO2
009,043,BACKGROUND,CONCLUSION,ENGLISH,FUNCTIONAL,HELMS,LABEL,LOW,MACCALLUM,MANAGEMENT,METHODS,PETER,RESULTS,SCALE,SHORTENED,SUBOPTIMAL,USING
004,028,035,160,183,215,261,AFTER,BACKGROUND,CDX,CONCLUSION,CUP,GEORG,INITIALLY,LABEL,METHODS,MRI,NEN,OPERATIVE,PRIMARY,RESULTS,STUTTGART,THREE,TTF
169,AUC,COPYRIGHT,EVALUATION,FIRST,LTD,MCCLISH,OPERATING,ROC,WILEY
BASED,C20,GYNOSTEMMA,MTT,NMR,ODS
026,960,ADDITIONAL,FIFTY,GST,LRP,MDR,MULTIDRUG,STUDIES
232,400,500,CONCLUSION,CTS,HISTOLOGY,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,SCREENING,SHORT,SIXTY,VDT
300,ALONG,BENCHMARK,LABORATORY,LUCAS,THESE
034,160,169,BACKGROUND,CAMBRIDGE,COPYRIGHT,EBC,LABEL,LTD,METHODS,NON,NSCLC,PCR,REFERENCE,RESULTS,T16217C
169,827,945,COPYRIGHT,EGFRS,ERBB2,GEFITINIB,HCC,HGF,INSTEAD,IRELAND,LTD,MET,THESE
169,365,COPYRIGHT,ECTOPIC,IRELAND,LTD,MICRORNAS
169,BECAUSE,COPYRIGHT,DESPITE,FDA,HENCE,HOWEVER,SAS
169,275,831,AFRICAN,AMONG,ANY,CHI,COLON,COPYRIGHT,CORPORATE,COX,HEALTHCARE,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OVARIAN,PSA,REGULAR,RESULTS,SCREENING,SEPTEMBER,TRIAL,VHA,WAREHOUSE
105,169,ADVERSE,AUSTRALIA,AUTHORS,BACKGROUND,COLLEGE,EIGHT,JANUARY,JOURNAL,LABEL,METHODS,NSCLC,OBJECTIVE,PHYSICIANS,RESULTS,ROYAL,THREE
002,100,169,250,ALK,BACKGROUND,COPYRIGHT,CRIZOTINIB,FORTY,LABEL,MET,METHODS,NSCLC,PROFILE,RESULTS,SINUS,SOCIETY,THERE
18F,262,554,AMONG,FDG,HOWEVER,IIA,LABEL,METHODS,OBJECTIVE,PET,RESULTS,T1AN0M0
AMONG,GRADE,LEVEL,PRONE,SINCE,SIXTEEN,STAGE,THERE
020,041,104,216,946,III,LOH,MSI,NSCLC,RAR,SCC,TNM,YEARS
CD146,CELLSEARCH,CSF,CSFMC,CTC,EPCAM,HMW,MAA,MRI,TUBES,VERIDEX
981,LABEL,METHODS,NYC,OBJECTIVE,PURPOSE,RESULTS,SES,STAGE,STATE,THERE
160,APC,ASIAN,BACKGROUND,INSTITUTE,JOINPOINT,LABEL,METHODS,PACIFIC,REGRESSION,REPORTS,RESULTS
007,177,353,715,967,APART,CHINESE,CONCLUSION,FATIGUE,INVENTORY,LABEL,METHODS,MFI,OBJECTIVE,PURPOSE,RESULTS,SCALE
BECAUSE
1ST,AIM,BACKGROUND,DYING,LABEL,MAY,METHODS,OBJECTIVE,PALLIATIVE,RESULTS,THEIR,THERE
169,177,956,COPYRIGHT,DSC,GMS,NOSCAPINE,PHASE,SSGMS
169,223,945,954,ADIPOR1,ADIPOR2,ADIPORS,AKT,COPYRIGHT,FINALLY,FURTHER,LTD,MCP,TAKEN,TNF
169,AKT,ATP,BACKGROUND,COPYRIGHT,GENERAL,HOWEVER,LABEL,METHODS,NSCLC,PRIOR,RESULTS,ROS,SRC
169,954,COPYRIGHT,IRELAND,LTD,MINNELIDE,NOTABLY,TRIPTOLIDE
169,BIOLOGY,COPYRIGHT,HEPARANASE,NOTABLY,PUBLISHED,SOCIETY
169,ALK,COEXISTING,COPYRIGHT,CROWN,IRELAND,LTD,PUBLISHED
001,009,100ML,122,123,298,BACKGROUND,CERTAIN,COX,HOWEVER,IQR,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RENAL,RESULTS
000,169,BACKGROUND,CNS,COLORECTAL,COPYRIGHT,LABEL,LTD,METHODS,OVERALL,RATES,RESULTS,THERE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PATHOLOGIC,RESULTS
169,241,454,COPYRIGHT,EARLY,PET
169,954,AKT,COPYRIGHT,DECREASED,IGFBP,IRELAND,LTD,NNK,THESE
BCL,PACLITAXEL,STMN1,TAX,THESE
169,ALK,BACKGROUND,COPYRIGHT,EVALUATION,KIRSTEN,LABEL,METHODS,MOLECULAR,REPEATING,RESULTS,SOCIETY,T790M,THREE
152,169,190,BACKGROUND,COMMUNITY,COPYRIGHT,ESS,ESTIMATES,HOWEVER,INVENTORY,LABEL,LTD,METHODS,REPORTS,RESULTS,WILEY
001,021,029,MVD,NSCLC,PECAM
ACP,AUSTRALIAN,CONCLUSION,GIVEN,LABEL,METHODS,OBJECTIVE,PURPOSE,REACTIONS,RESPONSES,RESULTS
008,160,BACKGROUND,FOXP3,IHC,LABEL,METHODS,REGULATORY,RESULTS,THESE,TREGS
143,161,349,GEP,MEIER,NEN,THEREFORE,TNM
137,ANNEXIN,COX,MEIER,MULTI,NSCLC
CRC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,VII
2D6,ALK,CURRENT,LIBRARY,LITERATURE,MEDICAL,NETWORK,SEVEN,SOCIETY,V600E
100,169,CONSISTENT,EGF,H1975,HSP90,IC100,NSCLC,NVP,THESE,XENOGRAFT
169,DAC,DACH1,DACHSHUND,DROSOPHILA,EGF,ENDOGENOUS,EXPRESSION,GIVEN,NSCLC
098,169,754,ATTENDANT,BACKGROUND,CAC,CARDIOLOGY,COLLEGE,COPYRIGHT,EARLY,FAMRI,FOUNDATION,INC,INSTITUTE,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PROGRAM,PUBLISHED,RESULTS
120,169,645,ADDITIONAL,APOA1,BACKGROUND,C4A,C4B,CONCLUSION,COPYRIGHT,HOWEVER,ILD,INC,LABEL,LOOCV,METHODS,NSCLC,RESULTS,SERUM
169,973,BACKGROUND,CONCLUSION,COPYRIGHT,EVALUATION,ICU,INTENSIVE,IQR,JANUARY,LABEL,LTD,MECHANICAL,METHODS,OBJECTIVE,RESULTS
169,467,610,BACKGROUND,CONCLUSION,COX,FIFTY,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,WILEY
000,169,400,ALK,CONSORTIUM,COPYRIGHT,CROWN,FGFR1,IRELAND,LTD,NSCLC,PUBLISHED,SUCCESSFUL,THESE
169,COPYRIGHT,IRELAND,LTD,UNDER
150,169,250,AFTER,BASED,CLINICIANS,COPYRIGHT,III,INVADER,IRELAND,LTD,PCR
154,169,2004WHO,474,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,RESULTS,TKI,TREATMENT
240,360,720,AMONG,BACKGROUND,BECAUSE,EVALUATION,FURTHER,LABEL,METHODS,PTC,RAF,RESULTS,SOLID,V600E
169,552,770,AIM,AMONG,BACKGROUND,CRC,CROHN,FOUNDATION,HEPATOLOGY,HOWEVER,JAPAN,JOURNAL,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,SIR,THERE,WILEY

AIM,BACKGROUND,CONCLUSION,DESPITE,FIFTY,FRAMEWORK,INTERVIEWS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
100,916,ADS,ADSQC,LCC,MEM,PLC,SCLCS,SGTTS,SQC,THERE
024,065,CARCINOIDS,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
99MTC,MDP,SPECT,THERE
139,178,615,AA861,ATP,CASPASE,CHELATION,CYSLT,ETH,INHIBITION,JANUS,NADPH,ROS,VSOAC
096,169,176,177,197,215,945,946,956,AGAIN,BINDING,COPYRIGHT,SAS
169,APOPTOSIS,BAX,BCL,COPYRIGHT,GRP78,GRP94,H71,HSP90,PROTEIN,TAKEN,UPR
169,COPYRIGHT,HOWEVER,IRELAND,L858R,LTD,NSCLC,RESISTANCE,T790M,THERAPY,TKI
077,199,418,ALZHEIMER,APC,BESIDES,CONCLUSION,DECREASES,END,INCIDENCE,LABEL,METHODS,NLTCS,OBJECTIVE,OBJECTIVES,PARKINSON,RESULTS,USA
169,4MM,CAD,CONCLUSION,COPYRIGHT,FIFTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,READING,RESULTS
HOWEVER,LINAC,MLC,MUS
214,AKT,HOWEVER,LTF,NPC
015,157,161,BACKGROUND,CD133,CONCLUSION,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,THESE,UNIVERSITY
153,188,634,822,AMONG,BACKGROUND,CONCLUSION,CXR,JANUARY,LABEL,METHODS,RESULTS,UNILATERAL
007,127,139,334,AMONG
001,105,223,244,477,BACKGROUND,BIOMARKER,CHINA,III,LABEL,METHODS,NSCLC,RESULTS,STUDIES,THERE,WEB
120,123,169,225,243,500,AMIFOSTINE,AUC,BACKGROUND,BID,CONCLUSION,COPYRIGHT,IRELAND,KPS,LABEL,LTD,METHODS,OVERALL,RESULTS,THERE
100,103,105,125,160,169,200,COPYRIGHT,D90,GROUP,IMPLANT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSI,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,STM,THERAPY
002,169,2ND,3RD,AFTER,COPYRIGHT,HEPATOCYTE,HGF,IHC,III,MET,NSCLC,PFS,SAS,SSP,TKI
109,169,177,CONCLUSION,COPYRIGHT,CTG,DIAGNOSES,DM1,LABEL,METHODS,OBJECTIVE,RESULTS,SANITAIRE,SAS,WHILE
001,005,137,169,383,481,618,COPYRIGHT,INC,LABEL,LOBECTOMY,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RECURRENCE,RESULTS,RFS,SURGERY
169,263,963,ABT,BCL,BH3,BIM,CELLS,ERK,GDC,H2122,MAP,MEK,TAKEN
169,CAF,DIPEPTIDES,NFS
169,4EBP1,945,AKT,ASPC1,BELINOSTAT,BXPC3,HDACI,HISTONE,INC,PANCREATIC,TAKEN,TREATMENT,WILEY
001,016,026,124,COX,MEIER,NSCLC
169,945,BOP,EARLIER,INC,MCP,MMP,PAR,THEIR,THESE,WILEY
946,967,BPL,COX,DFS,ESTROGENS,IHC,MEIER,NSCLC,NUCLEAR,PEARSON,WESTERN
CONCLUSION,FURTHER,INORGANIC,LABEL,UNLABELLED,WHETHER
579,CRF,FORMULA,GIVEN,RADIATION
DEFORMABLE,FIRST,HOWEVER,MRF
106,109,183,239,500,AMONG,BACKGROUND,LABEL,METHODS,NSCLC,PEMETREXED,PFS,PRE,RESULTS,SIXTY
BECAUSE,HOWEVER
486,ARHGAP5,LUCIFERASE,NSCLC,PCR,REDUCED
ABCB1,ABCG2,ALA,FUNCTIONAL,HOECHST,HOWEVER,MMP,PCR
182,4T1,ECTOPIC,HENCE,MCF10,METASTASIS,MIM,MISSING,RESTORING
169,COPYRIGHT,IRELAND,LTD,MMP,ROS
169,ATUPLEXES,BT474,CDC,COPYRIGHT,FEDERATION,KNOCKDOWN,PERTUZUMAB,PUBLISHED,SKOV3,SOCIETIES
169,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,IRELAND,LABEL,LTD,MATERIALS,METHODS
HOWEVER,IRELAND,LTD,NSCLC,PUBLISHED,TIRON,WHILE
093,118,155,169,250,331,500,544,569,580,620,AUC,BOOTSTRAP,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,143,148,169,291,AFTER,AWARENESS,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
001,030,035,103,160,162,169,191,AUR,CONCLUSION,COPYRIGHT,HOUNSFIELD,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,RATIONALE,RESULTS
169,COLLEGE,COPYRIGHT,LTD,PUBLISHED,ROYAL,THESE
169,195,29B,818,COPYRIGHT,FAM,UNIFORM,VCH,WILEY
HAMDOUN,HOWEVER,MTT,RESULTS,TUNISIA
001,168,201,CENTRAL,CHINA,GENOMIC,HAN,HUNAN,PCR,SOUTH,THESE
121,COX,MEIER,NSCLC,PCR,RUNX2,WESTERN
014,704,AFTER,AOR,AUG,CHINESE,CONCLUSION,CSF,ELDERLY,IQR,JAN,LABEL,METHODS,OBJECTIVE,RESULTS,VARIABLES
BASED,LTQ,MALDI,TOF,VELOS
160,177,4T1,800CW,BLI,CD105,IRDYE,PET,SUCCESSFUL
BACKGROUND,EARLY,LABEL,METHODS,RESULTS,STENT,TEN,TRIAL,URL
003,013,107,BACKGROUND,CONCLUSION,LABEL,METHODS,RESTENOSIS,RESULTS,SEPTEMBER,SEVENTY
BACKGROUND,CAM,CONCLUSION,COUNSELING,EDUCATION,FINANCIAL,KOREA,LABEL,METHODS,NEEDS,RESULTS,SUPPORTIVE,THERE,UNMET
002,004,149,499,BACKGROUND,DFS,LABEL,METHODS,MICRORNAS,NSCLC,RESULTS,THESE,THREE
169,C57BL,FINALLY,RAC,WILEY
003,153,177,ASIAN,ATS,CONCLUSION,ERS,GGO,HISTOLOGIC,IASLC,IASLE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STUDENT
029,100,179,208,253,272,905,CONCLUSION,IPA,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,ROC,THERE
001,002,023,100,207,212,223,240,245,246,274,280,967,CONCLUSION,FDG,FLT,LABEL,MARCH,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE
169,945,ADENOVIRUS,DESPITE,EMT,FINALLY,SMA
ADDITIONAL,BACKGROUND,CONCLUSION,DENOSUMAB,LABEL,METHODS,RESULTS,USA
FUTHERMORE,THEREFORE
001,006,046,169,BACKGROUND,COMPANY,CONCLUSION,COPYRIGHT,DFI,INC,LABEL,METHODS,PULMONARY,RESULTS,WILEY
000,192,558,BMJ,CIGARETTE,GREEK,GROUP,LABEL,LIMITED,METHODS,NATIONS,OBJECTIVE,OBJECTIVES,PROJECTED,PUBLISHED,PUBLISHING,RESULTS
100,342,OWING,THERE
043,3DCRT,CGE,D95,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN,THERE,V20
169,COPYRIGHT,F68
169,COPYRIGHT,INC,MOSBY,PUBLISHED,SOCIETY,SURGERY
001,017,169,177,5MM,7CM,9CM,CENTRAL,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PULMONARY,PURPOSE,RESULTS
008,047,132,160,169,181,735,BACKGROUND,COPYRIGHT,DECREASES,INC,LABEL,MATERIALS,METHODS,MMP,RESULTS
169,AUR,CONVERSELY,COPYRIGHT,ENGLISH,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PPV,PUBLISHED,RATIONALE,RESULTS
169,294,CLINICALLY,COPYRIGHT,IGG,INC,NSCLC,TMA
169,COPYRIGHT,INC
100,169,BASED,COPYRIGHT,IHC,INC,L858R
160,169,LTD,MODEL,PUBLISHED,RADON,SWISS,WILEY
169,556,804,BACKGROUND,CONCLUSION,FOUNDATION,FOV,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIMILARLY
038,052,169,BACKGROUND,CONCLUSION,FOUNDATION,JANUARY,KLEBSIELLA,LABEL,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR,UNIVARIATE,UNTIL
103,133,177,ASSESSMENT,BLOOD,CONCLUSION,LABEL,LPS,METHODS,MNA,NSCLC,OBJECTIVE,PFS,RESULTS,TOTALLY
177,BLOOD,CONCLUSION,DECREASED,ELISA,IL6,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,THERE,TSP
169,954,COPYRIGHT,ECS,HEALTHY,LEWIS,STAT3,THESE
001,102,131,CONCLUSION,DTC,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SERUM
002,023,118,132,150,152,160,198,439,478,BACKGROUND,LABEL,MEIER,METHODS,PATIENT,RESULTS,THERE
160
513,825,CAUCASIAN,CAUCASIANS,CHINA,CHINESE,CIS,FUNCTIONAL,FURTHER,HOWEVER,KNOWLEDGE,LAIRD,ORS,SUMMARY,THESE,THREE
001,145,155,847,HOWEVER,PCR,THERE,USING,VALIDATION
FPC,NORTH,REGISTRIES,SPC
169,963,CARLO,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RBE,RESULTS,SMALLER,TEN,USING,V20
169,177,COPYRIGHT,DEFORMABLE,DIR,DSC,END,INC,INSIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIAN,PURPOSE,RESULTS,SICLE,TOOLKIT
169,AE3,CAM,CKAE1,COPYRIGHT,HOWEVER,INC,NASAL,TCS
15Q24,GESAT,HARVARD,SNP
005,APRIL,BACKGROUND,CURRENT,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,RCT,RESULTS,RPA,THERE,THEREFORE
109,169,AIM,CONCLUSION,DIAGNOSTIC,GERIATRICS,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,THERE,UNIVERSITY
ANTIGEN,AP20178,APC,BACKGROUND,CALEDONIA,CSF1R,DCS,ELISPOT,FAS,LABEL,MAFIA,METHODS,PROTECTIVE,RESULTS
033,100,252,BETWEEN,CHEST,CWR,DISEASE,LABEL,LOCAL,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESECTION,RESULTS
103,7TH,ADVERSE,AGAINST,APRIL,BACKGROUND,CONCLUSION,FORTY,GRADE,GYE,LABEL,METHODS,NSCLC,RESULTS,T2A,T2B,TOXICITIES,UNION,VERSION
5MC,BCN,BRESLOW,CMD,DCN,SEVERAL,SSM
169,33A,ASSAY,BACKGROUND,COPYRIGHT,CSF,ELISA,GENERAL,GLO,LABEL,LUCIFERASE,METHODS,MICRORNAS,OPG,PCR,PTHRP,RANKL,RESULTS,THESE
0GY,169,53BP1,947,ATM,ATP,BACKGROUND,CONCLUSION,COPYRIGHT,GENERAL,KNOCKDOWN,LABEL,METHODS,P2Y,RADIATION,RELEASE,RESULTS,SIMILARLY,TRP,TRPM2,TRPV1,UVB
100,169,AIM,BRITAIN,COLORECTAL,CONCLUSION,CRS,DENMARK,DISEASE,FAVOURABLE,GREAT,HIPEC,IRELAND,LABEL,METHODS,MORBIDITY,OBJECTIVE,RESULTS,SHORT,SIX
016,026,035,108,169,201,309,BACKGROUND,BILIARY,LABEL,MEDICAL,MEIER,METHODS,PANCREATO,RESULTS,THESE
169,COPYRIGHT,CURRENTLY,LABEL,LTD,MEASURE,METHODS,MRI,OBJECTIVE,RESULTS,WILEY
100,125,133,177,CONCLUSION,GROUP,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,THERE
105,150,164,256,ASSESSMENT,BACKGROUND,CHINESE,CONCLUSION,ERLOTINIB,FUNCTIONAL,INDEX,L858R,LABEL,LCS,METHODS,NSCLC,OPTIMAL,OUTCOME,PFS,QOL,RESULTS,THERAPY,TOI,TRIAL
001,015,016,219,557,956,HBXAP,HEPATITIS,HOWEVER,PCR,SERUM,TAKEN,TNM
FINALLY,FURTHER,JNK,MAPKS,MCL,NOTABLY,NSCLC,STRATEGIES,TRAIL
BECAUSE,CD133,SELECTIVE
945,948,HOWEVER,WORKERS
104,BACKGROUND,BRACHYURY,EXPRESSION,LABEL,METHODS,RESULTS
18F,947,AFTER,BECAUSE,FDG,HIV,IFN,MAC,NTM,PET
99M,MDP
DIAGNOSTIC,FDG,FINAL,FLT,HNSCC,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PET,RESULTS,THERE
945,946,EM09902,EM22703,INTEGRINS,LM609,RABMABS
169,229,331,COPYRIGHT,COSTS,COUNTRY,FIGURES,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OSAKIDETZA,PUBLISHED,RESULTS,SCIENTIFIC,SPAIN,SPANISH
169,946,AKT,COPYRIGHT,FINALLY,IRELAND,LTD,MYC,PROTEIN
169,945,COPYRIGHT,EBP,JUN,LC3,LC3II,LTD,NCI,NOTABLY,TAKEN,VAD
169,ADP,COPYRIGHT,COROSOLIC,CRA,LTD,NAC,ROS,THESE
105MG,169,200MG,2B6,4HS,5DAYS,COPYRIGHT,CYP2F,INC,MOA,PUBLISHED,STYRENE
169,BACKGROUND,CONCLUSION,COPYRIGHT,DENMARK,EARLY,LABEL,LTD,METHODS,RESULTS
169,COPYRIGHT,HGF,LTD,MET,ONGOING,PUBLISHED,THESE
100,116,169,177,549,916,936,945,946,956,BHT,COPYRIGHT,ESI,GENTIOSIDE,HCT,HOP,IRIDOID,LOGANIC,MIAPACA,PANCREATIC,SRB,SWEROSIDE,SWERTISIN,THP
151,169,175,221,ALK,AMONG,ASC,BACKGROUND,COPYRIGHT,FURTHER,INCREASED,IRELAND,LABEL,LCC,LTD,METHODS,NSCLC,RESULTS,SCC,WHILE
169,BBB,CNS,COPYRIGHT,HOWEVER,IRELAND,LTD,NSCLC,TKI
169,AMONG,COPYRIGHT,IRELAND,LTD
001,169,272,BASED,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SCALE,SEEMINGLY,VARIATIONS
003,102,169,199,210,454,467,CIS,COPYRIGHT,EXISTENCE,HRS,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RATES,RESULTS,SEVENTY,SIR
169,COPYRIGHT,INC,LAD,MEDICAL,PUBLISHED,TEN
169,BACKGROUND,COPYRIGHT,DEPARTMENT,EMERGENCY,INC,LABEL,METHODS,OBJECTIVE
036,049,069,169,238,287,994,AEC,AGE,BACKGROUND,COMPLETELY,COPYRIGHT,LABEL,MAXIMUM,METHODS,NSCLC,PUBLISHED,RESULTS
AREAS,BACKGROUND,COVERED,LABEL,METHODS,NSCLC,OPINION,PHASE,SEVERAL,SINCE,TKI
169,EMT,HBECS,MYC,V12
100,995,996,998,CONCLUSION,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
177,318,CONCLUSION,CWT,INFECTION,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCWIS,RESULTS,SCWIS
169,COPYRIGHT,CTC,HOWEVER,PANCREATIC,THERE
DIAGNOSIS,HOWEVER,WEDGE
174,BPF,CONCLUSION,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TACHOCOMB,UNIVARIATE
PRIMARY
15Q25,248,307,NORTH,NOVEL
119,956,AFTER,BJ46A,C57BL,ENZCHEK,GELATIN,KINETIC,LINEWEAVER,MHCC97H,MMP,STUDIES
073,100,BACKGROUND,CONCLUSION,LABEL,MEANWHILE,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFA,SONOVUE,THERE,THESE
169,274,7TH,BETWEEN,CONTROL,CRT,EMR,ENDOSCOPIC,ESOPHAGUS,HOWEVER,IIA,IIB,III,INC,JANUARY,JAPAN,LOCAL,SALVAGE,SOCIETY,UNION,WILEY
100,102,14022,169,AIM,BIOMARKER,CONCLUSION,EARLY,LABEL,LTD,METHODS,OBJECTIVE,PROTEIN,PTY,PUBLISHING,RESULTS,SAX,SELDI,SERUM,TOF,WILEY
169,273,COPYRIGHT,LASSO,LTD,WILEY
152,177,713,CONCLUSION,ICU,INDEX,LABEL,METHODS,OBJECTIVE,PITTSBURGH,QUALITY,RESULTS,SLEEP
MCF,NCI,SIDERIN,THREE
169,COPYRIGHT,IRELAND,LTD,THEREFORE,WHILE
183,18F,FDG,GEORG,INCREASED,PET,STUTTGART
CURRENTLY,SAMPLES
017,109,946,COX,LOG,MEIER,TGF,THESE
445,472,816,BACKGROUND,GAC,JAPAN,LABEL,METHODS,RESULTS,THERE,THEREFORE
025,030,BACKGROUND,DFS,GROUP,HOWEVER,LABEL,MARCH,MEIER,METHODS,OVERALL,RECURRENCE,RESECTION,RESULTS,SIMILARLY,THEREFORE
143,177,CEA,CTP,CYFRA,DISTANT,JANUARY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
001,127,140,177,340,945,982,ABO,AMONG,CALCULATED,CHRONIC,HIF,HYPOXIA,IGG,JANUARY,NIH,OCTOBER,SCT,THESE
CLINICALLY,DESPITE,HIF,METASTATIC,THEREFORE,THESE
147,169,395,782,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,PURPOSE,RECURRENCE,RESULTS,THERE,THOSE,UNIVARIATE,UROLOGICAL
169,ALK,BASCA,COPYRIGHT,HOWEVER,INC,MUTATIONS,NSCLC
CTF,THEREFORE
110,160,169,ANNEXIN,BACKGROUND,COPYRIGHT,HSP90,LABEL,LTD,METHODS,MOLECULAR,NSCLC,OBJECTIVE,PROTEIN,PTACH,RESULTS,USING
119,169,823,857,989,CONCLUSION,COPYRIGHT,EMPHYSEMA,HOUNSFIELD,IRELAND,LABEL,LTD,METHODS,MLD,OBJECTIVE,OBJECTIVES,PFT,RESULTS
169,966,BACKGROUND,CONCLUSION,COPYRIGHT,DAILY,DUE,HOWEVER,LABEL,LTD,MEDLINE,METHODS,PRE,PREMEDLINE,QOL,RESULTS
169,945,CONCLUSION,COPYRIGHT,DISTANT,INC,LABEL,LMS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE,THREE,TREATMENT
169,516,967,CONCLUSION,CONVERSELY,COPYRIGHT,FIFTY,HISTOLOGIC,INC,LABEL,LRF,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS
107,123,169,COPYRIGHT,FGFR1,FIBROBLAST,LABEL,LTD,MATERIALS,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,OTSCC,OUTCOME,RESULTS
169,401,BACKGROUND,EXTENSIVE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,RESULTS,SOCIETY
947,948,ANNATTO,UNDERLYING
946,DAE,OVERALL
002,213,AGGRESSIVE,BACKGROUND,BETWEEN,FORTY,LABEL,MATERIALS,METHODS,MST,NON,NSCLC,OCTOBER,RESULTS,SRS
014,024,177,232,452,899,ADIPOKINES,NSCLC,SERUM,THERE,THESE
100,150,956,CONCLUSION,EMBOLIZED,EVALUATION,FORTY,LABEL,LOCAL,METHODS,OBJECTIVE,PURPOSE,RCC,RESULTS,SAP,SIXTEEN,SOLID,TAE
485,887,895,AWARENESS,DISEASE,FACTORS,JANUARY,LABEL,LOWER,METHODS,OBJECTIVE,PURPOSE,RESULTS
III,NOVEL,NSCLC,STAGE
180,803,817,BACKGROUND,CIS,FOLLOWING,INCENTIVE,LABEL,METHODS,PPC,RESULTS,SOCIETY
EPIGENETIC,NET,RASSF1A
169,COPYRIGHT,INC,LABEL,UNASSIGNED,UNLABELLED
166,BETWEEN,LABEL,METHODS,MLT,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,THERE,THREE,WHILE
100,BASED,FSS,NSCLC,THESE
002,008,021,041,119,567,BETWEEN,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,THERE,THESE,UNIVARIATE
169,CURRENTLY,INC,THEREFORE,THESE,WILEY
001,003,004,136,APRIL,BACKGROUND,COMPARING,CXR,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THREE
025,527,BACKGROUND,CONCLUSION,DISTANT,LABEL,LRC,METHODS,PET,RESULTS,VIDEO
015,FIFTY,FVC,IVPCA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SUBJECTIVE
169,BRITAIN,CONVERSELY,COPYRIGHT,CRC,GREAT,HMT,HOWEVER,IRELAND,KNOCKDOWN,LTD,PUBLISHED,SOCIETY,STAT3,VDR,WILEY
001,012,013,092,138,193,CONCLUSION,COX,DCR,III,LABEL,MEIER,METHODS,OBJECTIVE,ORR,PFS,RESULTS
002,005,014,106,118,BE1,KNOCKDOWN,NSCLC,TNM
102,262,266,290,329,334,402,894,ELISA,FIXED,LABEL,METHODS,MPM,OBJECTIVE,PURPOSE,RESULTS,WHILE
AREAS,BACKGROUND,COVERED,FINALLY,FUNCTIONS,LABEL,METHODS,OPINION,RATIONALE
169,954,HMGB1,HOWEVER,LOW,TREATMENT
100,578,ASSESSMENT,CHRONIC,FORMULA,FUNCTIONAL,GROUP,HOWEVER,ILLNESS,KRUSKAL,LABEL,MEDICAL,METHODS,OBJECTIVE,ONGOING,OUTCOME,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SHORT,SPIRITUAL,SWB,THERAPY,THERE
946,CTC,CUB,DCE,EGF,EMT,HOWEVER,LOX,MICROARRAY,MMP,MRI,NSCLC
PET
160,CONCLUSION,CRT,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,006,109,247,289,300,418,882,913,BASED,DFS,RESULTS,TMPRSS4
100,169,177,24H,956,COPYRIGHT,DOX,IRELAND,LDH,LTD,PEG,PLD
169,946,CBP,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LTD,SMAD2,SMAD3,TGF,THEREFORE
001,544,935,967,CONCLUSION,DESPITE,END,FACTORS,IMAGING,LABEL,MATERIALS,METHODS,NORTH,NORTHEAST,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SOUTH,UNIVERSITY
169,CD11B,CONCLUSION,LABEL,METHODS,RESULTS,SCOPE,SINCE,STAT3,VCH,WILEY
111,123,CUP,FDG,FDOPA,NET,PET,PREVIOUSLY,SPECT,UNION
169,COPYRIGHT,HISTONE,INC
169,500,AMONG,BAC,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PEMETREXED,PFS,RESULTS,TREATMENT
169,BECAUSE,COPYRIGHT,GAUSSIA,IGM,JAPAN,PUBLISHED,SBC,SOCIETY
024,165,169,ALK,AMONG,COPYRIGHT,EXCLUDING,INC,KIRSTEN,REVERSE
169,270,287,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE,THESE
169,COPYRIGHT,ELEMENT,LTD,REPRESSOR,SILENCING
001,169,BACKGROUND,COPYRIGHT,END,INC,LABEL,MCT,METHODS,PREDICTORS,RESULTS,SURGERY
169,CATALDO,LCS,LTD,THERE,THESE,WILEY
120,197,240,360,ARQ,AUC,BACKGROUND,CONCLUSION,CYP2C19,EMS,FORTY,LABEL,MET,METHODS,NSCLC,PMS,REGARDLESS,RESULTS,TIVANTINIB
001,HOWEVER,THERE,VIDEO
177,3MM,7MM,POSTERIOR,RIGHT,SETUP,SRT
HOWEVER,METASTATIC,MRI,MSD,PET,RFA,THERE
CHEST,PALLIATIVE,THERE
122,BACKGROUND,CONCLUSION,LABEL,METHODS,NON,NPV,NSCLC,RESULTS,THERE
169,945,946,COPYRIGHT,LTD
169,COPYRIGHT,DIFFUSE,IRELAND,LTD
121,169,344,353,388,BACKGROUND,CYTOLYT,CYTOPATHOL,GENOTYPING,HOWEVER,LABEL,LBC,METHODS,RED,RESULTS,SEVERAL,SOCIETY,SPRAY
169,BACKGROUND,CEA,CNPES,COPYRIGHT,CYFRA,CYRFA,LABEL,LAC,METHODS,PES,RESULTS,SOCIETY,THEIR
169,ALK,BACKGROUND,LABEL,METHODS,RESULTS,SOCIETY
215
041,CHEAPER,CUMULATIVE,LABEL,MAY,METHODS,OBJECTIVE,PEMETREXED,PURPOSE,RESULTS
116,147,AUSTRALIA,BOARD,CONSENTING,DDB,LABEL,MALIGNANT,METHODS,MPM,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THOSE
214,215,658,802,936,BACKGROUND,BMJ,DESPITE,GROUP,IHD,LABEL,LCD,LER,LIMITED,METHODS,MINNESOTA,PUBLISHED,PUBLISHING,RESULTS,SHS,THESE
100,177,BACKGROUND,LABEL,LCNEC,METHODS,PFS,RESULTS
040,169,203,930,963,974,JAPAN,LTD,MODEL,PTY,PUBLISHING,WILEY
169,174,CDT,COPYRIGHT,HOWEVER,INC,SVC,THROMBOSIS,UACDT,ULTRASOUND,WILEY
000,100,400,HIT,LABEL,LIT,METHODS,OBJECTIVE,QALYS,RESULTS,SEK,SEK26,SEK50,SWEDISH
001,007,CONCLUSION,FIFTEEN,LABEL,METHODS,NSCCL,NSCLC,OBJECTIVE,PCR,PURPOSE,RCR,RESULTS,REVERSE
124,516,625,III,LABEL,MATERIALS,METHODS,OBJECTIVE,RCC,RESULTS
143,ASIAN,BACKGROUND,CONCLUSION,EVE,EXE,GRADE,LABEL,METHODS,PBO,PFS,PRIMARY,QUALITY,RESULTS,SECONDARY,TREATMENT
169,COPYRIGHT,FURTHER,LTD
169,945,ACTIVATED,COPYRIGHT,HOWEVER,IRELAND,LTD,MITOGEN,NSCLC,PROTEIN
169,954,AKT,CNE,COPYRIGHT,CXCL8,CXCR2,EBV,FUNCTIONAL,FURTHER,HNE,HOWEVER,IRELAND,LTD,MACROPHAGE,MIF,NPC,TAKEN,THEREFORE
169,COPYRIGHT,IRELAND,LARGE,LTD
169,947,COPYRIGHT,HES,HEY,IRELAND,LTD,NOTABLY,NOTCH,PANCREATIC,PDA
169,BIO,COPYRIGHT,EFIRM,GFP
CHERNOBYL,CONFERENCE,LABEL,MAINE,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RUSSIAN,USA
169,302,ALK,COPYRIGHT,ERBB2,FGFR1,FGFR2,FGFR3,IGF1R,KIT,MET,NSCLC,OVERALL,PCR,THRESHOLDS
001,003,015,169,270,432,708,877,888,ALA,ALA499VAL,ASIAN,COPYRIGHT,DESPITE,GLN,LYS,LYS939GLN,MEDLINE,OVERALL,VAL,XPC
036,050,071,100,106,134,956,CONCLUSION,FDG,GLUCOSE,LABEL,METHODS,MMR,MRGLC,OBJECTIVE,PET,PURPOSE,RESULTS,SKM,TCP
100,200,256,ANOVA,CNR,COMPARISON,DUNNETT,FBP,GGO,SIMULATED,THERE,TUKEY
352,AGE,AUSTRALIA,BACKGROUND,DENMARK,HOWEVER,LABEL,METHODS,NET,RESULTS,ROUTINELY,SIMILAR,STAGE,THERE,TNM
150,151,COX,DEPRESSION,FORTY,FURTHER,LABEL,MDS,METHODS,NSCLC,OBJECTIVE,PATIENT,PHQ,RESULTS
183,CVD,DENMARK,ESTIMATES,HALVING,IHD,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING
169,219,230,CEA,COPYRIGHT,HAGAN,HOWEVER,IRELAND,LTD,MEDICAL,NAG,STEVENS,UNDER
001,121,160,169,233,254,259,312,424,545,COPYRIGHT,GROUP,INC,JAPAN,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
THESE
350,351,360,ADJ,CONCLUSION,EFFECTIVE,HOWEVER,LABEL,MED,METHODS,NSCLC,OBJECTIVE,ONCOL,PURPOSE,RESULTS,VARIABLES
000,029,235,281,632,774,950,AMONG,CHINA,FUDAN,HUASHAN,LABEL,LIVER,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
178,252,832,COX,CRT,HRS,INCREASED,INSTITUTE,SIR,THERE,UNIVERSITY,VILNIUS
BIOVU,DISCUSSION,FINALLY,FREQUENCY,ICD,LABEL,MATERIALS,METHODS,NINTH,OBJECTIVE,RESULTS,USING,VANDERBILT
008,27632,BEIGE,METASTATIC,MLC,ROCKI,SMALL,TREATMENT
189,349,397,956,AKT,ERK,LPA,PAK,RHO,RKI,ROCK1,ROCK2
169,COPYRIGHT,INC,MICRORNAS,PUBLISHED,SOCIETY
169,233,BACKGROUND,BCA,COPYRIGHT,INTUITIVE,LABEL,MEIER,METHODS,OBJECTIVE,OUTCOME,PARAMETERS,PUBLISHED,RESULTS,SETTING,SIX,THESE,THREE,URINARY,UROLOGY,USA,VINCI
169,BECAUSE,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,THREE,VIRTUAL
001,169,177,AIDED,BACKGROUND,CAT,COLLECTING,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
AOM,DSS,SRX,THESE
127,139,BACKGROUND,BETWEEN,C30,EORTC,GIVEN,HRQOL,LABEL,METHODS,NSCLC,OCTOBER,OVERALL,QLQ,QOL,RESULTS,TAXOL
400,AFTER,BORON,CAPTURE,INSTITUTE,KURRI,KYOTO,NEUTRON,REACTOR,SINCE,THERAPY,UNIVERSITY
113,BSC,FURTHER,HOWEVER,SEVERAL,THEREFORE,WHETHER
FINALLY,MRI,NSCLC,SURGERY
001,047,389,DESPITE,GROUP,JANUARY,LABEL,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,THERE
100,177,BETWEEN,FEW,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
017,169,AES,BACKGROUND,CONCLUSION,COPYRIGHT,FDA,FEDERAL,INC,LABEL,MAY,METHODS,ORR,OVERALL,PFS,PUBLISHED,RESULTS,TOPOTECAN,TREATMENT,TTR
048,127,AFRICAN,BACKGROUND,EFFECTS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
945,946,AKT,CL1,CONVERSELY,FURTHER,HOWEVER,JAGGED2,LEWIS,THESE
125,132,139,152,7TH,ACCORDING,AMONG,BACKGROUND,CRC,FURTHER,IVA,IVB,JANUARY,LABEL,METHODS,NPC,PC1,PERITONEAL,RESULTS,THERE,TNM
180,COMPARING,LABEL,METHODS,MST,OBJECTIVE,OBJECTIVES,RESULTS,SENSITIVE,SIXTY,TFI,THERE
ANOTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
011,CONCURRENT,FORTY,HOWEVER,INCLUSION,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
231,MDA,METASTASIS,MMP
232,BHD,DUB
123,160,184,967,BACKGROUND,COX,ESTIMATED,HOWEVER,LABEL,LAR,METHODS,OVERALL,RESULTS,THERE
100,169,CORRECT,ESOPHAGUS,INC,LOCAL,RFA,SOCIETY,THREE,WILEY
100,132,177,BAP,LABEL,MATERIALS,METHODS,OBJECTIVE,PAP,PURPOSE,RESULTS,TBP,THERE,TOTAL
001,173,ALTERED,BACKGROUND,CRMP1,CRMP2,CRMPS,LABEL,METHODS,REDUCED,RESULTS
169,COPYRIGHT,HOWEVER,LBS,TEM
100,111,169,BACKGROUND,BASED,CLUSTER,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EARLY,FUNCTIONAL,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
200,AUC,CAM,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,THERE
169,BACKGROUND,BECAUSE,COMPARING,COMPARISON,CONCLUSION,FOUNDATION,INCREASED,LABEL,LTD,METHODS,PUBLISHED,RESULTS,THEREFORE,THESE,WILEY
009,011,126,BASED,FUNCTIONAL,HCC,LOWER,PCR
152,177,378,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,TNM
160,197,BOARD,COMPARISON,CONCLUSION,FORMULA,IMAGE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIRIO,SISTEMA
BACKGROUND,CONCLUSION,EVIDENT,GPS,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PATIENT,REASONS,RESULTS,SIMILAR,SOLUTIONS,SUBTHEMES,THOSE,ZEALAND
193,365,966,AFTER,BACKGROUND,CONCLUSION,FOLLOWING,LABEL,MATERIALS,METHODS,RESULTS
FDG,PET
169,COPYRIGHT,DESPITE,FURTHER,ISSUE,NOVEL,REFINEMENT,SECRETOME,SPECIAL,UPDATED
169,COPYRIGHT,ISSUE,SECRETOME,SPECIAL,THEREFORE,UPDATED
009,169,AKT,BACKGROUND,COPYRIGHT,HCC,HOWEVER,LABEL,LIVER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SILENCING,SMALL
100,141,169,194,335,ACHAETE,COPYRIGHT,HOWEVER,INC,USING
169,AMONG,BECAUSE,COPYRIGHT,FURTHER,INC,LPA,MEDLINE,OCTOBER
LND,LNS,NSCLC,THERE,THESE
001,007,BOOTSTRAP,COX,FURTHER,INVENTORY,LABEL,MDASI,METHODS,OBJECTIVE,PATIENT,PRO,PURPOSE,RESULTS,SEVERAL,SHORT,SYMPTOM
169,177,181,AKT,COX,EPA,H1299,INC,TAKEN,WHILE,WILEY
001,104,178,215,948,CONCLUSION,CRC,CSS,CTX,FIFTY,FORTY,IQR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,SMR,SURGERY
169,CD138,COPYRIGHT,IRELAND,LTD,NSCLC
169,COPYRIGHT,F18,FDG,INC,PET
006,025,027,ACUTE,DVH,GRADE,III,NSCLC,PURPOSE,THERE,V35
AFTER,ALK,FDG,HOWEVER,ICE,INTERIM,KETTERING,NKTCL,NOS,PET,PFS,PTCLS,SLOAN,THERE
157,438,452,460,BACKGROUND,FERRARA,FINALLY,ITALY,LABEL,MATERIALS,MAY,METHODS,NSCLC,RESULTS,UNIVERSITY
946,956,CACO2,HEPG2,MTT,VIABILITY
114,121,169,361,369,BACKGROUND,COMPARISON,CYTOPATHOL,LABEL,LASER,METHODS,NSCLC,RESULTS,SOCIETY,SPECIMENS
DYSPNEA,PPS,UNDER
001,226,ACS,ATS,CONCLUSION,ERS,HOWEVER,IASLC,III,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE,TUMOURS
12L,AFTER,IIA,STAGE,T1A,T1B,TTF,WEDGE
PAPVC
SIX
001,006,019,027,046,266,277,486,521,AUSTRALIA,BACKGROUND,GEOMETRIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,TDI,THERE,THESE,WESTERN
969,BACKGROUND,CONCLUSION,CONTEXT,HOWEVER,LABEL,METHODS,NNN,NPS,OBJECTIVE,THERE,THESE,WESTERN
53BP1,947,ADF,ATM,CFL,COMET,CONCLUSION,DSB,FINALLY,H1299,HOWEVER,HRR,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,S3A,S3D
169,ARACHIDIN,ERCC1,H1975,LTD,METFORMIN,NSCLC,PUBLISHED,SOCIETY,WILEY
160,AFTER
EXPRESSION,PROPERTIES,SPC,TRANSWELL,TREATMENT,WESTERN
043,098,207,420,544,648,664,701,794,967,BACKGROUND,COX,CUGBP,EXPRESSION,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PCR,RESULTS,TNM
160,185,214,215,257,500,BACKGROUND,CISPLATIN,CONCLUSION,FIFTY,LABEL,MATERIALS,METHODS,NSCLC,RESULTS

003,113,146,160,600,CHT,CONCLUSION,HFX,III,LABEL,METHODS,MST,OBJECTIVE,PURPOSE,RESULTS
945,FURTHER,HOWEVER,SNP
000,105,156,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THEREFORE
056,230,ADC,BAC,COX,EPIDERMAL,III,KIRSTEN,L858R,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SURGERY
FORTY,HOWEVER,KARNOFSKY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PALLIATIVE,RESULTS
001,002,AFTER,DESPITE,GROUP,LABEL,LES,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
110,169,BAX,BCL,BKV,COPYRIGHT,JCV,MCPYV,NSCLC,PCR,RB1,RESULTS
160,BASED,CAREFUL,EIGHT,LABEL,METASTATIC,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS
100,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS
105,EARLY,EASTERN,GROUP,UPPER
169,253,656,COPYRIGHT,GENERAL,HOWEVER,OUTCOME,PREVIOUSLY,STRONGEST,THESE
005,139,144,160,170,270,353,ABDOMINAL,BACKGROUND,COMPETING,DSS,GRADE,HOWEVER,LABEL,METHODS,OVERALL,RESULTS
BACKGROUND,CAUSE,COX,CUMULATIVE,DISEASE,LABEL,LNM,MEDICAL,MEIER,METHODS,MORTALITY,OVERALL,RECURRENCE,RESULTS
001,002,107,160,169,198,836,843,887,898,926,973,AUC,BPE,CEA,COPYRIGHT,CYFRA,MICROARRAY,MPE,PCR
169,COPYRIGHT,IPF,LTD,MUTATIONS,PCR,PROTEIN,SURFACTANT
113,169,BACKGROUND,CNS,COPYRIGHT,COX,LABEL,LTD,MBC,MEIER,METHODS,RESULTS
169,COPYRIGHT,DEPARTMENT,IIA,IIB,LABEL,METHODS,OBJECTIVE,OCTUBRE,PSC,PUBLISHED,RESULTS,SEPAR,SEVEN,SPAIN,SURGERY,TEN
177,183,787,APRIL,MORTALITY,OCTOBER,THEIR,VITAL
THESE,USING
34A,947,COX,H1299,LYGDI,NSCLC,RESULTS,TAKEN
001,005,006,010,019,042,127,128,139,141,177,795,866,CTV,DMEAN,DVH,HOWEVER,THERE,V30,V40,V50
001,177,916,AUC,BETWEEN,CHANGES,DYNAMIC,FVC,LABEL,METHODS,MPM,NPV,OBJECTIVE,OBJECTIVES,PPV,RESULTS,ROC,STUDENT
001,004,005,008,015,040,062,118,136,170,194,236,245,273,288,297,344,379,460,478,487,518,542,585,743,783,793,801,810,853,862,919,975,INITIAL,LABEL,METHODS,NSCLC,OBJECTIVE,PRS,PRT,RESULTS
BACKGROUND,CRF,DESPITE,FIT,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,RESULTS,WII
169,THREE,UROLOGICAL
002,004,BOOTSTRAP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SOCIETY,STS,USING
005,174,177,228,249,AXIAL,BACKGROUND,CONCLUSION,CONSENSUS,LABEL,MATERIALS,MAXIMUM,METHODS,MIP,OBJECTIVE,OVERALL,RESULTS,THERE,THREE,USING
18F,AKT,AZD5363,DEOXY,FDG,GIVEN,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,U87
183,DSA,FOLLOWING,GEORG,LABEL,METHODS,OBJECTIVE,RESULTS,STUTTGART,VAT
183,GEORG,HOWEVER,STUTTGART,THERE
183,GEORG,STUTTGART,THERE
CTV,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,TYPICALLY
110,117,126,159,164,212,AFTER,BACKGROUND,DFI,FIFTY,JANUARY,LABEL,LYMPH,METHODS,MINIMALLY,RESULTS
000,400,ASSOCIATED,CARCINOMA,CURRENTLY,RANKL,TREATMENT,TREATMENTS
MMP,MVD,NSCLC,THEREFORE,USING,VEGFR
160,AGREEMENT,CAD,CHEST,LOW,MCNEMAR,ONGUARD,SIMILARLY
169,AE1,AE3,COPYRIGHT,CSF,GIVEN,INC,LMM,WILEY
AMERICANS,CANSASA,COMMERCIAL,INDIANS,NATIVES,THESE,USING,YET
169,AFTER,CD133,CELLS,CIC,COPYRIGHT,CXCR4,NOD,NOTABLY,PACIC,PANCREATIC
056,057,065,084,128,169,228,406,670,800,824,864,930,COPYRIGHT,HOWEVER,OVERALL,THERE
109,240,267,C15,C30,CONCLUSION,EORTC,LABEL,METHODS,OBJECTIVE,PAL,PALLIATIVE,QLQ,QOL,QUALITY,RESULTS,SPECIAL,THREE,TREATMENT,UNIVARIATE
109,120,130,177,207,366,406,437,475,518,580,599,677,861,960,ASYMMETRIC,COSTS,EASTERN,EIGHT,GROUP,ICU,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TMC
ALDH1,BACKGROUND,CONCLUSION,LABEL,METHODS,PNS,RESULTS,THERE
001,037,132,169,494,COPYRIGHT,CRP,KCO,LTD,PULMONARY,SIXTY
166,169,213,379,ADDITIONAL,COPYRIGHT,HOPKINS,INC,JOHNS,MUTATIONAL,SEVERAL,USING
LTDDS,THEREFORE
BACKGROUND,CONCLUSION,GTV,LABEL,METHODS,RESULTS
169,947,CD8,COPYRIGHT,ELISPOT,FOWLPOX,MALIGNANT,PCR
RIGHT
HENCE,NSCLC,PLP,PYRIDOXAL
148,160,759,944,BACKGROUND,BETWEEN,CRC,LABEL,METHODS,POTENTIAL,RESULTS
00001,100,160,169,461,BARRETT,COMPARING,COPYRIGHT,CYTOLOGIC,DESPITE,GASTRIC,INC,MUC,SURFACE,THESE
169,COPYRIGHT,IMPROVING,IRELAND,LTD,THESE
169,AKT,COPYRIGHT,DESPITE,FIRST,GIVEN,HOWEVER,INC,MUTATIONS,NSCLC,TKI
103,115,125,160,169,191,209,218,ACADEMY,AUTHORS,INTER,INTRA,JOURNAL,LABEL,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OVERALL,PET,PPV,RESULTS,VOLUMETRIC,WHOLE
ABOUT,CASES,EXPERTS,INTERVIEWS,LABEL,METHODS,OBJECTIVE,RESULTS
177,ANCHORS,BACKGROUND,FEV,IMPACTS,LABEL,LAM,METHODS,PLOTS,RESULTS,SIROLIMUS,USING,WHETHER
946,CHEST
SEVERAL,THERE,WNT
626,813,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POISSON,PREVENTIVE,RESULTS,SIR,SWEDISH,TOTAL
LEE,PROJECTING,SMOKING
169,CONCLUSION,COPYRIGHT,COUPLED,ERK,EXPRESSION,HEPATOLOGY,INCREASED,LABEL,LIVER,MAT2B,MEK,METHIONINE,PROTEIN,UNLABELLED,USING
116,117,202,AUC,EIGHT,LASSO,ROC
100,236,568,956,ERR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMR
006,177,BIA,FATIGUE,LABEL,METHODS,NUMERAL,OBJECTIVE,RESULTS,SCALE
118,161,169,309,613,CIS,COPYRIGHT,GIVEN,OPIUM,ORS,THERE
169,AKT,COPYRIGHT,EXOGENOUS,HGF,MET,SEVERAL,THESE,TKI,USING
042,183,607,723,748,905,954,ACCORDING,BACKGROUND,CONCLUSION,GEORG,JANUARY,LABEL,METHODS,OVERALL,PATHOLOGIC,PET,RESULTS,STUTTGART,THERE
12P40,169,946,947,B16,CD4,COPYRIGHT,CPG,IFN,ODN,STUDIES,TREATMENT
2DG,ACCORDING,ECTOPIC,GRP78,IHC,KNOCKDOWN,RRBP1,TAKEN,UNRAVELING,UPR
CPG,ECSOD,EXPRESSION,REPRESSION
FURTHER,THESE
945,AKT,HOWEVER,NEU,NEUNT,PROTEIN,PTP,PTPRA
200,28B,EMT,HMGA2,INHIBITION,KNOCK,LIN,MCF,OSM,STAT3,THESE
120,169,COPYRIGHT,CRC,FURTHER,HOWEVER,INC,TNM
169,241,COPYRIGHT,FDG,HODGKIN,NON
002,004,148,169,177,577,BASED,ESOPHAGUS,FIFTY,INC,OPTIMAL,SIXTY,SOCIETY,WILEY
169,AKT,COPYRIGHT,EPH,EPHA2,ERK,HEPATOLOGY,HOWEVER,LIVER,MEK,RAF,SRC,THESE
580,AMONG,BORTEZOMIB,LABEL,METHODS,NCI,OBJECTIVE,PURPOSE,RESULTS
INCREASING
300,AIM,ANOVA,ANTICANCER,BACKGROUND,FIFTY,GRADE,INDEX,LABEL,METHODS,PRIMARY,QUALITY,RESULTS,TOXICITIES,TREATMENT
ACUTE,APRIL,ASSESSMENT,CHRONIC,EASTERN,EVALUATION,FAILURE,GROUP,HOWEVER,ICU,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,ORGAN,PURPOSE,RESULTS,SAMSUNG,SCALE,SEQUENTIAL,THERE
067,ANXIETY,ASSESSMENT,DEPRESSION,ENGLISH,FORTY,FUNCTIONAL,HRQOL,INVENTORY,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,SHORT,SYMPTOM,TABLE,THERAPY,THEREFORE,WHILE
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,SMART,STROKELIKE
046,ABSORBABLE,CHEST,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGARDLESS,RESULTS
169,177,COPYRIGHT,DAH,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SCT,SIXTEEN
042,105,169,ADHERENCE,ASSESSMENT,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DCR,DISEASE,EFFECTIVE,INC,LABEL,METHODS,NSCLC,RESULTS,SCALE,VAS
001,002,010,120,169,170,290,373,832,BACKGROUND,COPYRIGHT,DESPITE,INC,LABEL,METHODS,NSCLC,PFS,RESULTS,SEOUL,TREATMENT,UNIVERSITY
007,015,203,259,429,BACKGROUND,HOWEVER,KLEBSIELLA,LABEL,LTD,METHODS,PRIOR,PUBLISHED,RESULTS,STATA
169,177,BACKGROUND,CONCLUSION,COPYRIGHT,GGO,HOWEVER,INC,LABEL,METHODS,PCH,RESULTS
197,AFTER,AGGRESSIVE,BOARD,CONCLUSION,DSS,DUE,ETE,KETTERING,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RAI,RESULTS,SLOAN,T4A,TEN
000CM,100NM,181,545,640,6MG,ACCORDING,BACKGROUND,CMD,FURTHER,HAZARDOUS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SUBSTANCES,THEREFORE
174,SUNITINIB
001,104,APRIL,INHALED,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS
ENGLISH,LITERATURE,PRIMARY,TREATMENT
196,203,211,298,509,945,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SERUM
343,683,700,846,HODGKIN,ISRAELI,NORTH,STUDIES
CUTANEOUS
177,BLAND,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THESE
120,630,AFTER,DCE,DYNAMIC,EVALUATION,KEY,LABEL,METABOLIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PET,RER,RER60,RESULTS,SOLID,USING
154,381,763,788,818,HOWEVER,LABEL,METHODS,NURSE,OBJECTIVE,PATIENT,PHYSICIAN,PHYSICIANS,PURPOSE,RESULTS,ZOL
AFRICAN,ARABIAN,ASIAN,BACKGROUND,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,METHODS,POLYMERASE,RESULTS,THERE,WORLDWIDE
105,108,149,152,170,190,196,412,608,AFTER,DISEASE,LABEL,METHODS,NCSLC,NSCLC,OBJECTIVE,OBJECTIVES,OPERATIVE,OVERALL,RESULTS,STAGE
109,206,443,AFTER,AMONG,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROCEEDING,PULMONARY,RESULTS,STAGE,WHETHER
169,AIM,APRIL,BETWEEN,CONCLUSION,DESPITE,HOSPITALS,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RECORDS,RESULTS,SEPTEMBER,TREATMENT,WILEY
10R,12L,12R,LABEL,LYMPH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SINCE,STAGE,THERE,THEREFORE
116,954,AKT,ANALOGS,HCT,LANTADENE,MCF,P50,PDB,THESE
100NM,169,48H,7DAYS,945,947,CNH,COPYRIGHT,HISTOLOGIC,HOWEVER,IFN,INC,LABEL,TNF,UNASSIGNED,UNLABELLED
001,006,024,098,169,226,234,451,560,898,BACKGROUND,COPYRIGHT,COX,FIFTY,FURTHER,III,INC,LABEL,METHODS,NSCLC,RESULTS,SCC,SIXTY
001,005,050,150,169,195,748,844,928,BACKGROUND,COPYRIGHT,FURTHER,INC,LABEL,MATERIALS,METHODS,MUTATIONS,NSCLC,RESULTS
100,200,ACA,BACKGROUND,BIOCARE,CALIFORNIA,CONCORD,CONTEXT,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SCC,SMCCS
AFTER,FDG,GROSS,GTV,III,LOCAL,NSCLC,NUMBERS,PET,PTV,SHRINKING
HYALURONAN,MES
740,783,BACKGROUND,ION,LABEL,LANGERHANS,MACHINE,METHODS,PANEL,PGM,PULMONARY,RESULTS,SEQUENCER,SMALL,V600E
DIAGNOSIS
PDT,SEPTEMBER
TOR,TREATMENT
169,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,PROCEDURES,RESULTS,TEN,THERE,THREE,WILEY
169,BECAUSE,COPYRIGHT,III,LTD,PFS,USING,WILEY
169,COPYRIGHT,HOWEVER,USING,VIRAL
169,INC,WILEY
169,BACKGROUND,BRAIN,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
CD79A,HHV,HIV,HODGKIN,HOWEVER,LNA,ORF73,PEL,PRIMARY,RITUXIMAB
169,232,945,946,APMIS,EPIDERMAL,GSK,LTD,NUCLEAR,PRESERVED,PUBLISHED,REDUCED,STROMAL,UNIVARIATE,WILEY
001,002,174,629,735,AFTER,FIFTY,METASTASIS,RCC
155,FNA,NSCLC,SOMATIC,THEREFORE
100,AMONG,BACKGROUND,DTP,LABEL,LIKELIHOOD,METHODS,PET,RESULTS,SIXTY,SUV
100,153,155,169,593,712,743,807,AUC,BACKGROUND,BCE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NTX,OSTEOMARK,PRINCETON,RESULTS,ROC,THERE
001,004,169,APRIL,BETWEEN,COPYRIGHT,GTV,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER
00001,009,169,CIS,COPYRIGHT,CROWN,DEPENDING,HRS,INC,JANUARY,MARCH,PFS,PUBLISHED
182,BETWEEN,COX,FIFTY,III,LABEL,MEIER,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
00132,525,ATP,AXL,HGF,I3O,KP4,LY2801653,MERTK,MET,MKN45,MKNK1,MST1R,TEK
441,DEMOCRATIC,DNT,HOWEVER,LABEL,LAENDER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR
BASED,NSCLC,THERE,TREATMENT
169,AKT,INC,INITIAL,MIGRATION,PI3KS,RAS
ADENOSINE,AMP,ATP,BECAUSE,FURTHER,METFORMIN,THESE,TORC2,VIRTUALLY
169,COPYRIGHT,FURTHER,INC
DRF,OPTIMAL,RESULTS,THESE
169,18F,241,COPYRIGHT,FDG,HOWEVER,PET,SEVERAL,THEREFORE
200,300,812,954,AFTER,BACKGROUND,CONTEXT,FOLLOWING,LABEL,METHODS,OBJECTIVE,RESULTS,SPECIMENS
100,181,AMONG,HT168
260,273,540,553,646,652,681,ABOUT,ASSESSMENT,GUIDELINES,LABEL,METHODS,OBJECTIVE,PROFILE,PURPOSE,RESULTS,SHEFFIELD,THOSE
215
VARIANT

022,160,455,BACKGROUND,DIAGNOSTIC,EHD,LABEL,METHODS,RESULTS,THEREFORE,USING
001,004,006,150,169,179,379,762,947,ADC,AMONG,COPYRIGHT,IGF,INC,INSULIN,SCC,THESE
233,BHD,DUB,GLN167X,HOWEVER
001,034,055,160,181,226,272,429,578,AUC,IGA,IGG,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,ROC,SINCE,WHITNEY
003,214,ANAEMIA,BACKGROUND,ESA,LABEL,MANAGEMENT,METHODS,RESULTS,SPAIN,SPANISH
160,243,ATS,BACKGROUND,ERS,HISTOLOGIC,HOWEVER,IASLC,INCIDENCE,LABEL,METHODS,NSCLC,PRECISE,RESULTS,SOCIETY
001,021,072,123,153,160,291,306,BETWEEN,HOWEVER,III,LABEL,LRR,METHODS,NEITHER,NSCLC,OBJECTIVE,OVERALL,PATHOLOGIC,PET,PURPOSE,RESULTS,USING
004,034,042,048,160,BACKGROUND,C30,DEPRESSION,EORTC,INTERVIEW,LABEL,METHODS,NSCLC,QLQ,RESULTS
THESE
BETWEEN,CHEST,CONCLUSION,FTCWR,GUARD,LABEL,METHODS,OBJECTIVE,PATCH,PLASTIC,RESULTS,SUCCESSFUL,SYNOVIS,USA
169,BACKGROUND,COPYRIGHT,COX,CRT,GIVEN,INC,LABEL,MEDICAL,MEIER,METHODS,NSCLC,OVERALL,PFS,RESULTS,UNIVERSITY
169,BACKGROUND,COPYRIGHT,EARLY,END,GROUP,INC,LABEL,METHODS,NSCLC,RESULTS,SINCE,STUDIES,THESE
MFH,PRIMARY,THERE
169,181,CNV,CONTINUOUS,FOXM1,INC,LOH,THESE,WILEY
169,AMONG,COPYRIGHT,DOCETAXEL,DTX,EMT,HOWEVER,INC,NSCLC,SPC,WILEY
001,169,COPYRIGHT,EMT,EPCAM,EPITHELIAL,INC,MPE,PCR,SNAIL,THEREFORE,TWIST,WILEY
HOWEVER,LATER,T10,THERE
BACKGROUND,CONCLUSION,FURTHER,LABEL,LCNEC,METHODS,RESULTS,SEPTEMBER,SMALL
177,CNR,THESE
946,HOWEVER,SEX,SOX,TCF,THESE,WNT
945,946,CONCURRENT,EMT,HIF,HYPOXIA,PRIMARY,RESPONSES,ROS,SRC
155,169,BIC,CLUSTER,GIVEN,MICRORNAS,MIR
169,BACKGROUND,BASED,BNI,COPYRIGHT,DAILY,EMBARKING,JANUARY,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,OVERALL,PSYCHINFO,PURPOSE,RESULTS,SEPTEMBER,SUPPORTIVE,THESE,THROUGH,YET
001,003,008,029,137,160,169,299,436,502,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SOLID,SURGERY
100,169,AIM,AML,CCMMT,CCSTS,COLLEGE,CONCLUSION,COPYRIGHT,DYNAMIC,HMB,JANUARY,KNOWLEDGE,LABEL,LAM,LTD,MARCH,MATERIALS,METHODS,MRI,OBJECTIVE,PECOMAS,PUBLISHED,RESULTS,ROYAL,THERE,THREE,TUMOURS
174,BIOGLUE,FDG,PET,SUBSEQUENT
001,027,039,177,COX,HISTOLOGY,III,LABEL,MEIER,METHODS,MORTALITY,MPM,OBJECTIVE,OBJECTIVES,RESULTS
202,824,CRP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TREATMENT,WBC
001,042,047,054,AXL,BACKGROUND,DOWNSTREAM,LABEL,METHODS,RESULTS,RTK
CUTANEOUS
100,119,127,135,163,169,172,270,COPYRIGHT,GROUP,INC,THERE,THESE,WILEY
169,980,CE6,COPYRIGHT,DOX,NIR,PDT,THREE,UCNPS,VCH,WILEY
006,012,017,036,051,105,169,916,ACCORDING,ADC,CHANGES,CONCLUSION,COPYRIGHT,FDG,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,SUV,WILEY
169,294,755,ASSESSMENT,CHI,CHINESE,CONCLUSION,COPYRIGHT,DEEKS,DIAGNOSTIC,DWI,ENGLISH,HOWEVER,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,QUALITY,RESULTS,ROC,SEN,SEPTEMBER,SPE,STUDIES,WILEY
APRIL,BACKGROUND,LABEL,MARCH,METHODS,NSCLC,RESULTS
424,945,946,CNS,EXPRESSION,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS
169,COPYRIGHT,TREATMENT,VIABILITY
001,003,004,007,009,022,113,HOWEVER,JEGHERS,PEUTZ,THEREFORE,USING
118,132,258,549,IHC,WESTERN
169,306,COPYRIGHT,CUP,HRS,LIMITED,MEIER,SWEDISH
015,033,1ST,263,AFTER,COX,LABEL,METHODS,NEITHER,NON,OBJECTIVE,OBJECTIVES,RESULTS
016,046,204,214,265,898,AMONG,BETWEEN,FDG,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEPTEMBER
FEDERAL,GIVEN
SINCE
100,169,956,ACTIVATING,BACKGROUND,COPYRIGHT,EXONS,LABEL,METHODS,NSCLC,RESULTS,SIXTY,SOCIETY
126,143,145,169,182,183,205,210,30A,30D,486,528,598,COPYRIGHT,HOWEVER,USING
004,035,183,929,BACKGROUND,BETWEEN,CONCLUSION,COX,GEORG,INSTITUTE,JIN,LABEL,MALIGNANT,MEDICAL,METHODS,NSCLC,OBJECTIVE,PROGNOSTIC,RESULTS,STAGE,STUTTGART,T1AN0M0,T1BN0M0,TNM,UNIVERSITY
160,GLY450VAL,PARK2,SER9THR
001,007,161,623,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PM1,PM2,PURPOSE,RESULTS
160,IMAGING,ORBITAL,TREATMENT
135,150,222,ASIATIC,BACKGROUND,CAUCASIAN,ERLOTINIB,III,ITALIAN,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS,TODAY
929,BACKGROUND,CANCORS,CRN,HMO,HOWEVER,III,LABEL,METHODS,NETWORK,OBJECTIVE,PPV,RESULTS,SECONDARY
169,174,200,200NM,215,320,320NM,COPYRIGHT,DOC,DOCETAXEL,INC,LABEL,PRINT,UNASSIGNED,UNLABELLED
169,956,CONCLUSION,FURTHER,GEP,LABEL,LTD,METHODS,MOLECULAR,NSCLC,OBJECTIVE,RESULTS,WILEY
001,115,169,APMIS,AUTOPHAGIC,BCL,BNIP3,LTD,NSCLC,PUBLISHED,STAGE,WILEY
001,002,036,090,452,6TH,7TH,BACKGROUND,CONCLUSION,COX,IASLC,IIA,IIB,KAROLINSKA,LABEL,METHODS,NSCLC,RESULTS,SWEDISH,T1A,T1B,TNM,UNIVERSITY
100,169,BRONCHIAL,COPYRIGHT,LTD,WILEY
CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,AMONG,COPYRIGHT,HCT,LNCAP,LTD,ROS,WILEY
00001,002,160,793,AIM,EGGER,GRADE,LABEL,MANAGER,METHODS,OBJECTIVE,RESULTS,RRS,SIX,STATA,STUDIES
MLN,NSCLC,TKI
183,BRONCHIAL,GEORG,STUTTGART
100,288,AFTER,THEREFORE
001,116,118,147,160,169,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EIGHT,GUIDELINES,HOUSTON,INC,IQR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SEPTEMBER
250,ADVERSE,ASSESSMENT,BACKGROUND,DISEASE,EVALUATION,FUNCTIONAL,LABEL,LOCAL,METHODS,NSCLC,RESULTS,SOLID,THERAPY,TREATMENT
AMONG,BRAIN,CCR,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,RESULTS,SEPTEMBER
177,183,BACKGROUND,DEPARTMENT,FACULTY,GEORG,III,LABEL,METHODS,PAMUKKALE,RESULTS,STUTTGART,SURGERY,UNIVERSITY
CSC,EMT,JAGGED1,THESE
USING
133,AFTER,LABEL,METHODS,OBJECTIVE,RESULTS,T24,WESTERN
AVILA,BMX,IRM,MERCK,TEC,THEREFORE,THESE
176,ADVERSE,AMONG,ELDERLY,GRADE,LABEL,METHODS,MLD,PREDICTORS,PTV,RESULTS,UNLABELLED
284,BACKGROUND,BLACK,CONTROL,HISPANICS,INTERVIEW,LABEL,LATINOS,METHODS,RESULTS,SUPPLEMENT,WHITE
012,042,043,100,169,177,BACKGROUND,CONCURRENT,COPYRIGHT,HOWEVER,INC,INOUE,LABEL,METHODS,RESULTS,WILEY
109,149,BOX,HMG,SIX,SOX10,SRY
003,017,450,962,END,HODGKIN,NHL,POISSON,PROGRAM,RESULTS,THERE
169,ADP,COPYRIGHT,LEWIS,LTD,THESE,WILEY
169,INC,WILEY
160,ENGLISH,INITIALLY
167,169,AMONG,CES,COPYRIGHT,DELAYED,DEPRESSION,DEPRESSIVE,FCS,GMM,IL1R2,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESILIENT,RESULTS,STUDIES,VARIATION,VARIATIONS,WHILE
CONCLUSION,COUPLED,ERK,HOWEVER,INNOVATION,LABEL,METHODS,NSCLC,OBJECTIVE,PRX,RESULTS,ROS,TAKEN,THESE,USING
106,169,ANZ,AUTHORS,BACKGROUND,COLLEGE,COLORECTAL,CONCLUSION,IQR,JOURNAL,LABEL,METHODS,PATIENT,RESULTS,ROYAL,SURGERY,THERE,WHITNEY,ZEALAND
BETWEEN,CONCLUSION,DFS,LABEL,LOBECTOMY,METHODS,MGC,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,SIX,TDT
169,AKT,C1Q,COPYRIGHT,CRP,DOWNSTREAM,HIF,LLC,PDT,PRESENT,SAP,SINCE,TREATMENT
169,COPYRIGHT,PUBLISHED,SAS
004,226,946,GYN,III,KEY,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,STAGE,SWB
166,COX,MBT
142,147,150,160,BACKGROUND,CAUSE,CLOSE,CONCLUSION,LABEL,METHODS,PATIENT,RESULTS
100,160,BACKGROUND,HCC,HOWEVER,ICG,LABEL,METHODS,RESULTS
400,500,800,B12,BACKGROUND,EIGHT,GRADE,LABEL,METHODS,MTD,PAZOPANIB,RESULTS,VEGFA
169,170,175,194,300,CONCLUSION,CREMOPHOR,LABEL,LTD,METHODS,NP220,NP300,OBJECTIVE,PACLITAXEL,PTY,PUBLISHING,RESULTS,WILEY
ALBERTA,BACKGROUND,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SECONDARY
169,4T1,945,COPYRIGHT,HIF,HYPOXIA,IRELAND,LTD,THEREFORE,TREATMENT
002,009,ANESTHESIA,ELDERLY,JANUARY,LABEL,LYMPH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,THERE
169,BACKGROUND,DCS,FIFTY,FRC,INC,INITIAL,IPFTS,LABEL,METHODS,OBJECTIVE,PEDIATR,RATIONALE,RESULTS,RVRTC,WILEY
108,169,522,COPYRIGHT,CYP24A1,CYP27A1,CYP27B1,HNC,SERUM,SPC,THESE,THREE,VDR
001,003,169,196,203,242,252,262,293,409,845,847,864,967,AIM,CHINESE,CONCLUSION,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,PTY,PUBLISHING,RESULTS,WILEY
148,169,289,389,AUSTRALIA,BOARD,CONCLUSION,IHC,INITIAL,LABEL,LTD,MARCH,METHODS,MPM,OBJECTIVE,PANEL,PTY,PUBLISHING,REFLECTING,RESULTS,ROYAL,TESTING,WILEY
169,BASED,CELLS,COPYRIGHT,HPF,INC,LCNEC,MITOTIC,NUCLEAR,PAPILLARY,PNETS,PULMONARY,WILEY
169,COPYRIGHT,HISTOLOGY,INC,PLEURAL,RIGHT,THESE,WILEY
001,169,242,AMONG,COVARIATES,FUHRMAN,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SOCIETY,UROLOGICAL
130,139,169,233,904,AML,BAL,CHEST,COPYRIGHT,INC,JANUARY,SEVEN,SIXTEEN,THERE,WILEY
169,COPYRIGHT,H1299,HOWEVER,THEREFORE,TREATMENT
AFTER,AMR,AMRUBICIN,CPT,SALVAGE,SMALL,SMCCE
169,954,ROS
001,004,005,114,160,164,169,BARRETT,CANCERS,COPYRIGHT,INC,JANUARY,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PATIENT,PUBLISHED,RESULTS,SEVEN,SEVENTY,SURGERY
001,006,183,774,946,ADOLESCENT,BLOOD,HEART,INCREASES,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,SETTING,UNASSIGNED,USA
169,ATPASES,AUTHORS,BECAUSE,JOURNAL,SERCA
169,237,241,COPYRIGHT,HISTOLOGY,NEUROCIRUG,PUBLISHED,SCLEROSING,SEF
001,ANOVA,BASED,C30,COX,DESPITE,FURTHER,III,MEIER,NSCLC,QUALITY,TREATMENT
160,200,CO2,UNDER,USING
169,AMONG,COPYRIGHT,HSV,NED,NOTABLY,THREE

000,001,100,349,613,BETWEEN,MEIER,TNM
001,027,160,169,AMONG,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,GLU_GLU,INC,INSTITUTE,LABEL,LYS_GLU,LYS_LYS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,T251A,THESE
123,177,205,ALTOGETHER,ATC,AUTOPSY,BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,RESULTS
169,549,BACKGROUND,CHECKLIST,COPYRIGHT,CPC,FATIGUE,LABEL,LTD,METHODS,PROBLEM,REFERRALS,RESULTS,ROUTINE,WILEY
BASED,FLOT2,FLOTILLIN,SHORT
001,006,014,120,CONCLUSION,LABEL,METHODS,OBJECTIVE,PSD,PURPOSE,RESULTS,SMALL
AIM,ALEXA,ARRPKLD,BASED,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SRXPXXX,THX
COX,GRADE,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS
007,012,017,038,LABEL,METHODS,OBJECTIVE,OVERDOSAGE,PRONE,PTV,PURPOSE,RESULTS,TEN
001,005,016,103,160,BACKGROUND,GRANT,III,LABEL,METHODS,NCI,NSCLC,OUTCOME,PHASE,PROGRAM,PROJECT,QOL,RESULTS,STAGE,THERE
EUS,IMAGING,PANCREATIC
169,241,COPYRIGHT,PUBLISHED,SEPAR
ERLOTINIB,NSCLC,TKI
005,654,AGE,BACKGROUND,CLINICO,CONCLUSION,FEW,LABEL,METHODS,NSCLC,RESULTS

100,150,400,600,800,BACKGROUND,ESCALATING,LABEL,METHODS,MTD,OVERALL,RESULTS,THESE
160,177,EOB,HDRBT,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX,TEN,THREE
169,ADIPOSE,AFT,CONVERSELY,COPYRIGHT,DIFFERENT,INC,THESE,TREATMENT,WILEY
003,169,407,499,ADDITIONAL,COPYRIGHT,LARGE,MENOPAUSAL
AIM,BACKGROUND,CONCLUSION,INTERVIEWS,LABEL,METHODS,MIXED,NON,OBJECTIVE,RESULTS,SETTING,SEVEN
113,ABCAM,ATM,BACKGROUND,BRCA1,CONCLUSION,DDR,DETECTION,DFS,III,LABEL,METHODS,MS110,NSCLC,PREVIOUSLY,RESULTS,S1524
403,624,FINALLY,GENOMIC,KNOCKDOWN,NMC,NUCLEAR,NUT,PCR,PER,SEQ,THESE
120,956,IRINOTECAN,THESE
028,036,110,160,187,363,AMONG,BACKGROUND,CONCLUSION,HLA,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,SEVENTY
CARLO,HOWEVER,MONTE,PROJECTION
160,CHEST
160,169,BACKGROUND,CONCLUSION,COPYRIGHT,CXCR4,EXPRESSION,INC,LABEL,MATERIALS,METHODS,RESULTS,TREATMENT
169,AIM,CONCLUSION,COPYRIGHT,III,LABEL,LTD,MANAGEMENT,METHODS,OBJECTIVE,RESULTS
001,002,023,620,774,AUC,COMMITTEE,COX,GROUP,JOINT,ROC,SMALL,TMN,TNM,UNIVARIATE,VALSG
117,451,BACKGROUND,FURTHER,IDENTIFIER,LABEL,METHODS,NSCLC,PULMONARY,RESULTS,SIXTY,THERE,TREATMENT,TRIAL
201,665,HISTOLOGY,INCREASED,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PET,RESULTS,SUV,UNIVERSITY
COX,HOWEVER,JANUARY,LABEL,LRC,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV,SUVPRIMARY
BAX,BCL,BECAUSE,CONSISTENT,FURTHER,H23,MCL,WESTERN
233,945,946,AMP,BHD,DUB,FNIP1,FNIP2,SINCE,TGF
4T1,562,945,946,DETROIT,ERK,NCI,SCREENING,TGF,VB6
231,549,COLON,MDA,MTT,NMR,SYNTHESIS
028,030,046,143,175,177,210,BACKGROUND,EVALUATION,GGO,HOUNSFIELD,LABEL,MATERIALS,METHODS,RESULTS,SOLID,TUMOURS
221,237,EGC,IIB,LABEL,LAG,METHODS,OBJECTIVE,RECURRENT,RESULTS,SIX,T1N3B,THERE

GENERALLY,HOWEVER,INC,OVERALL,PUBLISHED,RAPID,THYROID
118,250,472,64257,HODGKIN,HOWEVER,NHL,RELATIVELY,RISKS,SMN
005,008,210,ANALYSING,BRONCHIAL,CANDIDA,POTENTIAL
130,BVI,CEA,CLUSTERED,HOWEVER,ITC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,SUV
169,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,QOL,REGARDING,RESULTS,WILEY
233,AMP,BHD,DISCOVERY,DUB,FOLLICULIN,RAB35
185,ASSESSMENT,BACKGROUND,FUNCTIONAL,GODIN,HOWEVER,LABEL,LEISURE,METHODS,OBJECTIVE,QOL,RESULTS,TAIWANESE,THERAPY
954,AKT,ALTOGETHER,COX,DESPITE,DHA,MAG,THEREFORE
169,COPYRIGHT,FDG,IRELAND,LTD,MRI,PET,SINCE
169,ACCORDING,CISPLATIN,COPYRIGHT,DESPITE,LTD,TOPOTECAN
010,015,017,022,169,177,BACKGROUND,COPYRIGHT,DTP,FCM,FDG,FORTY,INC,LABEL,METHODS,PET,RESULTS,SEVENTY,SPF,SUV
000,956,AGS,AIM,BALTIMORE,BASED,BECAUSE,COMMITTEE,CONCLUSION,HAZARDOUS,LABEL,METHODS,OBJECTIVE,RESULTS,SUBSTANCES
999,ABOUT,ARIZONA,DVT,THERE
169,945,EKR,ERK,INC,OLEANDRIN,SIMILARLY,THESE,WHILE,WILEY
100,945,HDACI,JNJ,SMA,SMN,TAIWANESE
122,256,398,BETWEEN,CONCLUSION,LABEL,MAXIMUM,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THREE
169,COLITIS,COPYRIGHT,CROHN,PUBLISHED,TREATMENT
001,164,169,1ST,2ND,4TH,DFS,INC,NSCLC,WILEY
421,ARTHRITIS,FUNCTIONAL,LABEL,METHODS,NORFOLK,OBJECTIVE,OBJECTIVES,RESULTS,RLD
169,398,BECAUSE,FURIN,INC,INHIBITION,NCI,NCSLC,NSCLC,PCSK4,PCSK6,PCSKS,PTGS2,WILEY
160,4TH,5TH,6TH,AGGRESSIVE,PULMONARY,RIB,THERE
956,DOX,F68,KRTGQYKLC,PEG2000,SIMILAR,USING
007,139,AFTER,ANY,HOWEVER,NSCLC,SPLCS
CLINICALLY,ENGLISH
224,8G7G3,ADC,CK5,CK7,SPT24,SQC,THESE,UNTIL
169,954,COPYRIGHT,GSH,LINES,LTD,MDA,ROS,SOD,THESE,WILEY
100,215,297,AGGREGATE,AREAS,CAD,CONCLUSION,CXR,LABEL,MATERIALS,MEDICAL,METHODS,MIAMISBURG,OBJECTIVE,ONGUARD,PURPOSE,RESULTS,VERSION
169,ADDITIONAL,COPYRIGHT,EBI,EIS,HOWEVER,LTD,PUBLISHED,SUCCESS
169,257,AIM,CONCLUSION,HOWEVER,INEQUITIES,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,QUESTIONS,RESULTS,UNDER,WHILE,WILEY,ZEALAND

AKT,CHK,DOWNSTREAM,JNK,PI3,RESULTS,WORTMANNIN
100,160,BRESENHAM
ANOTHER,BACKGROUND,CONCLUSION,III,IVC,LABEL,METHODS,RESULTS
AFTER,BAMBERGER,HOA,MARIE,SECONDARY
946,947,BACKGROUND,CD3,CHI,LABEL,METHODS,OBJECTIVE,RESULTS,TAI,TC1,TC2,TH1,TH2,WHEREAS
BACKGROUND,BRITISH,INDEX,JANUARY,LABEL,MEDLINE,METHODS,NURSING,OBJECTIVE,PSYCHINFO,RESULTS,SCN,THEREFORE,WHEREAS
BACKGROUND,DISCUSSION,HRQOL,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
AXL,CUB,EPHA2,HGF,HOWEVER,MET,NSCLC,SIMILARLY,TARGETING,THEREFORE,TKI
AKT,DESPITE,GATEKEEPER,H1975,SILENCING,T790M,TKI,TREATMENT
160,169,BASED,COPYRIGHT,FIFTY,HELICAL,IEC,LTD,PUBLISHED,THESE
160,169,231,233,CD3,COPYRIGHT,EBV,EPSTEIN,HISTOLOGY,III,PUBLISHED,SAS,SEVERAL,SNFMI
150,164,BACKGROUND,BETWEEN,CONCLUSION,GRADE,HOWEVER,LABEL,MARCH,METHODS,MITOMYCIN,RESULTS,SEPTEMBER
160,169,194,BECAUSE,CELLS,COPYRIGHT,COX,DETECTION,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
128,147,169,215,2D3,88T,945,BECAUSE,COPYRIGHT,CYP24,EPIDERMAL,H1975,ISSUE,LTD,NSCLC,SPECIAL,THESE,VDR,VITAMIN
169,COPYRIGHT,EPIDERMAL,HOWEVER,III,LTD,NSCLC
001,009,044,296,448,L858R,MPE,PATIENT,THERE
160,169,177,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EXERTIONAL,FRAMEWORK,INC,INTERVIEWS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
ETOAC,LEISHMANIA,SIX,TARENNA,THEIR
000,100,160,250,342,448,BACKGROUND,CONCLUSION,DESPITE,GUIDELINES,LABEL,METHODS,OVERALL,RESULTS,USING
160,AUC,BACKGROUND,CONCLUSION,EASTERN,GROUP,IMPROVING,LABEL,METHODS,NSCLC,PHASE,RESULTS,SEQUENTIAL,SIXTEEN,THEREAFTER
IRELAND,LTD,PUBLISHED
169,BRONCHIAL,COPYRIGHT,FNA,FOCAL,INC,MEC,NEITHER,RAPID,THEREFORE,THESE,WILEY
ORIGINALLY
BACKGROUND,CEA,LABEL,METASTASES,METHODS,OBJECTIVE,OVERALL,PROGNOSTIC,RESULTS,SEVERAL,THEREFORE,UNIVARIATE
522,NEOPLASTIC
160,AMONG,FOCAL,SCLEROSING
004,009,235,AIM,BACKGROUND,CAREGIVERS,CLINICIAN,CLINICIANS,DYADS,GENERAL,LABEL,METHODS,MIXED,OBJECTIVE,RESULTS,SETTING,SUPPORT,THOSE,USING
AKT,BMS,CANCERS,FLT,G2M,IGF,NSCLC,PET
357,6PL,946,954,EMT,HENCE,SIMILAR,SMAD3,SMAD4,SNAIL,TAKEN,TGF
BACKGROUND,CONCLUSION,FDG,LABEL,LOUTH,METHODS,PET,RESULTS,SWEDISH,THERE,THESE,WORLDWIDE
ROBOTIC
100,169,200,956,BAX,COPYRIGHT,LTD,THESE,WILEY
006,CONCURRENT,EARLY
169,CARLO,COPYRIGHT,FDG,LABEL,LTD,MAXIMUM,METHODS,MONTE,NSCLC,OBJECTIVE,PET,PTV,PUBLISHED,PURPOSE,RESULTS,THEREFORE
169,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,SELDINGER,TIVAP,WILEY
FATAL,HOWEVER,SURGERY,THERE
ERK,FURTHER,MEK,NSCLC,SMALL
338,378,946,ACTIVATION,AKT,ALPHA,CT99021,DSGIS,ECH,GSK,KEAP1,KELCH,NAD,PKB,PRE,THESE
945,ANOTHER,BMDCS,HIF,SIMILARLY
30B,DESPITE,TAP63,TRAIL
CALIBAN,DROSOPHILA,FINALLY,HID,NSCLC
COUGH,NEBULIZED,PERSISTENT,STUDIES,SUCCESSFUL
000,120,163,278,BACKGROUND,HOWEVER,LABEL,LYS,METHODS,NHS,QALYS,RESULTS,SIMILARLY
458,461,956,BAVARIA,CONCLUSION,CURRENT,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS
CHURG,SEVERAL,STRAUSS
001,150,15Q25,394,CONFIRMING,CPG,DECITABINE,H1299,PA549,THESE
169,CAM,CAREGIVERS,COPYRIGHT,FORTY,LABEL,LTD,METHODS,OBJECTIVE,PRIMARY,RESULTS,SUPPORT,WILEY
169,443,519,547,CAREGIVERS,COPYRIGHT,INCREASED,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,TOP,UNMET,WILEY
169,COPYRIGHT,IRELAND,LTD,MIAPACA,NAS,THESE
169,AFTER,COPYRIGHT,INC,LABEL,OBJECTIVE,OBJECTIVES,RESULTS,THREE
H3G,M3G,OIH,OPIOIDS,POTENTIAL
000,018,019,160,169,215,468,572,COPYRIGHT,HODGKIN,LTD,PERIPHERAL,PUBLISHED,VII
012,028,029,169,HOWEVER,HOXB7,IHC,INC,INCREASED,LAC,SILENCING,WILEY
169,BACKGROUND,COPYRIGHT,INC,KAPOSIFORM,KHE,LABEL,METHODS,PACLITAXEL,RESULTS,WILEY
AMONG,CPG,HAND1,MOTIF,NEUROD1,OWING,SMALL,THESE
400,CHINA,CHINESE,EDUCATION,PATIENT,THOSE
169,BASCS,CD133,COPYRIGHT,EPITHELIAL,HYPOTHESIS,IRELAND,LTD,NOTCH,WNT
169,721,CONCLUSION,COX,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,WILEY
169,CONVERSELY,COPYRIGHT,DRAWING,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,WILEY
AKT,AXL,BCL,CURRENT,FAK,MER,NON,NSCLC,PROMISING,THESE
946,ARMADILLO,CATENIN,CHROMATIN,DIAP1,DROSOPHILA,ENDOCRINE,HDACS,JNK,NEOPLASIA,RET,RHO,SEQ,SIN3A,SRC,TCF,WNT
NOTABLY,THEREFORE
169,AMBIGUITY,ASSESSMENT,AVOIDANCE,BACKGROUND,COPYRIGHT,DEPRESSION,EMOTIONAL,EVENT,EYSENCK,FUNCTIONAL,GIVEN,HYPOTHESES,ILLNESS,LABEL,LTD,METHODS,NON,PERCEIVED,RESULTS,REVISED,SCALE,SHORT,STUDIES,THERAPY,WILEY
169,1ST,2ND,3RD,AUTHORS,CENTRAL,COPYRIGHT,ESOPHAGUS,INC,JOURNAL,OLV,SOCIETY,TLV,WILEY
CD3,CHL,EBV,EPSTEIN,HODGKIN,HOWEVER,ISH,LMP,LPD,PCR,STERNBERG
001,160,191,590,965,969,973,977,981,988,I00,I99,ICD,J00,J99,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,AFTER,SEGMENTAL
PREGABALIN,THERE
165,169,456,BACKGROUND,COPYRIGHT,GERMANY,LABEL,LTD,METHODS,RESULTS,WILEY
045,567,CONCLUSION,EIGHT,IPC,LABEL,METHODS,NSCLC,OBJECTIVE,PLC,PURPOSE,RESULTS,THREE
169,ABL,COPYRIGHT,DESPITE,DHA,EPA,HOWEVER,III,LTD,THESE
169,740,749,916,936,AIF,COMET,COPYRIGHT,ENVIRON,INC,ROS,TOXICOL,WILEY
204,325,AMERICANS,CASES,HEALTHY,MEXICAN,PRIOR,THESE
112,205,445,967,DESPITE,KRUSKAL,LABEL,METHODS,OBJECTIVE,RAE,RESIDENTS,RESULTS,SEPTEMBER,WHITNEY
100,169,COPYRIGHT,CRC,EPIDERMAL,INC,NSCLC,WILEY
100,600,800,DLT,FIBONACCI,MATUZUMAB,NSCLC,SIX,THERE
231,CDC42,CORTACTIN,ECM,EGF,MDA,METASTATIC,ORTHOTOPIC,SH3,SRC,TAKEN
BCL,CONSISTENT,HCC,MCL,SUBSEQUENT,THESE
169,COPYRIGHT,IRELAND,LTD,NNN,THEREFORE,USING
00002,001,1377A,169,200,ARG194ARG,ARG194TRP,FAS,INC,MDR,MULTI,NSCLC,PAT,WILEY,XPC,XRCC1
169,ANTIBODIES,BACKGROUND,BECAUSE,COPYRIGHT,COX,HOWEVER,INC,LABEL,METHODS,SECONDARY,TKTL1
089,169,386,826,956,AFTER,BMDL0,CAMBODIAN,COPYRIGHT,HOWEVER,KAMPONG,RESULTS,RIVER
169,COPYRIGHT,III,LTD
106,169,946,BRITAIN,COPYRIGHT,DACT2,EIGHT,GREAT,HOWEVER,IRELAND,LEF,LOH,LTD,MSP,PCR,PUBLISHED,SNP,SOCIETY,TCF,WILEY,WNT,XENOPUS
145,ASIAN,LABEL,MEDLINE,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,QOL,RESULTS,STUDIES
ADAPTOR,BACKGROUND,EXPRESSION,FURTHER,HOWEVER,KNOCKDOWN,LABEL,METHODS,RESULTS,TE2,TE5,TE9,THESE,WESTERN,XB130
169,ADDITIONAL,BACKGROUND,COLLEGE,CONCLUSION,CONTENT,COS,CVI,DENMARK,FOLLOWING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RASCH,RATIONALE,RESULTS,SCALE,SCIENCE,SCREENING,SWEDISH
BRAIN,RHO,THESE,USING
169,488,ALEXA,COPYRIGHT,EEEEPYFELV,IRELAND,LCC,LIPID,LTD,NPS
169,231,233,435,AKT,AUTHORS,HDAC2,HEPG2,LNM35,MB231,MCF,MDA
BTC,COX,GEM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFS,RECORDS,RESULTS
100,GRADE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS
100,FLORIDA,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIX,THREE,UNIVERSITY
ADVERSE,DLT,LABEL,METHODS,MTX,OBJECTIVE,OBJECTIVES,RESULTS,VLP
001,131,169,CRK,FURTHER,H1299,HBE,HOWEVER,INC,NSCLC,TNM,WILEY
407,600,647,APRIL,BACKGROUND,CONCLUSION,EVALUATION,JAPAN,LABEL,MAJOR,MARCH,METHODS,RESULTS,SORAFENIB,SPECIAL,THEREFORE
AFTER,CUSHING,EAS,LABEL,METHODS,OBJECTIVE,RESULTS,S10,SELECTIVE
18F,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SUV
001,128,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SCEPTICISM,SMOKING
132,172,219,BACKGROUND,C30,EORTC,HODGKIN,LABEL,METHODS,MYELOMA,NON,OBJECTIVE,QLQ,QUALITY,REGRESSION,RESULTS,SMALL,UTILITY,VALIDATION,YEARS
LCA,PROGNOSTIC
120,169,916,AFRICAN,AIS,BLACKWELL,HOWEVER,THESE
169,946,AMONG,BLOOD,COPYRIGHT,LTD,PCB,WILEY
045,160,667,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIR,SWEDISH
001,038,169,173,233,ARGONAUTE2,CHINESE,FINALLY,INC,NPC,PCR,RESULTS,TAKEN,THESE,USING,WILEY
101,169,177,182,BACKGROUND,BMI,CIGARETTE,COLORECTAL,COPYRIGHT,ESTIMATION,INC,LABEL,METHODS,OVARIAN,RESULTS,THESE,WILEY
AFTER,HOWEVER,PULMONARY,THESE
100,500,BETWEEN,FURTHER,LABEL,METHODS,OBJECTIVE,PFS,PLANNED,RESULTS
169,COPYRIGHT,HOWEVER,LTD,METABOLISM,NUTRITION,OVERALL,SOCIETY
148,193,CONVERSION,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS
169,300,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,RESULTS,ROBOTIC,WILEY
009,169,215,559,679,AFTER,CHINESE,HOWEVER,INC,TAKEN,VEGAS,WILEY
176,624,BACKGROUND,CONCLUSION,FACTORS,IVA,IVB,LABEL,METHODS,RESULTS,STAGE
125,954,BACKGROUND,COX,CSS,INCREASES,LABEL,MEIER,METHODS,NSCLC,PCR,RESULTS,RFS
CHINESE,COF,STUDIES,THERE
169,181,BAX,BCL,BLI,CCNA2,CCNE2,CISPLATIN,HOWEVER,INC,INCREASED,P53,WESTERN,WILEY
169,AUTHORS,BASAL,BCC,COLLEGE,JOURNAL,PULMONARY,THESE
100,AFTER,AMONG,BACKGROUND,BARRETT,BCC,BOWEN,CONCLUSION,COX,HRP,IHC,LABEL,METHODS,OBJECTIVE,RESULTS,SCC
C8ORF34,G3D,G4N,NSCLC,PLCB1
AIM,CONCLUSION,FOLLOWING,LABEL,METHODS,OBJECTIVE,RESULTS,SIX
169,COPYRIGHT,INC,REPORTS,SCLEROSING,WILEY
169,COPYRIGHT,EPITHELIAL,FNA,INC,SMA,STROMAL,TTF,WILEY
113,160,292,488,HOWEVER,INCIDENCE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SHIFT,SIR,SWEDISH,TESTICULAR
001,002,019,274,BACKGROUND,CAUSALITY,IVC,LABEL,METHODS,OVERALL,RESULTS,VTE
BACKGROUND,LABEL,METHODS,RESULTS,TRT
009,026,039,048,169,COPYRIGHT,DOSIMETRIC,FRAME,HOWEVER,ITV,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THREE
001,169,200,375,537,947,GAG,GCL,GSH,INC,PCR,SIMILARLY,THESE,WILEY
ANALYZING,EPCAM,FOS,HLA,OVERALL,SIMILAR
169,BRITISH,COPYRIGHT,LTD,PUBLISHED,SUSPICIOUS
522,EARLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,THEREFORE
001,006,100,200,384,919,AMONG,BANKS,STOMACH,THYROID
169,946,AKT,AMF,BAD,HEP3B,INC,MMP,PGI,SRC,STAT3,TGF,WILEY
BACKGROUND,BOWEL,CRT,FORTY,LABEL,MATERIALS,METHODS,NSABP,OTHER,PLANS,PREOP,PROJECT,RESULTS,THESE,THREE
177,FEV,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,VRI
001,AGGRESSIVE,EWING,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS
169,COPYRIGHT,IRELAND,LTD,MOLECULAR,THESE
100,169,COPYRIGHT,CSS,EIGHT,ESTIMATES,FORTY,IIA,IIB,IIC,INC,LABEL,MAJOR,MATERIALS,MCE,MEIER,METHODS,NOS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RFS,STAGE,TEN
112,200,400,ADM,BACKGROUND,BECAUSE,CBDCA,EIGHT,HOWEVER,JAPAN,LABEL,METHODS,RESULTS
800,ADVANTAGE,BACKGROUND,END,ENROLLEES,LABEL,MEDICAL,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SMALL,VDW,VIRTUAL,WAREHOUSE
001,100,132,215,275,510,551,945,946,BED,FACTORS,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
166,TMEM166,VARYING
AGING,AMSTERDAM,BACKGROUND,CONCLUSION,EQUATIONS,ESTIMATING,GEE,LABEL,METHODS,RESULTS,SRH,STUDIES,THERE,THEREFORE
169,956,BECAUSE,COPYRIGHT,GALAXOLIDE,INC,MOLECULAR,SINCE,SYNTHETIC,THESE,WILEY,WORLDWIDE
169,CONVERSELY,COPYRIGHT,DOX,FAS,INC,LEWIS,LLC,WILEY
111,169,306,BACKGROUND,BETWEEN,COPYRIGHT,FACTORS,GKS,INC,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,RESULTS,RPA,SIXTY,UNIVERSITY
000,009,019,126,290,964,BACKGROUND,CONCLUSION,FIRST,GUIDELINES,IIA,IIB,III,JAPAN,LABEL,METHODS,RESULTS,THESE,TMS
183,GEORG,STUTTGART
275,354,375,406,80203,89803,CALGB,CENTERS,CMS,COMPARING,FOLFIRI,GROUP,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
150,176,180,956,EIGHT,HOP,NCI,PDB,RESULTS
001,169,193,200,CHINESE,COPYRIGHT,H1299,IIA,INC,T2A,TANSHINONE,WILEY
169,177,AIM,BACKGROUND,COPYRIGHT,DESPITE,ENGLAND,FOLLOWING,INTERVIEWS,KEY,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SETTING
001,014,019,BACKGROUND,BRAIN,CEREBELLAR,FEW,LABEL,METHODS,RADIATION,RECORDS,RESULTS,THERE
181,FAS,FATTY,MCF,SINCE,THREE
CHINESE,HOWEVER,MALIGNANT,SWNTS,WATER,WESTERN
156,160,ANOTHER,BACKGROUND,HOWEVER,LABEL,MATERIALS,MBC,METHODS,RESULTS
107,115,169,ABOUT,BBX,COPYRIGHT,DIAGNOSTIC,INC,WILEY
946,BACKGROUND,CONCLUSION,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,TUBB3
169,945,AKT,CHINESE,COPYRIGHT,HIF,HYPOXIA,INC,MEANWHILE,THESE,WILEY
169,956,COPYRIGHT,ICP,INC,SEVERAL,WILEY
169,3CM,CONCLUSION,COPYRIGHT,JANUARY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERAM,THESE,TYPICAL
AKT,BECAUSE,CUZNSOD,G129E,G129R,GPX,NSCLC,PHOSPHATES,SOD,THEREFORE,THESE,WHILE
169,174,ASPIRATION,CEA,CK7,COPYRIGHT,IMAGING,INC,ROMANOWSKY,THESE,ULTRASOUND,WILEY
000,001,003,027,169,201,311,CHINESE,COPYRIGHT,COX,FURTHER,GTT,HAN,HAPLOVIEW,INC,LABEL,MATERIALS,METHODS,MYC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,STRUCTURAL,USING
251,AFTER,CHINESE,CONCLUSION,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,SINGAPORE,SMOKING
169,AE1,AE3,CK7,COPYRIGHT,FURTHER,INC,NESTS,PRIMARY,TTF,WILEY,WORLD
169,59E22,759B7,BAC,CEP,CONCLUSION,COPYRIGHT,D3S1560,D3S1766,D3S2406,D3S2454,FURTHER,III,INC,LABEL,LOH,MEC,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,PCR,RCC,RESULTS,ROH,VALIDATION,VHL
169,COPYRIGHT,EUS,FNA,HOWEVER,HURTHLE,INC,WILEY
169,AFTER,COPYRIGHT,PUBLISHED,SERAM
100,169,COMPANY,COPYRIGHT,DIAGNOSIS,EUS,FNA,INC,USING,WILEY
169,945,COMPANY,COMPARISON,COPYRIGHT,INC,PAH,POLYCYCLIC,THESE,WILEY
160,GCDFP
COX,HOWEVER,NON
RAYNAUD,TAKEN,THESE
